nsaids/anti-inflammatory	JJ	B-TREATMENT
classifier	NN	I-TREATMENT
/	NNP	O
vancomycin	NN	B-TREATMENT

mesenteric	JJ	B-TEST
angiograpm	NN	I-TEST
w/	NN	O
coil	NN	B-TREATMENT
embolization	NN	I-TREATMENT
of	IN	O
bleeding	VBG	B-PROBLEM
vessel	NN	I-PROBLEM
.	.	O

sigmoidoscopy	NN	B-TEST
.	.	O

colonoscopy	NN	B-TEST
.	.	O

hpi:	NN	O
pt	NN	O
is	VBZ	O
a	DT	O
71	CD	O
y/o	NN	O
male	NN	O
with	IN	O
h/o	JJ	O
dm2	NN	B-PROBLEM
,	,	O
cad	NN	B-PROBLEM
s/p	NN	O
cabg	NN	B-TREATMENT
,	,	O
dvt/pe	NN	B-PROBLEM
on	IN	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
anti-coagulation	NN	I-TREATMENT
,	,	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
on	IN	O
asacol	JJ	B-TREATMENT
presents	NNS	O
with	IN	O
brbpr	JJ	B-PROBLEM
starting	VBG	O
at	IN	O
9am	CD	O
of	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
.	.	O

he	PRP	O
'd	MD	O
been	VBN	O
having	VBG	O
lower	RBR	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
for	IN	O
approximately	RB	O
the	DT	O
past	JJ	O
week	NN	O
,	,	O
a	DT	B-PROBLEM
symptom	NN	I-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
's	VBZ	O
been	VBN	O
admitted	VBN	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

his	PRP$	O
pcp	NN	O
had	VBD	O
recently	RB	O
started	VBN	O
ciprofloxacin	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
uti	NN	I-PROBLEM
.	.	O

at	IN	O
9am	CD	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
he	PRP	O
passed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
,	,	I-PROBLEM
bloody	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
movement	NN	I-PROBLEM
and	CC	O
came	VBD	O
to	TO	O
the	DT	O
michael	NN	O
.	.	O
there	RB	O
,	,	O
his	PRP$	B-TEST
vitals	NNS	I-TEST
were	VBD	O
intially	RB	O
stable	JJ	O
with	IN	O
a	DT	B-TEST
hct	NN	I-TEST
of	IN	O
36.7	CD	O
,	,	O
though	IN	O
he	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
hypovolemic	JJ	B-PROBLEM
and	CC	O
this	DT	O
hemoconcentrated	VBN	B-PROBLEM
;	:	O
his	PRP$	B-TEST
previous	JJ	I-TEST
hct	NN	I-TEST
was	VBD	O
39	CD	O
about	IN	O
five	CD	O
months	NNS	O
ago	RB	O
.	.	O

he	PRP	O
refused	VBD	O
an	DT	B-TREATMENT
ng	JJ	I-TREATMENT
lavage	NN	I-TREATMENT
.	.	O

although	IN	O
an	DT	B-TEST
initial	JJ	I-TEST
dre	NN	I-TEST
showed	VBD	O
only	RB	O
clot	NN	B-PROBLEM
,	,	O
he	PRP	O
later	RB	O
passed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
,	,	I-PROBLEM
bloody	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
movement	NN	I-PROBLEM
,	,	O
and	CC	O
his	PRP$	B-TEST
bp	NN	I-TEST
nadired	VBD	O
to	TO	O
the	DT	O
low	JJ	O
90's	CD	O
but	CC	O
rested	VBD	O
there	EX	O
only	RB	O
transiently	RB	O
and	CC	O
easily	RB	O
rebounded	VBD	O
to	TO	O
the	DT	O
130's-140's	JJ	O
with	IN	O
fluid	NN	B-TREATMENT
;	:	O
he	PRP	O
then	RB	O
went	VBD	O
to	TO	O
angiography	VB	O
for	IN	O
a	DT	B-TEST
tagged	JJ	I-TEST
rbc	NN	I-TEST
scan	JJ	I-TEST
where	WRB	O
they	PRP	O
found	VBD	O
and	CC	O
embolized	VBD	O
two	CD	O
vessels	NNS	O
to	TO	O
the	DT	O
sigmoid	NN	O
colon	NN	O
.	.	O

his	PRP$	B-TEST
hct	NN	I-TEST
had	VBD	O
dropped	VBN	O
from	IN	O
36.7	CD	O
to	TO	O
30.8	CD	O
despite	IN	O
2u	CD	B-TREATMENT
prbc	NNS	I-TREATMENT
and	CC	O
3	CD	B-TREATMENT
u	JJ	I-TREATMENT
ffp	NN	I-TREATMENT
.	.	O

is	VBZ	O
called	VBN	O
out	IN	O
of	IN	O
the	DT	O
ficu	NN	O
as	IN	O
has	VBZ	O
been	VBN	O
been	VBN	O
hd	JJ	O
and	CC	O
stable	JJ	O
hct	NN	B-TEST
.	.	O

currently	RB	O
denies	VBZ	O
cp	NN	B-PROBLEM
,	,	O
sob	NN	B-PROBLEM
,	,	O
abd	JJ	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
continued	VBN	B-PROBLEM
brbpr	NN	I-PROBLEM
.	.	O

1.)	CD	O
dm-2	JJ	B-PROBLEM

2.)	CD	O
cad	JJ	B-PROBLEM
s/p	NN	O
3v-cabg	JJ	B-TREATMENT
2003	CD	O
and	CC	O
subsequent	JJ	O
stenting	NN	B-TREATMENT
of	IN	O
svg	NN	B-TREATMENT
and	CC	O
lima	NN	O

3.)	CD	O
chf	NN	B-PROBLEM
with	IN	O
ef	JJ	B-TEST
30-35%	JJ	O
on	IN	O
07-10	JJ	O
echo	NN	B-TEST

4.)	CD	O
right	JJ	B-PROBLEM
parietal	JJ	I-PROBLEM
intracranial	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
following	VBG	O
1996	CD	O
cardiac	JJ	B-TEST
cath	NN	I-TEST

5.)	CD	O
lbbb	NN	B-PROBLEM

6.)	CD	O
sinus	NN	B-PROBLEM
node	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
s/p	NN	O
pacemaker	NN	B-TREATMENT

7.)	CD	O
h/o	NN	O
dvt	NN	B-PROBLEM
(	(	O
right	RB	O
sided	VBN	O
)	)	O
and	CC	O
subsequent	JJ	O
pe	NN	B-PROBLEM
,	,	O
put	VBD	O
onto	IN	O
lifetime	NN	O
warfarin	NN	B-TREATMENT

8.)	CD	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM

1.)	CD	O
c4-7	JJ	B-TREATMENT
anterior	JJ	I-TREATMENT
discectomies	NNS	I-TREATMENT

2.)	CD	O
cabg	NN	B-TREATMENT
2003	CD	O

3.)	CD	O
r	JJ	B-TREATMENT
intracerebral	JJ	I-TREATMENT
hemorrhage	NN	I-TREATMENT
drainage	NN	I-TREATMENT

sochx	NN	O
:	:	O
mr	NN	O
peres	VBZ	O
generally	RB	O
lives	VBZ	O
with	IN	O
his	PRP$	O
wife	NN	O
but	CC	O
has	VBZ	O
spent	VBN	O
a	DT	O
great	JJ	O
deal	NN	O
of	IN	O
time	NN	O
recently	RB	O
at	IN	O
rehab	NN	B-TREATMENT
.	.	O

vs	NN	B-TEST
98.4	CD	O
,	,	O
62	CD	O
,	,	O
103/37	CD	O
,	,	O
15	CD	O
97%2l	CD	O

gen	NN	O
-	:	O
lying	NN	O
in	IN	O
bed	NN	O
,	,	O
nad	NN	B-PROBLEM

heent	NN	O
-	:	O
anicteric	JJ	B-PROBLEM
sclera	NN	I-PROBLEM
,	,	O
op	JJ	O
clear	JJ	O
with	IN	O
mmm	NN	O

neck	SYM	O
-	:	O
jvd	NN	B-PROBLEM
flat	JJ	O

cv	SYM	O
-	:	O
rrr	NN	O
,	,	O
s1s2	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

pul	SYM	O
-	:	O
ctab	NN	O
without	IN	O
rales	NNS	B-PROBLEM

abd	SYM	O
-	:	O
soft	JJ	O
,	,	O
minimally	RB	B-PROBLEM
distended	VBN	I-PROBLEM
,	,	O
nt	RB	B-PROBLEM
,	,	O
no	DT	O
rebound/guarding	NN	B-PROBLEM
,	,	O
nabs	NN	O

extrm	SYM	O
-	:	O
trace	NN	B-PROBLEM
edema	NN	I-PROBLEM
at	IN	I-PROBLEM
ankles	NNS	I-PROBLEM
,	,	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
warm/dry	NN	O

color	NN	B-TEST
-	:	O
straw	NN	O
appear	VBP	B-TEST
-	:	O
clear	JJ	O
sp	NN	O
marquez	SYM	O
-	:	O
1.021	CD	O

blood	NN	O
-	:	O
lg	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O

glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
7.0	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

rbc-21-50*	JJ	B-TEST
wbc-0-2	JJ	B-TEST
bacteria	NNS	B-TEST
-	:	O
few	JJ	O

yeast	SYM	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
<1	NN	O

lactate	NN	B-TEST
-	:	O
1.8	CD	O

glucose	JJ	B-TEST
-	:	O
197*	CD	O
urea	JJ	B-TEST
n-25*	JJ	I-TEST
creat	NN	B-TEST
-	:	O
0.8	CD	O
sodium	NN	B-TEST
-	:	O
141	CD	O

potassium	NN	B-TEST
-	:	O
3.7	CD	O
chloride	NN	B-TEST
-	:	O
105	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
22	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
18	CD	O

wbc	SYM	B-TEST
-	:	O
5.6	CD	O
rbc	NN	B-TEST
-	:	O
4.35*	CD	O
hgb	NN	B-TEST
-	:	O
12.6*	CD	O
hct	NN	B-TEST
-	:	O
36.7*	CD	O
mcv	SYM	B-TEST
-	:	O
84	CD	O

mch	SYM	B-TEST
-	:	O
28.9	CD	O
mchc	SYM	B-TEST
-	:	O
34.3	CD	O
rdw	NN	B-TEST
-	:	O
15.7*	CD	O

neuts	NNS	B-TEST
-	:	O
80.5*	CD	O
lymphs	SYM	B-TEST
-	:	O
13.1*	CD	O
monos	NNS	B-TEST
-	:	O
3.5	CD	O
eos	SYM	B-TEST
-	:	O
2.5	CD	O

basos	SYM	B-TEST
-	:	O
0.4	CD	O

poikilocy	SYM	B-TEST
-	:	O
1+	CD	O
microcyt	SYM	B-TEST
-	:	O
1+	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
102*	CD	O

pt	SYM	B-TEST
-	:	O
20.5*	CD	O
ptt	NN	B-TEST
-	:	O
29.4	CD	O
inr(pt)	JJ	B-TEST
-	:	O
3.0	CD	O

gi	NN	B-TEST
bleeding	NN	I-TEST
study	NN	I-TEST

impression	NN	O
:	:	O
increased	JJ	B-PROBLEM
tracer	NN	I-PROBLEM
activity	NN	I-PROBLEM
demonstrated	VBD	O
within	IN	O
the	DT	O
left	NN	O
lower	RBR	O
quadrant	NN	O
,	,	O
most	RBS	O
likely	JJ	O
sigmoid	NN	O
colonic	JJ	O
loops	NNS	O
of	IN	O
bowel	NN	O
,	,	O
consistent	JJ	O
with	IN	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
abdomen	NNS	I-TEST
w/contrast	VBP	I-TEST

1.	CD	O
no	DT	O
evidence	NN	O
of	IN	O
colitis	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
pathology	NN	I-PROBLEM
present	NN	O
to	TO	O
explain	VB	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
bright	JJ	I-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

2.	CD	O
stable	JJ	O
appearance	NN	O
of	IN	O
left	JJ	B-PROBLEM
adrenal	JJ	I-PROBLEM
fat-containing	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
myelolipoma	NN	I-PROBLEM
.	.	O

3.	CD	O
stable	JJ	O
appearance	NN	O
of	IN	O
hypodense	NN	B-PROBLEM
lesion	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
caudate	NN	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	O
the	DT	O
liver	NN	O
,	,	O
too	RB	O
small	JJ	O
to	TO	O
fully	RB	O
characterize	VB	O
.	.	O

4.	CD	O
subcentimeter	JJ	B-PROBLEM
attenuation	NN	I-PROBLEM
lesion	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
pole	NN	I-PROBLEM
of	IN	O
the	DT	O
right	JJ	O
kidney	NN	O
,	,	O
too	RB	O
small	JJ	O
to	TO	O
characterize	VB	O
.	.	O

5.	CD	O
3-mm	JJ	B-PROBLEM
noncalcified	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

if	IN	O
the	DT	O
patient	NN	O
does	VBZ	O
not	RB	O
have	VB	O
a	DT	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
primary	JJ	I-PROBLEM
malignancy	NN	I-PROBLEM
,	,	O
followup	JJ	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
in	IN	O
1	CD	O
year	NN	O
is	VBZ	O
recommended	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
stability	NN	O
of	IN	O
this	DT	O
finding	NN	O
.	.	O

71	CD	O
y/o	NNS	O
male	JJ	O
with	IN	O
dm2	NN	B-PROBLEM
,	,	O
cad	NN	B-PROBLEM
,	,	O
chf	NN	B-PROBLEM
,	,	O
uc	JJ	B-PROBLEM
presents	NNS	O
with	IN	O
one	CD	O
week	NN	O
of	IN	O
lower	JJR	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
2	CD	O
episodes	NNS	O
of	IN	O
brpbr	NN	B-PROBLEM
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

#	#	O
brbpr	NN	B-PROBLEM
--	:	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
given	VBN	O
his	PRP$	B-PROBLEM
lower	JJR	I-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
angiography	NN	I-TEST
showed	VBD	O
bleeding	VBG	B-PROBLEM
in	IN	I-PROBLEM
two	CD	I-PROBLEM
vessels	NNS	I-PROBLEM
off	IN	O
of	IN	O
the	DT	O
minnie	NN	O
supplying	VBG	O
the	DT	O
sigmoid	NN	O
that	WDT	O
were	VBD	O
succesfully	RB	O
embolized	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transfused	VBN	O
from	IN	O
a	DT	B-TEST
hct	NN	I-TEST
29	CD	O
to	TO	O
34	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
during	IN	O
his	PRP$	O
stay	NN	O
given	VBN	O
his	PRP$	B-PROBLEM
acute	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
but	CC	O
restarted	VBN	O
per	IN	O
his	PRP$	O
pcp	NN	O
with	IN	O
the	DT	O
guidance	NN	O
of	IN	O
gi	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

-	:	O
the	DT	O
patient	JJ	O
underwent	NN	O
a	DT	B-TEST
flex	JJ	I-TEST
sigmoidoscopy	NN	I-TEST
on	IN	O
friday	NN	O
,	,	O
11-02	JJ	O
,	,	O
which	WDT	O
showed	VBD	O
old	JJ	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
rectal	JJ	I-PROBLEM
vault	NN	I-PROBLEM
but	CC	O
no	DT	O
active	JJ	B-PROBLEM
source	NN	I-PROBLEM
of	IN	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

given	VBN	O
this	DT	O
,	,	O
it	PRP	O
was	VBD	O
advised	VBN	O
that	IN	O
the	DT	O
patient	NN	O
have	VBP	O
a	DT	B-TEST
colonoscopy	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
further	RB	O
bleeding	NN	B-PROBLEM
.	.	O

-	:	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
colonoscopy	NN	I-TEST
on	IN	O
monday	JJ	O
11-05	JJ	O
but	CC	O
unfortunately	RB	O
,	,	O
was	VBD	O
unable	JJ	O
to	TO	O
complete	VB	O
the	DT	O
study	NN	O
as	IN	O
his	PRP$	O
bowel	NN	O

therefore	RB	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
colonoscopy	NN	I-TEST
on	IN	O
11-06	JJ	O
which	WDT	O
showed	VBD	O
expected	VBN	O
mucosal	JJ	B-PROBLEM
signs	NNS	I-PROBLEM
of	IN	O
moderate	JJ	B-PROBLEM
ulcerative	JJ	I-PROBLEM
colitis	NN	I-PROBLEM
,	,	O
no	DT	O
polyps	NNS	B-PROBLEM
,	,	O
w/	VBD	O
8	CD	B-PROBLEM
mm	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
at	IN	I-PROBLEM
junction	NN	I-PROBLEM
of	IN	I-PROBLEM
distal	JJ	I-PROBLEM
descending	NN	I-PROBLEM
colon	NN	I-PROBLEM
and	CC	I-PROBLEM
sigmoid	JJ	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

-	:	O
biopsies	NNS	B-TEST
were	VBD	O
obtained	VBN	O
during	IN	O
his	PRP$	B-TEST
colonoscopy	NN	I-TEST
and	CC	O
he	PRP	O
should	MD	O
follow	VB	O
up	RP	O
with	IN	O
gastroenterology	NN	O
for	IN	O
the	DT	O
results	NNS	O
.	.	O

#	#	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
--	:	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
asacol	NN	I-TREATMENT
was	VBD	O
originally	RB	O
held	VBN	O
but	CC	O
restarted	VBN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
per	IN	O
gi	NN	O
.	.	O

#	#	O
cad/chf	SYM	B-PROBLEM
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
prior	RB	O
to	TO	O
discharge	VB	O
as	IN	O
it	PRP	O
was	VBD	O
held	VBN	O
temporarily	RB	O
given	VBN	O
his	PRP$	B-PROBLEM
acute	NN	I-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

the	DT	O
exception	NN	O
is	VBZ	O
that	IN	O
per	IN	O
his	PRP$	O
pcp	NN	O
,	,	O
jason	NN	O
aspirin	NN	B-TREATMENT
will	MD	O
be	VB	O
held	VBN	O
for	IN	O
2	CD	O
weeks	NNS	O
given	VBN	O
that	IN	O
he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
with	IN	O

his	PRP$	B-PROBLEM
risk	NN	I-PROBLEM
of	IN	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

#	#	O
dm-2	NN	B-PROBLEM
--	:	O
the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
insulin	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

#	#	O
h/o	NN	O
dvt/pe	NN	B-PROBLEM
:	:	O

coumadin	NN	B-TREATMENT
was	VBD	O
initially	RB	O
held	VBN	O
.	.	O

it	PRP	O
was	VBD	O
unclear	JJ	O
at	IN	O
first	RB	O
as	IN	O
to	TO	O
why	WRB	O
the	DT	O
patient	NN	O
required	VBN	O
life-long	JJ	B-TREATMENT
anticoagulation	NN	I-TREATMENT
.	.	O

after	IN	O
discussing	VBG	O
this	DT	O
with	IN	O
his	PRP$	O
pcp	NN	O
,	,	O
leon	NN	O
was	VBD	O
clear	JJ	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
had	VBN	O
recurrent	VBN	B-PROBLEM
dvts	NNS	I-PROBLEM
and	CC	O
ultimately	RB	O
a	DT	B-PROBLEM
pe	NN	I-PROBLEM
and	CC	O
his	PRP$	O
pcp	NN	O
felt	VBD	O
strongly	RB	O
that	IN	O
he	PRP	O
required	VBD	O
long-term	JJ	B-TREATMENT
anticoagulation	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
goal	NN	I-TEST
inr	NN	I-TEST
should	MD	O
be	VB	O
1.6-2.0	JJ	O
.	.	O
if	IN	O
bleeding	VBG	B-PROBLEM
continues	VBZ	O
to	TO	O
occur	VB	O
,	,	O
consider	VB	O
v.	JJ	B-TREATMENT
winchester	NN	I-TREATMENT
filter	NN	I-TREATMENT
.	.	O

#	#	O
access	NN	O
--	:	O
2	CD	B-TREATMENT
large	JJ	I-TREATMENT
bore	NN	I-TREATMENT
piv's	NN	I-TREATMENT

1.)	CD	O
spironolactone/hctz	JJ	B-TREATMENT
25/25	CD	O
daily	JJ	O

2.)	CD	O
atenolol	JJ	B-TREATMENT
12.5mg	CD	O
daily	JJ	O

3.)	CD	O
insulin	NN	B-TREATMENT
45n/8r	CD	O
qam	NN	O
and	CC	O
33n	CD	O
qpm	NN	O

4.)	CD	O
furosemide	JJ	B-TREATMENT
10	CD	O
mg	NN	O
every	DT	O
other	JJ	O
day	NN	O

5.)	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NNS	O
daily	RB	O

6.)	CD	O
zoloft	JJ	B-TREATMENT
40	CD	O
mg	NN	O
qam	NN	O

7.)	CD	O
flomax	NN	B-TREATMENT

8.)	CD	O
atorvastatin	JJ	B-TREATMENT
40	CD	O
mg	NNS	O
daily	RB	O

9.)	CD	O
ritalin	NN	B-TREATMENT
20	CD	O
mg	JJ	O
daily	JJ	O

10.)	CD	O
ramipril	NN	B-TREATMENT
2.5	CD	O
mg	JJ	O
daily	JJ	O

11.)	CD	O
asacol	JJ	B-TREATMENT
400	CD	O
mg	NN	O
3	CD	O
,	,	O
tid	NN	O

12.)	CD	O
carafate	NN	B-TREATMENT
1	CD	O
gm	NN	O
bid	NN	O

13.)	CD	O
actos	NNS	B-TREATMENT
15	CD	O
mg	NNS	O
daily	RB	O

14.)	CD	O
folate	JJ	B-TREATMENT
1	CD	O
mg	NNS	O
daily	RB	O

15.)	CD	O
warfarin	JJ	B-TREATMENT
2	CD	O
mg	NNS	O
daily	RB	O

1.	CD	O
tamsulosin	NN	B-TREATMENT
0.4	CD	O
mg	NN	O
capsule	NN	O
,	,	O
sust	NN	O
.	.	O
release	VB	O
24hr	CD	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sust	NN	O
.	.	O
release	VB	O
24hr	CD	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

2.	CD	O
atorvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
methylphenidate	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

5.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
spironolactone	NN	B-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

8.	CD	O
ramipril	NN	B-TREATMENT
1.25	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

9.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

10.	CD	O
pioglitazone	NN	B-TREATMENT
15	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
dm	NN	B-PROBLEM
.	.	O

11.	CD	O
mesalamine	NN	B-TREATMENT
400	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
w/o	NN	O
recent	JJ	O
severe	JJ	B-PROBLEM
flares	NNS	I-PROBLEM
.	.	O

12.	CD	O
insulin	NN	B-TREATMENT
45	CD	O
nph	NN	B-TREATMENT
in	IN	O
am	VBP	O
with	IN	O
33	CD	O
nph	NNS	B-TREATMENT
at	IN	O
bedtime	NN	O

continue	NN	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

13.	CD	O
sertraline	JJ	B-TREATMENT
20	CD	O
mg/ml	NN	O
concentrate	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
po	NN	O
at	IN	O
bedtime	NN	O
.	.	O

14.	CD	O
coumadin	NN	B-TREATMENT
2	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
from	IN	I-PROBLEM
inferior	JJ	I-PROBLEM
mesenteric	JJ	I-PROBLEM
artery	NN	I-PROBLEM
tributaries	NNS	I-PROBLEM
supplying	VBG	O
sigmoid	JJ	O
colon	NN	O
.	.	O

please	VB	O
call	VB	O
physician	JJ	O
if	IN	O
you	PRP	O
develop	VBP	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
in	IN	I-PROBLEM
your	PRP$	I-PROBLEM
legs	NNS	I-PROBLEM
or	CC	I-PROBLEM
arms	NNS	I-PROBLEM
,	,	O
sudden	JJ	B-PROBLEM
blurry	NN	I-PROBLEM
vision	NN	I-PROBLEM
or	CC	O
slurred	VBN	B-PROBLEM
speech	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
faintness	NN	B-PROBLEM
,	,	O
or	CC	O
significant	JJ	B-PROBLEM
unexplained	JJ	I-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
28-year-old	JJ	O
woman	NN	O
who	WP	O
is	VBZ	O
hiv	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
for	IN	O
two	CD	O
years	NNS	O
.	.	O

she	PRP	O
presented	VBD	O
with	IN	O
left	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
which	WDT	O
is	VBZ	O
a	DT	B-PROBLEM
long-standing	JJ	I-PROBLEM
complaint	NN	I-PROBLEM
.	.	O

she	PRP	O
claims	VBZ	O
she	PRP	O
does	VBZ	O
not	RB	O
know	VB	O
why	WRB	O
she	PRP	O
is	VBZ	O
hiv	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
from	IN	O
maryland	NN	O
,	,	O
apparently	RB	O
had	VBD	O
no	DT	O
blood	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
before	IN	O
the	DT	O
birth	NN	O
of	IN	O
her	PRP$	O
children	NNS	O
so	IN	O
it	PRP	O
is	VBZ	O
presumed	VBN	O
heterosexual	JJ	B-PROBLEM
transmission	NN	I-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
also	RB	O
had	VBD	O
cat	VBN	B-PROBLEM
scratch	NN	I-PROBLEM
fever	NN	I-PROBLEM
and	CC	O
she	PRP	O
had	VBD	O
resection	NN	B-TREATMENT
of	IN	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
used	VBN	O
any	DT	B-TREATMENT
anti	JJ	I-TREATMENT
retroviral	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
since	IN	O
then	RB	O
,	,	O
because	IN	O
of	IN	O
pancytopenia	NN	B-PROBLEM
and	CC	O
vomiting	VBG	B-PROBLEM
on	IN	O
ddi	NN	B-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
complaints	NNS	O
of	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
left	VBN	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
and	CC	O
off	IN	O
getting	VBG	O
progressively	RB	O
worse	JJR	O
over	IN	O
the	DT	O
past	JJ	O
month	NN	O
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
similar	JJ	B-PROBLEM
pain	NN	I-PROBLEM
intermittently	RB	O
for	IN	O
last	JJ	O
year	NN	O
.	.	O

she	PRP	O
described	VBD	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
a	DT	B-PROBLEM
burning	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
positional	JJ	O
,	,	O
worse	JJR	O
when	WRB	O
she	PRP	O
walks	VBD	O
or	CC	O
does	VBZ	O
any	DT	O
type	NN	O
of	IN	O
exercise	NN	O
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
relief	NN	O
from	IN	O
antacids	NNS	B-TREATMENT
or	CC	O
h2	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
.	.	O

in	IN	O
10/92	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
which	WDT	O
showed	VBD	O
fatty	JJ	B-PROBLEM
infiltration	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
liver	NN	I-PROBLEM
diffusely	RB	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
cyst	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
pancreas	NN	O
at	IN	O
that	DT	O
time	NN	O
,	,	O
however	RB	O
,	,	O
hyperdense	JJ	B-PROBLEM
kidneys	NNS	I-PROBLEM
.	.	O

her	PRP$	B-TEST
alkaline	JJ	I-TEST
phosphatase	NN	I-TEST
was	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
but	CC	O
otherwise	RB	O
relatively	RB	O
normal	JJ	O
.	.	O

her	PRP$	B-TEST
amylase	NN	I-TEST
was	VBD	O
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
but	CC	O
has	VBZ	O
been	VBN	O
down	RB	O
since	IN	O
then	RB	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
progressive	JJ	B-PROBLEM
failure	NN	I-PROBLEM
to	TO	I-PROBLEM
thrive	VB	I-PROBLEM
and	CC	O
steady	JJ	B-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
brought	VBN	O
in	IN	O
for	IN	O
an	DT	B-TEST
esophagogastroduodenoscopy	NN	I-TEST
on	IN	O
9/26	CD	O
but	CC	O
she	PRP	O
basically	RB	O
was	VBD	O
not	RB	O
sufficiently	RB	O
sedated	VBN	B-TREATMENT
and	CC	O
readmitted	VBN	O
at	IN	O
this	DT	O
time	NN	O
for	IN	O
a	DT	B-TEST
gi	JJ	I-TEST
work-up	NN	I-TEST
as	RB	O
well	RB	O
as	IN	O
an	DT	B-TEST
evaluation	NN	I-TEST
of	IN	O
new	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
calf	NN	I-PROBLEM
and	CC	O
right	JJ	O
medial	NN	O
lower	JJR	O
extremity	NN	O
quadriceps	NNS	O
muscle	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
admitted	VBN	O
to	TO	O
be	VB	O
connected	VBN	O
up	RP	O
with	IN	O
social	JJ	O
services	NNS	O
for	IN	O
hiv	JJ	B-PROBLEM
patients	NNS	O
.	.	O

bactrim	NN	B-TREATMENT
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
percocet	NN	B-TREATMENT
,	,	O
prinovil	NN	B-TREATMENT
,	,	O
dapsone	NN	B-TREATMENT
,	,	O
mycelex	JJ	B-TREATMENT
troches	NNS	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
revealed	VBD	O
a	DT	O
cachetic	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
not	RB	O
orthostatic	JJ	B-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
110/80	CD	O
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
bilaterally	RB	O
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

extremities	NNS	O
revealed	VBD	O
a	DT	B-PROBLEM
2	CD	I-PROBLEM
x	NN	I-PROBLEM
3	CD	I-PROBLEM
cm	JJ	I-PROBLEM
tender	NN	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
left	NN	I-PROBLEM
calf	NN	I-PROBLEM
,	,	O
medial	JJ	B-PROBLEM
1	CD	I-PROBLEM
cm	JJ	I-PROBLEM
mass	NN	I-PROBLEM
above	IN	I-PROBLEM
her	PRP$	I-PROBLEM
knee	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
edema	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
bun	JJ	B-TEST
/	NNP	O
creatinine	NN	B-TEST
of	IN	O
33/2.1	CD	O
.	.	O

sodium	NN	B-TEST
141	CD	O
.	.	O

potassium	NN	B-TEST
4.2	CD	O
.	.	O

hematocrit	NN	B-TEST
23	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
2.1	CD	O
with	IN	O
56	CD	B-TEST
polys	NNS	I-TEST
and	CC	O
1	CD	B-TEST
band	NN	I-TEST
.	.	O

platelet	NN	B-TEST
count	NN	I-TEST
411,000	CD	O
.	.	O

amylase	NN	B-TEST
143	CD	O
.	.	O

lipase	NN	B-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
to	TO	O
600	CD	O
.	.	O

esr	NN	B-TEST
was	VBD	O
greater	JJR	O
than	IN	O
140	CD	O
.	.	O

alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
190	CD	O
.	.	O

alt	RB	B-TEST
52	CD	O
.	.	O

ast	RB	B-TEST
65	CD	O
.	.	O

beta	NN	B-TEST
hcg	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
positive	JJ	B-PROBLEM
for	IN	I-PROBLEM
protein	NN	I-PROBLEM
.	.	O

bilirubin	NN	B-TEST
0.4	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
revealed	VBD	O
clear	JJ	O
lung	NN	O
fields	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
rib	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
many	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
which	WDT	O
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	O
of	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

on	IN	O
the	DT	O
third	JJ	O
hospital	NN	O
day	NN	O
,	,	O
she	PRP	O
did	VBD	O
have	VB	O
some	DT	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
percocet	NN	B-TREATMENT
.	.	O

she	PRP	O
went	VBD	O
for	IN	O
a	DT	B-TREATMENT
debridement	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
calf	NN	I-PROBLEM
lesion	NN	I-PROBLEM
on	IN	O
10/2/93	CD	O
and	CC	O
was	VBD	O
started	VBN	O
empirically	RB	O
on	IN	O
iv	NN	B-TREATMENT
ceftriaxone	NN	I-TREATMENT
which	WDT	O
was	VBD	O
changed	VBN	O
to	TO	O
po	VB	B-TREATMENT
doxycycline	NN	I-TREATMENT
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

a	DT	B-TEST
follow-up	JJ	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
did	VBD	O
not	RB	O
show	VB	O
any	DT	O
evidence	NN	O
for	IN	O
splenomegaly	NN	B-PROBLEM
or	CC	O
hepatomegaly	NN	B-PROBLEM
.	.	O

the	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
cyst	NN	I-PROBLEM
which	WDT	O
was	VBD	O
seen	VBN	O
in	IN	O
10/92	CD	O
was	VBD	O
still	RB	O
present	JJ	O
.	.	O

there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
cyst	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
kidney	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
stone	NN	I-PROBLEM
right	RB	O
below	IN	O
the	DT	B-PROBLEM
cyst	NN	I-PROBLEM
,	,	O
although	IN	O
this	DT	O
did	VBD	O
not	RB	O
seem	VB	O
to	TO	O
be	VB	O
clinically	RB	O
significant	JJ	O
.	.	O

cultures	NNS	B-TEST
were	VBD	O
pending	VBG	O
on	IN	O
her	PRP$	B-TEST
aspirate	NN	I-TEST
and	CC	O
will	MD	O
be	VB	O
treated	VBN	O
with	IN	O
po	JJ	B-TREATMENT
doxycycline	NN	I-TREATMENT
.	.	O

cough	NN	B-PROBLEM
,	,	O
rhinorrhea	NN	B-PROBLEM
,	,	O
dehydration	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
80	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
lumpectomy	NN	B-TREATMENT
/	NNP	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
/	NNP	O
tamoxifen	NN	B-TREATMENT
(	(	O
2000	CD	O
)	)	O
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
who	WP	O
presents	VBP	O
with	IN	O
a	DT	O
four	CD	O
day	NN	O
prodrome	NN	O
of	IN	O
dry	JJ	B-PROBLEM
cough	NN	I-PROBLEM
,	,	O
rhinorrhea	NN	B-PROBLEM
,	,	O
coryza	NN	B-PROBLEM
,	,	O
malaise	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
p.o.	JJ	I-PROBLEM
intake	NN	I-PROBLEM
,	,	O
loose	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
movements	NNS	I-PROBLEM
with	IN	O
diarrhea	NN	B-PROBLEM
and	CC	O
no	DT	O
blood	NN	B-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
no	DT	O
sick	JJ	O
contacts	NNS	O
,	,	O
had	VBD	O
flu	VBN	B-TREATMENT
shot	NN	I-TREATMENT
this	DT	O
year	NN	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
she	PRP	O
had	VBD	O
labile	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
with	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
80	CD	O
s	NN	O
.	.	O

her	PRP$	O
usual	JJ	O
is	VBZ	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
120	CD	O
s	NN	O
,	,	O
this	DT	O
was	VBD	O
despite	IN	O
two	CD	B-TREATMENT
liters	NNS	I-TREATMENT
of	IN	I-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
closer	RBR	O
monitoring	NN	O
for	IN	O
possible	JJ	O
early	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
.	.	O

the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
initially	RB	O
receiving	VBG	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
11.0	CD	O
with	IN	O
15	CD	O
bands	NNS	B-TEST
.	.	O

she	PRP	O
was	VBD	O
ultimately	RB	O
changed	VBN	O
to	TO	O
levaquin	VB	B-TREATMENT
for	IN	O
a	DT	O
possible	JJ	O
early	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
pending	VBG	B-TEST
cultures	NNS	I-TEST
.	.	O

the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
was	VBD	O
also	RB	O
notable	JJ	O
for	IN	O
negative	JJ	O
chest	NN	O
x-ray	NN	O
,	,	O
two	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
24.0	CD	O
with	IN	O
appropriate	JJ	O
bump	NN	O
in	IN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
and	CC	O
no	DT	O
evidence	NN	B-PROBLEM
of	IN	I-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
stable	JJ	O
blood	NN	B-TEST
pressure	NN	I-TEST
despite	IN	O
a	DT	B-TEST
net	JJ	I-TEST
fluid	NN	I-TEST
balance	NN	I-TEST
of	IN	O
negative	JJ	O
2.5	CD	O
liters	NNS	O
.	.	O

no	DT	O
central	JJ	B-TREATMENT
access	NN	I-TREATMENT
was	VBD	O
needed	VBN	O
.	.	O

the	DT	B-TREATMENT
sepsis	NN	I-TREATMENT
protocol	NN	I-TREATMENT
was	VBD	O
aborted	VBN	O
.	.	O

also	RB	O
of	IN	O
note	NN	O
,	,	O
her	PRP$	B-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
had	VBD	O
been	VBN	O
normal	JJ	O
.	.	O

random	NN	B-TEST
cortisol	NN	I-TEST
was	VBD	O
17	CD	O
and	CC	O
her	PRP$	B-TEST
dfa	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
influenzae	NN	B-PROBLEM
a	DT	I-PROBLEM
with	IN	O
a	DT	B-TEST
viral	JJ	I-TEST
culture	NN	I-TEST
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

blood	NN	B-TEST
and	CC	I-TEST
urine	JJ	I-TEST
cultures	NNS	I-TEST
were	VBD	O
no	DT	O
growth	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
as	IN	O
well	RB	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
noninvasive	JJ	I-TEST
ultrasound	NN	I-TEST
that	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

past	JJ	O
medical	JJ	O
history	NN	O
:	:	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
diagnosed	VBN	O
in	IN	O
2010	CD	O
,	,	O
stage	NN	O
i	NN	O
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
left	VBD	I-TREATMENT
lumpectomy	NN	I-TREATMENT
,	,	O
on	IN	O
2012-05-08	JJ	O
,	,	O
and	CC	O
repeat	NN	B-TREATMENT
surgery	NN	I-TREATMENT
with	IN	O
sentinel	NN	B-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
on	IN	O
2012-06-05	JJ	O
.	.	O

invasive	JJ	B-PROBLEM
mucinous	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
with	IN	O
estrogen	NN	B-PROBLEM
receptor	NN	I-PROBLEM
positivity	NN	I-PROBLEM
and	CC	O
her2/neu	NN	B-PROBLEM
negative	JJ	O
.	.	O

left	VBN	B-TREATMENT
chest	JJS	I-TREATMENT
radiation	NN	I-TREATMENT
,	,	O
on	IN	O
tamoxifen	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

question	NN	O
of	IN	O
vertebral	JJ	B-PROBLEM
basilar	JJ	I-PROBLEM
cerebrovascular	JJ	I-PROBLEM
accident	NN	I-PROBLEM
in	IN	O
2016-08-17	JJ	O
,	,	O
with	IN	O
associated	VBN	O
limb	NN	B-PROBLEM
ataxia	NN	I-PROBLEM
.	.	O

magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
was	VBD	O
negative	JJ	O
except	IN	O
for	IN	O
some	DT	B-PROBLEM
microvascular	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

question	NN	O
peripheral	JJ	B-PROBLEM
vertigo	NN	I-PROBLEM
,	,	O
takes	VBZ	O
meclizine	JJ	B-TREATMENT
p.r.n.	NN	O

hypothyroidism	NN	B-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

hypercholesterolemia	NN	B-PROBLEM
.	.	O

glaucoma	NN	B-PROBLEM
.	.	O

cataract	NN	B-PROBLEM
.	.	O

osteopenia	NN	B-PROBLEM
.	.	O

left	VBN	B-PROBLEM
hip	NN	I-PROBLEM
arthritis	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

anemia	NN	B-PROBLEM
,	,	O
with	IN	O
a	DT	B-TEST
baseline	NN	I-TEST
hematocrit	NN	I-TEST
of	IN	O
31.0	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
tibc	NN	I-TEST
that	WDT	O
was	VBD	O
low	JJ	B-PROBLEM
and	CC	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
ferritin	NN	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
in	IN	O
2016-09-16	JJ	O
,	,	O
with	IN	O
preserved	JJ	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
60	CD	O
percent	NN	O
with	IN	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
mild	NN	B-PROBLEM
left	VBD	I-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
in	IN	O
2016-03-17	JJ	O
,	,	O
that	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
inducible	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
evista	JJ	B-TREATMENT
60	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

2.	CD	O
tamoxifen	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

3.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

4.	CD	O
triamterene/hydrochlorothiazide	JJ	B-TREATMENT
37.5/25	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

5.	CD	O
enteric	JJ	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	JJ	I-TREATMENT
325	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

6.	CD	O
meclizine	NN	B-TREATMENT
25	CD	O
mg	NN	O
q8hours	NNS	O
p.r.n.	VBP	O

7.	CD	O
aggrenox	JJ	B-TREATMENT
twice	RB	O
a	DT	O
day	NN	O
,	,	O
the	DT	O
dose	NN	O
was	VBD	O
not	RB	O
known	VBN	O
.	.	O

8.	CD	O
synthroid	JJ	B-TREATMENT
125	CD	O
mcg	JJ	O
daily	RB	O
.	.	O

breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
multiple	JJ	O
female	JJ	O
relatives	NNS	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
presentation	NN	O
,	,	O
temperature	NN	B-TEST
100.8	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
89	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
106	CD	O
systolic	NN	B-TEST
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97	CD	O
percent	NN	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
is	VBZ	O
read	VBN	O
off	IN	O
the	DT	O
admitting	VBG	O
note	NN	O
from	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
team	NN	O
and	CC	O
is	VBZ	O
not	RB	O
reflective	JJ	O
of	IN	O
the	DT	B-TEST
examination	NN	I-TEST
by	IN	O
this	DT	O
dictator	NN	O
.	.	O

general	JJ	O
-	:	O
the	DT	O
patient	NN	O
appears	VBZ	O
stated	VBN	O
age	NN	O
,	,	O
found	VBD	O
lying	VBG	O
flat	JJ	O
in	IN	O
bed	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

head	NN	O
,	,	O
eyes	NNS	O
,	,	O
ears	NNS	O
,	,	O
nose	RB	O
and	CC	O
throat	VB	O
-	:	O
sclera	NN	B-PROBLEM
anicteric	NN	I-PROBLEM
,	,	O
conjunctiva	NN	B-PROBLEM
injected	VBD	I-PROBLEM
,	,	O
the	DT	O
pupils	NNS	O
are	VBP	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
the	DT	O
mucous	JJ	O
membranes	NNS	O
are	VBP	O
dry	JJ	B-PROBLEM
,	,	O
oropharynx	JJ	O
clear	JJ	O
.	.	O

neck	SYM	O
-	:	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

cardiac	JJ	O
regular	JJ	O
rate	NN	B-TEST
and	CC	O
rhythm	NN	B-TEST
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
i/vi	JJ	B-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

chest	NN	O
clear	JJ	O
to	TO	O
percussion	NN	B-TEST
and	CC	O
auscultation	NN	B-TEST
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

extremities	NNS	O
-	:	O
no	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

neurologically	RB	O
,	,	O
mental	JJ	B-TEST
status	NN	I-TEST
examination	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

cranial	JJ	B-TEST
nerves	NNS	I-TEST
ii	VBP	I-TEST
through	IN	I-TEST
xii	NNS	I-TEST
are	VBP	O
intact	JJ	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
chest	VB	B-TEST
x-ray	NN	I-TEST
with	IN	O
no	DT	O
acute	JJ	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
notable	JJ	O
for	IN	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
rate	NN	I-TEST
of	IN	O
104	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
normal	JJ	O
intervals	NNS	O
,	,	O
new	JJ	B-PROBLEM
t	NN	I-PROBLEM
wave	VBP	I-PROBLEM
inversion	NN	I-PROBLEM
in	IN	I-PROBLEM
iii	NN	I-PROBLEM
and	CC	O
old	JJ	B-PROBLEM
t	NN	I-PROBLEM
wave	NN	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
avl	NN	I-PROBLEM
and	CC	I-PROBLEM
v1	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
7.3	CD	O
,	,	O
73	CD	O
percent	NN	O
neutrophils	NNS	B-TEST
,	,	O
15	CD	O
percent	NN	O
bands	NNS	B-TEST
,	,	O
6	CD	O
percent	NN	O
lymphocytes	NNS	B-TEST
,	,	O
hematocrit	NN	B-TEST
30.4	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
228,000	CD	O
.	.	O

sodium	NN	B-TEST
136	CD	O
,	,	O
potassium	NN	B-TEST
3.5	CD	O
,	,	O
chloride	RB	B-TEST
98	CD	O
,	,	O
bicarbonate	NN	B-TEST
23	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
16	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
142	CD	O
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
80	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
stage	NN	B-PROBLEM
i	JJ	I-PROBLEM
breast	NN	I-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	B-PROBLEM
leukocytosis/bandemia	NN	I-PROBLEM
,	,	O
hypotension	NN	B-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
dehydration	NN	B-PROBLEM
and	CC	O
influenza	NN	B-PROBLEM
.	.	O

hypotension	NN	B-PROBLEM
-	:	O
this	DT	O
was	VBD	O
likely	JJ	O
secondary	JJ	O
to	TO	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
a	DT	B-PROBLEM
diarrheal	NN	I-PROBLEM
and	CC	I-PROBLEM
viral	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
stable	JJ	O
after	IN	O
three	CD	B-TREATMENT
liters	NNS	I-TREATMENT
of	IN	I-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
receive	VB	O
two	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
or	CC	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
during	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	B-TEST
evaluation	NN	I-TEST
.	.	O

her	PRP$	B-TREATMENT
antihypertensives	NNS	I-TREATMENT
were	VBD	O
initially	RB	O
held	VBN	O
and	CC	O
reinstated	VBN	O
upon	IN	O
discharge	NN	O
.	.	O

influenza	VB	B-PROBLEM
a	DT	I-PROBLEM
-	:	O
dfa	NN	B-TEST
confirmed	VBD	O
,	,	O
the	DT	B-TEST
viral	JJ	I-TEST
cultures	NNS	I-TEST
were	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	B-PROBLEM
initial	JJ	I-PROBLEM
bandemia	NN	I-PROBLEM
would	MD	O
not	RB	O
have	VB	O
been	VBN	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
typical	JJ	I-PROBLEM
influenza	NN	I-PROBLEM
presentation	NN	I-PROBLEM
,	,	O
so	IN	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
a	DT	O
fourteen	JJ	O
day	NN	O
course	NN	O
of	IN	O
levaquin	NN	B-TREATMENT
to	TO	O
eliminate	VB	O
any	DT	O
possibility	NN	O
of	IN	O
a	DT	B-PROBLEM
bacterial	JJ	I-PROBLEM
superinfection	NN	I-PROBLEM
or	CC	O
early	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

loose	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
movements	NNS	I-PROBLEM
-	:	O
this	DT	O
problem	NN	O
was	VBD	O
resolved	VBN	O
and	CC	O
had	VBD	O
been	VBN	O
a	DT	B-PROBLEM
viral	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
on	IN	O
presentation	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
diarrhea	NN	B-PROBLEM
during	IN	O
medical	JJ	O
lawrence	NN	O
memorial	JJ	O
hospital	NN	O
stay	NN	O
.	.	O

anemia	SYM	B-PROBLEM
-	:	O
this	DT	O
is	VBZ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
problem	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
known	VBN	B-PROBLEM
iron	NN	I-PROBLEM
deficiency	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	B-PROBLEM
of	IN	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
and	CC	O
the	DT	B-TEST
hemophilus	JJ	I-TEST
panel	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
was	VBD	O
reinstated	VBN	O
on	IN	O
iron	NN	B-TREATMENT
at	IN	O
discharge	NN	O
and	CC	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
stable	JJ	O
.	.	O

hypothyroid	NN	B-PROBLEM
-	:	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
synthroid	NN	I-TREATMENT
.	.	O

osteopenia	SYM	B-PROBLEM
-	:	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
evista	NN	B-TREATMENT
.	.	O

fluids	NNS	B-TREATMENT
,	,	O
electrolytes	NNS	B-TREATMENT
and	CC	O
nutrition	NN	B-TREATMENT
-	:	O
she	PRP	O
was	VBD	O
tolerating	VBG	O
a	DT	O
house	NN	O
diet	JJ	O
upon	IN	O
discharge	NN	O
.	.	O

1.	CD	O
evista	JJ	B-TREATMENT
60	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

2.	CD	O
tamoxifen	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

3.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

4.	CD	O
triamterene/hydrochlorothiazide	JJ	B-TREATMENT
37.5/25	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

5.	CD	O
enteric	JJ	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	JJ	I-TREATMENT
325	CD	O
mg	JJ	O
p.o.	JJ	O
daily	NN	O
.	.	O

6.	CD	O
meclizine	NN	B-TREATMENT
25	CD	O
mg	NN	O
q8hours	NNS	O
p.r.n.	VBP	O

7.	CD	O
aggrenox	JJ	B-TREATMENT
twice	RB	O
a	DT	O
day	NN	O
,	,	O
the	DT	O
dose	NN	O
was	VBD	O
not	RB	O
known	VBN	O
.	.	O

8.	CD	O
synthroid	JJ	B-TREATMENT
125	CD	O
mcg	JJ	O
daily	RB	O
.	.	O

9.	CD	O
levofloxacin	JJ	B-TREATMENT
250	CD	O
mg	JJ	O
p.o.	JJ	O
daily	JJ	O
to	TO	O
complete	VB	O
a	DT	O
fourteen	JJ	O
day	NN	O
course	NN	O
.	.	O

influenza	NN	B-PROBLEM
a	DT	I-PROBLEM
.	.	O

hypotension	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
volume	NN	B-PROBLEM
depletion	NN	I-PROBLEM
.	.	O

anemia	NN	B-PROBLEM
.	.	O

hypothyroidism	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
normotensive	JJ	O
and	CC	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
stable	JJ	O
at	IN	O
her	PRP$	O
baseline	NN	O
upon	IN	O
discharge	NN	O
.	.	O

vt	NN	B-PROBLEM
s/p	NN	O
cardiac	JJ	B-TEST
cath	NN	I-TEST
,	,	O
stent	NN	B-TREATMENT
and	CC	O
amp	NN	O
;	:	O
amio	CC	B-TREATMENT
loading	VBG	I-TREATMENT

amiodarone	RB	B-TREATMENT
400	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
starting	VBG	O
today	NN	O
(	(	O
01/06	CD	O
)	)	O

serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

digoxin	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
hcl	NN	I-TREATMENT

ok	JJ	O
enteric	NN	B-TREATMENT
coated	VBN	I-TREATMENT
asa	NN	I-TREATMENT
(	(	I-TREATMENT
aspirin	JJ	I-TREATMENT
enteric	RB	I-TREATMENT
coated	VBN	I-TREATMENT
)	)	I-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
qd	NN	O
digoxin	NN	B-TREATMENT
0.0625	CD	O
mg	NN	O
po	NN	O
qd	NN	O

override	RB	O
added	VBD	O
on	IN	O
01/03/04	CD	O
by	IN	O
tikneav	NN	O
,	,	O
jeffci	NN	O
suot	NN	O
a.	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
amiodarone	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
23731718	CD	O
)	)	O

serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

digoxin	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
hcl	NN	I-TREATMENT

override	RB	O
added	VBD	O
on	IN	O
01/02/04	CD	O
by	IN	O
koteslent	NN	O
,	,	O
ant	JJ	O
odewyju	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
amiodarone	NN	B-TREATMENT
iv	NN	I-TREATMENT
1	CD	O
(	(	O
ref	JJ	O
#	#	O
45803793	CD	O
)	)	O

serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

digoxin	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
hcl	NN	I-TREATMENT

serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

amiodarone	NN	B-TREATMENT
hcl	NN	I-TREATMENT
and	CC	O
digoxin	NN	B-TREATMENT

mvi	NN	B-TREATMENT
therapeutic	JJ	I-TREATMENT
w	NN	I-TREATMENT
/	NN	I-TREATMENT
minerals	NNS	I-TREATMENT
(	(	I-TREATMENT
therap	VB	I-TREATMENT
vits	NNS	I-TREATMENT
/	NNP	I-TREATMENT
minerals	NNS	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	NN	O

override	RB	O
added	VBD	O
on	IN	O
01/02/04	CD	O
by	IN	O
koteslent	NN	O
,	,	O
ant	JJ	O
odewyju	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
zocor	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
71920299	CD	O
)	)	O

niacin	RB	B-TREATMENT
,	,	O
vit	NN	O
.	.	O

b-3	NN	O
and	CC	O
simvastatin	NN	B-TREATMENT

zocor	NN	B-TREATMENT
(	(	I-TREATMENT
simvastatin	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

niacin	RB	B-TREATMENT
,	,	O
vit	NN	O
.	.	O

b-3	NN	O
and	CC	O
simvastatin	NN	B-TREATMENT

toprol	NN	B-TREATMENT
xl	NNP	I-TREATMENT
(	(	I-TREATMENT
metoprolol	NN	I-TREATMENT
(	(	I-TREATMENT
sust.	JJ	I-TREATMENT
rel.	NN	I-TREATMENT
)	)	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
qd	NN	O

5	CD	B-TREATMENT
plavix	NN	I-TREATMENT
(	(	I-TREATMENT
clopidogrel	NN	I-TREATMENT
)	)	I-TREATMENT
75	CD	O
mg	NN	O
po	NN	O
qd	NN	O
starting	VBG	O
today	NN	O
(	(	O
01/06	CD	O
)	)	O
keflex	NN	B-TREATMENT
(	(	I-TREATMENT
cephalexin	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
qid	NN	O
x	VBD	O
40	CD	O
doses	NNS	O
amiodarone	RB	B-TREATMENT
400	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O

serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

digoxin	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
hcl	NN	I-TREATMENT

nka	NN	B-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
vt	NN	B-PROBLEM
s	JJ	O
/	NNP	O
p	NN	O
cardiac	JJ	B-TEST
cath	NN	I-TEST
,	,	O
stent	NN	B-TREATMENT
and	CC	O
amio	NN	B-TREATMENT
loading	NN	I-TREATMENT

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
vt	RB	B-PROBLEM
,	,	O
cad	JJ	B-PROBLEM
s	NN	O
/	NNP	O
p	NN	O
mi	NN	B-PROBLEM
ischemic	JJ	B-PROBLEM
cardiomyopathy	JJ	I-PROBLEM
bilateral	JJ	B-TREATMENT
knee	NN	I-TREATMENT
replacement	NN	I-TREATMENT

cardiac	JJ	B-TEST
cath	NN	I-TEST
1/6/0004	CD	O

78	CD	O
m	NN	O
w/	NN	O
longstanding	VBG	B-PROBLEM
cad	JJ	I-PROBLEM
s	NN	O
/	NNP	O
p	NN	O
cabg	NN	B-TREATMENT
'97	CD	O
,	,	O
had	VBD	O
ppm	NN	B-TREATMENT
and	CC	O
aicd	NN	B-TREATMENT
placed	VBN	O
in	IN	O
'02	CD	O
after	IN	O
admitted	VBN	O
for	IN	O
presyncope	NN	B-PROBLEM
and	CC	O
found	VBN	O
to	TO	O
have	VB	O
inducible	JJ	B-PROBLEM
vt	NN	I-PROBLEM
.	.	O

in	IN	O
usoh	JJ	O
until	IN	O
this	DT	O
am	VBP	O
when	WRB	O
felt	NN	O
lh	NN	B-PROBLEM
and	CC	O
then	RB	O
icd	VB	B-TREATMENT
discharge	NN	I-TREATMENT
.	.	O

subsequent	JJ	O
4	CD	B-TREATMENT
icd	NN	I-TREATMENT
discharges	NNS	I-TREATMENT
at	IN	O
rest	NN	O
.	.	O

denies	NNS	O
change	VBP	B-PROBLEM
in	IN	I-PROBLEM
et	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
sob	NN	B-PROBLEM
.	.	O

went	VBD	O
to	TO	O
osh	VB	O
c	VB	O
further	JJ	B-TREATMENT
icd	NN	I-TREATMENT
shocks	NNS	I-TREATMENT
,	,	O
vt	NN	B-PROBLEM
on	IN	O
monitor	NN	B-TEST
but	CC	O
stable	JJ	O
vs	NN	O
.	.	O

given	VBN	O
amio	JJ	B-TREATMENT
bolu	NN	I-TREATMENT
,	,	O
started	VBD	O
on	IN	O
gtt	NN	B-TREATMENT
and	CC	O
transferred	VBD	O
to	TO	O
nvh	VB	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

exam	NN	B-TEST
remarkable	NN	O
for	IN	O
b	NN	B-PROBLEM
/	NNP	I-PROBLEM
l	NN	I-PROBLEM
carotid	NN	I-PROBLEM
bruits	NNS	I-PROBLEM
,	,	O
soft	JJ	B-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
l	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
,	,	O
clear	JJ	O
chest	NN	O
,	,	O
1+	CD	B-PROBLEM
b	NN	I-PROBLEM
/	NN	I-PROBLEM
l	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

labs	NNS	B-TEST
at	IN	O
osh	JJ	O
c	JJ	O
cr	NN	B-TEST
:	:	O

hct	NN	B-TEST
:	:	O

gluc	NN	B-TEST
:	:	O

ck	NN	B-TEST
:	:	O

mb	NN	B-TEST
:	:	O

ecg	NN	B-TEST
is	VBZ	O
av	JJ	O
paced	JJ	O
but	CC	O
prior	JJ	O
shower	JJR	B-PROBLEM
r	NN	I-PROBLEM
on	IN	I-PROBLEM
t	NN	I-PROBLEM
vpb	NN	I-PROBLEM
c	VBP	O
monomorphic	JJ	B-PROBLEM
vt	NN	I-PROBLEM
then	RB	O
overdrive	JJ	O
paced	NNS	O
.	.	O

1)	CD	O
cv	NN	O
(	(	O
r	NN	O
)	)	O
finished	VBD	O
amio	JJ	B-TREATMENT
iv	NN	I-TREATMENT
load	NN	I-TREATMENT
then	RB	O
started	VBD	O
on	IN	O
po	NN	O
,	,	O
agressive	JJ	B-TREATMENT
lytes	NNS	I-TREATMENT
;	:	O
although	IN	O
interrogation	NN	B-TEST
showed	VBD	O
>100	NNP	O
episodes	NNS	O
of	IN	O
vt	NN	B-PROBLEM
(	(	O
as	IN	O
/	NNP	O
x	NNP	O
)	)	O
,	,	O
pt	JJ	O
prefers	NNS	O
med	VBD	B-TREATMENT
therapy	NN	I-TREATMENT
as	IN	O
opposed	VBN	O
to	TO	O
ablation	NN	B-TREATMENT
(	(	O
i	NN	O
)	)	O
enzymes	VBZ	B-TEST
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
but	CC	O
not	RB	O
actively	RB	B-PROBLEM
ischemic	JJ	I-PROBLEM
;	:	O
lipids	NNS	B-TEST
,	,	O
asa	NN	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
bb	NN	B-TREATMENT
;	:	O
adenosine	JJ	B-TEST
thal	NN	I-TEST
1/4	CD	O
and	CC	O
echo	$	B-TEST
1/4	CD	O
to	TO	O
look	VB	O
for	IN	O
signs	NNS	O
of	IN	O
ischemia	NN	B-PROBLEM
as	IN	O
active	JJ	O
cause	NN	O
for	IN	O
vt	NN	B-PROBLEM
(	(	O
p	NN	O
)	)	O
jvp	NN	B-TEST
at	IN	O
angle	NN	O
of	IN	O
jaw	NN	O
1/4	CD	O
-->	NN	O
giving	VBG	O
20	CD	B-TREATMENT
lasix	NN	I-TREATMENT
;	:	O
dig	CC	B-TEST
level	VBP	I-TEST
1/4	CD	O
1.3	CD	O
-->	JJ	O
1/2	CD	O
dose	NN	O
as	IN	O
on	IN	O
amio	NN	B-TREATMENT

elevated	VBN	B-PROBLEM
glu	NN	I-PROBLEM
on	IN	O
admit	NN	O
bmp	NN	B-TEST
and	CC	O
fsg	NN	B-TEST
also	RB	O
concurring	VBG	O
-->	NNP	O
follow	NN	O
and	CC	O
lispro	NN	B-TREATMENT
;	:	O
will	MD	O
probably	RB	O
need	VB	O
w	JJ	B-TEST
/	NNP	I-TEST
u	NN	I-TEST
as	IN	O
outpt	NN	O

baseline	NN	B-TEST
pfts	NNS	I-TEST
as	IN	O
staring	VBG	O
amio	NN	B-TREATMENT

baseline	NN	B-TEST
lfts	NNS	I-TEST
wnl	VBP	O
;	:	O
taking	VBG	O
cardiac	JJ	B-TREATMENT
/	NNP	I-TREATMENT
ada	NN	I-TREATMENT
diet	NN	I-TREATMENT
as	IN	O
glu	NN	B-TEST
remains	VBZ	O
elevated	JJ	B-PROBLEM

baseline	NN	B-TEST
cri	NN	I-TEST
(	(	O
1.2-1.6	JJ	O
)	)	O
with	IN	O
elevation	NN	B-PROBLEM
at	IN	O
admission	NN	O
probably	RB	O
prerenal	JJ	O
;	:	O
will	MD	O
monitor	VB	O
bun	JJ	B-TEST
/	NNP	O
cr	NN	B-TEST
after	IN	O
giving	VBG	O
lasix	NN	B-TREATMENT

ppi	NN	B-TREATMENT
and	CC	O
pneumoboots	NNS	B-TREATMENT

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cardiology	NN	O
service	NN	O
and	CC	O
commenced	VBD	O
amiodarone	NN	B-TREATMENT
loading	NN	I-TREATMENT
.	.	O

adenosine	JJ	B-TEST
stress	NN	I-TEST
mibi	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
reversible	JJ	I-PROBLEM
defect	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pda	NN	I-PROBLEM
territory	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	JJ	O
underwent	JJ	O
coronary	JJ	B-TEST
catheterisation	NN	I-TEST
on	IN	O
1/6/0004	CD	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
70%	CD	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
svg	NN	I-PROBLEM
to	TO	I-PROBLEM
pda	VB	I-PROBLEM
->	NNP	O
cypher	NN	B-TREATMENT
stented	VBD	I-TREATMENT
successfully	RB	O
.	.	O

he	PRP	O
had	VBD	O
occasional	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
extopyon	NN	I-PROBLEM
telemetry	NN	B-TEST
but	CC	O
no	DT	O
further	JJ	B-PROBLEM
recurrence	NN	I-PROBLEM
of	IN	O
ventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

during	IN	O
his	PRP$	O
admission	NN	O
,	,	O
his	PRP$	B-TEST
am	VBP	I-TEST
fasting	VBG	I-TEST
glucose	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
intermittently	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
and	CC	O
his	PRP$	B-TEST
hba1c	NN	I-TEST
was	VBD	O
greater	JJR	O
than	IN	O
7	CD	O
.	.	O

i	NNS	O
have	VBP	O
explained	VBN	O
to	TO	O
him	PRP	O
that	IN	O
he	PRP	O
may	MD	O
have	VB	O
developed	VBN	O
some	DT	B-PROBLEM
glucose	JJ	I-PROBLEM
intolerance	NN	I-PROBLEM
and	CC	O
that	DT	O
,	,	O
in	IN	O
the	DT	O
first	JJ	O
instance	NN	O
,	,	O
he	PRP	O
should	MD	O
see	VB	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
and	CC	O
attempt	JJ	O
dietary	JJ	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
he	PRP	O
noticed	VBD	O
a	DT	O
small	JJ	O
area	NN	O
of	IN	O
erythema	NN	B-PROBLEM
surrounding	VBG	O
his	PRP$	B-TREATMENT
r	NN	I-TREATMENT
antecubital	VBP	I-TREATMENT
venous	JJ	I-TREATMENT
access	NN	I-TREATMENT
site	NN	I-TREATMENT
.	.	O

this	DT	O
will	MD	O
be	VB	O
treated	VBN	O
empirically	RB	O
with	IN	O
a	DT	O
10	CD	O
day	NN	O
course	NN	O
of	IN	O
keflex	NN	B-TREATMENT
.	.	O

i	NNS	O
have	VBP	O
instructed	VBN	O
him	PRP	O
to	TO	O
see	VB	O
his	PRP$	O
pcp	NN	O
if	IN	O
it	PRP	O
does	VBZ	O
not	RB	O
improve	VB	O
in	IN	O
a	DT	O
few	JJ	O
days	NNS	O
or	CC	O
if	IN	O
he	PRP	O
develops	VBZ	O
fevers	NNS	B-PROBLEM
.	.	O

in	IN	O
terms	NNS	O
of	IN	O
his	PRP$	B-TREATMENT
amiodarone	NN	I-TREATMENT
,	,	O
he	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
400mg	CD	O
po	NNS	O
bid	NN	O
for	IN	O
a	DT	O
further	JJ	O
7	CD	O
days	NNS	O
followed	VBN	O
by	IN	O
400mg	CD	O
qd	JJ	O
thereafter	RB	O
.	.	O

i	NNS	O
have	VBP	O
advised	VBN	O
him	PRP	O
that	IN	O
he	PRP	O
must	MD	O
not	RB	O
drive	VB	O
until	IN	O
he	PRP	O
is	VBZ	O
seena	JJ	O
gain	NN	O
in	IN	O
clinic	NN	O
and	CC	O
his	PRP$	B-TREATMENT
device	NN	I-TREATMENT
interrogated	VBD	O
.	.	O

coumadin	NN	B-TREATMENT

fever	NN	B-PROBLEM
,	,	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
redness	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
urinate	VB	I-PROBLEM

transesophageal	NN	B-TEST
echocardiogram	NN	I-TEST

62	CD	O
year-old	JJ	O
status-post	JJ	O
gastric	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
and	CC	O
laprascopic	NN	B-TREATMENT
cholecystectomy	VBP	I-TREATMENT
7	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
who	WP	O
presented	VBD	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
and	CC	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
extemity	NN	I-PROBLEM
redness	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
multiple	JJ	O
hospitalizations	NNS	O
for	IN	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
and	CC	O
noted	VBD	O
that	IN	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
the	DT	O
appearance	NN	O
of	IN	O
his	PRP$	O
left	JJ	O
leg	NN	O
mirrored	VBD	O
previous	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

he	PRP	O
denied	VBD	O
recent	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
area	NN	I-PROBLEM
or	CC	O
travel	NN	O
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
significant	JJ	O
only	RB	O
for	IN	O
painful	JJ	B-PROBLEM
urination	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
and	CC	O
a	DT	B-PROBLEM
reduction	NN	I-PROBLEM
in	IN	I-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

he	PRP	O
denied	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
n/v	NN	B-PROBLEM
,	,	O
penile	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

1.	CD	O
morbid	NN	B-PROBLEM
obesity	NN	I-PROBLEM

2.	CD	O
frequent	JJ	B-PROBLEM
cellulitis	NN	I-PROBLEM

3.	CD	O
lymphedema	NN	B-PROBLEM
.	.	O

4.	CD	O
cad	NN	B-PROBLEM
s/p	NN	O
velocity	NN	B-TREATMENT
stenting	VBG	I-TREATMENT
proximal	JJ	I-TREATMENT
lad	NN	I-TREATMENT
2002	CD	O

5.	CD	O
osteoarthritis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM

6.	CD	O
hypertension	NN	B-PROBLEM

7.	CD	O
hypercholesterolemia	NN	B-PROBLEM

8.	CD	O
obstructive	JJ	B-PROBLEM
sleep	NN	I-PROBLEM
apnea	NN	I-PROBLEM

9.	CD	O
cva	NNS	B-PROBLEM
x2	JJ	O
with	IN	O
left-sided	JJ	B-PROBLEM
weakness	NN	I-PROBLEM

10.	CD	O
gastric	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
7	CD	O
weeks	NNS	O
pta	NN	O

11.	CD	O
lap	JJ	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
7	CD	O
weeks	NNS	O
pta	NN	O

vs	NN	B-TEST
t	VBZ	O
101.4	CD	O
bp	NN	B-TEST
85/50	CD	O
hr	NN	B-TEST
130	CD	O

rr	NN	B-TEST
20	CD	O
o2	JJ	B-TEST
sat	NN	I-TEST
:	:	O
98%	CD	O
ra	NN	O

gen	NN	O
:	:	O
obese	JJ	B-PROBLEM
male	NN	O
,	,	O
aaox3	NN	O

heent	NN	O
:	:	O
mm	NN	B-PROBLEM
dry	NN	I-PROBLEM
,	,	O
jvd	NN	B-PROBLEM
cannot	NN	O
be	VB	O
assessed	VBN	O

cv	NN	O
:	:	O
irregularly	RB	B-PROBLEM
irregular	JJ	I-PROBLEM
rhytmm	NN	I-PROBLEM
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

abd	NN	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
nt/nd	JJ	B-PROBLEM
,	,	O
no	DT	O
rebound/guarding	NN	B-PROBLEM

ext	NN	O
:	:	O
3+	CD	B-PROBLEM
bilateral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
lle	CC	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
erythema	NN	B-PROBLEM
,	,	O
no	DT	O
chords	NNS	B-PROBLEM
,	,	O
+	NNP	O
warmth	NN	B-PROBLEM
,	,	O
+	NNP	O
chronic	VBZ	B-PROBLEM
venous	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
negative	JJ	O
homens	NNS	O

wbc	SYM	B-TEST
-	:	O
6.3	CD	O
rbc	NN	B-TEST
-	:	O
4.90	CD	O
hgb	NN	B-TEST
-	:	O
14.1	CD	O
hct	NN	B-TEST
-	:	O
41.0	CD	O
mcv	SYM	B-TEST
-	:	O
84	CD	O
mch	SYM	B-TEST
-	:	O
28.7	CD	O
mchc	SYM	B-TEST
-	:	O
34.4	CD	O
rdw	NN	B-TEST
-	:	O
15.0	CD	O

neuts	NNS	B-TEST
-	:	O
92	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
4	CD	O
lymphs	SYM	B-TEST
-	:	O
2	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
2	CD	O
eos	SYM	B-TEST
-	:	O
0	CD	O
basos	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
0	CD	O
metas	NNS	B-TEST
-	:	O
0	CD	O
myelos	SYM	B-TEST
-	:	O
0	CD	O

plt	NN	B-TEST
smr	SYM	I-TEST
-	:	O
normal	JJ	O
plt	NN	B-TEST
count	NN	I-TEST
-	:	O
143	CD	O
*#	NN	O

2015-10-10	JJ	O
02:16pm	CD	O
urine	NN	B-TEST

blood	NN	B-TEST
-	:	O
neg	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
5.0	CD	O
leuk	SYM	B-TEST
-	:	O
sm	NN	O

calcium	NN	B-TEST
-	:	O
9.6	CD	O
phosphate	NN	B-TEST
-	:	O
0.8	CD	O
*#	JJ	O
magnesium	NN	B-TEST
-	:	O
1.4	CD	O
*	NN	O

ck-mb	JJ	B-TEST
-	:	O
2	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

ck(cpk)	SYM	B-TEST
-	:	O
109	CD	O

lactate	NN	B-TEST
-	:	O
2.4	CD	O
*	NN	O

pt	SYM	B-TEST
-	:	O
16.6	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
32.2	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.7	CD	O

albumin	SYM	B-TEST
-	:	O
3.0	CD	O
*	JJ	O
calcium	NN	B-TEST
-	:	O
7.6	CD	O
*	NN	O
phosphate	NN	B-TEST
-	:	O
1.6	CD	O
*	JJ	O
magnesium	NN	B-TEST
-	:	O
1.1	CD	O
*	NN	O

alt(sgpt)	SYM	B-TEST
-	:	O
28	CD	O
ast(sgot)	SYM	B-TEST
-	:	O
27	CD	O
ld(ldh)	SYM	B-TEST
-	:	O
191	CD	O
ck(cpk)	NN	B-TEST
-	:	O
58	CD	O
alk	NN	B-TEST
phos	NN	I-TEST
-	:	O
63	CD	O
amylase	NN	B-TEST
-	:	O
27	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.9	CD	O

lactate	NN	B-TEST
-	:	O
1.9	CD	O

this	DT	O
62	CD	O
year-old	JJ	O
obese	JJ	O
male	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
cellulitis	NN	B-PROBLEM
and	CC	O
presumed	JJ	O
bacteremia	NN	B-PROBLEM
.	.	O

in	IN	O
the	DT	O
john	NN	O
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
in	IN	O
hypotensive	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
icu	NN	O
where	WRB	O
his	PRP$	B-PROBLEM
hypotension	NN	I-PROBLEM
was	VBD	O
managed	VBN	O
with	IN	O
ivf	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
a	DT	B-TREATMENT
diltiazam	NN	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

after	IN	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
controlled	VBN	O
,	,	O
he	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
oral	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
transferred	VBN	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
.	.	O

1.	CD	O
cellulitis	NN	B-PROBLEM
/	NN	O
bacteremia	NN	B-PROBLEM

review	NN	O
of	IN	O
the	DT	O
medical	JJ	O
record	NN	O
revealed	VBD	O
several	JJ	O
previous	JJ	O
admissions	NNS	O
for	IN	O
cellulitis	NN	B-PROBLEM
and	CC	O
bacteremia	NN	B-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
on	IN	O
this	DT	O
admission	NN	O
and	CC	O
were	VBD	O
positive	JJ	O
for	IN	O
beta	NN	B-PROBLEM
streptococcus	NN	I-PROBLEM
group	NN	I-PROBLEM
b	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
previous	JJ	O
episodes	NNS	O
of	IN	O
the	DT	B-PROBLEM
same	JJ	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
with	IN	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
the	DT	O
likely	JJ	O
source	NN	O
.	.	O

a	DT	B-TEST
left	VBD	I-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
too	RB	B-PROBLEM
large	JJ	I-PROBLEM
to	TO	O
have	VB	O
a	DT	B-TEST
cta	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
zosyn	NN	B-TREATMENT
while	IN	O
awaiting	VBG	O
culture	NN	B-TEST
results	NNS	O
.	.	O

once	RB	O
the	DT	B-PROBLEM
organism	NN	I-PROBLEM
was	VBD	O
identified	VBN	O
,	,	O
he	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
a	DT	O
regimen	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
penicillin	NN	I-TREATMENT
and	CC	O
oral	JJ	B-TREATMENT
levofloxacin	NN	I-TREATMENT
,	,	O
which	WDT	O
had	VBD	O
successfully	RB	O
treated	VBN	O
the	DT	B-PROBLEM
infection	NN	I-PROBLEM
during	IN	O
his	PRP$	O
most	RBS	O
recent	JJ	O
admission	NN	O
1	CD	O
year	NN	O
prior	RB	O
.	.	O

he	PRP	O
completed	VBD	O
7	CD	O
days	NNS	O
of	IN	O
levofloxacin	NN	B-TREATMENT
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
to	TO	O
facilitate	VB	O
a	DT	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
iv	JJ	B-TREATMENT
penicillin	NN	I-TREATMENT
.	.	O

2.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM

the	DT	O
patient	NN	O
's	POS	O
development	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
was	VBD	O
believed	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
infection	NN	B-PROBLEM
and	CC	O
structural	JJ	B-PROBLEM
heart	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
initially	RB	O
managed	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
diltiazam	NNS	I-TREATMENT
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
later	RB	O
managed	VBN	O
with	IN	O
metoprolol	NN	B-TREATMENT
and	CC	O
anticoagulation	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
and	CC	I-PROBLEM
elongated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
markedly	RB	I-PROBLEM
dilated	VBN	I-PROBLEM
right	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
occasional	JJ	O
episodes	NNS	O
of	IN	O
rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
that	WDT	O
were	VBD	O
controlled	VBN	O
with	IN	O
responded	VBN	O
to	TO	O
iv	VB	B-TREATMENT
metoprolol	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
his	PRP$	B-TEST
rate	NN	I-TEST
proved	VBD	O
difficult	JJ	O
to	TO	O
control	VB	O
despite	IN	O
metoprolol	NNS	B-TREATMENT
and	CC	O
diltiazam	NN	B-TREATMENT
.	.	O

the	DT	O
ep	JJ	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
recommended	VBN	O
transesophageal	NN	B-TEST
echocardiogram	NN	I-TEST
and	CC	O
cardioversion	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
tee	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
thrombus	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
successfully	RB	O
cardioverted	VBN	O
to	TO	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
ibutilide	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
subsequently	RB	O
started	VBN	O
on	IN	O
amiodarone	NN	B-TREATMENT
and	CC	O
is	VBZ	O
scheduled	VBN	O
to	TO	O
complete	VB	O
a	DT	O
10	CD	O
week	NN	O
course	NN	O
.	.	O

ekg	NN	B-TEST
before	IN	O
discharge	NN	O
showed	VBD	O
mild	JJ	B-PROBLEM
qt	JJ	I-PROBLEM
prolongation	NN	I-PROBLEM
and	CC	O
no	DT	O
effect	NN	O
from	IN	O
amiodarone	NN	B-TREATMENT
.	.	O

ekg	NN	B-TEST
and	CC	O
lfts	NNS	B-TEST
should	MD	O
be	VB	O
monitored	VBN	O
by	IN	O
his	PRP$	O
pcp	NN	O
,	,	O
william	VB	O
given	VBN	O
the	DT	O
high	JJ	O
dose	NN	O
of	IN	O
amiodarone	NN	B-TREATMENT
he	PRP	O
will	MD	O
receive	VB	O
.	.	O

he	PRP	O
demonstrated	VBD	O
several	JJ	B-PROBLEM
asymptomatic	JJ	I-PROBLEM
electrolyte	NN	I-PROBLEM
deficiecies	NNS	I-PROBLEM
;	:	O
these	DT	O
were	VBD	O
likely	RB	O
due	JJ	O
to	TO	O
inadequate	VB	B-PROBLEM
absorption	NN	I-PROBLEM
following	VBG	O
his	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
he	PRP	O
responded	VBD	O
well	RB	O
to	TO	O
repletion	NN	B-TREATMENT
.	.	O

vitamin	NN	B-TEST
d	NN	I-TEST
and	CC	O
parathyroid	JJ	B-TEST
tests	NNS	I-TEST
were	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

he	PRP	O
was	VBD	O
sent	VBN	O
with	IN	O
a	DT	B-TEST
king	NN	I-TEST
of	IN	I-TEST
hearts	NNS	I-TEST
monitor	NN	I-TEST
and	CC	O
scheduled	VBN	O
for	IN	O
follow-up	NN	O
with	IN	O
cardiology	NN	O
and	CC	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
.	.	O

1.	CD	O
amiodarone	NN	B-TREATMENT
hcl	NN	I-TREATMENT
400	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	VBP	O
one	CD	O
tid	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
,	,	O
then	RB	O
1	CD	O
qd	NN	O
for	IN	O
2	CD	O
months	NNS	O
for	IN	O
2	CD	O
months	NNS	O
:	:	O
please	VB	O
take	VB	O
1	CD	O
tablet	NN	O
3	CD	O
times	NNS	O
per	IN	O
day	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
,	,	O
then	RB	O
take	VB	O
1	CD	O
tablet	NNS	O
per	IN	O
day	NN	O
for	IN	O
2	CD	O
months	NNS	O
.	.	O

2.	CD	O
atorvastatin	JJ	B-TREATMENT
calcium	NN	I-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qd	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
).	NN	O

3.	CD	O
zolpidem	NN	B-TREATMENT
tartrate	NN	I-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

4.	CD	O
potassium	NN	B-TREATMENT
&	CC	I-TREATMENT
sodium	NN	I-TREATMENT
phosphates	NNS	I-TREATMENT
(	(	O
875	CD	O
)	)	O
623	CD	O
9797	CD	O
mg	NN	O
packet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
packet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
warfarin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
).	NN	O

6.	CD	O
penicillin	NN	B-TREATMENT
g	NN	I-TREATMENT
pot	NN	I-TREATMENT
in	IN	I-TREATMENT
dextrose	JJ	I-TREATMENT
2,000,000	CD	O
unit	NN	O
/	VBD	O
50	CD	O
ml	NN	O
piggyback	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
intravenous	JJ	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
).	VBP	O

7.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qd	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

9.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

10.	CD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
cellulitis	NN	B-PROBLEM
,	,	O
bacteremia	NN	B-PROBLEM

please	VB	O
take	VB	O
all	DT	O
over	IN	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
or	CC	O
lightheadedness	NN	B-PROBLEM
.	.	O

please	VB	O
call	VB	O
dr.	JJ	O
pytel	NN	O
(	(	O
760	CD	O
)	)	O
496-3627	CD	O
and	CC	O
make	VB	O
a	DT	O
follow-up	JJ	O
appointment	NN	O
for	IN	O
1	CD	O
week	NN	O
,	,	O
and	CC	O
discuss	VB	O
resuming	VBG	O
your	PRP$	B-TREATMENT
other	JJ	I-TREATMENT
outpatient	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

left	VBN	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

left	VBN	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
with	IN	O
diabetic	JJ	B-PROBLEM
renopathy	NN	I-PROBLEM
,	,	O
renovascular	JJ	B-PROBLEM
occlusive	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
with	IN	O
thrombosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
probably	RB	O
renal	JJ	O
vascular	NN	O
,	,	O
hypertensive	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
history	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

03/03/92	CD	O
-	:	O
left	VBD	B-TREATMENT
carotid	JJ	I-TREATMENT
endarterectomy	NN	I-TREATMENT
with	IN	O
continuous	JJ	B-TEST
interoperative	JJ	I-TEST
electroencephalogram	NN	I-TEST
monitoring	NN	I-TEST
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NNS	I-TREATMENT
patch	VBP	I-TREATMENT
closure	NN	I-TREATMENT
.	.	O

sep/24/05	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
coronary	JJ	B-TEST
angiography	NN	I-TEST
,	,	O
02/23/92	CD	O
-	:	O
transfemoral	JJ	B-TEST
aortogram	NN	I-TEST
,	,	O
bilateral	JJ	B-TEST
carotid	NN	I-TEST
arteriogram	NN	I-TEST
,	,	O
abdominal	JJ	B-TEST
aortogram	NN	I-TEST
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
72	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
known	VBN	B-PROBLEM
carotid	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
and	CC	O
recent	JJ	B-TEST
carotid	NN	I-TEST
noninvasives	NNS	I-TEST
at	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
which	WDT	O
showed	VBD	O
90%	CD	B-PROBLEM
left	NNS	I-PROBLEM
sided	VBD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
a	DT	B-PROBLEM
stroke	NN	I-PROBLEM
,	,	O
or	CC	O
transient	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
attack	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
recently	RB	O
discharged	VBN	O
from	IN	O
the	DT	O
per	NN	O
naplesspecrycet	NN	O
hospital	NN	O
after	IN	O
an	DT	O
admission	NN	O
for	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
having	VBG	O
had	VBD	O
a	DT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
and	CC	O
hysterectomy	NN	B-TREATMENT
,	,	O
tonsillectomy	NN	B-TREATMENT
and	CC	O
adenoidectomy	NN	B-TREATMENT
,	,	O
and	CC	O
mastoidectomy	NN	B-TREATMENT
.	.	O

insulin	NN	B-TREATMENT
44	CD	O
units	NNS	O
nph	JJ	B-TREATMENT
qam	NN	O
;	:	O
8	CD	O
units	NNS	O
qpm	RB	O
;	:	O
vasotec	JJ	B-TREATMENT
2.5	CD	O
qd	NN	O
;	:	O
lasix	CC	B-TREATMENT
40	CD	O
qd	NN	O
;	:	O
mevacor	CC	B-TREATMENT
40	CD	O
qd	NN	O
;	:	O
cardizem	JJ	B-TREATMENT
cd	NN	I-TREATMENT
180	CD	O
qd	NN	O
;	:	O
ciprofloxacin	NN	B-TREATMENT
for	IN	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
;	:	O
aspirin	NN	B-TREATMENT
.	.	O

seldane	NN	B-TREATMENT
causes	VBZ	O
gastrointestinal	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

revealed	VBD	O
2+	CD	B-TEST
carotid	NN	I-TEST
pulses	NNS	I-TEST
with	IN	O
bruits	NNS	B-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
2+	CD	B-TEST
radial	NN	I-TEST
,	,	O
2+	CD	B-TEST
femoral	JJ	I-TEST
,	,	O
1+	CD	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
bilaterally	RB	I-TEST
.	.	O

significant	JJ	O
for	IN	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
33/2.4	CD	O
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
dr.	JJ	O
freiermthalskush	NN	O
of	IN	O
the	DT	O
renal	JJ	O
service	NN	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

on	IN	O
02/22	CD	O
,	,	O
she	PRP	O
underwent	JJ	O
angiography	NN	B-TEST
,	,	O
which	WDT	O
revealed	VBD	O
minimal	JJ	B-PROBLEM
right	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
proximal	JJ	B-PROBLEM
left	VBD	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
2	CD	O
cm	NN	O
in	IN	O
length	NN	O
for	IN	O
the	DT	O
1	CD	O
mm	NN	O
residual	JJ	O
lumen	NNS	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
seen	VBN	O
by	IN	O
cardiology	NN	O
,	,	O
and	CC	O
she	PRP	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
,	,	O
as	IN	O
part	NN	O
of	IN	O
her	PRP$	B-TEST
preop	JJ	I-TEST
evaluation	NN	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
normal	JJ	O
resting	VBG	O
hemodynamics	NNS	O
,	,	O
and	CC	O
a	DT	O
moderate	JJ	O
posterior	NN	O
descending	VBG	O
artery	NN	O
,	,	O
and	CC	O
obtuse	IN	B-PROBLEM
marginal	JJ	I-PROBLEM
stenoses	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
,	,	O
therefore	RB	O
,	,	O
cleared	VBD	O
for	IN	O
the	DT	O
operating	NN	O
room	NN	O
,	,	O
and	CC	O
on	IN	O
3/3/92	CD	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
endarterectomy	NN	I-TREATMENT
,	,	O
with	IN	O
continuous	JJ	B-TEST
electroencephalogram	NNS	I-TEST
monitoring	NN	I-TEST
and	CC	O
vein	JJ	B-TREATMENT
patch	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
uneventful	JJ	O
.	.	O

her	PRP$	O
postoperative	JJ	O
course	NN	O
was	VBD	O
marked	VBN	O
only	RB	O
by	IN	O
prolonged	JJ	B-PROBLEM
ileus	NN	I-PROBLEM
,	,	O
perhaps	RB	O
secondary	JJ	O
to	TO	O
constipation	NN	B-PROBLEM
,	,	O
with	IN	O
persistent	JJ	B-PROBLEM
vomiting	NN	I-PROBLEM
,	,	O
requiring	VBG	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
however	RB	O
,	,	O
on	IN	O
03/07/92	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	O
large	JJ	O
bowel	NN	O
movement	NN	O
,	,	O
after	IN	O
aggressive	JJ	B-TREATMENT
bowel	NN	I-TREATMENT
regime	NN	I-TREATMENT
,	,	O
felt	VBD	O
significantly	RB	O
better	JJR	O
,	,	O
was	VBD	O
able	JJ	O
to	TO	O
tolerate	VB	O
po	JJ	O
&apos;s	NN	O
.	.	O

she	PRP	O
is	VBZ	O
now	RB	O
able	JJ	O
to	TO	O
be	VB	O
discharged	VBN	O
home	NN	O
on	IN	O
her	PRP$	B-TREATMENT
admission	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
the	DT	O
fact	NN	O
that	IN	O
vasotec	NN	B-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
10	CD	O
mg	NNS	O
po	JJ	O
bid	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
30	CD	O
and	CC	O
08-01	JJ	O
week	NN	O
gestation	NN	O
female	NN	O
,	,	O
triplet	VB	O
number	NN	O
two	CD	O
,	,	O
delivered	VBN	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
due	JJ	O
to	TO	O
progressive	JJ	B-PROBLEM
preterm	JJ	I-PROBLEM
labor	NN	I-PROBLEM
and	CC	O
triplet	NN	B-PROBLEM
gestation	NN	I-PROBLEM
.	.	O

prenatal	JJ	B-TEST
screen	NN	I-TEST
,	,	O
o	RB	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
reportedly	RB	O
gbs	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	JJ	B-TEST
immune	NN	O
.	.	O

pregnancy	NN	O
complicated	VBN	O
by	IN	O
gestational	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
,	,	O
then	RB	O
possible	JJ	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

mother	RB	O
presented	VBN	O
with	IN	O
abdominal	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
and	CC	O
vaginal	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
at	IN	O
23	CD	O
and	CC	O
1/7	CD	O
weeks	NNS	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
she	PRP	O
was	VBD	O
admitted	VBN	O
and	CC	O
received	VBN	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
betamethasone	NN	I-TREATMENT
at	IN	O
24	CD	O
weeks	NNS	O
and	CC	O
remained	VBD	O
in	IN	O
house	NN	O
until	IN	O
delivery	NN	B-TREATMENT
.	.	O

mother	RB	O
presented	VBN	O
on	IN	O
day	NN	O
of	IN	O
delivery	NN	B-TREATMENT
with	IN	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
,	,	O
cervical	JJ	B-PROBLEM
dilation	NN	I-PROBLEM
,	,	O
therefore	RB	O
delivered	VBN	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
.	.	O

this	DT	O
triplet	NN	O
required	VBN	O
only	RB	O
blow	VB	B-TREATMENT
by	IN	I-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
routine	JJ	B-TREATMENT
care	NN	I-TREATMENT
in	IN	O
delivery	NN	O
room	NN	O
.	.	O

apgars	NNS	B-TEST
were	VBD	O
8	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
9	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

infant	NN	O
demonstrated	VBD	O
mild	NNS	B-PROBLEM
increased	VBD	I-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	VBG	I-PROBLEM
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
.	.	O

infant	NN	O
transported	VBD	O
to	TO	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
on	IN	O
facial	JJ	B-TREATMENT
cpap	NN	I-TREATMENT
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
1455	CD	O
grams	NN	O
(	(	O
50th	CD	O
percentile	NN	O
),	JJ	O
head	NN	B-TEST
circumference	NN	I-TEST
29.25	CD	O
cm	NN	O
(	(	O
50th	CD	O
percentile	NN	O
),	NN	O
length	NN	B-TEST
41.5	CD	O
cm	NN	O
(	(	O
50th	CD	O
percentile	NN	O
).	NN	O

nondysmorphic	JJ	B-PROBLEM
with	IN	O
overall	JJ	O
appearance	NN	O
consistent	NN	O
with	IN	O
gestational	JJ	O
age	NN	O
.	.	O

anterior	JJ	O
fontanel	NN	O
soft	JJ	O
,	,	O
open	JJ	O
,	,	O
flat	JJ	O
,	,	O
red	JJ	B-TEST
reflex	JJ	I-TEST
present	NN	O
bilaterally	RB	O
,	,	O
palate	JJ	O
intact	NN	O
.	.	O

intermittent	NN	B-PROBLEM
grunting	NN	I-PROBLEM
,	,	O
moderate	JJ	B-PROBLEM
intercostal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
,	,	O
diminished	VBD	B-PROBLEM
air	NN	I-PROBLEM
entry	NN	I-PROBLEM
,	,	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
,	,	O
2+	CD	O
femoral	JJ	B-TEST
pulses	NNS	I-TEST
.	.	O

abdomen	NNS	O
benign	VBP	O
with	IN	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
the	DT	O
infant	NN	O
required	VBN	O
cpap	RB	B-TREATMENT
6	CD	O
cm	NN	O
of	IN	O
water	NN	O
,	,	O
30%	CD	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

initial	JJ	B-TEST
capillary	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
ph	JJ	B-TEST
7.29	CD	O
,	,	O
co2	NN	B-TEST
47	CD	O
.	.	O

infant	NN	O
was	VBD	O
intubated	VBN	B-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
for	IN	O
increased	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
received	VBD	O
one	CD	O
dose	NN	O
of	IN	O
surfactant	NN	B-TREATMENT
.	.	O

infant	NN	O
was	VBD	O
extubated	VBN	B-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
four	CD	O
to	TO	O
cpap	VB	B-TREATMENT
and	CC	O
transitioned	VBN	O
to	TO	O
room	NN	O
air	NN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
.	.	O

caffeine	NN	B-TREATMENT
citrate	NN	I-TREATMENT
was	VBD	O
started	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
and	CC	O
was	VBD	O
discontinued	VBN	O
on	IN	O
05-23	JJ	O
(	(	O
day	NN	O
of	IN	O
life	NN	O
18	CD	O
).	NN	O

the	DT	B-PROBLEM
last	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
was	VBD	O
on	IN	O
06-10	NN	O
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
remained	VBN	O
hemodynamically	RB	O
stable	JJ	O
throughout	IN	O
this	DT	O
hospitalization	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
150	CD	O
to	TO	O
160	CD	O
,	,	O
mean	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
40	CD	O
to	TO	O
54	CD	O
.	.	O

infant	NN	O
was	VBD	O
initially	RB	O
nothing	NN	B-TREATMENT
by	IN	I-TREATMENT
mouth	NN	I-TREATMENT
receiving	VBG	O
80	CD	O
cc	JJ	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
of	IN	O
d10w	NN	B-TREATMENT
intravenously	RB	I-TREATMENT
.	.	O

infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
four	CD	O
and	CC	O
advanced	VBD	O
to	TO	O
full	JJ	O
volume	NN	O
feedings	NNS	O
of	IN	O
150	CD	O
cc	NNS	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
by	IN	O
day	NN	O
of	IN	O
life	NN	O
seven	CD	O
.	.	O

during	IN	O
feeding	VBG	B-TREATMENT
advancement	JJ	I-TREATMENT
infant	NN	O
was	VBD	O
given	VBN	O
parenteral	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
and	CC	O
intralipids	NNS	B-TREATMENT
.	.	O

the	DT	O
infant	NN	O
tolerated	VBD	O
feeding	JJ	B-TREATMENT
advancement	NN	I-TREATMENT
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

infant	NN	O
was	VBD	O
advanced	VBN	O
to	TO	O
maximum	VB	O
caloric	JJ	O
density	NN	O
of	IN	O
breast	NN	O
milk	NN	O
or	CC	O
premature	NN	B-TREATMENT
enfamil	VBP	I-TREATMENT
26	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
with	IN	O
promod	JJ	B-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
11	CD	O
.	.	O

infant	NN	O
is	VBZ	O
currently	RB	O
on	IN	O
breast	NN	O
milk	NN	O
or	CC	O
enfamil	JJ	B-TREATMENT
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
po	NN	O
minimum	JJ	O
140	CD	O
cc	NN	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
.	.	O

the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
weight	NN	I-TEST
is	VBZ	O
2525	CD	O
g.	NN	O

head	NN	B-TEST
circumference	NN	I-TEST
24.5	CD	O
cm	NN	O
,	,	O
length	VBZ	B-TEST
45.5	CD	O
cm	NN	O
.	.	O

the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
electrolytes	NNS	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
were	VBD	O
sodium	NN	B-TEST
145	CD	O
,	,	O
chloride	RB	B-TEST
115	CD	O
,	,	O
potassium	NN	B-TEST
4	CD	O
,	,	O
tco2	NN	B-TEST
of	IN	O
21	CD	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
25	CD	O
,	,	O
calcium	NN	B-TEST
10.1	CD	O
,	,	O
phosphorus	NN	B-TEST
6.9	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
341	CD	O
.	.	O

infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
double	JJ	B-TREATMENT
phototherapy	NN	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
for	IN	O
a	DT	B-TEST
maximum	JJ	I-TEST
bilirubin	JJ	I-TEST
level	NN	I-TEST
of	IN	O
8.1	CD	O
with	IN	O
a	DT	B-TEST
direct	NN	I-TEST
of	IN	O
0.3	CD	O
.	.	O

infant	NN	O
decreased	VBD	O
to	TO	O
single	JJ	B-TREATMENT
phototherapy	NN	I-TREATMENT
and	CC	O
phototherapy	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
.	.	O

rebound	NN	B-TEST
bilirubin	VBZ	I-TEST
level	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
seven	CD	O
was	VBD	O
5.3	CD	O
with	IN	O
a	DT	B-TEST
direct	NN	I-TEST
of	IN	O
0.3	CD	O
.	.	O

the	DT	O
infant	NN	O
did	VBD	O
not	RB	O
receive	VB	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
hematocrit	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
was	VBD	O
47%	CD	O
.	.	O

cbc	NN	B-TEST
on	IN	O
admission	NN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
8.9	CD	O
,	,	O
hematocrit	NN	B-TEST
47%	CD	O
,	,	O
platelets	NNS	B-TEST
243,000	CD	O
,	,	O
6%	CD	O
neutrophils	NNS	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
.	.	O

repeat	NN	B-TEST
cbc	NNS	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
8.4	CD	O
,	,	O
platelets	NNS	B-TEST
95	CD	O
,	,	O
41%	CD	O
neutrophils	NNS	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
.	.	O

repeat	NN	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
was	VBD	O
229	CD	O
.	.	O

the	DT	O
infant	NN	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
for	IN	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

infant	NN	O
has	VBZ	O
not	RB	O
had	VBN	O
any	DT	B-PROBLEM
issues	NNS	I-PROBLEM
with	IN	I-PROBLEM
sepsis	NN	I-PROBLEM
this	DT	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

head	NN	B-TEST
ultrasound	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
seven	CD	O
showed	VBD	O
no	DT	O
intraventricular	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ultrasound	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
33	CD	O
06-07	NN	O
showed	VBD	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
increase	NN	I-PROBLEM
of	IN	I-PROBLEM
echogenicity	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
caudothalamic	JJ	I-PROBLEM
groove	NN	I-PROBLEM
,	,	O
which	WDT	O
may	MD	O
represent	VB	O
tiny	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
germinal	JJ	I-PROBLEM
matrix	NN	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
,	,	O
no	DT	O
periventricular	JJ	B-PROBLEM
leukomalacia	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ultrasound	NN	I-TEST
is	VBZ	O
recommended	VBN	O
in	IN	O
one	CD	O
month	NN	O
.	.	O

sensory	NN	B-TEST
,	,	I-TEST
hearing	VBG	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

ophthalmology	NN	O
,	,	O
eyes	NNS	O
examined	VBD	O
most	JJS	O
recently	RB	O
on	IN	O
05-30	JJ	O
revealing	JJ	O
immaturity	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
retinal	JJ	I-PROBLEM
vessels	NNS	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
rop	NN	B-PROBLEM
as	IN	O
of	IN	O
yet	RB	O
.	.	O

a	DT	B-TEST
follow	JJ	I-TEST
up	RP	I-TEST
examination	NN	I-TEST
should	MD	O
be	VB	O
scheduled	VBN	O
for	IN	O
the	DT	O
week	NN	O
of	IN	O
06-20	NN	O
.	.	O

feedings	NNS	O
breast	VBP	O
milk	NN	O
or	CC	O
enfamil	JJ	B-TREATMENT
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
,	,	O
breast	NN	O
milk	NN	O
mixed	VBN	O
with	IN	O
4	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
of	IN	O
enfamil	JJ	B-TREATMENT
powder	NN	I-TREATMENT
,	,	O
minimum	NN	O
of	IN	O
140	CD	O
cc	NNS	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
po	NN	O
.	.	O

ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
25	CD	O
mg	NN	O
per	IN	O
ml	NN	O
,	,	O
2	CD	O
mg	NN	O
per	IN	O
kilogram	FW	O
per	IN	O
day	NN	O
.	.	O

car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	VBG	I-TEST
passed	VBN	O
on	IN	O
06-07	NN	O
.	.	O

hearing	VBG	B-TEST
screen	NN	I-TEST
passed	VBN	O
on	IN	O
2016-06-07	JJ	O
.	.	O

state	NN	B-TEST
newborn	JJ	I-TEST
screens	NNS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
05-08	JJ	O
and	CC	O
05-19	JJ	O
.	.	O

no	DT	O
abnormal	JJ	B-PROBLEM
results	NNS	I-PROBLEM
have	VBP	O
been	VBN	O
reported	VBN	O
.	.	O

immunizations	NNS	B-TREATMENT
,	,	O
the	DT	O
infant	NN	O
received	VBD	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
2016-06-02	JJ	O
.	.	O

immunizations	NNS	B-TREATMENT
recommended	VBD	O
,	,	O
synagis	JJ	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
,	,	O
born	VBN	O
at	IN	O
less	JJR	O
then	RB	O
32	CD	O
weeks	NNS	O
,	,	O
born	VBN	O
between	IN	O
32	CD	O
and	CC	O
35	CD	O
weeks	NNS	O
with	IN	O
two	CD	O
of	IN	O
three	CD	O
of	IN	O
the	DT	O
following	JJ	O
,	,	O
day	NN	O
care	NN	O
during	IN	O
rsv	NN	O
season	NN	O
,	,	O
smoker	NN	O
on	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
airway	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
school	NN	O
age	NN	O
siblings	NNS	O
or	CC	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
child	NN	O
's	POS	O
life	NN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
triplet	NN	O
number	NN	O
two	CD	O
.	.	O

2.	CD	O
status	NN	O
post	NN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

3.	CD	O
status	NN	O
post	NN	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
,	,	O
ruled	VBD	O
out	RP	O
.	.	O

4.	CD	O
status	NN	O
post	NN	O
apnea	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

5.	CD	O
status	NN	O
post	NN	O
indirect	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
.	.	O

osteochondromatosis	NN	B-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
knee	NN	I-PROBLEM
.	.	O

osteochondromatosis	NN	B-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
knee	NN	I-PROBLEM
.	.	O

this	DT	O
68	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
who	WP	O
had	VBD	O
a	DT	O
seven	CD	O
to	TO	O
eight	CD	O
year	NN	O
history	NN	O
of	IN	O
knee	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

in	IN	O
1984	CD	O
,	,	O
he	PRP	O
had	VBD	O
the	DT	O
right	JJ	O
knee	NN	O
aspirated	VBD	O
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	O
uric	JJ	B-PROBLEM
acid	NN	I-PROBLEM
crystals	NNS	I-PROBLEM
,	,	O
although	IN	O
serum	JJ	B-TEST
uric	JJ	I-TEST
acid	NN	I-TEST
was	VBD	O
normal	JJ	O
and	CC	O
erythrocyte	JJ	B-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
intermittent	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
fullness	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
suprapatellar	JJ	I-PROBLEM
pouch	NN	I-PROBLEM
.	.	O

plain	NN	B-TEST
films	NNS	I-TEST
taken	VBN	O
by	IN	O
his	PRP$	O
orthopedist	NN	O
in	IN	O
mongcana	NN	O
ster	NN	O
staarv	NN	O
revealed	VBD	O
some	DT	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
calcification	NN	I-PROBLEM
within	IN	O
the	DT	O
medial	JJ	O
and	CC	O
lateral	JJ	O
compartments	NNS	O
of	IN	O
the	DT	O
joint	JJ	O
.	.	O

an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
demonstrated	VBD	O
calcification	NN	B-PROBLEM
densities	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
suprapatellar	JJ	I-PROBLEM
bursa	NN	I-PROBLEM
region	NN	I-PROBLEM
,	,	O
also	RB	O
with	IN	O
hypertrophia	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
synovium	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
synovial	JJ	B-PROBLEM
chondromatosis	NN	I-PROBLEM
and	CC	O
would	MD	O
benefit	VB	O
from	IN	O
an	DT	B-TREATMENT
open	JJ	I-TREATMENT
synovectomy	NN	I-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
that	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
tonsillectomy	VBN	B-TREATMENT
at	IN	O
the	DT	O
age	NN	O
of	IN	O
five	CD	O
,	,	O
and	CC	O
appendectomy	NN	B-TREATMENT
in	IN	O
1940	CD	O
.	.	O

he	PRP	O
had	VBD	O
right	JJ	B-TREATMENT
knee	NN	I-TREATMENT
aspirations	NNS	I-TREATMENT
done	VBN	O
in	IN	O
1986	CD	O
,	,	O
otherwise	RB	O
,	,	O
he	PRP	O
does	VBZ	O
not	RB	O
suffer	VB	O
from	IN	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
general	JJ	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

heart	NN	B-TEST
,	,	I-TEST
chest	NN	I-TEST
,	,	I-TEST
and	CC	I-TEST
abdominal	JJ	I-TEST
examinations	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

the	DT	B-TEST
right	JJ	I-TEST
knee	NN	I-TEST
examination	NN	I-TEST
showed	VBD	O
some	DT	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
peripheral	JJ	I-TEST
pulses	NNS	I-TEST
were	VBD	O
palpable	JJ	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
44.4	CD	O
,	,	O
with	IN	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
11.9	CD	O
,	,	O
and	CC	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
410	CD	O
.	.	O

his	PRP$	B-TEST
mcv	NN	I-TEST
was	VBD	O
92	CD	O
,	,	O
mch	FW	B-TEST
32.1	CD	O
,	,	O
and	CC	O
mche	$	B-TEST
34.8	CD	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	B-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
nonspecific	JJ	B-PROBLEM
t-wave	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
otherwise	RB	O
,	,	O
it	PRP	O
was	VBD	O
normal	JJ	O
.	.	O

he	PRP	O
underwent	VBD	O
right	JJ	B-TREATMENT
knee	NN	I-TREATMENT
open	JJ	I-TREATMENT
synovectomy	NN	I-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
of	IN	O
synovial	JJ	B-PROBLEM
chondromatosis	NN	I-PROBLEM
on	IN	O
10-28-93	JJ	O
.	.	O

he	PRP	O
is	VBZ	O
mobilized	VBN	O
with	IN	O
the	DT	O
help	NN	O
of	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
on	IN	O
a	DT	B-TREATMENT
continuous	JJ	I-TREATMENT
passive	JJ	I-TREATMENT
motion	NN	I-TREATMENT
machine	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
on	IN	O
pain	NN	B-TREATMENT
medication	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
also	RB	O
on	IN	O
percocet	NN	B-TREATMENT
,	,	O
but	CC	O
now	RB	O
he	PRP	O
can	MD	O
manage	VB	O
without	IN	O
the	DT	O
percocet	NN	B-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
on	IN	O
coumadin	NN	B-TREATMENT
which	WDT	O
is	VBZ	O
to	TO	O
be	VB	O
continued	VBN	O
for	IN	O
six	CD	O
weeks	NNS	O
.	.	O

percocet	JJ	B-TREATMENT
1-2	JJ	O
po	NN	O
q4h	NN	O
prn	NN	O
.	.	O

on	IN	O
discharge	NN	O
,	,	O
he	PRP	O
is	VBZ	O
mobilized	VBN	O
,	,	O
partial	JJ	O
weight	NN	O
bearing	VBG	O
with	IN	O
the	DT	O
help	NN	O
of	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
.	.	O

neuropathic	JJ	B-PROBLEM
pain	NN	I-PROBLEM

post	NN	B-PROBLEM
thoracotomy	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
trial	NN	I-TREATMENT
on	IN	O
07/21/99	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
trial	NN	I-TREATMENT
on	IN	O
07/24/99	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
post	NN	B-PROBLEM
thoracotomy	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
that	WDT	O
occurred	VBD	O
on	IN	O
the	DT	O
site	NN	O
of	IN	O
her	PRP$	B-PROBLEM
thoracotomy	JJ	I-PROBLEM
incision	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
thoracic	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
repaired	VBN	O
in	IN	O
the	DT	O
past	JJ	O
and	CC	O
subsequently	RB	O
developed	VBD	O
neuropathic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
at	IN	O
the	DT	B-PROBLEM
incision	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
currently	RB	O
on	IN	O
vicodin	NN	B-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
every	DT	O
four	CD	O
hours	NNS	O
p.r.n.	RB	O
,	,	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
25	CD	O
mcg	NN	O
an	DT	O
hour	NN	O
,	,	O
change	NN	O
of	IN	O
patch	NN	O
every	DT	O
72	CD	O
hours	NNS	O
,	,	O
elavil	VBP	B-TREATMENT
50	CD	O
mgq	JJ	O
.h.s.	NN	O
,	,	O
neurontin	RB	B-TREATMENT
600	CD	O
mg	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
with	IN	O
still	RB	O
what	WP	O
she	PRP	O
reports	VBZ	O
as	IN	O
stabbing	VBG	B-PROBLEM
left-sided	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
that	WDT	O
can	MD	O
be	VB	O
as	RB	O
severe	JJ	O
as	IN	O
a	DT	O
7/10.	CD	O

she	PRP	O
has	VBZ	O
failed	VBN	O
conservative	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
is	VBZ	O
admitted	VBN	O
for	IN	O
a	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
trial	NN	I-TREATMENT
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2.	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

3.	CD	O
paraplegia	NN	B-PROBLEM
status	NN	O
post	NN	O
thoracic	NN	B-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

4.	CD	O
left	VBD	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM
paralysis	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
recurrent	NN	B-PROBLEM
lung	NN	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

5.	CD	O
sacral	JJ	B-PROBLEM
decubitus	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

6.	CD	O
home	NN	B-TREATMENT
oxygen	NN	I-TREATMENT
at	IN	O
two	CD	O
liters	NNS	O
a	DT	O
minute	NN	O
when	WRB	O
she	PRP	O
is	VBZ	O
at	IN	O
home	NN	O
;	:	O
she	PRP	O
does	VBZ	O
not	RB	O
use	VB	O
the	DT	B-TREATMENT
oxygen	NN	I-TREATMENT
when	WRB	O
she	PRP	O
is	VBZ	O
in	IN	O
a	DT	B-TREATMENT
wheelchair	NN	I-TREATMENT
or	CC	O
is	VBZ	O
out	IN	O
of	IN	O
the	DT	O
house	NN	O
.	.	O

1.	CD	O
atrovent	JJ	B-TREATMENT
nebulizers	NNS	I-TREATMENT
0.5	CD	O
mg	NNS	O
mixed	JJ	O
with	IN	O
albuterol	NN	B-TREATMENT
,	,	O
nebulizer	NN	B-TREATMENT
is	VBZ	O
given	VBN	O
every	DT	O
six	CD	O
hours	NNS	O
.	.	O

2.	CD	O
norvasc	JJ	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

3.	CD	O
colistin	NN	B-TREATMENT
30	CD	O
mg	NN	O
nebulizer	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
give	VB	O
30	CD	O
minutes	NNS	O
post	VBP	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	NN	B-TREATMENT
.	.	O

4.	CD	O
pressure	NN	B-TREATMENT
,	,	I-TREATMENT
dermal	JJ	I-TREATMENT
ulcer	NN	I-TREATMENT
care	NN	I-TREATMENT
b.i.d.	IN	O
dressing	VBG	B-TREATMENT
change	NN	I-TREATMENT
with	IN	O
antibiotic	JJ	B-TREATMENT
solution	NN	I-TREATMENT
.	.	O

5.	CD	O
neurontin	JJ	B-TREATMENT
600	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

6.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

7.	CD	O
albuterol	NN	B-TREATMENT
neb	RB	I-TREATMENT
2.5	CD	O
mg	NN	O
every	DT	O
six	CD	O
hours	NNS	O
,	,	O
30	CD	O
minutes	NNS	O
before	IN	O
colistin	NN	B-TREATMENT
.	.	O

8.	CD	O
amitriptyline	JJ	B-TREATMENT
50	CD	O
mg	NNS	O
q.h.s.	NN	O

9.	CD	O
vitamin	JJ	B-TREATMENT
c	NN	I-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

10.	CD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
125.0	CD	O
mg	NN	O
t.i.d.	NN	O

11.	CD	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
25	CD	O
mcg	NN	O
an	DT	O
hour	NN	O
,	,	O
change	NN	O
patch	NN	B-TREATMENT
every	DT	O
72	CD	O
hours	NNS	O
.	.	O

12.	CD	O
folate	JJ	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

13.	CD	O
synthroid	JJ	B-TREATMENT
50	CD	O
mcg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

14.	CD	O
zinc	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
220	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

15.	CD	O
multivitamin	NN	B-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

16.	CD	O
hydrocodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
with	IN	O
tylenol	NN	B-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
every	DT	O
four	CD	O
hours	NNS	O
p.r.n.	RB	O
pain	VBP	B-PROBLEM
.	.	O

17.	CD	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
30	CD	O
cc	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
constipation	NN	B-PROBLEM
.	.	O

penicillin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
well-appearing	JJ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
is	VBZ	O
150/90	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
90	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
with	IN	O
saturation	NN	B-TEST
of	IN	O
98%	CD	O
.	.	O

the	DT	O
patient	NN	O
wears	VBZ	O
dentures	NNS	B-TREATMENT
.	.	O

full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

decreased	VBN	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
with	IN	O
coarse	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

epidural	JJ	O
site	NN	O
is	VBZ	O
without	IN	O
erythema	NN	B-PROBLEM
,	,	O
drainage	NN	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

left	VBN	O
buttock	NN	O
area	NN	O
has	VBZ	O
a	DT	B-TREATMENT
dressing	NN	I-TREATMENT
over	IN	O
the	DT	B-PROBLEM
sacral	JJ	I-PROBLEM
decubitus	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

flaccid	JJ	B-PROBLEM
paralysis	NN	I-PROBLEM
of	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
07/20/99	CD	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
left	JJ	B-PROBLEM
chest	JJS	I-PROBLEM
wall	NN	I-PROBLEM
pain	NN	I-PROBLEM
from	IN	O
postthoracotomy	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
the	DT	B-PROBLEM
syndrome	NN	I-PROBLEM
after	IN	O
her	PRP$	B-TREATMENT
thoracic	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
failed	VBD	O
the	DT	B-TREATMENT
conservative	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
is	VBZ	O
admitted	VBN	O
for	IN	O
a	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
trial	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
placed	VBD	O
on	IN	O
07/21/99	CD	O
.	.	O

she	PRP	O
underwent	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
very	RB	O
well	RB	O
.	.	O

the	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
was	VBD	O
programmed	VBN	O
with	IN	O
setting	NN	O
of	IN	O
a	DT	O
rate	NN	O
of	IN	O
80	CD	O
,	,	O
power	NN	O
450	CD	O
and	CC	O
4.0	CD	O
amps	NNS	O
.	.	O

the	DT	O
patient	NN	O
the	DT	O
next	JJ	O
two	CD	O
days	NNS	O
did	VBD	O
not	RB	O
notice	VB	O
any	DT	O
significant	JJ	O
change	NN	O
in	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
pattern	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	O
lot	NN	O
of	IN	O
musculoskeletal	JJ	B-PROBLEM
component	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

so	RB	O
,	,	O
an	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
on	IN	O
07/23/99	CD	O
.	.	O

the	DT	B-TREATMENT
epidural	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
the	DT	O
l1-2	JJ	O
region	NN	O
and	CC	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
the	DT	O
t7	JJ	O
region	NN	O
using	VBG	O
fluoroscope	NN	B-TEST
to	TO	O
guide	VB	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

within	IN	O
the	DT	O
next	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
,	,	O
the	DT	O
patient	NN	O
noticed	VBD	O
a	DT	O
significant	JJ	O
improvement	NN	O
in	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
pattern	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
stabbing	NN	I-PROBLEM
,	,	I-PROBLEM
sharp	JJ	I-PROBLEM
pain	NN	I-PROBLEM
that	IN	O
she	PRP	O
occasionally	RB	O
has	VBZ	O
on	IN	O
the	DT	O
left	NN	O
chest	JJS	O
wall	NN	O
was	VBD	O
significantly	RB	O
diminished	VBN	O
and	CC	O
she	PRP	O
also	RB	O
noticed	VBD	O
periods	NNS	O
of	IN	O
time	NN	O
when	WRB	O
she	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	O
of	IN	O
that	DT	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
had	VBD	O
a	DT	B-TREATMENT
morphine	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
initially	RB	O
started	VBD	O
at	IN	O
1	CD	O
mg	NNS	O
a	DT	O
day	NN	O
and	CC	O
increased	VBD	O
to	TO	O
3	CD	O
mg	NNS	O
a	DT	O
day	NN	O
in	IN	O
a	DT	O
period	NN	O
of	IN	O
three	CD	O
days	NNS	O
.	.	O

the	DT	B-TREATMENT
epidural	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
07/26/99	CD	O
and	CC	O
was	VBD	O
considered	VBN	O
a	DT	B-TREATMENT
successful	JJ	I-TREATMENT
trial	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
schedule	VB	O
with	IN	O
the	DT	O
pain	NN	O
clinic	JJ	O
regarding	VBG	O
upcoming	JJ	B-TREATMENT
epidural	JJ	I-TREATMENT
pump	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

dr.	NN	O
falccouette	NN	O
would	MD	O
like	VB	O
to	TO	O
perform	VB	O
an	DT	B-TREATMENT
excision	NN	I-TREATMENT
and	CC	O
closure	NN	B-TREATMENT
flap	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
ischial	JJ	I-PROBLEM
decubitusin	NN	I-PROBLEM
the	DT	O
near	JJ	O
future	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
in	IN	O
stable	JJ	O
conditionand	NN	O
will	MD	O
follow	VB	O
up	RP	O
for	IN	O
(	(	O
1	CD	O
)	)	O
sacral	JJ	B-TREATMENT
decubitus	NN	I-TREATMENT
closure	NN	I-TREATMENT
,	,	O
and	CC	O
(	(	O
2	CD	O
)	)	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
epidural	JJ	I-TREATMENT
pump	NN	I-TREATMENT
in	IN	O
the	DT	O
future	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
have	VB	O
smh	JJ	O
service	NN	O
that	WDT	O
comes	VBZ	O
to	TO	O
her	PRP$	O
home	NN	O
once	IN	O
a	DT	O
day	NN	O
for	IN	O
adressing	VBG	B-TREATMENT
change	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
kayschird	NN	O
to	TO	O
schedule	NN	O
for	IN	O
the	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
pump	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr.	NN	O
falccouette	NN	O
to	TO	O
schedule	NN	O
for	IN	O
excision	NN	B-TREATMENT
and	CC	O
closure	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
ischial	JJ	I-PROBLEM
sacral	JJ	I-PROBLEM
decubitus	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
myelomonocytic	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM
,	,	O
without	IN	O
remission	NN	O
,	,	O

chronic	JJ	B-PROBLEM
myelomonocytic	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM
,	,	O
without	IN	O
remission	NN	O
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
airway	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
,	,	O
hypopotassemia	NN	B-PROBLEM
,	,	O
cellulitis	NN	B-PROBLEM
,	,	O
orbital	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
protein	NN	B-PROBLEM
calorie	NN	I-PROBLEM
malnutrition	NN	I-PROBLEM
,	,	O
gastrointestinal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
/	NNP	O
pneumonia	NN	B-PROBLEM
,	,	O
hyperglycemia	NN	B-PROBLEM
,	,	O
renal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
hyperuricemia	NN	B-PROBLEM
,	,	O
hypophosphatemia	NN	B-PROBLEM
.	.	O

this	DT	O
75	CD	O
year	NN	O
old	JJ	O
male	NN	O
had	VBD	O
been	VBN	O
noted	VBN	O
to	TO	O
be	VB	O
anemic	JJ	B-PROBLEM
with	IN	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
count	NN	I-PROBLEM
since	IN	O
at	IN	O
least	JJS	O
november	JJ	O
1993	CD	O
,	,	O
while	IN	O
he	PRP	O
was	VBD	O
living	VBG	O
in	IN	O
aersing	VBG	O
rocuch	JJ	O
sun	NN	O
and	CC	O
his	PRP$	O
physicians	NNS	O
there	EX	O
had	VBD	O
begun	VBN	O
to	TO	O
manage	VB	O
him	PRP	O
with	IN	O
transfusions	NNS	B-TREATMENT
,	,	O
and	CC	O
low	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
hydroxyurea	NN	I-TREATMENT
.	.	O

apparently	RB	O
,	,	O
a	DT	B-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
confirmed	VBD	O
the	DT	O
diagnosis	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
myelomonocytic	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
noting	VBG	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
fatigue	NN	I-PROBLEM
,	,	O
anorexia	NN	B-PROBLEM
,	,	O
and	CC	O
dyspnea	NN	B-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
not	RB	O
particularly	RB	O
improved	VBN	O
by	IN	O
increased	JJ	B-TREATMENT
transfusions	NNS	I-TREATMENT
or	CC	O
alterations	NNS	O
of	IN	O
hydroxy	JJ	B-TREATMENT
urea	NN	I-TREATMENT
.	.	O

he	PRP	O
became	VBD	O
profoundly	RB	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM
,	,	O
and	CC	O
ultimately	RB	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
on	IN	O
2/15	CD	O
with	IN	O
headache	NN	B-PROBLEM
and	CC	O
weakness	NN	B-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
managed	VBD	O
with	IN	O
an	DT	O
italian	JJ	O
variation	NN	O
of	IN	O
digoxin	NN	B-TREATMENT
,	,	O
and	CC	O
amioadrone	NN	B-TREATMENT
,	,	O
hypertension	NN	B-PROBLEM
managed	VBD	O
with	IN	O
an	DT	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
managed	VBD	O
with	IN	O
a	DT	B-TREATMENT
zanthine	NN	I-TREATMENT
preparation	NN	I-TREATMENT
and	CC	O
low	JJ	B-TREATMENT
dose	NN	I-TREATMENT
steroids	NNS	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
an	DT	B-TREATMENT
occasional	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
.	.	O

other	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
included	VBD	O
chronic	JJ	B-PROBLEM
liver	NN	I-PROBLEM
disease	NN	I-PROBLEM
of	IN	O
uncertain	JJ	O
etiology	NN	O
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
had	VBD	O
been	VBN	O
advised	VBN	O
not	RB	O
to	TO	O
drink	VB	O
any	DT	O
alcohol	NN	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
penetrating	JJ	I-PROBLEM
injury	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
eye	NN	I-PROBLEM
,	,	O
which	WDT	O
had	VBD	O
rendered	VBN	O
him	PRP	O
blind	IN	B-PROBLEM
10	CD	O
years	NNS	O
previously	RB	O
.	.	O

he	PRP	O
was	VBD	O
a	DT	O
chronically	RB	O
ill	JJ	O
appearing	VBG	O
elderly	JJ	O
man	NN	O
,	,	O
with	IN	O
a	DT	B-TEST
respiratory	JJ	I-TEST
rate	NN	I-TEST
of	IN	O
30	CD	O
,	,	O
temperature	NN	B-TEST
99.6	CD	O
,	,	O
pulse	RB	B-TEST
100	CD	O
,	,	O
and	CC	O
irregularly	RB	B-PROBLEM
irregular	JJ	I-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
148/71	CD	O
.	.	O

he	PRP	O
had	VBD	O
some	DT	B-PROBLEM
petechiae	NN	I-PROBLEM
on	IN	I-PROBLEM
his	PRP$	I-PROBLEM
extremities	NNS	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
his	PRP$	O
mucosal	NN	O
membranes	NNS	O
with	IN	O
some	DT	B-PROBLEM
hemorrhagic	JJ	I-PROBLEM
bullae	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
bibasilar	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
with	IN	O
some	DT	B-PROBLEM
wheezing	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
cardiac	JJ	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

his	PRP$	O
abdomen	NNS	O
was	VBD	O
distended	VBN	B-PROBLEM
with	IN	O
massive	JJ	B-PROBLEM
hepatosplenomegaly	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
somewhat	RB	B-PROBLEM
tender	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
aside	RB	O
from	IN	O
the	DT	B-PROBLEM
blind	NN	I-PROBLEM
right	JJ	I-PROBLEM
eye	NN	I-PROBLEM
was	VBD	O
unremarkable	JJ	O
.	.	O

included	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
140,000	CD	O
,	,	O
7%	CD	B-TEST
polys	NN	I-TEST
,	,	O
1%	CD	B-TEST
bands	NNS	I-TEST
,	,	O
3%	CD	B-TEST
lymphs	NN	I-TEST
,	,	O
1%	CD	B-TEST
monos	NNS	I-TEST
,	,	O
2	CD	B-TEST
basos	NN	I-TEST
,	,	O
4	CD	B-TEST
blasts	NNS	I-TEST
,	,	O
76%	CD	B-TEST
pearl	NN	I-TEST
monocytes	NNS	I-TEST
,	,	O
6%	CD	B-TEST
meta	NN	I-TEST
&apos;s	NN	I-TEST
,	,	O
3	CD	B-TEST
nucleated	VBN	I-TEST
red	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

there	EX	O
were	VBD	O
some	DT	O
oval	JJ	B-PROBLEM
tear	JJ	I-PROBLEM
drop	NN	I-PROBLEM
cells	NNS	I-PROBLEM
and	CC	O
target	NN	B-PROBLEM
cells	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
schistocytes	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
was	VBD	O
9,000	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
26.5	CD	O
,	,	O
with	IN	O
an	DT	B-TEST
mean	JJ	I-TEST
corpuscular	JJ	I-TEST
volume	NN	I-TEST
of	IN	O
about	IN	O
73	CD	O
.	.	O

his	PRP$	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
and	CC	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

his	PRP$	B-TEST
uric	JJ	I-TEST
acid	NN	I-TEST
was	VBD	O
up	RB	O
at	IN	O
97	CD	O
,	,	O
his	PRP$	B-TEST
total	JJ	I-TEST
bilirubin	NN	I-TEST
was	VBD	O
up	RB	O
at	IN	O
1.8	CD	O
,	,	O
his	PRP$	B-TEST
ldh	NN	I-TEST
was	VBD	O
428	CD	O
,	,	O
his	PRP$	B-TEST
phosphorus	NN	I-TEST
was	VBD	O
1.2	CD	O
,	,	O
calcium	NN	B-TEST
8.6	CD	O
,	,	O
digoxin	NN	B-TEST
level	NN	I-TEST
was	VBD	O
1.0	CD	O
,	,	O
potassium	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
2.9	CD	O
,	,	O
sodium	NN	B-TEST
135	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
13/1.6	CD	O
,	,	O
and	CC	O
sugar	NN	B-TEST
of	IN	O
267	CD	O
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
of	IN	O
his	PRP$	O
head	NN	O
showed	VBD	O
no	DT	O
signs	NNS	O
of	IN	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
no	DT	O
new	JJ	B-PROBLEM
infiltrates	NNS	I-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
cardiomegaly	NN	B-PROBLEM
with	IN	O
prominent	JJ	B-PROBLEM
vascularity	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
effusions	NNS	B-PROBLEM
.	.	O

an	DT	B-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
begun	VBN	O
on	IN	O
high	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
hydroxyurea	NNS	I-TREATMENT
,	,	O
with	IN	O
a	DT	O
gradual	JJ	O
improvement	NN	O
in	IN	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
.	.	O

he	PRP	O
did	VBD	O
spike	VB	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
and	CC	O
began	VBD	O
ancef	NNS	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
,	,	O
although	IN	O
cultures	NNS	B-TEST
never	RB	O
revealed	VBD	O
a	DT	O
source	NN	O
for	IN	O
this	DT	O
.	.	O

he	PRP	O
also	RB	O
tried	VBD	O
amicar	NN	B-TREATMENT
and	CC	O
continued	VBN	O
on	IN	O
low	JJ	B-TREATMENT
dose	NN	I-TREATMENT
prednisone	NN	I-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
headache	NN	I-PROBLEM
improved	VBD	O
,	,	O
but	CC	O
her	PRP$	O
remained	VBD	O
profoundly	RB	B-PROBLEM
weak	JJ	I-PROBLEM
and	CC	O
intermittently	RB	B-PROBLEM
febrile	JJ	I-PROBLEM
with	IN	O
dyspnea	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
hemoptysis	NN	B-PROBLEM
and	CC	O
intermittent	JJ	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
while	IN	O
he	PRP	O
remained	VBD	O
profoundly	RB	B-PROBLEM
thrombocytopenia	JJ	I-PROBLEM
.	.	O

transfusions	NNS	B-TREATMENT
of	IN	I-TREATMENT
platelets	NNS	I-TREATMENT
did	VBD	O
not	RB	O
change	VB	O
his	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
,	,	O
presumably	RB	O
because	IN	O
of	IN	O
sequestration	NN	B-PROBLEM
and	CC	O
a	DT	B-PROBLEM
massive	JJ	I-PROBLEM
spleen	NN	I-PROBLEM
.	.	O

amicar	NN	B-TREATMENT
was	VBD	O
of	IN	O
uncertain	JJ	O
value	NN	O
,	,	O
but	CC	O
used	VBD	O
intermittently	RB	O
.	.	O

a	DT	B-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
revealed	VBD	O
the	DT	O
transformation	NN	O
of	IN	O
his	PRP$	B-PROBLEM
cmml	NN	I-PROBLEM
to	TO	O
acute	VB	B-PROBLEM
myelogenous	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM
,	,	O
and	CC	O
given	VBN	O
his	PRP$	B-PROBLEM
other	JJ	I-PROBLEM
underlying	JJ	I-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
we	PRP	O
chose	VBD	O
chemotherapy	NN	B-TREATMENT
with	IN	O
subcutaneous	JJ	B-TREATMENT
cystosine	NN	I-TREATMENT
arabinoside	NN	I-TREATMENT
and	CC	O
6-thioguanine	NN	B-TREATMENT
,	,	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
without	IN	O
incident	NN	O
and	CC	O
this	DT	O
brought	VBD	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
down	RB	O
to	TO	O
below	IN	O
1,000	CD	O
,	,	O
and	CC	O
his	PRP$	O
spleen	JJ	O
shrank	NN	O
noticeably	RB	O
,	,	O
but	CC	O
he	PRP	O
still	RB	O
could	MD	O
not	RB	O
maintain	VB	O
a	DT	O
bump	NN	O
in	IN	O
platelet	NN	B-TEST
count	NN	I-TEST
with	IN	O
platelet	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
intermittently	RB	B-PROBLEM
congested	VBN	I-PROBLEM
limiting	VBG	O
our	PRP$	O
ability	NN	O
to	TO	O
give	VB	O
intravenous	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
,	,	O
for	IN	O
his	PRP$	B-TREATMENT
hydrea	NN	I-TREATMENT
,	,	O
although	IN	O
we	PRP	O
kept	VBD	O
him	PRP	O
on	IN	O
allopurinol	NN	B-TREATMENT
.	.	O

the	DT	O
renal	JJ	O
function	NN	O
deteriorated	VBD	O
somewhat	RB	O
,	,	O
hampering	VBG	O
our	PRP$	O
ability	NN	O
to	TO	O
give	VB	O
him	PRP	O
his	PRP$	B-TREATMENT
gentamicin	NN	I-TREATMENT
.	.	O

the	DT	O
family	NN	O
maintained	VBD	O
an	DT	O
extraordinary	JJ	O
vigil	NN	O
over	IN	O
the	DT	O
days	NNS	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
,	,	O
providing	VBG	O
him	PRP	O
with	IN	O
some	DT	O
food	NN	O
and	CC	O
constant	JJ	O
attention	NN	O
,	,	O
while	IN	O
we	PRP	O
awaited	VBD	O
the	DT	O
results	NNS	O
of	IN	O
his	PRP$	B-TREATMENT
chemotherapy	NN	I-TREATMENT
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
intermittently	RB	B-PROBLEM
restless	JJ	I-PROBLEM
and	CC	O
somewhat	RB	B-PROBLEM
confused	JJ	I-PROBLEM
,	,	O
and	CC	O
as	IN	O
his	PRP$	O
respiratory	NN	O
status	NN	O
deteriorated	VBN	O
,	,	O
the	DT	O
family	NN	O
agreed	VBD	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
dose	JJ	I-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
which	WDT	O
made	VBD	O
him	PRP	O
much	RB	O
more	RBR	O
comfortable	JJ	O
.	.	O

they	PRP	O
agreed	VBD	O
with	IN	O
a	DT	O
do	NN	O
not	RB	O
resuscitate	VB	O
status	NN	O
early	RB	O
on	IN	O
in	IN	O
the	DT	O
hospitalization	NN	O
and	CC	O
in	IN	O
the	DT	O
course	NN	O
of	IN	O
being	VBG	O
maintain	VBN	O
on	IN	O
low	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
morphine	NN	I-TREATMENT
,	,	O
he	PRP	O
ultimately	RB	O
expired	VBD	O
on	IN	O
2/28/94	CD	O
with	IN	O
the	DT	O
family	NN	O
present	NN	O
.	.	O

no	DT	O
autopsy	NN	B-TEST
was	VBD	O
obtained	VBN	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
64-year-old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
endocarditis	NN	B-PROBLEM
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
and	CC	O
mitral	JJ	B-TREATMENT
valve	FW	I-TREATMENT
replacement	NN	I-TREATMENT
on	IN	O
2010-08-13	JJ	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
erich	VB	O
lindemann	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
from	IN	O
the	DT	O
rehabilitation	NN	O
center	NN	O
where	WRB	O
he	PRP	O
had	VBD	O
been	VBN	O
discharged	VBN	O
to	TO	O
on	IN	O
2010-08-25	JJ	O
following	VBG	O
his	PRP$	B-TREATMENT
cabg/mvr	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
rehabilitation	NN	O
center	NN	O
the	DT	O
patient	NN	O
developed	VBD	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
done	VBN	O
at	IN	O
that	DT	O
time	NN	O
revealed	VBD	O
a	DT	B-PROBLEM
left-sided	JJ	I-PROBLEM
infiltrate	NN	I-PROBLEM
versus	NN	O
effusion	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
mass.	VB	O
eye	NN	O
&	CC	O
ear	JJ	O
infirmary	NN	O
for	IN	O
treatment	NN	B-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
he	PRP	O
complained	VBD	O
of	IN	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
or	CC	O
cough	NN	B-PROBLEM
,	,	O
although	IN	O
he	PRP	O
is	VBZ	O
intermittently	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
anticoagulated	VBN	B-TREATMENT
during	IN	O
his	PRP$	O
stay	NN	O
at	IN	O
rehabilitation	NN	O
for	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

1.	CD	O
significant	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
cabg/mvr	NN	B-TREATMENT
.	.	O

2.	CD	O
endocarditis	NN	B-PROBLEM
.	.	O

3.	CD	O
rectal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

4.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
b.i.d.	NN	O

3.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
b.i.d.	NN	O

4.	CD	O
ampicillin	JJ	B-TREATMENT
2	CD	O
grams	NNS	O
q.	RB	O
4	CD	O
hours	NNS	O
.	.	O

5.	CD	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	JJ	B-TREATMENT
p.r.n.	NN	O

6.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
q.d.	NN	O

7.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
q.d.	NN	O

8.	CD	O
nystatin	JJ	B-TREATMENT
swish	JJ	O
and	CC	O
swallow	JJ	O
5	CD	O
cc	NN	O
t.i.d.	NN	O

9.	CD	O
colace	NN	B-TREATMENT
100	CD	O
b.i.d.	NN	O

10.	CD	O
percocet	NN	B-TREATMENT
5/325	CD	O
,	,	O
1-2	JJ	O
tablets	NNS	O
q.	VBD	O
4	CD	O
hours	NNS	O
p.r.n.	NN	O

white	JJ	B-TEST
count	NN	I-TEST
12.6	CD	O
,	,	O
hematocrit	NN	B-TEST
28.9	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
259	CD	O
,	,	O
pt	NN	B-TEST
21.4	CD	O
,	,	O
ptt	NN	B-TEST
40.2	CD	O
,	,	O
inr	NN	B-TEST
3.0	CD	O
,	,	O
sodium	NN	B-TEST
137	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
100	CD	O
,	,	O
co2	NN	B-TEST
27	CD	O
,	,	O
bun	NN	B-TEST
26	CD	O
,	,	O
creatinine	NN	B-TEST
1.3	CD	O
,	,	O
glucose	VBD	B-TEST
120	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
shows	VBZ	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
temperature	JJ	B-TEST
100.1	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
83	CD	O
and	CC	O
sinus	JJ	O
rhythm	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
108/50	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
25	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97%	CD	O
on	IN	O
three	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

generally	RB	O
he	PRP	O
was	VBD	O
a	DT	O
pleasant	JJ	O
man	NN	O
with	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

lungs	NNS	O
had	VBD	O
decreased	VBN	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
on	IN	O
the	DT	O
left	NN	O
.	.	O

cardiac	JJ	B-TEST
examination	NN	I-TEST
showed	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s1	NN	O
and	CC	O
s2	NN	O
.	.	O

chest	JJS	B-PROBLEM
incision	NN	I-PROBLEM
was	VBD	O
with	IN	O
steri-strips	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
had	VBD	O
bilateral	JJ	B-PROBLEM
pedal	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
leg	NN	I-PROBLEM
wound	NN	I-PROBLEM
had	VBD	O
steri-strips	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
to	TO	O
correct	VB	O
his	PRP$	B-TEST
inr	NN	I-TEST
and	CC	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

over	IN	O
the	DT	O
first	JJ	O
12	CD	O
hours	NNS	O
the	DT	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
drained	VBD	O
2,500	CD	O
cc	NN	O
.	.	O

his	PRP$	B-PROBLEM
chest	JJS	I-PROBLEM
tube	NN	I-PROBLEM
drainage	NN	I-PROBLEM
reduced	VBD	O
significantly	RB	O
after	IN	O
the	DT	O
first	JJ	O
24	CD	O
hours	NNS	O
and	CC	O
on	IN	O
hospital	JJ	O
day	NN	O
three	CD	O
his	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
the	DT	O
patient	NN	O
remained	VBD	O
in	IN	O
the	DT	O
hospital	NN	O
to	TO	O
reassess	VB	O
for	IN	O
recurrent	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
time	NN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
as	IN	O
follows	VBZ	O
:	:	O

vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
temperature	JJ	B-TEST
97.8	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
and	CC	O
sinus	JJ	O
rhythm	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
140/82	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O

o2	JJ	B-TEST
saturation	NN	I-TEST
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

weight	NN	B-TEST
on	IN	I-TEST
admission	NN	I-TEST
was	VBD	O
64	CD	O
kg	NN	O
,	,	O
at	IN	O
discharge	NN	O
was	VBD	O
51.6	CD	O
kg	NN	O
.	.	O

laboratory	NN	O
data	NNS	O
showed	VBD	O
an	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
31.6	CD	O
,	,	O
pt	NN	B-TEST
13	CD	O
,	,	O
inr	NN	B-TEST
1.2	CD	O
,	,	O
potassium	NN	B-TEST
4.5	CD	O
,	,	O
bun	NN	B-TEST
18	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
.	.	O

respiratory	NN	B-TEST
examination	NN	I-TEST
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

incisions	NNS	B-PROBLEM
had	VBD	O
steri-strips	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
with	IN	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
were	VBD	O
warm	JJ	O
and	CC	O
well	RB	O
perfused	VBN	O
with	IN	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

right	RB	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
incision	NN	I-PROBLEM
with	IN	O
steri-strips	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

1.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
nystatin	JJ	B-TREATMENT
swish	JJ	O
and	CC	O
swallow	JJ	O
,	,	O
5	CD	O
cc	NN	O
q.	NN	O
8	CD	O
hours	NNS	O
.	.	O

4.	CD	O
ampicillin	JJ	B-TREATMENT
2	CD	O
grams	NNS	O
iv	VBP	O
q.	JJ	O
6	CD	O
through	IN	O
09-08	NN	O
.	.	O

5.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
q.d.	NN	O

6.	CD	O
percocet	NN	B-TREATMENT
5/325	CD	O
,	,	O
1-2	JJ	O
tablets	NNS	O
q.	VBD	O
6	CD	O
hours	NNS	O
p.r.n.	NN	O

7.	CD	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
30	CD	O
cc	NN	O
q.h.s.	NN	O
p.r.n.	NN	O

metastatic	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

secondary	JJ	O
diagnoses	NNS	O
include	VBP	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
lymphangitic	JJ	I-PROBLEM
spread	NN	I-PROBLEM
,	,	O
and	CC	O
liver	RB	B-PROBLEM
and	CC	I-PROBLEM
spleen	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

echocardiogram	JJ	B-TEST
times	NNS	O
two	CD	O
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
28	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
iv	NN	O
,	,	O
para	VBZ	O
2	CD	O
with	IN	O
metastatic	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
admitted	VBN	O
with	IN	O
a	DT	O
question	NN	O
of	IN	O
malignant	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

patient	JJ	O
underwent	NN	O
a	DT	B-TREATMENT
total	JJ	I-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
in	IN	O
02/90	CD	O
for	IN	O
a	DT	B-PROBLEM
4x3.6x2	CD	I-PROBLEM
cm	NN	I-PROBLEM
cervical	JJ	I-PROBLEM
mass	NN	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
fibroid	NN	I-PROBLEM
at	IN	O
vanor	NN	O
.	.	O

pathology	NN	B-TEST
revealed	VBD	O
poorly	RB	B-PROBLEM
differentiated	VBN	I-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cervix	NN	I-PROBLEM
with	IN	O
spots	NNS	O
of	IN	O
vaginal	JJ	O
margins	NNS	O
and	CC	O
metastatic	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
cardinal	JJ	I-PROBLEM
ligaments	NNS	I-PROBLEM
with	IN	O
extensive	JJ	B-PROBLEM
lymphatic	JJ	I-PROBLEM
invasion	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
felt	VBN	O
to	TO	O
have	VB	O
stage	NN	B-PROBLEM
2b	CD	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
post-operatively	RB	O
,	,	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
intracavitary	JJ	B-TREATMENT
and	CC	I-TREATMENT
external	JJ	I-TREATMENT
beam	NN	I-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
low	JJ	B-TREATMENT
dose	NN	I-TREATMENT
cisplatin	NN	I-TREATMENT
.	.	O

on	IN	O
ultrasound	NN	B-TEST
in	IN	O
02/91	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
bilateral	JJ	B-PROBLEM
cystic	JJ	I-PROBLEM
adnexal	NN	I-PROBLEM
masses	NNS	I-PROBLEM
confirmed	VBD	O
on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
.	.	O

she	PRP	O
underwent	JJ	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
bilateral	JJ	I-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
and	CC	O
appendectomy	NN	B-TREATMENT
.	.	O

pathology	NN	B-TEST
was	VBD	O
negative	JJ	O
for	IN	O
tumor	NN	B-PROBLEM
and	CC	O
showed	VBD	O
peritubal	NNS	B-PROBLEM
and	CC	I-PROBLEM
periovarian	JJ	I-PROBLEM
adhesions	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
now	RB	O
presents	VBZ	O
with	IN	O
a	DT	O
three	CD	O
to	TO	O
four	CD	O
week	NN	O
history	NN	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
non-productive	JJ	I-PROBLEM
cough	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
dr.	NN	O
mielke	NN	O
,	,	O
a	DT	O
pulmonologist	NN	O
,	,	O
who	WP	O
found	VBD	O
her	PRP	O
to	TO	O
be	VB	O
wheezing	VBG	B-PROBLEM
and	CC	O
performed	VBD	O
pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
which	WDT	O
showed	VBD	O
an	DT	B-TEST
fev1	NN	I-TEST
of	IN	O
1.1	CD	O
and	CC	O
an	DT	B-TEST
fvc	NN	I-TEST
of	IN	O
1.8	CD	O
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
weekscook	VB	O
university	NN	O
medical	JJ	O
center	NN	O
with	IN	O
a	DT	O
diagnosis	NN	O
of	IN	O
possible	JJ	O
asthma	NN	B-PROBLEM
.	.	O

room	NN	B-TEST
air	NN	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
po2	NN	I-TEST
of	IN	O
56	CD	O
,	,	O
a	DT	B-TEST
pco2	NN	I-TEST
of	IN	O
35	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.52	CD	O
.	.	O

ekg	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
100	CD	O
and	CC	O
echo	VB	B-TEST
revealed	VBN	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
10	CD	I-PROBLEM
mm	NN	I-PROBLEM
pulsus	NN	I-PROBLEM
paradoxus	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
,	,	O
and	CC	O
no	DT	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

given	VBN	O
the	DT	O
patient	JJ	O
&apos;s	NNP	O
history	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
the	DT	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
most	RBS	O
likely	JJ	O
to	TO	O
be	VB	O
malignant	JJ	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
therefore	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

02/90	CD	O
,	,	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
complicated	VBN	O
by	IN	O
ureteral	JJ	B-TREATMENT
transection	NN	I-TREATMENT
with	IN	O
right	JJ	B-TREATMENT
ureteral	JJ	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
for	IN	O
six	CD	O
weeks	NNS	O
,	,	O
stent	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placed	VBN	O
in	IN	O
left	JJ	O
ureter	JJ	O
six	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
for	IN	O
a	DT	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
post	NN	O
,	,	O
in	IN	O
03/91	CD	O
,	,	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
and	CC	O
appendectomy	NN	B-TREATMENT
.	.	O

prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.a.m.	NN	O
with	IN	O
10	CD	O
mg	NNS	O
p.o.	JJ	O
q.p.m.	RB	O
,	,	O
uniphyl	JJ	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
augmentin	RB	B-TREATMENT
250	CD	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
estrase	VB	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
30	CD	O
mg	NN	O
q.12h.	NN	O
,	,	O
and	CC	O
morphine	NN	B-TREATMENT
p.r.n.	NN	O

emaciated	VBN	O
white	JJ	O
female	NN	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
was	VBD	O
98.1	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
116	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
120/68	CD	O
,	,	O
and	CC	O
room	NN	B-TEST
air	NN	I-TEST
o2	JJ	I-TEST
saturation	NN	I-TEST
was	VBD	O
93%	CD	O
.	.	O

dry	JJ	B-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
and	CC	O
myotic	JJ	B-PROBLEM
pupils	NNS	I-PROBLEM
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

few	JJ	B-PROBLEM
inspiratory	NN	I-PROBLEM
wheezes	NNS	I-PROBLEM
and	CC	O
no	DT	O
rhonchi	NN	B-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
tachycardia	NN	B-PROBLEM
and	CC	O
no	DT	O
rubs	NN	B-PROBLEM
or	CC	O
murmur	NN	B-PROBLEM
.	.	O

well	RB	B-PROBLEM
healed	VBN	I-PROBLEM
pfannenstiel	NN	I-PROBLEM
scars	NNS	I-PROBLEM
and	CC	O
no	DT	O
masses	NNS	B-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

no	DT	O
edema	NN	B-PROBLEM
or	CC	O
cyanosis	NN	B-PROBLEM
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
40	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
21	CD	O
,	,	O
and	CC	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
723,000	CD	O
.	.	O

pt	NN	B-TEST
and	CC	O
ptt	NN	B-TEST
were	VBD	O
12	CD	O
and	CC	O
26	CD	O
.	.	O

electrolytes	NNS	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
and	CC	O
ekg	NN	B-TEST
showed	VBD	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
128	CD	O
,	,	O
axis	RB	B-TEST
73	CD	O
,	,	O
and	CC	O
possible	JJ	O
ectopic	NN	B-PROBLEM
p	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
which	WDT	O
was	VBD	O
felt	VBN	O
most	RBS	O
likely	JJ	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
metastatic	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
scheduled	VBN	O
and	CC	O
cardiology	NN	O
was	VBD	O
consulted	VBN	O
.	.	O

echocardiogram	NN	B-TEST
showed	VBD	O
moderate	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
of	IN	O
approximately	RB	O
600	CD	O
cc	NNS	O
with	IN	O
diastolic	JJ	B-PROBLEM
indications	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
and	CC	O
low	JJ	B-PROBLEM
velocity	NN	I-PROBLEM
paradox	NN	I-PROBLEM
.	.	O

cardiology	NN	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
tamponade	NN	B-PROBLEM
at	IN	O
this	DT	O
time	NN	O
was	VBD	O
a	DT	O
concern	NN	O
and	CC	O
that	IN	O
a	DT	B-TREATMENT
tap	NN	I-TREATMENT
need	MD	O
not	RB	O
be	VB	O
performed	VBN	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
pulmonary	JJ	B-PROBLEM
wheezing	NN	I-PROBLEM
,	,	O
unknown	JJ	O
origin	NN	O
,	,	O
without	IN	O
history	NN	O
of	IN	O
asthma	NN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
tapered	VBN	O
and	CC	O
pulmonary	JJ	O
was	VBD	O
consulted	VBN	O
who	WP	O
recommended	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
to	TO	O
evaluate	VB	O
the	DT	O
lung	NN	O
parenchyma	NN	O
,	,	O
induce	VB	O
sputum	NN	O
for	IN	O
cbc	NN	B-TEST
,	,	O
arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
,	,	O
continuing	VBG	O
of	IN	O
the	DT	B-TREATMENT
beta	NN	I-TREATMENT
agonist	NN	I-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
and	CC	O
trial	NN	O
of	IN	O
steroid	JJ	B-TREATMENT
inhalers	NNS	I-TREATMENT
.	.	O

they	PRP	O
felt	VBD	O
it	PRP	O
was	VBD	O
most	RBS	O
likely	JJ	O
a	DT	B-PROBLEM
malignant	JJ	I-PROBLEM
lymphangitic	JJ	I-PROBLEM
spread	NN	I-PROBLEM
with	IN	O
pericardial	JJ	B-PROBLEM
involvement	NN	I-PROBLEM
versus	NN	O
infectious	JJ	B-PROBLEM
,	,	O
other	JJ	B-PROBLEM
cardiovascular	JJ	I-PROBLEM
causes	NNS	I-PROBLEM
,	,	O
or	CC	O
viral	JJ	B-PROBLEM
bronchiolitis	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
repeated	VBD	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
fev1	NN	I-TEST
of	IN	O
36%	CD	O
of	IN	O
predicted	VBN	O
and	CC	O
fvc	NN	B-TEST
of	IN	O
56%	CD	O
of	IN	O
predicted	VBN	O
.	.	O

room	NN	B-TEST
air	NN	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.45	CD	O
,	,	O
po2	NN	B-TEST
of	IN	O
63	CD	O
,	,	O
a	DT	B-TEST
pco2	NN	I-TEST
of	IN	O
41	CD	O
,	,	O
and	CC	O
fairly	RB	B-PROBLEM
significant	JJ	I-PROBLEM
aa	JJ	I-PROBLEM
gradient	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
two	CD	O
liters	NNS	O
of	IN	O
oxygen	NN	B-TREATMENT
awaiting	VBG	O
her	PRP$	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
on	IN	O
06/14	CD	O
and	CC	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
junctional	JJ	I-PROBLEM
rhythm	NN	I-PROBLEM
with	IN	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
rub	NN	I-PROBLEM
versus	NN	O
murmur	NN	B-PROBLEM
on	IN	O
examination	NN	B-TEST
.	.	O

cardiology	NN	O
felt	VBD	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
rub	NN	I-PROBLEM
and	CC	O
her	PRP$	B-TEST
pulsus	NN	I-TEST
was	VBD	O
still	RB	O
10	CD	O
.	.	O

ekg	NN	B-TEST
showed	VBD	O
an	DT	B-PROBLEM
ectopic	NN	I-PROBLEM
low	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
p	NN	I-PROBLEM
and	CC	O
they	PRP	O
thought	VBD	O
she	PRP	O
was	VBD	O
still	RB	O
stable	JJ	O
without	IN	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

she	PRP	O
should	MD	O
have	VB	O
a	DT	B-TEST
follow-up	JJ	I-TEST
echocardiogram	NN	I-TEST
.	.	O

echocardiogram	NN	B-TEST
showed	VBD	O
left	JJ	O
ventricle	NN	O
at	IN	O
the	DT	O
upper	JJ	O
limits	NNS	O
of	IN	O
normal	JJ	O
for	IN	O
size	NN	O
,	,	O
low	JJ	B-PROBLEM
normal	JJ	I-PROBLEM
function	NN	I-PROBLEM
,	,	O
moderate	VB	B-PROBLEM
to	TO	I-PROBLEM
mild	VB	I-PROBLEM
effusion	NN	I-PROBLEM
with	IN	O
pericardial	JJ	B-TEST
pressures	NNS	I-TEST
exceeding	VBG	O
right	JJ	B-TEST
atrial	JJ	I-TEST
pressures	NNS	I-TEST
,	,	O
and	CC	O
right	RB	B-TEST
ventricular	JJ	I-TEST
pressures	NNS	I-TEST
at	IN	O
various	JJ	O
points	NNS	O
of	IN	O
patient	JJ	O
&apos;s	JJ	O
cycle	NN	O
without	IN	O
any	DT	O
change	NN	O
in	IN	O
the	DT	B-PROBLEM
effusion	NN	I-PROBLEM
from	IN	O
06/11	CD	O
.	.	O

thoracic	NN	O
surgery	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
and	CC	O
they	PRP	O
felt	VBD	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
need	NN	O
for	IN	O
a	DT	B-TREATMENT
pericardial	JJ	I-TREATMENT
window	NN	I-TREATMENT
at	IN	O
the	DT	O
time	NN	O
.	.	O

she	PRP	O
should	MD	O
be	VB	O
continued	VBN	O
with	IN	O
pulmonary	JJ	B-TEST
oximetry	NN	I-TEST
testing	NN	I-TEST
.	.	O

she	PRP	O
underwent	VBD	O
her	PRP	B-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
.	.	O

this	DT	O
showed	VBD	O
lymphangitic	JJ	B-PROBLEM
spread	NN	I-PROBLEM
of	IN	O
cancer	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
chest	NN	I-PROBLEM
,	,	O
question	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
nodules	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
chest	NN	I-PROBLEM
,	,	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
liver	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
,	,	O
decreased	VBN	B-PROBLEM
function	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
kidney	NN	I-PROBLEM
,	,	O
dilated	VBN	B-PROBLEM
left	VBD	I-PROBLEM
intrarenal	JJ	I-PROBLEM
collecting	NN	I-PROBLEM
system	NN	I-PROBLEM
and	CC	I-PROBLEM
proximal	JJ	I-PROBLEM
ureter	NN	I-PROBLEM
,	,	O
and	CC	O
periaortic	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

pulmonary	JJ	O
felt	VBD	O
this	DT	O
was	VBD	O
consistent	JJ	O
also	RB	O
with	IN	O
lymphangitic	JJ	B-PROBLEM
spread	NN	I-PROBLEM
and	CC	O
they	PRP	O
did	VBD	O
not	RB	O
feel	VB	O
that	IN	O
a	DT	B-TEST
bronchoscopy	NN	I-TEST
would	MD	O
be	VB	O
of	IN	O
any	DT	O
assistance	NN	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

chemotherapy	NN	B-TREATMENT
for	IN	O
metastatic	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
was	VBD	O
discussed	VBN	O
with	IN	O
the	DT	O
patient	NN	O
and	CC	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
5-fu	JJ	B-TREATMENT
800	CD	O
mg	NN	O
per	IN	O
meter	NN	O
squared	VBD	O
days	NNS	O
06/18	CD	O
,	,	O
06/19	CD	O
,	,	O
and	CC	O
06/20	CD	O
.	.	O

she	PRP	O
also	RB	O
received	VBD	O
cisplatin	JJ	B-TREATMENT
35	CD	O
per	IN	O
meter	NN	O
squared	VBN	O
on	IN	O
06/19	CD	O
and	CC	O
ifex	NN	B-TREATMENT
and	CC	O
mesna	NN	B-TREATMENT
on	IN	O
06/18	CD	O
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
,	,	O
on	IN	O
06/16	CD	O
,	,	O
to	TO	O
have	VB	O
numerous	JJ	B-PROBLEM
erythematous	JJ	I-PROBLEM
maculopapules	NNS	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
back	NN	I-PROBLEM
and	CC	O
chest	NN	O
.	.	O

dermatology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
they	PRP	O
felt	VBD	O
that	IN	O
this	DT	O
was	VBD	O
most	RBS	O
likely	JJ	O
steroid	JJ	B-PROBLEM
acne	NN	I-PROBLEM
.	.	O

they	PRP	O
therefore	VBP	O
felt	VBD	O
a	DT	B-TREATMENT
rapid	JJ	I-TREATMENT
steroid	JJ	I-TREATMENT
taper	NN	I-TREATMENT
was	VBD	O
indicated	VBN	O
and	CC	O
topical	JJ	B-TREATMENT
erythromycin	NN	I-TREATMENT
if	IN	O
desired	VBN	O
by	IN	O
the	DT	O
patient	NN	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
wheezing	VBG	B-PROBLEM
continued	VBN	O
but	CC	O
without	IN	O
change	NN	O
.	.	O

her	PRP$	B-TEST
cardiac	JJ	I-TEST
examination	NN	I-TEST
remained	VBD	O
the	DT	O
same	JJ	O
and	CC	O
there	EX	O
continued	VBN	O
to	TO	O
be	VB	O
no	DT	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

cardiology	NN	O
felt	VBD	O
that	IN	O
follow-up	JJ	B-TEST
echo	NN	I-TEST
was	VBD	O
indicated	VBN	O
on	IN	O
06/18	CD	O
as	IN	O
she	PRP	O
had	VBD	O
another	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
change	NN	O
or	CC	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

they	PRP	O
therefore	VBP	O
felt	VBD	O
that	IN	O
she	PRP	O
could	MD	O
be	VB	O
continued	VBN	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
examination	NN	B-TEST
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
with	IN	O
confusion	NN	B-PROBLEM
and	CC	O
hallucinations	NNS	B-PROBLEM
on	IN	O
06/18	CD	O
originating	VBG	O
from	IN	O
narcotics	NNS	B-TREATMENT
versus	NNS	O
decreased	VBD	B-PROBLEM
po2	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
ifex	NN	I-TREATMENT
was	VBD	O
held	VBN	O
as	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
it	PRP	O
could	MD	O
have	VB	O
precipitated	VBN	O
the	DT	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
that	IN	O
she	PRP	O
was	VBD	O
to	TO	O
receive	VB	O
no	DT	O
further	JJ	B-TREATMENT
ifex	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
hallucinations	NNS	I-PROBLEM
since	IN	O
stopping	VBG	O
the	DT	O
ifex	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
hooked	VBN	O
up	RP	O
with	IN	O
support	NN	O
services	NNS	O
in	IN	O
collot	NN	O
ln	NN	O
,	,	O
dugo	NN	O
,	,	O
indiana	VBP	O
68961	CD	O
for	IN	O
further	JJ	B-TREATMENT
counselling	NN	I-TREATMENT
and	CC	O
given	VBN	O
xanax	NNS	B-TREATMENT
for	IN	O
symptoms	NNS	B-PROBLEM
of	IN	O
anxiety	NN	B-PROBLEM
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
no	DT	O
change	NN	O
in	IN	O
her	PRP$	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
cardiac	JJ	B-TEST
examination	NN	I-TEST
and	CC	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
06/22/91	CD	O
after	IN	O
completing	VBG	O
her	PRP$	B-TREATMENT
5-fu	JJ	I-TREATMENT
and	CC	O
cisplatin	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

premarin	NN	B-TREATMENT
0.625	CD	O
q.d.	NN	O
,	,	O
proventil	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
two	CD	O
puffs	NNS	O
q.i.d.	RB	O
,	,	O
beclovent	JJ	B-TREATMENT
four	CD	O
puffs	NNS	O
b.i.d.	RB	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
elavil	VBZ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
trilisate	VB	B-TREATMENT
750	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
ms	NN	B-TREATMENT
elixir	NN	I-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.2h.	NN	O
p.r.n.	NN	O
,	,	O
robitussin	NN	B-TREATMENT
with	IN	O
codeine	JJ	B-TREATMENT
5	CD	O
cc	NN	O
p.o.	NN	O
q.2h.	NN	O
,	,	O
and	CC	O
home	NN	B-TREATMENT
o2	NN	I-TREATMENT
two	CD	I-TREATMENT
liters	NNS	I-TREATMENT
via	IN	O
nasal	NN	B-TREATMENT
prong	IN	I-TREATMENT
with	IN	O
increase	NN	O
to	TO	O
four	CD	O
liters	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
symptoms	NNS	B-PROBLEM
p.r.n.	NNS	O

prenatal	NN	B-TEST
screens	NNS	I-TEST
-	:	O
a	DT	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	JJ	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
gbs	JJ	B-TEST
unknown	NN	O
.	.	O

remarkable	NN	O
for	IN	O
an	DT	B-PROBLEM
intrauterine	JJ	I-PROBLEM
fetal	JJ	I-PROBLEM
demise	NN	I-PROBLEM
at	IN	O
30	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

this	DT	O
pregnancy	NN	O
complicated	VBN	O
by	IN	O
hydramnios	NNS	B-PROBLEM
also	RB	O
.	.	O

the	DT	B-TEST
baby	NN	I-TEST
's	POS	I-TEST
autopsy	NN	I-TEST
was	VBD	O
reported	VBN	O
to	TO	O
be	VB	O
normal	JJ	O
.	.	O

dates	NNS	O
are	VBP	O
by	IN	O
first	JJ	B-TEST
trimester	NN	I-TEST
ultrasound	NN	I-TEST
.	.	O

pregnancy	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
severe	JJ	B-PROBLEM
polyhydramnios	NNS	I-PROBLEM
with	IN	O
an	DT	B-TEST
afi	NN	I-TEST
of	IN	O
45	CD	O
just	RB	O
prior	RB	O
to	TO	O
delivery	NN	O
.	.	O

mother	NN	O
has	VBZ	O
had	VBN	O
multiple	JJ	B-TEST
ultrasounds	NNS	I-TEST
and	CC	O
fetal	JJ	B-TEST
surveys	NNS	I-TEST
at	IN	O
17	CD	O
and	CC	O
21	CD	O
weeks	NNS	O
that	WDT	O
had	VBD	O
been	VBN	O
unremarkable	JJ	O
.	.	O

mother	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
debbie-monaco	NN	O
from	IN	O
western	JJ	O
mass.	NNS	O
hospital	VBP	O
hospital	NN	O
in	IN	O
the	DT	O
middle	NN	O
of	IN	O
january	JJ	O
with	IN	O
increasing	VBG	B-PROBLEM
polyhydramnios	NNS	I-PROBLEM
and	CC	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
betamethasone	NN	I-TREATMENT
on	IN	O
03-28	JJ	O
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
until	IN	O
04-12	NNP	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
1	CD	O
dose	NN	O
of	IN	O
nifedipine	JJ	B-TREATMENT
2	CD	O
days	NNS	O
ago	RB	O
as	IN	O
a	DT	B-TREATMENT
tocolytic	JJ	I-TREATMENT
without	IN	O
effect	NN	O
.	.	O

delivery	NN	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
was	VBD	O
prompted	VBN	O
by	IN	O
ongoing	VBG	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
with	IN	O
new	JJ	O
onset	NN	O
of	IN	O
late	JJ	B-PROBLEM
decelerations	NNS	I-PROBLEM
and	CC	O
breech	JJ	B-PROBLEM
presentation	NN	I-PROBLEM
.	.	O

nuchal	JJ	B-PROBLEM
cord	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
at	IN	O
delivery	NN	O
.	.	O

the	DT	O
infant	NN	O
cried	VBD	O
after	IN	O
bulb	NN	B-TREATMENT
suctioning	NN	I-TREATMENT
and	CC	O
stimulation	NN	B-TREATMENT
.	.	O

apgars	NNS	B-TEST
were	VBD	O
8	CD	O
and	CC	O
8	CD	O
.	.	O

weight	NN	B-TEST
2.985	CD	O
kg	NN	O
,	,	O
95th	CD	O
percentile;	NN	O
length	NN	B-TEST
48	CD	O
cm	NN	O
,	,	O
85th	CD	O
percentile;	NN	O
head	NN	B-TEST
circumference	NN	I-TEST
35	CD	O
cm	NN	O
,	,	O
greater	JJR	O
than	IN	O
95th	CD	O
percentile	NN	O
.	.	O

anterior	JJ	O
fontanel	NNS	O
soft	JJ	O
and	CC	O
flat.	JJ	O
head	NN	O
shape	NN	O
normal	JJ	O
with	IN	O
mildly	RB	B-PROBLEM
flattened	VBN	I-PROBLEM
on	IN	I-PROBLEM
top	JJ	I-PROBLEM
consistent	NN	O
with	IN	O
breech	NN	B-PROBLEM
positioning	NN	I-PROBLEM
in	IN	I-PROBLEM
utero	NN	I-PROBLEM
.	.	O

facies	NNS	O
nondysmorphic	JJ	B-PROBLEM
,	,	O
palate	JJ	O
intact	NN	O
.	.	O

mild	JJ	B-PROBLEM
intermittent	NN	I-PROBLEM
grunting	VBG	I-PROBLEM
noted	VBN	O
with	IN	O
mild	JJ	B-PROBLEM
subcostal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
.	.	O

no	DT	O
murmur	NN	B-PROBLEM
noted	VBD	O
.	.	O

abdomen	NNS	O
soft	JJ	O
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
.	.	O

tone	NN	B-PROBLEM
initially	RB	I-PROBLEM
low	JJ	I-PROBLEM
normal	JJ	I-PROBLEM
but	CC	O
improved	JJ	O
within	IN	O
normal	JJ	O
limits	NNS	O
on	IN	O
admission	NN	O
.	.	O

hips	NNS	O
increased	VBD	B-PROBLEM
lax	JJ	I-PROBLEM
knee	NN	I-PROBLEM
but	CC	O
no	DT	O
obvious	JJ	B-PROBLEM
dislocation	NN	I-PROBLEM
.	.	O

infant	NN	O
has	VBZ	O
an	DT	B-PROBLEM
audible	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

echocardiogram	JJ	B-TEST
results	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
revealing	VBG	O
a	DT	B-PROBLEM
pps	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
2.985	CD	O
kg	NN	O
.	.	O

discharge	NN	B-TEST
weight	VBD	I-TEST
..	NNS	O

the	DT	O
infant	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
60	CD	O
cc	NNS	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
of	IN	O
d10w	NN	B-TREATMENT
.	.	O

enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
no.1	NN	O
.	.	O

the	DT	O
infant	NN	O
is	VBZ	O
currently	RB	O
on	IN	O
a	DT	O
120	CD	O
cc	NN	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
of	IN	O
premature	NN	B-TREATMENT
enfamil	FW	I-TREATMENT
20	CD	O
calorie	NN	O
or	CC	O
breast	NN	O
milk	NN	O
,	,	O
tolerating	VBG	O
feeds	NNS	O
well	RB	O
.	.	O

electrolytes	NNS	B-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
1	CD	O
showed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
142	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
5.1	CD	O
,	,	O
chloride	NN	B-TEST
of	IN	O
108	CD	O
,	,	O
and	CC	O
total	JJ	B-TEST
co2	NN	I-TEST
of	IN	O
23	CD	O
.	.	O

bilirubin	NN	B-TEST
on	IN	O
04-17	NN	O
was	VBD	O
8.2/0.3	CD	O
.	.	O

surgery	NN	O
was	VBD	O
consulted	VBN	O
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
te	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
as	IN	O
the	DT	O
infant	NN	O
had	VBD	O
an	DT	B-PROBLEM
incidental	JJ	I-PROBLEM
pass	NN	I-PROBLEM
of	IN	O
a	DT	B-TREATMENT
gavage	NN	I-TREATMENT
tube	NN	I-TREATMENT
into	IN	O
his	PRP$	O
right	JJ	O
bronchus	NN	O
.	.	O

tef	NN	B-PROBLEM
was	VBD	O
primarily	RB	O
ruled	VBN	O
out	RP	O
as	IN	O
baker	NN	O
was	VBD	O
passed	VBN	O
easily	RB	O
to	TO	O
stomach	VB	O
and	CC	O
x-ray	JJ	B-TEST
revealed	VBD	O
good	JJ	O
position	NN	O
.	.	O

hematocrit	NN	B-TEST
on	IN	I-TEST
admission	NN	I-TEST
was	VBD	O
38.2	CD	O
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
not	RB	O
required	VBN	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

cbc	NN	B-TEST
and	CC	O
blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
obtained	VBN	O
on	IN	O
admission	NN	O
.	.	O

cbc	NN	B-TEST
was	VBD	O
benign	JJ	O
and	CC	O
blood	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
at	IN	O
48	CD	O
hours	NNS	O
at	IN	O
which	WDT	O
time	NN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

initial	JJ	B-TEST
cbc	NN	I-TEST
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
16	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
204	CD	O
,	,	O
53	CD	O
polys	NN	B-TEST
and	CC	O
0	CD	O
bands	NNS	B-TEST
.	.	O

of	IN	O
note	NN	O
incidental	JJ	O
finding	NN	O
on	IN	O
x-ray	NN	B-TEST
,	,	O
the	DT	O
infant	NN	O
has	VBZ	O
a	DT	B-PROBLEM
hemivertebra	NN	I-PROBLEM
at	IN	I-PROBLEM
t11	NN	I-PROBLEM
.	.	O

hearing	VBG	B-TEST
screen	NN	I-TEST
has	VBZ	O
not	RB	O
been	VBN	O
done	VBN	O
but	CC	O
should	MD	O
be	VB	O
done	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
:	:	O
not	RB	O
applicable	JJ	O
.	.	O

3.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
has	VBZ	O
not	RB	O
been	VBN	O
performed	VBN	O
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
3	CD	O
.	.	O

5.	CD	O
immunizations	NNS	B-TREATMENT
received:	VBP	O
the	DT	O
infant	NN	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
immunizations	NNS	I-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
with	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

left	VBN	B-PROBLEM
renal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
63	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
long-standing	JJ	O
history	NN	O
of	IN	O
polycythemia	NN	B-PROBLEM
vera	NN	I-PROBLEM
,	,	O
managed	VBD	O
medically	RB	O
,	,	O
who	WP	O
on	IN	O
a	DT	B-TEST
routine	JJ	I-TEST
follow-up	JJ	I-TEST
examination	NN	I-TEST
complained	VBD	O
of	IN	O
left	JJ	B-PROBLEM
side	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
had	VBD	O
an	DT	B-TEST
ultrasound	NN	I-TEST
that	WDT	O
demonstrated	VBD	O
a	DT	B-PROBLEM
complex	JJ	I-PROBLEM
left	VBD	I-PROBLEM
renal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	JJ	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
contrast	NN	I-PROBLEM
enhancing	VBG	I-PROBLEM
complex	JJ	I-PROBLEM
left	VBD	I-PROBLEM
renal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

metastatic	JJ	B-TEST
work-up	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
for	IN	O
nephrectomy	NN	B-TREATMENT
.	.	O

past	JJ	O
medical	JJ	O
history	NN	O
included	VBD	O
polycythemia	NN	B-PROBLEM
vera	NN	I-PROBLEM
.	.	O

past	JJ	O
surgical	JJ	O
history	NN	O
included	VBD	O
appendectomy	NN	B-TREATMENT
and	CC	O
bunionectomy	NN	B-TREATMENT
.	.	O

medications	NNS	O
on	IN	O
admission	NN	O
were	VBD	O
hydrea	NNS	B-TREATMENT
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
negative	JJ	O
in	IN	O
detail	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
robust	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
afebrile	RB	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
165/80	CD	O
.	.	O

rectal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

extremities	NNS	B-TEST
and	CC	I-TEST
neurological	JJ	I-TEST
examinations	NNS	I-TEST
were	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
by	IN	O
dr.	JJ	O
suot	NN	O
n.	JJ	O
dragtente	NN	O
on	IN	O
02-21-91	NN	O
,	,	O
where	WRB	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
radical	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

at	IN	O
operation	NN	B-TREATMENT
,	,	O
there	EX	O
was	VBD	O
no	DT	O
gross	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
or	CC	O
renal	JJ	B-PROBLEM
vein	NN	I-PROBLEM
involvement	NN	I-PROBLEM
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
was	VBD	O
completely	RB	O
excised	VBN	O
.	.	O

the	DT	O
oncology	NN	O
fellows	VBZ	O
from	IN	O
venbonlea	NN	O
health	NN	O
followed	VBD	O
her	PRP$	O
course	NN	O
and	CC	O
recommended	VBD	O
holding	VBG	O
off	RP	O
on	IN	O
her	PRP$	B-TREATMENT
hydrea	NN	I-TREATMENT
while	IN	O
she	PRP	O
is	VBZ	O
hospitalized	VBN	O
,	,	O
and	CC	O
they	PRP	O
will	MD	O
follow	VB	O
her	PRP	O
as	IN	O
an	DT	O
outpatient	NN	O
and	CC	O
restart	VB	O
her	PRP$	B-TREATMENT
hydrea	NN	I-TREATMENT
when	WRB	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
is	VBZ	O
over	IN	O
40%	CD	O
.	.	O

medications	NNS	O
on	IN	O
discharge	NN	O
included	VBD	O
percocet	RB	B-TREATMENT
1	CD	O
to	TO	O
2	CD	O
tablets	NNS	O
by	IN	O
mouth	NN	O
every	DT	O
4	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
,	,	O
colace	NN	B-TREATMENT
100	CD	O
milligrams	NNS	O
by	IN	O
mouth	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
3285	CD	O
gm	NN	O
infant	NN	O
born	VBN	O
at	IN	O
37	CD	O
5/7	CD	O
weeks	NNS	O
to	TO	O
a	DT	O
21	CD	O
year	NN	O
old	JJ	O
g3	NN	O
p1	NN	O
now	RB	O
2	CD	O
mother	NN	O
with	IN	O
prenatal	JJ	B-TEST
screens	NNS	I-TEST
as	IN	O
follows	VBZ	O
:	:	O

o	RB	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
gbs	JJ	B-TEST
negative	JJ	O
.	.	O

unremarkable	JJ	O
pregnancy	NN	O
except	IN	O
for	IN	O
minor	JJ	B-PROBLEM
fullness	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
pelvis	NN	I-PROBLEM
reported	VBD	O
during	IN	O
the	DT	O
week	NN	O
prior	RB	O
to	TO	O
delivery	NN	B-TREATMENT
.	.	O

past	JJ	O
ob	JJ	O
history	NN	O
remarkable	NN	O
for	IN	O
postpartum	NN	B-PROBLEM
depression	NN	I-PROBLEM
.	.	O

mother	NN	O
was	VBD	O
admitted	VBN	O
in	IN	O
labor	NN	B-PROBLEM
.	.	O

baby	NN	O
was	VBD	O
delivered	VBN	O
by	IN	O
repeat	NN	B-TREATMENT
c-section	NN	I-TREATMENT
with	IN	O
rupture	NN	B-TREATMENT
of	IN	I-TREATMENT
membranes	NNS	I-TREATMENT
at	IN	O
delivery	NN	B-TREATMENT
.	.	O

apgars	NNS	B-TEST
were	VBD	O
8	CD	O
and	CC	O
9	CD	O
.	.	O

cmed	VBN	O
csru	JJ	O
staff	NN	O
was	VBD	O
called	VBN	O
about	RB	O
30	CD	O
minutes	NNS	O
of	IN	O
age	NN	O
for	IN	O
grunting	NN	B-PROBLEM
,	,	O
flaring	VBG	B-PROBLEM
and	CC	O
retractions	NNS	B-PROBLEM
and	CC	O
the	DT	O
baby	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
.	.	O

exam	NN	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	O
term	NN	O
infant	NN	O
with	IN	O
flat	JJ	O
anterior	JJ	O
fontanelle	NN	O
,	,	O
pink	VBP	O
color	NN	O
,	,	O
normal	JJ	O
facies	NNS	O
,	,	O
intact	JJ	O
palate	NN	O
,	,	O
mild	JJ	B-PROBLEM
retractions	NNS	I-PROBLEM
,	,	O
good	JJ	O
air	NN	O
entry	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

femoral	JJ	B-TEST
pulses	NNS	I-TEST
present	JJ	O
.	.	O

flat	JJ	O
,	,	O
soft	JJ	O
and	CC	O
nontender	JJ	B-PROBLEM
abdomen	NNS	I-PROBLEM
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

initial	JJ	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
19.4	CD	O
thousand	NN	O
,	,	O
64	CD	O
polys	NN	B-TEST
,	,	O
3	CD	O
bands	NNS	B-TEST
,	,	O
hematocrit	NN	B-TEST
35.8	CD	O
,	,	O
platelets	NNS	B-TEST
281,000	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
streaky	JJ	B-PROBLEM
lung	NN	I-PROBLEM
fields	NNS	I-PROBLEM
of	IN	O
normal	JJ	O
situs	NN	O
,	,	O
no	DT	O
consolidation	NN	B-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
retained	JJ	B-PROBLEM
fetal	JJ	I-PROBLEM
lung	NN	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

the	DT	O
athol	NN	O
memorial	JJ	O
hospital	NN	O
hospital	NN	O
course	NN	O
was	VBD	O
initially	RB	O
consistent	JJ	O
with	IN	O
transient	JJ	B-PROBLEM
tachypnea	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
newborn	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
mild	JJ	B-PROBLEM
streakiness	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
fields	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
placed	VBN	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
with	IN	O
subsequent	JJ	O
resolution	NN	O
of	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
off	RP	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
3	CD	O
and	CC	O
he	PRP	O
initially	RB	O
was	VBD	O
maintaining	VBG	O
o2	JJ	B-TEST
sat	NNS	I-TEST
above	IN	O
94%	CD	O
and	CC	O
breathing	VBG	O
comfortably	RB	O
.	.	O

he	PRP	O
was	VBD	O
subsequently	RB	O
placed	VBN	O
back	RP	O
on	IN	O
nasal	NN	B-TREATMENT
cannula	NN	I-TREATMENT
for	IN	O
mild	JJ	B-PROBLEM
oxygen	NN	I-PROBLEM
desaturation	NN	I-PROBLEM
and	CC	O
was	VBD	O
requiring	VBG	O
25	CD	O
c/min	NN	O
flow	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

no	DT	O
apneic	NN	B-PROBLEM
or	CC	I-PROBLEM
brady	JJ	I-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

no	DT	O
murmur	NN	B-PROBLEM
on	IN	O
exam	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
tolerating	VBG	O
oral	JJ	O
feeding	NN	O
as	IN	O
of	IN	O
day	NN	O
of	IN	O
life	NN	O
2	CD	O
and	CC	O
is	VBZ	O
currently	RB	O
taking	VBG	O
enfamil	JJ	B-TREATMENT
20	CD	O
p.o.	NN	O
ad	NN	O
lib	NN	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
weaned	VBN	O
off	RP	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
has	VBZ	O
been	VBN	O
maintaining	VBG	O
good	JJ	O
blood	NN	O
glucose	NN	O
.	.	O

his	PRP$	B-TEST
birth	NN	I-TEST
weight	NN	I-TEST
was	VBD	O
3285	CD	O
gm	NN	O
.	.	O

his	PRP$	B-TEST
weight	NN	I-TEST
is	VBZ	O
3015	CD	O
gm	NN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
5	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
bilirubin	JJ	I-TEST
level	NN	I-TEST
at	IN	O
24	CD	O
hours	NNS	O
of	IN	O
life	NN	O
was	VBD	O
4.6.	CD	O

no	DT	O
phototherapy	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
not	RB	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
,	,	O
given	VBN	O
lack	NN	O
of	IN	O
sepsis	NN	B-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
initial	JJ	I-TEST
cbc	NN	I-TEST
showed	VBD	O
no	DT	O
left	JJ	B-PROBLEM
shift	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
culture	NN	I-TEST
had	VBD	O
remained	VBN	O
no	RB	O
growth	NN	B-PROBLEM
to	TO	O
date	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
initial	JJ	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
35.8	CD	O
.	.	O

no	DT	O
transfusion	NN	B-TREATMENT
during	IN	O
this	DT	B-TREATMENT
admission	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
doing	VBG	O
well	RB	O
on	IN	O
low	JJ	B-TREATMENT
flow	NN	I-TREATMENT
nasal	NN	I-TREATMENT
cannula.	NN	I-TREATMENT
he	PRP	O
has	VBZ	O
been	VBN	O
tolerating	VBG	O
p.o.	NN	O
ad	NN	O
lib	NN	O
feeds	NNS	O
.	.	O

1.	CD	O
feeds	NNS	O
at	IN	O
discharge	NN	O
:	:	O
enfamil	NN	B-TREATMENT
20	CD	O
p.o.	NN	O
ad	NN	O
lib	NN	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
:	:	O
none	NN	O
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screening	NN	I-TEST
sent	NN	O
.	.	O

5.	CD	O
immunizations	NNS	B-TREATMENT
:	:	O
received	VBN	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
on	IN	O
09-16	NN	O
.	.	O

1.	CD	O
prolonged	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
transition	NN	I-PROBLEM
.	.	O

1.	CD	O
hyaline	JJ	B-PROBLEM
membrane	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
without	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
73-year-old	JJ	O
man	NN	O
with	IN	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
lobectomy	NN	B-TREATMENT
and	CC	O
resection	NN	B-TREATMENT
of	IN	O
left	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
recurrence	NN	I-PROBLEM
,	,	O
admitted	VBN	O
here	RB	O
with	IN	O
fever	NN	B-PROBLEM
and	CC	O
neutropenia	NN	B-PROBLEM
.	.	O

recently	RB	O
he	PRP	O
had	VBD	O
been	VBN	O
receiving	VBG	O
a	DT	O
combination	NN	O
of	IN	O
outpatient	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
with	IN	O
the	DT	O
camp	NN	O
program	NN	O
.	.	O

other	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
include	VBP	O
hypothyroidism	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
and	CC	O
neuropathy	JJ	B-PROBLEM
from	IN	O
taxol	NN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
was	VBD	O
101.3	CD	O
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
percussion	NN	B-TEST
and	CC	O
auscultation	NN	B-TEST
with	IN	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
scattered	JJ	I-PROBLEM
rales	NNS	I-PROBLEM
,	,	O
left	VBD	O
greater	JJR	O
than	IN	O
right	NN	O
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

the	DT	B-TEST
wbc	NN	I-TEST
was	VBD	O
0.9	CD	O
,	,	O
the	DT	B-TEST
anc	NN	I-TEST
was	VBD	O
540	CD	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
156,000	CD	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
neupogen	NN	B-TREATMENT
,	,	O
400	CD	O
mcg.	NN	O
subq.	NN	O
q.d.	NN	O

he	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
antibiotic	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
questionable	JJ	O
nodule	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	O
reasonably	RB	O
stable	JJ	O
.	.	O

calcium	NN	B-TEST
8.7	CD	O
,	,	O
bilirubin	NN	B-TEST
0.3/1.3	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
,	,	O
glucose	VBD	B-TEST
128	CD	O
.	.	O

hematocrit	NN	B-TEST
24.6	CD	O
.	.	O

wbc	NN	B-TEST
rose	VBD	O
to	TO	O
1.7	CD	O
on	IN	O
10/19	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
some	DT	B-PROBLEM
diarrhea	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
diarrhea	NN	B-PROBLEM
on	IN	O
10/20	CD	O
.	.	O

he	PRP	O
was	VBD	O
feeling	VBG	O
well	RB	O
and	CC	O
afebrile	RB	B-PROBLEM
.	.	O

the	DT	B-PROBLEM
neutropenia	NN	I-PROBLEM
resolved	VBD	O
and	CC	O
he	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
in	IN	O
satisfactory	JJ	O
condition	NN	O
on	IN	O
discharge	NN	O
on	IN	O
10/20/95	CD	O
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
neupogen	NN	B-TREATMENT
.	.	O

fever	NN	B-PROBLEM
neutropenia	NN	I-PROBLEM
,	,	O
metastatic	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
.	.	O

include	NN	O
neupogen	NN	B-TREATMENT
,	,	O
480	CD	O
mcg.	NN	O
subq.	NN	O
q.d.	NN	O
and	CC	O
usual	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

penicillins	NNS	B-TREATMENT
/	VBP	O
norvasc	JJ	B-TREATMENT
/	NNP	O
verapamil	NN	B-TREATMENT

preop	NN	B-TEST
w/	NN	I-TEST
for	IN	O
knee	NN	B-TREATMENT
surgery	NN	I-TREATMENT
revealed	VBD	O
cardiac	JJ	B-PROBLEM
dz	NN	I-PROBLEM
,	,	O
asymptomatic	JJ	B-PROBLEM

cabgx4	NN	B-TREATMENT
(	(	O
06-26	CD	O
)	)	O

69yom	CD	O
with	IN	O
oa	JJ	B-PROBLEM
having	VBG	O
workup	NN	B-TEST
for	IN	O
knee	NN	B-TREATMENT
replacements	NNS	I-TREATMENT
found	VBD	O
to	TO	O
be	VB	O
in	IN	O
afib	NN	B-PROBLEM
,	,	O
had	VBD	O
stress	JJ	B-TEST
test	NN	I-TEST
that	WDT	O
was	VBD	O
positive	JJ	O
followed	VBN	O
by	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
severe	JJ	B-PROBLEM
3vd	CD	I-PROBLEM
.	.	O

then	RB	O
referred	VBN	O
for	IN	O
cabg	NN	B-TREATMENT

htn	NN	B-PROBLEM

chol	NN	B-PROBLEM

afib	NN	B-PROBLEM

oa	NN	B-PROBLEM
needs	VBZ	O
bilat	JJ	B-TREATMENT
arthroplasty	NN	I-TREATMENT

cri	NN	B-PROBLEM

brother	NN	O
died	VBD	O
64	CD	O
/	NNP	O
mi	NN	B-PROBLEM

vs	NN	B-TEST
t	VBZ	B-TEST
98	CD	O
hr	NN	B-TEST
74	CD	O
bp	NN	B-TEST
136/88	CD	O
rr	NN	B-TEST
18	CD	O

gen	NN	O
nad	NN	B-PROBLEM

cv	JJ	O
irreg-irreg	NN	B-PROBLEM
,	,	O
no	DT	O
m/r	NN	B-PROBLEM

abdn	NN	O
soft	JJ	O
,	,	O
nt/nd/+bs	JJ	B-PROBLEM

ext	JJ	O
warm	JJ	O
no	DT	O
edema	NN	B-PROBLEM

t99.9	NN	B-TEST
hr	VBD	B-TEST
70af	CD	O
bp	NN	B-TEST
120/69	CD	O
rr	NN	B-TEST
20	CD	O
o2sat	VBD	B-TEST
94%ra	CD	O

neuro	JJ	O
a&ox3	NN	O
mae	NN	O
,	,	O
non	JJ	B-TEST
focal	JJ	I-TEST
exam	NN	I-TEST

cv	NN	O
irreg	NN	B-PROBLEM
irreg	NN	I-PROBLEM
,	,	O
sternum	NN	B-PROBLEM
stable	JJ	I-PROBLEM
incision	NN	I-PROBLEM
cdi	NN	O

abdm	NN	O
soft	JJ	O
,	,	O
nt/nd/+bs	JJ	B-PROBLEM

ext	JJ	O
warm	JJ	O
2+	CD	B-PROBLEM
edema	NN	I-PROBLEM

glucose	JJ	B-TEST
-	:	O
97	CD	O
urea	JJ	B-TEST
n	SYM	O
-	:	O
44	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
2.0	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
143	CD	O
potassium	NN	B-TEST
-	:	O
4.1	CD	O
chloride	NN	B-TEST
-	:	O
107	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
27	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
13	CD	O

alt(sgpt)	SYM	B-TEST
-	:	O
19	CD	O
ast(sgot)	SYM	B-TEST
-	:	O
19	CD	O
ld(ldh)	SYM	B-TEST
-	:	O
153	CD	O
alk	NN	B-TEST
phos	NN	I-TEST
-	:	O
58	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.4	CD	O

albumin	SYM	B-TEST
-	:	O
4.3	CD	O

%hba1c	SYM	B-TEST
-	:	O
5.7	CD	O

tsh	SYM	B-TEST
-	:	O
1.2	CD	O

wbc	SYM	B-TEST
-	:	O
7.0	CD	O
rbc	NN	B-TEST
-	:	O
3.92	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
36.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
32.1	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
34.6	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
207	CD	O

pt	SYM	B-TEST
-	:	O
11.8	CD	O
ptt	NN	B-TEST
-	:	O
22.4	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.0	CD	O

2019-07-01	JJ	O
07:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
8.7	CD	O
rbc	NN	B-TEST
-	:	O
3.18	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.4	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
30.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
96	CD	O
mch	SYM	B-TEST
-	:	O
32.7	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
34.3	CD	O
rdw	NN	B-TEST
-	:	O
13.5	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
303	CD	O

2019-07-01	JJ	O
07:30	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
303	CD	O

2019-07-01	JJ	O
07:30	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
14.4	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
24.2	CD	O
inr(pt)-	JJ	B-TEST
1.3	CD	O
*	NN	O

2019-06-30	JJ	O
06:45	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
99	CD	O
urean	JJ	B-TEST
-	:	O
40	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.9	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
137	CD	O
k	SYM	O
-	:	O
4.1	CD	O
cl	NN	B-TEST
-	:	O
99	CD	O
hco3	NN	B-TEST
-	:	O
28	CD	O
angap	NN	B-TEST
-	:	O
14	CD	O

chest	NN	B-TEST
(	(	I-TEST
portable	JJ	I-TEST
a	DT	I-TEST
p)	NN	I-TEST

chest	NN	B-TEST
(	(	I-TEST
portable	JJ	I-TEST
ap	NN	I-TEST
)	)	I-TEST

reason	NN	O
:	:	O
effusion	NN	B-PROBLEM
?	.	O
pntx	NN	B-PROBLEM
?	.	O

69	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
s/p	JJ	O
off	RP	B-TREATMENT
pump	NN	I-TREATMENT
cabg	NN	I-TREATMENT

effusion	NN	B-PROBLEM
?	.	O
pntx	NN	B-PROBLEM
?	.	O

portable	JJ	B-TEST
chest	NN	I-TEST
on	IN	O
2019-06-30	JJ	O
at	IN	O
11:39	CD	O

indication	NN	O
:	:	O
cabg	NN	B-TREATMENT
with	IN	O
chest	JJ	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

findings	NNS	O
:	:	O
left	VBD	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
remains	VBZ	O
in	IN	O
place	NN	O
with	IN	O
some	DT	B-PROBLEM
density	NN	I-PROBLEM
adjacent	JJ	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
tip	NN	I-PROBLEM
,	,	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
significant	JJ	B-PROBLEM
interval	JJ	I-PROBLEM
change	NN	I-PROBLEM
vs	NN	O
.	.	O
prior	RB	O
.	.	O

specifically	RB	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
and	CC	O
no	DT	O
interval	JJ	B-PROBLEM
development	NN	I-PROBLEM
of	IN	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

69	CD	O
yo	NNS	O
m	JJ	O
with	IN	O
known	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
admitted	VBD	O
preop	NN	O
for	IN	O
transition	NN	O
fro	NN	O
coumadin	NN	B-TREATMENT
to	TO	O
heparin	VB	B-TREATMENT
.	.	O

brought	VBN	O
to	TO	O
the	DT	O
or	CC	O
on	IN	O
06-26	JJ	O
for	IN	O
cabg	NN	B-TREATMENT
,	,	O
please	VB	O
see	VB	O
or	CC	O
report	VB	O
for	IN	O
details	NNS	O
.	.	O

in	IN	O
summary	JJ	O
pt	NN	O
had	VBD	O
off	RP	B-TREATMENT
pump	JJ	I-TREATMENT
cabgx4	NN	I-TREATMENT
with	IN	O
lima-lad	JJ	B-TREATMENT
,	,	O
svg	JJ	B-TREATMENT
om-y	JJ	I-TREATMENT
graft	NN	I-TREATMENT
-	:	I-TREATMENT
diag	NN	I-TREATMENT
,	,	O
svg-pda	NN	B-TREATMENT
.	.	O

pt	NN	O
tolerated	VBD	O
surgery	NN	B-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
ct	VB	O
cmed	JJ	O
icu	NN	O
.	.	O

he	PRP	O
did	VBD	O
well	RB	O
in	IN	O
immediate	JJ	O
post-op	JJ	O
period	NN	O
was	VBD	O
extubated	VBN	B-TREATMENT
and	CC	O
on	IN	O
pod1	NN	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
step	NN	O
down	RP	O
floor	NN	O
.	.	O

on	IN	O
pod2	PDT	O
his	PRP$	B-TREATMENT
chest	NN	I-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	O
epicardial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
and	CC	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
restarted	VBN	O
.	.	O

atenolol	RB	B-TREATMENT
200	CD	O
'	''	O

hctz	RB	B-TREATMENT
25	CD	O
'	''	O

lisinopril	RB	B-TREATMENT
20	CD	O
'	''	O

ultram	JJ	B-TREATMENT
50	CD	O
'	''	O

prilosec	RB	B-TREATMENT
20	CD	O
'	''	O

zocor	NN	B-TREATMENT
40	CD	O
'	''	O

levitra	JJ	B-TREATMENT
/	NNP	O
prn	NN	O

warfarin	RB	B-TREATMENT
4	CD	O
'	''	O

1.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
ellis	NN	O
).	NN	O

2.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
leukhardt	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

3.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
sustained	VBN	O
release	NN	O
po	NN	O
once	RB	O
a	DT	O
sine	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

4.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
costa	NN	O
).	NN	O

5.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
warfarin	JJ	B-TREATMENT
2	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
avrett	NN	O
:	:	O
target	NN	B-TEST
inr	JJ	I-TEST
1.5-2	JJ	O
.	.	O

7.	CD	O
oxycodone	CD	B-TREATMENT
-	:	I-TREATMENT
acetaminophen	NN	I-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

8.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
once	RB	O
a	DT	O
gray	NN	O
.	.	O

10.	CD	O
ultram	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6	NN	O
hrs	NN	O
/	NNP	O
prn	NN	O
.	.	O

s/p	VB	O
off	RP	B-TREATMENT
pump	NN	I-TREATMENT
cabgx4	NN	I-TREATMENT
lima-lad	JJ	B-TREATMENT
,y	JJ	B-TREATMENT
svg-om-diag,	JJ	I-TREATMENT
svg-pda	NN	B-TREATMENT
(	(	O
06-26	JJ	O
)	)	O
pmh	NN	O
:	:	O
htn	NN	B-PROBLEM
,	,	O
chol	NN	B-PROBLEM
,	,	O
af	NN	B-PROBLEM
,	,	O
oa	NN	B-PROBLEM
,	,	O
cri	NN	B-PROBLEM
,	,	O
s/p	JJ	O
bilat	JJ	B-TREATMENT
knee	NN	I-TREATMENT
surgery	NN	I-TREATMENT

keep	VB	O
wounds	NNS	B-PROBLEM
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O

call	NN	O
for	IN	O
any	DT	O
fever	NN	B-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
from	IN	O
wounds	NNS	B-PROBLEM
.	.	O

right	JJ	B-PROBLEM
le	NN	I-PROBLEM
pain	NN	I-PROBLEM

tylenol	NN	B-TREATMENT
(	(	I-TREATMENT
acetaminophen	JJ	I-TREATMENT
)	)	I-TREATMENT
325-650	JJ	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
temperature	NN	B-TEST
greater	JJR	O
than	IN	O
:	:	O

101	CD	O
colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
oxycodone	CD	B-TREATMENT
10-25	JJ	O
mg	NN	O
po	NN	O
q3h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

excesive	JJ	B-PROBLEM
sedation	NN	I-PROBLEM
rr	NN	B-TEST
&lt;	VBD	O
6	CD	O
flexeril	NN	B-TREATMENT
(	(	I-TREATMENT
cyclobenzaprine	JJ	I-TREATMENT
hcl	NN	I-TREATMENT
)	)	I-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
tid	NN	O
prn	NN	O
pain	NN	B-PROBLEM

nka	NN	B-PROBLEM

r	NN	B-PROBLEM
leg	NN	I-PROBLEM
pain	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
right	NN	B-PROBLEM
le	NN	I-PROBLEM
pain	NN	I-PROBLEM

dm	NN	B-PROBLEM

pt	NN	B-TEST
spien	NN	I-TEST
mri	NN	I-TEST
pelvis	NN	B-TEST
xr	NNP	I-TEST
r	NN	B-TEST
hip	NN	I-TEST
xray	NN	I-TEST

hibbskote	NN	O
has	VBZ	O
severe	RB	B-PROBLEM
low	JJ	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
down	RP	O
the	DT	O
right	JJ	O
leg	NN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
suffering	VBG	O
from	IN	O
this	DT	B-PROBLEM
problem	NN	I-PROBLEM
for	IN	O
the	DT	O
last	JJ	O
few	JJ	O
weeks	NNS	O
.	.	O

a	DT	O
week	NN	O
and	CC	O
half	NN	O
ago	RB	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
steroid	JJ	I-TREATMENT
injection	NN	I-TREATMENT
in	IN	O
an	DT	O
efforts	NNS	O
to	TO	O
ameliorate	VB	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
presents	VBZ	O
now	RB	O
with	IN	O
worsening	VBG	B-PROBLEM
low	JJ	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
down	RP	O
the	DT	O
right	JJ	O
leg	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
numbness	RB	B-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
in	IN	O
any	DT	O
part	NN	O
of	IN	O
the	DT	O
body	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
fever	NN	B-PROBLEM
.	.	O

she	PRP	O
denies	VBZ	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	NN	B-PROBLEM
,	,	O
and	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

she	PRP	O
denies	VBZ	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
says	VBZ	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
sharp	JJ	O
in	IN	O
character	NN	O
,	,	O
and	CC	O
radiates	VBZ	O
with	IN	O
a	DT	B-PROBLEM
shock	NN	I-PROBLEM
like	IN	I-PROBLEM
intensity	NN	I-PROBLEM
down	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

she	PRP	O
says	VBZ	O
that	IN	O
oral	JJ	B-TREATMENT
analgesics	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
of	IN	O
little	JJ	O
help	NN	O
.	.	O

on	IN	O
detailed	JJ	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
,	,	O
she	PRP	O
admitted	VBD	O
to	TO	O
one	CD	O
episode	NN	O
of	IN	O
urinary	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
changes	NNS	I-PROBLEM
in	IN	I-PROBLEM
bowel	NN	I-PROBLEM
habits	NNS	I-PROBLEM
.	.	O

non-insulin-requiring	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

metformin	NN	B-TREATMENT
,	,	O
zocor	NN	B-TREATMENT
,	,	O
and	CC	O
analgesics	NNS	B-TREATMENT
.	.	O

awake	NN	O
,	,	O
alert	NN	O
,	,	O
spontaneous	JJ	O
and	CC	O
appropriate	JJ	O
,	,	O
and	CC	O
somewhat	RB	B-PROBLEM
uncomfortable	JJ	I-PROBLEM
due	JJ	O
to	TO	O
pain	VB	B-PROBLEM
but	CC	O
looked	VBD	O
well	RB	O
.	.	O

she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
had	VBD	O
normal	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

the	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
normal	JJ	O
at	IN	O
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

heart	NN	O
was	VBD	O
regular	JJ	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
no	DT	O
organomegaly	NN	B-PROBLEM
.	.	O

the	DT	O
skin	NN	O
and	CC	O
extremities	NNS	O
were	VBD	O
normal	JJ	O
with	IN	O
no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
,	,	O
edema	NN	B-PROBLEM
,	,	O
lesions	NNS	B-PROBLEM
,	,	O
or	CC	O
rashes	NNS	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

straight	RB	B-TEST
leg	NN	I-TEST
raise	NN	I-TEST
test	NN	I-TEST
was	VBD	O
difficult	JJ	O
to	TO	O
perform	VB	O
due	JJ	O
to	TO	O
pain	VB	B-PROBLEM
but	CC	O
seemed	VBD	O
to	TO	O
be	VB	O
positive	JJ	B-PROBLEM
on	IN	O
the	DT	O
right	NN	O
.	.	O

psychiatric	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

examination	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
back	NN	I-TEST
revealed	VBD	O
lumbar	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
with	IN	O
no	DT	O
point	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
spine	NN	I-TEST
showed	VBD	O
l4/5	JJ	B-PROBLEM
facet	JJ	I-PROBLEM
enhancement	NN	I-PROBLEM
.	.	O

thad	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
was	VBD	O
read	VBN	O
as	IN	O
a	DT	B-PROBLEM
facet	NN	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
not	RB	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
.	.	O

esr	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
and	CC	O
cpr	NN	B-TEST
was	VBD	O
mildly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
.	.	O

an	DT	B-TEST
ap	NN	I-TEST
of	IN	I-TEST
pelvis	NN	I-TEST
and	CC	O
r	NN	B-TEST
hip	NN	I-TEST
films	NNS	I-TEST
were	VBD	O
unremarkable	JJ	O
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
rle	NN	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
hip	NN	I-PROBLEM
with	IN	O
some	DT	O
movements	NNS	O
.	.	O

when	WRB	O
patient	NN	O
was	VBD	O
distracted	VBN	O
,	,	O
some	DT	O
maneuvers	NNS	O
were	VBD	O
not	RB	O
painful	JJ	B-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
weaned	VBN	O
from	IN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
tolerated	VBD	O
a	DT	O
regular	JJ	O
diet	JJ	O
prior	NN	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
pneumoboots	NNS	B-TREATMENT
and	CC	O
lovenox	NN	B-TREATMENT
for	IN	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O
.	.	O

patient	NN	O
should	MD	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
pain	NN	O
doctor	NN	O
,	,	O
dr.	NN	O
maa	NN	O
bloch	IN	O
381-389-5852	JJ	O
,	,	O
for	IN	O
her	PRP$	B-TREATMENT
chronic	JJ	I-TREATMENT
pain	NN	I-TREATMENT
management	NN	I-TREATMENT

do	VB	O
not	RB	O
drive	VB	O
or	CC	O
drink	VB	O
alcohol	NN	O
while	IN	O
taking	VBG	O
narcotics	NNS	B-TREATMENT
.	.	O

resume	VB	O
all	DT	O
of	IN	O
your	PRP$	B-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
but	CC	O
please	VB	O
avoid	JJ	O
motrin	NN	B-TREATMENT
/	NNP	I-TREATMENT
advil	NN	I-TREATMENT
for	IN	O
1	CD	O
week	NN	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
fevers	NNS	B-PROBLEM
&gt;	VBP	O
101.5	CD	O
f	NN	O
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
or	CC	O
increased	VBD	B-PROBLEM
redness	NN	I-PROBLEM
,	,	O
swelling	VBG	B-PROBLEM
,	,	O
or	CC	O
discharge	NN	B-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
,	,	O
call	VB	O
your	PRP$	O
md	NN	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
nearest	JJS	O
er	NN	O
.	.	O

penicillins	NNS	B-TREATMENT

respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
hemoptysis	NN	B-PROBLEM
transferred	VBD	O
from	IN	O
osh	NN	O

debridement	NN	B-TREATMENT
of	IN	O
mass	NN	B-PROBLEM
from	IN	O
tracheal	JJ	O
lumen	NNS	O
by	IN	O
interventional	JJ	O
pulmonary	NN	O

95	CD	O
yo	NNS	O
male	JJ	O
with	IN	O
pmh	JJ	O
large	JJ	B-PROBLEM
right	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
cystic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
eroding	VBG	I-PROBLEM
into	IN	O
trachea	NN	O
,	,	O
who	WP	O
presented	VBD	O
to	TO	O
st.	VB	O
anne	NN	O
's	POS	O
hospital	JJ	O
2018-04-22	JJ	O
with	IN	O
hemoptysis	NN	B-PROBLEM
and	CC	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
now	RB	O
diagnosed	VBN	O
with	IN	O
anaplastic	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

pt	NN	O
reports	NNS	O
that	IN	O
he	PRP	O
noticed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
neck	NN	I-PROBLEM
mass	NN	I-PROBLEM
last	JJ	O
october	NN	O
.	.	O

the	DT	B-PROBLEM
mass	NN	I-PROBLEM
grew	VBD	O
larger	JJR	O
,	,	O
to	TO	O
the	DT	O
size	NN	O
of	IN	O
a	DT	O
baseball	NN	O
.	.	O

it	PRP	O
appears	VBZ	O
that	IN	O
fna	NN	B-TEST
was	VBD	O
performed	VBN	O
but	CC	O
was	VBD	O
non-diagnostic	JJ	O
(	(	O
probably	RB	O
because	IN	O
anaplastic	JJ	B-PROBLEM
tumors	NNS	I-PROBLEM
tend	VBP	O
to	TO	O
be	VB	O
necrotic	JJ	O
)	)	O
.	.	O

the	DT	B-PROBLEM
mass	NN	I-PROBLEM
appears	VBZ	O
to	TO	O
be	VB	O
cystic	JJ	B-PROBLEM
in	IN	O
nature	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
aspirated	VBN	O
at	IN	O
least	JJS	O
3	CD	O
times	NNS	O
,	,	O
which	WDT	O
decrease	VBP	O
in	IN	O
size	NN	O
each	DT	O
time	NN	O
.	.	O

plan	NN	O
for	IN	O
surgery	NN	B-TREATMENT
in	IN	O
oct	NN	O
was	VBD	O
deferred	VBN	O
04-05	JJ	O
syncope	NN	B-PROBLEM
and	CC	O
pacer	NN	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
sss;	NN	B-PROBLEM
again	RB	O
deferred	VBD	O
2	CD	O
weeks	NNS	O
ago	RB	O
04-05	JJ	O
uri;	NN	B-PROBLEM
was	VBD	O
planned	VBN	O
for	IN	O
surgery	NN	B-TREATMENT
this	DT	O
thurday	NN	O
.	.	O

pt	NN	O
was	VBD	O
o/w	VBN	O
in	IN	O
his	PRP$	O
usoh	JJ	O
until	IN	O
2-3	JJ	O
weeks	NNS	O
ago	RB	O
when	WRB	O
he	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
uri	JJ	I-PROBLEM
with	IN	O
symptoms	NNS	B-PROBLEM
of	IN	O
dry	JJ	B-PROBLEM
cough;	NN	I-PROBLEM
no	DT	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
sore	RB	B-PROBLEM
throat	NN	I-PROBLEM
,	,	O
myalgias	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
3	CD	O
days	NNS	O
of	IN	O
an	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
followed	VBN	O
by	IN	O
a	DT	O
10	CD	O
day	NN	O
course	NN	O
of	IN	O
levaquin	NN	B-TREATMENT
(	(	O
completed	VBN	O
2	CD	O
days	NNS	O
pta	RB	O
)	)	O
.	.	O

per	IN	O
pt	NN	O
and	CC	O
son	NN	O
,	,	O
no	DT	O
james	NNS	B-PROBLEM
pna	RB	I-PROBLEM
.	.	O

2	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
pt	NN	O
developed	VBD	O
hemoptysis;	VB	B-PROBLEM
states	NNS	O
he	PRP	O
coughed	VBD	O
up	RP	O
4	CD	O
tsp	NNS	O
of	IN	O
blood	NN	B-PROBLEM
.	.	O

1	CD	O
day	NN	O
pta	NN	O
,	,	O
pt	NN	O
developed	VBD	O
stridorous	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
and	CC	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
initially	RB	O
seen	VBN	O
at	IN	O
lahey	JJ	O
north	NN	O
,	,	O
where	WRB	O
he	PRP	O
was	VBD	O
given	VBN	O
steroids	NNS	B-TREATMENT
,	,	O
with	IN	O
improvement	NN	O
in	IN	O
respiratory	NN	O
status	NN	O
.	.	O

thyroid	JJ	B-PROBLEM
cyst	NN	I-PROBLEM
was	VBD	O
aspirated	VBN	O
with	IN	O
removal	NN	O
of	IN	O
300cc	CD	O
of	IN	O
fluid	NN	O
.	.	O

pt	NN	O
was	VBD	O
given	VBN	O
racemic	JJ	B-TREATMENT
epinephrine	NN	I-TREATMENT
and	CC	O
decadron	NN	B-TREATMENT
10mg	CD	O
iv	NN	O
x1.	NNP	O
ct	NN	B-TEST
neck	NN	I-TEST
showed	VBD	O
tracheal	JJ	B-PROBLEM
mass	NN	I-PROBLEM
per	IN	O
nursing	NN	O
s/o	NN	O
(	(	O
pt	JJ	O
brought	VBN	O
ct	NN	B-TEST
)	)	O
.	.	O

he	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
fever	NN	B-PROBLEM
and	CC	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
but	CC	O
reports	NNS	O
weakness	NN	B-PROBLEM
and	CC	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
for	IN	O
several	JJ	O
months	NNS	O
recently	RB	O
.	.	O

r	NN	B-PROBLEM
thyroid	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
(	(	O
as	IN	O
above	NN	O
)	)	O

goiter	NN	B-PROBLEM

cri	NN	B-PROBLEM

htn	NN	B-PROBLEM

sss	NN	B-PROBLEM
(	(	O
s/p	JJ	O
pacer	NN	B-TREATMENT
michelle	NN	O
matthew	NNP	O
mccaulley	NN	O
)	)	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
-dx	VBZ	O
10	CD	O
years	NNS	O
ago;	RB	O
received	VBD	O
monthly	JJ	B-TREATMENT
shots	NNS	I-TREATMENT
which	WDT	O
were	VBD	O
discontinued	VBN	O
recently	RB	O
.	.	O

anemia	NN	B-PROBLEM
afib	NN	I-PROBLEM
(	(	O
19	CD	O
episodes	NNS	O
since	IN	O
2017-12-02	JJ	O
,	,	O
as	IN	O
documented	VBN	O
on	IN	O
pacer	NN	B-TEST
interogation	NN	I-TEST
2018-04-04	CD	O
)	)	O

no	DT	O
history	NN	O
of	IN	O
thyroid	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

sister	NN	O
with	IN	O
lung	NN	B-PROBLEM
ca	MD	I-PROBLEM
.	.	O

brother	NN	O
with	IN	O
gastric	JJ	B-PROBLEM
ca	MD	I-PROBLEM
.	.	O

sister	NN	O
with	IN	O
unknown	JJ	B-PROBLEM
ca	MD	I-PROBLEM
.	.	O

father	NN	O
with	IN	O
stroke	NN	B-PROBLEM
.	.	O

vs	NN	B-TEST
:	:	O

t	NN	B-TEST
99.4	CD	O
,	,	O
bp	NN	B-TEST
119/59	CD	O
,	,	O
hr	NN	B-TEST
76	CD	O
,	,	O
rr	NN	B-TEST
18	CD	O
,	,	O
99%	CD	O
ra	NN	O

nad	NN	B-PROBLEM

large	JJ	B-PROBLEM
~6	NNP	I-PROBLEM
x	NNP	I-PROBLEM
6	CD	I-PROBLEM
cm	NN	I-PROBLEM
sized	VBN	I-PROBLEM
right	RB	I-PROBLEM
thyroid	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
soft	JJ	O
,	,	O
possibly	RB	O
cystic	JJ	B-PROBLEM
,	,	O
non-tender.	JJ	B-PROBLEM

l	NN	O
lobe	NN	O
of	IN	O
the	DT	O
thyroid	NN	O
gland	NN	O
also	RB	O
prominent	JJ	B-PROBLEM
.	.	O

rrr	NN	O
,	,	O
nl	JJ	O
s1	NN	O
s2	NN	O
,	,	O
no	DT	O
m/g/r	NN	B-PROBLEM

lungs	NNS	O
:	:	O
transmitted	VBN	B-PROBLEM
upper	JJ	I-PROBLEM
airway	RB	I-PROBLEM
stridor;	JJ	I-PROBLEM
otherwise	RB	O
clear	JJ	O

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
nd	JJ	B-PROBLEM
,	,	O
+bs	VB	O

ext	NN	O
:	:	O
no	DT	O
edema	NN	B-PROBLEM

cn	JJ	B-TEST
04-15	JJ	O
intact	JJ	O
,	,	O
07-06	JJ	O
bilateral	JJ	O
upper	NN	O
and	CC	O
lower	JJR	O
extremity	NN	O
strength	NN	O
.	.	O

ct	NN	B-TEST
neck	SYM	I-TEST
-	:	O
impression	NN	O
:	:	O

1.	CD	O
7-cm	JJ	B-PROBLEM
diameter	NN	I-PROBLEM
right	RB	I-PROBLEM
neck	RB	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
with	IN	O
direct	JJ	B-PROBLEM
invasion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
subglottic	JJ	I-PROBLEM
,	,	I-PROBLEM
cervical	JJ	I-PROBLEM
and	CC	I-PROBLEM
proximal	JJ	I-PROBLEM
thoracic	NN	I-PROBLEM
trachea	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
mass	NN	I-PROBLEM
is	VBZ	O
reportedly	RB	O
thyroid	JJ	O
in	IN	O
origin	NN	O
.	.	O

differential	JJ	O
diagnosis	NN	O
includes	VBZ	O
primary	JJ	B-PROBLEM
head/neck	NN	I-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
lymphoma	NN	B-PROBLEM
.	.	O

2.	CD	O
left	VBD	B-PROBLEM
lobe	NN	I-PROBLEM
thyroid	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
with	IN	O
heterogeneous	JJ	O
appearance	NN	O
.	.	O

3.	CD	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
paratracheal	NN	I-PROBLEM
and	CC	I-PROBLEM
prevascular	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
additional	JJ	B-PROBLEM
nodes	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

dedicated	VBN	B-TEST
mr	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
neck	NN	I-TEST
may	MD	O
be	VB	O
helpful	JJ	O
for	IN	O
more	JJR	B-TEST
complete	JJ	I-TEST
assessment	NN	I-TEST
of	IN	O
the	DT	B-PROBLEM
neck	NN	I-PROBLEM
mass	NN	I-PROBLEM
and	CC	O
lymphadenopathy	JJ	B-PROBLEM
if	IN	O
warranted	VBN	O
clinically	RB	O
.	.	O

the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
is	VBZ	O
composed	VBN	O
of	IN	O
a	DT	B-PROBLEM
relatively	RB	I-PROBLEM
monotonous	JJ	I-PROBLEM
proliferation	NN	I-PROBLEM
of	IN	I-PROBLEM
spindle	NN	I-PROBLEM
cells	NNS	I-PROBLEM
which	WDT	O
grow	VBP	O
in	IN	O
sheets	NNS	O
with	IN	O
a	DT	O
prominent	JJ	O
vascular	JJ	O
pattern	NN	O
.	.	O

immunostains	NNS	B-TEST
for	IN	O
cytokeratin	NN	B-TEST
ae1/3	NN	I-TEST
and	CC	O
cam	NN	B-TEST
5.2	CD	I-TEST
,	,	O
cd-68	NN	B-TEST
,	,	O
cd-79a	JJ	B-TEST
,	,	O
cd-138	JJ	B-TEST
,	,	O
s-100	JJ	B-TEST
,	,	O
lca	JJ	B-TEST
absorbed	VBD	I-TEST
cea	NN	I-TEST
,	,	O
ema	NN	B-TEST
,	,	O
cd34	NN	B-TEST
,	,	O
cd31	NN	B-TEST
,	,	O
ttf-1	JJ	B-TEST
,	,	O
actin	NN	B-TEST
,	,	O
desmin	NN	B-TEST
,	,	O
mnf-116	NN	B-TEST
,	,	O
calcitonin	NN	B-TEST
,	,	O
and	CC	O
thyroglobulin	NNS	B-TEST
are	VBP	O
negative	JJ	O
.	.	O

these	DT	O
results	NNS	O
exclude	VBP	O
both	DT	O
melanoma	NN	B-PROBLEM
and	CC	O
hematopoietic	JJ	B-PROBLEM
neoplasms	NNS	I-PROBLEM
.	.	O

the	DT	O
differential	JJ	O
diagnosis	NN	O
includes	VBZ	O
,	,	O
but	CC	O
is	VBZ	O
not	RB	O
limited	VBN	O
to	TO	O
,	,	O
sarcoma	NN	B-PROBLEM
,	,	O
spindle	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinomas	NN	I-PROBLEM
(	(	O
sarcomatoid	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
aerodigestive	JJ	I-PROBLEM
tract	NN	I-PROBLEM
and	CC	O
anaplastic	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
)	)	O
,	,	O
and	CC	O
malignant	JJ	B-PROBLEM
salivary	JJ	I-PROBLEM
gland	NN	I-PROBLEM
neoplasms	NNS	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
transferred	VBN	O
here	RB	O
for	IN	O
further	JJ	B-TREATMENT
mgmt	NN	I-TREATMENT
of	IN	I-TREATMENT
airway	NN	I-TREATMENT
and	CC	O
large	JJ	B-PROBLEM
thyroid	JJ	I-PROBLEM
mass	NN	I-PROBLEM
by	IN	O
our	PRP$	O
ip	NN	O
team	NN	O
.	.	O

ip	NN	O
found	VBD	O
endotracheal	RB	B-PROBLEM
obstructing	VBG	I-PROBLEM
tumor	NN	I-PROBLEM
and	CC	O
extrinsic	JJ	B-PROBLEM
compression	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
high	JJ	I-PROBLEM
trachea	NN	I-PROBLEM
by	IN	O
thyroid	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

after	IN	O
rigid	JJ	B-TEST
bronchoscopy	NN	I-TEST
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
intratracheal	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
component	NN	I-PROBLEM
on	IN	O
2018-04-24	JJ	O
,	,	O
stat	JJ	B-TEST
pathology	NN	I-TEST
showed	VBD	O
anaplastic	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

subsequently	RB	O
extubated	VBN	O
and	CC	O
his	PRP$	O
respiratory	NN	B-PROBLEM
sx	NNS	I-PROBLEM
are	VBP	O
now	RB	O
improved	VBN	O
.	.	O

pt	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
rad	NN	O
onc	NN	O
,	,	O
who	WP	O
recommended	VBD	O
transfer	NN	O
to	TO	O
the	DT	O
east	JJ	O
campus	NN	O
for	IN	O
xrt	NN	B-TREATMENT
.	.	O

on	IN	O
the	DT	O
morning	NN	O
of	IN	O
possible	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
,	,	O
patient	NN	O
and	CC	O
family	NN	O
met	VBD	O
with	IN	O
interventional	JJ	O
pulmonary	JJ	O
team	NN	O
who	WP	O
explained	VBD	O
that	IN	O
the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
ct	NN	I-TEST
showed	VBD	O
further	JJ	B-PROBLEM
invasion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
tumor	NN	I-PROBLEM
into	IN	O
the	DT	O
trachea	NN	O
.	.	O

after	IN	O
a	DT	O
long	JJ	O
discussion	NN	O
,	,	O
patient	NN	O
and	CC	O
family	NN	O
asked	VBD	O
to	TO	O
be	VB	O
made	VBN	O
cmo	NN	B-TREATMENT
.	.	O

patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
morphine	NN	B-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
palliative	JJ	O
care	NN	O
team	NN	O
was	VBD	O
consulted	VBN	O
with	IN	O
recommendations	NNS	O
to	TO	O
ensure	VB	O
comfort	NN	O
.	.	O

acute	NN	B-PROBLEM
pancreatitis	NN	I-PROBLEM

acute	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

gastroesophageal	NN	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

ri	NN	O
strength	NN	O
is	VBZ	O
a	DT	O
40	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
gerd	NN	B-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
of	IN	O
seven	CD	O
days	NNS	O
duration	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
general	JJ	O
good	JJ	O
health	NN	O
until	IN	O
seven	CD	O
days	NNS	O
ago	RB	O
(	(	O
2/11/00	CD	O
)	)	O
,	,	O
when	WRB	O
he	PRP	O
had	VBD	O
a	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
sharp	JJ	B-PROBLEM
left	JJ	I-PROBLEM
flank	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
abdomen	NNS	I-PROBLEM
and	CC	O
then	RB	O
to	TO	O
the	DT	O
epigastrium	NN	O
.	.	O

the	DT	O
patient	NN	O
described	VBD	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
as	IN	O
&quot;	JJ	O
knife-like	JJ	B-PROBLEM
&quot;	NN	O
with	IN	O
a	DT	O
severity	NN	O
of	IN	O
1/25	CD	O
at	IN	O
its	PRP$	O
worse	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
reports	VBZ	O
blood-streaked	JJ	B-PROBLEM
diarrhea	NNS	I-PROBLEM
for	IN	O
two	CD	O
days	NNS	O
.	.	O

he	PRP	O
denies	VBZ	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
recent	JJ	B-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
,	,	O
no	DT	O
light-headedness	NN	B-PROBLEM
or	CC	O
dizziness	NN	B-PROBLEM
.	.	O

he	PRP	O
denies	VBZ	O
increased	VBD	B-PROBLEM
urinary	JJ	I-PROBLEM
frequent	NN	I-PROBLEM
or	CC	O
urgency	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
the	DT	O
sloan-	JJ	O
center	NN	O
emergency	NN	O
department	NN	O
,	,	O
where	WRB	O
he	PRP	O
was	VBD	O
resuscitated	VBN	O
with	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
and	CC	O
received	VBD	O
morphine	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
general	JJ	O
medicine	NN	O
service	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

(1)	JJ	O
gerd	NN	B-PROBLEM
;	:	O
(2)	CC	O
pneumonia	NN	B-PROBLEM
with	IN	O
partially	RB	B-PROBLEM
collapsed	VBN	I-PROBLEM
lung	NN	I-PROBLEM
in	IN	O
1999	CD	O
.	.	O

prilosec	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

gerd	NN	B-PROBLEM
and	CC	O
pud	NN	B-PROBLEM
.	.	O

temp	NN	B-TEST
98.5	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
74	CD	O
,	,	O
bp	NN	B-TEST
140/90	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
o2	PRP	B-TEST
sat	VBD	I-TEST
98%	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
but	CC	O
in	IN	O
mild	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
,	,	O
no	DT	O
jvd	NN	B-PROBLEM
.	.	O

bibasilar	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
normal	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
non-distended	JJ	B-PROBLEM
.	.	O

tender	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
at	IN	I-TEST
the	DT	I-TEST
left	NN	I-TEST
lower	RBR	I-TEST
quadrant	NN	I-TEST
and	CC	O
especially	RB	O
at	IN	O
the	DT	O
epigastrium	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
splenomegaly	NN	B-PROBLEM
or	CC	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

point	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
costovertebral	JJ	I-PROBLEM
angle	NN	I-PROBLEM
.	.	O

warm	NN	O
to	TO	O
touch	VB	O
,	,	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
equal	JJ	O
and	CC	O
adequate	JJ	O
in	IN	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
.	.	O

sensation	NN	O
was	VBD	O
intact	JJ	O
to	TO	O
pain	VB	B-PROBLEM
and	CC	O
light	JJ	B-TEST
touch	NN	I-TEST
.	.	O

chem-7	JJ	B-TEST
-	:	O
na	NN	B-TEST
139	CD	O
,	,	O
k	VBD	B-TEST
3.7	CD	O
,	,	O
cl	NN	B-TEST
99	CD	O
,	,	O
bicarb	NN	B-TEST
28	CD	O
,	,	O
bun	NN	B-TEST
15	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
,	,	O
glucose	VBD	B-TEST
89	CD	O
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
significant	JJ	O
for	IN	O
an	DT	B-TEST
alt	NN	I-TEST
41	CD	O
,	,	O
ast	RB	B-TEST
31	CD	O
,	,	O
alk	VBP	B-TEST
phos	JJ	I-TEST
76	CD	O
,	,	O
t.	NN	B-TEST
bili	NN	I-TEST
0.7	CD	O
,	,	O
d.	NN	B-TEST
bili	NN	I-TEST
0.2	CD	O
,	,	O
amylase	NN	B-TEST
345	CD	O
,	,	O
lipase	NN	B-TEST
2510	CD	O
,	,	O
t.	EX	B-TEST
protein	RB	I-TEST
8.1	CD	O
,	,	O
albumin	RB	B-TEST
4.9	CD	O
,	,	O
globulin	NN	B-TEST
3.2	CD	O
,	,	O
ca	MD	B-TEST
9.9	CD	O
.	.	O

cbc	SYM	B-TEST
-	:	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
8.82	CD	O
,	,	O
hemoglobin	NN	B-TEST
15.2	CD	O
,	,	O
hematocrit	NN	B-TEST
43	CD	O
,	,	O
and	CC	O
platelets	VBZ	B-TEST
322	CD	O
.	.	O

imaging	VBG	B-TEST
studies	NNS	I-TEST
:	:	O

abdominal	JJ	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
on	IN	O
2/21/00	CD	O
-	:	O
study	NN	B-TEST
revealed	VBD	O
a	DT	B-PROBLEM
prominent	JJ	I-PROBLEM
pancreas	NN	I-PROBLEM
with	IN	O
associated	JJ	B-PROBLEM
mesenteric	JJ	I-PROBLEM
stranding	NN	I-PROBLEM
.	.	O

no	DT	O
abscess	NN	B-PROBLEM
or	CC	O
pseudocyst	NN	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
gallstone	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
gallbladder	NN	O
neck	NN	O
.	.	O

bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
were	VBD	O
seen	VBN	O
with	IN	O
associated	JJ	B-PROBLEM
compression	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

abdominal	JJ	B-TEST
ultrasound	NN	I-TEST
on	IN	O
2/23/00	CD	O
-	:	O
this	DT	B-TEST
study	NN	I-TEST
revealed	VBD	O
gallbladder	NN	B-PROBLEM
sludge	NN	I-PROBLEM
but	CC	O
no	DT	O
cholelithiasis	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
swelling	VBG	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
body	NN	I-PROBLEM
and	CC	O
tail	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

portable	JJ	B-TEST
chest	NN	I-TEST
on	IN	O
2/23/00	CD	O
-	:	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

chest	NN	B-TEST
(	(	I-TEST
pa	JJ	I-TEST
and	CC	I-TEST
lateral	JJ	I-TEST
)	)	I-TEST
on	IN	O
2/25/00	CD	O
-	:	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
infiltrates	NNS	B-PROBLEM
or	CC	O
consolidation	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
acute	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
made	VBN	O
npo	NN	B-TREATMENT
and	CC	O
was	VBD	O
resuscitated	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

pain	NN	B-TREATMENT
control	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
with	IN	O
morphine	NN	B-TREATMENT
but	CC	O
was	VBD	O
then	RB	O
changed	VBN	O
to	TO	O
demerol	VB	B-TREATMENT
,	,	O
which	WDT	O
gave	VBD	O
the	DT	O
patient	NN	O
better	RBR	O
relief	NN	O
of	IN	O
his	PRP$	B-PROBLEM
epigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

from	IN	O
2/17/00	CD	O
to	TO	O
2/21/00	CD	O
,	,	O
the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
persistent	JJ	B-PROBLEM
and	CC	I-PROBLEM
occasionally	RB	I-PROBLEM
severe	JJ	I-PROBLEM
epigastric	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
pain	NN	I-TREATMENT
medication	NN	I-TREATMENT
was	VBD	O
then	RB	O
changed	VBN	O
to	TO	O
dilaudid	VB	B-TREATMENT
iv	NN	I-TREATMENT
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
better	JJR	O
alleviate	VB	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

dilaudid	NN	B-TREATMENT
iv	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
for	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
hospitalization	NN	O
.	.	O

the	DT	O
severity	NN	O
and	CC	O
persistent	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
epigastric	NN	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
concerning	VBG	O
for	IN	O
a	DT	B-PROBLEM
pancreatic	JJ	I-PROBLEM
complication	NN	I-PROBLEM
such	JJ	O
as	IN	O
necrosis	NN	B-PROBLEM
or	CC	O
abscess	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
gallbladder	NN	I-PROBLEM
neck	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
biliary	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
stranding	VBG	B-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
pancreas	NNS	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
necrosis	NN	B-PROBLEM
,	,	O
abscess	NN	B-PROBLEM
,	,	O
or	CC	O
pseudocyst	NN	B-PROBLEM
.	.	O

on	IN	O
2/22/00	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
fevers	NNS	B-PROBLEM
to	TO	O
103.5	CD	O
.	.	O

blood	NN	B-TEST
and	CC	I-TEST
urine	JJ	I-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
done	VBN	O
,	,	O
which	WDT	O
revealed	VBD	O
no	DT	O
infiltrate	NN	B-PROBLEM
or	CC	O
effusion	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
cefotaxime	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
for	IN	O
empiric	JJ	B-TREATMENT
antibiotic	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

all	DT	B-TEST
cultures	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

on	IN	O
2/23/00	CD	O
,	,	O
the	DT	B-PROBLEM
high	JJ	I-PROBLEM
grade	NN	I-PROBLEM
fever	NN	I-PROBLEM
persisted	VBN	O
.	.	O

an	DT	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
done	VBN	O
to	TO	O
r	VB	O
/	NNP	O
o	JJ	O
cholestasis	NN	B-PROBLEM
or	CC	O
cholangitis	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
ultrasound	NN	I-TEST
showed	VBD	O
biliary	JJ	B-PROBLEM
sludge	NN	I-PROBLEM
and	CC	O
swelling	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
body	NN	I-PROBLEM
and	CC	O
tail	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

no	DT	O
other	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
.	.	O

on	IN	O
2/24/00	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
exacerbation	NN	O
of	IN	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
left	VBN	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
subsequently	RB	O
relieved	VBN	O
with	IN	O
high	JJ	B-TREATMENT
dose	NN	I-TREATMENT
dilaudid	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
follow-up	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
,	,	O
which	WDT	O
was	VBD	O
essentially	RB	O
unchanged	JJ	O
from	IN	O
previously	RB	O
,	,	O
showing	VBG	O
a	DT	O
normal	JJ	O
heart	NN	O
and	CC	O
lungs	NNS	O
without	IN	O
infiltrate	NN	B-PROBLEM
.	.	O

from	IN	O
2/25	CD	O
-	:	O
2/27/00	CD	O
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
fever	NN	I-PROBLEM
defervesced	VBD	O
and	CC	O
his	PRP$	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
gradually	RB	O
subsided	VBD	O
.	.	O

the	DT	B-TREATMENT
cefotaxime	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
since	IN	O
no	DT	O
infection	NN	B-PROBLEM
was	VBD	O
identified	VBN	O
.	.	O

on	IN	O
2/28/00	CD	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
diet	NN	O
was	VBD	O
advanced	VBN	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
fat	NN	I-TREATMENT
solids	NNS	I-TREATMENT
(	(	O
per	IN	O
pancreatitis	NN	B-TEST
study	NN	I-TEST
)	)	O
,	,	O
which	WDT	O
the	DT	O
patient	NN	O
tolerated	VBN	O
well	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
2/29/00	CD	O
,	,	O
with	IN	O
much	JJ	O
improvement	NN	O
of	IN	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

prilosec	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
percocet	CC	B-TREATMENT
1-2	JJ	O
tabs	NNS	O
p.o.	IN	O
q.6-8h.	JJ	O
x5	NNP	O
days	NNS	O
;	:	O
mvi	CC	B-TREATMENT
1	CD	O
tab	NN	O
p.o.	NN	O
q.d.	NN	O

this	DT	O
is	VBZ	O
a	DT	O
37-year-old	JJ	O
female	NN	O
who	WP	O
presents	VBZ	O
on	IN	O
an	DT	O
elective	JJ	O
basis	NN	O
for	IN	O
a	DT	B-TREATMENT
living-related	JJ	I-TREATMENT
kidney	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
end-stage	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
type	VB	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
with	IN	O
a	DT	B-TEST
baseline	JJ	I-TEST
creatinine	NN	I-TEST
of	IN	O
around	IN	O
5	CD	O
.	.	O

she	PRP	O
is	VBZ	O
receiving	VBG	O
a	DT	B-TREATMENT
kidney	NN	I-TREATMENT
from	IN	O
her	PRP$	O
sister	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
for	IN	O
32	CD	O
years	NNS	O
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
april	NN	O
of	IN	O
this	DT	O
year	NN	O
and	CC	O
subsequently	RB	O
underwent	JJ	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

she	PRP	O
present	VBD	O
electively	RB	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
her	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
with	IN	O
no	DT	O
recent	JJ	O
changes	NNS	O
in	IN	O
her	PRP$	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

1.	CD	O
sarcoidosis	NN	B-PROBLEM
since	IN	O
2001	CD	O
.	.	O

2.	CD	O
she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
.	.	O

3.	CD	O
status	NN	O
post	NN	O
tubal	JJ	B-TREATMENT
ligation	NN	I-TREATMENT
.	.	O

4.	CD	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
arteriovenous	JJ	I-TREATMENT
graft	NN	I-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
hemodialysis	NN	B-TREATMENT
.	.	O

5.	CD	O
insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
times	NNS	O
32	CD	O
years	NNS	O
.	.	O

6.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

7.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
2012-05-06	JJ	O
.	.	O

8.	CD	O
end-stage	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
on	IN	O
hemodialysis	NN	B-TREATMENT
for	IN	O
1.5	CD	O
years	NNS	O
.	.	O

allergies	NNS	B-PROBLEM
include	VBP	O
amoxicillin	JJ	B-TREATMENT
and	CC	O
codeine	NN	B-TREATMENT
.	.	O

1.	CD	O
insulin	NN	B-TREATMENT
by	IN	O
sliding-scale	JJ	O
,	,	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
16	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
6	CD	O
units	NNS	O
in	IN	O
the	DT	O
evening	NN	O
.	.	O

2.	CD	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
zoloft	JJ	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

4.	CD	O
reglan	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

5.	CD	O
lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

6.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
multivitamin	NN	B-TREATMENT
1	CD	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
remeron	NN	B-TREATMENT
p.o.	NN	O
q.d.	NN	O

physical	JJ	B-TEST
examination	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
revealed	VBD	O
she	PRP	O
was	VBD	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
150/79	CD	O
,	,	O
a	DT	B-TEST
pulse	NN	I-TEST
of	IN	O
81	CD	O
.	.	O

she	PRP	O
is	VBZ	O
legally	RB	B-PROBLEM
blind	JJ	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
without	IN	O
any	DT	B-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

her	PRP$	O
chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

heart	NN	O
had	VBD	O
a	DT	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
gallops	NNS	B-PROBLEM
or	CC	O
rubs	NNS	B-PROBLEM
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
with	IN	O
well-healed	JJ	B-PROBLEM
incisions	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
organomegaly	NN	B-PROBLEM
.	.	O

extremities	NNS	O
were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
functioning	VBG	I-PROBLEM
arteriovenous	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
thrill	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
bruit	NN	I-PROBLEM
in	IN	O
her	PRP$	O
left	JJ	O
arm	NN	O
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
living-related	JJ	I-TREATMENT
renal	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
iliac	NN	I-TREATMENT
fossa	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
somewhat	RB	O
technically	RB	O
difficult	JJ	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
short	JJ	I-PROBLEM
segment	NN	I-PROBLEM
of	IN	I-PROBLEM
ureter	NN	I-PROBLEM
which	WDT	O
was	VBD	O
anastomosed	VBN	O
over	IN	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
to	TO	O
the	DT	O
bladder	NN	O
.	.	O

otherwise	RB	O
,	,	O
there	EX	O
were	VBD	O
difficulties	NNS	B-PROBLEM
,	,	O
and	CC	O
estimated	VBD	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
minimal	JJ	O
.	.	O

intraoperatively	RB	O
,	,	O
for	IN	O
immunosuppression	NN	B-TREATMENT
she	PRP	O
received	VBD	O
thymoglobulin	JJ	B-TREATMENT
and	CC	O
solu-medrol	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
prograf	NN	B-TREATMENT
and	CC	O
cellcept	NN	B-TREATMENT
in	IN	O
the	DT	O
postoperative	JJ	O
period	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
maintained	VBN	O
on	IN	O
bactrim	NN	B-TREATMENT
postoperatively	RB	O
and	CC	O
did	VBD	O
not	RB	O
require	VB	O
ganciclovir	NN	B-TREATMENT
,	,	O
as	IN	O
she	PRP	O
and	CC	O
her	PRP$	O
sister	NN	O
were	VBD	O
cytomegalovirus	JJ	B-PROBLEM
negative	JJ	O
.	.	O

her	PRP$	B-TEST
creatinine	NN	I-TEST
,	,	O
which	WDT	O
was	VBD	O
5	CD	O
initially	RB	O
postoperatively	RB	O
,	,	O
slowly	RB	O
dropped	VBD	O
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
until	IN	O
eventually	RB	O
reaching	VBG	O
a	DT	O
low	NN	O
of	IN	O
1	CD	O
.	.	O

she	PRP	O
did	VBD	O
receive	VB	O
pamidronate	NN	B-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
and	CC	O
received	VBD	O
a	DT	O
total	NN	O
of	IN	O
four	CD	O
doses	NNS	O
thymoglobulin	NN	B-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
steroid	JJ	I-TREATMENT
doses	NNS	I-TREATMENT
were	VBD	O
slowly	RB	O
tapered	VBN	O
over	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
,	,	O
and	CC	O
her	PRP$	B-TEST
prograf	JJ	I-TEST
level	NN	I-TEST
was	VBD	O
adjusted	VBN	O
to	TO	O
maintain	VB	O
therapeutic	JJ	O
values	NNS	O
between	IN	O
10	CD	O
and	CC	O
15	CD	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
make	VB	O
good	JJ	O
urine	NN	O
over	IN	O
the	DT	O
first	JJ	O
few	JJ	O
days	NNS	O
and	CC	O
had	VBD	O
her	PRP$	O
urine	JJ	O
losses	NNS	O
replaced	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
episode	NN	I-PROBLEM
of	IN	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
that	WDT	O
was	VBD	O
evaluated	VBN	O
by	IN	O
both	DT	O
the	DT	O
renal	NN	O
and	CC	O
surgical	JJ	O
residents	NNS	O
.	.	O

it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
in	IN	O
acute	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
required	VBN	O
transfer	NN	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
incident	NN	O
was	VBD	O
in	IN	O
the	DT	O
range	NN	O
of	IN	O
200/120	CD	O
.	.	O

her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
no	DT	O
specific	JJ	B-PROBLEM
st	NN	I-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
but	CC	O
there	EX	O
was	VBD	O
some	DT	B-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
r	NN	I-PROBLEM
wave	NN	I-PROBLEM
progression	NN	I-PROBLEM
laterally	RB	I-PROBLEM
.	.	O

serial	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
drawn	VBN	O
,	,	O
and	CC	O
cardiology	NN	O
was	VBD	O
consulted	VBN	O
.	.	O

with	IN	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
via	IN	O
a	DT	B-TREATMENT
nitroglycerin	JJ	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
,	,	O
the	DT	O
patient	JJ	O
quickly	RB	O
improved	VBN	O
and	CC	O
a	DT	O
had	VBD	O
a	DT	O
relatively	RB	O
short	JJ	O
stay	NN	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

throughout	IN	O
this	DT	O
time	NN	O
,	,	O
her	PRP$	B-TEST
creatinine	NN	I-TEST
continued	VBD	O
to	TO	O
drop	VB	O
,	,	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
apparent	JJ	B-PROBLEM
deleterious	JJ	I-PROBLEM
effect	NN	I-PROBLEM
on	IN	O
her	PRP$	B-TREATMENT
transplant	NN	I-TREATMENT
from	IN	O
this	DT	O
episode	NN	O
.	.	O

her	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
was	VBD	O
progressively	RB	O
increased	VBN	O
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
nitroglycerin	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
down	RP	O
.	.	O

two	CD	O
days	NNS	O
after	IN	O
this	DT	O
event	NN	O
,	,	O
she	PRP	O
underwent	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
was	VBD	O
significant	JJ	O
for	IN	O
slightly	RB	B-PROBLEM
depressed	VBN	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
function	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
posterior	NN	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
a	DT	O
change	NN	O
from	IN	O
her	PRP$	B-TEST
prior	JJ	I-TEST
echocardiogram	NN	I-TEST
and	CC	O
demonstrated	VBD	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

clinically	RB	O
,	,	O
she	PRP	O
did	VBD	O
much	RB	O
better	RBR	O
and	CC	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
optimized	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

1.	CD	O
prograf	JJ	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
(	(	O
this	DT	O
may	MD	O
change	VB	O
depending	VBG	O
on	IN	O
her	PRP	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
prograf	NN	I-TEST
level	NN	I-TEST
which	WDT	O
will	MD	O
be	VB	O
drawn	VBN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
11-28	JJ	O
)	)	O
.	.	O

2.	CD	O
prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
cellcept	JJ	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
bactrim	JJ	B-TREATMENT
1	CD	O
single-strength	JJ	O
tablet	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

6.	CD	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
16	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
6	CD	O
units	NNS	O
q.p.m.	RB	O

7.	CD	O
zoloft	JJ	B-TREATMENT
175	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

9.	CD	O
reglan	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

10.	CD	O
percocet	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
q.4-6h.	JJ	O
p.r.n.	NN	O

11.	CD	O
lopressor	NN	B-TREATMENT
125	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

12.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

13.	CD	O
cardizem-cd	JJ	B-TREATMENT
180	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

status	NN	O
post	NN	O
living-related	JJ	B-TREATMENT
renal	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
with	IN	O
perioperative	JJ	B-PROBLEM
small	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM

saujule	NN	O
study	NN	O
is	VBZ	O
a	DT	O
77-year-old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
obesity	NN	B-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
x	$	O
5	CD	O
days	NNS	O
.	.	O

her	PRP$	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
progressive	JJ	O
over	IN	O
the	DT	O
last	JJ	O
2-3	JJ	O
years	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
an	DT	B-PROBLEM
associated	VBN	I-PROBLEM
dry	JJ	I-PROBLEM
cough	NN	I-PROBLEM
but	CC	O
no	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
or	CC	O
leg	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
dyspnea	VBN	B-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

she	PRP	O
ambulates	VBZ	O
with	IN	O
walker	NN	B-TREATMENT
and	CC	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
osteoarthritis	VB	B-PROBLEM
.	.	O

she	PRP	O
becomes	VBZ	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
just	RB	O
by	IN	O
getting	VBG	O
up	RP	O
from	IN	O
her	PRP$	O
chair	NN	O
and	CC	O
can	MD	O
only	RB	O
walk	VB	O
2-3	JJ	O
steps	NNS	O
on	IN	O
a	DT	O
flat	JJ	O
surface	NN	O
.	.	O

she	PRP	O
feels	VBD	O
light	NN	B-PROBLEM
headed	VBN	I-PROBLEM
when	WRB	O
getting	VBG	O
up	RP	O
.	.	O

her	PRP$	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
has	VBZ	O
been	VBN	O
progressive	JJ	O
for	IN	O
the	DT	O
past	JJ	O
several	JJ	O
years	NNS	O
.	.	O

she	PRP	O
sleeps	VBZ	O
in	IN	O
a	DT	O
chair	NN	O
up	RP	O
right	RB	O
for	IN	O
the	DT	O
last	JJ	O
2	CD	O
1/2	CD	O
years	NNS	O
secondary	JJ	O
to	TO	O
osteoarthritis	VB	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
orthopnea	VBN	B-PROBLEM
as	RB	O
well	RB	O
but	CC	O
noparoxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

she	PRP	O
occasionally	RB	O
feels	VBZ	O
chest	JJS	B-PROBLEM
twinges	NNS	I-PROBLEM
which	WDT	O
are	VBP	O
nonradiating	VBG	B-PROBLEM
but	CC	O
are	VBP	O
sharp	JJ	B-PROBLEM
.	.	O

they	PRP	O
last	JJ	O
a	DT	O
few	JJ	O
seconds	NNS	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
and	CC	O
are	VBP	O
not	RB	O
associated	VBN	O
with	IN	O
sweating	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
syncope	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
for	IN	O
thelast	JJ	O
several	JJ	O
years	NNS	O
with	IN	O
multiple	JJ	O
episodes	NNS	O
of	IN	O
cellulitis	NN	B-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
has	VBZ	O
increased	VBN	O
for	IN	O
the	DT	O
several	JJ	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	VB	O
secondary	JJ	O
to	TO	O
an	DT	O
inability	NN	O
to	TO	O
elevate	VB	O
her	PRP$	O
legs	NNS	O
due	JJ	O
to	TO	O
a	DT	O
broken	JJ	O
chair	NN	O
at	IN	O
home	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
pleural	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

negative	JJ	O
for	IN	O
headaches	NNS	B-PROBLEM
,	,	O
vision	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
numbness	NN	B-PROBLEM
,	,	O
tingling	VBG	B-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
,	,	O
hematuria	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
melena	NN	B-PROBLEM
or	CC	O
hematochezia	NN	B-PROBLEM
.	.	O

obesity	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
and	CC	O
edema	NN	B-PROBLEM
,	,	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
1988	CD	O
treated	VBD	O
with	IN	O
right	JJ	B-TREATMENT
lumpectomy	NN	I-TREATMENT
and	CC	O
xrt	NN	B-TREATMENT
,	,	O
partial	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
in	IN	O
1963	CD	O
,	,	O
osteoarthritis	NN	B-PROBLEM
with	IN	O
right	JJ	B-PROBLEM
leg	NN	I-PROBLEM
deformities	NNS	I-PROBLEM
,	,	O
hernia	VBP	B-TREATMENT
repair	NN	I-TREATMENT
50	CD	O
years	NNS	O
ago	RB	O
,	,	O
bilateral	JJ	B-TREATMENT
cataract	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

codeine	NN	B-TREATMENT
.	.	O

hydrochlorothiazide	RB	B-TREATMENT
50	CD	O
mg	NNS	O
p.o.	JJ	O
q	JJ	O
day	NN	O
,	,	O
atenolol	RB	B-TREATMENT
50	CD	O
mg	NNS	O
p.o.	JJ	O
q	JJ	O
day	NN	O
,	,	O
dicloxacillin	NN	B-TREATMENT
started	VBD	O
on	IN	O
december	NN	O
29	CD	O
,	,	O
2002	CD	O
,	,	O
naproxen	CC	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
aspirin	RB	B-TREATMENT
81	CD	O
mg	NNS	O
p.o.	JJ	O
q	JJ	O
day	NN	O
,	,	O
tylenol	NN	B-TREATMENT
p.r.n.	NN	O

son	NN	O
died	VBD	O
at	IN	O
50	CD	O
of	IN	O
diabetes	NNS	B-PROBLEM
and	CC	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
vitals	NNS	B-TEST
were	VBD	O
temperature	JJ	B-TEST
96.4	CD	O
,	,	O
pulse	RB	B-TEST
40-50	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
154-58	CD	O
,	,	O
satting	VBG	O
86%	CD	O
on	IN	O
room	NN	O
air	NN	O
,	,	O
99%	CD	O
on	IN	O
3	CD	O
liters	NNS	O
of	IN	O
3	CD	B-TREATMENT
liters	NNS	I-TREATMENT
cannula	VBP	I-TREATMENT
.	.	O

rate	NN	B-TEST
28	CD	O
.	.	O

anicteric	NN	B-PROBLEM
.	.	O

2	CD	B-TEST
plus	JJ	I-TEST
carotids	NNS	I-TEST
.	.	O

no	DT	O
delayed	JJ	B-PROBLEM
upstroke	NN	I-PROBLEM
.	.	O

oropharynx	NN	O
is	VBZ	O
clear	JJ	O
without	IN	O
lymphadenopathyin	PDT	B-PROBLEM
the	DT	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
to	TO	O
the	DT	O
jaw	NN	O
.	.	O

crackles	NNS	B-PROBLEM
1/3	CD	I-PROBLEM
up	RB	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

3/6	CD	B-PROBLEM
crescendo	NN	I-PROBLEM
decrescendo	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
carotids	NNS	I-PROBLEM
.	.	O

no	DT	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
obese	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

3	CD	B-PROBLEM
plus	CC	I-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
knee	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
with	IN	O
areas	NNS	O
of	IN	O
darkened	VBN	B-PROBLEM
erythema	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
crusted	VBN	B-PROBLEM
,	,	O
indented	VBN	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
shallow	JJ	I-PROBLEM
chronic	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
shin	NN	I-PROBLEM
with	IN	O
desquamation	NN	B-PROBLEM
bilaterally	RB	I-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
ankle	NN	I-PROBLEM
and	CC	O
half	NN	O
way	NN	O
up	IN	O
the	DT	O
shin	NN	O
.	.	O

1	CD	B-PROBLEM
x	JJ	I-PROBLEM
2	CD	I-PROBLEM
cm	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
clean	JJ	O
sharp	JJ	O
borders	NNS	O
to	TO	O
the	DT	O
dermatome	NN	O
on	IN	O
the	DT	O
left	NN	O
posterior	JJ	O
thigh	NN	O
.	.	O

unable	JJ	O
to	TO	O
assess	VB	O
reflexes	NNS	B-TEST
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
knee	NN	I-PROBLEM
deformities	NNS	I-PROBLEM
.	.	O

2	CD	B-TEST
plus	CC	I-TEST
reflexes	NNS	I-TEST
in	IN	O
the	DT	O
upper	JJ	O
extremities	NNS	O
symmetrically	RB	O
bilaterally	RB	O
.	.	O

sodium	NN	B-TEST
134	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
91	CD	O
,	,	O
bicarbonate	NN	B-TEST
33	CD	O
,	,	O
bun	NN	B-TEST
21	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
,	,	O
glucose	RB	B-TEST
99	CD	O
,	,	O
ck	NN	B-TEST
22	CD	O
,	,	O
troponin	NN	B-TEST
0	CD	O
.	.	O

calcium	NN	B-TEST
8.8	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
10.6	CD	O
,	,	O
hematocrit	NN	B-TEST
37.1	CD	O
,	,	O
platelets	NNS	B-TEST
289	CD	O
.	.	O

inr	NN	B-TEST
1.1	CD	O
,	,	O
ptt	VBD	B-TEST
30.3.chest	CD	B-TEST
x-ray	NN	I-TEST
shows	NNS	O
cardiomegaly	NN	B-PROBLEM
.	.	O

small	JJ	B-PROBLEM
left	VBD	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

lobular	JJ	B-PROBLEM
density	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
hilum	NN	I-PROBLEM
.	.	O

no	DT	O
pneumonia	NN	B-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
shows	NNS	O
normal	JJ	O
sinus	JJ	O
rhythm	NN	O
at	IN	O
50	CD	O
.	.	O

primary	JJ	B-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
acute	NN	B-PROBLEM
and	CC	I-PROBLEM
chronic	JJ	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
in	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
thought	VBD	O
likely	RB	O
secondary	JJ	O
to	TO	O
diastolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
hypertension	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

she	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
3	CD	O
negative	JJ	O
enzymes	NNS	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
she	PRP	O
was	VBD	O
diuresed	VBN	O
with	IN	O
lasix	NN	B-TREATMENT
and	CC	O
was	VBD	O
negative	JJ	O
1-2	JJ	O
liters	NNS	O
per	IN	O
day	NN	O
for	IN	O
several	JJ	O
days	NNS	O
.	.	O

the	DT	B-TREATMENT
diuresis	NN	I-TREATMENT
was	VBD	O
backed	VBN	O
off	RP	O
when	WRB	O
her	PRP$	B-TEST
bicarbonate	NN	I-TEST
increased	VBD	O
from	IN	O
36	CD	O
to	TO	O
39	CD	O
.	.	O

her	PRP$	B-TEST
lipids	NNS	I-TEST
were	VBD	O
checked	VBN	O
with	IN	O
a	DT	B-TEST
total	JJ	I-TEST
cholesterol	NN	I-TEST
of	IN	O
110	CD	O
,	,	O
triglycerides	NNS	B-TEST
59	CD	O
,	,	O
hdl32	NN	B-TEST
,	,	O
ldl	VBZ	B-TEST
64	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
d-dimer	JJ	I-TEST
greater	JJR	O
than	IN	O
1000	CD	O
with	IN	O
lower	JJR	B-TEST
extremity	NN	I-TEST
non-invasive	JJ	I-TEST
studies	NNS	I-TEST
which	WDT	O
were	VBD	O
positive	JJ	O
for	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
common	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
clot	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
tte	NN	I-TEST
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
60%	CD	O
,	,	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressures	NNS	I-TEST
of	IN	O
44	CD	B-TEST
plus	CC	I-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
intra-atrial	JJ	I-PROBLEM
shunt	NN	I-PROBLEM
from	IN	O
the	DT	O
right	NN	O
to	TO	O
the	DT	O
left	VBN	O
through	IN	O
a	DT	B-PROBLEM
patent	NN	I-PROBLEM
foramen	NNS	I-PROBLEM
ovale	VBP	I-PROBLEM
.	.	O

chest	JJS	B-TEST
ct	NN	I-TEST
was	VBD	O
a	DT	B-TEST
poor	JJ	I-TEST
study	NN	I-TEST
but	CC	O
did	VBD	O
not	RB	O
show	VB	O
a	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolus	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
subsequent	JJ	B-TEST
dobutamine	NN	I-TEST
mibi	NN	I-TEST
which	WDT	O
was	VBD	O
positive	JJ	O
for	IN	O
inducible	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
in	IN	O
the	DT	O
distribution	NN	O
of	IN	O
posterior	JJ	O
descending	VBG	O
coronary	JJ	O
artery	NN	O
and	CC	O
posterolateral	JJ	O
coronary	JJ	O
artery	NN	O
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
to	TO	I-PROBLEM
medium	VB	I-PROBLEM
perfusion	NN	I-PROBLEM
defect	NN	I-PROBLEM
in	IN	O
the	DT	O
inferolateral	JJ	O
wall	NN	O
and	CC	O
basal	NN	O
inferior	VBP	O
wall	NN	O
which	WDT	O
was	VBD	O
partially	RB	O
reversible	JJ	O
.	.	O

the	DT	O
cardiology	NN	O
service	NN	O
saw	VBD	O
the	DT	O
patient	NN	O
and	CC	O
recommended	VBD	O
medical	JJ	O
management	NN	O
only	RB	O
without	IN	O
catheterization	NN	B-TEST
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
high	JJ	B-PROBLEM
so	RB	O
captopril	NN	B-TREATMENT
was	VBD	O
titrated	VBN	O
up	RB	O
to	TO	O
50	CD	O
mg	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
.	.	O

she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
lisinopril	NN	B-TREATMENT
with	IN	O
further	JJ	O
titration	NN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

she	PRP	O
is	VBZ	O
on	IN	O
hydrochlorothiazide	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

her	PRP$	B-TREATMENT
atenolol	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
due	JJ	O
to	TO	O
bradycardia	VB	B-PROBLEM
on	IN	O
admission	NN	O
but	CC	O
this	DT	O
may	MD	O
be	VB	O
restarted	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
in	IN	O
gentle	JJ	B-TREATMENT
doses	NNS	I-TREATMENT
with	IN	O
careful	JJ	O
monitoring	NN	O
of	IN	O
heart	NN	B-TEST
rate	NN	I-TEST
.	.	O

she	PRP	O
is	VBZ	O
on	IN	O
an	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
lasix	NN	B-TREATMENT
20	CD	O
mg	NN	O
for	IN	O
continued	JJ	O
control	NN	O
of	IN	O
her	PRP$	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
as	IN	O
seen	VBN	O
on	IN	O
echocardiogram	NN	B-TEST
.	.	O

unclear	JJ	O
whether	IN	O
there	EX	O
are	VBP	O
chronic	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolus	NN	I-PROBLEM
but	CC	O
did	VBD	O
have	VB	O
positive	JJ	O
test	NN	O
for	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
and	CC	O
will	MD	O
be	VB	O
treated	VBN	O
with	IN	O
coumadin	NN	B-TREATMENT
.	.	O

an	DT	B-TEST
abg	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
showed	VBD	O
ph	IN	B-TEST
7.34	CD	O
,	,	O
pco2	NN	B-TEST
78	CD	O
,	,	O
po2	RB	B-TEST
92	CD	O
on	IN	O
2	CD	O
liters	NNS	O
.	.	O

her	PRP$	B-TEST
bicarbonate	NN	I-TEST
peaked	VBD	O
at	IN	O
39	CD	O
and	CC	O
generally	RB	O
is	VBZ	O
in	IN	O
the	DT	O
36-38	JJ	O
range	NN	O
.	.	O

she	PRP	O
has	VBZ	O
severe	JJ	B-PROBLEM
sleep	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
falls	VBZ	O
asleep	JJ	O
midsentence	NN	O
.	.	O

she	PRP	O
has	VBZ	O
episodes	NNS	O
of	IN	O
not	RB	B-PROBLEM
breathing	VBG	I-PROBLEM
.	.	O

bipap	NN	B-TREATMENT
was	VBD	O
attempted	VBN	O
for	IN	O
3	CD	O
nights	NNS	O
in	IN	O
a	DT	O
row	NN	O
and	CC	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
tolerate	VB	O
this	DT	O
.	.	O

she	PRP	O
will	MD	O
need	VB	O
pulmonary	JJ	B-TEST
function	NN	I-TEST
studies	NNS	I-TEST
as	IN	O
an	DT	O
outpatient	NN	O
as	IN	O
these	DT	O
were	VBD	O
not	RB	O
done	VBN	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

the	DT	O
pulmonary	JJ	O
team	NN	O
saw	VBD	O
the	DT	O
patient	NN	O
and	CC	O
only	RB	O
recommended	VBD	O
the	DT	B-TEST
above	JJ	I-TEST
testing	NN	I-TEST
.	.	O

she	PRP	O
needs	VBZ	O
home	NN	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
is	VBZ	O
currently	RB	O
at	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	JJ	I-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

3.	CD	O
infectious	JJ	B-PROBLEM
disease	NN	I-PROBLEM
:	:	O

evidence	NN	O
for	IN	O
cellulitis	NN	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
legs	NN	I-PROBLEM
,	,	O
likely	RB	O
due	JJ	O
to	TO	O
distention	NN	B-PROBLEM
from	IN	O
edema	NN	B-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
perfusion	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
originally	RB	O
started	VBN	O
on	IN	O
cefazolin	NN	B-TREATMENT
which	WDT	O
was	VBD	O
then	RB	O
changed	VBN	O
to	TO	O
keflex	VB	B-TREATMENT
with	IN	O
good	JJ	O
improvement	NN	O
.	.	O

she	PRP	O
will	MD	O
need	VB	O
to	TO	O
continue	VB	O
for	IN	O
at	IN	O
least	JJS	O
10	CD	O
more	JJR	O
days	NNS	O
or	CC	O
as	IN	O
clinically	RB	O
indicated	VBN	O
by	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	B-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

d-dimer	NN	B-TEST
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
was	VBD	O
greater	JJR	O
than	IN	O
1000	CD	O
and	CC	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
common	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
clot	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

this	DT	B-PROBLEM
clot	NN	I-PROBLEM
was	VBD	O
small	JJ	O
and	CC	O
it	PRP	O
was	VBD	O
questionable	JJ	O
as	IN	O
to	TO	O
whether	IN	O
it	PRP	O
was	VBD	O
old	JJ	O
or	CC	O
new	JJ	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
anticoagulation	NN	B-TREATMENT
given	VBN	O
the	DT	B-PROBLEM
positive	JJ	I-PROBLEM
d-dimer	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
ct	NN	I-TEST
was	VBD	O
nondiagnostic	JJ	O
but	CC	O
did	VBD	O
not	RB	O
show	VB	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
a	DT	B-TEST
poor	JJ	I-TEST
study	NN	I-TEST
.	.	O

heparin	NN	B-TREATMENT
was	VBD	O
maintained	VBN	O
during	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
and	CC	O
then	RB	O
lovenox	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

her	PRP$	B-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
7.5	CD	O
mg	NNS	O
q	JJ	O
day	NN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
this	DT	O
dose	NN	O
in	IN	O
addition	NN	O
to	TO	O
1	CD	O
day	NN	O
of	IN	O
lovenox	NN	B-TREATMENT
.	.	O

discharge	NN	B-TEST
inr	VBZ	I-TEST
1.8	CD	O
.	.	O

goal	NN	B-TEST
inr	NN	I-TEST
is	VBZ	O
2.0-3.0	JJ	O
.	.	O

low	JJ	B-TREATMENT
salt	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

low	JJ	B-TREATMENT
cholesterol	NN	I-TREATMENT
,	,	I-TREATMENT
low	JJ	I-TREATMENT
fat	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

to	TO	O
rehabilitation	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
needs	VBZ	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
increase	VB	O
stability	NN	O
in	IN	O
mobilization	NN	O
.	.	O

need	NN	O
to	TO	O
try	VB	O
to	TO	O
control	VB	O
blood	NN	B-TEST
pressure	NN	I-TEST
.	.	O

can	MD	O
increase	VB	O
her	PRP$	B-TREATMENT
ace	JJ	I-TREATMENT
inhibitor	NN	I-TREATMENT
as	IN	O
tolerated	VBN	O
.	.	O

may	MD	O
start	VB	O
beta-blocker	NN	B-TREATMENT
at	IN	O
a	DT	O
low	JJ	O
dose	NN	O
given	VBN	O
mild	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
at	IN	O
atenolol	JJ	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

need	NN	O
to	TO	O
continue	VB	O
oxygen	NN	B-TREATMENT
2	CD	O
liters	NNS	O
via	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

needs	NNS	O
anticoagulation	NN	B-TREATMENT
for	IN	O
6	CD	O
months	NNS	O
for	IN	O
right	JJ	B-PROBLEM
common	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
deep	RB	I-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

goal	NN	B-TEST
inr	NN	I-TEST
is	VBZ	O
2.0-3.0	JJ	O
.	.	O

should	MD	O
continue	VB	O
keflex	VB	B-TREATMENT
for	IN	O
10	CD	O
more	JJR	O
days	NNS	O
or	CC	O
as	IN	O
clinically	RB	O
indicated	VBN	O
.	.	O

need	NN	O
to	TO	O
follow	VB	O
inr	NN	B-TEST
after	IN	O
keflex	NN	B-TREATMENT
is	VBZ	O
discontinued	VBN	O
as	IN	O
expect	NN	O
it	PRP	O
will	MD	O
change	VB	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
severe	JJ	B-PROBLEM
sleep	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
stops	VBZ	O
breathing	VBG	O
during	IN	O
sleep	NN	O
.	.	O

tylenol	RB	B-TREATMENT
650	CD	O
mg	NNS	O
p.o.	JJ	O
q	JJ	O
4-6	JJ	O
hours	NNS	O
p.r.n.	VBP	O
headache	NN	B-PROBLEM
,	,	O
enteric	RB	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	JJ	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
,	,	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
1000	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
enema	NN	B-TREATMENT
of	IN	I-TREATMENT
choice	NN	I-TREATMENT
and	CC	O
laxative	NN	B-TREATMENT
of	IN	I-TREATMENT
choice	NN	I-TREATMENT
p.o.	NNS	O
q	VBP	O
day	NN	O
p.r.n.	JJ	O
constipation	NN	B-PROBLEM
,	,	O
lasix	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
,	,	O
coumadin	VBP	B-TREATMENT
7.5	CD	O
mg	NNS	O
p.o.q.h.s.	NN	O
for	IN	O
goal	NN	B-TEST
inr	NN	I-TEST
of	IN	O
2.0-3.0	JJ	O
.	.	O

keflex	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
x	VBD	O
10	CD	O
more	JJR	O
days	NNS	O
,	,	O
miconazole	JJ	B-TREATMENT
2%	CD	O
powder	NN	O
topically	RB	O
b.i.d.	VBZ	O
apply	VB	O
to	TO	O
affected	JJ	O
areas	NNS	O
of	IN	O
breasts	NNS	O
and	CC	O
groins	NNS	O
b.i.d.	VBP	O
,	,	O
lisinopril	VBP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q	NN	O
day	NN	O
hold	VB	O
of	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
less	JJR	O
than	IN	O
110	CD	O
,	,	O
lovenox	VBD	B-TREATMENT
100	CD	O
mg	NN	O
subcutaneously	RB	O
q	VBZ	O
12	CD	O
hours	NNS	O
x	VBD	O
2	CD	O
doses	NNS	O
and	CC	O
then	RB	O
discontinued	VBN	O
,	,	O
atenolol	VBZ	B-TREATMENT
12.5	CD	O
mg	NN	O
p.o.	NN	O
q	NN	O
day	NN	O
hold	VB	O
for	IN	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
less	JJR	O
than	IN	O
110	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
less	JJR	O
than	IN	O
55	CD	O
.	.	O

ciprofloxacin	NN	B-TREATMENT
/	CD	O
flagyl	NN	B-TREATMENT

pelvic	JJ	B-PROBLEM
organ	NN	I-PROBLEM
prolapse	NN	I-PROBLEM

total	JJ	B-TREATMENT
vaginal	JJ	I-TREATMENT
hysterectomy;	NN	I-TREATMENT
combined	VBN	O
anterior-posterior	JJ	B-TREATMENT
colporrhaphy	NN	I-TREATMENT
with	IN	O
posterior	JJ	B-TREATMENT
mesh;	NN	I-TREATMENT
subpubic	JJ	B-TREATMENT
urethral	JJ	I-TREATMENT
sling;	NN	I-TREATMENT
sacrospinous	JJ	B-TEST
colpopexy	NN	I-TEST
exploratory	NN	I-TEST
laparotomy	NN	I-TEST

reexploration	NN	B-TEST
of	IN	I-TEST
vaginal	JJ	I-TEST
surgical	JJ	I-TEST
area	NN	I-TEST
pelvic	NN	I-TEST
angiography	NN	I-TEST

34	CD	O
yo	NNS	O
g3p3	NN	O
with	IN	O
pelvic	JJ	B-PROBLEM
organ	NNS	I-PROBLEM
prolapse	NN	I-PROBLEM
after	IN	O
her	PRP$	O
second	JJ	O
delivery;	NN	O
after	IN	O
her	PRP$	O
third	JJ	O
delivery	NN	O
it	PRP	O
became	VBD	O
much	JJ	B-PROBLEM
worse	JJR	I-PROBLEM
.	.	O

she	PRP	O
urinates	VBZ	O
frequently	RB	O
,	,	O
but	CC	O
occasionally	RB	O
the	DT	O
urine	NN	O
is	VBZ	O
very	RB	B-PROBLEM
slow	JJ	I-PROBLEM
to	TO	I-PROBLEM
start	VB	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
prolapse	NN	I-PROBLEM
is	VBZ	O
especailly	RB	O
large	JJ	B-PROBLEM
and	CC	I-PROBLEM
uncomfotable	JJ	I-PROBLEM
when	WRB	O
she	PRP	O
tries	VBZ	O
to	TO	O
move	VB	O
her	PRP$	O
bowels	NNS	O
and	CC	O
it	PRP	O
is	VBZ	O
easier	JJR	O
for	IN	O
her	PRP$	O
to	TO	O
do	VB	O
sowhile	VB	O
standing	VBG	O
rather	RB	O
than	IN	O
sitting	VBG	O
.	.	O

she	PRP	O
has	VBZ	O
deep	JJ	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	O
intercourse	NN	O
.	.	O

chronic	JJ	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
:	:	O
several	JJ	B-PROBLEM
discs	NNS	I-PROBLEM
and	CC	O
spondylolisthesis	NN	B-PROBLEM

left	VBN	B-TREATMENT
salpingo	JJ	I-TREATMENT
oophorectomy	NN	I-TREATMENT
2002	CD	O
for	IN	O
torsion;	NN	B-PROBLEM
coloposcopy	NN	B-TEST
and	CC	O
cryotherapy	NN	B-TREATMENT
2001;	CD	O
appendectomy;	NN	B-TREATMENT
t	NN	B-TREATMENT
+	VBZ	I-TREATMENT
a	DT	I-TREATMENT

mother	NN	O
had	VBD	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM

nad	NN	B-PROBLEM

rrr	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM

clear	JJ	O
to	TO	O
percussion	NN	B-TEST
and	CC	O
auscultation	NN	B-TEST

anterior	RB	B-PROBLEM
wall	NN	I-PROBLEM
prolapses	VBZ	I-PROBLEM
3	CD	O
cm	NN	O
past	IN	O
the	DT	O
hymen	NNS	O
with	IN	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
urine	NN	I-PROBLEM
on	IN	I-PROBLEM
valsalva;	NN	I-PROBLEM
cervix	NN	O
1cm	CD	O
above	IN	O
the	DT	O
hymen;	NN	O
posterior	NN	B-PROBLEM
prolapse	NN	I-PROBLEM
only	RB	O
to	TO	O
the	DT	O
hymen	NNS	O
but	CC	O
3.4	CD	O
cm	NN	O
of	IN	O
perineal	JJ	B-PROBLEM
descent	NN	I-PROBLEM
.	.	O

anterior	RB	O
,	,	O
tender	NN	B-PROBLEM
on	IN	O
motion	NN	O

radiolabled	VBN	B-TEST
red	JJ	I-TEST
cell	NN	I-TEST
study	VB	I-TEST
12-05	JJ	O

no	DT	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
abdomen	NNS	I-PROBLEM
or	CC	I-PROBLEM
pelvis	NN	I-PROBLEM
.	.	O

pelvic	JJ	B-TEST
arterogram	VBZ	I-TEST
12-05	JJ	O

images	NNS	O
demonstrate	VBP	O
diffusely	RB	B-PROBLEM
small	JJ	I-PROBLEM
caliber	NN	I-PROBLEM
vasculature	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
shock	NN	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
luminal	JJ	B-PROBLEM
irregularity	NN	I-PROBLEM
seen	VBN	O
in	IN	O
segments	NNS	O
of	IN	O
both	DT	O
the	DT	O
left	NN	O
and	CC	O
right	JJ	O
external	JJ	O
iliac	NN	O
arteries	NNS	O
consistent	VBP	O
with	IN	O
spasm	NN	B-PROBLEM
.	.	O

specifically	RB	O
,	,	O
no	DT	O
extravasation	NN	B-PROBLEM
of	IN	I-PROBLEM
contrast	NN	I-PROBLEM
,	,	O
obstruction	NN	B-PROBLEM
of	IN	I-PROBLEM
blood	NN	I-PROBLEM
flow	NN	I-PROBLEM
,	,	O
av	JJ	B-PROBLEM
fistulization	NN	I-PROBLEM
or	CC	O
intimal	JJ	B-PROBLEM
injury	NN	I-PROBLEM
was	VBD	O
observed	VBN	O
.	.	O

thus	RB	O
,	,	O
no	DT	O
embolotherapy	NN	B-TREATMENT
was	VBD	O
embarked	VBN	O
upon	IN	O
.	.	O

no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
was	VBD	O
observed	VBN	O
.	.	O

1.	CD	O
uterus	JJ	O
and	CC	O
cervix	NN	O
,	,	O
hysterectomy	NN	B-TREATMENT
(	(	O
a-e	JJ	O
):	NN	O

a.	JJ	O
secretory	JJ	B-PROBLEM
endometrium	NN	I-PROBLEM
.	.	O

b.	NN	O
cervix	NN	O
with	IN	O
squamous	JJ	B-PROBLEM
metaplasia	NN	I-PROBLEM
.	.	O

d.	VB	O
one	CD	B-TREATMENT
intrauterine	NN	I-TREATMENT
device	NN	I-TREATMENT
,	,	O
gross	JJ	O
description	NN	O
.	.	O

squamous	JJ	B-PROBLEM
mucosa	NN	I-PROBLEM
and	CC	O
skin	NN	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
pathologic	JJ	I-PROBLEM
change	NN	I-PROBLEM
.	.	O

wbc	SYM	B-TEST
-	:	O
20.0*	CD	O
rbc	NN	B-TEST
-	:	O
3.31*	CD	O
hgb	NN	B-TEST
-	:	O
10.2*#	CD	O
hct	NN	B-TEST
-	:	O
31.2*	CD	O

mcv	SYM	B-TEST
-	:	O
95	CD	O
mch	SYM	B-TEST
-	:	O
30.9	CD	O
mchc	SYM	B-TEST
-	:	O
32.7	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
297	CD	O

hct	SYM	B-TEST
-	:	O
19.5*#	CD	O

wbc	SYM	B-TEST
-	:	O
20.0*	CD	O
rbc	NN	B-TEST
-	:	O
3.96*	CD	O
hgb	NN	B-TEST
-	:	O
12.5	CD	O
hct	NN	B-TEST
-	:	O
34.4*#	CD	O

mcv	SYM	B-TEST
-	:	O
87#	CD	O
mch	SYM	B-TEST
-	:	O
31.5	CD	O
mchc	SYM	B-TEST
-	:	O
36.4*#	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
89*#	CD	O

wbc	SYM	B-TEST
-	:	O
12.7*	CD	O
rbc	NN	B-TEST
-	:	O
3.17*	CD	O
hgb	NN	B-TEST
-	:	O
9.9*	CD	O
hct	NN	B-TEST
-	:	O
27.6*	CD	O

mcv	SYM	B-TEST
-	:	O
87	CD	O
mch	SYM	B-TEST
-	:	O
31.3	CD	O
mchc	SYM	B-TEST
-	:	O
35.9*	CD	O
rdw	NN	B-TEST
-	:	O
14.2	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
104*	CD	O

wbc	SYM	B-TEST
-	:	O
12.1*	CD	O
rbc	NN	B-TEST
-	:	O
3.73*	CD	O
hgb	NN	B-TEST
-	:	O
11.3*	CD	O
hct	NN	B-TEST
-	:	O
31.5*	CD	O

mcv	SYM	B-TEST
-	:	O
84	CD	O
mch	SYM	B-TEST
-	:	O
30.2	CD	O
mchc	SYM	B-TEST
-	:	O
35.8*	CD	O
rdw	NN	B-TEST
-	:	O
15.4	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
91*	CD	O

hct	SYM	B-TEST
-	:	O
28.7*	CD	O

hct	SYM	B-TEST
-	:	O
27.9*	CD	O

wbc	SYM	B-TEST
-	:	O
12.6*	CD	O
rbc	NN	B-TEST
-	:	O
3.53*	CD	O
hgb	NN	B-TEST
-	:	O
10.5*	CD	O
hct	NN	B-TEST
-	:	O
30.1*	CD	O

mcv	SYM	B-TEST
-	:	O
85	CD	O
mch	SYM	B-TEST
-	:	O
29.8	CD	O
mchc	SYM	B-TEST
-	:	O
35.0	CD	O
rdw	NN	B-TEST
-	:	O
14.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
308#	CD	O

pt	SYM	B-TEST
-	:	O
13.0	CD	O
ptt	NN	B-TEST
-	:	O
26.1	CD	O
inr	NN	B-TEST
(	(	O
pt	NN	B-TEST
)	)	O
-	:	O
1.1	CD	O

pt	SYM	B-TEST
-	:	O
13.2*	CD	O
ptt	NN	B-TEST
-	:	O
24.2	CD	O
inr	NN	B-TEST
(	(	O
pt	NN	B-TEST
)	)	O
-	:	O
1.1	CD	O

pt	SYM	B-TEST
-	:	O
11.6	CD	O
ptt	NN	B-TEST
-	:	O
23.8	CD	O
inr	NN	B-TEST
(	(	O
pt	NN	B-TEST
)	)	O
-	:	O
1.0	CD	O

glucose	JJ	B-TEST
-	:	O
146*	CD	O
urean	JJ	B-TEST
-	:	O
12	CD	O
creat	NN	B-TEST
-	:	O
0.6	CD	O
na	SYM	B-TEST
-	:	O
140	CD	O

k	SYM	B-TEST
-	:	O
4.1	CD	O
cl	NN	B-TEST
-	:	O
108	CD	O
hco3	NN	B-TEST
-	:	O
21*	CD	O
angap	NN	B-TEST
-	:	O
15	CD	O

glucose	JJ	B-TEST
-	:	O
96	CD	O
urean	JJ	B-TEST
-	:	O
5*	CD	O
creat	NN	B-TEST
-	:	O
0.4	CD	O
na	SYM	B-TEST
-	:	O
139	CD	O

k	SYM	B-TEST
-	:	O
3.1*	CD	O
cl	NN	B-TEST
-	:	O
108	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
8	CD	O

urean	JJ	B-TEST
-	:	O
4*	CD	O
creat	NN	B-TEST
-	:	O
0.3*	CD	O
na	SYM	B-TEST
-	:	O
140	CD	O
k	SYM	B-TEST
-	:	O
4.0	CD	O
cl	NN	B-TEST
-	:	O
108	CD	O

hco3	SYM	B-TEST
-	:	O
27	CD	O
angap	NN	B-TEST
-	:	O
9	CD	O

calcium	NN	B-TEST
-	:	O
7.9*	CD	O
phos	NN	B-TEST
-	:	O
4.5	CD	O
mg	SYM	B-TEST
-	:	O
1.5*	CD	O

calcium	NN	B-TEST
-	:	O
7.3*	CD	O
phos	NN	B-TEST
-	:	O
2.3*	CD	O
mg	SYM	B-TEST
-	:	O
1.7	CD	O

calcium	NN	B-TEST
-	:	O
7.5*	CD	O
mg	SYM	B-TEST
-	:	O
1.6	CD	O

calcium	NN	B-TEST
-	:	O
7.5*	CD	O
phos	NN	B-TEST
-	:	O
2.7	CD	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

type	NN	O
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
229*	CD	O
pco2	NN	B-TEST
-	:	O
44	CD	O
ph	NN	B-TEST
-	:	O
7.26*	CD	O
caltco2	NN	B-TEST
-	:	O
21	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
-6	NN	O
intubat	NN	O
-	:	O
intubated	JJ	O
vent	NN	O
-	:	O
controlled	VBD	O

type	NN	O
-	:	O
art	NN	O
temp	SYM	B-TEST
-	:	O
37.2	CD	O
rates	NNS	B-TEST
-	:	O
/12	NN	O
tidal	JJ	B-TEST
v	NN	I-TEST
-	:	O
560	CD	O

peep	JJ	B-TEST
-	:	O
5	CD	O
fio2	JJ	B-TEST
-	:	O
50	CD	O
po2	NN	B-TEST
-	:	O
176*	CD	O
pco2	NN	B-TEST
-	:	O
42	CD	O
ph	NN	B-TEST
-	:	O
7.35	CD	O
caltco2	NN	B-TEST
-	:	O
24	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
-2	NN	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2018-12-04	JJ	O
for	IN	O
tvh	NN	B-TREATMENT
,	,	O
sacrospinous	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
,	,	O
sparc	NN	B-TREATMENT
,	,	O
anterior	JJ	B-TREATMENT
and	CC	I-TREATMENT
posterior	JJ	I-TREATMENT
repair	NN	I-TREATMENT
with	IN	I-TREATMENT
mesh	NN	I-TREATMENT
,	,	O
cystoscopy;	NN	B-TEST
for	IN	O
pelvic	JJ	B-PROBLEM
organ	JJ	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
intraoperative	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
and	CC	O
the	DT	O
surgical	JJ	O
field	NN	O
was	VBD	O
hemostatic	JJ	O
at	IN	O
the	DT	O
conclusion	NN	O
of	IN	O
the	DT	O
case	NN	O
(	(	O
see	VB	O
operative	JJ	O
report	NN	O
for	IN	O
full	JJ	O
description	NN	O
)	)	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
stable	JJ	O
in	IN	O
the	DT	O
pacu	NN	O
and	CC	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
floor	NN	O
for	IN	O
routine	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

at	IN	O
1645	CD	O
12-04	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
hypotensive	JJ	B-PROBLEM
to	TO	O
70/40	CD	O

hr	NN	B-TEST
84	CD	O
with	IN	O
symptoms	NNS	B-PROBLEM
of	IN	I-PROBLEM
lightheadedness	NN	I-PROBLEM
while	IN	O
lying	VBG	O
supine	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
noted	VBD	O
at	IN	O
the	DT	O
surgical	JJ	O
site	NN	O
on	IN	O
examination	NN	B-TEST
.	.	O

a	DT	B-TEST
stat	NN	I-TEST
hct	NN	I-TEST
drawn	NN	O
at	IN	O
this	DT	O
time	NN	O
was	VBD	O
31.2	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
re-evalutated	VBN	O
at	IN	O
2000	CD	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
tacchycardic	JJ	B-PROBLEM
to	TO	O
115	CD	O
with	IN	O
bp	NN	B-TEST
104/50	CD	O
using	VBG	O
a	DT	O
manual	JJ	O
cuff	NN	O
.	.	O

urine	JJ	B-TEST
output	NN	I-TEST
during	IN	O
the	DT	O
prior	JJ	O
two	CD	O
hours	NNS	O
had	VBD	O
been	VBN	O
50cc	CD	O
and	CC	O
24cc	CD	O
.	.	O

a	DT	B-TEST
stat	NN	I-TEST
hct	NN	I-TEST
drawn	NN	O
at	IN	O
this	DT	O
time	NN	O
was	VBD	O
19.5	CD	O
.	.	O

the	DT	O
clinical	JJ	O
picture	NN	O
was	VBD	O
concerning	VBG	O
for	IN	O
a	DT	B-PROBLEM
post-operative	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

the	DT	O
icu	NN	O
was	VBD	O
alerted	VBN	O
to	TO	O
the	DT	O
patient	NN	O
's	POS	O
disposition	NN	O
and	CC	O
the	DT	O
operating	NN	O
room	NN	O
was	VBD	O
activated	VBN	O
for	IN	O
urgent	JJ	B-TEST
re-exploration	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
or	CC	O
on	IN	O
pod#0	NN	O
for	IN	O
re-exploration	NN	B-TEST
with	IN	I-TEST
incision	NN	I-TEST
at	IN	O
2243	CD	O
.	.	O

exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
revealed	VBD	O
hemoperitonium	NN	B-PROBLEM
and	CC	O
approximately	RB	O
1	CD	O
l	NN	O
of	IN	O
blood	NN	B-PROBLEM
was	VBD	O
evacuated	VBN	O
.	.	O

there	EX	O
was	VBD	O
approximately	RB	O
500cc	CD	O
of	IN	O
retroperitoneal	NN	B-PROBLEM
clot	NN	I-PROBLEM
.	.	O

despite	IN	O
laparotomy	JJ	B-TEST
and	CC	O
re-exploration	NN	B-TEST
through	IN	I-TEST
the	DT	I-TEST
vaginal	JJ	I-TEST
cuff	NN	I-TEST
,	,	O
no	DT	O
source	NN	O
for	IN	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
could	MD	O
be	VB	O
found	VBN	O
.	.	O

the	DT	B-TREATMENT
endotracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
left	VBN	O
in	IN	O
place	NN	O
.	.	O

intraoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
recieved	VBD	O
5u	CD	O
prbc	NN	B-TREATMENT
.	.	O

ir	NN	O
was	VBD	O
consulted	VBN	O
to	TO	O
identify	VB	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
vessel	NN	I-PROBLEM
with	IN	O
angiography	NN	B-TEST
,	,	O
then	RB	O
perform	VB	O
embolization	NN	B-TREATMENT
.	.	O

tagged	VBN	B-TEST
cell	NN	I-TEST
and	CC	I-TEST
angiographic	JJ	I-TEST
studies	NNS	I-TEST
performed	VBD	O
immediately	RB	O
after	IN	O
re-exploration	NN	B-TEST
on	IN	O
12-05	NNS	O
did	VBD	O
not	RB	O
indetify	VB	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
no	DT	O
emobolization	NN	B-TREATMENT
was	VBD	O
indicated	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
and	CC	O
remained	VBD	O
intubated	VBN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
continued	JJ	O
bleeding	NN	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
hct	NN	I-TEST
remained	VBD	O
stable	JJ	O
around	IN	O
30	CD	O
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
fever	NN	I-PROBLEM
to	TO	O
100.1	CD	O
on	IN	O
pod#1	NN	O
which	WDT	O
persisted	VBD	O
to	TO	O
pod#2	VB	O
and	CC	O
imperic	VB	B-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
gent/clinda	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
pod#8	NN	O
and	CC	O
pt	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
thereafter	RB	O
.	.	O

on	IN	O
pod#9	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
,	,	O
ambultating	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
and	CC	O
voiding	VBG	O
spontaneously	RB	O
.	.	O

zoloft	RB	B-TREATMENT
100mg	CD	O
qd	NN	O

ritalin	NN	B-TREATMENT
0.5mg	CD	O
bid	NN	O

loraze3pam	RB	B-TREATMENT
0.5mg	CD	O
bid	NN	O

percocet	NN	B-TREATMENT
5/325	CD	O
qhs	NN	O

cipro	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT

1.	CD	O
ibuprofen	JJ	B-TREATMENT
600	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
oxycodone-acetaminophen	JJ	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

continue	NN	O
home	NN	B-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

pelvic	JJ	B-PROBLEM
organ	MD	I-PROBLEM
prolapse	VB	I-PROBLEM
stress	NN	B-PROBLEM
urinary	JJ	I-PROBLEM
incontinence	NN	I-PROBLEM
retroperitoneal	NN	B-PROBLEM
bleed	NN	I-PROBLEM
hemoperitoneum	NN	I-PROBLEM

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
s	JJ	O
/	NNP	O
p	NN	O
fall	NN	O
/	NNP	O
weak	JJ	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
tecal	JJ	O
galencounxopt	NN	O
community	NN	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
shuffcuch	JJ	O
,	,	O
seysharmse	JJ	O
n	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
hyperglycemia	VBN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
discharged	VBN	O
to	TO	O
rehabilitation	VB	B-TREATMENT
in	IN	O
brain	NN	O
tree	NN	O
maryland	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
continued	VBN	O
on	IN	O
medications	NNS	B-TREATMENT
per	IN	O
discharge	NN	O
summary	NN	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
captopril	NN	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
since	IN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
is	VBZ	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
with	IN	O
no	DT	O
new	JJ	B-PROBLEM
events	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
continues	VBZ	O
to	TO	O
improve	VB	O
with	IN	O
regard	NN	O
to	TO	O
his	PRP$	B-PROBLEM
scrotal	NN	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
ulcers	NNS	I-PROBLEM
,	,	O
and	CC	O
all	DT	B-PROBLEM
former	JJ	I-PROBLEM
leg	NN	I-PROBLEM
excoriations	NNS	I-PROBLEM
are	VBP	O
healing	VBG	O
well	RB	O
.	.	O

the	DT	O
patient	NN	O
ambulating	VBG	O
three	CD	O
to	TO	O
four	CD	O
times	NNS	O
per	IN	O
day	NN	O
and	CC	O
able	JJ	O
to	TO	O
get	VB	O
out	IN	O
of	IN	O
bed	NN	O
using	VBG	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
get	VB	O
rehabilitation	NN	B-TREATMENT
and	CC	O
continue	VB	O
to	TO	O
get	VB	O
care	NN	O
for	IN	O
his	PRP$	B-PROBLEM
fluid	NN	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

syncope	NN	B-PROBLEM

1	CD	O
)	)	O
presyncope	NN	B-PROBLEM
.	.	O

2	CD	O
)	)	O
dizziness	NN	B-PROBLEM
.	.	O

1	CD	O
)	)	O
iron	NN	B-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
colonoscopy	NN	B-TEST
in	IN	O
1990	CD	O
followed	NN	O
by	IN	O
hematology	NN	O
oncology	NN	O
through	IN	O
lympnanier	JJR	O
health	NN	O
services	NNS	O
,	,	O
dr.	JJ	O
number	NN	O
.	.	O

2	CD	O
)	)	O
history	NN	O
of	IN	O
diastolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
in	IN	O
february	NN	O
of	IN	O
1998	CD	O
demonstrating	VBG	O
a	DT	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
with	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
admission	NN	O
at	IN	O
lympnanier	JJR	O
health	NN	O
services	NNS	O
in	IN	O
january	NN	O
of	IN	O
1999	CD	O
for	IN	O
diastolic	JJ	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
requiring	VBG	O
an	DT	O
admission	NN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
.	.	O

3	LS	O
)	)	O
hypothyroidism	NN	B-PROBLEM
.	.	O

4	CD	O
)	)	O
rheumatoid	NN	B-PROBLEM
arthritis	NN	I-PROBLEM
/	NNP	O
cutaneous	JJ	B-PROBLEM
lupus	NN	I-PROBLEM
(	(	I-PROBLEM
mixed	JJ	I-PROBLEM
connective	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
disease	NN	I-PROBLEM
)	)	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
80	CD	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diastolic	JJ	B-PROBLEM
function	NN	I-PROBLEM
and	CC	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
and	CC	O
rheumatoid	JJ	B-PROBLEM
arthritis	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
presyncope	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reports	NNS	O
dizziness	NN	B-PROBLEM
intermittently	RB	I-PROBLEM
times	VBZ	O
several	JJ	O
months	NNS	O
now	RB	O
increasing	VBG	O
in	IN	O
frequency	NN	O
described	VBN	O
as	IN	O
episodes	NNS	O
where	WRB	O
she	PRP	O
feels	VBZ	O
faint	NN	B-PROBLEM
.	.	O

the	DT	O
room	NN	O
spins	VBZ	O
with	IN	O
no	DT	O
visual	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
no	DT	O
palpitations	NNS	B-PROBLEM
or	CC	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
with	IN	O
some	DT	O
friends	NNS	O
,	,	O
rose	VBD	O
from	IN	O
a	DT	O
chair	NN	O
to	TO	O
leave	VB	O
and	CC	O
felt	VBD	O
dizzy	NNS	B-PROBLEM
while	IN	O
ambulating	VBG	O
,	,	O
fell	VBD	O
and	CC	O
hit	VBD	O
elbow	NNS	O
with	IN	O
minor	JJ	B-PROBLEM
head	NN	I-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
no	DT	O
bowel	NN	B-PROBLEM
or	CC	I-PROBLEM
bladder	NN	I-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
50	CD	I-PROBLEM
point	NN	I-PROBLEM
discrepancy	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
mediastinal	JJ	B-PROBLEM
widening	NN	I-PROBLEM
on	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
,	,	O
but	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
verg	VB	O
medical	JJ	O
center	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	JJ	I-TEST
temperature	NN	I-TEST
was	VBD	O
98.8	CD	O
degrees	NNS	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
73	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
in	IN	I-TEST
the	DT	I-TEST
left	JJ	I-TEST
arm	NN	I-TEST
demonstrated	VBD	O
125/89	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
in	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
arm	NN	I-TEST
was	VBD	O
177/119	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
3/6	CD	O
that	WDT	O
radiated	VBD	O
to	TO	O
the	DT	O
carotids	NNS	O
with	IN	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
left	JJ	I-PROBLEM
radial	JJ	I-PROBLEM
pulse	NN	I-PROBLEM
per	IN	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
chest	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
demonstrating	VBG	O
no	DT	O
dissection	NN	B-PROBLEM
or	CC	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
nitropaste	NN	B-TREATMENT
,	,	O
aspirin	NN	B-TREATMENT
,	,	O
laboratory	NN	B-TEST
studies	NNS	I-TEST
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
further	JJ	O
management	NN	O
.	.	O

the	DT	O
patient	NN	O
denies	VBZ	O
melena	RBS	B-PROBLEM
,	,	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
,	,	O
no	DT	O
emesis	NN	B-PROBLEM
,	,	O
or	CC	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
anemia	NN	B-PROBLEM
as	IN	O
per	IN	O
past	JJ	O
medical	JJ	O
history	NN	O
above	IN	O
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
62	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
16	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
right	JJ	I-TEST
arm	NN	I-TEST
205/84	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97%	CD	O
on	IN	O
two	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
tired	VBD	B-PROBLEM
,	,	O
easily	RB	O
arousable	JJ	O
older	JJR	O
female	NN	O
.	.	O

heent	JJ	B-TEST
examination	NN	I-TEST
demonstrated	VBD	O
that	IN	O
the	DT	O
pupils	NNS	O
were	VBD	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	NN	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
cataract	NN	I-PROBLEM
on	IN	O
the	DT	B-TEST
fundoscopic	NN	I-TEST
examination	NN	I-TEST
.	.	O

neck	NN	O
was	VBD	O
supple	JJ	O
,	,	O
bilateral	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
,	,	O
although	IN	O
possibly	RB	O
radiating	VBG	O
from	IN	O
cardiac	JJ	O
base	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distension	NN	I-PROBLEM
.	.	O

chest	NN	O
demonstrated	VBD	O
bilateral	JJ	B-PROBLEM
holosystolic	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
subclavians	NNS	I-PROBLEM
,	,	O
left	VBD	O
greater	JJR	O
than	IN	O
right	NN	O
with	IN	O
few	JJ	B-PROBLEM
bibasilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
demonstrated	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
2/6	CD	B-PROBLEM
cresendo	NNS	I-PROBLEM
/	JJ	I-PROBLEM
descrecendo	JJ	I-PROBLEM
murmur	FW	I-PROBLEM
heard	NN	O
best	JJS	O
at	IN	O
the	DT	O
apex	NN	O
with	IN	O
preservation	NN	O
of	IN	O
the	DT	O
second	JJ	O
heart	NN	O
sound	NN	O
,	,	O
no	DT	O
s3	NN	B-PROBLEM
or	CC	O
s4	NN	B-PROBLEM
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
no	DT	O
abdominal	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
there	EX	O
were	VBD	O
bilateral	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
and	CC	O
femoral	JJ	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
per	IN	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

extremities	NNS	O
demonstrated	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

extremity	NN	B-TEST
pulses	NNS	I-TEST
revealed	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
radial	NN	I-TEST
of	IN	O
2+	CD	O
,	,	O
left	VBD	B-TEST
radial	NN	I-TEST
of	IN	O
1+	CD	O
,	,	O
2+	CD	B-TEST
distal	JJ	I-TEST
pulses	NNS	I-TEST
in	IN	I-TEST
the	DT	I-TEST
lower	JJR	I-TEST
extremities	NNS	I-TEST
bilaterally	RB	I-TEST
.	.	O

lower	JJR	B-TEST
extremity	NN	I-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
demonstrated	VBD	O
systolics	NNS	B-TEST
of	IN	O
205-210	JJ	O
.	.	O

laboratory	NN	O
values	NNS	O
on	IN	O
admission	NN	O
included	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
142	CD	O
,	,	O
potassium	NN	B-TEST
4.8	CD	O
,	,	O
chloride	RB	B-TEST
106	CD	O
,	,	O
bicarbonate	NN	B-TEST
27	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
39	CD	O
and	CC	O
1.6	CD	O
respectively	RB	O
,	,	O
glucose	JJ	B-TEST
113	CD	O
.	.	O

calcium	NN	B-TEST
was	VBD	O
9.6	CD	O
.	.	O

ck	NN	B-TEST
was	VBD	O
62	CD	O
.	.	O

troponin	NN	B-TEST
was	VBD	O
0.2	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.5	CD	O
,	,	O
85	CD	B-TEST
polys	NN	I-TEST
,	,	O
5	CD	B-TEST
bands	NNS	I-TEST
,	,	O
hematocrit	NN	B-TEST
37.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
328	CD	O
.	.	O

coagulation	NN	B-TEST
studies	NNS	I-TEST
were	VBD	O
11.3/25.5/0.9	CD	O
.	.	O

urinalysis	NN	B-TEST
demonstrated	VBD	O
trace	NN	B-PROBLEM
leukocyte	NN	I-PROBLEM
esterase	NN	I-PROBLEM
,	,	O
5-10	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
and	CC	O
1+	CD	B-PROBLEM
squamous	JJ	I-PROBLEM
epithelial	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

ekg	RB	B-TEST
demonstrated	VBN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
,	,	O
rate	NN	B-TEST
of	IN	O
73	CD	O
,	,	O
borderline	NN	B-PROBLEM
left	VBD	I-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
axis	JJ	B-TEST
of-28	JJ	O
,	,	O
t-wave	JJ	B-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v4	NN	I-PROBLEM
through	IN	O
v6	NN	O
,	,	O
i	NN	O
and	CC	O
avl	NN	O
,	,	O
borderline	NN	B-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
strain	NN	B-PROBLEM
compared	VBN	O
to	TO	O
earlier	RBR	O
this	DT	O
am	VBP	O
.	.	O

there	RB	O
appeared	VBN	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
t-wave	JJ	I-PROBLEM
inversion	NN	I-PROBLEM
in	IN	O
v4	NN	O
.	.	O

1	CD	O
)	)	O
aspirin	NN	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2	CD	O
)	)	O
os-cal	JJ	B-TREATMENT
1250	CD	O
mg	NN	O
p.o.	VBD	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3	LS	O
)	)	O
lasix	VBD	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.o.d.	NN	O

4	CD	O
)	)	O
plaquenil	NN	B-TREATMENT
200	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5	CD	O
)	)	O
ibuprofen	NN	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

6	CD	O
)	)	O
levoxyl	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

7	CD	O
)	)	O
arava	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8	CD	O
)	)	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

9	CD	O
)	)	O
isosorbide	NN	B-TREATMENT
dinitrate	NN	I-TREATMENT
unclear	JJ	O
dose	NN	O
.	.	O

10	CD	O
)	)	O
diltiazem	NN	B-TREATMENT
240	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

11	CD	O
)	)	O
epogen	NN	B-TREATMENT
q.	RB	O
two	CD	O
weeks	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
rule	NN	O
out	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
on	IN	O
telemetry	NN	B-TEST
for	IN	O
greater	JJR	O
than	IN	O
48	CD	O
hours	NNS	O
which	WDT	O
demonstrated	VBD	O
no	DT	O
dysrhythmia	NN	B-PROBLEM
during	IN	O
this	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
a	DT	O
preserved	JJ	O
ejection	NN	O
fraction	NN	O
with	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
no	DT	O
significant	JJ	B-PROBLEM
valvular	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
lasix	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
diltiazem	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
increased	JJ	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
labetalol	NN	B-TREATMENT
which	WDT	O
was	VBD	O
gradually	RB	O
titrated	VBN	O
up	RP	O
to	TO	O
a	DT	B-TEST
target	NN	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
160-170	JJ	B-TEST
systolic	NN	I-TEST
in	IN	O
her	PRP$	O
right	JJ	O
arm	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
underwent	VBD	O
an	DT	B-TEST
adenosine	NN	I-TEST
mibi	NN	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
which	WDT	O
showed	VBD	O
only	RB	O
mild	JJ	B-PROBLEM
lateral	JJ	I-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
presyncopal	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
not	RB	O
felt	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
a	DT	O
cardiovascular	JJ	O
etiology	NN	O
.	.	O

the	DT	B-PROBLEM
discrepancy	NN	I-PROBLEM
in	IN	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
pulses	NNS	I-TEST
and	CC	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
subclavian	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
mri	NN	B-TEST
/	NNP	I-TEST
mra	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
,	,	I-TEST
neck	NN	I-TEST
and	CC	I-TEST
upper	JJ	I-TEST
chest	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
a	DT	B-PROBLEM
proximal	JJ	I-PROBLEM
left	NN	I-PROBLEM
subclavian	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
proximal	NN	O
to	TO	O
the	DT	O
take	VB	O
off	NN	O
of	IN	O
the	DT	O
left	JJ	O
vertebral	JJ	O
artery	NN	O
.	.	O

the	DT	O
left	JJ	O
vertebral	JJ	O
artery	NN	O
had	VBD	O
a	DT	B-PROBLEM
decreased	VBN	I-PROBLEM
flow	NN	I-PROBLEM
consistent	NN	O
with	IN	O
either	DT	O
native	JJ	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
some	DT	B-PROBLEM
degree	NN	I-PROBLEM
of	IN	I-PROBLEM
retrograde	NN	I-PROBLEM
flow	NN	I-PROBLEM
with	IN	O
subclavian	JJ	B-PROBLEM
steal	NN	I-PROBLEM
phenomenon	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
patent	NN	O
carotids	NNS	O
bilaterally	RB	O
on	IN	O
her	PRP$	B-TEST
neck	NN	I-TEST
mra	NN	I-TEST
.	.	O

mri	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
was	VBD	O
likely	RB	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
right	NN	I-PROBLEM
cerebellar	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
non-invasive	JJ	B-TEST
carotid	NN	I-TEST
ultrasounds	NNS	I-TEST
which	WDT	O
demonstrated	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
noted	VBN	O
to	TO	O
have	VB	O
antegrade	VBN	B-PROBLEM
flow	NN	I-PROBLEM
in	IN	O
both	DT	O
of	IN	O
her	PRP$	O
vertebral	JJ	O
arteries	NNS	O
bilaterally	RB	O
.	.	O

the	DT	O
results	NNS	O
of	IN	O
these	DT	B-TEST
studies	NNS	I-TEST
suggested	VBD	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
not	RB	O
due	JJ	O
to	TO	O
subclavian	JJ	B-PROBLEM
steal	NN	I-PROBLEM
phenomenon	NN	I-PROBLEM
,	,	O
and	CC	O
therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
the	DT	O
patient	NN	O
would	MD	O
not	RB	O
go	VB	O
further	RBR	O
to	TO	O
angio	VB	B-TREATMENT
and	CC	O
/	VB	O
or	CC	O
surgical	JJ	B-TREATMENT
or	CC	I-TREATMENT
percutaneous	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

a	DT	O
neurology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	B-TREATMENT
most	RBS	I-TREATMENT
valuable	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
that	WDT	O
could	MD	O
be	VB	O
done	VBN	O
for	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
intervascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
would	MD	O
be	VB	O
adequate	JJ	O
control	NN	O
of	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

outside	JJ	B-TEST
hip	NN	I-TEST
films	NNS	I-TEST
were	VBD	O
obtained	VBN	O
,	,	O
but	CC	O
were	VBD	O
not	RB	O
available	JJ	O
for	IN	O
view	NN	O
.	.	O

repeat	NN	B-TEST
hip	NN	I-TEST
films	NNS	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
right	NN	I-PROBLEM
sided	VBN	I-PROBLEM
pubic	JJ	I-PROBLEM
rami	NN	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
likely	JJ	O
new	JJ	O
.	.	O

an	DT	O
orthopedics	NNS	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
encouraged	VBN	O
to	TO	O
weight	VB	O
bear	NN	O
as	IN	O
tolerated	VBN	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
assistance	NN	I-TREATMENT
.	.	O

a	DT	B-TEST
bone	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
also	RB	O
obtained	VBN	O
to	TO	O
rule	VB	O
out	RP	O
an	DT	B-PROBLEM
occult	NN	I-PROBLEM
hip	NN	I-PROBLEM
fracture	NN	I-PROBLEM
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
bear	VB	O
weight	NN	O
with	IN	O
the	DT	O
assistance	NN	O
of	IN	O
physical	JJ	O
therapy	NN	O
and	CC	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
.	.	O

plans	NNS	O
were	VBD	O
made	VBN	O
for	IN	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
discharged	VBN	O
to	TO	O
dwardmegriff	VB	O
rehabilitation	NN	O
for	IN	O
rehabilitation	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
rami	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
her	PRP$	B-PROBLEM
described	JJ	I-PROBLEM
vertigo	NN	I-PROBLEM
while	IN	O
lying	VBG	O
in	IN	O
bed	NN	O
and	CC	O
on	IN	O
the	DT	B-TEST
monitor	NN	I-TEST
during	IN	O
which	WDT	O
no	DT	O
dysrhythmia	NN	B-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
complained	VBD	O
of	IN	O
frequent	JJ	B-PROBLEM
vomiting	VBG	I-PROBLEM
at	IN	O
least	JJS	O
once	RB	O
a	DT	O
day	NN	O
,	,	O
occasionally	RB	O
associated	VBN	O
with	IN	O
ingestion	NN	O
of	IN	O
her	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
but	CC	O
sometimes	RB	O
associated	VBN	O
with	IN	O
ambulation	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
long-standing	JJ	O
history	NN	O
of	IN	O
spontaneous	JJ	B-PROBLEM
emesis	NN	I-PROBLEM
due	JJ	O
to	TO	O
overwhelming	JJ	O
stress	NN	O
or	CC	O
excitement	NN	O
.	.	O

however	RB	O
,	,	O
the	DT	O
patient	NN	O
reports	NNS	O
emesis	NN	B-PROBLEM
in	IN	O
the	DT	O
hospital	NN	O
more	RBR	O
frequently	RB	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
emesis	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
bilious	JJ	B-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
new	JJ	B-PROBLEM
or	CC	I-PROBLEM
old	JJ	I-PROBLEM
blood	NN	I-PROBLEM
.	.	O

the	DT	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
nausea	NN	I-PROBLEM
remained	VBD	O
unclear	JJ	O
as	IN	O
she	PRP	O
demonstrated	VBD	O
ability	NN	O
to	TO	O
keep	VB	O
down	RP	O
many	JJ	O
of	IN	O
her	PRP$	O
meals	NNS	O
which	WDT	O
did	VBD	O
not	RB	O
suggest	VB	O
an	DT	B-PROBLEM
anatomical	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM
tract	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
meclizine	NN	B-TREATMENT
on	IN	O
december	NN	O
31	CD	O
,	,	O
2000	CD	O
for	IN	O
her	PRP$	B-PROBLEM
nausea	NN	I-PROBLEM
and	CC	O
vertigo	NN	B-PROBLEM
.	.	O

an	DT	O
attempt	NN	O
was	VBD	O
also	RB	O
made	VBN	O
to	TO	O
reduce	VB	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
large	JJ	O
number	NN	O
of	IN	O
medications	NNS	B-TREATMENT
and	CC	O
the	DT	B-TREATMENT
patient	JJ	I-TREATMENT
&apos;s	NNP	I-TREATMENT
os-cal	JJ	I-TREATMENT
,	,	O
multivitamin	NN	B-TREATMENT
,	,	O
lasix	NN	B-TREATMENT
and	CC	O
colace	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
incontinence	NN	I-PROBLEM
and	CC	O
difficulty	NN	O
initiating	VBG	O
urine	NN	O
on	IN	O
december	NN	O
30	CD	O
,	,	O
2000	CD	O
.	.	O

urinalysis	NN	B-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
likely	JJ	I-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
for	IN	O
a	DT	O
possible	JJ	O
nosocomial	JJ	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
urine	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
increase	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
during	IN	O
her	PRP$	O
hospitalization	NN	O
which	WDT	O
promptly	RB	O
returned	VBD	O
to	TO	O
her	PRP$	O
baseline	NN	O
levels	NNS	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

lightheadedness	NN	B-PROBLEM
,	,	O
slight	JJ	B-PROBLEM
doe	NN	I-PROBLEM

redo	NN	B-TREATMENT
avr	NN	I-TREATMENT
with	IN	O
aortic	JJ	B-TREATMENT
root	NN	I-TREATMENT
enlargement	NN	I-TREATMENT
(	(	O
21	CD	O
mm	NN	O
ce	NN	O
magna	VBP	O
pericardial	JJ	O
valve	NN	O
)	)	O

68	CD	O
yo	JJ	O
female	NN	O
trasnferred	VBN	O
in	IN	O
from	IN	O
catholic	NN	O
cmed	VBN	O
csru.	JJ	O
ctr.	NN	O
with	IN	O
periprosthetic	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
thrombus	NN	I-PROBLEM
.	.	O

no	DT	O
cath	NN	B-TEST
done	VBN	O
,	,	O
but	CC	O
echo	VBP	B-TEST
05-07	JJ	O
showed	VBD	O
ef	JJ	B-TEST
60-65%	JJ	O
,	,	O
stenotic	JJ	B-PROBLEM
mech.	NN	I-PROBLEM
valve	NN	I-PROBLEM
,	,	O
mean	JJ	B-TEST
gradient	NN	I-TEST
33	CD	O
mm	NN	O
,	,	O
decreased	VBD	B-PROBLEM
disc	JJ	I-PROBLEM
motion	NN	I-PROBLEM
,	,	O
mobile	JJ	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
lvot	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
ai	NN	I-PROBLEM
,	,	O
mild	NN	B-PROBLEM
to	TO	I-PROBLEM
moderate	VB	I-PROBLEM
mr	NN	I-PROBLEM
,	,	O
trace	NN	B-PROBLEM
tr.	NN	I-PROBLEM
referred	VBD	O
for	IN	O
surgical	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

htn	NN	B-PROBLEM
elev.	NN	B-PROBLEM
lipids	NNS	I-PROBLEM
hypothyroidism	NN	B-PROBLEM
back	RB	B-PROBLEM
pain	NN	I-PROBLEM

gerd	NN	B-PROBLEM

s/p	NN	O
avr	NN	B-TREATMENT
2000	CD	O
remote	JJ	B-TREATMENT
tonsillectomy/adenoidectomy	NN	I-TREATMENT
partial	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
rem.	NN	B-TREATMENT
right	JJ	I-TREATMENT
wrist	NN	I-TREATMENT
ganglion	NN	I-TREATMENT
cyst	NN	I-TREATMENT
left	VBD	B-TREATMENT
foot	JJ	I-TREATMENT
bunionectomy	NN	I-TREATMENT
breast	NN	B-TEST
biopsies	NNS	I-TEST

father	RB	O
died	VBD	O
at	IN	O
57	CD	O
of	IN	O
heart	NN	B-PROBLEM
problems	NNS	I-PROBLEM
brother	RB	O
died	VBD	O
at	IN	O
age	NN	O
7	CD	O
of	IN	O
"leaky	JJ	B-PROBLEM
valve"	NNS	I-PROBLEM
sister	NN	O
with	IN	O
cad/cabg	NN	B-PROBLEM

hr	NN	B-TEST
68	CD	O

rr	NN	B-TEST
18	CD	O

95%	CD	O
sat	VBD	B-TEST

nad	JJ	B-PROBLEM
skin/heent	NN	O
unremarkable	JJ	O
neck	NN	O
supple	NN	O
,	,	O
murmur	NN	B-PROBLEM
radiates	NNS	O
bilat.	VBP	O
to	TO	O
carotids	NNS	O

rrr	NN	O
with	IN	O
holosystolic	JJ	B-PROBLEM
murmur	NN	I-PROBLEM
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
nd	JJ	B-PROBLEM
,	,	O
+	JJ	O
bs	NN	O
warm	NN	O
,	,	O
well-perfused	JJ	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
superficial	JJ	B-PROBLEM
varicosities	NNS	I-PROBLEM
neuro	VBP	O
grossly	RB	O
intact	JJ	O

cardiology	NN	O
report	NN	O
echo	VBP	B-TEST
study	NN	I-TEST
date	NN	O
of	IN	O
2014-05-11	JJ	O

pt	NN	O
is	VBZ	O
being	VBG	O
av	RB	O
paced	VBN	O
,	,	O
on	IN	O
an	DT	B-TREATMENT
infusion	NN	I-TREATMENT
of	IN	I-TREATMENT
phenylephrine	NN	I-TREATMENT

1.	CD	O
a	DT	B-TREATMENT
bioprosthesis	NN	I-TREATMENT
is	VBZ	O
well	RB	O
seated	VBN	O
in	IN	O
the	DT	O
aortic	JJ	O
position	NN	O
,	,	O
leaflets	VBZ	O
open	JJ	O
well	RB	O
,	,	O
trace	JJ	B-PROBLEM
central	JJ	I-PROBLEM
ai	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

trace	NN	B-PROBLEM
ai	NN	I-PROBLEM
is	VBZ	O
also	RB	O
noted	VBN	O
between	IN	O
the	DT	O
left	NN	O
and	CC	O
right	JJ	O
coronary	NN	O
cusps	NN	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
paravavluar	NN	I-PROBLEM
leak	NN	I-PROBLEM
in	IN	O
the	DT	O
area	NN	O
adjacent	NN	O
to	TO	O
the	DT	O
anterior	JJ	O
mitral	JJ	O
leaflet	NN	O
,	,	O
resulting	VBG	O
in	IN	O
some	DT	B-PROBLEM
trace	NN	I-PROBLEM
insuffiency	NN	I-PROBLEM
outside	IN	O
the	DT	O
sewing	VBG	O
ring	NN	O
.	.	O

2.	CD	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
from	IN	O
before	IN	O
.	.	O

4.	CD	O
aorta	NN	O
is	VBZ	O
intact	JJ	O
post	NN	O
decannulation	NN	B-TREATMENT

6.	CD	O
all	DT	O
findings	NNS	O
discussed	VBN	O
with	IN	O
surgeon	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
the	DT	B-TEST
exam	NN	I-TEST
.	.	O

hct	SYM	B-TEST
-	:	O
29.2*	CD	O

wbc	SYM	B-TEST
-	:	O
12.4*	CD	O
rbc	NN	B-TEST
-	:	O
2.89*	CD	O
hgb	NN	B-TEST
-	:	O
9.0*	CD	O
hct	NN	B-TEST
-	:	O
26.0*	CD	O

mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
31.3	CD	O
mchc	SYM	B-TEST
-	:	O
34.9	CD	O
rdw	NN	B-TEST
-	:	O
13.5	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
262	CD	O

pt	SYM	B-TEST
-	:	O
16.8*	CD	O
ptt	NN	B-TEST
-	:	O
65.3*	CD	O
inr	NN	B-TEST
(	(	O
pt	NN	B-TEST
)	)	O
-	:	O
1.5*	CD	O

glucose	JJ	B-TEST
-	:	O
115*	CD	O
urean	JJ	B-TEST
-	:	O
20	CD	O
creat	NN	B-TEST
-	:	O
1.3*	CD	O
na	SYM	B-TEST
-	:	O
137	CD	O

k	SYM	B-TEST
-	:	O
4.8	CD	O
cl	NN	B-TEST
-	:	O
96	CD	O
hco3	NN	B-TEST
-	:	O
34*	CD	O
angap	NN	B-TEST
-	:	O
12	CD	O

admitted	VBN	O
05-08	CD	O
to	TO	O
cardiology	VB	O
service	NN	O
for	IN	O
surgical	JJ	B-TEST
work-up	NN	I-TEST
.	.	O

inr	NN	B-TEST
2.7	CD	O
and	CC	O
echo	RB	B-TEST
repeated	VBN	O
,	,	O
coumadin	JJ	B-TREATMENT
held	NN	O
,	,	O
and	CC	O
heparin	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
started	VBD	O
.	.	O

review	NN	O
of	IN	O
osh	JJ	B-TEST
echo	NN	I-TEST
revealed	VBD	O
peak	JJ	B-TEST
gradient	NN	I-TEST
of	IN	O
64mm	CD	O
(	(	O
not	RB	O
30	CD	O
's	POS	O
)	)	O
.	.	O

new	JJ	B-TEST
echo	NN	I-TEST
showed	VBD	O
pannus	IN	B-PROBLEM
involving	VBG	O
the	DT	O
valve	NN	O
and	CC	O
?	.	O
thrombus	NN	B-PROBLEM
.	.	O

seen	VBN	O
by	IN	O
dr.	JJ	O
laura	NN	O
of	IN	O
cardiac	JJ	O
surgery	NN	O
and	CC	O
underwent	JJ	O
redo	NN	B-TREATMENT
avr	NN	I-TREATMENT
with	IN	O
aortic	JJ	B-TREATMENT
root	NN	I-TREATMENT
enlargement	NN	I-TREATMENT
on	IN	O
05-11	NN	O
.	.	O

transferred	VBN	O
to	TO	O
the	DT	O
csru	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
phenylephrine	NN	B-TREATMENT
and	CC	O
propofol	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

weaned	VBN	O
to	TO	O
extubation	VB	O
on	IN	O
pod	NN	O
#2	NNS	O
and	CC	O
off	IN	O
all	DT	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

episode	NN	B-PROBLEM
of	IN	I-PROBLEM
afib	NN	I-PROBLEM
that	IN	O
evening	VBG	O
treated	VBN	O
with	IN	O
amiodarone	NN	B-TREATMENT
and	CC	O
converted	VBD	O
to	TO	O
sr	VB	O
.	.	O

chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	O
wires	NNS	B-TREATMENT
removed	VBN	O
without	IN	O
incident	NN	B-PROBLEM
.	.	O

synthroid	JJ	B-TREATMENT
75	CD	O
mcg	NNS	O
daily	RB	O

hctz	NN	B-TREATMENT
37.5	CD	O
mg	JJ	O
daily	JJ	O

mvi	NNS	B-TREATMENT
daily	RB	O

vit.c	NN	B-TREATMENT
500	CD	O
mg	JJ	O
daily	JJ	O
prevacid	NN	B-TREATMENT
15	CD	O
mg	JJ	O
daily	JJ	O
coumadin	NN	B-TREATMENT
(	(	O
held	VBN	O
)	)	O
toprol	NN	B-TREATMENT
xl	$	I-TREATMENT
100	CD	O
mg	JJ	O
daily	JJ	O
zocor	NN	B-TREATMENT
40	CD	O
mg	JJ	O
daily	JJ	O

kcl	VB	B-TREATMENT
12-27	JJ	O
meq	NNS	O
daily	JJ	O
cozaar	VBP	B-TREATMENT
25	CD	O
mg	NNS	O
daily	RB	O

1.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
1	CD	O
months	NNS	O
.	.	O

3.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
oxycodone-acetaminophen	JJ	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
levothyroxine	JJ	B-TREATMENT
75	CD	O
mcg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

8.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
for	IN	O
2	CD	O
days	NNS	O
:	:	O
for	IN	O
2	CD	O
days	NNS	O
,	,	O
then	RB	O
start	VB	O
200	CD	O
mg	JJ	O
daily	JJ	O
ongoing	VBG	O
on	IN	O
05-20	NN	O
.	.	O

9.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

10.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

prosthetic	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM

htn	NN	B-PROBLEM
elev.	NN	B-PROBLEM
lipds	VBD	I-PROBLEM
hypothyroidism	NN	B-PROBLEM
back	RB	B-PROBLEM
pain	NN	I-PROBLEM

gerd	NN	B-PROBLEM

a	DT	B-PROBLEM
fib	JJ	I-PROBLEM
s/p	NN	O
avr	NN	B-TREATMENT
2000	CD	O

no	DT	O
driving	NN	O
for	IN	O
one	CD	O
month	NN	O
no	DT	O
lifting	VBG	O
greater	JJR	O
than	IN	O
10	CD	O
pounds	NNS	O
for	IN	O
10	CD	O
weeks	NNS	O
no	DT	O
lotions	NNS	O
,	,	O
creams	NNS	O
or	CC	O
powders	NNS	O
on	IN	O
any	DT	O
incision	NN	B-PROBLEM
may	MD	O
shower	VB	O
over	IN	O
incisions	NNS	B-PROBLEM
and	CC	O
pat	VB	O
dry	JJ	O
call	NN	O
for	IN	O
fever	NN	B-PROBLEM
greater	JJR	O
than	IN	O
100.5	CD	O
,	,	O
redness	NN	B-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM

uterine	JJ	B-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
70	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
iv	NN	O
,	,	O
para	VBP	O
4	CD	O
who	WP	O
presented	VBD	O
for	IN	O
a	DT	B-TREATMENT
vaginal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
uterine	VB	B-PROBLEM
prolapse	NN	I-PROBLEM
and	CC	O
also	RB	O
presented	VBN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
a	DT	B-PROBLEM
suspicious	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
seen	VBN	O
on	IN	O
a	DT	B-TEST
mammogram	NN	I-TEST
.	.	O

patient	NN	B-PROBLEM
&apos;s	NN	I-PROBLEM
problem	NN	I-PROBLEM
started	VBD	O
four	CD	O
years	NNS	O
ago	RB	O
when	WRB	O
she	PRP	O
first	RB	O
experienced	VBD	O
a	DT	B-PROBLEM
pushing	VBG	I-PROBLEM
forward	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
uterus	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
described	VBD	O
this	DT	O
sensation	NN	O
as	IN	O
uncomfortable	JJ	B-PROBLEM
and	CC	O
becoming	VBG	O
more	RBR	O
prominent	JJ	O
over	IN	O
the	DT	O
following	JJ	O
three	CD	O
years	NNS	O
with	IN	O
increasing	VBG	B-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
.	.	O

two	CD	O
months	NNS	O
ago	RB	O
,	,	O
the	DT	O
patient	NN	O
slipped	VBD	O
and	CC	O
fell	VBD	O
with	IN	O
valsalva	NN	O
that	WDT	O
precipitated	VBD	O
an	DT	O
exacerbation	NN	O
of	IN	O
her	PRP$	B-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

she	PRP	O
subsequently	RB	O
could	MD	O
not	RB	O
urinate	VB	O
and	CC	O
was	VBD	O
in	IN	O
pain	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
problem	NN	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
she	PRP	O
decided	VBD	O
that	IN	O
she	PRP	O
needed	VBD	O
the	DT	B-PROBLEM
prolapse	NN	I-PROBLEM
fixed	VBN	O
and	CC	O
actually	RB	O
wrote	VBD	O
to	TO	O
the	DT	O
norri	JJ	O
hospital	NN	O
to	TO	O
try	VB	O
and	CC	O
find	VB	O
a	DT	O
gynecologist	NN	O
.	.	O

her	PRP$	O
letter	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
dr.	VB	O
earllamarg	JJ	O
para	NN	O
who	WP	O
saw	VBD	O
her	PRP	O
in	IN	O
the	DT	O
office	NN	O
and	CC	O
recommended	VBD	O
vaginal	JJ	B-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

patient	NN	O
has	VBZ	O
never	RB	O
had	VBD	O
a	DT	B-TREATMENT
pessary	JJ	I-TREATMENT
and	CC	O
refused	VBD	O
one	CD	O
and	CC	O
denies	VBZ	O
nausea	NN	B-PROBLEM
,	,	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
dysuria	NNS	B-PROBLEM
,	,	O
or	CC	O
stress	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
on	IN	O
her	PRP$	O
current	JJ	O
admission	NN	O
.	.	O

significant	JJ	O
for	IN	O
a	DT	B-PROBLEM
lower	JJR	I-PROBLEM
left	RBR	I-PROBLEM
saphenous	JJ	I-PROBLEM
vein	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
diagnosed	VBN	O
with	IN	O
lower	JJR	B-TEST
extremity	NN	I-TEST
non-invasives	NNS	I-TEST
and	CC	O
on	IN	O
may	MD	O
2	CD	O
,	,	O
1993	CD	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
and	CC	O
clearance	NN	O
by	IN	O
dr.	NN	O
ribreefcheampner	NN	O
for	IN	O
further	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
a	DT	B-PROBLEM
heart	NN	I-PROBLEM
murmur	NN	I-PROBLEM
since	IN	O
childhood	NN	O
.	.	O

last	JJ	O
menstrual	JJ	O
period	NN	O
was	VBD	O
at	IN	O
age	NN	O
fifty	NN	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
not	RB	O
on	IN	O
hormonal	JJ	B-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
she	PRP	O
has	VBZ	O
a	DT	O
four	CD	O
history	NN	O
of	IN	O
uterine	JJ	B-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

aspirin	RB	B-TREATMENT
one	CD	O
per	IN	O
day	NN	O
which	WDT	O
the	DT	O
patient	NN	O
quit	NN	O
taking	VBG	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

this	DT	O
was	VBD	O
a	DT	O
well-developed	JJ	O
,	,	O
well-nourished	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

patient	NN	O
had	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
128/72	CD	O
,	,	O
a	DT	B-TEST
pulse	NN	I-TEST
of	IN	O
84	CD	O
that	WDT	O
was	VBD	O
regular	JJ	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
at	IN	O
98.4	CD	O
.	.	O

examination	NN	B-TEST
showed	VBD	O
right	JJ	B-PROBLEM
axillary	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
posterior	NN	I-PROBLEM
axillary	JJ	I-PROBLEM
skin	NN	I-PROBLEM
tags	NNS	I-PROBLEM
and	CC	O
crusted	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

pupils	NNS	O
were	VBD	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
extraocular	JJ	O
muscles	NNS	O
were	VBD	O
intact	JJ	O
,	,	O
and	CC	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

examination	NN	B-TEST
showed	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
s3	NN	B-PROBLEM
or	CC	O
s4	VB	B-PROBLEM
heard	NN	O
and	CC	O
a	DT	B-PROBLEM
grade	NN	I-PROBLEM
ii/vi	NN	I-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
loudest	JJS	O
at	IN	O
the	DT	O
left	JJ	O
sternal	JJ	O
border	NN	O
.	.	O

examination	NN	B-TEST
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	I-TEST

examination	NN	B-TEST
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
mid	NN	I-PROBLEM
small	JJ	I-PROBLEM
breast	NN	I-PROBLEM
mass	NN	I-PROBLEM
which	WDT	O
was	VBD	O
detected	VBN	O
actually	RB	O
by	IN	O
dr.	JJ	O
para	NN	O
.	.	O

soft	JJ	O
and	CC	O
non-tender	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
left	VBN	B-PROBLEM
lower	JJR	I-PROBLEM
leg	NN	I-PROBLEM
varicose	NN	I-PROBLEM
veins	NNS	I-PROBLEM
,	,	O
no	DT	O
venous	JJ	B-PROBLEM
cords	NNS	I-PROBLEM
,	,	O
and	CC	O
bilateral	JJ	B-TEST
2+	CD	I-TEST
pedal	JJ	I-TEST
pulses	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
12	CD	O
and	CC	O
1.2	CD	O
,	,	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
6.7	CD	O
,	,	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
39.4	CD	O
,	,	O
negative	JJ	O
urinalysis	NN	O
,	,	O
and	CC	O
a	DT	B-TEST
potassium	NN	I-TEST
of	IN	O
4.6	CD	O
.	.	O

her	PRP$	O
ca-125	NN	B-TEST
was	VBD	O
20	CD	O
and	CC	O
she	PRP	O
had	VBD	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
that	WDT	O
showed	VBD	O
no	DT	O
infiltrates	NNS	B-PROBLEM
and	CC	O
a	DT	B-TEST
mammogram	NN	I-TEST
that	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
large	JJ	I-PROBLEM
calcified	VBD	I-PROBLEM
fibroadenoma	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
upper	NN	I-PROBLEM
mid	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
calcification	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TEST
ekg	NN	I-TEST
that	WDT	O
showed	VBD	O
a	DT	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

cardiology	NN	O
was	VBD	O
consulted	VBN	O
to	TO	O
evaluate	VB	O
this	DT	O
and	CC	O
felt	VBD	O
that	IN	O
the	DT	B-PROBLEM
changes	NNS	I-PROBLEM
seen	VBN	O
on	IN	O
the	DT	B-TEST
ekg	NN	I-TEST
were	VBD	O
not	RB	O
significant	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
seen	VBN	O
by	IN	O
dr.	JJ	O
nusc	NN	O
from	IN	O
general	JJ	O
surgery	NN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
micro	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
breast	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
refused	VBD	O
a	DT	B-TEST
biopsy	NN	I-TEST
for	IN	O
this	DT	O
admission	NN	O
and	CC	O
desires	VBZ	O
follow-up	JJ	B-TEST
mammograms	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
a	DT	B-TREATMENT
total	JJ	I-TREATMENT
vaginal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
on	IN	O
june	NN	O
4	CD	O
,	,	O
1993	CD	O
which	WDT	O
she	PRP	O
tolerated	VBD	O
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
throughout	IN	O
her	PRP$	O
admission	NN	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
by	IN	O
post-operative	JJ	O
day	NN	O
two	CD	O
and	CC	O
was	VBD	O
discharged	VBN	O
on	IN	O
june	NN	O
6	CD	O
,	,	O
1993	CD	O
with	IN	O
percocet	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
urinating	VBG	O
on	IN	O
her	PRP$	O
own	JJ	O
.	.	O

percocet	RB	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
q.4-6h.	JJ	O
p.r.n.	NN	O
,	,	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
and	CC	O
one	CD	O
aspirin	NN	B-TREATMENT
q.d.	NN	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

tia/palpitations	NNS	B-PROBLEM

2014-04-21	JJ	O
-	:	O
pfo	NN	B-TREATMENT
closure	NN	I-TREATMENT
via	IN	O
right	JJ	B-TREATMENT
mini	NN	I-TREATMENT
thoracotomy	NN	I-TREATMENT

this	DT	O
53-year-old	JJ	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
multiple	JJ	B-PROBLEM
transient	JJ	I-PROBLEM
ischemic	JJ	I-PROBLEM
attacks	NNS	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
was	VBD	O
investigated	VBN	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
patent	NN	I-PROBLEM
foramen	NNS	I-PROBLEM
ovale	VBP	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
electively	RB	O
admitted	VBN	O
for	IN	O
closure	NN	B-TREATMENT
of	IN	O
the	DT	O
same	JJ	O
.	.	O

his	PRP$	B-TEST
preoperative	JJ	I-TEST
investigations	NNS	I-TEST
with	IN	O
coronary	JJ	B-TEST
angiogram	NN	I-TEST
showed	VBD	O
normal	JJ	O
coronary	JJ	O
arteries	NNS	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
valvular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
nodule	NN	I-PROBLEM

tia	NN	B-PROBLEM
's	POS	I-PROBLEM

childhood	NN	B-PROBLEM
skull	NN	I-PROBLEM
fracture	NN	I-PROBLEM

pfo	NN	B-PROBLEM

brother	NN	O
with	IN	O
mi	NN	B-PROBLEM
at	IN	O
age	NN	O
35	CD	O

father	NN	O
with	IN	O
mi/cabg	NN	B-PROBLEM
died	VBN	O
at	IN	O
age	NN	O
60	CD	O
.	.	O

bp	NN	B-TEST
144/90	CD	O
,	,	O
hr	NN	B-TEST
64	CD	O
,	,	O
rr	VBD	B-TEST
14	CD	O

well	RB	O
developed	VBN	O
male	NN	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM

oropharynx	JJ	O
benign	NN	O
,	,	O
poor	JJ	B-PROBLEM
dental	JJ	I-PROBLEM
health	NN	I-PROBLEM

supple	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

regular	JJ	O
rate	NN	O
,	,	O
normal	JJ	O
s1s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
normoactive	JJ	O
bowel	NN	O
sounds	NNS	O

warm	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM

2014-04-24	JJ	O
07:30am	CD	O
blood	NN	B-TEST

hct	SYM	B-TEST
-	:	O
25.9*	CD	O

2014-04-23	JJ	O
07:05am	CD	O
blood	NN	B-TEST

wbc	SYM	B-TEST
-	:	O
5.9	CD	O
rbc	NN	B-TEST
-	:	O
2.72*	CD	O
hgb	NN	B-TEST
-	:	O
8.6*	CD	O
hct	NN	B-TEST
-	:	O
25.2*	CD	O

mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
31.5	CD	O
mchc	SYM	B-TEST
-	:	O
34.0	CD	O
rdw	NN	B-TEST
-	:	O
13.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
150	CD	O

2014-04-23	JJ	O
07:05am	CD	O
blood	NN	B-TEST

plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
150	CD	O

2014-04-24	JJ	O
07:30am	CD	O
blood	NN	B-TEST

urean	JJ	B-TEST
-	:	O
11	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
k	SYM	O
-	:	O
4.4	CD	O

2014-04-21	JJ	O
echo	NN	B-TEST

no	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
.	.	O

no	DT	O
mass/thrombus	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
or	CC	O
left	VBN	O
atrial	JJ	O
appendage	NN	O
.	.	O

no	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
right	JJ	O
atrium	NN	O
.	.	O

a	DT	B-PROBLEM
patent	NN	I-PROBLEM
foramen	NNS	I-PROBLEM
ovale/secundum	VBP	I-PROBLEM
asd	NN	I-PROBLEM
is	VBZ	O
present	JJ	O
.	.	O

a	DT	B-PROBLEM
left-to-right	JJ	I-PROBLEM
shunt	NN	I-PROBLEM
across	IN	I-PROBLEM
the	DT	I-PROBLEM
interatrial	JJ	I-PROBLEM
septum	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
at	IN	O
rest	NN	O
.	.	O

a	DT	B-PROBLEM
right-to-left	JJ	I-PROBLEM
shunt	NN	I-PROBLEM
across	IN	I-PROBLEM
the	DT	I-PROBLEM
interatrial	JJ	I-PROBLEM
septum	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
at	IN	O
rest	NN	O
with	IN	O
injection	NN	B-TEST
of	IN	I-TEST
agitated	JJ	I-TEST
saline	NN	I-TEST
contrast	NN	I-TEST
.	.	O

the	DT	O
inferior	JJ	O
vena	NN	O
cava	NN	O
is	VBZ	O
dilated	VBN	B-PROBLEM
(	(	O
>2.5	NNP	O
cm	NN	O
)	)	O
.	.	O

left	VBN	O
ventricular	JJ	O
wall	NN	O
thickness	NN	O
,	,	O
cavity	NN	O
size	NN	O
,	,	O
and	CC	O
systolic	JJ	O
function	NN	O
are	VBP	O
normal	JJ	O
(	(	O
lvef	JJ	B-TEST
>55%	NN	I-TEST
)	)	O
.	.	O

overall	JJ	O
left	VBD	O
ventricular	JJ	O
systolic	JJ	O
function	NN	O
is	VBZ	O
normal	JJ	O
(	(	O
lvef>55%	JJ	B-TEST
)	)	O
.	.	O

the	DT	O
ascending	NN	O
,	,	O
transverse	NN	O
and	CC	O
descending	VBG	O
thoracic	NN	O
aorta	NNS	O
are	VBP	O
normal	JJ	O
in	IN	O
diameter	NN	O
and	CC	O
free	JJ	O
of	IN	O
atherosclerotic	JJ	B-PROBLEM
plaque	NN	I-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
appear	VBP	O
structurally	RB	O
normal	JJ	O
with	IN	O
good	JJ	O
leaflet	NN	O
excursion	NN	O
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
appears	VBZ	O
structurally	RB	O
normal	JJ	O
with	IN	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

post	NN	O
bypass	NN	B-TREATMENT

flow	NN	O
across	IN	O
the	DT	O
interatrial	JJ	O
septum	NN	O
is	VBZ	O
no	RB	O
longer	RBR	O
visualized	VBN	O
with	IN	O
color	NN	B-TEST
flow	NN	I-TEST
doppler	NN	I-TEST
or	CC	O
with	IN	O
injection	NN	B-TEST
of	IN	I-TEST
agitatated	JJ	I-TEST
saline	NN	I-TEST
at	IN	O
rest	NN	O
or	CC	O
with	IN	O
valsalva	NN	O
.	.	O

the	DT	B-TEST
study	NN	I-TEST
is	VBZ	O
otherwise	RB	O
unchanged	JJ	O
from	IN	O
pre-bypass	NN	B-TEST
.	.	O

2014-04-22	JJ	O
cxr	NN	B-TEST

previous	JJ	B-PROBLEM
right	NN	I-PROBLEM
pneumothorax	NN	I-PROBLEM
has	VBZ	O
resolved	VBN	O
except	IN	O
for	IN	O
what	WP	O
is	VBZ	O
either	CC	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
fissural	JJ	I-PROBLEM
component	NN	I-PROBLEM
or	CC	O
a	DT	B-PROBLEM
bulla	NN	I-PROBLEM
adjacent	NN	O
to	TO	O
the	DT	O
minor	JJ	O
fissure	NN	O
.	.	O

may	MD	O
be	VB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

right	RB	B-TREATMENT
apical	JJ	I-TREATMENT
pleural	JJ	I-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

left	VBN	O
lung	NN	O
clear	JJ	O
from	IN	O
basal	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

paratracheal	JJ	B-PROBLEM
mediastinal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
is	VBZ	O
resolving	VBG	O
.	.	O

mr.	NN	O
freeman	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
nantucket	NN	O
cottage	NN	O
hospital	NN	O
on	IN	O
2014-04-21	JJ	O
for	IN	O
surgical	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
pfo	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
mini-thoracotomy	JJ	I-TREATMENT
with	IN	O
closure	NN	B-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
patent	NN	I-PROBLEM
foramen	NNS	I-PROBLEM
ovale	VBP	I-PROBLEM
(	(	I-PROBLEM
pfo	NN	I-PROBLEM
)	)	I-PROBLEM
.	.	O

within	IN	O
a	DT	O
few	JJ	O
hours	NNS	O
,	,	O
he	PRP	O
woke	VBD	O
neurologically	RB	O
intact	JJ	O
and	CC	O
was	VBD	O
extubated	VBN	B-TREATMENT
.	.	O

aspirin	NN	B-TREATMENT
was	VBD	O
resumed.	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
surgical	JJ	O
step	NN	O
down	RB	O
unit	NN	O
.	.	O

iron	NN	B-TREATMENT
and	CC	O
vitamin	JJ	B-TREATMENT
c	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
for	IN	O
postoperative	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
.	.	O

plavix	RB	B-TREATMENT
75mg	CD	O
daily	JJ	O
aspirin	RB	B-TREATMENT
81mg	CD	O
daily	JJ	O

1.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
5	CD	O
days	NNS	O
.	.	O

2.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
oxycodone-acetaminophen	JJ	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
:	:	O
take	VB	O
for	IN	O
one	CD	O
month	NN	O
then	RB	O
stop	VB	O
.	.	O

6.	CD	O
camphor-menthol	JJ	B-TREATMENT
0.5-0.5	CD	O
%	NN	O
lotion	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
:	:	O
take	VB	O
for	IN	O
one	CD	O
month	NN	O
then	RB	O
stop	VB	O
.	.	O

8.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
5	CD	O
days	NNS	O
.	.	O

pfo	NN	B-PROBLEM

tia	NN	B-PROBLEM
lung	NN	I-PROBLEM
nodule	NN	I-PROBLEM
(	(	O
followed	VBN	O
by	IN	O
dr.	NN	O
belt	NN	O
)	)	O
s/p	VBZ	O
fissurectomy/skull	JJ	B-PROBLEM
fx	NN	I-PROBLEM

1)	CD	O
shower	NN	O
,	,	O
wash	JJ	O
incisions	NNS	B-PROBLEM
with	IN	O
mild	JJ	O
soap	NN	O
and	CC	O
water	NN	O
and	CC	O
pat	NN	O
dry	NN	O
.	.	O

no	DT	O
lotions	NNS	B-TREATMENT
,	,	O
creams	NNS	B-TREATMENT
or	CC	O
powders	NNS	B-TREATMENT
to	TO	O
incisions	NNS	B-PROBLEM
.	.	O

2)	CD	O
call	NN	O
with	IN	O
fever	NN	B-PROBLEM
>101	NN	I-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
from	IN	I-PROBLEM
incision	NN	I-PROBLEM
,	,	O
or	CC	O
weight	VBD	B-PROBLEM
gain	NN	I-PROBLEM
more	JJR	I-PROBLEM
than	IN	I-PROBLEM
2	CD	I-PROBLEM
pounds	NNS	I-PROBLEM
in	IN	O
one	CD	O
day	NN	O
or	CC	O
five	CD	O
pounds	NNS	O
in	IN	O
one	CD	O
week	NN	O
.	.	O

3)	CD	O
no	DT	O
driving	VBG	O
while	NN	O
on	IN	O
narcotics	NNS	B-TREATMENT
.	.	O

4)	CD	O
take	NN	O
lasix	NN	B-TREATMENT
twice	RB	O
daily	RB	O
with	IN	O
potassium	NN	B-TREATMENT
for	IN	O
five	CD	O
days	NNS	O
then	RB	O
stop	VB	O
.	.	O

5)	CD	O
take	NN	O
vitamin	NN	B-TREATMENT
c	NN	I-TREATMENT
with	IN	O
iron	NN	B-TREATMENT
for	IN	O
one	CD	O
month	NN	O
then	RB	O
stop	VB	O
.	.	O

sternal	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

infected	VBN	B-PROBLEM
aortic	JJ	I-PROBLEM
graft	NN	I-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

08/31/98	CD	O
ascending	VBG	B-TREATMENT
aortic	JJ	I-TREATMENT
root	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
homograft	NN	B-TREATMENT
with	IN	O
omentopexy	NN	B-TREATMENT
.	.	O

09/02/98	CD	O
sternal	JJ	B-TREATMENT
debridement	NN	I-TREATMENT
.	.	O

bilateral	JJ	B-TREATMENT
pectoralis	NN	I-TREATMENT
major	JJ	I-TREATMENT
myocutaneous	JJ	I-TREATMENT
advancement	NN	I-TREATMENT
flap	NN	I-TREATMENT
.	.	O

right	RB	B-TREATMENT
superiorly	RB	I-TREATMENT
based	VBN	I-TREATMENT
rectus	NN	I-TREATMENT
abdominis	NN	I-TREATMENT
flap	NN	I-TREATMENT
.	.	O

primary	JJ	B-TREATMENT
closure	NN	I-TREATMENT
of	IN	O
wound	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
79	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
an	DT	B-TREATMENT
ascending	VBG	I-TREATMENT
aortic	JJ	I-TREATMENT
graft	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
1991	CD	O
for	IN	O
aortic	JJ	B-PROBLEM
dissection	NN	I-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
the	DT	O
patient	NN	O
's	POS	O
hospital	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
requiring	VBG	O
a	DT	B-TREATMENT
sternal	JJ	I-TREATMENT
debridement	NN	I-TREATMENT
and	CC	O
subsequent	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
flap	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
continued	VBN	O
by	IN	O
report	NN	O
on	IN	O
dicloxacillin	NN	B-TREATMENT
for	IN	O
approximately	RB	O
one	CD	O
year	NN	O
following	VBG	O
that	IN	B-TREATMENT
reconstructive	JJ	I-TREATMENT
operation	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
apparently	RB	O
did	VBD	O
well	RB	O
until	IN	O
june	NNS	O
1998	CD	O
when	WRB	O
he	PRP	O
noted	VBD	O
a	DT	B-PROBLEM
bulge	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
sternal	JJ	I-PROBLEM
area	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
ruptured	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
or	CC	O
pseudoaneurysm	NN	B-PROBLEM
at	IN	O
the	DT	O
junction	NN	O
of	IN	O
the	DT	B-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
arch	NN	O
was	VBD	O
diagnosed	VBN	O
and	CC	O
this	DT	O
was	VBD	O
subsequently	RB	O
repaired	VBN	O
.	.	O

the	DT	O
patient	NN	O
then	RB	O
had	VBD	O
recurrent	VBN	B-PROBLEM
bleeding	VBG	I-PROBLEM
two	CD	O
weeks	NNS	O
later	RB	O
which	WDT	O
was	VBD	O
once	RB	O
again	RB	O
repaired	VBN	O
.	.	O

however	RB	O
the	DT	B-PROBLEM
same	JJ	I-PROBLEM
problem	NN	I-PROBLEM
recurred	VBD	O
for	IN	O
a	DT	O
third	JJ	O
time	NN	O
and	CC	O
a	DT	B-TEST
computer	NN	I-TEST
tomogram	NN	I-TEST
scan	NN	I-TEST
at	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
showed	VBD	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

by	IN	O
report	NN	O
the	DT	O
patient	NN	O
was	VBD	O
at	IN	O
that	DT	O
time	NN	O
told	VBD	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
more	JJR	O
that	DT	O
could	MD	O
be	VB	O
done	VBN	O
for	IN	O
him	PRP	O
and	CC	O
was	VBD	O
then	RB	O
apparently	RB	O
placed	VBN	O
on	IN	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
and	CC	O
pain	VB	B-TREATMENT
control	NN	I-TREATMENT
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

however	RB	O
the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
fairm	VB	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
upon	IN	O
request	NN	O
of	IN	O
the	DT	O
family	NN	O
on	IN	O
8/24/98	CD	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
and	CC	O
possible	JJ	O
intervention	NN	B-TREATMENT
.	.	O

as	IN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
early	JJ	I-TEST
evaluation	NN	I-TEST
the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
aortogram	NN	I-TEST
which	WDT	O
showed	VBD	O
an	DT	B-TREATMENT
ascending	VBG	I-TREATMENT
aortic	JJ	I-TREATMENT
graft	NN	I-TREATMENT
with	IN	O
bulging	VBG	B-PROBLEM
flaps	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
pseudoaneurysm	NN	I-PROBLEM
at	IN	O
the	DT	O
anastomosis	NN	O
of	IN	O
the	DT	B-TREATMENT
graft	NN	I-TREATMENT
and	CC	O
arch	NN	O
just	RB	O
below	IN	O
the	DT	O
great	JJ	O
vessels	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
for	IN	O
a	DT	B-PROBLEM
definite	JJ	I-PROBLEM
leak	NN	I-PROBLEM
but	CC	O
there	EX	O
was	VBD	O
evidence	NN	O
for	IN	O
gas	NN	B-PROBLEM
bubbles	NNS	I-PROBLEM
in	IN	O
the	DT	O
anterior	JJ	O
posterior	JJ	O
distal	JJ	O
ends	NNS	O
of	IN	O
the	DT	B-TREATMENT
grafts	NNS	I-TREATMENT
consistent	NN	O
with	IN	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
same	JJ	O
time	NN	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
who	WP	O
upon	IN	O
culturing	VBG	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
sternal	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
switched	VBD	O
the	DT	O
patient	NN	O
from	IN	O
intravenous	JJ	B-TREATMENT
unasyn	NNS	I-TREATMENT
to	TO	O
levofloxacin	VB	B-TREATMENT
for	IN	O
what	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
citrobacter	NN	B-PROBLEM
and	CC	O
diphtheroids	NNS	B-PROBLEM
in	IN	O
the	DT	B-TEST
wound	NN	I-TEST
cultures	NNS	I-TEST
.	.	O

subsequent	NN	O
to	TO	O
starting	VBG	O
this	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
wound	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
appeared	VBD	O
to	TO	O
subside	VB	O
.	.	O

given	VBN	O
all	PDT	O
the	DT	O
findings	NNS	O
on	IN	O
the	DT	B-TEST
aortogram	NN	I-TEST
and	CC	O
the	DT	B-TEST
subsequent	JJ	I-TEST
chest	NN	I-TEST
computer	NN	I-TEST
tomogram	NN	I-TEST
scan	VBD	I-TEST
it	PRP	O
was	VBD	O
discovered	VBN	O
that	IN	O
the	DT	O
patient	NN	O
's	POS	O
only	JJ	O
real	JJ	O
surgical	JJ	O
option	NN	O
for	IN	O
cure	NN	O
was	VBD	O
a	DT	B-TREATMENT
risky	JJ	I-TREATMENT
operation	NN	I-TREATMENT
that	WDT	O
involved	VBD	O
removal	NN	B-TREATMENT
and	CC	I-TREATMENT
replacement	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
aortic	JJ	I-TREATMENT
graft	NN	I-TREATMENT
probably	RB	O
with	IN	O
homograft	NN	B-TREATMENT
and	CC	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
antibiotic	JJ	I-TREATMENT
coverage	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
a	DT	B-TREATMENT
plastic	JJ	I-TREATMENT
surgical	JJ	I-TREATMENT
reconstructive	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
understood	VBD	O
the	DT	O
risks	NNS	O
and	CC	O
potential	JJ	O
benefits	NNS	O
of	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
was	VBD	O
willing	JJ	O
to	TO	O
proceed	VB	O
.	.	O

the	DT	O
patient	JJ	O
otherwise	NN	O
complained	VBD	O
of	IN	O
no	DT	O
angina	NN	B-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
no	DT	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
palpitations	NNS	B-PROBLEM
or	CC	O
symptoms	NNS	O
of	IN	O
syncope	NN	B-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
report	VB	O
a	DT	B-PROBLEM
20	CD	I-PROBLEM
lbs	JJ	I-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
several	JJ	O
months	NNS	O
.	.	O

1.	CD	O
thoracic	JJ	B-TREATMENT
aneurysm	RB	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
status	NN	O
post	NN	O
hernia	NN	B-TREATMENT
repair	NN	I-TREATMENT
.	.	O

1.	CD	O
lopressor	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

2.	CD	O
captopril	NN	B-TREATMENT
75	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
per	IN	O
day	NN	O
.	.	O

4.	CD	O
hydralazine	NN	B-TREATMENT
12.5	CD	O
mg	NN	O
four	CD	O
times	NNS	O
per	IN	O
day	NN	O
.	.	O

5.	CD	O
reglan	NN	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	JJ	I-TEST
exam	NN	I-TEST
:	:	O

there	EX	O
was	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

2+	CD	B-TEST
carotids	NNS	I-TEST
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
:	:	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
2/6	CD	I-PROBLEM
diastolic	JJ	I-PROBLEM
___	NN	O
and	CC	O
a	DT	B-PROBLEM
1/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

his	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
without	IN	O
any	DT	O
evidence	NN	O
for	IN	O
crackles	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
2+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
and	CC	O
1+	CD	B-TEST
pedal	NN	I-TEST
pulses	NNS	I-TEST
.	.	O

sodium	NN	B-TEST
137	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
16	CD	O
,	,	O
creatinine	NN	B-TEST
.9	NN	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
4.9	CD	O
,	,	O
hematocrit	NN	B-TEST
29.7	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
207	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
preoperative	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
bilateral	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
and	CC	O
bibasilar	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
sternal	JJ	I-PROBLEM
incision	NN	I-PROBLEM
had	VBD	O
a	DT	O
superior	JJ	O
edge	NN	O
that	WDT	O
was	VBD	O
dehisced	VBN	B-PROBLEM
with	IN	O
evidence	NN	O
for	IN	O
stay	NN	B-TREATMENT
sutures	NNS	I-TREATMENT
and	CC	O
some	DT	O
superficial	JJ	B-TREATMENT
closure	NN	I-TREATMENT
sutures	NNS	I-TREATMENT
exposed	VBN	O
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
hospital	NN	O
days	NNS	O
the	DT	O
patient	JJ	O
underwent	JJ	O
aortogram	NN	B-TEST
as	RB	O
well	RB	O
as	IN	O
chest	NN	B-TEST
computer	NN	I-TEST
tomogram	NN	I-TEST
as	IN	O
outlined	VBN	O
earlier	RBR	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
cardiology	NN	O
service	NN	O
who	WP	O
assisted	VBD	O
in	IN	O
managing	VBG	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
intermittent	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
seen	VBN	O
preoperatively	RB	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
plastic	JJ	O
surgical	JJ	O
service	NN	O
for	IN	O
potential	JJ	B-TREATMENT
sternal	JJ	I-TREATMENT
reconstruction	NN	I-TREATMENT
.	.	O

after	IN	O
lengthy	JJ	O
discussions	NNS	O
with	IN	O
the	DT	O
patient	NN	O
and	CC	O
the	DT	O
patient	NN	O
's	POS	O
family	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
various	JJ	O
consultant	NN	O
services	NNS	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
viable	JJ	O
candidate	NN	O
for	IN	O
aortic	JJ	B-TREATMENT
root	NN	I-TREATMENT
replacement	NN	I-TREATMENT
procedure	NN	I-TREATMENT
using	VBG	O
homograft	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
subsequently	RB	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
08/31/98	CD	O
with	IN	O
the	DT	O
preoperative	JJ	O
diagnosis	NN	O
of	IN	O
ascending	VBG	B-PROBLEM
aortic	JJ	I-PROBLEM
graft	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
performed	VBD	O
was	VBD	O
homograft	JJ	B-TREATMENT
replacement	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
ascending	VBG	I-TREATMENT
aorta	NN	I-TREATMENT
with	IN	O
omentopexy	NN	B-TREATMENT
and	CC	O
an	DT	B-PROBLEM
open	JJ	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
graft	NN	I-TREATMENT
used	VBN	O
was	VBD	O
a	DT	B-TREATMENT
homograft	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
fairly	RB	O
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
intubated	VBN	B-TREATMENT
to	TO	O
the	DT	O
cardiac	JJ	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
his	PRP$	B-PROBLEM
chest	NN	I-PROBLEM
open	JJ	I-PROBLEM
.	.	O

the	DT	O
immediate	JJ	O
postoperative	JJ	O
plans	NNS	O
were	VBD	O
for	IN	O
a	DT	O
short	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
and	CC	O
subsequent	JJ	B-TREATMENT
plastic	NN	I-TREATMENT
surgical	JJ	I-TREATMENT
reconstruction	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
sternum	NN	I-TREATMENT
.	.	O

of	IN	O
note	NN	O
,	,	O
intraoperatively	RB	B-TEST
multiple	JJ	I-TEST
tissue	NN	I-TEST
cultures	NNS	I-TEST
had	VBD	O
been	VBN	O
sent	VBN	O
.	.	O

in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
the	DT	O
patient	NN	O
was	VBD	O
kept	VBN	O
intubated	JJ	B-TREATMENT
and	CC	O
sedated	VBD	B-TREATMENT
until	IN	O
09/02/98	CD	O
which	WDT	O
was	VBD	O
postoperative	JJ	O
day	NN	O
no.	IN	O
1	CD	O
following	VBG	O
the	DT	B-TREATMENT
homograft	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

on	IN	O
that	DT	O
day	NN	O
the	DT	O
plastic	JJ	O
surgical	JJ	O
service	NN	O
performed	VBD	O
further	JJ	B-TREATMENT
sternal	JJ	I-TREATMENT
debridement	NN	I-TREATMENT
and	CC	O
subsequent	JJ	B-TREATMENT
reconstruction	NN	I-TREATMENT
using	VBG	O
bilateral	JJ	B-TREATMENT
pectoralis	NNS	I-TREATMENT
major	JJ	I-TREATMENT
myocutaneous	JJ	I-TREATMENT
advancement	NN	I-TREATMENT
flaps	NNS	I-TREATMENT
and	CC	O
right	JJ	B-TREATMENT
superiorly	RB	I-TREATMENT
rectus	VBP	I-TREATMENT
abdominis	RB	I-TREATMENT
flap	JJ	I-TREATMENT
to	TO	O
cover	VB	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
with	IN	O
subsequent	JJ	B-TREATMENT
primary	JJ	I-TREATMENT
closure	NN	I-TREATMENT
of	IN	O
that	DT	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

a	DT	O
number	NN	O
of	IN	O
indwelling	VBG	B-TREATMENT
closed	JJ	I-TREATMENT
suction	NN	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
left	VBN	O
in	IN	O
place	NN	O
so	RB	O
as	IN	O
to	TO	O
drain	VB	O
the	DT	O
bed	NN	O
underneath	IN	O
the	DT	O
muscle	NN	O
flaps	NNS	O
.	.	O

at	IN	O
this	DT	O
point	NN	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
followed	VBN	O
by	IN	O
infectious	JJ	O
disease	NN	O
service	NN	O
and	CC	O
continued	VBD	O
to	TO	O
be	VB	O
on	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
which	WDT	O
included	VBD	O
vancomycin	NN	B-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
operating	NN	I-TEST
room	NN	I-TEST
cultures	NNS	I-TEST
at	IN	O
that	DT	O
point	NN	O
were	VBD	O
positive	JJ	O
for	IN	O
crinobactermium	NN	B-PROBLEM
with	IN	O
sputum	NN	B-TEST
cultures	NNS	I-TEST
being	VBG	O
sensitive	JJ	O
for	IN	O
yeast	NN	B-PROBLEM
and	CC	O
gram	NN	B-PROBLEM
positive	JJ	I-PROBLEM
cocci	NN	I-PROBLEM
in	IN	I-PROBLEM
clusters	NNS	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
next	JJ	O
postoperative	JJ	O
day	NN	O
the	DT	O
patient	NN	O
was	VBD	O
awakened	VBN	O
and	CC	O
weaned	VBN	O
to	TO	O
extubate	VB	O
without	IN	O
significant	JJ	B-PROBLEM
difficulties	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
's	POS	O
subsequent	JJ	O
postoperative	JJ	O
course	NN	O
was	VBD	O
characterized	VBN	O
by	IN	O
persistent	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
which	WDT	O
required	VBD	O
a	DT	O
significant	JJ	O
amount	NN	O
of	IN	O
antihypertensives	NNS	B-TREATMENT
including	VBG	O
lopressor	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
captopril	VBP	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
procardia	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
otherwise	RB	O
continued	VBN	O
to	TO	O
do	VB	O
well	RB	O
and	CC	O
was	VBD	O
becoming	VBG	O
more	RB	O
oriented	VBN	O
as	IN	O
time	NN	O
went	VBD	O
on	IN	O
and	CC	O
as	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
brought	VBN	O
under	IN	O
control	NN	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
who	WP	O
felt	VBD	O
that	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
jackson	NN	I-TREATMENT
pratt	NN	I-TREATMENT
drains	VBZ	I-TREATMENT
needed	VBN	O
to	TO	O
stay	VB	O
in	IN	O
as	IN	O
there	EX	O
was	VBD	O
still	RB	O
some	DT	B-PROBLEM
significant	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
them	PRP	O
.	.	O

as	IN	O
per	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
as	IN	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

however	RB	O
on	IN	O
09/08/98	CD	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
was	VBD	O
made	VBN	O
aware	JJ	O
that	IN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
intraoperative	JJ	I-TEST
cultures	NNS	I-TEST
had	VBD	O
also	RB	O
grown	VBN	O
out	RP	O
mycoplasma	JJ	B-PROBLEM
humilius	NN	I-PROBLEM
.	.	O

given	VBN	O
this	DT	O
finding	VBG	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
would	MD	O
certainly	RB	O
need	VB	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
to	TO	O
include	VB	O
at	IN	O
least	JJS	O
six	CD	O
weeks	NNS	O
of	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
then	RB	O
subsequent	JJ	B-TREATMENT
levofloxacin	NN	I-TREATMENT
for	IN	O
the	DT	B-PROBLEM
citrobacter	NN	I-PROBLEM
and	CC	O
mycoplasma	NN	B-PROBLEM
as	RB	O
well	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
scheduled	VBN	O
for	IN	O
peripherally	RB	B-TREATMENT
inserted	JJ	I-TREATMENT
central	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT
knowing	NN	O
that	IN	O
he	PRP	O
was	VBD	O
going	VBG	O
to	TO	O
need	VB	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
placed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
no.	NN	O
9	CD	O
without	IN	O
any	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
same	JJ	O
time	NN	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
be	VB	O
stable	JJ	O
on	IN	O
his	PRP$	B-TREATMENT
antihypertensive	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
becoming	VBG	O
more	JJR	O
mobile	JJ	O
and	CC	O
was	VBD	O
taking	VBG	O
a	DT	B-TREATMENT
high	JJ	I-TREATMENT
protein	NN	I-TREATMENT
high	JJ	I-TREATMENT
calories	NNS	I-TREATMENT
diet	VBP	I-TREATMENT
which	WDT	O
he	PRP	O
tolerated	VBD	O
well	RB	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
be	VB	O
afebrile	JJ	B-PROBLEM
and	CC	O
otherwise	RB	O
very	RB	O
stable	JJ	O
.	.	O

subsequent	JJ	B-TEST
hand	NN	I-TEST
x-rays	NNS	I-TEST
obtained	VBD	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
but	CC	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
plastic	NN	O
surgery	NN	O
hand	NN	O
service	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
benefit	VB	O
from	IN	O
splinting	VBG	B-TREATMENT
of	IN	I-TREATMENT
his	PRP$	I-TREATMENT
finger	NN	I-TREATMENT
while	IN	O
the	DT	B-PROBLEM
swelling	VBG	I-PROBLEM
subsided	VBD	O
and	CC	O
subsequent	JJ	B-TREATMENT
early	JJ	I-TREATMENT
mobilization	NN	I-TREATMENT
to	TO	O
prevent	VB	O
any	DT	B-PROBLEM
rigidity	NN	I-PROBLEM
in	IN	I-PROBLEM
that	DT	I-PROBLEM
joint	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
seen	VBN	O
subsequently	RB	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
plastic	JJ	O
surgical	JJ	O
service	NN	O
who	WP	O
discontinued	VBD	O
a	DT	O
number	NN	O
of	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
indwelling	NN	I-TREATMENT
drains	NNS	I-TREATMENT
but	CC	O
they	PRP	O
felt	VBD	O
that	IN	O
others	NNS	O
needed	VBN	O
to	TO	O
stay	VB	O
while	IN	O
the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
rehabilitation	NN	O
.	.	O

these	DT	B-TREATMENT
drains	NNS	I-TREATMENT
will	MD	O
then	RB	O
be	VB	O
subsequently	RB	O
taken	VBN	O
out	RP	O
by	IN	O
dr.	JJ	O
general	JJ	O
upon	IN	O
his	PRP$	O
followup	NN	O
with	IN	O
the	DT	O
patient	NN	O
.	.	O

prior	RB	O
to	TO	O
discharge	VB	O
the	DT	O
patient	NN	O
also	RB	O
underwent	VBD	O
an	DT	B-TEST
audiogram	NN	I-TEST
as	IN	O
a	DT	B-TEST
baseline	NN	I-TEST
hearing	VBG	I-TEST
test	NN	I-TEST
while	IN	O
the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
stay	VB	O
on	IN	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

as	IN	O
a	DT	O
matter	NN	O
of	IN	O
fact	NN	O
the	DT	O
patient	NN	O
made	VBD	O
remarkable	JJ	O
progress	NN	O
given	VBN	O
the	DT	O
severity	NN	O
of	IN	O
his	PRP$	B-PROBLEM
disease	NN	I-PROBLEM
condition	NN	I-PROBLEM
prior	RB	O
to	TO	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
.	.	O

in	IN	O
consultation	NN	O
with	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
stay	VB	O
on	IN	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

high	JJ	B-TREATMENT
calorie	NN	I-TREATMENT
,	,	I-TREATMENT
high	JJ	I-TREATMENT
protein	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
treatment	NN	I-TREATMENT
will	MD	O
include	VB	O
typical	JJ	B-TREATMENT
peripherally	RB	I-TREATMENT
inserted	JJ	I-TREATMENT
central	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
line	NN	I-TREATMENT
care	NN	I-TREATMENT
with	IN	O
frequent	JJ	B-TEST
wound	NN	I-TEST
checks	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
was	VBD	O
fitted	VBN	O
with	IN	O
an	DT	B-TREATMENT
orthoplast	JJ	I-TREATMENT
finger	NN	I-TREATMENT
splint	NN	I-TREATMENT
as	IN	O
manufactured	VBN	O
by	IN	O
occupational	JJ	O
therapy	NN	O
services	NNS	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
instructed	VBN	O
in	IN	O
range	NN	B-TREATMENT
of	IN	I-TREATMENT
motion	NN	I-TREATMENT
exercises	NNS	I-TREATMENT
for	IN	O
the	DT	O
left	NN	O
middle	JJ	O
finger	NN	O
.	.	O

the	DT	O
patient	NN	O
on	IN	O
discharge	NN	O
is	VBZ	O
to	TO	O
have	VB	O
twice	RB	O
weekly	JJ	O
vancomycin	NN	B-TEST
peak	NN	I-TEST
and	CC	I-TEST
trough	NN	I-TEST
levels	NNS	I-TEST
while	IN	O
he	PRP	O
continues	VBZ	O
on	IN	O
long	JJ	B-TREATMENT
term	NN	I-TREATMENT
vancomycin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
return	VB	O
to	TO	O
fairm	VB	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
if	IN	O
he	PRP	O
developed	VBD	O
any	DT	O
signs	NNS	O
of	IN	O
wound	JJ	B-PROBLEM
infection	NN	I-PROBLEM
such	PDT	O
a	DT	B-PROBLEM
erythema	NN	I-PROBLEM
,	,	O
drainage	NN	B-PROBLEM
,	,	O
or	CC	O
increasing	VBG	B-PROBLEM
incisional	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
be	VB	O
vigilant	JJ	O
for	IN	O
any	DT	B-PROBLEM
fevers	NNS	I-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

1.	CD	O
vancomycin	JJ	B-TREATMENT
750	CD	O
mg	RB	O
intravenous	JJ	O
q	NNS	O
18h.	CD	O

2.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
per	IN	O
day	NN	O
.	.	O

3.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
per	IN	O
day	NN	O
.	.	O

4.	CD	O
captopril	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
lopressor	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

6.	CD	O
albuterol	NN	B-TREATMENT
nebulizers	NNS	I-TREATMENT
q6h	VBP	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
atrovent	JJ	B-TREATMENT
nebulizers	NNS	I-TREATMENT
q6h	VBP	O
as	IN	O
needed	VBN	O
.	.	O

8.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
per	IN	O
day	NN	O
.	.	O

9.	CD	O
kay-ciel	JJ	B-TREATMENT
20	CD	O
meq	NN	O
po	NN	O
per	IN	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
instructed	VBN	O
to	TO	O
followup	VB	O
with	IN	O
dr.	JJ	O
both	DT	O
of	IN	O
the	DT	O
cardiology	NN	O
service	NN	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
following	VBG	O
his	PRP$	O
discharge	NN	O
so	IN	O
that	IN	O
his	PRP$	B-TREATMENT
antihypertension	NN	I-TREATMENT
medications	NNS	I-TREATMENT
could	MD	O
be	VB	O
appropriately	RB	O
adjusted	VBN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
also	RB	O
be	VB	O
seen	VBN	O
in	IN	O
followup	NN	O
by	IN	O
dr.	NN	O
chpo	NN	O
e.	NN	O
enla	VBZ	O
general	JJ	O
of	IN	O
the	DT	O
plastic	NN	O
surgery	NN	O
service	NN	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
so	IN	O
that	IN	O
his	PRP$	B-TREATMENT
indwelling	VBG	I-TREATMENT
jackson	NN	I-TREATMENT
pratt	NN	I-TREATMENT
drains	VBZ	I-TREATMENT
be	VB	O
appropriately	JJ	O
management	NN	O
and	CC	O
if	IN	O
needed	VBN	O
be	VB	O
discontinued	VBN	O
by	IN	O
him	PRP	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
also	RB	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
so	RB	O
as	IN	O
to	TO	O
ascertain	VB	O
the	DT	O
exact	JJ	O
length	NN	O
and	CC	O
course	NN	O
of	IN	O
his	PRP$	B-TREATMENT
antibiotic	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

dr.	NN	O
dau	NN	O
's	POS	O
recommendation	NN	O
is	VBZ	O
that	IN	O
the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
stay	VB	O
on	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT
for	IN	O
approximately	RB	O
six	CD	O
weeks	NNS	O
following	VBG	O
discharge	NN	O
and	CC	O
then	RB	O
subsequently	RB	O
on	IN	O
antibiotic	JJ	B-TREATMENT
regimen	NNS	I-TREATMENT
for	IN	O
chronic	JJ	B-TREATMENT
suppression	NN	I-TREATMENT
.	.	O

medicine	NN	B-TREATMENT

zosyn	NN	B-TREATMENT

transfer	NN	O
from	IN	O
tewksbury	NN	O
state	NN	O
hospital	NN	O
hospital	NN	O
cmed	VBD	O
ccu	NN	O
for	IN	O
neurologic	JJ	B-PROBLEM
compromise	NN	I-PROBLEM
,	,	O
at	IN	O
request	NN	O
of	IN	O
family	NN	O
for	IN	O
second	JJ	O
opinion	NN	O
.	.	O

30-year-old	JJ	O
woman	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	O
unknown	JJ	O
primary	NN	O
.	.	O

at	IN	O
chelseawomens	NNS	O
'	POS	O
,	,	O
about	IN	O
04-25	NN	O
,	,	O
she	PRP	O
developed	VBD	O
pseudomonal	JJ	B-PROBLEM
urosepsis	NN	I-PROBLEM
and	CC	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
from	IN	O
tumor	NN	B-PROBLEM
extension/anti-coagulation	NN	I-PROBLEM
.	.	O

her	PRP$	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
post-hypotensive	JJ	B-PROBLEM
coma	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
subarachnoid	JJ	B-PROBLEM
hemorrhages	NNS	I-PROBLEM
and	CC	O
intraparenchymal	JJ	B-PROBLEM
bleeds	NNS	I-PROBLEM
.	.	O

patient	NN	O
transferred	VBD	O
from	IN	O
women	NNS	O
and	CC	O
infants	NNS	O
hospital	NN	O
to	TO	O
ri	VB	O
hospital	JJ	O
2016-04-25	JJ	O
with	IN	O
weaknes	NNS	B-PROBLEM
,	,	O
vag	NN	B-PROBLEM
bleeding	VBG	I-PROBLEM
x	JJ	O
several	JJ	O
days	NNS	O
,	,	O
fever	RB	B-PROBLEM
102.5	CD	O
,	,	O
hypotension	NN	B-PROBLEM
,	,	O
hypoxic	VBZ	B-PROBLEM
84%	CD	O
on	IN	O
4l	CD	B-TREATMENT
nc	NNS	I-TREATMENT
,	,	O
tachypnic	JJ	B-PROBLEM
to	TO	O
30	CD	O
,	,	O
with	IN	O
labs	JJ	B-TEST
significant	JJ	O
for	IN	O
lactate	JJ	B-TEST
6.3	CD	O
,	,	O
wbc	NN	B-TEST
<1.0	NN	O
,	,	O
plt	NN	B-TEST
9	CD	O
,	,	O
hgb	NN	B-TEST
8.9	CD	O
,	,	O
and	CC	O
inr	RB	B-TEST
greater	JJR	O
than	IN	O
lab	JJR	O
threshold	NN	O
.	.	O

intubated	VBN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
(	(	O
abg	JJ	B-TEST
7.39/26.5/73.6	CD	O
)	)	O
and	CC	O
placed	VBN	O
on	IN	O
levophed	NNS	B-TREATMENT
.	.	O

placed	VBN	O
on	IN	O
reynolds/vanc/fluc/gentamicin	NN	B-TREATMENT
for	IN	O
neutropenic	JJ	B-PROBLEM
fever	NN	I-PROBLEM
and	CC	O
thrush	NN	B-PROBLEM
initially	RB	O
.	.	O

ivc	JJ	B-TREATMENT
filter	NN	I-TREATMENT
placed	VBD	O
04-26	CD	O
.	.	O

ct	JJ	B-TEST
abdomen	NNS	I-TEST
consistent	JJ	O
with	IN	O
large	JJ	B-PROBLEM
necrotic	JJ	I-PROBLEM
pelvic	NN	I-PROBLEM
mass	NN	I-PROBLEM
-	:	O
not	RB	O
sampled	VBN	O
02-12	NN	O
coagulopathy	NN	B-PROBLEM
.	.	O

04-27	JJ	O
results	NNS	O
from	IN	O
blood	NN	B-TEST
cx	NN	I-TEST
from	IN	O
w+i	NN	O
:	:	O

04-24	JJ	O
picc	NN	B-TEST
bld	NN	I-TEST
cx	NN	I-TEST
:	:	O
pseudomonas	NN	B-PROBLEM
diaz	NN	O
to	TO	O
zosyn	VB	B-TREATMENT
,	,	O
cipro	VB	B-TREATMENT
,	,	O
cefepime	NN	B-TREATMENT
,	,	O
tardugno	NN	O
--	:	O
staph	JJ	B-PROBLEM
epi-	JJ	I-PROBLEM
gray	NN	O
to	TO	O
vanc	VB	B-TREATMENT

04-24	JJ	O
peripheral	JJ	B-TEST
bld	NN	I-TEST
cx	NN	I-TEST
:	:	O
pseudomonas	NN	B-PROBLEM
as	IN	O
above	IN	O

04-24	JJ	O
urine	JJ	B-TEST
cx	NN	I-TEST
:	:	O
pseudomonas	NN	B-PROBLEM
as	IN	O
above	IN	O

abx	RB	B-TREATMENT
changed	VBN	O
to	TO	O
vanc	VB	B-TREATMENT
,	,	O
zosyn	NN	B-TREATMENT
,	,	O
cipro	NN	B-TREATMENT
,	,	O
fluc	NN	B-TREATMENT
,	,	O
azith	NN	B-TREATMENT
.	.	O

pressors	NNS	B-TREATMENT
weaned	VBD	O
off	RP	O
by	IN	O
04-27	NN	O
.	.	O

completed	VBN	O
7	CD	O
days	NNS	O
of	IN	O
vanc/fluc	NN	B-TREATMENT
,	,	O
13/14	CD	O
days	NNS	O
of	IN	O
cipro/zosyn	NN	B-TREATMENT
.	.	O

continued	VBN	O
to	TO	O
have	VB	O
recurrent	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
.	.	O

seen	VBN	O
by	IN	O
urology	NN	O
who	WP	O
did	VBD	O
not	RB	O
change	VB	O
stents	NNS	B-TREATMENT
given	VBN	O
severe	JJ	B-PROBLEM
coagulopathy	NN	I-PROBLEM
and	CC	O
worsening	VBG	B-PROBLEM
renal	JJ	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

found	VBN	O
to	TO	O
be	VB	O
in	IN	O
dic	JJ	B-PROBLEM
and	CC	O
supported	VBD	O
with	IN	O
daily	JJ	B-TREATMENT
blood	NN	I-TREATMENT
products	NNS	I-TREATMENT
.	.	O

seen	VBN	O
by	IN	O
heme	NN	O
and	CC	O
gcsf	NN	B-TREATMENT
started	VBD	O
.	.	O

despite	IN	O
aggressive	JJ	B-TREATMENT
blood	NN	I-TREATMENT
product	NN	I-TREATMENT
repletion	NN	I-TREATMENT
patient	JJ	O
poorly	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
02-12	JJ	O
alloimmunization	NN	B-PROBLEM
.	.	O

plt	NN	B-TEST
count	NN	I-TEST
1	CD	O
on	IN	O
2016-04-29	JJ	O
.	.	O

supported	VBN	O
on	IN	O
tpn	NN	B-TREATMENT
for	IN	O
nutrition	NN	O
then	RB	O
switched	VBD	O
to	TO	O
tube	VB	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

developed	VBN	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
cr	JJ	B-TEST
peak	NN	I-TEST
of	IN	O
2.9.	CD	O

seen	VBN	O
by	IN	O
renal	NN	O
who	WP	O
felt	VBD	O
was	VBD	O
c/w	JJ	O
atn	NN	B-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
done	VBN	O
05-04	JJ	O
with	IN	O
bilateral	JJ	B-PROBLEM
sah	NN	I-PROBLEM
and	CC	O
l	JJ	B-PROBLEM
temporal	JJ	I-PROBLEM
parenchymal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

also	RB	O
with	IN	O
multiple	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
metastasis	NN	B-PROBLEM
.	.	O

placed	VBN	O
on	IN	O
dilantin	NN	B-TREATMENT
.	.	O

felt	RB	O
secondary	JJ	O
to	TO	O
low	JJ	B-PROBLEM
platelets	NNS	I-PROBLEM
with	IN	O
no	DT	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
indicated	VBD	O
.	.	O

then	RB	O
progressed	VBN	O
to	TO	O
withdrawal	VB	O
of	IN	O
care	NN	O
05-06	JJ	O
with	IN	O
plan	NN	O
to	TO	O
extubate	VB	B-TREATMENT
05-07	NN	O
.	.	O

however	RB	O
there	EX	O
was	VBD	O
dissent	NN	O
among	IN	O
neurologists	NNS	O
about	IN	O
patient	NN	O
's	POS	O
ability	NN	O
to	TO	O
recover	VB	O
from	IN	O
the	DT	B-PROBLEM
sah	NN	I-PROBLEM
while	IN	O
awaiting	VBG	O
family	NN	O
members	NNS	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
changed	VBN	O
to	TO	O
full	JJ	O
code	NN	O
.	.	O

given	VBN	O
48	CD	O
hours	NNS	O
off	IN	O
sedation	NN	B-TREATMENT
with	IN	O
out	RP	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
(	(	O
last	JJ	O
morphine	NN	B-TREATMENT
was	VBD	O
2016-05-07	JJ	O
)	)	O
.	.	O

on	IN	O
arrival	NN	O
to	TO	O
the	DT	O
ficu	NN	O
the	DT	O
patient	NN	O
was	VBD	O
intubated	VBN	B-TREATMENT
and	CC	O
non-sedated	JJ	O
.	.	O

-	:	O
retroperitoneal	NN	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	O
unknown	JJ	O
primary	NN	O
,	,	O
dx	NN	O

12-15	JJ	O
,	,	O
s/p	JJ	O
xrt	NNP	B-TREATMENT
(	(	O
last	JJ	O
tx	IN	O
2015-04-20	JJ	O
)	)	O
,	,	O
s/p	JJ	O
cisplatin	NN	B-TREATMENT
(	(	O
last	JJ	O
dose	RB	O
3/22	CD	O
)	)	O

-	:	O
l	NN	B-PROBLEM
hydroureter	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
,	,	O
s/p	NN	O
r	NN	B-TREATMENT
ureteral	JJ	I-TREATMENT
stent	NN	I-TREATMENT
2016-03-24	JJ	O

-	:	O
h/o	NN	O
lle	VBZ	B-PROBLEM
dvt	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT

-	:	O
laser	NN	B-TREATMENT
conization	NN	I-TREATMENT
of	IN	I-TREATMENT
cervix	NN	I-TREATMENT
2004	CD	O

vs	SYM	B-TEST
-	:	O
tm	NN	B-TEST
101.7	CD	O

tc	RB	B-TEST
99.7	CD	O
p	JJ	B-TEST
123	CD	O
bp	NN	B-TEST
137/75	CD	O

resp	LS	O
-	:	O
pcv	NN	B-TEST
pinsp	NN	I-TEST
26	CD	O
r	NN	B-TEST
16	CD	O
fio2	JJ	B-TEST
50%	CD	O
rate	NN	B-TEST
8	CD	O
,	,	O
breathing	VBG	B-TEST
20	CD	O
,	,	O
sat	VBD	B-TEST
100%	CD	O

gen	NN	O
-	:	O
lying	NN	O
in	IN	O
bed	NN	O
unresponsive	JJ	B-PROBLEM

chest	JJS	O
-	:	O
diffuse	NN	B-PROBLEM
ronchi	NN	I-PROBLEM

abd	SYM	O
-	:	O
mass	NN	B-PROBLEM
in	IN	I-PROBLEM
llq	NN	I-PROBLEM
,	,	O
nephrostomy	NN	B-TREATMENT
with	IN	O
yellow	JJ	O
clear	JJ	O
output	NN	O

ext	JJ	O
-	:	O
diffuse	NN	B-PROBLEM
anasarca	NN	I-PROBLEM
x	VBD	O
4	CD	O
ext	NN	O

neuro	SYM	O
-	:	O
perrl	NN	O
,	,	O
corneal	NN	O
reflex	NN	O
,	,	O
gag	NN	O
reflex	NN	O
,	,	O
dolls	VBZ	B-PROBLEM
eyes	NNS	I-PROBLEM
,	,	O
spont	JJ	O
mvt	NN	O
of	IN	O
head	NN	O
with	IN	O
out	RP	O
purpose	JJ	O
side	NN	O
to	TO	O
side	VB	O

pt	SYM	B-TEST
-	:	O
14.6*	CD	O
ptt	NN	B-TEST
-	:	O
29.1	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	NN	I-TEST
)	)	I-TEST
-	:	O
1.3*	CD	O

plt	NN	B-TEST
smr	SYM	I-TEST
-	:	O
low	JJ	B-PROBLEM
plt	NN	I-PROBLEM
count	NN	I-PROBLEM
-	:	O
86*	CD	O

wbc	SYM	B-TEST
-	:	O
3.7*	CD	O
rbc	NN	B-TEST
-	:	O
2.78*	CD	O
hgb	NN	B-TEST
-	:	O
8.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
25.8*	CD	O
mcv	SYM	B-TEST
-	:	O
93	CD	O

mch	SYM	B-TEST
-	:	O
31.1	CD	O
mchc	SYM	B-TEST
-	:	O
33.5	CD	O
rdw	NN	B-TEST
-	:	O
14.9	CD	O

calcium	NN	B-TEST
-	:	O
7.1*	CD	O
phosphate	NN	B-TEST
-	:	O
5.1*	CD	O
magnesium	NN	B-TEST
-	:	O
1.7	CD	O

alt	NN	B-TEST
(	(	I-TEST
sgpt	NN	I-TEST
)	)	I-TEST
-	:	O
23	CD	O
ast	NN	B-TEST
(	(	I-TEST
sgot	NN	I-TEST
)	)	I-TEST
-	:	O
19	CD	O
alk	NN	B-TEST
phos	NN	I-TEST
-	:	O
101	CD	O

estgfr	SYM	B-TEST
-	:	O
using	VBG	O
this	DT	O

glucose	JJ	B-TEST
-	:	O
96	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
113*	CD	O
creat	NN	B-TEST
-	:	O
2.3*	CD	O
sodium	NN	B-TEST
-	:	O
150*	CD	O

potassium	NN	B-TEST
-	:	O
3.9	CD	O
chloride	NN	B-TEST
-	:	O
110*	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
28	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
16	CD	O

2016-05-15	JJ	O
06:02am	CD	O
blood	NN	B-TEST

wbc	SYM	B-TEST
-	:	O
9.5	CD	O
rbc	NN	B-TEST
-	:	O
2.78*	CD	O
hgb	NN	B-TEST
-	:	O
8.8*	CD	O
hct	NN	B-TEST
-	:	O
25.7*	CD	O

mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
31.7	CD	O
mchc	SYM	B-TEST
-	:	O
34.2	CD	O
rdw	NN	B-TEST
-	:	O
14.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
26*	CD	O

2016-05-11	JJ	O
04:30am	CD	O
blood	NN	B-TEST

neuts	NNS	B-TEST
-	:	O
80.4*	CD	O
bands	NNS	B-TEST
-	:	O
9.3*	CD	O
lymphs	SYM	B-TEST
-	:	O
4.1*	CD	O

monos	SYM	B-TEST
-	:	O
3.1	CD	O
eos	SYM	B-TEST
-	:	O
1.0	CD	O
baso	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
1.0*	CD	O
metas	NNS	B-TEST
-	:	O
1.0*	CD	O

2016-05-15	JJ	O
06:02am	CD	O
blood	NN	B-TEST

fibrino	NN	B-TEST
-	:	O
406*	CD	O

2016-05-15	JJ	O
06:02am	CD	O
blood	NN	B-TEST

glucose	JJ	B-TEST
-	:	O
120*	CD	O
urean	JJ	B-TEST
-	:	O
79*	CD	O
creat	NN	B-TEST
-	:	O
1.8*	CD	O
na	SYM	B-TEST
-	:	O
144	CD	O

k	SYM	B-TEST
-	:	O
3.6	CD	O
cl	NN	B-TEST
-	:	O
110*	CD	O
hco3	NN	B-TEST
-	:	O
23	CD	O
angap	NN	B-TEST
-	:	O
15	CD	O

2016-05-11	JJ	O
04:30am	CD	O
blood	NN	B-TEST

alt	SYM	B-TEST
-	:	O
19	CD	O
ast	IN	B-TEST
-	:	O
18	CD	O
ld	NN	B-TEST
(	(	I-TEST
ldh	NN	I-TEST
)	)	I-TEST
-	:	O
313*	CD	O
alkphos	SYM	B-TEST
-	:	O
104	CD	O

amylase	NN	B-TEST
-	:	O
37	CD	O
totbili	SYM	B-TEST
-	:	O
0.8	CD	O

calcium	NN	B-TEST
-	:	O
7.4*	CD	O
phos	NN	B-TEST
-	:	O
3.6	CD	O
mg	SYM	B-TEST
-	:	O
2.2	CD	O

2016-05-11	JJ	O
04:30am	CD	O
blood	NN	B-TEST

albumin	SYM	B-TEST
-	:	O
2.3	CD	O

2016-05-13	JJ	O
08:32am	CD	O
blood	NN	B-TEST

type	NN	O
-	:	O
art	NN	B-TEST
temp	SYM	I-TEST
-	:	O
38.2	CD	O
tidal	JJ	B-TEST
v	NN	I-TEST
-	:	O
500	CD	O
peep	JJ	B-TEST
-	:	O
5	CD	O

fio2	SYM	B-TEST
-	:	O
40	CD	O
po2	NN	B-TEST
-	:	O
104	CD	O
pco2	NN	B-TEST
-	:	O
50*	CD	O
ph	NN	B-TEST
-	:	O
7.36	CD	O
caltco2	NN	B-TEST
-	:	O
29	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
1	CD	O

-assist/con	NN	O
intubat	NN	O
-	:	O
intubated	VBN	B-TREATMENT

2016-05-11	JJ	O
02:08am	CD	O
blood	NN	B-TEST

lactate	NN	B-TEST
-	:	O
1.6	CD	O

2016-05-11	JJ	O
mri	NN	B-TEST
head:	NN	I-TEST

the	DT	B-TEST
sagittal	JJ	I-TEST
t1	NN	I-TEST
images	NNS	I-TEST
demonstrate	VBP	O
several	JJ	O
areas	NNS	O
of	IN	O
high	JJ	B-PROBLEM
signal	NN	I-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
sulci	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
secondary	JJ	O
to	TO	O
subarachnoid	VB	B-PROBLEM
hemorrhages	NNS	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
several	JJ	O
areas	NNS	O
of	IN	O
hyperintensities	NNS	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
convexity	NN	I-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
intraaxial	JJ	O
and	CC	O
could	MD	O
be	VB	O
related	VBN	O
to	TO	O
hemorrhage	VB	B-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
metastatic	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
but	CC	O
in	IN	O
absence	NN	O
of	IN	O
gradient	NN	B-TEST
echo	NN	I-TEST
images	NNS	I-TEST
,	,	O
this	DT	O
could	MD	O
not	RB	O
be	VB	O
further	RB	O
confirmed	VBN	O
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
would	MD	O
help	VB	O
for	IN	O
further	JJ	O
assessment	NN	O
if	IN	O
indicated	VBN	O
.	.	O

there	EX	O
is	VBZ	O
increased	JJ	B-PROBLEM
signal	NN	I-PROBLEM
seen	VBN	O
in	IN	O
both	DT	O
basal	NN	O
ganglia	JJ	O
region	NN	O
as	RB	O
well	RB	O
as	IN	O
along	IN	O
the	DT	O
rolandic	JJ	O
region	NN	O
bilaterally	RB	O
which	WDT	O
is	VBZ	O
suggestive	JJ	O
of	IN	O
global	JJ	B-PROBLEM
hypoxic	JJ	I-PROBLEM
injury	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
brain	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
several	JJ	O
areas	NNS	O
of	IN	O
brain	NN	B-PROBLEM
edema	NN	I-PROBLEM
identified	VBN	O
in	IN	O
the	DT	O
left	JJ	O
frontal	NN	O
and	CC	O
parietal	JJ	O
lobe	NN	O
and	CC	O
both	DT	O
temporal	JJ	O
lobes	NN	O
,	,	O
which	WDT	O
are	VBP	O
suspicious	JJ	O
for	IN	O
areas	NNS	B-PROBLEM
of	IN	I-PROBLEM
metastatic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
surrounding	VBG	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
hydrocephalus	NN	B-PROBLEM
or	CC	O
midline	NN	B-PROBLEM
shift	NN	I-PROBLEM
seen	VBN	O
.	.	O

no	DT	O
herniation	NN	B-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

images	NNS	B-TEST
through	IN	I-TEST
the	DT	I-TEST
skull	JJ	I-TEST
base	NN	I-TEST
demonstrate	NN	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
changes	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
sphenoid	NN	I-PROBLEM
sinus	NN	I-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
retained	JJ	B-PROBLEM
secretions	NNS	I-PROBLEM
from	IN	O
intubation	NN	B-TREATMENT
.	.	O

there	EX	O
is	VBZ	O
increased	JJ	B-PROBLEM
signal	NN	I-PROBLEM
seen	VBN	O
along	IN	O
the	DT	O
sulci	NN	O
on	IN	O
flair	NN	B-TEST
images	NNS	I-TEST
at	IN	O
the	DT	O
convexity	NN	O
which	WDT	O
could	MD	O
be	VB	O
secondary	JJ	O
to	TO	O
subarachnoid	VB	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
would	MD	O
help	VB	O
for	IN	O
further	JJ	O
assessment	NN	O
and	CC	O
exclude	VBP	O
proteinaceous	JJ	B-PROBLEM
material	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
sulci	NN	I-PROBLEM
.	.	O

gadolinium-enhanced	JJ	B-TEST
mri	NN	I-TEST
would	MD	O
also	RB	O
help	VB	O
for	IN	O
further	JJ	O
assessment	NN	O
.	.	O

pcxr	JJ	B-TEST
2016-05-11	CD	O
5:01am:	CD	O

tip	NN	O
of	IN	O
the	DT	B-TREATMENT
ett	JJ	I-TREATMENT
projects	NNS	O
roughly	RB	O
5	CD	O
cm	NNS	O
above	IN	O
the	DT	O
carina	NN	O
.	.	O

a	DT	B-TREATMENT
right	JJ	I-TREATMENT
ij	JJ	I-TREATMENT
central	JJ	I-TREATMENT
venous	JJ	I-TREATMENT
line	NN	I-TREATMENT
is	VBZ	O
at	IN	O
the	DT	O
level	NN	O
of	IN	O
the	DT	O
mid	NN	O
svc	NN	O
.	.	O

tip	NN	O
of	IN	O
the	DT	B-TREATMENT
ngt	NN	I-TREATMENT
is	VBZ	O
below	IN	O
the	DT	O
edge	NN	O
of	IN	O
the	DT	O
image	NN	O
.	.	O

ivc	NN	B-TREATMENT
filter	NN	I-TREATMENT
and	CC	O
probable	JJ	O
nu	JJ	B-TREATMENT
stent	NN	I-TREATMENT
catheter	NN	I-TREATMENT
on	IN	I-TREATMENT
the	DT	I-TREATMENT
left	NN	I-TREATMENT
also	RB	O
noted	VBD	O
.	.	O

heart	NN	O
and	CC	O
mediastinum	NN	O
are	VBP	O
unremarkable	JJ	O
allowing	VBG	O
for	IN	O
technique	NN	O
,	,	O
no	DT	O
sizeable	JJ	B-PROBLEM
pneumothorax	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
somewhat	RB	I-PROBLEM
wedge-shaped	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
which	WDT	O
could	MD	O
represent	VB	O
aspiration	NN	B-PROBLEM
or	CC	O
pneumonia	NN	B-PROBLEM
.	.	O

no	DT	O
other	JJ	B-PROBLEM
confluent	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
are	VBP	O
appreciated	VBN	O

pcxr	JJ	B-TEST
2016-05-11.	CD	O
1:46pm:	CD	O

1.	CD	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

2.	CD	O
vague	JJ	B-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
opacity	NN	I-PROBLEM
most	RBS	O
likely	JJ	O
represents	VBZ	O
pulmonary	JJ	B-PROBLEM
edema	NNS	I-PROBLEM
though	IN	O
if	IN	O
opacity	NN	B-PROBLEM
persistent	NN	O
after	IN	O
diuresis	NN	B-TREATMENT
,	,	O
aspiration	NN	B-PROBLEM
and	CC	O
pneumonia	NN	B-PROBLEM
will	MD	O
become	VB	O
considerations	NNS	O
.	.	O

3.	CD	O
ett	JJ	B-TREATMENT
4	CD	O
cm	NN	O
above	IN	O
the	DT	O
carina	NN	O
with	IN	O
ng	JJ	B-TREATMENT
tube	NN	I-TREATMENT
advancement	NN	O
into	IN	O
the	DT	O
stomach	NN	O
.	.	O

eeg	JJ	B-TEST
2016-05-12:	JJ	O

abnormal	JJ	B-PROBLEM
portable	JJ	I-PROBLEM
eeg	NN	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
slow	JJ	I-PROBLEM
and	CC	I-PROBLEM
disorganized	VBN	I-PROBLEM
background	NN	I-PROBLEM
and	CC	O
bursts	NNS	B-PROBLEM
of	IN	I-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
.	.	O

these	DT	O
findings	NNS	O
indicate	VBP	O
a	DT	B-PROBLEM
widespread	JJ	I-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
,	,	O
metabolic	JJ	B-PROBLEM
disturbances	NNS	I-PROBLEM
,	,	O
and	CC	O
infection	NN	B-PROBLEM
are	VBP	O
among	IN	O
the	DT	O
most	RBS	O
common	JJ	O
causes	NNS	O
.	.	O

subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
another	DT	O
possible	JJ	O
explanation	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
areas	NNS	O
of	IN	O
prominent	JJ	B-PROBLEM
focal	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
,	,	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
epileptiform	NN	B-PROBLEM
features	NNS	I-PROBLEM

trans-thoracic	JJ	B-TEST
echocardiogram	JJ	I-TEST
2016-05-12	NN	O
:	:	O

left	VBN	O
ventricular	JJ	O
wall	NN	O
thickness	NN	O
,	,	O
cavity	NN	O
size	NN	O
,	,	O
and	CC	O
systolic	JJ	O
function	NN	O
are	VBP	O
normal	JJ	O
(	(	O
lvef>55%	JJ	B-TEST
)	)	O
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
appear	VBP	O
structurally	RB	O
normal	JJ	O
with	IN	O
good	JJ	O
leaflet	NN	O
excursion	NN	O
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
appears	VBZ	O
structurally	RB	O
normal	JJ	O
with	IN	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
pulmonary	JJ	I-TEST
artery	NN	I-TEST
systolic	JJ	I-TEST
pressure	NN	I-TEST
could	MD	O
not	RB	O
be	VB	O
determined	VBN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

pcxr	JJ	B-TEST
2016-05-13	CD	O
:	:	O

mild	NN	B-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
perihilar	JJ	I-PROBLEM
opacification	NN	I-PROBLEM
has	VBZ	O
improved	VBN	O
,	,	O
probably	RB	O
resolving	VBG	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
more	JJR	B-PROBLEM
rightward	JJ	I-PROBLEM
mediastinal	JJ	I-PROBLEM
shift	NN	I-PROBLEM
,	,	O
suggesting	VBG	O
new	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

enlargement	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
hilus	NN	I-PROBLEM
could	MD	O
represent	VB	O
adenopathy	NN	B-PROBLEM
.	.	O

et	NN	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
standard	JJ	O
placement	NN	O
.	.	O

nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
passes	NNS	O
below	IN	O
the	DT	O
diaphragm	NN	O
and	CC	O
out	IN	O
of	IN	O
view	NN	O
.	.	O

no	DT	O
appreciable	JJ	B-PROBLEM
pneumothorax	NN	I-PROBLEM
or	CC	O
pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM

pcxr	JJ	B-TEST
2016-05-14	CD	O
:	:	O

increasing	VBG	B-PROBLEM
opacification	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lungs	NNS	I-PROBLEM
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
mild	VB	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
multiple	JJ	B-PROBLEM
micrometastases	NNS	I-PROBLEM
,	,	O
worsened	VBD	O
slightly	RB	O
since	IN	O
05-13	NN	O
at	IN	O
10:57	CD	O
p.m.	NN	O

there	EX	O
is	VBZ	O
no	DT	O
pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
et	NN	I-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
right	JJ	B-TREATMENT
picc	NN	I-TREATMENT
line	NN	I-TREATMENT
in	IN	O
standard	JJ	O
placements	NNS	O
.	.	O

nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
passes	NNS	O
below	IN	O
the	DT	O
diaphragm	NN	O
and	CC	O
out	IN	O
of	IN	O
view	NN	O
.	.	O

no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

05-11-	JJ	O
blood	NN	B-TEST
cultures	NNS	I-TEST
:	:	O
no	DT	O
growth	NN	B-PROBLEM
to	TO	O
date	NN	O
on	IN	O
2/2	CD	O
bottles	NNS	O

05-12-	JJ	O
blood	NN	B-TEST
cultures	NNS	I-TEST
:	:	O
no	DT	O
growth	NN	B-PROBLEM
to	TO	O
date	NN	O
on	IN	O
6/6	CD	O
bottles	NNS	O

05-14-	JJ	O
blood	NN	B-TEST
cultures	NNS	I-TEST
:	:	O
no	DT	O
growth	NN	B-PROBLEM
to	TO	O
date	NN	O
on	IN	O
4/4	CD	O
bottles	NNS	O

05-11-	JJ	O
urine	JJ	B-TEST
culture	NN	I-TEST
:	:	O
no	DT	O
growth	NN	B-PROBLEM
(	(	O
final	JJ	O
)	)	O

05-12-	JJ	O
urine	JJ	B-TEST
culture	NN	I-TEST
:	:	O
no	DT	O
growth	NN	B-PROBLEM
(	(	O
final	JJ	O
)	)	O

05-14-	JJ	O
urine	JJ	B-TEST
culture	NN	I-TEST
:	:	O
no	DT	O
growth	NN	B-PROBLEM
to	TO	O
date	NN	O

05-11-	JJ	O
stool	NN	B-TEST
:	:	O
negative	JJ	O
for	IN	O
cdiff	NN	B-PROBLEM
toxin	NN	I-PROBLEM

05-12-	JJ	O
stool	NN	B-TEST
:	:	O
negative	JJ	O
for	IN	O
cdiff	NN	B-PROBLEM
toxin	NN	I-PROBLEM

05-12-	JJ	O
swab	NN	B-TEST
from	IN	O
nephrostomy	NN	B-TREATMENT
:	:	O

gram	NN	B-TEST
stain	NN	I-TEST
(	(	O
final	JJ	O
2016-05-12	NN	O
)	)	O
:	:	O

no	DT	O
polymorphonuclear	NN	B-PROBLEM
leukocytes	VBZ	I-PROBLEM
seen	VBN	O
.	.	O

no	DT	O
microorganisms	NN	B-PROBLEM
seen	VBN	O
.	.	O

wound	JJ	B-TEST
culture	NN	I-TEST
(	(	O
preliminary	JJ	O
)	)	O
:	:	O

due	JJ	O
to	TO	O
mixed	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
types	NNS	I-PROBLEM
(	(	O
>=	$	O
3	CD	O
colony	NN	O
types	NNS	O
)	)	O
an	DT	B-TEST
abbreviated	JJ	I-TEST
workup	NN	I-TEST
is	VBZ	O
performed	VBN	O
appropriate	JJ	O
to	TO	O
the	DT	O
isolates	NNS	O
recovered	VBD	O
from	IN	O
the	DT	O
site	NN	O
(	(	O
including	VBG	O
a	DT	B-TEST
screen	NN	I-TEST
for	IN	O
pseudomonas	NN	B-PROBLEM
aeruginosa	NN	I-PROBLEM
,	,	O
staphylococcus	VB	B-PROBLEM
aureus	NN	I-PROBLEM
and	CC	O
beta	NN	B-PROBLEM
streptococcus	NN	I-PROBLEM
)	)	O
.	.	O

staphylococcus	NN	B-PROBLEM
,	,	I-PROBLEM
coagulase	NN	I-PROBLEM
negative	JJ	O
.	.	O

rare	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

corynebacterium	NN	B-PROBLEM
species	NNS	I-PROBLEM
(	(	I-PROBLEM
diphtheroids	NNS	I-PROBLEM
)	)	I-PROBLEM
.	.	O

sparse	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

pseudomonas	NNS	B-PROBLEM
aeruginosa	NN	I-PROBLEM
.	.	O

rare	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

pseudomonas	NNS	B-PROBLEM
aeruginosa	VBP	I-PROBLEM

gram	NN	B-TEST
stain	NN	I-TEST
(	(	O
final	JJ	O
2016-05-12	NN	O
)	)	O
:	:	O

11-03	JJ	O
pmns	NN	B-TEST
and	CC	O
<10	NNP	O
epithelial	JJ	O
cells/100x	NN	O
field	NN	O
.	.	O

no	DT	O
microorganisms	NN	B-PROBLEM
seen	VBN	O
.	.	O

respiratory	JJ	B-TEST
culture	NN	I-TEST
(	(	O
final	JJ	O
2016-05-14	NN	O
)	)	O
:	:	O

no	DT	O
growth	NN	B-PROBLEM
.	.	O

fungal	JJ	B-TEST
culture	NN	I-TEST
(	(	O
preliminary	JJ	O
)	)	O
:	:	O

no	DT	O
fungus	NN	B-PROBLEM
isolated	VBD	O
.	.	O

nocardia	JJ	B-TEST
culture	NN	I-TEST
(	(	O
preliminary	JJ	O
)	)	O
:	:	O

no	DT	O
nocardia	NN	B-PROBLEM
isolated	VBD	O
.	.	O

gram	NN	B-TEST
stain	NN	I-TEST
(	(	O
final	JJ	O
2016-05-14	NN	O
)	)	O
:	:	O

>25	JJ	O
pmns	NN	B-TEST
and	CC	O
<10	NNP	O
epithelial	JJ	O
cells/100x	NN	O
field	NN	O
.	.	O

gram	NN	B-PROBLEM
positive	JJ	I-PROBLEM
cocci	NN	I-PROBLEM
.	.	O

yeast(	RB	B-PROBLEM
s	NN	I-PROBLEM
)	)	I-PROBLEM
.	.	O

05-14-	JJ	O
catheter	NN	B-TREATMENT
tip	NN	I-TREATMENT
(	(	I-TREATMENT
iv	JJ	I-TREATMENT
):	NN	I-TREATMENT

wound	JJ	B-TEST
culture	NN	I-TEST
(	(	O
final	JJ	O
2016-05-15	NN	O
)	)	O
:	:	O

no	DT	O
significant	JJ	B-PROBLEM
growth	NN	I-PROBLEM

30	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
metastatic	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	O
unknown	JJ	O
primary	NN	O
who	WP	O
presented	VBD	O
to	TO	O
osh	VB	O
04-25	JJ	O
with	IN	O
pseudomonal	JJ	B-PROBLEM
urosepsis	NN	I-PROBLEM
,	,	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
from	IN	O
tumor	NN	B-PROBLEM
extension/anti-coagulation	NN	I-PROBLEM
.	.	O

course	NN	O
complicated	VBN	O
by	IN	O
sub	JJ	B-PROBLEM
arachnoid	JJ	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
and	CC	O
intraparenchymal	JJ	B-PROBLEM
bleeds	NNS	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
potential	JJ	O
hypotensive	NN	B-PROBLEM
brain	NN	I-PROBLEM
injury	NN	I-PROBLEM
with	IN	O
poor	JJ	O
prognosis	NN	O
per	IN	O
neurology	NN	O
.	.	O

#	#	O
neurologic	JJ	O
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
neurology	NN	O
consult	NN	O
service	NN	O
and	CC	O
underwent	JJ	O
mri	NN	B-TEST
head	NN	I-TEST
which	WDT	O
revealed	VBD	O
lesions	NNS	B-PROBLEM
suspicious	JJ	O
for	IN	O
metastases	NNS	B-PROBLEM
,	,	O
possible	JJ	O
hemorrhages	NNS	B-PROBLEM
,	,	O
and	CC	O
findings	NNS	O
consistent	JJ	O
with	IN	O
hypoxic	JJ	B-PROBLEM
brain	NN	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

eeg	NN	B-TEST
was	VBD	O
performed	VBN	O
and	CC	O
revealed	VBN	O
encephalopathy	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
neurologic	JJ	I-TEST
exam	NN	I-TEST
(	(	O
performed	VBN	O
after	IN	O
sedation	NN	B-TREATMENT
removed	VBD	O
>48	NNP	O
hours	NNS	O
)	)	O
revealed	VBD	O
intact	JJ	O
brainstem	NN	O
function	NN	O
without	IN	O
evidence	NN	O
of	IN	O
higher	JJR	O
cortical	JJ	O
activity	NN	O
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
metabolic	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
which	WDT	O
were	VBD	O
corrected	VBN	O
(	(	O
hypernatremia	NN	B-PROBLEM
,	,	O
hyperphosphatemia	NN	B-PROBLEM
)	)	O
,	,	O
but	CC	O
neurologic	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
unchanged	JJ	O
.	.	O

final	JJ	B-TEST
neurologic	NN	I-TEST
assessment	NN	I-TEST
was	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
unlikely	JJ	O
to	TO	O
regain	VB	O
meaningful	JJ	O
neurologic	JJ	O
functioning	NN	O
.	.	O

#	#	O
respiratory	NN	B-PROBLEM
failure	NN	I-PROBLEM
-	:	O
pt	NN	O
arrived	VBD	O
on	IN	O
pressure	NN	B-TREATMENT
support	NN	I-TREATMENT
ventilation	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
changed	VBN	O
to	TO	O
assist	VB	B-TREATMENT
control	NN	I-TREATMENT
to	TO	O
make	VB	O
patient	NN	O
more	RBR	O
comfortable	JJ	O
.	.	O

she	PRP	O
was	VBD	O
originally	RB	O
intubated	VBN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
felt	VBN	O
she	PRP	O
could	MD	O
likely	RB	O
be	VB	O
weaned	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
although	IN	O
she	PRP	O
would	MD	O
be	VB	O
extremely	RB	O
high	JJ	O
risk	NN	O
for	IN	O
aspiration	NN	B-PROBLEM
.	.	O

due	JJ	O
to	TO	O
family	NN	O
request	NN	O
to	TO	O
move	VB	O
patient	NN	O
to	TO	O
a	DT	O
hospital	NN	O
closer	NN	O
to	TO	O
home	NN	O
,	,	O
she	PRP	O
will	MD	O
remain	VB	O
intubated	JJ	B-TREATMENT
until	IN	O
transfer	NN	O
,	,	O
with	IN	O
plan	NN	O
to	TO	O
extubate	VB	B-TREATMENT
upon	IN	O
arrival	NN	O
to	TO	O
women	NNS	O
and	CC	O
infants	NNS	O
hospital	NN	O
with	IN	O
initiation	NN	O
of	IN	O
full	JJ	B-TREATMENT
palliative	NN	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
compliance	NN	O
of	IN	O
dni	NN	O
status	NN	O
.	.	O

#	#	O
fevers/infection	NN	B-PROBLEM
-	:	O
per	IN	O
outside	IN	O
hospital	NN	O
records	NNS	O
,	,	O
the	DT	O
patient	NN	O
grew	VBD	O
pseudomonas	NNS	B-PROBLEM
from	IN	O
blood	NN	O
and	CC	O
urine	NN	O
.	.	O

at	IN	O
osh	NN	O
,	,	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
7	CD	O
days	NNS	O
of	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
13	CD	O
days	NNS	O
(	(	O
of	IN	O
14-day	JJ	O
planned	JJ	O
course	NN	O
)	)	O
of	IN	O
ciprofloxacin	NN	B-TREATMENT
and	CC	O
zosyn	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
intially	RB	O
continued	VBN	O
on	IN	O
cipro/zosyn	NN	B-TREATMENT
.	.	O

cxr	JJ	B-TEST
05-11	NN	O
revealed	VBN	O
?	.	O
pneumonia	NN	B-PROBLEM
vs	NN	O
atelectasis	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
r	NN	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

continues	VBZ	O
to	TO	O
spike	VB	O
fever	NN	B-PROBLEM
.	.	O

could	MD	O
have	VB	O
still	RB	O
seeding	VBG	O
of	IN	O
nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

urology	NN	O
at	IN	O
osh	FW	O
against	IN	O
pulling	VBG	O
tube	NN	B-TREATMENT
because	IN	O
coagulopathy	NN	B-PROBLEM
and	CC	O
may	MD	O
not	RB	O
be	VB	O
able	JJ	O
to	TO	O
replace	VB	O
.	.	O

fevers	NNS	B-PROBLEM
also	RB	O
may	MD	O
be	VB	O
from	IN	O
head	NN	B-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
cancer	NN	B-PROBLEM
,	,	O
or	CC	O
drug	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
zosyn	NN	B-TREATMENT
and	CC	O
vancomycin	NN	B-TREATMENT
to	TO	O
complete	VB	O
a	DT	O
>14	JJ	O
day	NN	O
course	NN	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
fevers	NNS	B-PROBLEM
.	.	O

antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
05-15	NN	O
.	.	O

no	DT	O
further	JJ	B-PROBLEM
infectious	JJ	I-PROBLEM
course	NN	I-PROBLEM
was	VBD	O
identified	VBN	O
and	CC	O
the	DT	B-PROBLEM
fevers	NNS	I-PROBLEM
may	MD	O
have	VB	O
been	VBN	O
due	JJ	O
to	TO	O
underlying	VBG	B-PROBLEM
malignant	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

#	#	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
cancer	NN	I-PROBLEM
-	:	O
unknown	JJ	O
primary	NN	O
.	.	O

upon	IN	O
discussion	NN	O
with	IN	O
him	PRP	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
progression	NN	O
of	IN	O
her	PRP$	B-PROBLEM
disease	NN	I-PROBLEM
after	IN	O
systemic	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
topotecan	JJ	B-TREATMENT
and	CC	O
cisplatin	NN	B-TREATMENT
.	.	O

she	PRP	O
then	RB	O
proceed	VBD	O
to	TO	O
xrt	VB	B-TREATMENT
with	IN	O
cisplatin	NN	B-TREATMENT
which	WDT	O
she	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
tolerate	VB	O
this	DT	O
secondary	JJ	O
to	TO	O
thrombocytopenia	VB	B-PROBLEM
(	(	O
40-50k	JJ	O
)	)	O
.	.	O

given	VBN	O
this	DT	O
we	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
offer	VB	O
her	PRP$	O
additional	JJ	B-TREATMENT
therapy.	NN	I-TREATMENT
hematology/oncology	NN	O
service	NN	O
at	IN	O
mediplex	JJ	O
rehab	JJ	O
hospital	NN	O
confirmed	VBD	O
her	PRP$	O
grim	JJ	O
prognosis	NN	O
and	CC	O
expective	JJ	O
survival	NN	O
in	IN	O
terms	NNS	O
of	IN	O
weeks	NNS	O
to	TO	O
months	NNS	O
with	IN	O
no	DT	O
further	JJ	B-TREATMENT
available	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

#	#	O
h/o	NN	O
dvt	SYM	B-PROBLEM
-	:	O
patient	NN	O
with	IN	O
head	NN	B-PROBLEM
bleed	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
contraindication	NN	O
to	TO	O
anti-coagulation	NN	B-TREATMENT
.	.	O

ivc	NN	B-TREATMENT
filter	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

patient	NN	O
was	VBD	O
on	IN	O
pneumoboots	NNS	B-TREATMENT
while	IN	O
in	IN	O
hospital	NN	O
.	.	O

#	#	O
hypernatremia	NN	B-PROBLEM
-	:	O
improved	VBN	O
from	IN	O
osh	NN	O
.	.	O

total	JJ	B-PROBLEM
body	NN	I-PROBLEM
volume	NN	I-PROBLEM
overloaded	VBD	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
free	JJ	B-TREATMENT
h20	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
and	CC	O
d5	$	B-TREATMENT
1/2	CD	I-TREATMENT
ns	NN	I-TREATMENT
and	CC	O
corrected	VBN	O
.	.	O

#	#	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
-	:	O
stable	NN	O
,	,	O
likely	JJ	O
02-12	JJ	O
hypotension	NN	B-PROBLEM
leading	VBG	O
to	TO	O
atn	VB	B-PROBLEM
that	DT	O
is	VBZ	O
slowly	RB	O
improving	VBG	O
.	.	O

#	#	O
access	NN	O
-	:	O
r	NN	B-TREATMENT
ij	NN	I-TREATMENT
changed	VBD	O
sterilly	RB	O
over	IN	O
wire	NN	B-TREATMENT
05-01	NN	O

#	#	O
fen	SYM	O
-	:	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
are	VBP	O
held	VBN	O
in	IN	O
route	NN	O
in	IN	O
anticipation	NN	O
of	IN	O
extubation	NN	O
.	.	O

she	PRP	O
was	VBD	O
made	VBN	O
dnr/dni	NN	O
and	CC	O
the	DT	O
plan	NN	O
is	VBZ	O
that	IN	O
she	PRP	O
will	MD	O
be	VB	O
transferred	VBN	O
to	TO	O
wih	VB	O
and	CC	O
extubated	VB	B-TREATMENT
there	RB	O
upon	IN	O
arrival	NN	O
with	IN	O
initiation	NN	O
of	IN	O
full	JJ	B-TREATMENT
palliative	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

they	PRP	O
understand	VBP	O
that	IN	O
there	EX	O
is	VBZ	O
no	DT	O
icu	NN	O
at	IN	O
wih	NN	O
and	CC	O
no	DT	O
further	RB	O
advanced	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
support	NN	I-TREATMENT
can	MD	O
be	VB	O
offered	VBN	O
.	.	O

1.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
fever	NN	B-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
.	.	O

2.	CD	O
albuterol-ipratropium	JJ	B-TREATMENT
103-18	JJ	O
mcg/actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
06-17	JJ	O
puffs	NNS	O
inhalation	NN	O
q2-4h	NN	O
(	(	O
every	DT	O
2	CD	O
to	TO	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
calcium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
667	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
w/meals	NNS	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
with	IN	O
meals	NNS	O
)	)	O
.	.	O

4.	CD	O
fentanyl	JJ	B-TREATMENT
citrate	NN	I-TREATMENT
(	(	O
pf	NN	O
)	)	O
0.05	CD	O
mg/ml	JJ	O
solution	NN	O
sig	NN	O
:	:	O
25-100	JJ	O
mcg	NN	O
injection	NN	O
q2h	NN	O
(	(	O
every	DT	O
2	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
comfort	NN	O
.	.	O

5.	CD	O
insulin	NN	B-TREATMENT
regular	JJ	I-TREATMENT
human	JJ	I-TREATMENT
100	CD	O
unit/ml	JJ	O
solution	NN	O
sig	NN	O
:	:	O
2-10	JJ	O
units	NNS	O
injection	NN	O
asdir	RB	O
(	(	O
as	IN	O
directed	VBN	O
)	)	O
:	:	O
per	IN	O
sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
for	IN	O
blood	NN	B-TEST
sugars	NNS	I-TEST
>	VBD	O
150mg/dl	CD	O
.	.	O

6.	CD	O
midazolam	JJ	B-TREATMENT
1	CD	O
mg/ml	JJ	O
solution	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
mg	NN	O
injection	NN	O
q2h	NN	O
(	(	O
every	DT	O
2	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
comfort	NN	O
.	.	O

7.	CD	O
phenytoin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
50	CD	O
mg/ml	JJ	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
95y	CD	O
(	(	O
150	CD	O
)	)	O
mg	NN	O
intravenous	JJ	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
.	.	O

8.	CD	O
ranitidine	NN	B-TREATMENT
hcl	NN	O
15	CD	O
mg/ml	NN	O
syrup	NN	O
sig	NN	O
:	:	O
one	CD	O
95y	CD	O
(	(	O
150	CD	O
)	)	O
mg	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

9.	CD	O
polyvinyl	JJ	B-TREATMENT
alcohol-povidone	JJ	I-TREATMENT
1.4-0.6	JJ	O
%	NN	O
dropperette	NN	O
sig	NN	O
:	:	O
01-12	JJ	O
drops	NNS	O
ophthalmic	JJ	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

1.	CD	O
hypoxic	NN	B-PROBLEM
brain	NN	I-PROBLEM
injury	NN	I-PROBLEM

2.	CD	O
cranial	JJ	B-PROBLEM
hemorrages	NNS	I-PROBLEM
(	(	I-PROBLEM
sub	JJ	I-PROBLEM
arachnoid	NN	I-PROBLEM
and	CC	I-PROBLEM
parenchemal	NN	I-PROBLEM
)	)	I-PROBLEM

3.	CD	O
pseudomonal	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
,	,	O
completed	VBN	O
antibiotic	JJ	B-TREATMENT
course	NN	I-TREATMENT

4.	CD	O
metastatic	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	O
unknown	JJ	O
primary	NN	O
.	.	O

5.	CD	O
thrombocytopenia	NN	B-PROBLEM

6.	CD	O
blood	NN	B-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM

intubated	VBN	B-TREATMENT
,	,	O
stable	JJ	O

you	PRP	O
are	VBP	O
being	VBG	O
transferred	VBN	O
to	TO	O
another	DT	O
hospital	NN	O
,	,	O
intubated	VBN	B-TREATMENT
,	,	O
with	IN	O
the	DT	O
plan	NN	O
to	TO	O
extubate	VB	B-TREATMENT
upon	IN	O
arrival	NN	O
to	TO	O
women	NNS	O
's	POS	O
and	CC	O
infants	NNS	O
hosptial	JJ	O
and	CC	O
initiation	NN	O
of	IN	O
palliative	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

your	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
stopped	VBN	O
2016-05-15	JJ	O
(	(	O
vancomycin	JJ	B-TREATMENT
1000mg	CD	O
q24	NN	O
and	CC	O
aztreonam	$	B-TREATMENT
1000mg	CD	O
q8	NN	O
)	)	O
as	IN	O
your	PRP$	O
micorbiology	NN	B-TEST
data	NNS	I-TEST
has	VBZ	O
been	VBN	O
negative	JJ	O
and	CC	O
your	PRP$	O
course	NN	O
for	IN	O
pseudomonal	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
completed	VBN	O
.	.	O

if	IN	O
you	PRP	O
continue	VBP	O
to	TO	O
have	VB	O
fevers	NNS	B-PROBLEM
,	,	O
blood	NN	B-TEST
cultures	NNS	I-TEST
should	MD	O
be	VB	O
repeated	VBN	O
.	.	O

pneumonia	NN	B-PROBLEM
.	.	O

1.	CD	O
pill	NN	B-PROBLEM
esophagitis	NN	I-PROBLEM
.	.	O

2.	CD	O
right	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

dobutamine	NN	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
,	,	O
cardiac	JJ	B-TEST
ultrasound	NN	I-TEST
,	,	O
egd	NN	B-TEST
,	,	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
,	,	O
picc	JJ	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
62-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
copd	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
and	CC	O
chf	NN	B-PROBLEM
who	WP	O
was	VBD	O
lying	VBG	O
in	IN	O
bed	NN	O
on	IN	O
the	DT	O
night	NN	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
developed	VBD	O
left-sided	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
located	VBN	O
in	IN	O
the	DT	O
mid-breast	JJ	O
region	NN	O
with	IN	O
some	DT	B-PROBLEM
fluttering	VBG	I-PROBLEM
her	PRP$	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
radiated	VBD	O
down	IN	O
her	PRP$	O
left	JJ	O
arm	NN	O
associated	VBN	O
with	IN	O
some	DT	B-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
cough	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
.	.	O

she	PRP	O
slept	VBD	O
through	IN	O
the	DT	O
night	NN	O
,	,	O
woke	VBD	O
with	IN	O
persistent	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
went	VBD	O
with	IN	O
her	PRP$	O
sister	NN	O
&apos;s	NN	O
husband	NN	O
to	TO	O
la	VB	O
community	NN	O
hospital	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
given	VBN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
with	IN	O
complete	JJ	O
relief	NN	O
of	IN	O
pain	NN	B-PROBLEM
.	.	O

she	PRP	O
arrived	VBD	O
pain	RB	B-PROBLEM
free	JJ	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
aspirin	RB	B-TREATMENT
,	,	O
lopressor	NN	B-TREATMENT
and	CC	O
insulin	NN	B-TREATMENT
for	IN	O
hyperglycemia	NN	B-PROBLEM
.	.	O

ekg	NN	B-TEST
was	VBD	O
unchanged	JJ	O
compared	VBN	O
to	TO	O
the	DT	B-TEST
prior	JJ	I-TEST
ekg	JJ	I-TEST
several	JJ	O
months	NNS	O
ago	RB	O
.	.	O

insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
,	,	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
copd	NN	B-PROBLEM
,	,	O
allergic	JJ	B-PROBLEM
rhinitis	NN	I-PROBLEM
,	,	O
gerd	NN	B-PROBLEM
,	,	O
obesity	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
.	.	O

codeine	NN	B-TREATMENT
,	,	O
reaction	NN	O
unknown	NN	O
.	.	O

atrovent	NN	B-TREATMENT
.	.	O

aspirin	NN	B-TREATMENT
.	.	O

flonase	NN	B-TREATMENT
.	.	O

quinine	NN	B-TREATMENT
celebrex	NN	B-TREATMENT
.	.	O

compazine	NN	B-TREATMENT
.	.	O

oxybutynin	JJ	B-TREATMENT
amitriptyline	NN	B-TREATMENT
.	.	O

zyrtec	NN	B-TREATMENT
.	.	O

prozac	NN	B-TREATMENT
.	.	O

trazodone	NN	B-TREATMENT
.	.	O

humulin	NN	B-TREATMENT
70	CD	O
units	NNS	O
bid	NN	O
.	.	O

albuterol	NN	B-TREATMENT
.	.	O

lasix	RB	B-TREATMENT
40	CD	O
po	JJ	O
bid	NN	O
.	.	O

triamcinolone	NN	B-TREATMENT
cream	NN	I-TREATMENT
.	.	O

miconazole	JJ	B-TREATMENT
cream	NN	I-TREATMENT
flovent	NN	B-TREATMENT
.	.	O

nifedipine	JJ	B-TREATMENT
er	$	I-TREATMENT
60	CD	O
daily	RB	O
.	.	O

lisinopril	NN	B-TREATMENT
,	,	O
30	CD	O
daily	RB	O
.	.	O

kcl	VB	B-TREATMENT
10	CD	O
meq	JJ	O
q	JJ	O
day	NN	O
.	.	O

protonix	NN	B-TREATMENT
,	,	O
40	CD	O
daily	RB	O
.	.	O

lipitor	NN	B-TREATMENT
,	,	O
20	CD	O
daily	RB	O
.	.	O

methadone	RB	B-TREATMENT
10	CD	O
bid	NN	O
.	.	O

on	IN	O
admission	NN	O
blood	NN	B-TEST
pressure	NN	I-TEST
165/70	CD	O
.	.	O

temperature	NN	B-TEST
99.8	CD	O
,	,	O
pulse	RB	B-TEST
86	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
.	.	O

obese	JJ	B-PROBLEM
,	,	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

heent	NN	O
,	,	O
ears	VBZ	O
poor	JJ	B-PROBLEM
hearing	NN	I-PROBLEM
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

chest	NN	O
,	,	O
lungs	NNS	O
clear	VBP	O
to	TO	O
auscultation	NN	B-TEST
with	IN	O
faint	NN	B-PROBLEM
wheezes	NNS	I-PROBLEM
,	,	O
no	DT	O
rales	NNS	B-PROBLEM
.	.	O

cardiac	JJ	O
,	,	O
normal	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

feet	NNS	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

pulses	NNS	O
2+	CD	B-TEST
pt	NN	I-TEST
and	CC	O
dp	NN	B-TEST
.	.	O

unremarkable	JJ	O
with	IN	O
normal	JJ	O
electrolytes	NNS	O
except	IN	O
for	IN	O
glucose	NN	B-TEST
of	IN	O
328	CD	O
.	.	O

cbc	NN	B-TEST
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
6.7	CD	O
,	,	O
hematocrit	NN	B-TEST
37.4	CD	O
,	,	O
platelets	NNS	B-TEST
280	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
low	JJ	B-PROBLEM
lung	NN	I-PROBLEM
volumes	NNS	I-PROBLEM
,	,	O
no	DT	O
consolidation	NN	B-PROBLEM
.	.	O

ekg	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
brady	NN	I-PROBLEM
at	IN	O
16	CD	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
normal	JJ	O
intervals	NNS	O
,	,	O
no	DT	O
stt	NN	B-PROBLEM
wave	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
team	VB	O
four	CD	O
for	IN	O
cardiac	JJ	O
monitoring	NN	O
and	CC	O
ruling	VBG	O
out	RP	O
for	IN	O
mi	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
ruled	VBD	O
out	RP	O
for	IN	O
mi	NN	B-PROBLEM
by	IN	O
cardiac	JJ	B-TEST
markers	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
set	VBN	O
to	TO	O
go	VB	O
for	IN	O
a	DT	B-TEST
dobutamine	NN	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
on	IN	O
11/16/04	CD	O
given	VBN	O
her	PRP$	O
history	NN	O
of	IN	O
copd	NN	B-PROBLEM
,	,	O
but	CC	O
the	DT	B-TEST
stress	JJ	I-TEST
portion	NN	I-TEST
was	VBD	O
canceled	VBN	O
when	WRB	O
she	PRP	O
was	VBD	O
down	RB	O
there	RB	O
due	JJ	O
to	TO	O
fever	VB	B-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
.	.	O

the	DT	O
next	JJ	O
day	NN	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
echo	NN	I-TEST
(	(	I-TEST
transthoracic	JJ	I-TEST
echocardiogram	NN	I-TEST
)	)	I-TEST
.	.	O

this	DT	B-TEST
echo	NN	I-TEST
showed	VBD	O
lv	JJ	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
50%	CD	O
with	IN	O
no	DT	O
wall	NN	B-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
the	DT	O
right	JJ	O
ventricular	NN	O
was	VBD	O
diffusely	RB	B-PROBLEM
hypokinetic	JJ	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
suboptimally	RB	O
imaged	VBN	O
,	,	O
so	IN	O
there	EX	O
was	VBD	O
no	DT	O
rvsp	NN	B-TEST
given	VBN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
suffered	VBD	O
a	DT	B-PROBLEM
hypotensive	JJ	I-PROBLEM
episode	NN	I-PROBLEM
while	IN	O
in	IN	O
the	DT	O
endoscopy	NN	O
suite	NN	O
for	IN	O
her	PRP$	B-TEST
egd	NN	I-TEST
on	IN	O
11/17/04	CD	O
.	.	O

this	DT	O
responded	VBD	O
to	TO	O
fluid	VB	B-TREATMENT
bolus	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
medicine	VB	O
team	NN	O
d	NN	O
given	VBN	O
her	PRP$	B-PROBLEM
tenuous	JJ	I-PROBLEM
hemodynamic	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
,	,	O
several	JJ	O
days	NNS	O
later	RB	O
11/23	CD	O
,	,	O
underwent	JJ	O
another	DT	B-TEST
dobutamine	NN	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
.	.	O

this	DT	B-TEST
stress	JJ	I-TEST
test	NN	I-TEST
,	,	O
although	IN	O
complicated	VBN	O
by	IN	O
hypotension	NN	B-PROBLEM
again	RB	O
,	,	O
to	TO	O
the	DT	O
60	CD	O
&apos;s	NN	O
or	CC	O
70	CD	O
&apos;s	NN	O
was	VBD	O
completed	VBN	O
and	CC	O
there	EX	O
was	VBD	O
some	DT	B-PROBLEM
mild	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
septal	NN	I-PROBLEM
thinning	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
and	CC	O
an	DT	B-TEST
ef	NN	I-TEST
from	IN	O
this	DT	B-TEST
test	NN	I-TEST
was	VBD	O
76%	CD	O
.	.	O

clearly	RB	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
hemodynamic	VBD	O
vascular	JJ	O
status	NN	O
was	VBD	O
very	RB	O
sensitive	JJ	O
to	TO	O
dobutamine	VB	B-TREATMENT
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
#2	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
increased	VBN	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

the	DT	O
next	JJ	O
day	NN	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
for	IN	O
a	DT	O
potential	JJ	O
uti	NN	B-PROBLEM
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
low-grade	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
and	CC	O
on	IN	O
the	DT	O
next	JJ	O
day	NN	O
,	,	O
11/17/04	CD	O
,	,	O
her	PRP	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
possible	JJ	O
new	JJ	B-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
started	VBN	O
on	IN	O
ceftriaxone	NN	B-TREATMENT
and	CC	O
azithromycin	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
urine	JJ	I-TEST
legionella	NN	I-TEST
antigen	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

on	IN	O
11/22/04	CD	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
gram-positive	JJ	B-PROBLEM
cocci	NN	I-PROBLEM
in	IN	O
her	PRP$	O
sputum	NN	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
for	IN	O
this	DT	O
.	.	O

these	DT	B-PROBLEM
bacteria	NNS	I-PROBLEM
turned	VBD	O
out	RP	O
to	TO	O
be	VB	O
mrsa	JJ	B-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
picc	JJ	B-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
for	IN	O
home	NN	B-TREATMENT
vancomycin	NN	I-TREATMENT
administration	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
nausea	NN	B-PROBLEM
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
11/16/04	CD	O
associated	VBN	O
with	IN	O
some	DT	B-PROBLEM
cough	NN	I-PROBLEM
,	,	O
apparent	JJ	B-PROBLEM
emesis	NN	I-PROBLEM
.	.	O

gi	NN	O
was	VBD	O
consulted	VBN	O
for	IN	O
an	DT	B-TEST
egd	NN	I-TEST
,	,	O
however	RB	O
,	,	O
while	IN	O
she	PRP	O
was	VBD	O
in	IN	O
the	DT	O
endoscopy	NN	O
suite	NN	O
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
hypotensive	JJ	I-PROBLEM
episode	NN	I-PROBLEM
,	,	O
which	WDT	O
responded	VBD	O
to	TO	O
some	DT	B-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
.	.	O

finally	RB	O
,	,	O
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
she	PRP	O
was	VBD	O
stabilized	VBN	O
to	TO	O
the	DT	O
point	NN	O
that	IN	O
she	PRP	O
could	MD	O
have	VB	O
her	PRP$	B-TEST
egd	NN	I-TEST
.	.	O

the	DT	B-TEST
egd	NN	I-TEST
did	VBD	O
show	VB	O
three	CD	B-PROBLEM
esophageal	JJ	I-PROBLEM
ulcers	NNS	I-PROBLEM
that	WDT	O
were	VBD	O
localized	VBN	O
and	CC	O
apparent	JJ	O
suggestion	NN	O
of	IN	O
pill	NN	B-PROBLEM
esophagitis	NN	I-PROBLEM
.	.	O

her	PRP$	O
stomach	NN	O
and	CC	O
duodenum	NN	O
were	VBD	O
normal	JJ	O
and	CC	O
it	PRP	O
was	VBD	O
suggested	VBN	O
that	IN	O
she	PRP	O
change	VBD	O
her	PRP	B-TREATMENT
nexium	NN	I-TREATMENT
doses	VBZ	I-TREATMENT
to	TO	O
daily	VB	O
and	CC	O
that	IN	O
she	PRP	O
also	RB	O
drink	VBP	O
plenty	NN	O
of	IN	O
fluids	NNS	O
and	CC	O
water	NN	O
with	IN	O
meals	NNS	O
,	,	O
sit	NN	O
upright	NN	O
when	WRB	O
she	PRP	O
would	MD	O
eat	VB	O
her	PRP$	O
meals	NNS	O
to	TO	O
decrease	VB	O
the	DT	O
chance	NN	O
of	IN	O
pills	NNS	B-TREATMENT
eroding	VBG	O
her	PRP$	O
esophagus	NN	O
.	.	O

4.	CD	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
:	:	O

as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
develop	VB	O
mrsa	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
that	WDT	O
was	VBD	O
started	VBN	O
to	TO	O
be	VB	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
she	PRP	O
did	VBD	O
also	RB	O
develop	VB	O
an	DT	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

at	IN	O
most	JJS	O
,	,	O
her	PRP$	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
was	VBD	O
4-5	JJ	O
liters	NNS	O
and	CC	O
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
she	PRP	O
was	VBD	O
satting	VBG	O
well	RB	O
on	IN	O
two	CD	O
liters	NNS	O
of	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
pneumonia	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
with	IN	O
her	PRP$	B-PROBLEM
right	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
it	PRP	O
is	VBZ	O
also	RB	O
possible	JJ	O
that	IN	O
she	PRP	O
may	MD	O
have	VB	O
an	DT	O
element	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
and	CC	O
may	MD	O
warrant	VB	O
further	JJ	O
investigation	NN	O
as	IN	O
an	DT	O
outpatient	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
with	IN	O
chest	JJ	B-TEST
ct	NN	I-TEST
.	.	O

several	JJ	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
some	DT	B-PROBLEM
erythematous	JJ	I-PROBLEM
rash	NN	I-PROBLEM
under	IN	O
her	PRP$	O
left	JJ	O
breast	NN	O
and	CC	O
left	VBD	O
side	NN	O
that	IN	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
yeast	VB	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
some	DT	B-TREATMENT
miconazole	JJ	I-TREATMENT
cream	NN	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
rash	NN	I-PROBLEM
was	VBD	O
always	RB	O
localized	VBN	O
to	TO	O
her	PRP$	O
left	JJ	O
side	NN	O
,	,	O
sometimes	RB	O
extending	VBG	O
down	RP	O
to	TO	O
her	PRP$	O
leg	NN	O
,	,	O
but	CC	O
never	RB	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
.	.	O

the	DT	B-PROBLEM
rash	NN	I-PROBLEM
appeared	VBD	O
to	TO	O
be	VB	O
resolving	VBG	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

tums	NNS	B-TREATMENT
,	,	O
500-1250	JJ	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
.	.	O

lipitor	NN	B-TREATMENT
,	,	O
20	CD	O
daily	RB	O
.	.	O

prozac	NN	B-TREATMENT
,	,	O
60	CD	O
daily	RB	O
.	.	O

flovent	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
,	,	O
220	CD	O
mcg	NN	O
bid	NN	O
.	.	O

atrovent	NN	B-TREATMENT
,	,	O
two	CD	O
puffs	NNS	O
qid	RB	O
.	.	O

ditropan	NN	B-TREATMENT
,	,	O
5	CD	O
mg	NN	O
tid	NN	O
.	.	O

colace	NN	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
tid	NN	O
.	.	O

aspirin	NN	B-TREATMENT
,	,	O
325	CD	O
mg	JJ	O
daily	RB	O
.	.	O

insulin	NN	B-TREATMENT
nph	NN	I-TREATMENT
,	,	O
36	CD	O
subcu	NN	O
q	NN	O
am	VBP	O
,	,	O
30	CD	O
subcu	NN	O
q	NN	O
pm	NN	O
.	.	O

nystatin	JJ	B-TREATMENT
mouthwash	NN	I-TREATMENT
swish	NN	O
and	CC	O
swallow	NN	O
.	.	O

nexium	NN	B-TREATMENT
,	,	O
20	CD	O
mg	NN	O
po	JJ	O
daily	RB	O
.	.	O

vancomycin	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
q12h	NN	O
.	.	O

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
71-year-old-female	JJ	O
with	IN	O
asthma	NN	B-PROBLEM
and	CC	O
a	DT	O
history	NN	O
of	IN	O
recent	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
of	IN	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
who	WP	O
,	,	O
at	IN	O
her	PRP$	O
baseline	NN	O
,	,	O
gets	VBZ	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
walking	NN	O
across	IN	O
the	DT	O
room	NN	O
and	CC	O
sleeps	NNS	O
on	IN	O
four	CD	O
pillows	NNS	O
times	RB	O
several	JJ	O
years	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
reported	VBN	O
that	IN	O
she	PRP	O
has	VBZ	O
had	VBN	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
times	NNS	O
several	JJ	O
days	NNS	O
with	IN	O
increasing	VBG	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
eventually	RB	O
at	IN	O
rest	NN	O
with	IN	O
marked	JJ	B-PROBLEM
wheezing	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
a	DT	B-PROBLEM
cough	NN	I-PROBLEM
with	IN	O
a	DT	O
small	JJ	O
amount	NN	O
of	IN	O
white	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
.	.	O

at	IN	O
3	CD	O
a.m.	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
she	PRP	O
became	VBD	O
much	JJ	O
worse	JJR	O
and	CC	O
after	IN	O
several	JJ	O
days	NNS	O
of	IN	O
increasing	VBG	O
her	PRP$	B-TREATMENT
meter-dosed	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
use	NN	O
,	,	O
she	PRP	O
call	VBP	O
emergency	NN	O
medical	JJ	O
services	NNS	O
which	WDT	O
assessed	VBD	O
her	PRP	O
as	IN	O
having	VBG	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
elevated	JJ	B-PROBLEM
jugular	NN	I-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
rales	NNS	B-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
aspirin	RB	B-TREATMENT
,	,	O
lasix	VBD	B-TREATMENT
40	CD	O
mg	NN	O
intravenously	RB	O
times	RB	O
two	CD	O
,	,	O
0.8	CD	O
mg	NN	O
of	IN	O
nitroglycerin	JJ	B-TREATMENT
times	NNS	O
four	CD	O
,	,	O
plus	CC	O
morphine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
up	RB	O
to	TO	O
220/110	CD	O
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
emergency	NN	O
room	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
assessed	VBN	O
as	IN	O
having	VBG	O
asthma	NN	B-PROBLEM
.	.	O

she	PRP	O
then	RB	O
received	VBD	O
continuous	JJ	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
for	IN	O
approximately	RB	O
eight	CD	O
hours	NNS	O
with	IN	O
minimal	JJ	O
improvement	NN	O
.	.	O

she	PRP	O
did	VBD	O
receive	VB	O
intravenous	JJ	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
for	IN	O
blood	NN	O
pressure	NN	O
controlled	VBD	O
to	TO	O
the	DT	O
170s	NNS	O
.	.	O

she	PRP	O
initially	RB	O
received	VBD	O
a	DT	O
treatment	NN	O
of	IN	O
bipap	NN	B-TREATMENT
on	IN	O
arrival	NN	O
as	IN	O
she	PRP	O
was	VBD	O
barely	RB	O
able	JJ	O
to	TO	O
speak	VB	O
.	.	O

she	PRP	O
also	RB	O
received	VBD	O
80	CD	B-TREATMENT
mg	NNS	I-TREATMENT
of	IN	I-TREATMENT
solu-medrol	NN	I-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

she	PRP	O
was	VBD	O
never	RB	O
hypoxic	VBN	B-PROBLEM
but	CC	O
initially	RB	O
her	PRP$	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
respiratory	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
pco2	NN	I-TEST
of	IN	O
71	CD	O
.	.	O

the	DT	O
patient	NN	O
does	VBZ	O
have	VB	O
a	DT	O
vague	JJ	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
is	VBZ	O
felt	VBN	O
to	TO	O
be	VB	O
inaccurate	JJ	O
.	.	O

she	PRP	O
also	RB	O
received	VBD	O
captopril	JJ	B-TREATMENT
12.5	CD	O
mg	NN	O
times	NNS	O
one	CD	O
.	.	O

recently	RB	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
treated	VBN	O
with	IN	O
several	JJ	B-TREATMENT
steroid	JJ	I-TREATMENT
tapers	NNS	I-TREATMENT
.	.	O

it	PRP	O
either	DT	O
ended	VBD	O
in	IN	O
2011-04-11	JJ	O
or	CC	O
continued	VBN	O
through	IN	O
2011-05-11	JJ	O
with	IN	O
use	NN	O
of	IN	O
augmentin	NN	B-TREATMENT
;	:	O
and	CC	O
,	,	O
by	IN	O
report	NN	O
,	,	O
lasted	VBN	O
until	IN	O
06-07	NNP	O
.	.	O

however	RB	O
,	,	O
the	DT	O
family	NN	O
said	VBD	O
the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
on	IN	O
steroids	NNS	B-TREATMENT
for	IN	O
several	JJ	O
weeks	NNS	O
.	.	O

1.	CD	O
asthma	NN	B-PROBLEM
as	IN	O
a	DT	O
child	NN	O
which	WDT	O
recurred	VBD	O
in	IN	O
2001	CD	O
.	.	O

she	PRP	O
takes	VBZ	O
an	DT	B-TREATMENT
albuterol	NN	I-TREATMENT
and	CC	O
atrovent	JJ	B-TREATMENT
inhalers	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
serevent	NN	B-TREATMENT
and	CC	O
flovent	NN	B-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
multiple	JJ	O
hospitalizations	NNS	O
and	CC	O
has	VBZ	O
never	RB	O
been	VBN	O
intubated	VBN	B-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
multiple	VBN	B-TREATMENT
prednisone	NN	I-TREATMENT
tapers	NNS	I-TREATMENT
(	(	O
see	VB	O
history	NN	O
of	IN	O
present	JJ	O
illness	NN	O
)	)	O
.	.	O

on	IN	O
prednisone	NN	B-TREATMENT
or	CC	O
sometime	RB	O
after	IN	O
it	PRP	O
was	VBD	O
discontinued	VBN	O
,	,	O
depending	VBG	O
on	IN	O
the	DT	O
version	NN	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
worsening	VBG	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
been	VBN	O
a	DT	B-PROBLEM
vega	NN	I-PROBLEM
problem	NN	I-PROBLEM
for	IN	O
her	PRP$	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
dyazide	NN	B-TREATMENT
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
most	RBS	O
recently	RB	O
in	IN	O
2009-01-10	JJ	O
were	VBD	O
not	RB	O
obstructive	JJ	O
.	.	O

they	PRP	O
showed	VBD	O
an	DT	B-TEST
fvc	NN	I-TEST
of	IN	O
91%	CD	O
of	IN	O
predicted	VBN	O
,	,	O
and	CC	O
a	DT	B-TEST
fev1	NN	I-TEST
of	IN	O
104%	CD	O
of	IN	O
predicted	VBN	O
,	,	O
with	IN	O
a	DT	B-TEST
ratio	NN	I-TEST
of	IN	O
114%	CD	O
.	.	O

in	IN	O
2003	CD	O
,	,	O
there	EX	O
was	VBD	O
19%	CD	O
change	NN	O
of	IN	O
the	DT	O
fev1	NN	O
and	CC	O
an	DT	O
11%	CD	O
change	NN	O
in	IN	O
the	DT	O
fvc	NN	O
with	IN	O
bronchodilators	NNS	B-TREATMENT
.	.	O

2.	CD	O
mild	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
especially	RB	O
on	IN	O
prednisone	NN	B-TREATMENT
.	.	O

3.	CD	O
hypoplastic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	O
hip	NN	B-TREATMENT
repair	NN	I-TREATMENT
at	IN	O
the	DT	O
age	NN	O
of	IN	O
five	CD	O
.	.	O

4.	CD	O
polio	NN	B-PROBLEM
.	.	O

5.	CD	O
status	NN	O
post	NN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

6.	CD	O
history	NN	O
of	IN	O
zoster	NN	B-PROBLEM
.	.	O

7.	CD	O
past	JJ	O
discharge	NN	O
summary	JJ	O
mention	NN	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
but	CC	O
the	DT	O
patient	NN	O
has	VBZ	O
never	RB	O
smoked	VBN	O
.	.	O

8.	CD	O
incontinent	NN	B-PROBLEM
of	IN	I-PROBLEM
both	DT	I-PROBLEM
stool	NN	I-PROBLEM
and	CC	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

9.	CD	O
allergic	JJ	B-PROBLEM
rhinitis	NN	I-PROBLEM
.	.	O

brother	NN	O
and	CC	O
sister	NN	O
both	DT	O
have	VBP	O
asthma	NN	B-PROBLEM
.	.	O

brother	NN	O
has	VBZ	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

dyazide	RB	B-TREATMENT
25/37.5	CD	O
p.o.	NN	O
q.d.	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
atrovent	NN	B-TREATMENT
,	,	O
albuterol	NN	B-TREATMENT
,	,	O
and	CC	O
flovent	JJ	B-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
and	CC	O
swanson	$	B-TREATMENT
60	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
and	CC	O
serevent	JJ	B-TREATMENT
2	CD	O
puffs	NNS	O
q.12h.	NN	O

on	IN	O
transfer	NN	O
,	,	O
she	PRP	O
also	RB	O
arrived	VBD	O
on	IN	O
200	CD	O
mcg	NN	O
of	IN	O
nitroglycerin	JJ	B-TREATMENT
and	CC	O
reports	NNS	O
p.r.n.	IN	O
alka-seltzer	NN	B-TREATMENT
,	,	O
sinus	NN	B-TREATMENT
and	CC	O
nyquil	NN	B-TREATMENT
use	NN	O
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
were	VBD	O
notable	JJ	O
for	IN	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
which	WDT	O
worsened	VBD	O
in	IN	O
may	MD	O
.	.	O

she	PRP	O
denies	VBZ	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
does	VBZ	O
have	VB	O
chest	JJS	B-PROBLEM
tightness	NN	I-PROBLEM
since	IN	O
two	CD	O
days	NNS	O
ago	RB	O
,	,	O
coinciding	VBG	O
with	IN	O
her	PRP$	B-PROBLEM
wheezing	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
paroxysms	NNS	B-PROBLEM
of	IN	I-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
which	WDT	O
resolves	VBZ	O
with	IN	O
water	NN	O
and	CC	O
sitting	VBG	O
up	RP	O
.	.	O

this	DT	O
is	VBZ	O
worse	JJR	O
when	WRB	O
she	PRP	O
has	VBZ	O
asthma	JJ	B-PROBLEM
flares	NNS	I-PROBLEM
.	.	O

she	PRP	O
denies	VBZ	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
and	CC	O
any	DT	B-PROBLEM
genitourinary	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
a	DT	B-PROBLEM
constant	JJ	I-PROBLEM
runny	NN	I-PROBLEM
nose	NN	I-PROBLEM
and	CC	O
has	VBZ	O
had	VBN	O
no	DT	O
sick	JJ	O
contacts	NNS	O
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
23	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
113	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
130s/90s	CD	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
this	DT	O
was	VBD	O
a	DT	O
female	NN	O
in	IN	O
moderate	JJ	B-PROBLEM
distress	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
shortness	VB	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
spoke	VBD	O
in	IN	O
short	JJ	O
phrases	NNS	O
and	CC	O
then	RB	O
in	IN	O
complete	JJ	O
sentences	NNS	O
as	IN	O
the	DT	O
night	NN	O
went	VBD	O
on	IN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
hdr	NN	B-PROBLEM
.	.	O

sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

cardiovascular	NN	O
revealed	VBD	O
she	PRP	O
was	VBD	O
tachycardic	JJ	B-PROBLEM
with	IN	O
a	DT	O
regular	JJ	O
first	JJ	O
heart	NN	O
sound	NN	O
and	CC	O
second	JJ	O
heart	NN	O
sound	NN	O
.	.	O

pulmonary	NN	O
revealed	VBD	O
she	PRP	O
had	VBD	O
diffuse	NN	B-PROBLEM
wheezes	NNS	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
rales	NNS	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
reduced	VBN	B-PROBLEM
but	CC	I-PROBLEM
adequate	JJ	I-PROBLEM
air	NN	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
revealed	VBD	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
obese	JJ	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

extremities	NNS	O
revealed	VBD	O
left	VBD	O
lower	JJR	O
extremity	NN	O
was	VBD	O
hypoplastic	JJ	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
pitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
on	IN	I-PROBLEM
both	DT	I-PROBLEM
sides	NNS	I-PROBLEM
of	IN	O
the	DT	O
lower	JJR	O
extremities	NNS	O
.	.	O

the	DT	O
right	JJ	O
ankle	NN	O
was	VBD	O
somewhat	RB	B-PROBLEM
tender	NN	I-PROBLEM
from	IN	O
this	DT	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

neurologically	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
oriented	VBN	O
to	TO	O
person	NN	O
,	,	O
place	NN	O
,	,	O
and	CC	O
time	NN	O
;	:	O
however	RB	O
,	,	O
she	PRP	O
was	VBD	O
somewhat	RB	B-PROBLEM
drowsy	JJ	I-PROBLEM
and	CC	O
at	IN	O
times	NNS	O
was	VBD	O
difficult	JJ	O
to	TO	O
keep	VB	O
awake	NN	O
during	IN	O
conversations	NNS	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
10.2	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
37.5	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
236	CD	O
.	.	O

inr	NN	B-TEST
of	IN	O
1.3	CD	O
,	,	O
ptt	NN	B-TEST
of	IN	O
30.3	CD	O
.	.	O

urinalysis	NN	B-TEST
revealed	VBD	O
6	CD	O
to	TO	O
10	CD	O
red	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
0	CD	O
to	TO	O
2	CD	O
white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
4	CD	O
epithelial	JJ	B-TEST
cells	NNS	I-TEST
with	IN	O
foley	NN	B-TREATMENT
in	IN	O
place	NN	O
.	.	O

urine	JJ	B-TEST
culture	NN	I-TEST
later	RB	O
grew	VBD	O
out	RP	O
contaminated	JJ	O
specimen	NNS	O
.	.	O

differential	NN	B-TEST
with	IN	O
72	CD	O
polys	NNS	B-TEST
,	,	O
16	CD	O
lymphocytes	NNS	B-TEST
,	,	O
4.6	CD	O
monocytes	NNS	B-TEST
,	,	O
6.3	CD	O
eosinophils	NNS	B-TEST
.	.	O

chem-7	NN	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
bicarbonate	NN	I-TEST
of	IN	O
31	CD	O
and	CC	O
a	DT	B-TEST
glucose	NN	I-TEST
of	IN	O
156	CD	O
.	.	O

arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
7.24/71/227	CD	O
.	.	O

creatine	NN	B-TEST
kinase	NN	I-TEST
was	VBD	O
243	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
mb	NN	I-TEST
of	IN	O
9	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
troponin	NN	I-TEST
of	IN	O
less	JJR	O
than	IN	O
0.3.	CD	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
showed	VBD	O
low	JJ	B-PROBLEM
lung	NN	I-PROBLEM
volumes	NNS	I-PROBLEM
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
115	CD	O
with	IN	O
a	DT	O
normal	JJ	O
axis	NN	O
,	,	O
intermittent	JJ	B-PROBLEM
q	NN	I-PROBLEM
wave	NN	I-PROBLEM
in	IN	I-PROBLEM
iii;	NN	I-PROBLEM
a	DT	B-PROBLEM
wavy	JJ	I-PROBLEM
baseline	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
stress	JJ	I-TEST
echocardiogram	NN	I-TEST
with	IN	O
a	DT	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
in	IN	O
2007	CD	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	NN	B-TREATMENT
continuous	JJ	I-TREATMENT
nebulizers	NNS	I-TREATMENT
and	CC	O
was	VBD	O
weaned	VBN	O
then	RB	O
to	TO	O
intermittent	VB	B-TREATMENT
nebulizer	JJ	I-TREATMENT
treatments	NNS	I-TREATMENT
and	CC	O
then	RB	O
to	TO	O
her	PRP$	B-TREATMENT
meter-dosed	JJ	I-TREATMENT
inhalers	NNS	I-TREATMENT
taking	VBG	O
them	PRP	O
q.4h.	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
salmeterol	NN	B-TREATMENT
and	CC	O
flovent	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
solu-medrol	NN	B-TREATMENT
80	CD	O
mg	NN	O
q.8h.	NN	O
then	RB	O
converted	VBD	O
to	TO	O
prednisone	VB	B-TREATMENT
at	IN	O
60	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
singulair	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

serial	JJ	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
were	VBD	O
followed	VBN	O
after	IN	O
an	DT	B-TREATMENT
arterial	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

her	PRP$	B-TEST
pco2	NN	I-TEST
gradually	RB	O
declined	VBD	O
to	TO	O
the	DT	O
48	CD	O
range	NN	O
.	.	O

despite	IN	O
episodes	NNS	O
of	IN	O
somnolence	NN	B-PROBLEM
the	DT	O
first	JJ	O
night	NN	O
which	WDT	O
were	VBD	O
presumably	RB	O
due	JJ	O
to	TO	O
having	VBG	O
spent	VBN	O
the	DT	O
entire	JJ	O
night	NN	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
she	PRP	O
never	RB	O
became	VBD	O
more	RBR	B-PROBLEM
hypercarbic	JJ	I-PROBLEM
,	,	O
and	CC	O
her	PRP$	B-TEST
pco2	NN	I-TEST
trended	VBD	O
to	TO	O
48	CD	O
by	IN	O
the	DT	O
time	NN	O
the	DT	B-TREATMENT
arterial	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

on	IN	O
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
and	CC	O
thereafter	RB	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
stridorous	JJ	I-PROBLEM
sounding	VBG	I-PROBLEM
breathing	NN	I-PROBLEM
when	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
asleep	RB	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
trial	NN	I-TREATMENT
of	IN	I-TREATMENT
80/20	CD	I-TREATMENT
mixed	JJ	I-TREATMENT
helium/oxygen	NN	I-TREATMENT
to	TO	O
decrease	VB	O
the	DT	B-PROBLEM
stridor	NN	I-PROBLEM
but	CC	O
had	VBD	O
minimal	JJ	O
effect	NN	O
.	.	O

ear/nose/throat	NN	O
recommended	VBD	O
not	RB	O
considering	VBG	O
this	DT	O
an	DT	B-PROBLEM
airway	NN	I-PROBLEM
problem	NN	I-PROBLEM
unless	IN	O
she	PRP	O
was	VBD	O
stridorous	JJ	B-PROBLEM
while	IN	I-PROBLEM
awake	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
serial	JJ	B-TEST
creatine	NN	I-TEST
kinases	NNS	I-TEST
,	,	O
although	IN	O
these	DT	O
did	VBD	O
rise	NN	O
to	TO	O
816	CD	O
.	.	O

mb	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
captopril	NN	B-TREATMENT
for	IN	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
this	DT	O
was	VBD	O
switched	VBN	O
to	TO	O
norvasc	VB	B-TREATMENT
7.5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
on	IN	O
discharge	NN	O
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
hyperdynamic	JJ	I-PROBLEM
left	NN	I-PROBLEM
ventricular	NN	I-PROBLEM
of	IN	O
normal	JJ	O
thickness	NN	O
and	CC	O
size	NN	O
,	,	O
and	CC	O
no	DT	O
significant	JJ	B-PROBLEM
valvular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
apparently	RB	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	O
cardiovascular	JJ	O
component	NN	O
to	TO	O
her	PRP$	B-PROBLEM
wheezing	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
she	PRP	O
was	VBD	O
to	TO	O
go	VB	O
home	NN	O
on	IN	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
to	TO	O
help	VB	O
with	IN	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
as	IN	O
she	PRP	O
experiences	VBZ	O
discomfort	NN	B-PROBLEM
with	IN	O
this	DT	O
,	,	O
and	CC	O
the	DT	O
team	NN	O
felt	VBD	O
this	DT	O
may	MD	O
be	VB	O
a	DT	O
limiting	JJ	O
factor	NN	O
with	IN	O
her	PRP$	B-TREATMENT
prednisone	NN	I-TREATMENT
compliance	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
sliding-scale	NN	I-TREATMENT
of	IN	I-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
while	IN	O
she	PRP	O
was	VBD	O
in	IN	O
house	NN	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
500	CD	O
mg	JJ	O
p.o.	NN	O
q.d.	NN	O
of	IN	O
metformin	NN	B-TREATMENT
to	TO	O
treat	VB	O
her	PRP$	B-PROBLEM
steroid-induced	JJ	I-PROBLEM
diabetes	NNS	I-PROBLEM
on	IN	O
discharge	NN	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
briefly	NN	O
with	IN	O
levofloxacin	NN	B-TREATMENT
because	IN	O
of	IN	O
the	DT	B-PROBLEM
gram-positive	JJ	I-PROBLEM
cocci	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
sputum	JJ	I-TEST
culture	NN	I-TEST
;	:	O
however	RB	O
,	,	O
her	PRP	B-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
viral	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
and	CC	O
levofloxacin	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

1.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
combivent	JJ	B-TREATMENT
meter-dosed	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
2	CD	O
puffs	NNS	O
q.4h.	RB	O
weaning	VBG	O
to	TO	O
albuterol	VB	B-TREATMENT
meter-dosed	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
2	CD	O
puffs	NNS	O
q.4h.	NN	O

3.	CD	O
salmeterol	NN	B-TREATMENT
2	CD	O
puffs	NNS	O
q.12h.	NN	O

4.	CD	O
flovent	JJ	B-TREATMENT
220	CD	O
mcg	NN	O
2	CD	O
puffs	NNS	O
q.12h.	NN	O

5.	CD	O
prednisone	NN	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
with	IN	O
taper	NN	O
.	.	O

6.	CD	O
fentress	JJ	B-TREATMENT
60	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

7.	CD	O
singulair	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
univasc	JJ	B-TREATMENT
7.5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
metformin	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

dyazide	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

discharge	NN	O
services	NNS	O
included	VBD	O
visiting	VBG	O
nursing	NN	O
which	WDT	O
was	VBD	O
to	TO	O
assess	VB	O
in	IN	O
her	PRP$	O
inhaler	NN	O
technique	NN	O
,	,	O
monitor	VB	O
her	PRP$	B-TEST
fasting	NN	I-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
,	,	O
as	RB	O
well	RB	O
as	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
,	,	O
monitor	NN	O
her	PRP$	B-TEST
peak	NN	I-TEST
flows	VBZ	I-TEST
,	,	O
and	CC	O
assess	IN	O
her	PRP$	O
mobility	NN	O
and	CC	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
at	IN	O
home	NN	O
.	.	O

1.	CD	O
asthma	JJ	B-PROBLEM
flare	NN	I-PROBLEM
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
steroid-induced	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
oaksgekesser/	VB	O
memorial	JJ	O
hospital	NN	O
.	.	O

your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
tubbolm	NN	O
,	,	O
lisswhiti	JJ	O
n	NN	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

a	DT	O
40-year-old	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
non-st-elevation	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
2016-09-30	JJ	O
with	IN	O
stent	NN	B-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
lad	NN	I-TREATMENT
and	CC	O
50%	CD	O
to	TO	O
the	DT	O
mid	NN	O
lad	NN	O
,	,	O
had	VBD	O
instent	JJ	B-PROBLEM
restenosis	NN	I-PROBLEM
in	IN	O
2017-04-02	JJ	O
and	CC	O
then	RB	O
underwent	JJ	O
brachytherapy	NN	B-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
rca	NN	I-TREATMENT
,	,	O
who	WP	O
presented	VBD	O
to	TO	O
baldpate	VB	O
hospital	NN	O
with	IN	O
several	JJ	O
weeks	NNS	O
of	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
similar	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
anginal	JJ	I-PROBLEM
equivalent	NN	I-PROBLEM
and	CC	O
mi	NN	B-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

no	DT	O
relief	NN	O
with	IN	O
nitroglycerin	JJ	B-TREATMENT
x3	NN	O
.	.	O

positive	JJ	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

troponins	NNS	B-TEST
have	VBP	O
been	VBN	O
less	JJR	O
than	IN	O
0.01.	CD	O

with	IN	O
history	NN	O
,	,	O
will	MD	O
go	VB	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
evaluation	NN	I-TEST
.	.	O

still	RB	O
getting	VBG	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
intermittently	RB	O
,	,	O
but	CC	O
relieved	VBN	O
by	IN	O
morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
.	.	O

was	VBD	O
on	IN	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
and	CC	O
nitroglycerin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
with	IN	O
only	JJ	O
intermittent	JJ	O
relief	NN	O
.	.	O

1.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

2.	CD	O
obesity	NN	B-PROBLEM
.	.	O

3.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

5.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
:	:	O

2016-09-30	JJ	O
non-st-elevation	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
100%	CD	O
rca	NN	O
,	,	O
three	CD	B-TREATMENT
stents	NNS	I-TREATMENT
,	,	O
50%	CD	O
mid	NN	O
lad	NN	O
.	.	O

2017-04-02	JJ	O
instent	NN	B-PROBLEM
restenosis	NN	I-PROBLEM
status	NN	O
post	NN	O
brachytherapy	NN	B-TREATMENT
.	.	O

6.	CD	O
gerd	NN	B-PROBLEM
.	.	O

7.	CD	O
asthma	NN	B-PROBLEM
.	.	O

8.	CD	O
sciatica	NN	B-PROBLEM
.	.	O

9.	CD	O
degenerative	JJ	B-PROBLEM
joint	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

10.	CD	O
glomerulosclerosis	NN	B-PROBLEM
.	.	O

brothers	NNS	O
with	IN	O
william	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
mi	NN	I-PROBLEM
.	.	O

father	NN	O
with	IN	O
emphysema	NN	B-PROBLEM
.	.	O

mother	NN	O
with	IN	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

aspirin	NN	B-TREATMENT
under	IN	O
which	WDT	O
she	PRP	O
develops	VBZ	O
worsening	NN	O
of	IN	O
her	PRP$	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
asthma	NN	B-PROBLEM
flare	NN	I-PROBLEM
,	,	O
tetracycline	NN	B-TREATMENT
,	,	O
sulfa	NN	B-TREATMENT
,	,	O

demerol	NN	B-TREATMENT
.	.	O

1.	CD	O
diovan	NN	B-TREATMENT
106	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
advair	JJ	B-TREATMENT
500/50	CD	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

3.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
crestor	NN	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	NN	O

5.	CD	O
neurontin	JJ	B-TREATMENT
300	CD	O
mg	NN	O
t.i.d.	NN	O

6.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
b.i.d.	NN	O

7.	CD	O
vicodin	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

8.	CD	O
trazodone	NN	B-TREATMENT
50	CD	O
mg	NN	O
q.d.	NN	O

9.	CD	O
singulair	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

10.	CD	O
flexeril	JJ	B-TREATMENT
10	CD	O
mg	NN	O
t.i.d.	NN	O

11.	CD	O
lopressor	NN	B-TREATMENT
75	CD	O
mg	NN	O
b.i.d.	NN	O

12.	CD	O
humibid	NN	B-TREATMENT
3600	CD	O
b.i.d.	NN	O

13.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

14.	CD	O
zetia	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

15.	CD	O
benadryl	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

16.	CD	O
tricor	JJ	B-TREATMENT
106	CD	O
mg	NN	O
q.d.	NN	O

17.	CD	O
premarin	JJ	B-TREATMENT
0.3	CD	O
mg	NN	O
q.d.	NN	O

18.	CD	O
prozac	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.d.	NN	O

19.	CD	O
omega-3	JJ	B-TREATMENT
fatty	JJ	I-TREATMENT
acids	NNS	I-TREATMENT
t.i.d.	NN	O

well	RB	O
appearing	VBG	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

no	DT	O
jvd	NN	B-PROBLEM
.	.	O

positive	JJ	O
tenderness	NN	B-PROBLEM
to	TO	I-PROBLEM
sternum	VB	I-PROBLEM
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
.	.	O

extremities	NNS	O
show	VBP	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
2+	CD	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
,	,	O

1+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
.	.	O

troponin-t	NN	B-TEST
less	JJR	O
than	IN	O
0.01.	CD	O

ekg	NN	B-TEST
:	:	O

sinus	NN	B-TEST
,	,	O
84	CD	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
qtc	RB	B-TEST
430	CD	O
,	,	O
q	NN	B-PROBLEM
's	POS	I-PROBLEM
in	IN	I-PROBLEM
iii	NN	I-PROBLEM
and	CC	I-PROBLEM
avf	NN	I-PROBLEM
,	,	O
no	DT	O

st	NN	B-PROBLEM
changes	NNS	I-PROBLEM
as	IN	O
compared	VBN	O
to	TO	O
2017-05-01	JJ	O
ekg	NN	B-TEST
.	.	O

1.	CD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
with	IN	O
her	PRP$	O
history	NN	O
of	IN	O
disease	NN	B-PROBLEM
,	,	O
patient	JJ	O
underwent	NN	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
at	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
to	TO	O
have	VB	O
mild	VBN	B-PROBLEM
diffuse	JJ	I-PROBLEM
instent	JJ	I-PROBLEM
restenosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
stent	NN	I-PROBLEM
,	,	O
otherwise	RB	O
hemodynamically	RB	O
normal	JJ	O
and	CC	O
the	DT	O
coronary	JJ	O
arteries	NNS	O
otherwise	RB	O
were	VBD	O
without	IN	O
flow-limiting	JJ	B-PROBLEM
stenoses	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
cardiac	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
if	IN	O
we	PRP	O
attempted	VBD	O
aspirin	JJ	B-TREATMENT
desensitize	VB	O
her	PRP$	O
while	IN	O
an	DT	O
inpatient	NN	O
,	,	O
then	RB	O
she	PRP	O
would	MD	O
benefit	VB	O
from	IN	O
the	DT	O
use	NN	O
of	IN	O
aspirin	NN	B-TREATMENT
and	CC	O
plavix	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
ccu	NN	O
and	CC	O
underwent	JJ	O
aspirin	JJ	B-TREATMENT
desensitization	NN	I-TREATMENT
protocol	NN	I-TREATMENT
,	,	O
which	WDT	O
she	PRP	O
tolerated	VBD	O
well	RB	O
.	.	O

she	PRP	O
had	VBD	O
mild	JJ	O
worsening	NN	O
of	IN	O
her	PRP$	B-PROBLEM
asthma	NN	I-PROBLEM
attacks	NNS	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
relieved	VBN	O
by	IN	O
benadryl	NN	B-TREATMENT
and	CC	O
occasionally	RB	O
albuterol	VB	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
found	VBD	O
that	IN	O
if	IN	O
she	PRP	O
took	VBD	O
the	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
in	IN	O
the	DT	O
evening	NN	O
with	IN	O
her	PRP$	B-TREATMENT
benadryl	NN	I-TREATMENT
that	IN	O
she	PRP	O
takes	VBZ	O
for	IN	O
sleep	NN	O
,	,	O
that	IN	O
the	DT	B-PROBLEM
asthma	JJ	I-PROBLEM
exacerbation	NN	I-PROBLEM
did	VBD	O
not	RB	O
occur	VB	O
.	.	O

aspirin	NN	B-TREATMENT
no	RB	O
longer	RBR	O
should	MD	O
be	VB	O
considered	VBN	O
an	DT	B-PROBLEM
allergy	NN	I-PROBLEM
for	IN	O
this	DT	O
patient	NN	O
,	,	O
and	CC	O
she	PRP	O
is	VBZ	O
going	VBG	O
to	TO	O
take	VB	O
this	DT	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

2.	CD	O
hyperlipidemia	NN	B-PROBLEM
:	:	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
lipitor	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
80	CD	O
mg	NNS	O
q.d.	NN	O

3.	CD	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
:	:	O

this	DT	O
is	VBZ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
issue	NN	I-PROBLEM
and	CC	O
was	VBD	O
controlled	VBN	O
with	IN	O
flexeril	NN	B-TREATMENT
and	CC	O
vicodin	NN	B-TREATMENT
.	.	O

patient	NN	O
is	VBZ	O
able	JJ	O
to	TO	O
ambulate	VB	O
without	IN	O
any	DT	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
discomfort	NN	B-PROBLEM
.	.	O

1.	CD	O
metoprolol	JJ	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

2.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
advair	NN	B-TREATMENT
550	CD	O
mcg	NN	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

4.	CD	O
neurontin	JJ	B-TREATMENT
300	CD	O
mg	NN	O
t.i.d.	NN	O

5.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.d.	NN	O

6.	CD	O
montelukast	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

7.	CD	O
bethanechol	NN	B-TREATMENT
25	CD	O
mg	NN	O
b.i.d.	NN	O

8.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

9.	CD	O
zetia	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

10.	CD	O
estrogen	NN	B-TREATMENT
0.3	CD	O
mg	NN	O
q.d.	NN	O

11.	CD	O
fluoxetine	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.d.	NN	O

12.	CD	O
vicodin	JJ	B-TREATMENT
5-500	JJ	O
mg	NN	O
tablets	NNS	O
q.4-6h.	RB	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

13.	CD	O
cyclobenzaprine	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
one	CD	O
tablet	NN	O
orally	RB	O
t.i.d.	VB	O

14.	CD	O
atorvastatin	JJ	B-TREATMENT
80	CD	O
mg	NN	O
q.d.	NN	O

15.	CD	O
valsartan	JJ	B-TREATMENT
320	CD	O
mg	NN	O
q.d.	NN	O

16.	CD	O
aspirin	JJ	B-TREATMENT
one	CD	O
q.d.	NN	O

17.	CD	O
benadryl	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

occipital	JJ	B-PROBLEM
cerebrovascular	JJ	I-PROBLEM
accident	NN	I-PROBLEM

1)	CD	O
extensive	JJ	B-PROBLEM
posterior	JJ	I-PROBLEM
circulation	NN	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

2)	CD	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
82	CD	O
year-old	JJ	O
right	NN	O
handed	VBN	O
gentleman	NN	O
who	WP	O
has	VBZ	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
and	CC	O
tobacco	NN	O
use	NN	O
presented	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
with	IN	O
acute	JJ	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
well	RB	O
until	IN	O
the	DT	O
evening	VBG	O
prior	JJ	O
to	TO	O
presentation	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
when	WRB	O
he	PRP	O
complained	VBD	O
of	IN	O
headache	NN	B-PROBLEM
across	IN	I-PROBLEM
the	DT	I-PROBLEM
forehead	NN	I-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
presentation	NN	O
,	,	O
he	PRP	O
was	VBD	O
then	RB	O
found	VBN	O
by	IN	O
his	PRP$	O
daughter	NN	O
lying	VBG	O
on	IN	O
his	PRP$	O
bed	NN	O
groaning	NN	O
,	,	O
being	VBG	O
relatively	RB	B-PROBLEM
unresponsive	JJ	I-PROBLEM
and	CC	O
unable	JJ	O
to	TO	O
speak	VB	O
.	.	O

the	DT	O
family	NN	O
reported	VBD	O
one	CD	O
episode	NN	O
of	IN	O
vomiting	VBG	B-PROBLEM
at	IN	O
home	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
73	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
158/53	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
16-20	NNS	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97%	CD	O
on	IN	O
three	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
somnolent	JJ	B-PROBLEM
,	,	O
breathing	VBG	O
comfortably	RB	O
,	,	O
occasionally	RB	B-PROBLEM
coughing	VBG	I-PROBLEM
.	.	O

no	DT	O
bruits	NNS	B-PROBLEM
were	VBD	O
heard	VBN	O
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
but	CC	O
with	IN	O
poor	JJ	B-PROBLEM
air	NN	I-PROBLEM
entry	NN	I-PROBLEM
.	.	O

heart	NN	O
sounds	NNS	O
were	VBD	O
regular	JJ	O
with	IN	O
one	CD	B-PROBLEM
out	NN	I-PROBLEM
of	IN	I-PROBLEM
six	CD	I-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	O
the	DT	O
left	NN	O
lower	RBR	O
sternal	JJ	O
border	NN	O
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
bowel	JJ	O
sounds	VBZ	O
present	JJ	O
.	.	O

extremities	NNS	O
were	VBD	O
without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
patient	NN	O
who	WP	O
was	VBD	O
intermittently	RB	B-PROBLEM
alert	JJ	I-PROBLEM
,	,	O
opening	VBG	O
eyes	NNS	O
to	TO	O
voice	VB	O
,	,	O
following	VBG	O
simple	JJ	O
commands	NNS	O
,	,	O
but	CC	O
without	IN	B-PROBLEM
any	DT	I-PROBLEM
speech	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
pupillary	JJ	B-PROBLEM
defect	NN	I-PROBLEM
.	.	O

dolls	NNS	B-TEST
eye	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

there	EX	O
was	VBD	O
a	DT	O
possible	JJ	O
right	NN	B-PROBLEM
gaze	NN	I-PROBLEM
preference	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
move	VB	O
his	PRP$	O
eyes	NNS	O
.	.	O

corneals	NNS	B-TEST
were	VBD	O
present	JJ	O
bilaterally	RB	O
.	.	O

gag	NN	B-TEST
was	VBD	O
present	JJ	O
weakly	RB	O
.	.	O

there	EX	O
was	VBD	O
only	RB	O
minimal	JJ	B-PROBLEM
movement	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

on	IN	O
sensory	JJ	B-TEST
testing	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
withdrew	VBD	O
all	DT	O
extremities	NNS	O
to	TO	O
pain	VB	B-PROBLEM
.	.	O

reflexes	NNS	B-TEST
were	VBD	O
2+	CD	O
and	CC	O
symmetrical	JJ	O
all	DT	O
over	IN	O
.	.	O

the	DT	O
left	NN	O
toe	NN	O
was	VBD	O
upgoing	JJ	B-PROBLEM
,	,	O
the	DT	O
right	JJ	O
toe	NN	O
was	VBD	O
downgoing	VBG	O
.	.	O

laboratory	NN	O
data	NNS	O
revealed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
139	CD	O
,	,	O
potassium	NN	B-TEST
3.4	CD	O
,	,	O
chloride	RB	B-TEST
101	CD	O
,	,	O
bicarbonate	NN	B-TEST
28	CD	O
,	,	O
bun	NN	B-TEST
11	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
,	,	O
glucose	VBD	B-TEST
151	CD	O
.	.	O

ast	NN	B-TEST
was	VBD	O
20	CD	O
,	,	O
alt	RB	B-TEST
12	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
80	CD	O
,	,	O
bilirubin	VBD	B-TEST
0.5.	CD	O
ck	NN	B-TEST
was	VBD	O
113	CD	O
.	.	O

thyroid	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

troponin	NN	B-TEST
i	NN	I-TEST
was	VBD	O
0.05	CD	O
.	.	O

total	JJ	B-TEST
protein	NN	I-TEST
was	VBD	O
8	CD	O
,	,	O
albumin	RB	B-TEST
4.3	CD	O
,	,	O
globulin	NN	B-TEST
3.7	CD	O
,	,	O
calcium	NN	B-TEST
9.9	CD	O
,	,	O
phosphate	NN	B-TEST
2.7	CD	O
,	,	O
magnesium	NN	B-TEST
2.0.	CD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
7	CD	O
,	,	O
hemoglobin	NN	B-TEST
14.1	CD	O
,	,	O
hematocrit	NN	B-TEST
43.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
241	CD	O
.	.	O

erythrocyte	JJ	B-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
41	CD	O
.	.	O

pt	NN	B-TEST
was	VBD	O
12.3	CD	O
,	,	O
ptt	RB	B-TEST
27.1.	CD	O
an	DT	B-TEST
ekg	NN	I-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
at	IN	O
53	CD	O
with	IN	O
a	DT	O
normal	JJ	O
axis	NN	O
,	,	O
first	RB	B-PROBLEM
degree	JJ	I-PROBLEM
atrioventricular	JJ	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
biphasic	JJ	B-PROBLEM
t-waves	NNS	I-PROBLEM
in	IN	O
v1	NN	O
to	TO	O
v3	VB	O
without	IN	O
any	DT	B-PROBLEM
acute	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
shows	NNS	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
consolidation	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
right	JJ	I-PROBLEM
occipital	NN	I-PROBLEM
infarct	NN	I-PROBLEM
without	IN	O
midline	NN	B-PROBLEM
shift	NN	I-PROBLEM
,	,	O
but	CC	O
positive	JJ	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
temporal	JJ	I-PROBLEM
horn	NN	I-PROBLEM
,	,	O
on	IN	O
the	DT	O
right	JJ	O
ventricle	NN	O
and	CC	O
some	DT	B-PROBLEM
effacement	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
sulci	NN	I-PROBLEM
in	IN	O
the	DT	O
right	JJ	O
parietal	JJ	O
area	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
a	DT	O
telemetry	NN	O
bed	NN	O
and	CC	O
started	VBD	O
on	IN	O
heparin	NN	B-TREATMENT
.	.	O

around	IN	O
4:00	CD	O
am	VBP	O
the	DT	O
next	JJ	O
day	NN	O
,	,	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
decompensation	NN	I-PROBLEM
in	IN	I-PROBLEM
respiratory	NN	I-PROBLEM
status	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

lung	NN	B-TEST
examination	NN	I-TEST
at	IN	O
that	DT	O
point	NN	O
showed	VBD	O
good	JJ	O
air	NN	O
entry	NN	O
,	,	O
no	DT	O
wheezing	NN	B-PROBLEM
,	,	O
coarse	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
throughout	IN	I-PROBLEM
.	.	O

withdrawal	NN	O
to	TO	O
pain	NN	B-TEST
was	VBD	O
still	RB	O
present	JJ	O
.	.	O

both	DT	O
plantars	NNS	O
were	VBD	O
upgoing	VBG	B-PROBLEM
.	.	O

a	DT	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
at	IN	O
this	DT	O
point	NN	O
showed	VBD	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.49	CD	O
,	,	O
po2	NN	B-TEST
61	CD	O
,	,	O
pco2	NN	B-TEST
of	IN	O
33	CD	O
on	IN	O
100%	CD	B-TREATMENT
non-rebreather	JJ	I-TREATMENT
mask	NN	I-TREATMENT
.	.	O

ekg	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	JJ	I-TEST
temperature	NN	I-TEST
was	VBD	O
102	CD	O
degrees	NNS	O
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
cat	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

this	DT	O
showed	VBD	O
continued	JJ	O
evolution	NN	O
of	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
posterior	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
infarction	NN	I-PROBLEM
now	RB	O
extending	VBG	O
into	IN	O
the	DT	O
right	JJ	O
cerebellar	NN	O
hemisphere	RB	O
.	.	O

there	EX	O
was	VBD	O
also	RB	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
density	NN	I-PROBLEM
adjacent	NN	O
to	TO	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
cerebellar	NN	I-PROBLEM
infarction	NN	I-PROBLEM
suggesting	VBG	O
the	DT	O
presence	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
and	CC	O
mra	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
was	VBD	O
arranged	VBN	O
to	TO	O
evaluate	VB	O
the	DT	O
extent	NN	O
of	IN	O
his	PRP$	B-PROBLEM
stroke	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
posterior	JJ	I-PROBLEM
circulation	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
mri	NN	I-TEST
showed	VBD	O
infarct	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cerebellar	JJ	I-PROBLEM
hemispheres	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
the	DT	O
right	JJ	O
occipital	NN	O
lobe	NN	O
,	,	O
the	DT	O
right	JJ	O
thalamus	NN	O
and	CC	O
bilateral	JJ	O
pons	NNS	O
.	.	O

the	DT	B-TEST
mra	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
intracranial	JJ	I-TEST
circulation	NN	I-TEST
demonstrated	VBD	O
gross	JJ	B-PROBLEM
patency	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
arteries	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
basilar	JJ	I-PROBLEM
arteries	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
mildly	RB	B-PROBLEM
reduced	VBN	I-PROBLEM
flow	NN	I-PROBLEM
in	IN	O
the	DT	O
branches	NNS	O
of	IN	O
the	DT	O
right	JJ	O
middle	JJ	O
cerebral	JJ	O
artery	NN	O
compared	VBN	O
to	TO	O
the	DT	O
left	NN	O
.	.	O

neurosurgery	NN	O
was	VBD	O
consulted	VBN	O
,	,	O
however	RB	O
the	DT	O
neurosurgeons	NNS	O
felt	VBD	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
surgical	JJ	O
option	NN	O
,	,	O
since	IN	O
even	RB	O
in	IN	O
the	DT	O
case	NN	O
of	IN	O
cerebellar	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
there	EX	O
would	MD	O
be	VB	O
no	DT	O
improvement	NN	O
from	IN	O
decompensation	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
therefore	RB	O
treated	JJ	O
conservatively	RB	O
with	IN	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
and	CC	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
management	NN	I-TREATMENT
.	.	O

heparin	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
because	IN	O
of	IN	O
the	DT	O
risk	NN	O
of	IN	O
intercerebral	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
aspiration	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
was	VBD	O
treated	VBN	O
with	IN	O
cefotaxime	NN	B-TREATMENT
and	CC	O
metronidazole	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
with	IN	O
n.	JJ	B-TEST
ramirez	NN	I-TEST
coma	NN	I-TEST
scale	NN	I-TEST
of	IN	O
15	CD	O
on	IN	O
arrival	NN	O
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

no	DT	O
crepitus	NN	B-PROBLEM
.	.	O

positive	JJ	O
tenderness	NN	B-PROBLEM
over	IN	O
the	DT	O
distal	JJ	O
half	NN	O
of	IN	O
the	DT	O
left	JJ	O
rib	NN	O
cage	NN	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
tender	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

positive	JJ	O
guarding	NN	B-PROBLEM
.	.	O

no	DT	O
deformities	NNS	B-PROBLEM
.	.	O

no	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

no	DT	O
deformities	NNS	B-PROBLEM
,	,	O
stepoff	NN	B-PROBLEM
,	,	O
or	CC	O
tenderness	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cervical	JJ	I-PROBLEM
spine	NN	I-PROBLEM
.	.	O

rectal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
guaiac-negative	JJ	O
.	.	O

the	DT	O
right	JJ	O
upper	JJ	O
extremity	NN	O
was	VBD	O
positive	JJ	O
for	IN	O
abrasions	NNS	B-PROBLEM
.	.	O

the	DT	O
right	NN	O
lower	JJR	O
extremity	NN	O
was	VBD	O
positive	JJ	O
for	IN	O
abrasions	NNS	B-PROBLEM
.	.	O

left	VBN	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
revealed	VBD	O
no	DT	O
deformities	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
resuscitation	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
responded	VBD	O
to	TO	O
aggressive	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
and	CC	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
kept	VBN	O
nothing	NN	O
by	IN	O
mouth	NN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
bed	VBD	B-TREATMENT
rest	NN	I-TREATMENT
,	,	O
every	DT	B-TEST
4-hour	CD	I-TEST
hematocrit	NN	I-TEST
checks	NNS	I-TEST
,	,	O
and	CC	O
serial	JJ	B-TEST
abdominal	JJ	I-TEST
examinations	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
throughout	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
relatively	RB	O
stable	JJ	O
with	IN	O
a	DT	B-PROBLEM
gradual	JJ	I-PROBLEM
drop	NN	I-PROBLEM
due	JJ	O
to	TO	O
dilutional	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

on	IN	O
post	NN	O
trauma	NNS	O
day	NN	O
four	CD	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
with	IN	O
a	DT	O
stable	JJ	O
hematocrit	NN	O
and	CC	O
a	DT	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
ambulated	VBD	O
with	IN	O
pain	NN	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
left	NN	I-PROBLEM
pubic	NN	I-PROBLEM
rami	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

physical	JJ	O
therapy	NN	O
was	VBD	O
consulted	VBN	O
,	,	O
and	CC	O
crutches	NNS	B-TREATMENT
were	VBD	O
given	VBN	O
to	TO	O
the	DT	O
patient	NN	O
.	.	O

pain	NN	B-PROBLEM
was	VBD	O
managed	VBN	O
with	IN	O
a	DT	B-TREATMENT
fentanyl	JJ	I-TREATMENT
patch	NN	I-TREATMENT
and	CC	O
by	IN	B-TREATMENT
mouth	NN	I-TREATMENT
dilaudid	NN	I-TREATMENT
with	IN	O
adequate	JJ	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
on	IN	O
discharge	NN	O
.	.	O

1.	CD	O
grade	VBD	B-PROBLEM
3	CD	I-PROBLEM
splenic	JJ	I-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

2.	CD	O
left	VBD	B-PROBLEM
rib	NN	I-PROBLEM
8	CD	I-PROBLEM
through	IN	I-PROBLEM
12	CD	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

3.	CD	O
left	VBD	B-PROBLEM
superior/inferior	JJ	I-PROBLEM
pubic	JJ	I-PROBLEM
rami	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

4.	CD	O
comorbidities	NNS	O
of	IN	O
anxiety	NN	B-PROBLEM
disorder/depression	NN	I-PROBLEM
.	.	O

1.	CD	O
the	DT	O
patient	NN	O
was	VBD	O
asked	VBN	O
to	TO	O
call	VB	O
his	PRP$	O
physician	NN	O
if	IN	O
he	PRP	O
experienced	VBD	O
any	DT	B-PROBLEM
lightheadedness	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

1.	CD	O
fentanyl	JJ	B-TREATMENT
75-mcg	JJ	O
per	IN	O
hour	NN	O
patch	NN	O
q.72h.	NN	O

2.	CD	O
zoloft	JJ	B-TREATMENT
50	CD	O
mg	NN	O
by	IN	O
mouth	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

3.	CD	O
wellbutrin	JJ	B-TREATMENT
200	CD	O
mg	NN	O
by	IN	O
mouth	NN	O
twice	RB	O
per	IN	O
day	NN	O
.	.	O

4.	CD	O
dilaudid	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
by	IN	O
mouth	JJ	O
q.4-6h.	JJ	O
as	IN	O
needed	VBN	O
(	(	O
for	IN	O
pain	NN	B-PROBLEM
)	)	O
.	.	O

abdominal	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
64	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
smoking	NN	O
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disese	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
l0	JJ	I-PROBLEM
cm	NN	I-PROBLEM
abdominal	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

patient	NN	O
presented	VBD	O
to	TO	O
his	PRP$	O
private	JJ	O
medical	JJ	O
doctor	NN	O
in	IN	O
gewestster	NN	O
with	IN	O
transient	JJ	B-PROBLEM
calf	NN	I-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
walking	VBG	O
less	JJR	O
than	IN	O
fifty	JJ	O
yards	NNS	O
.	.	O

abdominal	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
was	VBD	O
discovered	VBN	O
on	IN	O
examination	NN	B-TEST
and	CC	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
retelk	VB	O
county	RB	O
medical	JJ	O
center	NN	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
10/17/06	CD	O
and	CC	O
echocardiogram	VB	B-TEST
done	VBN	O
on	IN	O
11/13/09	CD	O
revealed	JJ	O
poor	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
function	NN	I-PROBLEM
and	CC	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
was	VBD	O
done	VBN	O
on	IN	O
admission	NN	O
which	WDT	O
showed	VBD	O
three	CD	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
cardiology	VB	O
and	CC	O
underwent	VB	O
a	DT	B-TREATMENT
three	CD	I-TREATMENT
vessel	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
on	IN	O
11/25/09	CD	O
.	.	O

his	PRP$	O
post-operative	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
an	DT	B-PROBLEM
e.	JJ	I-PROBLEM
coli	NNS	I-PROBLEM
urinary	JJ	I-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
transient	JJ	B-PROBLEM
acute	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
increasing	VBG	B-PROBLEM
creatinine	NN	I-PROBLEM
.	.	O

patient	JJ	B-TEST
&apos;s	NNP	I-TEST
renal	NN	I-TEST
function	NN	I-TEST
returned	VBD	O
to	TO	O
normal	JJ	O
over	IN	O
several	JJ	O
days	NNS	O
,	,	O
however	RB	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
last	JJ	I-TEST
ultrasound	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
aorta	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
l0	JJ	I-PROBLEM
cm	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
and	CC	O
he	PRP	O
presented	VBD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
for	IN	O
an	DT	B-TREATMENT
abdominal	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
also	RB	O
in	IN	O
l983	NN	O
and	CC	O
l988	NN	O
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
l989	NN	O
,	,	O
diverticulitis	NN	B-PROBLEM
in	IN	O
l978	NN	O
,	,	O
and	CC	O
spontaneous	JJ	B-PROBLEM
pneumothorax	NN	I-PROBLEM
in	IN	O
l956	NN	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	I-TREATMENT
three	CD	I-TREATMENT
as	IN	O
mentioned	VBN	O
above	IN	O
.	.	O

he	PRP	O
came	VBD	O
in	IN	O
on	IN	O
carafate	NN	B-TREATMENT
,	,	O
enteric	RB	B-TREATMENT
coated	VBN	I-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
,	,	O
atrovent	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
,	,	O
procan	JJ	B-TREATMENT
sr	NN	I-TREATMENT
,	,	O
mevacor	NN	B-TREATMENT
,	,	O
and	CC	O
digoxin	NN	B-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
,	,	O
inderal	JJ	B-TREATMENT
,	,	O
and	CC	O
also	RB	O
to	TO	O
procan	VB	B-TREATMENT
.	.	O

on	IN	O
admission	NN	O
was	VBD	O
remarkable	JJ	O
for	IN	O
an	DT	O
abdomen	NN	O
which	WDT	O
was	VBD	O
soft	JJ	O
and	CC	O
non-tender	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
pulsatile	JJ	I-PROBLEM
mass	NN	I-PROBLEM
felt	VBD	O
in	IN	O
the	DT	O
right	JJ	O
upper	NN	O
quadrant	NN	O
near	IN	O
the	DT	O
midline	NN	O
.	.	O

he	PRP	O
had	VBD	O
dopplerable	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
pulses	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
they	PRP	O
were	VBD	O
palpable	JJ	O
.	.	O

patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
the	DT	O
next	JJ	O
day	NN	O
on	IN	O
12/24/09	CD	O
where	WRB	O
patient	NN	O
underwent	VBD	O
an	DT	B-TREATMENT
abdominal	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

in	IN	O
his	PRP$	O
post-operative	JJ	O
course	NN	O
,	,	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
unit	NN	O
and	CC	O
was	VBD	O
put	VBN	O
on	IN	O
perioperative	JJ	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

post-operatively	RB	O
,	,	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
frequent	JJ	B-PROBLEM
aberrant	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
premature	NN	I-PROBLEM
beats	NNS	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
rare	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
premature	NN	I-PROBLEM
beats	NNS	I-PROBLEM
.	.	O

his	PRP$	O
lungs	NNS	O
were	VBD	O
found	VBN	O
to	TO	O
have	VB	O
decreased	VBN	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
with	IN	O
a	DT	O
question	NN	O
of	IN	O
fluid	NN	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
whether	IN	O
to	TO	O
start	VB	O
him	PRP	O
on	IN	O
quinidine	NN	B-TREATMENT
versus	NN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
moderate	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
with	IN	O
hypokinetic	JJ	B-PROBLEM
and	CC	I-PROBLEM
akinetic	JJ	I-PROBLEM
areas	NNS	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
loaded	VBN	O
with	IN	O
quinidine	NN	B-TREATMENT
and	CC	O
then	RB	O
started	VBD	O
on	IN	O
a	DT	B-TREATMENT
maintenance	NN	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

patient	NN	O
converted	VBD	O
to	TO	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
once	RB	O
on	IN	O
quinidine	NN	B-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
digoxin	NN	I-TREATMENT
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
elevated	VBN	B-PROBLEM
so	RB	O
his	PRP$	B-TREATMENT
digoxin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
for	IN	O
four	CD	O
days	NNS	O
while	IN	O
levels	NNS	B-TEST
slowly	RB	O
came	VBD	O
down	RB	O
.	.	O

patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
digoxin	NN	B-TREATMENT
just	RB	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

patient	NN	O
also	RB	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
ldh	NN	I-PROBLEM
,	,	I-PROBLEM
alkaline	JJ	I-PROBLEM
phosphatase	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
amylase	VB	I-PROBLEM
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

lipase	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

ultrasound	NN	B-TEST
was	VBD	O
obtained	VBN	O
of	IN	O
the	DT	O
biliary	JJ	O
tree	NN	O
which	WDT	O
demonstrated	VBD	O
no	DT	O
abnormalities	NNS	B-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
several	JJ	O
complaints	NNS	O
of	IN	O
awaking	VBG	O
in	IN	O
the	DT	O
middle	NN	O
of	IN	O
the	DT	O
night	NN	O
with	IN	O
tachypnea	NN	B-PROBLEM
and	CC	O
some	DT	B-PROBLEM
bilateral	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
associated	VBN	O
with	IN	O
breathing	NN	O
.	.	O

serial	JJ	B-TEST
ekg	NN	I-TEST
and	CC	I-TEST
ck	NN	I-TEST
were	VBD	O
obtained	VBN	O
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
demonstrated	VBD	O
some	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
po2	NNS	B-TEST
of	IN	O
68	CD	O
,	,	O
saturation	NN	B-TEST
of	IN	O
95%	CD	O
,	,	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.5l	CD	O
,	,	O
pco2	NN	B-TEST
of	IN	O
37	CD	O
,	,	O
a	DT	B-TEST
bicarbonate	NN	I-TEST
of	IN	O
37	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
pco2	NN	I-TEST
of	IN	O
3l	CD	O
with	IN	O
a	DT	B-TEST
+7	JJ	I-TEST
base	NN	I-TEST
.	.	O

patient	JJ	B-TEST
&apos;s	JJ	I-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
,	,	O
as	IN	O
mentioned	VBN	O
above	IN	O
,	,	O
showed	VBD	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
aggressively	RB	O
diuresed	VBN	O
with	IN	O
resolution	NN	O
of	IN	O
symptoms	NNS	B-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
being	VBG	O
sent	VBN	O
home	NN	O
on	IN	O
ecotrin	JJ	B-TREATMENT
one	CD	O
q.d.	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.l25	CD	O
mg	NN	O
every	DT	O
three	CD	O
days	NNS	O
,	,	O
quinidine	JJ	B-TREATMENT
648	CD	O
mg	NN	O
q.a.m.	NN	O
and	CC	O
324	CD	O
mg	NN	O
q.p.m.	NN	O
and	CC	O
q.h.s.	NN	O
,	,	O
mevacor	FW	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
carafate	VB	B-TREATMENT
one	CD	O
gram	NN	O
p.o.	NN	O
q.i.d.	NN	O
,	,	O
colace	NN	B-TREATMENT
l00	NN	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
potassium	NN	B-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
and	CC	O
iron	NN	B-TREATMENT
supplements	NNS	I-TREATMENT
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

mental	JJ	B-PROBLEM
status	NN	I-PROBLEM
change	NN	I-PROBLEM

intubation	NN	B-TREATMENT

39	CD	O
year	NN	O
old	JJ	O
male	NN	O
w/	NN	O
h/o	VBD	O
low	JJ	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
chronic	JJ	B-TREATMENT
narcotics	NNS	I-TREATMENT
presents	NNS	O
after	IN	O
being	VBG	O
found	VBD	O
unresponsive	JJ	B-PROBLEM
at	IN	O
home	NN	O
.	.	O

his	PRP$	O
daughter	NN	O
awoke	VBD	O
him	PRP	O
at	IN	O
7	CD	O
a.m.	RB	O
,	,	O
reports	NNS	O
he	PRP	O
said	VBD	O
he	PRP	O
felt	VBD	O
"	NNP	O
cold	NN	B-PROBLEM
and	CC	O
shivery	NN	B-PROBLEM
,"	RB	O
vomited	VBD	O
several	JJ	O
times	NNS	O
,	,	O
then	RB	O
drove	VBD	O
her	PRP	O
to	TO	O
school	NN	O
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
notice	VB	O
any	DT	B-PROBLEM
blood	NN	I-PROBLEM
/	NN	I-PROBLEM
urine	JJ	I-PROBLEM
/	NNP	I-PROBLEM
emesis	NN	I-PROBLEM
/	NNP	I-PROBLEM
stool	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bed	NN	I-PROBLEM
.	.	O

ems	NNS	O
found	VBD	O
him	PRP	O
with	IN	O
agonal	JJ	B-PROBLEM
respirations	NNS	I-PROBLEM
and	CC	O
pinpoint	NN	B-PROBLEM
pupils	NNS	I-PROBLEM
.	.	O

fs	RB	B-TEST
420	CD	O
.	.	O

he	PRP	O
received	VBD	O
1	CD	O
mg	NNS	O
iv	JJ	B-TREATMENT
narcan	JJ	I-TREATMENT
(	(	O
numerous	JJ	O
bottles	NNS	O
of	IN	O
oxycontin	NN	B-TREATMENT
,	,	O
percocet	NN	B-TREATMENT
were	VBD	O
found	VBN	O
in	IN	O
room	NN	O
);	IN	O
his	PRP$	O
pupils	NNS	O
dilated	VBN	O
to	TO	O
~	VB	O
8	CD	O
mm	NN	O
and	CC	O
he	PRP	O
became	VBD	O
combative	JJ	B-PROBLEM
/	NN	O
agitated	VBD	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
intubated	VBN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
(	(	O
etomidate	JJ	B-TREATMENT
/	NN	O
succinate	NN	B-TREATMENT
);	VBD	O
it	PRP	O
was	VBD	O
a	DT	B-TREATMENT
traumatic	JJ	I-TREATMENT
intubation	NN	I-TREATMENT

he	PRP	O
was	VBD	O
transported	VBN	O
to	TO	O
hallmark	VB	O
health	NN	O
system	NN	O
monica	NN	O
,	,	O
where	WRB	O
abg	RB	B-TEST
7.14/82/44	CD	O
while	IN	O
bagging	VBG	O
on	IN	O
100%	CD	B-TREATMENT
fio2	NN	I-TREATMENT
.	.	O

in	IN	O
monica	NN	O
,	,	O
pt	NN	O
received	VBD	O
charcoal	NN	B-TREATMENT
,	,	O
500	CD	O
mg	NN	O
iv	NN	B-TREATMENT
levofloxacin	NN	I-TREATMENT
,	,	O
500	CD	O
mg	NN	O
iv	NN	B-TREATMENT
metronidazole	NN	I-TREATMENT
for	IN	O
presumed	JJ	O
aspiration	NN	B-PROBLEM
pna	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
lbp	NN	I-PROBLEM
,	,	O
htn	NN	B-PROBLEM
,	,	O
anxiety	NN	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
,	,	O
l	JJ	B-TREATMENT
arm	NN	I-TREATMENT
surgeries	NNS	I-TREATMENT
(	(	O
hardware	NN	B-TREATMENT
in	IN	O
place	NN	O
)	)	O

on	IN	O
disability	NN	O
secondary	JJ	O
to	TO	O
work-related	JJ	B-PROBLEM
back	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

no	DT	O
other	JJ	O
known	VBN	O
drug	NN	O
use	NN	O
other	JJ	O
than	IN	O
oxycontin	JJ	B-TREATMENT
/	JJ	O
percocet	NN	B-TREATMENT
.	.	O

no	DT	O
family	NN	O
history	NN	O
of	IN	O
heart	NN	B-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
cancer	NN	B-PROBLEM

pe	NN	O
:	:	O
tc	NN	B-TEST
98.7	CD	O
,	,	O
pc	NN	B-TEST
88	CD	O
,	,	O
bpc	NN	B-TEST
120/60	CD	O
,	,	O
ac	RB	B-TEST
600/20	CD	O
,	,	O
fio2	RB	B-TEST
100%	CD	O
,	,	O
peep	RB	B-TEST
10	CD	O

gen	NN	O
:	:	O
young	JJ	O
male	NN	O
,	,	O
intubated	VBN	B-TREATMENT
,	,	O
sedated	VBN	B-TREATMENT
,	,	O
in	IN	O
hard	JJ	B-TREATMENT
collar	NN	I-TREATMENT
.	.	O

heent	NN	O
:	:	O
pupils	NNS	B-PROBLEM
pinpoint	NN	I-PROBLEM
,	,	O
equal	JJ	O
,	,	O
anicteric	JJ	B-PROBLEM
,	,	O
normal	JJ	O
conjunctiva	NN	O
,	,	O
intubated	VBN	B-TREATMENT
,	,	O
ogt	PRP	B-TREATMENT
in	IN	O
place	NN	O
,	,	O
ommm	NN	O
,	,	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM

cardiac	NN	O
:	:	O
rrr	NN	O
,	,	O
i/vi	JJ	B-PROBLEM
sm	NN	I-PROBLEM
at	IN	I-PROBLEM
apex	NN	I-PROBLEM
,	,	O
no	DT	O
r/g	NN	B-PROBLEM
appreciated	VBD	O

pulm	NN	O
:	:	O
coarse	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
throughout	IN	I-PROBLEM

abd	NN	O
:	:	O
mildly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
hypoactive	JJ	B-PROBLEM
bs	NN	I-PROBLEM
,	,	O
soft	JJ	O
,	,	O
no	DT	O
hsm	NN	B-PROBLEM

ext	NN	O
:	:	O
trace	NN	B-PROBLEM
le	NN	I-PROBLEM
edema	NN	I-PROBLEM
at	IN	I-PROBLEM
ankles	NNS	I-PROBLEM
,	,	O
extremities	NNS	B-PROBLEM
cool	VBP	I-PROBLEM
w/	RB	O
2+	CD	O
radial	JJ	B-TEST
,	,	O
1+	CD	O
dp/pt	NN	B-TEST
pulses	NNS	I-TEST
.	.	O

well-healed	JJ	B-PROBLEM
scars	NNS	I-PROBLEM
over	IN	I-PROBLEM
dorsal	JJ	I-PROBLEM
/	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
distal	NN	I-PROBLEM
lue	NN	I-PROBLEM

neuro	NN	O
:	:	O
dtr	NN	B-TEST
3+	CD	O
upper	NN	O
and	CC	O
lower	JJR	O
extremities	NNS	O
,	,	O
symmetric	JJ	O
bilaterally	RB	O
.	.	O

ekg	NN	B-TEST
nsr	NN	O
@	VBD	O
92	CD	O
bpm	NN	O
,	,	O
nl	JJ	O
axis	NN	O
,	,	O
borderline	NN	B-PROBLEM
qt	NN	I-PROBLEM
(	(	O
qtc	JJ	B-TEST
0.442	CD	O
),	JJ	O
j	NN	B-PROBLEM
pt	NN	I-PROBLEM
elevtation	NN	I-PROBLEM
v3	NN	B-TEST
,	,	O
twf	NN	B-TEST
ii	NN	I-TEST
,	,	O
iii	NN	B-TEST
,	,	O
avf	NN	B-TEST
,	,	O
i	NN	B-TEST
,	,	O
avl	NN	B-TEST
(	(	O
no	DT	O
prior	RB	B-TEST
ekg	NN	I-TEST
for	IN	O
comparison	NN	O
)	)	O

type	NN	O
-	:	O
art	NN	B-TEST
po2	VBZ	I-TEST
-	:	O
122	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
38	CD	O
ph	NN	B-TEST
-	:	O
7.43	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
26	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
1	CD	O

lactate	NN	B-TEST
-	:	O
2.0	CD	O

2012-03-23	JJ	O
01:30	CD	O
pm	NN	O
urine	NN	B-TEST

2012-03-23	JJ	O
01:30	CD	O
pm	NN	O
urine	NN	B-TEST

bnzodzpn	SYM	B-TEST
-	:	O
pos	NN	B-PROBLEM
barbitrt	SYM	B-TEST
-	:	O
neg	NN	O
opiates	VBZ	B-TEST
-	:	O
neg	NN	O
cocaine	NN	B-TEST
-	:	O
neg	NN	O
amphetmn	SYM	B-TEST
-	:	O
neg	NN	O
mthdone	NN	B-TEST
-	:	O
neg	NN	O

2012-03-23	JJ	O
01:30	CD	O
pm	NN	O
urine	NN	B-TEST

color	NN	O
-	:	O
straw	NN	O
appear	VBP	O
-	:	O
clear	JJ	O
sp	NN	B-TEST
barajas	SYM	I-TEST
-	:	O
1.015	CD	O

2012-03-23	JJ	O
01:30	CD	O
pm	NN	O
urine	NN	B-TEST

blood	NN	B-TEST
-	:	O
sm	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
30	CD	O
glucose	JJ	B-TEST
-	:	O
1000	CD	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
6.0	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

2012-03-23	JJ	O
01:30	CD	O
pm	NN	O
urine	NN	B-TEST

rbc	LS	B-TEST
-	:	O
03-10	JJ	O
*	NN	O
wbc	SYM	B-TEST
-	:	O
0-2	JJ	O
bacteria	NNS	B-TEST
-	:	O
few	JJ	B-PROBLEM
yeast	JJ	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
0	CD	O

2012-03-23	JJ	O
01:30	CD	O
pm	NN	O
urine	NN	B-TEST

mucous	JJ	B-TEST
-	:	O
few	JJ	O

po2	SYM	B-TEST
-	:	O
44	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
82	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.14	CD	O
*	JJ	O
total	NN	B-TEST
co2	NN	I-TEST
-	:	O
30	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
--	:	O
4	CD	O

glucose	JJ	B-TEST
-	:	O
296	CD	O
*	NN	O
lactate	NN	B-TEST
-	:	O
4.8	CD	O
*	NN	O
na+	SYM	B-TEST
-	:	O
140	CD	O
k+	SYM	B-TEST
-	:	O
5.2	CD	O
cl	NN	B-TEST
--	:	O
101	CD	O

urea	JJ	B-TEST
n	SYM	O
-	:	O
20	CD	O
creat	NN	B-TEST
-	:	O
1.1	CD	O

alt(sgpt)	SYM	B-TEST
-	:	O
30	CD	O
ast(sgot)	SYM	B-TEST
-	:	O
38	CD	O
ld(ldh)	SYM	B-TEST
-	:	O
217	CD	O
ck(cpk)	NN	B-TEST
-	:	O
1152	CD	O
*	NN	O
alk	NN	B-TEST
phos	IN	I-TEST
-	:	O
52	CD	O
amylase	NN	B-TEST
-	:	O
426	CD	O
*	JJ	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.4	CD	O

lipase	NN	B-TEST
-	:	O
22	CD	O

ck-mb	JJ	B-TEST
-	:	O
45	CD	O
*	JJ	O
mb	NN	B-TEST
indx	SYM	I-TEST
-	:	O
3.9	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

albumin	SYM	B-TEST
-	:	O
4.4	CD	O

asa	SYM	B-TEST
-	:	O
neg	NN	O
ethanol	SYM	B-TEST
-	:	O
neg	NN	O
acetmnphn	SYM	B-TEST
-	:	O
neg	NN	O
bnzodzpn	SYM	B-TEST
-	:	O
neg	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	JJ	O
tricyclic	JJ	B-TEST
-	:	O
neg	NN	O

wbc	SYM	B-TEST
-	:	O
8.9	CD	O
rbc	NN	B-TEST
-	:	O
3.93	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.1	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
36.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
30.8	CD	O
mchc	SYM	B-TEST
-	:	O
33.0	CD	O
rdw	NN	B-TEST
-	:	O
13.0	CD	O

neuts	NNS	B-TEST
-	:	O
84.7	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
13.1	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
1.5	CD	O
*	NN	O
eos	SYM	B-TEST
-	:	O
0.3	CD	O
basos	SYM	B-TEST
-	:	O
0.4	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
227	CD	O

pt	SYM	B-TEST
-	:	O
14.1	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
21.0	CD	O
*	NN	O
inr(pt)	NN	B-TEST
-	:	O
1.2	CD	O

fibrinoge	SYM	B-TEST
-	:	O
375	CD	O

2012-03-26	JJ	O
04:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
6.9	CD	O
rbc	NN	B-TEST
-	:	O
3.28	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.8	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
29.0	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
29.7	CD	O
mchc	SYM	B-TEST
-	:	O
33.6	CD	O
rdw	NN	B-TEST
-	:	O
13.1	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
206	CD	O

2012-03-26	JJ	O
04:30	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
206	CD	O

2012-03-26	JJ	O
04:30	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
88	CD	O
urean	JJ	B-TEST
-	:	O
10	CD	O
creat	NN	B-TEST
-	:	O
0.7	CD	O
na	SYM	B-TEST
-	:	O
143	CD	O
k-3.6	JJ	B-TEST
cl	NN	B-TEST
-	:	O
108	CD	O
hco3	NN	B-TEST
-	:	O
28	CD	O
angap	NN	B-TEST
-	:	O
11	CD	O

2012-03-26	JJ	O
04:30	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.5	CD	O
phos	NN	B-TEST
-	:	O
3.1	CD	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

2012-03-25	JJ	O
04:00	CD	O
am	VBP	O
blood	NN	B-TEST
caltibc	NN	B-TEST
-	:	O
237	CD	O
*	NN	O
ferritn	SYM	B-TEST
-	:	O
534	CD	O
*	NN	O
trf	SYM	B-TEST
-	:	O
182	CD	O
*	NN	O

a	DT	O
:	:	O
39	CD	O
year	NN	O
old	JJ	O
male	NN	O
w/	NN	O
htn	NN	B-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
lbp	NN	I-PROBLEM
on	IN	O
narcotics	NNS	B-TREATMENT
presents	NNS	O
after	IN	O
being	VBG	O
found	VBD	O
unresponsive	JJ	B-PROBLEM
at	IN	O
home	NN	O
.	.	O

1)	CD	O
unresponsiveness	JJ	B-PROBLEM
:	:	O
this	DT	O
is	VBZ	O
likely	JJ	O
due	JJ	O
todrug	NNS	B-PROBLEM
overdose	VBP	I-PROBLEM
(	(	O
known	VBN	O
oxycontin	NN	B-TREATMENT
use	NN	O
,	,	O
(+)	NNP	B-PROBLEM
bnz	NN	I-PROBLEM
on	IN	O
tox	NN	B-TEST
screen	NN	I-TEST
).	NN	O

ddx	NN	O
:	:	O
cardiac	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
(	(	O
no	DT	O
ischemic	NN	B-PROBLEM
ekg	NN	I-PROBLEM
changes	NNS	I-PROBLEM
noted	VBD	O
),	JJ	O
seizure	NN	B-PROBLEM
w/	VBD	O
post-ictal	JJ	B-PROBLEM
state	NN	I-PROBLEM
,	,	O
cva	NN	B-PROBLEM
(	(	O
head	JJ	B-TEST
ct	NN	I-TEST
neg	NN	O
).	NN	O

his	PRP$	B-TEST
cardiac	JJ	I-TEST
enzymes	NNS	I-TEST
include	VBP	O
only	RB	O
elevated	JJ	B-PROBLEM
ck	NN	I-PROBLEM
,	,	O
but	CC	O
not	RB	O
shaffer	VB	O
,	,	O
juan	NN	O
he	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
mi	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
communicate	VB	O
appropriately	RB	O
as	IN	O
his	PRP$	B-TEST
level	NN	I-TEST
of	IN	O
narcotic	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
waned	VBD	O
in	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
maintain	VB	O
a	DT	O
stable	JJ	O
mental	JJ	O
level	NN	O
for	IN	O
extubation	NN	B-TREATMENT
on	IN	O
03-24	NN	O
.	.	O

as	IN	O
of	IN	O
3/21	CD	O
,	,	O
he	PRP	O
was	VBD	O
alert	JJ	O
,	,	O
appropriate	JJ	O
and	CC	O
answers	NNS	O
questions	NNS	O
and	CC	O
follows	VBZ	O
command	NN	O
on	IN	O
exam	NN	B-TEST
.	.	O

2)	CD	O
pulmonary	JJ	B-PROBLEM
infiltrates	NNS	I-PROBLEM
:	:	O
there	EX	O
was	VBD	O
initially	RB	O
concern	NN	O
that	IN	O
he	PRP	O
was	VBD	O
developing	VBG	O
ards	NNS	B-PROBLEM
from	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
being	VBG	O
found	VBN	O
unconscious	JJ	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
intubated	VBN	O
and	CC	O
was	VBD	O
on	IN	O
mechanical	JJ	B-TREATMENT
ventilation	NN	I-TREATMENT
from	IN	O
9/13-10/11	CD	O
,	,	O
but	CC	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT

and	CC	O
flagyl	NN	B-TREATMENT
for	IN	O
total	NN	O
of	IN	O
4	CD	O
days	NNS	O
.	.	O

on	IN	O
03-26	NN	O
,	,	O
his	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
as	IN	O
this	DT	O
most	RBS	O
likely	JJ	O
represent	NN	O
a	DT	B-PROBLEM
transiet	JJ	I-PROBLEM
aspiration	NN	I-PROBLEM
episode	NN	I-PROBLEM
and	CC	O
not	RB	O
ards	NNS	B-PROBLEM
.	.	O

3)	CD	O
airway	JJ	B-TREATMENT
protection	NN	I-TREATMENT
:	:	O
he	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
in	IN	O
the	DT	O
field	NN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT

he	PRP	O
was	VBD	O
extubated	VBN	B-TREATMENT
on	IN	O
03-24	NN	O
and	CC	O
was	VBD	O
weaned	VBN	O
off	RP	O
oxygen	JJ	B-TREATMENT
slowly	RB	O
from	IN	O
03-24	JJ	O
to	TO	O
03-26	CD	O
without	IN	O
significant	JJ	O
event	NN	O
.	.	O

4)	CD	O
hypertension	NN	B-PROBLEM
:	:	O
he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
atenolol	NN	I-TREATMENT
and	CC	O
verapamil	NN	B-TREATMENT
once	RB	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
stabilized	VBN	O
on	IN	O
03-25	NN	O
.	.	O

5)	CD	O
depression	NN	B-PROBLEM
:	:	O
he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
paxil	NN	I-TREATMENT
on	IN	O
03-25	JJ	O
and	CC	O
was	VBD	O
given	VBN	B-TREATMENT
1:1	CD	I-TREATMENT
sitter	NN	I-TREATMENT
for	IN	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
leading	VBG	O
up	RP	O
to	TO	O
his	PRP$	O
suicide	NN	O
leading	VBG	O
up	RP	O
to	TO	O
this	DT	O
admission	NN	O
.	.	O

he	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
further	RBR	B-PROBLEM
episodes	NNS	I-PROBLEM
while	IN	O
he	PRP	O
was	VBD	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

-	:	O
plan	NN	O
to	TO	O
restart	VB	O
paxil	NN	B-TREATMENT
when	WRB	O
taking	VBG	O
po	NN	O

6)	CD	O
hyperglycemia	NN	B-PROBLEM
:	:	O
although	IN	O
he	PRP	O
has	VBZ	O
no	DT	O
known	VBN	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
his	PRP$	B-PROBLEM
elevated	JJ	I-PROBLEM
fs	NN	I-PROBLEM
noted	VBD	O
in	IN	O
field	NN	O
with	IN	O
glycosuria	NNS	B-PROBLEM
prompted	VBN	O
fingerstick	JJ	B-TEST
check	NN	I-TEST
but	CC	O
he	PRP	O
has	VBZ	O
not	RB	O
required	VBN	O
insulin	NN	B-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

7)	CD	O
high	JJ	B-PROBLEM
amylase	NN	I-PROBLEM
:	:	O
he	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
03-23	NN	O
with	IN	O
elevated	JJ	B-PROBLEM
amylase	NN	I-PROBLEM
but	CC	O
non-elevated	JJ	B-PROBLEM
lipase	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
amylase	NN	I-TEST
trended	VBD	O
down	RB	O
.	.	O

he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
regular	JJ	O
diet	NN	O
on	IN	O
4/14-4/17	JJ	O
after	IN	O
his	PRP$	B-TREATMENT
extubation	NN	I-TREATMENT

8)	CD	O
anemia	NN	B-PROBLEM
-	:	O
he	PRP	O
was	VBD	O
admitted	VBN	O
with	IN	O
borderline	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
with	IN	O
fe	JJ	B-TEST
studies	NNS	I-TEST
suggestive	VBP	O
of	IN	O
anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
his	PRP$	B-TEST
hct	NN	I-TEST
decreased	VBN	O
in	IN	O
the	DT	O
setting	NN	O
fluid	JJ	B-TREATMENT
resucitation	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
hct	NN	I-TEST
has	VBZ	O
stabilized	VBN	O
and	CC	O
improved	VBN	O
to	TO	O
close	VB	O
to	TO	O
30	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
3/21	CD	O
.	.	O

he	PRP	O
reports	VBZ	O
that	IN	O
his	PRP$	O
primary	JJ	O
physician	NN	O
is	VBZ	O
aware	JJ	O
of	IN	O
his	PRP$	B-PROBLEM
anemia	NN	I-PROBLEM
and	CC	O
was	VBD	O
in	IN	O
the	DT	O
process	NN	O
of	IN	O
followup	NN	O
.	.	O

oxycontin	NN	B-TREATMENT

percocet	NN	B-TREATMENT

paxil	NN	B-TREATMENT

gabapentin	NN	B-TREATMENT

atenolol	NN	B-TREATMENT

benzodiazipine	NN	B-PROBLEM
overdose	NN	I-PROBLEM

please	VB	O
take	VB	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
call	VB	O
your	PRP$	O
doctor	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
any	DT	B-PROBLEM
thoughts	NNS	I-PROBLEM
of	IN	I-PROBLEM
hurting	VBG	I-PROBLEM
yourself	PRP	I-PROBLEM
or	CC	I-PROBLEM
anyone	NN	I-PROBLEM
else	RB	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
lymphocytic	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM

chronic	JJ	B-PROBLEM
lymphocytic	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM
.	.	O

1.	CD	O
frequent	JJ	B-PROBLEM
headaches	NNS	I-PROBLEM
.	.	O

2.	CD	O
cholecystitis	NN	B-PROBLEM
.	.	O

3.	CD	O
spastic	JJ	B-PROBLEM
colon	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47-year-old	JJ	O
man	NN	O
with	IN	O
advanced	JJ	B-PROBLEM
stage	NN	I-PROBLEM
chronic	JJ	I-PROBLEM
lymphocytic	JJ	I-PROBLEM
leukemia	NN	I-PROBLEM
who	WP	O
was	VBD	O
admitted	VBN	O
for	IN	O
autologous	JJ	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
as	IN	O
per	IN	O
protocol	NN	O
94-055	CD	O
of	IN	O
the	DT	O
santusli	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
originally	RB	O
diagnosed	VBN	O
in	IN	O
06/98	CD	O
during	IN	O
a	DT	B-TEST
routine	JJ	I-TEST
physical	NN	I-TEST
when	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
20,000	CD	O
,	,	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
and	CC	O
swelling	VBG	B-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
neck	NN	I-PROBLEM
and	CC	I-PROBLEM
groin	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
watched	VBN	O
after	IN	O
his	PRP$	B-PROBLEM
initial	JJ	I-PROBLEM
diagnosis	NN	I-PROBLEM
,	,	O
but	CC	O
six	CD	O
months	NNS	O
later	RB	O
he	PRP	O
developed	VBD	O
rapidly	RB	B-PROBLEM
increasing	VBG	I-PROBLEM
leukocytosis	NN	I-PROBLEM
and	CC	O
he	PRP	O
became	VBD	O
more	RBR	B-PROBLEM
symptomatic	JJ	I-PROBLEM
.	.	O

after	IN	O
treatment	NN	B-TREATMENT
with	IN	I-TREATMENT
three	CD	I-TREATMENT
cycles	NNS	I-TREATMENT
of	IN	I-TREATMENT
fludarabine	NN	I-TREATMENT
he	PRP	O
had	VBD	O
90%	CD	B-PROBLEM
involvement	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
intratrabecular	JJ	I-PROBLEM
space	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
therefore	RB	O
treated	VBN	O
with	IN	O
three	CD	B-TREATMENT
cycles	NNS	I-TREATMENT
of	IN	I-TREATMENT
fludarabine	NN	I-TREATMENT
in	IN	O
combination	NN	O
with	IN	O
cytoxan	NN	B-TREATMENT
.	.	O

after	IN	O
this	DT	B-TREATMENT
therapy	NN	I-TREATMENT
he	PRP	O
achieved	VBD	O
a	DT	B-PROBLEM
protocol	NN	I-PROBLEM
eligible	JJ	I-PROBLEM
minimal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
he	PRP	O
did	VBD	O
have	VB	O
relative	JJ	B-PROBLEM
pancytopenia	NN	I-PROBLEM
following	VBG	O
this	DT	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
bone	VB	B-TREATMENT
marrow	NN	I-TREATMENT
harvest	NN	I-TREATMENT
in	IN	O
08/22	CD	O
at	IN	O
which	WDT	O
time	NN	O
insufficient	NN	B-PROBLEM
cells	NNS	I-PROBLEM
were	VBD	O
obtained	VBN	O
to	TO	O
proceed	VB	O
.	.	O

he	PRP	O
was	VBD	O
returned	VBN	O
previous	JJ	O
to	TO	O
this	DT	O
admission	NN	O
for	IN	O
repeat	NN	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
harvest	NN	I-TREATMENT
and	CC	O
at	IN	O
that	DT	O
time	NN	O
he	PRP	O
was	VBD	O
given	VBN	O
neupogen	RB	B-TREATMENT
prior	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
harvest	NN	I-TREATMENT
,	,	O
and	CC	O
sufficient	JJ	O
cells	NNS	O
were	VBD	O
not	RB	O
obtained	VBN	O
to	TO	O
proceed	VB	O
with	IN	O
autologous	JJ	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
revealed	VBD	O
less	JJR	B-PROBLEM
than	IN	I-PROBLEM
5%	CD	I-PROBLEM
of	IN	I-PROBLEM
intratrabecular	JJ	I-PROBLEM
space	NN	I-PROBLEM
involvement	NN	I-PROBLEM
.	.	O

recent	JJ	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

1.	CD	O
episode	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
in	IN	O
1996	CD	O
.	.	O

2.	CD	O
at	IN	O
the	DT	O
age	NN	O
of	IN	O
40	CD	O
he	PRP	O
had	VBD	O
problems	NNS	O
with	IN	O
frequent	JJ	B-PROBLEM
headaches	NNS	I-PROBLEM
.	.	O

3.	CD	O
episodes	NNS	O
of	IN	O
cholecystitis	NN	B-PROBLEM
and	CC	O
spastic	JJ	B-PROBLEM
colon	NN	I-PROBLEM
.	.	O

no	DT	O
medications	NNS	B-TREATMENT
upon	IN	O
admission	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

his	PRP$	O
father	NN	O
had	VBD	O
prostate	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

mother	NN	O
had	VBD	O
breast	VBN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

has	VBZ	O
a	DT	O
cousin	NN	O
with	IN	O
a	DT	B-PROBLEM
brain	NN	I-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

no	DT	O
family	NN	O
history	NN	O
of	IN	O
leukemia	NN	B-PROBLEM
or	CC	O
lymphoma	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
he	PRP	O
had	VBD	O
no	DT	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
tract	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
bowel	NN	I-PROBLEM
habits	NNS	I-PROBLEM
or	CC	O
abdomen	NNS	B-PROBLEM
pain	VBP	I-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
complain	NN	O
of	IN	O
frequent	JJ	B-PROBLEM
headaches	NNS	I-PROBLEM
.	.	O

following	VBG	O
his	PRP$	B-TREATMENT
recent	JJ	I-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
harvest	NN	I-TREATMENT
he	PRP	O
had	VBD	O
protracted	VBN	O
episodes	NNS	O
of	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
well-appearing	JJ	O
and	CC	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

weight	NN	B-TEST
70.4	CD	O
kilograms	NNS	O
,	,	O
temperature	NN	B-TEST
96.5	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
105/60	CD	O
,	,	O
pulse	RB	B-TEST
76	CD	O
.	.	O

unremarkable	JJ	O
without	IN	O
rashes	NNS	B-PROBLEM
or	CC	O
lesions	NNS	B-PROBLEM
.	.	O

sclerae	NN	B-PROBLEM
anicteric	NN	I-PROBLEM
.	.	O

oropharynx	NN	O
,	,	O
lips	NNS	O
,	,	O
teeth	NNS	O
and	CC	O
gums	NNS	O
were	VBD	O
without	IN	O
lesions	NNS	B-PROBLEM
and	CC	O
without	IN	O
evidence	NN	O
of	IN	O
mucositis	NN	B-PROBLEM
.	.	O

no	DT	O
cervical	JJ	B-PROBLEM
,	,	I-PROBLEM
supraclavicular	JJ	I-PROBLEM
or	CC	I-PROBLEM
axillary	JJ	I-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

heart	NN	B-TEST
sounds	VBZ	I-TEST
normal	JJ	O
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
without	IN	O
any	DT	B-PROBLEM
masses	NNS	I-PROBLEM
and	CC	O
without	IN	O
any	DT	B-PROBLEM
hepatosplenomegaly	NN	I-PROBLEM
.	.	O

without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

electrolytes	NNS	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
10.4	CD	O
,	,	O
hemoglobin	NN	B-TEST
11.9	CD	O
,	,	O
platelets	NNS	B-TEST
124	CD	O
,	,	O
pt	NN	B-TEST
and	CC	O
ptt	NN	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
10/22/00	CD	O
and	CC	O
received	VBD	O
cytoxan	NNS	B-TREATMENT
and	CC	O
total	JJ	B-TREATMENT
body	NN	I-TREATMENT
irradiation	NN	I-TREATMENT
per	IN	O
protocol	NN	O
.	.	O

autologous	JJ	B-TREATMENT
bone	NN	I-TREATMENT
marrow	NN	I-TREATMENT
infusion	NN	I-TREATMENT
occurred	VBD	O
on	IN	O
10/29/00	CD	O
and	CC	O
was	VBD	O
uneventful	JJ	O
.	.	O

his	PRP$	O
post-transplant	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
pain	NN	B-PROBLEM
from	IN	O
mucositis	NN	B-PROBLEM
and	CC	O
recalcitrant	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
and	CC	I-PROBLEM
vomiting	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
tolerate	VB	O
antiemetics	NNS	B-TREATMENT
well	RB	O
and	CC	O
it	PRP	O
was	VBD	O
subsequently	RB	O
decided	VBN	O
to	TO	O
avoid	VB	O
phenothiazides	NNS	B-TREATMENT
secondary	JJ	O
to	TO	O
jitteryness	NN	B-PROBLEM
and	CC	O
restless	NN	B-PROBLEM
legs	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
until	IN	O
day	NN	O
+11	VBD	O
when	WRB	O
he	PRP	O
spiked	VBD	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
ceftazidime	NN	B-TREATMENT
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
acquired	VBD	O
intermittent	JJ	B-TREATMENT
transfusions	NNS	I-TREATMENT
for	IN	O
pancytopenia	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
well	RB	O
nourished	VBN	O
so	RB	O
tpn	JJ	B-TREATMENT
was	VBD	O
not	RB	O
started	VBN	O
.	.	O

i	NN	B-TEST
&apos;s	NN	I-TEST
and	CC	I-TEST
o	JJ	I-TEST
&apos;s	NNS	I-TEST
were	VBD	O
balanced	VBN	O
and	CC	O
maintained	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

tylenol	RB	B-TREATMENT
650	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
4-6h	JJ	O
p.r.n.	NN	O
headache	NN	B-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
;	:	O
acyclovir	CC	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.;	NN	O
acyclovir	JJ	B-TREATMENT
topical	JJ	I-TREATMENT
t.i.d.	NN	O
to	TO	O
be	VB	O
applied	VBN	O
to	TO	O
lesion	VB	B-PROBLEM
on	IN	I-PROBLEM
corner	NN	I-PROBLEM
of	IN	I-PROBLEM
mouth	NN	I-PROBLEM
;	:	O
peridex	CC	B-TREATMENT
15	CD	O
ml	NN	O
p.o.	NN	O
b.i.d.;	NN	O
mycelex	VBD	B-TREATMENT
1	CD	O
troche	NN	O
p.o.	NN	O
t.i.d.;	VBD	O
g-csf	JJ	O
404	CD	O
mcg	NN	O
subcu	NN	O
q.d.;	VBZ	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.;	JJ	O
lorazepam	JJ	B-TREATMENT
1-2	JJ	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
4-6h	JJ	O
p.r.n.	NN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
;	:	O
miracle	CC	B-TREATMENT
cream	VB	I-TREATMENT
topical	JJ	O
q.d.	NN	O
p.r.n.	JJ	O
perianal	JJ	B-PROBLEM
irritation	NN	I-PROBLEM
;	:	O
eucerin	CC	B-TREATMENT
cream	VB	I-TREATMENT
topical	JJ	O
b.i.d.;	NN	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.;	NN	O
restoril	VBD	B-TREATMENT
15-30	JJ	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O
insomnia	NN	B-PROBLEM
;	:	O
multivitamin	CC	B-TREATMENT
1	CD	O
tablet	NN	O
p.o.	NN	O
q.d.;	RB	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT
15	CD	O
ml	NN	O
p.o.	NN	O
q.	$	O
3h	CD	O
can	MD	O
be	VB	O
applied	VBN	O
to	TO	O
corner	NN	O
of	IN	O
mouth	NN	O
or	CC	O
lips	NNS	O
p.r.n.	VBP	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
knows	VBZ	O
to	TO	O
go	VB	O
to	TO	O
sper	VB	O
medical	JJ	O
center	NN	O
every	DT	O
day	NN	O
for	IN	O
line	NN	B-TREATMENT
care	NN	I-TREATMENT
,	,	O
blood	NN	B-TEST
draws	NNS	I-TEST
,	,	O
and	CC	O
monitoring	NN	B-TEST
.	.	O

penicillins	NNS	B-TREATMENT
/	VBP	O
estrogens	NNS	B-TREATMENT
/	VBP	O
ancef	JJ	B-TREATMENT
/	NNP	O
tegretol	NN	B-TREATMENT
/	NN	O
keflex	NN	B-TREATMENT

hypotension	NN	B-PROBLEM

nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT

47	CD	O
yo	JJ	O
f	NN	O
w/	NN	O
h/o	VBD	O
steroid-induced	JJ	B-PROBLEM
hyperglycemia	NN	I-PROBLEM
,	,	O
sle	JJ	B-PROBLEM
w/	NN	O
h/o	NN	O
pericarditis	NN	B-PROBLEM
,	,	O
transverse	JJ	B-PROBLEM
myelitis	NN	I-PROBLEM
w/	NN	O
paraplegia	NN	B-PROBLEM
and	CC	O
neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
s/p	NN	B-TREATMENT
urostomy	JJ	I-TREATMENT
w/	JJ	O
ileal	NN	B-TREATMENT
conduit	NN	I-TREATMENT
,	,	O
h/o	NN	O
ureteropelvic	JJ	B-PROBLEM
stone	NN	I-PROBLEM
and	CC	O
urosepsis	NN	B-PROBLEM
,	,	O
and	CC	O
h/o	JJ	O
rle	NN	B-PROBLEM
dvt	NN	I-PROBLEM
a/w	JJ	O
f	JJ	O
2014-11-29	JJ	O
transferred	VBN	O
to	TO	O
cmed	VB	O
2014-11-30	JJ	O
for	IN	O
hypotn	NN	B-PROBLEM
resistant	NN	O
to	TO	O
ivfs	VB	B-TREATMENT
and	CC	O
stress	VB	B-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

patient	NN	O
initially	RB	O
p/w	JJ	O
c/o	NN	O
sudden	JJ	B-PROBLEM
onset	NN	I-PROBLEM
n/abd	NN	I-PROBLEM
pain/chills	NNS	I-PROBLEM
w/	VBP	O
t	JJ	B-TEST
103	CD	O
at	IN	O
nh	NN	O
.	.	O

rigors	NNS	B-PROBLEM
progressed	VBD	O
so	RB	O
she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
robert	VB	O
.	.	O

she	PRP	O
reported	VBD	O
h/o	JJ	O
fatigue	NN	B-PROBLEM
and	CC	O
anorexia	NN	B-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
and	CC	O
had	VBD	O
noticed	VBN	O
foul	JJ	B-PROBLEM
smelling	VBG	I-PROBLEM
urine	NN	I-PROBLEM
and	CC	O
some	DT	O
abdominal	JJ	B-PROBLEM
distension	NN	I-PROBLEM
,	,	O
similar	JJ	O
to	TO	O
prior	VB	O
episodes	NNS	O
of	IN	O
pyelo	NN	B-PROBLEM
.	.	O

she	PRP	O
also	RB	O
c/o	VBP	O
llq	NNS	B-PROBLEM
and	CC	I-PROBLEM
groin	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
responded	VBD	O
to	TO	O
tylenol	VB	B-TREATMENT
.	.	O

she	PRP	O
denies	VBZ	O
v	NN	B-PROBLEM
or	CC	O
d	NN	B-PROBLEM
.	.	O

no	DT	O
ams	NN	B-PROBLEM
.	.	O

no	DT	O
c/o	NN	O
cp	NN	B-PROBLEM
.	.	O

on	IN	O
arrival	NN	O
to	TO	O
shirley	VB	O
,	,	O
temperature	NN	B-TEST
was	VBD	O
101.2	CD	O
.	.	O

ct	NN	B-TEST
abd	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
8	CD	I-PROBLEM
mm	NN	I-PROBLEM
right	RB	I-PROBLEM
proximal	JJ	I-PROBLEM
ureteral	JJ	I-PROBLEM
stone	NN	I-PROBLEM
with	IN	O
right-sided	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
and	CC	O
inflammatory	NN	B-PROBLEM
stranding	NN	I-PROBLEM
,	,	O
in	IN	O
addition	NN	O
to	TO	O
pyelonephritis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
kidney	NN	I-PROBLEM
without	IN	O
left	NN	B-PROBLEM
sided	VBD	I-PROBLEM
hydronephrosis	NN	I-PROBLEM
.	.	O

labs	NNS	B-TEST
were	VBD	O
remarkable	JJ	O
for	IN	O
wbc	JJ	B-TEST
23.5	CD	O
w/	NN	O
1%	CD	O
bands	NNS	B-TEST
which	WDT	O
decreased	VBD	O
to	TO	O
14	CD	O
today	NN	O
but	CC	O
now	RB	O
w/	VBZ	O
15%	CD	O
bands	NNS	B-TEST
on	IN	O
vanc	NN	B-TREATMENT
(	(	O
h/o	JJ	O
mrsa	NN	B-PROBLEM
urosepsis	NN	I-PROBLEM
)	)	O
and	CC	O
gent	NN	B-TREATMENT
(	(	O
mult	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
)	)	O
.	.	O

ag	NN	B-TEST
on	IN	O
admission	NN	O
18	CD	O
(	(	O
bicarb	NN	B-TEST
17	CD	O
,	,	O
down	RB	O
from	IN	O
23	CD	O
on	IN	O
a	DT	O
previous	JJ	O
admission	NN	O
)	)	O
,	,	O
down	RB	O
to	TO	O
ag	VB	B-TEST
15	CD	O
this	DT	O
am	VBP	O
.	.	O

abg	RB	B-TEST
prior	RB	O
to	TO	O
transfer	VB	O
(	(	O
on	IN	O
room	NN	O
air	NN	O
)	)	O
:	:	O

7.43/24/69	CD	O
w/	JJ	O
lactate	NN	B-TEST
1.3	CD	O
(	(	O
down	IN	O
from	IN	O
1.4	CD	O
on	IN	O
the	DT	O
prior	JJ	O
day	NN	O
)	)	O
.	.	O

currently	RB	O
,	,	O
03-14	JJ	O
blood	NN	B-TEST
cx	NNS	I-TEST
are	VBP	O
growing	VBG	O
gnr	NN	B-PROBLEM
in	IN	O
both	DT	O
anaerobic	JJ	O
bottles	NNS	O
.	.	O

urine	JJ	B-TEST
cx	NN	I-TEST
is	VBZ	O
pending	VBG	O
.	.	O

prior	RB	O
to	TO	O
transfer	VB	O
,	,	O
patient	NN	O
dropped	VBD	O
bp	NN	B-TEST
to	TO	O
68/40s	CD	O
.	.	O

bp	NN	B-TEST
did	VBD	O
not	RB	O
improve	VB	O
despite	IN	O
2	CD	O
l	NN	O
ns	NN	B-TREATMENT
and	CC	O
100	CD	O
mg	NN	O
iv	NN	B-TREATMENT
hydrocortisone	NN	I-TREATMENT
.	.	O

a	DT	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
ir	VB	O
for	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
nephrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

##	JJ	O
h/o	NN	O
nephrolithiasis	NN	B-PROBLEM
s/p	NN	O
lithotripsy	NN	B-TREATMENT
and	CC	O
h/o	NN	O
left	VBD	B-PROBLEM
ureteropelvic	JJ	I-PROBLEM
junction	NN	I-PROBLEM
stone	NN	I-PROBLEM
'03	POS	O
spontaneously	RB	O
passing	VBG	O
by	IN	O
u/s	JJ	B-TEST
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
right	JJ	B-PROBLEM
stone	NN	I-PROBLEM
on	IN	O
most	JJS	B-TEST
recent	JJ	I-TEST
u/s	JJ	I-TEST
5	CD	O
months	NNS	O
ago	RB	O

##	JJ	O
h/o	NN	O
pyelo	NN	B-PROBLEM
,	,	O
last	JJ	O
episode	NN	O
in	IN	O
'03	NNP	O
(	(	O
mrsa	NN	B-PROBLEM
in	IN	I-PROBLEM
blood	NN	I-PROBLEM
and	CC	I-PROBLEM
urine	NN	I-PROBLEM
)	)	O

##	JJ	O
sle	NN	B-PROBLEM
w/	NN	O
h/o	NN	O
pericarditis	NN	B-PROBLEM
,	,	O
last	JJ	O
flare	JJ	O
couple	NN	O
years	NNS	O
ago	RB	O
,	,	O
didn	NN	O
't	POS	O
flare	NN	O
w/	NN	O
urosepsis	NN	B-PROBLEM

##	JJ	O
devic	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
:	:	O

recurrent	JJ	B-PROBLEM
transverse	NN	I-PROBLEM
myelitis	NN	I-PROBLEM
with	IN	O
sequelae	NN	O
of	IN	O
paraplegia-exacerbation	NN	B-PROBLEM
in	IN	O
93	CD	O
recurrent	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
optic	JJ	I-PROBLEM
neuritis	NN	I-PROBLEM
with	IN	O
legal	JJ	O

(	(	O
neurologist	NN	O
:	:	O
dr.	JJ	O
heaton	NN	O
,	,	O
umass	JJ	O
memorial	JJ	O
medical	JJ	O
center	NN	O
)	)	O
-	:	O
(	(	O
steroids	NNS	B-TREATMENT
increased	VBD	O
to	TO	O
40	CD	O
qd	NNS	O
in	IN	O
renee	NN	O
for	IN	O
concern	NN	O
for	IN	O
recurrent	NN	B-PROBLEM
optic	JJ	I-PROBLEM
neuritis	NN	I-PROBLEM
which	WDT	O
turned	VBD	O
out	RP	O
to	TO	O
be	VB	O
capsular	JJ	B-PROBLEM
ossification	NN	I-PROBLEM
)	)	O

##	JJ	O
blindness	NN	B-PROBLEM
in	IN	I-PROBLEM
right	NN	I-PROBLEM
cmed	VBN	O
csru	NN	O
.	.	O

##	JJ	O
bilateral	JJ	B-PROBLEM
knee	NN	I-PROBLEM
arthritis	NN	I-PROBLEM

##	RB	O
suspected	VBN	O
glaucoma	NN	B-PROBLEM
in	IN	I-PROBLEM
left	NN	I-PROBLEM
cmed	VBN	O
csru	NN	O
,	,	O
turned	VBD	O
out	RP	O
to	TO	O
be	VB	O
capsular	JJ	B-PROBLEM
ossification	NN	I-PROBLEM
or	CC	O
a	DT	B-PROBLEM
secondary	JJ	I-PROBLEM
cataract	NN	I-PROBLEM
,	,	O
corrected	VBN	O
w/	NN	O
laser	NN	B-TREATMENT
surgery	NN	I-TREATMENT

##	JJ	O
urostomy	JJ	B-TREATMENT
s/p	NN	O
ileal	NN	B-TREATMENT
loop	NN	I-TREATMENT
conduit	NN	I-TREATMENT
in	IN	O
2007	CD	O
for	IN	O
neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
w/	NN	O
persistent	NN	B-PROBLEM
leak	NN	I-PROBLEM

##	JJ	O
steroid-induced	JJ	B-PROBLEM
hyperglycemia	NN	I-PROBLEM

##	NN	O
hypothyroid	NN	B-PROBLEM

##	JJ	O
osteoporosis	NN	B-PROBLEM

##	JJ	O
hx	NN	O
of	IN	O
dvt	NN	B-PROBLEM
in	IN	I-PROBLEM
rle	NN	I-PROBLEM
'93	CD	O
-	:	O
on	IN	O
coumadin	NN	B-TREATMENT
for	IN	O
a	DT	O
couple	NN	O
years	NNS	O
and	CC	O
then	RB	O
asa	VB	B-TREATMENT
until	IN	O
a	DT	O
couple	JJ	O
months	NNS	O
ago	IN	O

lives	NNS	O
at	IN	O
lowell	NNP	O
home	NN	O
nh	NN	O
x	VBD	O
11	CD	O
yrs	NNS	O
due	JJ	O
to	TO	O
chronic	JJ	B-PROBLEM
cmed	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

wheelchair	NN	B-PROBLEM
dependent	JJ	I-PROBLEM
+	NN	O
requires	VBZ	O
hoyer	JJ	B-TREATMENT
lift	NN	I-TREATMENT
.	.	O

ue	JJ	B-TEST
strength	NN	I-TEST
intact	JJ	O
but	CC	O
poor	JJ	B-PROBLEM
motor	NN	I-PROBLEM
movements	NNS	I-PROBLEM
due	JJ	O
to	TO	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
sensation	NN	I-PROBLEM
.	.	O

mother	NN	O
died	VBD	O
at	IN	O
51	CD	O
metastatic	JJ	B-PROBLEM
bca	NN	I-PROBLEM

father	RB	O
died	VBD	O
at	IN	O
36	CD	O
aplastic	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
only	RB	O
child	NN	O

t	RB	B-TEST
100.0	CD	O
bp	NNS	B-TEST
109/56	CD	O

cvp	NN	B-TEST
11	CD	O
hr	NN	B-TEST
113	CD	O
rr	NN	B-TEST
16	CD	O

o2	RB	B-TEST
95%	CD	O
on	IN	O
3l	CD	B-TREATMENT
nc	JJ	I-TREATMENT
mixed	JJ	O
quinn	NN	O
82%	CD	O
genrl	NN	O
:	:	O
in	IN	O
nad	NN	B-PROBLEM
,	,	O
resting	VBG	O
comfortably	RB	O
heent	NN	O
:	:	O
perrla	NN	O
(	(	O
4->3	JJ	O
mm	NN	O
)	)	O
bilaterally	RB	O
,	,	O
blind	NN	B-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
visual	JJ	I-PROBLEM
field	NN	I-PROBLEM
,	,	O
eomi	RB	O
,	,	O
dry	JJ	B-PROBLEM
mm	NN	I-PROBLEM
,	,	O
?	.	O
thrush	JJ	B-PROBLEM
neck	NN	O
:	:	O
no	DT	O
bruits	NNS	B-PROBLEM
cv	NN	O
:	:	O
rrr	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM
,	,	O
faint	NN	B-PROBLEM
s1/s2	NN	I-PROBLEM
pulm	NN	O
:	:	O
cta	NN	O
bilaterally	RB	O
abd	VBZ	O
:	:	O
midline	NN	B-PROBLEM
scar	NN	I-PROBLEM
(	(	O
from	IN	O
urostomy	NN	B-TREATMENT
)	)	O
,	,	O
nabs	UH	O
,	,	O
soft	JJ	O
,	,	O
appears	VBZ	O
distended	JJ	B-PROBLEM
but	CC	O
patient	JJ	O
denies	NNS	O
,	,	O
ostomy	JJ	B-TREATMENT
rlq	NN	O
c/d/i	NN	O
,	,	O
nt	NN	B-PROBLEM
to	TO	O
palpation	VB	B-TEST
back	RB	O
:	:	O
right	NN	B-TREATMENT
flank	NN	I-TREATMENT
urostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
,	,	O
c/d/i	NN	O
,	,	O
nt	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
extr	NN	O
:	:	O
no	DT	O
gardner	NN	B-TEST
neuro	RB	O
:	:	O
a	DT	O
,	,	O
ox3	NN	O
,	,	O
wiggles	VBZ	O
toes	NNS	O
bilaterally	RB	O
,	,	O
unable	JJ	B-PROBLEM
to	TO	I-PROBLEM
lift	VB	I-PROBLEM
le	NN	I-PROBLEM
,	,	O
06-12	JJ	O
grip	NN	O
bilaterally	RB	O
w/	JJ	O
ue	NN	O
,	,	O
decrease	NN	B-PROBLEM
sensation	NN	I-PROBLEM
to	TO	O
soft	JJ	O
touch	NN	O
in	IN	O
left	NN	O

wbc	SYM	B-TEST
-	:	O
23.5*#	CD	O
rbc	NN	B-TEST
-	:	O
3.81*	CD	O
hgb	NN	B-TEST
-	:	O
9.4*	CD	O
hct	NN	B-TEST
-	:	O
29.2*	CD	O

mcv	SYM	B-TEST
-	:	O
77*#	CD	O
mch	SYM	B-TEST
-	:	O
24.6*#	CD	O
mchc	SYM	B-TEST
-	:	O
32.1	CD	O
rdw	NN	B-TEST
-	:	O
18.1*	CD	O

neuts	NNS	B-TEST
-	:	O
93*	CD	O
bands	NNS	B-TEST
-	:	O
1	CD	O
lymphs	SYM	B-TEST
-	:	O
0	CD	O
monos	NNS	B-TEST
-	:	O
6	CD	O
eos	SYM	B-TEST
-	:	O
0	CD	O

basos	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
0	CD	O
metas	NNS	B-TEST
-	:	O
0	CD	O
myelos	SYM	B-TEST
-	:	O
0	CD	O

glucose	JJ	B-TEST
-	:	O
229*	CD	O
urea	JJ	B-TEST
n	SYM	O
-	:	O
25*	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
sodium	NN	B-TEST
-	:	O
136	CD	O

potassium	NN	B-TEST
-	:	O
5.3*	CD	O
chloride	NN	B-TEST
-	:	O
101	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
17*	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
23*	CD	O

ld	NN	B-TEST
(	(	I-TEST
ldh	NN	I-TEST
)	)	I-TEST
-	:	O
214	CD	O

lactate	NN	B-TEST
-	:	O
1.4	CD	O

2014-11-29	JJ	O
05:11pm	CD	O
urine	NN	B-TEST

color	NN	B-TEST
-	:	O
straw	NN	O
appear	VBP	B-TEST
-	:	O
hazy	NN	O
sp	NN	O
thibodeaux	SYM	B-TEST
-	:	O
1.008	CD	O

2014-11-29	JJ	O
05:11pm	CD	O
urine	NN	B-TEST

blood	NN	B-TEST
-	:	O
lg	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
tr	NN	O

glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
9.0*	CD	O

leuk	SYM	B-TEST
-	:	O
sm	NN	O

2014-11-29	JJ	O
05:11pm	CD	O
urine	NN	B-TEST

rbc	LS	B-TEST
-	:	O
21-50*	JJ	O
wbc	JJ	B-TEST
-	:	O
04-12	NN	O
bacteria	NNS	B-TEST
-	:	O
many	JJ	O

yeast	SYM	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
0-2	NN	O

2014-11-29	JJ	O
05:11pm	CD	O
urine	NN	B-TEST

3phosphat	LS	B-TEST
-	:	O
occ	NN	O

2014-11-29	JJ	O
ct	NN	B-TEST
cap	NN	I-TEST
:	:	O

1.	CD	O
an	DT	B-PROBLEM
8	CD	I-PROBLEM
x	NN	I-PROBLEM
7	CD	I-PROBLEM
x	JJ	I-PROBLEM
7	CD	I-PROBLEM
mm	JJ	I-PROBLEM
stone	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
ureter	NN	I-PROBLEM
with	IN	O
associated	JJ	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
and	CC	O
inflammatory	JJ	B-PROBLEM
perinephric	JJ	I-PROBLEM
stranding	NN	I-PROBLEM
.	.	O

additional	JJ	B-PROBLEM
smaller	JJR	I-PROBLEM
non-obstructing	JJ	I-PROBLEM
right	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
stones	NNS	I-PROBLEM
.	.	O

2.	CD	O
left	VBD	B-PROBLEM
renal	JJ	I-PROBLEM
stones	NNS	I-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
hydronephrosis	NN	B-PROBLEM
.	.	O

ileal	JJ	B-TREATMENT
conduit	NN	I-TREATMENT
is	VBZ	O
not	RB	O
well	RB	O
evaluated	VBN	O
.	.	O

3.	CD	O
right	JJ	B-PROBLEM
breast	NN	I-PROBLEM
calcification	NN	I-PROBLEM
.	.	O

correlation	NN	O
with	IN	O
mammography	NN	B-TEST
is	VBZ	O
suggested	VBN	O
.	.	O

2014-11-29	JJ	O
cxr	NN	B-TEST
:	:	O

no	DT	O
evidence	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

2014-11-29	JJ	O
ct	NN	B-TEST
ap	NN	I-TEST
#2	NNP	I-TEST
(	(	I-TEST
with	IN	I-TEST
contrast	NN	I-TEST
)	)	I-TEST
:	:	O

1.	CD	O
eight	CD	B-PROBLEM
mm	NNS	I-PROBLEM
right	RB	I-PROBLEM
proximal	JJ	I-PROBLEM
ureteral	JJ	I-PROBLEM
stone	NN	I-PROBLEM
with	IN	O
right-sided	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
and	CC	O
inflammatory	JJ	B-PROBLEM
stranding	NN	I-PROBLEM
.	.	O

pyelonephritis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
kidney	NN	I-PROBLEM
without	IN	O
left	NN	B-PROBLEM
sided	VBD	I-PROBLEM
hydronephrosis	NN	I-PROBLEM
.	.	O

2.	CD	O
no	DT	O
evidence	NN	O
of	IN	O
intraabdominal	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
or	CC	O
of	IN	O
diverticulitis	NN	B-PROBLEM
.	.	O

3.	CD	O
bilateral	JJ	B-PROBLEM
round	NN	I-PROBLEM
,	,	I-PROBLEM
hypodense	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
too	RB	O
small	JJ	O
to	TO	O
accurately	RB	O
characterize	VB	O
but	CC	O
likely	JJ	O
representing	VBG	O
cysts	NNS	B-PROBLEM
.	.	O

4.	CD	O
1.4	CD	B-PROBLEM
cm	NN	I-PROBLEM
hypodense	NN	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
is	VBZ	O
incompletely	RB	O
characterized	VBN	O
.	.	O

2014-11-30	JJ	O
ct	NN	B-TEST
cap	NN	I-TEST
:	:	O

1.	CD	O
nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
kidney	NN	I-TREATMENT
with	IN	O
an	DT	B-PROBLEM
8	CD	I-PROBLEM
mm	NN	I-PROBLEM
right	RB	I-PROBLEM
ureteric	JJ	I-PROBLEM
stone	NN	I-PROBLEM
.	.	O

2.	CD	O
6	CD	B-PROBLEM
mm	NN	I-PROBLEM
nonobstructing	VBG	I-PROBLEM
calculus	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
kidney	NN	I-PROBLEM
.	.	O

3.	CD	O
calcified	JJ	B-PROBLEM
focus	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
hypodense	NN	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
,	,	O
incompletely	RB	O
characterized	VBN	O
.	.	O

4.	CD	O
bibasilar	JJ	B-PROBLEM
and	CC	I-PROBLEM
dependent	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
.	.	O

2014-11-29	JJ	O
5:10	CD	O
pm	NN	O
blood	NN	B-TEST
culture	NN	I-TEST

aerobic	JJ	B-TEST
bottle	NN	I-TEST
(	(	O
final	JJ	O
2014-12-04	NN	O
)	)	O
:	:	O

klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM
.	.	O

identification	NN	B-TEST
and	CC	O
sensitivities	NNS	B-TEST
performed	VBN	O
from	IN	O

anaerobic	JJ	B-TEST
bottle	NN	I-TEST
.	.	O

of	IN	O
two	CD	B-PROBLEM
colonial	JJ	I-PROBLEM
morphologies	NNS	I-PROBLEM
.	.	O

anaerobic	JJ	B-TEST
bottle	NN	I-TEST
(	(	O
final	JJ	O
2014-12-04	NN	O
)	)	O
:	:	O

klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM
.	.	O

final	JJ	B-TEST
sensitivities	NNS	I-TEST
.	.	O

trimethoprim/sulfa	JJ	B-TEST
sensitivity	NN	I-TEST
testing	VBG	I-TEST
available	JJ	O
on	IN	O
request	NN	O
.	.	O

klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM
.	.	O

final	JJ	B-TEST
sensitivities	NNS	I-TEST
.	.	O

trimethoprim/sulfa	JJ	B-TEST
sensitivity	NN	I-TEST
testing	VBG	I-TEST
available	JJ	O
on	IN	O
request	NN	O
.	.	O

sensitivities	NNS	B-TEST
:	:	O

mic	NNS	B-TEST
expressed	VBN	O
in	IN	O
mcg/ml	NN	O

klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM

klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM

ampicillin/sulbactam--	NN	B-TREATMENT

cefazolin-------------	NN	B-TREATMENT

cefepime--------------	NN	B-TREATMENT

ceftazidime-----------	NN	B-TREATMENT

ceftriaxone-----------	NN	B-TREATMENT

cefuroxime------------	NN	B-TREATMENT

ciprofloxacin---------	NN	B-TREATMENT

gentamicin------------	NN	B-TREATMENT

imipenem--------------	NN	B-TREATMENT

levofloxacin----------	NN	B-TREATMENT

meropenem-------------	NN	B-TREATMENT

piperacillin/tazo-----	NN	B-TREATMENT

tobramycin------------	NN	B-TREATMENT

fluid	JJ	B-TEST
culture	NN	I-TEST
(	(	O
final	JJ	O
2014-12-03	NN	O
)	)	O
:	:	O

due	JJ	O
to	TO	O
mixed	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
types	NNS	I-PROBLEM
(	(	O
>=	$	O
3	CD	B-PROBLEM
colony	NN	I-PROBLEM
types	NNS	I-PROBLEM
)	)	O
an	DT	B-TEST
abbreviated	JJ	I-TEST
workup	NN	I-TEST
is	VBZ	O
performed	VBN	O
appropriate	JJ	O
to	TO	O
the	DT	O
isolates	NNS	O
recovered	VBD	O
from	IN	O
the	DT	O
site	NN	O
(	(	O
including	VBG	O
a	DT	B-TEST
screen	NN	I-TEST
for	IN	O
pseudomonas	NN	B-PROBLEM
aeruginosa	NN	I-PROBLEM
,	,	O
staphylococcus	VB	B-PROBLEM
aureus	NN	I-PROBLEM
and	CC	O
beta	NN	B-PROBLEM
streptococcus	NN	I-PROBLEM
)	)	O
.	.	O

staph	NN	B-PROBLEM
aureus	NN	I-PROBLEM
coag	NN	I-PROBLEM
+	NN	I-PROBLEM
.	.	O

>100,000	CD	O
organisms/ml.	NN	B-TEST
.	.	O

of	IN	O
two	CD	B-PROBLEM
colonial	JJ	I-PROBLEM
morphologies	NNS	I-PROBLEM
.	.	O

oxacillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococci	NN	I-PROBLEM
must	MD	O
be	VB	O
reported	VBN	O
as	IN	O
also	RB	O
resistant	VBP	O
to	TO	O
other	JJ	O
penicillins	NNS	B-TREATMENT
,	,	O
cephalosporins	NNS	B-TREATMENT
,	,	O
carbacephems	NNS	B-TREATMENT
,	,	O
carbapenems	NNS	B-TREATMENT
,	,	O
and	CC	O
beta-lactamase	JJ	B-TREATMENT
inhibitor	NN	I-TREATMENT
combinations	NNS	I-TREATMENT
.	.	O

rifampin	NN	B-TREATMENT
should	MD	O
not	RB	O
be	VB	O
used	VBN	O
alone	RB	O
for	IN	O
therapy	NN	B-TREATMENT
.	.	O

>100,000	CD	O
organisms/ml.	NN	B-TEST
.	.	O

of	IN	O
two	CD	B-PROBLEM
colonial	JJ	I-PROBLEM
morphologies	NNS	I-PROBLEM
.	.	O

sensitivities	NNS	B-TEST
:	:	O

mic	NNS	B-TEST
expressed	VBN	O
in	IN	O

staph	NN	B-PROBLEM
aureus	NN	I-PROBLEM
coag	NN	I-PROBLEM
+	NN	O

gentamicin------------	NN	B-TREATMENT

levofloxacin----------	NN	B-TREATMENT

nitrofurantoin--------	JJ	B-TREATMENT

oxacillin-------------	NN	B-TREATMENT

penicillin------------	NN	B-TREATMENT

tetracycline----------	NN	B-TREATMENT

vancomycin------------	NN	B-TREATMENT

2014-12-03	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST

aerobic	JJ	B-TEST
bottle	SYM	I-TEST
-	:	O
pending	NN	O
;	:	O
anaerobic	JJ	B-TEST
bottle	SYM	I-TEST
-	:	O
pending	VBG	O

2014-12-03	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST

aerobic	JJ	B-TEST
bottle	SYM	I-TEST
-	:	O
pending	NN	O
;	:	O
anaerobic	JJ	B-TEST
bottle	SYM	I-TEST
-	:	O
pending	VBG	O

2014-12-02	JJ	O
urine	NN	B-TEST

urine	JJ	B-TEST
culture	NN	I-TEST
-	:	O
final	JJ	O
no	DT	O
growth	NN	O

2014-12-02	JJ	O
catheter	NN	B-TREATMENT
tip	SYM	I-TREATMENT
-	:	I-TREATMENT
iv	NN	I-TREATMENT

wound	JJ	B-TEST
culture	NN	I-TEST
-	:	O
final	JJ	O
no	DT	O
growth	NN	O

2014-12-02	JJ	O
blood	NN	B-TEST
culture	NN	I-TEST

aerobic	JJ	B-TEST
bottle	SYM	I-TEST
-	:	O
pending	NN	O
;	:	O
anaerobic	JJ	B-TEST
bottle	SYM	I-TEST
-	:	O
pending	VBG	O

47	CD	O
yo	JJ	O
f	NN	O
w/	NN	O
h/o	VBD	O
steroid-induced	JJ	B-PROBLEM
hyperglycemia	NN	I-PROBLEM
,	,	O
sle	JJ	B-PROBLEM
w/	NN	O
h/o	NN	O
pericarditis	NN	B-PROBLEM
,	,	O
transverse	JJ	B-PROBLEM
myelitis	NN	I-PROBLEM
w/	NN	O
paraplegia	NN	B-PROBLEM
and	CC	O
neurogenic	JJ	B-PROBLEM
bladder	NN	I-PROBLEM
s/p	NN	O
urostomy	JJ	B-TREATMENT
w/	JJ	O
ileal	NN	B-TREATMENT
conduit	NN	I-TREATMENT
,	,	O
h/o	NN	O
ureteropelvic	JJ	B-PROBLEM
stone	NN	I-PROBLEM
and	CC	O
urosepsis	NN	B-PROBLEM
,	,	O
and	CC	O
h/o	JJ	O
rle	NN	B-PROBLEM
dvt	NN	I-PROBLEM
admitted	VBD	O
11-29	JJ	O
w/	NN	O
left	VBD	B-PROBLEM
pyelo	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
8	CD	I-PROBLEM
mm	NN	I-PROBLEM
proximal	JJ	I-PROBLEM
ureteral	JJ	I-PROBLEM
stone	NN	I-PROBLEM
w/	NN	O
right	JJ	B-PROBLEM
hydro	NN	I-PROBLEM
s/p	NN	O
perc	NN	B-TREATMENT
urostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
to	TO	O
relieve	VB	O
right	JJ	B-PROBLEM
hydro	NN	I-PROBLEM
.	.	O

##	JJ	O
gnr	NN	B-PROBLEM
sepsis:	NN	I-PROBLEM

upon	IN	O
admission	NN	O
,	,	O
pt	NN	O
was	VBD	O
febrile	JJ	B-PROBLEM
to	TO	O
101.2	CD	O
with	IN	O
u/a	JJ	B-TEST
consistent	JJ	O
with	IN	O
uti	JJ	B-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
abd	NN	I-TEST
showed	VBD	O
8mm	CD	B-PROBLEM
obstructing	VBG	I-PROBLEM
stone	NN	I-PROBLEM
,	,	O
hydro	NN	B-PROBLEM
with	IN	O
stranding	VBG	B-PROBLEM
consistent	JJ	O
with	IN	O
pylonephritis	NN	B-PROBLEM
.	.	O

her	PRP$	O
presentation	NN	O
was	VBD	O
thought	VBN	O
likely	RB	O
due	JJ	O
to	TO	O
urosepsis	VB	B-PROBLEM
given	VBN	O
h/o	JJ	O
foul	NN	B-PROBLEM
smelling	VBG	I-PROBLEM
urine	JJ	I-PROBLEM
and	CC	O
in	IN	O
setting	NN	O
of	IN	O
stone	NN	B-PROBLEM
w/	NN	O
hydro	NN	B-PROBLEM
+	NNP	O
pyelo	NN	B-PROBLEM
by	IN	O
ct.	VBG	B-TEST
the	DT	O
patient	NN	O
went	VBD	O
to	TO	O
ir	VB	O
on	IN	O
2014-11-30	JJ	O
given	VBN	O
evidence	NN	O
of	IN	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
on	IN	O
imaging	VBG	B-TEST
for	IN	O
decompression	NN	B-TREATMENT
and	CC	O
drainage.	NN	B-TREATMENT
upon	IN	O
admission	NN	O
,	,	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
the	DT	B-TREATMENT
must	MD	I-TREATMENT
protocol	VB	I-TREATMENT
with	IN	O
high	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
as	IN	O
well	RB	O
and	CC	O
a	DT	O
goal	NN	O
svo2	NN	B-TEST
>70%	NN	O
.	.	O

she	PRP	O
was	VBD	O
hypoxic	JJ	B-PROBLEM
requiring	VBG	O
3l	CD	B-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
o2	NN	I-TREATMENT
.	.	O

she	PRP	O
subsequently	RB	O
developed	VBD	O
hypotension	NN	B-PROBLEM
with	IN	O
sbp	NN	B-TEST
in	IN	O
the	DT	O
70s	CD	O
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
where	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
the	DT	B-TREATMENT
must	MD	I-TREATMENT
protocol	VB	I-TREATMENT
with	IN	O
goais	NN	O
of	IN	O
cvp	JJ	B-TEST
10-12	JJ	O
,	,	O
svo2	RB	B-TEST
greater	JJR	O
than	IN	O
70%	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
bolused	VBN	O
with	IN	O
ns	JJ	B-TREATMENT
and	CC	O
did	VBD	O
not	RB	O
required	VBN	O
pressors	NNS	B-TREATMENT
.	.	O

on	IN	O
the	DT	O
day	NN	O
after	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
small	JJ	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
with	IN	O
2l	CD	B-TREATMENT
nc	NNS	I-TREATMENT
.	.	O

repeat	NN	B-TEST
imaging	VBG	I-TEST
revealed	VBD	O
evidence	NN	O
of	IN	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
congestion	NN	I-PROBLEM
which	WDT	O
was	VBD	O
thought	VBN	O
to	TO	O
account	VB	O
for	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
mild	JJ	I-PROBLEM
hypoxia	NN	I-PROBLEM
.	.	O

given	VBN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
maintaining	VBG	O
a	DT	B-TEST
map	NN	I-TEST
of	IN	O
60	CD	O
without	IN	O
fluids	NNS	B-TREATMENT
or	CC	O
pressors	NNS	B-TREATMENT
,	,	O
her	PRP$	O
goal	NN	O
cvp	NN	B-TEST
was	VBD	O
decreased	VBN	O
to	TO	O
>8	VB	O
to	TO	O
avoid	VB	O
fluid	JJ	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
while	IN	O
speciation	NN	B-TEST
and	CC	O
sensitivities	NNS	B-TEST
were	VBD	O
pending	VBG	O
.	.	O

ciprofloxacin	NN	B-TREATMENT
was	VBD	O
added	VBN	O
on	IN	O
2014-12-01	JJ	O
for	IN	O
synergy	NN	O
when	WRB	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
growing	VBG	O
again	RB	O
gnr	NN	B-PROBLEM
.	.	O

gent	NN	B-TREATMENT
and	CC	O
cipro	NN	B-TREATMENT
were	VBD	O
then	RB	O
discontinued	VBN	O
and	CC	O
changed	VBN	O
to	TO	O
meropenem	VB	B-TREATMENT
when	WRB	O
blood	NN	B-TEST
culture	NN	I-TEST
sensitivities	NNS	I-TEST
became	VBD	O
available	JJ	O
revealing	VBG	O
gnr	NN	B-PROBLEM
sensitive	JJ	O
to	TO	O
jacoby	VB	B-TREATMENT
but	CC	O
resistant	VB	O
to	TO	O
both	DT	O
gent	NN	B-TREATMENT
and	CC	O
cipro	NN	B-TREATMENT
.	.	O

additionaly	JJ	O
surveillance	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
drawn	VBN	O
daily	RB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
floor	NN	O
with	IN	O
no	DT	O
subsequent	JJ	B-PROBLEM
pressor	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
cltures	NNS	I-TEST
from	IN	O
11-30	JJ	O
grew	VBD	O
klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM
and	CC	O
12-01	JJ	O
grew	VBD	O
klebsiella	NN	B-PROBLEM
pneumoniae	NN	I-PROBLEM
and	CC	O
proteus	NN	B-PROBLEM
mirabilis	NNS	I-PROBLEM
both	DT	O
sensitive	JJ	O
to	TO	O
the	DT	B-TREATMENT
meropenam	NN	I-TREATMENT
which	WDT	O
she	PRP	O
had	VBD	O
already	RB	O
been	VBN	O
receiving	VBG	O
.	.	O

urine	JJ	B-TEST
cultures	NNS	I-TEST
from	IN	O
11-30	JJ	O
grew	VBD	O
staph	JJ	B-PROBLEM
aureus	JJ	I-PROBLEM
coag	NN	I-PROBLEM
+	NN	O
,	,	O
and	CC	O
gram	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
of	IN	O
two	CD	O
morphologies	NNS	O
(	(	O
not	RB	O
further	RB	O
speciated	VBN	O
)	)	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
blood	NN	B-TEST
cultures	NNS	I-TEST
from	IN	O
12-02	JJ	O
and	CC	O
12-03	NNS	O
have	VBP	O
no	DT	O
growth	NN	B-PROBLEM
to	TO	O
date	NN	O
.	.	O

she	PRP	O
received	VBD	O
a	DT	B-TREATMENT
midline	NN	I-TREATMENT
on	IN	O
12-04	JJ	O
with	IN	O
a	DT	O
goal	NN	O
of	IN	O
16	CD	O
days	NNS	O
of	IN	O
further	JJ	B-TREATMENT
antibiotic	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
meropenam	NN	B-TREATMENT
(	(	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
3	CD	O
weeks	NNS	O
)	)	O
upon	IN	O
discharge	NN	O
back	RB	O
to	TO	O
the	DT	O
nursing	NN	O
home	NN	O
where	WRB	O
she	PRP	O
lives	VBZ	O
.	.	O

##	RB	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
:	:	O

given	VBN	O
right	RB	B-PROBLEM
sided	VBN	I-PROBLEM
hydronephrosis	NN	I-PROBLEM
and	CC	O
gnr	NN	B-PROBLEM
bactermeia	NN	I-PROBLEM
,	,	O
a	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
nephrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
by	IN	O
ir	JJ	O
2014-11-30	JJ	O
.	.	O

the	DT	O
patient	NN	O
put	VBD	O
out	RP	O
1385	CD	O
cc	NN	O
urine	JJ	O
the	DT	O
day	NN	O
after	IN	O
placement	NN	O
,	,	O
950	CD	O
cc	NN	O
of	IN	O
which	WDT	O
came	VBD	O
from	IN	O
nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
tube	NN	I-TREATMENT
appeared	VBD	O
to	TO	O
be	VB	O
functioning	VBG	O
well	RB	O
,	,	O
draining	VBG	O
urine	JJ	O
with	IN	O
occasional	JJ	B-PROBLEM
clot	NN	I-PROBLEM
passage	NN	I-PROBLEM
.	.	O

urology	NN	O
was	VBD	O
notified	VBN	O
about	IN	O
the	DT	B-PROBLEM
clots	NNS	I-PROBLEM
and	CC	O
occasional	JJ	B-PROBLEM
blood	NN	I-PROBLEM
tinged	VBD	I-PROBLEM
urine	JJ	I-PROBLEM
but	CC	O
they	PRP	O
did	VBD	O
not	RB	O
make	VB	O
any	DT	O
further	JJ	O
recommendations	NNS	O
.	.	O

cultures	NNS	B-TEST
from	IN	I-TEST
urine	JJ	I-TEST
drawn	NN	O
from	IN	O
the	DT	B-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
are	VBP	O
currently	RB	O
growing	VBG	O
>	PRP	O
100k	CD	O
gnr	NN	B-PROBLEM
,	,	O
possibly	RB	O
of	IN	O
two	CD	B-PROBLEM
colony	NN	I-PROBLEM
morphologies	NNS	I-PROBLEM
,	,	O
speciation	NN	B-TEST
and	CC	O
sensitivity	NN	B-TEST
pending	NN	O
.	.	O

##	JJ	O
hct	JJ	B-PROBLEM
drop	NN	I-PROBLEM
:	:	O

on	IN	O
admission	NN	O
to	TO	O
hospital	VB	O
patient	NN	O
had	VBD	O
hct	NN	B-TEST
of	IN	O
29.2	CD	O
.	.	O

in	IN	O
the	DT	O
setting	NN	O
of	IN	O
right	JJ	B-TREATMENT
sublavian	JJ	I-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
nephrostomy	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	VBD	I-TREATMENT
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
drifting	NN	I-PROBLEM
hct	NN	I-PROBLEM
,	,	O
concerning	VBG	O
for	IN	O
bleed	NN	B-PROBLEM
,	,	O
with	IN	O
nadir	NN	B-TEST
of	IN	O
22.8	CD	O
on	IN	O
2014-12-01	JJ	O
.	.	O

a	DT	B-TEST
ct	JJ	I-TEST
abdomen	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
did	VBD	O
not	RB	O
demonstrate	VB	O
any	DT	B-PROBLEM
retroperitoneal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

hct	NN	B-TEST
stabilized	VBD	O
to	TO	O
24	CD	O
for	IN	O
three	CD	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

anemia	NN	B-TEST
workup	NN	I-TEST
revealed	VBD	O
a	DT	O
picture	NN	O
of	IN	O
anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
(	(	O
tibc	JJ	B-TEST
225	CD	O
,	,	O
b12	NN	B-TEST
and	CC	O
folate	NN	B-TEST
normal	JJ	O
,	,	O
hapto	JJ	B-TEST
397	CD	O
,	,	O
ferritin	RB	B-TEST
51	CD	O
,	,	O
trf	NN	B-TEST
173	CD	O
,	,	O
iron	RB	B-TEST
35	CD	O
)	)	O
.	.	O

##	NN	O
hypoxia:	NN	B-PROBLEM

the	DT	O
patient	NN	O
on	IN	O
admission	NN	O
was	VBD	O
requiring	VBG	O
3	CD	B-TREATMENT
l	NN	I-TREATMENT
nc	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
receiving	VBG	O
2l	CD	B-TREATMENT
ns	JJ	I-TREATMENT
and	CC	O
chest	JJS	B-TEST
film	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
pulmonary	JJ	B-PROBLEM
congestion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
not	RB	O
diuresed	VBN	O
but	CC	O
allowed	VBN	O
to	TO	O
auto-diurese	JJ	O
any	DT	O
additional	JJ	O
fluids	NNS	O
and	CC	O
is	VBZ	O
currently	RB	O
with	IN	O
o2	JJ	B-TEST
sats	NNS	I-TEST
97-98%	VBP	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

as	IN	O
her	PRP$	B-TEST
bp	NN	I-TEST
remained	VBD	O
stable	JJ	O
she	PRP	O
did	VBD	O
not	RB	O
receiving	VBG	O
any	DT	B-TREATMENT
standing	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
but	CC	O
was	VBD	O
be	VB	O
bolused	VBN	B-TREATMENT
as	IN	O
appropriate	NN	O
for	IN	O
a	DT	B-TEST
map	NN	I-TEST
<	VBZ	O
60	CD	O
or	CC	O
cvp	VB	B-TEST
<	JJ	O
8	CD	O
with	IN	O
careful	JJ	O
monitoring	NN	O
of	IN	O
pulmonary	JJ	O
status	NN	O
.	.	O

patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
in	IN	O
2012	CD	O
which	WDT	O
demonstrated	VBD	O
an	DT	B-TEST
ef	NN	I-TEST
of	IN	O
60-65%	JJ	O
.	.	O

her	PRP$	B-PROBLEM
o2	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
by	IN	O
discharge	NN	O
was	VBD	O
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
with	IN	O
no	DT	O
sob	NN	B-PROBLEM
.	.	O

##	JJ	O
steroid-induced	JJ	B-PROBLEM
hyperglycemia	NN	I-PROBLEM
:	:	O

at	IN	O
home	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
metformin	NNS	B-TREATMENT
and	CC	O
ssi	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
metformin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
maintained	VBN	O
on	IN	O
ssi	NNS	B-TREATMENT
qid	NNS	O
while	IN	O
in	IN	O
the	DT	O
cmed	NN	O
.	.	O

as	IN	O
the	DT	O
patient	NN	O
appeared	VBD	O
to	TO	O
be	VB	O
clinically	RB	O
stable	JJ	O
,	,	O
her	PRP$	B-TREATMENT
stress	NN	I-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
changed	VBN	O
back	RB	O
to	TO	O
her	PRP$	O
home	NN	O
dose	NN	O
of	IN	O
prednisone	NN	B-TREATMENT
40mg	CD	O
po	NN	O
qd	NN	O
for	IN	O
maintenance	NN	O
with	IN	O
anticipated	JJ	O
decrease	NN	O
in	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
.	.	O

her	PRP$	B-TREATMENT
metformin	NN	I-TREATMENT
was	VBD	O
re-added	JJ	O
2	CD	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
as	RB	O
well	RB	O
and	CC	O
fingerstick	JJ	B-TEST
glucoses	NNS	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
were	VBD	O
93	CD	O
and	CC	O
156	CD	O
,	,	O
respectively	RB	O
.	.	O

##	JJ	O
hypothyroidism	NN	B-PROBLEM
:	:	O

repeat	NN	B-TEST
tsh	NNS	I-TEST
and	CC	O
free	JJ	B-TEST
t4	NN	I-TEST
were	VBD	O
appropriate	JJ	O
on	IN	O
current	JJ	B-TREATMENT
outpatient	JJ	I-TREATMENT
regimen.	NN	I-TREATMENT
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
levothyroxine	NN	B-TREATMENT
75mcg	CD	O
po	NN	O
qd	NN	O
.	.	O

##	JJ	O
h/o	NN	O
transverse	NN	B-PROBLEM
myelitis/optic	JJ	I-PROBLEM
neuritis	NN	I-PROBLEM
:	:	O

on	IN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
originally	RB	O
given	VBN	O
must	MD	B-TREATMENT
protocol	VB	I-TREATMENT
and	CC	O
sepsis	VB	B-PROBLEM
,	,	O
as	IN	O
patient	JJ	O
clinically	RB	O
stabilized	VBN	O
,	,	O
she	PRP	O
was	VBD	O
changed	VBN	O
back	RB	O
to	TO	O
home	NN	O
dose	NN	O
of	IN	O
prednisone	NN	B-TREATMENT
40mg	CD	O
po	NN	O
qd	NN	O
.	.	O

##	JJ	O
sle	NN	B-PROBLEM
:	:	O

currently	RB	O
no	DT	O
sx	NN	B-PROBLEM
of	IN	I-PROBLEM
active	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

no	DT	O
manifestations	NNS	O
of	IN	O
sle	NN	B-PROBLEM
during	IN	O
this	DT	O
admission	NN	O
.	.	O

#	#	O
osteoporosis	SYM	B-PROBLEM
-	:	O
we	PRP	O
continued	VBD	O
actonel/vit	JJ	B-TREATMENT
d	NN	I-TREATMENT
,	,	O
tums	NNS	B-TREATMENT

##	JJ	O
capsular	JJ	B-PROBLEM
ossification	NN	I-PROBLEM
:	:	O

we	PRP	O
continued	VBD	O
cmed	VBN	B-TREATMENT
csru	JJ	I-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
bicarb	NN	I-PROBLEM
likely	RB	O
due	JJ	O
to	TO	O
renal	JJ	B-PROBLEM
wasting	NN	I-PROBLEM
but	CC	O
there	EX	O
is	VBZ	O
an	DT	B-PROBLEM
anion	NN	I-PROBLEM
gap	NN	I-PROBLEM
present	NN	O
.	.	O

serum	NN	B-TEST
acetone	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

we	PRP	O
followed	VBD	O
lactate	NN	B-TEST
while	IN	O
she	PRP	O
was	VBD	O
in	IN	O
the	DT	O
cmed	NN	O
which	WDT	O
was	VBD	O
normal	JJ	O
.	.	O

she	PRP	O
was	VBD	O
npo	JJ	B-TREATMENT
periodically	RB	O
but	CC	O
maintained	VBD	O
a	DT	O
normal	JJ	O
diet	JJ	O
prior	JJ	O
to	TO	O
discharge	VB	O
.	.	O

#	#	O
ppx	SYM	O
-	:	O
sq	NN	B-TREATMENT
heparin	NN	I-TREATMENT
during	IN	O
this	DT	O
admission	NN	O
,	,	O
ppi	NN	B-TREATMENT

home	NN	B-TREATMENT
meds	NNS	I-TREATMENT
:	:	O

ascorbic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
500	CD	O
tid	NN	O

cranberry	NN	B-TREATMENT
extract	JJ	I-TREATMENT
425	CD	O
bid	NN	O

bisacodyl	NN	B-TREATMENT
10mg	CD	O

senna	NN	B-TREATMENT

dephenhydramine	NN	B-TREATMENT
50mg	CD	O
prn	NN	O
loperamide	NN	B-TREATMENT
prn	NN	O
famotidine	NN	B-TREATMENT
20mg	CD	O

kcl	VB	B-TREATMENT
20mg	CD	O
qd	NN	O

metformin	NN	B-TREATMENT
1000	CD	O
qd	NN	O
tums	NNS	B-TREATMENT
1500	CD	O
bid	NN	O

mvi	NN	B-TREATMENT

timolol	NN	B-TREATMENT
1	CD	O
drop	NN	O
bid	NN	O
0.5%	CD	O
l	NN	O
cmed	VBD	O
csru	NN	O

synthroid	JJ	B-TREATMENT
75	CD	O
qd	NN	O

compro	JJ	B-TREATMENT
25mg	CD	O
pr	NN	O

citrucel	NN	B-TREATMENT

vitamin	NN	B-TREATMENT
d	VBZ	I-TREATMENT
50k	CD	O
qmondays	NNS	O

oxazepam	RB	B-TREATMENT
15mg	CD	O
qhs	JJ	O
tizamidine	NN	B-TREATMENT
8mg	CD	O
qhs	NN	O
actonel	NN	B-TREATMENT
35	CD	O
qwed	VBD	O

diovan	NN	B-TREATMENT
80	CD	O
qd	NN	O
prednisone	NN	B-TREATMENT
40	CD	O
qd	NN	O
bactrim	JJ	B-TREATMENT
ds	NN	I-TREATMENT
qmwf	NN	O
baclofen	JJ	B-TREATMENT
pump	NN	I-TREATMENT
2-3yrs	JJ	O

insulin	NN	B-TREATMENT
ss	NN	I-TREATMENT

actonel	RB	B-TREATMENT
35	CD	O
mg	JJ	O
oral	JJ	O
qwednesdays	NNS	O

ascorbic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
tid	NN	O

sodium	NN	B-TREATMENT
polystyrene	NN	I-TREATMENT
sulfonate	NN	I-TREATMENT
15	CD	O
gm	NN	O
po	NN	O
once	RB	O
11-29	CD	O
@	NN	O
2201	CD	O

famotidine	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NNS	O
daily	RB	O

sulfameth/trimethoprim	JJ	B-TREATMENT
ds	NN	O
1	CD	O
tab	NN	O
po	NN	O
qmowefr	NN	O

gentamicin	NN	B-TREATMENT
80	CD	O
mg	NN	O
iv	NN	O
q8h	NN	O

timolol	NN	B-TREATMENT
maleate	NN	I-TREATMENT
0.5%	CD	O
1	CD	O
drop	NN	O
os	NN	O
bid	NN	O

heparin	NN	B-TREATMENT
5000	CD	O
unit	NN	O
sc	VBD	O
tid	NN	O

tizanidine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
8	CD	O
mg	NN	O
po	NN	O
qhs	NN	O

hydrocortisone	NN	B-TREATMENT
na	TO	I-TREATMENT
succ.	VB	I-TREATMENT
100	CD	O
mg	NN	O
iv	NN	O
q8h	NN	O

valsartan	RB	B-TREATMENT
80	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O

insulin	NN	B-TREATMENT
sc	NN	I-TREATMENT
(	(	O
per	IN	O
insulin	NN	O
flowsheet	NN	O
)	)	O

vancomycin	NN	B-TREATMENT
hcl	NN	I-TREATMENT
1000	CD	O
mg	NN	O
iv	NN	O
q	VBD	O
12h	CD	O

levothyroxine	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
75	CD	O
mcg	NN	O
po	NNS	O
daily	RB	O

vitamin	NN	B-TREATMENT
d	VBZ	I-TREATMENT
50,000	CD	O
unit	NN	O
po	NN	O
qwednesdays	NNS	O

gnr	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
;	:	O
steroid	CC	B-PROBLEM
induced	JJ	I-PROBLEM
hyperglycemia	NN	I-PROBLEM
;	:	O
hydronephrosis	NN	B-PROBLEM
;	:	O
sle	NN	B-PROBLEM

pls	NNS	O
take	VBP	O
all	DT	B-TREATMENT
meds	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

call	VB	O
your	PRP$	O
doctor	NN	O
immediately	RB	O
if	IN	O
any	DT	B-PROBLEM
new	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
develop	VBP	O
including	VBG	O
fevers	NNS	B-PROBLEM
,	,	O
rash	NN	B-PROBLEM
,	,	O
increase	NN	B-PROBLEM
in	IN	I-PROBLEM
bloody	JJ	I-PROBLEM
urine	NN	I-PROBLEM
in	IN	O
nephrostomy	NN	B-TREATMENT
or	CC	O
urostomy	NN	B-TREATMENT
bags	NNS	I-TREATMENT
,	,	O
etc	FW	O
.	.	O

myasthenia	NN	B-PROBLEM
gravis	NN	I-PROBLEM
.	.	O

1.	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

2.	CD	O
history	NN	O
of	IN	O
thymoma	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
resection	NN	B-TREATMENT
.	.	O

3.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

4.	CD	O
history	NN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
resection	NN	B-TREATMENT
.	.	O

5.	CD	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

6.	CD	O
hydrocele	NN	B-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
,	,	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
,	,	O
emg	NN	B-TEST
,	,	O
ct	JJ	B-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
q.d.	NN	O
;	:	O
albuterol	CC	B-TREATMENT
nebs	$	I-TREATMENT
2.5	CD	O
mg	NN	O
q.	NN	O
4h	CD	O
;	:	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O
;	:	O
heparin	CC	B-TREATMENT
5,000	CD	O
units	NNS	O
subcu	JJ	O
b.i.d.	NN	O
;	:	O
synthroid	CC	B-TREATMENT
200	CD	O
mcg	NN	O
q.d.	NN	O
;	:	O
ocean	JJ	B-TREATMENT
spray	NN	I-TREATMENT
2	CD	O
sprays	NNS	O
q.	JJ	O
i.d.	NN	O
;	:	O
simvastatin	CC	B-TREATMENT
10	CD	O
mg	NN	O
q.	JJ	O
h.s.	NN	O
;	:	O
flovent	JJ	B-TREATMENT
220	CD	O
mcg	NN	O
2	CD	O
puffs	NNS	O
b.i.d.	RB	O
;	:	O
zantac	CC	B-TREATMENT
150	CD	O
b.i.d.	NN	O
;	:	O
nystatin	CC	B-TREATMENT
ointment	NN	I-TREATMENT
to	TO	O
the	DT	O
gluteal	NN	O
fold	JJ	O
b.i.d.	NN	O
;	:	O
lisinopril	CC	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	NN	O
;	:	O
mestinon	CC	B-TREATMENT
controlled	VBD	I-TREATMENT
release	NN	I-TREATMENT
180	CD	O
q.	JJ	O
h.s.	NN	O
;	:	O
mestinon	CC	B-TREATMENT
30	CD	O
mg	NN	O
q.	VBD	O
4h	CD	O
while	IN	O
awake	NN	O
;	:	O
prednisone	CC	B-TREATMENT
60	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
im	NN	O
;	:	O
atrovent	JJ	B-TREATMENT
nebs	FW	I-TREATMENT
0.5	CD	O
mg	NN	O
q.	NN	O
i.d.	NN	O

this	DT	O
is	VBZ	O
a	DT	O
72-year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
thymoma	NN	B-PROBLEM
resected	VBN	O
in	IN	O
1996	CD	O
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
gobay	JJ	O
hos	NN	O
memorial	JJ	O
hospital	NN	O
for	IN	O
an	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
at	IN	O
home	NN	O
and	CC	O
the	DT	O
emts	NN	O
were	VBD	O
called	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
in	IN	O
respiratory	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
gobay	VB	O
hos	JJ	O
memorial	JJ	O
hospital	NN	O
where	WRB	O
chest	NN	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
and	CC	O
cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
elevated	VBN	B-PROBLEM
with	IN	O
a	DT	B-TEST
ck	NN	I-TEST
of	IN	O
297	CD	O
,	,	O
mb	JJR	B-TEST
fraction	NN	I-TEST
of	IN	O
38	CD	O
and	CC	O
troponin	NN	B-TEST
of	IN	O
12	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
at	IN	O
the	DT	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
and	CC	O
underwent	JJ	O
cardiac	NN	B-TEST
catheterization	NN	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
disease	NN	B-PROBLEM
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
complain	VB	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
an	DT	O
episode	NN	O
of	IN	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
the	DT	O
hospital	NN	O
requiring	VBG	O
100%	CD	B-TREATMENT
nonrebreather	RB	I-TREATMENT
.	.	O

neurology	NN	O
was	VBD	O
consulted	VBN	O
for	IN	O
difficulty	NN	B-PROBLEM
lifting	VBG	I-PROBLEM
his	PRP$	I-PROBLEM
arms	NNS	I-PROBLEM
.	.	O

on	IN	O
consultation	NN	O
the	DT	O
patient	NN	O
admitted	VBD	O
to	TO	O
dysphasia	VB	B-PROBLEM
and	CC	O
periods	NNS	O
of	IN	O
diplopia	NN	B-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
weakness	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
muscles	NNS	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
the	DT	O
capability	NN	O
of	IN	O
the	DT	O
muscles	NNS	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
iv	NN	B-TREATMENT
ig	NN	I-TREATMENT
and	CC	O
iv	JJ	B-TREATMENT
solu-medrol	NN	I-TREATMENT
for	IN	O
a	DT	O
diagnosis	NN	O
of	IN	O
myasthenia	NN	B-PROBLEM
gravis	NN	I-PROBLEM
given	VBN	O
his	PRP$	O
past	JJ	O
history	NN	O
of	IN	O
thymoma	NN	B-PROBLEM
.	.	O

he	PRP	O
markedly	RB	O
improved	VBD	O
after	IN	O
a	DT	O
dose	NN	O
of	IN	O
mestinon	NN	B-TREATMENT
.	.	O

he	PRP	O
completed	VBD	O
a	DT	O
five-day	JJ	O
course	NN	O
of	IN	O
iv	JJ	B-TREATMENT
ig	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
work	NN	I-TEST
up	RB	I-TEST
included	VBD	O
acetylcholine	JJ	B-TEST
esterase	NN	I-TEST
,	,	O
receptor	NN	B-TEST
antibodies	NNS	I-TEST
,	,	O
thyroglobulin	NN	B-TEST
antibody	NN	I-TEST
is	VBZ	O
pending	VBG	O
.	.	O

an	DT	B-TEST
ana	NN	I-TEST
and	CC	O
rheumatoid	JJ	B-TEST
factor	NN	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

sed	JJ	B-TEST
rate	NN	I-TEST
was	VBD	O
58	CD	O
and	CC	O
repeat	VB	O
75	CD	O
.	.	O

emg	JJ	B-TEST
studies	NNS	I-TEST
were	VBD	O
performed	VBN	O
,	,	O
the	DT	O
result	NN	O
is	VBZ	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
chest	NN	I-TEST
ct	NN	I-TEST
which	WDT	O
showed	VBD	O
a	DT	O
question	NN	O
of	IN	O
recurrence	NN	O
of	IN	O
the	DT	B-PROBLEM
thymoma	NN	I-PROBLEM
.	.	O

thoracic	NN	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
recommended	VBN	O
repeating	VBG	O
the	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
in	IN	O
six	CD	O
weeks	NNS	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

this	DT	O
could	MD	O
represent	VB	O
either	CC	O
recurrence	NN	O
of	IN	O
scar	NN	B-PROBLEM
tissue	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
tapered	VBN	O
to	TO	O
p.o.	VB	B-TREATMENT
prednisone	NN	I-TREATMENT
and	CC	O
tolerated	VBD	O
mestinon	NN	B-TREATMENT
30	CD	O
mg	NN	O
q.	VBD	O
4h	CD	O
with	IN	O
180	CD	O
mg	NNS	O
longacting	VBG	O
at	IN	O
bedtime	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
overnight	RB	O
without	IN	O
incident	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
good	JJ	O
cardiac	NN	O
index	NN	O
off	IN	O
all	DT	B-TREATMENT
inotropic	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
swan-ganz	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TREATMENT
exchange	NN	I-TREATMENT
peritoneal	JJ	I-TREATMENT
dialysis	NN	I-TREATMENT
.	.	O

the	DT	O
parrack	NN	O
diabetes	VBZ	O
center	NN	O
was	VBD	O
consulted	VBN	O
to	TO	O
help	VB	O
manage	VB	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
hyperglycemia	NN	I-PROBLEM
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
remained	VBN	O
in	IN	O
sinus	NN	O
rhythm	NN	O
and	CC	O
his	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
.	.	O

he	PRP	O
was	VBD	O
having	VBG	O
a	DT	O
bit	NN	O
of	IN	O
a	DT	B-PROBLEM
respiratory	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
,	,	O
therefore	RB	O
,	,	O
bicarbonate	NN	B-TREATMENT
was	VBD	O
added	VBN	O
to	TO	O
the	DT	B-TREATMENT
dialysate	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
mediastinal	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
,	,	O
however	RB	O
,	,	O
his	PRP$	B-TREATMENT
pleural	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tubes	NNS	I-TREATMENT
remained	VBN	O
in	IN	O
place	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
it	PRP	O
was	VBD	O
apparent	JJ	O
that	IN	O
,	,	O
despite	IN	O
an	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
of	IN	O
99%	CD	O
on	IN	O
three	CD	O
liters	NNS	O
,	,	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
still	RB	O
in	IN	O
a	DT	B-PROBLEM
respiratory	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
received	VBD	O
aggressive	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
toilette	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
pleural	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
four	CD	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
cordis	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

his	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
another	DT	O
increment	NN	O
.	.	O

once	RB	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	O
uneventful	JJ	O
hospital	NN	O
course	NN	O
,	,	O
remaining	VBG	O
afebrile	NN	B-PROBLEM
for	IN	O
the	DT	O
remainder	NN	O
of	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

the	DT	O
patient	NN	O
's	POS	O
only	JJ	O
issue	NN	O
was	VBD	O
his	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
seven	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
peak	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
210/100	CD	O
.	.	O

the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
start	VB	O
the	DT	O
patient	NN	O
on	IN	O
lisinopril	NN	B-TREATMENT
,	,	O
and	CC	O
the	DT	O
initial	JJ	O
dose	NN	O
of	IN	O
7.5	CD	O
mg	NN	O
was	VBD	O
increased	VBN	O
to	TO	O
10	CD	O
mg	NNS	O
daily	RB	O
by	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
in	IN	O
order	NN	O
to	TO	O
control	VB	O
his	PRP$	B-TEST
pressure	NN	I-TEST
more	RBR	O
tightly	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
seven	CD	O
and	CC	O
arrangements	NNS	O
were	VBD	O
made	VBN	O
to	TO	O
have	VB	O
physical	JJ	O
therapy	NN	O
perform	NN	O
a	DT	B-TEST
home	NN	I-TEST
safety	NN	I-TEST
evaluation	NN	I-TEST
for	IN	O
the	DT	O
patient	NN	O
,	,	O
to	TO	O
which	WDT	O
he	PRP	O
agreed	VBD	O
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
times	NNS	O
three	CD	O
.	.	O

lopressor	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.b.i.d.	NN	O

lisinopril	RB	B-TREATMENT
10	CD	O
mg	NNS	O
p.o.q.d.	NN	O

lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.q.d.	NN	O

aspirin	RB	B-TREATMENT
81	CD	O
mg	NNS	O
p.o.q.d.	NN	O

percocet	RB	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.q.	VBP	O
3-4	JJ	O
h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.b.i.d.	NN	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
98.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
72	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
154/89	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
and	CC	O
oxygen	JJ	B-TEST
saturation	NN	I-TEST
90%	CD	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

his	PRP$	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
faint	NN	B-PROBLEM
bibasilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
on	IN	O
lung	NN	B-TEST
examination	NN	I-TEST
.	.	O

his	PRP$	O
heart	NN	O
had	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

his	PRP$	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
nonerythematous	JJ	I-PROBLEM
peritoneal	JJ	I-PROBLEM
dialysis	NN	I-PROBLEM
insertion	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
69	JJ	O
year-old	JJ	O
white	JJ	O
gentleman	NN	O
who	WP	O
is	VBZ	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1985	CD	O
with	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
septal	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
intraoperatively	RB	O
.	.	O

two	CD	O
years	NNS	O
after	IN	O
this	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
he	PRP	O
required	VBD	O
a	DT	B-TREATMENT
pacer	NN	I-TREATMENT
implantation	NN	I-TREATMENT
for	IN	O
sick	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
presents	NNS	O
now	RB	O
with	IN	O
progressive	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
anginal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

ejection	NN	B-TEST
fraction	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
20%	CD	O
.	.	O

he	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
multiple	NN	B-TREATMENT
angioplasty	JJ	I-TREATMENT
stents	NNS	I-TREATMENT
.	.	O

he	PRP	O
presents	VBZ	O
now	RB	O
for	IN	O
possible	JJ	O
reoperative	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

1	CD	O
)	)	O
non-insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

2	CD	O
)	)	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
anterior	RB	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
sick	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
vvi	NN	I-TREATMENT
pacer	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
demonstrates	VBZ	O
severe	JJ	B-PROBLEM
triple	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
rca	VBZ	B-PROBLEM
100%	CD	I-PROBLEM
occluded	JJ	I-PROBLEM
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	O
om1	VB	B-TREATMENT
graft	NN	I-TREATMENT
was	VBD	O
100%	CD	B-PROBLEM
occluded	JJ	I-PROBLEM
and	CC	O
a	DT	O
patent	NN	O
lima	NN	O
,	,	O
but	CC	O
severely	RB	B-PROBLEM
diseased	JJ	I-PROBLEM
lad	NN	I-PROBLEM
.	.	O

1	CD	O
)	)	O
enteric	NN	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	RB	I-TREATMENT
325	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
.	.	O

2	CD	O
)	)	O
capoten	VBD	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

3	LS	O
)	)	O
lanoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4	CD	O
)	)	O
cardizem	NN	B-TREATMENT
125	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5	CD	O
)	)	O
glucotrol	NN	B-TREATMENT
xl	$	I-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

6	CD	O
)	)	O
glucophage	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

7	CD	O
)	)	O
amaryl	NN	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

physical	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
that	IN	O
the	DT	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

heart	NN	O
was	VBD	O
irregular	JJ	B-PROBLEM
with	IN	O
no	DT	O
murmurs	NN	B-PROBLEM
palpated	VBD	O
.	.	O

pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
throughout	IN	O
.	.	O

subsequent	JJ	B-TEST
exercise	NN	I-TEST
treadmill	NN	I-TEST
test	NN	I-TEST
demonstrated	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
by	IN	O
ekg	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
reoperative	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	I-TREATMENT
three	CD	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
subaortic	JJ	I-TREATMENT
proximal	NN	I-TREATMENT
graft	NN	I-TREATMENT
from	IN	O
the	DT	O
aorta	NN	O
to	TO	O
the	DT	O
om1	NN	O
and	CC	O
then	RB	O
om2	NN	O
and	CC	O
aorta	NN	O
to	TO	O
the	DT	O
lad	NN	O
with	IN	O
a	DT	B-TREATMENT
wide	JJ	I-TREATMENT
graft	NN	I-TREATMENT
per	IN	O
dr.	NN	O
lumar	NN	O
jongguild	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
weaned	VBN	O
off	RP	O
an	DT	B-TREATMENT
epinephrine	NN	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

rhythm	NN	B-TEST
became	VBD	O
more	RBR	O
stable	JJ	O
.	.	O

balloon	NN	B-TREATMENT
was	VBD	O
weaned	VBN	O
and	CC	O
finally	RB	O
discontinued	VBN	O
.	.	O

his	PRP$	B-TREATMENT
melranon	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
off	RP	O
and	CC	O
his	PRP$	B-TREATMENT
ace	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
began	VBD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
amiodarone	NN	B-TREATMENT
and	CC	O
diuresed	VBN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
lower	JJR	O
extremities	NNS	O
began	VBD	O
to	TO	O
swell	VB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
hirudin	NN	B-TREATMENT
for	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
heparin	NN	I-PROBLEM
induced	VBD	I-PROBLEM
thrombocytopenia	NN	I-PROBLEM
became	VBD	O
positive	JJ	O
and	CC	O
so	RB	O
he	PRP	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
heparin	VB	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
and	CC	O
he	PRP	O
stayed	VBD	O
several	JJ	O
days	NNS	O
for	IN	O
coumadinization	NN	B-TREATMENT
and	CC	O
was	VBD	O
finally	RB	O
discharged	VBN	O
on	IN	O
therapeutic	JJ	B-TREATMENT
coumadin	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
a	DT	O
regular	JJ	O
diet	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
thirteen	NN	O
from	IN	O
his	PRP$	B-TREATMENT
reoperative	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

1	CD	O
)	)	O
amiodarone	NN	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2	CD	O
)	)	O
captopril	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

3	LS	O
)	)	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4	CD	O
)	)	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

5	CD	O
)	)	O
lasix	NN	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

6	CD	O
)	)	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
40	CD	O
meq	NN	O
p.o.	NN	O
b.i.d.	NN	O

7	CD	O
)	)	O
glucophage	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8	CD	O
)	)	O
glucotrol	NN	B-TREATMENT
xl	$	I-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

9	CD	O
)	)	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

vicodin	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

cardiac	JJ	B-TEST
catheterization	NN	I-TEST

50	CD	O
yo	JJ	O
male	NN	O
,	,	O
h/o	JJ	O
cad	NN	B-PROBLEM
s/p	NN	O
stent	NN	B-TREATMENT
to	TO	I-TREATMENT
lad	VB	I-TREATMENT
in	IN	O
2011	CD	O
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
dm	NN	B-PROBLEM
,	,	O
cocaine	NN	O
abuse	NN	O
,	,	O
presenting	VBG	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

he	PRP	O
states	VBZ	O
he	PRP	O
had	VBD	O
onset	VBN	O
of	IN	O
this	DT	B-PROBLEM
pain	NN	I-PROBLEM
today	NN	O
;	:	O
described	VBN	O
as	IN	O
anterior	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
right	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
,	,	O
09-26	JJ	O
,	,	O
was	VBD	O
increasing	VBG	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
45	CD	O
minutes	NNS	O
to	TO	O
1	CD	O
hour	NN	O
(	(	O
occurred	VBN	O
after	IN	O
arrested	VBN	O
).	NN	O

he	PRP	O
states	VBZ	O
that	IN	O
he	PRP	O
also	RB	O
felt	VBD	O
sob	JJ	B-PROBLEM
and	CC	O
diaphoretic	JJ	B-PROBLEM
but	CC	O
denies	VBZ	O
n/v/palpitations	NNS	B-PROBLEM
.	.	O

he	PRP	O
reports	VBZ	O
that	IN	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
increasing	VBG	O
in	IN	O
intensity	NN	O
.	.	O

he	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
providence	VB	O
behavioral	JJ	O
health	NN	O
hospital	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
positive	JJ	O
urine	JJ	O
cocaine	NN	O
,	,	O
ekg	FW	B-TEST
with	IN	O
new	JJ	O
2-7392	JJ	O
w.	JJ	O
second	JJ	O
cr.	NN	O
elevations	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
leads	NNS	I-PROBLEM
(	(	I-PROBLEM
v2-5	NN	I-PROBLEM
)	)	I-PROBLEM
and	CC	O
some	DT	B-PROBLEM
st	JJ	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
avf	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
lopressor	RB	B-TREATMENT
5	CD	O
mg	NNS	O
x	JJ	O
2	CD	O
(	(	O
3rd	CD	O
dose	RB	O
given	VBN	O
by	IN	O
medflight	NN	O
,	,	O
5	CD	O
mg	NN	O
morphine	NN	B-TREATMENT
,	,	O
ativan	NN	B-TREATMENT
,	,	O
nitro	JJ	B-TREATMENT
gtt	NN	I-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
,	,	O
and	CC	O
integrillin	NN	B-TREATMENT
.	.	O

pain	NN	B-PROBLEM
was	VBD	O
12-28	JJ	O
at	IN	O
time	NN	O
of	IN	O
transfer	NN	O
.	.	O

in	IN	O
the	DT	O
cath	NN	O
lab	NN	O
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
hazy	JJ	B-PROBLEM
plaque	NN	I-PROBLEM
in	IN	I-PROBLEM
lad	NN	I-PROBLEM
(	(	O
prior	JJ	B-TREATMENT
stent	NN	I-TREATMENT
)	)	O
,	,	O
80%	CD	B-PROBLEM
hazy	NN	I-PROBLEM
plaque	NN	I-PROBLEM
in	IN	I-PROBLEM
circumflex	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
totally	RB	I-PROBLEM
occluded	JJ	I-PROBLEM
plb	NN	I-PROBLEM
(	(	I-PROBLEM
with	IN	I-PROBLEM
collaterals	NNS	I-PROBLEM
)	)	I-PROBLEM
.	.	O

1	CD	B-TREATMENT
cypher	NN	I-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
place	NN	O
in	IN	O
the	DT	O
lad	NN	O
while	IN	O
2	CD	O
were	VBD	O
placed	VBN	O
in	IN	O
lcx	NN	O
.	.	O

right	JJ	O
system	NN	O
was	VBD	O
not	RB	O
intervened	VBN	O
upon	IN	O
,	,	O
for	IN	O
the	DT	O
plb	NN	O
was	VBD	O
unable	JJ	O
to	TO	O
be	VB	O
crossed	VBN	O
by	IN	O
wire	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
ccu	NN	O
for	IN	O
observation	NN	B-TEST
.	.	O

1.	CD	O
cad	NN	B-PROBLEM
,	,	O
s/p	JJ	O
mi	NN	B-PROBLEM
in	IN	O
2011	CD	O
with	IN	O
stenting	NN	B-TREATMENT
of	IN	I-TREATMENT
lad	NN	I-TREATMENT

2.	CD	O
hypercholesterolemia	NN	B-PROBLEM

3.	CD	O
dm	NN	B-PROBLEM

no	DT	O
cad	NN	B-PROBLEM
in	IN	O
1st	CD	O
degree	JJ	O
relatives	NNS	O
.	.	O

robert	JJ	O
sudden	JJ	B-PROBLEM
death	NN	I-PROBLEM

vs	NN	B-TEST
:	:	O
94.1	CD	O
130/81	CD	O
71	CD	O
21	CD	O
99%	CD	O
4l	CD	B-TREATMENT
nc	NN	I-TREATMENT

gen	NN	O
:	:	O
somnolent	NN	B-PROBLEM
,	,	O
pleasant	JJ	O
male	NN	O
,	,	O
lying	VBG	O
in	IN	O
bed	NN	O

heent	NN	O
:	:	O
perrl	NN	O
,	,	O
some	DT	B-PROBLEM
dried	VBD	I-PROBLEM
blood	NN	I-PROBLEM
on	IN	I-PROBLEM
lips	NNS	I-PROBLEM
,	,	I-PROBLEM
tongue	NN	I-PROBLEM

neck	NN	O
:	:	O
no	DT	O
lad	NN	B-PROBLEM
,	,	O
?	.	O
enlarged	VBD	B-PROBLEM
parotid	NN	I-PROBLEM
glands	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM

cv	NN	O
:	:	O
rrr	NN	O
,	,	O
nl	JJ	O
s1/s2	NN	O
,	,	O
with	IN	O
s4	NN	B-PROBLEM
,	,	O
no	DT	O
m/r	NN	B-PROBLEM

lungs	NNS	O
:	:	O
cta	NN	O
bilaterally	RB	O
,	,	O
no	DT	O
w/r/r	NN	B-PROBLEM

abdomen	NNS	O
:	:	O
protuberant	NN	B-PROBLEM
,	,	O
nt/nd	RB	B-PROBLEM
,	,	O
nabs	NNS	O

right	JJ	O
groin	NN	O
:	:	O
with	IN	O
sheath	NN	B-TREATMENT
in	IN	O
place	NN	O

extr	NN	O
:	:	O
dp/pt	NN	B-TEST
2+	CD	O
bilaterally	RB	O
,	,	O
no	DT	O
c/c/e	NN	B-PROBLEM

catheterization	NN	B-TEST
on	IN	O
2016-03-31	JJ	O
:	:	O

hemoglobin	NN	B-TEST
:	:	O

fick	NN	B-TEST

right	RB	B-TEST
atrium	NN	I-TEST
{	(	O
a/v/m	JJ	O
}	)	O
18/17/13	CD	O

right	JJ	B-TEST
ventricle	NN	I-TEST
{	(	O
s/ruben	NN	O
}	)	O
45/18	CD	O

pulmonary	JJ	B-TEST
artery	NN	I-TEST
{	(	O
s/d/m	NN	O
}	)	O
45/22	CD	O

pulmonary	JJ	B-TEST
wedge	NN	I-TEST
{	(	O
a/v/m	JJ	O
}	)	O
21/22/20	CD	O

aorta	RB	B-TEST
{	(	O
s/d/m	NN	O
}	)	O
97/66/81	CD	O

heart	NN	B-TEST
rate	NN	I-TEST
{	(	O
beats/min	NN	O
}	)	O
88	CD	O

o2	JJ	B-TEST
cons.	NN	I-TEST
ind	NN	I-TEST
{	(	O
ml/min/m2	NN	O
}	)	O
125	CD	O

a-v	JJ	B-TEST
o2	NN	I-TEST
difference	NN	I-TEST
{	(	O
ml/ltr	NN	O
}	)	O
32	CD	O

card.	NN	B-TEST
op/ind	MD	I-TEST
fick	VB	I-TEST
{	(	O
l/mn/m2	NN	O
}	)	O
7.3/3.9	CD	O

systemic	JJ	B-TEST
vasc.	NN	I-TEST
resistance	NN	I-TEST
745	CD	O

svc	RB	B-TEST
low	JJ	I-TEST
81	CD	O

pa	NN	B-TEST
main	JJ	I-TEST
81	CD	O

ao	RB	B-TEST
98	CD	O

the	DT	B-TEST
oxygen	NN	I-TEST
consumption	NN	I-TEST
was	VBD	O
assumed	VBN	O
.	.	O

1)	CD	O
proximal	JJ	B-TEST
rca	NN	I-TEST
:	:	O
normal	JJ	O

2)	CD	O
mid	JJ	B-TEST
rca	NN	I-TEST
:	:	O
normal	JJ	O

2a)	CD	O
acute	JJ	B-TEST
marginal	JJ	I-TEST
:	:	O
normal	JJ	O

3)	CD	O
distal	JJ	B-TEST
rca	NN	I-TEST
:	:	O
normal	JJ	O

4)	CD	O
r-pda	JJ	B-TEST
:	:	O
normal	JJ	O

4a)	CD	O
r-post-lat	JJ	B-TEST
:	:	O
discrete	JJ	O
100	CD	O

4b)	CD	O
r-lv	JJ	B-TEST
:	:	O
normal	JJ	O

5)	CD	O
left	VBD	B-TEST
main	JJ	I-TEST
:	:	O
normal	JJ	O

6)	CD	O
proximal	JJ	B-TEST
lad	NN	I-TEST
:	:	O
ulcerated	JJ	B-PROBLEM

6a)	CD	O
septal-1	JJ	B-TEST
:	:	O
normal	JJ	O

7)	CD	O
mid-lad	JJ	B-TEST
:	:	O
normal	JJ	O

8)	CD	O
distal	JJ	B-TEST
lad	NN	I-TEST
:	:	O
normal	JJ	O

9)	CD	O
diagonal-1	JJ	B-TEST
:	:	O
normal	JJ	O

10)	CD	O
diagonal-2	JJ	B-TEST
:	:	O
normal	JJ	O

12)	CD	O
proximal	JJ	B-TEST
cx	NN	I-TEST
:	:	O
discrete	JJ	O
80	CD	O

13)	CD	O
mid	JJ	B-TEST
cx	NN	I-TEST
:	:	O
normal	JJ	O

13a)	CD	O
distal	JJ	B-TEST
cx	NN	I-TEST
:normal	NN	O

14)	CD	O
obtuse	IN	B-TEST
marginal	JJ	I-TEST
-	:	I-TEST
1	CD	I-TEST
:	:	O
normal	JJ	O

15)	CD	O
obtuse	IN	B-TEST
marginal	JJ	I-TEST
-	:	I-TEST
2	CD	I-TEST
:	:	O
normal	JJ	O

16)	CD	O
obtuse	IN	B-TEST
marginal	JJ	I-TEST
-	:	I-TEST
3	CD	I-TEST
:	:	O
normal	JJ	O

proximal	JJ	O
lad	NN	O
with	IN	O
hazy	JJ	B-PROBLEM
ulceration	NN	I-PROBLEM
,	,	O
proximal	JJ	O
circumflex	NN	O
with	IN	O
80%	CD	B-PROBLEM
hazy	NN	I-PROBLEM
,	,	O
totally	RB	B-PROBLEM
occluded	VBD	I-PROBLEM
plb	NN	I-PROBLEM
with	IN	I-PROBLEM
collaterals	NNS	I-PROBLEM

1	CD	B-TREATMENT
cypher	JJ	I-TREATMENT
stent	NN	I-TREATMENT
placed	VBN	O
in	IN	O
lad	NN	O
,	,	O
2	CD	B-TREATMENT
cypher	NN	I-TREATMENT
stents	NNS	I-TREATMENT
placed	VBN	O
in	IN	O
left	NN	O

echo	NN	B-TEST
:	:	O

1.	CD	O
the	DT	O
left	NN	O
ventricular	JJ	O
cavity	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
severe	JJ	B-PROBLEM
global	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
to	TO	O
akinesis	VB	B-PROBLEM
with	IN	O
some	DT	O
sparing	NN	O
of	IN	O
basal	NN	O
wall	NN	O
motion	NN	O
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
severely	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

2.	CD	O
the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
."	NNS	O

glucose	JJ	B-TEST
-	:	O
180	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
10	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
sodium	NN	B-TEST
-	:	O
142	CD	O
potassium	NN	B-TEST
-	:	O
3.7	CD	O
chloride	NN	B-TEST
-	:	O
104	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
30	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
12	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	CD	I-TEST
137	CD	O

ck-mb	JJ	B-TEST
-	:	O
4	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

calcium	NN	B-TEST
-	:	O
8.6	CD	O
phosphate	NN	B-TEST
-	:	O
3.4	CD	O
magnesium	NN	B-TEST
-	:	O
1.7	CD	O

wbc	SYM	B-TEST
-	:	O
9.1	CD	O
rbc	NN	B-TEST
-	:	O
4.08	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.7	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
35.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
31.0	CD	O
mchc	SYM	B-TEST
-	:	O
35.4	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
12.7	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
253	CD	O

1.	CD	O
cad	NN	B-PROBLEM
:	:	O
presented	VBN	O
with	IN	O
anginal	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
ekg	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
(	(	O
stemi	NN	B-PROBLEM
)	)	O
,	,	O
with	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
revealing	VBG	O
lesions	NNS	B-PROBLEM
in	IN	I-PROBLEM
lad	NN	I-PROBLEM
,	,	I-PROBLEM
lcx	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
plb	NN	I-PROBLEM
.	.	O

unclear	JJ	O
if	IN	O
hazy	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
significant	JJ	O
or	CC	O
if	IN	O
this	DT	O
was	VBD	O
cocaine	NN	O
induced	VBN	O
vasospasm	NN	O
.	.	O

lad	NN	O
and	CC	O
lcx	NN	O
were	VBD	O
stented	VBN	B-TREATMENT
,	,	O
but	CC	O
plb	NNS	O
could	MD	O
not	RB	O
be	VB	O
crossed	VBN	O
by	IN	O
guidewire	NN	B-TREATMENT
(	(	O
were	VBD	O
collaterals	NNS	O
)	)	O
.	.	O

-	:	O
continue	NN	O
asa	NN	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
;	:	O
will	MD	O
hold	VB	O
bb	VB	B-TREATMENT
given	VBN	O
recent	JJ	O
cocaine	NN	O
use	NN	O
(	(	O
?	.	O
can	MD	O
consider	VB	O
labetalol	JJ	B-TREATMENT
if	IN	O
necessary	JJ	O
)	)	O
,	,	O
integrillin	NN	B-TREATMENT
for	IN	O
18	CD	O
hours	NNS	O

-	:	O
ck	NN	B-TEST
negative	JJ	O
.	.	O

tn	NN	B-TEST
wnl	NN	O
.	.	O

-	:	O
post	NN	B-TEST
cath	NN	I-TEST
check	NN	I-TEST
normal	JJ	O

2.	CD	O
chf	NN	B-PROBLEM
:	:	O
ef	JJ	B-TEST
25%	CD	O
on	IN	O
echo	NN	B-TEST
,	,	O
states	VBZ	O
he	PRP	O
takes	VBZ	O
lasix	NN	B-TREATMENT
at	IN	O
home	NN	O

-	:	O
started	VBD	O
lisinopril	NN	B-TREATMENT
.	.	O

-	:	O
consider	NN	O
repeat	NN	B-TEST
echo	NN	I-TEST
in	IN	O
1	CD	O
month	NN	O
and	CC	O
quincy	NN	O
medical	JJ	O
center	NN	O
-	:	O
v/icd	NN	B-TREATMENT
per	IN	O
discretion	NN	O
of	IN	O
primary	JJ	O
cardiologist	NN	O
.	.	O

-	:	O
kept	NN	O
euvolemic	JJ	O
and	CC	O
monitored	VBD	O
for	IN	O
signs	NNS	O
of	IN	O
overload	NN	B-PROBLEM

-	:	O
low	NN	B-TREATMENT
na	TO	I-TREATMENT
diet	NN	I-TREATMENT
with	IN	O
1	CD	B-TREATMENT
liter	NN	I-TREATMENT
fluid	NN	I-TREATMENT
restriction	NN	I-TREATMENT

-	:	O
may	MD	O
need	VB	O
to	TO	O
diurese	VB	O
based	VBN	O
on	IN	O
clinical	JJ	O
status	NN	O
,	,	O
swan	NN	B-TEST
numbers	NNS	I-TEST

3.	CD	O
rhythm	NN	B-TEST
:	:	O
no	DT	O
ectopy	NN	B-PROBLEM
post	NN	I-PROBLEM
cath/mi	NN	I-PROBLEM

4.	CD	O
dm	NN	B-PROBLEM
:	:	O
on	IN	O
metformin	NN	B-TREATMENT
at	IN	O
home	NN	O
,	,	O
will	MD	O
hold	VB	O
given	VBN	O
cath	JJ	B-TREATMENT
/	NNP	I-TREATMENT
dye	NN	I-TREATMENT
adn	NN	O
cover	NN	O
with	IN	O
ssi	NN	B-TREATMENT

5.	CD	O
cocaine	NN	O
use	NN	O
:	:	O
last	JJ	O
use	NN	O
this	DT	O
morning	NN	O
,	,	O
no	DT	O
bb	NN	B-TREATMENT
given	VBN	O
this	DT	O
;	:	O
considered	VBN	O
using	VBG	O
ccb	JJ	B-TREATMENT
/	NNP	O
phentolamine	NN	B-TREATMENT
if	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
recurs	NN	O
.	.	O

--	:	O
will	MD	O
discuss	VB	O
beta-blocker	NN	B-TREATMENT
risks	NNS	O
and	CC	O
benefits	NNS	O
with	IN	O
primary	JJ	O
cardiologist	NN	O

6.	CD	O
etoh	JJ	O
use	NN	O
:	:	O
unclear	JJ	O
how	WRB	O
much	RB	O
,	,	O
monitor	NN	O
on	IN	O
ciwa	NN	B-TEST
for	IN	O
signs	NNS	O
of	IN	O
withdrawal	NN	B-PROBLEM
,	,	O
ativan	NN	B-TREATMENT
prn	NN	O

--	:	O
ciwas	NN	B-TEST
were	VBD	O
0	CD	O
throughout	IN	O
admission	NN	O

7.	CD	O
hyperlipidemia	NN	B-PROBLEM
:	:	O
on	IN	O
lipitor	NN	B-TREATMENT
80	CD	O
.	.	O

ldl	NN	B-TEST
79	CD	O
,	,	O
hdl	VBD	B-TEST
51	CD	O

9.	CD	O
fen	NN	O
:	:	O
cardiac	JJ	B-TREATMENT
diet	NN	I-TREATMENT
,	,	O
watch	NN	O
for	IN	O
aspiration	NN	B-PROBLEM
given	VBN	O
somnolent	JJ	B-PROBLEM
status	NN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
,	,	O
ck	NN	B-TEST
and	CC	O
replete	JJ	O
mg/k/ca	NN	B-TREATMENT
aggressively	RB	O

lipitor	NN	B-TREATMENT
80	CD	O

coreg	NN	B-TREATMENT

asa	RB	B-TREATMENT
81	CD	O
mg	NN	O

lasix	NN	B-TREATMENT

glucophage	NN	B-TREATMENT

all	DT	O
:	:	O
vicodin	NN	B-TREATMENT
-?	VBZ	O
rash	NN	B-PROBLEM

1.	CD	O
please	NN	O
continue	VB	O
your	PRP$	B-TREATMENT
previous	JJ	I-TREATMENT
diabetes	NNS	I-TREATMENT
medications	NNS	I-TREATMENT

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
clopidogrel	NN	B-TREATMENT
bisulfate	NN	I-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

5.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

6.	CD	O
atorvastatin	JJ	B-TREATMENT
calcium	NN	I-TREATMENT
80	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM

please	VB	O
notify	JJ	O
nurses	NNS	O
,	,	O
doctors	NNS	O
marilyn	VBP	O
kristen	JJ	O
layne	JJ	O
workers	NNS	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
or	CC	O
lightheadedness	NN	B-PROBLEM
.	.	O

cocaine	NN	O
use	NN	O
has	VBZ	O
been	VBN	O
associated	VBN	O
with	IN	O
an	DT	O
increased	VBN	O
risk	NN	O
of	IN	O
heart	NN	B-PROBLEM
attacks	NNS	I-PROBLEM
,	,	O
stroke	NN	B-PROBLEM
and	CC	O
death	NN	B-PROBLEM
.	.	O

you	PRP	O
must	MD	O
continue	VB	O
to	TO	O
take	VB	O
plavix	NN	B-TREATMENT
.	.	O

please	VB	O
discuss	VB	O
the	DT	O
use	NN	O
of	IN	O
beta-blockers	NNS	B-TREATMENT
with	IN	O
your	PRP$	O
cardiologist	NN	O
.	.	O

beta-blockers	NNS	B-TREATMENT
should	MD	O
not	RB	O
be	VB	O
used	VBN	O
while	IN	O
using	VBG	O
cocaine	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
37-year-old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
aids	NNS	B-PROBLEM
complicated	VBN	O
by	IN	O
recurrent	NN	B-PROBLEM
pseudomonas	NNS	I-PROBLEM
infections	NNS	I-PROBLEM
presently	RB	O
on	IN	O
ceftazidime	NN	B-TREATMENT
and	CC	O
aztrenam	NN	B-TREATMENT
complicated	VBN	O
by	IN	O
mai	NN	B-PROBLEM
who	WP	O
comes	VBZ	O
in	IN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
and	CC	O
blood	NN	B-TEST
cultures	NNS	I-TEST
positive	JJ	O
for	IN	O
candida	JJ	B-PROBLEM
species	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
multiple	JJ	B-PROBLEM
aids	NNS	I-PROBLEM
illnesses	NNS	I-PROBLEM
including	VBG	O
mai	NN	B-PROBLEM
who	WP	O
has	VBZ	O
multiple	JJ	O
admissions	NNS	O
for	IN	O
pseudomonas	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

his	PRP$	O
most	RBS	O
recent	JJ	O
admission	NN	O
was	VBD	O
on	IN	O
08/23/92	CD	O
to	TO	O
08/25/92	CD	O
with	IN	O
fever	NN	B-PROBLEM
and	CC	O
chills	NNS	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
again	RB	O
treated	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
ceftazidime	NN	I-TREATMENT
for	IN	O
presumed	JJ	O
pseudomonal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
discharged	VBD	O
home	NN	O
on	IN	O
iv	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
which	WDT	O
he	PRP	O
is	VBZ	O
presently	RB	O
on	IN	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
at	IN	O
home	NN	O
with	IN	O
decreasing	VBG	O
fever	NN	O
and	CC	O
good	JJ	O
appetite	NN	O
until	IN	O
the	DT	O
night	NN	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
developed	VBD	O
fever	NN	B-PROBLEM
and	CC	O
chills	NNS	B-PROBLEM
.	.	O

concurrent	NN	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
grew	VBD	O
out	RP	O
candida	JJ	B-PROBLEM
species	NNS	I-PROBLEM
at	IN	O
hchp	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
baseline	NN	I-TEST
o2	NN	I-TEST
saturation	NN	I-TEST
is	VBZ	O
92%	CD	O
on	IN	O
three	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
arm	NN	I-TREATMENT
graft	NN	I-TREATMENT
placed	VBD	O
for	IN	O
access	NN	O
three	CD	O
weeks	NNS	O
ago	RB	O
which	WDT	O
is	VBZ	O
used	VBN	O
for	IN	O
blood	NN	B-TREATMENT
drawing	NN	I-TREATMENT
and	CC	O
iv	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

he	PRP	O
notes	VBZ	O
no	DT	O
tenderness	NN	B-PROBLEM
,	,	O
erythema	NN	B-PROBLEM
,	,	O
warmth	NN	B-PROBLEM
or	CC	O
exudate	NN	B-PROBLEM
from	IN	O
the	DT	B-TREATMENT
passport	NN	I-TREATMENT
site	NN	I-TREATMENT
.	.	O

medications	NNS	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
include	VBP	O
dapsone	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
on	IN	O
monday	NN	O
,	,	O
wednesday	JJ	O
and	CC	O
friday	JJ	O
,	,	O
ceftazidime	JJ	B-TREATMENT
1	CD	O
gram	NN	O
iv	NN	O
q.	VBD	O
8	CD	O
hours	NNS	O
,	,	O
cipro	VBP	B-TREATMENT
750	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
acyclovir	RB	B-TREATMENT
400	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
,	,	O
megastrol	NN	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
and	CC	O
g-csf	JJ	B-TREATMENT
150	CD	O
micrograms	NNS	O
subcu	VBP	O
b.i.d.	NN	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
his	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
101	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
110/60	CD	O
,	,	O
pulse	RB	B-TEST
96	CD	O
,	,	O
respirations	NNS	B-TEST
16	CD	O
.	.	O

o2	JJ	B-TEST
saturation	NN	I-TEST
on	IN	O
three	CD	B-TREATMENT
liters	NNS	I-TREATMENT
was	VBD	O
96%	CD	O
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

chest	NN	O
revealed	VBD	O
bilateral	JJ	B-PROBLEM
basilar	JJ	I-PROBLEM
rales	NNS	I-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
has	VBZ	O
a	DT	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
without	IN	O
murmurs	NNS	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

the	DT	O
extremities	NNS	O
had	VBD	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

neurological	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
x	NNP	O
three	CD	O
.	.	O

notable	JJ	O
on	IN	O
admission	NN	O
were	VBD	O
bun	JJ	B-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
8.0	CD	O
and	CC	O
0.7	CD	O
.	.	O

sodium	NN	B-TEST
134	CD	O
,	,	O
alt	RB	B-TEST
18	CD	O
,	,	O
ast	RB	B-TEST
27	CD	O
,	,	O
ldh	VBD	B-TEST
221	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
2.05	CD	O
,	,	O
hematocrit	NN	B-TEST
23	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
137,000	CD	O
.	.	O

the	DT	B-TEST
differential	NN	I-TEST
showed	VBD	O
45	CD	B-TEST
polys	NN	I-TEST
,	,	O
6	CD	B-TEST
bands	NNS	I-TEST
,	,	O
8	CD	B-TEST
lymphs	NN	I-TEST
,	,	O
32	CD	B-TEST
monos	NNS	I-TEST
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

sputum	NN	B-TEST
gram	NN	I-TEST
stain	NN	I-TEST
showed	VBD	O
no	DT	O
polys	NN	B-PROBLEM
and	CC	O
no	DT	O
bacteria	NN	B-PROBLEM
.	.	O

afb	NN	B-TEST
stain	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
an	DT	B-TEST
old	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
on	IN	O
08/08/92	CD	O
showing	VBG	O
a	DT	B-PROBLEM
resolving	NN	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
and	CC	I-PROBLEM
lingular	JJ	I-PROBLEM
infiltrate	NN	I-PROBLEM
and	CC	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
right	NN	I-PROBLEM
mid	NN	I-PROBLEM
lung	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

1.	CD	O
infectious	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
amphotericine	NN	B-TREATMENT
at	IN	O
.6	NNP	O
mg	FW	O
/	NNP	O
kg	NN	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
250	CD	O
mg	NN	O
for	IN	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
for	IN	O
candida	NN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
passport	NN	I-TREATMENT
in	IN	I-TREATMENT
his	PRP$	I-TREATMENT
left	JJ	I-TREATMENT
arm	NN	I-TREATMENT
was	VBD	O
pulled	VBN	O
and	CC	O
will	MD	O
be	VB	O
replaced	VBN	O
if	IN	O
needed	VBN	O
after	IN	O
the	DT	B-TREATMENT
amphotericine	NN	I-TREATMENT
is	VBZ	O
completed	VBN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
continue	VB	O
on	IN	O
his	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
pseudomonas	NNS	B-PROBLEM
pneumonia	VBP	I-PROBLEM
to	TO	O
complete	VB	O
the	DT	O
fourteen	JJ	O
day	NN	O
course	NN	O
which	WDT	O
was	VBD	O
completed	VBN	O
on	IN	O
09/06/92	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
admission	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
g-csf	NN	I-TREATMENT
with	IN	O
an	DT	O
increase	NN	O
in	IN	O
his	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
to	TO	O
8	CD	O
from	IN	O
1.8	CD	O
.	.	O

the	DT	O
patient	NN	O
required	VBN	O
multiple	JJ	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
hematocrit	NN	I-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
are	VBP	O
g-csf	JJ	B-TREATMENT
300	CD	O
micrograms	NNS	O
subcu	JJ	O
q.	JJ	O
day	NN	O
,	,	O
acyclovir	RB	B-TREATMENT
200	CD	O
mg	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
erythromycin	VBZ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
dapsone	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
monday	NN	O
,	,	O
wednesday	JJ	O
and	CC	O
friday	JJ	O
,	,	O
imodium	JJ	B-TREATMENT
1-2	JJ	O
tablets	NNS	O
p.o.	VBP	O
q.	RB	O
6	CD	O
hours	NNS	O
p.r.n.	RB	O
,	,	O
nystatin	RB	B-TREATMENT
5	CD	O
cc	JJ	O
swish	JJ	O
and	CC	O
swallow	JJ	O
q.i.d.	NN	O
,	,	O
serax	VBD	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
6	CD	O
hours	NNS	O
p.r.n.	JJ	O
and	CC	O
kay-ceil	JJ	B-TREATMENT
40	CD	O
meq	NN	O
p.o.	NN	O
b.i.d.	NN	O

the	DT	O
patient	NN	O
needs	VBZ	O
to	TO	O
have	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
drawn	NN	I-TEST
the	DT	O
day	NN	O
after	IN	O
discharge	NN	O
to	TO	O
check	VB	O
a	DT	B-TEST
potassium	NN	I-TEST
and	CC	O
magnesium	NN	B-TEST
which	WDT	O
he	PRP	O
has	VBZ	O
been	VBN	O
wasting	VBG	O
secondary	JJ	O
to	TO	O
amphotericine	VB	B-TREATMENT
.	.	O

he	PRP	O
will	MD	O
probably	RB	O
need	VB	O
potassium	NN	B-TREATMENT
and	CC	O
magnesium	NN	B-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

he	PRP	O
will	MD	O
need	VB	O
follow	VB	B-TEST
up	RP	I-TEST
lytes	NNS	I-TEST
drawn	VBN	O
throughout	IN	O
the	DT	O
week	NN	O
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
53	JJ	O
-	:	O
year-old	JJ	O
female	NN	O
found	VBD	O
down	RB	O
in	IN	O
hotel	NN	O
room	NN	O
by	IN	O
ems	NNS	O
with	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
lethargy	NN	B-PROBLEM
.	.	O

a	DT	O
suicide	JJ	O
note	NN	O
found	VBD	O
at	IN	O
the	DT	O
scene	NN	O
referenced	VBD	O
multiple	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
suggested	VBN	O
ingestion	NN	O
of	IN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
muscle	NN	B-TREATMENT
relaxant	NN	I-TREATMENT
,	,	O
and	CC	O
neurontin	RB	B-TREATMENT
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
on	IN	O
arrival	NN	O
in	IN	O
the	DT	O
david	NN	O
,	,	O
but	CC	O
the	DT	O
patient	NN	O
was	VBD	O
minimally	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
and	CC	O
subsequently	RB	O
intubated	VBN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
.	.	O

patient	NN	O
initially	RB	O
given	VBN	O
2	CD	O
mg	NN	O
of	IN	O
narcan	JJ	B-TREATMENT
,	,	O
4	CD	O
amps	NNS	O
of	IN	O
sodium	NN	B-TREATMENT
bicarb	NN	I-TREATMENT
,	,	O
and	CC	O
5	CD	O
grams	NNS	O
of	IN	O
activated	JJ	B-TREATMENT
charcoal	NN	I-TREATMENT
.	.	O

patient	NN	B-TEST
's	POS	I-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
were	VBD	O
noted	VBN	O
to	TO	O
decrease	VB	B-PROBLEM
systolics	NNS	I-PROBLEM
to	TO	O
the	DT	O
80s	CD	O
,	,	O
which	WDT	O
responded	VBD	O
to	TO	O
iv	VB	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
insulin	NN	B-TREATMENT
/	VBP	O
glucose	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

also	RB	O
noted	VBN	O
to	TO	O
be	VB	O
bradycardic	JJ	B-PROBLEM
to	TO	O
the	DT	O
50s	CD	O
,	,	O
which	WDT	O
responded	VBD	O
to	TO	O
atropine	VB	B-TREATMENT
.	.	O

1.	CD	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
.	.	O

2.	CD	O
hypertrophic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

3.	CD	O
lumbar	NN	B-PROBLEM
and	CC	I-PROBLEM
cervical	JJ	I-PROBLEM
degenerative	JJ	I-PROBLEM
disk	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

4.	CD	O
sarcoid	NN	B-PROBLEM
.	.	O

5.	CD	O
depression	NN	B-PROBLEM
.	.	O

6.	CD	O
headaches	NNS	B-PROBLEM
.	.	O

1.	CD	O
neurontin	NN	B-TREATMENT
.	.	O

2.	CD	O
propanolol	NN	B-TREATMENT
.	.	O

3.	CD	O
tylenol	JJ	B-TREATMENT
#3	NN	I-TREATMENT
.	.	O

4.	CD	O
butalbital	NN	B-TREATMENT
.	.	O

5.	CD	O
morphine	NN	B-TREATMENT
.	.	O

6.	CD	O
protonix	NN	B-TREATMENT
.	.	O

7.	CD	O
doxepin	NN	B-TREATMENT
.	.	O

8.	CD	O
dilaudid	NN	B-TREATMENT
.	.	O

9.	CD	O
inderal	JJ	B-TREATMENT
.	.	O

10.	CD	O
skelaxin	NN	B-TREATMENT
.	.	O

11.	CD	O
zantac	NN	B-TREATMENT
.	.	O

12.	CD	O
flexeril	NN	B-TREATMENT
.	.	O

13.	CD	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
.	.	O

temperature	NN	B-TEST
96.8	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
81	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
92/47	CD	O
,	,	O
and	CC	O
saturating	VBG	O
100%	CD	O
on	IN	O
40%	CD	O
fio2	NN	B-TREATMENT
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

pulmonary	NN	O
is	VBZ	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
20.0	CD	O
,	,	O
hematocrit	NN	B-TEST
52	CD	O
,	,	O
platelets	NNS	B-TEST
439	CD	O
.	.	O

chem-7	NN	B-TEST
:	:	O

urinalysis	NN	B-TEST
negative	JJ	O
except	IN	O
for	IN	O
large	JJ	B-PROBLEM
blood	NN	I-PROBLEM
.	.	O

ekg	NN	B-TEST
:	:	O

sinus	NN	B-PROBLEM
bradycardia	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
bundle	JJ	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
prolonged	VBD	B-PROBLEM
qrs	NN	I-PROBLEM
.	.	O

urine	JJ	B-TEST
tox	NN	I-TEST
positive	JJ	B-PROBLEM
for	IN	I-PROBLEM
barbiturates	NNS	I-PROBLEM
,	,	I-PROBLEM
opiates	NNS	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
methadone	NN	I-PROBLEM
.	.	O

serum	NN	B-TEST
tylenol	NN	I-TEST
level	NN	I-TEST
is	VBZ	O
8.3	CD	O
.	.	O

positive	JJ	B-PROBLEM
for	IN	I-PROBLEM
serum	NN	I-PROBLEM
barbiturates	NNS	I-PROBLEM
.	.	O

ck	NN	B-TEST
15,000	CD	O
.	.	O

alt	RB	B-TEST
77	CD	O
,	,	O
ast	RB	B-TEST
159	CD	O
,	,	O
amylase	NN	B-TEST
153	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
216	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
0.6	CD	O
.	.	O

inr	RB	B-TEST
1.1	CD	O
.	.	O

in	IN	O
summary	JJ	O
,	,	O
patient	NN	O
is	VBZ	O
a	DT	O
53	JJ	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
multiple	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
and	CC	O
history	NN	O
of	IN	O
depression	NN	B-PROBLEM
with	IN	O
intentional	JJ	O
overdose	NN	O
of	IN	O
barbiturates	NNS	B-TREATMENT
,	,	O
opiates	NNS	B-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT
,	,	O
and	CC	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
.	.	O

patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
insulin	NN	B-TREATMENT
,	,	O
d10	NN	B-TREATMENT
and	CC	O
glucagon	NN	B-TREATMENT
drips	NNS	I-TREATMENT
to	TO	O
maintain	VB	O
her	PRP$	O
hemodynamics	NNS	O
.	.	O

psychiatry	NN	O
was	VBD	O
consulted	VBN	O
after	IN	O
the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
,	,	O
and	CC	O
felt	VBD	O
that	IN	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
suicide	NN	I-PROBLEM
risk	NN	I-PROBLEM
,	,	O
and	CC	O
plan	NN	O
was	VBD	O
for	IN	O
her	PRP$	O
to	TO	O
be	VB	O
admitted	VBN	O
to	TO	O
the	DT	O
psychiatry	NN	O
service	NN	O
once	RB	O
medically	RB	O
stable	JJ	O
.	.	O

patient	NN	O
's	POS	O
renal	JJ	O
function	NN	O
remained	VBD	O
stable	JJ	O
and	CC	O
her	PRP$	B-TEST
cks	NNS	I-TEST
trended	VBD	O
down	RB	O
gradually	RB	O
.	.	O

patient	NN	O
remained	VBD	O
on	IN	O
suicide	JJ	B-TREATMENT
precautions	NNS	I-TREATMENT
,	,	O
but	CC	O
was	VBD	O
deemed	VBN	O
not	RB	O
to	TO	O
need	VB	O
icu	JJ	B-TEST
level	NN	I-TEST
monitoring	NN	I-TEST
,	,	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
on	IN	O
01-11	NN	O
.	.	O

in	IN	O
the	DT	O
a.m.	NN	O
of	IN	O
01/08	CD	O
,	,	O
the	DT	O
patient	NN	O
experienced	VBD	O
episode	NN	O
of	IN	O
tongue	NN	B-PROBLEM
biting	NN	I-PROBLEM
,	,	O
unresponsiveness	JJ	B-PROBLEM
,	,	O
disorientation	NN	B-PROBLEM
.	.	O

was	VBD	O
loaded	VBN	O
on	IN	O
dilantin	NN	B-TREATMENT
.	.	O

became	VBD	O
progressively	RB	O
hypoxic	JJ	B-PROBLEM
and	CC	O
tachypneic	JJ	B-PROBLEM
throughout	IN	O
the	DT	O
day	NN	O
with	IN	O
respiratory	JJ	B-TEST
rates	NNS	I-TEST
of	IN	O
30-40	JJ	O
with	IN	O
a	DT	B-TEST
max	JJ	I-TEST
respiratory	NN	I-TEST
rate	NN	I-TEST
of	IN	O
116	CD	O
,	,	O
tachycardia	NN	B-PROBLEM
to	TO	O
120s	CD	O
.	.	O

patient	NN	O
subsequently	RB	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
on	IN	O
2017-01-13	JJ	O
for	IN	O
further	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

patient	NN	B-PROBLEM
's	POS	I-PROBLEM
hypoxia	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
most	RBS	O
likely	JJ	O
to	TO	O
be	VB	O
caused	VBN	O
by	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
appropriate	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

etiology	NN	O
of	IN	O
patient	NN	B-PROBLEM
's	POS	I-PROBLEM
tachypnea	NN	I-PROBLEM
was	VBD	O
unclear	JJ	O
.	.	O

initially	RB	O
,	,	O
the	DT	O
patient	NN	O
's	POS	O
etiology	NN	O
of	IN	O
seizure	NN	B-PROBLEM
was	VBD	O
not	RB	O
quite	RB	O
clear	JJ	O
,	,	O
but	CC	O
thought	VBD	O
possibly	RB	O
secondary	JJ	O
to	TO	O
alcohol	VB	B-PROBLEM
and	CC	I-PROBLEM
benzodiazepine	VB	I-PROBLEM
withdrawal	NN	I-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
eeg	RB	B-TEST
,	,	O
mri	NN	B-TEST
,	,	O
lp	NN	B-TEST
.	.	O

subsequently	RB	O
eeg	NN	B-TEST
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
no	DT	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
.	.	O

mri	NN	B-TEST
was	VBD	O
suboptimal	JJ	O
due	JJ	O
to	TO	O
motion	VB	O
artifact	NN	O
and	CC	O
lp	NN	B-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

despite	IN	O
absence	NN	O
of	IN	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
on	IN	O
eeg	NN	B-TEST
,	,	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
dilantin	NN	B-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
delirium	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
possibly	RB	O
secondary	JJ	O
to	TO	O
withdrawal	VB	B-PROBLEM
versus	NN	O
toxic	JJ	B-PROBLEM
metabolic	NN	I-PROBLEM
,	,	O
but	CC	O
gradually	RB	O
improved	JJ	O
slowly	RB	O
,	,	O
and	CC	O
therefore	RB	O
patient	NN	O
did	VBD	O
not	RB	O
receive	VB	O
treatment	NN	B-TREATMENT
for	IN	O
barbiturate	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
.	.	O

her	PRP$	O
mental	JJ	O
status	NN	O
,	,	O
tachypnea	NN	B-PROBLEM
,	,	O
and	CC	O
hypoxia	VB	B-PROBLEM
all	DT	O
improved	VBN	O
,	,	O
and	CC	O
patient	NN	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
floor	NN	O
medical	JJ	O
team	NN	O
on	IN	O
2017-01-15	JJ	O
.	.	O

while	IN	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
the	DT	O
patient	NN	O
's	POS	O
mental	JJ	O
status	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
improved	VBN	O
back	RB	O
at	IN	O
baseline	NN	O
compared	VBN	O
to	TO	O
that	DT	O
back	RB	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
,	,	O
and	CC	O
she	PRP	O
exhibited	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
barbiturate	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
suicide	JJ	B-TREATMENT
precautions	NNS	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
one-to-one	JJ	I-TREATMENT
sitter	NN	I-TREATMENT
,	,	O
and	CC	O
plan	NN	O
was	VBD	O
for	IN	O
psychiatric	JJ	O
admission	NN	O
when	WRB	O
medical	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
had	VBD	O
resolved	VBN	O
.	.	O

on	IN	O
2017-01-16	JJ	O
,	,	O
the	DT	O
night	NN	O
float	NN	O
intern	NN	O
was	VBD	O
called	VBN	O
to	TO	O
see	VB	O
the	DT	O
patient	NN	O
as	IN	O
she	PRP	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
.	.	O

patient	JJ	O
unresponsive	JJ	B-PROBLEM
to	TO	O
verbal	JJ	B-TEST
command	NN	I-TEST
,	,	O
sternal	JJ	B-TEST
rub	NN	I-TEST
.	.	O

pupils	NNS	O
were	VBD	O
fixed	VBN	B-PROBLEM
and	CC	O
dilated	VBN	B-PROBLEM
.	.	O

patient	NN	O
noted	VBD	O
to	TO	O
be	VB	O
without	IN	B-PROBLEM
corneal	JJ	I-PROBLEM
reflexes	NNS	I-PROBLEM
,	,	I-PROBLEM
spontaneous	JJ	I-PROBLEM
breathing	NN	I-PROBLEM
,	,	I-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	I-PROBLEM
or	CC	I-PROBLEM
palpable	JJ	I-PROBLEM
pulses	NNS	I-PROBLEM
.	.	O

patient	NN	O
's	POS	O
family	NN	O
was	VBD	O
notified	VBN	O
and	CC	O
declined	VBD	O
autopsy	NN	B-TEST
.	.	O

of	IN	O
note	NN	O
at	IN	O
time	NN	O
of	IN	O
death	NN	O
,	,	O
patient	NN	O
was	VBD	O
dnr	JJ	B-TREATMENT
/	NNP	O
dni	NN	B-TREATMENT
.	.	O

this	DT	O
was	VBD	O
initiated	VBN	O
after	IN	O
several	JJ	O
conversations	NNS	O
with	IN	O
the	DT	O
patient	NN	O
's	POS	O
mother	NN	O
,	,	O
who	WP	O
stated	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
desired	VBN	O
to	TO	O
be	VB	O
dnr	JJ	B-TREATMENT
/	NNP	O
dni	NN	B-TREATMENT
for	IN	O
many	JJ	O
years	NNS	O
,	,	O
not	RB	O
just	RB	O
in	IN	O
the	DT	O
recent	JJ	O
past	NN	O
.	.	O

neuropathic	JJ	B-PROBLEM
pain	NN	I-PROBLEM

post	NN	B-PROBLEM
thoracotomy	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
spinal	JJ	I-TEST
cord	NN	I-TEST
stimulator	NN	I-TEST
trial	NN	I-TEST
on	IN	O
07/21/99	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
epidural	JJ	I-TEST
trial	NN	I-TEST
on	IN	O
07/24/99	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
post	NN	B-PROBLEM
thoracotomy	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
that	WDT	O
occurred	VBD	O
on	IN	O
the	DT	O
site	NN	O
of	IN	O
her	PRP$	B-PROBLEM
thoracotomy	JJ	I-PROBLEM
incision	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
thoracic	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
repaired	VBN	O
in	IN	O
the	DT	O
past	JJ	O
and	CC	O
subsequently	RB	O
developed	VBD	O
neuropathic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
at	IN	O
the	DT	B-PROBLEM
incision	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
currently	RB	O
on	IN	O
vicodin	NN	B-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
every	DT	O
four	CD	O
hours	NNS	O
p.r.n.	RB	O
,	,	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
25	CD	O
mcg	NN	O
an	DT	O
hour	NN	O
,	,	O
change	NN	O
of	IN	O
patch	NN	O
every	DT	O
72	CD	O
hours	NNS	O
,	,	O
elavil	VBP	B-TREATMENT
50	CD	O
mgq	JJ	O
.h.s.	NN	O
,	,	O
neurontin	RB	B-TREATMENT
600	CD	O
mg	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
with	IN	O
still	RB	O
what	WP	O
she	PRP	O
reports	VBZ	O
as	IN	O
stabbing	VBG	B-PROBLEM
left-sided	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
that	WDT	O
can	MD	O
be	VB	O
as	RB	O
severe	JJ	O
as	IN	O
a	DT	O
7/10.	CD	O

she	PRP	O
has	VBZ	O
failed	VBN	O
conservative	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
is	VBZ	O
admitted	VBN	O
for	IN	O
a	DT	B-TEST
spinal	JJ	I-TEST
cord	NN	I-TEST
stimulator	NN	I-TEST
trial	NN	I-TEST
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2.	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

3.	CD	O
paraplegia	NN	B-PROBLEM
status	NN	O
post	NN	O
thoracic	NN	B-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

4.	CD	O
left	VBD	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM
paralysis	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
recurrent	NN	B-PROBLEM
lung	NN	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

5.	CD	O
sacral	JJ	B-PROBLEM
decubitus	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

6.	CD	O
home	NN	B-TREATMENT
oxygen	NN	I-TREATMENT
at	IN	O
two	CD	O
liters	NNS	O
a	DT	O
minute	NN	O
when	WRB	O
she	PRP	O
is	VBZ	O
at	IN	O
home	NN	O
;	:	O
she	PRP	O
does	VBZ	O
not	RB	O
use	VB	O
the	DT	B-TREATMENT
oxygen	NN	I-TREATMENT
when	WRB	O
she	PRP	O
is	VBZ	O
in	IN	O
a	DT	B-TREATMENT
wheelchair	NN	I-TREATMENT
or	CC	O
is	VBZ	O
out	IN	O
of	IN	O
the	DT	O
house	NN	O
.	.	O

1.	CD	O
atrovent	JJ	B-TREATMENT
nebulizers	NNS	I-TREATMENT
0.5	CD	O
mg	NNS	O
mixed	JJ	O
with	IN	O
albuterol	NN	B-TREATMENT
,	,	O
nebulizer	NN	B-TREATMENT
is	VBZ	O
given	VBN	O
every	DT	O
six	CD	O
hours	NNS	O
.	.	O

2.	CD	O
norvasc	JJ	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

3.	CD	O
colistin	NN	B-TREATMENT
30	CD	O
mg	NN	O
nebulizer	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
give	VB	O
30	CD	O
minutes	NNS	O
post	VBP	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	NN	B-TREATMENT
.	.	O

4.	CD	O
pressure	NN	B-TREATMENT
,	,	I-TREATMENT
dermal	JJ	I-TREATMENT
ulcer	NN	I-TREATMENT
care	NN	I-TREATMENT
b.i.d.	IN	O
dressing	VBG	B-TREATMENT
change	NN	I-TREATMENT
with	IN	O
antibiotic	JJ	B-TREATMENT
solution	NN	I-TREATMENT
.	.	O

5.	CD	O
neurontin	JJ	B-TREATMENT
600	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

6.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

7.	CD	O
albuterol	NN	B-TREATMENT
neb	RB	I-TREATMENT
2.5	CD	O
mg	NN	O
every	DT	O
six	CD	O
hours	NNS	O
,	,	O
30	CD	O
minutes	NNS	O
before	IN	O
colistin	NN	B-TREATMENT
.	.	O

8.	CD	O
amitriptyline	JJ	B-TREATMENT
50	CD	O
mg	NNS	O
q.h.s.	NN	O

9.	CD	O
vitamin	JJ	B-TREATMENT
c	NN	I-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

10.	CD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
125.0	CD	O
mg	NN	O
t.i.d.	NN	O

11.	CD	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
25	CD	O
mcg	NN	O
an	DT	O
hour	NN	O
,	,	O
change	NN	O
patch	NN	O
every	DT	O
72	CD	O
hours	NNS	O
.	.	O

12.	CD	O
folate	JJ	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

13.	CD	O
synthroid	JJ	B-TREATMENT
50	CD	O
mcg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

14.	CD	O
zinc	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
220	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

15.	CD	O
multivitamin	NN	B-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

16.	CD	O
hydrocodone	NN	B-TREATMENT
5	CD	I-TREATMENT
mg	NN	I-TREATMENT
with	IN	I-TREATMENT
tylenol	NN	I-TREATMENT
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
every	DT	O
four	CD	O
hours	NNS	O
p.r.n.	RB	O
pain	VBP	B-PROBLEM
.	.	O

17.	CD	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
30	CD	O
cc	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
constipation	NN	B-PROBLEM
.	.	O

penicillin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
well-appearing	JJ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
is	VBZ	O
150/90	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
90	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
with	IN	O
saturation	NN	B-TEST
of	IN	O
98%	CD	O
.	.	O

the	DT	O
patient	NN	O
wears	VBZ	O
dentures	NNS	B-TREATMENT
.	.	O

full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
on	IN	O
the	DT	O
right	NN	O
.	.	O

decreased	VBN	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
with	IN	O
coarse	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

epidural	JJ	B-TREATMENT
site	NN	I-TREATMENT
is	VBZ	O
without	IN	O
erythema	NN	B-PROBLEM
,	,	O
drainage	NN	B-PROBLEM
or	CC	O
tenderness	NN	B-PROBLEM
.	.	O

left	VBN	O
buttock	NN	O
area	NN	O
has	VBZ	O
a	DT	B-TREATMENT
dressing	NN	I-TREATMENT
over	IN	O
the	DT	B-PROBLEM
sacral	JJ	I-PROBLEM
decubitus	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

flaccid	JJ	B-PROBLEM
paralysis	NN	I-PROBLEM
of	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
07/20/99	CD	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
left	JJ	B-PROBLEM
chest	JJS	I-PROBLEM
wall	NN	I-PROBLEM
pain	NN	I-PROBLEM
from	IN	O
postthoracotomy	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
the	DT	B-PROBLEM
syndrome	NN	I-PROBLEM
after	IN	O
her	PRP$	B-TREATMENT
thoracic	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
failed	VBD	O
the	DT	B-TREATMENT
conservative	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
is	VBZ	O
admitted	VBN	O
for	IN	O
a	DT	B-TEST
spinal	JJ	I-TEST
cord	NN	I-TEST
stimulator	NN	I-TEST
trial	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
placed	VBD	O
on	IN	O
07/21/99	CD	O
.	.	O

she	PRP	O
underwent	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
very	RB	O
well	RB	O
.	.	O

the	DT	B-TREATMENT
spinal	JJ	I-TREATMENT
cord	NN	I-TREATMENT
stimulator	NN	I-TREATMENT
was	VBD	O
programmed	VBN	O
with	IN	O
setting	NN	O
of	IN	O
a	DT	O
rate	NN	O
of	IN	O
80	CD	O
,	,	O
power	NN	O
450	CD	O
and	CC	O
4.0	CD	O
amps	NNS	O
.	.	O

the	DT	O
patient	NN	O
the	DT	O
next	JJ	O
two	CD	O
days	NNS	O
did	VBD	O
not	RB	O
notice	VB	O
any	DT	O
significant	JJ	O
change	NN	O
in	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
pattern	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	O
lot	NN	O
of	IN	O
musculoskeletal	JJ	B-PROBLEM
component	NN	I-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

so	RB	O
,	,	O
an	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
on	IN	O
07/23/99	CD	O
.	.	O

the	DT	B-TREATMENT
epidural	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
the	DT	O
l1-2	JJ	O
region	NN	O
and	CC	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
the	DT	O
t7	JJ	O
region	NN	O
using	VBG	O
fluoroscope	NN	B-TREATMENT
to	TO	O
guide	VB	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

within	IN	O
the	DT	O
next	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
,	,	O
the	DT	O
patient	NN	O
noticed	VBD	O
a	DT	O
significant	JJ	O
improvement	NN	O
in	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
pattern	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
stabbing	NN	I-PROBLEM
,	,	I-PROBLEM
sharp	JJ	I-PROBLEM
pain	NN	I-PROBLEM
that	IN	O
she	PRP	O
occasionally	RB	O
has	VBZ	O
on	IN	O
the	DT	O
left	NN	O
chest	JJS	O
wall	NN	O
was	VBD	O
significantly	RB	O
diminished	VBN	O
and	CC	O
she	PRP	O
also	RB	O
noticed	VBD	O
periods	NNS	O
of	IN	O
time	NN	O
when	WRB	O
she	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	O
of	IN	O
that	DT	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
had	VBD	O
a	DT	B-TREATMENT
morphine	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
initially	RB	O
started	VBD	O
at	IN	O
1	CD	O
mg	NNS	O
a	DT	O
day	NN	O
and	CC	O
increased	VBD	O
to	TO	O
3	CD	O
mg	NNS	O
a	DT	O
day	NN	O
in	IN	O
a	DT	O
period	NN	O
of	IN	O
three	CD	O
days	NNS	O
.	.	O

the	DT	B-TREATMENT
epidural	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
07/26/99	CD	O
and	CC	O
was	VBD	O
considered	VBN	O
a	DT	O
successful	JJ	O
trial	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
schedule	VB	O
with	IN	O
the	DT	O
pain	NN	O
clinic	JJ	O
regarding	VBG	O
upcoming	JJ	O
epidural	JJ	B-TREATMENT
pump	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

dr.	NN	O
falccouette	NN	O
would	MD	O
like	VB	O
to	TO	O
perform	VB	O
an	DT	B-TREATMENT
excision	NN	I-TREATMENT
and	CC	O
closure	NN	B-TREATMENT
flap	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
ischial	JJ	I-PROBLEM
decubitusin	NN	I-PROBLEM
the	DT	O
near	JJ	O
future	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
in	IN	O
stable	JJ	O
conditionand	NN	O
will	MD	O
follow	VB	O
up	RP	O
for	IN	O
(	(	O
1	CD	O
)	)	O
sacral	JJ	B-TREATMENT
decubitus	NN	I-TREATMENT
closure	NN	I-TREATMENT
,	,	O
and	CC	O
(	(	O
2	CD	O
)	)	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
epidural	JJ	I-TREATMENT
pump	NN	I-TREATMENT
in	IN	O
the	DT	O
future	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
have	VB	O
smh	JJ	O
service	NN	O
that	WDT	O
comes	VBZ	O
to	TO	O
her	PRP$	O
home	NN	O
once	IN	O
a	DT	O
day	NN	O
for	IN	O
adressing	VBG	B-TREATMENT
change	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
kayschird	NN	O
to	TO	O
schedule	NN	O
for	IN	O
the	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
pump	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr.	NN	O
falccouette	NN	O
to	TO	O
schedule	NN	O
for	IN	O
excision	NN	B-TREATMENT
and	CC	O
closure	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
ischial	JJ	I-PROBLEM
sacral	JJ	I-PROBLEM
decubitus	NN	I-PROBLEM
.	.	O

this	DT	O
20	CD	O
year	NN	O
old	JJ	O
driver	NN	O
was	VBD	O
in	IN	O
a	DT	O
major	JJ	O
motor	NN	O
vehicle	NN	O
accident	NN	O
and	CC	O
brought	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
saints	VBZ	O
medical	JJ	O
center	NN	O
following	VBG	O
this	DT	O
,	,	O
with	IN	O
multiple	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
involved	VBN	O
in	IN	O
a	DT	O
long	JJ	O
extrication	NN	O
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
88	CD	O
at	IN	O
the	DT	O
scene	NN	O
.	.	O

he	PRP	O
was	VBD	O
tachycardic	JJ	B-PROBLEM
with	IN	O
an	DT	B-TEST
initial	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
120	CD	O
/	NNS	O
palpable	JJ	O
.	.	O

a	DT	B-TREATMENT
groin	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
sedated	VBN	O
and	CC	O
paralyzed	VBN	O
.	.	O

he	PRP	O
was	VBD	O
resuscitated	VBN	O
with	IN	O
crystalloid	NN	B-TREATMENT
and	CC	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
grossly	RB	I-PROBLEM
deformed	VBN	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
.	.	O

on	IN	O
examination	NN	B-TEST
,	,	O
belmont	JJ	B-TEST
coma	NN	I-TEST
scale	NN	I-TEST
was	VBD	O
6t	CD	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
120	CD	O
/	NNP	O
palpable	JJ	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
122	CD	O
.	.	O

rectal	NN	O
was	VBD	O
heme	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
with	IN	O
normal	JJ	O
prostate	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
meatal	JJ	B-PROBLEM
blood	NN	I-PROBLEM
.	.	O

the	DT	O
left	NN	O
femur	NN	O
was	VBD	O
grossly	RB	B-PROBLEM
deformed	VBN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
pinhole	JJ	I-PROBLEM
opening	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
thigh	NN	I-PROBLEM
.	.	O

his	PRP$	O
left	VBD	O
forearm	NN	O
was	VBD	O
also	RB	O
grossly	RB	B-PROBLEM
deformed	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
step-off	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
back	NN	I-PROBLEM
.	.	O

admission	NN	B-TEST
laboratories	NNS	I-TEST
included	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
43.3	CD	O
and	CC	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
25.2	CD	O
,	,	O
normal	JJ	O
electrolytes	NNS	O
and	CC	O
amylase	NN	B-TEST
of	IN	O
98	CD	O
.	.	O

arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
metabolic	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

additional	JJ	B-TEST
assay	NN	I-TEST
shows	NNS	O
slight	VBD	B-PROBLEM
widening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
mediastinum	NN	I-PROBLEM
on	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

the	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
and	CC	I-TEST
chest	NN	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
liver	NN	I-PROBLEM
laceration	NN	I-PROBLEM
seen	VBN	O
on	IN	O
the	DT	B-TEST
a/p	NN	I-TEST
pelvis	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
distal	JJ	I-PROBLEM
ulnar	NN	I-PROBLEM
and	CC	I-PROBLEM
radial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
mid-shaft	NN	I-PROBLEM
comminuted	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
femur	NN	I-PROBLEM
.	.	O

he	PRP	O
went	VBD	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
quickly	RB	O
and	CC	O
had	VBD	O
an	DT	B-TREATMENT
intramedullary	JJ	I-TREATMENT
rodding	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
femur	NN	I-TREATMENT
and	CC	O
open	JJ	B-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
radius	NN	I-TREATMENT
and	CC	I-TREATMENT
ulna	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
neurosurgery	NN	O
for	IN	O
his	PRP$	B-PROBLEM
head	NN	I-PROBLEM
injury	NN	I-PROBLEM
which	WDT	O
showed	VBD	O
multiple	JJ	B-PROBLEM
contusions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
frontal	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
some	DT	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
20.9	CD	O
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
no	DT	O
change	NN	O
.	.	O

he	PRP	O
was	VBD	O
begun	VBN	O
on	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
but	CC	O
remained	VBD	O
agitated	VBN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
psychiatry	NN	O
due	JJ	O
to	TO	O
some	DT	B-PROBLEM
delirium	NN	I-PROBLEM
and	CC	O
question	NN	O
of	IN	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
evaluated	VBN	O
by	IN	O
the	DT	O
neuro-rehabilitation	JJ	O
service	NN	O
who	WP	O
thought	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
post-head	JJ	I-PROBLEM
injury	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
diffuse	NN	B-PROBLEM
cognitive	JJ	I-PROBLEM
deficits	NNS	I-PROBLEM
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
some	DT	O
episodes	NNS	O
of	IN	O
agitation	NN	B-PROBLEM
which	WDT	O
were	VBD	O
treated	VBN	O
with	IN	O
medication	NN	B-TREATMENT
.	.	O

he	PRP	O
required	VBD	O
some	DT	B-TREATMENT
sedation	NN	I-TREATMENT
and	CC	O
restraint	NN	B-TREATMENT
and	CC	O
was	VBD	O
begun	VBN	O
on	IN	O
whatever	WDT	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
he	PRP	O
could	MD	O
have	VB	O
given	VBN	O
his	PRP$	B-PROBLEM
head	NN	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
episodes	NNS	O
of	IN	O
confusion	NN	B-PROBLEM
.	.	O

he	PRP	O
removed	VBD	O
the	DT	B-TREATMENT
cast	NN	I-TREATMENT
that	WDT	O
had	VBD	O
been	VBN	O
placed	VBN	O
and	CC	O
then	RB	O
a	DT	B-TREATMENT
long-leg	JJ	I-TREATMENT
cast	NN	I-TREATMENT
was	VBD	O
then	RB	O
placed	VBN	O
so	IN	O
it	PRP	O
would	MD	O
be	VB	O
difficult	JJ	O
for	IN	O
him	PRP	O
to	TO	O
remove	VB	O
or	CC	O
to	TO	O
ambulate	VB	O
on	IN	O
his	PRP$	O
leg	NN	O
,	,	O
which	WDT	O
might	MD	O
jeopardize	VB	O
his	PRP$	O
closure	NN	O
.	.	O

he	PRP	O
does	VBZ	O
of	IN	O
buspar	NN	B-TREATMENT
,	,	O
trazodone	NN	B-TREATMENT
and	CC	O
haldol	NN	B-TREATMENT
were	VBD	O
continued	VBN	O
and	CC	O
were	VBD	O
adjusted	VBN	O
by	IN	O
psychiatry	NN	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
observation	NN	B-TEST
and	CC	O
sitters	NNS	O
and	CC	O
finally	RB	O
became	VBD	O
more	RBR	O
docile	JJ	O
and	CC	O
cooperative	JJ	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
with	IN	O
his	PRP$	O
mother	NN	O
present	NN	O
,	,	O
he	PRP	O
began	VBD	O
to	TO	O
follow	VB	O
commands	NNS	O
much	RB	O
more	RBR	O
appropriately	RB	O
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
be	VB	O
rehabilitated	VBN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
finally	RB	O
sent	VBN	O
home	NN	O
for	IN	O
home	NN	B-TREATMENT
rehabilitation	NN	I-TREATMENT
on	IN	O
2011-02-23	JJ	O
.	.	O

1.	CD	O
multiple	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
frontal	JJ	I-PROBLEM
head	NN	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

2.	CD	O
open	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
femur	NN	I-PROBLEM
.	.	O

3.	CD	O
radial	JJ	B-PROBLEM
and	CC	I-PROBLEM
ulnar	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

4.	CD	O
liver	JJ	B-PROBLEM
laceration	NN	I-PROBLEM
.	.	O

1.	CD	O
open	JJ	B-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
of	IN	I-TREATMENT
femur	JJ	I-TREATMENT
2011-01-21	JJ	O
.	.	O

2.	CD	O
open	JJ	B-TREATMENT
reduction	NN	I-TREATMENT
and	CC	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
of	IN	I-TREATMENT
radius	NN	I-TREATMENT
and	CC	I-TREATMENT
ulna	JJ	I-TREATMENT
2011-01-21	JJ	O
.	.	O

1.	CD	O
percocet	NN	B-TREATMENT
,	,	O
one	CD	O
p.o.	NN	O
q.	VB	O
four	CD	O
hours	NNS	O
p.r.n.	RB	O
pain	VBP	B-PROBLEM
.	.	O

2.	CD	O
haldol	JJ	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	JJ	O
agitation	NN	B-PROBLEM
.	.	O

3.	CD	O
trazodone	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
h.s.	NN	O

4.	CD	O
droperidol	JJ	B-TREATMENT
1.5	CD	O
to	TO	O
2.5	CD	O
mg	NNS	O
p.r.n.	JJ	O
agitation	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
discharged	VBN	O
home	NN	O
with	IN	O
home	NN	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

pelvic	JJ	B-PROBLEM
mass	NN	I-PROBLEM

pelvic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

include	JJ	O
hypertension	NN	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
57-year-old	JJ	O
female	NN	O
status	NN	O
post	NN	O
ert	NN	B-TREATMENT
with	IN	O
recurrence	NN	O
of	IN	O
a	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
and	CC	O
resection	NN	B-TREATMENT
at	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
in	IN	O
06/22	CD	O
.	.	O

per	IN	O
the	DT	O
patient	NN	O
,	,	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
benign	JJ	O
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
severe	JJ	B-PROBLEM
left	VBN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	JJ	I-PROBLEM
pain	NN	I-PROBLEM
in	IN	O
07/24	CD	O
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
was	VBD	O
done	VBN	O
on	IN	O
08/27/03	CD	O
that	WDT	O
showed	VBD	O
an	DT	B-PROBLEM
8	CD	I-PROBLEM
cm	NN	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
mass	NN	I-PROBLEM
with	IN	O
both	DT	B-PROBLEM
cystic	JJ	I-PROBLEM
and	CC	I-PROBLEM
solid	JJ	I-PROBLEM
components	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
lupron	NN	B-TREATMENT
on	IN	O
10/18/03	CD	O
,	,	O
but	CC	O
pain	NN	B-PROBLEM
was	VBD	O
not	RB	O
affected	VBN	O
.	.	O

she	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
vicodin	NN	B-TREATMENT
es	NN	I-TREATMENT
and	CC	O
ultram	JJ	B-TREATMENT
with	IN	O
minimal	JJ	O
relief	NN	O
.	.	O

on	IN	O
11/16/03	CD	O
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
pain	NN	I-PROBLEM
increased	VBD	O
and	CC	O
she	PRP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
and	CC	O
an	DT	B-PROBLEM
inability	NN	I-PROBLEM
to	TO	I-PROBLEM
tolerate	VB	I-PROBLEM
p.o.	NNS	I-PROBLEM
intake	VB	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
groin	NN	I-PROBLEM
radiated	VBD	O
to	TO	O
the	DT	O
left	JJ	O
knee	NN	O
.	.	O

no	DT	O
fevers	NNS	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
,	,	O
no	DT	O
vaginal	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
or	CC	O
bleeding	NN	B-PROBLEM
.	.	O

potassium	NN	B-TEST
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
was	VBD	O
3.1	CD	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
27.3	CD	O
with	IN	O
16%	CD	B-TEST
bands	NNS	I-TEST
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
28.7	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
nvh	VB	O
after	IN	O
receiving	VBG	O
intravenous	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
with	IN	O
potassium	NN	B-TREATMENT
,	,	O
demerol	NN	B-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
,	,	O
valium	NN	B-TREATMENT
and	CC	O
droperidol	NN	B-TREATMENT
.	.	O

hypothyroidism	NN	B-PROBLEM
,	,	O
arthritis	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
anemia	NN	B-PROBLEM
and	CC	O
asthma	NN	B-PROBLEM
.	.	O

a	DT	B-TREATMENT
tah-bso	NN	I-TREATMENT
in	IN	O
1980	CD	O
and	CC	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
with	IN	O
resection	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	O
06/22	CD	O
.	.	O

1.	CD	O
vicodin	JJ	B-TREATMENT
75/750	CD	O
p.r.n.	NN	O

2.	CD	O
ultram	NN	B-TREATMENT
.	.	O

3.	CD	O
verapamil	JJ	B-TREATMENT
240	CD	O
mg	NN	O
b.i.d.	NN	O

4.	CD	O
synthroid	JJ	B-TREATMENT
100	CD	O
mcg	NN	O
q.d.	NN	O

5.	CD	O
hctz	JJ	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O

6.	CD	O
arthrotec	JJ	B-TREATMENT
0.2	CD	O
mg	NN	O
b.i.d.	NN	O

7.	CD	O
advair	NN	B-TREATMENT
250/50	CD	O
mcg	NN	O
one	CD	O
puff	NN	O
q.a.m.	NN	O

8.	CD	O
tofranil	NN	B-TREATMENT
.	.	O

9.	CD	O
ambien	JJ	B-TREATMENT
10	CD	O
mg	NNS	O
q.h.s.	NN	O

10.	CD	O
trazadone	NN	B-TREATMENT
150	CD	O
mg	NN	O
q.h.s.	NN	O

11.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
mg	NN	O
t.i.d.	NN	O

12.	CD	O
colace	NN	B-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
allergies	NNS	I-PROBLEM
are	VBP	O
penicillin	NN	B-TREATMENT
,	,	O
which	WDT	O
cause	VBP	O
throat	NN	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
nvh	VB	O
and	CC	O
started	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
levofloxacin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

cultures	NNS	B-TEST
were	VBD	O
taken	VBN	O
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
done	VBN	O
for	IN	O
a	DT	O
possible	JJ	O
rectosigmoid	JJ	B-PROBLEM
mass	NN	I-PROBLEM
or	CC	O
fistula	NN	B-PROBLEM
and	CC	O
a	DT	B-TEST
ct	NN	I-TEST
showed	VBD	I-TEST
questionable	JJ	O
abscess	JJ	B-PROBLEM
versus	NN	O
tumor	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
done	VBN	O
on	IN	O
11/17/03	CD	O
grew	VBD	O
c.	NN	B-PROBLEM
perfringens	NNS	I-PROBLEM
.	.	O

other	JJ	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

on	IN	O
11/20/03	CD	O
,	,	O
a	DT	B-TEST
pe	NN	I-TEST
protocol	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
both	DT	O
dvt	NN	B-PROBLEM
and	CC	O
pe	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
bilateral	JJ	B-TREATMENT
stent	NN	I-TREATMENT
placement	NN	I-TREATMENT
,	,	O
resection	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
left	VBD	B-TREATMENT
ureterolysis	NN	I-TREATMENT
,	,	O
rectosigmoid	JJ	B-TREATMENT
resection	NN	I-TREATMENT
,	,	O
sbr	NN	B-TREATMENT
,	,	O
removal	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
vaginal	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
,	,	O
omentectomy	RB	B-TREATMENT
complicated	VBN	O
by	IN	O
an	DT	B-PROBLEM
enterotomy	NN	I-PROBLEM
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
icu	NN	O
postoperatively	RB	O
on	IN	O
11/21/03	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
pcea	NN	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
,	,	O
then	RB	O
a	DT	B-TREATMENT
dilaudid	NN	I-TREATMENT
pca	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
anxious	JJ	B-PROBLEM
with	IN	O
depression	NN	B-PROBLEM
poorly	RB	I-PROBLEM
controlled	VBN	I-PROBLEM
until	IN	O
12/14/03	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
onc	JJ	O
psychiatry	NN	O
consult	NN	O
,	,	O
who	WP	O
recommended	VBD	O
imipramine	NN	B-TREATMENT
75	CD	O
mg	NN	O
;	:	O
that	WDT	O
was	VBD	O
subsequently	RB	O
increased	VBN	O
to	TO	O
150	CD	O
mg	NNS	O
p.o.	JJ	O
q.h.s.	NN	O
,	,	O
trazadone	NN	B-TREATMENT
100	CD	O
mg	NN	O
q.h.s.	NN	O
and	CC	O
ambien	$	B-TREATMENT
10	CD	O
mg	NN	O
q.h.s.	NN	O

the	DT	O
patient	NN	O
has	VBZ	O
baseline	VBN	B-PROBLEM
hypertension	NN	I-PROBLEM
that	WDT	O
was	VBD	O
difficult	JJ	O
to	TO	O
control	VB	O
.	.	O

in	IN	O
the	DT	O
icu	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
enalapril	NN	B-TREATMENT
,	,	O
hydralazine	NN	B-TREATMENT
and	CC	O
labetalol	NN	B-TREATMENT
.	.	O

after	IN	O
a	DT	O
cardiology	NN	O
consulton	NN	O
12/13/03	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
metoprolol	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
,	,	O
lisinopril	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
hydrochlorothiazide	RB	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O
.	.	O

hydralazine	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
stayed	VBD	O
high	JJ	B-PROBLEM
with	IN	O
an	DT	B-TEST
sbp	NN	I-TEST
in	IN	O
the	DT	O
170s	CD	O
,	,	O
so	RB	O
amlodipine	JJ	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O
was	VBD	O
added	VBN	O
and	CC	O
that	IN	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
still	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
________	NNP	O
onc	MD	O
service	VB	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
.	.	O

once	RB	O
the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
,	,	O
after	IN	O
the	DT	B-TREATMENT
third	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
could	MD	O
not	RB	O
be	VB	O
weaned	VBN	O
off	RP	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
of	IN	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
was	VBD	O
to	TO	O
______	VB	O
to	TO	O
20	CD	O
breaths	NNS	O
per	IN	O
minute	NN	O
despite	IN	O
nebulizer	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
advair	NN	B-TREATMENT
and	CC	O
by	IN	O
12/15/03	CD	O
,	,	O
was	VBD	O
weaned	VBN	O
to	TO	O
room	NN	O
air	NN	O
likely	RB	O
an	DT	O
effective	JJ	O
advair	NN	B-TREATMENT
and	CC	O
control	NN	O
of	IN	O
anxiety	NN	B-PROBLEM
and	CC	O
psychiatric	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
4	CD	O
,	,	O
after	IN	O
the	DT	B-TREATMENT
initial	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
increased	VBN	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
tachycardia	NN	B-PROBLEM
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
revealed	VBD	O
increased	JJ	B-PROBLEM
free	JJ	I-PROBLEM
air	NN	I-PROBLEM
under	IN	I-PROBLEM
the	DT	I-PROBLEM
diaphragm	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
revealed	VBD	O
a	DT	O
large	JJ	O
amount	NN	O
of	IN	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
or	CC	O
on	IN	O
postop	JJ	O
day	NN	O
5	CD	O
for	IN	O
emergent	JJ	B-TEST
exploratory	NN	I-TEST
laparotomy	NN	I-TEST
that	WDT	O
disclosed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
enterotomy	NN	I-PROBLEM
with	IN	O
2	CD	O
liters	NNS	O
of	IN	O
bilious	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
peritoneum	NN	I-PROBLEM
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
9	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
similar	JJ	I-PROBLEM
increased	VBN	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
episode	NN	I-PROBLEM
and	CC	O
was	VBD	O
taken	VBN	O
back	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
another	DT	B-TEST
emergent	JJ	I-TEST
exploratory	NN	I-TEST
laparotomy	NN	I-TEST
revealing	VBG	O
another	DT	B-PROBLEM
peroration	NN	I-PROBLEM
at	IN	O
the	DT	B-PROBLEM
site	NN	I-PROBLEM
of	IN	I-PROBLEM
previous	JJ	I-PROBLEM
repair	NN	I-PROBLEM
.	.	O

intraoperatively	RB	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
suffered	VBD	O
hypotension	NN	B-PROBLEM
with	IN	O
induction	NN	O
and	CC	O
respiratory	NN	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
icu	NN	O
intubated	VBN	B-TREATMENT
with	IN	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
kept	VBN	O
npo	RB	B-TREATMENT
with	IN	O
an	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
until	IN	O
postop	JJ	O
day	NN	O
14	CD	O
and_____	NN	O
started	VBD	O
on	IN	O
clear	JJ	B-TREATMENT
sips	NNS	I-TREATMENT
with	IN	O
tpn	NN	B-TREATMENT
for	IN	O
nutritional	JJ	B-TREATMENT
supplementation	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
intermittently	RB	O
tolerated	VBD	O
diet	JJ	B-TREATMENT
advancement	NN	I-TREATMENT
,	,	O
but	CC	O
then	RB	O
would	MD	O
vomit	VB	O
and	CC	O
would	MD	O
have	VB	O
the	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
replaced	VBD	O
.	.	O

the	DT	O
patient	NN	O
,	,	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
was	VBD	O
tolerating	VBG	O
clears	NNS	B-TREATMENT
with	IN	O
low	JJ	B-PROBLEM
stoma	NN	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
likely	RB	O
to	TO	O
tolerate	VB	O
slow	JJ	O
advancement	NN	O
.	.	O

the	DT	O
patient	NN	O
still	RB	O
had	VBD	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
at	IN	O
the	DT	O
time	NN	O
,	,	O
although	IN	O
tpn	NN	B-TREATMENT
was	VBD	O
being	VBG	O
held	VBN	O
and	CC	O
calorie	JJ	B-TREATMENT
counts	NNS	I-TREATMENT
were	VBD	O
done	VBN	O
to	TO	O
evaluate	VB	O
the	DT	O
benefit	NN	O
of	IN	O
p.o.	JJ	O
nutrition	NN	O
.	.	O

presumably	RB	O
,	,	O
should	MD	O
follow	VB	O
up	RP	O
with	IN	O
the	DT	O
urology	NN	O
clinic	NN	O
for	IN	O
removal	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
ureteral	JJ	I-TREATMENT
stents	NNS	I-TREATMENT
at	IN	O
some	DT	O
point	NN	O
.	.	O

6.	CD	O
infectious	JJ	B-PROBLEM
disease	NN	I-PROBLEM
:	:	O

blood	NN	B-TEST
cultures	NNS	I-TEST
mentioned	VBD	O
previously	RB	O
were	VBD	O
positive	JJ	O
for	IN	O
c.	NN	B-PROBLEM
perfringens	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
empiricvancomycin	NN	B-TREATMENT
,	,	O
levofloxacin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
after	IN	O
the	DT	B-TEST
second	JJ	I-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
levofloxacin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
doxycycline	NN	B-TREATMENT
and	CC	O
fluconazole	NN	B-TREATMENT
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
drawn	VBP	O
on	IN	O
12/01/03	CD	O
were	VBD	O
negative	JJ	O
.	.	O

jp	NN	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
cultured	VBN	B-TEST
on	IN	O
12/11/03	CD	O
along	IN	O
with	IN	O
aurine	JJ	B-TEST
culture	NN	I-TEST
.	.	O

tlc	NN	B-TEST
,	,	O
tib	NN	B-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

these	DT	O
were	VBD	O
cultured	VBN	O
because	IN	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
increasing	VBG	O
to	TO	O
the	DT	O
mid	NN	O
20s	CD	O
without	IN	O
fever	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
for	IN	O
explanation	NN	O
.	.	O

the	DT	O
patient	NN	O
,	,	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
to	TO	O
the	DT	O
gyn	NN	O
/	NNP	O
onc	NN	O
service	NN	O
was	VBD	O
not	RB	O
antibiotics	NNS	B-TREATMENT
and	CC	O
the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
trending	VBG	O
down	RP	O
.	.	O

she	PRP	O
was	VBD	O
receiving	VBG	O
sub	JJ	B-TREATMENT
.q.	NNP	I-TREATMENT
heparin	NN	I-TREATMENT
for	IN	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
postoperatively	RB	O
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
6	CD	O
,	,	O
an	DT	O
id	NN	O
consult	NN	O
noted	VBD	O
erythema	NN	B-PROBLEM
at	IN	O
the	DT	B-TREATMENT
right	JJ	I-TREATMENT
ij	NN	I-TREATMENT
line	NN	I-TREATMENT
site	NN	I-TREATMENT
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
8	CD	O
,	,	O
the	DT	B-TREATMENT
right	JJ	I-TREATMENT
ij	NN	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
pulled	VBN	O
.	.	O

the	DT	O
tip	NN	O
was	VBD	O
cultured	VBN	O
with	IN	O
no	DT	O
growth	NN	B-PROBLEM
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
9	CD	O
,	,	O
bilateral	JJ	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
dopplers	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
ij	NN	I-PROBLEM
clot	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
transitioned	VBD	O
to	TO	O
lovenox	VB	B-TREATMENT
on	IN	O
12/09/03	CD	O
after	IN	O
a	DT	O
cardiology	NN	O
consult	NN	O
indicated	VBD	O
increased	VBD	O
survival	NN	O
with	IN	O
lovenox	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypothyroidism	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
home	NN	B-TREATMENT
synthroid	NN	I-TREATMENT
dose	NN	I-TREATMENT
during	IN	O
her	PRP$	O
hospitalization	NN	O
,	,	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
with	IN	O
q.6h.	JJ	O
fingersticks	NNS	B-TEST
while	IN	O
she	PRP	O
was	VBD	O
on	IN	O
tpn	NN	B-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
104	CD	O
year	NN	O
old	JJ	O
female	JJ	O
patient	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
and	CC	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
cough	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
she	PRP	O
has	VBZ	O
no	DT	O
idea	NN	O
why	WRB	O
she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
and	CC	O
denies	VBZ	O
any	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

she	PRP	O
reports	VBZ	O
an	DT	B-PROBLEM
occasional	JJ	I-PROBLEM
nonproductive	JJ	I-PROBLEM
cough	NN	I-PROBLEM
that	IN	O
she	PRP	O
has	VBZ	O
had	VBN	O
"for	VBN	O
years"	NNS	O
and	CC	O
feels	NNS	O
that	IN	O
she	PRP	O
has	VBZ	O
been	VBN	O
experiencing	VBG	O
alternating	VBG	B-PROBLEM
chills	NNS	I-PROBLEM
and	CC	I-PROBLEM
feeling	VBG	I-PROBLEM
hot	JJ	I-PROBLEM
.	.	O

a	DT	O
progress	NN	O
note	NN	O
in	IN	O
the	DT	O
patient	NN	O
's	POS	O
chart	NN	O
from	IN	O
her	PRP$	O
assisted	JJ	O
living	NN	O
facility	NN	O
indicates	VBZ	O
that	IN	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
cough	NN	B-PROBLEM
for	IN	O
one	CD	O
day	NN	O
with	IN	O
chills	NNS	B-PROBLEM
but	CC	O
no	DT	O
fever	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
recently	RB	O
evaluated	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
for	IN	O
bradycardia	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
her	PRP$	O
cardiologist	NN	O
,	,	O
dr.	JJ	O
clements	NNS	O
and	CC	O
had	VBD	O
a	DT	B-TEST
holter	NN	I-TEST
monitor	NN	I-TEST
on	IN	O
2015-05-01	JJ	O
,	,	O
that	WDT	O
showed	VBD	O
first	JJ	B-PROBLEM
degree	NN	I-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
rate	NN	I-TEST
that	WDT	O
ranged	VBD	O
between	IN	O
35	CD	O
to	TO	O
53	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
nebulizer	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
,	,	O
started	VBD	O
on	IN	O
antibiotics	NNS	B-TREATMENT
for	IN	O
presumed	JJ	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
lateral	JJ	B-PROBLEM
st	NN	I-PROBLEM
depressions	NNS	I-PROBLEM
and	CC	O
given	VBN	O
aspirin	NNS	B-TREATMENT
.	.	O

she	PRP	O
continues	VBZ	O
to	TO	O
deny	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
,	,	O
melena	NN	B-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
urinary	JJ	B-PROBLEM
frequency	NN	I-PROBLEM
and	CC	I-PROBLEM
urgency	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
asthmatic	JJ	B-PROBLEM
component	NN	I-PROBLEM
.	.	O

hypothyroidism	NN	B-PROBLEM
.	.	O

gastroenteritis	NN	B-PROBLEM
.	.	O

anxiety	NN	B-PROBLEM
.	.	O

insomnia	NN	B-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

osteoporosis	NN	B-PROBLEM
.	.	O

history	NN	O
of	IN	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
with	IN	O
residual	JJ	B-PROBLEM
right	NN	I-PROBLEM
sided	VBD	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

scoliosis	NN	B-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
kidney	NN	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
lower	JJR	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingo-	JJ	I-TREATMENT
oophorectomy	NN	I-TREATMENT
.	.	O

left	VBN	B-PROBLEM
cataract	NN	I-PROBLEM
.	.	O

bradycardia	NN	B-PROBLEM
followed	VBN	O
by	IN	O
outpatient	JJ	O
cardiologist	NN	O
with	IN	O
a	DT	B-TEST
holter	NN	I-TEST
monitor	NN	I-TEST
on	IN	O
2015-05-01	JJ	O
,	,	O
with	IN	O
first	JJ	B-PROBLEM
degree	NN	I-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
ranging	VBG	O
between	IN	O
35	CD	O
to	TO	O
53	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

penicillin	NN	B-TREATMENT
,	,	O
erythromycin	NN	B-TREATMENT
,	,	O
valium	NN	B-TREATMENT
,	,	O
compazine	NN	B-TREATMENT
,	,	O

demerol	NN	B-TREATMENT
,	,	O
percodan	NN	B-TREATMENT
.	.	O

1.	CD	O
levothyroxine	JJ	B-TREATMENT
50	CD	O
mcg	NN	O
p.o.	NN	O
once	RB	O
daily	RB	O
.	.	O

2.	CD	O
combivent	JJ	B-TREATMENT
two	CD	O
puffs	NNS	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
flovent	JJ	B-TREATMENT
two	CD	O
puffs	NNS	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

5.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
daily	RB	O
.	.	O

6.	CD	O
norvasc	JJ	B-TREATMENT
5	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

8.	CD	O
senna	JJ	B-TREATMENT
one	CD	O
once	RB	O
daily	JJ	O
.	.	O

9.	CD	O
dulcolax	JJ	B-TREATMENT
10	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
p.r.n.	NN	O

tums	NNS	B-TREATMENT
500	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

temperature	NN	B-TEST
98.1	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST

144/38	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
41	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST

in	IN	O
general	JJ	O
,	,	O
a	DT	O
well	RB	O
appearing	VBG	O
elderly	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

skin	NN	O
is	VBZ	O
warm	JJ	O
and	CC	O
dry	JJ	O
with	IN	O
decreased	JJ	B-PROBLEM
skin	NN	I-PROBLEM
turgor	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
examination	NN	I-TEST
-	:	O
the	DT	O
pupils	NNS	O
are	VBP	O
equal	JJ	O
,	,	O
round	NN	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
.	.	O

dry	JJ	B-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

neck	NN	O
is	VBZ	O
supple	JJ	O
,	,	O
full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
,	,	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distension	NN	I-PROBLEM
or	CC	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

the	DT	O
heart	NN	O
was	VBD	O
bradycardic	JJ	B-PROBLEM
with	IN	O
regular	JJ	O
rhythm	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
-	:	O
diffuse	NN	B-PROBLEM
expiratory	NN	I-PROBLEM
wheezes	VBZ	I-PROBLEM
with	IN	O
bibasilar	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
,	,	O
left	VBD	O
over	RP	O
right	JJ	O
.	.	O

the	DT	O
abdomen	NNS	O
revealed	VBD	O
normoactive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

rectal	NN	O
is	VBZ	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
per	IN	O
emergency	NN	O
department	NN	O
.	.	O

extremities	NNS	O
-	:	O
no	DT	O
cyanosis	NN	B-PROBLEM
or	CC	O
clubbing	NN	B-PROBLEM
,	,	O
one	CD	B-PROBLEM
plus	CC	I-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
right	JJ	O
worse	JJR	O
than	IN	O
left	JJR	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
8.5	CD	O
(	(	O
80	CD	O
percent	NN	O
neutrophils	NNS	B-TEST
,	,	O
13	CD	O
percent	NN	O
lymphocytes	NNS	B-TEST
)	)	O
,	,	O
hematocrit	$	B-TEST
27.4	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
277,000	CD	O
.	.	O

sodium	NN	B-TEST
133	CD	O
,	,	O
potassium	NN	B-TEST
4.8	CD	O
,	,	O
chloride	NN	B-TEST

94	CD	O
,	,	O
bicarbonate	NN	B-TEST
24	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
39	CD	O
,	,	O
creatinine	NN	B-TEST
2.0	CD	O
,	,	O
glucose	VBD	B-TEST
111	CD	O
.	.	O

ck	NN	B-TEST
152	CD	O
,	,	O
ck	NN	B-TEST
mb	NN	I-TEST
3.0	CD	O
,	,	O
troponin	NN	B-TEST
0.04.	CD	O

inr	NN	B-TEST
1.1.	CD	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
equivocal	JJ	B-PROBLEM
retrocardiac	NN	I-PROBLEM
opacity	NN	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
at	IN	O
40	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

first	RB	B-PROBLEM
degree	JJ	I-PROBLEM
av	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
pr	NN	B-TEST
interval	NN	I-TEST
220	CD	O
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
fascicular	JJ	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
0.1103	CD	O
n.	JJ	O
fifth	JJ	O
cir.	NN	O
depressions	NNS	O
in	IN	O

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
-	:	O
though	IN	O
the	DT	O
patient	NN	O
denied	VBD	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
on	IN	O
admission	NN	O
,	,	O
a	DT	O
progress	NN	O
note	NN	O
from	IN	O

norwood	NN	O
nursing	NN	O
facility	NN	O
suggested	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
having	VBG	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
cough	NN	B-PROBLEM
for	IN	O
approximately	RB	O
one	CD	O
day	NN	O
with	IN	O
difficulty	NN	B-PROBLEM
ambulating	VBG	I-PROBLEM
,	,	O
needing	VBG	O
to	TO	O
travel	VB	O
in	IN	O
a	DT	B-TREATMENT
wheelchair	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
on	IN	O
admission	NN	O
with	IN	O
a	DT	O
normal	JJ	O
white	JJ	O
blood	NN	O
cell	NN	O
count	NN	O
but	CC	O
had	VBD	O
significant	JJ	B-PROBLEM
wheezing	NN	I-PROBLEM
and	CC	O
rales	NNS	B-PROBLEM
on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
with	IN	O
a	DT	O
possible	JJ	O
left	NN	B-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
opacity	NN	I-PROBLEM
seen	VBN	O
on	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

the	DT	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
was	VBD	O
considered	VBN	O
a	DT	O
likely	JJ	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	JJ	B-TREATMENT
nebulizers	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
doxycycline	NN	B-TREATMENT
given	VBN	O
the	DT	O
concern	NN	O
for	IN	O
pneumonia	NN	B-PROBLEM
on	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
continued	VBN	O
on	IN	O
steroids	NNS	B-TREATMENT
given	VBN	O
evidence	NN	O
of	IN	O
severe	JJ	B-PROBLEM
airway	JJ	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
was	VBD	O
also	RB	O
considered	VBN	O
possibly	RB	O
related	VBN	O
to	TO	O
a	DT	B-PROBLEM
coronary	JJ	I-PROBLEM
event	NN	I-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
rule	NN	O
out	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
enzymes	NNS	I-TEST
were	VBD	O
cycled	VBN	O
and	CC	O
were	VBD	O
negative	JJ	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
electrocardiogram	NN	I-TEST
performed	VBN	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
two	CD	O
was	VBD	O
concerning	VBG	O
for	IN	O
2:1	CD	B-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
the	DT	O
cardiology	NN	O
consult	NN	O
service	NN	O
was	VBD	O
contacted	VBN	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
late	RB	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
two	CD	O
and	CC	O
received	VBD	O
a	DT	B-TREATMENT
temporary	JJ	I-TREATMENT
wire	NN	I-TREATMENT
.	.	O

the	DT	O
following	JJ	O
day	NN	O
the	DT	O
patient	NN	O
received	VBD	O
a	DT	B-TREATMENT
permanent	JJ	I-TREATMENT
dual	JJ	I-TREATMENT
chamber	NN	I-TREATMENT
rate	NN	I-TREATMENT
responsive	JJ	I-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
general	JJ	O
medicine	NN	O
service	NN	O
where	WRB	O
she	PRP	O
continued	VBD	O
to	TO	O
exhibit	VB	O
signs	NNS	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
and	CC	O
nebulizers	NNS	B-TREATMENT
,	,	O
steroids	NNS	B-TREATMENT
and	CC	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
continued	VBN	O
.	.	O

the	DT	O
patient	NN	O
's	POS	O
respiratory	NN	O
status	NN	O
improved	VBN	O
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
hospitalization	NN	O
and	CC	O
oxygen	NN	B-TREATMENT
was	VBD	O
eventually	RB	O
weaned	VBN	O
.	.	O

once	RB	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
out	IN	O
of	IN	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
,	,	O
she	PRP	O
appeared	VBD	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
element	NN	I-PROBLEM
of	IN	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
in	IN	O
addition	NN	O
to	TO	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
20	CD	O
mg	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
with	IN	O
impressive	JJ	O
urine	JJ	O
output	NN	O
and	CC	O
improvement	NN	O
in	IN	O
her	PRP$	B-TEST
overall	JJ	I-TEST
fluid	NN	I-TEST
status	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
eventually	RB	O
restarted	VBN	O
on	IN	O
her	PRP$	O
outpatient	NN	O
dose	NN	O
of	IN	O
lasix	NN	B-TREATMENT
once	IN	O
her	PRP$	B-TEST
renal	JJ	I-TEST
function	NN	I-TEST
improved	VBD	O
to	TO	O
baseline	VB	O
and	CC	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

heart	NN	B-PROBLEM
block	NN	I-PROBLEM
-	:	O
as	IN	O
noted	VBN	O
previously	RB	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
significant	JJ	O
for	IN	O
a	DT	B-PROBLEM
2:1	CD	I-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
and	CC	O
cardiology	NN	O
consult	NN	O
service	NN	O
was	VBD	O
contacted	VBN	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
a	DT	B-TREATMENT
temporary	JJ	I-TREATMENT
pacing	NN	I-TREATMENT
wire	NN	I-TREATMENT
on	IN	O
the	DT	O
evening	NN	O
of	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
two	CD	O
and	CC	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
three	CD	O
received	VBD	O
a	DT	B-TREATMENT
dual	JJ	I-TREATMENT
chamber	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

renal	JJ	O
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
1.8	CD	O
,	,	O
considered	VBN	O
likely	RB	O
secondary	JJ	O
to	TO	O
hypovolemia	VB	B-PROBLEM
.	.	O

her	PRP$	B-TEST
calculated	JJ	I-TEST
fractional	JJ	I-TEST
excretion	NN	I-TEST
of	IN	I-TEST
sodium	NN	I-TEST
was	VBD	O
0.13	CD	O
percent	NN	O
suggesting	VBG	O
a	DT	B-PROBLEM
prerenal	JJ	I-PROBLEM
cause	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
improved	VBD	O
to	TO	O
1.1	CD	O
with	IN	O
hydration	NN	B-TREATMENT
.	.	O

once	RB	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
had	VBD	O
improved	VBN	O
to	TO	O
baseline	VB	O
,	,	O
her	PRP$	B-TREATMENT
lasix	NN	I-TREATMENT
and	CC	O
ace	NN	B-TREATMENT
inhibitor	NN	I-TREATMENT
were	VBD	O
restarted	VBN	O
and	CC	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
creatinine	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
stable	JJ	O
.	.	O

gastrointestinal	JJ	O
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
with	IN	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
trend	NN	O
down	RP	O
after	IN	O
transfusion	NN	B-TREATMENT
of	IN	O
one	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
on	IN	O
admission	NN	O
.	.	O

given	VBN	O
guaiac	NNS	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
and	CC	O
her	PRP$	O
history	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
in	IN	O
addition	NN	O
to	TO	O
use	VB	O
of	IN	O
steroids	NNS	B-TREATMENT
for	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
,	,	O
the	DT	O
gastroenterology	NN	O
consult	NN	O
service	NN	O
was	VBD	O
contacted	VBN	O
.	.	O

the	DT	O
results	NNS	O
of	IN	O
that	DT	O
consultation	NN	O
and	CC	O
potential	JJ	O
esophagogastroduodenoscopy	NN	B-TEST
are	VBP	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
dictation	NN	O
.	.	O

hypertension	NN	B-PROBLEM
-	:	O
the	DT	O
patient	NN	O
had	VBD	O
moderate	JJ	O
control	NN	O
of	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
throughout	IN	O
her	PRP$	O
admission	NN	O
.	.	O

her	PRP$	B-TREATMENT
calcium	NN	I-TREATMENT
channel	NN	I-TREATMENT
blocker	NN	I-TREATMENT
and	CC	O
ace	NN	B-TREATMENT
inhibitor	NN	I-TREATMENT
were	VBD	O
continued	VBN	O
.	.	O

hematology	NN	O
-	:	O
as	IN	O
noted	VBN	O
previously	RB	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
drop	VB	O
after	IN	O
transfusion	NN	B-TREATMENT
with	IN	O
one	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
on	IN	O
admission	NN	O
.	.	O

given	VBN	O
guaiac	NNS	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
's	POS	O
history	NN	O
of	IN	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
gastroenterology	NN	O
consult	NN	O
service	NN	O
was	VBD	O
contacted	VBN	O
for	IN	O
possible	JJ	O
esophagogastroduodenoscopy	NN	B-TEST
and/or	NN	O
colonoscopy	NN	B-TEST
.	.	O

the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
hubbard	JJ	O
regional	JJ	O
hospital	NN	O
hospital	NN	O
course	NN	O
,	,	O
discharge	NN	O
diagnoses	NNS	O
,	,	O
medications	NNS	B-TREATMENT
and	CC	O
follow-up	NN	O
will	MD	O
be	VB	O
dictated	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

1.	CD	O
status	NN	O
post	NN	O
motorvehicle	NN	O
accident	NN	O
with	IN	O
transient	JJ	B-PROBLEM
paraplegia	NN	I-PROBLEM
.	.	O

2.	CD	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
on	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
.	.	O

there	EX	O
was	VBD	O
apparent	JJ	B-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
at	IN	O
the	DT	O
scene	NN	O
and	CC	O
significant	JJ	O
deformity	NN	O
of	IN	O
the	DT	O
anterior	JJ	O
portion	NN	O
of	IN	O
the	DT	O
motorvehicle	NN	O
with	IN	O
positive	JJ	O
starring	NN	O
of	IN	O
the	DT	O
windshield	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
conscious	JJ	O
on	IN	O
the	DT	O
scene	NN	O
when	WRB	O
evaluated	VBN	O
by	IN	O
emt	JJ	O
&apos;s	NNS	O
but	CC	O
at	IN	O
the	DT	O
scene	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
apparently	RB	B-PROBLEM
paraplegic	JJ	I-PROBLEM
below	IN	I-PROBLEM
the	DT	I-PROBLEM
umbilicus	NN	I-PROBLEM
with	IN	O
absence	NN	B-PROBLEM
of	IN	I-PROBLEM
movement	NN	I-PROBLEM
and	CC	I-PROBLEM
sensation	NN	I-PROBLEM
below	IN	I-PROBLEM
the	DT	I-PROBLEM
umbilicus	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
laparotomy	NN	B-TREATMENT
for	IN	O
an	DT	B-PROBLEM
ovarian	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
in	IN	O
1988	CD	O
.	.	O

on	IN	O
initial	JJ	B-TEST
exam	NN	I-TEST
,	,	O
her	PRP$	O
left	JJ	O
shoulder	NN	O
was	VBD	O
tender	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
over	IN	O
the	DT	O
proximal	JJ	O
humerus	NN	O
with	IN	O
decreased	JJ	B-PROBLEM
range	NN	I-PROBLEM
of	IN	I-PROBLEM
motion	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
without	IN	O
the	DT	O
ability	NN	O
to	TO	O
move	VB	O
her	PRP$	O
left	JJ	O
lower	JJR	O
extremity	NN	O
with	IN	O
decreased	JJ	B-PROBLEM
sensation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
leg	NN	O
was	VBD	O
with	IN	O
decreased	JJ	B-PROBLEM
range	NN	I-PROBLEM
of	IN	I-PROBLEM
motion	NN	I-PROBLEM
of	IN	O
thigh	JJ	O
flexion	NN	O
and	CC	O
extension	NN	O
.	.	O

the	DT	O
back	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
tenderness	NN	B-PROBLEM
at	IN	O
the	DT	O
level	NN	O
of	IN	O
l3-l5	NN	O
.	.	O

initial	JJ	B-TEST
radiologic	NN	I-TEST
evaluation	NN	I-TEST
showed	VBD	O
negative	JJ	O
c-spine	NN	O
,	,	O
thoracic	JJ	O
spine	NN	O
,	,	O
and	CC	O
lumbosacral	JJ	O
spine	NN	O
films	NNS	O
.	.	O

abdominal	JJ	B-TEST
ct	NN	I-TEST
was	VBD	O
negative	JJ	O
except	IN	O
for	IN	O
right	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
right	JJ	I-PROBLEM
hydroureter	NN	I-PROBLEM
.	.	O

back	RB	B-TEST
mri	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

film	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
left	NN	I-TEST
humerus	NN	I-TEST
was	VBD	O
also	RB	O
negative	JJ	O
.	.	O

a	DT	O
neurosurgery	JJ	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
their	PRP$	O
impression	NN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
paraplegia	NN	I-PROBLEM
might	MD	O
possibly	RB	O
represent	VB	O
a	DT	B-PROBLEM
cord	NN	I-PROBLEM
concussion	NN	I-PROBLEM
,	,	O
and	CC	O
recommended	VBD	O
treatment	NN	B-TREATMENT
with	IN	I-TREATMENT
intravenous	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
for	IN	O
24	CD	O
hours	NNS	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
paraplegia	NN	I-PROBLEM
resolved	VBN	O
by	IN	O
the	DT	O
morning	NN	O
of	IN	O
her	PRP$	O
second	JJ	O
hospital	JJ	O
day	NN	O
,	,	O
and	CC	O
she	PRP	O
maintained	VBD	O
5/5	CD	O
motor	NN	O
strength	NN	O
in	IN	O
all	DT	O
groups	NNS	O
.	.	O

a	DT	O
urology	JJ	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
recommended	VBN	O
that	IN	O
an	DT	B-TEST
ivp	NN	I-TEST
be	VB	O
obtained	VBN	O
.	.	O

this	DT	O
was	VBD	O
obtained	VBN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
,	,	O
however	RB	O
,	,	O
due	JJ	O
to	TO	O
residual	JJ	B-PROBLEM
contrast	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM
from	IN	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
prior	JJ	I-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
,	,	O
the	DT	B-TEST
exam	NN	I-TEST
was	VBD	O
postponed	VBN	O
after	IN	O
a	DT	B-TEST
scout	NN	I-TEST
film	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

she	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
throughout	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

additionally	RB	O
on	IN	O
the	DT	O
night	NN	O
before	IN	O
discharge	NN	O
,	,	O
flexion	NN	B-TEST
and	CC	I-TEST
extension	NN	I-TEST
views	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
lumbosacral	JJ	I-TEST
spine	NN	I-TEST
were	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
showed	VBD	O
no	DT	O
fracture	NN	B-PROBLEM
or	CC	O
instability	NN	B-PROBLEM
.	.	O

tylenol	RB	B-TREATMENT
650	CD	O
mg	NNS	O
p.o.	JJ	O
q4	JJ	O
hours	NNS	O
p.r.n.	VBP	O
pain	NN	B-PROBLEM
.	.	O

she	PRP	O
will	MD	O
have	VB	O
an	DT	B-TEST
ivp	NN	I-TEST
repeated	VBN	O
in	IN	O
one	CD	O
week	NN	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
should	MD	O
have	VB	O
cleared	VBN	O
the	DT	B-PROBLEM
residual	JJ	I-PROBLEM
contrast	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

she	PRP	O
will	MD	O
have	VB	O
urology	JJ	O
followup	NNS	O
after	IN	O
her	PRP$	B-TEST
ivp	NN	I-TEST
.	.	O

mychelia	NNS	O
boyd	NN	O
was	VBD	O
born	VBN	O
at	IN	O
28-2/7	JJ	O
weeks	NNS	O
gestation	NN	O
and	CC	O
delivered	VBN	O
due	JJ	O
to	TO	O
unstoppable	JJ	B-PROBLEM
premature	NN	I-PROBLEM
labor	NN	I-PROBLEM
.	.	O

prenatal	JJ	B-TEST
screens	NNS	I-TEST
include	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
o	NN	O
negative	JJ	O
.	.	O

other	JJ	B-TEST
prenatal	JJ	I-TEST
screens	NNS	I-TEST
were	VBD	O
unknown	JJ	O
at	IN	O
time	NN	O
of	IN	O
delivery	NN	B-TREATMENT
.	.	O

pregnancy	NN	O
was	VBD	O
uncomplicated	VBN	O
until	IN	O
the	DT	O
day	NN	O
of	IN	O
delivery	NN	B-TREATMENT
when	WRB	O
mother	NN	O
presented	VBD	O
to	TO	O
healthsouth	VB	O
new	JJ	O
england	NN	O
rehab	NN	O
hospital	JJ	O
hospital	NN	O
with	IN	O
bleeding	NN	B-PROBLEM
and	CC	O
was	VBD	O
sent	VBN	O
home	NN	O
.	.	O

she	PRP	O
then	RB	O
presented	VBD	O
to	TO	O
jordan	VB	O
hospital	JJ	O
hospital	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
5	CD	B-PROBLEM
cm	NNS	I-PROBLEM
dilated	VBN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
transverse	JJ	I-PROBLEM
lie	NN	I-PROBLEM
presentation	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
betamethasone	NN	B-TREATMENT
times	CC	O
one	CD	O
and	CC	O
transferred	VBD	O
to	TO	O
the	DT	O
nantucket	NN	O
cottage	NN	O
hospital	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
delivered	VBN	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
with	IN	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
at	IN	O
time	NN	O
of	IN	O
delivery	NN	B-TREATMENT
notable	JJ	O
for	IN	O
slight	JJ	B-PROBLEM
meconium	NN	I-PROBLEM
stained	VBD	I-PROBLEM
amniotic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

the	DT	O
baby	NN	O
emerged	VBD	O
with	IN	O
spontaneous	JJ	O
cry	NN	O
,	,	O
received	VBD	O
routine	JJ	B-TREATMENT
care	NN	I-TREATMENT
and	CC	O
then	RB	O
was	VBD	O
intubated	VBN	O
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
due	JJ	O
to	TO	O
inconsistent	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
effort	NN	I-PROBLEM
and	CC	O
increased	JJ	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	NN	I-PROBLEM
.	.	O

apgars	NNS	B-TEST
were	VBD	O
6	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
admission	NN	I-TEST
physical	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
birth	NN	I-TEST
weight	NN	I-TEST
of	IN	O
901	CD	O
gm	NN	O
,	,	O
20th	CD	O
percentile	NN	O
;	:	O
length	CC	B-TEST
34	CD	O
cm	NN	O
,	,	O
25th	CD	O
percentile	NN	O
;	:	O
head	NN	B-TEST
circumference	NN	I-TEST
25	CD	O
cm	NN	O
,	,	O
25th	CD	O
percentile	NN	O
.	.	O

red	JJ	B-TEST
reflex	NN	I-TEST
was	VBD	O
difficult	JJ	O
to	TO	O
appreciate	VB	O
bilaterally	RB	O
.	.	O

palate	NN	O
deferred	VBD	O
due	JJ	O
to	TO	O
oral	JJ	B-TREATMENT
intubation	NN	I-TREATMENT
.	.	O

no	DT	O
defect	NN	B-PROBLEM
noted	VBD	O
during	IN	O
procedure	NN	B-TREATMENT
.	.	O

increased	JJ	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	VBG	I-PROBLEM
prior	JJ	O
to	TO	O
intubation	NN	B-TREATMENT
,	,	O
but	CC	O
presently	RB	O
comfortable	JJ	O
.	.	O

breath	NN	O
sounds	VBZ	O
slightly	RB	B-PROBLEM
crackly	JJ	I-PROBLEM
,	,	O
symmetric	JJ	O
equal	JJ	O
air	NN	O
entry	NN	O
.	.	O

cardiovascular	JJ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

peripheral	JJ	B-TEST
pulses	NNS	I-TEST
plus	CC	O
2	CD	O
and	CC	O
symmetric	JJ	O
.	.	O

abdomen	NNS	O
soft	VBP	O
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

the	DT	O
baby	NN	O
was	VBD	O
intubated	VBN	O
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
,	,	O
received	VBD	O
two	CD	O
doses	NNS	O
of	IN	O
surfactant	NN	B-TREATMENT
.	.	O

radiograph	NN	B-TEST
revealed	VBD	O
bilateral	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
granular	JJ	I-PROBLEM
pattern	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
surfactant	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
.	.	O

maximum	JJ	B-TREATMENT
mechanical	JJ	I-TREATMENT
ventilation	NN	I-TREATMENT
pip	NN	B-TREATMENT
26	CD	O
,	,	O
peep	RB	B-TREATMENT
6	CD	O
,	,	O
rate	NN	B-TREATMENT
of	IN	O
25	CD	O
,	,	O
maximum	JJ	B-TREATMENT
fio2	JJ	I-TREATMENT
35	CD	O
percent	NN	O
.	.	O

mychelia	NN	O
was	VBD	O
extubated	VBN	O
to	TO	O
a	DT	B-TREATMENT
cpap	NN	I-TREATMENT
of	IN	O
6	CD	O
cm	NNS	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
where	WRB	O
she	PRP	O
remained	VBD	O
until	IN	O
day	NN	O
of	IN	O
life	NN	O
20	CD	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
,	,	O
she	PRP	O
was	VBD	O
also	RB	O
loaded	VBN	O
with	IN	O
caffeine	NN	B-TREATMENT
and	CC	O
continues	VBZ	O
on	IN	O
caffeine	NN	B-TREATMENT
at	IN	O
time	NN	O
of	IN	O
transfer	NN	O
.	.	O

she	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
a	DT	B-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
20	CD	O
and	CC	O
remains	VBZ	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
o2	VBZ	I-TREATMENT
100	CD	O
percent	NN	O
at	IN	O
13	CD	O
cc	NN	O
flow	NN	O
.	.	O

she	PRP	O
averaged	VBD	O
2-3	JJ	O
apnea	NN	B-PROBLEM
episodes	VBZ	I-PROBLEM
a	DT	O
day	NN	O
with	IN	O
bradycardia	NN	B-PROBLEM
and	CC	O
desaturations	NNS	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
comfortable	JJ	O
respiratory	NN	B-TEST
rate	NN	I-TEST
and	CC	O
good	JJ	O
air	NN	O
exchange	NN	O
.	.	O

she	PRP	O
received	VBD	O
a	DT	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
bolus	NN	I-TREATMENT
times	NNS	O
one	CD	O
initially	RB	O
for	IN	O
poor	JJ	B-PROBLEM
perfusion	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
dopamine	NN	B-TREATMENT
with	IN	O
a	DT	O
maximum	JJ	O
infusion	NN	O
rate	NN	O
of	IN	O
6	CD	O
mcg	NNS	O
per	IN	O
kg	FW	O
per	IN	O
hour	NN	O
.	.	O

this	DT	O
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
to	TO	O
maintain	VB	O
a	DT	B-TEST
mean	JJ	I-TEST
arterial	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
33	CD	O
.	.	O

initially	RB	O
maintained	VBN	O
npo	NN	B-TREATMENT
.	.	O

uac	JJ	B-TREATMENT
and	CC	I-TREATMENT
uvc	JJ	I-TREATMENT
lines	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
upon	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	NN	O
.	.	O

the	DT	B-TREATMENT
uac	NN	I-TREATMENT
was	VBD	O
left	VBN	O
in	IN	O
place	NN	O
until	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
and	CC	O
was	VBD	O
removed	VBN	O
after	IN	O
wean	NN	O
from	IN	O
dopamine	NN	B-TREATMENT
.	.	O

uvc	NN	B-TREATMENT
remained	VBD	O
in	IN	O
place	NN	O
through	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
and	CC	O
was	VBD	O
utilized	VBN	O
to	TO	O
administer	VB	O
parenteral	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
.	.	O

electrolytes	NNS	B-TEST
and	CC	O
glucose	NN	B-TEST
remained	VBN	O
in	IN	O
the	DT	O
normal	JJ	O
range	NN	O
throughout	IN	O
the	DT	O
first	JJ	O
week	NN	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
with	IN	O
a	DT	O
slow	JJ	O
advance	NN	O
secondary	JJ	O
to	TO	O
increased	VBN	B-PROBLEM
abdominal	JJ	I-PROBLEM
girth	NN	I-PROBLEM
which	WDT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
cpap	VB	B-TREATMENT
.	.	O

calories	NNS	O
were	VBD	O
gradually	RB	O
increased	VBN	O
to	TO	O
breast	VB	O
milk	NN	O
30	CD	O
calories	NNS	O
with	IN	O
promod	JJ	B-TREATMENT
consisting	VBG	O
of	IN	O
four	CD	O
of	IN	O
human	JJ	O
milk	NN	O
fortifier	NN	O
,	,	O
four	CD	O
of	IN	O
mct	NNS	B-TREATMENT
and	CC	O
two	CD	O
of	IN	O
polycose	NN	B-TREATMENT
with	IN	O
a	DT	O
12-28	JJ	O
teaspoon	NN	O
of	IN	O
promod	NN	B-TREATMENT
per	IN	O
50	CD	O
ml	NN	O
of	IN	O
breast	NN	O
milk	NN	O
or	CC	O
60	CD	O
ml	NN	O
of	IN	O
formula	NN	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
due	JJ	O
to	TO	O
concerns	NNS	O
for	IN	O
hyperglycemia	NN	B-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
distention	NN	I-PROBLEM
,	,	O
sepsis	NN	B-TEST
evaluation	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
at	IN	O
this	DT	O
time	NN	O
to	TO	O
have	VB	O
hyperglycemia	VBN	B-PROBLEM
requiring	VBG	O
two	CD	O
subcutaneous	JJ	O
doses	NNS	O
of	IN	O
insulin	NN	B-TREATMENT
and	CC	O
a	DT	B-TREATMENT
decreased	JJ	I-TREATMENT
glucose	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
rate	NN	I-TREATMENT
to	TO	O
achieve	VB	O
euglycemia	NN	O
.	.	O

urine	JJ	B-TEST
output	NN	I-TEST
was	VBD	O
always	RB	O
noted	VBN	O
to	TO	O
be	VB	O
of	IN	O
sufficient	JJ	O
quantity	NN	O
.	.	O

mychelia	NNS	O
demonstrated	VBD	O
slow	JJ	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
motility	NN	I-PROBLEM
and	CC	O
abdominal	JJ	B-PROBLEM
distention	NN	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
cpap	VB	B-TREATMENT
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
15	CD	O
,	,	O
she	PRP	O
was	VBD	O
made	VBN	O
npo	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
distended	JJ	I-PROBLEM
abdomen	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
bilious	JJ	I-PROBLEM
spit	NN	I-PROBLEM
.	.	O

serial	JJ	B-TEST
kubs	NNS	I-TEST
revealed	VBD	O
nonspecific	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
with	IN	O
dilated	JJ	B-PROBLEM
loops	NNS	I-PROBLEM
.	.	O

no	DT	O
pneumatosis	NN	B-PROBLEM
or	CC	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
bluish	JJ	B-PROBLEM
discoloration	NN	I-PROBLEM
thought	VBD	O
to	TO	O
perhaps	RB	O
be	VB	O
a	DT	B-PROBLEM
bruise	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

again	RB	O
,	,	O
she	PRP	O
was	VBD	O
advanced	VBN	O
to	TO	O
full	JJ	O
volume	NN	O
but	CC	O
was	VBD	O
made	VBN	O
npo	NNS	B-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
20	CD	O
for	IN	O
abdominal	JJ	B-PROBLEM
distention	NN	I-PROBLEM
.	.	O

this	DT	B-TREATMENT
npo	NN	I-TREATMENT
was	VBD	O
temporary	JJ	O
for	IN	O
that	DT	O
day	NN	O
and	CC	O
she	PRP	O
then	RB	O
resumed	VBD	O
feedings	NNS	O
and	CC	O
has	VBZ	O
been	VBN	O
tolerating	VBG	O
full	JJ	B-TREATMENT
enteral	JJ	I-TREATMENT
feeds	NNS	I-TREATMENT
well	RB	O
,	,	O
improved	VBN	O
since	IN	O
off	NN	O
of	IN	O
cpap	NN	B-TREATMENT
,	,	O
passing	VBG	O
normal	JJ	O
stools	NNS	O
,	,	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

mychelia	NN	O
was	VBD	O
also	RB	O
treated	VBN	O
for	IN	O
physiologic	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
under	IN	O
phototherapy	NN	B-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
one	CD	O
through	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
serum	NN	I-TEST
bilirubin	NN	I-TEST
of	IN	O
4.7/0.3	CD	O
.	.	O

initial	JJ	B-TEST
cbc	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
5.5	CD	O
with	IN	O
49	CD	B-TEST
polys	NNS	I-TEST
,	,	O
1	CD	B-TEST
band	NN	I-TEST
and	CC	O
47	CD	B-TEST
lymphs	NN	I-TEST
.	.	O

initial	JJ	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
46.3	CD	O
percent	NN	O
and	CC	O
platelets	NNS	B-TEST
320,000	CD	O
.	.	O

her	PRP$	B-TEST
initial	JJ	I-TEST
blood	NN	I-TEST
culture	NN	I-TEST
remained	VBD	O
negative	JJ	O
and	CC	O
she	PRP	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

as	IN	O
previously	RB	O
noted	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
with	IN	O
hyperglycemia	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
distention	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
cbc	NN	I-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
were	VBD	O
again	RB	O
obtained	VBN	O
revealing	VBG	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
9.1	CD	O
with	IN	O
30	CD	B-TEST
polys	NNS	I-TEST
,	,	O
0	CD	B-TEST
bands	NNS	I-TEST
and	CC	O
58	CD	B-TEST
lymphs	NN	I-TEST
.	.	O

hematocrit	NN	B-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
31	CD	O
and	CC	O
platelets	NNS	B-TEST
370,000	CD	O
.	.	O

blood	NN	B-TEST
culture	NN	I-TEST
grew	VBD	O
staph	JJ	B-PROBLEM
coagulase	NN	I-PROBLEM
negative	JJ	I-PROBLEM
and	CC	O
the	DT	O
baby	NN	O
received	VBD	O
seven	CD	O
days	NNS	O
of	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
was	VBD	O
also	RB	O
performed	VBN	O
to	TO	O
rule	VB	O
out	RP	O
meningitis	NN	B-PROBLEM
.	.	O

this	DT	B-TEST
culture	NN	I-TEST
remained	VBD	O
negative	JJ	O
with	IN	O
normal	JJ	O
cell	NN	O
counts	NNS	O
and	CC	O
chemistries	NNS	O
.	.	O

antibiotic	JJ	B-TEST
levels	NNS	I-TEST
were	VBD	O
monitored	VBN	O
and	CC	O
doses	NNS	O
adjusted	VBN	O
accordingly	RB	O
.	.	O

mychelia	NNS	O
required	VBD	O
two	CD	B-TREATMENT
transfusions	NNS	I-TREATMENT
during	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
15	CD	O
for	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
29	CD	O
,	,	O
she	PRP	O
received	VBD	O
20	CD	O
cc	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

she	PRP	O
started	VBD	O
on	IN	O
iron	NN	B-TREATMENT
and	CC	O
vitamin	NN	B-TREATMENT
e	NN	I-TREATMENT
supplements	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
25	CD	O
and	CC	O
continues	VBZ	O
on	IN	O
that	DT	O
at	IN	O
this	DT	O
time	NN	O
of	IN	O
transfer	NN	O
.	.	O

however	RB	O
,	,	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
34	CD	O
,	,	O
12-04	CD	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
pale	JJ	B-PROBLEM
and	CC	O
less	JJR	B-PROBLEM
stress	NN	I-PROBLEM
tolerant	NN	I-PROBLEM
,	,	O
mottling	VBG	O
easily	RB	O
with	IN	O
care	NN	O
.	.	O

a	DT	B-TEST
hematocrit	NN	I-TEST
and	CC	O
reticulocyte	NN	B-TEST
count	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
23	CD	O
percent	NN	O
and	CC	O
a	DT	B-TEST
reticulocyte	NN	I-TEST
count	NN	I-TEST
of	IN	O
1.9	CD	O
percent	NN	O
.	.	O

therefore	RB	O
,	,	O
with	IN	O
blood	NN	B-TREATMENT
available	JJ	O
from	IN	O
the	DT	O
first	JJ	O
aliquot	NN	O
,	,	O
a	DT	O
second	JJ	O
20	CD	O
cc	NN	O
per	IN	O
kg	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
were	VBD	O
infused	VBN	O
without	IN	O
incident	NN	O
.	.	O

initial	JJ	B-TEST
head	NN	I-TEST
ultrasound	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
seven	CD	O
was	VBD	O
normal	JJ	O
.	.	O

at	IN	O
one	CD	O
month	NN	O
of	IN	O
age	NN	O
,	,	O
on	IN	O
12-03	JJ	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
absent	JJ	I-PROBLEM
septum	NN	I-PROBLEM
pellucidum	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
obtained	VBN	O
and	CC	O
reviewed	VBN	O
by	IN	O
the	DT	O
hallmark	NN	O
health	NN	O
system	NN	O
radiology	NN	O
department	NN	O
revealed	VBD	O
focal	JJ	B-PROBLEM
gyral	JJ	I-PROBLEM
morphology	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
prematurity	NN	B-PROBLEM
,	,	O
normal	JJ	O
midline	NN	O
structures	NNS	O
,	,	O
normal	JJ	O
myelination	NN	O
,	,	O
no	DT	O
lesions	NNS	B-PROBLEM
,	,	O
no	DT	O
signal	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
extracerebral	JJ	B-PROBLEM
collections	NNS	I-PROBLEM
.	.	O

the	DT	O
septal	JJ	O
leaflets	NNS	O
may	MD	O
be	VB	O
partially	RB	B-PROBLEM
absent	JJ	I-PROBLEM
,	,	O
but	CC	O
there	EX	O
are	VBP	O
no	DT	O
coronal	JJ	B-TEST
images	NNS	I-TEST
provided	VBN	O
for	IN	O
confirmation	NN	O
and	CC	O
the	DT	O
pituitary	JJ	O
stalk	NN	O
is	VBZ	O
present	JJ	O
.	.	O

several	JJ	B-TEST
labs	NNS	I-TEST
were	VBD	O
ordered	VBN	O
.	.	O

electrolytes	NNS	B-TEST
and	CC	O
thyroid	JJ	B-TEST
studies	NNS	I-TEST
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
the	DT	O
normal	JJ	O
range	NN	O
with	IN	O
serum	JJ	B-TEST
sodium	NN	I-TEST
of	IN	O
136	CD	O
,	,	O
potassium	NN	B-TEST
4.7	CD	O
,	,	O
chloride	RB	B-TEST
98	CD	O
and	CC	O
co2	VB	B-TEST
34	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
calcium	NN	I-TEST
of	IN	O
10.3	CD	O
,	,	O
a	DT	B-TEST
phosphorus	NN	I-TEST
of	IN	O
4.8	CD	O
and	CC	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
of	IN	O
440	CD	O
.	.	O

thyroid	JJ	B-TEST
function	NN	I-TEST
studies	NNS	I-TEST
revealed	VBD	O
a	DT	B-TEST
tsh	NN	I-TEST
of	IN	O
2.2	CD	O
,	,	O
t4	NN	B-TEST
of	IN	O
5.7	CD	O
,	,	O
t3	NN	B-TEST
of	IN	O
101	CD	O
and	CC	O
a	DT	B-TEST
cortisol	JJ	I-TEST
level	NN	I-TEST
of	IN	O
43	CD	O
,	,	O
all	DT	O
within	IN	O
the	DT	O
normal	JJ	O
range	NN	O
.	.	O

a	DT	B-TEST
growth	NN	I-TEST
hormone	NN	I-TEST
was	VBD	O
sent	VBN	O
and	CC	O
the	DT	O
results	NNS	O
were	VBD	O
pending	VBG	O
at	IN	O
time	NN	O
of	IN	O
transfer	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
an	DT	B-TEST
fsh	NN	I-TEST
and	CC	O
lh	NN	B-TEST
were	VBD	O
obtained	VBN	O
on	IN	O
12-10	JJ	O
and	CC	O
results	NNS	O
are	VBP	O
pending	VBG	O
at	IN	O
time	NN	O
of	IN	O
transfer	NN	O
.	.	O

the	DT	B-TEST
baby	NN	I-TEST
's	POS	I-TEST
neurologic	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
appropriate	JJ	O
for	IN	O
corrected	JJ	O
gestational	JJ	O
age	NN	O
which	WDT	O
is	VBZ	O
33	CD	O
and	CC	O
6/7	CD	O
weeks	NNS	O
on	IN	O
day	NN	O
of	IN	O
transfer	NN	O
.	.	O

by	IN	O
mother	NN	O
's	POS	O
report	NN	O
,	,	O
a	DT	O
maternal	JJ	O
cousin	NN	O
also	RB	O
has	VBZ	O
an	DT	B-PROBLEM
absent	JJ	I-PROBLEM
septum	NN	I-PROBLEM
pellucidum	NN	I-PROBLEM
.	.	O

given	VBN	O
normal	JJ	O
pituitary	JJ	O
tests	NNS	O
thus	RB	O
far	RB	O
and	CC	O
normal	JJ	O
optic	JJ	O
nerve	NN	O
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
septic	JJ	B-PROBLEM
optic	JJ	I-PROBLEM
dysplasia	NN	I-PROBLEM
.	.	O

pediatrician	NN	O
should	MD	O
have	VB	O
low	JJ	O
threshold	NN	O
for	IN	O
endocrinology	NN	O
reconsult	NN	O
if	IN	O
any	DT	B-PROBLEM
signs	NNS	I-PROBLEM
of	IN	I-PROBLEM
pituitary	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

initial	JJ	B-TEST
rop	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
done	VBN	O
on	IN	O
12-02	JJ	O
and	CC	O
revealed	JJ	O
immature	NN	B-PROBLEM
retinas	NN	I-PROBLEM
to	TO	I-PROBLEM
zone	CD	I-PROBLEM
2	CD	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

they	PRP	O
recommended	VBD	O
follow-up	JJ	B-TEST
examination	NN	I-TEST
due	JJ	O
on	IN	O
the	DT	O
week	NN	O
of	IN	O
12/20	CD	O
.	.	O

feedings	NNS	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
include	VBP	O
breast	NN	O
milk	NN	O
30	CD	O
with	IN	O
promod	NN	B-TREATMENT
at	IN	O
150	CD	O
cc	NN	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
,	,	O
all	DT	O
gavage	NN	B-TREATMENT
given	VBN	O
over	IN	O
one	CD	O
hour	NN	O
.	.	O

medications	NNS	B-TREATMENT
include	VBP	O
fer-in-norman	JJ	B-TREATMENT
,	,	O
vitamin	JJ	B-TREATMENT
e	NN	I-TREATMENT
5	CD	O
international	JJ	O
units	NNS	O
each	DT	O
day	NN	O
and	CC	O
caffeine	NN	B-TREATMENT
citrate	NN	I-TREATMENT
once	IN	O
a	DT	O
day	NN	O
.	.	O

car	NN	B-TEST
seat	NN	I-TEST
positioning	VBG	I-TEST
screening	NN	I-TEST
has	VBZ	O
not	RB	O
been	VBN	O
obtained	VBN	O
.	.	O

newborn	JJ	B-TEST
state	NN	I-TEST
screens	NNS	I-TEST
have	VBP	O
been	VBN	O
sent	VBN	O
per	IN	O
protocol	NN	O
.	.	O

mychelia	NNS	O
received	VBD	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
11-02	JJ	O
due	JJ	O
to	TO	O
unknown	JJ	O
maternal	JJ	O
hepatitis	NN	O
b	NN	O
surface	NN	O
antigen	NN	O
status	NN	O
.	.	O

she	PRP	O
also	RB	O
received	VBD	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
immune	JJ	I-TREATMENT
globulin	NN	I-TREATMENT
on	IN	O
11-02	JJ	O
.	.	O

on	IN	O
12-06	JJ	O
,	,	O
she	PRP	O
received	VBD	O
her	PRP	B-TREATMENT
second	JJ	I-TREATMENT
hepatitis	NN	I-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
two	CD	I-TREATMENT
month	NN	I-TREATMENT
immunizations	NNS	I-TREATMENT
have	VBP	O
not	RB	O
yet	RB	O
been	VBN	O
given	VBN	O
.	.	O

synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
november	CC	O
through	IN	O
march	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

daycare	NN	O
during	IN	O
rsv	NN	O
season	NN	O
,	,	O
a	DT	O
smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
airway	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
school	NN	O
age	NN	O
siblings	NNS	O
or	CC	O

3)	CD	O
infants	NNS	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
infant	NN	O
's	POS	O
life	NN	O
,	,	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
at	IN	O
28-2/7	JJ	O
weeks	NNS	O
.	.	O

2.	CD	O
surfactant	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
.	.	O

3.	CD	O
hypotension	NN	B-PROBLEM
.	.	O

4.	CD	O
sepsis	NN	B-PROBLEM
suspect	NN	O
.	.	O

5.	CD	O
physiologic	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
.	.	O

6.	CD	O
coagulase	NN	B-PROBLEM
negative	JJ	I-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

7.	CD	O
anemia	NN	B-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

8.	CD	O
apnea	NN	B-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

9.	CD	O
absent	JJ	B-PROBLEM
septum	NN	I-PROBLEM
pellucidum	NN	I-PROBLEM
.	.	O

c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

1.	CD	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
chronic	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

3.	CD	O
history	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
.	.	O

4.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
azotemia	NN	B-PROBLEM
.	.	O

thoracentesis	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
on	IN	O
7-12-91	NNS	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
85-year-old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
status	NN	O
post	NN	O
recent	JJ	O
admission	NN	O
for	IN	O
urosepsis	NN	B-PROBLEM
and	CC	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

he	PRP	O
returns	VBZ	O
from	IN	O
the	DT	O
nursing	NN	O
home	NN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
leukocytosis	NN	B-PROBLEM
,	,	O
and	CC	O
azotemia	NN	B-PROBLEM
.	.	O

briefly	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
ethanol	JJ	O
abuse	NN	O
,	,	O
chronic	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
and	CC	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

he	PRP	O
presented	VBD	O
to	TO	O
gaanvantsir	VB	O
on	IN	O
04-17-92	JJ	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
bloody	NN	B-PROBLEM
diarrhea	NN	I-PROBLEM
.	.	O

workup	NN	B-TEST
revealed	VBD	O
ischemic	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
celiac	VB	B-PROBLEM
and	CC	O
sma	VB	B-PROBLEM
stenoses	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
sma	NN	I-PROBLEM
from	IN	O
90-20%	JJ	O
residual	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
gram	VBN	B-PROBLEM
negative	JJ	I-PROBLEM
rod	NN	I-PROBLEM
sepsis	NN	I-PROBLEM
with	IN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
times	NNS	O
two	CD	O
growing	VBG	O
e.	NNS	B-PROBLEM
coli	NNS	I-PROBLEM
and	CC	O
b.	NN	B-PROBLEM
fragilis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
readmitted	VBN	O
on	IN	O
5-21-91	JJ	O
with	IN	O
a	DT	B-PROBLEM
falling	VBG	I-PROBLEM
hematocrit	NN	I-PROBLEM
from	IN	O
36	CD	O
to	TO	O
22	CD	O
,	,	O
mild	FW	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
and	CC	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
colonoscopy	NN	I-TEST
and	CC	O
upper	JJ	B-TEST
gastrointestinal	JJ	I-TEST
series	NN	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
h2	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
31	CD	O
on	IN	O
discharge	NN	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
31	CD	O
on	IN	O
discharge	NN	O
.	.	O

on	IN	O
6-12-91	JJ	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
ingtermst.gay	VB	O
health	NN	O
center	NN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
equalled	VBD	O
128/8.6	CD	O
,	,	O
co2	NN	B-TEST
equaled	VBD	O
12	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
kefzol	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
gaanvantsir	VB	O
.	.	O

1)	CD	O
serratia	JJ	B-PROBLEM
urosepsis	NN	I-PROBLEM
treated	VBN	O
with	IN	O
ceftizoxime	NN	B-TREATMENT
.	.	O

2)	CD	O
azotemia	NN	B-PROBLEM
presumed	VBD	O
secondary	JJ	O
to	TO	O
sepsis	VB	B-PROBLEM
and	CC	O
dehydration	NN	B-PROBLEM
,	,	O
creatinine	NN	B-TEST
decreased	VBD	O
to	TO	O
2.1	CD	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
antibiotics	NNS	B-TREATMENT
.	.	O

renal	JJ	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
abscess	JJ	B-PROBLEM
orhydronephrosis	NN	I-PROBLEM
.	.	O

3)	CD	O
loculated	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

thoracentesis	NN	B-TEST
revealed	VBD	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.18	CD	O
,	,	O
glucose	RB	B-TEST
52	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
200	CD	O
;	:	O
evaluated	VBN	O
by	IN	O
thoracic	NN	O
surgery	NN	O
,	,	O
no	DT	O
chest	NN	B-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
.	.	O

4)	CD	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
with	IN	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
rising	VBG	O
to	TO	O
51,000	CD	O
,	,	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
and	CC	I-TREATMENT
p.o.	JJ	I-TREATMENT
flagyl	NN	I-TREATMENT
.	.	O

c.	NN	B-TEST
difficile	NN	I-TEST
was	VBD	O
negative	JJ	O
times	NNS	O
three	CD	O
prior	JJ	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
patient	NN	O
went	VBD	O
to	TO	O
his	PRP$	O
nursing	NN	O
home	NN	O
on	IN	O
7-9-91	JJ	O
but	CC	O
the	DT	O
next	JJ	O
day	NN	O
he	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
temperature	NN	I-PROBLEM
to	TO	O
102.4	CD	O
degrees	NNS	O
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
and	CC	O
orthostasis	NN	B-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
gaanvantsir	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
question	NN	O
of	IN	O
sepsis	NN	B-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
40,000	CD	O
with	IN	O
left	JJ	B-PROBLEM
shift	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
bun	NN	I-TEST
was	VBD	O
35	CD	O
,	,	O
creatinine	NN	B-TEST
4.3	CD	O
.	.	O

urinalysis	NN	B-TEST
had	VBD	O
5-10	JJ	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
and	CC	O
2+	CD	B-TEST
bacteria	NNS	I-TEST
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
thoracentesis	NN	B-TEST
without	IN	O
evidence	NN	O
of	IN	O
empyema	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
with	IN	O
ceftizoxime	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
vancomycin	NN	I-TREATMENT
for	IN	O
question	NN	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
now	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
medicine	NN	O
service	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

2)	CD	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

3)	CD	O
chronic	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

4)	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
baseline	JJ	B-TEST
creatinine	NN	I-TEST
1.8-2	CD	O
.	.	O

5)	CD	O
ischemic	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
status	NN	O
post	NN	O
sma	VBP	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

6)	CD	O
serratiaurosepsis	NN	B-PROBLEM
.	.	O

7)	CD	O
positive	JJ	B-PROBLEM
ppd	NN	I-PROBLEM
.	.	O

8)	CD	O
status	NN	O
post	NN	O
total	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

9)	CD	O
right	JJ	B-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
hemiblock	NN	I-PROBLEM
on	IN	O
electrocardiogram	NN	B-TEST
.	.	O

allergies	NNS	B-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
,	,	O
sulfa	NN	B-TREATMENT
,	,	O
codeine	NN	B-TREATMENT
,	,	O
morphine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
.medications	NNS	B-TREATMENT
on	IN	I-TREATMENT
transfer	NN	I-TREATMENT
included	VBD	O
thiamine	NN	B-TREATMENT
;	:	O
multivitamin	CC	B-TREATMENT
;	:	O
pepcid	NN	B-TREATMENT
;	:	O
ceftizoxime	CC	B-TREATMENT
1	CD	O
gm	NN	O
intravenously	RB	O
q.	JJ	O
eight	CD	O
hours	NNS	O
;	:	O
flagyl	VBZ	B-TREATMENT
500	CD	O
mg	NN	O
intravenously	RB	O
q.	JJ	O
eight	CD	O
hours	NNS	O
;	:	O
gentamicin	VBZ	B-TREATMENT
80	CD	O
mg	NN	O
iv	NN	O
q.	VBD	O
24	CD	O
hours	NNS	O
;	:	O
ventolin	NNP	B-TREATMENT
inhaler	NN	I-TREATMENT
;	:	O
lotrimin	CC	B-TREATMENT
cream	NN	I-TREATMENT
;	:	O
sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
nitro	JJ	I-TREATMENT
paste	NN	I-TREATMENT
;	:	O
pyridium	NN	B-TREATMENT
;	:	O
vancomycin	CC	B-TREATMENT
125	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
;	:	O
and	CC	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
.	.	O

family	NN	O
history	NN	O
is	VBZ	O
positive	JJ	O
for	IN	O
tuberculosis	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
alcoholism	NN	O
.	.	O

he	PRP	O
is	VBZ	O
a	DT	O
drowsy	NN	O
,	,	O
elderly	JJ	O
white	JJ	O
male	NN	O
lying	VBG	O
with	IN	O
o2	NN	B-TREATMENT
on	IN	O
,	,	O
asking	VBG	O
to	TO	O
be	VB	O
scratched	VBN	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
110/50	CD	O
,	,	O
pulse	JJ	B-TEST
rate	NN	I-TEST
94	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
22	CD	O
,	,	O
temperature	NN	B-TEST
maximum	JJ	I-TEST
101	CD	O
degrees	NNS	O
,	,	O
decreasing	VBG	O
to	TO	O
99	CD	O
degrees	NNS	O
.	.	O

without	IN	O
rash	NN	B-PROBLEM
or	CC	O
petechiae	NN	B-PROBLEM
.	.	O

dry	JJ	B-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

bibasilar	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	JJR	O
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
i	JJ	B-PROBLEM
/	VBP	I-PROBLEM
vi	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

distended	VBN	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
mild	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	NN	I-PROBLEM
,	,	O
no	DT	O
rebound	NN	B-PROBLEM
.	.	O

tender	NN	B-PROBLEM
,	,	O
external	JJ	B-PROBLEM
hemorrhoids	NNS	I-PROBLEM
,	,	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

without	IN	O
edema	NN	B-PROBLEM
.	.	O

alert	NN	O
and	CC	O
oriented	VBN	O
to	TO	O
person	NN	O
and	CC	O
place	NN	O
,	,	O
no	DT	O
asterixis	NN	B-PROBLEM
or	CC	O
tremor	NN	B-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
3	CD	O
,	,	O
bun	NN	B-TEST
35	CD	O
,	,	O
creatinine	NN	B-TEST
3.6	CD	O
,	,	O
liver	JJR	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
calcium	NN	B-TEST
6.6	CD	O
,	,	O
albumin	RB	B-TEST
2	CD	O
,	,	O
magnesium1.4	NN	B-TEST
,	,	O
pt	NN	B-TEST
14	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
30.1	CD	O
with	IN	O
77	CD	O
polys	NNS	B-TEST
,	,	O
13	CD	O
bands	NNS	B-TEST
,	,	O
5	CD	O
lymphs	NN	B-TEST
,	,	O
and	CC	O
5	CD	O
monos	NNS	B-TEST
.	.	O

urine	JJ	B-TEST
sodium	NN	I-TEST
is	VBZ	O
75	CD	O
,	,	O
urine	JJ	B-TEST
creatinine	NN	I-TEST
143	CD	O
,	,	O
urine	JJ	B-TEST
osmose	RB	I-TEST
392	CD	O
.	.	O

pleural	JJ	B-TEST
fluid	NN	I-TEST
ph	NN	I-TEST
is	VBZ	O
7.29	CD	O
,	,	O
glucose	RB	B-TEST
91	CD	O
,	,	O
total	JJ	B-TEST
protein3.1	NN	I-TEST
,	,	O
ldh	VBZ	B-TEST
296	CD	O
,	,	O
70	CD	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
,	,	O
50	CD	B-TEST
red	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

1.	CD	O
colitis	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
ischemic	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
status	NN	O
post	NN	O
sma	VBP	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
with	IN	O
recent	JJ	O
admission	NN	O
for	IN	O
gram	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
rod	NN	I-PROBLEM
urosepsis	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
flagyl	NN	I-TREATMENT
and	CC	O
was	VBD	O
c.	VBN	B-TEST
difficile	JJ	I-TEST
toxin	NN	I-TEST
negative	JJ	O
times	NNS	O
three	CD	O
prior	JJ	O
to	TO	O
transfer	VB	O
.	.	O

he	PRP	O
now	RB	O
returns	VBZ	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
rising	VBG	B-PROBLEM
white	JJ	I-PROBLEM
count	NN	I-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
and	CC	O
dehydration	NN	B-PROBLEM
.	.	O

initially	RB	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
ceftizoxime	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
for	IN	O
presumed	JJ	O
sepsis	NN	B-PROBLEM
,	,	O
either	RB	O
with	IN	O
urine	NN	O
or	CC	O
bowel	NN	O
source	NN	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
negative	JJ	O
.	.	O

stool	NN	B-TEST
for	IN	I-TEST
c.	NN	I-TEST
difficile	NN	I-TEST
returned	VBD	O
positive	JJ	B-PROBLEM
.	.	O

the	DT	O
diagnosis	NN	O
,	,	O
therefore	RB	O
,	,	O
was	VBD	O
relapsed	VBN	B-PROBLEM
c.	NN	I-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

he	PRP	O
improved	VBD	O
clinically	RB	O
with	IN	O
defervescence	NN	O
,	,	O
decreased	VBD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
to	TO	O
10,000	CD	O
with	IN	O
resolution	NN	O
of	IN	O
left	JJ	B-PROBLEM
shift	NN	I-PROBLEM
,	,	O
and	CC	O
some	DT	O
decrease	NN	O
in	IN	O
abdominal	JJ	B-PROBLEM
distention	NN	I-PROBLEM
on	IN	O
exam	NN	B-TEST
.	.	O

an	DT	B-TEST
abdominal	JJ	I-TEST
cat	NN	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
thickened	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
wall	NN	I-PROBLEM
and	CC	O
thumb	NN	B-PROBLEM
printing	NN	I-PROBLEM
,	,	O
primarily	RB	O
involving	VBG	O
the	DT	O
cecum	NN	O
and	CC	O
right	JJ	O
colon	NN	O
greater	JJR	O
than	IN	O
the	DT	O
left	NN	O
,	,	O
consistent	JJ	O
with	IN	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

the	DT	O
diagnosis	NN	O
of	IN	O
recurrent	NN	B-PROBLEM
bowel	NN	I-PROBLEM
ischemia	NN	I-PROBLEM
,	,	O
however	RB	O
,	,	O
was	VBD	O
not	RB	O
ruled	VBN	O
out	RP	O
and	CC	O
this	DT	O
will	MD	O
continue	VB	O
to	TO	O
be	VB	O
a	DT	O
concern	NN	O
in	IN	O
the	DT	O
future	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
n.p.o.	JJ	B-TREATMENT
and	CC	O
was	VBD	O
then	RB	O
advanced	JJ	O
to	TO	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
which	WDT	O
he	PRP	O
tolerated	VBD	O
.	.	O

he	PRP	O
will	MD	O
be	VB	O
advanced	VBN	O
to	TO	O
soft	JJ	B-TREATMENT
solids	NNS	I-TREATMENT
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

2.	CD	O
azotemia	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
baseline	JJ	B-TEST
creatinine	NN	I-TEST
1.8-2	CD	O
.	.	O

creatinine	NN	B-TEST
had	VBD	O
risen	VBN	O
to	TO	O
4.3	CD	O
on	IN	O
admission	NN	O
presumed	VBN	O
secondary	JJ	O
to	TO	O
sepsis	VB	B-PROBLEM
and	CC	O
dehydration	NN	B-PROBLEM
.	.	O

with	IN	O
intravenous	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
the	DT	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
fell	VBD	O
to	TO	O
12/1.9	CD	O
which	WDT	O
is	VBZ	O
within	IN	O
normal	JJ	O
limits	NNS	O
for	IN	O
this	DT	O
patient	NN	O
.	.	O

the	DT	B-TEST
abdominal	JJ	I-TEST
cat	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
hydronephrosis	NN	B-PROBLEM
orrenal	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
written	VBN	O
for	IN	O
haldol	NN	B-TREATMENT
1	CD	O
mg	NN	O
p.o.b.i.d.	NN	O
p.r.n.	NN	O
to	TO	O
help	VB	O
with	IN	O
this	DT	B-PROBLEM
problem	NN	I-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
on	IN	I-TREATMENT
transfer	NN	I-TREATMENT
include	VBP	O
multivitamin	$	B-TREATMENT
1	CD	O
tablet	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
pepcid	CC	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
;	:	O
ventolin	CC	B-TREATMENT
inhaler	VB	I-TREATMENT
two	CD	O
puffs	NNS	O
q.i.d.	VBP	O
;	:	O
vancomycin	$	B-TREATMENT
125	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
;	:	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
1250	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
;	:	O
lotrimin	CC	B-TREATMENT
cream	NN	I-TREATMENT
to	TO	O
groin	VB	O
b.i.d.	JJ	O
p.r.n.	NN	O
;	:	O
o2	CC	B-TREATMENT
at	IN	O
four	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
;	:	O
and	CC	O
haldol	VB	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
p.r.n.	NN	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM

major	JJ	O
surgical	JJ	O
or	CC	O
invasive	JJ	O
procedure	NN	O
:	:	O
pheresis	NN	B-TEST
renal	JJ	I-TEST
biopsy	NN	I-TEST

this	DT	O
is	VBZ	O
a	DT	O
32	CD	O
year	NN	O
old	JJ	O
male	NN	O
who	WP	O
was	VBD	O
recently	RB	O
discharged	VBN	O
from	IN	O
mediplex	JJ	O
rehab	NN	O
hospital	NN	O
and	CC	O
presents	NNS	O
again	RB	O
to	TO	O
us	PRP	O
with	IN	O
chief	JJ	O
complaint	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
sudden	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
left-sided	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
).	NN	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
recent	JJ	I-TEST
kidney	NN	I-TEST
biopsy	NN	I-TEST
on	IN	O
2018-07-30	JJ	O
and	CC	O
his	PRP$	B-TEST
cr	NN	I-TEST
bumped	VBD	O
from	IN	O
4.7	CD	O
to	TO	O
5.7	CD	O
.	.	O

also	RB	O
,	,	O
hct	NN	B-TEST
on	IN	O
admission	NN	O
21	CD	O
from	IN	O
25	CD	O
.	.	O

esrd	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
(	(	O
m,w,f	NN	O
)	)	O
(	(	O
03-30	JJ	O
glomerulonephritis	NN	B-PROBLEM
)	)	O

htn	NN	B-PROBLEM

hypercholesterolemia	NN	B-PROBLEM

avf	SYM	B-TREATMENT
-	:	I-TREATMENT
r	NN	I-TREATMENT
radial	JJ	I-TREATMENT
-	:	I-TREATMENT
cephalic	NN	I-TREATMENT

avf	SYM	B-TREATMENT
-	:	I-TREATMENT
l	NN	I-TREATMENT
aneurysm	NN	I-TREATMENT
resection	NN	I-TREATMENT

tunneled	VBN	B-TREATMENT
l	NN	I-TREATMENT
subclavian	JJ	I-TREATMENT
catheter	NN	I-TREATMENT

family	NN	O
history	NN	O
:	:	O
sister	NN	O
who	WP	O
is	VBZ	O
26	CD	O
also	RB	O
has	VBZ	O
esrd	VBN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
(	(	O
?	.	O
etiology	NN	O
)	)	O

vs	NN	B-TEST
:	:	O
afebrile	NN	B-PROBLEM
,	,	O
hr	NN	B-TEST
:	:	O
70-80	JJ	O
,	,	O
99/70	CD	O

abd	NN	O
:	:	O
non-distended	JJ	B-PROBLEM
,	,	O
tender	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
llq	NN	I-TEST

wbc	SYM	B-TEST
-	:	O
6.8	CD	O
rbc	NN	B-TEST
-	:	O
2.50	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
6.8	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
21.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
85	CD	O
mch	SYM	B-TEST
-	:	O
27.2	CD	O
mchc	SYM	B-TEST
-	:	O
32.1	CD	O
rdw	NN	B-TEST
-	:	O
18.0	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
149	CD	O
*	NN	O
pt	NN	B-TEST
-	:	O
11.9	CD	O
ptt	NN	B-TEST
-	:	O
31.1	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	NN	I-TEST
)	)	I-TEST
-	:	O
1.0	CD	O
fibrinogen	NN	B-TEST
-	:	O
148	CD	O
*	NN	O
glucose	VBD	B-TEST
-	:	O
144	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
52	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
5.7	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
138	CD	O
k	SYM	B-TEST
-	:	O
4.1	CD	O
cl	NN	B-TEST
-	:	O
107	CD	O
hco3	NN	B-TEST
-	:	O
17	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
18	CD	O

2018-08-04	JJ	O
06:09	CD	O
pm	NN	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.3	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
5.0	CD	O
*	NN	O
mg	SYM	B-TEST
-	:	O
2.2	CD	O

wbc	SYM	B-TEST
-	:	O
5.7	CD	O
rbc	NN	B-TEST
-	:	O
3.10	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
85	CD	O
mch	SYM	B-TEST
-	:	O
28.7	CD	O
mchc	SYM	B-TEST
-	:	O
33.9	CD	O
rdw	NN	B-TEST
-	:	O
15.4	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
186	CD	O
pt	NN	B-TEST
-	:	O
11.5	CD	O
ptt	NN	B-TEST
-	:	O
25.6	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
1.0	CD	O
fibrinogen	NN	B-TEST
-	:	O
443	CD	O
*	NN	O
glucose	VBD	B-TEST
-	:	O
104	CD	O
urean	JJ	B-TEST
-	:	O
60	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
4.8	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
139	CD	O
k	SYM	B-TEST
-	:	O
4.3	CD	O
cl	NN	B-TEST
-	:	O
105	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
12	CD	O
calcium	NN	B-TEST
-	:	O
8.8	CD	O
phos	NN	B-TEST
-	:	O
5.0	CD	O
*	NN	O
mg	SYM	B-TEST
-	:	O
2.2	CD	O

blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
5.7	CD	O
rbc	NN	B-TEST
-	:	O
3.10	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
85	CD	O
mch	SYM	B-TEST
-	:	O
28.7	CD	O
mchc	SYM	B-TEST
-	:	O
33.9	CD	O
rdw	NN	B-TEST
-	:	O
15.4	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
186	CD	O

blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
186	CD	O

blood	NN	B-TEST
pt	SYM	B-TEST
-	:	O
11.5	CD	O
ptt	NN	B-TEST
-	:	O
25.6	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.0	CD	O

blood	NN	B-TEST
fibrino	NN	B-TEST
-	:	O
443	CD	O
*	NN	O

blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
104	CD	O
urean	JJ	B-TEST
-	:	O
60	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
4.8	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
139	CD	O
k	SYM	B-TEST
-	:	O
4.3	CD	O
cl	NN	B-TEST
-	:	O
105	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
12	CD	O

blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.8	CD	O
phos	NN	B-TEST
-	:	O
5.0	CD	O
*	NN	O
mg	SYM	B-TEST
-	:	O
2.2	CD	O

this	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
08-04	NN	O
after	IN	O
a	DT	O
recent	JJ	O
discharge	NN	O
from	IN	O
the	DT	O
hospital	NN	O
for	IN	O
sudden	JJ	O
onset	NN	O
of	IN	O
left	NN	B-PROBLEM
sided	VBD	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
his	PRP$	B-TEST
ultrasound	NN	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
with	IN	O
new	JJ	B-PROBLEM
perinephric	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
surrounding	VBG	O
the	DT	O
transplant	NN	O
kidney	NN	O
and	CC	O
hence	NN	O
,	,	O
underwent	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
abdomen	NNS	I-TEST
/	NNP	I-TEST
pelvis	NN	I-TEST
which	WDT	O
showed	VBD	O
a	DT	O
large	JJ	O
left-sided	JJ	O
of	IN	O
retroperitoneal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
extending	VBG	O
down	RP	O
to	TO	O
the	DT	O
level	NN	O
of	IN	O
the	DT	B-TREATMENT
renal	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
possibly	RB	O
related	VBN	O
to	TO	O
recent	JJ	B-TEST
transplant	NN	I-TEST
biopsy	NN	I-TEST
.	.	O

serial	JJ	B-TEST
hematocrits	NNS	I-TEST
and	CC	O
abdominal	JJ	B-TEST
exams	NNS	I-TEST
were	VBD	O
performed	VBN	O
.	.	O

on	IN	O
08-06	NN	O
,	,	O
he	PRP	O
received	VBD	O
2	CD	O
units	NNS	O
of	IN	O
prbc	NN	B-TREATMENT
and	CC	O
underwent	JJ	O
plasmaphersis	NN	B-TREATMENT
,	,	O
followed	VBN	O
by	IN	O
10mg	CD	O
of	IN	O
ivig	NN	B-TREATMENT
.	.	O

he	PRP	O
received	VBD	O
another	DT	B-TREATMENT
unit	NN	I-TREATMENT
prbc	NN	I-TREATMENT
on	IN	O
08-07	NN	O
.	.	O

by	IN	O
08-07	JJ	O
,	,	O
it	PRP	O
was	VBD	O
thought	VBN	O
there	RB	O
was	VBD	O
improvement	NN	O
of	IN	O
his	PRP$	B-TEST
labs	NN	I-TEST
.	.	O

in	IN	O
the	DT	O
am	VBP	O
of	IN	O
6/13	CD	O
,	,	O
he	PRP	O
was	VBD	O
given	VBN	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
prbc	NN	I-TREATMENT
for	IN	O
a	DT	B-TEST
hct	NN	I-TEST
of	IN	O
21.8	CD	O
.	.	O

his	PRP$	B-TEST
hct	NN	I-TEST
was	VBD	O
stable	JJ	O
on	IN	O
08-09	NN	O
at	IN	O
24.4	CD	O
;	:	O
he	PRP	O
had	VBD	O
plasmapheresis	NN	B-TREATMENT
on	IN	O
08-09	NN	O
(	(	O
followed	VBN	O
by	IN	O
10	CD	O
mg	NNS	O
ivig	JJ	B-TREATMENT
).	NN	O

on	IN	O
08-10	NN	O
,	,	O
his	PRP$	B-TEST
am	VBP	I-TEST
hct	NN	I-TEST
was	VBD	O
21.9	CD	O
,	,	O
hence	RB	O
,	,	O
he	PRP	O
received	VBD	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
prbc	NN	I-TREATMENT
.	.	O

on	IN	O
08-10	JJ	O
class	NN	B-TEST
i	NN	I-TEST
and	CC	I-TEST
ii	VB	I-TEST
antibody	NN	I-TEST
levels	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

he	PRP	O
had	VBD	O
plasmapheresis	NN	B-TREATMENT
on	IN	O
08-11	NN	O
,	,	O
followed	VBN	O
by	IN	O
10	CD	B-TREATMENT
mg	NNS	I-TREATMENT
ivig	NN	I-TREATMENT
.	.	O

hct	NN	B-TEST
remained	VBD	O
stable	JJ	O
.	.	O

on	IN	O
08-15	NN	O
,	,	O
he	PRP	O
went	VBD	O
for	IN	O
pheresis	NN	B-TREATMENT
/	NNP	O
ivig	NN	B-TREATMENT
.	.	O

no	DT	O
new	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

llq	NN	B-PROBLEM
pain	NN	I-PROBLEM
has	VBZ	O
improved	VBN	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
this	DT	O
hospitalization	NN	O
.	.	O

he	PRP	O
is	VBZ	O
eating	VBG	O
and	CC	O
ambulating	VBG	O
w/o	JJ	O
difficulties	NNS	B-PROBLEM
.	.	O

pheresis	NN	B-TREATMENT
to	TO	O
continue	VB	O
as	IN	O
an	DT	O
outpatient	NN	O
with	IN	O
supervision	NN	O
of	IN	O
transplant	JJ	O
nephrology	NN	O
on	IN	O
08-17	JJ	O
,	,	O
08-20	JJ	O
and	CC	O
08-22	JJ	O
.	.	O

prograf	NN	B-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
12	CD	O
mg	NNS	O
bid	NN	O
on	IN	O
08-16	NN	O
for	IN	O
a	DT	B-TEST
trough	JJ	I-TEST
level	NN	I-TEST
of	IN	O
7.1	CD	O
.	.	O

he	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
have	VB	O
labs	NNS	B-TEST
drawn	VBN	O
on	IN	O
08-17	NN	O
to	TO	O
check	VB	O
trough	IN	B-TEST
level	NN	I-TEST
of	IN	I-TEST
prograf	NN	I-TEST
as	RB	O
well	RB	O
as	IN	O
cbc	NN	B-TEST
,	,	O
chem	NN	B-TEST
10	CD	I-TEST
,	,	O
coags	NNS	B-TEST
.	.	O

bactrim	NN	B-TREATMENT
,	,	O
valcyte	NN	B-TREATMENT
,	,	O
mmf	NN	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
,	,	O
fk	NN	B-TREATMENT
,	,	O
nifedipine	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
mycophenolate	NN	B-TREATMENT
mofetil	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
valganciclovir	JJ	B-TREATMENT
450	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q48h	NN	O
(	(	O
every	DT	O
48	CD	O
hours	NNS	O
)	)	O
.	.	O

4.	CD	O
trimethoprim	JJ	B-TREATMENT
-	:	O
sulfamethoxazole	JJ	B-TREATMENT
80-400	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

5.	CD	O
nifedipine	JJ	B-TREATMENT
60	CD	O
mg	JJ	O
tablet	NN	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBN	O
release	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
labetalol	JJ	B-TREATMENT
200	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
four	CD	O
(	(	O
4	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
oxycodone	CD	B-TREATMENT
-	:	O
acetaminophen	NN	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

9.	CD	O
sevelamer	JJ	B-TREATMENT
800	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
.	.	O

11.	CD	O
minoxidil	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

12.	CD	O
nystatin	JJ	B-TREATMENT
100,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
five	CD	O
(	(	O
5	CD	O
)	)	O
ml	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

13.	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

14.	CD	O
epogen	NN	B-TREATMENT
40,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
ml	NN	O
injection	NN	O
once	RB	O
a	DT	O
week	NN	O
.	.	O

15.	CD	O
syringes	NNS	B-TREATMENT
for	IN	O
epogen	NN	B-TREATMENT
q	NN	O
week	NN	O

16.	CD	O
tacrolimus	JJ	B-TREATMENT
5	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
.	.	O

17.	CD	O
tacrolimus	JJ	B-TREATMENT
1	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

18.	CD	O
outpatient	JJ	B-TEST
lab	NN	I-TEST
work	NN	I-TEST

friday	JJ	O
08-17	CD	O
and	CC	O
monday	JJ	O
08-20	JJ	O
cbc	NN	B-TEST
,	,	O
chem10	NN	B-TEST
,	,	O
pt/ptt/inr	NN	B-TEST
and	CC	O
trough	JJ	B-TEST
prograf	NN	I-TEST
level	NN	I-TEST
.	.	O

discharge	NN	O
diagnosis	NN	O
:	:	O
humoral	JJ	B-PROBLEM
rejection	NN	I-PROBLEM
of	IN	I-PROBLEM
renal	JJ	I-PROBLEM
transplant	NN	I-PROBLEM
perinephric	NN	B-PROBLEM
transplant	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM

please	VB	O
call	VB	O
transplant	JJ	O
office	NN	O
(	(	O
789	CD	O
)	)	O
583	CD	O
5023	CD	O
if	IN	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
bleeding	NN	B-PROBLEM
,	,	O
decreased	VBN	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
weight	VBD	B-PROBLEM
gain	NN	I-PROBLEM
of	IN	O
3	CD	O
pounds	NNS	O
in	IN	O
a	DT	O
day	NN	O
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM

pheresis	NN	B-TREATMENT
friday	JJ	O
08-17	JJ	O
then	RB	O
monday	VBZ	O
08-20	NN	O

labwork	NN	B-TEST
every	DT	O
monday	NN	O
and	CC	O
thursday	JJ	O
per	IN	O
transplant	NN	O
clinic	NN	O
:	:	O
cbc	NN	B-TEST
,	,	O
chem	NN	B-TEST
7	CD	I-TEST
,	,	O
ca	MD	B-TEST
,	,	O
phos	VB	B-TEST
,	,	O
ast	NN	B-TEST
,	,	O
t	NN	B-TEST
bili	NN	I-TEST
,	,	O
u/a	JJ	B-TEST
and	CC	O
trough	JJ	B-TEST
prograf	NN	I-TEST
level	NN	I-TEST
.	.	O

pheresis	NN	B-TREATMENT
,	,	O
bed	VBD	O
five	CD	O
pheresis	NN	O
rooms	NNS	O
date	NN	O
/	JJ	O
time	NN	O
:	:	O
2018-08-17	JJ	O
9:15	CD	O

pheresis	NN	B-TREATMENT
,	,	O
bed	VBD	O
six	CD	O
pheresis	NN	O
rooms	NNS	O
date	NN	O
/	JJ	O
time	NN	O
:	:	O
2018-08-20	JJ	O
2:00	CD	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

07/09/00	CD	O
at	IN	O
04:00	CD	O
pm	NN	O
contingent	NN	O
upon	IN	O
attending	VBG	B-TEST
evaluation	NN	I-TEST

tylenol	NN	B-TREATMENT
#3	NNP	I-TREATMENT
(	(	I-TREATMENT
acetaminophen	JJ	I-TREATMENT
w	NN	I-TREATMENT
/	NNP	I-TREATMENT
codeine	NN	I-TREATMENT
30mg	CD	O
)	)	O
1-2	CD	O
tab	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
allopurinol	IN	B-TREATMENT
300	CD	O
mg	NNS	O
po	JJ	O
qd	JJ	O
colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
hydrochlorothiazide	RB	B-TREATMENT
25	CD	O
mg	NNS	O
po	JJ	O
qd	JJ	O
levofloxacin	NN	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
qd	NN	O
starting	VBG	O
today	NN	O
(	(	O
07/09	CD	O
)	)	O

flagyl	NN	B-TREATMENT
(	(	I-TREATMENT
metronidazole	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
tid	NN	O

dr.	NN	O
mandessquarc	NN	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
unclear	JJ	I-PROBLEM
etiology	NN	I-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

80	CD	O
yo	JJ	O
woman	NN	O
recently	RB	O
diagnosed	VBD	O
with	IN	O
metastatic	JJ	B-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
ca	MD	I-PROBLEM
.	.	O

mets	NNS	B-PROBLEM
to	TO	I-PROBLEM
spine	VB	I-PROBLEM
,	,	I-PROBLEM
femur	NN	I-PROBLEM
.	.	O

on	IN	O
xrt	NN	B-TREATMENT
.	.	O

tumor	NN	B-PROBLEM
invasive	NN	I-PROBLEM
of	IN	I-PROBLEM
pleura	NN	I-PROBLEM
and	CC	I-PROBLEM
rib	NN	I-PROBLEM
.	.	O

admitted	VBN	O
after	IN	O
acute	JJ	B-PROBLEM
onset	NN	I-PROBLEM
left	VBD	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

transferred	VBN	O
today	NN	O
from	IN	O
ez	FW	O
ephtro	FW	O
health	NN	O
center	NN	O
on	IN	O
lmwh	NN	O
for	IN	O
r	NN	O
/	NNP	O
o	VBZ	O
pe	JJ	B-PROBLEM
vs	NN	O
pneumonia	NN	B-PROBLEM
vs	NN	O
tumor	NN	B-PROBLEM
invasion	NN	I-PROBLEM
.	.	O

following	VBG	O
enzymes	NNS	B-TEST
to	TO	O
rule	VB	O
out	RP	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
(	(	O
no	DT	O
ekg	NN	B-PROBLEM
changes	NNS	I-PROBLEM
)	)	O
.	.	O

v	NN	B-TEST
/	NN	I-TEST
q	NN	I-TEST
at	IN	O
outside	JJ	O
hospital	NN	O
read	VBD	O
as	IN	O
low	JJ	O
prob.	NN	O
leni	NN	O
&apos;s	NN	O
here	RB	O
neg.	JJ	O
d/c&apos;ed	NN	O
on	IN	O
levo	NN	B-TREATMENT
/	NNP	O
flagyl	NN	B-TREATMENT
for	IN	O
presumed	JJ	O
post-obstructive	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

1.	CD	O
continue	NN	O
with	IN	O
medications	NNS	B-TREATMENT
as	IN	O
prescribed	NNS	O
,	,	O
including	VBG	O
antibiotics	NNS	B-TREATMENT
(	(	O
levofloxacin	JJ	B-TREATMENT
/	NNP	O
flagyl	NN	B-TREATMENT
)	)	O
through	IN	O
7/16/00	CD	O
.	.	O

2.	CD	O
if	IN	O
you	PRP	O
have	VBP	O
further	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
or	CC	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
which	WDT	O
concern	NN	O
you	PRP	O
,	,	O
call	VB	O
your	PRP$	O
doctor	NN	O
.	.	O

iodine	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
sp	JJ	O
cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
/	NN	O
colitis	NN	B-PROBLEM

sp	NN	O
left	VBD	B-TREATMENT
subclavian	JJ	I-TREATMENT
cvl	NN	I-TREATMENT
placement	NN	I-TREATMENT

sp	RB	O
right	JJ	B-TREATMENT
femoral	JJ	I-TREATMENT
cvl	NN	I-TREATMENT
placement	NN	I-TREATMENT

79f	CD	O
pmhx	NN	O
chf,copd	NN	B-PROBLEM
,	,	O
found	VBD	O
down	RB	O
at	IN	O
home	NN	O
,	,	O
pulseless	JJ	B-PROBLEM
-	:	O
cpr	NN	B-TREATMENT
initiated	JJ	O
w/	NN	O
conciousness	NN	O
regained	VBD	O
on	IN	O
scene	NN	O
.	.	O

at	IN	O
osh	JJ	O
abg	NN	B-TEST
7.19/94/110	CD	O
,	,	O
bipap	NN	B-TREATMENT
started	VBD	O
.	.	O

pt	NN	O
found	VBD	O
to	TO	O
be	VB	O
hypothermic	JJ	B-PROBLEM
w/	NN	O
wbc	NN	B-TEST
17	CD	O
(	(	O
pt	NN	O
on	IN	O
steroids	NNS	B-TREATMENT
)	)	O
pnuemobilia	NN	B-PROBLEM
and	CC	O
thickening	NN	B-PROBLEM
of	IN	I-PROBLEM
sigmoid	NN	I-PROBLEM
.	.	O

currently	RB	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
02	CD	I-TREATMENT
+	NNP	O
hemodymamically	RB	O
stable	JJ	O
.	.	O

chf	NN	B-PROBLEM
(	(	O
ef	JJ	B-TEST
25%	CD	O
,	,	O
mod	NN	B-PROBLEM
as,ar	NN	I-PROBLEM
,	,	O
mod	NN	B-PROBLEM
mr	NN	I-PROBLEM
,	,	O
cad,paf	NN	B-PROBLEM
,	,	O
angina	NN	B-PROBLEM
,	,	O
copd	NN	B-PROBLEM
(	(	O
o2	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
-	:	O
2	CD	O
l	NN	O
)	)	O
pvd	NN	B-PROBLEM
,	,	O
recurrent	NN	B-PROBLEM
uti	NN	I-PROBLEM
's	POS	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
bronchitis	NN	I-PROBLEM
,	,	O
?	.	O
h/o	NN	O

dm	NN	B-PROBLEM
,	,	O
sp	JJ	O
l	NN	B-TREATMENT
ax-bifem	NN	I-TREATMENT
,	,	O
l	JJ	B-TREATMENT
fem-cmed	JJ	I-TREATMENT
,	,	O
ercp	JJ	B-TREATMENT
'04	CD	O
,	,	O
t+a	NN	B-TREATMENT
,	,	O
appy	JJ	B-TREATMENT
,	,	O
cea	JJ	B-TREATMENT
,	,	O
l4-l5	JJ	B-TREATMENT
laminectomy	NN	I-TREATMENT
.	.	O

irrr	NN	B-PROBLEM

decreased	VBN	B-PROBLEM
bs	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM

soft	JJ	O
,	,	O
mild	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
r	NN	I-PROBLEM
and	CC	I-PROBLEM
l	NN	I-PROBLEM
lower	JJR	I-PROBLEM
quadrants	NNS	I-PROBLEM
-	:	O
not	RB	O
reproducible	VB	O

visible	JJ	B-TREATMENT
fem-fem	JJ	I-TREATMENT
graft	NN	I-TREATMENT

ext	JJ	O
warm	NN	O
,	,	O
+	$	B-PROBLEM
1	CD	I-PROBLEM
edema	NN	I-PROBLEM

2013-09-22	JJ	O
04:20	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
13.8	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.17	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
28.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
28.2	CD	O
mchc	SYM	B-TEST
-	:	O
31.4	CD	O
rdw	NN	B-TEST
-	:	O
15.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
185	CD	O

2013-09-24	JJ	O
03:15	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
6.8	CD	O
rbc	NN	B-TEST
-	:	O
2.86	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
7.7	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
25.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
27.0	CD	O
mchc	SYM	B-TEST
-	:	O
29.9	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.1	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
178	CD	O

2013-09-25	JJ	O
02:41	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
5.3	CD	O
rbc	NN	B-TEST
-	:	O
2.94	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.2	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
27.9	CD	O
mchc	SYM	B-TEST
-	:	O
29.9	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
194	CD	O

2013-09-23	JJ	O
03:07	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
14.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
30.1	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
1.2	CD	O
*	NN	O

2013-09-22	JJ	O
04:20	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
86	CD	O
urean	JJ	B-TEST
-	:	O
18	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
na	SYM	B-TEST
-	:	O
144	CD	O
k	SYM	B-TEST
-	:	O
3.7	CD	O
cl	NN	B-TEST
-	:	O
101	CD	O
hco3	NN	B-TEST
-	:	O
40	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
7	CD	O
*	NN	O

2013-09-24	JJ	O
09:36	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
202	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
25	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.1	CD	O
na	SYM	B-TEST
-	:	O
139	CD	O
k	SYM	B-TEST
-	:	O
3.9	CD	O
cl	NN	B-TEST
-	:	O
100	CD	O
hco3	NN	B-TEST
-	:	O
37	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
6	CD	O
*	NN	O

2013-09-25	JJ	O
02:41	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
122	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
31	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
139	CD	O
k	SYM	B-TEST
-	:	O
4.1	CD	O
cl	NN	B-TEST
-	:	O
99	CD	O
hco3	NN	B-TEST
-	:	O
35	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
9	CD	O

2013-09-22	JJ	O
04:20	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
51	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
86	CD	O
*	JJ	O
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
638	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
65	CD	O
amylase	NN	B-TEST
-	:	O
120	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
0.4	CD	O

2013-09-22	JJ	O
12:38	CD	O
pm	NN	O
blood	NN	B-TEST
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
1086	CD	O
*	NN	O

2013-09-22	JJ	O
09:45	CD	O
pm	NN	O
blood	NN	B-TEST
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
972	CD	O
*	NN	O

2013-09-25	JJ	O
02:41	CD	O
am	VBP	O
blood	NN	B-TEST
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
218	CD	O
*	NN	O

2013-09-22	JJ	O
04:20	CD	O
am	VBP	O
blood	NN	B-TEST
ctropnt	NN	B-TEST
-	:	O
0.18	CD	O
*	NN	O

2013-09-22	JJ	O
12:38	CD	O
pm	JJ	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
18	CD	O
*	JJ	O
mb	NN	B-TEST
indx	SYM	I-TEST
-	:	O
1.7	CD	O
ctropnt	NN	B-TEST
-	:	O
0.17	CD	O
*	NN	O

2013-09-22	JJ	O
09:45	CD	O
pm	JJ	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-14	NN	O
*	NNP	O
mb	NN	B-TEST
indx	NN	I-TEST
-	:	O
1.4	CD	O

2013-09-23	JJ	O
04:26	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
10	CD	O
mb	NN	B-TEST
indx	NN	I-TEST
-	:	O
1.4	CD	O
ctropnt	NN	B-TEST
-	:	O
0.12	CD	O
*	NN	O

2013-09-25	JJ	O
02:41	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
5	CD	O
ctropnt	NN	B-TEST
-	:	O
0.10	CD	O
*	NN	O

2013-09-22	JJ	O
04:20	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.1	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
3.2	CD	O
mg	SYM	B-TEST
-	:	O
2.0	CD	O

2013-09-25	JJ	O
02:41	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.2	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
5.3	CD	O
*	NN	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

2013-09-23	JJ	O
07:36	CD	O
am	VBP	O
blood	NN	B-TEST
vanco	NN	B-TEST
-	:	O
16.2	CD	O
*	NN	O

2013-09-24	JJ	O
10:26	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
105	CD	O
pco2	NN	B-TEST
-	:	O
95	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.19	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
38	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
4	CD	O

2013-09-24	JJ	O
11:05	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
may	MD	O
po2	VB	B-TEST
-	:	O
35	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
107	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.17	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
41	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
5	CD	O

2013-09-24	JJ	O
11:31	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
144	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
80	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.23	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
35	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
3	CD	O

2013-09-24	JJ	O
07:42	CD	O
pm	NN	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
127	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
105	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.16	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
40	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
4	CD	O

2013-09-24	JJ	O
09:19	CD	O
pm	NN	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
76	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
85	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.26	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
40	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
7	CD	O

2013-09-25	JJ	O
01:50	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
47	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
105	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.15	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
39	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
3	CD	O

2013-09-25	JJ	O
02:54	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
64	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
91	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.23	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
40	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
6	CD	O

ct	JJ	B-TEST
cspine	NN	I-TEST
:	:	O

no	DT	O
evidence	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
spine	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

cervical	JJ	B-PROBLEM
spondylosis	NN	I-PROBLEM
as	IN	O
described	VBN	O
above	IN	O
.	.	O

cxr	NN	B-TEST
post	NN	O
cvl	JJ	B-TREATMENT
placement	NN	I-TREATMENT
09-23	NN	O
:	:	O

a	DT	B-TREATMENT
left	JJ	I-TREATMENT
subclavian	JJ	I-TREATMENT
vascular	NN	I-TREATMENT
catheter	NN	I-TREATMENT
terminates	NNS	O
in	IN	O
the	DT	O
superior	JJ	O
vena	NN	O
cava	NN	O
.	.	O

several	JJ	O
skin	NN	O
folds	NNS	O
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
left	JJ	O
hemithorax	NN	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

there	EX	O
are	VBP	O
bilateral	JJ	B-PROBLEM
moderate	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
,	,	O
both	DT	O
of	IN	O
which	WDT	O
have	VBP	O
increased	VBN	O
in	IN	O
size	NN	O
since	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
study	NN	I-TEST
.	.	O

new	JJ	B-PROBLEM
perihilar	NN	I-PROBLEM
and	CC	I-PROBLEM
basilar	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
may	MD	O
reflect	VB	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
sparing	VBG	O
the	DT	O
upper	JJ	O
lobes	NN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
emphysema	NN	B-PROBLEM
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
difficult	JJ	O
to	TO	O
exclude	VB	O
underlying	JJ	B-PROBLEM
aspiration	NN	I-PROBLEM
or	CC	O
infectious	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

surgical	JJ	B-TREATMENT
clips	NNS	I-TREATMENT
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
left	JJ	O
axilla	NN	O
.	.	O

09-25	JJ	O
cxr	NN	B-TEST
:	:	O

interval	NN	O
development	NN	O
of	IN	O
large	JJ	B-PROBLEM
left	VBD	I-PROBLEM
pneumothorax	NN	I-PROBLEM
with	IN	O
almost	RB	B-PROBLEM
complete	JJ	I-PROBLEM
collapse	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

79f	CD	O
w/	WRB	O
a	DT	O
multiple	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
including	VBG	O
sylvia	NN	O
(	(	O
ef20%	NN	B-TEST
)	)	O
,	,	O
copd	NN	B-PROBLEM
(	(	O
on	IN	O
home	NN	B-TREATMENT
o2	NN	I-TREATMENT
)	)	O
,	,	O
found	VBD	O
down	RB	O
at	IN	O
home	NN	O
,	,	O
pulseless	JJ	B-PROBLEM
-	:	O
cpr	NN	B-TREATMENT
initiated	JJ	O
w/conciousness	NN	O
regained	VBD	O
on	IN	O
scene	NN	O
.	.	O

at	IN	O
osh	JJ	O
abg	NN	B-TEST
7.19/94/110	CD	O
,	,	O
bipap	NN	B-TREATMENT
started	VBD	O
.	.	O

pt	NN	O
found	VBD	O
to	TO	O
be	VB	O
hypothermic	JJ	B-PROBLEM
w/	NN	O
wbc	NN	B-TEST
17	CD	O
(	(	O
pt	NN	O
on	IN	O
steroids	NNS	B-TREATMENT
)	)	O
pnuemobilia	NN	B-PROBLEM
and	CC	O
thickening	NN	B-PROBLEM
of	IN	I-PROBLEM
sigmoid	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
with	IN	O
wishes	NNS	O
from	IN	O
the	DT	O
pt	NN	O
and	CC	O
family	NN	O
to	TO	O
reverse	VB	O
dnr/dni	NN	O
status	NN	O
if	IN	O
surgery	NN	B-TREATMENT
was	VBD	O
indicated	VBN	O
.	.	O

on	IN	O
transfer	NN	O
,	,	O
the	DT	O
pt	NN	O
had	VBD	O
vss	VBN	O
with	IN	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
tender	NN	I-PROBLEM
abdomen	NNS	I-PROBLEM
without	IN	O
peritoneal	JJ	O
signs	NNS	O
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
treat	VB	O
her	PRP$	O
conservatively	RB	O
with	IN	O
bowel	NN	B-TREATMENT
and	CC	I-TREATMENT
iv	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

she	PRP	O
improved	VBD	O
and	CC	O
was	VBD	O
tolerating	VBG	O
po	NN	O
's	POS	O
without	IN	O
difficulty	NN	O
after	IN	O
passing	VBG	O
a	DT	B-TEST
swallow	NN	I-TEST
study	NN	I-TEST
.	.	O

her	PRP$	O
cpine	NN	O
was	VBD	O
clearly	RB	O
with	IN	O
both	DT	O
a	DT	O
negative	JJ	O
ct	NN	O
cspine	NN	O
and	CC	O
clinical	JJ	B-TEST
exam	NN	I-TEST
.	.	O

her	PRP$	B-TREATMENT
groin	NN	I-TREATMENT
cvl	NN	I-TREATMENT
was	VBD	O
dc	JJ	O
'd	MD	O
after	IN	O
a	DT	B-TREATMENT
l	NN	I-TREATMENT
sc	NN	I-TREATMENT
svl	NN	I-TREATMENT
was	VBD	O
palced	VBN	O
.	.	O

cxr	NN	B-TEST
confirmed	VBD	O
good	JJ	O
position	NN	O
and	CC	O
no	DT	O
ptx	NN	B-PROBLEM
.	.	O

overnight	VBN	O
on	IN	O
hd	NN	O
3	CD	O
,	,	O
pt	NN	O
became	VBD	O
mildly	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
and	CC	O
an	DT	B-TEST
abg	NN	I-TEST
was	VBD	O
drawn	VBN	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
resp	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
and	CC	O
bipap	NN	B-TREATMENT
was	VBD	O
initiated	VBN	O
.	.	O

the	DT	O
pt	NN	O
subsequently	RB	O
developed	VBD	O
severe	JJ	B-PROBLEM
hypoxia	NN	I-PROBLEM
with	IN	O
hypotension	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
cxr	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
complete	JJ	B-PROBLEM
collapse	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
l	NN	I-PROBLEM
lung	NN	I-PROBLEM
thought	VBD	O
to	TO	O
be	VB	O
a	DT	O
result	NN	O
of	IN	O
bursting	VBG	O
a	DT	B-PROBLEM
bleb	NN	I-PROBLEM
associated	VBN	O
with	IN	O
her	PRP$	B-PROBLEM
severe	JJ	I-PROBLEM
copd	NN	I-PROBLEM
.	.	O

family	NN	O
did	VBD	O
not	RB	O
want	VB	O
a	DT	B-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
and	CC	O
decided	VBD	O
to	TO	O
make	VB	O
the	DT	O
pt	NN	O
cmo	NN	B-TREATMENT
measures	NNS	I-TREATMENT
.	.	O

on	IN	O
hd	$	O
4	CD	O
pt	NN	O
continued	VBD	O
to	TO	O
show	VB	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
acidosis	NN	I-PROBLEM
,	,	O
was	VBD	O
continued	VBN	O
on	IN	O
a	DT	B-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
,	,	O
and	CC	O
was	VBD	O
difficult	JJ	O
to	TO	O
arouse	VB	O
.	.	O

coreg	NN	B-TREATMENT
6.25	CD	O
"	NN	O
,	,	O
captopril	VBP	B-TREATMENT
12.5	CD	O
"	NN	O
,	,	O
effexor	RB	B-TREATMENT
150	CD	O
'	''	O
,	,	O
colace	VBP	B-TREATMENT
100	CD	O
"	JJ	O
prn	NN	O
,	,	O
calcium	NN	B-TREATMENT
"	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
40	CD	O
'	''	O
,	,	O
kcl	VBD	B-TREATMENT
20	CD	O
'	''	O
,	,	O
pred	VBD	B-TREATMENT
5	CD	O
'	''	O
,	,	O
opscal	JJ	B-TREATMENT
'	''	O
,	,	O
protonix	VBZ	B-TREATMENT
40	CD	O
'	''	O
,	,	O
diamoxx	VBZ	B-TREATMENT
250	CD	O
'	''	O
,	,	O
albuterol	NN	B-TREATMENT
prn	NN	O
,	,	O
darvocet	NN	B-TREATMENT
prn	NN	O
,	,	O
senekot	NN	B-TREATMENT
,	,	O
trazadone	RB	B-TREATMENT
25	CD	O
'	''	O

discharge	NN	O
diagnosis	NN	O
:	:	O
respiratory	NN	B-PROBLEM
failure	NN	I-PROBLEM

sepsis	NN	B-PROBLEM
,	,	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
ards	NNS	B-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM

penicillins	NNS	B-TREATMENT

sepsis	NN	B-PROBLEM
,	,	O
ards	NNS	B-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
sepsis	NN	B-PROBLEM
,	,	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
ards	NNS	B-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
dm2	RB	B-PROBLEM
,	,	O
s	JJ	O
/	NNP	O
p	NN	O
splenectomy	NN	B-TREATMENT
,	,	O
depression	NN	B-PROBLEM

patient	NN	O
on	IN	O
vent	NN	B-TREATMENT
,	,	O
febrile	NN	B-PROBLEM
,	,	O
hypotensive	NN	B-PROBLEM
.	.	O

developed	JJ	O
requirement	NN	B-PROBLEM
for	IN	O
multiple	JJ	B-TREATMENT
pressors	NNS	I-TREATMENT
,	,	O
then	RB	O
arrhythmias	NN	B-PROBLEM
.	.	O

full	JJ	B-TREATMENT
code	NN	I-TREATMENT
carried	VBD	O
out	RP	O
.	.	O

despite	IN	O
extraordinary	JJ	B-TREATMENT
measures	NNS	I-TREATMENT
,	,	O
stable	JJ	O
sinus	NN	O
rhythm	NN	O
could	MD	O
not	RB	O
be	VB	O
restored	VBN	O
.	.	O

subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	I-PROBLEM
posttraumatic	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
79	CD	O
-	:	O
year-old	JJ	O
gentleman	NN	O
found	VBD	O
down	RB	O
at	IN	O
home	NN	O
unresponsive	NN	B-PROBLEM
by	IN	O
his	PRP$	O
wife	NN	O
after	IN	O
lunch	NN	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
history	NN	O
of	IN	O
headaches	NNS	B-PROBLEM
or	CC	O
recent	JJ	B-PROBLEM
illness	NN	I-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
when	WRB	O
the	DT	O
ambulance	NN	O
arrived	VBD	O
.	.	O

systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
reported	VBN	O
250	CD	O
on	IN	O
arrival	NN	O
to	TO	O
the	DT	O
mass.	NN	O
eye	NN	O
&	CC	O
ear	JJ	O
infirmary	JJ	O
emergency	NN	O
department	NN	O
.	.	O

he	PRP	O
was	VBD	O
intubated	VBN	O
and	CC	O
given	VBN	O
versed	JJ	B-TREATMENT
and	CC	O
fentanyl	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
gcs	NN	I-TEST
was	VBD	O
reported	VBN	O
as	IN	O
3	CD	O
on	IN	O
arrival	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

pacemaker	NN	B-TREATMENT
implantation	NN	I-TREATMENT
.	.	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
.	.	O

previous	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

aspirin	NN	B-TREATMENT
,	,	O
folate	NN	B-TREATMENT
,	,	O
multivitamin	NN	B-TREATMENT
,	,	O
amiodarone	NN	B-TREATMENT
,	,	O
lasix	NN	B-TREATMENT
,	,	O
imdur	NN	B-TREATMENT
,	,	O
celexa	NN	B-TREATMENT
,	,	O
lipitor	NN	B-TREATMENT
,	,	O
potassium	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
154/75	CD	O
,	,	O
on	IN	O
nipride	JJ	B-TREATMENT
drip	NN	I-TREATMENT
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
81	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
97%	CD	O
.	.	O

he	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT
at	IN	O
the	DT	O
time	NN	O
.	.	O

pinpoint	NN	B-PROBLEM
pupils	NNS	I-PROBLEM
,	,	O
intact	JJ	O
corneal	NN	O
reflexes	NNS	O
bilaterally	RB	O
.	.	O

doll	NN	B-PROBLEM
's	POS	I-PROBLEM
eyes	NNS	I-PROBLEM
.	.	O

he	PRP	O
withdrew	VBD	O
both	DT	O
lower	JJR	O
extremities	NNS	O
to	TO	O
peripheral	JJ	B-TEST
stimulation	NN	I-TEST
,	,	O
as	RB	O
well	RB	O
as	IN	O
his	PRP$	O
upper	JJ	O
extremities	NNS	O
to	TO	O
peripheral	JJ	B-TEST
stimulation	NN	I-TEST
.	.	O

he	PRP	O
also	RB	O
withdrew	VBD	O
his	PRP$	O
left	JJ	O
upper	JJ	O
extremity	NN	O
to	TO	O
peripheral	JJ	B-TEST
stimulation	NN	I-TEST
but	CC	O
not	RB	O
his	PRP$	O
right	JJ	O
upper	JJ	O
extremity	NN	O
.	.	O

his	PRP$	B-TEST
reflexes	NNS	I-TEST
were	VBD	O
brisk	VBN	O
in	IN	O
his	PRP$	O
patellas	NN	O
bilaterally	RB	O
,	,	O
and	CC	O
he	PRP	O
had	VBD	O
upgoing	JJ	B-PROBLEM
toes	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
showed	VBD	O
diffuse	IN	B-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neuro	JJ	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
close	JJ	O
monitoring	NN	O
and	CC	O
neuro-checks	NNS	B-TEST
.	.	O

a	DT	B-TREATMENT
vent	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
to	TO	O
monitor	VB	O
and	CC	O
cp	VB	O
and	CC	O
relieved	VB	O
fluid	NN	O
.	.	O

he	PRP	O
received	VBD	O
12	CD	O
u	NN	O
of	IN	O
platelets	NNS	B-TREATMENT
.	.	O

his	PRP$	B-TEST
neurologic	JJ	I-TEST
exam	NN	I-TEST
did	VBD	O
not	RB	O
change	VB	O
significantly	RB	O
.	.	O

his	PRP$	B-TEST
icps	NN	I-TEST
were	VBD	O
in	IN	O
the	DT	O
range	NN	O
of	IN	O
11-22	JJ	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	B-TREATMENT
nipride	JJ	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

he	PRP	O
developed	VBD	O
extensive	JJ	B-PROBLEM
posturing	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
cta	NN	I-TEST
showed	VBD	O
diffuse	IN	B-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
and	CC	O
intraventricular	JJ	B-PROBLEM
blood	NN	I-PROBLEM
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
ct	NN	I-TEST
on	IN	O
09-26	NN	O
showed	VBD	O
worsening	NN	O
of	IN	O
the	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
cerebellar	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

the	DT	O
family	NN	O
was	VBD	O
informed	VBN	O
of	IN	O
the	DT	O
patient	NN	O
's	POS	O
condition	NN	O
and	CC	O
repeat	NN	B-TEST
scan	JJ	I-TEST
.	.	O

a	DT	O
family	NN	O
discussion	NN	O
resulted	VBD	O
in	IN	O
the	DT	O
decision	NN	O
to	TO	O
make	VB	O
the	DT	O
patient	NN	O
comfort	NN	B-TREATMENT
measures	VBZ	I-TREATMENT
only	RB	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
extubated	VBN	O
and	CC	O
passed	VBN	O
away	RB	O
at	IN	O
10:55	CD	O
a.m.	RB	O
on	IN	O
2011-09-27	JJ	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
40	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
on	IN	O
hemodialysis	NN	B-TREATMENT
since	IN	O
12/91	CD	O
.	.	O

this	DT	O
was	VBD	O
secondary	JJ	O
to	TO	O
polycystic	JJ	B-PROBLEM
kidneydisease	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
noted	VBN	O
since	IN	O
age	NN	O
12	CD	O
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
cadaveric	JJ	B-TREATMENT
renal	NN	I-TREATMENT
allograft	NN	I-TREATMENT
in	IN	O
03/93	CD	O
,	,	O
and	CC	O
she	PRP	O
subsequently	RB	O
underwent	VBD	O
an	DT	B-TREATMENT
early	JJ	I-TREATMENT
postoperative	NN	I-TREATMENT
transplant	NN	I-TREATMENT
nephrectomy	JJ	I-TREATMENT
secondary	JJ	O
to	TO	O
rupture	VB	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
having	VBG	O
difficult	JJ	B-PROBLEM
access	NN	I-PROBLEM
problems	NNS	I-PROBLEM
and	CC	O
now	RB	O
has	VBZ	O
a	DT	B-TREATMENT
left	VBN	I-TREATMENT
upper	JJ	I-TREATMENT
arm	NN	I-TREATMENT
ptfe	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
been	VBN	O
placed	VBN	O
on	IN	O
emergency	NN	B-TREATMENT
transplant	NN	I-TREATMENT
for	IN	O
this	DT	B-PROBLEM
difficult	JJ	I-PROBLEM
access	NN	I-PROBLEM
problem	NN	I-PROBLEM
.	.	O

otherwise	RB	O
,	,	O
she	PRP	O
has	VBZ	O
been	VBN	O
healthy	JJ	O
and	CC	O
her	PRP$	B-TREATMENT
last	JJ	I-TREATMENT
hemodialysis	NN	I-TREATMENT
was	VBD	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
transplant	VB	B-TREATMENT
.	.	O

significant	JJ	O
for	IN	O
hypertension	NN	B-PROBLEM
.	.	O

multiple	JJ	B-TREATMENT
angio	NN	I-TREATMENT
accesses	NNS	I-TREATMENT
,	,	O
tah	NN	B-TREATMENT
at	IN	O
age	NN	O
18	CD	O
,	,	O
cadaveric	JJ	B-TREATMENT
renal	NN	I-TREATMENT
allograft	NN	I-TREATMENT
in	IN	O
03/93	CD	O
,	,	O
reoperation	NN	B-TREATMENT
for	IN	O
bleed	NN	B-PROBLEM
followed	VBN	O
by	IN	O
transplant	JJ	B-TREATMENT
nephrectomy	NN	I-TREATMENT
.	.	O

iron	NN	B-TREATMENT
,	,	O
nephro-caps	JJ	B-TREATMENT
,	,	O
calcium	JJ	B-TREATMENT
carbonate	NN	I-TREATMENT
and	CC	O
valium	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
11/30/93	CD	O
where	WRB	O
dr.	NN	O
tiveloydherdes	NNS	O
performed	VBD	O
a	DT	B-TREATMENT
cadaveric	JJ	I-TREATMENT
renal	NN	I-TREATMENT
allograft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
iliac	NN	I-TREATMENT
fossa	NN	I-TREATMENT
which	WDT	O
she	PRP	O
tolerated	VBD	O
well	RB	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
immunosuppressive	JJ	I-TREATMENT
agents	NNS	I-TREATMENT
as	IN	O
per	IN	O
protocol	NN	O
.	.	O

her	PRP$	B-TEST
creatinine	NN	I-TEST
fell	VBD	O
to	TO	O
the	DT	O
normal	JJ	O
range	NN	O
early	RB	O
.	.	O

her	PRP$	B-TREATMENT
prednisone	NN	I-TREATMENT
was	VBD	O
tapered	VBN	O
to	TO	O
a	DT	B-TREATMENT
stable	JJ	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
prednisone	RB	B-TREATMENT
30	CD	O
q.d.	NN	O
,	,	O
imuran	VBD	B-TREATMENT
120	CD	O
q.d.	NN	O
,	,	O
cyclosporin	VBP	B-TREATMENT
400	CD	O
b.i.d.	NN	O
and	CC	O
pepcid	NN	B-TREATMENT
20	CD	O
b.i.d.	NN	O
and	CC	O
colace	NN	B-TREATMENT
100	CD	O
b.i.d.	NN	O

no	DT	O
drug	NN	B-PROBLEM
allergy	VBZ	I-PROBLEM
information	NN	O
on	IN	O
file	NN	O

left	VBN	B-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
slurred	VBD	B-PROBLEM
speech	NN	I-PROBLEM
.	.	O

intubation	NN	B-TREATMENT
and	CC	O
mechanical	JJ	B-TREATMENT
ventilation	NN	I-TREATMENT
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
75	CD	O
year	NN	O
old	JJ	O
right	NN	O
handed	VBD	O
male	NN	O
with	IN	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	JJ	O
nqwmi	JJ	B-PROBLEM
02-25	NN	O
,	,	O
s/p	NN	O
lad	NN	B-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
stent	JJ	B-TREATMENT
05-26	NN	O
,	,	O
dementia	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
who	WP	O
presented	VBD	O
from	IN	O
his	PRP$	O
cmed	VBN	O
csru	NN	O
doctor	NN	O
's	POS	O
office	NN	O
wtih	NN	O
acute	NN	B-PROBLEM
onset	NN	I-PROBLEM
left	VBD	I-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
dysarthria	NN	B-PROBLEM
.	.	O

was	VBD	O
at	IN	O
this	DT	O
doctor	NN	O
's	POS	O
office	NN	O
and	CC	O
complained	VBD	O
of	IN	O
severe	JJ	B-PROBLEM
headache	NN	I-PROBLEM
.	.	O

thereafter	RB	O
,	,	O
wife	NN	O
noted	VBD	O
development	NN	O
of	IN	O
left	NN	B-PROBLEM
sided	VBD	I-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
facial	JJ	B-PROBLEM
droop	NN	I-PROBLEM
,	,	O
slurring	VBG	B-PROBLEM
of	IN	I-PROBLEM
speech	NN	I-PROBLEM
.	.	O

sent	NN	O
to	TO	O
hahnemann	VB	O
general	JJ	O
hospital	NN	O
for	IN	O
evaluation	NN	B-TEST
emergently	RB	O
.	.	O

finger	NN	B-TEST
stick	VB	I-TEST
blood	NN	I-TEST
glucose	JJ	I-TEST
120	CD	O
.	.	O

rest	NN	O
of	IN	O
vitals	NNS	B-TEST
bp	VBP	B-TEST
112/70	CD	O
,	,	O
hr	VBD	B-TEST
60	CD	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
up	IN	O
to	TO	O
230	CD	O
s	NNS	O
systolic	JJ	O
.	.	O

initial	JJ	B-TEST
nih	NNS	I-TEST
stroke	VBD	I-TEST
scale	NN	I-TEST
of	IN	O
33	CD	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
showed	VBD	O
large	JJ	B-PROBLEM
right	JJ	I-PROBLEM
intracerebral	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

intubated	VBN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
at	IN	O
13:35	CD	O
after	IN	O
fentanyl	NN	B-TREATMENT
,	,	O
etomidate	NN	B-TREATMENT
,	,	O
vecuronium	NN	B-TREATMENT
and	CC	O
succhinylcholine	VB	B-TREATMENT
given	VBN	O
.	.	O

started	VBN	O
on	IN	O
labetalol	NN	B-TREATMENT
and	CC	O
then	RB	O
nipride	RB	B-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
bp	NN	B-TREATMENT
control	NN	I-TREATMENT
;	:	O
discontinued	VBN	O
as	IN	O
goal	NN	B-TEST
bp	NN	I-TEST
in	IN	O
130-160	JJ	O
s.	NN	O

received	VBD	O
10	CD	B-TREATMENT
mg	NNS	I-TREATMENT
sc	JJ	I-TREATMENT
vitamin	NN	I-TREATMENT
k	NN	I-TREATMENT
and	CC	O
2	CD	B-TREATMENT
units	NNS	I-TREATMENT
ffp	VBP	I-TREATMENT
while	IN	O
in	IN	O
gary	NN	O
.	.	O

pupils	NNS	O
noted	VBD	O
to	TO	O
be	VB	O
fixed	VBN	B-PROBLEM
and	CC	O
dilated	VBN	B-PROBLEM
at	IN	O
14:10	CD	O
.	.	O

loaded	VBN	O
with	IN	O
dilantin	NN	B-TREATMENT
and	CC	O
50	CD	B-TREATMENT
grams	NNS	I-TREATMENT
mannitol	NN	I-TREATMENT
.	.	O

1.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
on	IN	O
coumadin	NN	B-TREATMENT

2.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
nqwmi	IN	B-PROBLEM
02-25	NN	O
,	,	O
s/p	NN	O
lad	NN	B-TREATMENT
angioplasty	NN	I-TREATMENT
and	CC	O
stent	JJ	B-TREATMENT
05-26	JJ	O
.	.	O
known	VBN	B-PROBLEM
non-dominant	JJ	I-PROBLEM
90%	CD	I-PROBLEM
rca	NN	I-PROBLEM
lesion	NN	I-PROBLEM
not	RB	O
intervened	VBN	O
upon	IN	O
.	.	O

3.	CD	O
dementia	NN	B-PROBLEM

4.	CD	O
mild-moderate	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM

5.	CD	O
hyperlipidemia	NN	B-PROBLEM

6.	CD	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM

7.	CD	O
obstructive	JJ	B-PROBLEM
sleep	NN	I-PROBLEM
apnea	NN	I-PROBLEM

8.	CD	O
anxiety	NN	B-PROBLEM

9.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	RB	I-PROBLEM
,	,	O
on	IN	O
oral	JJ	B-TREATMENT
medications	NNS	I-TREATMENT

physical	JJ	B-TEST
exam	NN	I-TEST
(	(	O
examined	VBN	O
off	IN	O
of	IN	O
propofol	NN	B-TREATMENT
):	NN	O

tc	NN	B-TEST
:	:	O
96.7	CD	O

bp	NN	B-TEST
:	:	O
120/48	CD	O

hr	NN	B-TEST
:	:	O
61	CD	O

rr	NN	B-TEST
:	:	O
14	CD	O

o2sat.	NN	B-TEST
:	:	O
100%	CD	O
,	,	O
ventilated	VBN	B-TREATMENT
.	.	O

gen	NN	O
:	:	O
wd/wn	JJ	O
male	NN	O
,	,	O
comfortable	JJ	O
appearing	VBG	O
,	,	O
intubated	VBN	B-TREATMENT
,	,	O
not	RB	O
sedated	VBN	B-TREATMENT
.	.	O

heent	NN	O
:	:	O
nc/at	NN	B-PROBLEM
.	.	O

anicteric	NN	B-PROBLEM
.	.	O

+endotracheal	JJ	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
lad	NN	B-PROBLEM
.	.	O

no	DT	O
jvd	NN	B-PROBLEM
.	.	O

no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

lungs	NNS	O
:	:	O
coarse	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
anterolaterally	RB	I-PROBLEM
.	.	O

cardiac	NN	O
:	:	O
irregularly	RB	B-PROBLEM
irregular	NN	I-PROBLEM
.	.	O

no	DT	O
m/r/g	NN	B-PROBLEM
.	.	O

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
nd	JJ	B-PROBLEM
,	,	O
+nabs	NNS	O
.	.	O

no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

no	DT	O
hsm	NN	B-PROBLEM
.	.	O

no	DT	O
c/c/e	NN	B-PROBLEM
.	.	O

no	DT	B-PROBLEM
response	NN	I-PROBLEM
to	TO	I-PROBLEM
voice	NN	I-PROBLEM
,	,	O
sternal	JJ	B-TEST
rub	NN	I-TEST
.	.	O

grimaces	NNS	O
to	TO	O
nasal	VB	B-TEST
tickle	NN	I-TEST
.	.	O

pupils	NNS	B-PROBLEM
fixed	VBN	I-PROBLEM
at	IN	O
7	CD	O
mm	NNS	O
bilaterally	RB	O
.	.	O

very	RB	O
weak	JJ	O
flicker	NN	O
of	IN	O
inner	JJ	O
canthus	NNS	O
on	IN	O
left	NN	O
with	IN	O
corneal	JJ	B-TEST
stimulation	NN	I-TEST
.	.	O

no	DT	B-PROBLEM
oculocephalic	JJ	I-PROBLEM
reflex	NN	I-PROBLEM
.	.	O

left	VBN	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
.	.	O

no	DT	B-PROBLEM
gag	NN	I-PROBLEM
provoked	VBD	O
,	,	O
but	CC	O
biting	VBG	O
ett	NN	B-TREATMENT
at	IN	O
times	NNS	O
.	.	O

no	DT	B-PROBLEM
withdrawal	NN	I-PROBLEM
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

no	DT	B-PROBLEM
withdrawal	NN	I-PROBLEM
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

reflexes	NNS	B-TEST
:	:	O

striking	VBG	O
left	VBD	O
patellar	JJ	O
tendon	NN	O
results	NNS	O
in	IN	O
sustained	JJ	B-PROBLEM
clonus	NN	I-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

toes	NNS	B-PROBLEM
upgoing	VBG	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

wbc	SYM	B-TEST
-	:	O
9.1	CD	O
rbc	NN	B-TEST
-	:	O
4.29	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
14.1	CD	O
hct	NN	B-TEST
-	:	O
38.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
32.8	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
36.4	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
14.7	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
147	CD	O
*	NN	O

pt	SYM	B-TEST
-	:	O
20.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
32.4	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
2.5	CD	O

glucose	JJ	B-TEST
-	:	O
101	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
25	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
sodium	NN	B-TEST
-	:	O
142	CD	O
potassium	NN	B-TEST
-	:	O
4.2	CD	O
chloride	NN	B-TEST
-	:	O
106	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
27	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
13	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
200	CD	O
*	NN	O

2013-11-11	JJ	O
12:39	CD	O
pm	NN	O
ctropnt	NN	B-TEST
-<	VBD	O
0.01	CD	O

ck-mb	JJ	B-TEST
-	:	O
7	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
196	CD	O
*	NN	O

ck-mb	JJ	B-TEST
-	:	O
3	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

2013-11-12	JJ	O
03:30	CD	O
am	VBP	O
blood	NN	B-TEST
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
312	CD	O
*	NN	O

2013-11-12	JJ	O
03:30	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
5	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

2013-11-11	JJ	O
01:55	CD	O
pm	JJ	O
urine	JJ	B-TEST
blood	NN	B-TEST
-	:	O
sm	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
100	CD	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
6.5	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

2013-11-12	JJ	O
11:16	CD	O
am	VBP	O
blood	NN	B-TEST
asa	NN	B-TEST
-	:	O
neg	NN	O
ethanol	SYM	B-TEST
-	:	O
neg	NN	O
acetmnp	SYM	B-TEST
-	:	O
neg	NN	O
bnzodzp	SYM	B-TEST
-	:	O
neg	NN	O
barbitr	SYM	B-TEST
-	:	O
neg	NN	O
tricycl	SYM	B-TEST
-	:	O
neg	NN	O

2013-11-12	JJ	O
10:17	CD	O
am	VBP	O
urine	JJ	B-TEST
bnzodzp	NN	B-TEST
-	:	O
neg	NN	O
barbitr	SYM	B-TEST
-	:	O
neg	NN	O
opiates	VBZ	B-TEST
-	:	O
neg	NN	O
cocaine	NN	B-TEST
-	:	O
neg	NN	O
amphetm	SYM	B-TEST
-	:	O
neg	NN	O
mthdone	NN	B-TEST
-	:	O
neg	NN	O

ct	JJ	B-TEST
head	NN	I-TEST
without	IN	I-TEST
contrast	NN	I-TEST
2013-11-11	CD	O
:	:	O

there	EX	O
is	VBZ	O
a	DT	O
large	JJ	O
region	NN	O
of	IN	O
high	JJ	B-PROBLEM
attenuation	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
and	CC	O
the	DT	O
region	NN	O
of	IN	O
the	DT	O
right	JJ	O
basal	NN	O
ganglia	NNS	O
.	.	O

this	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
intraparenchymal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
more	RBR	O
likely	JJ	O
hypertensive	NN	B-PROBLEM
in	IN	O
etiology	NN	O
.	.	O

no	DT	O
significant	JJ	B-PROBLEM
subarachnoid	NN	I-PROBLEM
or	CC	O
intraventricular	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
appreciated	VBN	O
.	.	O

there	EX	O
is	VBZ	O
mass	JJ	B-PROBLEM
effect	NN	I-PROBLEM
present	NN	O
with	IN	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
towards	IN	O
the	DT	O
left	NN	O
.	.	O

there	EX	O
is	VBZ	O
also	RB	O
left	VBN	B-PROBLEM
sided	JJ	I-PROBLEM
subfalcine	NN	I-PROBLEM
herniation	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
hydrocephalus	NN	B-PROBLEM
.	.	O

large	JJ	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

this	DT	O
most	RBS	O
likely	JJ	O
relates	NNS	O
to	TO	O
hypertensive	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
as	IN	O
opposed	VBN	O
to	TO	O
a	DT	B-PROBLEM
ruptured	VBN	I-PROBLEM
right	NN	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
a	DT	O
75	CD	O
year	NN	O
old	JJ	O
right	NN	O
handed	VBD	O
male	NN	O
with	IN	O
past	JJ	O
medical	JJ	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
dementia	NN	B-PROBLEM
with	IN	O
sudden	JJ	B-PROBLEM
onset	NN	I-PROBLEM
left	VBD	I-PROBLEM
sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
dysarthria	NN	B-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
right	JJ	I-PROBLEM
intracerebral	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
centered	VBN	O
around	IN	O
basal	NN	O
ganglia	NNS	O
and	CC	O
putamen	NNS	O
.	.	O

we	PRP	O
felt	VBD	O
this	DT	O
was	VBD	O
likely	JJ	O
secondary	JJ	O
to	TO	O
hypertension	NN	B-PROBLEM
.	.	O

while	IN	O
still	RB	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
he	PRP	O
had	VBD	O
rapid	JJ	B-PROBLEM
decompensation	NN	I-PROBLEM
necessitating	VBG	O
intubation	NN	B-TREATMENT
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
.	.	O

examination	NN	B-TEST
post	NN	O
intubation	NN	B-TREATMENT
but	CC	O
off	IN	O
intubations	NNS	B-TREATMENT
showed	VBD	O
clinical	JJ	O
evidence	NN	O
of	IN	O
elevated	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
brainstem	NN	B-PROBLEM
compression	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
loaded	VBN	O
with	IN	O
mannitol	NN	B-TREATMENT
and	CC	O
dilantin	NN	B-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
neurosurgery	NN	O
service	NN	O
and	CC	O
they	PRP	O
did	VBD	O
not	RB	O
feel	VB	O
a	DT	B-TREATMENT
surgical	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
or	CC	O
ventriculary	JJ	B-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
warranted	VBN	O
.	.	O

after	IN	O
arrival	NN	O
in	IN	O
the	DT	O
icu	NN	O
,	,	O
patient	NN	O
was	VBD	O
followed	VBN	O
with	IN	O
neuro	JJ	B-TEST
checks	NNS	I-TEST
every	DT	O
1	CD	O
hour	NN	O
.	.	O

sedation	NN	B-TREATMENT
was	VBD	O
held	VBN	O
to	TO	O
allow	VB	O
for	IN	O
frequent	JJ	B-TEST
exams	NNS	I-TEST
.	.	O

labetalol	RB	B-TREATMENT
continuous	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
was	VBD	O
titrated	VBN	O
for	IN	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
130-160	JJ	O
.	.	O

mannitol	NN	B-TREATMENT
and	CC	O
dilantin	NN	B-TREATMENT
were	VBD	O
continued	VBN	O
.	.	O

overnight	RB	O
,	,	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
was	VBD	O
given	VBN	O
for	IN	O
goal	NN	B-TEST
inr	NN	I-TEST
of	IN	O
<	$	O
1.4	CD	O
.	.	O

on	IN	O
serial	JJ	B-TEST
exams	NNS	I-TEST
by	IN	O
neurology	NN	O
and	CC	O
icu	JJ	O
attendings	NNS	O
in	IN	O
the	DT	O
morning	NN	O
on	IN	O
2013-11-12	JJ	O
,	,	O
patient	JJ	O
had	VBD	O
no	DT	B-PROBLEM
clinical	JJ	I-PROBLEM
signs	NNS	I-PROBLEM
of	IN	I-PROBLEM
brainstem	NN	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

namely	RB	O
,	,	O
he	PRP	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
.	.	O

pupils	NNS	O
were	VBD	O
fixed	VBN	B-PROBLEM
and	CC	O
dilated	VBN	B-PROBLEM
.	.	O

no	DT	O
corneal	NN	B-TEST
,	,	I-TEST
gag	NN	I-TEST
,	,	I-TEST
oculocephalic	JJ	I-TEST
,	,	I-TEST
and	CC	I-TEST
oculovestibular	JJ	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
elicited	VBN	O
.	.	O

he	PRP	O
was	VBD	O
not	RB	O
overbreathing	VBG	O
his	PRP$	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

at	IN	O
this	DT	O
point	NN	O
,	,	O
patient	NN	O
was	VBD	O
felt	VBN	O
to	TO	O
have	VB	O
clinical	JJ	O
signs	NNS	O
consistent	JJ	O
with	IN	O
brain	NN	B-PROBLEM
death	NN	I-PROBLEM
.	.	O

plans	NNS	O
were	VBD	O
made	VBN	O
to	TO	O
proceed	VB	O
with	IN	O
apnea	JJ	B-TEST
testing	VBG	I-TEST
.	.	O

however	RB	O
,	,	O
after	IN	O
discussion	NN	O
with	IN	O
patient	NN	O
's	POS	O
wife	NN	O
,	,	O
this	DT	O
was	VBD	O
postponed	VBN	O
with	IN	O
test	NN	B-TEST
planned	VBN	O
on	IN	O
2013-11-13	JJ	O
.	.	O

full	JJ	B-TREATMENT
medical	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
managment	NN	B-TREATMENT
continued	VBD	O
overnight	JJ	O
11/9-11/20/2002	NNS	O
.	.	O

at	IN	O
approximately	RB	O
06:00	CD	O
on	IN	O
2013-11-13	JJ	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
bradycardic	JJ	B-PROBLEM
.	.	O

he	PRP	O
lapsed	VBD	O
first	RB	O
into	IN	O
a	DT	B-PROBLEM
junctional	JJ	I-PROBLEM
rhythm	NN	I-PROBLEM
and	CC	O
then	RB	O
had	VBD	O
very	RB	B-PROBLEM
infrequent	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
escape	NN	I-PROBLEM
beats	NNS	I-PROBLEM
on	IN	O
telemetry	NN	B-TEST
.	.	O

finally	RB	O
,	,	O
he	PRP	O
went	VBD	O
asystolic	JJ	B-PROBLEM
.	.	O

ronald	NN	O
was	VBD	O
pronounced	VBN	O
dead	JJ	B-PROBLEM
at	IN	O
06:59	CD	O
am	VBP	O
.	.	O

1.	CD	O
coumadin	NN	B-TREATMENT

2.	CD	O
lipitor	NN	B-TREATMENT

3.	CD	O
toprol	NN	B-TREATMENT
xl	NN	I-TREATMENT

4.	CD	O
asa	NN	B-TREATMENT

5.	CD	O
zoloft	NN	B-TREATMENT

6.	CD	O
glucophage	NN	B-TREATMENT

7.	CD	O
aricept	NN	B-TREATMENT

8.	CD	O
namenda	NN	B-TREATMENT

9.	CD	O
artificial	JJ	B-TREATMENT
tears	NNS	I-TREATMENT

probably	RB	O
sigmoid	JJ	B-PROBLEM
volvulus	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
81	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
and	CC	O
dementia	NN	B-PROBLEM
who	WP	O
is	VBZ	O
status	NN	O
post	NN	O
laparoscopic	NN	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
one	CD	O
week	NN	O
ago	IN	O
who	WP	O
currently	RB	O
presents	VBZ	O
with	IN	O
a	DT	O
4	CD	O
day	NN	O
history	NN	O
of	IN	O
no	DT	B-PROBLEM
bowel	NN	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
complaints	NNS	O
of	IN	O
abdominal	JJ	B-PROBLEM
distention	NN	I-PROBLEM
,	,	O
emesis	NN	B-PROBLEM
,	,	O
and	CC	O
constipation	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
fever	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
dysuria	NNS	B-PROBLEM
,	,	O
hematochezia	NN	B-PROBLEM
,	,	O
or	CC	O
melena	NN	B-PROBLEM
.	.	O

she	PRP	O
presented	VBD	O
to	TO	O
the	DT	O
ponta,itri-	JJ	O
university	NN	O
medical	JJ	O
center	NN	O
emergency	NN	O
department	NN	O
on	IN	O
12/01/02	CD	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
this	DT	B-PROBLEM
constipation	NN	I-PROBLEM
.	.	O

1.	CD	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
.	.	O

2.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
.	.	O

3.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
type	JJ	I-PROBLEM
2	CD	I-PROBLEM
.	.	O

4.	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

5.	CD	O
mild	JJ	B-PROBLEM
dementia	NN	I-PROBLEM
.	.	O

6.	CD	O
proteinuria	NNS	B-PROBLEM
.	.	O

7.	CD	O
nephropathy	JJ	B-PROBLEM
.	.	O

8.	CD	O
anemia	NN	B-PROBLEM
.	.	O

9.	CD	O
hearing	NN	B-PROBLEM
impaired	VBN	I-PROBLEM
.	.	O

1.	CD	O
laparoscopic	JJ	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
as	IN	O
above	NN	O
.	.	O

2.	CD	O
total	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
2002	CD	O
.	.	O

3.	CD	O
appendectomy	NN	B-TREATMENT
.	.	O

4.	CD	O
diskectomy	NN	B-TREATMENT
.	.	O

1.	CD	O
digoxin	NN	B-TREATMENT
.125	NNP	O
mg	NN	O
qod	NN	O
,	,	O
.25	NNP	O
mg	NN	O
qod	NN	O
.	.	O

2.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

3.	CD	O
levoxyl	JJ	B-TREATMENT
100	CD	O
ugm	JJ	O
po	NN	O
qd	NN	O
.	.	O

4.	CD	O
prinivil	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

5.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

6.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
qd	NN	O
.	.	O

7.	CD	O
aricept	JJ	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

8.	CD	O
glyburide	JJ	B-TREATMENT
1.25	CD	O
mg	NN	O
po	NN	O
qam	NN	O
.	.	O

9.	CD	O
oxybutynin	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

10.	CD	O
coumadin	NN	B-TREATMENT
7.5	CD	O
mg	NN	O
on	IN	O
sun	NN	O
,	,	O
tues	NNS	O
,	,	O
wed	VBD	O
,	,	O
fri	NN	O
and	CC	O
sat	NN	O
.	.	O

fluoroquinolones	NNS	B-TREATMENT
.	.	O

temperature	NN	B-TEST
96.7f	CD	O
,	,	O
pulse	RB	B-TEST
63	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
167/68	CD	O
,	,	O
02	CD	O
sat	VBD	O
99%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
the	DT	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
exam	NN	I-TEST
is	VBZ	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

abdomen	NNS	B-PROBLEM
grossly	RB	I-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
tympanitic	JJ	B-PROBLEM
,	,	O
plus	CC	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
no	DT	O
rebound	NN	B-PROBLEM
.	.	O

rectal	NN	O
had	VBD	O
normal	JJ	O
tone	NN	O
,	,	O
empty	JJ	B-PROBLEM
rectal	NN	I-PROBLEM
vault	NN	I-PROBLEM
,	,	O
and	CC	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

on	IN	O
admission	NN	O
digoxin	NN	B-TREATMENT
7.3	CD	O
,	,	O
sodium	NN	B-TREATMENT
142	CD	O
,	,	O
potassium	NN	B-TREATMENT
2.8	CD	O
(	(	O
was	VBD	O
supplemented	VBN	O
)	)	O
,	,	O
blood	VBD	B-TREATMENT
urea	JJ	I-TREATMENT
nitrogen	NN	I-TREATMENT
15	CD	O
,	,	O
creatinine	NN	B-TREATMENT
.9	NN	O
,	,	O
calcium	NN	B-TREATMENT
9.3	CD	O
,	,	O
phosphorus	NN	B-TREATMENT
1.9	CD	O
,	,	O
magnesium	NN	B-TREATMENT
1.8	CD	O
.	.	O

liver	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

hematocrit	NN	B-TEST
36	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
8.3	CD	O
,	,	O
platelets	NNS	B-TEST
342	CD	O
.	.	O

electrocardiogram	NN	B-TEST
shows	NNS	O
sinus	VBP	B-PROBLEM
bradycardia	NN	I-PROBLEM
with	IN	O
digitalis	JJ	B-PROBLEM
effect	NN	I-PROBLEM
.	.	O

urinalysis	NN	B-TEST
is	VBZ	O
pending	VBG	O
.	.	O

abdominal	JJ	B-TEST
series	NN	I-TEST
showed	VBD	O
non-specific	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
large	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
ileus	NN	B-PROBLEM
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NN	I-TEST
showed	VBD	O
dilated	JJ	B-PROBLEM
colon	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
and	CC	O
no	DT	O
bowel	NN	B-PROBLEM
wall	NN	I-PROBLEM
thickening	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
obstruction	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
bowel	JJ	I-TREATMENT
regimen	NN	I-TREATMENT
of	IN	O
dulcolax	NN	B-TREATMENT
,	,	O
fleet	NN	B-TREATMENT
enema	NN	I-TREATMENT
,	,	O
and	CC	O
colace	NN	B-TREATMENT
.	.	O

on	IN	O
12/03/02	CD	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TEST
repeat	NN	I-TEST
kub	NN	I-TEST
which	WDT	O
was	VBD	O
suggestive	NN	O
of	IN	O
volvulus	NN	B-PROBLEM
.	.	O

she	PRP	O
then	RB	O
underwent	VBD	O
a	DT	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
volvulus	NN	B-PROBLEM
.	.	O

rigid	JJ	B-TEST
sigmoidoscopy	NN	I-TEST
revealed	VBD	O
no	DT	O
obvious	JJ	B-PROBLEM
mucosal	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
but	CC	O
during	IN	O
the	DT	O
time	NN	O
of	IN	O
the	DT	O
procedure	NN	O
22cc	CD	O
of	IN	O
mucous	JJ	B-PROBLEM
like	IN	I-PROBLEM
stool	NN	I-PROBLEM
was	VBD	O
evacuated	VBN	O
with	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
gas	NN	I-PROBLEM
.	.	O

subsequent	NN	O
to	TO	O
that	IN	O
the	DT	O
patients	NNS	O
abdomen	NNS	O
was	VBD	O
significantly	RB	B-PROBLEM
less	JJR	I-PROBLEM
distended	JJ	I-PROBLEM
and	CC	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
decreased	VBD	O
as	RB	O
well	RB	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
again	RB	O
far	RB	B-PROBLEM
less	RBR	I-PROBLEM
distended	JJ	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
tolerating	VBG	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
ad	NN	O
lib	NN	O
.	.	O

she	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
kub	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
volvulus	NN	B-PROBLEM
.	.	O

1.	CD	O
digoxin	NN	B-TREATMENT
.125	NNP	O
mg	NN	O
qod	NN	O
,	,	O
.25	NNP	O
mg	NN	O
qod	NN	O
.	.	O

2.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

3.	CD	O
levoxyl	JJ	B-TREATMENT
100	CD	O
ugm	JJ	O
po	NN	O
qd	NN	O
.	.	O

4.	CD	O
prinivil	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

5.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

6.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
qd	NN	O
.	.	O

7.	CD	O
aricept	JJ	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

8.	CD	O
glyburide	JJ	B-TREATMENT
1.25	CD	O
mg	NN	O
po	NN	O
qam	NN	O
.	.	O

9.	CD	O
oxybutynin	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

10.	CD	O
coumadin	NN	B-TREATMENT
7.5	CD	O
mg	NN	O
on	IN	O
sun	NN	O
,	,	O
tues	NNS	O
,	,	O
wed	VBD	O
,	,	O
fri	NN	O
and	CC	O
sat	NN	O
.	.	O

bactrim	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
altered	VBD	B-PROBLEM
metnal	JJ	I-PROBLEM
status	NN	I-PROBLEM

major	JJ	O
surgical	JJ	O
or	CC	O
invasive	JJ	O
procedure	NN	O
:	:	O
bronchoscopy	NN	B-TEST

79	CD	O
-	:	O
year-old	JJ	O
m	NN	O
recently	RB	O
diagnosed	VBN	O
by	IN	O
biopsy	NN	B-TEST
with	IN	O
gliomatosis	NN	B-PROBLEM
cerebri	NN	I-PROBLEM
(	(	I-PROBLEM
grade	JJ	I-PROBLEM
ii	NN	I-PROBLEM
astrocytoma	NN	I-PROBLEM
)	)	I-PROBLEM
in	IN	O
8/04	CD	O
,	,	O
being	VBG	O
treated	VBN	O
with	IN	O
xrt	NNP	B-TREATMENT
,	,	O
timidar	NN	B-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
currently	RB	O
on	IN	O
a	DT	B-TREATMENT
decadron	NN	I-TREATMENT
taper	NN	I-TREATMENT
after	IN	O
it	PRP	O
was	VBD	O
increased	VBN	O
several	JJ	O
months	NNS	O
ago	RB	O
secondary	JJ	O
to	TO	O
increasing	VBG	B-PROBLEM
ocular	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

seen	VBN	O
by	IN	O
pmd	NN	O
on	IN	O
12-14	JJ	O
w/	NN	O
symptoms	NNS	O
of	IN	O
cough	JJ	B-PROBLEM
productive	NN	O
of	IN	O
yellow	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
,	,	O
which	WDT	O
wife	NN	O
also	RB	O
had	VBD	O
,	,	O
prescribed	VBN	O
zpak	NN	B-TREATMENT
w/o	NN	O
improvement	NN	O
.	.	O

pt	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
victor	NN	O
for	IN	O
increasing	VBG	B-PROBLEM
somnolence	NN	I-PROBLEM
over	IN	O
past	JJ	O
several	JJ	O
days-weeks	NNS	O
.	.	O

he	PRP	O
is	VBZ	O
confused	VBN	B-PROBLEM
,	,	O
has	VBZ	O
had	VBN	O
hallucinations	NNS	B-PROBLEM
.	.	O

family	NN	O
believed	VBD	O
pt	NN	O
was	VBD	O
becoming	VBG	O
dehydrated	VBN	B-PROBLEM
.	.	O

he	PRP	O
used	VBD	O
to	TO	O
be	VB	O
able	JJ	O
to	TO	O
walk	VB	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
,	,	O
and	CC	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
has	VBZ	O
required	VBN	O
a	DT	B-TREATMENT
wheelchair	NN	I-TREATMENT
.	.	O

+	JJ	O
incontinence	NN	B-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
2	CD	O
weeks	NNS	O
.	.	O

+	JJ	O
non-bloody	JJ	B-PROBLEM
diarrhea	NN	I-PROBLEM
x	$	O
1	CD	O
on	IN	O
doa	NN	O
.	.	O

in	IN	O
the	DT	O
deborah	NN	O
vs	NN	B-TEST
on	IN	O
arrival	NN	O
were	VBD	O
t	NNS	B-TEST
:	:	O
97.5	CD	O
;	:	O
bp	NN	B-TEST
:	:	O
90/65	CD	O
;	:	O
hr	NN	B-TEST
:	:	O
82	CD	O
;	:	O
rr	NN	B-TEST
:	:	O
16	CD	O
;	:	O
94	CD	O
on	IN	O
ra	NN	O
.	.	O

cxr	NN	B-TEST
shows	NNS	O
diffuse	VBP	B-PROBLEM
b/l	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
r	VBP	I-PROBLEM
>	JJ	I-PROBLEM
l	NN	I-PROBLEM
and	CC	O
pt	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
bandemia	NN	I-PROBLEM
.	.	O

ldh	NN	B-TEST
was	VBD	O
511	CD	O
.	.	O

pt	NN	O
received	VBD	O
bactrim	JJ	B-TREATMENT
500	CD	O
mg	NN	O
x	VBD	O
1	CD	O
for	IN	O
possible	JJ	O
pcp	NN	B-PROBLEM
.	.	O

lillian	JJ	O
r.	NN	O
/	NNP	O
hypoxic	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

during	IN	O
admission	NN	O
,	,	O
became	VBD	O
steadily	RB	B-PROBLEM
more	RBR	I-PROBLEM
sob	JJ	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
lethargy	NN	I-PROBLEM
.	.	O

12-20	JJ	O
satting	VBG	O
initially	RB	O
~	$	O
90%	CD	O
on	IN	O
40%	CD	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
.	.	O

abg	RB	B-TEST
7.45/33/57	CD	O
.	.	O

he	PRP	O
was	VBD	O
switched	VBN	O
to	TO	O
a	DT	B-TREATMENT
100%	CD	I-TREATMENT
nrb	NN	I-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
abg	NN	B-TEST
was	VBD	O
7.47/31/80	CD	O
.	.	O

on	IN	O
floor	NN	O
on	IN	O
day	NN	O
of	IN	O
transfer	NN	O
7.25/50/70	CD	O
on	IN	O
100%	CD	B-TREATMENT
nrb	NNS	I-TREATMENT
.	.	O

during	IN	O
evaluation	NN	B-TEST
pt	NNS	O
responsive	VBP	O
to	TO	O
sternal	JJ	B-TEST
rub	NN	I-TEST
but	CC	O
could	MD	O
not	RB	O
follow	VB	O
commands	NNS	O
.	.	O

intubated	VBN	O
for	IN	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
protect	VB	I-PROBLEM
airway	RB	I-PROBLEM
,	,	O
transferred	VBD	O
to	TO	O
icu	VB	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
mi	JJ	B-PROBLEM
20	CD	O
years	NNS	O
ago	RB	O

2.	CD	O
hypertension	NN	B-PROBLEM

3.	CD	O
hyperlipidemia	NN	B-PROBLEM

4.	CD	O
djd	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
c-spine	NN	I-PROBLEM

5.	CD	O
depression	NN	B-PROBLEM

6.	CD	O
h/o	NN	O
dvt	NN	B-PROBLEM

7.	CD	O
shingles	NNS	B-PROBLEM
recently	RB	O
finished	VBD	O
treatment	NN	B-TREATMENT

physical	JJ	B-TEST
exam	NN	I-TEST
:	:	O
t	NN	B-TEST
98.9	CD	O
,	,	O
bp	RB	B-TEST
63/28	CD	O
on	IN	O
neo	NN	B-TREATMENT
,	,	O
p	NN	B-TEST
114	CD	O
,	,	O
ac	RB	B-TREATMENT
fi02	JJ	B-TREATMENT
1/	CD	O
vt	NN	B-TREATMENT
550/	CD	O
peep	NN	B-TREATMENT
5/	CD	O
breathing	NN	O
at	IN	O
16/22	CD	O
,	,	O
w/	JJR	O
volumes	NNS	B-TEST
of	IN	O
500	CD	O
s	NNS	O
.	.	O

intubated	VBN	O
,	,	O
minimally	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
,	,	O
localized	JJ	O
pain	NN	O
.	.	O

jvd	NN	B-PROBLEM
not	RB	O
appreciated	VBD	O
03-07	JJ	O
to	TO	O
deep	VB	O
inspiratory	JJ	O
breaths	NNS	O
.	.	O

distended	VBN	B-PROBLEM
.	.	O

nt	NNS	B-PROBLEM
>	VBP	O

no	DT	O
le	NN	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

2011-12-23	JJ	O
07:54	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
9.7	CD	O
rbc	NN	B-TEST
-	:	O
3.02	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.0	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
29.0	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
96	CD	O
mch	SYM	B-TEST
-	:	O
33.1	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
34.4	CD	O
rdw	NN	B-TEST
-	:	O
17.7	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
307	CD	O

2011-12-23	JJ	O
07:54	CD	O
pm	NN	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
88	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
7	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
3	CD	O
eos	SYM	B-TEST
-	:	O
0	CD	O
baso	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
0	CD	O
metas	NNS	B-TEST
-	:	O
1	CD	O
*	NN	O
myelos	SYM	B-TEST
-	:	O
1	CD	O
*	NN	O

2011-12-23	JJ	O
07:54	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
16.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
35.7	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.6	CD	O

chem	NN	B-TEST
7	CD	I-TEST
:	:	O

2011-12-23	JJ	O
07:54	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
108	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
27	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.9	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
132	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
4.6	CD	O
cl	NN	B-TEST
-	:	O
102	CD	O
hco3	NN	B-TEST
-	:	O
20	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
15	CD	O

2011-12-18	JJ	O
06:15	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
29	CD	O
ast	IN	B-TEST
-	:	O
25	CD	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	I-TEST
400	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
52	CD	O
totbili	SYM	B-TEST
-	:	O
0.3	CD	O

2011-12-23	JJ	O
11:16	CD	O
pm	NN	O
blood	NN	B-TEST
type	NN	B-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
202	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
40	CD	O
ph	NN	B-TEST
-	:	O
7.29	CD	O
*	NN	O
calhco3	NN	B-TEST
-	:	O
20	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
--	:	O
6	CD	O

2011-12-20	JJ	O
07:53	CD	O
am	VBP	O
blood	NN	B-TEST
lactate	NN	B-TEST
-	:	O
1.1	CD	O

71	CD	O
yo	JJ	O
m	NN	O
w/	NN	O
astrocytoma	NN	B-PROBLEM
on	IN	O
xrt	NN	B-TREATMENT
and	CC	O
chemotx	NN	B-TREATMENT
,	,	O
who	WP	O
p/w	VBD	O
1	CD	O
wk	NN	O
h/o	NN	O
productive	JJ	B-PROBLEM
cough	NN	I-PROBLEM
,	,	O
sick	JJ	O
contact	NN	O
,	,	O
hypoxic	NN	B-PROBLEM
,	,	O
now	RB	O
intubated	VBN	O
,	,	O
w/	JJ	O
increasing	VBG	B-PROBLEM
infiltrates	NNS	I-PROBLEM
b/l	NN	I-PROBLEM
.	.	O

1)	CD	O
resp	JJ	B-PROBLEM
failure	NN	I-PROBLEM
-	:	O
pt	NN	O
admitted	VBD	O
w/	JJ	O
primarily	RB	B-PROBLEM
hypoxic	JJ	I-PROBLEM
respiratory	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

following	VBG	O
admission	NN	O
to	TO	O
the	DT	O
floor	NN	O
the	DT	O
pt	NN	O
developed	VBD	O
increasing	VBG	B-PROBLEM
hypoxia	NN	I-PROBLEM
and	CC	O
somnolence	NN	B-PROBLEM
,	,	O
requiring	VBG	O
intubation	NN	B-TREATMENT
on	IN	O
hd	NN	O
5	CD	O
.	.	O

pulm	NN	O
had	VBD	O
previously	RB	O
been	VBN	O
consulted	VBN	O
and	CC	O
felt	VBD	O
that	IN	O
presentation	NN	O
was	VBD	O
c/w	JJ	O
pcp	NN	B-PROBLEM
,	,	O
joann	NN	O
started	VBD	O
on	IN	O
bactrim	NN	B-TREATMENT
.	.	O

previously	RB	O
treated	VBN	O
for	IN	O
cap	NN	B-PROBLEM
as	IN	O
outpt	NN	O
but	CC	O
hypoxia	NN	B-PROBLEM
continued	VBD	O
to	TO	O
progress	VB	O
.	.	O

similar	JJ	O
lack	NN	O
of	IN	O
improvement	NN	O
w/	VBP	O
additional	JJ	B-TREATMENT
broad	JJ	I-TREATMENT
spectrum	NN	I-TREATMENT
coverage	NN	I-TREATMENT
following	VBG	O
admission	NN	O
.	.	O

pt	JJ	O
underwent	JJ	O
bronchoscopy	NN	B-TEST
on	IN	O
11-22	JJ	O
following	VBG	O
transfer	NN	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
hypoxic	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
intubation	NN	B-TREATMENT
(	(	O
7.25/52/70	CD	O
on	IN	O
100%	CD	B-TREATMENT
nrb	NN	I-TREATMENT
)	)	O
.	.	O

on	IN	O
admission	NN	O
to	TO	O
the	DT	O
icu	NN	O
the	DT	B-TREATMENT
pt	NN	I-TREATMENT
'	POS	I-TREATMENT
steroid	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
8	CD	O
mg	NNS	O
bid	VBD	O
03-07	CD	O
to	TO	O
a	DT	B-TEST
dead	JJ	I-TEST
space	NN	I-TEST
measurement	NN	I-TEST
of	IN	O
50%	CD	O
.	.	O

he	PRP	O
was	VBD	O
subsequently	RB	O
tranferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
,	,	O
where	WRB	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
stable	JJ	I-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

repeat	NN	B-TEST
cxr	NN	I-TEST
was	VBD	O
unchanged	JJ	O
from	IN	O
previously	RB	O
in	IN	O
the	DT	O
icu	NN	O
(	(	O
official	JJ	O
read	NN	O
noted	VBD	O
mild	JJ	B-PROBLEM
chf	NN	I-PROBLEM
,	,	O
but	CC	O
pt	NN	O
was	VBD	O
continuing	VBG	O
to	TO	O
autodiurese	JJ	O
and	CC	O
has	VBZ	O
remained	VBN	O
net	JJ	O
negative	JJ	O
everyday	NN	O
while	IN	O
on	IN	O
the	DT	O
floor	NN	O
.	.	O

on	IN	O
discharge	PDT	O
the	DT	O
patient	NN	O
has	VBZ	O
stable	JJ	B-PROBLEM
o2	NN	I-PROBLEM
req	NN	I-PROBLEM
,	,	O
90%	CD	O
on	IN	O
ra	NN	O
.	.	O

2)	CD	O
astrocytoma	SYM	B-PROBLEM
-	:	I-PROBLEM
grade	NN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	O
as	IN	O
per	IN	O
d/w	NN	O
pmd	NN	O
,	,	O
dr.	NN	O
holscher	NN	O
,	,	O
pt	NN	O
has	VBZ	O
poor	JJ	O
prognosis	NN	O
,	,	O
but	CC	O
reasonable	JJ	O
for	IN	O
ongoing	VBG	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

pt	NN	O
has	VBZ	O
had	VBN	O
two	CD	O
recent	JJ	O
neg	NNS	O
head	VBP	O
ct	JJ	O
s	NN	O
,	,	O
so	RB	O
unlikely	JJ	O
the	DT	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
ms	JJ	I-PROBLEM
change	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
keppra	NN	B-TREATMENT
during	IN	O
admission	NN	O
for	IN	O
sz	JJ	B-PROBLEM
px	NN	I-PROBLEM
.	.	O

initially	RB	O
he	PRP	O
had	VBD	O
been	VBN	O
on	IN	O
lamotrigine	NN	B-TREATMENT
but	CC	O
the	DT	O
was	VBD	O
stopped	VBN	O
in	IN	O
10/12	CD	O
when	WRB	O
the	DT	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
developing	VBG	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
rash	NN	I-PROBLEM
.	.	O

decadron	NN	B-TREATMENT
has	VBZ	O
been	VBN	O
steadily	RB	O
tapered	VBN	O
since	IN	O
arrival	NN	O
on	IN	O
the	DT	O
floor	NN	O
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
keppra	NN	I-TREATMENT
should	MD	O
be	VB	O
continued	VBN	O
for	IN	O
sz	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

3)	CD	O
ms	NN	B-PROBLEM
change	NN	I-PROBLEM
-	:	O
on	IN	O
admission	NN	O
pt	NN	O
was	VBD	O
agitated	VBN	B-PROBLEM
,	,	O
requiring	VBG	O
restraints	NNS	B-TREATMENT
and	CC	O
antipsychotics	NNS	B-TREATMENT
,	,	O
however	RB	O
as	IN	O
he	PRP	O
became	VBD	O
increasingly	RB	B-PROBLEM
hypoxic	JJ	I-PROBLEM
he	PRP	O
became	VBD	O
somnolent	JJ	B-PROBLEM
.	.	O

in	IN	O
the	DT	O
icu	NN	O
the	DT	O
pt	NN	O
remained	VBD	O
stuporous	JJ	B-PROBLEM
,	,	O
responsive	JJ	O
to	TO	O
painful	JJ	B-TEST
stimuli	NNS	I-TEST
.	.	O

on	IN	O
the	DT	O
floor	NN	O
the	DT	O
patient	NN	O
intially	RB	O
was	VBD	O
imporved	VBN	O
,	,	O
but	CC	O
has	VBZ	O
plateaued	VBN	O
,	,	O
responding	VBG	O
to	TO	O
simple	VB	O
commands	NNS	O
and	CC	O
verbalizing	VBG	O
groans	NNS	O
but	CC	O
no	DT	B-PROBLEM
real	JJ	I-PROBLEM
speech	NN	I-PROBLEM
.	.	O

improvement	NN	O
has	VBZ	O
correlated	VBN	O
w/	IN	O
tapering	NN	O
of	IN	O
steroids	NNS	B-TREATMENT
,	,	O
one	CD	O
of	IN	O
the	DT	O
causes	NNS	O
in	IN	O
the	DT	B-TEST
differential	NN	I-TEST
.	.	O

pt	NN	O
had	VBD	O
multiple	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
s	NN	I-TEST
which	WDT	O
ruled	VBD	O
out	RP	O
progression	NN	O
of	IN	O
astrocytoma	NN	B-PROBLEM
.	.	O

mri	NN	B-TEST
has	VBZ	O
been	VBN	O
deferred	VBN	O
given	VBN	O
that	IN	O
the	DT	O
pt	NN	O
currently	RB	O
would	MD	O
not	RB	O
tolerate	VB	O
the	DT	B-TEST
procedure	NN	I-TEST
.	.	O

eeg	NN	B-TEST
was	VBD	O
w/o	JJ	O
evidence	NN	O
of	IN	O
epileptiform	NN	B-PROBLEM
activity	NN	I-PROBLEM
and	CC	O
c/w	NN	O
toxic	NN	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

plan	NN	O
to	TO	O
continue	VB	O
to	TO	O
follow	VB	O
ms	NN	B-PROBLEM
,	,	O
expect	VBP	O
improvement	NN	O
as	IN	O
steroids	NNS	B-TREATMENT
are	VBP	O
continued	VBN	O
to	TO	O
be	VB	O
tapered	VBN	O
.	.	O

4)	CD	O
h/o	NN	O
dvt	SYM	B-PROBLEM
-	:	O
cont	NN	O
heparin	NN	B-TREATMENT
,	,	O
previously	RB	O
on	IN	O
enoxaparin	JJ	B-TREATMENT
x10	JJ	O
days	NNS	O
at	IN	O
treatment	NN	O
dose	NN	O
,	,	O
followed	VBN	O
by	IN	O
prophylactic	JJ	B-TREATMENT
dose	NN	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
pt	NN	O
was	VBD	O
started	VBN	O
on	IN	O
treatment	NN	O
doses	NNS	O
of	IN	O
enoxaparin	NN	B-TREATMENT
.	.	O

upon	NN	O
transfer	NN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
the	DT	O
pt	NN	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

course	NN	O
was	VBD	O
c/b	JJ	O
one	CD	O
episode	NN	O
of	IN	O
gross	JJ	B-PROBLEM
hematochezia	NN	I-PROBLEM
on	IN	O
12-28	JJ	O
,	,	O
w/	JJ	O
concomitant	NN	B-PROBLEM
hct	VBD	I-PROBLEM
drop	NN	I-PROBLEM
of	IN	O
~	$	O
3	CD	O
pts	NNS	O
.	.	O

b/l	NN	B-TEST
lower	RBR	I-TEST
ext	NN	I-TEST
duplex	JJ	I-TEST
us	PRP	I-TEST
and	CC	O
a	DT	B-TEST
cta	NN	I-TEST
were	VBD	O
performed	VBN	O
,	,	O
both	DT	O
of	IN	O
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

given	VBN	O
that	IN	O
the	DT	O
pt	NN	O
was	VBD	O
w/o	JJ	O
evidence	NN	O
of	IN	O
dvt	NN	B-PROBLEM
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
risks	NNS	O
of	IN	O
anticoagulation	NN	B-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
gross	JJ	B-PROBLEM
gib	NN	I-PROBLEM
,	,	O
outweigh	VBP	O
the	DT	O
risks	NNS	O
of	IN	O
undetected	JJ	B-PROBLEM
deep	JJ	I-PROBLEM
vv	NN	I-PROBLEM
thrombosis/pe	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
prophylactic	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

4)	CD	O
hypersensitivity	NN	B-PROBLEM
reaction	NN	I-PROBLEM
-	:	O
on	IN	O
11-24	JJ	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
developing	VBG	O
rash	NN	B-PROBLEM
of	IN	I-PROBLEM
abdomen	NNS	I-PROBLEM
and	CC	I-PROBLEM
anterior	JJ	I-PROBLEM
thighs	NNS	I-PROBLEM
.	.	O

derm	NNS	O
initially	RB	O
reviewed	VBD	O
and	CC	O
thought	VBD	O
that	IN	O
it	PRP	O
was	VBD	O
not	RB	O
c/w	JJ	O
hypersensitivity	NN	B-PROBLEM
rxn	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
next	JJ	O
the	DT	B-PROBLEM
rash	NN	I-PROBLEM
progressed	VBD	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
subsequently	RB	O
began	VBD	O
spiking	VBG	O
fevers	NNS	B-PROBLEM
to	TO	O
approx	VB	O
103	CD	O
f	NN	O
,	,	O
c/b	JJ	O
hypotension	NN	B-PROBLEM
requiring	VBG	O
aggressive	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
repletion	NN	I-TREATMENT
and	CC	O
pressors	NNS	B-TREATMENT
,	,	O
and	CC	O
tachycardia	NN	B-PROBLEM
to	TO	O
the	DT	O

the	DT	O
patient	NN	O
also	RB	O
developed	VBD	O
elevated	JJ	B-PROBLEM
transaminases	NNS	I-PROBLEM
and	CC	I-PROBLEM
pancreatic	JJ	I-PROBLEM
enzymes	NNS	I-PROBLEM
during	IN	O
this	DT	O
time	NN	O
.	.	O

on	IN	O
the	DT	O
second	JJ	O
day	NN	O
that	IN	O
the	DT	B-PROBLEM
rash	NN	I-PROBLEM
had	VBD	O
been	VBN	O
noted	VBN	O
,	,	O
derm	NN	O
was	VBD	O
asked	VBN	O
to	TO	O
see	VB	O
again	RB	O
,	,	O
felt	VBD	O
c/w	JJ	O
hypersensitivity	NN	B-PROBLEM
,	,	O
bactrim	NN	B-TREATMENT
was	VBD	O
switched	VBN	O
to	TO	O
pentamidine	VB	B-TREATMENT
,	,	O
and	CC	O
lamictal	NN	B-TREATMENT
was	VBD	O
held	VBN	O
.	.	O

pt	NN	O
continued	VBD	O
to	TO	O
have	VB	O
elev	VBN	B-PROBLEM
pancreatic	JJ	I-PROBLEM
enzymes	NNS	I-PROBLEM
and	CC	O
pentamidine	NN	B-TREATMENT
was	VBD	O
switched	VBN	O
to	TO	O
clinda/primaquine	VB	B-TREATMENT
.	.	O

following	VBG	O
discontinuation	NN	O
of	IN	O
the	DT	B-TREATMENT
bactrim	NN	I-TREATMENT
the	DT	O
patient	NN	O
defervesced	VBD	O
,	,	O
and	CC	O
remained	VBD	O
normotensive	JJ	O
.	.	O

he	PRP	O
received	VBD	O
one	CD	O
dose	NN	O
of	IN	O
furosemide	NN	B-TREATMENT
in	IN	O
the	DT	O
icu	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
the	DT	O
next	JJ	O
day	NN	O
.	.	O

on	IN	O
arrival	NN	O
to	TO	O
the	DT	O
floor	NN	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
lacy	NN	I-PROBLEM
reticular	JJ	I-PROBLEM
rash	NN	I-PROBLEM
of	IN	I-PROBLEM
upper	JJ	I-PROBLEM
arms	NNS	I-PROBLEM
,	,	O
which	WDT	O
resolved	VBD	O
over	IN	O
the	DT	O
next	JJ	O
48h	CD	O
.	.	O

felt	RBR	O
likely	JJ	O
03-07	JJ	O
the	DT	B-TREATMENT
sulfa	JJ	I-TREATMENT
moiety	NN	O
of	IN	O
the	DT	B-TREATMENT
furosemide	NN	I-TREATMENT
.	.	O

plan	NN	O
for	IN	O
pt	NN	O
to	TO	O
complete	VB	O
total	NN	O
of	IN	O
28	CD	O
day	NN	O
course	NN	O
of	IN	O
therapy	NN	B-TREATMENT
for	IN	O
pcp	NN	B-PROBLEM
,	,	O
james	NNS	O
will	MD	O
be	VB	O
completed	VBN	O
on	IN	O
01-16	NN	O
.	.	O

5)	CD	O
anemia	SYM	B-PROBLEM
-	:	O
previous	JJ	B-TEST
w/u	NN	I-TEST
c/w	NN	O
acd	NN	B-PROBLEM
(	(	O
elev	JJ	B-PROBLEM
ferritin	NN	I-PROBLEM
,	,	O
low	JJ	B-PROBLEM
transferrin	NN	I-PROBLEM
saturation	NN	I-PROBLEM
)	)	O
.	.	O

-	:	O
transfuse	NN	B-TEST
threshold	VBD	I-TEST
<	CD	O
24	CD	O

6)	CD	O
arf	JJ	B-PROBLEM
-	:	O
cr	NN	B-TEST
mildly	RB	B-PROBLEM
elevated	VBD	I-PROBLEM
on	IN	O
tx	NN	O
to	TO	O
icu	VB	O
,	,	O
u	JJ	B-TEST
lytes	NNS	I-TEST
c/w	VBP	O
prerenal	JJ	B-PROBLEM
azotemia	NN	I-PROBLEM
,	,	O
which	WDT	O
resolved	VBD	O
w/	NN	O
ivf	NN	B-TREATMENT
.	.	O

7)	CD	O
hyponatremia	NN	B-PROBLEM
-	:	O
also	RB	O
hyponatremic	VBP	B-PROBLEM
on	IN	O
transfer	NN	O
,	,	O
resolved	VBD	O
w/	JJ	O
ivf	NN	B-TREATMENT
.	.	O

8)	CD	O
cad	SYM	B-PROBLEM
-	:	O
w/	NN	O
abnl	NN	B-PROBLEM
ef	NN	I-PROBLEM
,	,	O
however	RB	O
pt	RB	O
tolerated	VBN	O
aggressive	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
resusciation	NN	I-TREATMENT
w/o	NN	O
significant	JJ	B-PROBLEM
hypoxia	NN	I-PROBLEM
.	.	O

continued	VBN	O
on	IN	O
valsartan	NN	B-TREATMENT
,	,	O
bb	NN	B-TREATMENT
continued	VBD	O
,	,	O
statin	NN	B-TREATMENT

9)	CD	O
nutrition	NN	O
-	:	O
pt	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
tfs	JJ	B-TREATMENT
via	IN	O
post-pyloric	JJ	B-TREATMENT

10)	CD	O
px	NN	O
:	:	O
heparin	NN	B-TREATMENT
(	(	O
full	JJ	O
dose	NN	O
)	)	O
,	,	O
iv	JJ	B-TREATMENT
ppi	NN	I-TREATMENT

11)	CD	O
comm	NN	O
:	:	O
family	NN	O
very	RB	O
involved	JJ	O
at	IN	O
bedside	NN	O
,	,	O
evaluating	VBG	O
rehab	NN	B-TREATMENT
today	NN	O

18)	CD	O
restraint	NN	B-TREATMENT

acyclovir	NN	B-TREATMENT

bactrim	NN	B-TREATMENT

zoloft	NN	B-TREATMENT

valsartan	NN	B-TREATMENT

metoprolol	NN	B-TREATMENT

keppra	NN	B-TREATMENT

lovenox	NN	B-TREATMENT

levofloxacin	NN	B-TREATMENT

ambisone	NN	B-TREATMENT

atrovent	NN	B-TREATMENT
nebs	NN	I-TREATMENT

albuterol	NN	B-TREATMENT
nebs	NN	I-TREATMENT

lasix	RB	B-TREATMENT
10	CD	O
mg	NNS	O
qd	NN	O

lipitor	NN	B-TREATMENT

haldol	NN	B-TREATMENT
prn	NN	O

1.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
powder	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
sertraline	JJ	B-TREATMENT
hcl	NN	I-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
albuterol	NN	B-TREATMENT
sulfate	VB	I-TREATMENT
0.083	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
.	.	O

4.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
.	.	O

5.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

6.	CD	O
bisacodyl	NN	B-TREATMENT
10	CD	O
mg	NN	O
suppository	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
suppository	NN	O
rectal	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

7.	CD	O
levetiracetam	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
nystatin	JJ	B-TREATMENT
100,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
five	CD	O
(	(	O
5	CD	O
)	)	O
ml	NN	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

9.	CD	O
heparin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
primaquine	JJ	B-TREATMENT
phosphate	NN	I-TREATMENT
26.3	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

12.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

13.	CD	O
dexamethasone	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
:	:	O
take	VB	O
2	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
for	IN	O
four	CD	O
days	NNS	O
,	,	O
then	RB	O
2	CD	O
tablet	NN	O
po	NN	O
qday	NN	O
for	IN	O
7	CD	O
days	NNS	O
,	,	O
then	RB	O
take	VB	O
one	CD	O
tablet	NN	O
qday	NN	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

then	RB	O
stop	VB	O
taking	VBG	O
the	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

14.	CD	O
acyclovir	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
500	CD	O
mg	NN	O
recon	NN	O
soln	NN	O
sig	NN	O
:	:	O
200mg	CD	O
recon	NN	O
solns	NN	O
intravenous	JJ	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
.	.	O

15.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
recon	NN	O
soln	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
recon	NN	O
soln	VBP	O
intravenous	JJ	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
.	.	O

16.	CD	O
clindamycin	JJ	B-TREATMENT
phosphate	NN	I-TREATMENT
in	IN	O
d5w	NN	B-TREATMENT
600	CD	O
mg	NN	O
/	VBD	O
50	CD	O
ml	NN	O
piggyback	NN	O
sig	NN	O
:	:	O
600	CD	O
mg	NN	O
intravenous	JJ	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

1)	CD	O
pcp	NN	B-PROBLEM
pna	NN	I-PROBLEM

2)	CD	O
astrocytoma	NN	B-PROBLEM

3)	CD	O
hypersensitivity	NN	B-PROBLEM
to	TO	O
bactrim	VB	B-TREATMENT

4)	CD	O
hematochezia	NN	B-PROBLEM

5)	CD	O
h/o	NN	O
dvt	NN	B-PROBLEM

good	JJ	O
,	,	O
still	RB	O
w/	VBZ	O
altered	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
but	CC	O
improving	VBG	O
.	.	O

1)	CD	O
take	VB	O
your	PRP$	O
medications	NNS	B-TREATMENT

renal	JJ	B-PROBLEM
tubular	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
distal	JJ	I-PROBLEM
type	NN	I-PROBLEM
i	NN	I-PROBLEM
;	:	O
shock	NN	B-PROBLEM
;	:	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM
;	:	O
severe	JJ	B-PROBLEM
acidosis	NN	I-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
electrolyte	NN	I-PROBLEM
imbalance	NN	I-PROBLEM
;	:	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

renal	JJ	B-PROBLEM
tubular	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
distal	JJ	I-PROBLEM
type	NN	I-PROBLEM
i	NN	I-PROBLEM
;	:	O
shock	NN	B-PROBLEM
;	:	O
severe	JJ	B-PROBLEM
acidosis	NN	I-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
electrolyte	NN	I-PROBLEM
imbalance	NN	I-PROBLEM
;	:	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM
;	:	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
,	,	O
varicella	NN	B-PROBLEM
.	.	O

this	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
5	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
type	NN	B-PROBLEM
i	NN	I-PROBLEM
renal	VBP	I-PROBLEM
tubular	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
on	IN	O
nephrocalcinosis	NN	B-PROBLEM
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
noughwell	VB	O
entanbon	JJ	O
health	NN	O
of	IN	O
washington	NN	O
on	IN	O
9/5/93	CD	O
at	IN	O
21:16	CD	O
hours	NNS	O
with	IN	O
a	DT	O
2-3	JJ	O
day	NN	O
history	NN	O
of	IN	O
chills	NNS	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
cough	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
and	CC	O
weakness	NN	B-PROBLEM
(	(	O
unable	JJ	O
to	TO	O
walk	VB	O
)	)	O
.	.	O

at	IN	O
noughwell	RB	O
entanbon	FW	O
health	NN	O
,	,	O
her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
101	CD	O
,	,	O
pulse	RB	B-TEST
135	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
94/74	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
.	.	O

positive	JJ	O
findings	NNS	O
of	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
include	VBP	O
chicken	VBN	B-PROBLEM
pox	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
on	IN	I-PROBLEM
thorax	NN	I-PROBLEM
,	,	O
sunken	JJ	B-PROBLEM
eyes	NNS	I-PROBLEM
,	,	O
thick	JJ	B-PROBLEM
nasal	NN	I-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
dry	JJ	B-PROBLEM
lips	NNS	I-PROBLEM
,	,	I-PROBLEM
tongue	NN	I-PROBLEM
and	CC	I-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
,	,	O
red	JJ	B-PROBLEM
tonsils	NNS	I-PROBLEM
.	.	O

the	DT	O
remainder	NN	O
of	IN	O
the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
considered	VBN	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

vomiting	VBG	B-PROBLEM
and	CC	O
dehydration	NN	B-PROBLEM
,	,	O
hypokalemia	NN	B-PROBLEM
,	,	O
hyponatremia	NN	B-PROBLEM
,	,	O
tonsillitis	NN	B-PROBLEM
.	.	O

a	DT	B-TREATMENT
peripheral	JJ	I-TREATMENT
intravenous	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
started	VBN	O
on	IN	O
labor	NN	O
day	NN	O
in	IN	O
the	DT	O
a.m.	NN	O
no	DT	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

oral	JJ	B-PROBLEM
cyanosis	NN	I-PROBLEM
and	CC	O
shallow	JJ	B-PROBLEM
respirations	NNS	I-PROBLEM
were	VBD	O
noted	VBN	O
on	IN	O
9/7/93	CD	O
at	IN	O
2:45	CD	O
a.m.	NN	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

cardiovascular	JJ	O
stable	NN	O
,	,	O
significant	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
on	IN	O
9/7/93	CD	O
at	IN	O
5:10	CD	O
a.m.	NN	O
and	CC	O
therefore	RB	O
10	CD	B-TREATMENT
cc&apos;s	NN	I-TREATMENT
per	IN	I-TREATMENT
kilo	FW	I-TREATMENT
albumin	NN	I-TREATMENT
was	VBD	O
given	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
was	VBD	O
started	VBN	O
on	IN	O
clear	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
tolerated	VBD	O
,	,	O
with	IN	O
d5	JJ	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
plus	CC	O
40	CD	O
meq	NN	O
per	IN	O
liter	NN	O
of	IN	O
kcl	NN	B-TREATMENT
at	IN	O
a	DT	O
rate	NN	O
of	IN	O
50	CD	O
cc	NNS	O
&apos;s	FW	O
per	IN	O
hour	NN	O
for	IN	O
9	CD	O
hours	NNS	O
.	.	O
(	(	O
100	CD	O
cc&apos;s	NN	O
per	IN	O
kilo	NN	O
)	)	O
.	.	O

sodium	NN	B-TEST
and	CC	O
potassium	NN	B-TEST
at	IN	O
this	DT	O
time	NN	O
were	VBD	O
128/1.5	CD	O
.	.	O

at	IN	O
labor	NN	O
day	NN	O
,	,	O
9:30	CD	O
a.m.	NN	O
,	,	O
the	DT	B-TREATMENT
fluids	NNS	I-TREATMENT
were	VBD	O
increased	VBN	O
to	TO	O
100	CD	O
cc&apos;s	NNS	O
per	IN	O
hour	NN	O
(	(	O
200	CD	O
cc&apos;s	NN	O
per	IN	O
kilo	NN	O
for	IN	O
5	CD	O
hours	NNS	O
)	)	O
.	.	O

electrolytes	NNS	B-TEST
at	IN	O
this	DT	O
point	NN	O
were	VBD	O
sodium	JJ	B-TEST
132	CD	O
,	,	O
potassium	NN	B-TEST
1.8	CD	O
.	.	O

at	IN	O
9/6/93	CD	O
,	,	O
2:30	CD	O
p.m.	NN	O
,	,	O
fluids	NNS	B-TREATMENT
were	VBD	O
decreased	VBN	O
to	TO	O
75	CD	O
cc&apos;s	NNS	O
per	IN	O
hour	NN	O
,	,	O
150	CD	O
cc&apos;s	NN	O
per	IN	O
kilo	NN	O
,	,	O
40	CD	O
meq	NN	O
of	IN	O
k	NN	B-TREATMENT
phosphate	NN	I-TREATMENT
added	VBD	O
to	TO	O
the	DT	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

electrolytes	NNS	B-TEST
at	IN	O
this	DT	O
point	NN	O
were	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
143	CD	O
and	CC	O
potassium	NN	B-TEST
1.7	CD	O
.	.	O

on	IN	O
9/6/93	CD	O
,	,	O
22:00	CD	O
,	,	O
fluids	NNS	B-TREATMENT
were	VBD	O
changed	VBN	O
to	TO	O
d5	VB	B-TREATMENT
normal	JJ	I-TREATMENT
saline	JJ	I-TREATMENT
plus	CC	O
40	CD	O
kcl	NN	B-TREATMENT
and	CC	O
40	CD	O
k	NN	B-TREATMENT
phosphate	NN	I-TREATMENT
at	IN	O
75	CD	O
cc	NN	O
&apos;s	FW	O
per	IN	O
hour	NN	O
.	.	O

electrolytes	NNS	B-TEST
at	IN	O
this	DT	O
time	NN	O
were	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
148	CD	O
,	,	O
potassium	NN	B-TEST
1.7	CD	O
.	.	O

at	IN	O
9/7/93	CD	O
,	,	O
1:00	CD	O
a.m.	NN	O
,	,	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
rate	NN	O
was	VBD	O
decreased	VBN	O
to	TO	O
50	CD	O
cc&apos;s	NNS	O
per	IN	O
hour	NN	O
,	,	O
total	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
given	VBN	O
during	IN	O
the	DT	O
first	JJ	O
24	CD	O
hours	NNS	O
were	VBD	O
140	CD	O
to	TO	O
150	CD	O
cc&apos;s	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
sodium	NN	B-TEST
was	VBD	O
147	CD	O
,	,	O
potassium	NN	B-TEST
2.6	CD	O
,	,	O
total	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
given	VBN	O
during	IN	O
the	DT	O
first	JJ	O
24	CD	O
hours	NNS	O
20	CD	O
meq	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
.	.	O

on	IN	O
9/7/93	CD	O
at	IN	O
4:00	CD	O
a.m.	RB	O
,	,	O
albumin	JJ	B-TREATMENT
bolus	CC	I-TREATMENT
5%	CD	O
10	CD	O
cc&apos;s	NN	O
per	IN	O
kilo	NN	O
was	VBD	O
given	VBN	O
,	,	O
a	DT	O
total	NN	O
of	IN	O
120	CD	O
cc&apos;s	NN	O
,	,	O
electrolytes	NNS	B-TEST
were	VBD	O
sodium	JJ	B-TEST
155	CD	O
,	,	O
potassium	NN	B-TEST
3.1	CD	O
.	.	O

at	IN	O
9/7/93	CD	O
at	IN	O
5:00	CD	O
a.m.	RB	O
,	,	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
given	VBN	O
60	CD	O
meq	NNS	O
,	,	O
calcium	NN	B-TREATMENT
bolus	NN	I-TREATMENT
10	CD	O
cc&apos;s	NN	O
given	VBN	O
.	.	O

on	IN	O
9/7	CD	O
,	,	O
5:30	CD	O
a.m.	NN	O
,	,	O
d5	JJ	B-TREATMENT
quarter	NN	I-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
,	,	O
and	CC	O
40	CD	O
of	IN	O
k	NN	B-TREATMENT
phosphate	NN	I-TREATMENT
at	IN	O
100	CD	O
cc&apos;s	NNS	O
per	IN	O
hour	NN	O
was	VBD	O
given	VBN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
abnormal	JJ	B-PROBLEM
findings	NNS	I-PROBLEM
in	IN	O
abdominal	JJ	B-TEST
exam	NN	I-TEST
.	.	O

on	IN	O
9/5/93	CD	O
,	,	O
hematocrit	NN	B-TEST
48	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
11.2	CD	O
,	,	O
neutrophiles	NNS	B-TEST
67	CD	O
,	,	O
bands	VBZ	B-TEST
14	CD	O
,	,	O
lymphs	VBD	B-TEST
11	CD	O
,	,	O
monos	FW	B-TEST
6%	CD	O
,	,	O
meta	NN	B-TEST
2%	CD	O
,	,	O
platelets	NNS	B-TEST
220,000	CD	O
.	.	O

copious	JJ	B-PROBLEM
urine	NN	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
bun	NN	B-TEST
1.0	CD	O
,	,	O
creatinine	NN	B-TEST
.8	NN	O
.	.	O

normal	JJ	O
neurologic	JJ	O
exam	NN	O
on	IN	O
admission	NN	O
,	,	O
then	RB	O
lethargic	VBZ	B-PROBLEM
on	IN	O
9/6/93	CD	O
at	IN	O
17:45	CD	O
,	,	O
then	RB	O
patient	NN	O
became	VBD	O
unresponsive	JJ	B-PROBLEM
,	,	O
areflexic	JJ	B-PROBLEM
and	CC	O
limp	NN	B-PROBLEM
at	IN	O
9/6/93	CD	O
,	,	O
at	IN	O
17:45	CD	O
to	TO	O
22:00	CD	O
.	.	O

patient	NN	O
was	VBD	O
having	VBG	O
seizures	NNS	B-PROBLEM
,	,	O
twitching	VBG	B-PROBLEM
of	IN	I-PROBLEM
face	NN	I-PROBLEM
and	CC	O
rapid	JJ	B-PROBLEM
movements	NNS	I-PROBLEM
of	IN	I-PROBLEM
eyes	NNS	I-PROBLEM
.	.	O

pupils	NNS	B-PROBLEM
dilated	VBN	I-PROBLEM
and	CC	I-PROBLEM
sluggish	JJ	I-PROBLEM
.	.	O

valium	NN	B-TREATMENT
was	VBD	O
given	VBN	O
at	IN	O
9/7/93	CD	O
,	,	O
00:02	CD	O
.	.	O

iv	NN	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
chloramphenicol	NN	B-TREATMENT
,	,	O
ceftriaxone	NN	B-TREATMENT
,	,	O
and	CC	O
culture	NN	B-TEST
were	VBD	O
sent	VBN	O
.	.	O

finally	RB	O
,	,	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
transport	NN	O
team	NN	O
was	VBD	O
called	VBN	O
and	CC	O
transport	NN	O
team	NN	O
arrived	VBD	O
on	IN	O
9/7/93	CD	O
,	,	O
6:30	CD	O
a.m.	NN	O
,	,	O
and	CC	O
on	IN	O
arrival	JJ	O
patient	NN	O
was	VBD	O
seizing	VBG	O
with	IN	O
rhythmic	JJ	B-PROBLEM
eye	NN	I-PROBLEM
movement	NN	I-PROBLEM
to	TO	I-PROBLEM
left	VB	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
,	,	O
poor	JJ	B-PROBLEM
perfusion	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
was	VBD	O
101.8	CD	O
.	.	O

a	DT	B-TREATMENT
second	JJ	I-TREATMENT
intravenous	JJ	I-TREATMENT
was	VBD	O
started	VBN	O
and	CC	O
given	VBN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
bolus	NN	I-TREATMENT
,	,	O
change	NN	O
in	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
to	TO	O
d5	VB	B-TREATMENT
water	NN	I-TREATMENT
with	IN	O
80	CD	O
meq	NNS	O
of	IN	O
bicarbonate	NN	B-TREATMENT
,	,	O
plus	CC	O
40	CD	O
meq	NN	O
of	IN	O
kcl	NN	B-TREATMENT
at	IN	O
45	CD	O
cc&apos;s	NNS	O
per	IN	O
hour	NN	O
,	,	O
bicarbonate	VB	B-TREATMENT
given	VBN	O
2	CD	O
meq	NNS	O
per	IN	O
kilo	NN	O
,	,	O
attempted	VBN	O
to	TO	O
start	VB	O
dopa	NN	B-TREATMENT
for	IN	O
poor	JJ	B-PROBLEM
perfusion	NN	I-PROBLEM
but	CC	O
worsening	VBG	B-PROBLEM
perfusion	NN	I-PROBLEM
.	.	O

therefore	RB	O
,	,	O
dopa	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
.	.	O

total	JJ	O
volume	NN	O
given	VBN	O
as	IN	O
bolus	JJ	B-TREATMENT
50	CD	O
cc&apos;s	NN	O
per	IN	O
kilo	NN	O
,	,	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
at	IN	O
2	CD	O
meq	NNS	O
per	IN	O
kilo	NN	O
was	VBD	O
given	VBN	O
.	.	O

last	JJ	O
abg	NN	B-TEST
there	EX	O
was	VBD	O
6.98	CD	O
,	,	O
31	CD	O
,	,	O
171	CD	O
,	,	O
bicarbonate	NN	B-TEST
of	IN	O
7	CD	O
.	.	O

phenobarbital	NN	B-TREATMENT
and	CC	O
dilantin	VB	B-TREATMENT
given	VBN	O
for	IN	O
seizure	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

electrolytes	NNS	B-TEST
before	IN	O
departure	NN	O
for	IN	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
was	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
176	CD	O
,	,	O
potassium	NN	B-TEST
2.5	CD	O
,	,	O
chloride	RB	B-TEST
140	CD	O
,	,	O
bicarbonate	NN	B-TEST
14	CD	O
,	,	O
calcium	NN	B-TEST
7.2	CD	O
,	,	O
magnesium	NN	B-TEST
2.7	CD	O
.	.	O

lines	NNS	B-TREATMENT
placed	VBN	O
were	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
triple	JJ	I-TREATMENT
lumen	NNS	I-TREATMENT
,	,	O
endotracheal	JJ	B-TREATMENT
tube	NN	I-TREATMENT
4.0	CD	O
,	,	O
arterial	JJ	B-TREATMENT
line	NN	I-TREATMENT
,	,	O
right	JJ	B-TREATMENT
radial	JJ	I-TREATMENT
line	NN	I-TREATMENT
,	,	O
foley	NN	B-TREATMENT
placed	VBD	O
,	,	O
peripheral	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
line	NN	I-TREATMENT
,	,	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
to	TO	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
,	,	O
temperature	NN	B-TEST
100.2	CD	O
,	,	O
pulse	RB	B-TEST
149	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
50	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
98/66	CD	O
,	,	O
mean	JJ	B-TEST
arterial	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
73	CD	O
,	,	O
weight	VBD	B-TEST
12	CD	O
kilos	NN	O
.	.	O

rta	NN	B-PROBLEM
diagnosed	VBD	O
at	IN	O
14	CD	O
months	NNS	O
of	IN	O
age	NN	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
scarlet	NN	B-PROBLEM
fever	NN	I-PROBLEM
at	IN	O
14	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
a	DT	O
recent	JJ	O
exposure	NN	O
to	TO	O
varicella	NN	B-PROBLEM
.	.	O

her	PRP$	O
brother	NN	O
had	VBD	O
developed	VBN	O
the	DT	B-PROBLEM
typical	JJ	I-PROBLEM
rash	NN	I-PROBLEM
on	IN	O
9/3/93	CD	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
fi02	NN	B-TREATMENT
was	VBD	O
50-60%	JJ	O
,	,	O
pid	JJ	B-TREATMENT
30-32/peep	CD	B-TREATMENT
of	IN	O
5.7	CD	O
,	,	O
total	JJ	B-TEST
volume	NN	I-TEST
was	VBD	O
between	IN	O
140	CD	O
to	TO	O
210	CD	O
during	IN	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

cvp	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
1	CD	O
cm	NN	O
of	IN	O
water	NN	O
.	.	O

then	RB	O
during	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
,	,	O
the	DT	O
cvp	NN	B-TEST
remained	VBD	O
between	IN	O
7	CD	O
to	TO	O
8	CD	O
after	IN	O
volume	NN	B-TREATMENT
resuscitation	NN	I-TREATMENT
.	.	O

dopamine	NN	B-TREATMENT
and	CC	O
epinephrine	VB	B-TREATMENT
given	VBN	O
for	IN	O
cardiovascular	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
electrocardiogram	JJ	I-TEST
findings	NNS	O
were	VBD	O
compatible	JJ	O
with	IN	O
hypokalemia	NN	B-PROBLEM
(	(	O
flattening	VBG	B-PROBLEM
t	NN	I-PROBLEM
waves	NNS	I-PROBLEM
and	CC	O
st	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
)	)	O
.	.	O

on	IN	O
admission	NN	O
to	TO	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
,	,	O
hypernatremia	NN	B-PROBLEM
and	CC	O
hypovolemic	JJ	B-PROBLEM
shock	NN	I-PROBLEM
.	.	O

fluids	NNS	B-TREATMENT
of	IN	I-TREATMENT
d5	JJ	I-TREATMENT
water	NN	I-TREATMENT
with	IN	O
30	CD	O
meq	NNS	O
of	IN	O
sodium	NN	B-TREATMENT
acetate	NN	I-TREATMENT
per	IN	O
liter	NN	O
,	,	O
30	CD	O
ml	NN	O
per	IN	O
liter	NN	O
of	IN	O
phosphate	NN	B-TREATMENT
,	,	O
and	CC	O
30	CD	O
meq	NN	O
of	IN	O
k	NN	B-TREATMENT
acetate	NN	I-TREATMENT
per	IN	O
liter	NN	O
at	IN	O
90	CD	O
cc&apos;s	NNS	O
per	IN	O
hour	NN	O
was	VBD	O
given	VBN	O
.	.	O

free	JJ	B-TREATMENT
water	NN	I-TREATMENT
deficit	NN	I-TREATMENT
over	IN	O
48	CD	O
hours	NNS	O
was	VBD	O
given	VBN	O
,	,	O
plus	CC	O
maintenance	NN	O
,	,	O
plus	CC	O
adjusting	VBG	O
the	DT	O
ongoing	JJ	O
losses	NNS	O
.	.	O

pediatric	JJ	O
nephrology	NN	O
recommended	VBD	O
on	IN	O
9/7/93	CD	O
,	,	O
5:50	CD	O
p.m.	NN	O
,	,	O
10	CD	O
cc	NN	O
&apos;s	FW	O
per	IN	O
kilo	NN	O
of	IN	O
150	CD	O
meq	NN	O
of	IN	O
sodium	NN	B-TREATMENT
bicarbonate	NN	I-TREATMENT
per	IN	O
liter	NN	O
,	,	O
(	(	O
1.5	CD	O
meq	NN	O
per	IN	O
kilo	NN	O
bicarbonate	NN	B-TREATMENT
,	,	O
one	CD	O
dose	NN	O
of	IN	O
lasix	NN	B-TREATMENT
and	CC	O
volume	NN	B-TREATMENT
as	IN	O
needed	VBN	O
)	)	O
.	.	O

the	DT	O
patient	NN	O
required	VBN	O
multiple	JJ	B-TREATMENT
boluses	NNS	I-TREATMENT
of	IN	I-TREATMENT
albumin	NN	I-TREATMENT
for	IN	O
hypotension	NN	B-PROBLEM
,	,	O
patient	NN	O
also	RB	O
required	VBD	O
multiple	JJ	B-TREATMENT
boluses	NNS	I-TREATMENT
of	IN	I-TREATMENT
calcium	NN	I-TREATMENT
because	IN	O
of	IN	O
hypocalcemia	NN	B-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
.	.	O

magnesium	NN	B-TREATMENT
2.0	CD	O
meq	NN	O
per	IN	O
liter	NN	O
,	,	O
phosphate	VBP	B-TREATMENT
8	CD	O
mg	NN	O
/	NNP	O
dl	NN	O
.	.	O

npo	NN	B-TREATMENT
.	.	O

albumin	NN	B-TEST
was	VBD	O
4.9	CD	O
.	.	O

globulin	NN	B-TEST
was	VBD	O
1.6	CD	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
was	VBD	O
6.5	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
150	CD	O
,	,	O
sgpt	VBD	B-TEST
11	CD	O
,	,	O
sgot	VBD	B-TEST
85	CD	O
,	,	O
ldh	VBD	B-TEST
524	CD	O
,	,	O
ck	NN	B-TEST
152	CD	O
,	,	O
nh3	RB	B-TEST
81	CD	O
.	.	O

white	JJ	B-TEST
cell	NN	I-TEST
count	NN	I-TEST
9.4	CD	O
,	,	O
hematocrit	NN	B-TEST
42	CD	O
,	,	O
platelets	NNS	B-TEST
151,000	CD	O
.	.	O

differential	NN	B-TEST
was	VBD	O
polys	JJ	B-TEST
59	CD	O
,	,	O
bands	VBZ	B-TEST
3	CD	O
,	,	O
lymphs	VBD	B-TEST
25	CD	O
.	.	O

repeat	NN	B-TEST
white	JJ	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
6.4	CD	O
,	,	O
hematocrit	NN	B-TEST
34	CD	O
,	,	O
platelets	NNS	B-TEST
103	CD	O
.	.	O

pt	NN	B-TEST
11.6/10.1	CD	O
,	,	O
repeat	NN	B-TEST
pt	NN	I-TEST
12.8/10.5	CD	O
.	.	O

ptt	NN	B-TEST
36.4	CD	O
,	,	O
repeat	NN	B-TEST
ptt	NN	I-TEST
50.9	CD	O
.	.	O

fibrinogen	NN	B-TEST
211	CD	O
.	.	O

urine	JJ	B-TEST
output	NN	I-TEST
was	VBD	O
about	RB	O
5	CD	O
to	TO	O
8	CD	O
cc&apos;s	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
hour	NN	O
.	.	O

renal	JJ	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
scheduled	VBN	O
during	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
.	.	O

urinalysis	NN	B-TEST
showed	VBD	O
specific	JJ	B-TEST
gravity	NN	I-TEST
1.005	CD	O
,	,	O
ph	NN	B-TEST
8.0	CD	O
,	,	O
positive	JJ	B-PROBLEM
proteins	NNS	I-PROBLEM
,	,	O
positive	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
negative	JJ	O
white	JJ	O
cell	NN	O
count	NN	O
,	,	O
positive	JJ	B-PROBLEM
glucose	NN	I-PROBLEM
.	.	O

patient	NN	O
did	VBD	O
not	RB	O
receive	VB	O
sedation	NN	B-TREATMENT
or	CC	O
muscle	NN	B-TREATMENT
relaxant	NN	I-TREATMENT
since	IN	O
admission	NN	O
to	TO	O
the	DT	O
pediatric	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

phenobarbital	JJ	B-TEST
levels	NNS	I-TEST
were	VBD	O
31.4	CD	O
,	,	O
30.2	CD	O
,	,	O
and	CC	O
50	CD	O
.	.	O

dilantin	NN	B-TEST
level	NN	I-TEST
was	VBD	O
22.6	CD	O
,	,	O
20.2	CD	O
,	,	O
20	CD	O
.	.	O

neurology	NN	O
consultation	NN	O
on	IN	O
the	DT	O
evening	NN	O
of	IN	O
9/7/93	CD	O
revealed	JJ	O
supple	NN	O
neck	NN	O
,	,	O
no	DT	B-PROBLEM
response	NN	I-PROBLEM
to	TO	O
external	JJ	B-TEST
rub	NN	I-TEST
.	.	O

pupils	NNS	O
were	VBD	O
3.5	CD	O
od	NN	O
,	,	O
and	CC	O
3.0	CD	O
os	NN	O
,	,	O
irregular	JJ	B-PROBLEM
and	CC	O
non	JJ	B-PROBLEM
reactive	NN	I-PROBLEM
.	.	O

corneal	NN	B-TEST
reflexes	NNS	I-TEST
and	CC	O
oculocephalic	JJ	B-TEST
reflexes	NNS	I-TEST
were	VBD	O
absent	JJ	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	B-PROBLEM
gag	NN	I-PROBLEM
.	.	O

muscle	NN	B-TEST
tone	NN	I-TEST
was	VBD	O
increased	VBN	B-PROBLEM
throughout	IN	I-PROBLEM
,	,	O
and	CC	O
the	DT	O
legs	NNS	O
were	VBD	O
both	DT	B-PROBLEM
extended	VBN	I-PROBLEM
and	CC	I-PROBLEM
internally	RB	I-PROBLEM
rotated	VBN	I-PROBLEM
.	.	O

deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
could	MD	O
not	RB	O
be	VB	O
elicited	VBN	O
and	CC	O
plantar	JJ	B-TEST
responses	NNS	I-TEST
were	VBD	O
silent	JJ	B-PROBLEM
.	.	O

repeat	NN	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
no	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
movement	NN	I-PROBLEM
and	CC	O
no	DT	B-PROBLEM
response	NN	I-PROBLEM
to	TO	O
voice	NN	B-TEST
or	CC	I-TEST
noxious	JJ	I-TEST
stimulation	NN	I-TEST
.	.	O

pupils	NNS	O
were	VBD	O
dilated	VBN	B-PROBLEM
and	CC	O
non	JJ	B-PROBLEM
reactive	NN	I-PROBLEM
.	.	O

disc	NN	O
margins	NNS	O
appeared	VBD	O
blurred	VBN	B-PROBLEM
on	IN	O
funduscopic	NN	B-TEST
exam	NN	I-TEST
.	.	O

a	DT	B-TEST
non	JJ	I-TEST
contrast	NN	I-TEST
head	NN	I-TEST
ct	VBP	I-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
ct	VB	B-TEST
revealed	VBN	O
severe	JJ	B-PROBLEM
cerebral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
thalamic	JJ	B-PROBLEM
mid	NN	I-PROBLEM
brain	NN	I-PROBLEM
,	,	I-PROBLEM
pons	NNS	I-PROBLEM
,	,	I-PROBLEM
medullar	JJ	I-PROBLEM
low	JJ	I-PROBLEM
attenuation	NN	I-PROBLEM
,	,	O
diffuse	VB	B-PROBLEM
cerebral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
gray	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
differentiation	NN	I-PROBLEM
.	.	O

cerebral	JJ	B-TEST
blood	NN	I-TEST
flow	NN	I-TEST
was	VBD	O
done	VBN	O
on	IN	O
9/7/93	CD	O
at	IN	O
2:30	CD	O
p.m.	NN	O
,	,	O
revealed	VBD	O
complete	JJ	B-PROBLEM
absence	NN	I-PROBLEM
of	IN	I-PROBLEM
blood	NN	I-PROBLEM
flow	NN	I-PROBLEM
to	TO	I-PROBLEM
brain	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
tiny	JJ	I-PROBLEM
region	NN	I-PROBLEM
of	IN	I-PROBLEM
activity	NN	I-PROBLEM
in	IN	O
what	WP	O
appears	VBZ	O
to	TO	O
be	VB	O
anterior	JJ	O
scalp	NN	O
.	.	O

ampicillin	NN	B-TREATMENT
and	CC	O
chloramphenicol	NN	B-TREATMENT
were	VBD	O
given	VBN	O
at	IN	O
noughwell	RB	O
entanbon	FW	O
health	NN	O
,	,	O
and	CC	O
ceftriaxone	NN	B-TREATMENT
was	VBD	O
given	VBN	O
at	IN	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
.	.	O

acyclovir	NN	B-TREATMENT
was	VBD	O
started	VBN	O
,	,	O
also	RB	O
considering	VBG	O
the	DT	B-PROBLEM
varicella	NN	I-PROBLEM
at	IN	O
120	CD	O
mg	NNS	O
intravenously	RB	O
every	DT	O
8	CD	O
hours	NNS	O
.	.	O

urine	JJ	B-TEST
cultures	NNS	I-TEST
,	,	O
blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
sputum	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

the	DT	O
situation	NN	O
of	IN	O
the	DT	O
patient	NN	O
was	VBD	O
extensively	RB	O
discussed	VBN	O
with	IN	O
the	DT	O
parents	NNS	O
,	,	O
and	CC	O
the	DT	O
attending	VBG	O
physician	NN	O
from	IN	O
neurology	NN	O
,	,	O
dr.	JJ	O
breunkote	NN	O
,	,	O
and	CC	O
the	DT	O
attending	VBG	O
physician	NN	O
from	IN	O
pediatric	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
dr.	NN	O
boormcose	NN	O
,	,	O
and	CC	O
the	DT	O
decision	NN	O
was	VBD	O
finally	RB	O
made	VBN	O
with	IN	O
the	DT	O
family	NN	O
and	CC	O
attendings	NNS	O
to	TO	O
disconnect	VB	O
the	DT	O
patient	NN	O
from	IN	O
the	DT	B-TREATMENT
mechanical	JJ	I-TREATMENT
ventilation	NN	I-TREATMENT
due	JJ	O
to	TO	O
severe	VB	B-PROBLEM
neurological	JJ	I-PROBLEM
injury	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
prognosis	NN	I-PROBLEM
.	.	O

penicillins	NNS	B-TREATMENT
/	VBP	O
codeine	JJ	B-TREATMENT
/	NNP	O
heparin	NN	B-TREATMENT
agents	NNS	I-TREATMENT
/	VBP	O
levofloxacin	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM

major	JJ	O
surgical	JJ	O
or	CC	O
invasive	JJ	O
procedure	NN	O
:	:	O
colonoscopy	NN	B-TEST
egd	NN	B-TEST

gi	NN	B-TEST
bleeding	NN	I-TEST
study	NN	I-TEST

patient	NN	O
is	VBZ	O
a	DT	O
77	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
gi	NN	B-PROBLEM
bleeding	VBG	I-PROBLEM
secondary	JJ	O
to	TO	O
arteriovenous	JJ	B-PROBLEM
malformations	NNS	I-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
maroon	NN	B-PROBLEM
stool	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
hematocrit	JJ	I-PROBLEM
drop	NN	I-PROBLEM
.	.	O

three	CD	O
days	NNS	O
ago	RB	O
began	VBD	O
to	TO	O
develop	VB	O
black	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
clear	JJ	B-PROBLEM
blood	NN	I-PROBLEM
in	IN	O
the	DT	O
toilet	NN	O
bowl	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
developed	VBD	O
nausea	NN	B-PROBLEM
and	CC	O
decreased	VBD	B-PROBLEM
po	NNS	I-PROBLEM
intake	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
cough	JJ	I-PROBLEM
productive	NN	O
of	IN	O
white	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
and	CC	O
felt	VBD	O
warm	NN	O
,	,	O
although	IN	O
she	PRP	O
did	VBD	O
not	RB	O
record	VB	O
her	PRP$	B-TEST
temperature	NN	I-TEST
.	.	O

at	IN	O
dialysis	NN	O
on	IN	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
she	PRP	O
related	VBD	O
these	DT	O
symptoms	NNS	O
for	IN	O
the	DT	O
first	JJ	O
time	NN	O
and	CC	O
had	VBD	O
a	DT	B-PROBLEM
bloody	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
deanna	NN	O
,	,	O
her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
96.5	CD	O
,	,	O
hr	NN	B-TEST
51	CD	O
,	,	O
bp	NN	B-TEST
112/60	CD	O
,	,	O
rr	NN	B-TEST
18	CD	O
,	,	O
and	CC	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
was	VBD	O
98%	CD	O
on	IN	O
ambient	JJ	O
air	NN	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
measured	VBN	O
at	IN	O
23.5	CD	O
,	,	O
while	IN	O
her	PRP$	B-TEST
baseline	NN	I-TEST
hematocrit	NN	I-TEST
is	VBZ	O
in	IN	O
the	DT	O
low	JJ	O
30	CD	O
s.	NN	O

an	DT	B-TEST
ng	JJ	I-TEST
lavage	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
there	EX	O
was	VBD	O
bilious	JJ	B-PROBLEM
return	NN	I-PROBLEM
.	.	O

rectal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
guiaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
maroon	NN	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
type	NN	O
and	CC	O
crossed	VBN	O
and	CC	O
transfused	VBN	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

iv	NN	B-TREATMENT
ppi	NN	I-TREATMENT
was	VBD	O
given	VBN	O
and	CC	O
the	DT	O
gi	NN	O
team	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
she	PRP	O
was	VBD	O
scheduled	VBN	O
for	IN	O
colonoscopy	NN	B-TEST
and	CC	O
egd	NN	B-TEST
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
6/8	CD	O
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
for	IN	O
observation	NN	B-TEST
.	.	O

dm2	NN	B-PROBLEM
on	IN	O
insulin	NN	B-TREATMENT

cri	JJ	B-PROBLEM
03-30	JJ	O
htn	NN	B-PROBLEM
and	CC	O
dm	NN	B-PROBLEM
nephropathy	NNS	I-PROBLEM
,	,	O
with	IN	O
baseline	JJ	B-TEST
creatinine	NN	I-TEST
4-4.5	JJ	O

chronic	JJ	B-PROBLEM
gi	NN	I-PROBLEM
bleeding	NN	I-PROBLEM
:	:	O
documented	VBN	B-PROBLEM
avms	NN	I-PROBLEM

anemia	NN	B-PROBLEM
w/	WRB	O
baseline	NN	B-TEST
hct	NN	I-TEST
27-30	JJ	O

thrombocytopenia	NN	B-PROBLEM

coagulopathy	NN	B-PROBLEM
,	,	O
hit	VBN	B-PROBLEM
in	IN	O
2014	CD	O

cardiomyopathy	NN	B-PROBLEM

mrsa	NN	B-PROBLEM
endocardiitis	NN	I-PROBLEM
(	(	O
01-28	CD	O
)	)	O

cad	NN	B-PROBLEM
;	:	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
two	CD	O
and	CC	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
2001	CD	O
and	CC	O
2000	CD	O
.	.	O

asthma	NN	B-PROBLEM

hypothyroidism	NN	B-PROBLEM

osteoarthritis	NN	B-PROBLEM

paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM

pud	NN	B-PROBLEM
,	,	O
barrett	NN	B-PROBLEM
's	POS	I-PROBLEM
esophagus	NN	I-PROBLEM

chf	NN	B-PROBLEM
ef	VBZ	B-TEST
50%	CD	O

primarily	RB	O
togolese	JJ	O
speaking	NN	O
,	,	O
wheelchair	NN	B-PROBLEM
bound	NN	I-PROBLEM
and	CC	O
lives	VBZ	O
alone	RB	O
but	CC	O
cared	VBD	O
for	IN	O
entirely	RB	O
by	IN	O
her	PRP$	O
daughter	NN	O
.	.	O

cad	NN	B-PROBLEM
and	CC	O
dm	NN	B-PROBLEM

t	NN	B-TEST
:	:	O
97.2	CD	O
bp	NN	B-TEST
:	:	O
127/57	CD	O
hr	NN	B-TEST
:	:	O
68	CD	O
rr	NN	B-TEST
:	:	O
11	CD	O
o2saturation	NN	B-TEST
:	:	O
97%	CD	O
on	IN	O
ambient	NN	O
air	NN	O

slight	JJ	B-PROBLEM
conjunctival	NN	I-PROBLEM
pallor	NN	I-PROBLEM
.	.	O

no	DT	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
.	.	O

slightly	RB	B-PROBLEM
dry	JJ	I-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

no	DT	O
jvd	NN	B-PROBLEM
.	.	O

systolic	JJ	B-PROBLEM
murmur	NN	I-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

no	DT	O
rubs	NN	B-PROBLEM
or	CC	O
andringa	NN	B-PROBLEM
appreciated	VBN	O
.	.	O

crackles	NNS	B-PROBLEM
in	IN	I-PROBLEM
lower	JJR	I-PROBLEM
lung	NN	I-PROBLEM
fields	NNS	I-PROBLEM
.	.	O

no	DT	O
wheezes	NN	B-PROBLEM
or	CC	O
rhonci	NN	B-PROBLEM
appreciated	VBN	O
.	.	O

slightly	RB	B-PROBLEM
hyperactive	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
throughout	IN	I-PROBLEM
.	.	O

nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

no	DT	O
guarding	NN	B-PROBLEM
or	CC	O
rebound	NN	B-PROBLEM
.	.	O

no	DT	O
splenomegaly	NN	B-PROBLEM
appreciated	VBD	O
.	.	O

guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
maroon	NN	I-PROBLEM
stool	NN	I-PROBLEM
in	IN	O
deanna	NN	O
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
or	CC	O
cyanosis	NN	B-PROBLEM
.	.	O

no	DT	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

2+	CD	B-TEST
dorsalis	JJ	I-TEST
pedis	NN	I-TEST
and	CC	I-TEST
radial	JJ	I-TEST
pulse	NN	I-TEST
on	IN	I-TEST
left	NN	I-TEST
.	.	O

no	DT	B-PROBLEM
radial	JJ	I-PROBLEM
pulse	NN	I-PROBLEM
on	IN	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

av	JJ	B-TREATMENT
fistula	NN	I-TREATMENT
on	IN	O
right	NN	O
.	.	O

2018-08-07	JJ	O
12:56	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
4.0	CD	O
rbc	NN	B-TEST
-	:	O
3.54	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
32.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
32.8	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
35.2	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
18.5	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
65	CD	O
*	NN	O

2018-08-02	JJ	O
12:29	CD	O
pm	NN	O
blood	NN	B-TEST
hct	SYM	B-TEST
-	:	O
23.5	CD	O
*#	NN	O

2018-08-02	JJ	O
04:40	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
3.2	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
2.49	CD	O
*#	NN	O
hgb	NN	B-TEST
-	:	O
8.4	CD	O
*#	NN	O
hct	NN	B-TEST
-	:	O
24.5	CD	O
*#	NN	O
mcv	SYM	B-TEST
-	:	O
98	CD	O
mch	SYM	B-TEST
-	:	O
33.7	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
34.3	CD	O
rdw	NN	B-TEST
-	:	O
18.5	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
69	CD	O
*	NN	O

2018-08-06	JJ	O
04:52	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
14.7	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
28.9	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
1.3	CD	O
*	NN	O

2018-08-07	JJ	O
12:56	CD	O
am	VBP	O
blood	NN	B-TEST
urean	JJ	B-TEST
-	:	O
27	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
4.1	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
130	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
3.7	CD	O
cl	NN	B-TEST
-	:	O
94	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
27	CD	O
angap	NN	B-TEST
-	:	O
13	CD	O

2018-08-06	JJ	O
04:52	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
129	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
24	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
3.4	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
134	CD	O
k	SYM	B-TEST
-	:	O
3.2	CD	O
*	NN	O
cl	NN	B-TEST
-	:	O
96	CD	O
hco3	NN	B-TEST
-	:	O
29	CD	O
angap	NN	B-TEST
-	:	O
12	CD	O

2018-08-02	JJ	O
04:40	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
187	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
21	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
2.0	CD	O
*#	NN	O
na	SYM	B-TEST
-	:	O
139	CD	O
k	SYM	B-TEST
-	:	O
3.2	CD	O
*	NN	O
cl	NN	B-TEST
-	:	O
96	CD	O
hco3	NN	B-TEST
-	:	O
35	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
11	CD	O

2018-08-07	JJ	O
12:56	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.0	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
3.5	CD	O
mg	SYM	B-TEST
-	:	O
1.8	CD	O

cardiology	NN	O
report	NN	O
ecg	NN	B-TEST
study	NN	I-TEST
date	NN	O
of	IN	O
2018-08-02	JJ	O
5:40:48	CD	O
pm	NN	O

sinus	NNS	B-PROBLEM
bradycardia	VBP	I-PROBLEM
with	IN	O
markedly	RB	B-PROBLEM
prolonged	VBN	I-PROBLEM
p-r	JJ	I-PROBLEM
interval	NN	I-PROBLEM
and	CC	O
wenckebach	NN	B-PROBLEM
type	NN	I-PROBLEM

atrio-ventricular	JJ	B-PROBLEM
conduction	NN	I-PROBLEM
delay	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
bundle-branch	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

indeterminate	JJ	B-PROBLEM
frontal	JJ	I-PROBLEM
plane	NN	I-PROBLEM
qrs	NN	I-PROBLEM
axis	NN	I-PROBLEM
.	.	O

compared	VBN	O
to	TO	O
the	DT	B-TEST
previous	JJ	I-TEST
tracing	NN	I-TEST
of	IN	O
2017-10-12	JJ	O
multiple	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
as	IN	O
previously	RB	O
noted	VBN	O
persist	NN	O
without	IN	O
major	JJ	B-PROBLEM
change	NN	I-PROBLEM
.	.	O

intervals	NNS	B-TEST
axes	NNS	I-TEST

rate	NN	B-TEST
pr	NNS	B-TEST
qrs	VBP	B-TEST
qt/qtc	JJ	B-TEST
p	NN	B-TEST
qrs	NN	B-TEST
t	NN	B-TEST

2018-08-03	JJ	O
5:40	CD	O
pm	NN	O
serology/blood	NN	B-TEST

line-central	JJ	B-TREATMENT
.	.	O

helicobacter	NN	B-TEST
pylori	NN	I-TEST
antibody	NN	I-TEST
test	NN	I-TEST
(	(	O
final	JJ	O
2018-08-06	NN	O
)	)	O
:	:	O

gi	NNS	B-TEST
bleed	VBP	I-TEST
study	SYM	I-TEST
-	:	O
impression	NN	O
:	:	O

active	JJ	B-PROBLEM
radiotracer	NN	I-PROBLEM
activity	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	NN	I-PROBLEM
in	IN	O
a	DT	O
serpingneous	JJ	O
f	JJ	O
fashion	NN	O
suggestive	NN	O
of	IN	O
distal	JJ	O
small	JJ	O
bowel	NN	O
.	.	O

egd	SYM	B-TEST
-	:	O
impression	NN	O
:	:	O

angioectasias	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
fundus	NN	I-PROBLEM

angioectasias	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
antrum	NN	I-PROBLEM

angioectasias	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
jejunum	NN	I-PROBLEM
and	CC	I-PROBLEM
mid	NN	I-PROBLEM
jejunum	NN	I-PROBLEM

angioectasia	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
duodenum	NN	I-PROBLEM

no	DT	O
site	NN	O
of	IN	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

the	DT	B-PROBLEM
fundal	JJ	I-PROBLEM
avms	NN	I-PROBLEM
are	VBP	O
a	DT	O
potential	JJ	O
site	NN	O
of	IN	O
bleeding	VBG	B-PROBLEM
although	IN	O
do	NN	O
not	RB	O
explain	VB	O
the	DT	O
extent	NN	O
of	IN	O
bleeding	NN	B-PROBLEM
.	.	O

consider	VB	O
endoscopic	NN	B-TREATMENT
argon	NN	I-TREATMENT
plasma	NN	I-TREATMENT
therapy	NN	I-TREATMENT

proceed	NN	O
with	IN	O
colonoscopy	NN	B-TEST
.	.	O

colonoscopy	NN	B-TEST
-	:	O

blood	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM

grade	NN	B-PROBLEM
1	CD	I-PROBLEM
external	JJ	I-PROBLEM
hemorrhoids	NNS	I-PROBLEM

angioectasia	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM

diverticulosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM

blood	NN	B-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM
from	IN	O
gi	NN	B-PROBLEM
bleeding	VBG	I-PROBLEM
-	:	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
was	VBD	O
likely	RB	O
from	IN	O
an	DT	B-PROBLEM
avm	NN	I-PROBLEM
.	.	O

egd	NN	B-TEST
,	,	O
colonoscopy	NN	B-TEST
and	CC	O
tagged	VBD	B-TEST
scan	JJ	I-TEST
results	NNS	O
as	IN	O
above	NN	O
.	.	O

eventhough	IN	O
uptake	NN	O
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
rt	NN	O
lq	NN	O
,	,	O
no	DT	O
clear	JJ	O
site	NN	O
of	IN	O
bleeding	NN	B-PROBLEM
was	VBD	O
noticed	VBN	O
on	IN	O
colonoscopy	NN	B-TEST
.	.	O

hence	NN	O
,	,	O
no	DT	O
intervention	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

she	PRP	O
was	VBD	O
transfused	VBN	O
with	IN	O
5	CD	O
units	NNS	O
of	IN	O
prbc	NN	B-TREATMENT
in	IN	O
the	DT	O
icu	JJ	O
andsent	NN	O
to	TO	O
the	DT	O
lahey	NN	O
clinic	JJ	O
-	:	O
north	NN	O
shore	NN	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
for	IN	O
4	CD	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

no	DT	O
further	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
noted	VBD	O
.	.	O

on	IN	O
discussion	NN	O
with	IN	O
dr	JJ	O
leigh	JJ	O
and	CC	O
dr	JJ	O
white	JJ	O
from	IN	O
gi	JJ	O
-	:	O
they	PRP	O
recommended	VBD	O
that	IN	O
she	PRP	O
follow	VB	O
with	IN	O
dr.	NN	O
taylor	NN	O
for	IN	O
consideration	NN	O
of	IN	O
argon	JJ	B-TREATMENT
photocoagulation	NN	I-TREATMENT
as	IN	O
out-patient	NN	O
.	.	O

given	VBN	O
the	DT	O
innumerable	JJ	O
number	NN	O
of	IN	O
avm	NN	B-PROBLEM
's	POS	I-PROBLEM
,	,	O
it	PRP	O
is	VBZ	O
diffcult	VBN	O
to	TO	O
assess	VB	O
which	WDT	O
the	DT	B-PROBLEM
culprit	NN	I-PROBLEM
lesion	NN	I-PROBLEM
is	VBZ	O
and	CC	O
gi	NN	O
may	MD	O
start	VB	O
apl	NN	B-TREATMENT
from	IN	I-TREATMENT
the	DT	I-TREATMENT
fundus	NN	I-TREATMENT
of	IN	O
stomach	NN	O
.	.	O

patient	NN	O
to	TO	O
get	VB	O
cbc	JJ	B-TEST
checked	VBN	O
with	IN	O
pcp	NN	O
this	DT	O
week	NN	O
as	IN	O
below	NN	O
.	.	O

asa	NN	B-TREATMENT
was	VBD	O
held	VBN	O
and	CC	O
may	MD	O
be	VB	O
restarted	VBN	O
if	IN	O
hct	JJ	B-TEST
stable	JJ	O
in	IN	O
clinic	NN	O
at	IN	O
the	DT	O
pcp	NN	O
's	POS	O
discretion	NN	O
.	.	O

chronic	JJ	B-PROBLEM
thrombocytopenia	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
,	,	O
however	RB	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
require	VB	O
platelet	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

has	VBZ	O
a	DT	O
h/o	NN	O
hit	NN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
metoprolol	NN	I-TREATMENT
was	VBD	O
held	VBN	O
during	IN	O
acute	JJ	B-PROBLEM
bleeding	VBG	I-PROBLEM
phase	NN	I-PROBLEM
and	CC	O
restarted	VBD	O
prior	RB	O
to	TO	O
discharge	VB	O
as	IN	O
her	PRP$	B-TEST
bp	NN	I-TEST
stabilized	VBN	O
.	.	O

other	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
stable	JJ	O
.	.	O

dialysis	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
3	CD	O
/	JJ	O
week	NN	O
.	.	O

-	:	O
atorvastatin	NN	B-TREATMENT
80	CD	O
mg	NN	O
qd	NN	O

-	:	O
hydroxyzine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
po	VB	O
q4-6h	JJ	O
prn	NN	O
for	IN	O
itching	VBG	B-PROBLEM

-	:	O
levothyroxine	NN	B-TREATMENT
175	CD	O
mcg	NN	O
po	NN	O
qd	NN	O

-	:	O
albuterol	NN	B-TREATMENT
90	CD	O
mcg	JJ	O
1-2	JJ	O
puffs	NNS	O
inh	VBP	O
q6hr	JJ	O
prn	NN	O

-	:	O
nitroglycerin	NN	B-TREATMENT
0.3	CD	O
mg	NN	O
tablet	NN	O
prn	NN	O

-	:	O
metoprolol	NN	B-TREATMENT
tartrate	NN	I-TREATMENT
12.5	CD	O
mg	NN	O
bid	NN	O

-	:	O
b	NN	B-TREATMENT
complex	JJ	I-TREATMENT
-	:	O
vitamin	NN	B-TREATMENT
c	SYM	I-TREATMENT
-	:	O
folic	JJ	B-TREATMENT
acid	VBP	I-TREATMENT
1	CD	O
mg	NN	O
capsule	NN	O
qd	NN	O

-	:	O
insulin	NN	B-TREATMENT
nph	JJ	I-TREATMENT
75-25	JJ	O
20units	CD	O
qam	NN	O
and	CC	O
humalog	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

1.	CD	O
atorvastatin	JJ	B-TREATMENT
80	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
albuterol	NN	B-TREATMENT
90	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
puffs	NNS	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
levothyroxine	JJ	B-TREATMENT
175	CD	O
mcg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

4.	CD	O
hydroxyzine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

5.	CD	O
b-complex	JJ	B-TREATMENT
with	IN	O
vitamin	JJ	B-TREATMENT
c	NNS	I-TREATMENT
tablet	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
menthol	SYM	B-TREATMENT
-	:	I-TREATMENT
cetylpyridinium	NN	I-TREATMENT
cl	VBZ	I-TREATMENT
2	CD	O
mg	NN	O
lozenge	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
lozenge	NN	O
mucous	JJ	O
membrane	NN	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
)	)	O
.	.	O

7.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
.	.	O

8.	CD	O
nitroglycerin	JJ	B-TREATMENT
0.3	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
sublingual	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
sublingual	NN	O
as	RB	O
needed	VBN	O
as	IN	O
needed	VBN	O
for	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

9.	CD	O
insulin	NN	B-TREATMENT

continue	NN	O
to	TO	O
take	VB	O
the	DT	B-TREATMENT
insulin	NN	I-TREATMENT
as	IN	O
you	PRP	O
were	VBD	O
taking	VBG	O
prior	JJ	O
to	TO	O
the	DT	O
hospital	NN	O
visit	NN	O

10.	CD	O
outpatient	JJ	B-TEST
lab	NN	I-TEST
work	NN	I-TEST

cbc	NN	B-TEST
(	(	O
to	TO	O
be	VB	O
checked	VBN	O
by	IN	O
dr	NN	O
pannell	NN	O
444-1034	JJ	O
on	IN	O
2018-08-10	JJ	O
)	)	O

11.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

acute	JJ	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM
from	IN	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM

thrombocytopenia	SYM	B-PROBLEM
-	:	I-PROBLEM
chronic	NN	I-PROBLEM

htn	NN	B-PROBLEM

dm	NN	B-PROBLEM
type	NN	I-PROBLEM
1	CD	I-PROBLEM

ckd	NN	B-PROBLEM
stage	NN	I-PROBLEM
5	CD	I-PROBLEM

hypothyroidism	NN	B-PROBLEM

asthma	NN	B-PROBLEM

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

weigh	JJ	O
yourself	PRP	O
every	DT	O
morning	NN	O
,	,	O
call	VB	O
md	NN	O
if	IN	O
weight	VBN	B-PROBLEM
>	VBP	I-PROBLEM
3	CD	I-PROBLEM
lbs	NN	I-PROBLEM
.	.	O

adhere	RB	O
to	TO	O
2	CD	B-TREATMENT
gm	NNS	I-TREATMENT
sodium	NN	I-TREATMENT
diet	NN	I-TREATMENT

do	VB	O
not	RB	O
take	VB	O
the	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
unless	IN	O
you	PRP	O
see	VBP	O
dr	JJ	O
pannell	NN	O
.	.	O

continue	NN	O
to	TO	O
take	VB	O
the	DT	B-TREATMENT
insulin	NN	I-TREATMENT
as	IN	O
you	PRP	O
were	VBD	O
taking	VBG	O
prior	JJ	O
to	TO	O
hospital	JJ	O
visit	NN	O
.	.	O

please	VB	O
see	VB	O
your	PRP$	O
doctor	NN	O
(	(	O
dr	VB	O
pannell	NN	O
)	)	O
on	IN	O
friday	JJ	O
2018-08-10	JJ	O
for	IN	O
a	DT	B-TEST
blood	NN	I-TEST
test	NN	I-TEST
(	(	O
cbc	NN	B-TEST
)	)	O
.	.	O

continue	VB	O
the	DT	B-TREATMENT
dialysis	NN	I-TREATMENT
three	CD	O
times	NNS	O
a	DT	O
week	NN	O
.	.	O

return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
if	IN	O
you	PRP	O
notice	VBP	O
bleeding	VBG	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
of	IN	O
concern	NN	O
to	TO	O
you	PRP	O
.	.	O

primary	JJ	O
doctor	NN	O
-	:	O
dr	NN	O
shirley	NN	O
,	,	O
james	NNS	O
m.	VBP	O
444-1034	JJ	O
-	:	O
please	NN	O
see	VB	O
your	PRP$	O
doctor	NN	O
mary	JJ	O
powell	NN	O
2018-08-10	JJ	O
for	IN	O
a	DT	B-TEST
blood	NN	I-TEST
test	NN	I-TEST
(	(	O
cbc	NN	B-TEST
)	)	O
.	.	O

dialysis	NN	B-TREATMENT
as	IN	O
scheduled	VBN	O
.	.	O

mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

tricuspid	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

04/22/94	CD	O
,	,	O
mitral	JJ	B-TREATMENT
valve	FW	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
tricuspid	JJ	B-TREATMENT
valve	NN	I-TREATMENT
reconstruction	NN	I-TREATMENT
.	.	O

this	DT	O
68	CD	O
year	NN	O
old	JJ	O
female	NN	O
had	VBD	O
rheumatic	JJ	B-PROBLEM
fever	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
,	,	O
and	CC	O
has	VBZ	O
had	VBN	O
chronic	VBN	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
progressive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
an	DT	B-TEST
evaluation	NN	I-TEST
demonstrated	VBD	O
worsening	VBG	B-PROBLEM
mitral	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
severe	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

because	IN	O
of	IN	O
her	PRP$	O
deteriorating	NN	O
status	NN	O
,	,	O
she	PRP	O
underwent	VBD	O
prior	JJ	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
,	,	O
which	WDT	O
confirmed	VBD	O
severe	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
secondary	JJ	B-PROBLEM
tricuspid	JJ	I-PROBLEM
valve	NN	I-PROBLEM
regurgitation	NN	I-PROBLEM
due	JJ	O
to	TO	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
referred	VBN	O
for	IN	O
valve	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
remarkable	JJ	O
for	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
due	JJ	O
to	TO	O
smoking	VBG	O
.	.	O

she	PRP	O
had	VBD	O
undergone	PRP	O
a	DT	B-TREATMENT
previous	JJ	I-TREATMENT
nasal	JJ	I-TREATMENT
arterial	JJ	I-TREATMENT
embolization	NN	I-TREATMENT
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
recurrent	NN	B-PROBLEM
epistaxis	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
partial	JJ	I-TREATMENT
gastrectomy	NN	I-TREATMENT
in	IN	O
1972	CD	O
.	.	O

her	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
on	IN	I-TREATMENT
admission	NN	I-TREATMENT
included	VBD	O
coumadin	NN	B-TREATMENT
,	,	O
digoxin	NN	B-TREATMENT
,	,	O
0.125	CD	O
,	,	O
qd	NN	O
,	,	O
lasix	NN	B-TREATMENT
,	,	O
40	CD	O
,	,	O
q.i.d.	NN	O
,	,	O
and	CC	O
vanceril	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
.	.	O

pertinent	JJ	B-TEST
examination	NN	I-TEST
demonstrated	VBD	O
mild	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
of	IN	O
her	PRP$	B-TEST
jugular	JJ	I-TEST
venous	JJ	I-TEST
pulse	NN	I-TEST
,	,	O
with	IN	O
prominent	JJ	B-PROBLEM
v-waves	NNS	I-PROBLEM
,	,	O
and	CC	O
systolic	JJ	B-PROBLEM
and	CC	I-PROBLEM
diastolic	JJ	I-PROBLEM
murmurs	NNS	I-PROBLEM
.	.	O

peripheral	JJ	B-TEST
pulses	NNS	I-TEST
were	VBD	O
all	DT	O
intact	JJ	O
,	,	O
and	CC	O
there	RB	O
was	VBD	O
venous	JJ	B-PROBLEM
stasis	NN	I-PROBLEM
changes	NNS	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
legs	NNS	I-PROBLEM
,	,	O
with	IN	O
some	DT	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
utilizing	VBG	O
a	DT	O
27	CD	O
mm	NN	O
.	.	O

st.	JJ	B-TREATMENT
jude	NN	I-TREATMENT
prosthesis	NN	I-TREATMENT
,	,	O
and	CC	O
tricuspid	JJ	B-TREATMENT
valve	NN	I-TREATMENT
reconstruction	NN	I-TREATMENT
by	IN	O
ring	VBG	B-TREATMENT
anuloplasty	NN	I-TREATMENT
.	.	O

she	PRP	O
weaned	VBD	O
from	IN	O
cardiopulmonary	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
with	IN	O
good	JJ	O
hemodynamics	NNS	O
.	.	O

she	PRP	O
initially	RB	O
awoke	VBD	O
after	IN	O
surgery	NN	B-TREATMENT
,	,	O
with	IN	O
good	JJ	O
hemodynamics	NNS	O
.	.	O

she	PRP	O
was	VBD	O
transiently	RB	O
in	IN	O
sinus	NN	O
rhythm	NN	O
,	,	O
but	CC	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
recurred	VBD	O
.	.	O

she	PRP	O
was	VBD	O
extubated	VBN	O
on	IN	O
the	DT	O
third	JJ	O
postoperative	JJ	O
day	NN	O
,	,	O
and	CC	O
was	VBD	O
initially	RB	B-PROBLEM
slightly	RB	I-PROBLEM
agitated	VBN	I-PROBLEM
and	CC	O
confused	VBN	B-PROBLEM
,	,	O
largely	RB	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
intensive	JJ	I-PROBLEM
care	NN	I-PROBLEM
unit	NN	I-PROBLEM
psychosis	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
slow	JJ	I-PROBLEM
ventricular	NN	I-PROBLEM
response	NN	I-PROBLEM
in	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
gradually	RB	O
improved	VBN	O
over	IN	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
noted	VBN	O
to	TO	O
be	VB	O
somewhat	RB	B-PROBLEM
anemic	JJ	I-PROBLEM
,	,	O
and	CC	O
received	VBD	O
transfusions	NNS	B-TREATMENT
.	.	O

coumadin	NN	B-TREATMENT
was	VBD	O
restarted	VBN	O
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
anticoagulation	NN	I-TREATMENT
came	VBD	O
into	IN	O
range	NN	O
.	.	O

she	PRP	O
was	VBD	O
ultimately	RB	O
discharged	VBN	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
in	IN	O
the	DT	O
90	CD	O
's	POS	O
,	,	O
and	CC	O
with	IN	O
resolving	VBG	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
a	DT	O
clear	JJ	O
chest	NN	O
.	.	O

her	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
on	IN	I-TREATMENT
discharge	NN	I-TREATMENT
included	VBD	O
lasix	NN	B-TREATMENT
,	,	O
40	CD	O
,	,	O
b.i.d.	NN	O
,	,	O
potassium	NN	B-TREATMENT
,	,	O
20	CD	O
meq.	NN	O
,	,	O
b.i.d.	NN	O
,	,	O
iron	NN	B-TREATMENT
,	,	O
and	CC	O
folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
and	CC	O
coumadin	NN	B-TREATMENT
.	.	O

leona	JJ	O
wheeler	NN	O
had	VBD	O
continued	VBN	O
episodes	NNS	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
which	WDT	O
were	VBD	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
amiodarone	NN	I-TREATMENT
and	CC	O
later	RB	O
intravenous	JJ	B-TREATMENT
diltiazem	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
progressively	RB	O
increased	VBN	O
to	TO	O
100	CD	O
mg	NN	O
tid	NN	O
.	.	O

amiodarone	RB	B-TREATMENT
400	CD	O
mg	NNS	O
tid	NN	O
was	VBD	O
continued	VBN	O
as	RB	O
well	RB	O
.	.	O

due	JJ	O
to	TO	O
this	DT	B-PROBLEM
continued	VBN	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
leona	FW	O
wheeler	NN	O
was	VBD	O
anticoagulated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
heparin	NNS	I-TREATMENT
.	.	O

coumadin	NN	B-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
started	VBN	O
and	CC	O
her	PRP$	B-TEST
inr	NN	I-TEST
were	VBD	O
followed	VBN	O
.	.	O

these	DT	O
episodes	NNS	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
have	VBP	O
diminished	VBN	O
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
in	IN	O
sinus	NN	O
rhythm	NN	O
for	IN	O
over	IN	O
24	CD	O
hours	NNS	O
now	RB	O
.	.	O

she	PRP	O
will	MD	O
be	VB	O
monitored	VBN	O
with	IN	O
a	DT	B-TEST
king	NN	I-TEST
of	IN	I-TEST
hearts	NNS	I-TEST
monitor	NN	I-TEST
.	.	O

metoprolol	NN	B-TREATMENT
100	CD	O
mg	NN	O
tid	NN	O
,	,	O
amiodarone	RB	B-TREATMENT
400	CD	O
mg	NN	O
tid	NN	O
times	NNS	O
7	CD	O
days	NNS	O
,	,	O
then	RB	O
bid	VBD	O
times	NNS	O
14	CD	O
days	NNS	O
,	,	O
then	RB	O
q	VBZ	O
d	JJ	O
times	NNS	O
14	CD	O
days	NNS	O
,	,	O
then	RB	O
200	CD	O
mg	NNS	O
q	JJ	O
d	NN	O
.	.	O

1.	CD	O
status	NN	O
post	NN	O
cabg	NN	B-TREATMENT
times	NNS	O
four	CD	O
.	.	O

epistaxis	NN	B-PROBLEM
.	.	O

epistaxis	NN	B-PROBLEM
.	.	O

mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
tricuspid	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
ectopy	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

epistaxis	NN	B-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

partial	JJ	B-TREATMENT
embolization	NN	I-TREATMENT
of	IN	I-TREATMENT
blood	NN	I-TREATMENT
supply	NN	I-TREATMENT
to	TO	O
nose	VB	O
,	,	O
8/22	CD	O
.	.	O

this	DT	O
68	CD	O
year	NN	O
old	JJ	O
female	NN	O
has	VBZ	O
rheumatic	JJ	B-PROBLEM
heart	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

mitral	JJ	B-TREATMENT
and	CC	I-TREATMENT
possibly	RB	I-TREATMENT
tricuspid	JJ	I-TREATMENT
valve	NN	I-TREATMENT
surgery	NN	I-TREATMENT
is	VBZ	O
scheduled	VBN	O
for	IN	O
labor	NN	O
day	NN	O
by	IN	O
dr.	NN	O
riemund	NN	O
c.	NN	O
kennedy	NN	O
.	.	O

she	PRP	O
is	VBZ	O
admitted	VBN	O
now	RB	O
for	IN	O
a	DT	B-TREATMENT
neuro-interventional	JJ	I-TREATMENT
radiology	NN	I-TREATMENT
procedure	NN	I-TREATMENT
to	TO	O
decrease	VB	O
the	DT	O
likelihood	NN	O
of	IN	O
epistaxis	NN	B-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
.	.	O

right	JJ	B-PROBLEM
neck	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
groin	NN	I-PROBLEM
catheterization	NN	I-PROBLEM
sites	NNS	I-PROBLEM
were	VBD	O
benign	JJ	O
.	.	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

examination	NN	B-TEST
was	VBD	O
otherwise	RB	O
unchanged	JJ	O
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
42	CD	O
,	,	O
pt	NN	B-TEST
was	VBD	O
10	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
3.6	CD	O
,	,	O
bun	NN	B-TEST
was	VBD	O
29	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
1.4	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
was	VBD	O
111	CD	O
.	.	O

ekg	NN	B-TEST
showed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
moderate	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
response	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
axis	NN	I-PROBLEM
deviation	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
interventional	JJ	I-TREATMENT
neuro-radiology	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
by	IN	O
dr.	VBG	O
a	DT	O
skizeis	NN	O
,	,	O
on	IN	O
august	JJ	O
22	CD	O
,	,	O
via	IN	O
the	DT	O
right	JJ	O
femoral	JJ	O
artery	NN	O
.	.	O

the	DT	O
right	JJ	O
internal	JJ	O
maxillary	JJ	O
artery	NN	O
supply	NN	O
to	TO	O
the	DT	O
nasal	NN	O
mucosa	NN	O
was	VBD	O
embolized	VBN	B-TREATMENT
.	.	O

the	DT	O
left	JJ	O
external	JJ	O
carotid	NN	O
artery	NN	O
was	VBD	O
occluded	VBN	B-PROBLEM
at	IN	O
its	PRP$	O
origin	NN	O
,	,	O
with	IN	O
collaterals	NNS	O
from	IN	O
the	DT	O
internal	JJ	O
carotid	NN	O
artery	NN	O
.	.	O

thus	RB	O
,	,	O
embolization	NN	B-TREATMENT
on	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
side	NN	I-TREATMENT
was	VBD	O
not	RB	O
possible	JJ	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
coumadin	NN	B-TREATMENT
,	,	O
10	CD	O
mg.	NN	O
,	,	O
on	IN	O
the	DT	O
evening	NN	O
following	VBG	O
the	DT	O
procedure	NN	O
,	,	O
and	CC	O
is	VBZ	O
discharged	VBN	O
the	DT	O
next	JJ	O
day	NN	O
.	.	O

her	PRP$	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
will	MD	O
be	VB	O
rechecked	VBN	O
on	IN	O
august	JJ	O
27	CD	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	NN	O
naka	NN	O
gift	NN	O
.	.	O

once	RB	O
her	PRP$	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
is	VBZ	O
in	IN	O
therapeutic	JJ	O
range	NN	O
,	,	O
she	PRP	O
will	MD	O
be	VB	O
observed	VBN	O
for	IN	O
epistaxis	NN	B-PROBLEM
.	.	O

she	PRP	O
will	MD	O
take	VB	O
her	PRP$	O
last	JJ	O
dose	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
on	IN	O
september	NN	O
1	CD	O
in	IN	O
anticipation	NN	O
of	IN	O
cardiac	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

if	IN	O
her	PRP$	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
does	VBZ	O
not	RB	O
come	VBN	O
into	IN	O
therapeutic	JJ	O
range	NN	O
promptly	RB	O
,	,	O
then	RB	O
surgery	NN	B-TREATMENT
may	MD	O
be	VB	O
delayed	VBN	O
.	.	O

coumadin	NN	B-TREATMENT
,	,	O
5	CD	O
mg.	NN	O
,	,	O
alternating	VBG	O
with	IN	O
2.5	CD	O
mg.	NNS	O
,	,	O
qd	NN	O
,	,	O
digoxin	NN	B-TREATMENT
,	,	O
0.125	CD	O
mg.	NN	O
,	,	O
qd	NN	O
,	,	O
lasix	NN	B-TREATMENT
,	,	O
80	CD	O
mg.	NN	O
,	,	O
qam	NN	O
and	CC	O
40	CD	O
mg.	NN	O
,	,	O
qpm	NN	O
,	,	O
vanceril	NN	B-TREATMENT
,	,	O
3	CD	O
puffs	NNS	O
,	,	O
b.i.d.	NN	O

baby	NN	O
boy	NNS	O
timberlake	NN	O
was	VBD	O
born	VBN	O
to	TO	O
a	DT	O
25	CD	O
-	:	O
year-old	JJ	O
g-8	JJ	O
,	,	O
p-4	JJ	O
to	TO	O
5	CD	O
mom	NN	O
with	IN	O
julie	NN	O
type	NN	O
b	NN	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	I-TEST
,	,	O
rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
gbs	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
with	IN	O
a	DT	O
history	NN	O
of	IN	O
infrequent	NN	O
prenatal	NN	O
care	NN	O
since	IN	O
28	CD	O
weeks	NNS	O
time	NN	O
and	CC	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

mother	NN	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
anxiety	NN	B-PROBLEM
and	CC	O
asthma	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
moderate	JJ	O
cigarette	NN	O
smoking	NN	O
.	.	O

the	DT	O
baby	NN	O
was	VBD	O
delivered	VBN	O
through	IN	O
normal	JJ	O
spontaneous	JJ	O
vaginal	JJ	O
delivery	NN	O
with	IN	O
brief	JJ	B-TREATMENT
blow	NN	I-TREATMENT
by	IN	I-TREATMENT
with	IN	O
apgars	NNS	B-TEST
of	IN	O
8	CD	O
and	CC	O
9	CD	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
birth	NN	I-TEST
weight	NN	I-TEST
was	VBD	O
1.705	CD	O
kilograms	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
50th	CD	O
percentile	NN	O
.	.	O

length	NN	B-TEST
was	VBD	O
40	CD	O
cm	NN	O
,	,	O
50th	CD	O
percentile	NN	O
.	.	O

head	NN	B-TEST
circumference	NN	I-TEST
was	VBD	O
30	CD	O
cm	NN	O
,	,	O
50th	CD	O
percentile	NN	O
.	.	O

after	IN	O
receiving	VBG	O
brief	JJ	B-TREATMENT
blow	NN	I-TREATMENT
by	IN	I-TREATMENT
oxygen	NN	I-TREATMENT
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
ventilatory	JJ	B-TREATMENT
assistance	NN	I-TREATMENT
required	VBN	O
with	IN	O
good	JJ	O
respiratory	NN	O
rate	NN	O
consistently	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
never	RB	O
placed	VBN	O
on	IN	O
caffeine	NN	B-TREATMENT
.	.	O

no	DT	O
history	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
.	.	O

on	IN	O
no	DT	O
medications	NNS	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

notably	RB	O
with	IN	O
respect	NN	O
to	TO	O
apnea	VB	B-PROBLEM
and	CC	O
bradycardia	VB	B-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
reached	VBN	O
5	CD	O
days	NNS	O
without	IN	O
significant	JJ	B-PROBLEM
apneic	NN	I-PROBLEM
or	CC	I-PROBLEM
bradycardic	JJ	I-PROBLEM
spells	NNS	I-PROBLEM
as	IN	O
of	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
reached	VBD	O
full	JJ	O
volume	NN	O
feeds	NNS	O
by	IN	O
day	NN	O
of	IN	O
life	NN	O
6	CD	O
and	CC	O
had	VBD	O
calories	NNS	O
increased	VBN	O
to	TO	O
maximum	VB	O
of	IN	O
26	CD	O
kilocalories	NNS	O
per	IN	O
ounce	NN	O
of	IN	O
similac	NN	B-TREATMENT
special	JJ	I-TREATMENT
care	NN	I-TREATMENT
until	IN	O
2014-12-03	JJ	O
,	,	O
at	IN	O
which	WDT	O
point	NN	O
this	DT	O
was	VBD	O
weaned	VBN	O
to	TO	O
24	CD	O
kilocalories	NNS	O
per	IN	O
ounce	NN	O
of	IN	O
straight	JJ	B-TREATMENT
similac	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
with	IN	O
peak	JJ	B-TEST
bilirubin	NN	I-TEST
of	IN	O
6.5	CD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
3	CD	O
.	.	O

no	DT	O
phototherapy	NN	B-TREATMENT
was	VBD	O
required	VBN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
at	IN	O
delivery	NN	O
was	VBD	O
48	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
11.2	CD	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
301,000	CD	O
.	.	O

initial	JJ	B-TEST
differential	NN	I-TEST
was	VBD	O
35	CD	B-TEST
polys	NN	I-TEST
and	CC	O
zero	NN	B-TEST
bands	NNS	I-TEST
,	,	O
not	RB	O
suspicious	JJ	O
for	IN	O
infectious	JJ	B-PROBLEM
condition	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
until	IN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
had	VBN	O
no	DT	O
antibiotics	NNS	B-TREATMENT
since	IN	O
that	DT	O
time	NN	O
.	.	O

hearing	VBG	B-TEST
screen	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	B-TEST
auditory	NN	I-TEST
brainstem	NN	I-TEST
responses	NNS	I-TEST
and	CC	O
was	VBD	O
normal	JJ	O
on	IN	O
2014-11-24	JJ	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
qualify	VB	O
for	IN	O
routine	JJ	B-TEST
ophthalmology	NN	I-TEST
exams	NNS	I-TEST
due	JJ	O
to	TO	O
his	PRP$	O
gestational	JJ	O
age	NN	O
at	IN	O
birth	NN	O
.	.	O

1.	CD	O
feedings	NNS	O
at	IN	O
discharge	NN	O
-	:	O
similac	NN	B-TREATMENT
24	CD	O
kilocalories	NNS	O
per	IN	O
ounce	NN	O
p.o.	NN	O
ad	NN	O
lib	NN	O
.	.	O

2.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
positioning	VBG	I-TEST
screening	VBG	I-TEST
passed	VBN	O
.	.	O

3.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screening	NN	I-TEST
sent	VBD	O
per	IN	O
protocol	NN	O
and	CC	O
no	DT	O
abnormal	JJ	B-PROBLEM
reports	NNS	I-PROBLEM
have	VBP	O
been	VBN	O
received	VBN	O
.	.	O

4.	CD	O
immunizations	NNS	B-TREATMENT
received	VBD	O
:	:	O

synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
given	VBN	O
today	NN	O
due	JJ	O
to	TO	O
multiple	JJ	O
siblings	NNS	O
at	IN	O
home	NN	O
with	IN	O
daycare	JJ	O
exposure	NN	O
and	CC	O
the	DT	O
patient	NN	O
being	VBG	O
between	IN	O
32	CD	O
and	CC	O
35	CD	O
weeks	NNS	O
.	.	O

synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
in	IN	O
general	JJ	O
from	IN	O
november	NN	O
through	IN	O
march	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	VBG	O
3	CD	O
criteria	NNS	O
:	:	O

daycare	NN	O
during	IN	O
rsv	NN	O
season	NN	O
,	,	O
a	DT	O
smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
airway	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
school	NN	O
age	NN	O
sibling	NN	O
,	,	O
or	CC	O
3.	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
child	NN	O
's	POS	O
life	NN	O
,	,	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
.	.	O

2.	CD	O
apnea	NN	B-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

3.	CD	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

this	DT	O
82	CD	O
year	NN	O
old	JJ	O
retired	VBD	O
engineer	NN	O
has	VBZ	O
had	VBN	O
multiple	JJ	O
admissions	NNS	O
to	TO	O
the	DT	O
ph	NN	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
for	IN	O
multiple	JJ	B-PROBLEM
strokes	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
prostatic	JJ	B-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
managing	VBG	O
at	IN	O
home	NN	O
on	IN	O
restricted	JJ	B-TREATMENT
activity	NN	I-TREATMENT
but	CC	O
able	JJ	O
to	TO	O
get	VB	O
around	RP	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
but	CC	O
on	IN	O
the	DT	O
day	NN	O
before	IN	O
admission	NN	O
he	PRP	O
became	VBD	O
increasing	VBG	B-PROBLEM
dyspneic	NN	I-PROBLEM
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
he	PRP	O
collapsed	VBD	O
and	CC	O
was	VBD	O
unable	JJ	O
to	TO	O
walk	VB	O
to	TO	O
his	PRP$	O
bed	NN	O
.	.	O

on	IN	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
the	DT	O
patient	NN	O
was	VBD	O
both	DT	O
chronically	RB	B-PROBLEM
and	CC	I-PROBLEM
acutely	RB	I-PROBLEM
ill	VB	I-PROBLEM
,	,	O
dyspneic	NN	B-PROBLEM
,	,	O
mildly	RB	B-PROBLEM
febrile	JJ	I-PROBLEM
and	CC	O
with	IN	O
coarse	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
in	IN	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
his	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
otherwise	RB	O
stable	JJ	O
.	.	O

his	PRP$	B-PROBLEM
prostate	NN	I-PROBLEM
enlarged	VBD	I-PROBLEM
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
mild	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
of	IN	O
the	DT	B-TEST
wbc	NN	I-TEST
intermittently	RB	B-PROBLEM
grossly	RB	I-PROBLEM
bloody	JJ	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

no	DT	O
cultures	NNS	B-TEST
were	VBD	O
positive	JJ	B-PROBLEM
but	CC	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
bilateral	JJ	B-PROBLEM
densities	NNS	I-PROBLEM
more	RBR	O
on	IN	O
the	DT	O
left	NN	O
than	IN	O
the	DT	O
right	JJ	O
compatible	NN	O
with	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
radiographic	JJ	O
indications	NNS	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
clindamycin	NN	B-TREATMENT
intravenous	JJ	I-TREATMENT
and	CC	O
cefuroxime	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
with	IN	O
clearing	NN	O
of	IN	O
his	PRP$	B-PROBLEM
fever	NN	I-PROBLEM
but	CC	O
persistence	NN	O
of	IN	O
cough	NN	B-PROBLEM
,	,	O
choking	NN	B-PROBLEM
,	,	O
and	CC	O
intermittently	RB	B-PROBLEM
many	JJ	I-PROBLEM
coarse	JJ	I-PROBLEM
rales	NNS	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
base	NN	I-PROBLEM
with	IN	O
no	DT	O
clearing	NN	O
by	IN	B-TEST
x-ray	NN	I-TEST
.	.	O

his	PRP$	O
ambulation	NN	O
was	VBD	O
minimal	JJ	O
and	CC	O
always	RB	O
with	IN	O
assistance	NN	O
but	CC	O
he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
transurethral	JJ	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
prostate	NN	I-TREATMENT
on	IN	O
09/14/96	CD	O
.	.	O

he	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
louline	VB	O
mauikings	NNS	O
medical	JJ	O
center	NN	O
for	IN	O
future	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
and	CC	O
hopeful	JJ	O
return	NN	O
home	NN	O
with	IN	O
considerable	JJ	O
support	NN	O
and	CC	O
assistance	NN	O
.	.	O

aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
bilateral	NN	I-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
strokes	NNS	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
prostatic	JJ	B-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
gross	JJ	B-PROBLEM
hematuria	NN	I-PROBLEM
.	.	O

digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
.	.	O

hytrin	NN	B-TREATMENT
2mg	CD	O
at	IN	O
bedtime	NN	O
.	.	O

ticlid	JJ	B-TREATMENT
0.25	CD	O
g	JJ	O
po	NN	O
bid	NN	O
.	.	O

bronchodilators	NNS	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

strict	JJ	B-TREATMENT
aspiration	NN	I-TREATMENT
precautions	NNS	I-TREATMENT
with	IN	O
avoidance	NN	B-TREATMENT
of	IN	I-TREATMENT
clear	JJ	I-TREATMENT
liquids	NNS	I-TREATMENT
and	CC	O
all	DT	O
other	JJ	O
liquids	NNS	O
thickened	VBD	O
.	.	O

increased	VBN	O
ambulation	NN	O
with	IN	O
assistance	NN	O
and	CC	O
daily	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
by	IN	O
family	NN	O
and	CC	O
friends	NNS	O
to	TO	O
be	VB	O
somewhat	RB	B-PROBLEM
confused	JJ	I-PROBLEM
and	CC	O
was	VBD	O
therefore	RB	O
taken	VBN	O
to	TO	O
newton-wellesley	JJ	O
hospital	NN	O
thereafter	RB	O
.	.	O

workup	NN	B-TEST
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
included	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
revealing	VBG	O
a	DT	O
possible	JJ	O
parietal	JJ	B-PROBLEM
subdural	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
gcs	NN	I-TEST
was	VBD	O
15	CD	O
.	.	O

she	PRP	O
was	VBD	O
thereafter	RB	O
transferred	VBN	O
to	TO	O
beverly	VB	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
and	CC	O
management	NN	B-TREATMENT
.	.	O

significant	JJ	O
for	IN	O
depression	NN	B-PROBLEM
.	.	O

1.	CD	O
prozac	NN	B-TREATMENT
.	.	O

2.	CD	O
tetracycline	NN	B-TREATMENT
for	IN	O
acne	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
presentation	NN	O
,	,	O
her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
98.8	CD	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
100	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
110/65	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
saturating	VBG	O
at	IN	O
100%	CD	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
she	PRP	O
is	VBZ	O
well	RB	O
appearing	VBG	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
examination	NN	I-TEST
-	:	O
the	DT	O
pupils	NNS	O
are	VBP	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
.	.	O

no	DT	O
obvious	JJ	O
evidence	NN	O
of	IN	O
trauma	NN	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

no	DT	O
crepitus	NN	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

extremities	NNS	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
step-off	NN	B-PROBLEM
,	,	O
palpable	JJ	O
pulses	NNS	O
peripherally	RB	O
.	.	O

rectal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
heme	JJ	B-TEST
negative	JJ	O
with	IN	O
normal	JJ	O
tone	NN	O
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

admission	NN	B-TEST
laboratories	NNS	I-TEST
were	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
13.1	CD	O
,	,	O
hematocrit	NN	B-TEST
34.0	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
280,000	CD	O
.	.	O

chemistries	NNS	B-TEST
were	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
143	CD	O
,	,	O
potassium	NN	B-TEST
3.2	CD	O
,	,	O
chloride	NN	B-TEST
and	CC	O
bicarbonate	NN	B-TEST
of	IN	O
104	CD	O
and	CC	O
24	CD	O
,	,	O
respectively	RB	O
,	,	O
with	IN	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
7	CD	O
and	CC	O
0.4	CD	O
,	,	O
respectively	RB	O
.	.	O

blood	NN	B-TEST
glucose	NN	I-TEST
was	VBD	O
116	CD	O
.	.	O

her	PRP$	B-TEST
admission	NN	I-TEST
coagulation	NN	I-TEST
studies	NNS	I-TEST
were	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
inr	NN	B-TEST
of	IN	O
11.8	CD	O
and	CC	O
0.9	CD	O
,	,	O
respectively	RB	O
with	IN	O
a	DT	B-TEST
partial	JJ	I-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
of	IN	O
25.2	CD	O
.	.	O

admission	NN	B-TEST
lactate	NN	I-TEST
was	VBD	O
0.8	CD	O
.	.	O

amylase	NN	B-TEST
was	VBD	O
87	CD	O
.	.	O

fibrinogen	NN	B-TEST
was	VBD	O
346	CD	O
.	.	O

hcg	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

serum	NN	B-TEST
toxicology	NN	I-TEST
and	CC	O
urine	JJ	B-TEST
toxicology	NN	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

urinalysis	NN	B-TEST
obtained	VBN	O
on	IN	O
admission	NN	O
was	VBD	O
additionally	RB	O
negative	JJ	O
.	.	O

she	PRP	O
had	VBD	O
three	CD	B-TEST
views	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
that	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

pelvis	NN	B-TEST
film	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
from	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
just	RB	O
revealed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
right	JJ	I-PROBLEM
parietal	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
blood	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
off	RB	O
tls	JJ	B-TREATMENT
precautions	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
monitoring	VBG	O
overnight	JJ	O
for	IN	O
neural	JJ	B-TEST
checks	NNS	I-TEST
and	CC	O
neurosurgical	JJ	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
.	.	O

neurosurgical	JJ	B-TEST
evaluation	NN	I-TEST
just	RB	O
recommended	VBN	O
serial	JJ	B-TEST
neurologic	JJ	I-TEST
checks	NNS	I-TEST
and	CC	O
a	DT	B-TEST
repeat	NN	I-TEST
cat	NN	I-TEST
scan	NN	I-TEST
on	IN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
to	TO	O
see	VB	O
if	IN	O
there	EX	O
was	VBD	O
any	DT	O
evidence	NN	O
of	IN	O
progression	NN	O
of	IN	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

on	IN	O
2010-02-05	JJ	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
cat	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
revealing	VBG	O
no	DT	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
subdural	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
neurologic	JJ	I-TEST
examination	NN	I-TEST
remained	VBD	O
nonfocal	JJ	O
.	.	O

she	PRP	O
was	VBD	O
kept	VBN	O
in	IN	O
the	DT	O
hospital	NN	O
for	IN	O
an	DT	O
additional	JJ	O
24	CD	O
hours	NNS	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

by	IN	O
2010-02-06	CD	O
,	,	O
which	WDT	O
would	MD	O
correlate	VB	O
with	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
complaints	NNS	O
except	IN	O
for	IN	O
some	DT	B-PROBLEM
small	JJ	I-PROBLEM
frontal	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
in	IN	O
the	DT	O
region	NN	O
of	IN	O
where	WRB	O
the	DT	B-PROBLEM
bleed	NN	I-PROBLEM
had	VBD	O
been	VBN	O
localized	VBN	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
.	.	O

she	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
hemodynamically	RB	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
other	JJ	O
complaints	NNS	O
by	IN	O
examination	NN	B-TEST
.	.	O

her	PRP$	B-TEST
neurologic	JJ	I-TEST
examination	NN	I-TEST
remained	VBD	O
completely	RB	O
nonfocal	JJ	O
and	CC	O
otherwise	RB	O
normal	JJ	O
.	.	O

1.	CD	O
tylenol	JJ	B-TREATMENT
#3	RB	I-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	JJ	O
q	JJ	O
4-6	JJ	O
hours	NNS	O
p.r.n.	VBP	O

2.	CD	O
motrin	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
prozac	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
daily	RB	O
.	.	O

4.	CD	O
tetracycline	NN	B-TREATMENT
which	WDT	O
she	PRP	O
was	VBD	O
taking	VBG	O
for	IN	O
her	PRP$	B-PROBLEM
acne	NN	I-PROBLEM
.	.	O

1.	CD	O
right	JJ	B-PROBLEM
parietal	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
fall	NN	O
from	IN	O
standing	VBG	O
position	NN	O
with	IN	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
and	CC	O
no	DT	O
neurologic	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
or	CC	O
progression	NN	B-PROBLEM
.	.	O

2.	CD	O
depression	NN	B-PROBLEM
.	.	O

3.	CD	O
acne	NN	B-PROBLEM
.	.	O

metastatic	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
breast	NN	I-PROBLEM
.	.	O

1.	CD	O
hyponatremia	NN	B-PROBLEM
,	,	O
1-13-94	JJ	O
.	.	O

2.	CD	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
,	,	O
1-14-94	JJ	O
.	.	O

3.	CD	O
diarrhea	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
,	,	O
fever	NN	B-PROBLEM
.	.	O

4.	CD	O
history	NN	O
of	IN	O
ovarian	JJ	B-TREATMENT
cyst	NN	I-TREATMENT
resection	NN	I-TREATMENT
,	,	O
1975	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
a	DT	B-PROBLEM
metastatic	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
breast	NN	I-PROBLEM
who	WP	O
is	VBZ	O
status	NN	O
post	NN	O
high	JJ	B-TREATMENT
dose	NN	I-TREATMENT
chemotherapy	NN	I-TREATMENT
with	IN	O
pbse	NN	B-TREATMENT
and	CC	O
ccss	JJ	B-TREATMENT
support	NN	I-TREATMENT
ending	VBG	O
june	NN	O
1994	CD	O
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
1-5-94	NNS	O
for	IN	O
fever	NN	B-PROBLEM
,	,	O
chest	VBP	B-PROBLEM
wall	NN	I-PROBLEM
ulceration	NN	I-PROBLEM
,	,	O
cellulitis	NN	B-PROBLEM
and	CC	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
first	RB	O
presented	VBN	O
in	IN	O
october	JJ	O
1991	CD	O
with	IN	O
a	DT	B-PROBLEM
tender	NN	I-PROBLEM
right	NN	I-PROBLEM
axillary	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
mammogram	NN	I-TEST
done	VBN	O
in	IN	O
november	JJ	O
1990	CD	O
was	VBD	O
negative	JJ	O
.	.	O

however	RB	O
,	,	O
mammography	NN	B-TEST
repeated	VBN	O
in	IN	O
october	NN	O
1991	CD	O
showed	VBD	O
bilateral	JJ	B-PROBLEM
breast	NN	I-PROBLEM
masses	NNS	I-PROBLEM
,	,	O
suspicious	JJ	O
for	IN	O
carcinoma	NN	B-PROBLEM
.	.	O

fine	JJ	B-TEST
needle	JJ	I-TEST
aspiration	NN	I-TEST
on	IN	O
october	$	O
23	CD	O
,	,	O
1991	CD	O
demonstrated	VBD	O
atypical	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
which	WDT	O
occurred	VBD	O
singly	RB	O
and	CC	O
in	IN	O
clusters	NNS	O
.	.	O

staging	VBG	B-TEST
evaluation	NN	I-TEST
included	VBD	O
normal	JJ	O
liver	JJ	O
function	NN	O
tests	NNS	O
,	,	O
normal	JJ	O
blood	NN	O
counts	NNS	O
and	CC	O
normal	JJ	O
chest	JJ	O
x-ray	NN	O
.	.	O

bone	NN	B-TEST
scan	JJ	I-TEST
showed	VBD	O
degenerative	JJ	B-PROBLEM
joint	JJ	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
shoulders	NNS	I-PROBLEM
and	CC	I-PROBLEM
lumbar	NN	I-PROBLEM
spine	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
increased	VBN	B-PROBLEM
radio	NN	I-PROBLEM
chaser	NN	I-PROBLEM
uptake	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
breast	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

dr.	NN	O
berca	NN	O
gachfrum	NN	O
performed	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
modified	VBN	I-TREATMENT
mastectomy	NN	I-TREATMENT
and	CC	O
left	VBD	B-TREATMENT
simple	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
on	IN	O
november	JJ	O
4	CD	O
,	,	O
1991	CD	O
.	.	O

the	DT	B-TREATMENT
right	NN	I-TREATMENT
modified	VBD	I-TREATMENT
radical	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
contained	VBD	O
a	DT	B-PROBLEM
5.5	CD	I-PROBLEM
cm	NN	I-PROBLEM
poorly	RB	I-PROBLEM
differentiated	VBN	I-PROBLEM
,	,	I-PROBLEM
grade	VB	I-PROBLEM
iii	NN	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
iii	NN	I-PROBLEM
infiltrating	VBG	I-PROBLEM
ductal	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

the	DT	O
margins	NNS	O
were	VBD	O
free	JJ	O
of	IN	O
tumor	NN	B-PROBLEM
,	,	O
but	CC	O
10	CD	O
out	IN	O
of	IN	O
21	CD	O
lymph	NN	O
nodes	NNS	O
were	VBD	O
positive	JJ	O
for	IN	O
metastatic	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

furthermore	RB	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
pectoralis	NN	I-PROBLEM
muscle	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
supposed	VBN	O
to	TO	O
be	VB	O
metastatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
left	JJ	I-TREATMENT
simple	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
also	RB	O
contained	VBD	O
5.5	CD	B-PROBLEM
cm	NNS	I-PROBLEM
poorly	RB	I-PROBLEM
differentiated	VBD	I-PROBLEM
infiltrating	JJ	I-PROBLEM
ductal	NN	I-PROBLEM
and	CC	I-PROBLEM
intraductal	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
with	IN	O
extensive	JJ	B-PROBLEM
lymphatic	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
invasion	NN	I-PROBLEM
.	.	O

estrogen	NN	B-TEST
receptor	NN	I-TEST
was	VBD	O
0%	CD	O
by	IN	O
erica	NN	O
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
requiring	VBG	O
surgical	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

therefore	RB	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
stage	NN	I-PROBLEM
iii-a	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
breast	NN	I-PROBLEM
.	.	O

since	IN	O
she	PRP	O
was	VBD	O
at	IN	O
high	JJ	O
risk	NN	O
for	IN	O
both	DT	O
local	JJ	B-PROBLEM
and	CC	I-PROBLEM
metastatic	JJ	I-PROBLEM
recurrence	NN	I-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
tumor	NN	I-PROBLEM
,	,	O
she	PRP	O
received	VBD	O
both	DT	O
systemic	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
cmsap	NN	B-TREATMENT
,	,	O
which	WDT	O
is	VBZ	O
cytoxan	NN	B-TREATMENT
,	,	O
methotrexate	NN	B-TREATMENT
,	,	O
leukovoranrescue	NN	B-TREATMENT
,	,	O
5-fu	JJ	B-TREATMENT
,	,	O
adriamycin	JJ	B-TREATMENT
and	CC	O
prednisone	NN	B-TREATMENT
for	IN	O
four	CD	O
cycles	NNS	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
dose	JJ	O
reductions	NNS	O
for	IN	O
mucositis	NN	B-PROBLEM
or	CC	O
myelosuppression	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
following	VBG	O
cycle	NN	O
4	CD	O
,	,	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
flu-like	JJ	I-PROBLEM
illness	NN	I-PROBLEM
,	,	O
followed	VBN	O
by	IN	O
fever	NN	B-PROBLEM
,	,	O
nonproductive	JJ	B-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

abgs	NN	B-TEST
showed	VBD	O
a	DT	B-TEST
po2	NN	I-TEST
of	IN	O
79	CD	O
,	,	O
ph	NN	B-TEST
7.44	CD	O
,	,	O
po2	RB	B-TEST
33	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
diffuse	IN	B-PROBLEM
interstitial	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
.	.	O

the	DT	O
differential	JJ	O
diagnosis	NN	O
included	VBD	O
viral	JJ	B-PROBLEM
pneumonitis	NN	I-PROBLEM
,	,	O
mycoplasma	NN	B-PROBLEM
,	,	O
chlamydia	NN	B-PROBLEM
.	.	O

basically	RB	O
in	IN	O
december	NN	O
1993	CD	O
,	,	O
she	PRP	O
returned	VBD	O
to	TO	O
the	DT	O
hem	NN	O
/	NNP	O
onc	VBZ	O
clinic	JJ	O
with	IN	O
chest	JJS	B-PROBLEM
wall	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
which	WDT	O
turned	VBD	O
out	RP	O
to	TO	O
be	VB	O
tumor	JJ	B-PROBLEM
recurrences	NNS	I-PROBLEM
and	CC	O
biopsied	VBN	O
.	.	O

although	IN	O
she	PRP	O
had	VBD	O
mediastinal	JJ	B-PROBLEM
recurrence	NN	I-PROBLEM
,	,	O
bone	NN	B-TEST
scan	JJ	I-TEST
,	,	O
head	NN	B-TEST
and	CC	I-TEST
liver	NN	I-TEST
ct	NNS	I-TEST
were	VBD	O
negative	JJ	O
for	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
thus	RB	O
started	VBN	O
on	IN	O
a	DT	O
protocol	NN	O
of	IN	O
high	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
with	IN	O
gcsf	NN	B-TREATMENT
and	CC	O
peripheral	JJ	B-TREATMENT
stem	NN	I-TREATMENT
cell	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

complications	NNS	B-PROBLEM
has	VBZ	O
mainly	RB	O
included	VBN	O
myelosuppression	NN	B-PROBLEM
and	CC	O
mucositis	NN	B-PROBLEM
.	.	O

she	PRP	O
also	RB	O
developed	VBD	O
klebsiella	NN	B-PROBLEM
uti	NN	I-PROBLEM
after	IN	O
the	DT	O
second	JJ	O
cycle	NN	O
of	IN	O
high	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
gent	NN	B-TREATMENT
and	CC	O
cipro	NN	B-TREATMENT
.	.	O

re-staging	VBG	B-TEST
done	VBN	O
in	IN	O
april	NN	O
1993	CD	O
showed	VBD	O
a	DT	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pretracheal	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
with	IN	O
question	NN	O
of	IN	O
some	DT	B-PROBLEM
lymphangitic	JJ	I-PROBLEM
spread	NN	I-PROBLEM
versus	IN	O
some	DT	B-PROBLEM
pneumonitis	NN	I-PROBLEM
.	.	O

in	IN	O
may	MD	O
1994	CD	O
she	PRP	O
received	VBD	O
her	PRP	O
first	JJ	O
course	NN	O
of	IN	O
thiotepa	NN	B-TREATMENT
and	CC	O
velban	NN	B-TREATMENT
and	CC	O
methotrexate	NN	B-TREATMENT
,	,	O
which	WDT	O
required	VBD	O
some	DT	B-TREATMENT
red	JJ	I-TREATMENT
cell	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

in	IN	O
mid	NN	O
may	MD	O
she	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
fever	NN	B-PROBLEM
and	CC	O
neutropenia	NN	B-PROBLEM
and	CC	O
at	IN	O
that	DT	O
time	NN	O
had	VBD	O
a	DT	B-PROBLEM
uti	JJ	I-PROBLEM
with	IN	O
blood	NN	B-PROBLEM
clots	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presents	NNS	O
today	NN	O
with	IN	O
complaints	NNS	O
of	IN	O
fever	NN	B-PROBLEM
and	CC	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
100	CD	O
.	.	O

she	PRP	O
has	VBZ	O
also	RB	O
been	VBN	O
having	VBG	O
diarrhea	NN	B-PROBLEM
since	IN	O
november	NN	O
and	CC	O
her	PRP$	O
other	JJ	O
complaints	NNS	O
of	IN	O
admission	NN	O
include	VBP	O
confusion	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
metastatic	JJ	B-PROBLEM
breast	NN	I-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
complicated	VBN	O
by	IN	O
fever	NN	B-PROBLEM
and	CC	O
neutropenia	NN	B-PROBLEM
.	.	O

utis	NN	B-PROBLEM
,	,	O
obstruction	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
subclavian	JJ	I-PROBLEM
vein	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
brachial	NN	I-PROBLEM
cephalic	NN	I-PROBLEM
vein	NN	I-PROBLEM
,	,	O
herpes	VBZ	B-PROBLEM
zoster	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
ovarian	JJ	B-TREATMENT
cyst	NN	I-TREATMENT
resection	NN	I-TREATMENT
in	IN	O
1975	CD	O
.	.	O

she	PRP	O
used	VBD	O
the	DT	B-TREATMENT
pill	NN	I-TREATMENT
for	IN	O
five	CD	O
years	NNS	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

she	PRP	O
is	VBZ	O
g	JJ	O
2	CD	O
,	,	O
p	VBD	O
2	CD	O
with	IN	O
spontaneous	JJ	B-TREATMENT
vaginal	JJ	I-TREATMENT
deliveries	NNS	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
easy	JJ	B-PROBLEM
bruis	JJ	I-PROBLEM
ability	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
augmentin	VB	B-TREATMENT
which	WDT	O
gives	VBZ	O
her	PRP	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
,	,	O
msir	NN	B-TREATMENT
,	,	O
and	CC	O
percocet	NN	B-TREATMENT
.	.	I-TREATMENT

t	NN	B-TEST
100.1	CD	O
,	,	O
p	NN	B-TEST
104	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
130/90	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
16	CD	O
,	,	O
she	PRP	O
was	VBD	O
sating	VBG	B-TEST
95%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

heent	NN	O
-	:	O
pupils	NNS	O
were	VBD	O
miotic	JJ	B-PROBLEM
,	,	O
measuring	VBG	O
2	CD	O
mm	NNS	O
but	CC	O
responsive	JJ	O
to	TO	O
light	NN	O
.	.	O

neck	SYM	O
-	:	O
tender	NN	B-PROBLEM
on	IN	O
the	DT	O
leftside	NN	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

chest	JJS	O
actually	RB	O
had	VBD	O
a	DT	B-PROBLEM
5	CD	I-PROBLEM
x	NN	I-PROBLEM
7	CD	I-PROBLEM
cm	JJ	I-PROBLEM
necrotic	JJ	I-PROBLEM
area	NN	I-PROBLEM
on	IN	O
the	DT	O
left	NN	O
chest	JJS	O
wall	NN	O
with	IN	O
some	DT	B-PROBLEM
pus	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
hsm	NN	B-PROBLEM
.	.	O

extremities	NNS	O
-	:	O
her	PRP$	O
left	JJ	O
arm	NN	O
was	VBD	O
very	RB	B-PROBLEM
swollen	JJ	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
tested	VBN	O
with	IN	O
no	DT	B-PROBLEM
voluntary	JJ	I-PROBLEM
movement	NN	I-PROBLEM
except	IN	O
at	IN	O
the	DT	O
finger	NN	O
tips	NNS	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
edema	NN	B-PROBLEM
elsewhere	RB	O
in	IN	O
her	PRP$	O
extremities	NNS	O
,	,	O
only	RB	O
the	DT	O
left	JJ	O
arm	NN	O
.	.	O

neuro	SYM	O
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
oriented	VBN	O
to	TO	O
place	VB	O
,	,	O
but	CC	O
had	VBD	O
difficulty	NN	B-PROBLEM
with	IN	I-PROBLEM
recent	JJ	I-PROBLEM
memory	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
mild	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
extremities	VBZ	I-PROBLEM
,	,	O
both	DT	O
upper	JJ	O
and	CC	O
lower	JJR	O
.	.	O

of	IN	O
note	NN	O
-	:	O
na	NN	B-TEST
133	CD	O
,	,	O
k	VBD	B-TEST
4	CD	O
,	,	O
wbc	VBD	B-TEST
8.82	CD	O
,	,	O
hematocrit	NN	B-TEST
35.1	CD	O
,	,	O
platelets	NNS	B-TEST
229	CD	O
.	.	O

pt	NN	B-TEST
13.8	CD	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.3	CD	O
,	,	O
ptt	NN	B-TEST
25.5	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
was	VBD	O
6.2	CD	O
,	,	O
albumin	RB	B-TEST
3.4	CD	O
,	,	O
globulin	NN	B-TEST
of	IN	O
2.8	CD	O
,	,	O
calcium	NN	B-TEST
of	IN	O
9.1	CD	O
,	,	O
phos	NN	B-TEST
2.7	CD	O
,	,	O
mag	FW	B-TEST
2.1	CD	O
,	,	O
urea	JJ	B-TEST
3.7	CD	O
.	.	O

alt	NN	B-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
at	IN	O
240	CD	O
,	,	O
ast	RB	B-TEST
85	CD	O
,	,	O
ldh	VBD	B-TEST
305	CD	O
,	,	O
alk	VBP	B-TEST
phos	JJ	I-TEST
85	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
1.3	CD	O
,	,	O
direct	JJ	B-TEST
bili	NN	I-TEST
was	VBD	O
.8	NNP	O
.	.	O

cholesterol	NN	B-TEST
188	CD	O
,	,	O
triglyceride	NN	B-TEST
was	VBD	O
127	CD	O
.	.	O

ua	JJ	B-TEST
-	:	O
trace	NN	B-PROBLEM
protein	NN	I-PROBLEM
,	,	O
trace	NN	B-PROBLEM
ketones	NNS	I-PROBLEM
,	,	O
positive	JJ	B-PROBLEM
for	IN	I-PROBLEM
bilirubin	NN	I-PROBLEM
and	CC	I-PROBLEM
nitrogen	NN	I-PROBLEM
and	CC	O
also	RB	O
4	CD	B-PROBLEM
to	TO	I-PROBLEM
6	CD	I-PROBLEM
wbcs	NN	I-PROBLEM
with	IN	O
1+	CD	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
-	:	O
showed	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
paratracheal	NN	I-PROBLEM
adenopathy	NN	I-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
left	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

in	IN	O
summary	JJ	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
breast	NN	I-PROBLEM
cell	NN	I-PROBLEM
ca	MD	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
chemotherapy	NN	B-TREATMENT
with	IN	O
cmsap	NN	B-TREATMENT
and	CC	O
pvsc	NN	B-TREATMENT
and	CC	O
xrt	NN	B-TREATMENT
who	WP	O
presented	VBD	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
four	CD	O
days	NNS	O
of	IN	O
diarrhea	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
and	CC	O
had	VBD	O
been	VBN	O
on	IN	O
keflex	NN	B-TREATMENT
for	IN	O
an	DT	B-PROBLEM
erythema	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
chest	NN	I-PROBLEM
wall	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
keflex	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
when	WRB	O
she	PRP	O
developed	VBD	O
the	DT	B-PROBLEM
diarrhea	NN	I-PROBLEM
.	.	O

when	WRB	O
she	PRP	O
arrived	VBD	O
the	DT	O
plan	NN	O
was	VBD	O
to	TO	O
go	VB	O
ahead	RB	O
and	CC	O
treat	VB	O
here	RB	B-PROBLEM
rythematous	JJ	I-PROBLEM
induration	NN	I-PROBLEM
and	CC	O
possible	JJ	O
cellulitis	NN	B-PROBLEM
with	IN	O
iv	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

so	IN	O
she	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
dicloxicillin	NN	B-TREATMENT
and	CC	O
we	PRP	O
did	VBD	O
local	JJ	B-TREATMENT
wound	NN	I-TREATMENT
care	NN	I-TREATMENT
with	IN	O
an	DT	B-TREATMENT
agent	NN	I-TREATMENT
called	VBN	O
santyl	NN	B-TREATMENT
,	,	O
which	WDT	O
is	VBZ	O
a	DT	B-TREATMENT
collagenace	NN	I-TREATMENT
ondebrided	VBD	I-TREATMENT
which	WDT	O
worked	VBD	O
very	RB	O
well	RB	O
for	IN	O
her	PRP$	O
.	.	O

also	RB	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
we	PRP	O
were	VBD	O
also	RB	O
considering	VBG	O
palliative	JJ	B-TREATMENT
taxol	NN	I-TREATMENT
chemotherapy	NN	I-TREATMENT
,	,	O
which	WDT	O
the	DT	O
patient	NN	O
declined	VBD	O
.	.	O

she	PRP	O
refused	VBD	O
the	DT	B-TREATMENT
taxol	NN	I-TREATMENT
therapy	NN	I-TREATMENT
so	IN	O
that	DT	O
was	VBD	O
not	RB	O
done	VBN	O
.	.	O

another	DT	O
major	JJ	O
issue	NN	O
with	IN	O
this	DT	O
patient	NN	O
was	VBD	O
pain	VBN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
been	VBN	O
in	IN	O
a	DT	O
whole	JJ	O
lot	NN	O
of	IN	O
pain	NN	B-PROBLEM
from	IN	O
her	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

so	RB	O
pain	JJ	B-TREATMENT
control	NN	I-TREATMENT
was	VBD	O
a	DT	O
big	JJ	O
issue	NN	O
so	IN	O
she	PRP	O
was	VBD	O
on	IN	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
and	CC	O
msir	NN	B-TREATMENT
at	IN	O
home	NN	O
she	PRP	O
thought	VBD	O
that	IN	O
clouded	VBD	O
her	PRP	O
thinking	NN	O
,	,	O
so	IN	O
we	PRP	O
tried	VBD	O
different	JJ	O
things	NNS	O
for	IN	O
pain	NN	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

one	CD	O
of	IN	O
them	PRP	O
was	VBD	O
to	TO	O
do	VB	O
a	DT	B-TREATMENT
subarachnoid	NN	I-TREATMENT
neurologic	JJ	I-TREATMENT
block	NN	I-TREATMENT
at	IN	I-TREATMENT
c6-c7	JJ	I-TREATMENT
interface	NN	I-TREATMENT
on	IN	O
1-6-94	NNS	O
.	.	O

after	IN	O
that	DT	O
the	DT	O
patient	NN	O
had	VBD	O
minimal	JJ	O
relief	NN	O
of	IN	O
pain	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
she	PRP	O
declined	VBD	O
further	RBR	B-TREATMENT
blocks	NNS	I-TREATMENT
,	,	O
which	WDT	O
were	VBD	O
offered	VBN	O
to	TO	O
her	PRP$	O
.	.	O

so	RB	O
accepted	VBN	O
to	TO	O
be	VB	O
on	IN	O
dilaudid	NN	B-TREATMENT
p.o.	NN	I-TREATMENT
which	WDT	O
was	VBD	O
started	VBN	O
at	IN	O
a	DT	O
dosage	NN	O
of	IN	O
2-4	JJ	O
meg	NN	O
but	CC	O
since	IN	O
then	RB	O
we	PRP	O
have	VBP	O
tapered	VBN	O
it	PRP	O
up	RP	O
.	.	O

she	PRP	O
is	VBZ	O
now	RB	O
getting	VBG	O
dilaudid	RB	B-TREATMENT
8	CD	O
mg	NNS	O
q2h	NN	O
and	CC	O
in	IN	O
addition	NN	O
she	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
now	RB	O
getting	VBG	O
75	CD	O
micrograms	NNS	O
per	IN	O
hour	NN	O
of	IN	O
the	DT	B-TREATMENT
fentanyl	NN	I-TREATMENT
patch	NN	I-TREATMENT
which	WDT	O
is	VBZ	O
changed	VBN	O
every	DT	O
72	CD	O
hours	NNS	O
.	.	O

we	PRP	O
can	MD	O
go	VB	O
up	RP	O
by	IN	O
25	CD	O
mg	NNS	O
on	IN	O
the	DT	B-TREATMENT
fentanyl	JJ	I-TREATMENT
patch	NN	I-TREATMENT
as	IN	O
needed	VBN	O
to	TO	O
control	VB	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
we	PRP	O
can	MD	O
always	RB	O
go	VB	O
up	RP	O
on	IN	O
the	DT	B-TREATMENT
dilaudid	NN	I-TREATMENT
because	IN	O
she	PRP	O
is	VBZ	O
still	RB	O
in	IN	O
considerable	JJ	O
amount	NN	O
of	IN	O
pain	NN	B-PROBLEM
.	.	O

other	JJ	O
things	NNS	O
that	WDT	O
happened	VBD	O
during	IN	O
this	DT	O
admission	NN	O
-	:	O
we	PRP	O
obtained	VBD	O
ahead	RB	B-TEST
ct	NN	I-TEST
for	IN	O
her	PRP$	O
on	IN	O
the	DT	O
8th	CD	O
of	IN	O
january	JJ	O
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
clouded	JJ	I-PROBLEM
thinking	NN	I-PROBLEM
and	CC	O
altered	VBD	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
probably	RB	O
due	JJ	O
to	TO	O
the	DT	B-TREATMENT
morphine	NN	I-TREATMENT
that	IN	O
she	PRP	O
was	VBD	O
taking	VBG	O
.	.	O

we	PRP	O
went	VBD	O
ahead	RB	O
and	CC	O
got	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
scanand	NN	O
it	PRP	O
showed	VBD	O
no	DT	O
enhancing	VBG	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
her	PRP$	B-TEST
liver	NN	I-TEST
transaminases	NNS	I-TEST
were	VBD	O
elevated	VBN	B-PROBLEM
,	,	O
we	PRP	O
thought	VBD	O
about	IN	O
doing	VBG	O
further	JJ	B-TEST
work-up	NN	I-TEST
,	,	O
but	CC	O
that	DT	O
was	VBD	O
deferred	VBN	O
because	IN	O
the	DT	O
patient	NN	O
wanted	VBD	O
to	TO	O
wait	VB	O
on	IN	O
that	DT	O
.	.	O

the	DT	O
patient	NN	O
on	IN	O
january	JJ	O
13	CD	O
became	VBD	O
hyponatremic	JJ	B-PROBLEM
.	.	O

her	PRP$	B-TEST
sodium	NN	I-TEST
went	VBD	O
down	RB	O
to	TO	O
121	CD	O
and	CC	O
before	IN	O
that	DT	O
on	IN	O
admission	NN	O
she	PRP	O
was	VBD	O
133	CD	O
.	.	O

a	DT	O
renal	JJ	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
their	PRP$	B-TEST
assessment	NN	I-TEST
was	VBD	O
that	IN	O
this	DT	O
was	VBD	O
probably	RB	O
a	DT	O
mixture	NN	O
of	IN	O
hypovolemia	NN	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
siadh	NN	B-PROBLEM
.	.	O

we	PRP	O
proceeded	VBD	O
to	TO	O
do	VB	O
for	IN	O
her	PRP$	B-PROBLEM
hyponatremia	NN	I-PROBLEM
-	:	O
we	PRP	O
gave	VBD	O
her	PRP	O
some	DT	B-TREATMENT
fluid	NN	I-TREATMENT
and	CC	O
her	PRP$	B-TEST
urine	JJ	I-TEST
sodium	NN	I-TEST
became	VBD	O
higher	JJR	O
than	IN	O
her	PRP$	B-TEST
serum	JJ	I-TEST
sodium	NN	I-TEST
;	:	O
we	PRP	O
stopped	VBD	O
it	PRP	O
.	.	O

we	PRP	O
had	VBD	O
given	VBN	O
her	PRP$	O
some	DT	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
and	CC	O
then	RB	O
we	PRP	O
proceeded	VBD	O
to	TO	O
just	RB	O
do	VB	O
fluid	JJR	B-TREATMENT
restriction	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
we	PRP	O
gave	VBD	O
her	PRP	O
a	DT	B-TREATMENT
sodium	NN	I-TREATMENT
chloride	NN	I-TREATMENT
one	CD	O
gram	NN	O
per	IN	O
day	NN	O
and	CC	O
that	IN	O
also	RB	O
helped	VBD	O
,	,	O
so	IN	O
that	DT	O
now	RB	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
sodium	NN	I-TEST
is	VBZ	O
between	IN	O
126	CD	O
and	CC	O
129	CD	O
;	:	O
prior	RB	O
to	TO	O
that	IN	O
it	PRP	O
had	VBD	O
gone	VBN	O
down	RB	O
to	TO	O
as	IN	O
low	JJ	O
116.	CD	O

we	PRP	O
suggest	VBP	O
continuing	VBG	O
increased	VBD	B-TREATMENT
salt	JJ	I-TREATMENT
intake	NN	I-TREATMENT
in	IN	O
her	PRP$	O
diet	NN	O
and	CC	O
also	RB	O
continuing	VBG	O
with	IN	O
the	DT	B-TREATMENT
fluid	JJ	I-TREATMENT
restriction	NN	I-TREATMENT
of	IN	I-TREATMENT
free	JJ	I-TREATMENT
water	NN	I-TREATMENT
intake	NN	I-TREATMENT
to	TO	O
one	CD	O
liter	NN	O
per	IN	O
day	NN	O
.	.	O

on	IN	O
the	DT	O
14th	CD	O
of	IN	O
january	NN	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
taken	VBN	O
showed	VBD	O
a	DT	B-PROBLEM
wedge	NN	I-PROBLEM
shaped	VBN	I-PROBLEM
infiltrate	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
lobe	NN	I-PROBLEM
which	WDT	O
was	VBD	O
consistent	JJ	O
with	IN	O
hampton	NN	B-PROBLEM
&apos;s	NNP	I-PROBLEM
hump	NN	I-PROBLEM
.	.	O

also	RB	O
a	DT	B-TEST
vq	JJ	I-TEST
scan	NN	I-TEST
obtained	VBD	O
the	DT	O
next	JJ	O
day	NN	O
showed	VBD	O
high	JJ	O
probability	NN	O
for	IN	O
pe	NN	B-PROBLEM
.	.	O

so	IN	O
we	PRP	O
proceeded	VBD	O
to	TO	O
put	VB	O
her	PRP$	O
on	IN	O
heparin	NN	B-TREATMENT
for	IN	O
anticoagulation	NN	B-TREATMENT
and	CC	O
then	RB	O
when	WRB	O
she	PRP	O
was	VBD	O
therapeutic	JJ	O
on	IN	O
heparin	NN	B-TREATMENT
,	,	O
we	PRP	O
went	VBD	O
ahead	RB	O
and	CC	O
started	VBD	O
her	PRP$	O
on	IN	O
coumadin	NN	B-TREATMENT
and	CC	O
she	PRP	O
is	VBZ	O
currently	RB	O
on	IN	O
coumadin	NN	B-TREATMENT
at	IN	O
2.5	CD	O
mg	NNS	O
q.h.s.	NN	O

her	PRP$	B-TEST
inr	NN	I-TEST
is	VBZ	O
2.3	CD	O
.	.	O

we	PRP	O
want	VBP	O
her	PRP$	B-TEST
inr	NN	I-TEST
to	TO	O
remain	VB	O
between	IN	O
2	CD	O
and	CC	O
3	CD	O
.	.	O

so	RB	O
if	IN	O
it	PRP	O
goes	VBZ	O
much	RB	O
lower	JJR	O
than	IN	O
2	CD	O
,	,	O
then	RB	O
we	PRP	O
would	MD	O
consider	VB	O
increasing	VBG	O
it	PRP	O
to	TO	O
perhaps	RB	O
coumadin	VB	B-TREATMENT
2.5	CD	O
and	CC	O
5	CD	O
alternating	NN	O
every	DT	O
other	JJ	O
night	NN	O
.	.	O

other	JJ	O
major	JJ	O
issues	NNS	O
-	:	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
all	PDT	O
the	DT	O
things	NNS	O
happened	VBD	O
and	CC	O
with	IN	O
her	PRP$	B-PROBLEM
hyponatremia	NN	I-PROBLEM
and	CC	O
also	RB	O
the	DT	B-PROBLEM
other	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
also	RB	O
.	.	O

we	PRP	O
put	VBD	O
her	PRP	O
on	IN	O
nifedipine	NN	B-TREATMENT
ir	NN	I-TREATMENT
,	,	O
sl	NN	O
and	CC	O
that	DT	O
was	VBD	O
not	RB	O
enough	RB	O
to	TO	O
control	VB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
which	WDT	O
was	VBD	O
in	IN	O
the	DT	O
200s	CD	O
in	IN	O
the	DT	B-TEST
systolic	NN	I-TEST
,	,	O
so	IN	O
we	PRP	O
had	VBD	O
started	VBN	O
her	PRP$	O
on	IN	O
atenolol	NN	B-TREATMENT
.	.	O

so	RB	O
on	IN	O
discharge	NN	O
she	PRP	O
is	VBZ	O
on	IN	O
atenolol	JJ	B-TREATMENT
100	CD	O
.	.	O

if	IN	O
needed	VBN	O
to	TO	O
you	PRP	O
can	MD	O
give	VB	O
her	PRP$	O
some	DT	B-TREATMENT
nifedipine	JJ	I-TREATMENT
sl	NN	I-TREATMENT
to	TO	O
decrease	VB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
also	RB	O
has	VBZ	O
significant	JJ	B-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
arms	NNS	I-PROBLEM
now	RB	O
and	CC	O
also	RB	O
some	DT	B-PROBLEM
mild	JJ	I-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
,	,	O
so	IN	O
i	JJ	O
think	VBP	O
that	IN	O
fluid	JJ	B-TREATMENT
restriction	NN	I-TREATMENT
should	MD	O
help	VB	O
with	IN	O
that	DT	O
.	.	O

she	PRP	O
is	VBZ	O
also	RB	O
a	DT	B-PROBLEM
little	JJ	I-PROBLEM
dry	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
oxygen	NN	B-TREATMENT
.	.	O

ever	RB	O
since	IN	O
the	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolus	NN	I-PROBLEM
she	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
oxygen	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
on	IN	O
4	CD	B-TREATMENT
liters	NNS	I-TREATMENT
;	:	O
now	RB	O
she	PRP	O
is	VBZ	O
on	IN	O
5	CD	B-TREATMENT
liters	NNS	I-TREATMENT
,	,	O
sating	VBG	B-TEST
94	CD	O
to	TO	O
96%	CD	O
on	IN	O
5	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

we	PRP	O
would	MD	O
like	VB	O
for	IN	O
her	PRP$	O
to	TO	O
remain	VB	O
on	IN	O
the	DT	B-TREATMENT
oxygen	NN	I-TREATMENT
as	RB	O
well	RB	O
.	.	O

the	DT	B-PROBLEM
complications	NNS	I-PROBLEM
that	IN	O
i	NN	O
have	VBP	O
listed	VBN	O
include	VBP	O
the	DT	B-PROBLEM
hyponatremia	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
and	CC	O
also	RB	O
the	DT	B-PROBLEM
elevatd	NN	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
.	.	O

discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
-	:	O
baclofen	NN	B-TREATMENT
10	CD	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
mvi	VB	B-TREATMENT
one	CD	O
tablet	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
mycostatin	NN	B-TREATMENT
powder	NN	I-TREATMENT
tp	NN	I-TREATMENT
q.d.	NN	O
to	TO	O
be	VB	O
applied	VBN	O
to	TO	O
the	DT	B-PROBLEM
rash	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
groin	JJ	I-PROBLEM
area	NN	I-PROBLEM
,	,	O
also	RB	O
dilaudid	VBZ	B-TREATMENT
8	CD	O
mg	NN	O
p.o.	NN	O
q2h	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
coumadin	VBP	B-TREATMENT
2.5	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
fentanyl	JJ	B-TREATMENT
patch	NN	I-TREATMENT
75	CD	O
micrograms	NNS	O
per	IN	O
hour	NN	O
topical	JJ	O
q72	NN	O
hours	NNS	O
,	,	O
atenolol	RB	B-TREATMENT
100	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O

she	PRP	O
remains	VBZ	O
very	RB	B-PROBLEM
weak	JJ	I-PROBLEM
and	CC	O
will	MD	O
most	RBS	O
likely	JJ	O
benefit	NN	O
from	IN	O
some	DT	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
andshe	NN	O
still	RB	O
has	VBZ	O
the	DT	B-PROBLEM
bilateral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
to	TO	O
go	VB	O
to	TO	O
the	DT	O
necsoncardel	JJ	O
medical	JJ	O
center	NN	O
for	IN	O
more	JJR	B-TREATMENT
chronic	JJ	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
very	RB	O
limited	JJ	O
in	IN	O
how	WRB	O
much	JJ	O
she	PRP	O
can	MD	O
do	VB	O
right	RB	O
now	RB	O
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
primarily	RB	O
and	CC	O
her	PRP$	B-PROBLEM
difficulty	NN	I-PROBLEM
breathing	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
mother	NN	I-TEST
's	POS	I-TEST
prenatal	JJ	I-TEST
screens	NNS	I-TEST
were	VBD	O
blood	NN	B-TEST
type	NN	I-TEST
b	NN	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
hepatitis	JJ	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
and	CC	O
group	NN	B-TEST
b	VBP	I-TEST
strep	NN	I-TEST
negative	JJ	O
.	.	O

this	DT	O
pregnancy	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	O
prenatal	JJ	O
diagnosis	NN	O
of	IN	O
a	DT	B-PROBLEM
congenital	JJ	I-PROBLEM
cystic	JJ	I-PROBLEM
adenomatoid	NN	I-PROBLEM
malformation	NN	I-PROBLEM

(	(	O
ccam	NN	B-PROBLEM
).	NN	O

the	DT	O
infant	NN	O
emerged	VBD	O
vigorous	JJ	O
with	IN	O
apgars	NNS	B-TEST
of	IN	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
.	.	O

his	PRP$	B-TEST
birth	NN	I-TEST
weight	NN	I-TEST
was	VBD	O
2905	CD	O
grams	NNS	O
.	.	O

wt	NN	B-TEST
2905	CD	O
gm	NN	O

length	NN	B-TEST
19	CD	O
inches	NNS	O

hc	NN	B-TEST
34.5	CD	O
cm	NN	O

his	PRP$	B-TEST
admission	NN	I-TEST
physical	JJ	I-TEST
exam	NN	I-TEST
reveals	VBZ	O
a	DT	B-PROBLEM
vigorous	JJ	I-PROBLEM
nondysmorphic	JJ	I-PROBLEM
term	NN	O
infant	NN	O
.	.	O

red	JJ	B-TEST
reflex	NN	I-TEST
not	RB	O
checked	VBN	O
.	.	O

neck	NN	O
supple	NN	O
and	CC	O
without	IN	O
masses	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
clear	JJ	O
bilaterally	RB	O
with	IN	O
slightly	RB	B-PROBLEM
decreased	VBN	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
but	CC	O
symmetric	JJ	O
chest	JJS	O
rise	NN	O
and	CC	O
fall	NN	O
.	.	O

heart	NN	O
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

femoral	JJ	B-TEST
pulses	NNS	I-TEST
present	JJ	O
bilaterally	RB	O
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

no	DT	O
sacral	JJ	B-PROBLEM
anomalies	NNS	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
remained	VBN	O
in	IN	O
room	NN	O
air	NN	O
well	RB	O
saturated	VBN	O
with	IN	O
comfortable	JJ	O
respirations	NNS	O
until	IN	O
approximately	RB	O
22	CD	O
hours	NNS	O
of	IN	O
age	NN	O
when	WRB	O
he	PRP	O
started	VBD	O
with	IN	O
increased	JJ	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	VBG	I-PROBLEM
although	IN	O
he	PRP	O
has	VBZ	O
remained	VBN	O
well-saturated	JJ	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
initially	RB	O
remarkable	JJ	O
for	IN	O
some	DT	B-PROBLEM
mediastinal	JJ	I-PROBLEM
shift	NN	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
right-sided	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
increasing	VBG	B-PROBLEM
shift	NN	I-PROBLEM
present	NN	O
on	IN	O
the	DT	B-TEST
last	JJ	I-TEST
x-ray	NN	I-TEST
.	.	O

there	EX	O
are	VBP	O
no	DT	O
cardiovascular	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
weight	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
is	VBZ	O
2800	CD	O
grams	NN	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
breast	VBN	O
feeding	NN	O
or	CC	O
taking	VBG	O
20	CD	O
calorie	NN	O
per	IN	O
ounce	NN	O
formula	NN	O
until	IN	O
the	DT	B-PROBLEM
increased	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
so	IN	O
that	DT	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
he	PRP	O
is	VBZ	O
npo	JJ	B-TREATMENT
with	IN	O
a	DT	B-TREATMENT
peripheral	JJ	I-TREATMENT
iv	NN	I-TREATMENT
with	IN	O
total	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
of	IN	O
150	CD	O
ml	NNS	O
/	JJ	O
kg	JJ	O
/	NNP	O
day	NN	O
of	IN	O
10%	CD	B-TREATMENT
dextrose	NN	I-TREATMENT
with	IN	O
electrolytes	NNS	B-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
blood	NN	B-TEST
work	NN	I-TEST
except	IN	O
for	IN	O
blood	NN	B-TEST
glucose	NN	I-TEST
checks	NNS	I-TEST
and	CC	O
he	PRP	O
has	VBZ	O
been	VBN	O
euglycemic	JJ	O
throughout	IN	O
his	PRP$	O
cmed	JJ	O
stay	NN	O
with	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
glucose	NN	I-TEST
being	VBG	O
in	IN	O
the	DT	O
70s	CD	O
.	.	O

he	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
a	DT	B-TEST
bilirubin	NN	I-TEST
checked	VBN	O
.	.	O

he	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
any	DT	B-TEST
blood	NN	I-TEST
work	NN	I-TEST
done	VBN	O
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
antibiotic	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
or	CC	O
blood	NN	B-TEST
cultures	NNS	I-TEST
sent	VBD	O
.	.	O

hearing	VBG	B-TEST
screening	NN	I-TEST
is	VBZ	O
recommended	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
infant	NN	O
is	VBZ	O
discharged	VBN	O
in	IN	O
guarded	JJ	B-PROBLEM
condition	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
transferred	VBN	O
to	TO	O
massachusetts	VB	O
general	JJ	O
hospital	NN	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
continuing	VBG	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

the	DT	O
infant	NN	O
is	VBZ	O
npo	JJ	B-TREATMENT
.	.	O

2.	CD	O
he	PRP	O
is	VBZ	O
on	IN	O
peripheral	JJ	B-TREATMENT
iv	NN	I-TREATMENT
of	IN	O
total	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
150	CD	O
ml	NNS	O
/	JJ	O
kg	JJ	O
/	NNP	O
day	NN	O
of	IN	O
10%	CD	O
dextrose	NN	B-TREATMENT
with	IN	O
2	CD	O
meq	NNS	O
of	IN	O
sodium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
per	IN	O
100	CD	O
ml	NN	O
and	CC	O
1	CD	O
meq	NN	O
of	IN	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
per	IN	O
100	CD	O
ml	NN	O
.	.	O

3.	LS	O
he	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
a	DT	B-TEST
car	NN	I-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	VBG	I-TEST
test	NN	I-TEST
.	.	O

4.	CD	O
a	DT	B-TEST
state	NN	I-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
will	MD	O
be	VB	O
done	VBN	O
prior	RB	O
to	TO	O
transfer	VB	O
.	.	O

5.	CD	O
he	PRP	O
has	VBZ	O
received	VBN	O
no	DT	O
immunizations	NNS	B-TREATMENT
.	.	O

2.	CD	O
right-sided	JJ	B-PROBLEM
congenital	JJ	I-PROBLEM
cystic	JJ	I-PROBLEM
adenomatoid	NN	I-PROBLEM
malformation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
increased	JJ	B-PROBLEM
lethargy	NN	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
tecal	JJ	O
galencounxopt	NN	O
community	NN	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
scimewhildajesc	JJ	O
,	,	O
la	JJ	O
r	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
dehydration	JJ	B-PROBLEM
..	NNS	O

lorazepam	NN	B-TREATMENT
/	NN	O
penicillins	VBZ	B-TREATMENT
/	NNP	O
prednisone	NN	B-TREATMENT
/	NNP	O
hydrochlorothiazide	NN	B-TREATMENT
/	NNP	O
ceftriaxone	NN	B-TREATMENT
/	NN	O
phenytoin	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
progressing	VBG	B-PROBLEM
slowing	NN	I-PROBLEM
of	IN	I-PROBLEM
mentation	NN	I-PROBLEM
and	CC	O
gait	NN	B-PROBLEM
difficulties	NNS	I-PROBLEM
since	IN	O
a	DT	O
week	NN	O
;	:	O
evaluation	NN	B-TEST
for	IN	O
ich	NN	B-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
83	CD	O
yo	JJ	O
r-handed	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
multiple	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
during	IN	O
the	DT	O
last	JJ	O
few	JJ	O
years	NNS	O
,	,	O
pacemaker	NN	B-TREATMENT
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
arrhythmia	NN	B-PROBLEM
who	WP	O
now	RB	O
presents	VBZ	O
with	IN	O
gradual	JJ	B-PROBLEM
decline	NN	I-PROBLEM
in	IN	I-PROBLEM
gait	NN	I-PROBLEM
and	CC	O
slowing	NN	B-PROBLEM
of	IN	I-PROBLEM
mentation	NN	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
week	NN	O
.	.	O

according	VBG	O
to	TO	O
his	PRP$	O
wife	NN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
abrasion	NN	I-PROBLEM
on	IN	O
the	DT	O
top	NN	O
of	IN	O
his	PRP$	O
head	NN	O
,	,	O
but	CC	O
nothing	NN	O
major	JJ	O
.	.	O

he	PRP	O
did	VBD	O
not	RB	O
complain	VB	O
about	IN	O
a	DT	B-PROBLEM
headache	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
at	IN	O
baseline	NN	O
with	IN	O
respect	NN	O
to	TO	O
his	PRP$	O
gait	NN	O
(	(	O
at	IN	O
baseline	NN	O
unsteady	JJ	B-PROBLEM
,	,	O
though	IN	O
he	PRP	O
refuses	VBZ	O
to	TO	O
walk	VB	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
)	)	O
and	CC	O
his	PRP$	O
mentation	NN	O
(	(	O
at	IN	O
baseline	NN	O
difficulties	NNS	B-PROBLEM
with	IN	I-PROBLEM
memory	NN	I-PROBLEM
since	IN	O
months	NNS	O
;	:	O
keeps	VBZ	O
forgetting	VBG	O
appointments	NNS	O
).	VB	O

then	RB	O
about	IN	O
a	DT	O
week	NN	O
ago	RB	O
,	,	O
the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
wife	NN	O
noted	VBD	O
that	IN	O
his	PRP$	O
gait	NN	O
became	VBD	O
even	RB	B-PROBLEM
more	RBR	I-PROBLEM
unsteady	JJ	I-PROBLEM
,	,	O
though	IN	O
he	PRP	O
did	VBD	O
not	RB	O
fall	VB	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
difficulties	NNS	B-PROBLEM
navigating	VBG	O
through	IN	O
his	PRP$	O
apartment	NN	O
,	,	O
having	VBG	O
difficulties	NNS	B-PROBLEM
finding	VBG	O
the	DT	O
fridge	NN	O
for	IN	O
example	NN	O
.	.	O

they	PRP	O
were	VBD	O
concerned	VBN	O
that	IN	O
the	DT	O
fall	NN	O
might	MD	O
have	VB	O
caused	VBN	O
another	DT	B-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
as	IN	O
had	VBD	O
happened	VBN	O
in	IN	O
the	DT	O
past	NN	O
,	,	O
and	CC	O
this	DT	O
prompted	VBD	O
them	PRP	O
to	TO	O
come	VB	O
to	TO	O
the	DT	O
deanna	NN	O
.	.	O

no	DT	O
headache	NN	B-PROBLEM
,	,	O
neckpain	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
or	CC	O
focal	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
/	NNP	O
numbness	NN	B-PROBLEM
.	.	O

review	NN	O
of	IN	O
systems	NNS	O
:	:	O
denies	VBZ	O
any	DT	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
hearing	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
dysphagia	NN	B-PROBLEM
,	,	O
tingling	VBG	B-PROBLEM
,	,	O
numbness	RB	B-PROBLEM
,	,	O
bowel-bladder	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
hematuria	NN	B-PROBLEM
,	,	O
or	CC	O
bright	RB	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

his	PRP$	O
legs	NNS	O
have	VBP	O
been	VBN	O
feeling	VBG	O
weaker	NN	B-PROBLEM
,	,	I-PROBLEM
bilaterally	RB	I-PROBLEM
since	IN	O
the	DT	O
last	JJ	O
week	NN	O
.	.	O

1.	CD	O
previous	JJ	B-PROBLEM
interventricular	JJ	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
:	:	O

06-30	JJ	O
resolved	VBD	O
as	IN	O
of	IN	O
repeat	NN	B-TEST
head	NN	I-TEST
ct	VBP	I-TEST
one	CD	O
month	NN	O
later	RB	O
,	,	O
no	DT	O
residual	JJ	B-PROBLEM
deficits;	NN	I-PROBLEM
03-03	NN	O
:	:	O
ich	NN	B-PROBLEM
in	IN	I-PROBLEM
3rd	CD	I-PROBLEM
,	,	I-PROBLEM
4th	CD	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
l-lat	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
;	:	O
no	DT	O
aneurysm	NN	B-PROBLEM
;	:	O
07-01	JJ	O
:	:	O
ich	NN	B-PROBLEM
in	IN	I-PROBLEM
r-temporal	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
;	:	O
question	NN	O
of	IN	O
underlying	VBG	B-PROBLEM
mass	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
per	IN	O
contrast	NN	B-TEST
ct	NN	I-TEST
;	:	O
decided	VBD	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
serial	JJ	B-TEST
scans	NNS	I-TEST
rather	RB	O
than	IN	O
to	TO	O
biopsy	VB	B-TEST

2.	CD	O
pacemaker	NN	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
arrhythmia	NN	B-PROBLEM
,	,	O
afibb	NN	B-PROBLEM
;	:	O
during	IN	O
last	JJ	O
hospitalization	NN	O
episodes	NNS	O
of	IN	O
nsvt	NN	B-PROBLEM

3.	CD	O
history	NN	O
of	IN	O
slowness	NN	B-PROBLEM
of	IN	I-PROBLEM
gait	NN	I-PROBLEM
,	,	O
?	.	O
parkinsons	NNS	B-PROBLEM
?	.	O
and	CC	O
possibly	RB	O
dementia	NN	B-PROBLEM
followed	VBN	O
by	IN	O
dr.	NN	O
ahern	NN	O
(	(	O
laurence	NN	O
eichorn	VBN	O
).	NN	O

sinemet	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
during	IN	O
last	JJ	O
admission	JJ	O
06-30	NN	O
as	IN	O
he	PRP	O
was	VBD	O
thought	VBN	O
to	TO	O
not	RB	O
have	VB	O
pd	NN	B-PROBLEM
.	.	O

4.	CD	O
depression	NN	B-PROBLEM

5.	CD	O
copd	NN	B-PROBLEM

6.	CD	O
hyperlipidemia	NN	B-PROBLEM

7.	CD	O
bilateral	JJ	B-TREATMENT
cataract	NN	I-TREATMENT
surgery	NN	I-TREATMENT

8.	CD	O
orthostatic	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
,	,	O
on	IN	O
midodrine	NN	B-TREATMENT

wife	NN	O
states	NNS	O
that	IN	O
he	PRP	O
would	MD	O
not	RB	O
want	VB	O
to	TO	O
be	VB	O
recussitated	VBN	O
,	,	O
and	CC	O
that	IN	O
osh	NN	O
placed	VBD	O
ett	NN	B-TREATMENT
before	IN	O
asking	VBG	O
her	PRP$	O
.	.	O

family	NN	O
history	NN	O
:	:	O
no	DT	O
kids	NNS	O
,	,	O
no	DT	O
bleeds	NNS	B-PROBLEM
or	CC	O
strokes	NNS	B-PROBLEM
in	IN	O
other	JJ	O
family	NN	O
members	NNS	O

vitals	NNS	B-TEST
:	:	O

96.7	CD	O
hr60	NN	B-TEST
bp153/52	NN	B-TEST
,	,	O
later	RB	O
178/85	CD	O
rr	NNS	B-TEST
18t	CD	O
so298%	NNS	B-TEST
ra	NN	I-TEST

nad	NN	B-PROBLEM
,	,	O
in	IN	O
bed	NN	O

neck	NN	O
:	:	O
no	DT	O
lad	NN	B-PROBLEM
;	:	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	VBZ	I-PROBLEM
;	:	O
limited	JJ	B-PROBLEM
range	NN	I-PROBLEM
neck	NN	I-PROBLEM
movements	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
gallops	NNS	B-PROBLEM
and	CC	O
rubs	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
:	:	O
normal	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM

extremities	NNS	O
:	:	O
no	DT	O
edema;	NN	B-PROBLEM
cold	JJ	B-PROBLEM
feet	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM

awake	NN	O
and	CC	O
alert	NN	O
,	,	O
cooperative	JJ	O
with	IN	O
exam	JJ	B-TEST
,	,	O
normal	JJ	O
affect	NN	O
;	:	O
facial	JJ	B-PROBLEM
expression	NN	I-PROBLEM
somewhat	RB	I-PROBLEM
sparse	JJ	I-PROBLEM
.	.	O

language	NN	O
:	:	O
fluent	NN	O
;	:	O
repetition	NN	O
:	:	O
intact	JJ	O
;	:	O
naming	VBG	O
intact	JJ	O
;	:	O
comprehension	NN	O
intact	NN	O
;	:	O
no	DT	O
dysarthria	NN	B-PROBLEM
,	,	O
no	DT	O
paraphasic	JJ	B-PROBLEM
errors	NNS	I-PROBLEM
.	.	O

3d-construction	NN	O
:	:	O
poor	JJ	O
,	,	O
difficulties	NNS	B-PROBLEM
putting	VBG	I-PROBLEM
handles	NNS	I-PROBLEM
in	IN	I-PROBLEM
clock	NN	I-PROBLEM
;	:	O
no	DT	O
apraxia	NN	B-PROBLEM
.	.	O

no	DT	O
neglect	NN	B-PROBLEM
.	.	O

extraocular	JJ	O
movements	NNS	O
intact	JJ	O
with	IN	O
few	JJ	O
beats	NNS	O
of	IN	O
horizontal	JJ	B-PROBLEM
endgaze	NN	I-PROBLEM
nystagmus	NN	I-PROBLEM
.	.	O

limited	VBN	B-PROBLEM
cmed	VBD	I-PROBLEM
ccu	JJ	I-PROBLEM
movements	NNS	I-PROBLEM
in	IN	I-PROBLEM
upgaze	NN	I-PROBLEM
.	.	O

facial	JJ	O
sensation	NN	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
and	CC	O
pinprick	NN	B-TEST
.	.	O

facial	JJ	O
movement	NN	O
symmetrical	NN	O
;	:	O
no	DT	O
facial	JJ	B-PROBLEM
droop	NN	I-PROBLEM
.	.	O

hearing	VBG	O
intact	JJ	O
to	TO	O
finger	VB	B-TEST
rub	VB	I-TEST
bilaterally	RB	O
.	.	O

tongue	NN	O
protrudes	NNS	O
in	IN	O
midline	NN	O
,	,	O
no	DT	O
fasciculations	NNS	B-PROBLEM
.	.	O

decreased	VBN	B-PROBLEM
bulk	NN	I-PROBLEM
throughout	IN	I-PROBLEM
;	:	O
tone	NN	O
normal	JJ	O
bilaterally	RB	O
.	.	O

no	DT	O
adventitious	JJ	B-PROBLEM
movements	NNS	I-PROBLEM
,	,	O
no	DT	O
tremor	NN	B-PROBLEM
,	,	O
no	DT	O
asterixis	NN	B-PROBLEM
.	.	O

d	LS	B-TEST
-	:	O
5	CD	O
;	:	O
t	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
b	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
wf	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
we	PRP	B-TEST
-	:	O
5	CD	O
;	:	O
fif	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
bruner	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
ip	JJ	B-TEST
-	:	O
5	CD	O
;	:	O
gl	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
q	JJ	B-TEST
-	:	O
5-	JJ	O
;	:	O
h	PRP$	B-TEST
-	:	O
5	CD	O
;	:	O
af	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
tf	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
te	SYM	B-TEST
-	:	O
5	CD	O

d	LS	B-TEST
-	:	O
5	CD	O
;	:	O
t	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
b	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
wf	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
we	PRP	B-TEST
-	:	O
5	CD	O
;	:	O
fif	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
bruner	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
ip	JJ	B-TEST
-	:	O
5	CD	O
;	:	O
gl	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
q	JJ	B-TEST
-	:	O
5-	JJ	O
;	:	O
h	PRP$	B-TEST
-	:	O
5	CD	O
;	:	O
af	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
tf	SYM	B-TEST
-	:	O
5	CD	O
;	:	O
te	JJ	B-TEST
-	:	O
5-	JJ	O

no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM
.	.	O

no	DT	O
rebound	NN	B-PROBLEM
.	.	O

sensation	NN	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
,	,	O
pin	NN	B-TEST
prick	NN	I-TEST
,	,	O
temperature	NN	B-TEST
(	(	I-TEST
cold	JJ	I-TEST
)	)	I-TEST
.	.	O

decreased	VBN	B-PROBLEM
vibration	NN	I-PROBLEM
in	IN	I-PROBLEM
feet	NNS	I-PROBLEM
and	CC	I-PROBLEM
ankles	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
some	DT	O
in	IN	O
knees	NNS	O
;	:	O
proprioception	NN	B-PROBLEM
decreased	VBD	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

reflexes	NNS	B-TEST
:	:	O

right	RB	B-TEST
b	SYM	I-TEST
-	:	O
2	CD	O
;	:	O
t	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
br	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
pa	SYM	B-TEST
-	:	O
1	CD	O
;	:	O
pl	SYM	B-TEST
-	:	O
0	CD	O

b	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
t	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
br	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
pa	SYM	B-TEST
-	:	O
1	CD	O
;	:	O
pl	SYM	B-TEST
-	:	O
0	CD	O
(	(	O
less	JJR	O
brisk	RB	O
than	IN	O
on	IN	O
r	NN	O
,	,	O
but	CC	O
exam	RB	B-TEST
limited	VBD	O
due	JJ	O
to	TO	O
cuff	VB	O
)	)	O

toes	NNS	O
:	:	O
mute	NN	O
bilaterally	RB	O
;	:	O
tfl	PRP	B-PROBLEM
contracted	VBD	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
l	NN	I-PROBLEM
.	.	O

no	DT	O
dysmetria	NN	B-PROBLEM
or	CC	O
pastpointing	NN	B-PROBLEM
.	.	O

(	(	O
later	RB	O
tested	VBN	O
and	CC	O
patient	JJ	O
markedly	RB	B-PROBLEM
unstable	JJ	I-PROBLEM
on	IN	I-PROBLEM
feet	NNS	I-PROBLEM
)	)	O

glucose	JJ	B-TEST
-	:	O
89	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	CD	I-TEST
128	CD	O

ck	SYM	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
6	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

2019-03-29	JJ	O
04:00	CD	O
pm	NN	O
urine	NN	B-TEST

2019-03-29	JJ	O
04:00	CD	O
pm	NN	O
urine	NN	B-TEST

gr	NN	B-TEST
hold	VBP	O
-	:	O
hold	NN	O

2019-03-29	JJ	O
04:00	CD	O
pm	NN	O
urine	NN	B-TEST

color	NN	B-TEST
-	:	O
straw	NN	O
appear	VBP	B-TEST
-	:	O
clear	JJ	O
sp	NN	B-TEST
stickney	NN	I-TEST
-	:	O
1.017	CD	O

2019-03-29	JJ	O
04:00	CD	O
pm	NN	O
urine	NN	B-TEST

blood	NN	B-TEST
-	:	O
neg	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
7.0	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

glucose	JJ	B-TEST
-	:	O
72	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
17	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
sodium	NN	B-TEST
-	:	O
140	CD	O
potassium	NN	B-TEST
-	:	O
4.4	CD	O
chloride	NN	B-TEST
-	:	O
103	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
29	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
12	CD	O

wbc	SYM	B-TEST
-	:	O
6.7	CD	O
rbc	NN	B-TEST
-	:	O
4.53	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
14.8	CD	O
hct	NN	B-TEST
-	:	O
44.6	CD	O
mcv	SYM	B-TEST
-	:	O
99	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
32.8	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
33.3	CD	O
rdw	NN	B-TEST
-	:	O
12.6	CD	O

neuts	NNS	B-TEST
-	:	O
65.5	CD	O
lymphs	SYM	B-TEST
-	:	O
25.8	CD	O
monos	NNS	B-TEST
-	:	O
7.0	CD	O
eos	SYM	B-TEST
-	:	O
1.4	CD	O
basos	SYM	B-TEST
-	:	O
0.2	CD	O

macrocyt	SYM	B-TEST
-	:	O
1+	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
213	CD	O

pt	SYM	B-TEST
-	:	O
12.3	CD	O
ptt	NN	B-TEST
-	:	O
24.5	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.1	CD	O

ct	NN	B-TEST
brain	NN	I-TEST
(	(	I-TEST
initial	JJ	I-TEST
)	)	I-TEST

there	EX	O
is	VBZ	O
a	DT	O
41	JJ	O
x	NN	O
23	CD	O
mm	JJ	O
area	NN	O
of	IN	O
hyperdensity	NN	B-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	O
with	IN	O
moderate	JJ	B-PROBLEM
surrounding	VBG	I-PROBLEM
vasogenic	JJ	I-PROBLEM
edema	NN	I-PROBLEM

(	(	O
series	NN	O
2	CD	O
,	,	O
image	NN	O
23	CD	O
)	)	O
,	,	O
compatible	JJ	O
with	IN	O
acute	JJ	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
encephalomalacic	NN	I-PROBLEM
changes	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
adjacent	JJ	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
and	CC	O
the	DT	O
right	JJ	O
parietal	NN	O
/	NNP	O
occipital	JJ	O
region	NN	O
remain	VBP	O
stable	JJ	O
in	IN	O
appearance	NN	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
upon	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
mims	NNS	I-PROBLEM
of	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
ventricle	NN	O
.	.	O

no	DT	O
further	JJ	O
intraaxial	NN	B-PROBLEM
or	CC	I-PROBLEM
extraaxial	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collections	NNS	I-PROBLEM
or	CC	O
hematoma	NN	B-PROBLEM
are	VBP	O
identified	VBN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
displacement	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
,	,	O
hydrocephalus	NN	B-PROBLEM
,	,	O
or	CC	O
effacement	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
basal	NN	I-PROBLEM
cisterns	VBZ	I-PROBLEM
at	IN	O
present	NN	O
.	.	O

review	NN	B-TEST
of	IN	I-TEST
bone	NN	I-TEST
windows	NNS	I-TEST
demonstrates	VBZ	O
no	DT	O
skull	JJ	B-PROBLEM
bulge	NN	I-PROBLEM
or	CC	O
skull	JJ	B-PROBLEM
base	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
an	DT	B-PROBLEM
air	NN	I-PROBLEM
/	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
level	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
maxillary	NN	I-PROBLEM
sinus	SYM	I-PROBLEM
-	:	O
?	.	O
acute	JJ	B-PROBLEM
sinusitis	NN	I-PROBLEM
,	,	O
but	CC	O
acute	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cannot	NN	O
be	VB	O
excluded	VBN	O
,	,	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
acute	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

41	CD	B-PROBLEM
x	JJ	I-PROBLEM
23	CD	I-PROBLEM
mm	JJ	I-PROBLEM
acute	NN	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	O
causing	VBG	O
mild	JJ	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
upon	IN	I-PROBLEM
the	DT	I-PROBLEM
ipsilateral	JJ	I-PROBLEM
lateral	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
,	,	O
suspicious	JJ	O
of	IN	O
hemorrhage	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
congophilic	VB	B-PROBLEM
angiopathy	RB	I-PROBLEM
in	IN	O
this	DT	O
age	NN	O
group	NN	O
.	.	O

chronic	JJ	B-PROBLEM
encephalomalacic	NN	I-PROBLEM
changes	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
lobe	NN	I-PROBLEM
and	CC	O
right	JJ	O
parietal	NN	O
/	NNP	O
occipital	JJ	O
region	NN	O
are	VBP	O
unchanged	JJ	O
in	IN	O
appearance	NN	O
since	IN	O
2018-11-27	CD	O
.	.	O

repeat	NN	B-TEST
head	NN	I-TEST
ct	VBD	I-TEST
03-30	JJ	O
:	:	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
from	IN	O
above	IN	O
.	.	O

ekg	NN	B-TEST
:	:	O

atrial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
.	.	O

since	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
tracing	NN	I-TEST
of	IN	O
2018-03-15	JJ	O
atrial	JJ	B-TREATMENT
pacing	NN	I-TREATMENT
is	VBZ	O
a	DT	O
new	JJ	O
finding	NN	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
is	VBZ	O
otherwise	RB	O
,	,	O
unchanged	JJ	O
and	CC	O
continues	VBZ	O
to	TO	O
weymouth	VB	B-TREATMENT
voltage	NN	I-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
limb	NN	I-TREATMENT
leads	VBZ	I-TREATMENT
and	CC	O
non-specific	JJ	B-PROBLEM
st-t	JJ	I-PROBLEM
wave	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

intervals	NNS	B-TEST
axes	NNS	I-TEST

rate	NN	B-TEST
60	CD	O
pr	NN	B-TEST
188	CD	O
qrs	NN	B-TEST
104	CD	O
qt/qtc	NN	B-TEST
460/460	CD	O
p	NN	B-TEST
85	CD	O
qrs	NN	B-TEST
55	CD	O
t	NN	B-TEST
75	CD	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
83	CD	O
yo	NN	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
past	JJ	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhages	NNS	I-PROBLEM
(	(	O
most	RBS	O
recent	JJ	O
07-01	JJ	O
with	IN	O
r-frontal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
)	)	O
who	WP	O
presented	VBD	O
with	IN	O
gradually	RB	B-PROBLEM
slowing	VBG	I-PROBLEM
of	IN	I-PROBLEM
mentation	NN	I-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
gait	NN	I-PROBLEM
instability	NN	I-PROBLEM
since	IN	O
one	CD	O
week	NN	O
.	.	O

on	IN	O
initial	JJ	B-TEST
exam	IN	I-TEST
the	DT	O
patient	NN	O
was	VBD	O
not	RB	B-PROBLEM
oriented	VBN	I-PROBLEM
to	TO	I-PROBLEM
time	NN	I-PROBLEM
,	,	O
seemed	VBD	O
somewhat	RB	B-PROBLEM
slow	JJ	I-PROBLEM
,	,	O
and	CC	O
had	VBD	O
difficulties	NNS	B-PROBLEM
generating	VBG	I-PROBLEM
a	DT	I-PROBLEM
list	NN	I-PROBLEM
of	IN	I-PROBLEM
animals	NNS	I-PROBLEM
.	.	O

his	PRP$	O
cranial	JJ	O
nerves	NNS	O
and	CC	O
strength	NN	O
were	VBD	O
full	JJ	O
,	,	O
and	CC	O
the	DT	B-TEST
sensory	JJ	I-TEST
exam	NN	I-TEST
showed	VBD	O
mildly	RB	B-PROBLEM
decreased	VBN	I-PROBLEM
vibration	NN	I-PROBLEM
and	CC	I-PROBLEM
proprioception	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
le	NN	I-PROBLEM
,	,	O
suggesting	VBG	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
deanna	NN	O
that	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
significant	JJ	I-PROBLEM
r-frontal	JJ	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
same	JJ	I-PROBLEM
location	NN	I-PROBLEM
as	IN	O
the	DT	B-PROBLEM
prior	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
both	DT	O
neurology	NN	O
and	CC	O
neurosurgery	NN	O
,	,	O
and	CC	O
the	DT	O
two	CD	O
teams	NNS	O
agreed	VBD	O
that	IN	O
the	DT	O
etiology	NN	O
seemed	VBD	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
underlying	JJ	B-PROBLEM
amyloidosis	NN	I-PROBLEM
.	.	O

during	IN	O
the	DT	O
last	JJ	O
admission	NN	O
the	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
underlying	VBG	O
a	DT	B-PROBLEM
hemorrhage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
r-frontal	JJ	I-PROBLEM
region	NN	I-PROBLEM
was	VBD	O
raised	VBN	O
.	.	O

the	DT	O
location	NN	O
of	IN	O
the	DT	B-PROBLEM
hemorrhage	NN	I-PROBLEM
was	VBD	O
not	RB	O
felt	VBN	O
to	TO	O
be	VB	O
typical	JJ	O
for	IN	O
hypertensive	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
(	(	I-PROBLEM
cortical	JJ	I-PROBLEM
)	)	I-PROBLEM
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
unlikely	JJ	O
that	IN	O
the	DT	O
recent	JJ	O
fall	NN	O
was	VBD	O
related	VBN	O
to	TO	O
the	DT	B-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
could	MD	O
not	RB	O
undergo	VB	O
an	DT	B-TEST
mri	NN	I-TEST
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
pacer	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neurology	NN	O
icu	NN	O
for	IN	O
closer	JJR	B-TEST
monitoring	NN	I-TEST
and	CC	O
was	VBD	O
stable	JJ	O
overnight	JJ	O
-	:	O
bp	NN	B-TEST
was	VBD	O
initially	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
and	CC	O
required	VBN	O
a	DT	B-TREATMENT
labetalol	JJ	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
<	$	O
24	CD	O
hours	NNS	O
,	,	O
then	RB	O
stabilized	VBN	O
.	.	O

the	DT	B-TEST
goal	NN	I-TEST
sbp	NN	I-TEST
of	IN	O
<	$	O
150	CD	O
was	VBD	O
achieved	VBN	O
.	.	O

coags	NNS	B-TEST
and	CC	O
ua	NNS	B-TEST
were	VBD	O
checked	VBN	O
and	CC	O
were	VBD	O
normal	JJ	O
.	.	O

for	IN	O
the	DT	O
question	NN	O
of	IN	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
associated	VBN	O
with	IN	O
a	DT	B-PROBLEM
cortical	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
started	VBN	O
prophylactically	RB	O
on	IN	O
keppra	NN	B-TREATMENT
(	(	O
given	VBN	O
questionable	JJ	O
allergy	NN	B-PROBLEM
to	TO	O
dilantin	VB	B-TREATMENT
)	)	O
,	,	O
at	IN	O
500	CD	O
mg	JJ	O
bid	NN	O
;	:	O
no	DT	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

this	DT	B-TREATMENT
medication	NN	I-TREATMENT
should	MD	O
be	VB	O
continued	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
at	IN	O
least	JJS	O
while	IN	O
the	DT	B-PROBLEM
bleed	NN	I-PROBLEM
has	VBZ	O
time	NN	O
to	TO	O
clear	VB	O
up	RP	O
,	,	O
with	IN	O
planned	VBN	O
titration	NN	O
up	RB	O
to	TO	O
1000	CD	O
mg	NN	O
bid	NN	O
on	IN	O
04-05	NN	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
repeated	VBN	O
on	IN	O
03-30	NN	O
was	VBD	O
unchanged	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
remained	VBD	O
stable	JJ	O
with	IN	O
only	JJ	O
very	RB	O
suble	JJ	O
focal	JJ	O
exam	NN	O
findings	NNS	O
(	(	O
very	RB	B-PROBLEM
mild	RB	I-PROBLEM
right	JJ	I-PROBLEM
pronator	NN	I-PROBLEM
drift	NN	I-PROBLEM
)	)	O
as	RB	O
well	RB	O
as	IN	O
his	PRP$	B-PROBLEM
persistently	RB	I-PROBLEM
poor	JJ	I-PROBLEM
memory	NN	I-PROBLEM
related	VBN	O
to	TO	O
dementia	VB	B-PROBLEM
.	.	O

cardiovascularly	RB	O
,	,	O
lipitor	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
were	VBD	O
continued	VBN	O
.	.	O

he	PRP	O
could	MD	O
not	RB	O
get	VB	O
an	DT	B-TEST
mri	NN	I-TEST
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

there	EX	O
were	VBD	O
no	DT	O
telemetry	NN	B-PROBLEM
events	NNS	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
ruled	VBD	O
out	RP	O
by	IN	O
enzyme	NN	B-TEST
.	.	O

pulmonlologically	RB	O
,	,	O
his	PRP$	B-TEST
chest	JJS	I-TEST
xray	NN	I-TEST
was	VBD	O
negative	JJ	O
and	CC	O
he	PRP	O
complained	VBD	O
of	IN	O
no	DT	O
breathing	NN	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

endocrinologically	RB	O
,	,	O
bg	NN	B-TEST
was	VBD	O
monitored	VBN	O
to	TO	O
improve	VB	O
outcome	NN	O
in	IN	O
icu	JJ	O
setting	NN	O
though	IN	O
he	PRP	O
had	VBD	O
no	DT	O
history	NN	O
of	IN	O
dm	NN	B-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
hba1c	VB	B-TEST
done	VBN	O
03-04	CD	O
was	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
(	(	O
"	JJ	O
borderline	NN	B-PROBLEM
dm	NN	I-PROBLEM
"	NN	O
)	)	O
at	IN	O
6.3	CD	O
;	:	O
this	DT	O
was	VBD	O
repeated	VBN	O
and	CC	O
was	VBD	O
still	RB	O
pending	VBG	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

ins	NNS	B-TEST
/	VBP	I-TEST
outs	NNS	I-TEST
and	CC	O
electrolytes	NNS	B-TEST
were	VBD	O
monitored	VBN	O
and	CC	O
were	VBD	O
not	RB	O
abnormal	JJ	B-PROBLEM
;	:	O
he	PRP	O
was	VBD	O
on	IN	O
a	DT	B-TREATMENT
bowel	NN	I-TREATMENT
regimen	NN	I-TREATMENT
,	,	O
vd	JJ	B-TREATMENT
boots	NNS	I-TREATMENT
and	CC	O
pud	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
with	IN	O
protonix	NN	B-TREATMENT
during	IN	O
the	DT	O
admission	NN	O
.	.	O

walking	NN	O
was	VBD	O
assessed	VBN	O
later	RB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
unstable	JJ	B-PROBLEM
on	IN	I-PROBLEM
his	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
asked	VBN	O
to	TO	O
see	VB	O
him	PRP	O
for	IN	O
this	DT	B-PROBLEM
gait	NN	I-PROBLEM
problem	NN	I-PROBLEM
.	.	O

follow-up	NN	O
was	VBD	O
arranged	VBN	O
with	IN	O
neurosurgery	NN	O
in	IN	O
5-6	JJ	O
weeks	NNS	O
with	IN	O
repeat	NN	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
to	TO	O
be	VB	O
arranged	VBN	O
by	IN	O
neurosurgery	JJ	O
office	NN	O
to	TO	O
make	VB	O
sure	JJ	O
blood	NN	B-PROBLEM
has	VBZ	O
cleared	VBN	O
,	,	O
and	CC	O
if	IN	O
indicated	VBN	O
,	,	O
to	TO	O
look	VB	O
for	IN	O
a	DT	O
possible	JJ	O
underlying	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
(	(	O
although	IN	O
unlikely	RB	O
)	)	O
.	.	O

amiodarone	RB	B-TREATMENT
200	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
qod	SYM	O
-	:	O
in	IN	O
march	NN	O
,	,	O
should	MD	O
be	VB	O
on	IN	O
odd	JJ	O
days	NNS	O
.	.	O

donepezil	RB	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

docusate	NN	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

mirtazapine	NN	B-TREATMENT
30	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

atorvastatin	RB	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
at	IN	O
bedtime	NN	O
.	.	O

ocuvite	JJ	B-TREATMENT
tablet	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

artificial	JJ	B-TREATMENT
tears	NNS	I-TREATMENT
drops	VBZ	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
drop	NN	O
ophthalmic	JJ	O
twice	RB	O
a	DT	O
day	NN	O
:	:	O
ou	NN	O
.	.	O

ensure	VB	B-TREATMENT
liquid	JJ	I-TREATMENT
sig	NN	O
:	:	O
0.5	CD	O
to	TO	O
1	CD	O
can	MD	O
po	VB	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

midodrine	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
twice	RB	O
a	DT	O
day	NN	O
:	:	O
at	IN	O
8am	CD	O
and	CC	O
noon	NN	O
.	.	O

ritalin	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
see	NN	O
below	IN	O
tablet	NN	O
po	NN	O
see	VBP	O
below	IN	O
:	:	O
1.5	CD	O
tablets	NNS	O
at	IN	O
10am	CD	O
(	(	O
7.5mg	CD	O
)	)	O
,	,	O
1	CD	O
tablet	NN	O
2pm	CD	O
(	(	O
5mg	CD	O
)	)	O
.	.	O

prilosec	NN	B-TREATMENT
20	CD	O
mg	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

guaifenesin	NN	B-TREATMENT
100	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
01-28	JJ	O
teaspoons	NNS	O
po	VBP	O
every	DT	O
six	CD	O
(	(	O
6	CD	O
)	)	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
cold	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

1.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
qod	SYM	O
-	:	O
in	IN	O
march	NN	O
,	,	O
should	MD	O
be	VB	O
on	IN	O
odd	JJ	O
days	NNS	O
.	.	O

2.	CD	O
donepezil	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

5.	CD	O
mirtazapine	NN	B-TREATMENT
30	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

6.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
at	IN	O
bedtime	NN	O
.	.	O

7.	CD	O
levetiracetam	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
:	:	O
on	IN	O
04-05	NN	O
,	,	O
please	VB	O
increase	VB	O
to	TO	O
two	CD	O
tablets	NNS	O
bid	VBD	O
(	(	O
1000	CD	O
mg	RB	O
bid	NN	O
)	)	O
.	.	O

8.	CD	O
ocuvite	JJ	B-TREATMENT
tablet	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
artificial	JJ	B-TREATMENT
tears	NNS	I-TREATMENT
drops	VBZ	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
drop	NN	O
ophthalmic	JJ	O
twice	RB	O
a	DT	O
day	NN	O
:	:	O
ou	NN	O
.	.	O

10.	CD	O
ensure	VB	B-TREATMENT
liquid	JJ	I-TREATMENT
sig	NN	O
:	:	O
0.5	CD	O
to	TO	O
1	CD	O
can	MD	O
po	VB	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

11.	CD	O
midodrine	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
twice	RB	O
a	DT	O
day	NN	O
:	:	O
at	IN	O
8	CD	O
am	VBP	O
and	CC	O
noon	NN	O
.	.	O

12.	CD	O
ritalin	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
see	NN	O
below	IN	O
tablet	NN	O
po	NN	O
see	VBP	O
below	IN	O
:	:	O
1.5	CD	O
tablets	NNS	O
at	IN	O
10	CD	O
am	VBP	O
(	(	O
7.5	CD	O
mg	NN	O
)	)	O
,	,	O
1	CD	O
tablet	NN	O
2	CD	O
pm	NN	O
(	(	O
5	CD	O
mg	NN	O
)	)	O
.	.	O

13.	CD	O
prilosec	JJ	B-TREATMENT
20	CD	O
mg	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

14.	CD	O
guaifenesin	NN	B-TREATMENT
100	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
01-28	JJ	O
teaspoons	NNS	O
po	VBP	O
every	DT	O
six	CD	O
(	(	O
6	CD	O
)	)	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
cold	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
sided	VBN	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM

stable	JJ	O
-	:	O
still	RB	O
with	IN	O
difficulty	NN	B-PROBLEM
walking	NN	I-PROBLEM
,	,	O
and	CC	O
mental	JJ	B-TEST
status	NN	I-TEST
exam	NN	I-TEST
with	IN	O
memory	NN	B-PROBLEM
loss	NN	I-PROBLEM
c/w	NN	O
dementia	NN	B-PROBLEM
,	,	O
but	CC	O
otherwise	RB	O
no	DT	O
focal	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

please	VB	O
call	VB	O
md	NN	O
or	CC	O
return	NN	O
to	TO	O
deanna	VB	O
if	IN	O
new	JJ	O
symptoms	NNS	O
suggestive	NN	O
of	IN	O
stroke	NN	B-PROBLEM
or	CC	O
brain	NN	B-PROBLEM
hemorrhage	NN	I-PROBLEM
including	VBG	O
weakness	NN	B-PROBLEM
,	,	O
numbness	JJ	B-PROBLEM
/	NN	O
tingling	NN	B-PROBLEM
,	,	O
facial	JJ	B-PROBLEM
droop	NN	I-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
vertigo	NN	B-PROBLEM
,	,	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
coordination	NN	I-PROBLEM
,	,	O
or	CC	O
worsened	VBD	B-PROBLEM
problems	NNS	I-PROBLEM
with	IN	I-PROBLEM
walking	NN	I-PROBLEM
.	.	O

please	VB	O
f/u	NN	O
with	IN	O
dr.	JJ	O
hernandez	NN	O
/	JJ	O
neurosurgery	NN	O
in	IN	O
6	CD	O
weeks	NNS	O
-	:	O
patient	NN	O
will	MD	O
receive	VB	O
a	DT	O
call	NN	O
from	IN	O
the	DT	O
neurosurgery	NN	O
office	NN	O
to	TO	O
set	VB	O
up	RP	O
a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
prior	RB	O
and	CC	O
to	TO	O
schedule	VB	O
this	DT	O
visit	NN	O
.	.	O

diverticulitis	NN	B-PROBLEM
,	,	O
s	JJ	O
/	NNP	O
p	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT

diverticulitis	NN	B-PROBLEM
,	,	O
presenting	VBG	O
for	IN	O
sigmoid	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
67-year-old	JJ	O
woman	NN	O
with	IN	O
occasional	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	NN	I-PROBLEM
and	CC	O
left	VBD	O
lower	JJR	O
quadrant	NN	O
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
complained	VBN	O
of	IN	O
any	DT	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
shaking	VBG	B-PROBLEM
,	,	O
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
no	DT	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
bowel	NN	I-PROBLEM
movements	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
attacks	NNS	B-PROBLEM
treated	VBN	O
with	IN	O
antibiotics	NNS	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
notably	RB	O
in	IN	O
12/96	CD	O
and	CC	O
08/97	CD	O
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
a	DT	O
diagnosis	NN	O
of	IN	O
diverticulitis	NN	B-PROBLEM
flairs	NNS	I-PROBLEM
and	CC	O
baseline	JJ	B-PROBLEM
diverticulosis	NN	I-PROBLEM
flairing	NN	I-PROBLEM
in	IN	O
09/96	CD	O
.	.	O

also	RB	O
,	,	O
three	CD	O
years	NNS	O
prior	RB	O
in	IN	O
1993	CD	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
attack	NN	I-PROBLEM
of	IN	I-PROBLEM
diverticulitis	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
worked	VBN	O
up	RP	O
with	IN	O
barium	NN	B-TEST
enema	NN	I-TEST
in	IN	O
09/97	CD	O
which	WDT	O
showed	VBD	O
multiple	JJ	B-PROBLEM
diverticula	NN	I-PROBLEM
throughout	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM
,	,	O
but	CC	O
mostly	RB	O
in	IN	O
the	DT	O
sigmoid	NN	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
there	EX	O
was	VBD	O
diverticulosis	NN	B-PROBLEM
with	IN	O
no	DT	O
acute	JJ	B-PROBLEM
diverticulitis	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
also	RB	O
no	DT	O
obstruction	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
also	RB	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
1996	CD	O
,	,	O
and	CC	O
presented	VBD	O
for	IN	O
heparinization	NN	B-TREATMENT
prior	RB	O
to	TO	O
her	PRP$	B-TREATMENT
elective	JJ	I-TREATMENT
valve	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
hypothyroidism	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
rheumatic	JJ	B-PROBLEM
fever	NN	I-PROBLEM
age	NN	O
6	CD	O
with	IN	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
11/96	CD	O
with	IN	O
a	DT	B-TREATMENT
st.	JJ	I-TREATMENT
jude	NN	I-TREATMENT
valve	NN	I-TREATMENT
and	CC	O
chronic	JJ	B-TREATMENT
coumadin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
;	:	O
breast	CC	B-TEST
biopsy	VB	I-TEST
negative	JJ	O
in	IN	O
1984	CD	O
;	:	O
appendectomy	JJ	B-TREATMENT
age	NN	O
15	CD	O
;	:	O
tonsillectomy	NN	B-TREATMENT
and	CC	O
adenoidectomy	JJ	B-TREATMENT
age	NN	O
6	CD	O
;	:	O
hysterotomy	JJ	B-TREATMENT
age	NN	O
30	CD	O
;	:	O
c-section	JJ	B-TREATMENT
age	NN	O
37	CD	O
due	JJ	O
to	TO	O
placenta	VB	B-PROBLEM
previa	NN	I-PROBLEM
.	.	O

lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
q.a.m.	NN	O
,	,	O
25	CD	O
mg	NN	O
q.p.m.	NN	O
,	,	O
and	CC	O
25	CD	O
mg	NN	O
q.h.s.;	NN	O
synthroid	VBD	B-TREATMENT
88	CD	O
mcg	NN	O
q.d.;	NN	O
norvasc	RB	B-TREATMENT
5	CD	O
mg	NNS	O
q.d.;	JJ	O
lescol	VBP	B-TREATMENT
20	CD	O
mg	NNS	O
q.p.m.	RB	O
with	IN	O
meal	NN	O
;	:	O
coumadin	NN	B-TREATMENT
is	VBZ	O
usually	RB	O
4	CD	O
mg	NNS	O
p.o.	RB	O
3x	CD	O
a	DT	O
week	NN	O
and	CC	O
3	CD	O
mg	NN	O
4x	CD	O
a	DT	O
week	NN	O
.	.	O

percodan	NN	B-TREATMENT
and	CC	O
codeine	NN	B-TREATMENT
.	.	O

negative	JJ	O
for	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
positive	JJ	O
for	IN	O
occasional	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
,	,	O
negative	JJ	O
for	IN	O
dyspnea	NN	B-PROBLEM
and	CC	O
she	PRP	O
has	VBZ	O
excellent	JJ	O
exercise	NN	O
tolerance	NN	O
.	.	O

there	EX	O
is	VBZ	O
occasional	JJ	B-PROBLEM
left	JJ	I-PROBLEM
chest	NN	I-PROBLEM
tightening	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
brief	NN	O
.	.	O

no	DT	O
bleeding	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
or	CC	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

occasional	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
when	WRB	O
she	PRP	O
flosses	VBZ	O
and	CC	O
occasional	JJ	B-PROBLEM
dizziness	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
drop	NN	I-PROBLEM
in	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
transiently	RB	O
at	IN	O
home	NN	O
.	.	O

vital	JJ	O
signs	NNS	O
-	:	O
temp	NN	B-TEST
98.8	CD	O
,	,	O
pulse	RB	B-TEST
60	CD	O
,	,	O
bp	NN	B-TEST
150/94	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
and	CC	O
saturation	NN	B-TEST
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

general	JJ	O
-	:	O
the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
older	JJR	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

heent	NN	O
-	:	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
.	.	O

neck	SYM	O
-	:	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
,	,	O
with	IN	O
2+	CD	B-TEST
carotid	NN	I-TEST
pulses	NNS	I-TEST
.	.	O

heart	NN	O
-	:	O
regular	NN	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
iii	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
left	VBD	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
-	:	O
there	EX	O
is	VBZ	O
a	DT	O
soft	JJ	O
abdomen	NNS	O
with	IN	O
a	DT	O
question	NN	O
of	IN	O
eventful	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

rectal	JJ	O
-	:	O
guaiac	JJ	B-TEST
negative	JJ	O
with	IN	O
normal	JJ	O
tone	NN	O
.	.	O

extremities	NNS	O
-	:	O
bilateral	JJ	B-TEST
radial	NN	I-TEST
,	,	O
dorsalis	NN	B-TEST
pedis	NN	I-TEST
,	,	O
posterior	JJ	B-TEST
tibial	NN	I-TEST
,	,	O
and	CC	O
femoral	JJ	B-TEST
pulses	NNS	I-TEST
are	VBP	O
all	DT	O
2+	CD	O
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

coagulation	NN	B-TEST
profile	NN	I-TEST
notable	JJ	O
for	IN	O
a	DT	B-TEST
pt	NN	I-TEST
18	CD	O
,	,	O
ptt	NN	B-TEST
36.7	CD	O
and	CC	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
2.4	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
begun	VBN	O
on	IN	O
cefotetan	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
heparin	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
inr	NN	I-TEST
dropped	VBD	O
to	TO	O
1.6	CD	O
prior	RB	O
to	TO	O
surgery	NN	B-TREATMENT
,	,	O
and	CC	O
her	PRP$	B-TEST
ptt	NN	I-TEST
was	VBD	O
in	IN	O
the	DT	O
mid	NN	O
80s	CD	O
prior	RB	O
to	TO	O
surgery	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
and	CC	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
bowel	NN	I-TREATMENT
prep	NN	I-TREATMENT
two	CD	O
days	NNS	O
before	IN	O
surgery	NN	B-TREATMENT
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
hospital	JJ	O
day	NN	O
#	#	O
3	CD	O
,	,	O
10/28/97	CD	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
underwent	JJ	O
sigmoid	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
and	CC	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O
(	(	O
a	DT	O
full	JJ	O
account	NN	O
of	IN	O
this	DT	B-TREATMENT
operation	NN	I-TREATMENT
can	MD	O
be	VB	O
found	VBN	O
in	IN	O
the	DT	O
operative	JJ	O
note	NN	O
)	)	O
.	.	O

she	PRP	O
tolerated	VBD	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
without	IN	O
complications	NNS	B-PROBLEM
initially	RB	O
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
recovery	NN	O
room	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

postoperatively	RB	O
,	,	O
she	PRP	O
had	VBD	O
her	PRP	B-TREATMENT
heparin	NN	I-TREATMENT
restarted	VBN	O
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TEST
ptt	NN	I-TEST
rising	VBG	O
to	TO	O
142.8	CD	O
and	CC	O
then	RB	O
down	RB	O
to	TO	O
92	CD	O
.	.	O

her	PRP$	O
primary	JJ	O
postoperative	JJ	O
development	NN	O
was	VBD	O
the	DT	B-PROBLEM
passage	NN	I-PROBLEM
of	IN	I-PROBLEM
some	DT	I-PROBLEM
blood	NN	I-PROBLEM
clots	NNS	I-PROBLEM
and	CC	O
blood	NN	B-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
2	CD	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
pass	VB	O
blood	NN	B-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
was	VBD	O
transfused	VBN	O
with	IN	O
one	CD	B-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TEST
preoperative	JJ	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
41	CD	O
and	CC	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
dropped	VBD	O
to	TO	O
30.4	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
2	CD	O
.	.	O

this	DT	O
was	VBD	O
a	DT	O
drop	NN	O
from	IN	O
an	DT	B-TEST
immediate	JJ	I-TEST
postoperative	JJ	I-TEST
hematocrit	NN	I-TEST
of	IN	O
35.4	CD	O
.	.	O

upon	IN	O
receiving	VBG	O
the	DT	B-TREATMENT
one	CD	I-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
returned	VBD	O
to	TO	O
33	CD	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
two	CD	O
days	NNS	O
subsequent	JJ	O
to	TO	O
the	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
,	,	O
returned	VBD	O
to	TO	O
34	CD	O
.	.	O

otherwise	RB	O
,	,	O
her	PRP	O
postoperative	JJ	O
course	NN	O
was	VBD	O
uneventful	JJ	O
with	IN	O
gradual	JJ	O
resolution	NN	O
of	IN	O
the	DT	O
passage	NN	O
of	IN	O
blood	NN	B-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
heparin	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
when	WRB	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
bleeding	VBG	B-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
her	PRP$	B-TEST
ptt	NN	I-TEST
drifted	VBD	O
to	TO	O
a	DT	O
normal	JJ	O
range	NN	O
of	IN	O
35	CD	O
by	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
3	CD	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
1	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
2	CD	O
mg	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
.	.	O

however	RB	O
,	,	O
due	JJ	O
to	TO	O
the	DT	O
episode	NN	O
of	IN	O
bleeding	VBG	B-PROBLEM
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
2	CD	O
,	,	O
the	DT	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
for	IN	O
two	CD	O
consecutive	JJ	O
days	NNS	O
,	,	O
and	CC	O
then	RB	O
restarted	VBD	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
4	CD	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
she	PRP	O
is	VBZ	O
given	VBN	O
3	CD	O
mg	NNS	O
and	CC	O
was	VBD	O
gradually	RB	O
increased	VBN	O
to	TO	O
her	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
of	IN	O
4	CD	O
mg	NNS	O
alternating	VBG	O
with	IN	O
3	CD	O
mg.	NNS	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
inr	NN	I-TEST
had	VBD	O
dropped	VBN	O
to	TO	O
1.7	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
operation	NN	B-TREATMENT
,	,	O
and	CC	O
remained	VBD	O
in	IN	O
this	DT	O
range	NN	O
initially	RB	O
,	,	O
but	CC	O
began	VBD	O
to	TO	O
rise	VB	O
to	TO	O
2.0	CD	O
with	IN	O
her	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
dosing	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
next	JJ	O
day	NN	O
,	,	O
it	PRP	O
was	VBD	O
1.6	CD	O
and	CC	O
she	PRP	O
returned	VBD	O
to	TO	O
a	DT	B-TREATMENT
normal	JJ	I-TREATMENT
dosing	NN	I-TREATMENT
of	IN	O
4	CD	O
mg	NN	O
followed	VBN	O
by	IN	O
outpatient	JJ	B-TEST
draws	NNS	I-TEST
to	TO	O
determine	VB	O
the	DT	B-TREATMENT
further	JJ	I-TREATMENT
coumadin	NN	I-TREATMENT
dosing	NN	I-TREATMENT
.	.	O

the	DT	O
rest	NN	O
of	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
was	VBD	O
unremarkable	JJ	O
,	,	O
with	IN	O
perioperative	JJ	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
flagyl	JJ	B-TREATMENT
discontinued	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
1	CD	O
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
initial	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
but	CC	O
had	VBD	O
no	DT	O
emesis	NN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
1	CD	O
,	,	O
and	CC	O
she	PRP	O
tolerated	VBD	O
a	DT	O
regular	JJ	O
diet	NN	O
by	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
3	CD	O
.	.	O

she	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
slight	JJ	I-PROBLEM
dizziness	NN	I-PROBLEM
upon	IN	O
getting	VBG	O
up	RP	O
.	.	O

for	IN	O
this	DT	O
reason	NN	O
,	,	O
her	PRP$	B-TREATMENT
normal	JJ	I-TREATMENT
lopressor	NN	I-TREATMENT
and	CC	O
norvasc	NN	B-TREATMENT
were	VBD	O
held	VBN	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	O
was	VBD	O
re-equalibration	NN	O
after	IN	O
being	VBG	O
sedentary	JJ	O
and	CC	O
mostly	RB	O
in	IN	O
bed	NN	O
following	VBG	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
slight	JJ	I-PROBLEM
headaches	NNS	I-PROBLEM
which	WDT	O
resolved	VBD	O
with	IN	O
tylenol	NN	B-TREATMENT
,	,	O
and	CC	O
the	DT	B-PROBLEM
dizziness	NN	I-PROBLEM
resolved	VBD	O
as	RB	O
well	RB	O
.	.	O

her	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
remained	VBD	O
benign	JJ	O
and	CC	O
was	VBD	O
healing	VBG	O
nicely	RB	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
q.a.m.	NN	O
,	,	O
25	CD	O
mg	NN	O
q.p.m.	NN	O
,	,	O
and	CC	O
25	CD	O
mg	NNS	O
q.h.s.	RB	O
,	,	O
synthroid	JJ	B-TREATMENT
88	CD	O
mcg	NN	O
q.d.	NN	O
,	,	O
norvasc	RB	B-TREATMENT
5	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
lescol	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
q.p.m.	NN	O
with	IN	O
meal	NN	O
,	,	O
coumadin	NN	B-TREATMENT
is	VBZ	O
usually	RB	O
4	CD	O
mg	NNS	O
p.o.	RB	O
3x	CD	O
a	DT	O
week	NN	O
and	CC	O
3	CD	O
mg	NN	O
4x	CD	O
a	DT	O
week	NN	O
;	:	O
percocet	CC	B-TREATMENT
1-2	JJ	O
tabs	NN	O
q.4h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
negative	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	JJ	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
and	CC	O
gbs	NN	B-TEST
negative	JJ	O
.	.	O

pregnancy	NN	O
was	VBD	O
iui	RB	O
assisted	VBN	O
for	IN	O
di-di	JJ	O
twin	JJ	O
gestation	NN	O
and	CC	O
was	VBD	O
relatively	RB	O
uncomplicated	JJ	B-PROBLEM
until	IN	O
mother	RB	O
presented	VBN	O
on	IN	O
12-15	NNS	O
,	,	O
with	IN	O
spontaneous	JJ	O
rupture	NN	O
of	IN	O
membranes	NNS	O
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
having	VBG	O
preterm	JJ	B-PROBLEM
contractions	NNS	I-PROBLEM
without	IN	O
cervical	JJ	B-PROBLEM
change	NN	I-PROBLEM
and	CC	O
was	VBD	O
admitted	VBN	O
for	IN	O
bedrest	NN	B-TREATMENT
.	.	O

she	PRP	O
received	VBD	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
betamethasone	NN	B-TREATMENT
complete	JJ	O
on	IN	O
12-17	JJ	O
,	,	O
magnesium	NN	B-TREATMENT
and	CC	O
erythromycin	NN	B-TREATMENT
for	IN	O
latency	NN	O
through	IN	O
12-21	JJ	O
.	.	O

intermittent	JJ	B-PROBLEM
maternal	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
noted	VBD	O
but	CC	O
without	IN	O
proteinuria	NNS	B-PROBLEM
.	.	O

ultrasounds	NNS	B-TEST
have	VBP	O
been	VBN	O
reassuring	VBG	O
with	IN	O
biophysicals	NNS	B-TEST
8	CD	O
out	IN	O
of	IN	O
8	CD	O
x2	NNS	O
.	.	O

on	IN	O
the	DT	O
evening	NN	O
of	IN	O
12-27	JJ	O
,	,	O
monitoring	NN	B-TEST
noted	VBD	O
child	NN	O
's	POS	O
increased	JJ	B-PROBLEM
preterm	NN	I-PROBLEM
contractions	NNS	I-PROBLEM
,	,	O
uterine	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
mildly	RB	B-PROBLEM
increased	VBD	I-PROBLEM
fetal	JJ	I-PROBLEM
heart	NN	I-PROBLEM
rates	NNS	I-PROBLEM
,	,	O
due	JJ	O
to	TO	O
concerns	NNS	O
of	IN	O
possible	JJ	O
chorioamnionitis	NN	B-PROBLEM
,	,	O
the	DT	O
mother	NN	O
was	VBD	O
taken	VBN	O
for	IN	O
cesarean	JJ	B-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

the	DT	O
infant	NN	O
delivered	VBN	O
with	IN	O
moderate	JJ	O
tone	NN	O
and	CC	O
respiratory	NN	O
effort	NN	O
responding	VBG	O
well	RB	O
to	TO	O
stimulation	NN	B-TREATMENT
and	CC	O
brief	JJ	B-TREATMENT
blow	NN	I-TREATMENT
by	IN	I-TREATMENT
o2	NN	I-TREATMENT
.	.	O

apgars	NNS	B-TEST
were	VBD	O
8	CD	O
and	CC	O
8	CD	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
weight	NN	B-TEST
1515	CD	O
grams	NN	O
,	,	O
10th	CD	O
to	TO	O
25th	CD	O
percentile	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
30	CD	O
cm	NN	O
,	,	O
25th	CD	O
to	TO	O
50th	CD	O
percentile	NN	O
,	,	O
length	VBZ	B-TEST
41	CD	O
cm	NN	O
,	,	O
10th	CD	O
to	TO	O
25th	CD	O
percentile	NN	O
.	.	O

warm	NN	O
,	,	O
dry	JJ	O
,	,	O
premature	JJ	B-PROBLEM
infant	NN	O
,	,	O
active	JJ	O
with	IN	O
exam	NN	B-TEST
,	,	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
at	IN	O
rest	NN	O
.	.	O

thin	NN	O
,	,	O
warm	JJ	O
,	,	O
dry	JJ	O
,	,	O
pink	VB	O
,	,	O
no	DT	O
rashes	NNS	B-PROBLEM
.	.	O

nondysmorphic	JJ	B-PROBLEM
.	.	O

positive	JJ	O
red	JJ	B-TEST
reflex	NN	I-TEST
bilaterally	RB	I-TEST
.	.	O

neck	NN	O
supple	NN	O
,	,	O
no	DT	O
lesions	NNS	B-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
grunting	NN	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
femoral	JJ	B-TEST
pulses	NNS	I-TEST
2+	CD	O
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
quiet	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
3	CD	O
vessel	NN	O
cord	NN	O
.	.	O

no	DT	O
lesions	NNS	B-PROBLEM
.	.	O

pocasset	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
left	NN	I-PROBLEM
pneumothorax	NN	I-PROBLEM
which	WDT	O
resolved	VBD	O
on	IN	O
its	PRP$	O
own	JJ	O
without	IN	O
intervention	NN	B-TREATMENT
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
remained	VBN	O
in	IN	O
room	NN	O
air	NN	O
throughout	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
with	IN	O
occasional	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
episodes	NNS	I-PROBLEM
,	,	O
the	DT	O
last	JJ	O
being	VBG	O
documented	VBN	O
on	IN	O
2020-01-14	JJ	O
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
1515	CD	O
grams	NNS	O
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
80	CD	O
cc	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
of	IN	O
d10w	NN	B-TREATMENT
.	.	O

enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#1	NN	O
.	.	O

full	JJ	B-TREATMENT
enteral	JJ	I-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
achieved	VBN	O
by	IN	O
day	NN	O
of	IN	O
life	NN	O
#7	NN	O
.	.	O

the	DT	O
infant	NN	O
had	VBD	O
a	DT	O
course	NN	O
of	IN	O
heme	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
with	IN	O
grossly	RB	B-PROBLEM
bloody	JJ	I-PROBLEM
streaks	NNS	I-PROBLEM
and	CC	O
mucus	VB	B-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
protein	JJ	B-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

the	DT	O
infant	NN	O
is	VBZ	O
now	RB	O
receiving	VBG	O
breast	NN	O
milk	NN	O
with	IN	O
nutramigen	JJ	B-TREATMENT
powder	NN	I-TREATMENT
concentrate	NN	I-TREATMENT
to	TO	O
24	CD	O
calorie	NN	O
.	.	O

stools	NNS	O
have	VBP	O
been	VBN	O
negative	JJ	O
to	TO	O
trace	VB	B-PROBLEM
positive	JJ	I-PROBLEM
and	CC	O
abdominal	JJ	B-TEST
exam	NN	I-TEST
is	VBZ	O
reassuring	VBG	O
.	.	O

discharge	NN	B-TEST
weight	NN	I-TEST
is	VBZ	O
2040	CD	O
gm	NN	O
,	,	O
the	DT	B-TEST
head	NN	I-TEST
circumference	NN	I-TEST
is	VBZ	O
32	CD	O
cm	NN	O
and	CC	O
the	DT	B-TEST
length	NN	I-TEST
is	VBZ	O
46	CD	O
cm.	NN	O
.	.	O

peak	NN	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#2	NN	O
of	IN	O
4.8/0.3	CD	O
.	.	O

hematocrit	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
41	CD	O
.	.	O

the	DT	O
infant	NN	O
did	VBD	O
not	RB	O
require	VB	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
during	IN	O
this	DT	O
hospital	JJ	O
course	NN	O
.	.	O

cbc	NN	B-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
were	VBD	O
obtained	VBN	O
on	IN	O
admission	NN	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
4.8	CD	O
,	,	O
7	CD	B-TEST
polys	NN	I-TEST
,	,	O
zero	CD	B-TEST
bands	NNS	I-TEST
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
316,000	CD	O
.	.	O

anc	NN	B-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
336	CD	O
.	.	O

a	DT	B-TEST
24	CD	I-TEST
hour	NN	I-TEST
cbc	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
5.1	CD	O
,	,	O
22	CD	B-TEST
polys	NN	I-TEST
,	,	O
zero	CD	B-TEST
bands	NNS	I-TEST
with	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
39.3	CD	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
313,000	CD	O
.	.	O

the	DT	O
infant	NN	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
which	WDT	O
were	VBD	O
discontinued	VBN	O
with	IN	O
a	DT	O
negative	JJ	O
blood	NN	O
culture	NN	O
.	.	O

audiology	NN	B-TEST
hearing	VBG	I-TEST
screen	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	B-TEST
auditory	NN	I-TEST
brainstem	NN	I-TEST
responses	NNS	I-TEST
and	CC	O
the	DT	O
infant	NN	O
passed	VBN	O
on	IN	O
both	DT	O
ears	NNS	O
.	.	O

1.	CD	O
continue	NN	O
breast	NN	O
milk	NN	O
24	CD	O
calories	NNS	O
of	IN	O
nutramigen	NN	B-TREATMENT
for	IN	O
concentration	NN	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
:	:	O
the	DT	O
infant	NN	O
is	VBZ	O
receiving	VBG	O
fer-in-phillip	JJ	B-TREATMENT
supplementation	NN	I-TREATMENT
of	IN	O
0.15	CD	O
ml	NNS	O
p.o.	JJ	O
once	RB	O
daily	JJ	O
.	.	O

3.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
for	IN	O
screening	NN	O
and	CC	O
the	DT	O
infant	NN	O
passed	VBD	O
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screens	NNS	I-TEST
have	VBP	O
been	VBN	O
sent	VBN	O
per	IN	O
protocol	NN	O
,	,	O
most	RBS	O
recently	RB	O
on	IN	O
01-11	NN	O
,	,	O
and	CC	O
have	VBP	O
been	VBN	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

5.	CD	O
immunizations	NNS	B-TREATMENT
received	VBD	O
:	:	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
2020-01-19	JJ	O
.	.	O

6.	CD	O
immunizations	NNS	B-TREATMENT
recommended	VBD	O
:	:	O

synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
november	CC	O
through	IN	O
march	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	VBG	O
3	CD	O
criteria	NNS	O
:	:	O

daycare	NN	O
during	IN	O
rsv	NN	O
season	NN	O
,	,	O
a	DT	O
smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
airway	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
school	NN	O
age	NN	O
sibling	NN	O
,	,	O
or	CC	O
3	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
child	NN	O
's	POS	O
life	NN	O
,	,	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

1.	CD	O
premature	NN	B-PROBLEM
twin	NN	I-PROBLEM
#1	NNP	O
born	NN	O
at	IN	O
32	CD	O
and	CC	O
5/7	CD	O
weeks	NNS	O
.	.	O

2.	CD	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
with	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

3.	CD	O
respiratory	JJ	B-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
pneumothorax	NN	I-PROBLEM
resolved	VBD	O
.	.	O

4.	CD	O
mild	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
.	.	O

5.	CD	O
mild	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
and	CC	I-PROBLEM
bradycardia	NN	I-PROBLEM
of	IN	O
prematurity	NN	B-PROBLEM
resolved	VBN	O
.	.	O

6.	CD	O
possible	JJ	O
milk	NN	B-PROBLEM
proteine	NN	I-PROBLEM
allergy	NN	I-PROBLEM

a	DT	B-TEST
hip	NN	I-TEST
ultrasound	NN	I-TEST
due	JJ	O
to	TO	O
breech	VB	B-PROBLEM
/	NNP	O
breech	JJ	B-PROBLEM
presentation	NN	I-PROBLEM
of	IN	I-PROBLEM
twins	NNS	I-PROBLEM
.	.	O

savd	NN	B-TREATMENT

dr.	JJ	O
kote	VB	O
6	CD	O
weeks	NNS	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

spontaneous	JJ	B-PROBLEM
vaginal	JJ	I-PROBLEM
delivery	NN	I-PROBLEM
laceration	NN	I-PROBLEM
2	CD	O
degrees	NNS	O

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
savd	NN	B-TREATMENT

savd	NN	B-TREATMENT

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
or	CC	O
further	JJ	B-PROBLEM
events	NNS	I-PROBLEM
while	IN	O
in	IN	O
house	NN	O
.	.	O

on	IN	O
thursday	JJ	O
-	:	O
2014-02-06	JJ	O
-	:	O
the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
two	CD	O
episodes	NNS	O
of	IN	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
;	:	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
given	VBN	O
nitroglycerin	JJ	B-TREATMENT
and	CC	O
those	DT	O
resolved	VBN	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
an	DT	O
evaluation	NN	O
of	IN	O
electrocardiogram	NN	B-TEST
done	VBN	O
by	IN	O
cardiology	NN	O
which	WDT	O
was	VBD	O
negative	JJ	O
and	CC	O
had	VBD	O
laboratory	NN	B-TEST
results	NNS	I-TEST
for	IN	O
rule	NN	O
out	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
which	WDT	O
were	VBD	O
also	RB	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
chest	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
and	CC	O
remained	VBD	O
afebrile	RB	B-PROBLEM
while	IN	O
in	IN	O
house	NN	O
.	.	O

endometrial	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM

endometrial	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

endometrial	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT

this	DT	O
is	VBZ	O
a	DT	O
48-year-old	JJ	O
g	NN	O
3	CD	O
p	NN	O
3	CD	O
who	WP	O
presented	VBD	O
to	TO	O
dr.	VB	O
fuscmadril	JJ	O
&apos;s	NNP	O
clinic	NN	O
after	IN	O
having	VBG	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
pap	NN	I-PROBLEM
smear	NN	I-PROBLEM
followed	VBN	O
by	IN	O
an	DT	B-TEST
endometrial	JJ	I-TEST
biopsy	NN	I-TEST
that	WDT	O
was	VBD	O
suggestive	JJ	O
of	IN	O
grade	NN	B-PROBLEM
1	CD	I-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
patient	NN	O
who	WP	O
,	,	O
over	IN	O
the	DT	O
past	JJ	O
year	NN	O
,	,	O
has	VBZ	O
had	VBN	O
no	DT	B-PROBLEM
menses	NNS	I-PROBLEM
and	CC	O
thought	VBD	O
she	PRP	O
had	VBD	O
become	VBN	O
menopausal	NN	B-PROBLEM
.	.	O

she	PRP	O
then	RB	O
began	VBD	O
spotting	VBG	B-PROBLEM
for	IN	O
several	JJ	O
months	NNS	O
with	IN	O
some	DT	B-PROBLEM
constant	JJ	I-PROBLEM
brown	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
pap	NN	I-TEST
smear	NN	I-TEST
that	WDT	O
was	VBD	O
obtained	VBN	O
by	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
showed	VBD	O
an	DT	B-PROBLEM
endometrial	JJ	I-PROBLEM
cell	NN	I-PROBLEM
and	CC	O
thus	RB	O
she	PRP	O
was	VBD	O
referred	VBN	O
to	TO	O
a	DT	O
gynecologist	NN	O
for	IN	O
an	DT	B-TEST
endometrial	JJ	I-TEST
biopsy	NN	I-TEST
.	.	O

the	DT	B-TEST
endometrial	JJ	I-TEST
biopsy	NN	I-TEST
showed	VBD	O
grade	JJ	B-PROBLEM
1	CD	I-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

a	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
proceed	VB	O
with	IN	O
surgical	JJ	B-TREATMENT
management	NN	I-TREATMENT
for	IN	O
this	DT	O
finding	NN	O
.	.	O

migraines	NNS	B-PROBLEM
.	.	O

penicillin	NN	B-TREATMENT
.	.	O

two	CD	B-TREATMENT
cesarean	JJ	I-TREATMENT
sections	NNS	I-TREATMENT
.	.	O

then	RB	O
becoming	VBG	O
irregular	NN	B-PROBLEM
for	IN	O
several	JJ	O
years	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
one	CD	O
normal	JJ	B-TREATMENT
spontaneous	JJ	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
and	CC	O
two	CD	O
cesarean	JJ	B-TREATMENT
sections	NNS	I-TREATMENT
.	.	O

imitrex	NN	B-TREATMENT
;	:	O
indocin	NN	B-TREATMENT
;	:	O
celebrex	NN	B-TREATMENT
;	:	O
verapamil	NN	B-TREATMENT
for	IN	O
migraines	NNS	B-PROBLEM
.	.	O

mother	NN	O
with	IN	O
colonic	JJ	B-PROBLEM
polyps	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
maternal	JJ	O
uncle	NN	O
and	CC	O
maternal	JJ	O
aunt	NN	O
both	DT	O
with	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
who	WP	O
have	VBP	O
passed	VBN	O
away	RB	O
from	IN	O
this	DT	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
additional	JJ	O
history	NN	O
of	IN	O
breast	NN	B-PROBLEM
,	,	I-PROBLEM
ovarian	JJ	I-PROBLEM
or	CC	I-PROBLEM
uterine	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
her	PRP$	O
family	NN	O
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
obese	JJ	I-PROBLEM
with	IN	O
pfannenstiel	JJ	B-PROBLEM
scar	NN	I-PROBLEM
visualized	VBN	O
.	.	O

no	DT	O
additional	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
or	CC	O
nodules	NNS	B-PROBLEM
appreciated	VBN	O
on	IN	O
exam	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
her	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
which	WDT	O
was	VBD	O
09/20/00	CD	O
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
tah-bso	JJ	I-TREATMENT
which	WDT	O
was	VBD	O
uncomplicated	VBN	B-PROBLEM
.	.	O

details	NNS	O
of	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
can	MD	O
be	VB	O
found	VBN	O
in	IN	O
the	DT	O
operative	JJ	O
dictation	NN	O
.	.	O

in	IN	O
short	JJ	O
,	,	O
frozen	JJ	B-TEST
pathology	NN	I-TEST
from	IN	I-TEST
the	DT	I-TEST
uterus	NN	I-TEST
showed	VBD	O
that	IN	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
grade	JJ	I-PROBLEM
1	CD	I-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
no	DT	O
invasion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
myometrium	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
nodal	JJ	B-TEST
dissection	NN	I-TEST
done	VBN	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
extremely	RB	O
well	RB	O
and	CC	O
did	VBD	O
well	RB	O
during	IN	O
her	PRP$	O
postoperative	JJ	O
course	NN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
with	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
:	:	O

percocet	NN	B-TREATMENT
;	:	O
colace	NN	B-TREATMENT
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

right-sided	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
difficulty	NN	B-PROBLEM
speaking	NN	I-PROBLEM

tpa	JJ	B-TREATMENT
administration	NN	I-TREATMENT

68	CD	O
year	NN	O
old	JJ	O
right	NN	O
handed	VBD	O
man	NN	O
with	IN	O
multiple	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
,	,	O
including	VBG	O
2	CD	B-PROBLEM
previous	JJ	I-PROBLEM
strokes	NNS	I-PROBLEM
and	CC	O
two	CD	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarctions	NNS	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
acute	JJ	B-PROBLEM
onset	NN	I-PROBLEM
right	NN	I-PROBLEM
sided	VBD	I-PROBLEM
hemiplegia	NN	I-PROBLEM
and	CC	O
dysarthria	NN	B-PROBLEM
.	.	O

his	PRP$	O
wife	NN	O
found	VBD	O
him	PRP	O
with	IN	O
weak	JJ	B-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
,	,	O
flaccid	RB	B-PROBLEM
right	JJ	I-PROBLEM
arm	NN	I-PROBLEM
,	,	O
and	CC	O
severe	JJ	B-PROBLEM
dysarthria	NN	I-PROBLEM
.	.	O

wife	NN	O
denies	VBZ	O
any	DT	B-PROBLEM
recent	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
surgeries	NNS	B-TREATMENT
,	,	O
or	CC	O
upper	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

1.	CD	O
1992	CD	O
anterior	JJ	B-PROBLEM
cerebellar	JJ	I-PROBLEM
infarction	NN	I-PROBLEM

2.	CD	O
silent	JJ	B-PROBLEM
stroke	NN	I-PROBLEM
affecting	VBG	O
anterior	JJ	O
part	NN	O
of	IN	O
brain	NN	O

3.	CD	O
2014-09-24	JJ	O
left	VBD	B-PROBLEM
mca	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
leaving	VBG	O
him	PRP	O
with	IN	O
right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM

4.	CD	O
cad	NN	B-PROBLEM
with	IN	O
mi	NN	B-PROBLEM
1999	CD	O
and	CC	O
cabg	VB	B-TREATMENT

5.	CD	O
hypercholesterolinemia	NN	B-PROBLEM

6.	CD	O
hypertension	NN	B-PROBLEM

8.	CD	O
depression	NN	B-PROBLEM

9.	CD	O
bipolar	JJ	B-PROBLEM
disorder	NN	I-PROBLEM

patient	NN	O
's	POS	O
mother	NN	O
died	VBD	O
of	IN	O
stroke	NN	B-PROBLEM
at	IN	O
the	DT	O
age	NN	O
of	IN	O
54	CD	O
.	.	O

vitals	NNS	B-TEST
97.2	CD	O
164/97	CD	O
59	CD	O
20	CD	O
100%	CD	O
room	NN	O
air	NN	O

general	JJ	B-TEST
exam	NN	I-TEST
including	VBG	O
head	NN	B-TEST
,	,	I-TEST
neck	NN	I-TEST
,	,	I-TEST
heart	NN	I-TEST
,	,	I-TEST
lung	NN	I-TEST
,	,	I-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
extremity	NN	I-TEST
exam	NN	I-TEST
,	,	O
was	VBD	O
normal	JJ	O
.	.	O

nonfluent	JJ	B-PROBLEM
speech	NN	I-PROBLEM
with	IN	O
inability	NN	O
to	TO	O
repeat	VB	O
.	.	O

no	DT	O
neglect	NN	B-PROBLEM

visual	JJ	O
field	NN	O
full	JJ	O
to	TO	O
hand	NN	B-TEST
waving	NN	I-TEST
.	.	O

right	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
.	.	O

motor	NN	O
-	:	O
decreased	VBN	B-PROBLEM
tone	NN	I-PROBLEM
on	IN	I-PROBLEM
right	JJ	I-PROBLEM
arm	NN	I-PROBLEM
.	.	O

sensory	JJ	O
-	:	O
dense	NN	B-PROBLEM
loss	NN	I-PROBLEM
to	TO	O
touch	VB	B-TEST
on	IN	O
the	DT	O
right	JJ	O
arm	NN	O
and	CC	O
leg	NN	O

reflex	JJ	B-TEST
-	:	O
1+	CD	O
/	JJ	O
4	CD	O
in	IN	O
upper	JJ	O
extremity	NN	O
,	,	O
2+	CD	O
/	NN	O
4	CD	O
at	IN	O
patellar	NN	O
,	,	O
trace	NN	O
ankle	NN	O
.	.	O

intact	NN	O
on	IN	O
left	JJ	O
finger	NN	B-TEST
to	TO	I-TEST
nose	VB	I-TEST
but	CC	O
limited	VBD	B-PROBLEM
on	IN	O
right	NN	O
due	JJ	O
to	TO	O
weakness	NN	B-PROBLEM

creatinine	NN	B-PROBLEM
slightly	RB	I-PROBLEM
elevated	VBD	I-PROBLEM
at	IN	O
1.3	CD	O
,	,	O
otherwise	RB	O
cbc	NN	B-TEST
,	,	O
chemistries	NNS	B-TEST
normal	JJ	O
.	.	O

cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
normal	JJ	O
.	.	O

valproate	NN	B-TEST
level	NN	I-TEST
within	IN	O
range	NN	O
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
:	:	O

slight	JJ	B-PROBLEM
effacement	NN	I-PROBLEM
of	IN	I-PROBLEM
posterior	JJ	I-PROBLEM
insular	JJ	I-PROBLEM
cortex	NN	I-PROBLEM
.	.	O

mri	JJ	B-TEST
head	NN	I-TEST
:	:	O

restricted	VBN	B-PROBLEM
diffusion	NN	I-PROBLEM
in	IN	I-PROBLEM
left	JJ	I-PROBLEM
frontotemporal	JJ	I-PROBLEM
region	NN	I-PROBLEM
in	IN	O
the	DT	O
distribution	NN	O
of	IN	O
the	DT	O
right	JJ	O
middle	JJ	O
cerebral	JJ	O
artery	NN	O
indicating	VBG	O
acute	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

brain	NN	B-PROBLEM
atrophy	NN	I-PROBLEM
.	.	O

changes	NNS	O
of	IN	O
small	JJ	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
lacunes	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
in	IN	I-PROBLEM
basal	NN	I-PROBLEM
ganglia	NN	I-PROBLEM
.	.	O

probable	JJ	O
chronic	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
cortex	NN	I-PROBLEM
.	.	O

also	RB	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
cerebellum	NN	I-PROBLEM
.	.	O

no	DT	O
acute	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

mra	NN	B-TEST
:	:	O

subtle	NN	B-PROBLEM
decreased	VBD	I-PROBLEM
flow	JJ	I-PROBLEM
signal	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
sylvian	JJ	I-PROBLEM
branches	NNS	I-PROBLEM
of	IN	O
the	DT	O
left	NN	O
middle	JJ	O
cerebral	JJ	O
artery	NN	O
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
major	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
seen	VBN	O
.	.	O

carotid	NN	B-TEST
ultrasound	NN	I-TEST
:	:	O

no	DT	O
stenosis	NN	B-PROBLEM

echo	NN	B-TEST
:	:	O

elongated	VBN	B-PROBLEM
left	VBD	I-PROBLEM
atrium	NN	I-PROBLEM
.	.	O

lv	JJ	B-PROBLEM
cavity	NN	I-PROBLEM
moderately	RB	I-PROBLEM
dilated	VBD	I-PROBLEM
.	.	O

lvef	JJ	B-TEST
30-35%	CD	O
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
thrombi	NNS	B-PROBLEM
are	VBP	O
seen	VBN	O
in	IN	O
the	DT	O
left	JJ	O
ventricle	NN	O
.	.	O

resting	VBG	B-PROBLEM
regional	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
include	VBP	O
apical	JJ	B-PROBLEM
dyskinesis	NN	I-PROBLEM
and	CC	O
distal	JJ	O
anterior	NN	O
,	,	O
septal	JJ	O
,	,	O
mid	JJ	O
and	CC	O
distal	JJ	B-PROBLEM
inferior	NN	I-PROBLEM
and	CC	I-PROBLEM
inferolateral	JJ	I-PROBLEM
wall	NN	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
aortic	JJ	I-PROBLEM
root	NN	I-PROBLEM
and	CC	I-PROBLEM
ascending	VBG	I-PROBLEM
aorta	NN	I-PROBLEM
.	.	O

no	DT	O
aortic	JJ	B-PROBLEM
or	CC	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

68m	CD	O
with	IN	O
multiple	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
presents	NNS	O
with	IN	O
acute	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
right-sided	JJ	I-PROBLEM
hemiparesis	NN	I-PROBLEM
and	CC	O
dysarthria	NN	B-PROBLEM
,	,	O
aphasia	NN	B-PROBLEM
concerning	VBG	O
for	IN	O
acute	NN	B-PROBLEM
left	VBD	I-PROBLEM
mca	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

patient	NN	O
arrived	VBN	O
in	IN	O
daniel	NN	O
within	IN	O
3	CD	O
hours	NNS	O
of	IN	O
symptom	JJ	B-PROBLEM
onset	NN	I-PROBLEM
and	CC	O
head	NN	B-TEST
ct	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
bleed	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
as	IN	O
wife	NN	O
had	VBD	O
not	RB	O
seen	VBN	O
patient	NN	O
before	IN	O
he	PRP	O
became	VBD	O
symptomatic	JJ	B-PROBLEM
,	,	O
there	EX	O
was	VBD	O
some	DT	O
concern	NN	O
that	IN	O
he	PRP	O
had	VBD	O
symptoms	NNS	B-PROBLEM
earlier	RBR	O
than	IN	O
6	CD	O
am	VBP	O
,	,	O
and	CC	O
therefore	RB	O
would	MD	O
be	VB	O
outside	IN	O
the	DT	O
3	CD	O
hour	NN	O
window	NN	O
for	IN	O
tpa	NN	B-TREATMENT
.	.	O

mri	NN	B-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
showed	VBD	O
diffusion	NN	B-PROBLEM
abnormalities	NNS	I-PROBLEM
but	CC	O
no	DT	O
hyperintensity	NN	B-PROBLEM
on	IN	O
t2	NN	B-TEST
/	NNP	I-TEST
flair	NN	I-TEST
imaging	VBG	I-TEST
supporting	VBG	O
the	DT	O
acute	NN	O
onset	NN	O
.	.	O

therefore	RB	O
,	,	O
iv	JJ	B-TREATMENT
tpa	NN	I-TREATMENT
thrombolytics	NNS	I-TREATMENT
were	VBD	O
administered	VBN	O
within	IN	O
3	CD	O
hours	NNS	O
of	IN	O
symptom	JJ	B-PROBLEM
onset	NN	I-PROBLEM
.	.	O

within	IN	O
minutes	NNS	O
the	DT	O
patient	NN	O
showed	VBD	O
decreased	JJ	B-PROBLEM
right	RB	I-PROBLEM
sided	VBN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
improved	VBN	O
from	IN	O
a	DT	B-PROBLEM
global	JJ	I-PROBLEM
aphasia	NN	I-PROBLEM
to	TO	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
aphasia	NN	I-PROBLEM
picture	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	O
likely	JJ	O
embolic	JJ	B-PROBLEM
etiology	NN	I-PROBLEM
of	IN	O
infarct	NN	B-PROBLEM
,	,	O
carotid	VBP	B-TEST
doppler	NN	I-TEST
and	CC	O
tte	NN	B-TEST
were	VBD	O
performed	VBN	O
.	.	O

doppler	NN	B-TEST
revealed	VBD	O
no	DT	O
hemodynamically	RB	B-PROBLEM
significant	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

echo	NN	B-TEST
did	VBD	O
not	RB	O
reveal	VB	O
potential	JJ	O
source	NN	O
of	IN	O
emboli	NN	B-PROBLEM
,	,	O
but	CC	O
showed	VBD	O
striking	JJ	B-PROBLEM
left	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
akinesis	NN	I-PROBLEM
and	CC	O
hypokinesis	NN	B-PROBLEM
presumbly	RB	O
due	JJ	O
to	TO	O
past	VB	B-PROBLEM
mi	NN	I-PROBLEM
x	NN	O
2	CD	O
.	.	O

given	VBN	O
that	IN	O
the	DT	B-PROBLEM
stroke	NN	I-PROBLEM
occurred	VBD	O
while	IN	O
taking	VBG	O
aspirin	NN	B-TREATMENT
and	CC	O
plavix	NN	B-TREATMENT
,	,	O
and	CC	O
given	VBN	O
the	DT	B-PROBLEM
severe	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
,	,	O
we	PRP	O
decided	VBD	O
to	TO	O
initiate	VB	O
anticoagulation	NN	B-TREATMENT
with	IN	O
warfarin	NN	B-TREATMENT
to	TO	O
help	VB	O
prevent	VB	O
future	JJ	B-PROBLEM
strokes	NNS	I-PROBLEM
.	.	O

anticoagulation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
with	IN	O
heparin	NN	B-TREATMENT
and	CC	O
coumadin	NN	B-TREATMENT
beginning	NN	O
on	IN	O
the	DT	O
evening	NN	O
of	IN	O
2016-08-23	JJ	O
.	.	O

the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
wife	NN	O
,	,	O
a	DT	O
nurse	NN	O
,	,	O
were	VBD	O
educated	VBN	O
on	IN	O
low	JJ	B-TREATMENT
molecular	JJ	I-TREATMENT
wt	NN	I-TREATMENT
heparin	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
started	VBN	O
in	IN	O
the	DT	O
hospital	NN	O
on	IN	O
2015-08-26	JJ	O
with	IN	O
close	JJ	O
follow-up	NNS	O
scheduled	VBN	O
with	IN	O
dr.	JJ	O
demmert	NN	O
of	IN	O
the	DT	O
wareham	NN	O
va	NN	O
primary	JJ	O
care	NN	O
clinic	VBZ	O
the	DT	O
next	JJ	O
morning	NN	O
.	.	O

his	PRP$	B-TREATMENT
depakote	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
for	IN	O
his	PRP$	B-PROBLEM
bipolar	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

on	IN	O
discharge	NN	O
,	,	O
strength	NN	O
was	VBD	O
nearly	RB	O
intact	JJ	O
in	IN	O
the	DT	O
limbs	NN	O
,	,	O
though	IN	O
he	PRP	O
still	RB	O
had	VBD	O
a	DT	B-PROBLEM
right-sided	JJ	I-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
.	.	O

additionally	RB	O
,	,	O
he	PRP	O
still	RB	O
had	VBD	O
mild	VBN	B-PROBLEM
dysarthria	NNS	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
aphasia	NN	I-PROBLEM
.	.	O

additionally	RB	O
,	,	O
risk	NN	B-TREATMENT
factor	NN	I-TREATMENT
modification	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

lipid	JJ	B-TEST
panel	NN	I-TEST
was	VBD	O
checked	VBN	O
and	CC	O
showed	VBD	O
good	JJ	O
control	NN	O
of	IN	O
lipids	NNS	O
on	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	I-TREATMENT
zocor	NN	I-TREATMENT
.	.	O

patient	NN	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
and	CC	O
fasting	VBG	B-TEST
glucose	NN	I-TEST
was	VBD	O
78	CD	O
,	,	O
but	CC	O
a1c	NN	B-TEST
was	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
5.9	CD	O
.	.	O

he	PRP	O
may	MD	O
need	VB	O
further	JJR	B-TEST
glucose	VB	I-TEST
monitoring	NN	I-TEST
in	IN	O
the	DT	O
future	NN	O
.	.	O

his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
hypertensive	NN	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
to	TO	O
help	VB	O
increase	VB	O
cerebral	JJ	O
perfusion	NN	O
and	CC	O
prevent	NN	O
further	RB	B-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

speech	NN	O
therapy	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
,	,	O
and	CC	O
recommended	VBD	O
oupatient	JJ	B-TREATMENT
speech	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

similarly	RB	O
,	,	O
outpatient	JJ	B-TREATMENT
pt	NN	I-TREATMENT
was	VBD	O
recommended	VBN	O
for	IN	O
his	PRP$	B-PROBLEM
gait	NN	I-PROBLEM
difficulties	NNS	I-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
previous	JJ	I-PROBLEM
strokes	NNS	I-PROBLEM
.	.	O

residual	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
include	VBP	O
right	JJ	B-PROBLEM
side	NN	I-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
from	IN	O
previous	JJ	B-PROBLEM
stroke	NN	I-PROBLEM
and	CC	O
moderately	RB	B-PROBLEM
severe	JJ	I-PROBLEM
dysarthria	NNS	I-PROBLEM
and	CC	O
anterior	JJ	B-PROBLEM
aphasia	NN	I-PROBLEM
with	IN	O
word	NN	B-PROBLEM
finding	VBG	I-PROBLEM
difficulties	NNS	I-PROBLEM
.	.	O

captopril	JJ	B-TREATMENT
50	CD	O
bid	NN	O
,	,	O
asa	RB	B-TREATMENT
81	CD	O
,	,	O
plavix	NN	B-TREATMENT
75	CD	O
,	,	O
zocor	NN	B-TREATMENT
40	CD	O
,	,	O
imdur	NN	B-TREATMENT
30	CD	O
,	,	O
lasix	VBD	B-TREATMENT
10	CD	O
,	,	O
prozac	NN	B-TREATMENT
20	CD	O
,	,	O
iron	NN	B-TREATMENT
,	,	O
mvi	NN	B-TREATMENT

1.	CD	O
enoxaparin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
80	CD	O
mg	NN	O
/	VBD	O
0.8	CD	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
syringe	NN	O
subcutaneous	JJ	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
:	:	O
may	MD	O
discontinue	VB	O
once	RB	O
inr	JJ	B-TEST
therapeutic	JJ	O
as	IN	O
directed	VBN	O
by	IN	O
your	PRP$	O
physician	NN	O
.	.	O

2.	CD	O
divalproex	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qd	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

4.	CD	O
warfarin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

5.	CD	O
simvastatin	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

6.	CD	O
prozac	JJ	B-TREATMENT
20	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

8.	CD	O
captopril	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
imdur	JJ	B-TREATMENT
30	CD	O
mg	JJ	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24hr	CD	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

infarction	NN	B-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
inferior	JJ	I-PROBLEM
division	NN	I-PROBLEM
,	,	O
s/p	NN	O

tpa	NN	B-TREATMENT
,	,	O
with	IN	O
residual	JJ	B-PROBLEM
dysarthria	NN	I-PROBLEM
and	CC	O
aphasia	NN	B-PROBLEM

hypertension	NN	B-PROBLEM

hypercholesterolemia	NN	B-PROBLEM

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

good	JJ	O
,	,	O
with	IN	O
no	DT	O
motor	NN	B-PROBLEM
deficits	NNS	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
dysarthria	NN	I-PROBLEM
and	CC	O
mild	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
aphasia	NN	I-PROBLEM

take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
directed	JJ	O
and	CC	O
go	VB	O
for	IN	O
all	DT	O
scheduled	JJ	O
appointments	NNS	O
for	IN	O
anticoagulation	NN	B-TEST
monitoring	NN	I-TEST
.	.	O

if	IN	O
problems	NNS	B-PROBLEM
with	IN	I-PROBLEM
speech	NN	I-PROBLEM
or	CC	O
weakness	NN	B-PROBLEM
worsen	NN	O
,	,	O
go	VB	O
immediately	RB	O
to	TO	O
an	DT	O
emergency	NN	O
room	NN	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

left	VBN	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
large	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
63	CD	O
year	NN	O
old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
mixed	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
and	CC	O
large	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	O
the	DT	O
lung	NN	O
who	WP	O
is	VBZ	O
being	VBG	O
admitted	VBN	O
for	IN	O
neoadjuvant	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
with	IN	O
cisplatinum	NN	B-TREATMENT
,	,	O
5-fu	JJ	B-TREATMENT
and	CC	O
velban	NN	B-TREATMENT
.	.	O

briefly	NN	O
,	,	O
she	PRP	O
was	VBD	O
originally	RB	O
diagnosed	VBN	O
in	IN	O
april	JJ	O
1993	CD	O
with	IN	O
lung	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

bronchoscopy	NN	B-TEST
and	CC	O
mediastinoscopy	NN	B-TEST
revealed	VBD	O
an	DT	B-PROBLEM
unresectable	JJ	I-PROBLEM
mediastinal	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
with	IN	O
the	DT	O
left	JJ	O
tracheobronchial	JJ	O
angle	NN	O
node	NN	O
positive	JJ	O
for	IN	O
cancer	NN	B-PROBLEM
,	,	O
and	CC	O
the	DT	O
right	JJ	O
paratracheal	NN	O
node	RB	O
positive	JJ	O
for	IN	O
anthracosis	NN	B-PROBLEM
.	.	O

formal	JJ	B-TEST
pathology	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
poorly	RB	I-PROBLEM
differentiated	VBN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
with	IN	O
focal	JJ	B-PROBLEM
giant	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

bone	NN	B-TEST
scan	NN	I-TEST
,	,	O
head	NN	B-TEST
ct	NN	I-TEST
and	CC	O
other	JJ	B-TEST
staging	VBG	I-TEST
studies	NNS	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
for	IN	O
evidence	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
being	VBG	O
treated	VBN	O
with	IN	O
preoperative	JJ	B-TREATMENT
neoadjuvant	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
using	VBG	I-TREATMENT
5	CD	I-TREATMENT
fu	NN	I-TREATMENT
,	,	O
vinblastine	NN	B-TREATMENT
,	,	O
cisplatinum	NN	B-TREATMENT
and	CC	O
concomitant	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
now	RB	O
admitted	VBN	O
for	IN	O
her	PRP$	B-TREATMENT
second	JJ	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
that	DT	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

temperature	NN	B-TEST
98.9	CD	O
,	,	O
pulse	RB	B-TEST
82	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
.	.	O

sclera	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
jvd	NN	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
showed	VBD	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
,	,	O
otherwise	RB	O
were	VBD	O
clear	JJ	O
.	.	O

the	DT	B-TEST
cardiac	NN	I-TEST
exam	NN	I-TEST
showed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
i	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
,	,	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

rectal	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

extremities	NNS	O
were	VBD	O
without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
resting	VBG	I-PROBLEM
tremor	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
hand	NN	I-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
6.2	CD	O
,	,	O
hemoglobin	NN	B-TEST
12.4	CD	O
,	,	O
hematocrit	NN	B-TEST
36.1	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
265,000	CD	O
.	.	O

the	DT	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

bun	NN	B-TEST
8	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
oncology	NN	O
service	NN	O
on	IN	O
founder	NN	O
&apos;s	NN	O
7	CD	O
and	CC	O
received	VBD	O
intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
72	CD	I-TREATMENT
hour	NN	I-TREATMENT
continuous	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
of	IN	I-TREATMENT
5-fu	JJ	I-TREATMENT
,	,	O
vinblastine	JJ	B-TREATMENT
on	IN	O
day	NN	O
1	CD	O
and	CC	O
day	NN	O
3	CD	O
,	,	O
and	CC	O
cisplatinum	NN	B-TREATMENT
on	IN	O
day	NN	O
1	CD	O
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
chemotherapy	NN	I-TREATMENT
well	RB	O
with	IN	O
mild	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
mild	JJ	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	O
her	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
during	IN	O
the	DT	O
hospitalization	NN	O
,	,	O
likely	RB	O
secondary	JJ	O
to	TO	O
fluid	VB	B-PROBLEM
overload	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
modest	JJ	I-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
30.9	CD	O
.	.	O

overall	JJ	O
there	EX	O
were	VBD	O
no	DT	O
unanticipated	JJ	B-PROBLEM
side	NN	I-PROBLEM
effects	NNS	I-PROBLEM
of	IN	O
this	DT	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

following	VBG	O
her	PRP$	O
recovery	NN	O
from	IN	O
chemotherapy	NN	B-TREATMENT
,	,	O
she	PRP	O
will	MD	O
proceed	VB	O
to	TO	O
surgical	JJ	B-TREATMENT
resection	NN	I-TREATMENT
.	.	O

intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
for	IN	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

slo-mag	JJ	B-TREATMENT
one	CD	O
tab	NN	O
p.o.	NN	O
b.i.d.	NN	O
stelazine	NN	B-TREATMENT
2	CD	O
mg.	NN	O
p.o.	NN	O
q.d.	NN	O
ativan	VBD	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
or	CC	O
s.l.	JJ	O
q.	JJ	O
4-6	JJ	O
hr.	NN	O
p.r.n.	NN	O
nausea	NN	B-PROBLEM
.	.	O

cephalosporins	NNS	B-TREATMENT
/	VBP	O
dilaudid	JJ	B-TREATMENT
/	NNP	O
metoclopramide	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
respiratory	NN	B-PROBLEM
failure	NN	I-PROBLEM

intubation	NN	B-TREATMENT

central	JJ	B-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT

bronchoscopy	NN	B-TEST

this	DT	O
is	VBZ	O
a	DT	O
39	CD	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
type	VBP	I-PROBLEM
i	NN	I-PROBLEM
on	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
pump	NN	I-TREATMENT
,	,	O
anemia	NN	B-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
gastroparesis	NN	B-PROBLEM
,	,	O
gerd	NN	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
mediplex	JJ	O
rehab	NN	O
hospital	NN	O
hospital	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
hypoxic	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

she	PRP	O
arrived	VBD	O
at	IN	O
mediplex	JJ	O
rehab	NN	O
hospital	NN	O
hospital	NN	O
on	IN	O
07-01	NN	O
for	IN	O
1	CD	O
day	NN	O
of	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
febrile	JJ	B-PROBLEM
to	TO	O
99	CD	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
likely	JJ	O
gastroparesis	NN	B-PROBLEM
and	CC	O
eventually	RB	O
had	VBD	O
a	DT	B-TEST
complete	JJ	I-TEST
fever	NN	I-TEST
work-up	NN	I-TEST
that	WDT	O
included	VBD	O
a	DT	O
negative	JJ	O
chest	NN	O
x-ray	NN	O
,	,	O
blood	NN	O
cultures	NNS	O
,	,	O
and	CC	O
urine	JJ	O
culture	NN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
07-02	NN	O
and	CC	O
represented	VBD	O
that	DT	O
day	NN	O
with	IN	O
continued	JJ	B-PROBLEM
nause	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
and	CC	O
fever	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
readmitted	VBN	O
and	CC	O
had	VBD	O
a	DT	B-TEST
complete	JJ	I-TEST
febrile	NN	I-TEST
work-up	NN	I-TEST
that	WDT	O
included	VBD	O
ct	JJ	B-TEST
abdomene	NN	I-TEST
/	NNP	I-TEST
pelvis	NN	I-TEST
,	,	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
,	,	O
blood	NN	B-TEST
culture	NN	I-TEST
's	POS	I-TEST
,	,	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
,	,	O
all	DT	O
of	IN	O
which	WDT	O
were	VBD	O
unremarkable	JJ	O
.	.	O

she	PRP	O
was	VBD	O
intubated	VBN	O
on	IN	O
07-03	NN	O
for	IN	O
progressive	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

workup	NN	B-TEST
continued	VBD	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

extubation	NN	B-TREATMENT
was	VBD	O
attempted	VBN	O
on	IN	O
07-14	NN	O
,	,	O
but	CC	O
she	PRP	O
was	VBD	O
re-intubated	JJ	O
due	JJ	O
to	TO	O
inspiratory	JJ	B-PROBLEM
stridor	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
neck	NN	I-TEST
showed	VBD	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
obliterating	VBG	O
the	DT	O
airway	NN	O
surrounding	VBG	O
the	DT	B-TREATMENT
ett	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

1.	CD	O
type	NN	B-PROBLEM
i	NN	I-PROBLEM
diabetes	NNS	I-PROBLEM
diagnosed	VBD	O
at	IN	O
age	NN	O
27	CD	O
.	.	O

she	PRP	O
is	VBZ	O
usually	RB	O
managed	VBN	O
on	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
pump	NN	I-TREATMENT
.	.	O

2.	CD	O
hashimoto	NN	B-PROBLEM
's	POS	I-PROBLEM
thyroiditis	NN	I-PROBLEM
.	.	O

3.	CD	O
gastroparesis	NN	B-PROBLEM

4.	CD	O
history	NN	O
of	IN	O
bulemia	NN	B-PROBLEM

5.	CD	O
anxiety	NN	B-PROBLEM
on	IN	O
clonazepam	NN	B-TREATMENT

6.	CD	O
history	NN	O
of	IN	O
diabetic	JJ	B-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

vitals	NNS	B-TEST
:	:	O

temperature	NN	B-TEST
:	:	O
98.8	CD	O
pulse	NN	B-TEST
:	:	O
79	CD	O

blood	NN	B-TEST
pressure	NN	I-TEST
:	:	O
125/89	CD	O

respiratory	NN	B-TEST
rate	NN	I-TEST
:	:	O
12	CD	O

oxygen	NN	B-TEST
saturation	NN	I-TEST
:	:	O
100%	CD	O
on	IN	O
ac	NN	B-TREATMENT
500x12	CD	O
,	,	O
peep5	NN	B-TREATMENT
,	,	O
50%	CD	O

intubated	VBN	B-TREATMENT
,	,	O
sedated	VBN	B-TREATMENT
,	,	O
not	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
to	TO	O
command	VB	B-TEST
,	,	O
retracts	NNS	O
to	TO	O
pain	VB	B-TEST

anicteric	JJ	B-PROBLEM
sclera	NN	I-PROBLEM
bilat	NN	I-PROBLEM
.	.	O

pupils	NNS	B-PROBLEM
minimally	RB	I-PROBLEM
reactive	VBP	I-PROBLEM

no	DT	O
elevated	JJ	B-PROBLEM
jvp	NN	I-PROBLEM
appreciated	VBD	O
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
anteriorly	RB	O
.	.	O

nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegally	RB	B-PROBLEM
.	.	O

mildly	RB	B-PROBLEM
hypoactive	JJ	I-PROBLEM
bowelsounds	NNS	I-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

pulses	NNS	B-PROBLEM
diminished	VBD	I-PROBLEM
but	CC	O
symmetric	JJ	O
.	.	O

sedated	VBN	B-TREATMENT
.	.	O

retracts	NNS	O
to	TO	O
painful	VB	B-TEST
stimuli	NNS	I-TEST

no	DT	O
rashes	NNS	B-PROBLEM

wbc	SYM	B-TEST
-	:	O
29.9	CD	O
hgb	NN	B-TEST
-	:	O
8.5	CD	O
hct	NN	B-TEST
-	:	O
26.8	CD	O
plt	NN	B-TEST
count	NN	I-TEST
-	:	O
323	CD	O
neuts	NNS	B-TEST
-	:	O
75	CD	O
bands	NNS	B-TEST
-	:	O
13	CD	O
lymphs	SYM	B-TEST
-	:	O
6	CD	O
monos	NNS	B-TEST
-	:	O
5	CD	O
eos	SYM	B-TEST
-	:	O
1	CD	O
basos	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
0	CD	O
metas	NNS	B-TEST
-	:	O
0	CD	O
myelos	SYM	B-TEST
-	:	O
0	CD	O

sodium	NN	B-TEST
-	:	O
137	CD	O
potassium	NN	B-TEST
-	:	O
4.5	CD	O
chloride	NN	B-TEST
-	:	O
106	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
22	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
41	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
glucose	JJ	B-TEST
-	:	O
231	CD	O
calcium	NN	B-TEST
-	:	O
7.7	CD	O
phosphate	NN	B-TEST
-	:	O
3.6	CD	O
magnesium	NN	B-TEST
-	:	O
2.4	CD	O

alt	NN	B-TEST
(	(	I-TEST
sgpt	JJ	I-TEST
)-	JJ	I-TEST
249	CD	O
ast	NN	B-TEST
(	(	I-TEST
sgot	JJ	I-TEST
)-	JJ	I-TEST
147	CD	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	I-TEST
241	CD	O
alk	NN	B-TEST
phos	NN	I-TEST
-	:	O
230	CD	O
amylase	NN	B-TEST
-	:	O
28	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.9	CD	O
lipase	NN	B-TEST
-	:	O
12	CD	O
albumin	SYM	B-TEST
-	:	O
2.6	CD	O

pt	SYM	B-TEST
-	:	O
13.8	CD	O
ptt	NN	B-TEST
-	:	O
24.3	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.2	CD	O

tsh	SYM	B-TEST
-	:	O
3.3	CD	O

1.	CD	O
nexk	JJ	B-TEST
ct	NN	I-TEST
:	:	O

increased	VBN	B-PROBLEM
soft	JJ	I-PROBLEM
tissues	NNS	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
pharynx	NN	I-PROBLEM
.	.	O

this	DT	O
may	MD	O
be	VB	O
secondary	JJ	O
to	TO	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
as	IN	O
indicated	VBN	O
in	IN	O
the	DT	O
patient	NN	O
's	POS	O
history	NN	O
,	,	O
and	CC	O
some	DT	O
may	MD	O
be	VB	O
secondary	JJ	O
to	TO	O
secretions	NNS	B-PROBLEM
above	IN	I-PROBLEM
the	DT	I-PROBLEM
ett	NN	I-PROBLEM
balloon	NN	I-PROBLEM
.	.	O

no	DT	O
retropharyngeal	NN	B-PROBLEM
fluid	NN	I-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

dependent	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
is	VBZ	O
present	JJ	O
within	IN	O
the	DT	O
visualized	JJ	O
portions	NNS	O
of	IN	O
the	DT	O
lung	NN	O
apices	NNS	O
.	.	O

2.	CD	O
chest	JJS	B-TEST
ct	NN	I-TEST
:	:	O

bilateral	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
consolidations	NNS	I-PROBLEM
mostly	RB	O
in	IN	O
dependent	JJ	O
portion	NN	O
,	,	O
with	IN	O
small	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
diffuse	VB	B-PROBLEM
ground-glass	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
in	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
upper	NN	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
lobes	NNS	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
ards	NNS	B-PROBLEM
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
given	VBN	O
the	DT	O
history	NN	O
.	.	O

ground-glass	NN	B-PROBLEM
opacity	NN	I-PROBLEM
is	VBZ	O
somewhat	RB	O
more	RBR	O
prominent	JJ	O
in	IN	O
right	JJ	O
upper	JJ	O
lobe	NN	O
,	,	O
and	CC	O
superimposed	VBD	B-PROBLEM
infection	NN	I-PROBLEM
cannot	NN	O
be	VB	O
totally	RB	O
excluded	VBN	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
39	CD	O
year-old	JJ	O
female	NN	O
with	IN	O
diabetes	NNS	B-PROBLEM
type	VBP	I-PROBLEM
i	NN	I-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
gastroparesis	NN	B-PROBLEM
who	WP	O
was	VBD	O
transfered	VBN	O
for	IN	O
hypoxic	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

1.	CD	O
hypoxic	JJ	B-PROBLEM
rspiratory	JJ	I-PROBLEM
failure	NN	I-PROBLEM
:	:	O

she	PRP	O
arrived	VBD	O
intubated	JJ	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT
from	IN	O
esteban	JJ	O
hospital	NN	O
.	.	O

on	IN	O
arrival	PDT	O
a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
perihilar	JJ	B-PROBLEM
and	CC	I-PROBLEM
bibasilar	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
,	,	O
which	WDT	O
appeared	VBD	O
conistent	NN	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
but	CC	O
also	RB	O
possibly	RB	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
ards	NNS	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
known	VBN	O
to	TO	O
have	VB	O
gram-positive	JJ	B-PROBLEM
cocci	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
sputum	NN	I-PROBLEM
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

a	DT	B-TEST
bronchoscopy	NN	I-TEST
with	IN	O
bal	NN	B-TEST
was	VBD	O
performed	VBN	O
and	CC	O
a	DT	B-TEST
sputum	NN	I-TEST
sample	NN	I-TEST
eventually	RB	O
grew	VBD	O
out	RP	O
mrsa	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
to	TO	O
cover	VB	O
her	PRP$	B-PROBLEM
mrsa	JJ	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
07-17	NN	O
to	TO	O
evaluate	VB	O
the	DT	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
seen	VBN	O
on	IN	O
ct	NN	B-TEST
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
showed	VBD	O
increased	JJ	B-PROBLEM
soft	JJ	I-PROBLEM
tissues	NNS	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
pharynx	NN	I-PROBLEM
which	WDT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
prolonged	JJ	B-TREATMENT
intubation	NN	I-TREATMENT
/	NNP	O
trauma	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
steroids	NNS	B-TREATMENT
for	IN	O
this	DT	B-PROBLEM
swelling	VBG	I-PROBLEM
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
and	CC	O
these	DT	O
were	VBD	O
continued	VBN	O
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
patient	NN	O
should	MD	O
receive	VB	O
one	CD	O
more	JJR	O
trial	NN	O
off	IN	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
before	IN	O
committing	VBG	O
her	PRP$	O
to	TO	O
a	DT	B-TREATMENT
tracheotomy	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
on	IN	O
minimal	JJ	B-TREATMENT
vent	JJ	I-TREATMENT
settings	NNS	I-TREATMENT
but	CC	O
it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
delay	VB	O
extubating	VBG	O
the	DT	O
patient	NN	O
until	IN	O
the	DT	O
morning	NN	O
of	IN	O
6/2	CD	O
.	.	O

overnight	RB	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
hypoxic	JJ	B-PROBLEM
,	,	O
dropping	VBG	O
to	TO	O
the	DT	O
80	CD	O
's	POS	O
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
that	IN	O
the	DT	B-TREATMENT
et	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
displaced	VBN	B-PROBLEM
to	TO	O
very	RB	O
high	JJ	O
in	IN	O
the	DT	O
trachea	NN	O
.	.	O

the	DT	B-TREATMENT
cuff	NN	I-TREATMENT
was	VBD	O
deflated	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
.	.	O

she	PRP	O
was	VBD	O
placed	VBN	O
in	IN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
by	IN	O
shovel	NN	B-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
her	PRP$	B-TEST
sats	NNS	I-TEST
immediately	RB	O
improved	VBN	O
.	.	O

she	PRP	O
was	VBD	O
weaned	VBN	O
down	RP	O
until	IN	O
she	PRP	O
was	VBD	O
maintaining	VBG	O
her	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
above	IN	O
90%	CD	O
on	IN	O
6l	CD	O
by	IN	O
nasal	JJ	B-TREATMENT
cannuala	NN	I-TREATMENT
.	.	O

as	IN	O
she	PRP	O
was	VBD	O
doing	VBG	O
well	RB	O
without	IN	O
evidence	NN	O
of	IN	O
stridor	NN	B-PROBLEM
,	,	O
the	DT	B-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
stopped	VBN	O
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
and	CC	O
was	VBD	O
weaned	VBN	O
from	IN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
need	VB	O
to	TO	O
complete	VB	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
mrsa	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
on	IN	O
2019-07-30	JJ	O
.	.	O

2.	CD	O
enterobacter	JJ	B-PROBLEM
bacteremia	NN	I-PROBLEM
:	:	O

she	PRP	O
was	VBD	O
initially	RB	O
covered	VBN	O
broadly	RB	O
with	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
ciprofloxacin	NN	B-TREATMENT
,	,	O
and	CC	O
falgyl	NN	B-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
at	IN	O
mediplex	JJ	O
rehab	NN	O
hospital	NN	O
hospital	NN	O
for	IN	O
gram	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

subsequently	RB	O
,	,	O
zosyn	NN	B-TREATMENT
was	VBD	O
added	VBN	O
.	.	O

the	DT	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
out	RP	O
enterobacter	JJ	B-PROBLEM
cloacae	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
unclear	JJ	O
the	DT	O
source	NN	O
of	IN	O
her	PRP$	B-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
stool	NN	I-TEST
cultures	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

her	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
the	DT	B-TREATMENT
tip	NN	I-TREATMENT
was	VBD	O
culture	NN	O
negative	JJ	O
.	.	O

she	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
on	IN	O
levofloxacin	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
positive	JJ	B-PROBLEM
cultures	NNS	I-PROBLEM
during	IN	O
this	DT	O
admission	NN	O
.	.	O

once	RB	O
she	PRP	O
was	VBD	O
more	RBR	O
stable	JJ	O
,	,	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
was	VBD	O
performed	VBN	O
to	TO	O
look	VB	O
for	IN	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

this	DT	B-TEST
study	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

however	RB	O
,	,	O
the	DT	B-TEST
study	NN	I-TEST
was	VBD	O
limited	VBN	O
due	JJ	O
to	TO	O
inadequate	VB	O
po	NN	O
contrast	NN	O
intake	NN	O
by	IN	O
the	DT	O
patient	NN	O
;	:	O
it	PRP	O
did	VBD	O
show	VB	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
cecal	JJ	I-PROBLEM
cystic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
verse	NN	O
normal	JJ	O
loop	NN	O
of	IN	O
bowel	NN	O
.	.	O

this	DT	B-TEST
study	NN	I-TEST
will	MD	O
need	VB	O
to	TO	O
be	VB	O
repeated	VBN	O
once	IN	O
she	PRP	O
is	VBZ	O
tolerating	VBG	O
po	NN	O
's	POS	O
.	.	O

she	PRP	O
will	MD	O
complete	VB	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
levofloxacin	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
bacteremia	NN	I-PROBLEM
on	IN	O
2019-07-30	JJ	O
.	.	O

3.	CD	O
diabetes	NNS	B-PROBLEM
type	JJ	I-PROBLEM
i	NN	I-PROBLEM
:	:	O

she	PRP	O
was	VBD	O
intially	RB	O
maintained	VBN	O
on	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
tight	JJ	B-TREATMENT
glycemic	JJ	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
maintained	VBN	O
on	IN	O
d5w	NN	B-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
increased	VBN	O
to	TO	O
d10w	VB	B-TREATMENT
as	IN	O
the	DT	O
patient	NN	O
was	VBD	O
persistently	RB	B-PROBLEM
borderline	JJ	I-PROBLEM
hypoglycemic	NN	I-PROBLEM
while	IN	O
on	IN	O
insulin	NN	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

once	RB	O
she	PRP	O
began	VBD	O
to	TO	O
take	VB	O
po	NN	O
's	POS	O
,	,	O
the	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
glargine	NN	B-TREATMENT
with	IN	O
a	DT	B-TREATMENT
humalog	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

while	IN	O
her	PRP$	O
po	NNS	O
intake	NN	O
was	VBD	O
minimal	JJ	O
she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
supplemental	JJ	B-TREATMENT
iv	NN	I-TREATMENT
dextrose	NN	I-TREATMENT
to	TO	O
suppress	VB	O
ketosis	NN	B-PROBLEM
.	.	O

while	IN	O
she	PRP	O
was	VBD	O
on	IN	O
the	DT	B-TREATMENT
iv	NN	I-TREATMENT
dextrose	NN	I-TREATMENT
,	,	O
she	PRP	O
required	VBD	O
up	RB	O
to	TO	O
26	CD	O
units	NNS	O
of	IN	O
glargine	NN	B-TREATMENT
for	IN	O
glycemic	JJ	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

as	IN	O
she	PRP	O
starting	VBG	O
taking	VBG	O
some	DT	O
foods	NNS	O
,	,	O
her	PRP$	B-TREATMENT
glargine	NN	I-TREATMENT
was	VBD	O
decrease	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
her	PRP$	B-TREATMENT
glargine	NN	I-TREATMENT
was	VBD	O
10	CD	O
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
glucose	NN	I-TEST
were	VBD	O
under	IN	O
good	JJ	O
control	NN	O
.	.	O

the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
she	PRP	O
was	VBD	O
nauseated	VBN	B-PROBLEM
and	CC	O
not	RB	O
taking	VBG	O
pos	NN	O
.	.	O

therefore	RB	O
,	,	O
she	PRP	O
received	VBD	O
1l	CD	O
of	IN	O
d5	NN	B-TREATMENT
,	,	O
and	CC	O
her	PRP$	B-TEST
sugars	NNS	I-TEST
were	VBD	O
elevated	VBN	B-PROBLEM
to	TO	O
400	CD	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

4.	CD	O
gastroparesis	NN	B-PROBLEM
:	:	O

she	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
gastroparesis	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
long-standing	JJ	B-PROBLEM
type	NN	I-PROBLEM
i	NN	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

once	RB	O
she	PRP	O
was	VBD	O
extubated	VBN	O
,	,	O
she	PRP	O
was	VBD	O
nauseated	VBN	B-PROBLEM
with	IN	O
emesis	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
intially	RB	O
treated	VBN	O
with	IN	O
erythromycin	NN	B-TREATMENT
for	IN	O
pro-motility	NN	O
as	IN	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
bad	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
reglan	VB	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
remained	VB	O
nauseated	VBN	B-PROBLEM
so	RB	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
phenergan	NN	B-TREATMENT
,	,	O
anzemet	NN	B-TREATMENT
,	,	O
zofran	NN	B-TREATMENT
,	,	O
and	CC	O
ativan	NN	B-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
nausea	NN	I-PROBLEM
was	VBD	O
accompanied	VBN	O
by	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
morphine	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
a	DT	B-TREATMENT
pca	NN	I-TREATMENT
for	IN	O
better	JJR	B-TREATMENT
pain	NN	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
nausea	VBN	B-PROBLEM
despite	IN	O
an	DT	B-TREATMENT
agressive	JJ	I-TREATMENT
anti-emetic	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
her	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
secondary	JJ	O
to	TO	O
gastroparesis	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
other	JJ	O
causes	NNS	O
were	VBD	O
looked	VBN	O
for	IN	O
including	VBG	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
and	CC	O
bowel	NN	B-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
abdominal	JJ	I-TEST
plain	NN	I-TEST
film	NN	I-TEST
showed	VBD	O
non-specific	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
gas	NN	I-PROBLEM
patterns	NNS	I-PROBLEM
that	WDT	O
may	MD	O
represent	VB	O
an	DT	B-PROBLEM
early	JJ	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
for	IN	O
decompression	NN	B-TREATMENT
given	VBN	O
the	DT	O
signs	NNS	O
of	IN	O
early	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
the	DT	O
day	NN	O
of	IN	O
transfer	NN	O
.	.	O

the	DT	O
gi	NN	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
they	PRP	O
felt	VBD	O
that	IN	O
her	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
all	DT	O
gastroparesis	NN	B-PROBLEM
.	.	O

they	PRP	O
recommended	VBD	O
erythromycin	NN	B-TREATMENT
and	CC	O
zelnorm	NN	B-TREATMENT
.	.	O

she	PRP	O
should	MD	O
eventually	RB	O
have	VB	O
a	DT	B-TEST
tissue	NN	I-TEST
transglutaminase	NN	I-TEST
to	TO	O
rule	VB	O
out	RP	O
celiac	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

5.	CD	O
transaminitis	NN	B-PROBLEM
:	:	O

per	IN	O
report	NN	O
,	,	O
she	PRP	O
had	VBD	O
elevated	VBN	B-PROBLEM
lfts	NNS	I-PROBLEM
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

a	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
was	VBD	O
negative	JJ	O
for	IN	O
any	DT	B-PROBLEM
acute	JJ	I-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
lfts	NNS	I-TEST
trended	VBD	O
down	RB	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

6.	CD	O
hypothyroidism	NN	B-PROBLEM
:	:	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
levothyroxine	NN	I-TREATMENT
.	.	O

while	IN	O
she	PRP	O
was	VBD	O
not	RB	O
taking	VBG	O
adequate	JJ	O
pos	NN	O
,	,	O
she	PRP	O
was	VBD	O
on	IN	O
iv	JJ	B-TREATMENT
levothyroxine	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
npo	RB	B-TREATMENT
while	IN	O
intubated	VBN	B-TREATMENT
and	CC	O
recived	VBN	O
tube	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
for	IN	O
nutrition	NN	O
.	.	O

after	IN	O
extubation	NN	B-TREATMENT
,	,	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
sips	NNS	O
and	CC	O
had	VBD	O
a	DT	B-TEST
speech	NN	I-TEST
and	CC	I-TEST
swallow	JJ	I-TEST
evaluation	NN	I-TEST
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
she	PRP	O
was	VBD	O
npo	RB	B-TREATMENT
given	VBN	O
her	PRP$	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

8.	CD	O
prophylaxis	NN	B-TREATMENT
:	:	O

ppi	NN	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
sq	NN	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
given	VBN	O
the	DT	O
concern	NN	O
for	IN	O
a	DT	B-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
double	JJ	I-TREATMENT
lumen	NNS	I-TREATMENT
picc	JJ	I-TREATMENT
place	NN	O
.	.	O

full	JJ	B-TREATMENT

anti-gbm	NN	B-TEST
is	VBZ	O
pending	VBG	O
.	.	O

vitamin	NN	B-TREATMENT
d	VBZ	I-TREATMENT
50000	CD	O
4662442	CD	O
one	CD	O
time	NN	O
a	DT	O
week	NN	O

cozaar	NN	B-TREATMENT
25	CD	O
mg	NN	O
1	CD	O
time	NN	O
per	IN	O
day	NN	O

procrit	NN	B-TREATMENT
-	:	O
multidose	JJ	O
20000	CD	O
u	JJ	O
/	NNP	O
ml	NN	O
20,000	CD	O
units	NNS	O
sq	VBN	O
every	DT	O
other	JJ	O
week	NN	O

levoxyl	RB	B-TREATMENT
150	CD	O
mcg	VBD	O
1	CD	O
1	CD	O
time	NN	O
per	IN	O
day	NN	O

iron	NN	B-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O

zoloft	RB	B-TREATMENT
100	CD	O
mg	NNS	O
1	CD	O
per	IN	O
day	NN	O
,	,	O
2	CD	O
tabs	NN	O

clonazepam	NN	B-TREATMENT
0.5	CD	O
mg	NN	O

humalog	NN	B-TREATMENT
100	CD	O
u	JJ	O
/	NNP	O
ml	NN	O
1	CD	O
as	IN	O
directed	VBN	O
pump	NN	O

zofran	NN	B-TREATMENT
8	CD	O
mg	NN	O
1	CD	O
as	IN	O
directed	VBN	O

prevacid	NN	B-TREATMENT
30	CD	O
mg	NN	O
1	CD	O
1	CD	O
time	NN	O
per	IN	O
day	NN	O

lorazepam	RB	B-TREATMENT
0.5	CD	O
mg	NNS	O
1	CD	O
to	TO	O
2	CD	O
tablets	NNS	O
twice	RB	O
daily	RB	O
if	IN	O
needed	VBN	O

cipro	JJ	B-TREATMENT
400	CD	O
"	NN	O

vanco	NN	B-TREATMENT
1	CD	O
g	NN	O
qd	NN	O

flagyl	RB	B-TREATMENT
500	CD	O
q8	NN	O

levophed	VBN	B-TREATMENT
gtt	NN	I-TREATMENT

propofol	NN	B-TREATMENT
gtt	NN	I-TREATMENT

solumedrol	NN	B-TREATMENT
40	CD	O
q6	NN	O

pepcid	NN	B-TREATMENT

feso4	RB	B-TREATMENT
325	CD	O
'	''	O

insulin	NN	B-TREATMENT
35	CD	O
lantus	NN	B-TREATMENT
qhs	NN	O

synthroid	JJ	B-TREATMENT
150	CD	O
'	''	O

losartan	RB	B-TREATMENT
25	CD	O
'	''	O

zoloft	RB	B-TREATMENT
200	CD	O
'	''	O

zelnorm	NN	B-TREATMENT
6	CD	O
"	NN	O

1.	CD	O
sertraline	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
heparin	NN	B-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	O
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
acetaminophen	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
headache	NN	B-PROBLEM
.	.	O

4.	CD	O
ondansetron	NN	B-TREATMENT
hcl	NN	I-TREATMENT
2	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
ml	NN	O
intravenous	JJ	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
nausea	NN	B-PROBLEM
.	.	O

5.	CD	O
pyridoxine	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
olanzapine	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
rapid	JJ	O
dissolve	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
rapid	JJ	O
dissolve	VBP	O
po	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
insulin	NN	B-TREATMENT
glargine	NN	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
cartridge	NN	O
sig	NN	O
:	:	O
ten	NN	O
(	(	O
10	CD	O
)	)	O
units	NNS	O
subcutaneous	JJ	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

8.	CD	O
humalog	NN	B-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
cartridge	NN	O
sig	NN	O
:	:	O
asdir	RB	O
subcutaneous	JJ	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
see	VB	O
attached	JJ	O
sheet	NN	O
for	IN	O
sliding	VBG	O
scale	NN	O
.	.	O

9.	CD	O
morphine	NN	B-TREATMENT
2	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
tegaserod	JJ	B-TREATMENT
hydrogen	NN	I-TREATMENT
maleate	NN	I-TREATMENT
6	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
)	)	O
.	.	O

11.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
iv	NN	O
q24h	NN	O

12.	CD	O
vancomycin	JJ	B-TREATMENT
hcl	NN	O
750	CD	O
mg	NN	O
iv	NN	O
q	VBD	O
12h	CD	O

13.	CD	O
dolasetron	NN	B-TREATMENT
mesylate	NN	I-TREATMENT
25	CD	O
mg	NN	O
iv	NN	O
q8h	NN	O
:	:	O
prn	NN	O
nausea	NN	B-PROBLEM

14.	CD	O
promethazine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
25	CD	O
mg	NN	O
iv	NN	O
q6h	NN	O
:	:	O
prn	NN	O

15.	CD	O
lorazepam	JJ	B-TREATMENT
0.5-1	JJ	O
mg	NN	O
iv	JJ	O
q3-4h	NN	O
:	:	O
prn	NN	O
anxiety	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
hold	NN	O
for	IN	O
sedation	NN	B-PROBLEM
.	.	O

16.	CD	O
levothyroxine	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
75	CD	O
mcg	NN	O
iv	JJ	O
daily	JJ	O

17.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	NN	O
iv	NN	O
q12h	NN	O

18.	CD	O
erythromycin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
iv	NN	O
q6h	NN	O

mrsa	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM

gastroparesis	NN	B-PROBLEM

enterobacter	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM

diabetes	NNS	B-PROBLEM
type	VBP	I-PROBLEM
i	NN	I-PROBLEM

hypothyroidism	NN	B-PROBLEM

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
.	.	O

you	PRP	O
should	MD	O
have	VB	O
a	DT	B-TEST
anti-tissue	JJ	I-TEST
transglutaminase	NN	I-TEST
antibody	NN	I-TEST
,	,	O
iga	NN	B-TEST
to	TO	O
rule	VB	O
out	RP	O
celiac	JJ	B-PROBLEM
disease	NN	I-PROBLEM
given	VBN	O
your	PRP$	B-PROBLEM
abdominal	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

back	RB	B-PROBLEM
pian	JJ	I-PROBLEM
standardized	NN	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

back	RB	B-PROBLEM
pain	NN	I-PROBLEM

evaluation	NN	B-TEST

ibuoprofen	RB	B-TREATMENT
800	CD	O
every	DT	O
6-8	JJ	O
hrs	NN	O
as	IN	O
needed	VBN	O
skelaxin	NN	B-TREATMENT
800mg	CD	O
for	IN	O
muscle	NN	B-TREATMENT
relaxation	NN	I-TREATMENT
vicodin	VBD	B-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
every	DT	O
4-6	CD	O
hrs	NN	O
for	IN	O
severe	JJ	B-PROBLEM
pain	NN	I-PROBLEM

take	VB	O
medication	NN	B-TREATMENT
as	IN	O
directed	JJ	O
,	,	O
return	NN	O
for	IN	O
severe	JJ	B-PROBLEM
or	CC	I-PROBLEM
significantly	RB	I-PROBLEM
worsening	VBG	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
weakness	NN	B-PROBLEM
or	CC	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
sensation	NN	I-PROBLEM
work	NN	O
restrictions	NNS	O
as	IN	O
written	VBN	O
on	IN	O
accompanying	VBG	O
form	NN	O
.	.	O

penicillins	NNS	B-TREATMENT
/	VBP	O
keflex	JJ	B-TREATMENT
/	NNP	O
sulfa	NN	B-TREATMENT
(	(	I-TREATMENT
sulfonamides	NNS	I-TREATMENT
)	)	O
/	VBP	O
nickel	JJ	O
/	NNP	O
erythromycin	NN	B-TREATMENT
ethylsuccinate	NN	I-TREATMENT

disconnected	VBN	B-PROBLEM
pigtail	NN	I-PROBLEM
catheter	NN	I-PROBLEM

removal	NN	B-TREATMENT
of	IN	I-TREATMENT
catheter	NN	I-TREATMENT

70	CD	O
y/o	JJ	O
f	NN	O
w/	NN	O
tracheobronchomalacia	NN	B-PROBLEM
,	,	O
copd	NN	B-PROBLEM
,	,	O
pmr	NN	B-PROBLEM
,	,	O
recurrent	NN	B-PROBLEM
pneumonias	NN	I-PROBLEM
who	WP	O
was	VBD	O
recently	RB	O
discharged	VBN	O
from	IN	O
hallmark	NN	O
health	NN	O
system	NN	O
to	TO	O
pocasset	VB	O
mental	JJ	O
health	NN	O
center	NN	O

06-07	NN	O
after	IN	O
tracheobronchoplasty	JJ	B-TREATMENT
/	JJ	O
tracheostomy	NN	B-TREATMENT
and	CC	O
pigtail	NN	B-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
pleural	JJ	B-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

since	IN	O
discharge	NN	O
pt	NN	O
has	VBZ	O
continued	VBN	O
at	IN	O
rehab	NN	O
on	IN	O
ps	JJ	B-TREATMENT
vent	JJ	I-TREATMENT
settings	NNS	I-TREATMENT
but	CC	O
pigtail	VBP	B-TREATMENT
catheter	NN	I-TREATMENT
fell	VBD	O
out	RP	O
today	NN	O
so	IN	O
pt	NN	O
was	VBD	O
referred	VBN	O
here	RB	O
for	IN	O
monitoring	NN	O
.	.	O

on	IN	O
ros	NNS	B-TEST
,	,	O
she	PRP	O
notes	VBZ	O
feeling	VBG	O
poorly	RB	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
and	CC	O
diarrhea	NN	B-PROBLEM
since	IN	O
d/c	NN	O
.	.	O

she	PRP	O
has	VBZ	O
pleuritic	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
she	PRP	O
has	VBZ	O
had	VBN	O
since	IN	O
she	PRP	O
arrested	VBD	O
during	IN	O
her	PRP$	O
admission	NN	O
here	RB	O
and	CC	O
had	VBD	O
cpr	NNS	B-TREATMENT
.	.	O

per	IN	O
husband	NN	O
she	PRP	O
has	VBZ	O
no	DT	O
cardiac	JJ	B-PROBLEM
history	NN	I-PROBLEM
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TEST
stress	JJ	I-TEST
test	NN	I-TEST
(	(	O
unclr	JJ	O
how	WRB	O
recent	JJ	O
)	)	O
that	WDT	O
was	VBD	O
normal	JJ	O

tracheobronchomalacia	NN	B-PROBLEM

pmr	NN	B-PROBLEM
s/p	NN	O
tah	NN	B-TREATMENT

copd	NN	B-PROBLEM

afib	NN	B-PROBLEM
post	NN	O
op	NN	O

recent	JJ	B-PROBLEM
uti	JJ	I-PROBLEM
rx	NN	O
w/aztreonam	NN	B-TREATMENT

mrsa	NN	B-PROBLEM
pna	NN	I-PROBLEM
rx	NN	O
w/vanc	NN	B-TREATMENT

anxiety	NN	B-PROBLEM

hx	NN	O
resp	NN	B-PROBLEM
arrest	IN	I-PROBLEM
post-op	NN	O

vs	NN	B-TEST
:	:	O

nad	NN	B-PROBLEM

rrr	NN	O
,	,	O
nl	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt,nd	JJ	B-PROBLEM
,	,	O
nabs	JJ	O

1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
blt	NN	I-PROBLEM

ecg	NNS	B-TEST
:	:	O
rate	NN	B-TEST
66	CD	O
,	,	O
sinus	VBD	O
w/pac	NN	B-PROBLEM
's	POS	I-PROBLEM
,	,	O
qt	VBZ	B-TEST
476	CD	O
,	,	O
twi	NN	B-PROBLEM
in	IN	I-PROBLEM
v1-6	NN	I-PROBLEM
(	(	O
deep	JJ	O
in	IN	O
v2-4	NN	O
)	)	O

cxr	NN	B-TEST
:	:	O

interval	JJ	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
no	DT	O
evidence	NN	O
of	IN	O
pneumothorax	NN	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
?	.	O

no	DT	O
changes	NNS	O
in	IN	O
the	DT	O
position	NN	O
or	CC	O
alignment	NN	O
of	IN	O
multiple	JJ	B-TREATMENT
lines	NNS	I-TREATMENT
and	CC	O
tubes	NNS	B-TREATMENT

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

height	NN	B-TEST
:	:	O
(	(	O
in	IN	O
)	)	O
62	CD	O

weight	NN	B-TEST
(	(	O
lb	JJ	O
)	)	O
:	:	O
180	CD	O

bsa	NN	B-TEST
(	(	O
m2	NN	O
)	)	O
:	:	O
1.83	CD	O
m2	NN	O

bp	NN	B-TEST
(	(	O
mm	JJ	O
hg	NN	O
)	)	O
:	:	O
115/48	CD	O

hr	NN	B-TEST
(	(	O
bpm	NN	O
)	)	O
:	:	O
60	CD	O

test	NN	O
:	:	O
tte	NN	B-TEST
(	(	O
complete	JJ	O
)	)	O

doppler	NN	B-TEST
:	:	O
full	JJ	B-TEST
doppler	NN	I-TEST
and	CC	O
color	NN	B-TEST
doppler	NN	I-TEST

left	JJ	B-TEST
atrium	NN	I-TEST
-	:	I-TEST
four	CD	I-TEST
chamber	NN	I-TEST
length	NN	I-TEST
:	:	O
5.1	CD	O
cm	NN	O
(	(	O
nl	JJ	O
<=	$	O
5.2	CD	O
cm	NN	O
)	)	O

right	RB	B-TEST
atrium	NN	I-TEST
-	:	I-TEST
four	CD	I-TEST
chamber	NN	I-TEST
length	NN	I-TEST
:	:	O
*	JJ	O
6.2	CD	O
cm	NN	O
(	(	O
nl	JJ	O
<=	$	O
5.0	CD	O
cm	NN	O
)	)	O

left	VBN	B-TEST
ventricle	NN	I-TEST
-	:	I-TEST
septal	NN	I-TEST
wall	NN	I-TEST
thickness	NN	I-TEST
:	:	O
0.8	CD	O
cm	NN	O
(	(	O
nl	JJ	O
0.6	CD	O
-	:	O
1.1	CD	O
cm	NN	O
)	)	O

left	VBN	B-TEST
ventricle	NN	I-TEST
-	:	I-TEST
inferolateral	JJ	I-TEST
thickness	NN	I-TEST
:	:	O
0.8	CD	O
cm	NN	O
(	(	O
nl	JJ	O
0.6	CD	O
-	:	O
1.1	CD	O
cm	NN	O
)	)	O

left	VBN	B-TEST
ventricle	NN	I-TEST
-	:	I-TEST
diastolic	JJ	I-TEST
dimension	NN	I-TEST
:	:	O
5.3	CD	O
cm	NN	O
(	(	O
nl	JJ	O
<=	$	O
5.6	CD	O
cm	NN	O
)	)	O

left	VBN	B-TEST
ventricle	NN	I-TEST
-	:	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
:	:	O
>=	NN	O
40%	CD	O
(	(	O
nl	JJ	O
>=	NNP	O
55%	CD	O
)	)	O

aortic	JJ	B-TEST
valve	SYM	I-TEST
-	:	I-TEST
peak	JJ	I-TEST
velocity	NN	I-TEST
:	:	O
1.4	CD	O
m	NN	O
/	NN	O
sec	NN	O
(	(	O
nl	JJ	O
<=	$	O
2.0	CD	O
m	NN	O
/	NNP	O
sec	NN	O
)	)	O

mitral	JJ	B-TEST
valve	SYM	I-TEST
-	:	I-TEST
e	NN	I-TEST
wave	NN	I-TEST
:	:	O
1.1	CD	O
m	NN	O
/	NN	O
sec	NN	O

mitral	JJ	B-TEST
valve	SYM	I-TEST
-	:	I-TEST
a	DT	I-TEST
wave	NN	I-TEST
:	:	O
1.0	CD	O
m	NN	O
/	NN	O
sec	NN	O

mitral	JJ	B-TEST
valve	SYM	I-TEST
-	:	I-TEST
e/a	NN	I-TEST
ratio	NN	I-TEST
:	:	O
1.10	CD	O

tr	JJ	B-TEST
gradient	NN	I-TEST
(	(	I-TEST
+	JJ	I-TEST
ra	NN	I-TEST
=	NNP	I-TEST
pasp	NN	I-TEST
)	)	I-TEST
:	:	O
*	$	O
36	CD	O
mm	NN	O
hg	NN	O
(	(	O
nl	JJ	O
<=	$	O
25	CD	O
mm	NN	O
hg	NN	O
)	)	O

this	DT	B-TEST
study	NN	I-TEST
was	VBD	O
compared	VBN	O
to	TO	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
of	IN	O
2017-06-01	JJ	O
.	.	O

wall	NN	B-TEST
thickness	NN	I-TEST
and	CC	O
cavity	NN	B-TEST
dimensions	NNS	I-TEST
were	VBD	O
obtained	VBN	O
from	IN	O
2d	CD	B-TEST
images	NNS	I-TEST
.	.	O

suboptimal	JJ	O
technical	JJ	O
quality	NN	O
,	,	O
a	DT	B-PROBLEM
focal	JJ	I-PROBLEM
lv	NN	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
cannot	NN	O
be	VB	O
fully	RB	O
excluded	VBN	O
.	.	O

focal	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
aortic	JJ	I-PROBLEM
root	NN	I-PROBLEM
.	.	O

no	DT	O
ar	NN	B-PROBLEM
.	.	O

mild	NN	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
mr	NN	I-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
pa	VBZ	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

based	VBN	O
on	IN	O
1997	CD	O
aha	NN	O
endocarditis	NN	O
prophylaxis	NN	O
recommendations	NNS	O
,	,	O
the	DT	O
echo	JJ	O
findings	NNS	O
indicate	VBP	O
a	DT	O
low	JJ	O
risk	NN	O
(	(	O
prophylaxis	IN	B-TREATMENT
not	RB	O
recommended	VBN	O
).	NN	O

clinical	JJ	O
decisions	NNS	O
regarding	VBG	O
the	DT	O
need	NN	O
for	IN	O
prophylaxis	NN	B-TREATMENT
should	MD	O
be	VB	O
based	VBN	O
on	IN	O
clinical	JJ	O
and	CC	O
echocardiographic	JJ	O
data	NNS	O
.	.	O

left	VBN	B-TEST
ventricular	JJ	I-TEST
wall	NN	I-TEST
thicknesses	NNS	I-TEST
and	CC	O
cavity	NN	B-TEST
size	NN	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

due	JJ	O
to	TO	O
suboptimal	VB	O
technical	JJ	O
quality	NN	O
,	,	O
a	DT	B-PROBLEM
focal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
cannot	NN	O
be	VB	O
fully	RB	O
excluded	VBN	O
.	.	O

overall	JJ	B-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
good	JJ	O
(	(	O
lvef	JJ	B-TEST
>	$	O
40%	CD	O
).	NN	O

right	RB	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
and	CC	O
free	JJ	B-TEST
wall	NN	I-TEST
motion	NN	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

no	DT	O
aortic	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

mild	NN	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
of	IN	O
2017-06-01	JJ	O
(	(	O
tape	NN	O
reviewed	VBN	O
)	)	O
was	VBD	O
of	IN	O
very	RB	O
suboptimal	JJ	O
technical	JJ	O
quality	NN	O
and	CC	O
not	RB	O
directly	RB	O
comparable	JJ	O
to	TO	O
the	DT	B-TEST
current	JJ	I-TEST
study	NN	I-TEST
.	.	O

if	IN	O
more	RBR	O
definitive	JJ	O
information	NN	O
regarding	VBG	O
ventricualr	NN	O
fuynction	NN	O
is	VBZ	O
needed	VBN	O
,	,	O
a	DT	B-TEST
cardiac	JJ	I-TEST
mri	NN	I-TEST
(	(	O
(	(	O
951	CD	O
)	)	O
247-0244	CD	O
)	)	O
or	CC	O
radionuclide	VB	B-TEST
study	NN	I-TEST
is	VBZ	O
suggested	VBN	O
.	.	O

based	VBN	O
on	IN	O
1997	CD	O
aha	NN	O
endocarditis	NN	O
prophylaxis	NN	O
recommendations	NNS	O
,	,	O
the	DT	O
echo	JJ	O
findings	NNS	O
indicate	VBP	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
risk	NN	I-PROBLEM
(	(	O
prophylaxis	IN	B-TREATMENT
not	RB	O
recommended	VBN	O
).	NN	O

clinical	JJ	O
decisions	NNS	O
regarding	VBG	O
the	DT	O
need	NN	O
for	IN	O
prophylaxis	NN	B-TREATMENT
should	MD	O
be	VB	O
based	VBN	O
on	IN	O
clinical	JJ	O
and	CC	O
echocardiographic	JJ	O
data	NNS	O
.	.	O

pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
:	:	O
s/p	JJ	O
pigtail	NN	B-TREATMENT
cath	NN	I-TREATMENT
drain	NN	I-TREATMENT
.	.	O

imaging	VBG	B-TEST
indicated	VBD	O
that	IN	O
the	DT	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
had	VBD	O
resolved	VBN	O
.	.	O

thoracics	NNS	O
agreed	VBD	O
to	TO	O
no	DT	O
need	NN	O
for	IN	O
pigtail	JJ	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

chf	NN	B-PROBLEM
:	:	O

they	PRP	O
recommended	VBD	O
continuing	VBG	O
beta-blocker	NN	B-TREATMENT
and	CC	O
titarting	VBG	O
ace	NN	B-TREATMENT
as	IN	O
tolerated	VBN	O
.	.	O

patient	NN	O
should	MD	O
be	VB	O
kept	VBN	O
euvolemic	JJ	O
once	RB	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
resolves	NNS	O
(	(	O
may	MD	O
use	VB	O
lasix	NN	B-TREATMENT
to	TO	O
decrease	VB	O
edema	NN	B-PROBLEM
).	NN	O

she	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
echo	NN	I-TEST
in	IN	O
3-6	JJ	O
months	NNS	O
(	(	O
since	IN	O
this	DT	B-TEST
echo	NN	I-TEST
showed	VBD	O
a	DT	O
question	NN	O
of	IN	O
focal	JJ	B-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
).	NN	O

also	RB	O
,	,	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
amiodarone	NN	B-TREATMENT
and	CC	O
digoxin	NN	B-TREATMENT
was	VBD	O
held	VBN	O
secondary	JJ	O
to	TO	O
high	JJ	B-PROBLEM
levels	NNS	I-PROBLEM
(	(	O
please	VB	O
restart	NN	O
when	WRB	O
level	NN	B-TEST
less	JJR	O
than	IN	O
2	CD	O
)	)	O

diarrhea	NN	B-PROBLEM
:	:	O

stool	NN	B-TEST
c.	NN	I-TEST
diff	NN	I-TEST
neg	JJ	O
x1	NN	O
.	.	O

she	PRP	O
will	MD	O
need	VB	O
two	CD	B-TEST
more	JJR	I-TEST
specimens	NNS	I-TEST
.	.	O

copd	NN	B-PROBLEM
:	:	O
cont	NN	O
nebs	NN	B-TREATMENT
.	.	O

paf	NN	B-PROBLEM
:	:	O
started	VBN	O
on	IN	O
amio	NN	B-TREATMENT
,	,	O
cont	JJ	O
b-blocker	NN	B-TREATMENT
,	,	O
and	CC	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
-	:	O
levels	NNS	B-TEST
(	(	I-TEST
inr	NN	I-TEST
)	)	I-TEST
should	MD	O
be	VB	O
monitored	VBN	O
.	.	O

patient	NN	O
should	MD	O
be	VB	O
started	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
at	IN	O
rehab	NN	O

rash	NN	B-PROBLEM
:	:	O

patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
erythematous	JJ	I-PROBLEM
rash	NN	I-PROBLEM
,	,	O
though	IN	O
to	TO	O
be	VB	O
an	DT	B-PROBLEM
id	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
a	DT	B-PROBLEM
recent	JJ	I-PROBLEM
fungal	JJ	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
satrted	VBN	O
on	IN	O
benadryl	NN	B-TREATMENT
and	CC	O
hydrocort	NN	B-TREATMENT
for	IN	O
sx	JJ	O
relief	NN	O
.	.	O

also	RB	O
a	DT	B-PROBLEM
drug	NN	I-PROBLEM
reaction	NN	I-PROBLEM
is	VBZ	O
in	IN	O
the	DT	O
ddx	NN	O
but	CC	O
unlikely	JJ	O
as	IN	O
rash	NN	B-PROBLEM
started	VBD	O
at	IN	O
rehab	NN	O
prior	RB	O
to	TO	O
receiving	VBG	O
drugs	NNS	B-TREATMENT
here	RB	O
.	.	O

meds	NNS	B-TREATMENT
at	IN	O
pocasset	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
:	:	O

sq	NN	B-TREATMENT
heparin	NN	I-TREATMENT
,	,	O
mvi	NN	B-TREATMENT
,	,	O
nystatin	NN	B-TREATMENT
,	,	O
colace	NN	B-TREATMENT
,	,	O
albuterol	NN	B-TREATMENT
,	,	O
atrovent	NN	B-TREATMENT
,	,	O
amiodarone	RB	B-TREATMENT
400	CD	O
bid	NN	O
,	,	O
pulmicort	NN	B-TREATMENT
,	,	O
digoxin	NN	B-TREATMENT
,	,	O
metoprolol	FW	B-TREATMENT
12.5	CD	O
tid	NN	O
,	,	O
reglan	NN	B-TREATMENT

discharge	NN	O
diagnosis	NN	O
:	:	O
tracheobronchomalecia	NN	B-PROBLEM
chf	NN	B-PROBLEM

paf	NN	B-PROBLEM

copd	NN	B-PROBLEM

discharge	NN	O
condition	NN	O
:	:	O
deconditioned	VBN	B-PROBLEM
but	CC	O
stable	JJ	O

please	VB	O
call	VB	O
your	PRP$	O
doctor	NN	O
or	CC	O
come	VBN	O
to	TO	O
robert	VB	O
if	IN	O
you	PRP	O
develop	VBP	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
cp	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
sx	NN	I-PROBLEM

you	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
echo	NN	I-TEST
within	IN	O
3-6	JJ	O
months	NNS	O

it	PRP	O
was	VBD	O
noted	VBN	O
on	IN	O
10/8/94	CD	O
that	IN	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
range	NN	I-PROBLEM
of	IN	I-PROBLEM
motion	NN	I-PROBLEM
in	IN	O
both	DT	O
her	PRP$	O
knees	NNS	O
with	IN	O
flexion	NN	O
to	TO	O
approximately	RB	O
40	CD	O
degrees	NNS	O
with	IN	O
maximum	JJ	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
postpone	VB	O
her	PRP$	O
discharge	NN	O
to	TO	O
rehab	VB	O
and	CC	O
take	VB	O
her	PRP$	O
back	NN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
a	DT	B-TREATMENT
manipulation	NN	I-TREATMENT
under	IN	O
anesthesia	NN	B-TREATMENT
.	.	O

baby	NN	O
girl	NN	O
kathryn	NN	O
frazier	NN	O
,	,	O
triplet	NN	O
iii	NN	O
,	,	O
delivered	VBN	O
at	IN	O
32	CD	O
-	:	O
5/7	CD	O
weeks	NNS	O
gestation	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
1630	CD	O
grams	NNS	O
.	.	O

prenatal	JJ	B-TEST
screens	NNS	I-TEST
included	VBD	O
blood	NN	B-TEST
type	NN	I-TEST
a+	NN	O
,	,	O
antibody	NN	B-TEST
screen	JJ	I-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
rpr	JJ	B-TEST
nonreactive	NN	O
.	.	O

hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
cystic	JJ	B-TEST
fibrosis	NN	I-TEST
negative	JJ	O
,	,	O
and	CC	O
group	NN	B-TEST
b	NN	I-TEST
strep	NN	I-TEST
unknown	JJ	O
.	.	O

mother	NN	O
's	POS	O
medical	JJ	O
history	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
depression	NN	B-PROBLEM
treated	VBN	O
with	IN	O
zoloft	NN	B-TREATMENT
.	.	O

ob	JJ	O
history	NN	O
notable	JJ	O
for	IN	O
infertility	NN	B-PROBLEM
treated	VBN	O
with	IN	O
clomid	NN	B-TREATMENT
.	.	O

this	DT	O
pregnancy	NN	O
was	VBD	O
complicate	VBN	O
by	IN	O
triplet	NN	B-PROBLEM
gestation	NN	I-PROBLEM
,	,	O
cervical	JJ	B-PROBLEM
shortening	NN	I-PROBLEM
,	,	O
and	CC	O
pregnancy	NN	B-PROBLEM
induced	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

delivery	NN	O
was	VBD	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
under	IN	O
spinal	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
for	IN	O
pre-eclampsia	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
labor	NN	B-PROBLEM
or	CC	I-PROBLEM
maternal	JJ	I-PROBLEM
fever	NN	I-PROBLEM
.	.	O

mother	NN	O
did	VBD	O
not	RB	O
receive	VB	O
any	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
prior	VBP	O
to	TO	O
delivery	NN	O
.	.	O

the	DT	O
infant	NN	O
emerged	VBD	O
vigorous	JJ	O
,	,	O
was	VBD	O
dried	VBN	O
,	,	O
bulb	NN	O
suctioned	VBD	O
and	CC	O
given	VBN	O
free	JJ	B-TREATMENT
flow	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

apgar	NN	B-TEST
scores	NNS	I-TEST
were	VBD	O
7	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
5	CD	O
minutes	NNS	O
.	.	O

on	IN	O
admission	NN	O
birth	NN	B-TEST
weight	NN	I-TEST
1630	CD	O
grams	NN	O
(	(	O
50th	CD	O
percentile	NN	O
)	)	O
,	,	O
length	$	B-TEST
43.5	CD	O
cm	NN	O
(	(	O
50th	CD	O
percentile	NN	O
)	)	O
,	,	O
head	VBD	B-TEST
circumference	NN	I-TEST
31.5	CD	O
cm	NN	O
(	(	O
75th	CD	O
percentile	NN	O
).	NN	O

infant	NN	O
with	IN	O
non-	JJ	B-PROBLEM
dysmorphic	JJ	I-PROBLEM
facies	NNS	I-PROBLEM
,	,	O
palate	JJ	O
intact	NN	O
.	.	O

anterior	JJ	O
fontanel	NNS	O
soft	JJ	O
and	CC	O
flat	JJ	O
,	,	O
moderate	JJ	B-PROBLEM
nasal	NN	I-PROBLEM
flaring	NN	I-PROBLEM
.	.	O

chest	NN	O
with	IN	O
moderate	JJ	B-PROBLEM
intercostal	JJ	I-PROBLEM
retractions	NNS	I-PROBLEM
,	,	O
fair	JJ	O
breath	NN	O
sounds	VBZ	O
bilaterally	RB	O
,	,	O
no	DT	O
crackles	NNS	B-PROBLEM
.	.	O

cardiovascular	NN	O
is	VBZ	O
well	RB	O
perfused	VBN	O
with	IN	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
and	CC	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
normal	JJ	O
pulses	NNS	O
and	CC	O
perfusion	NN	O
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
not	RB	O
distended	VBN	B-PROBLEM
.	.	O

no	DT	O
organomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

skin	NN	O
without	IN	O
rashes	NNS	B-PROBLEM
or	CC	O
lesions	NNS	B-PROBLEM
.	.	O

active	JJ	O
,	,	O
alert	JJ	O
,	,	O
responding	VBG	O
to	TO	O
stimulation	NN	B-TEST
.	.	O

tone	NN	B-PROBLEM
decreased	VBD	I-PROBLEM
slightly	RB	I-PROBLEM
in	IN	O
symmetric	JJ	O
distribution	NN	O
,	,	O
moves	VBZ	O
all	DT	O
extremities	NNS	O
equally	RB	O
.	.	O

initially	RB	O
was	VBD	O
placed	VBN	O
on	IN	O
continuous	JJ	B-TREATMENT
positive	JJ	I-TREATMENT
airway	NN	I-TREATMENT
pressure	NN	I-TREATMENT
40%	CD	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

due	JJ	O
to	TO	O
increasing	VBG	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
was	VBD	O
intubated	VBN	O
,	,	O
placed	VBN	O
on	IN	O
conventional	JJ	B-TREATMENT
ventilation	NN	I-TREATMENT
and	CC	O
pressures	NNS	B-TREATMENT
of	IN	O
24/6	CD	O
,	,	O
rate	NN	B-TREATMENT
of	IN	O
25	CD	O
.	.	O

she	PRP	O
received	VBD	O
one	CD	O
dose	NN	O
of	IN	O
survanta	NN	B-TREATMENT
and	CC	O
then	RB	O
weaned	VBD	O
well	RB	O
on	IN	O
ventilator	NN	B-TREATMENT
settings	NNS	I-TREATMENT
.	.	O

has	VBZ	O
remained	VBN	O
in	IN	O
room	NN	O
air	NN	O
since	IN	O
with	IN	O
comfortable	JJ	O
work	NN	O
of	IN	O
breathing	NN	O
,	,	O
respiratory	NN	B-TEST
rates	NNS	I-TEST
in	IN	O
the	DT	O
40	CD	O
's	POS	O
to	TO	O
70	CD	O
's.	NNS	O

no	DT	O
apnea	NN	B-PROBLEM
.	.	O

heart	NN	B-TEST
rates	NNS	I-TEST
range	VBP	O
in	IN	O
the	DT	O
140	CD	O
to	TO	O
160	CD	O
's	POS	O
,	,	O
no	DT	O
heart	NN	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

recent	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
71/31	CD	O
with	IN	O
a	DT	O
mean	NN	O
of	IN	O
48	CD	O
.	.	O

was	VBD	O
initially	RB	O
npo	JJ	B-TREATMENT
on	IN	O
receiving	VBG	O
d10-w	JJ	B-TREATMENT
by	IN	O
peripheral	JJ	O
intravenous	JJ	O
.	.	O

enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
one	CD	O
and	CC	O
she	PRP	O
advanced	VBD	O
to	TO	O
full	JJ	B-TREATMENT
volume	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
of	IN	O
breast	NN	O
milk	NN	O
or	CC	O
special	JJ	B-TREATMENT
care	NN	I-TREATMENT
formula	NN	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
(	(	O
2013-07-29	JJ	O
)	)	O
without	IN	O
problems	NNS	B-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
presently	RB	O
receiving	VBG	O
breast	NN	O
milk	NN	O
or	CC	O
special	JJ	B-TREATMENT
care	NN	I-TREATMENT
formula	NN	I-TREATMENT
24	CD	O
cal	NN	O
at	IN	O
150	CD	O
mls	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
with	IN	O
tolerance	NN	O
.	.	O

most	RBS	B-TEST
recent	JJ	I-TEST
electrolytes	NNS	I-TEST
done	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
one	CD	O
showed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
132	CD	O
,	,	O
potassium	NN	B-TEST
6.1	CD	O
,	,	O
chloride	RB	B-TEST
100	CD	O
,	,	O
co2	NN	B-TEST
20	CD	O
.	.	O

discharge	NN	B-TEST
weight	NN	I-TEST
is	VBZ	O
1700	CD	O
grams	NN	O
up	RB	O
15	CD	O
grams	NNS	O
..	VBP	O

received	VBN	O
phototherapy	NN	B-TREATMENT
from	IN	O
07-27	JJ	O
to	TO	O
2013-07-28	JJ	O
for	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
bilirubin	NN	I-TEST
of	IN	O
8.1	CD	O
.	.	O

phototherapy	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
when	WRB	O
bilirubin	NN	B-TEST
was	VBD	O
a	DT	B-TEST
total	NN	I-TEST
of	IN	O
4.7	CD	O
.	.	O

most	RBS	B-TEST
recent	JJ	I-TEST
bilirubin	NN	I-TEST
on	IN	O
2013-07-29	JJ	O
total	NN	B-TEST
of	IN	O
4.2	CD	O
,	,	O
direct	JJ	B-TEST
.4	NN	O
.	.	O

hematocrit	NN	B-TEST
on	IN	O
admission	NN	O
47%	CD	O
.	.	O

no	DT	O
transfusions	NNS	B-TREATMENT
given	VBN	O
.	.	O

received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
for	IN	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

cbc	NN	B-TEST
on	IN	O
admission	NN	O
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
9.3	CD	O
with	IN	O
37	CD	B-TEST
polys	NNS	I-TEST
,	,	O
0	CD	B-TEST
bands	NNS	I-TEST
,	,	O
platelets	NNS	B-TEST
399,000	CD	O
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

head	NN	B-TEST
ultrasound	IN	I-TEST
not	RB	O
indicated	VBN	O
.	.	O

a	DT	B-TEST
hearing	NN	I-TEST
screening	NN	I-TEST
has	VBZ	O
not	RB	O
been	VBN	O
performed	VBN	O
,	,	O
will	MD	O
need	VB	O
prior	RB	O
to	TO	O
discharge	VB	O
home	NN	O
.	.	O

breast	NN	O
milk	NN	O
or	CC	O
special	JJ	B-TREATMENT
care	NN	I-TREATMENT
formula	NN	I-TREATMENT
24	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
at	IN	O
150	CD	O
mls	NNS	O
per	IN	O
kilo	FW	O
per	IN	O
day	NN	O
with	IN	O
plans	NNS	O
to	TO	O
advance	VB	O
calories	NNS	O
.	.	O

currently	RB	O
on	IN	O
no	DT	O
medications	NNS	B-TREATMENT
.	.	O

3.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
2013-07-26	JJ	O
and	CC	O
is	VBZ	O
pending	VBG	O
.	.	O

4.	CD	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
immunization	NN	I-TREATMENT
.	.	O

3.	CD	O
respiratory	JJ	B-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
resolved	VBD	O
.	.	O

4.	CD	O
physiologic	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
.	.	O

5.	CD	O
perinatal	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
ruled	VBD	O
out	RP	O
.	.	O

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

partial	JJ	B-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
49	CD	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
resection	NN	I-TREATMENT
in	IN	O
may	MD	O
of	IN	O
1998	CD	O
and	CC	O
a	DT	B-PROBLEM
recurrence	NN	I-PROBLEM
of	IN	O
metastasis	NN	B-PROBLEM
with	IN	O
asleeve	NN	O
of	IN	O
section	NN	O
of	IN	O
left	JJ	B-TREATMENT
colon	NN	I-TREATMENT
diverting	VBG	I-TREATMENT
ileostomy	NN	I-TREATMENT
for	IN	O
recurrent	NN	B-PROBLEM
metastasis	NN	I-PROBLEM
later	RB	O
in	IN	O
may	MD	O
of	IN	O
1999	CD	O
who	WP	O
presents	VBZ	O
with	IN	O
anterior	JJ	B-PROBLEM
midepigastric	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
began	VBD	O
at	IN	O
10:30	CD	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
with	IN	O
increase	NN	O
during	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
with	IN	O
positive	JJ	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
,	,	O
no	DT	O
diarrhea	NN	B-PROBLEM
,	,	O
decreased	VBN	B-PROBLEM
output	NN	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
ostomy	NN	I-PROBLEM
,	,	O
and	CC	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
radiating	VBG	O
to	TO	O
the	DT	O
back	NN	O
.	.	O

percocet	NN	B-TREATMENT
and	CC	O
naprosyn	NN	B-TREATMENT
.	.	O

demerol	NN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
98.8	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
68	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
107/82	CD	O
,	,	O
and	CC	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
99%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
and	CC	O
tympanic	JJ	B-PROBLEM
with	IN	O
midepigastric	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
and	CC	O
no	DT	O
rebound	NN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
ostomy	NN	I-TREATMENT
was	VBD	O
pink	VBN	O
with	IN	O
minimal	JJ	O
fluid	NN	O
in	IN	O
the	DT	B-TREATMENT
ostomy	JJ	I-TREATMENT
bag	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

no	DT	O
signs	NNS	O
of	IN	O
edema	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
warm	JJ	O
and	CC	O
palpable	JJ	O
pulses	NNS	O
distally	RB	O
.	.	O

assessment	NN	B-TEST
was	VBD	O
continued	VBN	O
with	IN	O
laboratory	NN	B-TEST
studies	NNS	I-TEST
which	WDT	O
showed	VBD	O
the	DT	O
patient	NN	O
to	TO	O
have	VB	O
a	DT	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
9	CD	O
,	,	O
hematocrit	NN	B-TEST
39	CD	O
,	,	O
and	CC	O
platelets	VBZ	B-TEST
470	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
normal	JJ	O
amylase	NN	O
and	CC	O
lipase	NN	B-TEST
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
basic	JJ	O
metabolic	JJ	O
panel	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
kub	NNS	B-TEST
that	WDT	O
showed	VBD	O
multiple	JJ	B-PROBLEM
dilated	JJ	I-PROBLEM
loops	NNS	I-PROBLEM
of	IN	I-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
and	CC	O
was	VBD	O
admitted	VBN	O
for	IN	O
a	DT	O
partial	JJ	B-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

an	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
had	VBD	O
an	DT	B-TREATMENT
h2	NN	I-TREATMENT
blocker	NN	I-TREATMENT
started	VBD	O
,	,	O
and	CC	O
was	VBD	O
admitted	VBN	O
for	IN	O
bowel	NN	B-TREATMENT
rest	NN	I-TREATMENT
and	CC	O
decompression	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
well	RB	O
.	.	O

the	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
hsp	JJ	O
day	NN	O
#	#	O
3	CD	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
improved	VBD	O
quickly	RB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	O
clear	JJ	B-TREATMENT
liquid	NN	I-TREATMENT
diet	NN	I-TREATMENT
which	WDT	O
was	VBD	O
advanced	VBN	O
as	IN	O
tolerated	VBN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
some	DT	B-PROBLEM
minimal	JJ	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
that	IN	O
occurred	VBD	O
after	IN	O
food	NN	O
but	CC	O
with	IN	O
negative	JJ	O
urinalysis	NN	O
and	CC	O
negative	JJ	O
fever	NN	B-PROBLEM
spikes	NNS	I-PROBLEM
over	IN	O
the	DT	O
entire	JJ	O
course	NN	O
of	IN	O
this	DT	O
stay	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
discharged	VBN	O
home	NN	O
on	IN	O
zantac	NN	B-TREATMENT
,	,	O
simethicone	NN	B-TREATMENT
,	,	O
and	CC	O
preoperative	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
with	IN	O
follow-up	JJ	O
with	IN	O
dr.	JJ	O
ur	NNS	O
in	IN	O
two	CD	O
weeks	NNS	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

major	JJ	O
surgical	JJ	O
or	CC	O
invasive	JJ	O
procedure	NN	O
:	:	O
persantine	NN	B-TEST
mibi	NN	I-TEST
cardiac	JJ	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
thoracentesis	NN	B-TEST

chest	NN	B-TREATMENT
tube	NN	I-TREATMENT

74	CD	O
yo	NNS	O
m	NN	O
with	IN	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
dvt	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
1	CD	O
day	NN	O
of	IN	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

patient	NN	O
developed	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
the	DT	O
night	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
substernal	JJ	O
07-08	JJ	O
,	,	O
did	VBD	O
not	RB	O
radiate	VB	O
.	.	O

he	PRP	O
reports	VBZ	O
that	IN	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
similar	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
prior	JJ	I-PROBLEM
mi	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
amanda	NN	O
the	DT	B-PROBLEM
patients	NNS	I-PROBLEM
pain	VBP	I-PROBLEM
resolved	VBN	O
with	IN	O
ntg	NNS	B-TREATMENT
and	CC	O
morphine	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
asa	NNS	B-TREATMENT
and	CC	O
bblocker	NN	B-TREATMENT
.	.	O

at	IN	O
time	NN	O
of	IN	O
my	PRP$	B-TEST
evaluation	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
denied	VBD	O
nausea	NN	B-PROBLEM
,	,	O
vomitting	NN	B-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
changes	NNS	B-PROBLEM
in	IN	I-PROBLEM
vision	NN	I-PROBLEM
/hearing	NN	I-PROBLEM

-	:	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
-	:	O
non-small	JJ	B-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
stage	NN	I-PROBLEM
iiia	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
weekly	JJ	B-TREATMENT
carboplatin	NN	I-TREATMENT
and	CC	O
taxol	NN	B-TREATMENT
chemotherapy	NN	I-TREATMENT
with	IN	O
xrt	NNP	B-TREATMENT
for	IN	O
seven	CD	O
weeks	NNS	O
followed	VBN	O
by	IN	O
surgery	NN	B-TREATMENT
on	IN	O
2015-04-14	NN	O
.	.	O

-	:	O
cad	NN	B-PROBLEM
-	:	O
s/p	NN	O
inferior	JJ	B-PROBLEM
stemi	JJ	I-PROBLEM
12-03	JJ	O
,	,	O
stent	JJ	B-TREATMENT
to	TO	I-TREATMENT
l	VB	I-TREATMENT
cx	NN	I-TREATMENT

-	:	O
chf	NN	B-PROBLEM
(	(	O
ef	JJ	B-TEST
55%	CD	O
on	IN	O
05-04	NN	O
)	)	O

-	:	O
htn	NN	B-PROBLEM

-	:	O
paroxismal	NN	B-PROBLEM
afib	NN	I-PROBLEM

-	:	O
cva	NN	B-PROBLEM

-	:	O
left	NN	B-PROBLEM
le	VBZ	I-PROBLEM
dvt	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT

-	:	O
s/p	NN	O
ivc	NN	B-TREATMENT
filter	NN	I-TREATMENT

family	NN	O
history	NN	O
:	:	O
father	NN	O
and	CC	O
mother	NN	O
with	IN	O
cad	NN	B-PROBLEM

vs	SYM	B-TEST
-	:	O
98.0	CD	O
67	CD	O
140/63	CD	O
22	CD	O
99%	CD	O
on	IN	O
ra	NN	O

gen	NN	O
-	:	O
a+ox3	NN	O
,	,	O
nad	NN	B-PROBLEM

neck	SYM	O
-	:	O
supple	NN	O
,	,	O
no	DT	O
lad	NN	B-PROBLEM
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

cor	SYM	O
-	:	O
rrr	NN	O
no	DT	O
murmurs	NN	B-PROBLEM

chest	JJS	O
-	:	O
r	NN	O
base	NN	O
with	IN	O
poor	JJ	B-PROBLEM
excursion	NN	I-PROBLEM
and	CC	O
poor	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

abd	SYM	O
-	:	O
s/nt/nd	NN	B-PROBLEM
+bs	NN	O

ext	JJ	O
-	:	O
w/wp	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
r	NN	B-PROBLEM
leg	NN	I-PROBLEM
swollen	VBN	I-PROBLEM
compared	VBN	O
to	TO	O
left	VB	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	CD	I-TEST
67	CD	O

ck	SYM	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
notdone	NN	O
ctropnt	NN	B-TEST
-<	VBD	O
0.01	CD	O

glucose	JJ	B-TEST
-	:	O
159	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
17	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
sodium	NN	B-TEST
-	:	O
137	CD	O
potassium	NN	B-TEST
-	:	O
3.6	CD	O
chloride	NN	B-TEST
-	:	O
100	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
27	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
14	CD	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	CD	I-TEST
76	CD	O

2015-06-29	JJ	O
09:55	CD	O
am	VBP	O
ctropnt	JJ	B-TEST
-<	CD	O
0.01	CD	O

ck	SYM	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
notdone	NN	O

wbc	SYM	B-TEST
-	:	O
10.4	CD	O
rbc	NN	B-TEST
-	:	O
4.41	CD	O
*#	NN	O
hgb	NN	B-TEST
-	:	O
12.8	CD	O
*#	NN	O
hct	NN	B-TEST
-	:	O
38.2	CD	O
*#	NN	O
mcv	SYM	B-TEST
-	:	O
87	CD	O
mch	SYM	B-TEST
-	:	O
29.0	CD	O
mchc	SYM	B-TEST
-	:	O
33.5	CD	O
rdw	NN	B-TEST
-	:	O
15.9	CD	O
*	NN	O

neuts	NNS	B-TEST
-	:	O
86.1	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
5.4	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
5.7	CD	O
eos	SYM	B-TEST
-	:	O
2.2	CD	O
basos	SYM	B-TEST
-	:	O
0.6	CD	O

microcyt	SYM	B-TEST
-	:	O
1+	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
372	CD	O

2015-06-29	JJ	O
09:50	CD	O
am	VBP	O
urine	JJ	B-TEST

2015-06-29	JJ	O
09:50	CD	O
am	VBP	O
urine	JJ	B-TEST

pt	SYM	B-TEST
-	:	O
20.4	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
28.6	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
2.0	CD	O
*	NN	O

2015-06-29	JJ	O
09:50	CD	O
am	VBP	O
urine	JJ	B-TEST

color	NN	B-TEST
-	:	O
yellow	NN	O
appear	VBP	O
-	:	O
clear	JJ	O
sp	NN	B-TEST
dickson	NN	I-TEST
-	:	O
1.013	CD	O

2015-06-29	JJ	O
09:50	CD	O
am	VBP	O
urine	JJ	B-TEST

blood	NN	B-TEST
-	:	O
mod	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
6.0	CD	O
leuk	SYM	O
-	:	O
neg	NN	O

2015-06-29	JJ	O
09:50	CD	O
am	VBP	O
urine	JJ	B-TEST

rbc	LS	B-TEST
-	:	O
05-03	JJ	O
*	NN	O
wbc	SYM	B-TEST
-	:	O
0	CD	O
bacteria	NNS	B-TEST
-	:	O
none	NN	O
yeast	SYM	B-TEST
-	:	O
none	NN	O
epi	NN	B-TEST
-<	VBD	O
1	CD	O

cxr	SYM	B-TEST
-	:	O
increased	VBN	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
partial	JJ	B-PROBLEM
collapse	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

ekg	SYM	B-TEST
-	:	O
nsr	NN	O
70	CD	O
,	,	O
nl	RB	O
axis	NN	O
,	,	O
nl	JJ	O
int	NN	O
,	,	O
old	JJ	B-PROBLEM
twi	NN	I-PROBLEM
iii	NN	I-PROBLEM
,	,	O
f	NN	O
;	:	O
old	JJ	B-PROBLEM
j	NN	I-PROBLEM
pointing	VBG	I-PROBLEM
v	JJ	I-PROBLEM
04-04	JJ	O

07-03	JJ	O
ct	NN	B-TEST

ct	NN	B-TEST
chest	NN	I-TEST
:	:	O

there	EX	O
is	VBZ	O
a	DT	O
small	JJ	O
amount	NN	O
of	IN	O
pericardial	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

no	DT	O
definite	JJ	B-PROBLEM
axillary	NN	I-PROBLEM
,	,	I-PROBLEM
mediastinal	JJ	I-PROBLEM
,	,	I-PROBLEM
or	CC	I-PROBLEM
hilar	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

again	RB	O
seen	VBN	O
is	VBZ	O
a	DT	B-PROBLEM
moderate	JJ	I-PROBLEM
-	:	I-PROBLEM
to	TO	I-PROBLEM
large	JJ	I-PROBLEM
-	:	I-PROBLEM
sized	VBN	I-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

there	EX	O
has	VBZ	O
been	VBN	O
interval	JJ	O
development	NN	O
of	IN	O
moderate	JJ	O
amount	NN	O
of	IN	O
high-attenuation	NN	B-PROBLEM
fluid	NN	I-PROBLEM
within	IN	O
the	DT	B-PROBLEM
effusion	NN	I-PROBLEM
consistent	NN	O
with	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

patchy	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
is	VBZ	O
stable	JJ	O
.	.	O

hazy	JJ	B-PROBLEM
patchy	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
are	VBP	O
noted	VBN	O
in	IN	O
the	DT	O
left	JJ	O
lung	NN	O
field	NN	O
but	CC	O
no	DT	O
frank	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

ct	JJ	B-TEST
abdomen	NNS	I-TEST
:	:	O

within	IN	O
the	DT	O
limits	NNS	O
of	IN	O
this	DT	B-TEST
non-contrast	JJ	I-TEST
study	NN	I-TEST
,	,	O
the	DT	O
liver	NN	O
,	,	O
gallbladder	NN	O
,	,	O
pancreas	NNS	O
,	,	O
spleen	NN	O
,	,	O
adrenal	JJ	O
glands	NNS	O
,	,	O
kidneys	NNS	O
,	,	O
stomach	NN	O
,	,	O
and	CC	O
small	JJ	O
bowel	NN	O
loops	NNS	O
are	VBP	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

there	EX	O
is	VBZ	O
colonic	JJ	B-PROBLEM
diverticulosis	NN	I-PROBLEM
most	RBS	O
prominent	JJ	O
at	IN	O
the	DT	O
hepatic	JJ	O
flexure	NN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
or	CC	O
free	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

no	DT	O
mesenteric	NN	B-PROBLEM
or	CC	I-PROBLEM
retroperitoneal	VB	I-PROBLEM
lymphadenopathy	JJ	I-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

an	DT	B-TREATMENT
ivc	JJ	I-TREATMENT
filter	NN	I-TREATMENT
is	VBZ	O
seen	VBN	O
.	.	O

ct	NN	B-TEST
pelvis	NN	I-TEST
:	:	O

the	DT	O
patient	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
status	NN	O
post	NN	O
prostatectomy	NN	B-TREATMENT
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
free	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
and	CC	O
no	DT	O
pelvic	NN	B-PROBLEM
or	CC	I-PROBLEM
inguinal	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
lytic	JJ	I-PROBLEM
area	NN	I-PROBLEM
is	VBZ	O
again	RB	O
seen	VBN	O
in	IN	O
the	DT	O
l5	JJ	O
vertebral	JJ	O
body	NN	O
but	CC	O
unchanged	JJ	O
from	IN	O
prior	JJ	B-TEST
examination	NN	I-TEST
.	.	O

several	JJ	B-PROBLEM
subacute	NN	I-PROBLEM
or	CC	I-PROBLEM
chronic	JJ	I-PROBLEM
rib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
identified	VBN	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

1.	CD	O
interval	JJ	O
development	NN	O
of	IN	O
a	DT	O
moderate	JJ	O
amount	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
within	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

2.	CD	O
no	DT	O
acute	JJ	B-PROBLEM
intra-abdominal	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
identified	VBN	O
.	.	O

07-01	JJ	O
stress	NN	B-TEST
mibi	NN	I-TEST

new	JJ	B-PROBLEM
moderate	JJ	I-PROBLEM
and	CC	I-PROBLEM
fixed	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	NN	I-PROBLEM
wall	NN	I-PROBLEM
perfusion	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

mild	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

calculated	VBN	B-TEST
lvef	JJ	I-TEST
42%	CD	O
.	.	O

a/p	RB	O
74	CD	O
yo	NNS	O
m	NN	O
with	IN	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
dvt	NN	B-PROBLEM
,	,	O
cad	NN	B-PROBLEM
s/p	NN	O
mi	NN	B-PROBLEM
presents	NNS	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

#	#	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
/	NN	O
ischemia	NN	B-PROBLEM
-	:	O
patient	NN	O
with	IN	O
history	NN	O
of	IN	O
cad	NN	B-PROBLEM
a/p	NN	O
mi	NN	B-PROBLEM
.	.	O

now	RB	O
with	IN	O
an	DT	O
episode	NN	O
of	IN	O
pain	NN	B-PROBLEM
consistent	JJ	O
with	IN	O
his	PRP$	B-PROBLEM
anginal	JJ	I-PROBLEM
equivalent	NN	I-PROBLEM
.	.	O

no	DT	O
changes	NNS	B-PROBLEM
on	IN	O
ekg	NN	B-TEST
but	CC	O
not	RB	O
in	IN	O
pain	NN	B-PROBLEM
at	IN	O
time	NN	O
of	IN	O
ekg	NN	B-TEST
.	.	O

patient	NN	O
was	VBD	O
ruled	VBN	O
out	RP	O
by	IN	O
enzymes	NNS	B-TEST
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
which	WDT	O
revealed	VBD	O
an	DT	B-PROBLEM
irreversible	JJ	I-PROBLEM
deficit	NN	I-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
prior	JJ	I-PROBLEM
known	VBN	I-PROBLEM
imi	NN	I-PROBLEM
.	.	O

continued	VBN	O
on	IN	O
asa	NN	B-TREATMENT
,	,	O
bblocker	NN	B-TREATMENT
,	,	O
hicks	NNS	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
.	.	O

bp	NN	B-TREATMENT
meds	NNS	I-TREATMENT
held	VBD	O
while	IN	O
was	VBD	O
unstable	JJ	B-PROBLEM
.	.	O

asa	NN	B-TREATMENT
,	,	O
plavix	JJ	B-TREATMENT
held	VBD	O
during	IN	O
hemothorax	NN	B-PROBLEM
.	.	O

#	#	O
chf	SYM	B-PROBLEM
-	:	O
patient	NN	O
does	VBZ	O
not	RB	O
seem	VB	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

he	PRP	O
has	VBZ	O
no	DT	O
jvd	NN	B-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM
in	IN	I-PROBLEM
legs	NNS	I-PROBLEM
(	(	O
other	JJ	O
than	IN	O
swelling	VBG	B-PROBLEM
from	IN	O
dvt	NN	B-PROBLEM
)	)	O
.	.	O

last	JJ	B-TEST
echo	NN	I-TEST
with	IN	O
ef	JJ	B-TEST
55%	CD	O
.	.	O

does	VBZ	O
have	VB	O
increased	VBN	B-PROBLEM
effusion	NN	I-PROBLEM
although	IN	O
loculated	VBN	O
.	.	O

continued	VBN	O
on	IN	O
lasix	NN	B-TREATMENT
,	,	O
bblocker	NN	B-TREATMENT
robertson	NN	O
.	.	O

bp	NN	B-TREATMENT
meds	NNS	I-TREATMENT
held	VBD	O
while	IN	O
unstable	JJ	B-PROBLEM
.	.	O

#	#	O
afib	SYM	B-PROBLEM
-	:	O
in	IN	O
sinus	NN	O
during	IN	O
admission	NN	O
.	.	O

patients	NNS	B-TREATMENT
anticoag	JJ	I-TREATMENT
held	VBD	O
during	IN	O
hemothorax	NN	B-PROBLEM
.	.	O

#	#	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
/	NN	O
loculated	VBD	B-PROBLEM
effusion	NN	I-PROBLEM
-	:	O
patient	NN	O
with	IN	O
increaing	VBG	B-PROBLEM
loculated	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

has	VBZ	O
chronic	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
worsened	VBN	O
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
days	NNS	O
.	.	O

no	DT	O
sign	NN	O
of	IN	O
infeciton	NN	B-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

had	VBD	O
thoracentesis	VBN	B-TEST
by	IN	O
interventional	JJ	O
pumonology	NN	O
on	IN	O
2015-07-01	JJ	O
revealing	NN	O
almost	RB	O
2	CD	O
l	NN	O
of	IN	O
serous	JJ	B-PROBLEM
exudative	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

cytology	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

however	RB	O
on	IN	O
07-02	JJ	O
hct	NN	B-TEST
dropped	VBD	O
.	.	O

ct	NN	B-TEST
revealed	VBD	O
hemothorax	NN	B-PROBLEM
.	.	O

all	DT	B-TREATMENT
anticoagulation	NN	I-TREATMENT
stopped	VBD	O
despite	IN	O
the	DT	O
risk	NN	O
of	IN	O
dvt	NN	B-PROBLEM
,	,	O
afib	NN	B-PROBLEM
.	.	O

thoracics	NNS	O
consulted	VBN	O
and	CC	O
chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
.	.	O

frank	JJ	B-PROBLEM
blood	NN	I-PROBLEM
was	VBD	O
taken	VBN	O
out	RP	O
.	.	O

patient	NN	O
continued	VBD	O
to	TO	O
bleed	VB	O
in	IN	O
and	CC	O
around	IN	O
the	DT	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

patient	NN	O
sent	VBD	O
to	TO	O
cmed	VB	O
for	IN	O
observation	NN	B-TEST
after	IN	O
hct	NN	B-TEST
continued	VBD	O
to	TO	O
drop	VB	O
.	.	O

patient	NN	O
spontaneously	RB	O
stablized	VBN	O
and	CC	O
output	NN	B-TEST
of	IN	O
ct	NN	B-TEST
became	VBD	O
more	RBR	O
serous	JJ	O
.	.	O

output	NN	B-TEST
resent	NN	O
for	IN	O
cytology	NN	B-TEST
which	WDT	O
was	VBD	O
pending	VBG	O
at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

when	WRB	O
output	NN	B-TEST
became	VBD	O
<	JJ	O
100	CD	O
cc	NN	O
the	DT	B-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

patient	NN	O
follwed	VBN	O
with	IN	O
serial	JJ	B-TEST
cxr	NN	I-TEST
that	WDT	O
did	VBD	O
not	RB	O
demonstrate	VB	O
reaccumulation	NN	B-PROBLEM
.	.	O

hct	NN	B-TEST
also	RB	O
remained	VBD	O
stable	JJ	O
.	.	O

#	#	O
dvt	SYM	B-PROBLEM
-	:	O
patient	JJ	O
therapeutic	JJ	O
on	IN	O
heparin	NN	B-TREATMENT
.	.	O

improving	VBG	O
clots	NNS	B-PROBLEM
on	IN	O
leni	NN	B-TREATMENT
.	.	O

cta	NN	B-TEST
neg	NN	O
for	IN	O
pe	NN	B-PROBLEM
.	.	O

anticoagulaiton	RB	B-TREATMENT
held	VBN	O
during	IN	O
hemothorax	NN	B-PROBLEM
.	.	O

patient	NN	O
restarted	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
and	CC	O
will	MD	O
be	VB	O
discharged	VBN	O
on	IN	O
3mg	CD	O
coumadin	NN	B-TREATMENT
qday	NN	O
.	.	O

#	#	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
-	:	O
patient	NN	O
currently	RB	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
disease	NN	B-PROBLEM
.	.	O

s/p	NN	O
neoadjuvant	JJ	B-TREATMENT
chemo/xrt	NN	I-TREATMENT
now	RB	O
s/p	VBZ	O
surgery	NN	B-TREATMENT
.	.	O

1st	CD	B-TEST
cytology	NN	I-TEST
negative	JJ	O
.	.	O

2ng	CD	B-TEST
cytology	NN	I-TEST
pending	VBG	O
.	.	O

lipitor	NN	B-TREATMENT
80	CD	O
mg	NN	O
qday	NN	O

asa	RB	B-TREATMENT
81	CD	O
mg	NNS	O
qday	JJ	O

bowel	NN	B-TREATMENT
reg	NN	I-TREATMENT

percocet	NN	B-TREATMENT
prn	NN	O

plavix	NN	B-TREATMENT
75	CD	O
mg	NN	O
qday	NN	O

losartan	JJ	B-TREATMENT
25	CD	O
mg	NN	O
qday	NN	O

coumadin	NN	B-TREATMENT
3	CD	O
mg	NN	O
qday	NN	O

lasix	RB	B-TREATMENT
20	CD	O
mg	NNS	O
qday	JJ	O

atenolol	RB	B-TREATMENT
25	CD	O
mg	NNS	O
qday	JJ	O

1.	CD	O
atorvastatin	JJ	B-TREATMENT
80	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

4.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

5.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

6.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

8.	CD	O
nitroglycerin	JJ	B-TREATMENT
0.3	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
sublingual	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
sublingual	JJ	O
sublingual	JJ	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
)	)	O
.	.	O

9.	CD	O
atenolol	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
losartan	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

11.	CD	O
benzonatate	NN	B-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
cough	NN	B-PROBLEM
.	.	O

12.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

13.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
codeine	JJ	B-TREATMENT
-	:	O
guaifenesin	NN	B-TREATMENT
10-100	JJ	O
mg	NN	O
/	$	O
5	CD	O
ml	NN	O
syrup	NN	O
sig	NN	O
:	:	O
5-10	JJ	O
mls	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

15.	CD	O
coumadin	NN	B-TREATMENT
3	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

angina	NN	B-PROBLEM

pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM

htn	NN	B-PROBLEM

non	RB	B-PROBLEM
small	JJ	I-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM

cad	NN	B-PROBLEM

dvt	NN	B-PROBLEM
h/o	NN	O
afib	NN	B-PROBLEM

please	VB	O
take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
listed	VBN	O
in	IN	O
the	DT	O
discharge	NN	O
paperwork	NN	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
chest	VBN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
concerning	VBG	I-PROBLEM
symptoms	NNS	I-PROBLEM
please	VB	O
call	VB	O
your	PRP$	O
md	NN	O
or	CC	O
come	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

i	NNS	O
have	VBP	O
changed	VBN	O
some	DT	O
of	IN	O
your	PRP$	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

your	PRP$	B-TREATMENT
atenolol	NN	I-TREATMENT
has	VBZ	O
increased	VBN	O
to	TO	O
50	CD	O
mg	NNS	O
a	DT	O
day	NN	O
.	.	O

your	PRP$	B-TREATMENT
losartan	NN	I-TREATMENT
has	VBZ	O
increased	VBN	O
to	TO	O
50	CD	O
mg	NNS	O
a	DT	O
day	NN	O
.	.	O

please	VB	O
see	VB	O
dr.	JJ	O
holbrook	NN	O
(	(	O
984	CD	O
)	)	O
452	CD	O
0816	CD	O
on	IN	O
monday	NN	O
and	CC	O
have	VB	O
your	PRP$	B-TEST
coumadin	NNS	I-TEST
level	NN	I-TEST
checked	VBD	O
.	.	O

he	PRP	O
was	VBD	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
rehabilitation	NN	I-TREATMENT
hospitalization	NN	I-TREATMENT
at	IN	O
the	DT	O
raya	NN	O
ma	NN	O
den	NN	O
erinmarg	NN	O
hospital	NN	O
with	IN	O
a	DT	O
recent	JJ	O
recrudescence	NN	O
of	IN	O
his	PRP$	O
drug	NN	O
abuse	NN	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
sephsandpot	NN	O
center	NN	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
4/9	CD	O
and	CC	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

at	IN	O
3:00	CD	O
a.m.	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
he	PRP	O
was	VBD	O
found	VBN	O
by	IN	O
the	DT	O
emergency	NN	O
medical	JJ	O
technicians	NNS	O
&quot;	VBP	O
crawling	VBG	O
on	IN	O
all	DT	O
fours	NNS	O
&quot;	NNP	O
,	,	O
confused	VBD	B-PROBLEM
,	,	O
and	CC	O
combative	JJ	B-PROBLEM
outside	IN	O
his	PRP$	O
home	NN	O
.	.	O

he	PRP	O
gave	VBD	O
an	DT	O
equivocal	JJ	O
history	NN	O
of	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
chills	NNS	B-PROBLEM
on	IN	O
the	DT	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
sephsandpot	NN	O
center	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
hypotensive	JJ	B-PROBLEM
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
105/85	CD	O
,	,	O
tachycardic	NN	B-PROBLEM
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
to	TO	O
186	CD	O
,	,	O
aneuric	NN	B-PROBLEM
,	,	O
hyperthermic	JJ	B-PROBLEM
,	,	O
with	IN	O
a	DT	B-TEST
temperature	NN	I-TEST
to	TO	O
105	CD	O
degrees	NNS	O
f	RB	O
,	,	O
and	CC	O
progressively	RB	B-PROBLEM
more	RBR	I-PROBLEM
confused	JJ	I-PROBLEM
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
clear	JJ	O
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
dopamine	NN	B-TREATMENT
for	IN	O
hypertension	NN	B-PROBLEM
and	CC	O
inderal	JJ	B-TREATMENT
for	IN	O
tachycardia	NN	B-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
two	CD	O
amps	NNS	O
of	IN	O
narcan	JJ	B-TREATMENT
.	.	O

he	PRP	O
received	VBD	O
one	CD	O
gram	NN	O
of	IN	O
ceftriaxone	NN	B-TREATMENT
intravenously	RB	O
after	IN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
drawn	VBN	O
.	.	O

his	PRP$	B-TEST
initial	JJ	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
at	IN	O
the	DT	O
sephsandpot	NN	O
center	NN	O
revealed	VBD	O
a	DT	B-TEST
p02	NN	I-TEST
of	IN	O
76	CD	O
,	,	O
pc02	NN	B-TEST
14	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.44	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

toxicology	NN	B-TEST
screen	NN	I-TEST
at	IN	O
sephsandpot	NN	O
center	NN	O
revealed	VBD	O
cocaine	NN	O
and	CC	O
quinine	NN	B-TREATMENT
.	.	O

shortly	RB	O
after	IN	O
his	PRP$	O
arrival	NN	O
to	TO	O
that	DT	O
hospital	NN	O
he	PRP	O
had	VBD	O
been	VBN	O
intubated	VBN	O
for	IN	O
a	DT	B-TEST
respiratory	JJ	I-TEST
rate	NN	I-TEST
of	IN	O
60	CD	O
.	.	O

he	PRP	O
required	VBD	O
medical	JJ	B-TREATMENT
paralysis	NN	I-TREATMENT
for	IN	O
this	DT	O
.	.	O

he	PRP	O
was	VBD	O
reported	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
seizure	NN	I-PROBLEM
,	,	O
although	IN	O
the	DT	O
nature	NN	O
of	IN	O
this	DT	O
was	VBD	O
unclear	JJ	O
,	,	O
and	CC	O
received	VBD	O
valium	NN	B-TREATMENT
for	IN	O
this	DT	O
.	.	O

he	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
recent	JJ	B-TREATMENT
left	VBD	I-TREATMENT
knee	NN	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
carpal	JJ	I-TREATMENT
tunnel	NN	I-TREATMENT
release	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
meds	NNS	I-TREATMENT
on	IN	O
transfer	NN	O
to	TO	O
fih	VB	O
were	VBD	O
levophed	VBN	B-TREATMENT
,	,	O
dopamine	NN	B-TREATMENT
,	,	O
and	CC	O
ceftriaxone	NN	B-TREATMENT
.	.	O

revealed	VBD	O
an	DT	O
obtunded	JJ	O
white	JJ	O
muscular	JJ	O
man	NN	O
who	WP	O
was	VBD	O
intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT
.	.	O

the	DT	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
showed	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
69	CD	O
,	,	O
pulse	RB	B-TEST
80	CD	O
,	,	O
respirations	NNS	B-TEST
14	CD	O
,	,	O
and	CC	O
temperature	NN	B-TEST
99.8	CD	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
contusion	NN	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
eye	NN	I-PROBLEM
but	CC	O
no	DT	O
laceration	NN	B-PROBLEM
,	,	O
abrasion	NN	B-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
,	,	O
no	DT	O
flank	JJ	B-PROBLEM
discoloration	NN	I-PROBLEM
,	,	O
blanching	VBG	B-PROBLEM
papules	NNS	I-PROBLEM
over	IN	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
without	IN	O
central	JJ	B-PROBLEM
necrosis	NN	I-PROBLEM
.	.	O

lymphatic-he	NN	O
had	VBD	O
shotty	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
normocephalic	JJ	O
,	,	O
with	IN	O
trauma	NN	B-PROBLEM
as	IN	O
described	NN	O
,	,	O
pupils	NNS	O
were	VBD	O
2	CD	O
mm	NNS	O
bilaterally	RB	O
which	WDT	O
were	VBD	O
minimally	RB	B-PROBLEM
reactive	JJ	I-PROBLEM
,	,	O
fundi	NN	O
was	VBD	O
not	RB	O
seen	VBN	O
,	,	O
conjunctivae	VB	O
without	IN	O
erythema	NN	B-PROBLEM
,	,	O
sclerae	NN	O
anicteric	NN	B-PROBLEM
,	,	O
positive	JJ	O
corneal	NN	B-TEST
reflexes	NNS	I-TEST
noted	VBD	O
.	.	O

ears-the	JJ	O
tympanic	JJ	O
membranes	NNS	O
were	VBD	O
clear	JJ	O
with	IN	O
no	DT	O
hemorrhage	NN	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

nose-no	JJ	O
sinus	NN	B-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
no	DT	O
hemorrhage	NN	B-PROBLEM
.	.	O

the	DT	O
oropharynx	NN	O
was	VBD	O
intubated	VBN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
scattered	VBN	B-PROBLEM
wheezes	NNS	I-PROBLEM
following	VBG	O
a	DT	B-TREATMENT
3	CD	I-TREATMENT
liter	NN	I-TREATMENT
bolus	NN	I-TREATMENT
for	IN	O
hypotension	NN	B-PROBLEM
.	.	O

no	DT	O
effusion	NN	B-PROBLEM
or	CC	O
rub	NN	B-PROBLEM
was	VBD	O
heard	VBN	O
.	.	O

the	DT	B-TEST
cardiac	NN	I-TEST
exam	NN	I-TEST
showed	VBD	O
point	NN	O
of	IN	O
maximal	JJ	O
impulse	NN	O
was	VBD	O
not	RB	O
displaced	VBN	O
,	,	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
normal	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
s3	NN	B-PROBLEM
or	CC	O
s4	NN	B-PROBLEM
,	,	O
a	DT	B-PROBLEM
grade	NN	I-PROBLEM
ii	NN	I-PROBLEM
/	NNP	I-PROBLEM
vi	VBZ	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
was	VBD	O
heard	VBN	O
at	IN	O
the	DT	O
left	JJ	O
upper	JJ	O
sternal	JJ	O
border	NN	O
without	IN	O
radiation	NN	B-PROBLEM
,	,	O
likely	RB	O
representing	VBG	O
a	DT	B-PROBLEM
flow	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

no	DT	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

the	DT	B-TEST
jugular	JJ	I-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
not	RB	O
assessed	JJ	O
secondary	JJ	O
to	TO	O
cervical	JJ	B-TREATMENT
collar	NN	I-TREATMENT
being	VBG	O
in	IN	O
place	NN	O
.	.	O

the	DT	B-TEST
carotid	NN	I-TEST
pulses	NNS	I-TEST
were	VBD	O
brisk	JJ	O
bilaterally	RB	O
.	.	O

the	DT	B-TEST
vascular	JJ	I-TEST
exam	NN	I-TEST
showed	VBD	O
normal	JJ	O
pulses	NNS	O
bilaterally	RB	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
bowel	JJ	O
sounds	NNS	O
of	IN	O
normal	JJ	O
character	NN	O
,	,	O
and	CC	O
there	RB	O
was	VBD	O
mild	JJ	B-PROBLEM
percussion	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
tenderness	NN	B-PROBLEM
to	TO	O
modest	JJ	B-TEST
palpation	NN	I-TEST
in	IN	I-TEST
all	DT	I-TEST
four	CD	I-TEST
quadrants	NNS	I-TEST
.	.	O

it	PRP	O
was	VBD	O
unclear	JJ	O
whether	IN	O
this	DT	O
was	VBD	O
due	JJ	O
to	TO	O
superficial	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
or	CC	O
abdominal	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
marked	VBN	B-PROBLEM
voluntary	JJ	I-PROBLEM
guarding	NN	I-PROBLEM
without	IN	O
rigidity	NN	B-PROBLEM
and	CC	O
no	DT	O
masses	NNS	B-PROBLEM
were	VBD	O
felt	VBN	O
.	.	O

the	DT	B-TEST
genitourinary	JJ	I-TEST
exam	NN	I-TEST
showed	VBD	O
normal	JJ	O
penis	NN	O
with	IN	O
normal	JJ	O
testicles	NNS	O
which	WDT	O
were	VBD	O
nontender	JJR	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
urethritis	NN	B-PROBLEM
,	,	O
no	DT	O
balinitis	NN	B-PROBLEM
,	,	O
normal	JJ	O
prostate	NN	O
,	,	O
nontender	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
tan	JJ	B-PROBLEM
guaiac	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
stool	NN	I-PROBLEM
with	IN	O
no	DT	O
masses	NNS	B-PROBLEM
.	.	O

the	DT	B-TEST
musculoskeletal	JJ	I-TEST
exam	NN	I-TEST
showed	VBD	O
well	RB	O
developed	VBN	O
,	,	O
symmetrical	JJ	O
muscular	NN	O
development	NN	O
with	IN	O
no	DT	O
fasciculations	NNS	B-PROBLEM
,	,	O
no	DT	O
joint	JJ	B-PROBLEM
erythema	NN	I-PROBLEM
,	,	O
no	DT	O
effusions	NNS	B-PROBLEM
.	.	O

neuro	JJ	B-TEST
exam-the	JJ	I-TEST
mental	NN	B-TEST
status	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
variable	JJ	O
,	,	O
intermittently	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
,	,	O
unable	JJ	B-PROBLEM
to	TO	O
follow	VB	O
commands	NNS	B-TEST
.	.	O

the	DT	B-TEST
motor	NN	I-TEST
exam-moves	VBZ	I-TEST
all	DT	O
four	CD	O
extremities	NNS	O
easily	RB	O
and	CC	O
on	IN	O
command	NN	O
.	.	O

the	DT	B-TEST
sensory	JJ	I-TEST
exam	NN	I-TEST
revealed	VBD	O
no	DT	O
focal	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
to	TO	O
limited	JJ	B-TEST
exam	NN	I-TEST
.	.	O

reflexes	NNS	B-TEST
were	VBD	O
trace	NN	O
in	IN	O
the	DT	O
upper	JJ	O
extremities	NNS	O
and	CC	O
absent	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
with	IN	O
downgoing	VBG	O
toes	NNS	O
bilaterally	RB	O
.	.	O

on	IN	O
admission	NN	O
the	DT	B-TEST
sodium	NN	I-TEST
was	VBD	O
144	CD	O
,	,	O
potassium	NN	B-TEST
2.6	CD	O
,	,	O
chloride	RB	B-TEST
114	CD	O
,	,	O
bicarbonate	NN	B-TEST
12.3	CD	O
,	,	O
bun	NN	B-TEST
30	CD	O
,	,	O
creatinine	NN	B-TEST
4.0	CD	O
,	,	O
glucose	VBD	B-TEST
89	CD	O
.	.	O

the	DT	B-TEST
sgot	NN	I-TEST
was	VBD	O
994	CD	O
,	,	O
ldh	VBD	B-TEST
1,888	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
92	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
2.9	CD	O
and	CC	O
direct	JJ	B-TEST
bilirubin	NN	I-TEST
11.2	CD	O
.	.	O

lactate	NN	B-TEST
was	VBD	O
6.3	CD	O
,	,	O
acetone	RB	B-TEST
negative	JJ	O
,	,	O
ammonia	JJ	B-TEST
26	CD	O
,	,	O
uric	JJ	B-TEST
acids	NNS	I-TEST
26.9	CD	O
,	,	O
albumin	RB	B-TEST
4.0	CD	O
,	,	O
globulin	NN	B-TEST
3.0	CD	O
,	,	O
amylase	NN	B-TEST
259	CD	O
,	,	O
lipase	NN	B-TEST
34	CD	O
,	,	O
magnesium	NN	B-TEST
3.5	CD	O
,	,	O
phosphorus	NN	B-TEST
1.9	CD	O
,	,	O
calcium	NN	B-TEST
9.4.	CD	O
the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
19.7	CD	O
with	IN	O
89%	CD	O
polys	NNS	B-TEST
,	,	O
7%	CD	O
bands	NNS	B-TEST
,	,	O
4%	CD	O
lymphs	NN	B-TEST
,	,	O
with	IN	O
toxic	JJ	B-PROBLEM
granulations	NNS	I-PROBLEM
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
45.2	CD	O
with	IN	O
a	DT	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
of	IN	O
132,000	CD	O
,	,	O
falling	VBG	O
rapidly	RB	O
to	TO	O
24,000	CD	O
.	.	O

the	DT	B-TEST
mcv	NN	I-TEST
is	VBZ	O
88	CD	O
.	.	O

the	DT	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
is	VBZ	O
27.7	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
is	VBZ	O
greater	JJR	O
than	IN	O
100	CD	O
.	.	O

the	DT	B-TEST
urinalysis	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
specific	JJ	I-TEST
gravity	NN	I-TEST
of	IN	O
1.15	CD	O
,	,	O
ph	NN	B-TEST
5.0	CD	O
,	,	O
and	CC	O
4+	CD	B-PROBLEM
albumin	NN	I-PROBLEM
,	,	O
positive	JJ	B-PROBLEM
occult	NN	I-PROBLEM
blood	NN	I-PROBLEM
,	,	O
with	IN	O
0-5	JJ	B-PROBLEM
granular	JJ	I-PROBLEM
casts	NNS	I-PROBLEM
and	CC	O
5-10	JJ	B-PROBLEM
rbcs	NN	I-PROBLEM
and	CC	O
3-5	JJ	B-PROBLEM
wbcs	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
ck	NN	I-TEST
was	VBD	O
17,890	CD	O
with	IN	O
0.6%	CD	O
mb	NNS	B-TEST
.	.	O

the	DT	B-TEST
urine	JJ	I-TEST
sodium	NN	I-TEST
was	VBD	O
147	CD	O
.	.	O

the	DT	B-TEST
serum	NN	I-TEST
toxicology	NN	I-TEST
was	VBD	O
positive	JJ	B-PROBLEM
for	IN	O
cocaine	NN	O
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
sephsandpot	NN	O
center	NN	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
revealed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
85	CD	O
with	IN	O
a	DT	B-PROBLEM
prolonged	JJ	I-PROBLEM
qt	NN	I-PROBLEM
at	IN	O
0.572	CD	O
.	.	O

an	DT	B-TEST
i-head	JJ	I-TEST
ct	NN	I-TEST
revealed	VBD	O
left	VBN	O
sphenoid	NN	O
and	CC	O
left	VBD	B-PROBLEM
maxillary	JJ	I-PROBLEM
sinusitis	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
cerebral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
no	DT	O
focal	JJ	B-PROBLEM
hemorrhages	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
revealed	VBD	O
mesenteric	JJ	B-PROBLEM
adenopathy	RB	I-PROBLEM
,	,	O
normal	JJ	O
bowels	NNS	O
,	,	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
and	CC	O
?	.	O
fatty	JJ	B-PROBLEM
liver	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
early	JJ	B-PROBLEM
interstitial	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
cocaine	NN	B-PROBLEM
induced	VBN	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM
,	,	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
disseminated	VBD	B-PROBLEM
intravascular	JJ	I-PROBLEM
coagulation	NN	I-PROBLEM
,	,	O
shock	NN	B-PROBLEM
,	,	O
hepatic	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
pancreatitis	NN	B-PROBLEM
,	,	O
and	CC	O
thrombocytopenia	NN	B-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
cocaine	NN	O
intoxication	NN	O
.	.	O

1-rhabdomyolysis	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
massive	JJ	B-PROBLEM
cocaine	NN	I-PROBLEM
induced	VBN	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM
.	.	O

this	DT	O
resulted	VBD	O
in	IN	O
tremendous	JJ	B-PROBLEM
third	JJ	I-PROBLEM
spacing	NN	I-PROBLEM
of	IN	I-PROBLEM
fluid	NN	I-PROBLEM
and	CC	O
persistent	JJ	B-PROBLEM
intervascular	JJ	I-PROBLEM
hypovolemia	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
creatinine	NN	I-TEST
______________	NNP	I-TEST
kinase	NN	I-TEST
peaked	VBD	O
at	IN	O
56,160	CD	O
with	IN	O
negative	JJ	O
mb	NN	B-TEST
percentages	NNS	I-TEST
.	.	O

the	DT	B-TEST
aldolase	NN	I-TEST
was	VBD	O
positive	JJ	O
at	IN	O
142	CD	O
.	.	O

this	DT	O
was	VBD	O
further	RBR	O
complicated	VBN	O
by	IN	O
hypocalcemia	NN	B-PROBLEM
which	WDT	O
resulted	VBD	O
in	IN	O
mild	JJ	B-PROBLEM
electrocardiographic	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
urine	NN	O
was	VBD	O
alkalinized	VBN	B-TREATMENT
with	IN	O
intravenous	JJ	B-TREATMENT
bicarbonate	NN	I-TREATMENT
to	TO	O
maximize	VB	O
the	DT	O
myoglobin	NN	O
secretion	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
urine	NN	I-TEST
output	NN	I-TEST
was	VBD	O
further	RB	O
augmented	VBN	O
by	IN	O
adding	VBG	O
dopamine	NN	B-TREATMENT
.	.	O

nevertheless	RB	O
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
continued	VBD	O
to	TO	O
progress	VB	O
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
hospitalization	NN	O
his	PRP$	B-TEST
ck	NN	I-TEST
fell	VBD	O
in	IN	O
the	DT	O
serum	NN	O
.	.	O

much	JJ	O
of	IN	O
his	PRP$	B-PROBLEM
diffuse	NN	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
this	DT	B-PROBLEM
massive	JJ	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM
.	.	O

2-renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
creatinine	NN	I-TEST
was	VBD	O
4.4	CD	O
on	IN	O
admission	NN	O
and	CC	O
peaked	VBD	O
at	IN	O
10.5	CD	O
on	IN	O
the	DT	O
15th	CD	O
.	.	O

the	DT	B-TEST
urinalysis	NN	I-TEST
revealed	VBD	O
4+	CD	B-PROBLEM
albumin	NN	I-PROBLEM
with	IN	O
marked	JJ	B-PROBLEM
occult	NN	I-PROBLEM
blood	NN	I-PROBLEM
.	.	O

peritoneal	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
was	VBD	O
instituted	VBN	O
on	IN	O
4/11	CD	O
after	IN	O
a	DT	B-TREATMENT
tenckhoff	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
by	IN	O
drs.	JJ	O
freierm	NN	O
,	,	O
le	NN	O
,	,	O
and	CC	O
round	NN	O
.	.	O

subsequently	RB	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
rose	VBD	O
for	IN	O
three	CD	O
days	NNS	O
and	CC	O
then	RB	O
stabilized	VBD	O
at	IN	O
10	CD	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
make	VB	O
minimal	JJ	B-PROBLEM
urine	NN	I-PROBLEM
throughout	IN	O
the	DT	O
hospitalization	NN	O
.	.	O

3-disseminated	JJ	B-PROBLEM
intravascular	JJ	I-PROBLEM
coagulation	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
was	VBD	O
27.7	CD	O
with	IN	O
a	DT	B-TEST
partial	JJ	I-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
100	CD	O
and	CC	O
a	DT	B-TEST
d-dimer	JJ	I-TEST
positive	JJ	O
at	IN	O
8	CD	O
with	IN	O
a	DT	B-TEST
fibrinogen	NN	I-TEST
of	IN	O
69	CD	O
.	.	O

he	PRP	O
went	VBD	O
on	IN	O
to	TO	O
develop	VB	O
profound	JJ	B-PROBLEM
thrombocytopenia	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
supported	VBN	O
with	IN	O
abundant	JJ	O
use	NN	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
cryoprecipitate	NN	B-TREATMENT
,	,	O
platelets	NNS	B-TREATMENT
,	,	O
and	CC	O
packed	VBD	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
dic	NN	I-PROBLEM
was	VBD	O
further	RB	O
complicated	VBN	O
by	IN	O
hepatic	JJ	B-PROBLEM
failure	NN	I-PROBLEM
which	WDT	O
resulted	VBD	O
in	IN	O
poor	JJ	B-PROBLEM
endogenous	JJ	I-PROBLEM
production	NN	I-PROBLEM
of	IN	I-PROBLEM
clotting	VBG	I-PROBLEM
factors	NNS	I-PROBLEM
and	CC	O
he	PRP	O
remained	VBD	O
fresh	JJ	B-PROBLEM
frozen	JJ	I-PROBLEM
plasma	NN	I-PROBLEM
dependent	NN	I-PROBLEM
.	.	O

4-septic	JJ	B-PROBLEM
shock	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
pressor	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

he	PRP	O
was	VBD	O
maintained	VBN	O
variously	RB	O
on	IN	O
levophed	VBN	B-TREATMENT
,	,	O
dobutamine	NN	B-TREATMENT
,	,	O
dopamine	NN	B-TREATMENT
,	,	O
and	CC	O
ultimately	RB	O
epinephrine	VB	B-TREATMENT
for	IN	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

hemodynamic	JJ	B-TEST
monitoring	NN	I-TEST
revealed	VBD	O
low	JJ	B-PROBLEM
systemic	JJ	I-PROBLEM
vascular	NN	I-PROBLEM
resistance	NN	I-PROBLEM
and	CC	O
high	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
multiple	JJ	O
sources	NNS	O
of	IN	O
infection	NN	B-PROBLEM
including	VBG	O
his	PRP$	O
sinuses	NNS	O
,	,	O
lungs	NNS	O
,	,	O
and	CC	O
multiple	JJ	B-TREATMENT
lines	NNS	I-TREATMENT
.	.	O

further	RB	O
he	PRP	O
had	VBD	O
massive	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
necrosis	NN	I-PROBLEM
and	CC	O
hepatic	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
4/12	CD	O
revealed	VBD	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
left	NN	I-PROBLEM
ventricle	NN	I-PROBLEM
which	WDT	O
was	VBD	O
diffusely	RB	B-PROBLEM
mildly	RB	I-PROBLEM
hypokinetic	JJ	I-PROBLEM
with	IN	O
no	DT	O
vegetations	NNS	B-PROBLEM
.	.	O

his	PRP$	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
was	VBD	O
55%	CD	O
.	.	O

on	IN	O
4/16	CD	O
the	DT	B-TEST
pulmonary	JJ	I-TEST
artery	NN	I-TEST
catheter	NN	I-TEST
was	VBD	O
placed	VBN	O
which	WDT	O
revealed	VBD	O
a	DT	B-TEST
wedge	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
8	CD	O
,	,	O
cardiac	JJ	B-TEST
index	NN	I-TEST
of	IN	O
4.5	CD	O
,	,	O
and	CC	O
an	DT	B-TEST
svr	NN	I-TEST
of	IN	O
5.8	CD	O
.	.	O

5-hepatic	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
sgpt	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
2,520	CD	O
with	IN	O
a	DT	O
peak	NN	O
at	IN	O
7,680	CD	O
on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
.	.	O

he	PRP	O
had	VBD	O
complete	JJ	B-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
synthetic	JJ	I-PROBLEM
and	CC	I-PROBLEM
conjugation	NN	I-PROBLEM
function	NN	I-PROBLEM
of	IN	O
the	DT	O
liver	NN	O
with	IN	O
rising	VBG	B-PROBLEM
bilirubin	NN	I-PROBLEM
and	CC	O
falling	VBG	B-PROBLEM
albumin	NN	I-PROBLEM
with	IN	O
dependence	NN	B-PROBLEM
on	IN	I-PROBLEM
transfusion	NN	I-PROBLEM
for	IN	O
support	NN	O
of	IN	O
his	PRP$	B-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
.	.	O

given	VBN	O
his	PRP$	B-PROBLEM
multiple	NN	I-PROBLEM
other	JJ	I-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
the	DT	O
direness	NN	O
of	IN	O
his	PRP$	O
situation	NN	O
,	,	O
and	CC	O
his	PRP$	O
ongoing	JJ	O
substance	NN	O
abuse	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
he	PRP	O
was	VBD	O
deemed	VBN	O
not	RB	O
to	TO	O
be	VB	O
a	DT	O
candidate	NN	O
for	IN	O
a	DT	B-TREATMENT
liver	JJ	I-TREATMENT
transplantation	NN	I-TREATMENT
.	.	O

serum	NN	B-TEST
cocaine	NN	I-TEST
was	VBD	O
positive	JJ	B-PROBLEM
6-12	JJ	O
hours	NNS	O
ingestion	NN	O
at	IN	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
.	.	O

further	RB	O
,	,	O
at	IN	O
ceanotsit	NN	O
ortgold	NN	O
center	NN	O
his	PRP$	B-TEST
serum	NN	I-TEST
toxicology	NN	I-TEST
screens	NNS	I-TEST
were	VBD	O
positive	JJ	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
thought	VBN	O
to	TO	O
be	VB	O
the	DT	O
insighting	NN	O
cause	NN	O
of	IN	O
his	PRP$	B-PROBLEM
massive	JJ	I-PROBLEM
rhabdomyolysis	NN	I-PROBLEM
and	CC	O
hepatic	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

7-pneumonia	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
two	CD	B-PROBLEM
pneumonias	NNS	I-PROBLEM
with	IN	O
two	CD	B-PROBLEM
separate	JJ	I-PROBLEM
organisms	NNS	I-PROBLEM
.	.	O

the	DT	O
first	JJ	O
was	VBD	O
acinetobacter	JJ	B-PROBLEM
calcoaceticus	NN	I-PROBLEM
subspecies	NNS	I-PROBLEM
anitratus	VBP	I-PROBLEM
,	,	O
treated	VBN	O
with	IN	O
ciprofloxacin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

he	PRP	O
subsequently	RB	O
developed	VBD	O
a	DT	B-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
which	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
dosed	VBN	O
to	TO	O
levels	NNS	O
appropriate	VB	O
for	IN	O
his	PRP$	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
service	NN	O
who	WP	O
advised	VBD	O
us	PRP	O
on	IN	O
antibiotic	JJ	B-TREATMENT
choices	NNS	I-TREATMENT
daily	RB	O
.	.	O

8-pancreatitis	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
amylase	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
279	CD	O
with	IN	O
a	DT	B-TEST
lipase	NN	I-TEST
of	IN	O
161	CD	O
.	.	O

although	IN	O
not	RB	O
fully	RB	O
this	DT	O
may	MD	O
have	VB	O
contributed	VBN	O
to	TO	O
his	PRP$	B-PROBLEM
hypocalcemia	NN	I-PROBLEM
and	CC	O
volume	NN	B-PROBLEM
requirements	NNS	I-PROBLEM
.	.	O

9-catheter	JJ	B-PROBLEM
tip	NN	I-PROBLEM
infections	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
grew	VBD	O
out	RP	O
coagulase	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
from	IN	O
the	DT	B-TREATMENT
femoral	JJ	I-TREATMENT
lines	NNS	I-TREATMENT
which	WDT	O
were	VBD	O
placed	VBN	O
during	IN	O
his	PRP$	B-PROBLEM
profound	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

these	DT	O
were	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
.	.	O

10-anemia	JJ	B-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
33%	CD	O
on	IN	O
admission	NN	O
and	CC	O
fell	VBD	O
to	TO	O
28	CD	O
requiring	VBG	O
4	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

11-coma	JJ	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
,	,	O
although	IN	O
initially	RB	O
minimally	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
,	,	O
went	VBD	O
on	IN	O
to	TO	O
develop	VB	O
a	DT	B-PROBLEM
deep	JJ	I-PROBLEM
comatose	NN	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
on	IN	O
admission	NN	O
revealed	VBN	O
no	DT	O
evidence	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
though	IN	O
he	PRP	O
did	VBD	O
have	VB	O
sphenoid	NN	B-PROBLEM
sinusitis	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
and	CC	O
sinus	NN	B-TEST
exploration	NN	I-TEST
were	VBD	O
unable	JJ	O
to	TO	O
be	VB	O
performed	VBN	O
given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
persistent	NN	I-PROBLEM
coagulopathy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
empirically	RB	O
with	IN	O
nafcillin	NN	B-TREATMENT
and	CC	O
ceftriaxone	NN	B-TREATMENT
for	IN	O
meningitis	NN	B-PROBLEM
and	CC	O
sinusitis	NN	B-PROBLEM
.	.	O

further	RB	O
complicating	VBG	O
this	DT	O
was	VBD	O
his	PRP$	B-PROBLEM
profound	NN	I-PROBLEM
liver	VBZ	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
rising	VBG	B-PROBLEM
ammonias	NNS	I-PROBLEM
and	CC	O
hepatic	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

despite	IN	O
maximal	JJ	B-TREATMENT
supports	NNS	I-TREATMENT
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
be	VB	O
hypotensive	JJ	B-PROBLEM
.	.	O

mid-way	NN	O
through	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
he	PRP	O
developed	VBD	O
trilobar	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
this	DT	O
was	VBD	O
probably	RB	O
complicated	VBN	O
further	RB	O
by	IN	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
multi-organ	JJ	I-PROBLEM
system	NN	I-PROBLEM
failure	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
mechanically	RB	B-TREATMENT
ventilated	VBN	I-TREATMENT
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

nevertheless	RB	O
,	,	O
he	PRP	O
developed	VBD	O
refractory	NN	B-PROBLEM
hypoxemia	NN	I-PROBLEM
,	,	O
hypotension	NN	B-PROBLEM
,	,	O
and	CC	O
ultimately	RB	O
the	DT	O
patient	NN	O
died	VBD	O
despite	IN	O
total	JJ	B-TREATMENT
life	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

cocaine	NN	O
intoxication	NN	O
,	,	O
rhabdomyolysis	NN	B-PROBLEM
,	,	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
disseminated	VBD	B-PROBLEM
intravascular	JJ	I-PROBLEM
coagulation	NN	I-PROBLEM
,	,	O
septic	JJ	B-PROBLEM
shock	NN	I-PROBLEM
,	,	O
hepatic	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM
,	,	O
pancreatitis	NN	B-PROBLEM
,	,	O
catheter	NN	B-PROBLEM
tip	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
anemia	NN	B-PROBLEM
,	,	O
coma	NN	B-PROBLEM
.	.	O

peritoneal	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT
,	,	O
peritoneal	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
,	,	O
arterial	JJ	B-TREATMENT
catheterization	NN	I-TREATMENT
,	,	O
venous	JJ	B-TREATMENT
catheterization	NN	I-TREATMENT
,	,	O
continuous	JJ	B-TREATMENT
mechanical	JJ	I-TREATMENT
ventilation	NN	I-TREATMENT
,	,	O
and	CC	O
parenteral	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
.	.	O

neck	NN	B-PROBLEM
hematoma	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
pulmonary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT
requiring	VBG	O
transfusion	NN	B-TREATMENT
,	,	O
catheter	NN	B-PROBLEM
tip	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

1.	CD	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
.	.	O

2.	CD	O
non-st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

3.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

1.	CD	O
persistent	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

2.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

3.	CD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
times	NNS	O
two	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
63	JJ	O
-	:	O
year-old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
and	CC	O
prior	JJ	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
hyperthyroidism	VB	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
left-sided	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
at	IN	O
rest	NN	O
.	.	O

the	DT	O
patient	NN	O
awoke	NN	O
with	IN	O
chest	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
the	DT	O
right	JJ	O
chest	NN	O
associated	VBN	O
with	IN	O
diaphoresis	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
170/108	CD	O
with	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
rapid	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
response	NN	I-PROBLEM
to	TO	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
140s	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
rate	NN	O
controlled	VBN	O
and	CC	O
transferred	VBN	O
to	TO	O
the	DT	O
stillman	NN	O
infirmary	NN	O
for	IN	O
emergent	JJ	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

1.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
hyperthyroidism	NN	B-PROBLEM
,	,	O
initially	RB	O
diagnosed	VBN	O
in	IN	O
2005	CD	O
.	.	O

2.	CD	O
status	NN	O
post	NN	O
current	JJ	O
cardioversion	NN	B-TREATMENT
times	NNS	O
four	CD	O
.	.	O

3.	CD	O
hyperthyroidism	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
radioactive	JJ	B-TREATMENT
iodine	NN	I-TREATMENT
ablation	NN	I-TREATMENT
.	.	O

4.	CD	O
status	NN	O
post	NN	O
carpal	JJ	B-TREATMENT
tunnel	NN	I-TREATMENT
release	NN	I-TREATMENT
.	.	O

5.	CD	O
status	NN	O
post	NN	O
umbilical	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

6.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

1.	CD	O
accupril	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
clonidine	NN	B-TREATMENT
0.1	CD	O
mg	NN	O
b.i.d.	NN	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
well	RB	O
developed	VBN	O
.	.	O

stable	JJ	O
,	,	O
afebrile	JJ	B-PROBLEM
.	.	O

normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
.	.	O

perrl	NN	O
,	,	O
anicteric	JJ	B-PROBLEM
,	,	O
eomi	NN	O
.	.	O

supple	NN	O
,	,	O
midline	NN	O
,	,	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

no	DT	O
bruit	NN	B-PROBLEM
or	CC	O
jvd	NN	B-PROBLEM
.	.	O

irregularly	RB	B-PROBLEM
/	JJ	I-PROBLEM
irregular	NN	I-PROBLEM
without	IN	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
,	,	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
organomegaly	NN	B-PROBLEM
.	.	O

warm	NN	O
,	,	O
noncyanotic	JJ	B-PROBLEM
,	,	O
nonedematous	JJ	B-PROBLEM
times	NNS	O
four	CD	O
.	.	O

cbc	NN	B-TEST
11.3	CD	O
/	NN	O
15.7	CD	O
/	NN	O
44.6	CD	O
/	NN	O
183	CD	O
.	.	O

pt	NN	B-TEST
14	CD	O
,	,	O
inr	NN	B-TEST
1.3	CD	O
,	,	O
ptt	RB	B-TEST
115	CD	O
.	.	O

chemistries	NNS	B-TEST
:	:	O

alt	RB	B-TEST
27	CD	O
,	,	O
ast	RB	B-TEST
21	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
72	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
1.2	CD	O
,	,	O
amylase	NN	B-TEST
47	CD	O
.	.	O

the	DT	B-TEST
u/a	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

emergent	JJ	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
revealed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
45%	CD	O
,	,	O
right	RB	B-PROBLEM
dominant	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
system	NN	I-PROBLEM
with	IN	O
occlusive	JJ	B-PROBLEM
single	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lad	NN	I-PROBLEM
.	.	O

multiple	JJ	B-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
used	VBN	O
to	TO	O
attempt	VB	O
to	TO	O
cross	VB	O
the	DT	B-PROBLEM
total	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
,	,	O
but	CC	O
were	VBD	O
ultimately	RB	O
unsuccessful	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

cardiothoracic	NN	O
surgery	NN	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2010-03-12	JJ	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
times	NNS	O
two	CD	O
;	:	O
lima	NNS	O
to	TO	O
the	DT	O
lad	NN	O
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
diagonal	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
deemed	VBN	O
to	TO	O
be	VB	O
too	RB	B-PROBLEM
lethargic	JJ	I-PROBLEM
and	CC	O
sleepy	NN	B-PROBLEM
to	TO	O
be	VB	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
zero	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
early	RB	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
without	IN	O
significant	JJ	B-PROBLEM
complication	NN	I-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
in	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
ep	JJ	O
service	NN	O
was	VBD	O
consulted	VBN	O
regarding	VBG	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
his	PRP$	B-PROBLEM
main	JJ	I-PROBLEM
issue	NN	I-PROBLEM
in	IN	O
the	DT	O
postoperative	JJ	O
course	NN	O
.	.	O

he	PRP	O
was	VBD	O
attempted	VBN	O
on	IN	O
multiple	JJ	B-TREATMENT
different	JJ	I-TREATMENT
drugs	NNS	I-TREATMENT
including	VBG	O
procainamide	NN	B-TREATMENT
,	,	O
diltiazem	NN	B-TREATMENT
,	,	O
esmolol	NN	B-TREATMENT
,	,	O
sotalol	NN	B-TREATMENT
,	,	O
amiodarone	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
kept	VBN	O
therapeutically	RB	B-TREATMENT
anticoagulated	VBN	I-TREATMENT
throughout	IN	O
this	DT	O
period	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
digoxin	NN	B-TREATMENT
.	.	O

ultimately	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
and	CC	O
anticoagulation	NN	B-TREATMENT
with	IN	O
coumadin	NN	B-TREATMENT
was	VBD	O
begun	VBN	O
.	.	O

the	DT	O
patient	NN	O
arrived	VBD	O
on	IN	O
the	DT	O
floor	NN	O
with	IN	O
medications	NNS	B-TREATMENT
as	IN	O
follows	VBZ	O
:	:	O

sotalol	NN	B-TREATMENT
180	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
diltiazem	VBZ	B-TREATMENT
90	CD	O
mg	NN	O
q.i.d.	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
q.d.	NN	O

while	IN	O
the	DT	O
patient	NN	O
was	VBD	O
awaiting	VBG	O
therapeutic	JJ	B-TREATMENT
anticoagulation	NN	I-TREATMENT
with	IN	O
coumadin	NN	B-TREATMENT
,	,	O
he	PRP	O
spontaneously	RB	O
converted	VBD	O
into	IN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
resting	JJ	I-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
approximately	RB	O
50	CD	O
subsequent	JJ	O
to	TO	O
this	DT	O
.	.	O

in	IN	O
consultation	NN	O
with	IN	O
the	DT	O
ep	NN	O
service	NN	O
,	,	O
diltiazem	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
.	.	O

after	IN	O
approximately	RB	O
24	CD	O
hours	NNS	O
,	,	O
the	DT	O
patient	NN	O
converted	VBD	O
back	RB	O
into	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
diltiazem	NN	B-TREATMENT
was	VBD	O
restarted	VBN	O
at	IN	O
60	CD	O
mg	NNS	O
q.i.d.	NN	O

the	DT	O
patient	NN	O
then	RB	O
had	VBD	O
one	CD	B-PROBLEM
more	JJR	I-PROBLEM
episode	NN	I-PROBLEM
where	WRB	O
he	PRP	O
was	VBD	O
converted	VBN	O
to	TO	O
normal	JJ	O
sinus	JJ	O
rhythm	NN	O
but	CC	O
this	DT	O
lasted	VBD	O
only	RB	O
a	DT	O
few	JJ	O
hours	NNS	O
before	IN	O
reverting	VBG	O
back	RB	O
to	TO	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
ultimately	RB	O
discharged	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
16	CD	O
,	,	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
,	,	O
and	CC	O
adequate	JJ	O
pain	NN	O
control	NN	O
on	IN	O
p.o.	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
having	VBG	O
no	DT	O
anginal	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
2.0	CD	O
.	.	O

the	DT	O
patient	NN	O
failed	VBD	O
multiple	JJ	O
attempts	NNS	O
at	IN	O
cardioversion	NN	B-TREATMENT
.	.	O

inr	NN	B-TEST
2.0.	CD	O

1.	CD	O
percocet	JJ	B-TREATMENT
5/325	CD	O
mg	NN	O
one	CD	O
to	TO	O
two	CD	O
q.	NNS	O
four	CD	O
hours	NNS	O
p.r.n.	VBP	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

4.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
q.d.	NN	O

5.	CD	O
sotalol	JJ	B-TREATMENT
180	CD	O
mg	NN	O
b.i.d.	NN	O

6.	CD	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
q.d.	NN	O

7.	CD	O
diltiazem	JJ	B-TREATMENT
60	CD	O
mg	NN	O
q.i.d.	NN	O

8.	CD	O
ambien	JJ	B-TREATMENT
5-10	JJ	O
mg	NN	O
q.h.s.	NN	O
p.r.n.	NN	O

he	PRP	O
will	MD	O
also	RB	O
go	VB	O
home	NN	O
with	IN	O
vna	NN	O
for	IN	O
inrs	JJ	B-TEST
twice	JJ	O
weekly	RB	O
with	IN	O
the	DT	O
results	NNS	O
reported	VBD	O
to	TO	O
his	PRP$	O
pcp	NN	O
or	CC	O
cardiologist	NN	O
for	IN	O
coumadin	JJ	B-TREATMENT
adjustment	NN	I-TREATMENT
.	.	O

back	RB	B-PROBLEM
pain	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

back	RB	B-PROBLEM
pain	NN	I-PROBLEM

if	IN	O
you	PRP	O
have	VBP	O
any	DT	O
bladder	NN	B-PROBLEM
incontinence	NN	I-PROBLEM
,	,	O
bowel	NN	B-PROBLEM
incontinence	NN	I-PROBLEM
,	,	O
worse	JJR	B-PROBLEM
numbness	NN	I-PROBLEM
,	,	O
any	DT	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	O
other	JJ	B-PROBLEM
concerns	NNS	I-PROBLEM
,	,	O
call	VB	O
your	PRP$	O
doctor	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
immediately	RB	O
.	.	O

blood	NN	B-TEST
type	NN	I-TEST
o+	NN	O
,	,	O
antibody	NN	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
group	NN	B-PROBLEM
beta	VBD	I-PROBLEM
strep	RB	I-PROBLEM
positive	JJ	I-PROBLEM
.	.	O

the	DT	O
pregnancy	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
anemia	NN	B-PROBLEM
.	.	O

mother	NN	O
has	VBZ	O
a	DT	O
prior	JJ	O
history	NN	O
of	IN	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
prolapse	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
prior	JJ	I-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
done	VBN	O
,	,	O
two	CD	O
vaginal	JJ	O
births	NNS	O
after	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

these	DT	O
infants	NNS	O
were	VBD	O
delivered	VBN	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
,	,	O
this	DT	O
twin	NN	O
emerged	VBD	O
with	IN	O
good	JJ	O
tone	NN	O
,	,	O
color	NN	O
,	,	O
and	CC	O
cry	NN	O
.	.	O

apgars	NNS	B-TEST
were	VBD	O
eight	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
nine	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

weight	NN	B-TEST
2.252	CD	O
kg	NN	O
,	,	O
65th	CD	O
percentile;	NN	O
length	NN	B-TEST
46	CD	O
cm	NN	O
,	,	O
50th	CD	O
percentile	NN	O
;	:	O
head	NN	B-TEST
circumference	NN	I-TEST
33	CD	O
cm	NN	O
75th	CD	O
percentile	NN	O
.	.	O

mild	JJ	B-PROBLEM
retractions	NNS	I-PROBLEM
,	,	O
occasional	JJ	B-PROBLEM
grunting	NN	I-PROBLEM
.	.	O

breath	NN	B-TEST
sounds	VBZ	I-TEST
equal	JJ	O
with	IN	O
good	JJ	O
aeration	NN	O
.	.	O

regular	JJ	O
,	,	O
rate	NN	O
,	,	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
+2	VBP	O
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
and	CC	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

raymond	NN	O
required	VBD	O
some	DT	B-TREATMENT
intermittent	JJ	I-TREATMENT
blow-by	JJ	I-TREATMENT
oxygen	NN	I-TREATMENT
for	IN	O
the	DT	O
first	JJ	O
two	CD	O
hours	NNS	O
of	IN	O
birth	NN	O
.	.	O

the	DT	B-PROBLEM
grunting	NN	I-PROBLEM
noted	VBD	O
on	IN	O
admission	NN	O
resolved	VBN	O
within	IN	O
the	DT	O
first	JJ	O
few	JJ	O
hours	NNS	O
after	IN	O
birth	NN	O
.	.	O

he	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	O
episodes	NNS	O
of	IN	O
spontaneous	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
or	CC	O
bradycardia	NN	B-PROBLEM
.	.	O

no	DT	O
murmurs	NNS	B-PROBLEM
were	VBD	O
noted	VBN	O
,	,	O
although	IN	O
normal	JJ	O
heart	NN	O
rates	NNS	O
and	CC	O
blood	NN	O
pressures	NNS	O
.	.	O

enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
on	IN	O
the	DT	O
date	NN	O
of	IN	O
birth	NN	O
and	CC	O
gradually	RB	O
advanced	VBD	O
to	TO	O
full	JJ	O
volume	NN	O
.	.	O

he	PRP	O
required	VBD	O
some	DT	B-TREATMENT
gavage	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
through	IN	O
day	NN	O
of	IN	O
life	NN	O
#4	NNP	O
,	,	O
and	CC	O
has	VBZ	O
been	VBN	O
all	DT	O
po	JJ	O
since	IN	O
day	NN	O
of	IN	O
life	NN	O
#5	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
he	PRP	O
is	VBZ	O
taking	VBG	O
enfamil	JJ	B-TREATMENT
20	CD	I-TREATMENT
calories	NNS	I-TREATMENT
/	JJ	I-TREATMENT
ounce	NN	I-TREATMENT
with	IN	I-TREATMENT
iron	NN	I-TREATMENT
.	.	O

discharge	NN	B-TEST
weight	NN	I-TEST
is	VBZ	O
2.37	CD	O
kg	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
32	CD	O
cm	NN	O
,	,	O
length	VBZ	B-TEST
47	CD	O
cm	NN	O
.	.	O

due	JJ	O
to	TO	O
the	DT	B-PROBLEM
unknown	JJ	I-PROBLEM
group	NN	I-PROBLEM
b	VBD	I-PROBLEM
strep	NN	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
prematurity	NN	B-PROBLEM
,	,	O
raymond	NN	O
was	VBD	O
evaluated	VBN	O
for	IN	O
sepsis	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
13,800	CD	O
with	IN	O
17%	CD	B-TEST
polys	NNS	I-TEST
,	,	O
0%	CD	B-TEST
bands	NNS	I-TEST
.	.	O

a	DT	O
repeat	NN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
,	,	O
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
13,000	CD	O
with	IN	O
50%	CD	B-TEST
polys	NNS	I-TEST
,	,	O
0%	CD	B-TEST
bands	NNS	I-TEST
.	.	O

a	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
obtained	VBD	O
prior	RB	O
to	TO	O
starting	VBG	O
antibiotics	NNS	B-TREATMENT
was	VBD	O
no	DT	O
growth	NN	B-PROBLEM
at	IN	O
48	CD	O
hours	NNS	O
.	.	O

peak	NN	B-TEST
serum	NN	I-TEST
bilirubin	NN	I-TEST
occurred	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#4	NNP	O
,	,	O
a	DT	B-TEST
total	NN	I-TEST
of	IN	O
10.0/0.3	CD	O
direct	JJ	B-TEST
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
bilirubin	NN	I-TEST
on	IN	O
2012-05-19	JJ	O
was	VBD	O
8.0/0.3	CD	O
direct	JJ	B-TEST
.	.	O

hematocrit	NN	B-TEST
at	IN	O
birth	NN	O
was	VBD	O
43.8%.	CD	O

raymond	NN	O
did	VBD	O
not	RB	O
receive	VB	O
any	DT	B-TREATMENT
transfusions	NNS	I-TREATMENT
of	IN	I-TREATMENT
blood	NN	I-TREATMENT
products	NNS	I-TREATMENT
during	IN	O
admission	NN	O
.	.	O

audiology	NN	B-TEST
hearing	VBG	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
.	.	O

adlib	NN	O
po	NN	B-TREATMENT
enfamil	NN	I-TREATMENT
with	IN	I-TREATMENT
iron	NN	I-TREATMENT
.	.	O

2.	CD	O
no	DT	O
medications	NNS	B-TREATMENT
.	.	O

3.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
successfully	RB	O
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#3	NN	O
.	.	O

a	DT	O
report	NN	O
of	IN	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
17-oh	NN	I-PROBLEM
was	VBD	O
called	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
.	.	O

a	DT	B-TEST
subsequent	JJ	I-TEST
sample	NN	I-TEST
was	VBD	O
done	VBN	O
(	(	O
05-21	JJ	O
)	)	O
and	CC	O
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

5.	CD	O
immunizations	NNS	B-TREATMENT
received	VBD	O
:	:	O

hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
was	VBD	O
administered	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
birth	NN	O
on	IN	O
2012-05-13	JJ	O
.	.	O

1.	CD	O
synagis	JJ	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

3)	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
preterm	JJ	B-PROBLEM
infants	NNS	I-PROBLEM
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
once	IN	O
they	PRP	O
reach	VBP	O
six	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
,	,	O
the	DT	O
family	NN	O
and	CC	O
other	JJ	O
caregivers	NNS	O
should	MD	O
be	VB	O
considered	VBN	O
for	IN	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
to	TO	O
protect	VB	O
the	DT	O
infant	NN	O
.	.	O

3.	CD	O
transitional	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

4.	CD	O
suspicion	NN	O
for	IN	O
sepsis	NN	B-PROBLEM
ruled	VBN	O
out	RP	O
.	.	O

s	NN	O
/	NNP	O
p	NN	O
total	JJ	B-TREATMENT
thyoidectomy	NN	I-TREATMENT

rocaltrol	NN	B-TREATMENT
(	(	I-TREATMENT
calcitriol	NN	I-TREATMENT
)	)	I-TREATMENT
0.5	CD	O
mcg	NN	O
po	NN	O
qd	NN	O
starting	VBG	O
today	NN	O
(	(	O
05/31	CD	O
)	)	O

start	NN	O
on	IN	O
day	NN	O
of	IN	O
surgery	NN	B-TREATMENT
and	CC	O
continue	VB	O
throughout	IN	O
hospitalization	NN	O
.	.	O

synthroid	NN	B-TREATMENT
(	(	I-TREATMENT
levothyroxine	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
125	CD	O
mcg	NN	O
po	NN	O
qd	NN	O

oxycodone	RB	B-TREATMENT
5-10	JJ	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
advair	NN	B-TREATMENT
diskus	VBZ	I-TREATMENT
100/50	CD	O
(	(	O
fluticasone	NN	B-TREATMENT
propionate/...	NN	I-TREATMENT
)	)	O
1	CD	O
puff	JJ	O
inh	NN	O
bid	NN	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
2,400	CD	O
mg	NN	O
po	NN	O
qid	NN	O
starting	VBG	O
today	NN	O
(	(	O
05/31	CD	O
)	)	O

nka	JJ	B-PROBLEM
admit	NN	O
diagnosis	NN	O
:	:	O

total	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
s	NN	O
/	NNP	O
p	NN	O
total	JJ	B-TREATMENT
thyoidectomy	NN	I-TREATMENT

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
asthma	RB	B-PROBLEM

05/30/05	CD	O
tland	NN	O
,	,	O
jr	NN	O
,	,	O
votribrendeve	VBP	O
n.	NN	O
,	,	O
m.d.	JJ	O
total	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT

40f	CD	O
with	IN	O
hurtle	NN	B-PROBLEM
cell	NN	I-PROBLEM
tumor	NN	I-PROBLEM
of	IN	I-PROBLEM
thyroid	NN	I-PROBLEM
had	VBD	O
total	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
without	IN	O
complication	NN	B-PROBLEM
.	.	O

pod#	NN	O
1	CD	O
pt	NN	O
was	VBD	O
tolerating	VBG	O
regular	JJ	O
diet	NN	O
,	,	O
ambulating	VBG	O
,	,	O
afebrile	NN	B-PROBLEM
,	,	O
and	CC	O
calcium	NN	B-TEST
was	VBD	O
stable	JJ	O
.	.	O

incicsion	NN	B-PROBLEM
was	VBD	O
clean	JJ	O
dry	JJ	O
and	CC	O
intact	JJ	O
and	CC	O
pt	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
in	IN	O
stable	JJ	O
condition	NN	O

keep	VB	O
incision	NN	B-PROBLEM
clean	JJ	O
and	CC	O
dry	JJ	O
,	,	O
may	MD	O
shower	VB	O
wed	NN	O
.	.	O

do	VB	O
not	RB	O
drive	VB	O
if	IN	O
taking	VBG	O
narcotics	NNS	B-TREATMENT
call	JJ	O
doctor	NN	O
if	IN	O
fever	NN	B-PROBLEM
&gt;	VBP	O
101.5	CD	O
,	,	O
worsening	VBG	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
swelling	VBG	B-PROBLEM
,	,	O
or	CC	O
redness	NN	B-PROBLEM
of	IN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
numbness	NN	B-PROBLEM
or	CC	I-PROBLEM
tingling	NN	I-PROBLEM
in	IN	I-PROBLEM
extremities	NNS	I-PROBLEM
or	CC	O
face	NN	O
or	CC	O
any	DT	O
other	JJ	O
concerns	NNS	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
worsening	NN	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM

coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x	VBD	O
2	CD	O
/	NNP	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
05-08	NN	O

mr.	NN	O
williams	NNP	O
is	VBZ	O
an	DT	O
85	CD	O
yo	NN	O
gentleman	NN	O
who	WP	O
has	VBZ	O
a	DT	B-PROBLEM
known	VBN	I-PROBLEM
cardiac	JJ	I-PROBLEM
history	NN	I-PROBLEM
and	CC	O
has	VBZ	O
had	VBN	O
a	DT	O
h/o	NN	O
worsening	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
showed	VBD	O
an	DT	B-TEST
ef	JJ	I-TEST
40-45%	JJ	O
and	CC	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
which	WDT	O
showed	VBD	O
an	DT	B-PROBLEM
80%	CD	I-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
chronically	RB	B-PROBLEM
occluded	VBD	I-PROBLEM
rca	NN	I-PROBLEM
,	,	O
anneurysmal	JJ	B-PROBLEM
mid	NN	I-PROBLEM
lcx	NN	I-PROBLEM
w/50%	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
refered	VBN	O
to	TO	O
dr.	VB	O
barber	NN	O
for	IN	O
surgical	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

s/p	NN	O
mi	NN	B-PROBLEM
1992	CD	O

as	IN	B-PROBLEM

h/o	NN	O
prostate	NN	B-PROBLEM
ca	MD	I-PROBLEM
s/p	VB	O
brachytherapy	NN	B-TREATMENT
and	CC	O
hormone	NN	B-TREATMENT
treatment	NN	I-TREATMENT

hyperlipidemia	NN	B-PROBLEM

htn	NN	B-PROBLEM

paf	NN	B-PROBLEM
h/o	NN	O
rectal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
s/p	NN	O
cauterization	NN	B-TREATMENT

cholelithiasis	NN	B-PROBLEM

s/p	JJ	O
aaa	NN	B-TREATMENT
repair	NN	I-TREATMENT
'95	POS	O

s/p	JJ	O
bilateral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT

s/p	NN	O
r	NN	B-TREATMENT
lung	NN	I-TREATMENT
surgery	NN	I-TREATMENT

cri	NN	B-PROBLEM

chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM

2017-05-16	JJ	O
06:20	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
8.0	CD	O
rbc	NN	B-TEST
-	:	O
3.35	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
31.0	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
30.7	CD	O
mchc	SYM	B-TEST
-	:	O
33.1	CD	O
rdw	NN	B-TEST
-	:	O
13.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
201	CD	O

2017-05-16	JJ	O
06:20	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
201	CD	O

2017-05-16	JJ	O
06:20	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
19.0	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	O
2.3	CD	O

2017-05-16	JJ	O
09:50	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
118	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
18	CD	O
creat	NN	B-TEST
-	:	O
1.6	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
137	CD	O
k	SYM	B-TEST
-	:	O
5.1	CD	O
cl	NN	B-TEST
-	:	O
98	CD	O
hco3	NN	B-TEST
-	:	O
29	CD	O
angap	NN	B-TEST
-	:	O
15	CD	O

mr.	NN	O
williams	NNS	O
was	VBD	O
admitted	VBN	O
to	TO	O
hallmark	VB	O
health	NN	O
system	NN	O
on	IN	O
05-08	NN	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
with	IN	O
dr.	JJ	O
barber	NN	O
for	IN	O
a	DT	B-TREATMENT
cabgx2	NN	I-TREATMENT
and	CC	O
avr	NN	B-TREATMENT
w/	VBP	O
25	CD	B-TREATMENT
mm	JJ	I-TREATMENT
pericardial	JJ	I-TREATMENT
valve	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
weaned	VBN	O
and	CC	O
extubated	VBN	O
from	IN	O
mechanical	JJ	B-TREATMENT
ventillation	NN	I-TREATMENT
on	IN	O
pod#1	NN	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

he	PRP	O
developed	VBD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
on	IN	O
pod#2	NN	O
with	IN	O
well	RB	O
controlled	VBN	O
rate	NN	O
and	CC	O
hemodynamically	RB	O
stable	JJ	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
and	CC	O
coumadin	NN	B-TREATMENT
for	IN	O
anticoagulation	NN	B-TREATMENT
on	IN	O
pod#5	NN	O
.	.	O

lasix	RB	B-TREATMENT
40	CD	O
mg	JJ	O
q	CD	O
m-w-f	NN	O

klorcon	NN	B-TREATMENT
10	CD	O
meq	NN	O
q	CD	O
m-w-f	NN	O

pepcid	NN	B-TREATMENT
40	CD	O
mg	NN	O
qd	NN	O

colexa	NN	B-TREATMENT
10	CD	O
mg	NN	O
qd	NN	O

metoprolol	NN	B-TREATMENT
50	CD	O
mg	NN	O
bid	NN	O

lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
qd	NN	O

aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
qd	NN	O

flovent	JJ	B-TREATMENT
110	CD	O
mcg	JJ	O
inhaler	NN	O
bid	NN	O

atrovent	JJ	B-TREATMENT
inhaler	NN	I-TREATMENT
tid	NN	O

1.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
fluticasone	NN	B-TREATMENT
propionate	NN	I-TREATMENT
110	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
puff	NN	O
inhalation	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
oxycodone	CD	B-TREATMENT
-	:	I-TREATMENT
acetaminophen	NN	I-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
ipratropium	NN	B-TREATMENT
bromide	NN	I-TREATMENT
18	CD	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
puff	NN	O
inhalation	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

7.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
bacitracin	NN	B-TREATMENT
zinc	NN	I-TREATMENT
500	CD	O
unit	NN	O
/	NNP	O
g	NN	O
ointment	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
celexa	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

11.	CD	O
warfarin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
1	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
five	CD	O
(	(	O
5	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
take	VB	O
5	CD	O
mg	NNS	O
on	IN	O
04-18	NN	O
.	.	O

12.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q	JJ	O
m-w-f	NN	O
.	.	O

13.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
q	JJ	O
m-w-f	NN	O
.	.	O

14.	CD	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
as	IN	O
directed	VBN	O
for	IN	O
goal	NN	B-TEST
inr	CD	I-TEST
2.0-2.5.	JJ	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

hyperlipidemia	NN	B-PROBLEM
.	.	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM

shower	JJR	O
daily	JJ	O
and	CC	O
wash	JJ	O
incisions	NNS	B-PROBLEM
with	IN	O
soap	NN	O
and	CC	O
water	NN	O
.	.	O

10%	CD	B-PROBLEM
body	NN	I-PROBLEM
burns	NNS	I-PROBLEM

(1)	JJ	O
third	JJ	B-PROBLEM
degree	NN	I-PROBLEM
burn	NN	I-PROBLEM
to	TO	I-PROBLEM
right	JJ	I-PROBLEM
hand	NN	I-PROBLEM
and	CC	I-PROBLEM
forearm	NN	I-PROBLEM

(2)	JJ	O
second	JJ	B-PROBLEM
degree	NN	I-PROBLEM
burn	NN	I-PROBLEM
to	TO	I-PROBLEM
face	NN	I-PROBLEM
procedure	NN	O
:	:	O

debridement	NN	B-TREATMENT
of	IN	O
burn	NN	B-PROBLEM
and	CC	O
application	NN	B-TREATMENT
of	IN	I-TREATMENT
artificial	JJ	I-TREATMENT
skin	NN	I-TREATMENT

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
59	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
who	WP	O
experienced	VBD	O
a	DT	B-PROBLEM
flash	JJ	I-PROBLEM
burn	NN	I-PROBLEM
from	IN	O
grease	NN	O
while	IN	O
working	VBG	O
on	IN	O
a	DT	O
stove	NN	O
on	IN	O
the	DT	O
night	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

the	DT	O
patient	NN	O
at	IN	O
that	DT	O
time	NN	O
treated	VBD	O
himself	PRP	O
symptomatically	RB	O
at	IN	O
home	NN	O
but	CC	O
presented	VBD	O
to	TO	O
roing	VBG	O
hospital	NN	O
on	IN	O
the	DT	O
day	NN	O
after	IN	O
the	DT	O
event	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
nimaconwood	NN	O
valley	NN	O
hospital	NN	O
immediately	RB	O
for	IN	O
evaluation	NN	B-TEST
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
extensive	JJ	I-PROBLEM
burns	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
walking	VBG	O
,	,	O
talking	VBG	O
,	,	O
and	CC	O
was	VBD	O
breathing	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
on	IN	O
arrival	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

99%	CD	O
saturation	NN	B-TEST
on	IN	O
room	NN	O
air	NN	O
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
76	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
169/100	CD	O
.	.	O

other	JJ	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
not	RB	O
anxious	JJ	O
or	CC	O
ill-appearing	JJ	B-PROBLEM
.	.	O

extensive	JJ	B-PROBLEM
first	JJ	I-PROBLEM
degree	NN	I-PROBLEM
and	CC	I-PROBLEM
second	JJ	I-PROBLEM
degree	NN	I-PROBLEM
burns	NNS	I-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
face	NN	I-PROBLEM
,	,	O
superficial	JJ	O
in	IN	O
nature	NN	O
,	,	O
with	IN	O
no	DT	O
blistering	NN	B-PROBLEM
.	.	O

his	PRP$	O
oropharynx	NN	O
was	VBD	O
wide	JJ	O
open	JJ	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
burn	NN	B-PROBLEM
.	.	O

lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

third	JJ	B-PROBLEM
degree	JJ	I-PROBLEM
burn	NN	I-PROBLEM
on	IN	I-PROBLEM
dorsum	NN	I-PROBLEM
of	IN	O
forearm	NN	O
and	CC	O
on	IN	O
dorsum	NN	O
of	IN	O
hand	NN	O
with	IN	O
extensive	JJ	B-PROBLEM
second	JJ	I-PROBLEM
degree	NN	I-PROBLEM
burn	NN	I-PROBLEM
around	IN	O
the	DT	O
remainder	NN	O
of	IN	O
his	PRP$	O
hand	NN	O
circumferentially	RB	O
and	CC	O
on	IN	O
his	PRP$	O
forearm	NN	O
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
compartment	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

evaluation	NN	B-TEST
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
revealed	VBD	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
stable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
ophthalmology	NN	O
who	WP	O
also	RB	O
felt	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
injury	NN	B-PROBLEM
to	TO	I-PROBLEM
his	PRP$	I-PROBLEM
eyes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
from	IN	O
the	DT	O
emergency	NN	O
room	NN	O
and	CC	O
transferred	VBD	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
airway	JJ	B-TEST
observation	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
three	CD	O
liters	NNS	O
of	IN	O
iv	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
with	IN	O
good	JJ	O
urine	NN	O
output	NN	O
response	NN	O
.	.	O

his	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
were	VBD	O
dressed	VBN	O
with	IN	O
antiointment	NN	B-TREATMENT
and	CC	O
xeroform	NN	B-TREATMENT
with	IN	O
the	DT	O
plan	NN	O
to	TO	O
take	VB	O
him	PRP	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
debridement	NN	B-TREATMENT
under	IN	O
general	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
and	CC	O
application	NN	B-TREATMENT
of	IN	I-TREATMENT
artificial	JJ	I-TREATMENT
skin	NN	I-TREATMENT
.	.	O

while	IN	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
the	DT	O
patient	NN	O
was	VBD	O
put	VBN	O
on	IN	O
delirium	NN	B-TREATMENT
tremons	NNS	I-TREATMENT
prophylaxis	VBP	I-TREATMENT
with	IN	O
serax	NN	B-TREATMENT
around	IN	O
the	DT	O
clock	NN	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
the	DT	O
patient	JJ	O
underwent	JJ	O
debridement	NN	B-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
facial	JJ	I-PROBLEM
wounds	NNS	I-PROBLEM
and	CC	O
debridement	NN	B-TREATMENT
of	IN	I-TREATMENT
his	PRP$	I-TREATMENT
right	JJ	I-TREATMENT
hand	NN	I-TREATMENT
and	CC	I-TREATMENT
forearm	NN	I-TREATMENT
with	IN	O
application	NN	B-TREATMENT
of	IN	I-TREATMENT
artificial	JJ	I-TREATMENT
skin	NN	I-TREATMENT
which	WDT	O
is	VBZ	O
the	DT	O
dermagraft	NN	B-TREATMENT
tc	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

postoperatively	RB	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
out	IN	O
of	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
to	TO	O
the	DT	O
burn	NN	O
floor	NN	O
where	WRB	O
he	PRP	O
received	VBD	O
dressing	VBG	B-TREATMENT
changes	NNS	I-TREATMENT
p.r.n.	VBP	O

the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
other	JJ	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NN	I-TREATMENT
dressing	NN	I-TREATMENT
was	VBD	O
taken	VBN	O
down	RP	O
completely	RB	O
and	CC	O
evaluation	NN	B-TEST
of	IN	O
the	DT	B-TREATMENT
derma	NN	I-TREATMENT
graft	NN	I-TREATMENT
was	VBD	O
made	VBN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
folate	VBP	B-TREATMENT
1	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
artificial	JJ	B-TREATMENT
tears	NNS	I-TREATMENT
2	CD	O
drops	NNS	O
each	DT	O
eye	NN	O
b.i.d.	NN	O
and	CC	O
p.r.n.	NN	O
,	,	O
serax	VBD	B-TREATMENT
15	CD	O
mg	NN	O
p.o.	NN	O
q6h	SYM	O
-	:	O
hold	NN	O
if	IN	O
patient	JJ	O
excessively	RB	B-PROBLEM
sleepy	JJ	I-PROBLEM
,	,	O
thiamine	JJ	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
ms	SYM	B-TREATMENT
-	:	I-TREATMENT
contin	NN	I-TREATMENT
30	CD	O
mg	NN	O
p.o.b.i.d.	NN	O
,	,	O
multivitamin	NN	B-TREATMENT
q.d.	NN	O
,	,	O
msir	FW	B-TREATMENT
15	CD	O
mg	NN	O
p.o.	NN	O
q3-4h	JJ	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
,	,	O
and	CC	O
axid	RB	B-TREATMENT
150	CD	O
mg	NNS	O
p.o.	JJ	O
b.i.d.	NN	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
undergo	VB	O
dry	JJ	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
and	CC	O
splint	NN	B-TREATMENT
to	TO	I-TREATMENT
his	PRP$	I-TREATMENT
right	JJ	I-TREATMENT
arm	NN	I-TREATMENT
q.d.	NN	O

codeine	NN	B-TREATMENT
/	''	O
shellfish	JJ	O
/	NN	O
ciprofloxacin	NN	B-TREATMENT

exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O

2013-10-21	JJ	O
cabg	NN	B-TREATMENT
x	$	O
3	CD	O
(	(	O
lima	JJ	O
->	NNP	O
lad	NN	O
,	,	O
svg	JJ	O
->	NNP	O
om	NN	O
,	,	O
svg	JJ	O
->	NNP	O
pda	NN	O
)	)	O

this	DT	O
is	VBZ	O
an	DT	O
85	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
prior	JJ	O
history	NN	O
of	IN	O
non-hodgkins	JJ	B-PROBLEM
lymphoma	NN	I-PROBLEM
,	,	O
s/p	JJ	O
cytoxan	NN	B-TREATMENT
in	IN	O
2003	CD	O
a	DT	O
with	IN	O
recurrence	NN	B-PROBLEM
in	IN	O
2009	CD	O
.	.	O

follow	VB	B-TEST
up	RP	I-TEST
examinations	NNS	I-TEST
have	VBP	O
found	VBN	O
a	DT	B-PROBLEM
suspicious	JJ	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
finding	VBG	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
workup	NN	I-TEST
prior	RB	O
to	TO	O
left	VB	B-TREATMENT
lower	JJR	I-TREATMENT
lobe	NN	I-TREATMENT
resection	NN	I-TREATMENT
led	VBD	O
to	TO	O
cardiac	VB	B-TEST
catheterization	NN	I-TEST
which	WDT	O
found	VBD	O
severe	RB	B-PROBLEM
three	CD	I-PROBLEM
vessel	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
04-05+	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

she	PRP	O
now	RB	O
present	VBP	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

non-hodgkins	NNS	B-PROBLEM
lymphoma	SYM	I-PROBLEM
-	:	O
s/p	NN	O
cytoxan	NN	B-TREATMENT
in	IN	O
2003	CD	O
and	CC	O
2001	CD	O
,	,	O
history	NN	O
of	IN	O
varicella	NN	B-PROBLEM
zoster	NN	I-PROBLEM
with	IN	O
opthalmic	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
menieres	NNS	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
gerd	NN	B-PROBLEM
,	,	O
glaucoma	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
sinusitis	NN	I-PROBLEM
,	,	O
s/p	JJ	O
cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
s/p	NN	O
tah	NN	B-TREATMENT
and	CC	O
bso	NN	B-TREATMENT
,	,	O
s/p	JJ	O
appendectomy	NN	B-TREATMENT
,	,	O
s/p	JJ	O
bilateral	JJ	B-TREATMENT
breast	NN	I-TREATMENT
reduction	NN	I-TREATMENT

daughter	NN	O
died	VBD	O
of	IN	O
mi	NN	B-PROBLEM
at	IN	O
age	NN	O
49	CD	O
.	.	O

vitals	NNS	B-TEST
:	:	O

bp	JJ	B-TEST
160-170/80-84	CD	O
,	,	O
hr	VBZ	B-TEST
82	CD	O
,	,	O
resp	VBD	B-TEST
20	CD	O

elderly	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM

supple	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM
,	,	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM

regular	JJ	O
rate	NN	O
,	,	O
04-07	JJ	O
holosystolic	NN	B-PROBLEM
murmur	NN	I-PROBLEM

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM

warm	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM

pulses	NNS	B-TEST
:	:	O

2013-10-29	JJ	O
06:10	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
10.9	CD	O
rbc	NN	B-TEST
-	:	O
3.99	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.6	CD	O
hct	NN	B-TEST
-	:	O
37.9	CD	O
mcv	SYM	B-TEST
-	:	O
95	CD	O
mch	SYM	B-TEST
-	:	O
31.5	CD	O
mchc	SYM	B-TEST
-	:	O
33.2	CD	O
rdw	NN	B-TEST
-	:	O
13.9	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
330	CD	O
#	#	O

2013-10-29	JJ	O
06:10	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
76	CD	O
urean	JJ	B-TEST
-	:	O
12	CD	O
creat	NN	B-TEST
-	:	O
0.9	CD	O
na	SYM	B-TEST
-	:	O
141	CD	O
k	SYM	B-TEST
-	:	O
3.5	CD	O
cl	NN	B-TEST
-	:	O
104	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
15	CD	O

2013-10-30	JJ	O
06:28	CD	O
am	VBP	O
blood	NN	B-TEST
phenyto	NN	B-TEST
-	:	O
5.5	CD	O
*	NN	O

mrs.	NN	O
mandelbaum	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
underwent	JJ	O
three	CD	B-TREATMENT
vessel	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
by	IN	O
dr.	NN	O
larry	NN	O
mckinney	NN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
intraoperative	JJ	B-TEST
transesophageal	NN	I-TEST
echocardiogram	NN	I-TEST
evaluation	NN	I-TEST
showed	VBD	O
only	RB	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
so	IN	O
no	DT	O
repair/replacement	NN	B-TREATMENT
was	VBD	O
indicated	VBN	O
.	.	O

following	VBG	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
csru	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
one	CD	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
largely	RB	B-PROBLEM
unresponsive	JJ	I-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
hemiparesis	NN	I-PROBLEM
.	.	O

restlessness	NN	B-PROBLEM
with	IN	O
body	NN	B-PROBLEM
tremors	NNS	I-PROBLEM
were	VBD	O
also	RB	O
noted	VBN	O
.	.	O

a	DT	B-TEST
stat	NN	I-TEST
mri	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
multiple	JJ	B-PROBLEM
abnormal	JJ	I-PROBLEM
foci	NN	I-PROBLEM
consistent	NN	O
with	IN	O
systemic	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

the	DT	O
neurology	NN	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
attributed	VBN	O
these	DT	O
findings	NNS	O
to	TO	O
cholesterol	VB	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

due	JJ	O
to	TO	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
,	,	O
dilantin	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

anticoagulation	NN	B-TREATMENT
was	VBD	O
not	RB	O
recommended	VBN	O
.	.	O

she	PRP	O
was	VBD	O
eventually	RB	O
extubated	VBN	O
without	IN	O
incident	NN	B-PROBLEM
.	.	O

she	PRP	O
went	VBD	O
on	IN	O
to	TO	O
experience	VB	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
which	WDT	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
amiodarone	NN	I-TREATMENT
.	.	O

she	PRP	O
concomitantly	RB	O
had	VBD	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
which	WDT	O
were	VBD	O
c.	NNS	B-TEST
diff	JJ	I-TEST
negative	JJ	O
.	.	O

she	PRP	O
remained	VBD	O
mostly	RB	O
in	IN	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
and	CC	O
transitioned	VBD	O
to	TO	O
oral	VB	B-TREATMENT
amiodarone	NN	I-TREATMENT
which	WDT	O
will	MD	O
need	VB	O
to	TO	O
continue	VB	O
for	IN	O
three	CD	O
months	NNS	O
postop	RB	O
.	.	O

she	PRP	O
tolerated	VBD	O
beta	NN	B-TREATMENT
blockade	NN	I-TREATMENT
which	WDT	O
was	VBD	O
slowly	RB	O
advanced	JJ	O
as	IN	O
tolerated	VBN	O
.	.	O

acyclovir	NN	B-TREATMENT
was	VBD	O
eventually	RB	O
increased	VBN	O
from	IN	O
her	PRP$	B-TREATMENT
maintenance	NN	I-TREATMENT
dose	NN	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
herpes	NNS	I-PROBLEM
zoster	NN	I-PROBLEM
breakout	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
back	RB	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
was	VBD	O
empirically	RB	O
started	VBN	O
on	IN	O
flagyl	NN	B-TREATMENT
for	IN	O
persistent	JJ	B-PROBLEM
diarrhea	NN	I-PROBLEM
(	(	O
despite	IN	O
negative	JJ	O
c.	NN	O
diff	NN	O
cultures	NNS	O
)	)	O
,	,	O
however	RB	O
she	PRP	O
developed	VBD	O
an	DT	B-PROBLEM
additional	JJ	I-PROBLEM
rash	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
buttocks	NNS	I-PROBLEM
after	IN	O
the	DT	O
first	JJ	O
dose	NN	O
of	IN	O
flagyl	NN	B-TREATMENT
,	,	O
so	IN	O
the	DT	B-TREATMENT
flagyl	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
bactrim	NN	B-TREATMENT
.	.	O

a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
inserted	VBN	O
given	VBN	O
her	PRP$	O
mutiple	JJ	O
episodes	NNS	O
of	IN	O
incontinence	NN	B-PROBLEM
that	WDT	O
were	VBD	O
adding	VBG	O
to	TO	O
skin	VB	B-PROBLEM
irritation	NN	I-PROBLEM
.	.	O

on	IN	O
insertion	NN	B-TREATMENT
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
retaining	VBG	O
1400	CD	O
cc	NN	O
of	IN	O
urine	NN	O
,	,	O
so	IN	O
the	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
left	VBN	O
in	IN	O
.	.	O

acyclovir	RB	B-TREATMENT
800	CD	O
qd	NN	O
,	,	O
nexium	JJ	B-TREATMENT
40	CD	O
qd	NN	O
,	,	O
lipitor	NN	B-TREATMENT
40	CD	O
qd	NN	O
,	,	O
coreg	JJ	B-TREATMENT
6.25	CD	O
bid	NN	O
,	,	O
asa	VBZ	B-TREATMENT
81	CD	O
qd	NN	O
,	,	O
timolol	NN	B-TREATMENT
cmed	VBD	I-TREATMENT
csru	JJ	I-TREATMENT
gtts	NN	I-TREATMENT
,	,	O
calcium	NN	B-TREATMENT
,	,	O
mvi	NN	B-TREATMENT
,	,	O
vitamin	FW	B-TREATMENT
c	NN	I-TREATMENT

1.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
fever	NN	B-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
.	.	O

2.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
phenytoin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
extended	VBD	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

6.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
7	CD	O
days	NNS	O
:	:	O
400	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O
for	IN	O
1	CD	O
week	NN	O
,	,	O
then	RB	O
decrease	NN	O
to	TO	O
200	CD	O
mg	NNS	O
po	JJ	O
daily	RB	O
.	.	O

7.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

8.	CD	O
acyclovir	JJ	B-TREATMENT
800	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
5x/d	CD	O
(	(	O
5	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
5	CD	O
days	NNS	O
:	:	O
then	RB	O
decrease	VB	O
dose	NN	O
to	TO	O
800	CD	O
mg	NNS	O
po	JJ	O
daily	RB	O
.	.	O

9.	CD	O
lipitor	NN	B-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
packet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
packet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

11.	CD	O
trimethoprim	JJ	B-TREATMENT
-	:	I-TREATMENT
sulfamethoxazole	JJ	I-TREATMENT
160-800	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

12.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
powder	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
-	:	O
s/p	NN	O
cabg	NN	B-TREATMENT

varicella	NN	B-PROBLEM
zoster	NN	I-PROBLEM

postop	NN	B-PROBLEM
cva	NN	I-PROBLEM

postop	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM

follow	JJ	O
medications	NNS	B-TREATMENT
on	IN	O
discharge	NN	O
instructions	NNS	O
.	.	O

call	VB	O
our	PRP$	O
office	NN	O
for	IN	O
sternal	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
,	,	O
temp	EX	B-PROBLEM
>	VBZ	O
101.5	CD	O

no	DT	O
lotions	NNS	O
,	,	O
creams	NNS	O
,	,	O
or	CC	O
powders	NNS	O
on	IN	O
wounds	NNS	B-PROBLEM
.	.	O

severe	JJ	B-PROBLEM
blunt	NN	I-PROBLEM
abdominal	JJ	I-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

severe	JJ	B-PROBLEM
blunt	NN	I-PROBLEM
abdominal	JJ	I-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

1.	CD	O
grade	NN	B-PROBLEM
ii	NN	I-PROBLEM
/	NNP	I-PROBLEM
v	NN	I-PROBLEM
laceration	NN	I-PROBLEM
of	IN	I-PROBLEM
liver	NN	I-PROBLEM
,	,	O

2.	CD	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
,	,	O

3.	CD	O
tear	NN	B-PROBLEM
of	IN	I-PROBLEM
transverse	NN	I-PROBLEM
mesocolon	NN	I-PROBLEM
,	,	O

4.	CD	O
serosal	JJ	B-PROBLEM
tear	NN	I-PROBLEM
of	IN	I-PROBLEM
transverse	NN	I-PROBLEM
colon	NN	I-PROBLEM
,	,	O

5.	CD	O
blunt	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	O
the	DT	O
neck	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
awake	RB	O
at	IN	O
the	DT	O
scene	NN	O
,	,	O
complaining	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
60	CD	O
systolic	JJ	O
upon	IN	O
arrival	NN	O
of	IN	O
the	DT	O
giles	NNS	O
min	VBP	O
general	JJ	O
hospital	NN	O
crew	NN	O
.	.	O

intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
was	VBD	O
given	VBN	O
.	.	O

he	PRP	O
was	VBD	O
paralyzed	VBN	B-PROBLEM
and	CC	O
endotracheally	RB	O
intubated	VBN	O
,	,	O
and	CC	O
a	DT	B-TREATMENT
14	CD	I-TREATMENT
gauge	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
inserted	VBN	O
in	IN	O
his	PRP$	O
left	JJ	O
chest	NN	O
because	IN	O
of	IN	O
poor	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

he	PRP	O
arrived	VBD	O
at	IN	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
at	IN	O
02:30	CD	O
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
86	CD	O
and	CC	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
170	CD	O
.	.	O

large	JJ	B-TREATMENT
bore	NN	I-TREATMENT
cannulas	NNS	I-TREATMENT
were	VBD	O
inserted	VBN	O
into	IN	O
the	DT	O
femoral	JJ	O
veins	NNS	O
,	,	O
bilateral	JJ	B-TREATMENT
chest	NN	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
,	,	O
and	CC	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
rose	VBD	O
to	TO	O
110	CD	O
systolic	NNS	O
after	IN	O
two	CD	O
liters	NNS	O
of	IN	O
crystalloid	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
an	DT	B-PROBLEM
ecchymosis	NN	I-PROBLEM
over	IN	O
the	DT	O
medial	JJ	O
right	JJ	O
costal	NN	O
margin	NN	O
and	CC	O
his	PRP$	O
abdomen	NNS	O
was	VBD	O
distended	VBN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
36	CD	O
,	,	O
and	CC	O
creatinine	NN	B-TEST
1.6	CD	O
.	.	O

the	DT	B-TEST
abdominal	JJ	I-TEST
tap	NN	I-TEST
was	VBD	O
grossly	RB	B-PROBLEM
positive	JJ	I-PROBLEM
for	IN	I-PROBLEM
blood	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
fell	VBD	O
to	TO	O
60	CD	O
systolic	NN	O
as	IN	O
he	PRP	O
was	VBD	O
being	VBG	O
transferred	VBN	O
to	TO	O
the	DT	O
computerized	JJ	O
tomography	NN	O
scan	JJ	O
table	NN	O
;	:	O
the	DT	B-TEST
scan	NN	I-TEST
was	VBD	O
aborted	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
taken	VBN	O
directly	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
at	IN	O
03:00	CD	O
.	.	O

at	IN	O
laparotomy	NN	B-TREATMENT
,	,	O
there	EX	O
was	VBD	O
a	DT	O
liter	NN	O
of	IN	O
blood	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
peritoneal	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
class	NN	I-PROBLEM
ii	NN	I-PROBLEM
laceration	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
liver	NN	I-PROBLEM
at	IN	O
the	DT	O
falciform	NN	O
ligament	NN	O
which	WDT	O
was	VBD	O
actively	RB	O
bleeding	VBG	O
,	,	O
a	DT	B-PROBLEM
tear	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
transverse	NN	I-PROBLEM
mesocolon	NN	I-PROBLEM
from	IN	O
its	PRP$	O
base	NN	O
to	TO	O
the	DT	O
bowel	NN	O
wall	NN	O
with	IN	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
7	CD	I-PROBLEM
cm	NN	I-PROBLEM
serosal	NN	I-PROBLEM
tear	IN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
adjacent	JJ	I-PROBLEM
transverse	NN	I-PROBLEM
colon	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
central	JJ	I-PROBLEM
retroperitoneal	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

control	NN	O
of	IN	O
the	DT	O
super-celiac	JJ	O
aorta	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
both	DT	O
left	VBD	B-TREATMENT
and	CC	I-TREATMENT
right	RB	I-TREATMENT
sided	VBD	I-TREATMENT
&quot;	NNP	I-TREATMENT
mattox	NN	I-TREATMENT
&quot;	NN	I-TREATMENT
maneuvers	NNS	I-TREATMENT
were	VBD	O
performed	VBN	O
.	.	O

the	DT	O
retroperitoneum	NN	O
was	VBD	O
opened	VBN	O
,	,	O
with	IN	O
vigorous	JJ	B-PROBLEM
bleeding	VBG	I-PROBLEM
resulting	VBG	O
.	.	O

this	DT	O
was	VBD	O
controlled	VBN	O
,	,	O
necessitating	VBG	O
ten	JJ	O
minutes	NNS	O
of	IN	O
aortic	JJ	B-TREATMENT
clamping	NN	I-TREATMENT
and	CC	O
found	VBN	O
to	TO	O
have	VB	O
originated	VBN	O
from	IN	O
the	DT	B-PROBLEM
rupture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
one	CD	O
centimeter	NN	O
from	IN	O
its	PRP$	O
junction	NN	O
with	IN	O
the	DT	O
inferior	JJ	O
vena	NN	O
cava	NN	O
.	.	O

the	DT	O
vein	NN	O
was	VBD	O
divided	VBN	O
and	CC	O
suture	NN	B-TREATMENT
ligated	VBN	O
.	.	O

bleeding	VBG	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
sutures	NNS	B-TREATMENT
.	.	O

the	DT	B-PROBLEM
tears	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
transverse	NN	I-PROBLEM
mesocolon	NN	I-PROBLEM
and	CC	I-PROBLEM
colon	NN	I-PROBLEM
serosa	NN	I-PROBLEM
were	VBD	O
repaired	VBN	O
.	.	O

the	DT	B-TEST
examination	NN	I-TEST
of	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
abdominal	JJ	O
contents	NNS	O
revealed	VBD	O
no	DT	O
other	JJ	B-PROBLEM
injury	NN	I-PROBLEM
;	:	O
in	IN	O
particular	JJ	O
,	,	O
the	DT	O
entire	JJ	O
anterior	JJ	O
surface	NN	O
and	CC	O
the	DT	O
immediately	RB	O
juxtaduodenal	JJ	O
posterior	JJ	O
surface	NN	O
of	IN	O
the	DT	O
pancreas	NNS	O
were	VBD	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
received	VBN	O
ten	JJ	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
five	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
seven	CD	O
units	NNS	O
of	IN	O
platelets	NNS	B-TREATMENT
,	,	O
and	CC	O
nine	CD	O
liters	NNS	O
of	IN	O
ringer	NN	B-TREATMENT
&apos;s	NNP	I-TREATMENT
lactate	NN	I-TREATMENT
.	.	O

an	DT	B-TEST
intracranial	JJ	I-TEST
pressure	NN	I-TEST
monitoring	NN	I-TEST
bolt	NN	I-TEST
had	VBD	O
been	VBN	O
placed	VBN	O
by	IN	O
the	DT	O
neurosurgery	JJ	O
service	NN	O
staff	NN	O
during	IN	O
the	DT	B-TREATMENT
laparotomy	NN	I-TREATMENT
.	.	O

intracranial	JJ	B-TEST
pressures	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

that	DT	O
day	NN	O
,	,	O
cranial	JJ	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	JJ	I-TEST
and	CC	O
cervical	JJ	B-TEST
spine	NN	I-TEST
films	NNS	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

an	DT	B-TEST
arch	NN	I-TEST
aortogram	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

over	IN	O
the	DT	O
ensuing	VBG	O
twenty-four	JJ	O
hours	NNS	O
,	,	O
bilateral	JJ	B-PROBLEM
infiltrates	NNS	I-PROBLEM
on	IN	O
chest	JJS	B-TEST
x-ray	JJ	I-TEST
with	IN	O
poor	JJ	B-PROBLEM
oxygenation	NN	I-PROBLEM
and	CC	O
labile	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
requiring	VBG	O
pa	JJ	B-TREATMENT
line	NN	I-TREATMENT
guided	VBN	I-TREATMENT
fluid	NN	I-TREATMENT
and	CC	O
pressors	NNS	B-TREATMENT
developed	VBD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
requirement	NN	I-PROBLEM
with	IN	O
total	JJ	B-PROBLEM
body	NN	I-PROBLEM
capillary	JJ	I-PROBLEM
leak	NN	I-PROBLEM
,	,	O
decreasing	VBG	B-PROBLEM
svr	NN	I-PROBLEM
,	,	O
oliguria	RB	B-PROBLEM
unresponsive	JJ	O
to	TO	O
lasix	VB	B-TREATMENT
/	NNP	O
mannitol	NNP	B-TREATMENT
accompanied	VBN	O
by	IN	O
a	DT	B-PROBLEM
rise	NN	I-PROBLEM
in	IN	O
creatinine	NN	B-TEST
to	TO	O
3.2	CD	O
,	,	O
worsening	VBG	B-PROBLEM
ards	NNS	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
rise	NN	I-PROBLEM
in	IN	O
temperature	NN	B-TEST
to	TO	O
103	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
serum	JJ	I-TEST
amylase	NN	I-TEST
of	IN	O
1265	CD	O
.	.	O

three	CD	O
liters	NNS	O
of	IN	O
clear	JJ	B-PROBLEM
green	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
were	VBD	O
found	VBN	O
in	IN	O
the	DT	O
abdominal	JJ	O
cavity	NN	O
.	.	O

exploration	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
pancreas	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
posterior	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
a	DT	I-PROBLEM
the	DT	I-PROBLEM
superior	JJ	I-PROBLEM
mesenteric	NN	I-PROBLEM
vessels	NNS	I-PROBLEM
.	.	O

because	IN	O
of	IN	O
the	DT	B-PROBLEM
intense	JJ	I-PROBLEM
diffuse	NN	I-PROBLEM
inflammatory	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
that	WDT	O
had	VBD	O
already	RB	O
set	VBN	O
in	IN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
neither	DT	O
distal	JJ	B-TREATMENT
pancreatic	JJ	I-TREATMENT
resection	NN	I-TREATMENT
nor	CC	O
roux-en-y	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
was	VBD	O
feasible	JJ	O
.	.	O

four	CD	B-TREATMENT
large	JJ	I-TREATMENT
flat	JJ	I-TREATMENT
jackson-pratt	NN	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
,	,	O
and	CC	O
gastrostomy	NN	B-TREATMENT
,	,	O
jejunostomy	NN	B-TREATMENT
,	,	O
and	CC	O
cholecystostomy	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
subclavian	JJ	I-TREATMENT
quinton	NN	I-TREATMENT
catheter	NN	I-TREATMENT
were	VBD	O
placed	VBN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NN	O
hemodynamics	NNS	O
had	VBD	O
improved	VBN	O
markedly	RB	O
with	IN	O
the	DT	B-TREATMENT
evacuation	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
peritoneal	JJ	I-PROBLEM
pancreatic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
,	,	O
so	RB	O
that	IN	O
he	PRP	O
was	VBD	O
no	RB	O
longer	JJR	O
on	IN	O
pressors	NNS	B-TREATMENT
.	.	O

however	RB	O
,	,	O
upon	IN	O
transfer	NN	O
from	IN	O
the	DT	O
operating	NN	O
room	NN	O
table	NN	O
to	TO	O
the	DT	O
ricu	NN	O
bed	NN	O
,	,	O
he	PRP	O
suffered	VBD	O
a	DT	B-PROBLEM
cardiac	JJ	I-PROBLEM
arrest	NN	I-PROBLEM
,	,	O
which	WDT	O
upon	IN	O
investigation	NN	B-TEST
was	VBD	O
a	DT	B-PROBLEM
primary	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
arrest	NN	I-PROBLEM
;	:	O
the	DT	B-TEST
initial	JJ	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
32/88/6.92	CD	O
.	.	O

he	PRP	O
was	VBD	O
successfully	RB	O
resuscitated	VBN	O
after	IN	O
fifteen	JJ	O
minutes	NNS	O
of	IN	O
cardiopulmonary	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
ricu	NN	O
.	.	O

continuous	JJ	B-TREATMENT
venovenous	JJ	I-TREATMENT
hemodialysis	NN	I-TREATMENT
was	VBD	O
started	VBN	O
on	IN	O
july	NN	O
5	CD	O
,	,	O
and	CC	O
continued	VBN	O
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
patient	JJ	O
&apos;s	JJ	O
course	NN	O
.	.	O

vancomycin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
aztreonam	NNS	B-TREATMENT
were	VBD	O
given	VBN	O
for	IN	O
gram	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
coccobacilli	NN	I-PROBLEM
(	(	O
later	RB	O
identified	VBN	O
as	IN	O
bacteroides	NNS	B-PROBLEM
)	)	O
that	WDT	O
had	VBD	O
grown	VBN	O
in	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
and	CC	O
gram	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
(	(	I-PROBLEM
enterobacter	NN	I-PROBLEM
)	)	I-PROBLEM
in	IN	O
his	PRP$	B-TEST
peritoneal	NN	I-TEST
fluid	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
kept	VBN	O
sedated	JJ	B-TREATMENT
and	CC	O
paralyzed	JJ	B-TREATMENT
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
severe	JJ	I-PROBLEM
adult	NN	I-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

total	JJ	B-TREATMENT
parenteral	JJ	I-TREATMENT
nutrition	NN	I-TREATMENT
was	VBD	O
started	VBN	O
on	IN	O
july	NN	O
5	CD	O
.	.	O

initial	JJ	O
improvement	NN	O
was	VBD	O
followed	VBN	O
by	IN	O
recurrence	NN	O
of	IN	O
low	JJ	B-PROBLEM
svr	NN	I-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
ongoing	VBG	B-PROBLEM
acidosis	NN	I-PROBLEM
,	,	O
requiring	VBG	O
norepinephrine	JJ	B-TREATMENT
infusion	NN	I-TREATMENT
in	IN	O
the	DT	O
30	CD	O
to	TO	O
40	CD	O
mcg	NNS	O
per	IN	O
minute	NN	O
range	NN	O
;	:	O
drainage	NN	B-PROBLEM
from	IN	O
the	DT	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
minimal	JJ	O
despite	IN	O
irrigation	NN	B-TREATMENT
and	CC	O
manipulation	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
returned	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
july	NN	O
10	CD	O
,	,	O
where	WRB	O
several	JJ	B-PROBLEM
loculated	VBD	I-PROBLEM
thin	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collections	NNS	I-PROBLEM
were	VBD	O
drained	VBN	O
and	CC	O
obviously	RB	B-PROBLEM
necrotic	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
was	VBD	O
debrided	VBN	O
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
place	VB	O
more	JJR	B-TREATMENT
drains	NNS	I-TREATMENT
and	CC	O
pack	VB	O
the	DT	O
lesser	JJR	O
sac	NN	O
with	IN	O
adaptic	JJ	B-TREATMENT
and	CC	O
laparotomy	JJ	B-TREATMENT
pads	NNS	I-TREATMENT
.	.	O

the	DT	O
abdomen	NN	O
was	VBD	O
left	VBN	O
open	JJ	O
,	,	O
with	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
margins	NNS	I-PROBLEM
connected	VBN	O
by	IN	O
a	DT	O
sheet	NN	O
of	IN	O
marlex	JJ	B-TREATMENT
mesh	NN	I-TREATMENT
to	TO	O
prevent	VB	O
evisceration	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
returned	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
july	NN	O
12	CD	O
,	,	O
13	CD	O
,	,	O
16	CD	O
,	,	O
19	CD	O
,	,	O
21	CD	O
,	,	O
and	CC	O
23	CD	O
for	IN	O
packing	VBG	B-TREATMENT
change	NN	I-TREATMENT
,	,	O
irrigation	NN	B-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
.	.	O

tracheostomy	NN	B-TREATMENT
was	VBD	O
also	RB	O
performed	VBN	O
on	IN	O
july	NN	O
17	CD	O
.	.	O

there	EX	O
was	VBD	O
severe	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
peritonitis	NN	I-PROBLEM
with	IN	O
intense	JJ	B-PROBLEM
inflammation	NN	I-PROBLEM
,	,	O
infection	NN	B-PROBLEM
,	,	O
and	CC	O
patchy	JJ	B-PROBLEM
necrosis	NN	I-PROBLEM
of	IN	I-PROBLEM
peritoneal	JJ	I-PROBLEM
surfaces	NNS	I-PROBLEM
and	CC	O
of	IN	O
the	DT	O
distal	JJ	O
pancreas	NN	O
.	.	O

the	DT	O
subsequent	JJ	O
overall	JJ	O
course	NN	O
was	VBD	O
a	DT	O
slow	JJ	O
downhill	NN	O
one	CD	O
,	,	O
with	IN	O
ongoing	JJ	B-PROBLEM
extreme	JJ	I-PROBLEM
hyperdynamic	NN	I-PROBLEM
(	(	O
cardiac	JJ	B-TEST
output	NN	I-TEST
12	CD	O
to	TO	O
15	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
)	)	O
and	CC	O
catabolic	JJ	B-PROBLEM
state	NN	I-PROBLEM
.	.	O

on	IN	O
july	NN	O
26	CD	O
,	,	O
abdominal	JJ	B-TREATMENT
irrigation	NN	I-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
in	IN	O
the	DT	O
ricu	NN	O
;	:	O
this	DT	O
was	VBD	O
repeated	VBN	O
daily	RB	O
for	IN	O
the	DT	O
next	JJ	O
three	CD	O
days	NNS	O
.	.	O

on	IN	O
july	NN	O
29	CD	O
,	,	O
the	DT	B-PROBLEM
septic	JJ	I-PROBLEM
state	NN	I-PROBLEM
with	IN	O
low	JJ	B-PROBLEM
svr	NN	I-PROBLEM
and	CC	O
acidosis	NN	B-PROBLEM
accelerated	VBN	O
beyond	IN	O
the	DT	O
control	NN	O
of	IN	O
maximal	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
gradually	RB	O
fell	VBD	O
,	,	O
and	CC	O
he	PRP	O
died	VBD	O
early	RB	O
on	IN	O
july	NN	O
30	CD	O
,	,	O
1993	CD	O
.	.	O

severe	JJ	B-PROBLEM
blunt	NN	I-PROBLEM
abdominal	JJ	I-PROBLEM
trauma	NN	I-PROBLEM
with	IN	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
liver	NN	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
renal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
,	,	I-PROBLEM
pancreas	NNS	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
transverse	JJ	I-PROBLEM
mesocolon	NN	I-PROBLEM
.	.	O

1.	CD	O
7-2-93	JJ	O
,	,	O
emergency	NN	O
room	NN	O
exploratory	NN	B-TEST
laparotomy	NN	I-TEST
,	,	O
repair	NN	B-TREATMENT
of	IN	O
liver	NN	B-PROBLEM
laceration	NN	I-PROBLEM
,	,	O
repair	NN	B-TREATMENT
of	IN	O
torn	JJ	B-PROBLEM
transverse	NN	I-PROBLEM
mesocolon	NN	I-PROBLEM
,	,	O
repair	NN	B-TREATMENT
of	IN	O
serosal	JJ	B-PROBLEM
tear	NN	I-PROBLEM
of	IN	I-PROBLEM
transverse	NN	I-PROBLEM
colon	NN	I-PROBLEM
,	,	O
ligation	NN	B-TREATMENT
and	CC	O
division	NN	B-TREATMENT
of	IN	O
ruptured	JJ	B-PROBLEM
left	VBD	I-PROBLEM
renal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
,	,	O
exploration	NN	B-TEST
of	IN	I-TEST
pancreas	NNS	I-TEST
,	,	O

2.	CD	O
7-4-93	JJ	O
,	,	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
,	,	O
irrigation	NN	B-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
,	,	O
pancreatic	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
placement	NN	I-TREATMENT
,	,	O
gastrostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
,	,	O
jejunostomy	NN	B-TREATMENT
,	,	O
cholecystostomy	NN	B-TREATMENT
,	,	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
right	JJ	I-TREATMENT
subclavian	JJ	I-TREATMENT
quinton	NN	I-TREATMENT
catheter	NN	I-TREATMENT
,	,	O

3.	CD	O
7-10-93	JJ	O
,	,	O
abdominal	JJ	B-TREATMENT
irrigation	NN	I-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
and	CC	O
packing	NN	B-TREATMENT
of	IN	I-TREATMENT
pancreas	NNS	I-TREATMENT
,	,	O

4.	CD	O
7-12-93	JJ	O
,	,	O
7-14	JJ	O
,	,	O
7-20	JJ	O
,	,	O
7-22	JJ	O
,	,	O
and	CC	O
7-24	NNS	O
,	,	O
were	VBD	O
the	DT	O
same	JJ	O
as	IN	O
7-10-93	JJ	O
,	,	O
and	CC	O
7-17	NNP	O
was	VBD	O
the	DT	O
same	JJ	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
tracheostomy	NN	B-TREATMENT
were	VBD	O
same	JJ	O
as	IN	O
7-10	JJ	O
,	,	O

severe	JJ	B-PROBLEM
necrotizing	VBG	I-PROBLEM
pancreatitis	NN	I-PROBLEM
and	CC	O
diffuse	NN	B-PROBLEM
peritonitis	NN	I-PROBLEM
.	.	O

sulfonamides	NNS	B-TREATMENT
/	VBP	O
zithromax	CD	B-TREATMENT
/	NNP	O
floxin	NN	B-TREATMENT
/	NN	O
penicillins	VBZ	B-TREATMENT
/	JJ	O
neurontin	JJ	B-TREATMENT
/	NN	O
demerol	NN	B-TREATMENT
/	NNP	O
morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
/	NNP	O
ativan	NN	B-TREATMENT

pyridium	NN	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
for	IN	O
uti	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
x	VBP	O
2	CD	O
days	NNS	O
.	.	O

1)	CD	O
staph	NN	B-PROBLEM
.	.	O

sepsis	NN	B-PROBLEM
related	VBN	O
to	TO	O
picc	VB	B-TREATMENT
line	NN	I-TREATMENT
.	.	O

2)	CD	O
previous	JJ	B-PROBLEM
anoxic	NN	I-PROBLEM

1)	CD	O
staph.	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
related	VBN	O
to	TO	O
picc	VB	B-TREATMENT
line	NN	I-TREATMENT
.	.	O

2)	CD	O
previous	JJ	B-PROBLEM
anoxicbrain	NN	I-PROBLEM
damage	NN	I-PROBLEM
.	.	O

3)	CD	O
previous	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

4)	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

5)	CD	O
status	NN	O
post	NN	O
cabg	NN	B-TREATMENT
surgery	NN	I-TREATMENT
in	IN	O
11/97	CD	O
.	.	O

6)	CD	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

7)	CD	O
mild	JJ	B-PROBLEM
chronic	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
with	IN	O
staph.	JJ	B-PROBLEM
aureus	JJ	I-PROBLEM
sensitiveto	NN	O
methicillin	NN	B-TREATMENT
.	.	O

hydralazine	NN	B-TREATMENT
10	CD	O
mgs	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mgs	NN	O
po	NN	O
q.d.	NN	O
,	,	O
thiamine	VB	B-TREATMENT
100	CD	O
mgs	NN	O
po	NN	O
q.d.	NN	O
,	,	O
multi-vitamin	JJ	B-TREATMENT
1	CD	O
tab.	NN	O
po	NN	O
q.d.	NN	O
,	,	O
peri	SYM	B-TREATMENT
-	:	I-TREATMENT
colace	NN	I-TREATMENT
100	CD	O
mgs	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
folate	VBP	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
q.d.	NN	O
,	,	O
norvasc	RB	B-TREATMENT
2.5	CD	O
mgs	NNS	O
po	JJ	O
q.hs	NN	O
,	,	O
ritalin	VBZ	B-TREATMENT
10	CD	O
mgs	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
trazodone	NN	B-TREATMENT
25	CD	O
mgs	NN	O
po	NN	O
q.hs	NN	O
,	,	O
nafcillin	RB	B-TREATMENT
2	CD	O
gramsiv	NN	O
q.4h	NN	O
which	WDT	O
wil	VBZ	O
conclude	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
day	NN	O
on	IN	O
1/16/98	CD	O
,	,	O
atroventnebulizer	NN	B-TREATMENT
prn	NN	O
,	,	O
albuterol	NN	B-TREATMENT
nebulizer	NN	I-TREATMENT
prn	NN	O
,	,	O
tylenol	VBZ	B-TREATMENT
650	CD	O
mgs	NN	O
po	NN	O
q.4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
.	.	O

mr.	NN	O
gach	NN	O
is	VBZ	O
an	DT	O
80	CD	O
year	NN	O
old	JJ	O
man	NN	O
with	IN	O
aprevious	JJ	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
linghs	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
to	TO	O
oaksgekesser/	VB	O
memorial	JJ	O
hospital	NN	O
because	IN	O
of	IN	O
an	DT	B-PROBLEM
apparent	JJ	I-PROBLEM
infected	VBN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
including	VBG	O
the	DT	B-TREATMENT
picc	NN	I-TREATMENT
line	NN	I-TREATMENT
in	IN	O
his	PRP$	O
right	JJ	O
elbow	NN	O
and	CC	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
for	IN	O
staph.	JJ	B-PROBLEM
aureus	NN	I-PROBLEM
associated	VBN	O
with	IN	O
fever	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarctions	NNS	I-PROBLEM
in	IN	O
1981	CD	O
,	,	O
1992	CD	O
and	CC	O
08/97	CD	O
with	IN	O
thelast	JJ	O
episode	NN	O
complicated	VBN	O
by	IN	O
anoxic	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

he	PRP	O
gradually	RB	O
improved	VBD	O
but	CC	O
had	VBD	O
recurrent	VBN	B-PROBLEM
angina	RB	I-PROBLEM
requiring	VBG	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
,	,	O
demonstrating	VBG	O
90%	CD	O
left	VBD	O
main	JJ	O
,	,	O
95%	CD	O
ostial	JJ	O
lad	NN	O
and	CC	O
30	CD	O
to	TO	O
40%	CD	O
mid-lad	NN	O
with	IN	O
an	DT	B-PROBLEM
occluded	JJ	I-PROBLEM
rca	NN	I-PROBLEM
.	.	O

cabg	NN	B-TREATMENT
surgery	NN	I-TREATMENT
with	IN	O
two	CD	B-TREATMENT
vessel	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
was	VBD	O
done	VBN	O
on	IN	O
11/18/97	CD	O
.	.	O

a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
his	PRP$	O
left	JJ	O
antecubital	JJ	O
fossa	NN	O
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
new	JJ	O
years	NNS	O
eve	VBP	O
he	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
of	IN	O
102	CD	O
and	CC	O
became	VBD	O
lethargic	JJ	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
picc	NN	I-TREATMENT
line	NN	I-TREATMENT
site	NN	I-TREATMENT
was	VBD	O
erythematous	JJ	B-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
out	RP	O
4	CD	O
out	IN	O
of	IN	O
4	CD	O
bottles	NNS	O
for	IN	O
gram	NN	B-PROBLEM
positive	JJ	I-PROBLEM
cocci	NN	I-PROBLEM
,	,	O
which	WDT	O
thereafter	RB	O
proved	VBD	O
to	TO	O
be	VB	O
staph.	JJ	B-PROBLEM
aureus	JJ	I-PROBLEM
methicillin	NN	B-TREATMENT
sensitive	NN	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
diarrhea	NN	B-PROBLEM
.	.	O

includes	VBZ	O
ischemic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
done	VBN	O
on	IN	O
11/13/97	CD	O
showing	VBG	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
28%	CD	O
and	CC	O
lv	JJR	O
that	DT	O
is	VBZ	O
diffusely	RB	B-PROBLEM
hypokinetic	JJ	I-PROBLEM
.	.	O

1)	CD	O
dementia	NN	B-PROBLEM
,	,	O

2)	CD	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation,	NN	I-PROBLEM

3)	CD	O
hypertension	NN	B-PROBLEM
,	,	O

4)	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
previous	JJ	B-TREATMENT
left	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
popliteal	NN	I-TREATMENT
bypass	NN	I-TREATMENT
,	,	O

5)	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O

6)	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency,	NN	I-PROBLEM

7)	CD	O
copd	NN	B-PROBLEM
,	,	O

8)	CD	O
previous	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
aneurysm	NN	I-TREATMENT
repair	NN	I-TREATMENT
in	IN	O
1981	CD	O
,	,	O

9)	CD	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
status	NN	O
post	NN	O
turp	NN	B-TREATMENT
surgery	NN	I-TREATMENT
in	IN	O
1982	CD	O
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mgs	NNS	O
po	JJ	O
q.d.	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
mgs	NN	O
po	NN	O
q.d.	NN	O
,	,	O
azmacort	RB	B-TREATMENT
2	CD	O
puffs	NNS	O
q.i.d.	JJ	O
prn	NN	O
,	,	O
atrovent	JJ	B-TREATMENT
2	CD	O
puffs	NNS	O
q.i.d.	JJ	O
prn	NN	O
,	,	O
heparin	VBZ	B-TREATMENT
5,000	CD	O
units	NNS	O
subcu.	JJ	O
b.i.d.	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mgs	NN	O
po	NN	O
q.d.	NN	O
,	,	O
wellbutrin	WP	B-TREATMENT
37.5	CD	O
mgs	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
kaopectate	VB	B-TREATMENT
prn	NN	O
,	,	O
betoptic	JJ	B-TREATMENT
0.25%	CD	O
ou	JJ	O
q.d.	NN	O
,	,	O
ritalin	VBZ	B-TREATMENT
10	CD	O
mgs	NN	O
po	NN	O
q.a.m.	NN	O
and	CC	O
at	IN	O
noon	JJ	O
time	NN	O
,	,	O
norvasc	RB	B-TREATMENT
2.5	CD	O
mgs	NNS	O
po	JJ	O
q.d.	NN	O

the	DT	O
patient	NN	O
reported	VBD	O
disorientation	NN	B-PROBLEM
with	IN	O
ambien	NN	B-TREATMENT
and	CC	O
halcyon	NN	B-TREATMENT
.	.	O

no	DT	O
other	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
other	JJ	O
than	IN	O
stated	VBN	O
above	IN	O
.	.	O

elderly	JJ	O
white	JJ	O
male	NN	O
who	WP	O
was	VBD	O
somnolent	NN	B-PROBLEM
,	,	O
looking	VBG	O
his	PRP$	O
stated	JJ	O
age	NN	O
.	.	O

his	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
97.5	CD	O
,	,	O
pulse	RB	B-TEST
90	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
104/60	CD	O
,	,	O
o2	PRP	B-TEST
sat.	VBD	I-TEST
97%.	CD	O

eyes	NNS	O
-	:	O
pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
sclera	JJ	O
non-icteric	JJ	B-PROBLEM
.	.	O

neck	SYM	O
-	:	O
supple	NN	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

lungs	NNS	O
-	:	O
clear	JJ	O
to	TO	O
percussion	NN	B-TEST
and	CC	O
auscultation	NN	B-TEST
on	IN	O
both	DT	O
sides	NNS	O
.	.	O

cardiovascular	JJ	O
examination	NN	O
-	:	O
normal	JJ	O
jugular	JJ	O
venous	JJ	O
pressure	NN	O
,	,	O
normal	JJ	O
carotid	NN	O
upstrokes	NNS	O
with	IN	O
bruits	NNS	B-PROBLEM
,	,	O
there	EX	O
are	VBP	O
distant	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
s1	NN	O
and	CC	O
s2	NN	O
are	VBP	O
normal	JJ	O
,	,	O
there	EX	O
are	VBP	O
no	DT	O
murmurs	NN	B-PROBLEM
detected	VBD	O
.	.	O

abdomen	NNS	O
-	:	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
without	IN	O
organomegaly	NN	B-PROBLEM
or	CC	O
masses	NNS	B-PROBLEM
.	.	O

extremities	NNS	O
-	:	O
without	IN	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
-	:	O
somnolent	NN	B-PROBLEM
,	,	O
awake	NN	O
,	,	O
arousable	JJ	O
to	TO	O
commands	NNS	O
,	,	O
though	IN	O
he	PRP	O
falls	VBZ	O
asleep	RB	O
rapidly	RB	O
.	.	O

deep	JJ	B-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
are	VBP	O
2+	CD	O
and	CC	O
symmetric	JJ	O
,	,	O
toes	NNS	O
were	VBD	O
up	RB	B-PROBLEM
going	VBG	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

sodium	NN	B-TEST
131	CD	O
,	,	O
potassium	NN	B-TEST
4.5	CD	O
,	,	O
bun	NN	B-TEST
45	CD	O
,	,	O
creatinine	NN	B-TEST
2.0	CD	O
,	,	O
glucose	RB	B-TEST
134	CD	O
,	,	O
bilirubin	VBD	B-TEST
0.4.	CD	O
blood	NN	B-TEST
gas	NN	I-TEST
on	IN	O
5	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
o2	SYM	I-TREATMENT
-	:	O
po2	NN	B-TEST
106	CD	O
,	,	O
pco227	NN	B-TEST
,	,	O
ph	JJ	B-TEST
7.41	CD	O
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
obtained	VBN	O
,	,	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
obtained	VBN	O
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
-	:	O
low	JJ	B-PROBLEM
lung	NN	I-PROBLEM
volumes	NNS	I-PROBLEM
,	,	O
bibasilar	JJ	B-PROBLEM
opacities	NNS	I-PROBLEM
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
heart	NN	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

ekg	SYM	B-TEST
-	:	O
technically	RB	O
poor	JJ	O
tracing	VBG	O
with	IN	O
what	WP	O
appears	VBZ	O
to	TO	O
be	VB	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
very	RB	B-PROBLEM
small	JJ	I-PROBLEM
p	NN	I-PROBLEM
waves	NNS	I-PROBLEM
,	,	O
there	EX	O
are	VBP	O
q-waves	NNS	B-PROBLEM
in	IN	I-PROBLEM
leads	NNS	I-PROBLEM
v1	NNS	I-PROBLEM
and	CC	I-PROBLEM
v2	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
v3	NN	O
.	.	O

there	EX	O
are	VBP	O
non-specific	JJ	B-PROBLEM
st	JJ	I-PROBLEM
t	NN	I-PROBLEM
wave	VBP	I-PROBLEM
changes.	NN	I-PROBLEM

the	DT	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
at	IN	O
linghs	NNS	O
county	RB	O
medical	JJ	O
center	NN	O
grew	VBD	O
out	RP	O
staph.	JJ	B-PROBLEM
aureus	RB	I-PROBLEM
sensitive	JJ	O
to	TO	O
methicillin	VB	B-TREATMENT
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
obtained	VBD	O
a	DT	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
were	VBD	O
negative	JJ	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
obtained	VBN	O
at	IN	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
obtained	VBD	O
as	IN	O
a	DT	B-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
33%	CD	O
,	,	O
wall	NN	B-TEST
thickness	NN	I-TEST
12	CD	O
mms	NN	O
at	IN	O
the	DT	O
septum	NN	O
,	,	O
posterior	VBP	B-TEST
wall	NN	I-TEST
11	CD	O
mms.	NN	O
,	,	O
left	VBD	B-TEST
atrial	JJ	I-TEST
size	NN	I-TEST
40	CD	O
mms	NN	O
.	.	O

there	EX	O
is	VBZ	O
anteroseptal	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
with	IN	O
mid	NN	B-PROBLEM
and	CC	I-PROBLEM
apical	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

a	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
normal	JJ	O
pressure	NN	O
and	CC	O
no	DT	O
cells	NNS	B-PROBLEM
.	.	O

the	DT	B-TEST
csf	JJ	I-TEST
culture	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

a	DT	B-TEST
stool	NN	I-TEST
assay	NN	I-TEST
was	VBD	O
taken	VBN	O
for	IN	O
clostridium	NN	B-PROBLEM
difficile	NN	I-PROBLEM
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
gradually	RB	O
improved	VBN	O
on	IN	O
the	DT	B-TREATMENT
current	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
was	VBD	O
quite	RB	O
awake	JJ	O
and	CC	O
alert	JJ	O
,	,	O
though	IN	O
still	RB	O
appeared	VBN	O
to	TO	O
have	VB	O
some	DT	O
evidence	NN	O
of	IN	O
dementia	NN	B-PROBLEM
and	CC	O
disorientation	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
encouraged	VBN	O
to	TO	O
eat	VB	O
and	CC	O
it	PRP	O
was	VBD	O
decided	VBN	O
not	RB	O
to	TO	O
place	VB	O
either	RB	O
a	DT	B-TREATMENT
feeding	NN	I-TREATMENT
tube	NN	I-TREATMENT
or	CC	O
to	TO	O
start	VB	O
tpn	NN	B-TREATMENT
.	.	O

he	PRP	O
still	RB	O
needs	VBZ	O
much	JJ	B-TREATMENT
intensive	JJ	I-TREATMENT
rehabilitation	NN	I-TREATMENT
,	,	O
encouragement	NN	O
to	TO	O
eat	VB	O
and	CC	O
encouragement	VB	O
to	TO	O
get	VB	O
out	IN	O
of	IN	O
bed	NN	O
to	TO	O
use	VB	O
the	DT	O
bathroom	NN	O
rather	RB	O
than	IN	O
abed	VB	B-TREATMENT
pain	NN	I-TREATMENT
or	CC	O
a	DT	B-TREATMENT
diaper	NN	I-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
transferred	VBN	O
to	TO	O
linghs	VB	O
county	RB	O
medical	JJ	O
center	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

briefly	NN	O
,	,	O
this	DT	O
68	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
was	VBD	O
admitted	VBN	O
originally	RB	O
to	TO	O
the	DT	O
podiatry	NN	O
service	NN	O
for	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
patellar	JJ	I-PROBLEM
mid-foot	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	JJ	O
angiogram	NN	B-TEST
on	IN	O
2013-08-28	JJ	O
,	,	O
to	TO	O
evaluate	VB	O
his	PRP$	O
circulation	NN	O
and	CC	O
found	VBN	O
at	IN	O
that	DT	O
time	NN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
poor	JJ	I-PROBLEM
circulation	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
leg	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
vascular	JJ	O
surgery	NN	O
service	NN	O
for	IN	O
bilateral	JJ	B-TREATMENT
iliac	JJ	I-TREATMENT
stenting	NN	I-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
followed	VBN	O
by	IN	O
cardiology	NN	O
and	CC	O
for	IN	O
preoperative	JJ	B-TEST
evaluation	NN	I-TEST
had	VBD	O
a	DT	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
which	WDT	O
was	VBD	O
positive	JJ	B-PROBLEM
and	CC	O
he	PRP	O
became	VBD	O
diaphoretic	JJ	B-PROBLEM
but	CC	O
denied	VBD	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

atropine	NN	B-TREATMENT
was	VBD	O
given	VBN	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
returned	VBD	O
to	TO	O
the	DT	O
70s	CD	O
and	CC	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
returned	VBD	O
to	TO	O
the	DT	O
120s	CD	O
over	IN	O
80s	CD	O
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
any	DT	O
orthopnea	NN	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
or	CC	O
cough	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
occasional	JJ	B-PROBLEM
leg	NN	I-PROBLEM
swelling	NN	I-PROBLEM
.	.	O

1	CD	O
.	.	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
2006	CD	O
and	CC	O
1997	CD	O
and	CC	O
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	JJ	I-TREATMENT
times	NNS	O
two	CD	O
.	.	O

2.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
type	NN	I-PROBLEM
2	CD	I-PROBLEM
since	IN	O
age	NN	O
25	CD	O
;	:	O
now	RB	O
currently	RB	O
on	IN	O
insulin	NN	B-TREATMENT
,	,	O
which	WDT	O
is	VBZ	O
complicated	VBN	O
by	IN	O
peripheral	JJ	B-PROBLEM
neuropathy	NNS	I-PROBLEM
,	,	O
nephropathy	JJ	B-PROBLEM
and	CC	O
charcot	NN	B-PROBLEM
's	POS	I-PROBLEM
foot	NN	I-PROBLEM
.	.	O

3.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

4.	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
iliac	JJ	I-TREATMENT
stent	NN	I-TREATMENT
and	CC	O
right	JJ	B-TREATMENT
femoral	JJ	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

5.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

6.	CD	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

7.	CD	O
question	NN	O
of	IN	O
tendonitis	NN	B-PROBLEM
.	.	O

1.	CD	O
insulin	NN	B-TREATMENT
70/30	CD	O
,	,	O
40	CD	O
units	NNS	O
q.	JJ	O
a.m.	RB	O
and	CC	O
40	CD	O
units	NNS	O
q.	CD	O
p.m.	NN	O

2.	CD	O
diovan	NN	B-TREATMENT
160	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
nortriptyline	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
h.s.	NN	O

4.	CD	O
norvasc	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
metoprolol	JJ	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

6.	CD	O
hydrochlorothiazide	NN	B-TREATMENT
,	,	O
15	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	RB	B-PROBLEM
;	:	O
his	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

his	PRP$	O
neck	NN	O
was	VBD	O
supple	RB	O
;	:	O
he	PRP	O
had	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

his	PRP$	O
carotids	NNS	O
were	VBD	O
two	CD	O
plus	CC	O
bilaterally	RB	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

his	PRP$	O
heart	NN	O
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

his	PRP$	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
bilateral	JJ	B-PROBLEM
femoral	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM
and	CC	O
he	PRP	O
had	VBD	O
one	CD	B-TEST
plus	CC	I-TEST
popliteal	JJ	I-TEST
pulses	NNS	I-TEST
.	.	O

his	PRP$	B-TEST
pedal	NN	I-TEST
pulses	NNS	I-TEST
are	VBP	O
absent	JJ	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
his	PRP$	B-TEST
bun	NN	I-TEST
was	VBD	O
13	CD	O
,	,	O
creatinine	NN	B-TEST
1.7	CD	O
,	,	O
hematocrit	NN	B-TEST
43	CD	O
and	CC	O
the	DT	B-TEST
cholesterol	NN	I-TEST
was	VBD	O
208	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
admitted	VBN	O
to	TO	O
this	DT	O
hospital	NN	O
through	IN	O
the	DT	O
podiatry	NN	O
service	NN	O
;	:	O
however	RB	O
,	,	O
the	DT	B-TEST
stress	NN	I-TEST
test	NN	I-TEST
showed	VBD	O
multi-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

podiatry	NN	O
continued	VBD	O
to	TO	O
follow	VB	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
he	PRP	O
was	VBD	O
having	VBG	O
acetic	JJ	B-TREATMENT
acid	JJ	I-TREATMENT
wet-to-dry	JJ	I-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
,	,	O
0.25%	CD	O
q.	JJ	O
day	NN	O
.	.	O

vascular	JJ	O
surgery	NN	O
was	VBD	O
following	VBG	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
and	CC	O
decided	VBD	O
that	IN	O
bilateral	JJ	B-TREATMENT
iliac	NN	I-TREATMENT
stenting	NN	I-TREATMENT
would	MD	O
be	VB	O
the	DT	B-TREATMENT
most	RBS	I-TREATMENT
optimum	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
currently	RB	O
and	CC	O
suggested	VBD	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
be	VB	O
worked	VBN	O
up	RP	O
for	IN	O
cardiac	JJ	B-PROBLEM
disease	NN	I-PROBLEM
prior	RB	O
to	TO	O
re-vascularization	NN	B-TREATMENT
.	.	O

medicine	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
at	IN	O
that	DT	O
time	NN	O
for	IN	O
high	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
for	IN	O
the	DT	B-PROBLEM
biceps	NNS	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

while	IN	O
having	VBG	O
angiography	NN	B-TEST
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
transient	JJ	I-PROBLEM
increase	NN	I-PROBLEM
in	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
and	CC	O
became	VBD	O
diaphoretic	JJ	B-PROBLEM
and	CC	O
thus	RB	O
precipitated	VBD	O
the	DT	B-TEST
evaluation	NN	I-TEST
for	IN	O
cardiac	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
managed	VBN	O
on	IN	O
the	DT	O
medical	JJ	O
service	NN	O
for	IN	O
his	PRP$	B-PROBLEM
drop	NN	I-PROBLEM
in	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
and	CC	O
cardiac	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
laboratory	NN	O
which	WDT	O
showed	VBD	O
multi-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
cardiothoracic	NN	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2013-09-04	JJ	O
,	,	O
where	WRB	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
four	CD	O
was	VBD	O
performed	VBN	O
,	,	O
left	VBD	B-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
to	TO	I-TREATMENT
left	VB	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
diagonal	VB	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
obtuse	VB	I-TREATMENT
marginal	JJ	I-TREATMENT
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
pc	VB	I-TREATMENT
by	IN	O
dr.	JJ	O
wright	NN	O
.	.	O

he	PRP	O
was	VBD	O
slowly	RB	O
weaned	VBN	O
from	IN	O
his	PRP$	B-TREATMENT
ventilator	NN	I-TREATMENT
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
be	VB	O
extubated	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
be	VB	O
weaned	VBN	O
to	TO	O
six	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
after	IN	O
extubation	NN	B-TREATMENT
,	,	O
however	RB	O
,	,	O
it	PRP	O
was	VBD	O
noted	VBN	O
on	IN	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
pneumothorax	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
resolution	NN	O
of	IN	O
that	DT	B-PROBLEM
pneumothorax	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
but	CC	O
continued	VBD	O
to	TO	O
improve	VB	O
.	.	O

his	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
in	IN	O
place	NN	O
for	IN	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
chest	NN	I-PROBLEM
tube	NN	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

physical	JJ	O
therapy	NN	O
was	VBD	O
consulted	VBN	O
in	IN	O
order	NN	O
to	TO	O
assess	VB	O
the	DT	O
patient	NN	O
's	POS	O
ambulation	NN	O
and	CC	O
mobility	NN	O
,	,	O
however	RB	O
,	,	O
with	IN	O
his	PRP$	B-PROBLEM
foot	NN	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
associated	VBN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
difficult	JJ	O
to	TO	O
assess	VB	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

after	IN	O
arriving	VBG	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
which	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
amiodarone	NN	B-TREATMENT
and	CC	O
lopressor	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
resolved	VBD	O
,	,	O
however	RB	O
,	,	O
lasix	NN	B-TREATMENT
was	VBD	O
also	RB	O
given	VBN	O
due	JJ	O
to	TO	O
some	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
increasing	VBG	B-PROBLEM
oxygen	NN	I-PROBLEM
need	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
have	VB	O
episodes	NNS	O
of	IN	O
rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
while	IN	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
which	WDT	O
required	VBD	O
continued	JJ	O
diuresis	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
intravenous	JJ	B-TREATMENT
lopressor	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
foley	NN	B-TREATMENT
catheter	NN	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
aggressive	JJ	B-TREATMENT
chest	NN	I-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
nebulizer	NN	B-TREATMENT
treatments	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
for	IN	I-TREATMENT
his	PRP$	I-TREATMENT
foot	NN	I-TREATMENT
continued	VBD	O
per	IN	O
the	DT	O
podiatry	NN	O
service	NN	O
and	CC	O
his	PRP$	B-PROBLEM
leg	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
slowly	RB	O
healing	VBG	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
multiple	JJ	O
episodes	NNS	O
of	IN	O
rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
which	WDT	O
again	RB	O
required	VBD	O
intravenous	JJ	B-TREATMENT
lopressor	NN	I-TREATMENT
.	.	O

amiodarone	NN	B-TREATMENT
boluses	NNS	I-TREATMENT
were	VBD	O
given	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
400	CD	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
of	IN	O
p.o.	NN	B-TREATMENT
amiodarone	NN	I-TREATMENT
,	,	O
aggressive	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
toilet	NN	I-TREATMENT
and	CC	O
continued	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
was	VBD	O
done	VBN	O
,	,	O
however	RB	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
have	VB	O
respiratory	NN	B-PROBLEM
difficulties	NNS	I-PROBLEM
when	WRB	O
in	IN	O
rapid	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
and	CC	O
it	PRP	O
was	VBD	O
decided	VBN	O
at	IN	O
that	DT	O
time	NN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
be	VB	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
respiratory	JJ	B-PROBLEM
difficulties	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
aggressively	RB	O
diuresed	VBN	O
as	RB	O
well	RB	O
as	IN	O
his	PRP$	B-TEST
rate	NN	I-TEST
was	VBD	O
controlled	VBN	O
and	CC	O
chest	JJS	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
nebulizer	NN	B-TREATMENT
treatments	NNS	I-TREATMENT
were	VBD	O
done	VBN	O
.	.	O

also	RB	O
,	,	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
rise	VB	O
to	TO	O
32.0	CD	O
;	:	O
this	DT	O
was	VBD	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
a	DT	B-PROBLEM
secondary	JJ	I-PROBLEM
infection	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
foot	NN	I-PROBLEM
and	CC	O
zosyn	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
do	VB	O
well	RB	O
and	CC	O
his	PRP$	B-PROBLEM
recurrent	NN	I-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
slowly	RB	O
improved	VBN	O
;	:	O
p.o.	JJ	O
doses	NNS	O
of	IN	O
lopressor	JJ	B-TREATMENT
slowly	RB	O
increased	VBN	O
to	TO	O
get	VB	O
better	JJR	O
control	NN	O
of	IN	O
his	PRP$	B-TEST
rate	NN	I-TEST
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
be	VB	O
controlled	VBN	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
in	IN	O
the	DT	O
50s	CD	O
to	TO	O
60s	CD	O
with	IN	O
lopressor	NN	B-TREATMENT
.	.	O

following	VBG	O
initiation	NN	O
of	IN	O
his	PRP$	B-TREATMENT
zosyn	NN	I-TREATMENT
,	,	O
the	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
continued	VBD	O
to	TO	O
improve	VB	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
planned	VBN	O
for	IN	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
for	IN	O
long-term	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
lopressor	NN	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
with	IN	O
good	JJ	O
control	NN	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
50s	CD	O
to	TO	O
60s	CD	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
preoperative	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
of	IN	O
amlodipine	NN	B-TREATMENT
and	CC	O
losartan	NN	B-TREATMENT
with	IN	O
improvement	NN	O
of	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
reduced	VBN	O
to	TO	O
400	CD	O
mg	NNS	O
q.	JJ	O
day	NN	O
of	IN	O
amiodarone	NN	B-TREATMENT
.	.	O

pulmonary	NN	O
was	VBD	O
consulted	VBN	O
at	IN	O
this	DT	O
time	NN	O
for	IN	O
this	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
of	IN	I-PROBLEM
diuresis	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

they	PRP	O
continued	VBD	O
to	TO	O
agree	VB	O
with	IN	O
the	DT	O
management	NN	O
of	IN	O
the	DT	O
patient	NN	O
and	CC	O
with	IN	O
aggressive	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
toilet	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
diuresis	NN	B-TREATMENT
and	CC	O
nebulizer	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

pulmonary	JJ	B-TREATMENT
toilet	NN	I-TREATMENT
and	CC	O
aggressive	JJ	B-TREATMENT
chest	NN	I-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
be	VB	O
weaned	VBN	O
from	IN	O
his	PRP$	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

furthermore	RB	O
,	,	O
his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
anti-coagulation	NN	B-TREATMENT
for	IN	O
his	PRP$	O
episodes	NNS	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
and	CC	O
that	DT	O
was	VBD	O
continued	VBN	O
.	.	O

coumadin	NN	B-TREATMENT
was	VBD	O
then	RB	O
begun	VBN	O
with	IN	O
a	DT	B-TEST
goal	NN	I-TEST
inr	NN	I-TEST
of	IN	O
2.0	CD	O
to	TO	O
3.0	CD	O
.	.	O

podiatry	NN	O
and	CC	O
vascular	JJ	O
surgery	NN	O
were	VBD	O
reconsulted	VBN	O
to	TO	O
assess	VB	O
the	DT	O
patient	NN	O
's	POS	O
needs	NNS	O
for	IN	O
revascularization	NN	B-TREATMENT
and	CC	O
for	IN	O
his	PRP$	B-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
at	IN	O
that	DT	O
time	NN	O
that	IN	O
the	DT	O
patient	NN	O
could	MD	O
be	VB	O
discharged	VBN	O
in	IN	O
follow-up	JJ	O
with	IN	O
vascular	JJ	O
surgery	NN	O
for	IN	O
revascularization	NN	B-TREATMENT
and	CC	O
podiatry	NN	O
thereafter	RB	O
.	.	O

on	IN	O
2013-08-28	JJ	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
for	IN	O
a	DT	O
six	CD	O
week	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
zosyn	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
also	RB	O
continued	VBN	O
.	.	O

1.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

2.	CD	O
coumadin	NN	B-TREATMENT
7.5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
for	IN	O
an	DT	B-TEST
inr	JJ	I-TEST
goal	NN	I-TEST
of	IN	O
2.0	CD	O
to	TO	O
3.0	CD	O
and	CC	O
adjust	VBP	O
the	DT	O
dose	NN	O
accordingly	RB	O
.	.	O

3.	CD	O
acetic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
0.25%	CD	O
wet-to-dry	JJ	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
q.	VBP	O
day	NN	O
for	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

4.	CD	O
amiodarone	NN	B-TREATMENT
400	CD	O
mg	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
albuterol	NN	B-TREATMENT
nebulizers	NNS	I-TREATMENT
q.	VBP	O
four	CD	O
hours	NNS	O
and	CC	O
q.	VB	O
two	CD	O
hours	NNS	O
p.r.n.	VBP	O

6.	CD	O
losartan	JJ	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

7.	CD	O
iron	NN	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8.	CD	O
albuterol	JJ	B-TREATMENT
ipratropium	NN	B-TREATMENT
two	CD	O
puffs	NNS	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
zosyn	NN	B-TREATMENT
4.5	CD	O
grams	NNS	O
intravenously	RB	O
q.	RB	O
six	CD	O
hours	NNS	O
times	RB	O
six	CD	O
weeks	NNS	O
;	:	O
started	VBN	O
on	IN	O
09-10	NN	O
.	.	O

10.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

11.	CD	O
amlodipine	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

12.	CD	O
nortriptyline	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
h.s.	NN	O

13.	CD	O
mecsazopam	$	B-TREATMENT
15	CD	O
to	TO	O
30	CD	O
mg	NNS	O
p.o.	JJ	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

14.	CD	O
dulcolax	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
or	CC	O
p.r.	JJ	O
q.	JJ	O
day	NN	O
p.r.n.	VB	O

15.	CD	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
30	CD	O
cc	NN	O
,	,	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

16.	CD	O
percocet	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
q.	RB	O
four	CD	O
hours	NNS	O
p.r.n.	VBP	O

17.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

18.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

20.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	RB	O
intravenous	JJ	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

21.	CD	O
lopressor	NN	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
he	PRP	O
is	VBZ	O
also	RB	O
instructed	VBN	O
to	TO	O
follow-up	JJ	O
with	IN	O
vascular	JJ	O
surgery	NN	O
and	CC	O
podiatry	NN	O
for	IN	O
revascularization	NN	B-TREATMENT
at	IN	O
the	DT	O
appropriate	JJ	O
time	NN	O
frame	NN	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
angioplasty	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

2.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
type	JJ	I-PROBLEM
2	CD	I-PROBLEM
,	,	O
now	RB	O
currently	RB	O
on	IN	O
insulin	NN	B-TREATMENT
.	.	O

3.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

4.	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
bilateral	JJ	B-TREATMENT
iliac	NN	I-TREATMENT
stenting	NN	I-TREATMENT
.	.	O

5.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

6.	CD	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

7.	CD	O
question	NN	O
tendonitis	NN	B-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
biceps	NNS	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

8.	CD	O
left	JJ	B-PROBLEM
foot	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
status	NN	O
post	NN	O
debridement	NN	B-TREATMENT
.	.	O

carcinoma	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
kidney	NN	I-PROBLEM
,	,	O
hypovolemia	NN	B-PROBLEM
,	,	O
metastatic	JJ	B-PROBLEM
liver	NN	I-PROBLEM

carcinoma	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
kidney	NN	I-PROBLEM
,	,	O
hypovolemia	NN	B-PROBLEM
,	,	O
metastatic	JJ	B-PROBLEM
liver	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
intrathoracic	NN	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

(	(	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
)	)	O
the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
100/65	CD	O
;	:	O

no	DT	O
masses	NNS	B-PROBLEM
,	,	O
neck	NN	O
revealed	VBD	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

liver	RB	B-PROBLEM
massively	RB	I-PROBLEM
enlarged	VBD	I-PROBLEM
down	RB	O
15	CD	O
cm	NN	O
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
:	:	O

(	(	O
at	IN	O
time	NN	O
of	IN	O
admission	NN	O
)	)	O
hematocrit	NN	B-TEST
32.7	CD	O
;	:	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
9,000	CD	O
;	:	O
platelet	NN	B-TEST
count	NN	I-TEST
336,000	CD	O
;	:	O
sodium	NN	B-TEST
126	CD	O
,	,	O
potassium	NN	B-TEST
4.3	CD	O
,	,	O
chloride	RB	B-TEST
93	CD	O
,	,	O
co2	NN	B-TEST
19	CD	O
,	,	O
bun	NN	B-TEST
36	CD	O
,	,	O
creatinine	NN	B-TEST
1.5	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
84	CD	O
,	,	O
calcium	NN	B-TEST
11.7	CD	O
;	:	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
normal	JJ	O
.	.	O

kub	NN	B-TEST
:	:	O

consistent	NN	O
with	IN	O
adynamic	JJ	B-PROBLEM
ileus	NN	I-PROBLEM
.	.	O

sulfonamides	NNS	B-TREATMENT

svd	NN	B-TREATMENT

d&c	NN	B-TREATMENT

supracervical	JJ	B-TREATMENT
hysterectomy	NN	I-TREATMENT

reexploration	NN	B-TEST
with	IN	O
vaginal	JJ	B-TREATMENT
artery	NN	I-TREATMENT
ligation	NN	I-TREATMENT

multiple	JJ	B-TREATMENT
transfusions	NNS	I-TREATMENT

36	CD	O
yo	JJ	O
g3p2	NN	O
at	IN	O
38+5	CD	O
weeks	NNS	O
ga	RB	O
presented	VBN	O
to	TO	O
l&d	VB	O
for	IN	O
elective	JJ	B-TREATMENT
induction	NN	I-TREATMENT
of	IN	I-TREATMENT
labor	NN	I-TREATMENT
.	.	O

narcolepsy	NN	B-PROBLEM
.	.	O

r	NN	B-PROBLEM
inguinal	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

svdx2	NN	B-TREATMENT

vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
on	IN	O
admission	NN	O
.	.	O

abd	NN	B-PROBLEM
gravid	NN	I-PROBLEM
,	,	O
nt	NN	B-PROBLEM

ext	NN	O
without	IN	O
edema	NN	B-PROBLEM

2016-12-15	JJ	O
03:31	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
6.2	CD	O
rbc	NN	B-TEST
-	:	O
3.82	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.2	CD	O
hct	NN	B-TEST
-	:	O
34.5	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
32.0	CD	O
mchc	SYM	B-TEST
-	:	O
35.4	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
12.7	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
246	CD	O

2016-12-21	JJ	O
07:45	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
6.6	CD	O
rbc	NN	B-TEST
-	:	O
2.79	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
23.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
86	CD	O
mch	SYM	B-TEST
-	:	O
30.5	CD	O
mchc	SYM	B-TEST
-	:	O
35.7	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
16.9	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
222	CD	O
#	#	O

after	IN	O
admission	NN	O
to	TO	O
l&d	VB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
administered	VBN	O
pitocin	NN	B-TREATMENT
for	IN	O
elective	JJ	B-TREATMENT
induction	NN	I-TREATMENT
of	IN	I-TREATMENT
labor	NN	I-TREATMENT
and	CC	O
progressed	VBD	O
uneventfully	RB	O
and	CC	O
went	VBD	O
on	IN	O
to	TO	O
deliver	VB	O
a	DT	O
viable	JJ	O
female	NN	O
infant	NN	O
,	,	O
weight	NN	B-TEST
3595	CD	O
g	NN	O
,	,	O
apgars	VBZ	B-TEST
11-11	JJ	O
.	.	O

ebl	NN	B-PROBLEM
during	IN	O
delivery	NN	O
was	VBD	O
300	CD	O
cc	NN	O
.	.	O

soon	RB	O
after	IN	O
transfer	NN	O
,	,	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
post	NN	I-PROBLEM
partum	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
treated	VBN	O
with	IN	O
transfer	NN	O
back	RB	O
to	TO	O
l&d	NN	O
,	,	O
bimanual	JJ	B-TREATMENT
massage	NN	I-TREATMENT
,	,	O
administration	NN	O
of	IN	O
various	JJ	B-TREATMENT
uterotonics	NNS	I-TREATMENT
,	,	O
namely	RB	O
pitocin	JJ	B-TREATMENT
100	CD	O
u	NN	O
,	,	O
methergine	NN	B-TREATMENT
x	NN	O
1	CD	O
,	,	O
hemabate	NN	B-TREATMENT
x	NN	O
1	CD	O
,	,	O
and	CC	O
cytotec	JJ	B-TREATMENT
1000	CD	O
mcgs	NN	O
with	IN	O
minimal	JJ	O
response	NN	O
.	.	O

patient	JJ	O
underwent	JJ	O
suction	NN	B-TREATMENT
curettage	NN	I-TREATMENT
and	CC	O
finally	RB	O
a	DT	B-TREATMENT
supercervical	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

ebl	NN	B-PROBLEM
4000	CD	O
cc	NN	O
;	:	O
ivf	JJ	B-TREATMENT
6000	CD	O
cc	NN	O
crystalloid	NN	B-TREATMENT
;	:	O
u/o	JJ	B-TEST
3500	CD	O
cc	NN	O
.	.	O

8	CD	B-TREATMENT
units	NNS	I-TREATMENT
rbc	VBP	I-TREATMENT
,	,	O
6ffp	CD	B-TREATMENT
,	,	O
1	CD	B-TREATMENT
cryo	NN	I-TREATMENT
,	,	O
1	CD	B-TREATMENT
pack	NN	I-TREATMENT
plt	NN	I-TREATMENT
.	.	O

after	IN	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
again	RB	O
hemorrhaged	VBN	O
in	IN	O
the	DT	O
icu	NN	O
and	CC	O
was	VBD	O
taken	VBN	O
back	RB	O
to	TO	O
the	DT	O
or	CC	O
for	IN	O
reexploration	NN	B-TEST
and	CC	O
ligation	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
bleeding	JJ	I-PROBLEM
vaginal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

ebl	JJ	B-PROBLEM
3500	CD	O
;	:	O
ivf	JJ	B-TREATMENT
4000	CD	O
;	:	O
uo	JJ	B-TEST
45	CD	O
;	:	O
rbc	VB	B-TREATMENT
9u	CD	O
;	:	O
plt	CC	B-TREATMENT
12	CD	O
pack	NN	O
;	:	O
1u	CD	B-TREATMENT
cryo	NN	I-TREATMENT
;	:	O
6u	CD	B-TREATMENT
ffp	NN	I-TREATMENT
.	.	O

for	IN	O
details	NNS	O
of	IN	O
these	DT	B-TREATMENT
procedures	NNS	I-TREATMENT
,	,	O
please	VB	O
see	VB	O
op	JJ	O
notes	NNS	O
dictated	VBN	O
by	IN	O
dr.	JJ	O
day	NN	O
on	IN	O
2016-12-16	JJ	O
.	.	O

overall	JJ	O
,	,	O
the	DT	O
pt	NN	O
maintained	VBD	O
good	JJ	O
bp	NN	B-TEST
throughout	IN	O
and	CC	O
was	VBD	O
on	IN	O
pressors	NNS	B-TREATMENT
only	RB	O
briefly	NN	O
.	.	O

hct	NN	B-TEST
was	VBD	O
maintained	VBN	O
in	IN	O
stable	JJ	O
range	NN	O
with	IN	O
product	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
,	,	O
she	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
off	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
percocet	NN	B-TREATMENT
and	CC	O
motrin	NN	B-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
she	PRP	O
voided	VBD	O
without	IN	O
problems	NNS	B-PROBLEM
.	.	O

cylert	NN	B-TREATMENT
.	.	O

1.	CD	O
ibuprofen	JJ	B-TREATMENT
600	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
oxycodone	CD	B-TREATMENT
-	:	I-TREATMENT
acetaminophen	NN	I-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

full	JJ	O
term	NN	O
pregnancy	NN	O
,	,	O
s/p	NN	O
svd	NN	B-TREATMENT

uterine	JJ	B-PROBLEM
atony	NN	I-PROBLEM
,	,	O
postpartum	NN	B-PROBLEM
hemorrhage	NN	I-PROBLEM

severe	JJ	B-PROBLEM
anemia	NN	I-PROBLEM

6	CD	O
wks	NN	O
for	IN	O
postpartum	NN	B-TEST
exam	NN	I-TEST

monday	NN	O
for	IN	O
staple	JJ	B-TREATMENT
removal	NN	I-TREATMENT
.	.	O

right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
osteoarthritis	NN	I-PROBLEM
.	.	O

asthma	NN	B-PROBLEM
,	,	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
constipation	NN	B-PROBLEM
.	.	O

right	JJ	B-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
arthroplasty	NN	I-TREATMENT
.	.	O

right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
62-year-old	JJ	O
hospice	NN	O
chaplain	NN	O
who	WP	O
was	VBD	O
referred	VBN	O
by	IN	O
dr.	NN	O
tomedankell	NN	O
flowayles	NNS	O
and	CC	O
dr.	NN	O
es	VBP	O
oarekote	NN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
right	JJ	I-PROBLEM
hip	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

he	PRP	O
states	VBZ	O
that	IN	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
has	VBZ	O
been	VBN	O
of	IN	O
seven	CD	O
to	TO	O
eight	CD	O
durations	NNS	O
,	,	O
and	CC	O
rated	VBN	O
as	IN	O
moderate	JJ	O
to	TO	O
severe	VB	O
(	(	O
7/10	CD	O
)	)	O
.	.	O

he	PRP	O
does	VBZ	O
not	RB	O
use	VB	O
a	DT	B-TREATMENT
cane	NN	I-TREATMENT
and	CC	O
he	PRP	O
requires	VBZ	O
a	DT	O
bannister	NN	O
for	IN	O
going	VBG	O
up	RB	O
and	CC	O
down	RB	O
stairs	NNS	O
.	.	O

he	PRP	O
uses	VBZ	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
.	.	O

asthma	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
non-small-cell	JJ	B-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
removed	VBN	O
from	IN	O
his	PRP$	O
right	NN	O
lung	NN	O
by	IN	O
dr.	JJ	O
vital	JJ	O
four	CD	O
years	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
status	NN	O
post	NN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
for	IN	O
the	DT	B-PROBLEM
non-small-cell	JJ	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
history	NN	O
of	IN	O
constipation	NN	B-PROBLEM
.	.	O

prilosec	NN	B-TREATMENT
,	,	O
20	CD	O
mg.	NN	O
po	NN	O
q.day	NN	O
;	:	O
singulair	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

he	PRP	O
walks	VBZ	O
with	IN	O
a	DT	B-PROBLEM
limp	NN	I-PROBLEM
related	VBN	O
to	TO	O
his	PRP$	O
right	JJ	O
hip	NN	O
.	.	O

his	PRP$	O
right	JJ	O
hip	NN	O
is	VBZ	O
irritable	JJ	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
10-degree	JJ	I-PROBLEM
fixed	JJ	I-PROBLEM
flexion	NN	I-PROBLEM
contracture	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
x-rays	JJ	I-TEST
show	NN	O
advanced	VBD	B-PROBLEM
osteoarthritis	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
right	JJ	I-PROBLEM
hip	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
62-year-old	JJ	O
male	NN	O
with	IN	O
severe	JJ	B-PROBLEM
osteoarthritis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
hip	NN	I-PROBLEM
who	WP	O
after	IN	O
discussion	NN	O
,	,	O
including	VBG	O
the	DT	O
nature	NN	O
,	,	O
risks	NNS	O
,	,	O
benefits	NNS	O
and	CC	O
alternative	JJ	O
treatment	NN	O
plans	NNS	O
,	,	O
signed	VBD	O
informed	JJ	O
consent	NN	O
for	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
march	NN	O
11	CD	O
,	,	O
2002	CD	O
,	,	O
and	CC	O
underwent	VBD	O
an	DT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT
right	JJ	I-TREATMENT
total	NN	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
post	NN	O
anesthesia	NN	O
care	NN	O
unit	NN	O
and	CC	O
then	RB	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

on	IN	O
postoperative	JJ	B-TEST
check	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
doing	VBG	O
well	RB	O
.	.	O

he	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
his	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
34.7	CD	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
for	IN	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
and	CC	O
ancef	NN	B-TREATMENT
for	IN	O
routine	JJ	B-TREATMENT
antimicrobial	JJ	I-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
posterior	JJ	B-TREATMENT
hip	NN	I-TREATMENT
dislocation	NN	I-TREATMENT
precautions	NNS	I-TREATMENT
and	CC	O
was	VBD	O
out	IN	O
of	IN	O
bed	NN	O
with	IN	O
physical	JJ	O
therapy	NN	O
and	CC	O
occupational	JJ	O
therapy	NN	O
.	.	O

he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

his	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

his	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
was	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
and	CC	O
intact	JJ	O
with	IN	O
no	DT	O
erythema	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
34.8	CD	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
,	,	O
lower	JJR	B-TEST
extremity	NN	I-TEST
noninvasive	JJ	I-TEST
ultrasounds	NNS	I-TEST
were	VBD	O
performed	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
,	,	O
1	CD	O
mg.	NN	O
po	NN	O
q.d.;	NN	O
multivitamin	NN	B-TREATMENT
,	,	O
one	CD	O
capsule	NN	O
po	NN	O
q.day	NN	O
;	:	O

ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
,	,	O
325	CD	O
mg.	NN	O
po	NN	O
t.i.d.;	NN	O

colace	NN	B-TREATMENT
,	,	O
100	CD	O
mg.	NN	O
po	NN	O
t.i.d.;	NN	O

tylenol	NN	B-TREATMENT
,	,	O
650	CD	O
mg.	NN	O
po	NN	O
q.4	NN	O
hours	NNS	O
,	,	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
;	:	O

milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
,	,	O
30	CD	O
ml.	NN	O
po	NN	O
q.day	NN	O
,	,	O
p.r.n.	JJ	O
constipation	NN	B-PROBLEM
;	:	O

coumadin	NN	B-TREATMENT
,	,	O
2.5	CD	O
mg.	NN	O
po	NN	O
q.p.m.	NN	O
,	,	O
dose	VB	O
to	TO	O
vary	JJ	O
per	IN	O
inr	JJ	B-TEST
level	NN	I-TEST
;	:	O

percocet	NN	B-TREATMENT
5/325	CD	O
mg.	NN	O
s	NN	O
,	,	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
po	VBP	O
q.4	NN	O
to	TO	O
6	CD	O
hours	NNS	O
p.r.n.	JJ	O
pain	NN	B-PROBLEM
;	:	O

singulair	NN	B-TREATMENT
,	,	O
10	CD	O
mg.	NN	O
po	NN	O
q.h.s.;	NN	O

nexium	NN	B-TREATMENT
,	,	O
10	CD	O
mg.	NN	O
po	NN	O
q.day	NN	O
;	:	O

metamucil	NN	B-TREATMENT
instant	JJ	I-TREATMENT
mix	NN	I-TREATMENT
,	,	O
one	CD	O
teaspoon	NN	O
po	NN	O
q.day	NN	O
;	:	O

peri-colace	NN	B-TREATMENT
,	,	O
two	CD	O
capsules	NNS	O
po	VBP	O
b.i.d.;	JJ	O
dulcolax	NN	B-TREATMENT
,	,	O
10	CD	O
mg.	NN	O
pr	NN	O
q.day	NN	O
,	,	O
p.r.n.	JJ	O
constipation	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
follow-up	JJ	O
with	IN	O
dr.	JJ	O
class	NN	O
six	CD	O
weeks	NNS	O
from	IN	O
the	DT	O
date	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
staples	NNS	I-TREATMENT
should	MD	O
be	VB	O
removed	VBN	O
10	CD	O
to	TO	O
14	CD	O
days	NNS	O
from	IN	O
the	DT	O
date	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

if	IN	O
his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
is	VBZ	O
dry	JJ	O
,	,	O
he	PRP	O
may	MD	O
shower	VB	O
.	.	O

he	PRP	O
is	VBZ	O
to	TO	O
ambulate	VB	O
with	IN	O
crutches	NNS	B-TREATMENT
or	CC	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
and	CC	O
be	VB	O
on	IN	O
posterior	JJ	B-TREATMENT
hip	NN	I-TREATMENT
dislocation	NN	I-TREATMENT
precautions	NNS	I-TREATMENT
for	IN	O
three	CD	O
months	NNS	O
following	VBG	O
the	DT	O
date	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

he	PRP	O
should	MD	O
be	VB	O
on	IN	O
coumadin	NN	B-TREATMENT
for	IN	O
anticoagulation	NN	B-TREATMENT
for	IN	O
three	CD	O
weeks	NNS	O
from	IN	O
the	DT	O
date	NN	O
of	IN	O
surgery	NN	B-TREATMENT
with	IN	O
twice	JJ	O
weekly	JJ	O
blood	NN	B-TEST
draws	NN	I-TEST
for	IN	O
inr	NN	B-TEST
with	IN	O
a	DT	O
goal	NN	O
of	IN	O
1.5	CD	O
to	TO	O
2.0	CD	O
.	.	O

after	IN	O
initial	JJ	B-TEST
trauma	JJ	I-TEST
assessment	NN	I-TEST
and	CC	O
initiation	NN	O
of	IN	O
resuscitation	NN	B-TREATMENT
,	,	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

images	NNS	B-TEST
of	IN	I-TEST
his	PRP$	I-TEST
head	NN	I-TEST
,	,	I-TEST
abdomen	NNS	I-TEST
,	,	I-TEST
and	CC	I-TEST
thorax	NN	I-TEST
were	VBD	O
obtained	VBN	O
.	.	O

his	PRP$	B-PROBLEM
injuries	NNS	I-PROBLEM
included	VBD	O
bilateral	JJ	B-PROBLEM
zygomal	NN	I-PROBLEM
and	CC	I-PROBLEM
orbital	JJ	I-PROBLEM
rim	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
bilateral	JJ	B-PROBLEM
frontal	JJ	I-PROBLEM
contusions	NNS	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
epidural	JJ	I-PROBLEM
versus	NN	O
subdural	JJ	B-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

the	DT	O
anterior	JJ	O
and	CC	O
posterior	NN	O
of	IN	O
the	DT	O
frontal	JJ	O
sinus	NN	O
was	VBD	O
fractured	VBN	B-PROBLEM
with	IN	O
communication	NN	B-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
ethmoid	JJ	I-PROBLEM
air	NN	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
presumably	RB	O
caused	VBD	O
air	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
orbit	NN	I-PROBLEM
.	.	O

initial	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
in	IN	O
the	DT	O
80s	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
150/80s	CD	O
.	.	O

he	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
with	IN	O
multiple	JJ	B-PROBLEM
abrasions	NNS	I-PROBLEM
,	,	O
and	CC	O
severe	JJ	B-PROBLEM
swelling	NN	I-PROBLEM
and	CC	O
contusions	NNS	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
face	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
boston	NN	I-TEST
coma	NN	I-TEST
scale	NN	I-TEST
was	VBD	O
16	CD	O
.	.	O

the	DT	B-TEST
response	NN	I-TEST
was	VBD	O
brisk	JJ	O
.	.	O

initial	JJ	B-TEST
evaluation	NN	I-TEST
revealed	VBD	O
corticate	JJ	B-PROBLEM
posturing	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
by	IN	O
the	DT	O
trauma	NN	O
team	NN	O
.	.	O

he	PRP	O
withdrew	VBD	O
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
equally	RB	O
and	CC	O
purposefully	RB	O
after	IN	O
20	CD	O
minutes	NNS	O
in	IN	O
the	DT	O
trauma	NN	O
bay	NN	O
.	.	O

upon	IN	O
arrival	NN	O
,	,	O
neurosurgery	RB	O
promptly	RB	O
placed	VBN	O
v.	NN	B-TREATMENT
holtzen	NN	I-TREATMENT
bolt	NN	I-TREATMENT
.	.	O

this	DT	O
allowed	VBD	O
continuous	JJ	B-TEST
monitoring	NN	I-TEST
of	IN	I-TEST
intracranial	JJ	I-TEST
pressure	NN	I-TEST
.	.	O

notably	RB	O
,	,	O
intracranial	JJ	B-TEST
pressure	NN	I-TEST
was	VBD	O
17	CD	O
when	WRB	O
the	DT	B-TREATMENT
bolt	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

during	IN	O
his	PRP$	O
hospitalization	NN	O
,	,	O
his	PRP$	B-TEST
intracranial	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
monitored	VBN	O
very	RB	O
closely	RB	O
and	CC	O
maintained	VBD	O
to	TO	O
a	DT	O
level	NN	O
of	IN	O
less	JJR	O
than	IN	O
20	CD	O
.	.	O

to	TO	O
do	VB	O
this	DT	O
,	,	O
mannitol	VBZ	B-TREATMENT
25	CD	O
mg	NN	O
q.	VBD	O
6h.	CD	O
was	VBD	O
used	VBN	O
.	.	O

while	IN	O
using	VBG	O
mannitol	NN	B-TREATMENT
,	,	O
his	PRP$	B-TEST
serum	NN	I-TEST
osmolalities	NNS	I-TEST
were	VBD	O
followed	VBN	O
closely	RB	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
to	TO	O
monitoring	VBG	O
his	PRP$	B-TEST
intracranial	JJ	I-TEST
pressure	NN	I-TEST
,	,	O
his	PRP$	B-TEST
systemic	JJ	I-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
were	VBD	O
maintained	VBN	O
in	IN	O
such	JJ	O
a	DT	O
manner	NN	O
that	IN	O
his	PRP$	B-TEST
cerebral	JJ	I-TEST
perfusion	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
maintained	VBN	O
at	IN	O
70	CD	O
mmhg	NN	O
.	.	O

a	DT	B-TEST
parameter	NN	I-TEST
monitor	NN	I-TEST
for	IN	O
his	PRP$	O
neurologic	JJ	O
status	NN	O
paco2	NN	B-TEST
which	WDT	O
was	VBD	O
maintained	VBN	O
between	IN	O
35	CD	O
and	CC	O
40	CD	O
during	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

mr.	NN	O
roach	NN	O
was	VBD	O
kept	VBN	O
sedated	VBN	B-TREATMENT
with	IN	O
propofol	NN	B-TREATMENT
and	CC	O
was	VBD	O
given	VBN	O
fentanyl	NNS	B-TREATMENT
and	CC	O
/	NN	O
or	CC	O
morphine	NN	B-TREATMENT
boluses	NNS	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
checks	NNS	I-TEST
were	VBD	O
followed	VBN	O
initially	RB	O
every	DT	O
one	CD	O
hour	NN	O
and	CC	O
then	RB	O
every	DT	O
two	CD	O
hours	NNS	O
to	TO	O
monitor	VB	O
for	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
neurologic	JJ	I-PROBLEM
examination	NN	I-PROBLEM
.	.	O

during	IN	O
his	PRP$	O
hospitalization	NN	O
,	,	O
two	CD	O
subsequent	JJ	O
cat	NN	B-TEST
scans	NNS	I-TEST
were	VBD	O
obtained	VBN	O
;	:	O
one	CD	O
on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
.	.	O

this	DT	B-TEST
cat	NN	I-TEST
scan	JJ	I-TEST
revealed	VBD	O
possible	JJ	O
worsening	NN	O
and	CC	O
was	VBD	O
read	VBN	O
as	IN	O
epidural	JJ	B-PROBLEM
versus	IN	O
subdural	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

after	IN	O
a	DT	O
discussion	NN	O
with	IN	O
both	DT	O
radiology	NN	O
and	CC	O
neurosurgery	NN	O
,	,	O
the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
that	IN	O
the	DT	O
worsening	NN	O
did	VBD	O
not	RB	O
appear	VB	O
significant	JJ	O
,	,	O
and	CC	O
this	DT	O
was	VBD	O
not	RB	O
accompanied	VBN	O
by	IN	O
a	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
clinical	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
intracranial	JJ	I-TEST
pressure	NN	I-TEST
remained	VBD	O
stable	JJ	O
,	,	O
and	CC	O
his	PRP$	B-TEST
clinical	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
unchanged	JJ	O
.	.	O

an	DT	B-TEST
additional	JJ	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
on	IN	O
hospital	NN	O
day	NN	O
three	CD	O
.	.	O

this	DT	B-TEST
examination	NN	I-TEST
was	VBD	O
unchanged	JJ	O
from	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
examination	NN	I-TEST
.	.	O

again	RB	O
,	,	O
his	PRP$	B-TEST
intracranial	JJ	I-TEST
pressure	NN	I-TEST
and	CC	O
neurologic	JJ	B-TEST
examination	NN	I-TEST
remained	VBD	O
the	DT	O
same	JJ	O
,	,	O
and	CC	O
conservative	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
was	VBD	O
opted	VBN	O
for	IN	O
.	.	O

as	IN	O
described	VBN	O
in	IN	O
previous	JJ	O
section	NN	O
,	,	O
neo-synephrine	JJ	B-TREATMENT
and	CC	O
eventually	RB	O
levophed	VBN	B-TREATMENT
were	VBD	O
used	VBN	O
to	TO	O
maintain	VB	O
a	DT	B-TEST
coronary	JJ	I-TEST
perfusion	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
70	CD	O
.	.	O

a	DT	B-TREATMENT
pulmonary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
on	IN	O
hospital	JJ	O
day	NN	O
four	CD	O
.	.	O

this	DT	B-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
when	WRB	O
the	DT	O
patient	NN	O
started	VBD	O
to	TO	O
demonstrate	VB	O
septic	JJ	B-PROBLEM
physiology	NN	I-PROBLEM
and	CC	O
for	IN	O
increasing	VBG	O
pressor	NN	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

mr.	NN	O
roach	NN	O
was	VBD	O
n.p.o.	RB	B-TREATMENT
from	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
admission	NN	O
.	.	O

a	DT	B-TREATMENT
orogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
passed	VBN	O
.	.	O

initially	RB	O
during	IN	O
admission	NN	O
,	,	O
carafate	NN	B-TREATMENT
was	VBD	O
given	VBN	O
down	RP	O
the	DT	B-TREATMENT
orogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
on	IN	O
a	DT	B-TEST
routine	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
shot	NN	O
on	IN	O
hospital	NN	O
day	NN	O
three	CD	O
,	,	O
a	DT	B-PROBLEM
mediastinum	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

this	DT	O
raised	VBD	O
the	DT	O
question	NN	O
of	IN	O
potential	JJ	O
esophageal	JJ	B-PROBLEM
rupture	NN	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
point	NN	O
,	,	O
his	PRP$	B-TREATMENT
carafate	NN	I-TREATMENT
was	VBD	O
switched	VBN	O
to	TO	O
intravenous	JJ	B-TREATMENT
protonix	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
strictly	RB	B-TREATMENT
n.p.o.	JJ	I-TREATMENT

throughout	IN	O
mr.	JJ	O
richard	JJ	O
admission	NN	O
,	,	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
in	IN	O
the	DT	O
low	JJ	O
30s	CD	O
.	.	O

as	IN	O
will	MD	O
be	VB	O
discussed	VBN	O
in	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
section	NN	O
,	,	O
he	PRP	O
developed	VBD	O
an	DT	O
episode	NN	O
of	IN	O
what	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
sepsis	NN	B-PROBLEM
,	,	O
and	CC	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
peaked	VBD	O
at	IN	O
23	CD	O
.	.	O

mr.	NN	O
roach	NN	O
was	VBD	O
on	IN	O
pneumo	JJ	B-TREATMENT
boots	NNS	I-TREATMENT
spontaneous	JJ	I-TREATMENT
compression	NN	I-TREATMENT
devices	NNS	I-TREATMENT
for	IN	O
deep	JJ	B-TREATMENT
venous	JJ	I-TREATMENT
thrombosis	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
not	RB	O
a	DT	O
candidate	NN	O
for	IN	O
subcutaneous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
as	IN	O
we	PRP	O
were	VBD	O
concerned	VBN	O
of	IN	O
an	DT	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

an	DT	B-TREATMENT
inferior	JJ	I-TREATMENT
vena	NN	I-TREATMENT
cava	NN	I-TREATMENT
filter	NN	I-TREATMENT
was	VBD	O
considered	VBN	O
but	CC	O
was	VBD	O
deferred	VBN	O
,	,	O
as	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
mr.	FW	O
roach	NN	O
was	VBD	O
too	RB	B-PROBLEM
unstable	JJ	I-PROBLEM
to	TO	O
undergo	VB	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

mr.	NN	O
marian	JJ	O
blood	NN	B-TEST
sugar	NN	I-TEST
was	VBD	O
maintained	VBN	O
under	IN	O
tight	JJ	O
control	NN	O
from	IN	O
100	CD	O
to	TO	O
130	CD	O
using	VBG	O
a	DT	B-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
sliding-scale	NN	I-TREATMENT
.	.	O

mr.	NN	O
roach	NN	O
had	VBD	O
a	DT	B-PROBLEM
spike	NN	I-PROBLEM
in	IN	I-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
count	NN	I-PROBLEM
and	CC	O
developed	VBD	O
fevers	NNS	B-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
pertinent	JJ	O
for	IN	O
one	CD	O
bottle	NN	O
of	IN	O
gram	JJ	B-PROBLEM
-	:	I-PROBLEM
positive	JJ	I-PROBLEM
coagulase	NN	I-PROBLEM
-	:	I-PROBLEM
negative	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
which	WDT	O
grew	VBD	O
from	IN	O
08-25	JJ	O
.	.	O

his	PRP$	B-TEST
preliminary	JJ	I-TEST
cultures	NNS	I-TEST
including	VBG	O
sputum	NN	O
from	IN	O
08-25	JJ	O
grew	VBD	O
escherichia	JJ	B-PROBLEM
coli	NN	I-PROBLEM
.	.	O

sputum	NN	B-TEST
from	IN	O
08-27	JJ	O
grew	VBD	O
gram-negative	JJ	B-PROBLEM
rods	NNS	I-PROBLEM
,	,	O
not	RB	O
yet	RB	O
speciated	VBN	O
,	,	O
and	CC	O
from	IN	O
08-27	CD	O
a	DT	B-TEST
bronchoalveolar	JJ	I-TEST
lavage	NN	I-TEST
grew	VBD	O
1+	CD	B-PROBLEM
gram-negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
and	CC	O
4+	CD	B-PROBLEM
polymorphonuclear	JJ	I-PROBLEM
lymphocytes	NNS	I-PROBLEM
.	.	O

throughout	IN	O
this	DT	O
time	NN	O
,	,	O
mr.	FW	O
richard	JJ	O
temperature	NN	B-TEST
continued	VBD	O
to	TO	O
increase	VB	O
and	CC	O
was	VBD	O
such	JJ	O
that	IN	O
on	IN	O
hospital	JJ	O
day	NN	O
four	CD	O
,	,	O
his	PRP$	B-TEST
temperature	NN	I-TEST
maximum	NN	I-TEST
was	VBD	O
42.2	CD	O
degrees	NNS	O
centigrade	NN	O
.	.	O

during	IN	O
his	PRP$	O
hospitalization	NN	O
,	,	O
his	PRP$	O
was	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
gram-negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
,	,	O
imipenem	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

initially	RB	O
,	,	O
he	PRP	O
had	VBD	O
been	VBN	O
placed	VBN	O
on	IN	O
clindamycin	NN	B-TREATMENT
to	TO	O
cover	VB	O
his	PRP$	B-TREATMENT
drain	NN	I-TREATMENT
,	,	O
but	CC	O
his	PRP$	B-TEST
cultures	NNS	I-TEST
became	VBD	O
positive	JJ	B-PROBLEM
,	,	O
and	CC	O
his	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
increased	VBD	O
.	.	O

he	PRP	O
was	VBD	O
switched	VBN	O
from	IN	O
clindamycin	NN	B-TREATMENT
to	TO	O
the	DT	B-TREATMENT
imipenem	NN	I-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

vancomycin	NN	B-TREATMENT
was	VBD	O
added	VBN	O
when	WRB	O
we	PRP	O
had	VBD	O
the	DT	B-PROBLEM
positive	JJ	I-PROBLEM
blood	NN	I-PROBLEM
culture	NN	I-PROBLEM
.	.	O

with	IN	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
of	IN	O
102	CD	O
,	,	O
up	RB	O
to	TO	O
42	CD	O
degrees	NNS	O
centigrade	VBN	O
,	,	O
aggressive	JJ	B-TREATMENT
measures	NNS	I-TREATMENT
including	VBG	O
cooling	VBG	B-TREATMENT
blankets	NNS	I-TREATMENT
,	,	O
alcohol	NN	B-TREATMENT
swabs	NN	I-TREATMENT
,	,	O
and	CC	O
fans	NNS	B-TREATMENT
were	VBD	O
used	VBN	O
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
bring	VB	O
his	PRP$	B-TEST
body	NN	I-TEST
temperature	NN	I-TEST
down	RP	O
.	.	O

hypercarbia	NN	B-PROBLEM
would	MD	O
result	VB	O
and	CC	O
increase	VB	O
in	IN	O
cerebral	JJ	O
perfusion	NN	O
,	,	O
paralysis	NN	B-TREATMENT
was	VBD	O
initiated	VBN	O
to	TO	O
decrease	VB	O
genesis	NN	O
of	IN	O
carbon	NN	O
dioxide	NN	O
secreted	VBD	O
during	IN	O
shivering	NN	B-PROBLEM
.	.	O

as	IN	O
discussed	VBN	O
in	IN	O
the	DT	O
infectious	JJ	O
disease	NN	O
section	NN	O
,	,	O
mr.	FW	O
roach	NN	O
developed	VBD	O
a	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
likely	RB	O
from	IN	O
gram-negative	JJ	B-PROBLEM
organisms	NNS	I-PROBLEM
,	,	O
but	CC	O
most	JJS	O
likely	JJ	O
from	IN	O
escherichia	JJ	B-PROBLEM
coli	NN	I-PROBLEM
.	.	O

for	IN	O
this	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
placed	VBN	O
empirically	RB	O
on	IN	O
imipenem	NN	B-TREATMENT
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

on	IN	O
hospital	NN	O
day	NN	O
three	CD	O
,	,	O
mr.	FW	O
roach	NN	O
had	VBD	O
developed	VBN	O
an	DT	O
episode	NN	O
of	IN	O
tachycardia	NN	B-PROBLEM
and	CC	O
tachypnea	NN	B-PROBLEM
.	.	O

for	IN	O
this	DT	O
,	,	O
a	DT	B-TEST
ct	NN	I-TEST
angiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
demonstrated	VBD	O
no	DT	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
four	CD	O
,	,	O
a	DT	B-TEST
routine	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
left-sided	JJ	I-PROBLEM
pneumothorax	NN	I-PROBLEM
.	.	O

for	IN	O
this	DT	O
,	,	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
#34	NN	I-TREATMENT
caucasian	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

on	IN	O
the	DT	O
evening	NN	O
of	IN	O
hospital	JJ	O
day	NN	O
four	CD	O
,	,	O
mr.	FW	O
roach	NN	O
had	VBD	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
episode	NN	I-PROBLEM
whereby	WRB	O
his	PRP$	B-TEST
central	JJ	I-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
rose	VBD	O
sharply	RB	O
and	CC	O
immediately	RB	O
followed	VBN	O
by	IN	O
a	DT	O
period	NN	O
of	IN	O
asystole	NN	B-PROBLEM
.	.	O

urgent	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
measures	NNS	I-TREATMENT
were	VBD	O
initiated	VBN	O
.	.	O

the	DT	B-TREATMENT
measures	NNS	I-TREATMENT
included	VBD	O
attempts	NNS	O
at	IN	O
pacing	NN	B-TREATMENT
.	.	O

epinephrine	NN	B-TREATMENT
and	CC	O
atropine	NN	B-TREATMENT
were	VBD	O
administered	VBN	O
as	IN	O
were	VBD	O
bicarbonate	NN	B-TREATMENT
and	CC	O
calcium	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
asystole	NN	B-PROBLEM
preceded	VBN	O
by	IN	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
rise	NN	I-PROBLEM
in	IN	I-PROBLEM
central	JJ	I-PROBLEM
venous	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
included	VBD	O
attention	NN	B-PROBLEM
pneumothorax	NN	I-PROBLEM
,	,	O
cardiac	JJ	B-PROBLEM
tamponade	NN	I-PROBLEM
,	,	O
and	CC	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

during	IN	O
the	DT	B-TREATMENT
resuscitation	NN	I-TREATMENT
afterwards	NNS	O
,	,	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
a	DT	B-TREATMENT
patent	NN	I-TREATMENT
left	VBD	I-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
present	JJ	O
in	IN	O
the	DT	O
left	NN	O
chest	NN	O
,	,	O
so	RB	O
initially	RB	O
neo-decompression	NN	B-TREATMENT
was	VBD	O
attempted	VBN	O
in	IN	O
the	DT	O
right	JJ	O
chest	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
sign	NN	O
of	IN	O
attention	NN	B-PROBLEM
pneumothorax	NN	I-PROBLEM
with	IN	O
decompression	NN	B-TREATMENT
,	,	O
and	CC	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

during	IN	O
this	DT	O
time	NN	O
,	,	O
a	DT	B-TEST
needle	JJ	I-TEST
aspiration	NN	I-TEST
of	IN	O
what	WP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
the	DT	O
pericardium	NN	O
was	VBD	O
performed	VBN	O
revealing	VBG	O
bloody	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
coming	VBG	O
back	RB	O
.	.	O

a	DT	B-TREATMENT
left	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
thoracotomy	NN	I-TREATMENT
was	VBD	O
made	VBN	O
by	IN	O
the	DT	O
cardiac	JJ	O
surgery	NN	O
fellow	NN	O
who	WP	O
was	VBD	O
present	JJ	O
.	.	O

after	IN	O
30	CD	O
minutes	NNS	O
of	IN	O
active	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
including	VBG	O
internal	JJ	B-TREATMENT
cardiac	JJ	I-TREATMENT
massage	NN	I-TREATMENT
,	,	O
there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
return	NN	O
of	IN	O
vital	JJ	B-TEST
signs	NNS	I-TEST
or	CC	O
electric	JJ	B-TEST
activity	NN	I-TEST
to	TO	I-TEST
the	DT	I-TEST
heart	NN	I-TEST
as	IN	O
noted	VBN	O
on	IN	O
electrocardiogram	JJ	B-TEST
monitors	NNS	I-TEST
.	.	O

resuscitation	NN	B-TREATMENT
was	VBD	O
terminated	VBN	O
at	IN	O
1914	CD	O
on	IN	O
08-27	NN	O
.	.	O

after	IN	O
the	DT	O
termination	NN	O
of	IN	O
resuscitation	NN	B-TREATMENT
,	,	O
both	CC	O
the	DT	O
anesthesia	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
attending	NN	O
and	CC	O
the	DT	O
surgical	JJ	O
attending	NN	O
were	VBD	O
present	JJ	O
to	TO	O
discuss	VB	O
the	DT	O
proceedings	NNS	O
events	NNS	O
with	IN	O
the	DT	O
patient	NN	O
's	POS	O
family	NN	O
members	NNS	O
including	VBG	O
his	PRP$	O
next	JJ	O
of	IN	O
kin	NN	O
,	,	O
his	PRP$	O
mother	NN	O
.	.	O

permission	NN	O
for	IN	O
a	DT	B-TEST
postmortem	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
granted	VBN	O
.	.	O

maintenance	NN	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

maintenance	NN	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

malignant	JJ	B-PROBLEM
fibrous	JJ	I-PROBLEM
histiocytoma	NN	I-PROBLEM
of	IN	I-PROBLEM
duodenum	NN	I-PROBLEM
,	,	O
metastases	VBZ	B-PROBLEM
to	TO	I-PROBLEM
liver	VB	I-PROBLEM
,	,	O
anemia	NN	B-PROBLEM
.	.	O

intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
12/4/95	CD	O
through	IN	O
12/8/95	CD	O
.	.	O

ativan	RB	B-TREATMENT
1	CD	O
mg	NN	O
or	CC	O
trilafon	VB	B-TREATMENT
4	CD	O
mg	NN	O
q	NN	O
4	CD	O
hours	NNS	O
prn	JJ	O
nausea	NN	B-PROBLEM
,	,	O
carafate	VB	B-TREATMENT
one	CD	O
gram	NN	O
q.i.d.	NN	O

this	DT	O
63-year-old	JJ	O
man	NN	O
had	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
duodenum	NN	I-PROBLEM
,	,	O
discovered	VBN	O
in	IN	O
02/95	CD	O
.	.	O

a	DT	B-PROBLEM
leiomyosarcoma	NN	I-PROBLEM
was	VBD	O
resected	VBN	B-TREATMENT
after	IN	O
embolization	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
splenic	JJ	I-TREATMENT
artery	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
it	PRP	O
could	MD	O
not	RB	O
be	VB	O
completely	RB	O
excised	VBN	O
,	,	O
moreover	RB	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
metastasized	VBD	O
to	TO	O
the	DT	O
liver	NN	O
was	VBD	O
discovered	VBN	O
on	IN	O
follow	VB	B-TEST
up	RP	I-TEST
scan	JJ	I-TEST
in	IN	O
06/95	CD	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
receiving	VBG	O
chemotherapy	NN	B-TREATMENT
since	IN	O
then	RB	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

the	DT	O
neck	NN	O
is	VBZ	O
without	IN	O
adenopathy	NN	B-PROBLEM
.	.	O

heart	NN	O
without	IN	O
gallop	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
without	IN	O
mass	NN	B-PROBLEM
.	.	O

extremities	NNS	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
intact	NN	O
.	.	O

hematocrit	NN	B-TEST
33	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
4.4	CD	O
,	,	O
with	IN	O
28%	CD	O
monos	NNS	B-TEST
and	CC	O
30%	CD	O
polys	NN	B-TEST
and	CC	O
bands	NNS	B-TEST
.	.	O

platelets	NNS	B-TEST
253	CD	O
thousand	NN	O
.	.	O

creatinine	NN	B-TEST
0.6	CD	O
,	,	O
sgot	VBD	B-TEST
52	CD	O
,	,	O
bilirubin	VBD	B-TEST
0.5	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
hydrated	VBN	O
well	RB	O
and	CC	O
given	VBN	O
adriamycin	NNS	B-TREATMENT
27	CD	O
mg	NNS	O
and	CC	O
dtic	JJ	B-TREATMENT
450	CD	O
mg	JJ	O
daily	RB	O
for	IN	O
four	CD	O
days	NNS	O
.	.	O

he	PRP	O
also	RB	O
got	VBD	O
ifosfamide	RB	B-TREATMENT
3.6	CD	O
grams	NNS	O
a	DT	O
day	NN	O
with	IN	O
mesna	NN	B-TREATMENT
.	.	O

he	PRP	O
tolerated	VBD	O
treatment	NN	B-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
discharged	VBN	O
in	IN	O
good	JJ	O
condition	NN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
s/p	JJ	O
fall	NN	O
with	IN	O
left	JJ	B-PROBLEM
arm	NN	I-PROBLEM
pain	NN	I-PROBLEM

orif	NN	B-TREATMENT
left	VBD	B-PROBLEM
distal	JJ	I-PROBLEM
radius	NN	I-PROBLEM
fracture	NN	I-PROBLEM

he	PRP	O
fell	VBD	O
15-20	JJ	O
feet	NNS	O
onto	IN	O
concrete	NN	O
,	,	O
denies	VBZ	O
any	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consiousness	NN	I-PROBLEM
.	.	O

tachycardiac	JJ	B-PROBLEM
120-140	CD	O
,	,	O
regular	JJ	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST

soft	JJ	O
non-tender	JJ	B-PROBLEM
non-distended	JJ	B-PROBLEM

left	VBN	B-PROBLEM
elbow	NN	I-PROBLEM
,	,	I-PROBLEM
gross	JJ	I-PROBLEM
deformity	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
over	IN	I-PROBLEM
dorsal	JJ	I-PROBLEM
forearm	NN	I-PROBLEM
,	,	O
gross	JJ	B-PROBLEM
deformity	NN	I-PROBLEM
left	VBD	I-PROBLEM
wrist	NN	I-PROBLEM
,	,	O
no	DT	O
skin	JJ	B-PROBLEM
lacerations	NNS	I-PROBLEM
.	.	O

+	JJ	O
sensation	NN	O
,	,	O
movment	NN	O
,	,	O
pulses	NNS	O
,	,	O
some	DT	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
rom	NN	O

he	PRP	O
was	VBD	O
intoxicated	VBN	O
and	CC	O
tachycardic	VBN	B-PROBLEM
in	IN	O
the	DT	O
trauma	NN	O
bay	NN	O
.	.	O

his	PRP$	B-PROBLEM
injuries	NNS	I-PROBLEM
were	VBD	O
identified	VBN	O
as	IN	O
a	DT	B-PROBLEM
left	NN	I-PROBLEM
elbow	NN	I-PROBLEM
disloaction	NN	I-PROBLEM
with	IN	O
was	VBD	O
reduced	VBN	O
and	CC	O
splinted	VBN	O
.	.	O

also	RB	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
distal	JJ	I-PROBLEM
radius	NN	I-PROBLEM
fracture	NN	I-PROBLEM
with	IN	O
was	VBD	O
reduced	VBN	O
and	CC	O
splinted	VBN	O
.	.	O

also	RB	O
a	DT	B-PROBLEM
left	NN	I-PROBLEM
non	NN	I-PROBLEM
displaced	VBD	I-PROBLEM
sacral	JJ	I-PROBLEM
wing	NN	I-PROBLEM
fracture	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
inferior	JJ	I-PROBLEM
pubic	JJ	I-PROBLEM
ramus	NN	I-PROBLEM
fx	NN	I-PROBLEM
extending	VBG	O
the	DT	O
to	TO	O
inferior	VB	O
acetabulum	NN	O
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
trauma	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
tachycardia	NN	I-PROBLEM
which	WDT	O
was	VBD	O
not	RB	O
resolved	VBN	O
with	IN	O
pain	JJ	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

on	IN	O
2019-10-11	JJ	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
lopressor	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
tachycardia	NN	I-PROBLEM
which	WDT	O
had	VBD	O
good	JJ	O
effect	NN	O
.	.	O

also	RB	O
on	IN	O
2019-10-11	JJ	O
he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
an	DT	B-TREATMENT
orif	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
distal	JJ	I-PROBLEM
radius	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
pelvis	NN	I-PROBLEM
fracture	NN	I-PROBLEM
are	VBP	O
closed	VBN	O
treated	JJ	O
and	CC	O
he	PRP	O
can	MD	O
be	VB	O
weight	JJ	O
bearing	NN	O
as	IN	O
tolerated	VBN	O
on	IN	O
his	PRP$	O
right	JJ	O
leg	NN	O
and	CC	O
and	CC	O
nonweight	JJ	O
bearing	NN	O
on	IN	O
his	PRP$	O
left	JJ	O
leg	NN	O
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
continued	VBD	O
to	TO	O
be	VB	O
well	RB	O
controlled	VBN	O
with	IN	O
his	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
.	.	O

throught	NN	O
the	DT	O
stay	NN	O
his	PRP$	B-TEST
labs	NN	I-TEST
remained	VBD	O
normal	JJ	O
and	CC	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
controlled	VBD	O
.	.	O

he	PRP	O
was	VBD	O
instructed	VBN	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
conway	NN	O
in	IN	O
2	CD	O
weeks	NNS	O
and	CC	O
an	DT	O
appointment	NN	O
was	VBD	O
made	VBN	O
on	IN	O
11-15	NNS	O
for	IN	O
him	PRP	O
at	IN	O
the	DT	O
louis	NN	O
schubert	VBP	O
community	NN	O
health	NN	O
center	NN	O
to	TO	O
follow	VB	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
and	CC	O
continued	VBD	O
need	NN	O
for	IN	O
lopressor	NN	B-TREATMENT
.	.	O

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
enoxaparin	JJ	B-TREATMENT
30	CD	O
mg	NN	O
/	VBD	O
0.3	CD	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
30	CD	O
mg	JJ	O
syringe	NN	O
subcutaneous	JJ	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
4	CD	O
weeks	NNS	O
.	.	O

3.	CD	O
oxycodone	CD	B-TREATMENT
-	:	O
acetaminophen	NN	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

continue	NN	O
to	TO	O
wear	VB	O
your	PRP$	B-TREATMENT
left	JJ	I-TREATMENT
arm	NN	I-TREATMENT
splint	NN	I-TREATMENT
,	,	O
but	CC	O
take	VB	O
it	PRP	O
off	RP	O
daily	JJ	O
to	TO	O
inspect	VB	O
your	PRP$	O
skin	NN	O

continue	VB	O
your	PRP$	B-TREATMENT
lovenox	JJ	I-TREATMENT
injections	NNS	I-TREATMENT
as	IN	O
instructed	JJ	O

if	IN	O
you	PRP	O
notice	VBP	O
any	DT	O
increase	NN	B-PROBLEM
in	IN	I-PROBLEM
swelling	VBG	I-PROBLEM
or	CC	O
erythemia	NN	B-PROBLEM
at	IN	O
the	DT	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
or	CC	O
if	IN	O
you	PRP	O
become	VBP	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
if	IN	O
you	PRP	O
have	VBP	O
a	DT	B-TEST
temperature	NN	I-TEST
greater	JJR	O
than	IN	O
101.4	CD	O
please	NN	O
call	VB	O
the	DT	O
office	NN	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O

treatments	NNS	O
frequency	NN	O
:	:	O
splint	NN	B-TREATMENT
to	TO	I-TREATMENT
left	VB	I-TREATMENT
arm	NN	I-TREATMENT

they	PRP	O
will	MD	O
monitor	VB	O
your	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
and	CC	O
lopressor	NN	B-TREATMENT
.	.	O

erosive	JJ	B-PROBLEM
esophagitis	NN	I-PROBLEM

no	DT	O
cpr	NN	B-TREATMENT
/	VBZ	O
no	DT	O
defib	NN	B-TREATMENT
/	NN	O

robitussin	NN	B-TREATMENT
(	(	I-TREATMENT
guaifenesin	NN	I-TREATMENT
)	)	I-TREATMENT
10	CD	O
milliliters	NNS	O
po	VBP	O
q4h	JJ	O
prn	JJ	O
cough	NN	B-PROBLEM
flagyl	NN	B-TREATMENT
(	(	I-TREATMENT
metronidazole	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
tid	NN	O
x	$	O
5	CD	O
days	NNS	O
starting	VBG	O
today	NN	O
(	(	O
08/08	CD	O
)	)	O
nitroglycerin	NN	B-TREATMENT
1/150	CD	O
(	(	O
0.4	CD	O
mg	NN	O
)	)	O
1	CD	O
tab	NN	O
sl	NN	O
q5min	NN	O
x	VBD	O
3	CD	O
prn	JJ	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

sbp	NN	B-TEST
&lt;	VBZ	O
100	CD	O
ambien	NN	B-TREATMENT
(	(	I-TREATMENT
zolpidem	JJ	I-TREATMENT
tartrate	NN	I-TREATMENT
)	)	I-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qhs	NN	O
prn	NN	O
insomnia	NN	B-PROBLEM

5	CD	B-TREATMENT
levofloxacin	JJ	I-TREATMENT
250	CD	O
mg	NN	O
po	NN	O
qd	NN	O
x	$	O
5	CD	O
days	NNS	O
starting	VBG	O
today	NN	O
(	(	O
08/08	CD	O
)	)	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

haloperidol	NN	B-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

haloperidol	NN	B-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT

override	RB	O
added	VBD	O
on	IN	O
08/07/01	CD	O
by	IN	O
ziskfuscjalk	NN	O
,	,	O
acri	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
haldol	NN	B-TREATMENT
im	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
09647807	CD	O
)	)	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

levofloxacin	NN	B-TREATMENT
and	CC	O
haloperidol	NN	B-TREATMENT

override	RB	O
added	VBD	O
on	IN	O
08/07/01	CD	O
by	IN	O
ziskfuscjalk	NN	O
,	,	O
acri	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
haldol	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
60739147	CD	O
)	)	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

levofloxacin	NN	B-TREATMENT
and	CC	O
haloperidol	NN	B-TREATMENT

omeprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
x	VBZ	O
45	CD	O
days	NNS	O
atenolol	RB	B-TREATMENT
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

dr.	NN	O
scaher	CC	O
grend	NN	O
,	,	O
rammco	NN	O
8/20	CD	O
,	,	O
3:30pm	CD	O
scheduled	VBN	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

hematemesis	NN	B-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
erosive	VBP	B-PROBLEM
esophagitis	NN	I-PROBLEM

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
right	RB	B-PROBLEM
scrotal	JJ	I-PROBLEM
hydrocele	NN	I-PROBLEM
bph	NN	B-PROBLEM
(	(	I-PROBLEM
benign	JJ	I-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
)	)	I-PROBLEM
?	.	O
nph	NN	B-PROBLEM
(	(	O
?	.	O
hydrocephalus	NN	B-PROBLEM
)	)	O
dementia	NN	B-PROBLEM
(	(	I-PROBLEM
dementia	NN	I-PROBLEM
)	)	I-PROBLEM

esophagogastroduodenoscopy	NN	B-TREATMENT

86	CD	O
yo	NNS	O
male	NN	O
with	IN	O
one	CD	O
day	NN	O
of	IN	O
hematemesis	NN	B-PROBLEM
(	(	O
history	NN	O
unclear	RB	O
)	)	O
.	.	O

no	DT	O
known	JJ	O
tb	NN	B-PROBLEM
or	CC	O
ca	MD	B-PROBLEM
history	NN	O
.	.	O

no	DT	O
sob	NN	B-PROBLEM
,	,	O
?	.	O
fever	NN	B-PROBLEM
at	IN	O
home	NN	O
.	.	O

no	DT	O
known	VBN	O
dysphagia	NN	B-PROBLEM
.	.	O

also	RB	O
c	VBP	O
/	JJ	O
o	JJ	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
substernal	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
for	IN	O
past	JJ	O
few	JJ	O
days	NNS	O
.	.	O

in	IN	O
ed	JJ	O
hr	NN	B-TEST
70	CD	O
,	,	O
bp	NN	B-TEST
130/80	CD	O
,	,	O
o2sat	VBD	B-TEST
96%	CD	O
.	.	O

hct	NN	B-TEST
44	CD	O
.	.	O

cxr	NN	B-TEST
notable	JJ	O
for	IN	O
rll	JJ	B-PROBLEM
infiltrate	NN	I-PROBLEM
with	IN	O
old	JJ	B-PROBLEM
b	NN	I-PROBLEM
upper	JJ	I-PROBLEM
lung	NN	I-PROBLEM
field	NN	I-PROBLEM
granulomas	NN	I-PROBLEM
.	.	O

chest	NN	B-TEST
ct	NN	I-TEST
notable	JJ	O
for	IN	O
esophageal	JJ	B-PROBLEM
diverticulum	NN	I-PROBLEM
and	CC	O
thickened	VBD	B-PROBLEM
distal	JJ	I-PROBLEM
1/3	CD	I-PROBLEM
of	IN	I-PROBLEM
esophagus	NN	I-PROBLEM
,	,	O
suspicious	JJ	O
for	IN	O
malignancy	NN	B-PROBLEM
.	.	O

+	JJ	O
alveolar	JJ	B-PROBLEM
opacities	NNS	I-PROBLEM
c	VBP	O
/	JJ	O
w	NN	O
alveolar	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
aspirated	VBN	B-PROBLEM
blood	NN	I-PROBLEM
.	.	O

also	RB	O
with	IN	O
multiple	JJ	B-PROBLEM
cystic	JJ	I-PROBLEM
hypodensities	NNS	I-PROBLEM
in	IN	I-PROBLEM
liver	NN	I-PROBLEM
seen	VBN	O
in	IN	O
previous	JJ	O
scans	NNS	B-TEST
.	.	O

throughout	IN	O
admission	NN	O
,	,	O
hematemesis	NN	B-PROBLEM
flow	NN	O
decreased	VBN	O
while	IN	O
on	IN	O
ppi	NN	B-TREATMENT
and	CC	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
.	.	O

egd	RB	B-TEST
08/08/01	CD	O
showed	VBD	O
mulitple	JJ	B-PROBLEM
non-bleeding	JJ	I-PROBLEM
linear	JJ	I-PROBLEM
erosions	NNS	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
irregular	JJ	I-PROBLEM
circumfrencial	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
ge	NN	I-PROBLEM
junction	NN	I-PROBLEM
.	.	O

tolerated	VBN	O
advancement	NN	O
to	TO	O
a	DT	B-TREATMENT
soft	JJ	I-TREATMENT
mechanical	JJ	I-TREATMENT
diet	NN	I-TREATMENT
well	RB	O
.	.	O

started	VBN	O
on	IN	O
omeprazole	NN	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
bid	NN	O
x6	NNP	O
wks	NN	O
.	.	O

cp	NN	B-PROBLEM
,	,	O
low	JJ	O
prob	NN	O
with	IN	O
atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
ck	NN	B-TEST
&apos;s	NNP	O
x3	NNP	O
flat	JJ	O
,	,	O
and	CC	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
cp	NN	B-PROBLEM
during	IN	O
the	DT	O
admission	NN	O
.	.	O

bp	NN	B-TEST
remained	VBD	O
stable	JJ	O
throughout	IN	O
the	DT	O
admission	NN	O
;	:	O
initially	RB	O
,	,	O
bp	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
,	,	O
but	CC	O
as	IN	O
vs	JJ	B-TEST
remai	NN	O
ned	VBD	O
stable	JJ	O
and	CC	O
bleeding	VBG	B-PROBLEM
subsided	VBN	O
,	,	O
lopressor	NN	B-TREATMENT
was	VBD	O
titrated	VBN	O
up	RB	O
to	TO	O
25	CD	O
mg	NNS	O
po	JJ	O
tid	NN	O
.	.	O

he	PRP	O
was	VBD	O
switched	VBN	O
back	RB	O
to	TO	O
his	PRP$	O
home	NN	O
dose	NN	O
of	IN	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

levo	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
for	IN	O
presumed	JJ	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
/	NNP	O
pneuomonitis	NN	B-PROBLEM
.	.	O

h	NN	O
/	NNP	O
o	RB	O
obstructive	JJ	B-PROBLEM
uropathy	JJ	I-PROBLEM
--	:	O
uop	NN	B-TEST
was	VBD	O
erratic	JJ	O
,	,	O
but	CC	O
no	DT	O
foley	NN	B-TREATMENT
was	VBD	O
needed	VBN	O
.	.	O

bun	NN	B-TEST
/	NN	O
cr	NN	B-TEST
were	VBD	O
stable	JJ	O
.	.	O

started	VBN	O
on	IN	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
.	.	O

once	RB	O
bleed	VBN	B-PROBLEM
ing	NN	I-PROBLEM
stopped	VBD	O
,	,	O
advanced	VBD	O
diet	JJ	O
to	TO	O
soft-mechanical	JJ	B-TREATMENT
.	.	O

dnr	NN	B-TREATMENT
,	,	O
no	DT	O
cpr	NN	B-TREATMENT
,	,	O
may	MD	O
intubate	VB	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
,	,	O
call	VB	O
son	NN	O
.	.	O

if	IN	O
biopsy	VBN	O
results	NNS	O
abnormal	JJ	B-PROBLEM
,	,	O
will	MD	O
need	VB	O
follow-up	JJ	B-TEST
intra-esophageal	JJ	I-TEST
ultrasound	NN	I-TEST
by	IN	O
gi	JJ	O
service	NN	O
.	.	O

you	PRP	O
have	VBP	O
been	VBN	O
admitted	VBN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
an	DT	B-PROBLEM
esophageal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

you	PRP	O
have	VBP	O
some	DT	B-PROBLEM
erosions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
esophagus	NN	I-PROBLEM
which	WDT	O
are	VBP	O
no	RB	O
longer	RB	O
bleeding	VBG	B-PROBLEM
.	.	O

you	PRP	O
will	MD	O
need	VB	O
to	TO	O
continue	VB	O
to	TO	O
take	VB	O
special	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
for	IN	O
these	DT	B-PROBLEM
erosions	NNS	I-PROBLEM
.	.	O

if	IN	O
you	PRP	O
experience	VBP	O
further	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
or	CC	O
increasing	VBG	B-PROBLEM
discomfort	NN	I-PROBLEM
with	IN	O
swallowing	NN	O
,	,	O
you	PRP	O
must	MD	O
tell	VB	O
your	PRP$	O
nurse	NN	O
and	CC	O
call	VB	O
your	PRP$	O
doctor	NN	O
right	RB	O
away	RB	O
.	.	O

you	PRP	O
may	MD	O
need	VB	O
to	TO	O
have	VB	O
further	JJ	B-TEST
studies	NNS	I-TEST
at	IN	O
a	DT	O
later	JJ	O
date	NN	O
.	.	O

continue	VB	O
all	DT	O
your	PRP$	B-TREATMENT
previous	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
directed	VBN	O
.	.	O

2	CD	O
)	)	O
schedule	NN	O
gi	JJ	O
follow-up	JJ	O
if	IN	O
biopsy	JJ	O
results	NNS	O
abnormal	JJ	B-PROBLEM
or	CC	O
if	IN	O
continued	VBN	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

3	LS	O
)	)	O
consider	VB	O
oncology	JJ	O
follow-up	NN	O
if	IN	O
biopsies	NNS	B-TEST
suggestive	VBP	O
of	IN	O
malignancy	NN	B-PROBLEM

4	CD	O
)	)	O
omeprazole	VBD	B-TREATMENT
40	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
x6	NNP	O
wks	NN	O
.	.	O

his	PRP$	O
hospital	JJ	O
course	NN	O
began	VBD	O
on	IN	O
2014-02-13	JJ	O
when	WRB	O
he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
endarterectomy	NN	I-TREATMENT
for	IN	O
95%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

his	PRP$	O
postoperative	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
nonspecific	JJ	B-PROBLEM
t	NNS	I-PROBLEM
wave	VBP	I-PROBLEM
changes	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
postoperatively	RB	O
as	RB	O
well	RB	O
as	IN	O
hematoma	NN	B-PROBLEM
formation	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
formation	NN	I-PROBLEM
was	VBD	O
rapidly	RB	O
expanding	VBG	O
and	CC	O
he	PRP	O
received	VBD	O
an	DT	B-TREATMENT
emergent	JJ	I-TREATMENT
surgical	JJ	I-TREATMENT
airway	NN	I-TREATMENT
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

this	DT	B-TREATMENT
emergent	JJ	I-TREATMENT
cricothyroidotomy	NN	I-TREATMENT
was	VBD	O
converted	VBN	O
then	RB	O
to	TO	O
a	DT	B-TREATMENT
formal	JJ	I-TREATMENT
tracheostomy	NN	I-TREATMENT
.	.	O

during	IN	O
his	PRP$	O
subsequent	JJ	O
hospital	NN	O
course	NN	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	B-PROBLEM
additional	JJ	I-PROBLEM
chf	NN	I-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
medically	RB	O
managed	VBN	O
and	CC	O
eventually	RB	O
his	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
was	VBD	O
decannulated	VBN	O
.	.	O

however	RB	O
,	,	O
just	RB	O
prior	RB	O
to	TO	O
admission	NN	O
to	TO	O
mass.	VB	O
eye	NN	O
&	CC	O
ear	JJ	O
infirmary	NN	O
he	PRP	O
had	VBD	O
another	DT	B-PROBLEM
acute	JJ	I-PROBLEM
decompensation	NN	I-PROBLEM
with	IN	O
chf	JJ	B-PROBLEM
exacerbation	NN	I-PROBLEM
.	.	O

this	DT	O
necessitated	JJ	O
emergent	NN	B-TREATMENT
intubation	NN	I-TREATMENT
.	.	O

with	IN	O
ekg	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
consistent	VBP	O
with	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
mass.	NN	O
eye	NN	O
&	CC	O
ear	JJ	O
infirmary	NN	O
for	IN	O
further	JJ	O
management	NN	O
.	.	O

1.	CD	O
diabetes	NNS	B-PROBLEM
type	JJ	I-PROBLEM
2	CD	I-PROBLEM
treated	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

2.	CD	O
cerebrovascular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
carotid	JJ	I-TREATMENT
endarterectomy	NN	I-TREATMENT
in	IN	O
2008	CD	O
.	.	O

3.	CD	O
status	NN	O
post	NN	O
right	RB	B-PROBLEM
cerebrovascular	JJ	I-PROBLEM
accident	NN	I-PROBLEM
in	IN	O
2009	CD	O
with	IN	O
residual	JJ	B-PROBLEM
left-sided	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

4.	CD	O
status	NN	O
post	NN	O
right	RB	B-TREATMENT
carotid	VBZ	I-TREATMENT
endarterectomy	VB	I-TREATMENT
on	IN	O
2014-02-13	JJ	O
.	.	O

5.	CD	O
fall	NN	O
from	IN	O
standing	VBG	O
on	IN	O
2014-01-29	JJ	O
with	IN	O
resultant	NN	O
displaced	VBN	B-PROBLEM
radial	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
which	WDT	O
was	VBD	O
reduced	VBN	O
,	,	O
closed	VBD	O
,	,	O
and	CC	O
casted	VBD	O
.	.	O

6.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

7.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

no	DT	O
history	NN	O
of	IN	O
catheterization	NN	B-TEST
prior	RB	O
to	TO	O
admission	NN	O
to	TO	O
the	DT	O
saint	NN	O
vincent	NN	O
hospital	NN	O
.	.	O

8.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
baseline	JJ	I-TEST
creatinine	NN	I-TEST
of	IN	O
2.0	CD	O
to	TO	O
2.7.	CD	O

1.	CD	O
lovenox	JJ	B-TREATMENT
1	CD	O
mg	NN	O
per	IN	O
kilogram	NN	O
subcutaneously	RB	O
b.i.d.	VBD	O

2.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

6.	CD	O
captopril	NN	B-TREATMENT
6.25	CD	O
mg	NN	O
q.i.d.	NN	O

7.	CD	O
lasix	JJ	B-TREATMENT
drip	NN	I-TREATMENT
at	IN	O
2	CD	O
per	IN	O
hour	NN	O
.	.	O

8.	CD	O
versed	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

9.	CD	O
tpn	NN	B-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
gentleman	NN	O
who	WP	O
is	VBZ	O
intubated	VBN	B-TREATMENT
,	,	O
comfortable	JJ	O
,	,	O
with	IN	O
minimal	JJ	B-TREATMENT
sedation	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
with	IN	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
99.1	CD	O
.	.	O

his	PRP$	B-TEST
pulse	NN	I-TEST
was	VBD	O
in	IN	O
the	DT	O
70s	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
119/58	CD	O
.	.	O

his	PRP$	B-TEST
cvp	NN	I-TEST
is	VBZ	O
ranging	VBG	O
from	IN	O
07-27	NN	O
.	.	O

he	PRP	O
was	VBD	O
intubated	VBN	O
and	CC	O
has	VBZ	O
a	DT	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

his	PRP$	O
neck	NN	O
has	VBZ	O
a	DT	B-PROBLEM
well-healed	JJ	I-PROBLEM
right	NN	I-PROBLEM
carotid	NN	I-PROBLEM
endarterectomy	JJ	I-PROBLEM
scar	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
also	RB	O
a	DT	B-PROBLEM
well-healing	JJ	I-PROBLEM
tracheostomy	NN	I-PROBLEM
scar	NN	I-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
with	IN	O
normoactive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

the	DT	O
extremities	NNS	O
were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

the	DT	O
left	JJ	O
arm	NN	O
was	VBD	O
in	IN	O
a	DT	B-TREATMENT
cast	NN	I-TREATMENT
.	.	O

upon	IN	O
admission	NN	O
,	,	O
he	PRP	O
was	VBD	O
treated	VBN	O
for	IN	O
his	PRP$	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
medically	RB	O
managed	VBN	O
for	IN	O
chf	NN	B-PROBLEM
and	CC	O
underwent	NN	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
on	IN	O
2014-03-06	JJ	O
.	.	O

his	PRP$	B-TEST
catheterization	NN	I-TEST
revealed	VBD	O
70%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
main	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
,	,	O
90%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lad	NN	I-PROBLEM
,	,	O
80%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
circumflex	NN	I-PROBLEM
,	,	O
90%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
om2	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
proximally	RB	I-PROBLEM
occluded	VBN	I-PROBLEM
right	RB	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

after	IN	O
reviewing	VBG	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
data	NNS	I-TEST
,	,	O
a	DT	O
consultation	NN	O
was	VBD	O
made	VBN	O
with	IN	O
cardiothoracic	JJ	O
surgery	NN	O
who	WP	O
deemed	VBD	O
that	IN	O
he	PRP	O
was	VBD	O
a	DT	O
good	JJ	O
candidate	NN	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
ensuing	JJ	O
days	NNS	O
,	,	O
mr.	JJ	O
nina	NNP	O
chf	NN	B-PROBLEM
was	VBD	O
managed	VBN	O
by	IN	O
the	DT	O
ccu	NN	O
team	NN	O
and	CC	O
he	PRP	O
received	VBD	O
treatment	NN	B-TREATMENT
for	IN	O
what	WP	O
was	VBD	O
now	RB	O
determined	VBN	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
klebsiella	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
zosyn	NN	B-TREATMENT
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
of	IN	I-TREATMENT
four	CD	I-TREATMENT
vessels	NNS	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
his	PRP$	I-TREATMENT
lad	NN	I-TREATMENT
and	CC	I-TREATMENT
diagonal	NN	I-TREATMENT
in	IN	O
a	DT	O
sequential	JJ	O
fashion	NN	O
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
his	PRP$	I-TREATMENT
pda	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
his	PRP$	I-TREATMENT
om	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
by	IN	O
dr.	NN	O
streeter	NN	O
and	CC	O
assisted	VBN	O
by	IN	O
dr	NN	O
.	.	O
.....................	VB	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
without	IN	O
complication	NN	B-PROBLEM
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	NN	O

surgery	JJ	O
recovery	NN	O
unit	NN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

his	PRP$	O
postoperative	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
hypertension	NN	B-PROBLEM
which	WDT	O
was	VBD	O
managed	VBN	O
medically	RB	O
.	.	O

during	IN	O
his	PRP$	O
postoperative	JJ	O
course	NN	O
,	,	O
he	PRP	O
did	VBD	O
not	RB	O
suffer	VB	O
from	IN	O
any	DT	B-PROBLEM
arrhythmias	JJ	I-PROBLEM
nor	CC	O
did	VBD	O
he	PRP	O
have	VB	O
any	DT	O
episode	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
he	PRP	O
was	VBD	O
on	IN	O
a	DT	B-TREATMENT
stable	JJ	I-TREATMENT
antihypertensive	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
appropriate	VBP	O
for	IN	O
someone	NN	O
with	IN	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
fraction	NN	I-PROBLEM
.	.	O

mr.	NN	O
knueppel	NNP	O
had	VBD	O
had	VBN	O
a	DT	O
long	JJ	O
protracted	JJ	O
period	NN	O
of	IN	O
intubation	NN	B-TREATMENT
prior	RB	O
to	TO	O
the	DT	O
operation	NN	B-TREATMENT
.	.	O

the	DT	O
status	NN	O
of	IN	O
mr.	NN	O
nina	NNP	O
pulmonary	JJ	O
system	NN	O
necessitated	VBD	O
a	DT	B-TREATMENT
prolonged	JJ	I-TREATMENT
postoperative	JJ	I-TREATMENT
intubation	NN	I-TREATMENT
.	.	O

after	IN	O
a	DT	O
very	RB	O
slow	JJ	O
wean	NN	O
from	IN	O
ventilatory	JJ	B-TREATMENT
support	NN	I-TREATMENT
,	,	O
mr.	NN	O
knueppel	NNP	O
was	VBD	O
successfully	RB	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
nine	CD	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
be	VB	O
very	RB	O
tenuous	JJ	O
from	IN	O
a	DT	O
pulmonary	JJ	O
point	NN	O
of	IN	O
view	NN	O
and	CC	O
required	VBN	O
frequent	JJ	B-TREATMENT
chest	NN	I-TREATMENT
pt	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
had	VBD	O
chest	JJS	B-TREATMENT
pt	NN	I-TREATMENT
performed	VBN	O
at	IN	O
very	RB	O
regular	JJ	O
intervals	NNS	O
by	IN	O
the	DT	O
icu	JJ	O
staff	NN	O
.	.	O

mr.	NN	O
knueppel	NNP	O
had	VBD	O
an	DT	B-TREATMENT
emergent	JJ	I-TREATMENT
cricothyroidotomy	NN	I-TREATMENT
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
formal	JJ	I-TREATMENT
tracheostomy	NN	I-TREATMENT
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
.	.	O

there	EX	O
is	VBZ	O
much	JJ	B-PROBLEM
scarring	VBG	I-PROBLEM
surrounding	VBG	I-PROBLEM
his	PRP$	I-PROBLEM
larynx	NN	I-PROBLEM
.	.	O

as	IN	O
is	VBZ	O
expected	VBN	O
,	,	O
mr.	FW	O
knueppel	NNP	O
failed	VBD	O
a	DT	B-TEST
swallowing	NN	I-TEST
study	NN	I-TEST
early	RB	O
on	IN	O
in	IN	O
his	PRP$	O
boston	NN	O
regional	JJ	O
medical	JJ	O
centerr	NN	O
hospital	NN	O
course	NN	O
.	.	O

the	DT	B-TEST
study	NN	I-TEST
was	VBD	O
repeated	VBN	O
and	CC	O
yet	RB	O
again	RB	O
mr.	JJ	O
knueppel	NNP	O
was	VBD	O
unable	JJ	O
to	TO	O
swallow	VB	O
without	IN	O
evidence	NN	O
of	IN	O
aspiration	NN	B-PROBLEM
.	.	O

after	IN	O
a	DT	O
prolonged	JJ	O
period	NN	O
of	IN	O
being	VBG	O
fed	VBN	O
via	IN	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
,	,	O
mr.	NN	O
knueppel	NNP	O
finally	RB	O
had	VBD	O
a	DT	B-TREATMENT
formal	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
endoscopic	NN	I-TREATMENT
gastrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBN	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
by	IN	O
dr.	NN	O
kevin	NN	O
taussig	NN	O
and	CC	O
assisted	VBN	O
by	IN	O
dr.	NN	O
carla	NN	O
solan	NN	O
.	.	O

the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
under	IN	O
endoscopic	NN	B-TREATMENT
guidance	NN	I-TREATMENT
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

mr.	NN	O
knueppel	NNP	O
robertson	VBZ	O
a	DT	B-PROBLEM
distal	JJ	I-PROBLEM
radius	NN	I-PROBLEM
fracture	NN	I-PROBLEM
prior	RB	O
to	TO	O
arriving	VBG	O
to	TO	O
the	DT	O
hospital	NN	O
.	.	O

this	DT	B-PROBLEM
injury	NN	I-PROBLEM
had	VBD	O
been	VBN	O
reduced	VBN	O
and	CC	O
casted	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
institution	NN	O
.	.	O

postoperatively	RB	O
,	,	O
there	EX	O
was	VBD	O
much	JJ	B-PROBLEM
edema	NN	I-PROBLEM
associated	VBN	O
in	IN	O
the	DT	O
postoperative	JJ	O
course	NN	O
from	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
cast	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
by	IN	O
the	DT	O
orthopedic	JJ	O
service	NN	O
in	IN	O
anticipation	NN	O
of	IN	O
this	DT	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
to	TO	O
avoid	VB	O
compartment	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
cast	NN	I-TREATMENT
was	VBD	O
replaced	VBN	O
by	IN	O
a	DT	B-TREATMENT
plaster	NN	I-TREATMENT
splint	NN	I-TREATMENT
.	.	O

mr.	NNS	O
knueppel	NNP	O
should	MD	O
follow-up	VB	O
with	IN	O
his	PRP$	O
orthopedic	JJ	O
surgeon	NN	O
in	IN	O
the	DT	O
worcester	NN	O
state	NN	O
hospital	NN	O
for	IN	O
reassessment	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
injury	NN	I-PROBLEM
and	CC	O
possible	JJ	O
removal	NN	B-TREATMENT
of	IN	O
the	DT	B-TREATMENT
splint	NN	I-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
well	RB	O
controlled	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
tolerating	VBG	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
,	,	I-TREATMENT
four	CD	I-TREATMENT
vessels	NNS	I-TREATMENT
.	.	O

2.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

3.	CD	O
klebsiella	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

4.	CD	O
failed	VBD	B-PROBLEM
swallow	NN	I-PROBLEM
study	NN	I-PROBLEM
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
endoscopic	NN	I-TREATMENT
gastrostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

5.	CD	O
central	JJ	B-TEST
line	NN	I-TEST
culture	NN	I-TEST
positive	JJ	O
for	IN	O
coagulase	NN	B-PROBLEM
-	:	I-PROBLEM
negative	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
14	CD	I-TREATMENT
day	NN	I-TREATMENT
treatment	NN	I-TREATMENT
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
removal	NN	B-TREATMENT
of	IN	O
the	DT	B-TREATMENT
line	NN	I-TREATMENT
.	.	O

1.	CD	O
methylphenidate	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3.	CD	O
captopril	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

4.	CD	O
glyburide	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5.	CD	O
miconazole	JJ	B-TREATMENT
powder	NN	I-TREATMENT
2%	CD	O
,	,	O
apply	RB	O
q.i.d.	JJ	O
p.r.n.	NN	O

6.	CD	O
paxil	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
albuterol	NN	B-TREATMENT
nebulizer	JJ	I-TREATMENT
solution	NN	I-TREATMENT
one	CD	O
nebulizer	NN	O
q.	VB	O
four	CD	O
hours	NNS	O
.	.	O

8.	CD	O
metoprolol	JJ	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

9.	CD	O
heparin	JJ	B-TREATMENT
5,000	CD	O
units	NNS	O
subcutaneously	RB	O
q.	RB	O
12	CD	O
hours	NNS	O
.	.	O

10.	CD	O
amlodipine	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

11.	CD	O
percocet	JJ	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
q.	RB	O
four	CD	O
hours	NNS	O
p.r.n.	RB	O
pain	VBP	B-PROBLEM
.	.	O

12.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

13.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

14.	CD	O
tube	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
;	:	O
mr.	CC	O
knueppel	VB	O
is	VBZ	O
to	TO	O
be	VB	O
discharged	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
,	,	O
promote	NN	B-TREATMENT
,	,	I-TREATMENT
with	IN	I-TREATMENT
fiber	JJ	I-TREATMENT
full-strength	NN	I-TREATMENT
at	IN	O
80	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
around	IN	O
the	DT	O
clock	NN	O
.	.	O

his	PRP$	B-TREATMENT
peg	NN	I-TREATMENT
tube	NN	I-TREATMENT
should	MD	O
be	VB	O
flushed	VBN	O
with	IN	O
30	CD	O
cc	NNS	O
of	IN	O
water	NN	O
after	IN	O
every	DT	O
use	NN	O
.	.	O

he	PRP	O
is	VBZ	O
also	RB	O
to	TO	O
be	VB	O
strict	JJ	B-TREATMENT
n.p.o.	NN	I-TREATMENT

he	PRP	O
should	MD	O
be	VB	O
n.p.o.	RB	B-TREATMENT
until	IN	O
he	PRP	O
has	VBZ	O
a	DT	B-TEST
repeat	NN	I-TEST
swallow	JJ	I-TEST
evaluation	NN	I-TEST
which	WDT	O
demonstrates	VBZ	O
his	PRP$	O
ability	NN	O
to	TO	O
swallow	VB	O
without	IN	O
aspiration	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
should	MD	O
follow-up	VB	O
with	IN	O
his	PRP$	O
orthopedic	JJ	O
surgeon	NN	O
at	IN	O
the	DT	O
next	JJ	O
convenient	NN	O
time	NN	O
to	TO	O
determine	VB	O
the	DT	O
length	NN	O
of	IN	O
duration	NN	O
of	IN	O
his	PRP$	B-TREATMENT
casting	NN	I-TREATMENT
.	.	O

mr.	NN	O
knueppel	NNP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
with	IN	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
97.1	CD	O
,	,	O
pulse	RB	B-TEST
77	CD	O
,	,	O
sinus	NN	O
rhythm	NN	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
142/68	CD	O
,	,	O
breathing	VBG	O
21	CD	O
breaths	NNS	O
per	IN	O
minute	NN	O
,	,	O
94%	CD	O
on	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

his	PRP$	O
head	NN	O
was	VBD	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
peg	JJ	I-TREATMENT
tube	NN	I-TREATMENT
in	IN	I-TREATMENT
his	PRP$	I-TREATMENT
left	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
quadrant	NN	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
site	NN	I-PROBLEM
was	VBD	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
necrosis	NN	B-PROBLEM
,	,	O
erythema	NN	B-PROBLEM
or	CC	O
exudate	NN	B-PROBLEM
at	IN	O
the	DT	B-PROBLEM
site	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
trace	NN	B-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

his	PRP$	O
right	NN	O
lower	RBR	O
extremity	NN	O
has	VBZ	O
ecchymosis	RB	B-PROBLEM
related	VBN	O
to	TO	O
a	DT	B-PROBLEM
saphenectomy	JJ	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

this	DT	B-PROBLEM
ecchymosis	NN	I-PROBLEM
is	VBZ	O
much	RB	O
improved	VBN	O
from	IN	O
previous	JJ	B-TEST
examinations	NNS	I-TEST
.	.	O

there	EX	O
was	VBD	O
no	DT	O
increased	JJ	B-PROBLEM
warmth	NN	I-PROBLEM
over	IN	O
this	DT	O
area	NN	O
nor	CC	O
is	VBZ	O
there	RB	O
any	DT	B-PROBLEM
exudate	NN	I-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
.	.	O

all	DT	O
of	IN	O
his	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
including	VBG	O
sternotomy	NN	B-PROBLEM
wound	NN	I-PROBLEM
were	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
.	.	O

right	JJ	B-PROBLEM
foot	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
71	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
ovarian	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
who	WP	O
recently	RB	O
underwent	VBD	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
on	IN	O
5/2	CD	O
by	IN	O
dr.	NN	O
korcblinknud	NN	O
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
widely	RB	B-PROBLEM
metastatic	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
sigmoid	JJ	B-PROBLEM
narrowing	NN	I-PROBLEM
near	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
left	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
and	CC	O
distal	JJ	B-PROBLEM
ileal	NN	I-PROBLEM
narrowing	NN	I-PROBLEM
by	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TREATMENT
ileostomy	NN	I-TREATMENT
performed	VBD	O
and	CC	O
had	VBD	O
had	VBN	O
her	PRP$	O
first	JJ	O
course	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
later	RB	O
debulking	VBG	B-TREATMENT
operation	NN	I-TREATMENT
by	IN	O
dr.	NN	O
median	NN	O
.	.	O

she	PRP	O
was	VBD	O
well	RB	O
at	IN	O
home	NN	O
until	IN	O
8:30	CD	O
p.m.	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
when	WRB	O
she	PRP	O
developed	VBD	O
acute	JJ	O
onset	NN	O
of	IN	O
right	JJ	B-PROBLEM
foot	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
worse	JJR	O
with	IN	O
walking	NN	O
.	.	O

she	PRP	O
complained	VBD	O
of	IN	O
increased	JJ	B-PROBLEM
numbness	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
over	IN	O
time	NN	O
,	,	O
and	CC	O
was	VBD	O
seen	VBN	O
at	IN	O
sephsandpot	NN	O
center	NN	O
,	,	O
where	WRB	O
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
palpable	JJ	O
right	JJ	O
femoral	NN	O
and	CC	O
popliteal	NN	O
pulses	NNS	O
,	,	O
and	CC	O
no	DT	B-PROBLEM
pedal	JJ	I-PROBLEM
pulses	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
previous	JJ	O
history	NN	O
of	IN	O
claudication	NN	B-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
glaucoma	NN	B-PROBLEM
,	,	O
right	JJ	B-TREATMENT
knee	NN	I-TREATMENT
arthroscopic	NN	I-TREATMENT
surgery	NN	I-TREATMENT
in	IN	O
1988	CD	O
,	,	O
appendectomy	NN	B-TREATMENT
,	,	O
dilation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
times	NNS	O
two	CD	O
,	,	O
and	CC	O
a	DT	B-PROBLEM
hiatus	NN	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

lorazepam	RB	B-TREATMENT
1	CD	O
mg.	NNS	O
po	JJ	O
q6	JJ	O
hours	NNS	O
prn	NN	O
,	,	O
and	CC	O
timoptic	JJ	B-TREATMENT
0.5%	CD	O
1	CD	O
drop	NN	O
b.i.d.	NN	O

iodine	NN	B-TREATMENT
and	CC	O
shellfish	JJ	O
cause	NN	O
throat	NN	B-PROBLEM
tightening	NN	I-PROBLEM
.	.	O

showed	VBD	O
a	DT	O
71	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
blood	JJ	B-TEST
pressure	NN	I-TEST
155/82	CD	O
,	,	O
pulse	RB	B-TEST
88	CD	O
,	,	O
temperature	NN	B-TEST
96.0.	CD	O

her	PRP$	O
right	JJ	O
foot	NN	O
was	VBD	O
without	IN	B-PROBLEM
capillary	JJ	I-PROBLEM
refill	NN	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
marked	JJ	I-PROBLEM
change	NN	I-PROBLEM
of	IN	O
temperature	NN	B-TEST
at	IN	O
a	DT	O
level	NN	O
of	IN	O
the	DT	O
mid	NN	O
calf	NN	O
.	.	O

there	EX	O
was	VBD	O
decreased	VBN	B-PROBLEM
sensation	NN	I-PROBLEM
to	TO	O
touch	VB	B-TEST
over	IN	O
the	DT	O
entire	JJ	O
foot	NN	O
.	.	O

radial	NN	B-TEST
,	,	I-TEST
carotid	NN	I-TEST
and	CC	I-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
were	VBD	O
symmetric	JJ	O
and	CC	O
strong	JJ	O
.	.	O

the	DT	B-TEST
popliteal	NN	I-TEST
pulse	NN	I-TEST
on	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
side	NN	I-TEST
was	VBD	O
diminished	VBN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	B-PROBLEM
dorsal	NN	I-PROBLEM
,	,	I-PROBLEM
pedal	JJ	I-PROBLEM
pulse	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

on	IN	O
5/14/92	CD	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
an	DT	B-TEST
arteriogram	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
an	DT	B-PROBLEM
embolus	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
profunda	NN	I-PROBLEM
/	NNP	I-PROBLEM
femoral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
occlusion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
calf	NN	I-PROBLEM
,	,	O
of	IN	O
the	DT	O
peroneal	NN	O
and	CC	O
anterior	JJ	O
tibial	JJ	O
arteries	NNS	O
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
occlusion	NN	I-PROBLEM
of	IN	I-PROBLEM
posterior	JJ	I-PROBLEM
tibial	JJ	I-PROBLEM
artery	NN	I-PROBLEM
at	IN	O
the	DT	O
ankle	NN	O
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
urgently	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
,	,	O
where	WRB	O
she	PRP	O
underwent	JJ	O
embolectomy	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
profunda	NN	I-TREATMENT
superficial	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
vessels	NNS	I-TREATMENT
.	.	O

the	DT	B-TEST
estimated	VBN	I-TEST
blood	NN	I-TEST
loss	NN	I-TEST
was	VBD	O
200	CD	O
cc.	NN	O
and	CC	O
she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

postoperatively	RB	O
,	,	O
she	PRP	O
was	VBD	O
again	RB	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
cold	JJ	I-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
extremity	NN	I-PROBLEM
with	IN	O
diminished	JJ	B-PROBLEM
pulses	NNS	I-PROBLEM
and	CC	O
was	VBD	O
again	RB	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
,	,	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
popliteal	NN	I-TEST
exploration	NN	I-TEST
and	CC	O
thrombectomy	NN	B-TREATMENT
.	.	O

she	PRP	O
again	RB	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
did	VBD	O
well	RB	O
postoperatively	RB	O
.	.	O

on	IN	O
5/19	CD	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
done	VBN	O
which	WDT	O
was	VBD	O
to	TO	O
be	VB	O
evaluated	VBN	O
as	IN	O
an	DT	O
out	IN	O
patient	NN	O
.	.	O

thromboembolus	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
profunda	NN	I-PROBLEM
femoris	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
superficial	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
nausea	NN	B-PROBLEM

intubation	NN	B-TREATMENT

ir	NN	B-TREATMENT
guided	VBD	I-TREATMENT
nephrostomy	JJ	I-TREATMENT
placement	NN	I-TREATMENT

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
78	CD	O
y/o	NN	O
wf	NN	O
w/a	NN	O
pmh	NN	O
significant	JJ	O
for	IN	O
htn	NN	B-PROBLEM
and	CC	O
afib	NN	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
an	DT	O
osh	JJ	O
w/	NN	O
complaints	NNS	O
of	IN	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
nausea	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
r	JJ	I-PROBLEM
ureteral	JJ	I-PROBLEM
stone	NN	I-PROBLEM
w/	NN	O
resultant	JJ	O
hydronephrosis	NN	B-PROBLEM
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
nantucket	VB	O
cottage	NN	O
hospital	NN	O
for	IN	O
ureteral	JJ	B-TREATMENT
stent	JJ	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
inr	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
elevated	VBN	B-PROBLEM
when	WRB	O
admitted	VBN	O
and	CC	O
,	,	O
in	IN	O
the	DT	O
course	NN	O
of	IN	O
waiting	VBG	O
for	IN	O
this	DT	O
to	TO	O
normalize	VB	O
,	,	O
the	DT	O
patient	NN	O
spiked	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
to	TO	O
105	CD	O
and	CC	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
to	TO	O
the	DT	O
70s	NNS	O
.	.	O

she	PRP	O
was	VBD	O
bolused	VBN	O
w/out	IN	O
effect	NN	O
and	CC	O
had	VBD	O
little	JJ	O
response	NN	O
to	TO	O
neo	VB	B-TREATMENT
so	RB	O
she	PRP	O
was	VBD	O
changed	VBN	O
to	TO	O
levophed	VB	B-TREATMENT
,	,	O
given	VBN	O
doses	NNS	O
of	IN	O
cipro	JJ	B-TREATMENT
/	FW	O
vanco	FW	B-TREATMENT
/	FW	O
gent	NN	B-TREATMENT
and	CC	O
transferred	VBD	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
management	NN	O
.	.	O

in	IN	O
the	DT	O
cmed	NN	O
,	,	O
urology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
a	DT	B-TREATMENT
r	NN	I-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
tube	EX	B-TREATMENT
placement	NN	I-TREATMENT
was	VBD	O
complicated	VBN	O
by	IN	O
renal	JJ	B-PROBLEM
artery	NN	I-PROBLEM
puncture	NN	I-PROBLEM
,	,	O
afib	NN	B-PROBLEM
,	,	O
and	CC	O
increased	VBD	B-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
intubated	VBN	O
for	IN	O
this	DT	B-PROBLEM
hypoxia	NN	I-PROBLEM
and	CC	O
treated	VBN	O
with	IN	O
lasix	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
and	CC	O
diltiazem	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
her	PRP$	B-TREATMENT
pressors	NNS	I-TREATMENT
on	IN	O
02-21	JJ	O
and	CC	O
maintained	VBD	O
her	PRP$	O
pressure	NN	O
w/out	IN	O
additional	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
sedation	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
down	RP	O
and	CC	O
she	PRP	O
was	VBD	O
successfully	RB	O
extubated	VBN	O
shortly	RB	O
thereafter	RB	O
.	.	O

ucx	JJ	B-TEST
grew	VBD	O
proteus	NN	B-PROBLEM
and	CC	O
her	PRP$	B-TREATMENT
abx	NN	I-TREATMENT
were	VBD	O
changed	VBN	O
to	TO	O
levaquin	VB	B-TREATMENT
alone	RB	O
and	CC	O
she	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
for	IN	O
>	JJ	O
24	CD	O
hr	NN	O
on	IN	O
this	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
trouble	NN	O
with	IN	O
afib	NNS	B-PROBLEM
and	CC	O
required	VBD	O
a	DT	B-TREATMENT
dilt	JJ	I-TREATMENT
gtt	NN	I-TREATMENT
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
call-out	NN	O
to	TO	O
control	VB	O
this	DT	O
rhythm	NN	O
but	CC	O
she	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
po	VB	B-TREATMENT
diltiazem	NN	I-TREATMENT
and	CC	O
has	VBZ	O
been	VBN	O
in	IN	O
nsr	JJ	O
since	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
prior	RB	O
to	TO	O
d/c	VB	O
as	IN	O
a	DT	O
bridge	NN	O
to	TO	O
therapeutic	JJ	B-TREATMENT
coumadin	NN	I-TREATMENT
anticoagulation	NN	I-TREATMENT
.	.	O

1.	CD	O
htn	NN	B-PROBLEM

2.	CD	O
a.fib	NN	B-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT

3.	CD	O
cataract	JJ	B-PROBLEM
disease	NN	I-PROBLEM

4.	CD	O
01-22	NN	O
closed	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
radius	NN	I-PROBLEM
s/p	NN	O
closed	VBD	B-TREATMENT
reduction	NN	I-TREATMENT

5.	CD	O
mv	NN	B-PROBLEM
,	,	I-PROBLEM
av	NN	I-PROBLEM
,	,	I-PROBLEM
tv	NN	I-PROBLEM
insufficiency	NN	I-PROBLEM

brother	NN	O
with	IN	O
"	NNP	O
heart	NN	B-PROBLEM
trouble	NN	I-PROBLEM
"	NN	O
.	.	O

pleasant	JJ	O
obese	JJ	O
female	NN	O
in	IN	O
nad	NN	B-PROBLEM
,	,	O
in	IN	O
wrist	NN	B-TREATMENT
restraints	NNS	I-TREATMENT

eomi	NN	O
,	,	O
perrla	NN	O
,	,	O
mm	NN	B-PROBLEM
dry	NN	I-PROBLEM
,	,	O
o/p	CD	O
clear	JJ	O

rrr	NN	O
,	,	O
s1/s2	JJ	O
intact	NN	O
,	,	O
3/6	CD	B-PROBLEM
sem	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
usb	NN	I-PROBLEM

s/nt/nd	NN	B-PROBLEM
,	,	O
obese	JJ	B-PROBLEM
,	,	O
+bs	VB	O

r	NN	B-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
in	IN	O
place	NN	O
and	CC	O
draining	NN	O

ext	NN	O
:	:	O
brace	NN	B-TREATMENT
on	IN	I-TREATMENT
l	JJ	I-TREATMENT
wrist	NN	I-TREATMENT
,	,	O
2+	CD	B-PROBLEM
le	NN	I-PROBLEM
edema	NN	I-PROBLEM

cxr	JJ	B-TEST
2013-02-21	JJ	O
:	:	O

right	JJ	B-TREATMENT
subclavian	JJ	I-TREATMENT
cv	NN	I-TREATMENT
line	NN	I-TREATMENT
overlies	NNS	O
proximal	JJ	O
svc	NN	O
.	.	O

there	EX	O
is	VBZ	O
cardiomegaly	JJ	B-PROBLEM
and	CC	O
tortuosity	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
thoracic	NN	I-PROBLEM
aorta	NN	I-PROBLEM
with	IN	O
small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
chf	NN	B-PROBLEM
.	.	O

no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

overall	JJ	O
appearances	NNS	O
are	VBP	O
essentially	RB	O
unchanged	JJ	O
since	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
film	NN	I-TEST
of	IN	O
2013-02-20	JJ	O
,	,	O
apart	RB	O
from	IN	O
removal	NN	B-TREATMENT
of	IN	O
the	DT	B-TREATMENT
et	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

ct	NN	B-TEST
abd	VBZ	I-TEST
2013-02-18	CD	O
:	:	O

1)	CD	O
moderate	JJ	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
right	JJ	I-PROBLEM
hydroureteronephrosis	NN	I-PROBLEM
with	IN	O
two	CD	B-PROBLEM
obstructing	VBG	I-PROBLEM
distal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
ureteral	JJ	I-PROBLEM
stones	NNS	I-PROBLEM
,	,	O
8	CD	O
mm	NN	O
and	CC	O
6	CD	O
mm	NN	O
respectively	RB	O
.	.	O

2)	CD	O
probable	JJ	O
obstructing	VBG	B-PROBLEM
5	CD	I-PROBLEM
mm	NN	I-PROBLEM
right	RB	I-PROBLEM
mid	JJ	I-PROBLEM
ureteral	JJ	I-PROBLEM
calculus	NN	I-PROBLEM
causing	VBG	O
mild	JJ	B-PROBLEM
hydroureter	NN	I-PROBLEM
,	,	O
though	IN	O
it	PRP	O
is	VBZ	O
difficult	JJ	O
to	TO	O
tell	VB	O
definitively	RB	O
if	IN	O
this	DT	B-PROBLEM
stone	NN	I-PROBLEM
is	VBZ	O
within	IN	O
or	CC	O
just	RB	O
medial	JJ	O
to	TO	O
the	DT	O
right	JJ	O
ureter	NN	O
on	IN	O
this	DT	B-TEST
ct	NN	I-TEST
without	IN	I-TEST
iv	JJ	I-TEST
contrast	NN	I-TEST
.	.	O

3)	CD	O
small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

4)	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
calcification	NN	I-PROBLEM
.	.	O

echo	JJ	B-TEST
2013-02-19	CD	O
:	:	O

1.	CD	O
the	DT	O
left	NN	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

2.	CD	O
the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

due	JJ	O
to	TO	O
suboptimal	VB	O
technical	JJ	O
quality	NN	O
,	,	O
a	DT	B-PROBLEM
focal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
cannot	NN	O
be	VB	O
fully	RB	O
excluded	VBN	O
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
normal	JJ	O
lvef	JJ	B-TEST
>	NNP	O
55%	CD	O
)	)	O
.	.	O

3.	CD	O
the	DT	O
right	NN	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
dilated	VBN	B-PROBLEM
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
appears	VBZ	O
depressed	JJ	B-PROBLEM
.	.	O

4.	CD	O
the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

5.	CD	O
the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
severe	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
annular	JJ	I-PROBLEM
calcification	NN	I-PROBLEM
.	.	O

trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
present	JJ	O
.	.	O

6.	CD	O
moderate	JJ	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
[	JJ	I-PROBLEM
3+	CD	I-PROBLEM
]	JJ	I-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

2013-02-18	JJ	O
05:49	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
36.6	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
4.29	CD	O
hgb	NN	B-TEST
-	:	O
13.4	CD	O
hct	NN	B-TEST
-	:	O
38.8	CD	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
31.3	CD	O
mchc	SYM	B-TEST
-	:	O
34.6	CD	O
rdw	NN	B-TEST
-	:	O
13.2	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
132	CD	O
*	NN	O

2013-02-27	JJ	O
05:17	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
11.8	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.61	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.8	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
32.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
29.8	CD	O
mchc	SYM	B-TEST
-	:	O
33.5	CD	O
rdw	NN	B-TEST
-	:	O
13.2	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
346	CD	O

2013-02-18	JJ	O
05:49	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
20.6	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
31.6	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
3.0	CD	O

2013-02-27	JJ	O
05:17	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
15.5	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
75.0	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.6	CD	O

2013-02-18	JJ	O
05:49	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
127	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
26	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.7	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
136	CD	O
k	SYM	B-TEST
-	:	O
3.9	CD	O
cl	NN	B-TEST
-	:	O
103	CD	O
hco3	NN	B-TEST
-	:	O
20	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
17	CD	O

2013-02-27	JJ	O
05:17	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
97	CD	O
urean	JJ	B-TEST
-	:	O
14	CD	O
creat	NN	B-TEST
-	:	O
1.2	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
144	CD	O
k	SYM	B-TEST
-	:	O
3.9	CD	O
cl	NN	B-TEST
-	:	O
106	CD	O
hco3	NN	B-TEST
-	:	O
29	CD	O
angap	NN	B-TEST
-	:	O
13	CD	O

2013-02-22	JJ	O
03:00	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
52	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
50	CD	O
*	JJ	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	I-TEST
300	CD	O
*	JJ	O
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
41	CD	O
alkphos	SYM	B-TEST
-	:	O
280	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
0.8	CD	O

2013-02-18	JJ	O
05:49	CD	O
pm	NN	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
7.7	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
3.3	CD	O
mg	SYM	B-TEST
-	:	O
1.1	CD	O
*	NN	O

2013-02-27	JJ	O
05:17	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.7	CD	O
phos	NN	B-TEST
-	:	O
4.0	CD	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

78	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
htn	NN	B-PROBLEM
,	,	O
a.fib	JJ	B-PROBLEM
presenting	VBG	O
with	IN	O
ureteral	JJ	B-PROBLEM
stone	NN	I-PROBLEM
,	,	O
hydronephrosis	NN	B-PROBLEM
,	,	O
and	CC	O
urosepsis	NN	B-PROBLEM
.	.	O

she	PRP	O
originally	RB	O
had	VBD	O
hypotension	NN	B-PROBLEM
and	CC	O
a	DT	B-PROBLEM
leukocytosis	NN	I-PROBLEM
in	IN	O
the	DT	O
er	NN	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
.	.	O

in	IN	O
the	DT	O
cmed	NN	O
,	,	O
urology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
a	DT	B-TREATMENT
r	NN	I-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
tube	EX	B-TREATMENT
placement	NN	I-TREATMENT
was	VBD	O
complicated	VBN	O
by	IN	O
renal	JJ	B-PROBLEM
artery	NN	I-PROBLEM
puncture	NN	I-PROBLEM
,	,	O
afib	NN	B-PROBLEM
,	,	O
and	CC	O
increased	VBD	B-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
intubated	VBN	O
for	IN	O
this	DT	B-PROBLEM
hypoxia	NN	I-PROBLEM
and	CC	O
treated	VBN	O
with	IN	O
lasix	NN	B-TREATMENT
,	,	O
metoprolol	NN	B-TREATMENT
,	,	O
and	CC	O
diltiazem	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
weaned	VBN	O
off	RP	O
her	PRP$	B-TREATMENT
pressors	NNS	I-TREATMENT
on	IN	O
02-21	JJ	O
and	CC	O
maintained	VBD	O
her	PRP$	B-TEST
pressure	NN	I-TEST
w/out	IN	O
additional	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
boluses	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
sedation	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
down	RP	O
and	CC	O
she	PRP	O
was	VBD	O
successfully	RB	O
extubated	VBN	O
shortly	RB	O
thereafter	RB	O
.	.	O

ucx	JJ	B-TEST
grew	VBD	O
proteus	NN	B-PROBLEM
and	CC	O
her	PRP$	B-TREATMENT
abx	NN	I-TREATMENT
were	VBD	O
changed	VBN	O
to	TO	O
levaquin	VB	B-TREATMENT
alone	RB	O
and	CC	O
she	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
for	IN	O
>	JJ	O
24hr	CD	O
on	IN	O
this	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
trouble	NN	O
with	IN	O
afib	NNS	B-PROBLEM
and	CC	O
required	VBD	O
a	DT	B-TREATMENT
dilt	JJ	I-TREATMENT
gtt	NN	I-TREATMENT
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
call-out	NN	O
to	TO	O
control	VB	O
this	DT	O
rhythm	NN	O
but	CC	O
she	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
po	VB	B-TREATMENT
diltiazem	NN	I-TREATMENT
on	IN	O
the	DT	O
day	NN	O
of	IN	O
call-out	NN	O
.	.	O

1.	CD	O
sepsis	NN	B-PROBLEM
-	:	O
the	DT	O
patient	NN	O
was	VBD	O
septic	JJ	B-PROBLEM
in	IN	O
the	DT	O
er	NN	O
and	CC	O
her	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
eventually	RB	O
grew	VBD	O
proteus	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
bcx	NN	I-TEST
remained	VBD	O
negative	JJ	O
throughout	IN	O
her	PRP$	O
stay	NN	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
levaquin	NN	B-TREATMENT
on	IN	O
the	DT	O
floor	NN	O
and	CC	O
will	MD	O
complete	VB	O
a	DT	O
14d	CD	O
course	NN	O
at	IN	O
rehab	NN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
afebrile	JJ	B-PROBLEM
since	IN	O
she	PRP	O
was	VBD	O
called	VBN	O
out	RP	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

2.	CD	O
ureteral	JJ	B-PROBLEM
stone	NN	I-PROBLEM
-	:	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBN	O
by	IN	O
ir	NN	O
to	TO	O
relieve	VB	O
her	PRP$	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
urology	NN	O
during	IN	O
her	PRP$	O
stay	NN	O
and	CC	O
will	MD	O
see	VB	O
them	PRP	O
again	RB	O
2	CD	O
wk	NN	O
after	IN	O
d/c	NN	O
for	IN	O
definitive	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
nephrolithiasis	NN	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
urology	NN	O
will	MD	O
coordinate	VB	O
removal	NN	B-TREATMENT
of	IN	O
her	PRP$	B-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
with	IN	O
ir	NN	O
.	.	O

her	PRP$	B-TREATMENT
nephrostomy	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
draining	VBG	O
clear	JJ	O
yellow	JJ	O
urine	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
d/c	NN	O
.	.	O

3.	CD	O
a.fib	SYM	B-PROBLEM
-	:	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
controlled	VBN	O
with	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
at	IN	O
home	NN	O
.	.	O

once	RB	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
one	CD	O
episode	NN	O
of	IN	O
afib	JJ	B-PROBLEM
w/	NN	O
rvr	NN	B-PROBLEM
that	WDT	O
responded	VBD	O
immediately	RB	O
to	TO	O
iv	VB	B-TREATMENT
metoprolol	NN	I-TREATMENT
.	.	O

because	IN	O
of	IN	O
this	DT	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
diltiazem	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
tid	NN	B-TREATMENT
metoprolol	NN	I-TREATMENT
.	.	O

after	IN	O
this	DT	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
with	IN	O
her	PRP$	B-TREATMENT
rate	NN	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
gtt	NN	I-TREATMENT
for	IN	O
bridge	NN	O
to	TO	O
coumadin	VB	B-TREATMENT
while	IN	O
on	IN	O
the	DT	O
floor	NN	O
after	IN	O
this	DT	O
was	VBD	O
cleared	VBN	O
by	IN	O
ir	NN	O
and	CC	O
urology	NN	O
.	.	O

she	PRP	O
will	MD	O
be	VB	O
d/c	JJ	O
w/out	IN	O
her	PRP$	B-TREATMENT
heparin	NN	I-TREATMENT
as	IN	O
she	PRP	O
is	VBZ	O
trending	VBG	O
upwards	NNS	O
with	IN	O
her	PRP$	B-TEST
inr	NN	I-TEST
and	CC	O
has	VBZ	O
no	DT	O
mr	NN	B-PROBLEM
paul	NN	I-PROBLEM
paquettec	JJ	I-PROBLEM
heart	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
will	MD	O
continue	VB	O
her	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
at	IN	O
rehab	NN	O
to	TO	O
achieve	VB	O
an	DT	B-TEST
inr	NN	I-TEST
between	IN	O
03-22	NNP	O
.	.	O

4.	CD	O
delirium	NN	B-PROBLEM
-	:	O
the	DT	O
patient	NN	O
had	VBD	O
troubles	NNS	O
with	IN	O
agitation	NN	B-PROBLEM
while	IN	O
in	IN	O
the	DT	O
cmed	JJ	O
ccu	NN	O
.	.	O

she	PRP	O
received	VBD	O
prn	JJ	B-TREATMENT
haldol	NN	I-TREATMENT
w/	NN	O
little	JJ	O
effect	NN	O
and	CC	O
improved	VBN	O
as	IN	O
her	PRP$	B-PROBLEM
infection	NN	I-PROBLEM
cleared	VBD	O
.	.	O

medications	NNS	O
on	IN	O
admission	NN	O
:	:	O
toprol	NN	B-TREATMENT
(	(	O
unknown	JJ	O
dose	NN	O
)	)	O
coumadin	VBZ	B-TREATMENT
1	CD	O
mg	NN	O
qhs	NN	O

1.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

2.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

3.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

4.	CD	O
warfarin	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

5.	CD	O
miconazole	JJ	B-TREATMENT
nitrate	RB	I-TREATMENT
2	CD	O
%	NN	O
powder	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
neb	NN	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
polyvinyl	NN	B-TREATMENT
alcohol	RB	I-TREATMENT
1.4	CD	O
%	NN	O
drops	JJ	O
sig	NN	O
:	:	O
1-2	JJ	O
drops	NNS	O
ophthalmic	JJ	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
)	)	O
.	.	O

9.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
outpatient	JJ	B-TEST
lab	NN	I-TEST
work	NN	I-TEST
please	NN	O
have	VB	O
your	PRP$	B-TEST
inr	NN	I-TEST
checked	VBD	O
at	IN	O
the	DT	O
rehab	NN	O
center	NN	O
with	IN	O
a	DT	O
goal	NN	O
of	IN	O
03-22	NN	O
.	.	O

urosepsis	NN	B-PROBLEM

nephrolithiasis	NN	B-PROBLEM

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM

please	VB	O
take	VB	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
directed	JJ	O

stage	NN	B-PROBLEM
3c	CD	I-PROBLEM
papillary	JJ	I-PROBLEM
serous	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ovary	JJ	I-PROBLEM
.	.	O

stage	NN	B-PROBLEM
3c	CD	I-PROBLEM
papillary	JJ	I-PROBLEM
serous	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ovary	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
seventy-one	JJ	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
stenotic	JJ	B-PROBLEM
area	NN	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
mid	NN	I-PROBLEM
sigmoid	NN	I-PROBLEM
,	,	O
noticed	VBN	O
on	IN	O
barium	NN	B-TEST
enema	NN	I-TEST
.	.	O

the	DT	B-TEST
ultrasound	NN	I-TEST
showed	VBD	O
ascites	NNS	B-PROBLEM
and	CC	O
question	NN	O
of	IN	O
pelvic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
explored	VBN	O
by	IN	O
general	JJ	O
surgery	NN	O
,	,	O
who	WP	O
saw	VBD	O
the	DT	B-PROBLEM
3c	CD	I-PROBLEM
ovarian	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
an	DT	B-TREATMENT
omentectomy	NN	I-TREATMENT
and	CC	O
ileostomy	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
one	CD	O
cycle	NN	O
of	IN	O
cytoxan	NN	B-TREATMENT
and	CC	O
cisplatin	NN	B-TREATMENT
,	,	O
and	CC	O
subsequently	RB	O
underwent	JJ	O
debulking	VBG	B-TREATMENT
in	IN	O
june	NN	O
1992	CD	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-TREATMENT
total	JJ	I-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy/	NN	I-TREATMENT
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
,	,	O
omentectomy	NN	B-TREATMENT
,	,	O
splenectomy	NN	B-TREATMENT
,	,	O
rectosigmoid	JJ	B-TREATMENT
resection	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
take	VBP	I-TREATMENT
down	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
ileostomy	NN	I-TREATMENT
.	.	O

also	RB	O
ileal	JJ	B-TREATMENT
cecal	JJ	I-TREATMENT
resection	NN	I-TREATMENT
,	,	O
mdr	NN	B-TEST
showed	VBD	O
that	IN	O
cisplatin	NN	B-TREATMENT
and	CC	O
vp	$	B-TREATMENT
16	CD	I-TREATMENT
were	VBD	O
more	RBR	O
effective	JJ	O
.	.	O

the	DT	O
patient	NN	O
now	RB	O
presents	VBZ	O
for	IN	O
line	NN	O
1	CD	O
,	,	O
cycle	NN	O
4	CD	O
to	TO	O
15	CD	O
of	IN	O
vp	NN	B-TREATMENT
16	CD	I-TREATMENT
and	CC	I-TREATMENT
cisplatin	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

as	IN	O
above	RB	O
,	,	O
including	VBG	O
an	DT	B-TREATMENT
embolectomy	NN	I-TREATMENT
in	IN	O
june	NN	O
1992	CD	O
.	.	O

coumadin	NN	B-TREATMENT
2.5	CD	O
mg.	NN	O
five	CD	O
times	NNS	O
a	DT	O
week	NN	O
,	,	O
ativan	NN	B-TREATMENT
and	CC	O
lomotil	JJ	B-TREATMENT
prn	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
,	,	O
but	CC	O
has	VBZ	O
shellfish	JJ	B-PROBLEM
allergy	NN	I-PROBLEM
,	,	O
and	CC	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
iodine	NN	I-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
well	RB	O
appearing	NN	O
,	,	O
elderly	JJ	O
white	JJ	O
female	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
is	VBZ	O
120/82	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
88	CD	O
,	,	O
weight	VBD	B-TEST
125	CD	O
pounds	NNS	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
alopecia	NN	B-PROBLEM
,	,	O
otherwise	RB	O
unremarkable	JJ	O
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
,	,	O
bilateral	JJ	B-TEST
cardiac	NN	I-TEST
exam	NN	I-TEST
showed	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
except	IN	O
for	IN	O
mild	NN	B-PROBLEM
left	VBD	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
well	NN	I-PROBLEM
healed	VBN	I-PROBLEM
,	,	I-PROBLEM
midline	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
scar	NN	I-PROBLEM
.	.	O

no	DT	O
other	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
quadrant	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

exam	NN	B-TEST
was	VBD	O
nonfocal	JJ	O
,	,	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
of	IN	O
9.5	CD	O
,	,	O
anc	RB	B-TEST
7.7	CD	O
,	,	O
hematocrit	NN	B-TEST
26	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
248	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
12.	CD	O
and	CC	O
1.2	CD	O
respectively	RB	O
,	,	O
magnesium	NN	B-TEST
1.1	CD	O
,	,	O
calcium	NN	B-TEST
8.7	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
received	VBD	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
for	IN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
of	IN	O
26	CD	O
,	,	O
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
magnesium	NN	I-TREATMENT
repleted	VBN	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
three	CD	O
days	NNS	O
of	IN	O
chemotherapy	NN	B-TREATMENT
,	,	O
consisting	VBG	O
of	IN	O
45	CD	O
mg.	NN	O
of	IN	O
cisplatin	NN	B-TREATMENT
160	CD	O
mg.	NN	O
of	IN	O
vp	NN	B-TREATMENT
16	CD	I-TREATMENT
,	,	O
and	CC	O
tolerated	VBD	O
chemotherapy	NN	B-TREATMENT
resonably	RB	O
well	RB	O
.	.	O

serial	JJ	B-TEST
pts	NNS	I-TEST
were	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-TEST
initial	JJ	I-TEST
pt	NN	I-TEST
of	IN	O
10.9	CD	O
on	IN	O
admission	NN	O
,	,	O
despite	IN	O
coumadin	NN	B-TREATMENT
at	IN	O
home	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	JJ	I-TEST
pro	JJ	I-TEST
time	NN	I-TEST
bumped	VBD	O
to	TO	O
19.5	CD	O
on	IN	O
hospital	JJ	O
day	NN	O
#	#	O
3	CD	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
continue	VB	O
with	IN	O
2	CD	O
1/2	CD	O
mg.	NN	O
qhs	NN	O
and	CC	O
is	VBZ	O
to	TO	O
followup	VB	O
with	IN	O
anticoagulation	NN	O
clinic	NN	O
in	IN	O
one	CD	O
week	NN	O
for	IN	O
further	JJ	B-TEST
pro	JJ	I-TEST
time	NN	I-TEST
checks	NNS	I-TEST
and	CC	O
adjustments	NNS	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
develop	VB	O
some	DT	B-PROBLEM
hypertension	NN	I-PROBLEM
during	IN	O
infusion	NN	B-TREATMENT
of	IN	I-TREATMENT
her	PRP$	I-TREATMENT
vp	NN	I-TREATMENT
16	CD	I-TREATMENT
to	TO	O
the	DT	O
170/100	CD	O
range	NN	O
,	,	O
which	WDT	O
apparently	RB	O
happened	VBD	O
during	IN	O
her	PRP$	B-TREATMENT
prior	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
followup	VB	O
with	IN	O
her	PRP	O
internist	NN	O
regarding	VBG	O
further	JJ	B-TEST
evaluation	NN	I-TEST
of	IN	O
her	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
and	CC	O
should	MD	O
be	VB	O
assessed	VBN	O
regarding	VBG	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
,	,	O
as	IN	O
an	DT	O
inpatient	NN	O
,	,	O
or	CC	O
while	IN	O
receiving	VBG	O
chemotherapy	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
coumadin	NN	B-TREATMENT
2.5	CD	O
mg.	NN	O
po	NN	O
q	NN	O
d	NN	O
,	,	O
and	CC	O
ativan	NN	B-TREATMENT
and	CC	O
lomotil	JJ	B-TREATMENT
prn	NN	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
62	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
who	WP	O
underwent	VBD	O
an	DT	B-TEST
exercise	NN	I-TEST
treadmill	NN	I-TEST
test	NN	I-TEST
for	IN	O
screening	VBG	B-TEST
through	IN	O
the	DT	O
beth	NN	O
israel	JJ	O
deaconess	JJ	O
hospital-needham	JJ	O
clinic	NN	O
.	.	O

the	DT	B-TEST
test	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
ekg	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
chest	NN	B-PROBLEM
pain;	NN	I-PROBLEM
no	DT	O
history	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
cambridge	VB	O
health	NN	O
alliance	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
50%	CD	O
,	,	O
left	VBD	B-TEST
ventricular	JJ	I-TEST
end	NN	I-TEST
diastolic	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
20	CD	O
,	,	O
90%	CD	B-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
80%	CD	B-PROBLEM
left	VBD	I-PROBLEM
circumflex	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
80%	CD	B-PROBLEM
mid	NN	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
lesion	NN	I-PROBLEM
and	CC	O
80%	CD	B-PROBLEM
distal	JJ	I-PROBLEM
right	RB	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
dr.	VB	O
rota	NN	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2.	CD	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

5.	CD	O
gout	NN	B-PROBLEM
.	.	O

6.	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

7.	CD	O
history	NN	O
of	IN	O
salivary	JJ	B-TREATMENT
gland	NN	I-TREATMENT
removal	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
glucophage	NN	B-TREATMENT
xr	NN	O
1000	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
avandia	JJ	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

3.	CD	O
diovan	NN	B-TREATMENT
160	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

6.	CD	O
niaspan	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

7.	CD	O
enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
saint	VB	O
vincent	JJ	O
hospital	NN	O
on	IN	O
2017-04-26	JJ	O
and	CC	O
underwent	JJ	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
four	CD	O
with	IN	O
left	VBN	B-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
to	TO	I-TREATMENT
left	VB	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
right	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
pda	VB	I-TREATMENT
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
obtuse	VB	I-TREATMENT
marginal	JJ	I-TREATMENT
with	IN	O
dr.	JJ	O
rota	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
neo-synephrine	JJ	B-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
weaned	VBN	O
the	DT	O
next	JJ	O
day	NN	O
from	IN	O
mechanical	JJ	B-TREATMENT
ventilation	NN	I-TREATMENT
on	IN	O
his	PRP$	O
first	JJ	O
postoperative	JJ	O
night	NN	O
.	.	O

postoperative	JJ	O
days	NNS	O
one	CD	O
and	CC	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
require	VB	O
neo-synephrine	JJ	B-TREATMENT
to	TO	O
maintain	VB	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
greater	JJR	O
than	IN	O
100	CD	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
23.1	CD	O
;	:	O
he	PRP	O
was	VBD	O
transfused	VBN	O
one	CD	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
given	VBN	O
a	DT	O
dose	NN	O
of	IN	O
lasix	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
neo-synephrine	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
off	RP	O
by	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
chest	JJS	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
without	IN	O
incident	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
low	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
lasix	NN	I-TREATMENT
and	CC	O
lopressor	NN	B-TREATMENT
which	WDT	O
he	PRP	O
tolerated	VBD	O
well	RB	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
four	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
to	TO	O
the	DT	O
regular	JJ	O
part	NN	O
of	IN	O
the	DT	O
hospital	NN	O
where	WRB	O
he	PRP	O
began	VBD	O
working	VBG	O
with	IN	O
physical	JJ	O
therapy	NN	O
and	CC	O
on	IN	O
his	PRP$	O
first	JJ	O
session	NN	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
ambulate	VB	O
500	CD	O
feet	NNS	O
and	CC	O
climb	VB	O
one	CD	O
flight	NN	O
of	IN	O
stairs	NNS	O
while	IN	O
remaining	VBG	O
hemodynamically	RB	O
stable	JJ	O
without	IN	O
requiring	VBG	O
any	DT	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
epicardial	JJ	I-TREATMENT
pacing	NN	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
without	IN	O
incident	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
cleared	VBN	O
for	IN	O
discharge	NN	O
to	TO	O
home	NN	O
.	.	O

temperature	NN	B-TEST
maximum	VBZ	I-TEST
99.8	CD	O
f.	NN	O
;	:	O
pulse	CC	B-TEST
76	CD	O
and	CC	O
sinus	JJ	O
rhythm	NN	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
107/61	CD	O
;	:	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
;	:	O
room	NN	B-TEST
air	NN	I-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
95%	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
weight	NN	I-TEST
on	IN	O
05-01	NN	O
was	VBD	O
101.4	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
5.8	CD	O
,	,	O
hematocrit	NN	B-TEST
23.5	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
118	CD	O
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
3.9	CD	O
,	,	O
chloride	RB	B-TEST
103	CD	O
,	,	O
bicarbonate	NN	B-TEST
18	CD	O
,	,	O
bun	NN	B-TEST
11	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
144	CD	O
.	.	O

pt	NN	B-TEST
29	CD	O
,	,	O
inr	NN	B-TEST
1.1	CD	O
and	CC	O
ptt	$	B-TEST
22.9	CD	O
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
is	VBZ	O
non-focal	JJ	O
.	.	O

heart	NN	O
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
rub	NN	B-PROBLEM
or	CC	O
murmur	NN	B-PROBLEM
.	.	O

respiratory	JJ	B-TEST
breath	NN	I-TEST
sounds	NNS	I-TEST
are	VBP	O
clear	JJ	O
bilaterally	RB	O
,	,	O
decreased	VBN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

abdomen	NNS	O
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
.	.	O

sternal	JJ	B-TREATMENT
incision	NN	I-TREATMENT
staples	NNS	I-TREATMENT
are	VBP	O
intact	JJ	O
and	CC	O
open	JJ	O
to	TO	O
air	NN	O
.	.	O

incision	NN	B-PROBLEM
is	VBZ	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
erythema	NN	B-PROBLEM
and	CC	O
sternum	NN	O
is	VBZ	O
stable	JJ	O
.	.	O

right	RB	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
vein	NN	I-PROBLEM
harvest	NN	I-PROBLEM
site	NN	I-PROBLEM
has	VBZ	O
a	DT	O
moderate	JJ	O
amount	NN	O
of	IN	O
ecchymosis	NN	B-PROBLEM
at	IN	O
the	DT	O
very	RB	O
distal	JJ	O
portion	NN	O
of	IN	O
the	DT	B-PROBLEM
incision	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
ankle	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	O
minimum	JJ	O
amount	NN	O
of	IN	O
serosanguinous	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
erythema	NN	B-PROBLEM
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
four	CD	O
.	.	O

3.	CD	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

4.	CD	O
postoperative	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
.	.	O

1.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
.	.	O

3.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
.	.	O

4.	CD	O
niferex	JJ	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
one	CD	O
month	NN	O
.	.	O

5.	CD	O
vitamin	JJ	B-TREATMENT
c	NN	I-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
times	VBZ	O
one	CD	O
month	NN	O
.	.	O

6.	CD	O
multivitamin	NN	B-TREATMENT
one	CD	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
one	CD	O
month	NN	O
.	.	O

7.	CD	O
ambien	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O

8.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

9.	CD	O
avandia	JJ	B-TREATMENT
4	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

10.	CD	O
glucophage	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

11.	CD	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

12.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

13.	CD	O
niaspan	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

14.	CD	O
percocet	NN	B-TREATMENT
5/325	CD	O
one	CD	O
to	TO	O
two	CD	O
p.o.	NNS	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

3.	CD	O
the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
return	VB	O
to	TO	O
smith	VB	O
on	IN	O
or	CC	O
about	IN	O
05-17	JJ	O
to	TO	O
have	VB	O
his	PRP$	B-TREATMENT
staples	NNS	I-TREATMENT
removed	VBN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
sscp	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
well	RB	O
general	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
reke	JJ	O
,	,	O
atota	JJ	O
s	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
acs	JJ	B-PROBLEM
..	NN	O

the	DT	O
patient	NN	O
originally	RB	O
presented	VBN	O
to	TO	O
her	PRP$	O
pcp	NN	O
approximately	RB	O
one	CD	O
week	NN	O
prior	RB	O
to	TO	O
admission	NN	O
here	RB	O
with	IN	O
increasing	VBG	B-PROBLEM
cough	NN	I-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
z-pak	NN	I-TREATMENT
for	IN	O
treatment	NN	B-TREATMENT
along	IN	O
with	IN	O
albuterol	NN	B-TREATMENT
.	.	O

despite	IN	O
this	DT	O
,	,	O
she	PRP	O
continued	VBD	O
to	TO	O
worsen	VB	O
and	CC	O
became	VBD	O
febrile	NN	B-PROBLEM
.	.	O

at	IN	O
the	DT	O
hospital	NN	O
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
rocephin	NN	B-TREATMENT
and	CC	O
levaquin	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
seen	VBN	O
on	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
increasing	VBG	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
hypoxia	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
significantly	RB	B-PROBLEM
tachypneic	VBZ	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
repeat	NN	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
bilateral	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
infiltrates	VBZ	I-PROBLEM
consistent	JJ	O
with	IN	O
ards	NNS	B-PROBLEM
.	.	O

hypothyroidism	NN	B-PROBLEM
.	.	O

depression	NN	B-PROBLEM
.	.	O

anxiety	NN	B-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

1.	CD	O
levoxyl	JJ	B-TREATMENT
112	CD	O
mcg	NN	O
q.d.	NN	O

2.	CD	O
prozac	NN	B-TREATMENT
.	.	O

3.	CD	O
codeine	NN	B-TREATMENT
for	IN	O
cough	NN	B-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
vital	JJ	B-TEST
signs:	NN	I-TEST

temperature	NN	B-TEST
101.4	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
101/62	CD	O
,	,	O
pulse	RB	B-TEST
80	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
19	CD	O
on	IN	O
a	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
with	IN	O
settings	NNS	O
of	IN	O
assist	NN	B-TREATMENT
control	NN	I-TREATMENT
at	IN	O
500/12	CD	O
and	CC	O
a	DT	B-TREATMENT
peep	NN	I-TREATMENT
of	IN	O
5	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
intubated	VBN	B-TREATMENT
and	CC	O
sedated	VBN	B-TREATMENT
,	,	O
but	CC	O
easily	RB	O
arousable	JJ	O
.	.	O

sclerae	NN	O
are	VBP	O
anicteric	JJ	B-PROBLEM
.	.	O

et	NN	B-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
in	IN	O
place	NN	O
.	.	O

faint	NN	B-PROBLEM
scattered	VBD	I-PROBLEM
wheezes	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

labs	NNS	B-TEST
on	IN	O
admission	NN	O
from	IN	O
outside	JJ	O
hospital	NN	O
,	,	O
cbc	NN	B-TEST
notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
21.9	CD	O
with	IN	O
hematocrit	NN	B-TEST
of	IN	O
36.3	CD	O
and	CC	O
normal	JJ	O
platelets	NNS	O
.	.	O

chem-7	NN	B-TEST
notable	JJ	O
for	IN	O
potassium	NN	B-TEST
of	IN	O
3.2	CD	O
and	CC	O
bicarbonate	NN	B-TEST
of	IN	O
30	CD	O
.	.	O

lfts	NNS	B-TEST
show	VBP	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
alt	NN	I-PROBLEM
of	IN	O
52	CD	O
and	CC	O
ast	NN	B-TEST
of	IN	O
101	CD	O
with	IN	O
normal	JJ	O
alkaline	JJ	O
phosphatase	NN	O
and	CC	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
.	.	O

latest	JJS	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gas	NN	I-TEST
with	IN	O
ph	NN	B-TEST
of	IN	O
7.45	CD	O
,	,	O
pco2	NN	B-TEST
43	CD	O
and	CC	O
po2	$	B-TEST
155	CD	O
on	IN	O
100	CD	B-TREATMENT
percent	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
via	IN	O
ventilator	NN	B-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
shows	NNS	O
right	RB	B-PROBLEM
middle	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	I-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
left	VBD	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
.	.	O

ekg	NN	B-TEST
shows	VBZ	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
at	IN	O
70	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
with	IN	O
normal	JJ	O
axis	NNS	O
and	CC	O
intervals	NNS	O
,	,	O
borderline	NN	B-PROBLEM
lvh	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
what	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
acute	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
community	NN	B-PROBLEM
-	:	I-PROBLEM
acquired	VBN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
a	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
and	CC	O
ventilated	VBD	O
according	VBG	O
to	TO	O
ardsnet	NN	O
protocol	NN	O
.	.	O

for	IN	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
levaquin	NN	B-TREATMENT
,	,	O
ceftriaxone	NN	B-TREATMENT
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
.	.	O

over	IN	O
the	DT	O
next	JJ	O
two	CD	O
days	NNS	O
after	IN	O
admission	NN	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
vent	JJ	I-TREATMENT
settings	NNS	I-TREATMENT
were	VBD	O
gradually	RB	O
weaned	VBN	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
extubated	VBN	O
two	CD	O
days	NNS	O
after	IN	O
being	VBG	O
transferred	VBN	O
to	TO	O
this	DT	O
hospital	NN	O
.	.	O

after	IN	O
extubation	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
oxygenating	VBG	O
well	RB	O
on	IN	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
continue	VB	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
fairly	RB	I-PROBLEM
severe	JJ	I-PROBLEM
cough	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
her	PRP	B-PROBLEM
cough	NN	I-PROBLEM
was	VBD	O
weak	JJ	B-PROBLEM
due	JJ	O
to	TO	O
abdominal	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
pain	NN	I-PROBLEM
from	IN	O
repeated	VBN	B-PROBLEM
coughing	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
cough	NN	I-PROBLEM
was	VBD	O
mostly	RB	B-PROBLEM
nonproductive	JJ	I-PROBLEM
.	.	O

as	IN	O
there	EX	O
was	VBD	O
no	DT	O
identified	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
pathogen	NN	I-PROBLEM
on	IN	O
any	DT	B-TEST
cultures	NNS	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
the	DT	B-TREATMENT
triple	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
first	JJ	O
several	JJ	O
days	NNS	O
of	IN	O
the	DT	O
hospitalization	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
on	IN	O
round-the-clock	JJ	B-TREATMENT
atrovent	NN	I-TREATMENT
and	CC	O
albuterol	NN	B-TREATMENT
nebulizers	NNS	I-TREATMENT
.	.	O

once	RB	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
out	IN	O
of	IN	O
the	DT	O
icu	NN	O
and	CC	O
after	IN	O
extubation	NN	B-TREATMENT
,	,	O
the	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
gradually	RB	O
narrowed	VBN	O
.	.	O

the	DT	B-TREATMENT
vancomycin	NN	I-TREATMENT
and	CC	O
levaquin	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
after	IN	O
approximately	RB	O
four	CD	O
days	NNS	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

the	DT	B-TREATMENT
ceftriaxone	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
after	IN	O
four	CD	O
days	NNS	O
in	IN	O
the	DT	O
hospital	NN	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
continue	VB	O
on	IN	O
levaquin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
gradual	JJ	O
improvement	NN	O
in	IN	O
her	PRP$	B-TEST
oxygenation	NN	I-TEST
.	.	O

pain	NN	B-TREATMENT
control	NN	I-TREATMENT
:	:	O

the	DT	O
patient	NN	O
had	VBD	O
fairly	RB	B-PROBLEM
significant	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
persistent	JJ	B-PROBLEM
cough	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	O
regimen	NN	O
of	IN	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
with	IN	O
oxycodone	NN	B-TREATMENT
for	IN	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

this	DT	O
helped	VBD	O
her	PRP	O
somewhat	RB	O
though	IN	O
she	PRP	O
has	VBZ	O
continued	VBN	O
to	TO	O
have	VB	O
difficulty	NN	B-PROBLEM
coughing	VBG	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

tylenol	NN	B-TREATMENT
and	CC	O
ibuprofen	NN	B-TREATMENT
were	VBD	O
also	RB	O
added	VBN	O
for	IN	O
better	JJR	O
control	NN	O
.	.	O

transaminitis	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
mild	VBN	B-PROBLEM
transaminitis	NN	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

however	RB	O
,	,	O
this	DT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
significant	JJ	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

anemia	NN	B-PROBLEM
:	:	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
reticulocyte	NN	I-TEST
count	NN	I-TEST
showed	VBD	O
inadequate	JJ	B-PROBLEM
production	NN	I-PROBLEM
.	.	O

iron	NN	B-TEST
studies	NNS	I-TEST
showed	VBD	O
a	DT	O
mixed	JJ	O
picture	NN	O
with	IN	O
decreased	JJ	B-PROBLEM
iron	NN	I-PROBLEM
and	CC	O
decreased	VBD	B-PROBLEM
iron	NN	I-PROBLEM
to	TO	I-PROBLEM
tibc	VB	I-PROBLEM
ratio	JJ	I-PROBLEM
suggestive	NN	O
of	IN	O
iron-deficiency	NN	B-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
but	CC	O
also	RB	O
normal	JJ	O
to	TO	O
high	JJ	B-PROBLEM
mcv	NN	I-PROBLEM
.	.	O

b12	NN	B-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
low	JJ	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
an	DT	O
injection	NN	O
of	IN	O
im	JJ	B-TREATMENT
b12	NN	I-TREATMENT
while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
iron	NN	B-TREATMENT
supplementation	NN	I-TREATMENT
.	.	O

hypothyroidism	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
synthroid	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
chronic	JJ	I-PROBLEM
hypothyroidism	NN	I-PROBLEM
.	.	O

community-acquired	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

acute	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

iron-deficiency	NN	B-PROBLEM
anemia	NN	I-PROBLEM
.	.	O

hypothyroidism	NN	B-PROBLEM
.	.	O

1.	CD	O
levothyroxine	JJ	B-TREATMENT
75	CD	O
mcg	NN	O
q.d.	NN	O

2.	CD	O
prozac	JJ	B-TREATMENT
40	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
levaquin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
q.d.	NN	O
for	IN	O
7	CD	O
days	NNS	O
after	IN	O
discharge	NN	O
.	.	O

4.	CD	O
guaifenesin	NN	B-TREATMENT
syrup	NN	I-TREATMENT
p.r.n.	JJ	O
cough	NN	B-PROBLEM
.	.	O

5.	CD	O
oxycodone	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.4	NN	O
h.	NN	O
p.r.n.	NN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O

7.	CD	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
30	CD	O
mg	NN	O
b.i.d.	NN	O

8.	CD	O
ibuprofen	JJ	B-TREATMENT
800	CD	O
mg	NN	O
q.8	NN	O
h	NN	O
.	.	O

9.	CD	O
albuterol	NN	B-TREATMENT
1	CD	O
to	TO	O
2	CD	O
puffs	NNS	O
q.6	JJ	O
h.	JJ	O
p.r.n.	NN	O

10.	CD	O
atrovent	JJ	B-TREATMENT
1	CD	O
puff	NN	O
q.6	NN	O
h.	NN	O
p.r.n.	NN	O

she	PRP	O
is	VBZ	O
also	RB	O
to	TO	O
call	VB	O
her	PRP$	O
pcp	NN	O
if	IN	O
she	PRP	O
has	VBZ	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
fevers	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
left	JJ	B-PROBLEM
leg	NN	I-PROBLEM
fx	NN	I-PROBLEM
hip	NN	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
ofthe	NN	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
bri	VB	O
health	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
heagleinchird	JJ	O
,	,	O
jeansia	JJ	O
s	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
hip	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
45	CD	O
-	:	O
year-old	JJ	O
female	NN	O
here	RB	O
for	IN	O
a	DT	B-TEST
diagnostic	JJ	I-TEST
cerebral	JJ	I-TEST
angiogram	NN	I-TEST
with	IN	O
coiling	NN	B-TREATMENT
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
102/82	CD	O
.	.	O

her	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
71	CD	O
.	.	O

her	PRP$	B-TEST
spo2	NN	I-TEST
was	VBD	O
98	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

1.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
times	NNS	O
6	CD	O
doses	NNS	O
.	.	O

2.	CD	O
xanax	CD	B-TREATMENT
q.d.	NN	O

3.	CD	O
prozac	JJ	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
cyclobenzaprine	NN	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

5.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
times	NNS	O
3	CD	O
doses	NNS	O
.	.	O

6.	CD	O
vitamin	JJ	B-TREATMENT
e	NN	I-TREATMENT
.	.	O

tubal	JJ	B-TREATMENT
ligation	NN	I-TREATMENT
,	,	O
1986	CD	O
.	.	O

cystectomy	NN	B-TREATMENT
,	,	O
1992	CD	O
and	CC	O
1998	CD	O
.	.	O

breast	NN	B-TREATMENT
lesion	NN	I-TREATMENT
excision	NN	I-TREATMENT
,	,	O
1989	CD	O
.	.	O

tetracycline	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
complaint	NN	O
of	IN	O
headaches	NNS	B-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

she	PRP	O
has	VBZ	O
fibromyalgia	VBN	B-PROBLEM
and	CC	O
a	DT	O
history	NN	O
of	IN	O
slurred	JJ	B-PROBLEM
speech	NN	I-PROBLEM
.	.	O

on	IN	O
2017-09-13	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
and	CC	O
underwent	NN	O
a	DT	B-TREATMENT
coiling	NN	I-TREATMENT
with	IN	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
left	NN	I-PROBLEM
carotid	NN	I-PROBLEM
ophthalmic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
coiling	NN	B-TREATMENT
and	CC	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

postoperative	JJ	B-TEST
check	NN	I-TEST
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
96.3	CD	O
degrees	NNS	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
128/63	CD	O
.	.	O

her	PRP$	B-TEST
pulse	NN	I-TEST
was	VBD	O
61	CD	O
,	,	O
respirations	NNS	B-TEST
12	CD	O
,	,	O
and	CC	O
her	PRP$	B-TEST
o2	JJ	I-TEST
saturation	NN	I-TEST
was	VBD	O
98	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

her	PRP$	B-TEST
labs	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
7.7	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
33.3	CD	O
,	,	O
and	CC	O
platelets	NNS	B-TEST
were	VBD	O
305	CD	O
.	.	O

her	PRP$	B-TEST
coags	NNS	I-TEST
,	,	O
her	PRP$	B-TEST
pt	NN	I-TEST
was	VBD	O
14.5	CD	O
,	,	O
ptt	NN	B-TEST
was	VBD	O
143.4	CD	O
,	,	O
and	CC	O
her	PRP$	B-TEST
inr	NN	I-TEST
was	VBD	O
1.3	CD	O
.	.	O

her	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
all	DT	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
,	,	O
and	CC	O
oriented	VBD	O
times	NNS	O
3	CD	O
.	.	O

her	PRP$	O
strength	NN	O
was	VBD	O
05-31	JJ	O
throughout	IN	O
except	IN	O
for	IN	O
right	NN	O
was	VBD	O
not	RB	O
tested	VBN	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
angiocele	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
groin	NN	I-PROBLEM
.	.	O

angiocele	NN	B-PROBLEM
was	VBD	O
intact	JJ	O
without	IN	O
hematoma	NN	B-PROBLEM
,	,	O
and	CC	O
she	PRP	O
exhibited	VBD	O
strong	JJ	O
pedal	NN	O
pulses	NNS	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
.	.	O

the	DT	B-TEST
assessment	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
she	PRP	O
was	VBD	O
neurologically	RB	O
stable	JJ	O
.	.	O

the	DT	O
plan	NN	O
was	VBD	O
q.	JJ	O
1-hour	JJ	O
neuro	NN	B-TEST
checks	NNS	I-TEST
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
drip	NN	I-TREATMENT
at	IN	O
800	CD	O
per	IN	O
hour	NN	O
.	.	O

her	PRP$	B-TEST
ptt	NN	I-TEST
goes	VBZ	O
50	CD	O
to	TO	O
60	CD	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

she	PRP	O
exhibited	VBD	O
no	DT	O
drift	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
ips	NNS	I-TEST
were	VBD	O
full	JJ	O
at	IN	O
5/5	CD	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
hematoma	NN	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
groin	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
with	IN	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
97.8	CD	O
degrees	NNS	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
104	CD	O
to	TO	O
121	CD	O
over	IN	O
50s	CD	O
.	.	O

pulse	NN	B-TEST
was	VBD	O
60	CD	O
to	TO	O
70	CD	O
.	.	O

respirations	NNS	B-TEST
were	VBD	O
15	CD	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
saturating	VBG	O
at	IN	O
96	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

her	PRP$	B-TEST
ptt	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
was	VBD	O
67.8	CD	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O
and	CC	O
plavix	NN	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O

postoperative	JJ	O
day	NN	O
2	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
without	IN	O
events	NNS	O
,	,	O
all	DT	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
stable	JJ	O
.	.	O

angio	JJ	B-PROBLEM
site	NN	I-PROBLEM
was	VBD	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
without	IN	O
bleeding	VBG	B-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
.	.	O

1.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

she	PRP	O
is	VBZ	O
to	TO	O
continue	VB	O
taking	VBG	O
medications	NNS	B-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
coiling	VBG	B-TREATMENT
with	IN	O
stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
left	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
ophthalmic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
also	RB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
to	TO	O
review	VB	O
her	PRP$	B-TREATMENT
hypertensive	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

coiling	VBG	B-TREATMENT
with	IN	O
a	DT	B-TREATMENT
stent	JJ	I-TREATMENT
placement	NN	I-TREATMENT
for	IN	O
left	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

failed	VBD	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
bypass	NN	I-PROBLEM
graft	NN	I-PROBLEM
,	,	O
prior	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
elevated	VBN	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
renal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

08/20/98	CD	O
dual	JJ	B-TREATMENT
chamber	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
generator	NN	I-TREATMENT
change	NN	I-TREATMENT
(	(	O
cpi	JJ	O
1276	CD	O
meridian	JJ	O
dr	NN	O
)	)	O
.	.	O

08/15/98	CD	O
bilateral	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
;	:	O
08/15/98	CD	O
left	VBD	B-TEST
ventriculography	NN	I-TEST
;	:	O
08/15/98	CD	O
bilateral	JJ	B-TEST
coronary	JJ	I-TEST
angiography	NN	I-TEST
;	:	O
08/15/98	CD	O
bypass	NN	B-TEST
graft	NN	I-TEST
angiography	NN	I-TEST
;	:	O
08/15/98	CD	O
internal	JJ	B-TEST
mammary	JJ	I-TEST
artery	NN	I-TEST
angiography	NN	I-TEST
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mg.	NNS	O
po	JJ	O
q.d.	NN	O

lipitor	NN	B-TREATMENT
80	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
50	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

lasix	RB	B-TREATMENT
80	CD	O
mg.	NNS	O
q.a.m.	RB	O
and	CC	O
40	CD	O
mg.	NNS	O
q.p.m.	RB	O

potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq.	NN	O
po	NN	O
b.i.d.	NN	O

citracal	JJ	B-TREATMENT
1	CD	O
packet	NN	O
q.d.	NN	O

imdur	NN	B-TREATMENT
60	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

vitamin	NN	B-TREATMENT
e	VBZ	I-TREATMENT
400	CD	O
international	JJ	O
units	NNS	O
q.d.	VBP	O

prilosec	NN	B-TREATMENT
20	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

she	PRP	O
is	VBZ	O
referred	VBN	O
for	IN	O
progressive	JJ	B-PROBLEM
angina	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
rheumatoid	JJ	B-PROBLEM
fever	NN	I-PROBLEM
as	IN	O
a	DT	O
child	NN	O
and	CC	O
a	DT	B-PROBLEM
heart	NN	I-PROBLEM
murmur	NN	I-PROBLEM
noted	VBD	O
but	CC	O
no	DT	O
further	JJ	B-TEST
testing	NN	I-TEST
.	.	O

she	PRP	O
has	VBZ	O
used	VBN	O
antibiotic	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
since	IN	O
1980	CD	O
.	.	O

in	IN	O
1980	CD	O
she	PRP	O
had	VBD	O
quadruple	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
surgery	NN	I-TREATMENT
by	IN	O
dr.	NN	O
elks	NNS	O
at	IN	O
feargunwake	JJ	O
otacaa	NN	O
community	NN	O
hospital	NN	O
and	CC	O
did	VBD	O
well	RB	O
until	IN	O
1988	CD	O
when	WRB	O
she	PRP	O
had	VBD	O
exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
stress	NN	I-PROBLEM
test	NN	I-PROBLEM
and	CC	O
found	VBD	O
that	IN	O
three	CD	B-TREATMENT
or	CC	I-TREATMENT
four	CD	I-TREATMENT
grafts	NNS	I-TREATMENT
were	VBD	O
occluded	VBN	B-PROBLEM
.	.	O

in	IN	O
october	NNP	O
,	,	O
1989	CD	O
,	,	O
dr.	VBZ	O
no	DT	O
re-did	JJ	O
her	PRP$	B-TREATMENT
bypass	NN	I-TREATMENT
operation	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
left	VBN	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
left	VBN	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
obtuse	NN	I-TREATMENT
marginal	JJ	I-TREATMENT
1	CD	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
obtuse	NN	I-TREATMENT
marginal	JJ	I-TREATMENT
2	CD	I-TREATMENT
.	.	O

in	IN	O
1993	CD	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
ddd	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
for	IN	O
complete	JJ	B-PROBLEM
heart	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
exertional	JJ	B-PROBLEM
angina	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

in	IN	O
november	NNP	O
,	,	O
1997	CD	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
as	IN	O
was	VBD	O
transferred	VBN	O
to	TO	O
ona	VB	O
hospital	NN	O
where	WRB	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
tight	JJ	I-PROBLEM
left	NN	I-PROBLEM
internal	JJ	I-PROBLEM
mammary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
to	TO	O
left	VB	B-PROBLEM
anterior	RP	I-PROBLEM
descending	VBG	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
high	JJ	O
grade	NN	O
saphenous	JJ	O
vein	NN	O
graft	NN	O
to	TO	O
obtuse	VB	B-PROBLEM
marginal	JJ	I-PROBLEM
1	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
patent	NN	O
obtuse	VBP	O
marginal	JJ	O
2	CD	O
graft	NN	O
.	.	O

she	PRP	O
had	VBD	O
normal	JJ	O
left	JJ	O
ventricular	JJ	O
function	NN	O
with	IN	O
apical	JJ	B-PROBLEM
tip	NN	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

since	IN	O
that	DT	O
time	NN	O
she	PRP	O
has	VBZ	O
continued	VBN	O
to	TO	O
have	VB	O
exertional	JJ	B-PROBLEM
left	VBN	I-PROBLEM
chest	JJS	I-PROBLEM
burning	NN	I-PROBLEM
,	,	O
radiating	VBG	O
to	TO	O
the	DT	O
left	VBN	O
neck	NN	O
and	CC	O
arm	NN	O
,	,	O
relieved	VBN	O
by	IN	O
nitroglycerin	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
turned	VBN	O
down	RP	O
for	IN	O
re-do	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
at	IN	O
that	DT	O
time	NN	O
and	CC	O
did	VBD	O
not	RB	O
have	VB	O
a	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

because	IN	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
have	VBP	O
been	VBN	O
increasing	VBG	O
,	,	O
particularly	RB	O
at	IN	O
cardiac	JJ	O
rehabilitation	NN	O
,	,	O
she	PRP	O
was	VBD	O
referred	VBN	O
here	RB	O
.	.	O

in	IN	O
may	MD	O
,	,	O
1998	CD	O
she	PRP	O
had	VBD	O
an	DT	B-TEST
exercise	NN	I-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
in	IN	O
which	WDT	O
her	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
went	VBD	O
to	TO	O
112	CD	O
and	CC	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
fell	VBD	O
to	TO	O
95	CD	O
systolic	NN	O
.	.	O

she	PRP	O
had	VBD	O
diffuse	NN	B-PROBLEM
ischemic	JJ	I-PROBLEM
st	NN	I-PROBLEM
segment	NN	I-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
lung	NN	I-PROBLEM
uptake	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
reversible	JJ	I-PROBLEM
anterior	NN	I-PROBLEM
and	CC	I-PROBLEM
lateral	JJ	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
no	DT	O
syncope	NN	B-PROBLEM
.	.	O

her	PRP$	O
cardiac	JJ	O
risk	NN	O
factors	NNS	O
are	VBP	O
hypertension	NN	B-PROBLEM
and	CC	O
elevated	VBN	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
very	RB	O
strong	JJ	O
family	NN	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
a	DT	O
mother	NN	O
,	,	O
sister	NN	O
and	CC	O
brother	NN	O
dying	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
lactose	JJ	B-PROBLEM
intolerance	NN	I-PROBLEM
,	,	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
remote	JJ	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
multiple	JJ	B-PROBLEM
ectopic	NN	I-PROBLEM
pregnancies	NNS	I-PROBLEM
and	CC	O
mid	JJ	B-PROBLEM
term	NN	I-PROBLEM
miscarriages	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
a	DT	B-TREATMENT
total	JJ	I-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
120/70	CD	O
,	,	O
pulse	RB	B-TEST
60	CD	O
and	CC	O
regular	JJ	O
.	.	O

neck	NN	O
veins	NNS	O
are	VBP	O
not	RB	O
distended	VBN	B-PROBLEM
.	.	O

respiratory	NN	B-TEST
rate	NN	I-TEST
12	CD	O
.	.	O

no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

1/6	CD	B-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

peripheral	JJ	B-TEST
pulses	NNS	I-TEST
intact	JJ	O
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
non-focal	JJ	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
includes	VBZ	O
an	DT	B-TEST
electrocardiogram	NN	I-TEST
that	WDT	O
shows	VBZ	O
ddd	RP	B-TREATMENT
pacing	VBG	I-TREATMENT
.	.	O

hematocrit	NN	B-TEST
39	CD	O
percent	NN	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
4500	CD	O
,	,	O
pt	NN	B-TEST
and	CC	O
ptt	NN	B-TEST
normal	JJ	O
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
105	CD	O
,	,	O
carbon	NN	B-TEST
dioxide	NN	I-TEST
30	CD	O
,	,	O
bun	NN	B-TEST
24	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
.	.	O

there	RB	O
,	,	O
her	PRP	B-TEST
pulmonary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
12	CD	O
and	CC	O
her	PRP$	B-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
4	CD	O
and	CC	O
pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
44/17	CD	O
.	.	O

her	PRP$	B-TEST
left	JJ	I-TEST
ventricular	JJ	I-TEST
contraction	NN	I-TEST
showed	VBD	O
akinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
with	IN	O
dyskinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

her	PRP$	O
native	JJ	O
right	NN	O
and	CC	O
left	VBD	O
anterior	RP	O
descending	VBG	O
vessels	NNS	O
were	VBD	O
occluded	VBN	B-PROBLEM
as	IN	O
was	VBD	O
an	DT	O
obtuse	NN	O
marginal	JJ	O
branch	NN	O
.	.	O

the	DT	O
saphenous	JJ	O
vein	NN	O
to	TO	O
the	DT	O
high	JJ	O
diagonal	NN	O
or	CC	O
high	JJ	O
obtuse	IN	O
marginal	NN	O
was	VBD	O
occluded	VBN	B-PROBLEM
.	.	O

the	DT	O
left	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
to	TO	O
the	DT	O
left	VBN	O
anterior	JJ	O
descending	NN	O
was	VBD	O
also	RB	O
occluded	VBN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
second	JJ	I-TREATMENT
obtuse	IN	I-TREATMENT
marginal	NN	I-TREATMENT
was	VBD	O
open	JJ	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
but	CC	O
there	EX	O
was	VBD	O
an	DT	B-PROBLEM
outflow	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
obtuse	NN	I-PROBLEM
marginal	JJ	I-PROBLEM
2	CD	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
severe	JJ	B-PROBLEM
distal	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
as	IN	O
the	DT	O
obtuse	NN	O
marginal	JJ	O
2	CD	O
fed	VBD	O
the	DT	O
posterior	JJ	O
descending	NN	O
artery	NN	O
.	.	O

this	DT	O
was	VBD	O
considered	VBN	O
her	PRP$	B-PROBLEM
culprit	NN	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
considered	VBN	O
too	RB	O
high	JJ	O
risk	NN	O
for	IN	O
angioplasty	JJ	B-TREATMENT
because	IN	O
of	IN	O
the	DT	B-PROBLEM
severe	JJ	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	O
the	DT	B-TREATMENT
graft	NN	I-TREATMENT
.	.	O

she	PRP	O
would	MD	O
not	RB	O
sense	VB	O
the	DT	O
atrial	JJ	O
contraction	NN	O
and	CC	O
the	DT	O
fire	NN	O
and	CC	O
this	DT	O
occasionally	RB	O
led	VBN	O
to	TO	O
competition	NN	B-PROBLEM
of	IN	I-PROBLEM
firing	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
p	NN	I-TEST
wave	VBP	I-TEST
amplitude	NN	I-TEST
was	VBD	O
.6	JJ	O
and	CC	O
this	DT	O
could	MD	O
not	RB	O
be	VB	O
totally	RB	O
sensed	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
evaluation	NN	B-TEST
of	IN	O
her	PRP$	B-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
she	PRP	O
became	VBD	O
very	RB	B-PROBLEM
symptomatic	JJ	I-PROBLEM
when	WRB	O
she	PRP	O
was	VBD	O
not	RB	O
on	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
but	CC	O
that	IN	O
on	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
she	PRP	O
had	VBD	O
significant	JJ	B-PROBLEM
pacemaker	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
pacemaker	NN	I-TREATMENT
was	VBD	O
set	VBN	O
to	TO	O
a	DT	O
vvi	NN	O
mode	NN	O
which	WDT	O
sensed	VBD	O
appropriately	RB	O
.	.	O

when	WRB	O
her	PRP$	B-TREATMENT
pacemaker	NN	I-TREATMENT
was	VBD	O
in	IN	O
a	DT	O
sinus	NN	O
rhythm	NN	O
without	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
she	PRP	O
had	VBD	O
significant	JJ	B-PROBLEM
angina	NN	I-PROBLEM
.	.	O

carotid	JJ	B-TEST
non-invasive	JJ	I-TEST
testing	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

he	PRP	O
felt	VBD	O
the	DT	O
patient	NN	O
was	VBD	O
not	RB	O
a	DT	O
coronary	JJ	O
artery	NN	O
bypass	NN	O
graft	NN	O
candidate	NN	O
because	IN	O
of	IN	O
the	DT	B-PROBLEM
lack	NN	I-PROBLEM
of	IN	I-PROBLEM
conduit	NN	I-PROBLEM
and	CC	O
because	IN	O
of	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

for	IN	O
this	DT	O
reason	NN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
maximize	VB	O
her	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
nitrates	NNS	B-TREATMENT
.	.	O

on	IN	O
august	JJ	O
20	CD	O
,	,	O
under	IN	O
local	JJ	B-TREATMENT
anesthesia	VBP	I-TREATMENT
the	DT	O
right	JJ	O
pectoral	JJ	O
region	NN	O
was	VBD	O
explored	VBN	O
and	CC	O
the	DT	O
leads	NNS	O
disconnected	VBD	O
and	CC	O
the	DT	B-TREATMENT
pulse	JJ	I-TREATMENT
generator	NN	I-TREATMENT
changed	VBD	O
to	TO	O
a	DT	B-TREATMENT
cpi	NN	I-TREATMENT
unit	NN	I-TREATMENT
in	IN	O
which	WDT	O
the	DT	O
sensitivity	NN	O
could	MD	O
be	VB	O
adjusted	VBN	O
to	TO	O
.15	VB	O
mm.	NN	O
,	,	O
which	WDT	O
permitted	VBD	O
appropriate	JJ	O
atrial	JJ	O
sensing	NN	O
.	.	O

there	EX	O
was	VBD	O
nothing	NN	O
wrong	JJ	O
with	IN	O
the	DT	B-TREATMENT
prior	JJ	I-TREATMENT
generator	NN	I-TREATMENT
and	CC	O
nothing	NN	O
wrong	JJ	O
with	IN	O
the	DT	B-TREATMENT
leads	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
resumed	VBN	O
.	.	O

she	PRP	O
ambulated	VBD	O
without	IN	O
difficulty	NN	O
and	CC	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	VB	O
to	TO	O
be	VB	O
followed	VBN	O
medically	RB	O
for	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
following	VBG	O
two	CD	B-TREATMENT
failed	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
procedure	NN	I-TREATMENT
by	IN	O
dr.	NN	O
brendniungand	NN	O
asilbekote	NN	O
in	IN	O
bi	JJ	O
masase	NN	O
,	,	O
ks	NN	O
.	.	O

clindamycin	NN	B-TREATMENT
/	NNP	O
erythromycin	VBZ	B-TREATMENT
base	NN	I-TREATMENT
/	NNP	O
amoxicillin	NN	B-TREATMENT
/	NNP	O
keflex	NNP	B-TREATMENT
/	NNP	O
wellbutrin	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
syncope	NN	B-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
on	IN	O
heywood	NN	O
memorial	JJ	O
hospital	NN	O
4	CD	O

central	JJ	B-TREATMENT
line	NN	I-TREATMENT
attempted	VBN	O
but	CC	O
never	RB	O
placed	VBD	O

57	CD	O
y/o	NNS	O
f	JJ	O
with	IN	O
multiple	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
including	VBG	O
polyendocrine	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
comprised	VBD	O
of	IN	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
dm	NN	B-PROBLEM
,	,	O
premature	NN	B-PROBLEM
ovarian	JJ	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
hypoparathyroidism	NN	B-PROBLEM
,	,	O
addison	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
also	RB	O
breast	NN	B-PROBLEM
ca	MD	I-PROBLEM
and	CC	O
depression	NN	B-PROBLEM
with	IN	O
multiple	JJ	O
suicide	NN	O
attempts	NNS	O
in	IN	O
the	DT	O
past	NN	O
who	WP	O
originally	RB	O
presented	VBN	O
s/p	JJ	O
tylenol	NN	B-PROBLEM
with	IN	I-PROBLEM
codeine	NN	I-PROBLEM
overdose	NN	I-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
,	,	O
was	VBD	O
intubated	VBN	O
and	CC	O
admitted	VBN	O
to	TO	O
the	DT	O
ficu	NN	O
.	.	O

subsequently	RB	O
,	,	O
she	PRP	O
was	VBD	O
transfered	VBN	O
to	TO	O
the	DT	O
psychiatric	JJ	O
mary	JJ	O
lane	NN	O
hospital	NN	O
in	IN	O
boston	NNP	O
medical	JJ	O
center	NN	O
4	CD	O
for	IN	O
further	JJ	B-TEST
psychiatric	JJ	I-TEST
w/u	NN	I-TEST
.	.	O

this	DT	O
morning	NN	O
,	,	O
2017-07-12	CD	O
,	,	O
ms.	FW	O
gallegos	NNS	O
king	VBG	O
feeling	VBG	O
weaker	JJR	B-PROBLEM
than	IN	I-PROBLEM
usual	JJ	I-PROBLEM
.	.	O

she	PRP	O
noted	VBD	O
that	IN	O
she	PRP	O
had	VBD	O
increased	VBN	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
lower	JJR	I-PROBLEM
back	NN	I-PROBLEM
,	,	O
which	WDT	O
she	PRP	O
attributed	VBD	O
to	TO	O
her	PRP$	B-PROBLEM
arthritis	NN	I-PROBLEM
.	.	O

later	RB	O
that	DT	O
am	VBP	O
,	,	O
she	PRP	O
stood	VBD	O
from	IN	O
her	PRP$	B-TREATMENT
wheelchair	NN	I-TREATMENT
,	,	O
had	VBD	O
a	DT	B-PROBLEM
prodrome	NN	I-PROBLEM
of	IN	I-PROBLEM
lh	NN	I-PROBLEM
and	CC	O
then	RB	O
reports	NNS	O
loc	NN	B-PROBLEM
and	CC	O
fall	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
tunnel	NN	I-PROBLEM
vision	NN	I-PROBLEM
,	,	O
darkened	VBN	B-PROBLEM
vision	NN	I-PROBLEM
,	,	O
or	CC	O
focal	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
this	DT	O
morning	NN	O
.	.	O

no	DT	O
bowel	NN	B-PROBLEM
/	VBZ	I-PROBLEM
bladder	JJR	I-PROBLEM
incont	NN	I-PROBLEM
,	,	O
no	DT	O
aura	NN	B-PROBLEM
,	,	O
no	DT	O
postictal	JJ	B-PROBLEM
state	NN	I-PROBLEM
.	.	O

she	PRP	O
does	VBZ	O
not	RB	O
describe	VB	O
decreased	JJ	B-PROBLEM
po	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
from	IN	O
her	PRP$	O
norm	NN	O
this	DT	O
morning	NN	O
,	,	O
but	CC	O
did	VBD	O
feel	VB	O
dehydrated	VBN	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
her	PRP$	O
fall	NN	O
.	.	O

loc	NN	B-PROBLEM
was	VBD	O
unwitnessed	VBN	O
.	.	O

early	RB	O
this	DT	O
morning	NN	O
before	IN	O
breakfast	NN	O
her	PRP$	B-TEST
bs	NN	I-TEST
was	VBD	O
reportedly	RB	O
145	CD	O
,	,	O
and	CC	O
after	IN	O
loc	NN	B-PROBLEM
,	,	O
her	PRP$	B-TEST
bs	NN	I-TEST
was	VBD	O
reportedly	RB	O
207	CD	O
.	.	O

she	PRP	O
reports	VBZ	O
that	IN	O
her	PRP$	B-TEST
bp	NN	I-TEST
was	VBD	O
read	VBN	O
at	IN	O
60/48	CD	O
after	IN	O
her	PRP$	O
fall	NN	O
.	.	O

her	PRP$	B-TEST
systolic	JJ	I-TEST
bp	NN	I-TEST
measurements	NNS	I-TEST
have	VBP	O
been	VBN	O
running	VBG	O
around	RB	O
100-110	CD	O
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
weeks	NNS	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
recent	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
but	CC	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
vomiting	VBG	B-PROBLEM
last	JJ	O
week	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	I-PROBLEM
urination	NN	I-PROBLEM
or	CC	O
incontinence	NN	B-PROBLEM
.	.	O

she	PRP	O
also	RB	O
denies	VBZ	O
any	DT	B-PROBLEM
recent	JJ	I-PROBLEM
cough	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
palpitations	NNS	I-PROBLEM
,	,	O
heart	NN	B-PROBLEM
racing	NN	I-PROBLEM
.	.	O

she	PRP	O
reports	VBZ	O
2	CD	O
nights	NNS	O
with	IN	O
soaking	VBG	B-PROBLEM
ns	NN	I-PROBLEM
.	.	O

denies	NNS	O
subj	VBP	B-PROBLEM
/	JJ	I-PROBLEM
obj	JJ	I-PROBLEM
fevers	NNS	I-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
.	.	O

she	PRP	O
describes	VBZ	O
her	PRP$	O
mood	NN	O
as	IN	O
depressed	JJ	B-PROBLEM
,	,	O
however	RB	O
she	PRP	O
denies	VBZ	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
reports	VBZ	O
that	IN	O
she	PRP	O
took	VBD	O
all	DT	B-TREATMENT
her	PRP$	I-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
usual	JJ	O
this	DT	O
morning	NN	O
,	,	O
with	IN	O
no	DT	O
changes	NNS	O
.	.	O

1)	CD	O
polyendocrine	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
type	NN	I-PROBLEM
i	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
comprised	VBN	O
of	IN	O
the	DT	O
following	NN	O
:	:	O

a)	JJ	O
hypoparathyroidism	NN	B-PROBLEM
,	,	O
dxed	JJ	O
1954	CD	O

b)	NN	O
addison	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
dxed	JJ	O
1960	CD	O

c)	JJ	O
premature	NN	B-PROBLEM
ovarian	JJ	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
dxed	JJ	O
1967	CD	O

d)	NN	O
alopecia	NN	B-PROBLEM
areata	NN	I-PROBLEM
and	CC	I-PROBLEM
totalis	NN	I-PROBLEM
,	,	O
dxed	VBD	O
1970s	CD	O

e)	RB	O
mucocutaneous	JJ	B-PROBLEM
candidiasis	NN	I-PROBLEM

f)	NN	O
diabetes	VBZ	B-PROBLEM
type	IN	I-PROBLEM
i	NN	I-PROBLEM

2)	CD	O
colonic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
alternating	VBG	O
with	IN	O
diarrhea	NN	B-PROBLEM
and	CC	O
constipation	NN	B-PROBLEM

3)	CD	O
?	.	O
unstable	JJ	B-PROBLEM
serum	NN	I-PROBLEM
calcium	NN	I-PROBLEM
since	IN	O
1999	CD	O

4)	CD	O
generalized	JJ	B-PROBLEM
osteoarthritis	NN	I-PROBLEM

5)	CD	O
depression	NN	B-PROBLEM
requiring	VBG	O
ect	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O

6)	CD	O
bilateral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
of	IN	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM

7)	CD	O
bilateral	JJ	B-PROBLEM
cataracts	NNS	I-PROBLEM

8)	CD	O
pvd	NN	B-PROBLEM

9)	CD	O
spontaneous	JJ	B-PROBLEM
dislocation	NN	I-PROBLEM
of	IN	I-PROBLEM
left	JJ	I-PROBLEM
hip	NN	I-PROBLEM
in	IN	O
2014	CD	O

10)	CD	O
gerd	NN	B-PROBLEM

11)	CD	O
low	JJ	B-PROBLEM
grade	NN	I-PROBLEM
anemia	NN	I-PROBLEM

12)	CD	O
elevated	VBN	B-PROBLEM
liver	NN	I-PROBLEM
enzymes	NNS	I-PROBLEM

13)	CD	O
h/o	JJ	O
amputation	NN	B-TREATMENT
of	IN	I-TREATMENT
right	JJ	I-TREATMENT
2nd	CD	I-TREATMENT
toe	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
osteomyelitis	VB	B-PROBLEM
in	IN	O
2005	CD	O

14)	CD	O
h/o	JJ	O
hemorrhoidectomy	NN	B-TREATMENT
in	IN	O
2007	CD	O

15)	CD	O
h/o	NN	O
left	VBD	B-TREATMENT
hip	JJ	I-TREATMENT
joint	JJ	I-TREATMENT
replacement	NN	I-TREATMENT
in	IN	O
2008	CD	O

16)	CD	O
h/o	JJ	O
total	JJ	B-TREATMENT
hysterectomy	NN	I-TREATMENT
in	IN	O
2009	CD	O

17)	CD	O
h/o	NN	O
breast	NN	B-PROBLEM
ca	MD	I-PROBLEM
s/p	VB	O
mastectomies	NNS	B-TREATMENT

18)	CD	O
recent	JJ	O
suicide	NN	O
attempt	NN	O
with	IN	O
tylenol	NN	B-TREATMENT
#3	NN	I-TREATMENT
requiring	VBG	O
cmed	VBN	O
admission	NN	O
but	CC	O
relatively	RB	O
jennifer	JJ	O
transaminitis	NN	B-PROBLEM
with	IN	O
full	JJ	O
recovery	NN	O

medically	RB	O
savvy	JJ	O
-	:	O
has	VBZ	O
spent	VBN	O
much	RB	O
of	IN	O
her	PRP$	O
life	NN	O
in	IN	O
the	DT	O
hospital	NN	O
with	IN	O
her	PRP$	B-PROBLEM
multiple	JJ	I-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

family	NN	O
history	NN	O
:	:	O
father	NN	O
with	IN	O
history	NN	O
of	IN	O
liver	NN	B-PROBLEM
cancer	NN	I-PROBLEM
at	IN	O
a	DT	O
late	JJ	O
age	NN	O

t	RB	B-TEST
98.4	CD	O
rr	NN	B-TEST
20	CD	O
sat	VBD	B-TEST
100%	CD	O
ra	NN	O
,	,	O
p	VBP	B-TEST
100	CD	O
in	IN	O
bed	NN	O
&	CC	O
same	JJ	O
standing	NN	O
,	,	O
bp	NN	B-TEST
=	VBD	O
120/65	CD	O
in	IN	O
bed	NN	O
,	,	O
same	JJ	O
standing	NN	O
.	.	O

nad	RB	B-PROBLEM
,	,	O
cooperative	JJ	O
and	CC	O
conversant	JJ	O
,	,	O
able	JJ	O
to	TO	O
ambulate	VB	O
independently	RB	O
around	IN	O
room	NN	O
using	VBG	O
crutches	NNS	B-TREATMENT

ncat	NN	B-PROBLEM
,	,	O
no	DT	O
tenderness	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
of	IN	I-TEST
scalp	NN	I-TEST
,	,	O
perrl	NN	O
,	,	O
eomi	NN	O
,	,	O
alopecia	NN	B-PROBLEM
,	,	O
no	DT	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
,	,	O
mucus	NN	B-PROBLEM
membranes	NNS	I-PROBLEM
moderately	RB	I-PROBLEM
dry	JJ	I-PROBLEM
,	,	O
slight	JJ	O
amount	NN	O
of	IN	O
crusted	VBN	B-PROBLEM
blood	NN	I-PROBLEM
on	IN	I-PROBLEM
tip	NN	I-PROBLEM
of	IN	O
r	NN	O
nostril	NN	O
from	IN	O
fall	NN	B-PROBLEM
injury	NN	I-PROBLEM

neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
supraclavicular	JJ	B-PROBLEM
lad	NN	I-PROBLEM
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

cv	NN	O
:	:	O
tachycardic	NN	B-PROBLEM
,	,	O
regular	JJ	O
rhythm	NN	O
,	,	O
iii/vi	JJ	B-PROBLEM
systolic	NN	I-PROBLEM
,	,	O
crescendo-decrescendo	NN	B-PROBLEM
at	IN	I-PROBLEM
usb	JJ	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

harsher	PRP$	B-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apex	JJ	I-PROBLEM
heard	NN	O
best	JJS	O
with	IN	O
bell	NN	O
.	.	O

ctab	NNS	O
aside	RB	O
from	IN	O
slightly	RB	B-PROBLEM
dull	JJ	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
slightly	RB	B-PROBLEM
obese	JJ	I-PROBLEM
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
+bs	VB	O

ext	NN	O
:	:	O
no	DT	O
edema	NN	B-PROBLEM
/	VBZ	O
cyanosis	NN	B-PROBLEM
,	,	O
2+	CD	B-TEST
peripheral	JJ	I-TEST
pulses	NNS	I-TEST
,	,	O
small	JJ	B-PROBLEM
1	CD	I-PROBLEM
cm	JJ	I-PROBLEM
abrasion	NN	I-PROBLEM
on	IN	I-PROBLEM
r	NN	I-PROBLEM
knee	NN	I-PROBLEM
,	,	O
no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
no	DT	O
brusing	NN	B-PROBLEM
,	,	O
no	DT	O
limited	JJ	O

rom	NN	B-PROBLEM
,	,	O
no	DT	O
signs	NNS	O
of	IN	O
effusion	NN	B-PROBLEM

a&ox3	NN	O
,	,	O
no	DT	O
asterixis	NN	B-PROBLEM
,	,	O
strength	NN	O
4+	CD	O
/	NN	O
5	CD	O
equal	JJ	O
throughout	IN	O
,	,	O
sensation	NN	O
light	VBD	O
touch	JJ	O
intact	JJ	O
,	,	O
toes	NNS	O
upgoing	VBG	O
bilaterally	RB	O
,	,	O
no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM
.	.	O

gait	NN	O
does	VBZ	O
not	RB	O
appear	VB	O
unsteady	JJ	B-PROBLEM
,	,	O
uses	VBZ	O
crutches	NNS	B-TREATMENT
for	IN	O
support	NN	O
.	.	O

2017-07-12	JJ	O
10:40	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
17.1	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.37	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.1	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
30.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
30.0	CD	O
mchc	SYM	B-TEST
-	:	O
33.6	CD	O
rdw	NN	B-TEST
-	:	O
18.8	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
526	CD	O
*	NN	O

2017-07-12	JJ	O
10:40	CD	O
am	VBP	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
86	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
5	CD	O
lymphs	SYM	B-TEST
-	:	O
4	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
5	CD	O
eos	SYM	B-TEST
-	:	O
0	CD	O
baso	SYM	B-TEST
-	:	O
0	CD	O
atyps	SYM	B-TEST
-	:	O
0	CD	O
metas	NNS	B-TEST
-	:	O
0	CD	O
myelos	SYM	B-TEST
-	:	O
0	CD	O

2017-07-12	JJ	O
10:40	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
smr	SYM	I-TEST
-	:	O
high	JJ	B-PROBLEM
plt	NN	I-PROBLEM
ct	SYM	I-PROBLEM
-	:	O
526	CD	O
*	NN	O

2017-07-13	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
11.3	CD	O
ptt	NN	B-TEST
-	:	O
24.9	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.0	CD	O

2017-07-11	JJ	O
08:00	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
137	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
19	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
na	SYM	B-TEST
-	:	O
142	CD	O
k	SYM	B-TEST
-	:	O
4.0	CD	O
cl	NN	B-TEST
-	:	O
105	CD	O
hco3	NN	B-TEST
-	:	O
29	CD	O
angap	NN	B-TEST
-	:	O
12	CD	O

2017-07-13	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
85	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
238	CD	O
*	JJ	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	I-TEST
316	CD	O
*	JJ	O
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
55	CD	O
alkphos	SYM	B-TEST
-	:	O
122	CD	O
*	JJ	O
amylase	NN	B-TEST
-	:	O
65	CD	O
totbili	SYM	B-TEST
-	:	O
0.3	CD	O

2017-07-13	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
lipase	NN	B-TEST
-	:	O
35	CD	O

2017-07-14	JJ	O
05:20	CD	O
am	VBP	O
blood	NN	B-TEST
ck	NN	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
notdone	NN	O
ctropnt	NN	B-TEST
-<	VBD	O
0.01	CD	O

2017-07-13	JJ	O
01:12	CD	O
pm	NN	O
blood	NN	B-TEST
ck	NN	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
2	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

2017-07-13	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
ck	NN	B-TEST
-	:	I-TEST
mb	NN	I-TEST
-	:	O
notdone	NN	O
ctropnt	NN	B-TEST
-<	VBD	O
0.01	CD	O

2017-07-11	JJ	O
08:00	CD	O
am	VBP	O
blood	NN	B-TEST
albumin	NN	B-TEST
-	:	O
3.4	CD	O
calcium	NN	B-TEST
-	:	O
8.0	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
5.0	CD	O
*	NN	O
mg	SYM	B-TEST
-	:	O
1.6	CD	O

2017-07-13	JJ	O
01:12	CD	O
pm	NN	O
blood	NN	B-TEST
hbsag	SYM	B-TEST
-	:	O
negative	JJ	O
hbsab	NN	B-TEST
-	:	O
negative	JJ	O
hbcab	NN	B-TEST
-	:	O
negative	JJ	O

2017-07-13	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
acetmnp	NN	B-TEST
-	:	O
neg	NN	O

2017-07-13	JJ	O
01:12	CD	O
pm	NN	O
blood	NN	B-TEST
hcv	NN	B-TEST
ab	SYM	I-TEST
-	:	O
negative	JJ	O

2017-07-13	JJ	O
08:40	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	B-TEST
-	:	O
art	NN	O
po2	VBZ	B-TEST
-	:	O
72	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
34	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.46	CD	O
*	NN	O
calhco3	NN	B-TEST
-	:	O
25	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
0	CD	O

2017-07-13	JJ	O
08:40	CD	O
am	VBP	O
blood	NN	B-TEST
lactate	NN	B-TEST
-	:	O
2.0	CD	O

2017-07-13	JJ	O
08:40	CD	O
am	VBP	O
blood	NN	B-TEST
freeca	NN	B-TEST
-	:	O
0.90	CD	O
*	NN	O

ekg	NN	B-TEST
:	:	O

2017-07-12	JJ	O
nsr	NN	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
likely	JJ	O
v1	NN	B-PROBLEM
and	CC	I-PROBLEM
v2	NN	I-PROBLEM
reversal	NN	I-PROBLEM
,	,	O
twi	NN	B-PROBLEM
in	IN	I-PROBLEM
v2	NN	I-PROBLEM
,	,	O
?	.	O
st	JJ	B-PROBLEM
depr	NN	I-PROBLEM
<	VBD	O
0.5	CD	O
mm	NN	O
in	IN	O
ii	NN	O
and	CC	O
v5/6	NN	O
-	:	O
repeat	NN	B-TEST
ekg	NN	I-TEST
without	IN	O
these	DT	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

no	DT	O
change	NN	O
from	IN	O
prior	JJ	B-TEST
ekg	NN	I-TEST
.	.	O

cxr	JJ	B-TEST
2017-07-12	CD	O
:	:	O

no	DT	O
effusions	NNS	B-PROBLEM
or	CC	O
pneumothorax	NN	B-PROBLEM
.	.	O

multiple	NN	B-PROBLEM
healed	VBD	I-PROBLEM
bilateral	JJ	I-PROBLEM
rib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
demonstrated	VBN	O
.	.	O

clips	NNS	B-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
left	NN	I-TREATMENT
axilla	NN	I-TREATMENT
demonstrate	NN	O
prior	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	DT	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

overall	JJ	O
,	,	O
no	DT	O
acute	JJ	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

2017-07-13	JJ	O
cxr	NN	B-TEST
:	:	O

aside	RB	O
from	IN	O
low	JJ	B-PROBLEM
lung	NN	I-PROBLEM
volumes	NNS	I-PROBLEM
,	,	O
the	DT	O
lungs	NNS	O
are	VBP	O
clear	JJ	O
.	.	O

clips	NNS	B-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
left	NN	I-TREATMENT
axilla	NN	I-TREATMENT
denote	NN	O
prior	RB	B-TREATMENT
lymph	JJ	I-TREATMENT
node	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

multiple	JJ	B-PROBLEM
bilateral	NN	I-PROBLEM
healed	VBD	I-PROBLEM
rib	NN	I-PROBLEM
fractures	NNS	I-PROBLEM
are	VBP	O
present	JJ	O
.	.	O

2017-07-13	JJ	O
ruq	NN	B-TEST
u/s	NN	I-TEST
:	:	O

no	DT	O
evidence	NN	O
of	IN	O
bile	JJ	B-PROBLEM
duct	NN	I-PROBLEM
dilatation	NN	I-PROBLEM
.	.	O

2.	CD	O
gallbladder	NN	B-PROBLEM
polyp	NN	I-PROBLEM
and	CC	O
possible	JJ	O
tiny	JJ	B-PROBLEM
stones	NNS	I-PROBLEM
.	.	O

no	DT	O
cholecystitis	NN	B-PROBLEM
.	.	O

2017-07-14	JJ	O
echo	NN	B-TEST
:	:	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
normal	JJ	O
(	(	O
lvef	JJ	B-TEST
>	$	O
55%	CD	O
).	NN	O

right	RB	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
and	CC	O
free	JJ	O
wall	NN	O
motion	NN	O
are	VBP	O
normal	JJ	O
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
moderately	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

no	DT	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
no	DT	O
echocardiographic	JJ	O
signs	NNS	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

compared	VBN	O
with	IN	O
the	DT	O
report	NN	O
of	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
images	NNS	O
unavailable	JJ	O
for	IN	O
review	NN	O
)	)	O
of	IN	O
2017-06-13	JJ	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
.	.	O

2017-07-17	JJ	O
04:50	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
7.2	CD	O
rbc	NN	B-TEST
-	:	O
2.69	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.0	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
24.0	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
29.7	CD	O
mchc	SYM	B-TEST
-	:	O
33.3	CD	O
rdw	NN	B-TEST
-	:	O
18.7	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
363	CD	O

2017-07-17	JJ	O
04:50	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
363	CD	O

2017-07-17	JJ	O
04:50	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
60	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
13	CD	O
creat	NN	B-TEST
-	:	O
0.9	CD	O
na	SYM	B-TEST
-	:	O
147	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
3.0	CD	O
*	NN	O
cl	NN	B-TEST
-	:	O
109	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
29	CD	O
angap	NN	B-TEST
-	:	O
12	CD	O

2017-07-17	JJ	O
04:50	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
73	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
50	CD	O
*	JJ	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	O
195	CD	O
alkphos	SYM	B-TEST
-	:	O
112	CD	O
totbili	SYM	B-TEST
-	:	O
0.3	CD	O

2017-07-15	JJ	O
06:47	CD	O
am	VBP	O
blood	NN	B-TEST
lipase	NN	B-TEST
-	:	O
17	CD	O

2017-07-17	JJ	O
04:50	CD	O
am	VBP	O
blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.2	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
3.2	CD	O
mg	SYM	B-TEST
-	:	O
1.5	CD	O
*	NN	O

2017-07-13	JJ	O
01:12	CD	O
pm	NN	O
blood	NN	B-TEST
hbsag	SYM	B-TEST
-	:	O
negative	JJ	O
hbsab	NN	B-TEST
-	:	O
negative	JJ	O
hbcab	NN	B-TEST
-	:	O
negative	JJ	O

2017-07-13	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
acetmnp	NN	B-TEST
-	:	O
neg	NN	O

2017-07-13	JJ	O
01:12	CD	O
pm	NN	O
blood	NN	B-TEST
hcv	NN	B-TEST
ab	SYM	I-TEST
-	:	O
negative	JJ	O

57	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
h/o	JJ	O
polyglandular	JJ	B-PROBLEM
autoimmune	NN	I-PROBLEM
syndrome	VBN	I-PROBLEM
initially	RB	O
admitted	VBN	O
in	IN	O
may	MD	O
to	TO	O
ficu	VB	O
for	IN	O
suicide	NN	B-PROBLEM
overdose	RB	I-PROBLEM
then	RB	O
transferred	VBN	O
to	TO	O
whittier	VB	O
rehab	JJ	O
hospital	NN	O
4	CD	O
for	IN	O
depression	NN	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
for	IN	O
a	DT	B-PROBLEM
syncopal	JJ	I-PROBLEM
episode	NN	I-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
to	TO	O
60	CD	B-TEST
systolic	NN	I-TEST
that	WDT	O
returned	VBD	O
to	TO	O
baseline	VB	O
with	IN	O
2.5l	CD	O
ivf	NNS	B-TREATMENT
who	WP	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
a	DT	O
recurrent	JJ	O
episode	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
and	CC	O
concern	NN	O
for	IN	O
sepsis	NN	B-PROBLEM
.	.	O

initially	RB	O
when	WRB	O
she	PRP	O
arrived	VBD	O
to	TO	O
the	DT	O
floor	NN	O
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
normotensive	JJ	O
without	IN	O
signs	NNS	O
of	IN	O
orthostasis	NN	B-PROBLEM
,	,	O
had	VBD	O
a	DT	O
negative	JJ	O
ua	NN	O
,	,	O
a	DT	O
clear	JJ	O
chest	NN	O
xray	NN	O
and	CC	O
no	DT	O
signs	NNS	O
/	VBP	O
symptoms	NNS	O
of	IN	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
slightly	RB	B-PROBLEM
tachycardic	JJ	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
not	RB	O
started	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
standing	VBG	I-TREATMENT
ivf	JJ	I-TREATMENT
order	NN	I-TREATMENT
.	.	O

overnight	JJ	O
she	PRP	O
became	VBD	O
febrile	JJ	B-PROBLEM
to	TO	O
102.3	CD	O
,	,	O
increasingly	RB	B-PROBLEM
tachycardic	JJ	I-PROBLEM
to	TO	O
125	CD	O
,	,	O
and	CC	O
hypotensive	JJ	B-PROBLEM
to	TO	O
80	CD	B-TEST
systolic	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
levo	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
vanco	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
4l	CD	O
of	IN	O
fluid	NN	B-TREATMENT
boluses	NNS	I-TREATMENT
and	CC	O
transfered	VBD	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
.	.	O

in	IN	O
the	DT	O
cmed	JJ	O
csru	NN	O
,	,	O
repeated	VBN	O
attempts	NNS	O
to	TO	O
place	VB	O
lines	NNS	B-TREATMENT
were	VBD	O
unsuccessful	JJ	O
.	.	O

the	DT	B-TREATMENT
above	JJ	I-TREATMENT
treatments	NNS	I-TREATMENT
were	VBD	O
continued	VBN	O
.	.	O

urine	JJ	B-TEST
cultures	NNS	I-TEST
returned	VBN	O
with	IN	O
10-100,000	CD	O
organisms	NNS	B-PROBLEM
coag	JJ	O
negative	JJ	O
staph	NN	B-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
stabilized	VBN	O
and	CC	O
she	PRP	O
was	VBD	O
transfered	VBN	O
back	RB	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
after	IN	O
2	CD	O
days	NNS	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
planned	VBN	O
for	IN	O
a	DT	O
7	CD	O
day	NN	O
course	NN	O
,	,	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
peeled	VBN	O
back	RB	O
to	TO	O
levofloxacin	VB	B-TREATMENT
alone	RB	O
,	,	O
and	CC	O
a	DT	B-TEST
r	NN	I-TEST
hip	NN	I-TEST
film	NN	I-TEST
revealed	VBD	O
no	DT	O
loosening	NN	B-PROBLEM
nor	CC	O
inflammation	NN	B-PROBLEM
.	.	O

echo	NN	B-TEST
showed	VBD	O
normal	JJ	O
function	NN	O
,	,	O
trace	NN	B-PROBLEM
ar	NN	I-PROBLEM
,	,	O
and	CC	O
no	DT	O
mr	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
floor	NN	O
the	DT	O
patient	NN	O
remained	VBD	O
stable	JJ	O
hemodynamically	RB	O
without	IN	O
recurrent	NN	B-PROBLEM
fever	NN	I-PROBLEM
and	CC	O
was	VBD	O
stable	JJ	O
for	IN	O
transfer	NN	O
back	RB	O
to	TO	O
franciscan	JJ	O
children	NNS	O
's	POS	O
hospital	NN	O
&	CC	O
rehab	NN	O
center	NN	O
4	CD	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
her	PRP$	B-TEST
potassium	NN	I-TEST
had	VBD	O
been	VBN	O
low	JJ	B-PROBLEM
despite	IN	O
repletion	NN	B-TREATMENT
,	,	O
na	NN	B-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
,	,	O
as	IN	O
was	VBD	O
blood	NN	B-TEST
pressure	NN	I-TEST
.	.	O

on	IN	O
recommendation	NN	O
from	IN	O
endocrine	NN	O
,	,	O
her	PRP$	B-TREATMENT
fludrocortisone	NN	I-TREATMENT
was	VBD	O
decreased	VBN	O
from	IN	O
0.2	CD	O
to	TO	O
0.1	CD	O
(	(	O
higher	JJR	O
than	IN	O
required	VBN	O
doses	NNS	O
of	IN	O
fludrocort	NN	B-TREATMENT
can	MD	O
cause	VB	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O
)	)	O
.	.	O

1.	CD	O
hypotension	NN	B-PROBLEM
:	:	O

patient	NN	O
presented	VBN	O
after	IN	O
episode	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
and	CC	O
syncope	NN	B-PROBLEM
on	IN	O
mass.	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
5	CD	O
.	.	O

initially	RB	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
this	DT	O
was	VBD	O
a	DT	O
result	NN	O
of	IN	O
poor	JJ	B-PROBLEM
po	NNS	I-PROBLEM
intake	VBP	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
without	IN	O
orthostatic	JJ	B-PROBLEM
vital	NN	I-PROBLEM
signs	NNS	I-PROBLEM
nor	CC	O
hypotension	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
symptoms	NNS	O
of	IN	O
infectious	JJ	B-PROBLEM
source	NN	I-PROBLEM
,	,	O
normal	JJ	O
ua	JJ	O
,	,	O
normal	JJ	O
chest	NN	O
xray	NN	O
,	,	O
and	CC	O
no	DT	O
symptoms	NNS	O
nor	CC	O
signs	NNS	O
of	IN	O
injury	NN	B-PROBLEM
after	IN	O
her	PRP$	O
fall	NN	O
with	IN	O
syncope	NN	B-PROBLEM
.	.	O

neuro	JJ	B-TEST
exam	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

subsequently	RB	O
overnight	VBN	O
,	,	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
to	TO	O
102.3	CD	O
and	CC	O
recurrent	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
tachycardia	NN	B-PROBLEM
that	WDT	O
was	VBD	O
concerning	VBG	O
for	IN	O
an	DT	B-PROBLEM
infectious	JJ	I-PROBLEM
source	NN	I-PROBLEM
.	.	O

she	PRP	O
still	RB	O
had	VBD	O
no	DT	O
localizing	JJ	O
signs	NNS	O
of	IN	O
infection	NN	B-PROBLEM
and	CC	O
culture	NN	B-TEST
data	NNS	I-TEST
was	VBD	O
negative	JJ	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

ruq	VB	B-TEST
us	PRP	I-TEST
was	VBD	O
ordered	VBN	O
and	CC	O
returned	VBN	O
without	IN	O
signs	NNS	O
of	IN	O
infection	NN	B-PROBLEM
later	RB	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
cultures	NNS	B-TEST
drawn	VBN	O
,	,	O
was	VBD	O
given	VBN	O
tylenol	NN	B-TREATMENT
(	(	O
tylenol	JJ	B-TEST
screen	NN	I-TEST
prior	RB	O
to	TO	O
this	DT	O
dose	NN	O
was	VBD	O
negative	JJ	O
,	,	O
as	IN	O
was	VBD	O
a	DT	B-TEST
urine	JJ	I-TEST
tox	NN	I-TEST
)	)	O
,	,	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
,	,	O
metronidazole	NN	B-TREATMENT
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
to	TO	O
cover	VB	O
emperically	RB	O
for	IN	O
hospital	NN	B-PROBLEM
aquired	VBD	I-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
gi	NN	B-PROBLEM
sources	NNS	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
potential	JJ	O
hip	NN	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
transaminases	NNS	I-TEST
were	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
later	RB	O
attributed	VBN	O
to	TO	O
shock	VB	B-PROBLEM
liver	RB	I-PROBLEM
as	IN	O
a	DT	O
result	NN	O
of	IN	O
her	PRP$	O
period	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
.	.	O

lipase	NN	B-TEST
and	CC	O
amylase	NN	B-TEST
remained	VBD	O
normal	JJ	O
.	.	O

in	IN	O
the	DT	O
icu	NN	O
she	PRP	O
also	RB	O
received	VBD	O
an	DT	B-TEST
echo	NN	I-TEST
that	WDT	O
revealed	VBD	O
normal	JJ	O
function	NN	O
and	CC	O
little	JJ	B-PROBLEM
valvular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
(	(	O
she	PRP	O
has	VBZ	O
two	CD	B-PROBLEM
loud	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
murmurs	NNS	I-PROBLEM
on	IN	O
exam	NN	B-TEST
)	)	O
,	,	O
and	CC	O
a	DT	B-TEST
hip	NN	I-TEST
film	NN	I-TEST
revealing	VBG	O
no	DT	O
inflammation	NN	B-PROBLEM
nor	CC	O
loosening	NN	B-PROBLEM
.	.	O

urine	JJ	B-TEST
culture	NN	I-TEST
twice	RB	O
grew	VBD	O
10-100,000	CD	O
coag	NNS	B-PROBLEM
negative	JJ	O
staph	NN	B-PROBLEM
.	.	O

a	DT	B-TREATMENT
line	NN	I-TREATMENT
could	MD	O
not	RB	O
be	VB	O
placed	VBN	O
for	IN	O
technical	JJ	O
reasons	NNS	O
,	,	O
however	RB	O
after	IN	O
4l	CD	O
ns	NN	B-TREATMENT
on	IN	O
the	DT	O
floor	NN	O
and	CC	O
01-30	NN	O
more	RBR	O
in	IN	O
the	DT	O
icu	NN	O
via	IN	O
peripheral	JJ	B-TREATMENT
iv	NN	I-TREATMENT
's	POS	I-TREATMENT
she	PRP	O
was	VBD	O
stable	JJ	O
.	.	O

she	PRP	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
with	IN	O
good	JJ	O
uop	NN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
being	VBG	O
started	VBN	O
on	IN	O
abx	NN	B-TREATMENT
and	CC	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
thought	VBN	O
to	TO	O
have	VB	O
helped	VBN	O
significantly	RB	O
in	IN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
addison	NN	B-PROBLEM
's	POS	I-PROBLEM
with	IN	O
possibely	RB	O
superimposed	VBN	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
planned	VBN	O
for	IN	O
a	DT	O
7	CD	O
day	NN	O
course	NN	O
of	IN	O
stress	NN	B-TREATMENT
dose	NN	I-TREATMENT
steroids	NNS	I-TREATMENT
followed	VBN	O
by	IN	O
a	DT	O
return	NN	O
to	TO	O
her	PRP$	B-TREATMENT
basal	NN	I-TREATMENT
predinisone	NN	I-TREATMENT
/	NNP	O
fludrocortisone	NN	B-TREATMENT
dose	NN	I-TREATMENT
.	.	O

2.	CD	O
elevated	JJ	B-PROBLEM
lfts	NNS	I-PROBLEM
:	:	O

lfts	NNS	B-TEST
wre	WDT	O
elevated	VBN	B-PROBLEM
at	IN	O
presentation	NN	O
.	.	O

initially	RB	O
the	DT	O
differential	NN	O
was	VBD	O
thought	VBN	O
to	TO	O
include	VB	O
shock	NN	B-PROBLEM
liver	NN	I-PROBLEM
from	IN	O
hypotension	NN	B-PROBLEM
,	,	O
hepatitis	NN	B-PROBLEM
,	,	O
cholangitis	NN	B-PROBLEM
or	CC	O
choledocholithiasis	NN	B-PROBLEM
.	.	O

hepatitis	NN	B-TEST
serologies	NNS	I-TEST
were	VBD	O
negative	JJ	O
and	CC	O
the	DT	O
pt	NN	O
was	VBD	O
eventually	RB	O
felt	VBN	O
to	TO	O
have	VB	O
had	VBN	O
shock	VBN	B-PROBLEM
liver	RB	I-PROBLEM
from	IN	O
her	PRP$	B-PROBLEM
hypotensive	JJ	I-PROBLEM
episode	NN	I-PROBLEM
as	IN	O
the	DT	B-PROBLEM
transaminitis	NN	I-PROBLEM
resolved	VBD	O
over	IN	O
time	NN	O
.	.	O

3.	CD	O
hypoparathyroidism	NN	B-PROBLEM
:	:	O

this	DT	O
is	VBZ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
problem	NN	I-PROBLEM
.	.	O

calcium	NN	B-TEST
levels	NNS	I-TEST
were	VBD	O
followed	VBN	O
with	IN	O
a	DT	O
goal	NN	O
to	TO	O
keep	VB	O
them	PRP	O
around	RB	O
8.0	CD	O
by	IN	O
continuing	VBG	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
,	,	O
calcitriol	NN	B-TREATMENT
.	.	O

the	DT	O
pt	NN	O
required	VBN	O
calcium	NN	B-TREATMENT
gluconate	NN	I-TREATMENT
x1	VBD	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

per	IN	O
endocrine	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	O
pt	NN	O
may	MD	O
need	VB	O
an	DT	O
increase	NN	O
in	IN	O
calcium	NN	B-TREATMENT
po	NN	I-TREATMENT
,	,	O
but	CC	O
at	IN	O
this	DT	O
time	NN	O
they	PRP	O
recommended	VBD	O
no	DT	O
change	NN	O
.	.	O

4.	CD	O
addison	JJ	B-PROBLEM
's-	CD	I-PROBLEM
the	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
basal	NN	B-TREATMENT
prednisone	NN	I-TREATMENT
/	NNP	O
fludrocortisone	NN	B-TREATMENT
.	.	O

these	DT	O
were	VBD	O
initially	RB	O
continued	VBN	O
as	IN	O
above	NN	O
and	CC	O
later	RB	O
,	,	O
when	WRB	O
she	PRP	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
febrile	JJ	B-PROBLEM
,	,	O
stress	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
and	CC	O
planned	VBN	O
for	IN	O
a	DT	O
7	CD	O
day	NN	O
course	NN	O
followed	VBN	O
by	IN	O
a	DT	O
return	NN	O
to	TO	O
her	PRP$	O
prior	JJ	O
dose	NN	O
of	IN	O
prednisone	NN	B-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
her	PRP$	B-TEST
potassium	NN	I-TEST
had	VBD	O
been	VBN	O
low	JJ	B-PROBLEM
despite	IN	O
repletion	NN	B-TREATMENT
,	,	O

na	NN	B-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
,	,	O
as	IN	O
was	VBD	O
blood	NN	B-TEST
pressure	NN	I-TEST
.	.	O

on	IN	O
recommendation	NN	O
from	IN	O
endocrine	NN	O
,	,	O
her	PRP$	B-TREATMENT
fludrocortisone	NN	I-TREATMENT
was	VBD	O
decreased	VBN	O
from	IN	O
0.2	CD	O
to	TO	O
0.1	CD	O
(	(	O
higher	JJR	O
than	IN	O
required	VBN	O
doses	NNS	O
of	IN	O
fludrocort	NN	B-TREATMENT
can	MD	O
cause	VB	O
these	DT	B-PROBLEM
symptoms.	NNS	I-PROBLEM
)	)	O
.	.	O

5.	CD	O
dm	NN	B-PROBLEM
:	:	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	O
prior	JJ	O
dose	NN	O
of	IN	O
steroids	NNS	B-TREATMENT
with	IN	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
per	IN	O
patient	NN	O
using	VBG	O
a	DT	B-TREATMENT
1:15	CD	I-TREATMENT
carb	NN	I-TREATMENT
counting	VBG	I-TREATMENT
scheme	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
1:30	CD	I-TREATMENT
correction	NN	I-TREATMENT
factor	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
her	PRP$	B-TREATMENT
glargine	NN	I-TREATMENT
was	VBD	O
decreased	VBN	O
by	IN	O
one	CD	O
unit	NN	O
because	IN	O
her	PRP$	B-TEST
glucose	NN	I-TEST
remained	VBD	O
somewhat	RB	B-PROBLEM
low	JJ	I-PROBLEM
in	IN	O
the	DT	O
mornings	NNS	O
.	.	O

6.	CD	O
r	NN	B-PROBLEM
hip	NN	I-PROBLEM
pain	NN	I-PROBLEM
:	:	O

later	RB	O
in	IN	O
her	PRP$	O
hospital	NN	O
course	NN	O
,	,	O
the	DT	O
pt	NN	O
complained	VBD	O
of	IN	O
hip	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
r	NN	I-TEST
hip	NN	I-TEST
film	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
pathology	NN	B-PROBLEM
or	CC	O
failure	NN	B-PROBLEM
of	IN	O
her	PRP$	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

pain	NN	B-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
and	CC	O
the	DT	O
pt	NN	O
was	VBD	O
reassured	VBN	O
.	.	O

the	DT	O
pt	NN	O
uses	VBZ	O
a	DT	B-TREATMENT
wheelchair	NN	I-TREATMENT
often	RB	O
at	IN	O
baseline	NN	O
due	JJ	O
to	TO	O
pain	VB	B-PROBLEM
from	IN	O
arthritis	NN	B-PROBLEM
.	.	O

7.	CD	O
depression	NN	B-PROBLEM
:	:	O

the	DT	O
pt	NN	O
was	VBD	O
being	VBG	O
treated	VBN	O
at	IN	O
mediplex	JJ	O
rehab	NN	O
hospital	NN	O
4	CD	O
for	IN	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
and	CC	O
a	DT	O
suicide	JJ	O
attempt	NN	O
on	IN	O
original	JJ	O
admission	NN	O
with	IN	O
tylenol	NN	B-TREATMENT
and	CC	O
oxycodone	NN	B-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
been	VBN	O
depressed	VBN	B-PROBLEM
for	IN	O
some	DT	O
time	NN	O
but	CC	O
her	PRP$	O
loved	JJ	O
ones	NNS	O
were	VBD	O
very	RB	O
surprised	JJ	O
at	IN	O
her	PRP$	O
attempt	NN	O
.	.	O

she	PRP	O
remained	VBD	O
very	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
at	IN	O
her	PRP$	O
inpatient	JJ	O
admission	NN	O
and	CC	O
refractory	NN	B-PROBLEM
to	TO	O
treatment	NN	B-TREATMENT
.	.	O

one	CD	O
day	NN	O
prior	RB	O
to	TO	O
her	PRP$	O
transfer	NN	O
to	TO	O
the	DT	O
medical	JJ	O
floor	NN	O
she	PRP	O
was	VBD	O
sectioned	VBN	O
to	TO	O
initiate	VB	O
ect	NN	B-TREATMENT
,	,	O
which	WDT	O
she	PRP	O
had	VBD	O
previously	RB	O
refused	VBN	O
.	.	O

as	IN	O
a	DT	O
result	NN	O
,	,	O
she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
her	PRP	B-TREATMENT
ativan	NN	I-TREATMENT
,	,	O
mirtazapine	NN	B-TREATMENT
,	,	O
risperidone	NN	B-TREATMENT
,	,	O
duloxetine	NN	B-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
exhibit	VB	O
psychotic	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
suicidality	NN	I-PROBLEM
but	CC	O
did	VBD	O
endorse	DT	O
depression	NN	B-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
hi	NN	B-PROBLEM
,	,	O
si	NN	B-PROBLEM
,	,	O
and	CC	O
illusions	NNS	B-PROBLEM
/	VBP	O
hallucinations	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
heparin	VBN	B-TREATMENT
subcutaneously	RB	I-TREATMENT
while	IN	O
on	IN	O
the	DT	O
medical	JJ	O
floor	NN	O
and	CC	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

she	PRP	O
remained	VBD	O
full	JJ	B-TREATMENT
code	NN	I-TREATMENT
throughout	IN	O
the	DT	O
hospitalization	NN	O
.	.	O

fludrocortisone	NN	B-TREATMENT
acetate	NN	I-TREATMENT
0.2	CD	O
mg	NN	O
po	JJ	O
daily	JJ	O
07-12	NN	O
@	NN	O
1033	CD	O

acetaminophen	RB	B-TREATMENT
650	CD	O
mg	JJ	O
po	JJ	O
bid	NN	O
07-11	CD	O
@	NN	O
1503	CD	O
view	NN	O

ibuprofen	NN	B-TREATMENT
400	CD	O
mg	NN	O
po	NN	O
bid	NN	O
07-11	CD	O
@	NN	O
1503	CD	O
view	NN	O

ibuprofen	NN	B-TREATMENT
400	CD	O
mg	NN	O
po	NN	O
q8h	NN	O
:	:	O
prn	JJ	O
07-11	CD	O
@	JJ	O
1503	CD	O
view	NN	O

insulin	NN	B-TREATMENT
sc	NN	I-TREATMENT
(	(	O
per	IN	O
insulin	NN	O
flowsheet	NN	O
)	)	O

risperidone	NN	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
hs	VBD	O
07-10	CD	O
@	JJ	O
1135	CD	O
view	NN	O

risperidone	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
po	JJ	O
daily	JJ	O
07-10	CD	O
@	JJ	O
1135	CD	O
view	NN	O

potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
po	NN	O
bid	NN	O

calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
1500	CD	O
mg	NN	O
po	NN	O
tid	IN	O
07-04	CD	O
@	JJ	O
1126	CD	O
view	NN	O

mirtazapine	NN	B-TREATMENT
15	CD	O
mg	NN	O
po	NN	O
hs	VBD	O
07-03	CD	O
@	JJ	O
1220	CD	O
view	NN	O

duloxetine	NN	B-TREATMENT
30	CD	O
mg	NN	O
po	NN	O
bid	VBD	O
start	NN	O
:	:	O
in	IN	O
am	VBP	O
07-03	JJ	O
@	NN	O
1214	CD	O

psyllium	NN	B-TREATMENT
1	CD	O
pkt	NN	O
po	NN	O
tid	NN	O
:	:	O
prn	JJ	O
06-30	CD	O
@	JJ	O
1248	CD	O
view	NN	O

memantine	NN	B-TREATMENT
*	NNP	O
n	VBZ	O
f*	JJ	O
10	CD	O
mg	JJ	O
oral	JJ	O
daily	JJ	O
06-27	CD	O
@	JJ	O
1124	CD	O
view	NN	O

calcitriol	NN	B-TREATMENT
0.25	CD	O
mcg	NN	O
po	NN	O
every	DT	O
other	JJ	O
day	NN	O
t/th/s/s	VB	O

calcitriol	NN	B-TREATMENT
0.5	CD	O
mcg	NN	O
po	NN	O
every	DT	O
other	JJ	O
day	NN	O
06-27	CD	O
@	NN	O
1051	CD	O

lorazepam	RB	B-TREATMENT
2	CD	O
mg	NNS	O
po	JJ	O
hs	JJ	O
06-23	CD	O
@	JJ	O
1215	CD	O
view	NN	O

alendronate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
70	CD	O
mg	NN	O
po	NN	O
qsun	JJ	O
06-22	CD	O
@	JJ	O
1106	CD	O
view	NN	O

lactulose	RB	B-TREATMENT
60	CD	O
ml	NNS	O
po	JJ	O
qthur	JJ	O
06-21	JJ	O
@	NN	O
1600	CD	O
view	NN	O

milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
60	CD	O
ml	NN	O
po	NN	O
qthur	VBD	O
06-21	CD	O
@	JJ	O
1600	CD	O
view	NN	O

arimidex	NN	B-TREATMENT
*	NNP	O
n	VBZ	O
f*	JJ	O
1	CD	O
mg	JJ	O
oral	JJ	O
daily	JJ	O
06-21	CD	O
@	JJ	O
1414	CD	O
view	NN	O

magnesium	NN	B-TREATMENT
oxide	RB	I-TREATMENT
400	CD	O
mg	JJ	O
po	JJ	O
bid	NN	O
06-20	CD	O
@	NN	O
2017	CD	O
view	NN	O

atorvastatin	RB	B-TREATMENT
20	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O
06-20	CD	O
@	JJ	O
2017	CD	O
view	NN	O

docusate	NN	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
tid	IN	O
06-20	JJ	O
@	JJ	O
2017	CD	O
view	NN	O

pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
q24h	JJ	O
06-20	CD	O
@	JJ	O
2017	CD	O
view	NN	O

prednisone	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
po	NN	O
q3pm	JJ	O
06-20	CD	O
@	JJ	O
2017	CD	O
view	NN	O

prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qam	JJ	O
06-20	CD	O
@	JJ	O
2017	CD	O
view	NN	O

chlorothiazide	RB	B-TREATMENT
500	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O
06-20	CD	O
@	JJ	O
2017	CD	O
view	NN	O

aspirin	RB	B-TREATMENT
81	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O

multivitamins	NNS	B-TREATMENT
1	CD	O
cap	NN	O
po	NNS	O
daily	RB	O

clindamycin	NN	B-TREATMENT
/	NNP	O
erythromycin	VBZ	B-TREATMENT
base	NN	I-TREATMENT
/	NNP	O
amoxicillin	NN	B-TREATMENT
/	NNP	O
keflex	NNP	B-TREATMENT
/	NNP	O
wellbutrin	NN	B-TREATMENT

1.	CD	O
risperidone	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

2.	CD	O
risperidone	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
mirtazapine	NN	B-TREATMENT
15	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
.	.	O

4.	CD	O
duloxetine	JJ	B-TREATMENT
30	CD	O
mg	NN	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

5.	CD	O
calcitriol	NN	B-TREATMENT
0.25	CD	O
mcg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
every	DT	O
other	JJ	O
day	NN	O
(	(	O
every	DT	O
other	JJ	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
calcitriol	NN	B-TREATMENT
0.5	CD	O
mcg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
every	DT	O
other	JJ	O
day	NN	O
(	(	O
every	DT	O
other	JJ	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
alendronate	JJ	B-TREATMENT
70	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
qsun	NN	O
(	(	O
every	DT	O
sunday	NN	O
)	)	O
.	.	O

8.	CD	O
lactulose	JJ	B-TREATMENT
10	CD	O
g	NN	O
/	VBD	O
15	CD	O
ml	NN	O
syrup	NN	O
sig	NN	O
:	:	O
sixty	NN	O
(	(	O
60	CD	O
)	)	O
ml	NN	O
po	NN	O
every	DT	O
thursday	NN	O
(	(	O
)	)	O
.	.	O

9.	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
anastrozole	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	RB	O
(	(	O
)	)	O
.	.	O

11.	CD	O
atorvastatin	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

12.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

13.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

14.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

15.	CD	O
multivitamin	NN	B-TREATMENT
capsule	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

16.	CD	O
ibuprofen	JJ	B-TREATMENT
400	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

17.	CD	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
325	CD	O
(	(	O
65	CD	O
)	)	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

18.	CD	O
maalox	JJ	B-TREATMENT
200-200-20	JJ	O
mg	NN	O
/	$	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
fifteen	NN	O
(	(	O
15	CD	O
)	)	O
ml	NN	O
po	NN	O
prn	NN	O
(	(	O
as	IN	O
needed	VBN	O
)	)	O
.	.	O

19.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
for	IN	O
2	CD	O
days	NNS	O
.	.	O

20.	CD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

21.	CD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
qid	NN	O
(	(	O
4	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

22.	CD	O
heparin	NN	B-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
5000	CD	O
(	(	O
5000	CD	O
)	)	O
units	NNS	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

23.	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

24.	CD	O
prednisone	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q	NN	O
3pm	CD	O
(	(	O
)	)	O
.	.	O

25.	CD	O
chlorothiazide	JJ	B-TREATMENT
250	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

26.	CD	O
fludrocortisone	NN	B-TREATMENT
0.1	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

27.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
four	CD	O
(	(	O
4	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
daily	RB	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

28.	CD	O
lorazepam	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

29.	CD	O
memantine	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	RB	O
(	(	O
)	)	O
.	.	O

30.	CD	O
insulin	NN	B-TREATMENT
glargine	NN	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
as	IN	O
instructed	VBN	O
subcutaneous	JJ	O
twice	RB	O
a	DT	O
day	NN	O
:	:	O
7	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
,	,	O
18	CD	O
units	NNS	O
in	IN	O
the	DT	O
evening	NN	O
.	.	O

hypotension	NN	B-PROBLEM

early	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM

adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM

diabetes	NNS	B-PROBLEM
i	VBP	I-PROBLEM

hypocalcemia	NN	B-PROBLEM
(	(	O
hypoparathyroidism	NN	B-PROBLEM
)	)	O

depression	NN	B-PROBLEM

transaminitis	NN	B-PROBLEM

stable	JJ	O
vitals	NNS	O
,	,	O
depressed	VBD	B-PROBLEM
.	.	O

you	PRP	O
were	VBD	O
admitted	VBN	O
with	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
developed	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

you	PRP	O
are	VBP	O
finishing	VBG	O
a	DT	O
course	NN	O
of	IN	O
antibiotics	NNS	B-TREATMENT
and	CC	O
have	VBP	O
been	VBN	O
stable	JJ	O
for	IN	O
days	NNS	O
.	.	O

if	IN	O
you	PRP	O
lose	VBP	O
consciousness	NN	O
,	,	O
develop	VB	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
bp	NN	I-PROBLEM
,	,	O
have	VBP	O
lightheadedness	VBN	B-PROBLEM
with	IN	O
standing	NN	O
,	,	O
develop	VB	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
or	CC	O
have	VBP	O
other	JJ	B-PROBLEM
worrisome	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
please	VB	O
seek	VB	O
medical	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

cardiogenic	JJ	B-PROBLEM
shock	NN	I-PROBLEM
.	.	O

including	VBG	O
cardiomyopathy	NN	B-PROBLEM
,	,	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
with	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65	CD	O
year	NN	O
old	JJ	O
male	NN	O
who	WP	O
sustained	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
first	RB	O
in	IN	O
1978	CD	O
,	,	O
with	IN	O
course	NN	O
thereafter	RB	O
including	VBG	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
by	IN	O
dr.	NN	O
wierst	NN	O
______________at	NNP	O
noughwell	RB	O
entanbon	VBZ	O
health	NN	O
in	IN	O
1986	CD	O
.	.	O

in	IN	O
1991	CD	O
he	PRP	O
presented	VBD	O
with	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
he	PRP	O
underwent	JJ	O
porcine	JJ	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

in	IN	O
the	DT	O
seven	CD	O
to	TO	O
eight	CD	O
months	NNS	O
preceding	VBG	O
admission	NN	O
,	,	O
he	PRP	O
developed	VBD	O
recurrent	JJ	B-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
in	IN	O
early	JJ	O
december	NN	O
,	,	O
1993	CD	O
.	.	O

significant	JJ	O
for	IN	O
vertebrobasilar	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
bipolar	JJ	B-PROBLEM
mood	NN	I-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
some	DT	B-PROBLEM
baseline	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

procardia	NN	B-TREATMENT
sustained	VBD	I-TREATMENT
release	NN	I-TREATMENT
60	CD	O
mg.	NN	O
po	NN	O
q.day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
.25	NNP	O
mg.	NN	O
po	NN	O
q.day	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
30	CD	O
mg.	NN	O
(	(	O
interval	JJ	O
unspecified	VBN	O
)	)	O
,	,	O
prozac	$	B-TREATMENT
40	CD	O
mg.	NN	O
po	NN	O
q.day	NN	O
,	,	O
lovestatin	VBZ	B-TREATMENT
20	CD	O
mg.	NN	O
po	NN	O
bid	NN	O
,	,	O
aspirin	JJ	B-TREATMENT
q.	JJ	O
day	NN	O
and	CC	O
supplemental	JJ	B-TREATMENT
potassium	NN	I-TREATMENT
.	.	O

remarkable	NN	O
for	IN	O
an	DT	O
oriented	VBN	O
,	,	O
alert	JJ	O
male	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
consistent	NN	O
with	IN	O
effusion	NN	B-PROBLEM
and	CC	O
a	DT	B-PROBLEM
3/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	FW	I-PROBLEM
consistent	NN	O
with	IN	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
pulse	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
intact	JJ	O
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
demonstrated	VBD	O
elevated	JJ	B-PROBLEM
right	NN	I-PROBLEM
and	CC	I-PROBLEM
left-sided	JJ	I-PROBLEM
filling	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
at	IN	O
rest	NN	O
,	,	O
with	IN	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
and	CC	O
normal	JJ	O
cardiac	JJ	O
index	NN	O
.	.	O

there	EX	O
was	VBD	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	O
70	CD	O
millimeter	NN	O
peak	NN	O
gradient	NN	O
,	,	O
native	JJ	B-PROBLEM
three	CD	I-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
patent	NN	B-TREATMENT
left	VBD	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
left	NN	I-TREATMENT
circumflex	NN	I-TREATMENT
,	,	O
dissection	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
main	JJ	I-PROBLEM
was	VBD	O
induced	VBN	O
by	IN	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
.	.	O

a	DT	B-TREATMENT
patent	NN	I-TREATMENT
right	JJ	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
left	VBN	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
and	CC	I-TREATMENT
diagonal	NN	I-TREATMENT
was	VBD	O
noted	VBN	O
,	,	O
and	CC	O
a	DT	B-TREATMENT
patent	NN	I-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
posterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
artery	NN	I-TREATMENT
was	VBD	O
present	JJ	O
.	.	O

also	RB	O
of	IN	O
note	NN	O
,	,	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
was	VBD	O
induced	VBN	O
by	IN	O
dye	NN	B-TREATMENT
and	CC	O
anxiety	NN	B-PROBLEM
and	CC	O
treated	VBN	O
with	IN	O
lasix	NN	B-TREATMENT
,	,	O
morphine	NN	B-TREATMENT
,	,	O
oxygen	NN	B-TREATMENT
and	CC	O
nitroglycerin	NN	B-TREATMENT
.	.	O

post-procedure	NN	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
ccu	NN	O
because	IN	O
of	IN	O
the	DT	O
history	NN	O
of	IN	O
left	NN	B-PROBLEM
main	JJ	I-PROBLEM
dissection	NN	I-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
but	CC	O
of	IN	O
note	NN	O
,	,	O
would	MD	O
not	RB	O
tolerate	VB	O
a	DT	B-TEST
transesophageal	NN	I-TEST
echo	NN	I-TEST
because	IN	O
of	IN	O
anxiety-he	NN	B-PROBLEM
would	MD	O
not	RB	O
swallow	VB	O
the	DT	B-TREATMENT
probe	NN	I-TREATMENT
.	.	O

transthoracic	NN	B-TEST
echo	NN	I-TEST
demonstrated	VBD	O
gradients	NNS	O
of	IN	O
100	CD	O
peak	NN	O
and	CC	O
65	CD	O
mean	NN	O
across	IN	O
the	DT	O
aortic	JJ	O
valve	NN	O
and	CC	O
there	EX	O
was	VBD	O
mild	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
and	CC	O
ejection	NN	B-TEST
fraction	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
18%	CD	O
with	IN	O
global	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
were	VBD	O
remarkable	JJ	O
for	IN	O
events	NNS	O
in	IN	O
which	WDT	O
the	DT	O
patient	NN	O
was	VBD	O
quite	RB	B-PROBLEM
agitated	JJ	I-PROBLEM
and	CC	O
was	VBD	O
evaluated	VBN	O
by	IN	O
psychiatry	NN	O
and	CC	O
treated	VBN	O
with	IN	O
ativan	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
evaluated	VBN	O
by	IN	O
cardiac	JJ	O
surgery	NN	O
for	IN	O
probable	JJ	O
re-do	JJ	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
possible	JJ	O
re-do	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

in	IN	O
the	DT	O
course	NN	O
of	IN	O
preoperative	JJ	B-TEST
workup	NN	I-TEST
,	,	O
mr.	NN	O
has	VBZ	O
was	VBD	O
evaluated	VBN	O
completely	RB	O
by	IN	O
psychiatry	NN	O
with	IN	O
diagnoses	NNS	O
including	VBG	O
underlying	VBG	B-PROBLEM
chronic	JJ	I-PROBLEM
depression	NN	I-PROBLEM
well-controlled	VBD	O
on	IN	O
prozac	NN	B-TREATMENT
,	,	O
underlying	VBG	B-PROBLEM
organ	JJ	I-PROBLEM
brain	NN	I-PROBLEM
vulnerability	NN	I-PROBLEM
of	IN	O
unclear	JJ	O
etiology	NN	O
,	,	O
possibly	RB	O
microvascular	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
acute	JJ	B-PROBLEM
paranoid	NN	I-PROBLEM
and	CC	I-PROBLEM
belligerent	NN	I-PROBLEM
behavior	NN	I-PROBLEM
,	,	O
possibly	RB	O
due	JJ	O
to	TO	O
medications	NNS	B-TREATMENT
.	.	O

on	IN	O
december	$	O
12	CD	O
the	DT	O
patient	NN	O
underwent	NN	O
surgery	NN	B-TREATMENT
,	,	O
including	VBG	O
a	DT	B-TREATMENT
re-do	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
#	#	B-TREATMENT
25	CD	I-TREATMENT
st.	JJ	I-TREATMENT
jude	NN	I-TREATMENT
and	CC	O
re-do	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
times	NNS	I-TREATMENT
one	CD	I-TREATMENT
;	:	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
posterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
artery	NN	I-TREATMENT
as	IN	O
a	DT	B-TREATMENT
veno-venous	JJ	I-TREATMENT
jump	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
postoperatively	RB	O
with	IN	O
stable	JJ	O
hemodynamics	NNS	O
on	IN	O
lidocaine	NN	B-TREATMENT
at	IN	O
one	CD	O
,	,	O
dobutamine	NN	B-TREATMENT
at	IN	O
200	CD	O
and	CC	O
nipride	RB	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
by	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
1	CD	O
but	CC	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
relatively	RB	B-PROBLEM
hypoxemic	JJ	I-PROBLEM
with	IN	O
high	JJ	B-PROBLEM
oxygen	NN	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
demonstrating	NN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

aggressive	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
was	VBD	O
undertaken	JJ	O
and	CC	O
the	DT	O
patient	NN	O
responded	VBD	O
,	,	O
albeit	IN	O
sluggishly	RB	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
remained	VBD	O
agitated	JJ	B-PROBLEM
.	.	O

this	DT	O
was	VBD	O
attributed	VBN	O
to	TO	O
mild	VB	B-PROBLEM
hypoxia	NN	I-PROBLEM
and	CC	O
/	NN	O
or	CC	O
his	PRP$	B-PROBLEM
underlying	JJ	I-PROBLEM
psychiatric	JJ	I-PROBLEM
diagnoses	NNS	I-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
haldol	NN	B-TREATMENT
appropriately	RB	O
.	.	O

on	IN	O
day	NN	O
#	#	O
2	CD	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
diurese	VB	O
and	CC	O
this	DT	O
was	VBD	O
maintained	VBN	O
with	IN	O
the	DT	B-TREATMENT
lasix/	NN	I-TREATMENT
mannitol	NN	I-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
remained	VBD	O
at	IN	O
150	CD	O
to	TO	O
200	CD	O
cc.	NNS	O
an	DT	O
hour	NN	O
.	.	O

despite	IN	O
this	DT	O
,	,	O
his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
continued	VBD	O
to	TO	O
show	VB	O
severe	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
the	DT	O
clinical	JJ	O
picture	NN	O
correlated	VBN	O
.	.	O

he	PRP	O
required	VBD	O
anti-hypertensive	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
initially	RB	O
with	IN	O
nipride	JJ	B-TREATMENT
which	WDT	O
was	VBD	O
changed	VBN	O
to	TO	O
hydralazine	VB	B-TREATMENT
to	TO	O
avoid	VB	O
shunting	NN	B-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
several	JJ	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
to	TO	O
increase	VB	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
and	CC	O
oncotic	JJ	B-TEST
pressure	NN	I-TEST
.	.	O

very	RB	O
early	RB	O
in	IN	O
the	DT	O
morning	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
3	CD	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
acutely	RB	B-PROBLEM
hypoxic	JJ	I-PROBLEM
after	IN	O
several	JJ	O
hours	NNS	O
of	IN	O
marginal	JJ	B-PROBLEM
oxygenation	NN	I-PROBLEM
with	IN	O
respiratory	JJ	B-TEST
rates	NNS	I-TEST
in	IN	O
the	DT	O
thirties	NNS	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
urgently	RB	O
intubated	VBN	O
,	,	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

with	IN	O
positive	JJ	B-TREATMENT
pressure	NN	I-TREATMENT
ventilation	NN	I-TREATMENT
and	CC	O
continued	JJ	B-TREATMENT
diuresis	NN	I-TREATMENT
,	,	O
his	PRP$	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
improved	VBN	O
.	.	O

exception	NN	O
was	VBD	O
a	DT	O
ten	JJ	O
beat	NN	O
run	NN	O
of	IN	O
ventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
which	WDT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
ischemic	JJ	B-PROBLEM
in	IN	O
origin	NN	O
and	CC	O
treated	VBN	O
with	IN	O
nitrates	NNS	B-TREATMENT
and	CC	O
lidocaine	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
blossomed	VBD	O
to	TO	O
demonstrate	VB	O
pulmonary	JJ	B-PROBLEM
infiltrate	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
began	VBD	O
to	TO	O
produce	VB	O
sputum	NN	B-PROBLEM
.	.	O

infectious	JJ	O
disease	NN	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
purulent	NN	I-PROBLEM
sputum	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
covered	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
ceftazidime	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

cardiology	NN	B-TEST
evaluation	NN	I-TEST
commented	VBN	O
on	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
increasing	VBG	I-PROBLEM
ventricular	JJ	I-PROBLEM
ectopy	NN	I-PROBLEM
and	CC	O
suggested	VBD	O
that	IN	O
these	DT	O
were	VBD	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
r	NN	I-PROBLEM
and	CC	I-PROBLEM
t	NN	I-PROBLEM
phenomenon	NN	I-PROBLEM
from	IN	O
his	PRP$	B-TREATMENT
pacer	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
prolonged	JJ	B-PROBLEM
qt	NN	I-PROBLEM
interval	NN	I-PROBLEM
.	.	O

consequently	RB	O
his	PRP$	B-TREATMENT
pronestyl	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
magnesium	NN	B-TREATMENT
to	TO	O
bring	VB	O
his	PRP$	B-TEST
level	NN	I-TEST
above	IN	O
2	CD	O
.	.	O

on	IN	O
the	DT	O
evening	NN	O
of	IN	O
the	DT	O
18th	CD	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
remain	VB	O
hemodynamically	RB	O
stable	JJ	O
,	,	O
although	IN	O
his	PRP$	B-TEST
oxygenation	NN	I-TEST
was	VBD	O
clearly	RB	O
deteriorating	VBG	O
and	CC	O
more	RBR	O
marginal	JJ	O
.	.	O

on	IN	O
60%	CD	O
fio2	NN	B-TREATMENT
his	PRP$	O
po2	NN	B-TEST
was	VBD	O
63	CD	O
.	.	O

it	PRP	O
was	VBD	O
increased	VBN	O
to	TO	O
65%	CD	O
with	IN	O
po2	NN	B-TEST
of	IN	O
81	CD	O
.	.	O

at	IN	O
approximately	RB	O
7:50	CD	O
a.m.	RB	O
,	,	O
house	NN	O
officer	NN	O
was	VBD	O
called	VBN	O
to	TO	O
the	DT	O
room	NN	O
for	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
70/40	CD	O
with	IN	O
falling	VBG	B-PROBLEM
oxygen	NN	I-PROBLEM
saturations	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
immediately	RB	O
given	VBN	O
400	CD	O
mg.	NN	O
of	IN	O
calcium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
i.v.	NN	I-TREATMENT
push	NN	I-TREATMENT
and	CC	O
ventilator	NN	B-TREATMENT
disconnected	VBN	O
and	CC	O
the	DT	O
patient	NN	O
manually	RB	B-TREATMENT
ventilated	VBN	I-TREATMENT
.	.	O

within	IN	O
one	CD	O
minute	NN	O
,	,	O
the	DT	O
patient	NN	O
lost	VBD	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
and	CC	O
cpr	NN	B-TREATMENT
was	VBD	O
initiated	VBN	O
and	CC	O
code	NN	O
was	VBD	O
called	VBN	O
.	.	O

the	DT	O
patient	NN	O
initially	RB	O
continued	VBD	O
to	TO	O
have	VB	O
rhythm	VBN	O
consistent	JJ	O
with	IN	O
emv	NN	B-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
bolused	VBN	O
with	IN	O
levophed	JJ	B-TREATMENT
and	CC	O
given	VBN	O
some	DT	O
volume	NN	O
while	IN	O
compressions	NNS	B-TREATMENT
continued	VBD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
prothrombin	NN	I-TEST
time	NN	I-TEST
had	VBD	O
been	VBN	O
23	CD	O
early	RB	O
the	DT	O
same	JJ	O
morning	NN	O
and	CC	O
tamponade	NN	B-PROBLEM
was	VBD	O
considered	VBN	O
and	CC	O
thoracotomy	JJ	B-TREATMENT
instruments	NNS	I-TREATMENT
obtained	VBN	O
.	.	O

the	DT	O
chest	NN	O
was	VBD	O
opened	VBN	O
partially	RB	O
and	CC	O
through	IN	O
sub-xyphoid	JJ	O
area	NN	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
tamponade	NN	B-PROBLEM
.	.	O

compressions	NNS	B-TREATMENT
were	VBD	O
continued	VBN	O
and	CC	O
adequate	JJ	O
pulse	NN	O
was	VBD	O
felt	VBN	O
and	CC	O
arterial	JJ	B-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
demonstrated	VBD	O
adequate	JJ	O
oxygenation	NN	O
and	CC	O
perfusion	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
rhythm	NN	I-TEST
degenerated	VBD	O
to	TO	O
ventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
shocked	VBN	O
,	,	O
initially	RB	O
without	IN	O
response	NN	O
but	CC	O
after	IN	O
several	JJ	O
doses	NNS	O
of	IN	O
epinephine	NN	B-TREATMENT
,	,	O
one-half	JJ	O
mg.	NN	O
of	IN	O
atropine	NN	B-TREATMENT
and	CC	O
a	DT	O
bolus	NN	O
of	IN	O
lidocaine	NN	B-TREATMENT
we	PRP	O
were	VBD	O
able	JJ	O
to	TO	O
obtain	VB	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
and	CC	O
rhythm	NN	B-TEST
only	RB	O
briefly	NN	O
,	,	O
and	CC	O
quickly	RB	O
deteriorated	VBD	O
back	RB	O
to	TO	O
ventricular	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

further	RB	O
attempts	NNS	O
at	IN	O
resuscitation	NN	B-TREATMENT
were	VBD	O
unsuccessful	JJ	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
pronounced	VBN	O
dead	JJ	O
at	IN	O
8:30	CD	O
a.m.	NN	O

lipitor	NN	B-TREATMENT
/	CD	O
codeine	NN	B-TREATMENT

gib	NN	B-PROBLEM

endoscopy	NN	B-TEST
2020-01-20	JJ	O

42	CD	O
yom	NN	O
with	IN	O
pmh	NN	O
of	IN	O
htn	NN	B-PROBLEM
,	,	O
hyperchol	NN	B-PROBLEM
admitted	VBD	O
to	TO	O
osh	VB	O
1	CD	O
day	NN	O
ago	IN	O
with	IN	O
black	JJ	B-PROBLEM
tarry	NN	I-PROBLEM
stools	NNS	I-PROBLEM
x	VBP	O
2	CD	O
days	NNS	O
.	.	O

patient	JJ	O
states	NNS	O
that	IN	O
he	PRP	O
had	VBD	O
chronically	RB	O
had	VBN	O
loose	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
but	CC	O
over	IN	O
2	CD	O
preeceeding	JJ	O
days	NNS	O
noticed	VBD	O
the	DT	O
stool	NN	O
to	TO	O
be	VB	O
dark	JJ	B-PROBLEM
and	CC	O
tarry	NN	B-PROBLEM
.	.	O

+	JJ	O
epigastric	JJ	B-PROBLEM
discomfort	NN	I-PROBLEM
,	,	O
gurgling	VBG	B-PROBLEM
gas-like	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
no	DT	O
association	NN	O
with	IN	O
food	NN	O
.	.	O

+	NN	O
lightheadedness	NN	B-PROBLEM
when	WRB	O
he	PRP	O
stood	VBD	O
up	RP	O
prompting	VBG	O
him	PRP	O
to	TO	O
go	VB	O
to	TO	O
osh	VB	O
nellie	NNS	O
.	.	O

he	PRP	O
states	VBZ	O
that	IN	O
he	PRP	O
takes	VBZ	O
asa	JJ	B-TREATMENT
daily	JJ	O
and	CC	O
takes	VBZ	O
motrin	$	B-TREATMENT
800	CD	O
mg	NN	O
tid	NN	O
sometimes	RB	O
for	IN	O
pain	NN	B-PROBLEM
,	,	O
last	JJ	O
use	NN	O
2	CD	O
wks	NN	O
pta	NN	O
.	.	O

denies	NNS	O
brbpr	VBP	B-PROBLEM
,	,	O
n/v/d	UH	B-PROBLEM
.	.	O

denies	NNS	O
recent	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
.	.	O

denies	NNS	O
any	DT	B-PROBLEM
hemetemesis	NN	I-PROBLEM
.	.	O

at	IN	O
osh	JJ	O
initial	JJ	B-TEST
hct	NN	I-TEST
=	VBD	O
26	CD	O
,	,	O
and	CC	O
22	CD	O
upon	IN	O
repeat	NN	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
orthostatic	JJ	B-PROBLEM
given	VBN	O
3	CD	O
units	NNS	O
prbc	NN	B-TREATMENT
and	CC	O
ivf	NN	B-TREATMENT
.	.	O

egd	RB	B-TEST
attempted	VBN	O
but	CC	O
pt	VBP	O
unable	JJ	O
to	TO	O
tolerate	VB	O
.	.	O

he	PRP	O
is	VBZ	O
now	RB	O
transferred	VBN	O
to	TO	O
mediplex	VB	O
rehab	JJ	O
hospital	NN	O
for	IN	O
futher	JJR	B-TEST
workup	NN	I-TEST
and	CC	O
rx	NN	B-TREATMENT
.	.	O

states	NNS	O
that	IN	O
lightheadedness	NN	B-PROBLEM
is	VBZ	O
resolved	VBN	O
.	.	O

htn	NN	B-PROBLEM

hyperchol	NN	B-PROBLEM
h/o	NN	O
a.	NN	B-PROBLEM
fib	VBD	I-PROBLEM
6	CD	O
yrs	NN	O
ago	RB	O
->	NNP	O
cardioverted	VBD	O
.	.	O

family	NN	O
hx	NN	O
:	:	O
father	NN	O
with	IN	O
lung	NN	B-PROBLEM
ca	MD	I-PROBLEM
.	.	O

t	NN	B-TEST
:	:	O
98	CD	O

p	NN	B-TEST
:	:	O
66	CD	O

r	NN	B-TEST
:	:	O
15	CD	O

bp	NN	B-TEST
:	:	O
122/51	CD	O

sao2	NN	B-TEST
:	:	O
100%	CD	O
ra	NN	O

general	JJ	O
:	:	O
young	JJ	O
male	NN	O
in	IN	O
nad	NN	B-PROBLEM
,	,	O
awake	VBP	O
alert	NN	O
oriented	VBN	O

neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM

lungs	NNS	O
cta	VBP	O
bilaterally	RB	O
without	IN	O
r/r/w	NN	B-PROBLEM

rrr	NN	O
,	,	O
nl.	JJ	O
s1s2	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM
noted	VBD	O

abdomen	NNS	O
:	:	O
obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
mild	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
,	,	O
nabs	NN	O

no	DT	O
c/c/e	NN	B-PROBLEM
bilaterally	RB	I-PROBLEM
,	,	O
2+	CD	B-TEST
radial	NN	I-TEST
,	,	I-TEST
dp	NN	I-TEST
and	CC	I-TEST
pt	NN	I-TEST
pulses	NNS	I-TEST
b/l	VBP	I-TEST
.	.	O

rectal	NN	O
:	:	O
no	DT	O
hemrroiids	NNS	B-PROBLEM
,	,	O
guiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
brown	JJ	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

osh	RB	O
27.5	CD	O
hct	NN	B-TEST
at	IN	O
2:50	CD	O
am	VBP	O
01-20	JJ	O
.	.	O

ekg	NN	B-TEST
:	:	O

osh	SYM	O
-	:	O
sinus	NN	B-PROBLEM
tach	NN	I-PROBLEM
at	IN	O
108	CD	O
,	,	O
nl	RB	O
axis	NN	O
,	,	O
nl	JJ	O
intevals	NNS	O
.	.	O

no	DT	O
st-t	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

pt	SYM	B-TEST
-	:	O
13.2	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
27.2	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.1	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
259	CD	O

wbc	SYM	B-TEST
-	:	O
9.3	CD	O
rbc	NN	B-TEST
-	:	O
3.21	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.3	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
85	CD	O
mch	SYM	B-TEST
-	:	O
29.9	CD	O
mchc	SYM	B-TEST
-	:	O
35.2	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.6	CD	O
*	NN	O

wbc	SYM	B-TEST
-	:	O
8.0	CD	O
rbc	NN	B-TEST
-	:	O
3.20	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.8	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
87	CD	O
mch	SYM	B-TEST
-	:	O
30.1	CD	O
mchc	SYM	B-TEST
-	:	O
34.7	CD	O
rdw	NN	B-TEST
-	:	O
15.7	CD	O
*	NN	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
264	CD	O

wbc	SYM	B-TEST
-	:	O
7.4	CD	O
rbc	NN	B-TEST
-	:	O
3.38	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.1	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
29.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
86	CD	O
mch	SYM	B-TEST
-	:	O
29.8	CD	O
mchc	SYM	B-TEST
-	:	O
34.5	CD	O
rdw	NN	B-TEST
-	:	O
15.5	CD	O

42	CD	O
yom	NN	O
with	IN	O
h/o	NN	O
nsaid	VBN	B-TREATMENT
use	NN	O
transferred	VBN	O
from	IN	O
osh	JJ	O
with	IN	O
black	JJ	B-PROBLEM
tarry	NN	I-PROBLEM
stools	NNS	I-PROBLEM
at	IN	O
home	NN	O
.	.	O

patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
cmed	VB	O
ccu	NN	O
with	IN	O
tid	JJ	O
hct	NN	B-TEST
check	NN	I-TEST
.	.	O

gi	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
performed	VBN	O
endoscopy	NN	B-TEST
under	IN	O
general	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
non	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
gastritis	NN	B-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
bid	NN	O
ppi	NN	B-TREATMENT
,	,	O
h	NN	B-TREATMENT
.	.	O

pylori	JJ	B-TEST
serology	NN	I-TEST
checked	VBD	O
(	(	O
pending	VBG	O
at	IN	O
time	NN	O
of	IN	O
discharge	NN	O
)	)	O
.	.	O

his	PRP$	B-TREATMENT
antihypertensives	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
given	VBN	O
concern	NN	O
for	IN	O
gi	NN	B-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
should	MD	O
be	VB	O
restarted	VBN	O
at	IN	O
follow	VB	O
up	RP	O
appointment	NN	O
with	IN	O
pcp	NN	O
.	.	O

marie	NN	O
was	VBD	O
discharged	VBN	O
with	IN	O
goal	NN	B-TREATMENT
ppi	NN	I-TREATMENT
twice	RB	O
day	NN	O
for	IN	O
1	CD	O
month	NN	O
followed	VBN	O
by	IN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

medications	NNS	B-TREATMENT
on	IN	O
transfer	NN	O
:	:	O
esmopreazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
iv	NN	O
bid	NN	O
hydrochlorthiazide	RB	B-TREATMENT
25	CD	O
mg	JJ	O
daily	JJ	O
lisinopril	VBZ	B-TREATMENT
5	CD	O
mg	JJ	O
daily	JJ	O
loratadine	NN	B-TREATMENT
10	CD	O
mg	JJ	O
daily	JJ	O
metprolol	NN	B-TREATMENT
150	CD	O
mg	JJ	O
daily	JJ	B-TREATMENT
multivitamin	NN	I-TREATMENT
niacin	RB	I-TREATMENT
500	CD	O
mg	NNS	O
daily	RB	O

asa	RB	B-TREATMENT
325	CD	O
mg	NNS	O
daily	RB	O

motrin	NN	B-TREATMENT
800	CD	O
mg	NN	O
tid	NN	O

lisinopril	RB	B-TREATMENT
5	CD	O
mg	NNS	O
daily	RB	O

hydrochlorthiazide	RB	B-TREATMENT
25	CD	O
mg	NNS	O
daily	RB	O

toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
150	CD	O
mg	JJ	O
daily	JJ	O

niaspan	RB	B-TREATMENT
500	CD	O
mg	NNS	O
daily	RB	O

loratidine	NN	B-TREATMENT
10	CD	O
mg	JJ	O
daily	RB	O
.	.	O

1.	CD	O
niacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
daily	RB	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
:	:	O

gi	NN	B-PROBLEM
bleeding	NN	I-PROBLEM

peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM

gastritis	NN	B-PROBLEM

hypertension	NN	B-PROBLEM

hypercholestrolemia	NN	B-PROBLEM

please	NN	O
continue	VB	O
to	TO	O
take	VB	O
all	DT	B-TREATMENT
your	PRP$	I-TREATMENT
medicaitons	NNS	I-TREATMENT
and	CC	O
follow	VB	O
up	RP	O
with	IN	O
your	PRP$	O
appointments	NNS	O
as	IN	O
below	NN	O
.	.	O

you	PRP	O
should	MD	O
avoid	VB	O
aspirin	NN	B-TREATMENT
,	,	O
motrin	NN	B-TREATMENT
or	CC	O
any	DT	B-TREATMENT
other	JJ	I-TREATMENT
nonsteroidal	JJ	I-TREATMENT
antiinflammatory	NN	I-TREATMENT
agents	NNS	I-TREATMENT
.	.	O

you	PRP	O
should	MD	O
restart	VB	O
your	PRP$	B-TREATMENT
bp	NN	I-TREATMENT
medications	NNS	I-TREATMENT
after	IN	O
you	PRP	O
see	VBP	O
your	PRP$	O
pcp	NN	O
.	.	O

if	IN	O
you	PRP	O
have	VBP	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
black	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
bleeding	NN	B-PROBLEM
,	,	O
lightheadedness	NN	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
please	VB	O
contact	VB	O
your	PRP$	O
pcp	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
sob	NN	B-PROBLEM
,	,	O
fever	NN	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ph	VB	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
chird	JJ	O
,	,	O
grajord	JJ	O
c	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
pna	JJ	B-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

abdomenal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
nausea	NN	B-PROBLEM

small	JJ	B-TREATMENT
bowel	NN	I-TREATMENT
resection	NN	I-TREATMENT

58	CD	O
year-old	JJ	O
female	NN	O
s/p	NN	O
gastric	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
03-01	NN	O
without	IN	O
complications	NNS	B-PROBLEM
post-operatively	RB	O
,	,	O
now	RB	O
presents	VBZ	O
with	IN	O
abomenal	JJ	B-PROBLEM
and	CC	I-PROBLEM
and	CC	I-PROBLEM
ascociated	VBD	I-PROBLEM
nausea	NN	I-PROBLEM
since	IN	O
the	DT	O
night	NN	O
before	IN	O
admission	NN	O
.	.	O

pain	NN	B-PROBLEM
is	VBZ	O
diffused	VBN	O
,	,	O
06-05	JJ	O
out	IN	O
of	IN	O
10	CD	O
in	IN	O
intensity	NN	O
,	,	O
and	CC	O
has	VBZ	O
not	RB	O
improved	VBN	O
overnight	NN	O
.	.	O

no	DT	O
flatus	NN	B-PROBLEM
x	VBZ	O
1	CD	O
day	NN	O
.	.	O

obesity	NN	B-PROBLEM

hypertension	NN	B-PROBLEM

gerd	NN	B-PROBLEM

hyperlipidemia	NN	B-PROBLEM

appendectomy	NN	B-TREATMENT

ovarian	JJ	B-PROBLEM
cyst	NN	I-PROBLEM

afebrile	NN	B-PROBLEM
,	,	O
pulse	JJ	B-TEST
70-80	NN	O
's	POS	O
,	,	O
vital	JJ	B-TEST
stable	JJ	O
and	CC	O
within	IN	O
normal	JJ	O
limits	NNS	O

alert	NN	O
,	,	O
anicterus	NN	B-PROBLEM
,	,	O
oropharynx	CD	O
clear	JJ	O

no	DT	O
lymphanopathy	NN	B-PROBLEM

lungs	NNS	O
clear	JJ	O
to	TO	O
ascultation	VB	B-TEST

abdomen	NNS	O
soft	JJ	O
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
diffuse	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
,	,	O
no	DT	O
peritomeal	NN	B-PROBLEM

extremities	NNS	O
no	DT	O
edema	NN	B-PROBLEM

ct	NN	B-TEST
pelvis	NN	I-TEST
(	(	O
07-17	JJ	O
)	)	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
loop	NN	I-PROBLEM
of	IN	O
slightly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
with	IN	O
fecalization	NN	B-PROBLEM
and	CC	O
possible	JJ	O
bowel	NN	B-PROBLEM
wall	NN	I-PROBLEM
thickening	NN	I-PROBLEM
.	.	O

this	DT	B-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
is	VBZ	O
likely	JJ	O
secondary	JJ	O
to	TO	O
closed	JJ	B-PROBLEM
loop	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

this	DT	O
could	MD	O
be	VB	O
due	JJ	O
to	TO	O
internal	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
or	CC	O
could	MD	O
be	VB	O
stricture	RB	B-PROBLEM
related	VBN	O
.	.	O

other	JJ	O
differential	JJ	O
includes	VBZ	O
ischemia	NN	B-PROBLEM
.	.	O

infectious	JJ	B-PROBLEM
etiology	NN	I-PROBLEM
is	VBZ	O
less	RBR	O
likely	JJ	O
due	JJ	O
to	TO	O
the	DT	O
focal	JJ	O
nature	NN	O
of	IN	O
the	DT	O
involvement	NN	O
.	.	O

upon	IN	O
presentation	NN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
intial	JJ	B-TEST
work-up	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
immediately	RB	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laporatomy	NN	I-TEST
.	.	O

intraoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
small	JJ	B-PROBLEM
bowel	NNS	I-PROBLEM
obstruction	NN	I-PROBLEM
with	IN	O
ischemic	JJ	B-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
afebrile	JJ	B-PROBLEM
post-operatively	RB	O
,	,	O
making	VBG	O
good	JJ	O
urine	NN	O
,	,	O
ambulating	VBG	O
,	,	O
eating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

1.	CD	O
oxycodone-acetaminophen	JJ	B-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

small	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
obstruction	NN	I-PROBLEM

ischemic	JJ	B-PROBLEM
small	JJ	I-PROBLEM
bowel	NN	I-PROBLEM

please	VB	O
take	VB	O
medications	NNS	B-TREATMENT
as	IN	O
prescribed	JJ	O
and	CC	O
read	JJ	O
warning	NN	O
labels	NNS	O
carefully	RB	O
.	.	O

if	IN	O
signs	NNS	O
and	CC	O
symptoms	NNS	O
of	IN	O
wound	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
such	JJ	O
as	IN	O
sudden	JJ	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
purulent	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
please	VB	O
go	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
or	CC	O
call	NN	O
.	.	O

pad	NN	O
dry	NN	O
--	:	O
do	VBP	O
not	RB	O
scrub	VB	O
wound	NN	B-PROBLEM
.	.	O

s	NN	O
/	NNP	O
p	VBZ	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT

colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
percocet	VBZ	B-TREATMENT
1-2	JJ	O
tab	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

dr.	NN	O
grendwierst	RB	O
1-2	JJ	O
weeks	NNS	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

s	NN	O
/	NNP	O
p	VBZ	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
s	NN	O
/	NNP	O
p	VBZ	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
s	RB	O
/	NNP	O
p	NN	O
roux	NN	B-TREATMENT
en	IN	I-TREATMENT
y	NN	I-TREATMENT
gastric	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
.	.	O

s	NN	O
/	CD	O
p	JJ	O
c-section	NN	B-TREATMENT
b12	NN	B-PROBLEM
deficiency	NN	I-PROBLEM
anemia	NN	I-PROBLEM

gerd	NN	B-TREATMENT
operations	NNS	I-TREATMENT
and	CC	O
procedures	NNS	B-TREATMENT
:	:	O

02/14/03	CD	O
grendwierst	NN	O
,	,	O
sonlyn	JJ	O
r.	NN	O
,	,	O
m.d.	JJ	O
ventral	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
w	JJ	I-TREATMENT
/	NNP	I-TREATMENT
mesh	NN	I-TREATMENT

this	DT	O
is	VBZ	O
a	DT	O
39	CD	O
year	NN	O
old	JJ	O
female	NN	O
,	,	O
s	JJ	O
/	NNP	O
p	NN	O
roux-en-y	NN	B-TREATMENT
gastric	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
in	IN	O
09/06	CD	O
who	WP	O
is	VBZ	O
admitted	VBN	O
for	IN	O
elective	JJ	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
a	DT	B-PROBLEM
ventral	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
went	VBD	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2/14/03	CD	O
for	IN	O
repair	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
overnight	VBD	O
for	IN	O
pai	NN	B-TREATMENT
n	JJ	I-TREATMENT
management	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
incision	NN	I-PROBLEM
with	IN	O
large	JJ	O
amounts	NNS	O
of	IN	O
dissection	NN	B-PROBLEM
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
overnight	JJ	O
with	IN	O
minimal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
medication	NN	I-PROBLEM
requirements	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
complaints	NNS	O
of	IN	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
and	CC	O
was	VBD	O
tolerating	VBG	O
po&apos;s	RB	O
well	RB	O
.	.	O

keep	VB	O
the	DT	B-TREATMENT
dressing	NN	I-TREATMENT
on	IN	O
and	CC	O
dry	JJ	O
for	IN	O
48	CD	O
hours	NNS	O
after	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

avoid	NN	O
getting	VBG	O
the	DT	B-PROBLEM
incision	NN	I-PROBLEM
soaking	VBG	O
wet	NN	O
.	.	O

take	VB	O
the	DT	B-TREATMENT
pain	NN	I-TREATMENT
medication	NN	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

you	PRP	O
can	MD	O
take	VB	O
regular	JJ	O
tylenol	NN	B-TREATMENT
or	CC	O
motrin	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
use	VB	O
the	DT	B-TREATMENT
percocet	NN	I-TREATMENT
for	IN	O
breakthrough	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

return	NN	O
to	TO	O
the	DT	O
er	NN	O
or	CC	O
call	VB	O
your	PRP$	O
doctor	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
fevers	NNS	B-PROBLEM
,	,	O
notice	RB	O
pus	NN	B-PROBLEM
from	IN	O
the	DT	B-PROBLEM
incision	NN	I-PROBLEM
,	,	O
develop	VB	O
surrounding	VBG	B-PROBLEM
redness	NN	I-PROBLEM
,	,	O
have	VBP	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
have	VBP	O
vomiting	VBG	B-PROBLEM
where	WRB	O
you	PRP	O
can	MD	O
&apos;t	VB	O
keep	VB	O
anything	NN	O
down	RP	O
or	CC	O
develop	VB	O
any	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
that	WDT	O
concern	NN	O
you	PRP	O
.	.	O

prenatal	JJ	B-TEST
screens	NNS	I-TEST
were	VBD	O
o	RB	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	JJ	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rapid	JJ	B-TEST
plasma	NN	I-TEST
reagent	NN	I-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
group	NN	B-TEST
b	VBD	I-TEST
strep	RB	I-TEST
negative	JJ	O
.	.	O

the	DT	O
infant	NN	O
delivered	VBN	O
by	IN	O
spontaneous	JJ	O
vaginal	JJ	O
delivery	NN	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
8	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
8	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
baby	NN	O
lucas	NN	O
is	VBZ	O
well	RB	O
appearing	VBG	O
,	,	O
no	DT	O
jaundice	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
is	VBZ	O
regular	JJ	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
are	VBP	O
2+	CD	O
and	CC	O
symmetrical	JJ	O
.	.	O

the	DT	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
with	IN	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
weight	NN	I-TEST
is	VBZ	O
3.160	CD	O
kilograms	NNS	O
(	(	O
7	CD	O
pounds	NNS	O
3	CD	O
ounces	NNS	O
)	)	O
at	IN	O
birth	NN	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
regular	JJ	O
heart	NN	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
and	CC	O
symmetric	JJ	O
.	.	O

the	DT	B-TEST
baby	NN	I-TEST
's	POS	I-TEST
weight	NN	I-TEST
was	VBD	O
3.160	CD	O
kilograms	NNS	O
(	(	O
7	CD	O
pounds	NNS	O
3	CD	O
ounces	NNS	O
).	VBP	O

he	PRP	O
is	VBZ	O
breast	JJ	O
and	CC	O
bottle	JJ	O
feeding	NN	O
every	DT	O
3	CD	O
hours	NNS	O
with	IN	O
expressed	VBN	O
breast	NN	O
milk	NN	O
and	CC	O
/	NN	O
or	CC	O
enfamil	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
discharge	NN	I-TEST
weight	NN	I-TEST
is	VBZ	O
3025	CD	O
gm	NN	O
,	,	O
and	CC	O
has	VBZ	O
been	VBN	O
stable	JJ	O
for	IN	O
past	JJ	O
2	CD	O
days	NNS	O
.	.	O

the	DT	B-TEST
baby	NN	I-TEST
's	POS	I-TEST
bilirubin	NN	I-TEST
on	IN	O
2018-12-31	JJ	O
,	,	O
was	VBD	O
15.5	CD	O
/	JJ	O
0.5	CD	O
at	IN	O
which	WDT	O
time	NN	O
double	JJ	B-TREATMENT
phototherapy	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

on	IN	O
01-01	NN	O
,	,	O
his	PRP$	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
17.3	CD	O
/	JJ	O
0.4	CD	O
at	IN	O
which	WDT	O
time	NN	O
triple	NN	B-TREATMENT
phototherapy	NN	I-TREATMENT
was	VBD	O
started	VBN	O
and	CC	O
then	RB	O
his	PRP$	B-TEST
subsequent	NN	I-TEST
bilirubins	NNS	I-TEST
are	VBP	O
16.5	CD	O
/	JJ	O
0.4	CD	O
on	IN	O
2019-01-01	JJ	O
,	,	O
and	CC	O
16.2	CD	O
/	NNS	O
0.5	CD	O
on	IN	O
2019-01-02	JJ	O
.	.	O

phototherapy	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
2019-01-04	JJ	O
for	IN	O
a	DT	B-TEST
bilirubin	NN	I-TEST
of	IN	O
12.1	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
rebound	NN	I-TEST
bilirubin	NN	I-TEST
will	MD	O
be	VB	O
checked	VBN	O
on	IN	O
01-05	NN	O
.	.	O

the	DT	B-TEST
hematocrit	NN	I-TEST
on	IN	O
01-02	NN	O
,	,	O
was	VBD	O
61	CD	O
with	IN	O
a	DT	B-TEST
reticulocyte	NN	I-TEST
of	IN	O
2.6%	CD	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
type	NN	I-TEST
is	VBZ	O
a+	JJ	O
,	,	O
coombs	JJ	B-TEST
negative	JJ	O
.	.	O

auditory	NN	B-TEST
hearing	VBG	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
brainstem	NN	O
responses	NNS	O
.	.	O

1.	CD	O
continue	NN	O
breast	NN	O
feeding	VBG	O
with	IN	O
post-feed	JJ	B-TREATMENT
supplemental	JJ	I-TREATMENT
ebm	NN	I-TREATMENT
.	.	O

2.	CD	O
follow-up	JJ	B-TEST
bilirubin	NN	I-TEST
in	IN	O
1	CD	O
day	NN	O
;	:	O
f/u	NN	O
with	IN	O
pmd	NN	O
in	IN	O
1-3	JJ	O
days	NNS	O
.	.	O

4.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
and	CC	I-TEST
screening	NN	I-TEST
:	:	O
not	RB	O
applicable	JJ	O
.	.	O

5.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screens	NNS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
2018-12-31	JJ	O
,	,	O
and	CC	O
the	DT	O
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

6.	CD	O
immunizations	NNS	B-TREATMENT
received	VBD	O
:	:	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
12-31	CD	O
,	,	O
2006	CD	O
.	.	O

7.	CD	O
immunization	NN	B-TREATMENT
recommended	VBD	O
:	:	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
(	(	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
child	NN	O
's	POS	O
life	NN	O
)	)	O
,	,	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
all	DT	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

2.	CD	O
exaggerated	JJ	B-PROBLEM
physiologic	JJ	I-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
responsive	NN	O
to	TO	O
phototherapy	VB	B-TREATMENT
.	.	O

self	NN	B-PROBLEM
inflicted	VBN	I-PROBLEM
gunshot	JJ	I-PROBLEM
wound	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

self	NN	B-PROBLEM
inflicted	VBN	I-PROBLEM
gunshot	JJ	I-PROBLEM
wound	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
poor	JJ	B-PROBLEM
dentition	NN	I-PROBLEM
.	.	O

suture	NN	B-TREATMENT
of	IN	O
right	JJ	B-PROBLEM
temporal	JJ	I-PROBLEM
head	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
performed	VBN	O
on	IN	O
april	NN	O
14	CD	O
,	,	O
1994	CD	O
.	.	O

mr.	NN	O
le	NN	O
is	VBZ	O
a	DT	O
seventy	NN	O
three	CD	O
year	NN	O
old	JJ	O
male	NN	O
who	WP	O
presents	VBZ	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
,	,	O
following	VBG	O
a	DT	B-PROBLEM
self	NN	I-PROBLEM
inflicted	VBN	I-PROBLEM
gunshot	JJ	I-PROBLEM
wound	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
head	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
sister	NN	O
died	VBD	O
eight	CD	O
years	NNS	O
prior	RB	O
to	TO	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
admission	NN	O
of	IN	O
leukemia	NN	B-PROBLEM
,	,	O
and	CC	O
he	PRP	O
otherwise	RB	O
has	VBZ	O
no	DT	O
next	JJ	O
of	IN	O
kin	NN	O
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
one	CD	O
brother	NN	O
in	IN	O
washington	NN	O
,	,	O
with	IN	O
whom	WP	O
his	PRP$	O
relationship	NN	O
is	VBZ	O
tenuous	JJ	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
denies	VBZ	O
any	DT	B-PROBLEM
suicidal	NN	I-PROBLEM
or	CC	I-PROBLEM
homicidal	JJ	I-PROBLEM
ideation	NN	I-PROBLEM
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
,	,	O

2.	CD	O
poor	JJ	B-PROBLEM
dentition	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
obese	JJ	O
male	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
temperature	NN	B-TEST
98.0	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
78	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
186/69	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
entry	NN	I-PROBLEM
wound	VBD	I-PROBLEM
approximately	RB	O
1	CD	O
1/2	CD	O
inches	NNS	O
above	IN	O
the	DT	O
right	JJ	O
ear	NN	O
,	,	O
which	WDT	O
is	VBZ	O
approximately	RB	O
1	CD	O
cm.	NNS	O
in	IN	O
length	NN	O
and	CC	O
surrounded	VBN	O
by	IN	O
powder	NN	B-PROBLEM
burn	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
lump	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
parietal	JJ	I-PROBLEM
region	NN	I-PROBLEM
,	,	O
which	WDT	O
corresponds	VBZ	O
with	IN	O
the	DT	O
bullet	NN	O
seen	VBN	O
on	IN	O
the	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
bruising	VBG	B-PROBLEM
about	IN	I-PROBLEM
the	DT	I-PROBLEM
eyes	NNS	I-PROBLEM
or	CC	I-PROBLEM
mastoid	NN	I-PROBLEM
sinuses	NNS	I-PROBLEM
,	,	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
fluid	NN	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
nose	NN	I-PROBLEM
or	CC	I-PROBLEM
ears	NNS	I-PROBLEM
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
supple	JJ	O
,	,	O
and	CC	O
without	IN	O
adenopathy	NN	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
sounds	VBZ	I-TEST
are	VBP	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
and	CC	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
are	VBP	O
appreciated	VBN	O
.	.	O

the	DT	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
,	,	O
without	IN	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

there	EX	O
are	VBP	O
no	DT	O
masses	NNS	B-PROBLEM
and	CC	O
the	DT	B-TEST
bowel	NN	I-TEST
sounds	NNS	I-TEST
are	VBP	O
present	JJ	O
.	.	O

the	DT	O
extremities	NNS	O
are	VBP	O
well	RB	O
perfused	VBN	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

examination	NN	B-TEST
revealed	VBD	O
a	DT	O
patient	NN	O
who	WP	O
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBD	O
x	NNP	O
3	CD	O
,	,	O
with	IN	O
short	JJ	O
term	NN	O
recall	NN	O
of	IN	O
2/3	CD	O
objects	NNS	O
at	IN	O
five	CD	O
minutes	NNS	O
and	CC	O
fluent	JJ	O
speech	NN	O
.	.	O

he	PRP	O
demonstrated	VBD	O
poor	JJ	B-PROBLEM
ability	NN	I-PROBLEM
for	IN	I-PROBLEM
abstract	JJ	I-PROBLEM
thinking	NN	I-PROBLEM
.	.	O

the	DT	O
pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
and	CC	O
the	DT	B-TEST
extra	JJ	I-TEST
ocular	JJ	I-TEST
movements	NNS	I-TEST
are	VBP	O
intact	JJ	O
.	.	O

the	DT	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
are	VBP	O
2+	CD	O
and	CC	O
symmetrical	JJ	O
throughout	IN	O
.	.	O

a	DT	B-TEST
panel	NN	I-TEST
of	IN	I-TEST
serum	NN	I-TEST
electrolytes	NNS	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
9.4	CD	O
,	,	O
hematocrit	NN	B-TEST
47.1	CD	O
,	,	O
and	CC	O
the	DT	B-TEST
platelets	NNS	I-TEST
253,000	CD	O
.	.	O

blood	NN	B-TEST
coagulation	NN	I-TEST
times	NNS	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

serum	NN	B-TEST
toxic	NN	I-TEST
screen	NN	I-TEST
is	VBZ	O
negative	JJ	O
.	.	O

leukocyte	JJ	B-TEST
differential	JJ	I-TEST
count	NN	I-TEST
reveals	NNS	O
64	CD	B-TEST
neutrophils	NNS	I-TEST
,	,	O
24%	CD	B-TEST
lymphocytes	NNS	I-TEST
,	,	O
8%	CD	B-TEST
monocytes	NNS	I-TEST
,	,	O
2%	CD	B-TEST
eosinophils	NNS	I-TEST
,	,	O
and	CC	O
2%	CD	B-TEST
basophils	NNS	I-TEST
.	.	O

a	DT	B-TEST
panel	NN	I-TEST
of	IN	I-TEST
serum	NN	I-TEST
enzymes	NNS	I-TEST
suggest	VBP	O
normal	JJ	O
hepatic	JJ	O
function	NN	O
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
reveals	VBZ	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
external	JJ	I-PROBLEM
skull	NN	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
approximately	RB	O
1-2	JJ	O
millemeters	NNS	O
in	IN	O
size	NN	O
,	,	O
near	IN	O
the	DT	O
right	JJ	O
frontoparietal	NN	O
apex	NN	O
.	.	O

a	DT	B-PROBLEM
right	JJ	I-PROBLEM
parietal	NN	I-PROBLEM
contusion	NN	I-PROBLEM
is	VBZ	O
also	RB	O
identified	VBN	O
,	,	O
with	IN	O
blood	NN	O
tracking	VBG	O
into	IN	O
the	DT	O
middle	JJ	O
focus	NN	O
.	.	O

standard	RB	B-TEST
12	CD	I-TEST
lead	JJ	I-TEST
electrocardiogram	NN	I-TEST
revealed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
a	DT	B-TEST
rate	NN	I-TEST
of	IN	O
85	CD	O
,	,	O
with	IN	O
poor	JJ	B-PROBLEM
r	NNS	I-PROBLEM
wave	VBP	I-PROBLEM
progression	NN	I-PROBLEM
in	IN	O
leads	NNS	O
v1	VBP	O
through	IN	O
v3	NN	O
suggesting	VBG	O
the	DT	O
possibility	NN	O
of	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
anteroseptal	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

nonspecific	JJ	B-PROBLEM
st	NN	I-PROBLEM
segment	NN	I-PROBLEM
and	CC	I-PROBLEM
t	NN	I-PROBLEM
wave	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
are	VBP	O
present	JJ	O
as	IN	O
well	RB	O
.	.	O

prior	RB	O
to	TO	O
his	PRP$	O
admission	NN	O
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
gunshot	NN	I-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
sutured	VBN	O
close	RB	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
suicide	JJ	B-TREATMENT
precautions	NNS	I-TREATMENT
,	,	O
and	CC	O
was	VBD	O
hydrated	VBN	O
with	IN	O
an	DT	B-TREATMENT
infusion	NN	I-TREATMENT
of	IN	I-TREATMENT
intravenous	JJ	I-TREATMENT
fluid	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
psychiatry	NN	O
service	NN	O
,	,	O
who	WP	O
began	VBD	O
a	DT	O
battery	NN	O
of	IN	O
testing	VBG	B-TEST
,	,	O
which	WDT	O
continues	VBZ	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	O
consulting	VBG	O
psychiatrist	NN	O
recommended	VBD	O
a	DT	O
minimum	NN	O
of	IN	O
2	CD	B-TREATMENT
point	NN	I-TREATMENT
restraints	NNS	I-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
,	,	O
and	CC	O
recommended	VBD	O
the	DT	O
patient	NN	O
be	VB	O
monitored	VBN	O
by	IN	O
a	DT	O
sitter	NN	O
.	.	O

the	DT	O
chief	JJ	O
obstacle	NN	O
was	VBD	O
bringing	VBG	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
under	IN	O
control	NN	O
and	CC	O
this	DT	O
was	VBD	O
ultimately	RB	O
achieved	VBN	O
with	IN	O
a	DT	O
combination	NN	O
of	IN	O
captopril	NN	B-TREATMENT
and	CC	O
nifedipine	NN	B-TREATMENT
.	.	O

after	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
had	VBD	O
stabilized	VBN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
neurology	NN	O
ward	NN	O
.	.	O

close	JJ	B-TEST
monitoring	NN	I-TEST
demonstrated	VBD	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
be	VB	O
stable	JJ	O
and	CC	O
within	IN	O
an	DT	O
acceptable	JJ	O
rang	NN	O
on	IN	O
his	PRP$	B-TREATMENT
dosage	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
undergone	JJ	O
full	JJ	B-TEST
psychiatric	JJ	I-TEST
evaluation	NN	I-TEST
,	,	O
and	CC	O
was	VBD	O
prepared	VBN	O
for	IN	O
transfer	NN	O
to	TO	O
a	DT	O
psychiatric	JJ	O
hospital	NN	O
.	.	O

therefore	RB	O
,	,	O
because	IN	O
of	IN	O
his	PRP$	O
need	NN	O
for	IN	O
intense	JJ	B-TREATMENT
psychiatric	JJ	I-TREATMENT
care	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
discharged	VBN	O
to	TO	O
the	DT	O
vo	JJ	O
black	JJ	O
doylestrictshore	NN	O
ft.	NN	O
clinics	NNS	O
medical	JJ	O
center	NN	O
on	IN	O
the	DT	O
7th	JJ	O
hospital	NN	O
day	NN	O
.	.	O

dilantin	NN	B-TREATMENT
100	CD	O
mg.	NN	O
po	NN	O
tid	NN	O
,	,	O
mylanta	FW	B-TREATMENT
30	CD	O
cc.	NN	O
po	NN	O
q	VBD	O
4	CD	O
hours	NNS	O
prn	RB	O
,	,	O
dyspepsia	NN	B-PROBLEM
,	,	O
milk	NN	B-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
30	CD	O
cc.	NN	O
po	NN	O
q	VBD	O
4	CD	O
hours	NNS	O
prn	JJ	O
constipation	NN	B-PROBLEM
,	,	O
cimetidine	VBP	B-TREATMENT
400	CD	O
mg.	JJ	O
po	NN	O
bid	NN	O
,	,	O
haloperidol	VBZ	B-TREATMENT
1	CD	O
mg.	NN	O
po	NN	O
or	CC	O
im	VB	O
q	JJ	O
3	CD	O
hours	NNS	O
prn	JJ	O
agitation	NN	B-PROBLEM
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg.	NN	O
po	NN	O
bid	NN	O
,	,	O
captopril	VBP	B-TREATMENT
50	CD	O
mg.	NN	O
po	NN	O
tid	NN	O
,	,	O
nifedipine	JJ	B-TREATMENT
20	CD	O
mg.	NN	O
po	NN	O
q	VBD	O
6	CD	O
hours	NNS	O
and	CC	O
nifedipine	JJ	B-TREATMENT
20	CD	O
mg.	NN	O
po	NN	O
or	CC	O
sublingual	JJ	O
q	NN	O
3	CD	O
hours	NNS	O
prn	VBP	O
systolic	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
greater	JJR	I-PROBLEM
than	IN	I-PROBLEM
160	CD	I-PROBLEM
millemeters	NNS	I-PROBLEM
of	IN	I-PROBLEM
mercury	NN	I-PROBLEM
.	.	O

mother	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
nantucket	NN	O
cottage	NN	O
hospital	NN	O
from	IN	O
lawrence	NN	O
general	JJ	O
hospital	NN	O
hospital	NN	O
on	IN	O
05-01	JJ	O
with	IN	O
cervical	JJ	O
effacement	NN	O
and	CC	O
preterm	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
previously	RB	O
been	VBN	O
admitted	VBN	O
here	RB	O
at	IN	O
the	DT	O
24th	CD	O
week	NN	O
after	IN	O
a	DT	O
motor	NN	O
vehicle	NN	O
accident.	IN	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
tocolysis	NN	B-TREATMENT
and	CC	O
betamethasone	NN	B-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

due	JJ	O
to	TO	O
progressing	VBG	O
labor	NN	O
and	CC	O
presentation	NN	O
of	IN	O
twins	NNS	O
,	,	O
delivery	NN	O
was	VBD	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

prenatal	JJ	B-TEST
screens	NNS	I-TEST
were	VBD	O
notable	JJ	O
for	IN	O
blood	NN	B-TEST
type	NN	I-TEST
0	CD	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	NN	O
.	.	O

rubella	NN	B-TEST
status	NN	I-TEST
was	VBD	O
not	RB	O
documented	VBN	O
.	.	O

group	NN	B-TEST
b	VBD	I-TEST
strep	NN	I-TEST
status	NN	I-TEST
was	VBD	O
unknown	JJ	O
.	.	O

infant	NN	O
emerged	VBD	O
from	IN	O
the	DT	B-PROBLEM
breech	JJ	I-PROBLEM
position	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
blow-by	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
and	CC	O
stimulation	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
apgars	NNS	I-TEST
were	VBD	O
7	CD	O
at	IN	O
1	CD	O
minute	NN	O
and	CC	O
9	CD	O
at	IN	O
5	CD	O
minutes	NNS	O
.	.	O

she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

on	IN	O
admission	NN	O
,	,	O
physical	JJ	B-TEST
examination	NN	I-TEST
reveals	VBZ	O
a	DT	B-PROBLEM
non	JJ	I-PROBLEM
dysmorphic	JJ	I-PROBLEM
infant	NN	I-PROBLEM
,	,	O
well	RB	O
saturated	VBN	O
and	CC	O
perfused	VBN	O
with	IN	O
multiple	JJ	B-PROBLEM
bruises	NNS	I-PROBLEM
noted	VBD	O
over	IN	O
the	DT	O
upper	JJ	O
legs	NN	O
,	,	O
left	VBD	O
arm	NN	O
and	CC	O
chest	NN	O
.	.	O

no	DT	O
bony	NN	B-PROBLEM
abnormalities	VBZ	I-PROBLEM
or	CC	O
petechiae	NN	B-PROBLEM
noted	VBN	O
.	.	O

normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
without	IN	O
a	DT	B-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
infant	NN	O
did	VBD	O
not	RB	O
require	VB	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
or	CC	O
respiratory	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

since	IN	O
that	DT	O
time	NN	O
,	,	O
jadiara	NN	O
has	VBZ	O
always	RB	O
been	VBN	O
in	IN	O
room	NN	O
air	NN	O
without	IN	O
requiring	VBG	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
apnea	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
,	,	O
treated	VBN	O
with	IN	O
caffeine	NN	B-TREATMENT
until	IN	O
2017-06-04	JJ	O
.	.	O

since	IN	O
that	DT	O
time	NN	O
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
very	RB	B-PROBLEM
rare	JJ	I-PROBLEM
spells	NNS	I-PROBLEM
,	,	O
with	IN	O
none	NN	O
for	IN	O
over	IN	O
one	CD	O
week	NN	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
15	CD	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
eventually	RB	O
prompting	VBG	O
evaluation	NN	B-TEST
by	IN	I-TEST
echo	NN	I-TEST
.	.	O

the	DT	B-TEST
echo	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
anomalous	JJ	I-PROBLEM
left	NN	I-PROBLEM
coronary	NN	I-PROBLEM
,	,	O
with	IN	O
one	CD	O
end	NN	O
entering	VBG	O
the	DT	O
right	JJ	O
ventricular	NN	O
outflow	IN	O
tract	NN	O
and	CC	O
the	DT	O
other	JJ	O
end	NN	O
not	RB	O
clearly	RB	O
defined	VBN	O
.	.	O

it	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
be	VB	O
delineated	VBN	O
whether	IN	O
this	DT	O
represented	VBD	O
an	DT	B-PROBLEM
anomalous	JJ	I-PROBLEM
left	VBD	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
arising	VBG	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
(	(	I-PROBLEM
lcapa	NN	I-PROBLEM
)	)	I-PROBLEM
or	CC	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
fistula	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
pulmonar	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
coronary	NN	O
was	VBD	O
prominent	JJ	O
,	,	O
and	CC	O
there	RB	O
appeared	VBD	O
to	TO	O
be	VB	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
collateral	NN	I-PROBLEM
vessels	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
posterior	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
myocardium	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
muscular	NN	I-PROBLEM
vsd	NN	I-PROBLEM
was	VBD	O
also	RB	O
noted	VBN	O
.	.	O

several	JJ	B-TEST
additional	JJ	I-TEST
echos	NN	I-TEST
were	VBD	O
performed	VBN	O
,	,	O
including	VBG	O
an	DT	B-TEST
echo	NN	I-TEST
in	IN	O
the	DT	O
cardiology	NN	O
department	NN	O
at	IN	O
healthsouth	NN	O
rehab	JJ	O
hospital	NN	O
of	IN	O
western	JJ	O
mass.	NN	O
,	,	O
but	CC	O
the	DT	O
anatomy	NN	O
of	IN	O
the	DT	O
left	JJ	O
coronary	JJ	O
artery	NN	O
could	MD	O
not	RB	O
be	VB	O
further	RB	O
defined	VBN	O
.	.	O

due	JJ	O
to	TO	O
the	DT	O
risks	NNS	O
of	IN	O
coronary	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
if	IN	O
this	DT	O
represented	VBD	O
an	DT	B-PROBLEM
lcapa	NN	I-PROBLEM
,	,	O
the	DT	O
infant	NN	O
was	VBD	O
followed	VBN	O
with	IN	O
regular	JJ	B-TEST
echos	NN	I-TEST
and	CC	O
ekgs	NN	B-TEST
during	IN	O
the	DT	O
remainder	NN	O
of	IN	O
hospitalization	NN	O
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
,	,	O
valvular	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
or	CC	O
compromised	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

she	PRP	O
will	MD	O
be	VB	O
continued	VBN	O
to	TO	O
be	VB	O
followed	VBN	O
closely	RB	O
by	IN	O
cardiology	NN	O
as	IN	O
an	DT	O
outpatient	NN	O
,	,	O
with	IN	O
likely	JJ	O
plans	NNS	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
surgical	JJ	B-TREATMENT
repair	NN	I-TREATMENT
when	WRB	O
she	PRP	O
grows	VBZ	O
to	TO	O
3.5	CD	O
to	TO	O
4	CD	O
kg	NNS	O
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
initially	RB	O
maintained	VBN	O
on	IN	O
ivf	NN	B-TREATMENT
,	,	O
with	IN	O
introduction	NN	O
of	IN	O
enteral	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
2	CD	O
.	.	O

she	PRP	O
was	VBD	O
advanced	VBN	O
to	TO	O
full	JJ	B-TREATMENT
volume	NN	I-TREATMENT
enteral	JJ	I-TREATMENT
feeds	NNS	I-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
7	CD	O
,	,	O
and	CC	O
then	RB	O
to	TO	O
a	DT	B-TREATMENT
maximum	JJ	I-TREATMENT
caloric	JJ	I-TREATMENT
density	NN	I-TREATMENT
of	IN	O
28	CD	O
cals	NNS	O
/	JJ	O
oz	NN	O
.	.	O

by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
infant	NN	O
is	VBZ	O
feedign	JJ	O
bm	NN	O
or	CC	O
enfamil	VB	B-TREATMENT
24	CD	O
cals	NNS	O
/	JJ	O
oz	JJ	O
po	NN	O
ad	NN	O
lib	NN	O
,	,	O
with	IN	O
adequate	JJ	O
intake	NN	O
and	CC	O
adequate	JJ	O
weight	NN	O
gain	NN	O
.	.	O

last	JJ	B-TEST
nutrition	NN	I-TEST
labs	NNS	I-TEST
were	VBD	O
on	IN	O
06-20	JJ	O
with	IN	O
ap	NN	B-TEST
of	IN	O
208	CD	O
,	,	O
ca	MD	B-TEST
10.8	CD	O
,	,	O
and	CC	O
phos	VBZ	B-TEST
7.4.	CD	O

the	DT	O
infant	NN	O
required	VBN	O
phototherapy	NN	B-TREATMENT
for	IN	O
hyperbilirubinemia	NN	B-PROBLEM
through	IN	O
day	NN	O
of	IN	O
life	NN	O
7	CD	O
,	,	O
with	IN	O
peak	JJ	B-TEST
bilirubin	NN	I-TEST
of	IN	O
7	CD	O
/	JJ	O
0.3	CD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
3	CD	O
,	,	O
and	CC	O
last	JJ	B-TEST
bilirubin	NN	I-TEST
of	IN	O
4.9	CD	O
/	JJ	O
0.3	CD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
9	CD	O
.	.	O

cbc	NN	B-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
were	VBD	O
obtained	VBN	O
upon	IN	O
admission	NN	O
revealing	VBG	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
9.0	CD	O
with	IN	O
25	CD	B-TEST
polys	NNS	I-TEST
and	CC	O
0	CD	B-TEST
bands	NNS	I-TEST
;	:	O
hematocrit	NN	B-TEST
was	VBD	O
46.9%	CD	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
222,000	CD	O
.	.	O

baby	NN	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
with	IN	O
negative	JJ	O
cultures	NNS	O
and	CC	O
a	DT	O
stable	JJ	O
clinical	JJ	O
course	NN	O
.	.	O

infant	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
supplemental	JJ	B-TREATMENT
iron	NN	I-TREATMENT
,	,	O
and	CC	O
did	VBD	O
not	RB	O
receive	VB	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

last	JJ	B-TEST
hct	NN	I-TEST
was	VBD	O
30.6	CD	O
on	IN	O
06-20	NN	O
with	IN	O
a	DT	B-TEST
reticulocyte	NN	I-TEST
count	NN	I-TEST
of	IN	O
6.5%.	CD	O

initial	JJ	B-TEST
opthalmologic	JJ	I-TEST
exam	NN	I-TEST
on	IN	O
06-05	NN	O
revealed	VBN	O
immature	NN	B-PROBLEM
retinas	NN	I-PROBLEM
in	IN	O
zone	NN	O
3	CD	O
,	,	O
and	CC	O
repeat	NN	B-TEST
exam	NN	I-TEST
on	IN	O
06-26	JJ	O
revealed	JJ	O
mature	NN	O
retinas	VBZ	O
bilaterally	RB	O
.	.	O

infant	NN	O
passed	VBD	O
hearing	VBG	B-TEST
screen	NN	I-TEST
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

enfamil	NN	B-TREATMENT
or	CC	O
breast	NN	O
milk	NN	O
24	CD	O
calories	NNS	O
per	IN	O
oz	NN	O
,	,	O
with	IN	O
enfamil	JJ	O
powder	NN	O
.	.	O

ferinsol	RB	B-TREATMENT
0.2	CD	O
ml	NNS	O
po	JJ	O
qd	NN	O
.	.	O

newborn	JJ	B-TEST
screen	NN	I-TEST
:	:	O

sent	NN	O
as	IN	O
per	IN	O
protocol;	NN	O
one	CD	B-TEST
specimen	NN	I-TEST
from	IN	O
2017-05-28	JJ	O
returned	VBN	O
with	IN	O
borderline	NN	B-PROBLEM
low	JJ	I-PROBLEM
thyroxine	NN	I-PROBLEM
,	,	O
but	CC	O
repeat	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
given	VBN	O
06-17	CD	O
.	.	O

car	NN	B-TEST
seat	NN	I-TEST
safety	NN	I-TEST
screening	VBG	I-TEST
passed	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

due	JJ	O
to	TO	O
breech	VB	B-PROBLEM
presentation	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
hip	NN	I-TEST
ultrasound	NN	I-TEST
can	MD	O
be	VB	O
considered	VBN	O
in	IN	O
2-4	JJ	O
weeks	NNS	O
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
at	IN	O
31	CD	O
weeks	NNS	O
,	,	O
twin	JJ	O
#1	NN	O
.	.	O

2.	CD	O
breech	JJ	B-PROBLEM
presentation	NN	I-PROBLEM
.	.	O

3.	CD	O
sepsis	NN	B-PROBLEM
suspect	NN	O
ruled	VBD	O
out	RP	O
with	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

4.	CD	O
physiologic	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
.	.	O

5.	CD	O
apnea	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

6.	CD	O
anemia	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

7.	CD	O
aberrant	JJ	B-PROBLEM
left	VBD	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

8.	CD	O
muscular	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

ovarian	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

ovarian	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

papanicolaou	NN	B-TEST
smear	VBP	I-TEST
positive	JJ	O
for	IN	O
somomabodies	NNS	B-PROBLEM
,	,	O
incontinence	NN	B-PROBLEM
.	.	O

total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
open	JJ	B-TREATMENT
laparoscopy	NN	I-TREATMENT
,	,	O
birch	NN	B-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
suprapubic	JJ	B-TREATMENT
bladder	NN	I-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
gravida	JJ	O
3	CD	O
para	NN	O
3	CD	O
who	WP	O
presents	VBZ	O
with	IN	O
complains	NNS	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
enlarged	VBD	B-PROBLEM
ovary	JJ	I-PROBLEM
by	IN	O
ultrasound	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
also	RB	O
complaining	VBG	O
of	IN	O
several	JJ	B-PROBLEM
years	NNS	I-PROBLEM
urinary	JJ	I-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	JJ	O
recent	JJ	O
history	NN	O
is	VBZ	O
also	RB	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
papanicolaou	NN	I-TEST
smear	NN	I-TEST
which	WDT	O
revealed	VBD	O
somomabodies	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
in	IN	O
april	JJ	O
1992	CD	O
following	VBG	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
initially	RB	O
presented	VBN	O
with	IN	O
hypercalcemia	NN	B-PROBLEM
and	CC	O
underwent	NN	O
a	DT	B-TREATMENT
parathyroidectomy	NN	I-TREATMENT
on	IN	O
june	NN	O
22	CD	O
,	,	O
1993	CD	O
.	.	O

it	PRP	O
was	VBD	O
at	IN	O
that	DT	O
time	NN	O
that	IN	O
her	PRP$	B-TEST
abnormal	JJ	I-TEST
papanicolaou	NN	I-TEST
smear	NN	I-TEST
was	VBD	O
obtained	VBN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
now	RB	O
admitted	VBN	O
for	IN	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
.	.	O

the	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
notable	JJ	O
for	IN	O
lymphosarcoma	NN	B-PROBLEM
in	IN	O
1970	CD	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

in	IN	O
1980	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
axillary	JJ	I-PROBLEM
recurrence	NN	I-PROBLEM
that	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hyperparathyroidism	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
papillary	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
history	NN	O
is	VBZ	O
also	RB	O
notable	JJ	O
for	IN	O
gallstones	NNS	B-PROBLEM
,	,	O
kidney	NN	B-PROBLEM
stones	NNS	I-PROBLEM
,	,	O
episodic	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
incontinence	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
has	VBZ	O
hypothyroidism	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
past	JJ	O
surgical	JJ	O
history	NN	O
is	VBZ	O
notable	JJ	O
for	IN	O
the	DT	B-TREATMENT
removal	NN	I-TREATMENT
of	IN	O
a	DT	B-PROBLEM
thyroid	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	O
february	JJ	O
1989	CD	O
.	.	O

this	DT	O
revealed	VBD	O
papillary	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
received	VBD	O
radioactive	JJ	B-TREATMENT
iodine	JJ	I-TREATMENT
ablation	NN	I-TREATMENT
.	.	O

in	IN	O
june	NN	O
1993	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
parathyroidectomy	NN	I-TREATMENT
and	CC	O
also	RB	O
of	IN	O
note	NN	O
,	,	O
in	IN	O
september	NN	O
1992	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

include	VBP	O
librax	$	B-TREATMENT
1	CD	O
po	NN	O
before	IN	O
meals	NNS	O
,	,	O
pancrease	NN	B-TREATMENT
2	CD	O
tabs	NN	O
before	IN	O
meals	NNS	O
,	,	O
synthroid	JJ	B-TREATMENT
0.125	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

tenormin	NN	B-TREATMENT
50	CD	O
mg	NN	O
bid	NN	O
,	,	O
valium	NN	B-TREATMENT
5	CD	O
mg	NN	O
bid	NN	O
to	TO	O
tid	VB	O
,	,	O
premarin	VB	B-TREATMENT
0.625	CD	O
mg	NN	O
qd	NN	O
,	,	O
provera	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
qod	NN	O
,	,	O
desyrel	VBZ	B-TREATMENT
50	CD	O
mg	NN	O
qhs	NN	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
include	VBP	O
septra	JJ	B-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
preoperative	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
normal	JJ	O
breasts	NNS	O
,	,	O
normal	JJ	O
heart	NN	O
and	CC	O
lungs	NNS	O
.	.	O

the	DT	B-TEST
pelvic	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
normal	JJ	O
except	IN	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
full	JJ	I-PROBLEM
right	NN	I-PROBLEM
ovary	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
rectovaginal	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
judged	VBN	O
to	TO	O
be	VB	O
at	IN	O
risk	NN	O
secondary	JJ	O
to	TO	O
her	PRP$	O
history	NN	O
of	IN	O
somomabodies	NNS	B-PROBLEM
and	CC	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

her	PRP$	O
differential	JJ	O
diagnosis	NN	O
included	VBD	O
ovarian	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
open	JJ	I-TREATMENT
laparoscopy	NN	I-TREATMENT
,	,	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
birch	NN	B-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
and	CC	O
suprapubic	JJ	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT
and	CC	O
jackson-pratt	JJ	B-TREATMENT
drain	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
estimated	VBN	I-TEST
blood	NN	I-TEST
loss	NN	I-TEST
was	VBD	O
300	CD	O
cc	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
returned	VBD	O
to	TO	O
the	DT	O
recovery	NN	O
room	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

her	PRP$	B-TEST
calcium	NN	I-TEST
was	VBD	O
followed	VBN	O
daily	JJ	O
and	CC	O
repleted	VBD	O
as	IN	O
needed	VBN	O
.	.	O

her	PRP$	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
101.6	CD	O
on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
.	.	O

her	PRP$	O
lungs	NNS	O
revealed	VBD	O
coarse	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
nebulizer	NN	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
and	CC	O
her	PRP$	B-TREATMENT
suprapubic	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
clamped	VBN	B-TREATMENT
starting	VBG	O
on	IN	O
postoperative	JJ	O
day	NN	O
four	CD	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
her	PRP$	B-TEST
post-void	JJ	I-TEST
residuals	NNS	I-TEST
range	VBP	O
from	IN	O
2	CD	O
cc	NN	O
to	TO	O
25	CD	O
cc	NN	O
.	.	O

the	DT	B-TREATMENT
suprapubic	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
therefore	RB	O
discontinued	VBN	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
performed	VBN	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
coarse	VBZ	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
,	,	O
however	RB	O
,	,	O
the	DT	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
clear	JJ	O
except	IN	O
for	IN	O
a	DT	O
small	JJ	O
amount	NN	O
of	IN	O
atelectasis	NN	B-PROBLEM
.	.	O

final	JJ	B-TEST
pathology	NN	I-TEST
revealed	VBD	O
right	JJ	O
fallopian	JJ	O
tube	NN	O
and	CC	O
ovary	JJ	O
with	IN	O
benign	JJ	B-PROBLEM
paratubal	JJ	I-PROBLEM
cysts	NNS	I-PROBLEM
and	CC	O
adhesions	NNS	B-PROBLEM
.	.	O

the	DT	O
cervix	NN	O
revealed	VBD	O
squamous	JJ	B-PROBLEM
metaplasia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
on	IN	O
admission	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
will	MD	O
take	VB	O
ciprofloxacin	NN	B-TREATMENT
for	IN	O
nine	CD	O
more	JJR	O
days	NNS	O
.	.	O

she	PRP	O
will	MD	O
also	RB	O
take	VB	O
percocet	NN	B-TREATMENT
.	.	O

1.	CD	O
stage	NN	B-PROBLEM
iv	JJ	I-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM

2.	CD	O
stage	NN	B-PROBLEM
iii-c	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
cancer	NN	I-PROBLEM

1.	CD	O
stage	NN	B-PROBLEM
iv	JJ	I-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM

2.	CD	O
stage	NN	B-PROBLEM
iii-c	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
cancer	NN	I-PROBLEM

chemotherapy	NN	B-TREATMENT
of	IN	O
ifex	NN	B-TREATMENT
,	,	O
mesna	NN	B-TREATMENT
and	CC	O
vp-16	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
31	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
0	CD	O
with	IN	O
stage	NN	B-PROBLEM
iv	JJ	I-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
stage	VB	B-PROBLEM
iii-c	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
vs	NN	O
metastatic	JJ	B-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
for	IN	O
line	NN	O
2	CD	O
,	,	O
cycle	NN	B-TREATMENT
1	CD	I-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
in	IN	O
10-90	JJ	O
,	,	O
with	IN	O
heavy	JJ	B-PROBLEM
bleeding	VBG	I-PROBLEM
per	IN	I-PROBLEM
vagina	NN	I-PROBLEM
.	.	O

d	NN	B-TEST
and	CC	I-TEST
c	NN	I-TEST
showed	VBD	O
grade	JJ	B-PROBLEM
ii-iii	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
with	IN	O
squamous	JJ	B-PROBLEM
differentiation	NN	I-PROBLEM
at	IN	O
wellla	NN	O
uxinny	JJ	O
:	:	O
mount	NN	O
medical	JJ	O
center	NN	O
in	IN	O
com	JJ	O
st.	NN	O
,	,	O
tton	NN	O
,	,	O
arkansas	RB	O
32167	CD	O
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
tah	NN	B-TREATMENT
/	NNP	O
bso	NN	B-TREATMENT
,	,	O
partial	JJ	B-TREATMENT
omentectomy	NN	I-TREATMENT
at	IN	O
ctmc	NN	O
in	IN	O
10-90	JJ	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
tumor	NN	B-PROBLEM
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
studding	VBG	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
diaphragm	NN	I-PROBLEM
,	,	O
gross	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
omentum	NN	I-PROBLEM
and	CC	I-PROBLEM
large	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
,	,	O
tumor	NN	B-PROBLEM
through	IN	I-PROBLEM
the	DT	I-PROBLEM
uterine	JJ	I-PROBLEM
serosa	NN	I-PROBLEM
.	.	O

pathology	NN	B-TEST
showed	VBD	O
grade	JJ	B-PROBLEM
ii-iii	JJ	I-PROBLEM
papillary	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrium	NN	I-PROBLEM
with	IN	O
squamous	JJ	B-PROBLEM
differentiation	NN	I-PROBLEM
which	WDT	O
was	VBD	O
focally	RB	B-PROBLEM
invasive	JJ	I-PROBLEM
and	CC	O
superficial	JJ	B-PROBLEM
myometrium	NN	I-PROBLEM
.	.	O

the	DT	O
ovary	JJ	O
showed	VBD	O
papillary	JJ	B-PROBLEM
serous	JJ	I-PROBLEM
adeno	NN	I-PROBLEM
with	IN	O
omental	JJ	B-PROBLEM
involvement	NN	I-PROBLEM
consistent	NN	O
with	IN	O
an	DT	B-PROBLEM
endometroid	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

the	DT	O
question	NN	O
was	VBD	O
whether	IN	O
or	CC	O
not	RB	O
whether	IN	O
she	PRP	O
had	VBD	O
two	CD	B-PROBLEM
primaries	NNS	I-PROBLEM
vs	VBP	O
metastatic	JJ	B-PROBLEM
endometrial	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
6	CD	O
cycles	NNS	O
of	IN	O
cap	NN	B-TREATMENT
in	IN	O
pemrancetul	JJ	O
tonsst.	NN	O
.	.	O

however	RB	O
,	,	O
during	IN	O
the	DT	B-TREATMENT
fourth	JJ	I-TREATMENT
cycle	NN	I-TREATMENT
,	,	O
cytoxan	NN	B-TREATMENT
was	VBD	O
dropped	VBN	O
.	.	O

her	PRP$	B-TEST
ca-125	NN	I-TEST
on	IN	O
6-27-91	JJ	O
,	,	O
was	VBD	O
249	CD	O
and	CC	O
on	IN	O
8-29-91	JJ	O
,	,	O
was	VBD	O
734	CD	O
.	.	O

in	IN	O
05-92	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
wellla	VB	O
uxinny	JJ	O
:	:	O
mount	NN	O
medical	JJ	O
center	NN	O
with	IN	O
left	JJ	B-PROBLEM
leg	NN	I-PROBLEM
dvt	NN	I-PROBLEM
and	CC	O
started	VBD	O
on	IN	O
heparin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
from	IN	O
there	RB	O
on	IN	O
coumadin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
complaints	NNS	O
except	IN	O
anxiety	NN	B-PROBLEM
.	.	O

coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
q	NN	O
d	NN	O
,	,	O
tagamet	VBD	B-TREATMENT
400	CD	O
mg	NN	O
po	NN	O
q	NN	O
d	NN	O
,	,	O
amoxicillin	NN	B-TREATMENT
which	WDT	O
was	VBD	O
started	VBN	O
on	IN	O
labor	NN	O
day	NN	O
,	,	O
for	IN	O
a	DT	B-PROBLEM
sore	NN	I-PROBLEM
throat	NN	I-PROBLEM
and	CC	O
ativan	$	B-TREATMENT
1	CD	O
mg	NN	O
po	NN	O
prn	NN	O
nausea	NN	B-PROBLEM
/	NNP	O
anxiety	NN	B-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
gets	VBZ	O
hives	NNS	B-PROBLEM
to	TO	O
aspirin	VB	B-TREATMENT
and	CC	O
tomatoes	NNS	O
also	RB	O
cause	VBP	O
her	PRP$	O
hives	NNS	B-PROBLEM
.	.	O

the	DT	B-TEST
temp	NN	I-TEST
was	VBD	O
99.4	CD	O
,	,	O
bp	NN	B-TEST
114/78	CD	O
,	,	O
pulse	RB	B-TEST
128	CD	O
and	CC	O
respirations	NNS	B-TEST
20	CD	O
.	.	O

she	PRP	O
was	VBD	O
an	DT	O
anxious	JJ	O
female	NN	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
showed	VBD	O
perrla	NN	O
,	,	O
eomi	NN	O
,	,	O
oropharynx	JJ	O
benign	NN	O
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

cv	NN	O
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
murmurs	NNS	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
non	JJ	B-PROBLEM
tender	NN	I-PROBLEM
,	,	O
large	JJ	B-PROBLEM
,	,	I-PROBLEM
hard	JJ	I-PROBLEM
mass	NN	I-PROBLEM
occupying	VBG	O
the	DT	O
lower	JJR	O
abdomen	NNS	O
and	CC	O
left	VBD	O
upper	JJ	O
quadrant	NN	O
.	.	O

the	DT	O
extremities	NNS	O
were	VBD	O
non	JJ	B-PROBLEM
tender	NN	I-PROBLEM
without	IN	O
edema	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	B-TEST
sodium	NN	I-TEST
was	VBD	O
136	CD	O
,	,	O
potassium	NN	B-TEST
3.0	CD	O
,	,	O
chloride	RB	B-TEST
98	CD	O
,	,	O
co2	NN	B-TEST
20	CD	O
,	,	O
bun	NN	B-TEST
8	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
and	CC	O
glucose	VB	B-TEST
94	CD	O
,	,	O
alt	RB	B-TEST
5	CD	O
,	,	O
ast	RB	B-TEST
10	CD	O
,	,	O
ldh	VBD	B-TEST
166	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
81	CD	O
,	,	O
total	JJ	B-TEST
bili	NN	I-TEST
0.6	CD	O
,	,	O
direct	JJ	B-TEST
bili	NN	I-TEST
.3	NN	O
,	,	O
albumin	RB	B-TEST
3.3	CD	O
,	,	O
calcium	NN	B-TEST
8.8	CD	O
and	CC	O
uric	JJ	B-TEST
acid	NN	I-TEST
3.1	CD	O
.	.	O

she	PRP	O
had	VBD	O
ca-125	NN	B-TEST
which	WDT	O
was	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
31.1	CD	O
,	,	O
wbc	VBD	B-TEST
11.6	CD	O
and	CC	O
151,000	CD	O
platelets	NNS	B-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
thus	RB	O
stage	JJ	B-PROBLEM
iv	JJ	I-PROBLEM
endometrial	JJ	I-PROBLEM
and	CC	O
stage	JJ	B-PROBLEM
iii-c	JJ	I-PROBLEM
ovarian	JJ	I-PROBLEM
vs	NN	O
metastatic	JJ	B-PROBLEM
endometrial	NN	I-PROBLEM
for	IN	I-PROBLEM
line	NN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	O
cycle	NN	B-TREATMENT
i	NN	I-TREATMENT
chemotherapy	VBP	I-TREATMENT
ifex	NN	B-TREATMENT
,	,	O
mesna	NN	B-TREATMENT
and	CC	O
vp-16	NN	B-TREATMENT
.	.	O

the	DT	O
plan	NN	O
was	VBD	O
for	IN	O
urinalysis	JJ	B-TEST
q	NN	O
d	NN	O
.	.	O

with	IN	O
the	DT	O
history	NN	O
of	IN	O
dvt	NN	B-PROBLEM
,	,	O
we	PRP	O
plan	VBP	O
coumadin	JJ	B-TREATMENT
and	CC	O
check	VB	O
her	PRP$	B-TEST
coags	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
tachycardiac	VBN	B-PROBLEM
on	IN	O
admission	NN	O
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
she	PRP	O
was	VBD	O
dehydrated	VBN	B-PROBLEM
and	CC	O
/	CD	O
or	CC	O
anxious	JJ	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
her	PRP$	B-TEST
initial	JJ	I-TEST
evaluation	NN	I-TEST
.	.	O

ekg	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
and	CC	O
incomplete	JJ	B-PROBLEM
right	NN	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

when	WRB	O
compared	VBN	O
with	IN	O
ecg	NN	B-TEST
of	IN	O
11-06-90	JJ	O
,	,	O
there	EX	O
was	VBD	O
borderline	NN	O
criteria	NNS	O
for	IN	O
anterior	JJ	B-PROBLEM
mi	NNS	I-PROBLEM
although	IN	O
the	DT	O
patient	NN	O
denied	VBD	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
at	IN	O
any	DT	O
point	NN	O
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
chemotherapy	NN	B-TREATMENT
on	IN	O
the	DT	O
following	JJ	O
doses	NNS	O
:	:	O

ifex	NN	B-TREATMENT
1.2	CD	O
grams	NNS	O
per	IN	O
meter	NN	O
squared	VBD	O
x	JJ	O
3	CD	O
days	NNS	O
,	,	O
mesna	VBP	B-TREATMENT
1.2	CD	O
grams	NNS	O
per	IN	O
meter	NN	O
squared	VBD	O
x	JJ	O
3	CD	O
days	NNS	O
continuous	JJ	B-TREATMENT
iv	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
vp-16	JJ	B-TREATMENT
mixed	JJ	O
with	IN	O
250	CD	O
cc	NNS	O
iv	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
given	VBN	O
over	IN	O
1	CD	O
hour	NN	O
each	DT	O
day	NN	O
for	IN	O
3	CD	O
days	NNS	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
mesna	VBN	B-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
.6	JJ	O
grams	NNS	O
per	IN	O
meter	NN	O
squared	VBN	O
after	IN	O
her	PRP$	B-TREATMENT
ifex	JJ	I-TREATMENT
/	JJ	O
mesna	NN	B-TREATMENT
were	VBD	O
completed	VBN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
urinalysis	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
significant	JJ	O
for	IN	O
red	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
which	WDT	O
were	VBD	O
tntc	NNS	O
as	RB	O
well	RB	O
as	IN	O
uric	JJ	B-TEST
acid	NN	I-TEST
.	.	O

because	IN	O
it	PRP	O
was	VBD	O
felt	VBN	O
the	DT	O
patient	NN	O
was	VBD	O
bleeding	VBG	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
contaminated	VBN	O
,	,	O
she	PRP	O
received	VBD	O
her	PRP	O
ifex	JJ	B-TREATMENT
/	JJ	O
mesna	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
straight	JJ	I-TEST
cath	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
rbc	NN	B-PROBLEM
's	POS	I-PROBLEM
.	.	O

after	IN	O
1	CD	O
day	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
8-10	JJ	B-PROBLEM
rbc	NN	I-PROBLEM
's	POS	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
but	CC	O
by	IN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
her	PRP$	B-TREATMENT
ifex	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
,	,	O
she	PRP	O
had	VBD	O
50-80	JJ	B-PROBLEM
rbc	NN	I-PROBLEM
's	POS	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
transitional	JJ	I-PROBLEM
epithelial	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

because	IN	O
of	IN	O
this	DT	O
finding	NN	O
,	,	O
her	PRP$	B-TREATMENT
ifex	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
before	IN	O
completion	NN	O
of	IN	O
her	PRP$	O
second	JJ	O
day	NN	O
of	IN	O
infusion	NN	B-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
mesna	NN	I-TREATMENT
alone	NN	O
was	VBD	O
continued	VBN	O
at	IN	O
that	DT	O
time	NN	O
for	IN	O
iv	JJ	B-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
receive	VB	O
her	PRP$	B-TREATMENT
vp-16	NN	I-TREATMENT
without	IN	O
complication	NN	B-PROBLEM
.	.	O

other	JJ	O
significant	JJ	O
issues	NNS	O
were	VBD	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
on	IN	O
admission	NN	O
at	IN	O
31.1	CD	O
which	WDT	O
dwindled	VBD	O
down	RB	O
to	TO	O
26.2	CD	O
by	IN	O
9-10	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
counselled	VBN	O
and	CC	O
received	VBN	O
2	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
rbc	NN	I-TREATMENT
's	POS	I-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

however	RB	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
bumped	VBD	O
only	RB	O
to	TO	O
28.1	CD	O
and	CC	O
a	DT	O
repeat	NN	O
later	RB	O
on	IN	O
9-11	CD	O
,	,	O
showed	VBD	O
hematocrit	NN	B-TEST
of	IN	O
27.6	CD	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
an	DT	O
additional	JJ	O
2	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
rbc	NN	I-TREATMENT
's	POS	I-TREATMENT
were	VBD	O
transfused	VBN	O
.	.	O

the	DT	O
third	JJ	O
issue	NN	O
was	VBD	O
that	IN	O
her	PRP$	B-TREATMENT
anticoagulation	NN	I-TREATMENT
was	VBD	O
grossly	RB	O
out	IN	O
of	IN	O
control	NN	O
on	IN	O
admission	NN	O
with	IN	O
pt	NN	B-TEST
of	IN	O
25.6	CD	O
and	CC	O
ptt	NN	B-TEST
of	IN	O
42.2	CD	O
.	.	O

her	PRP$	O
repeat	NN	O
on	IN	O
9-8	CD	O
,	,	O
was	VBD	O
36.0	CD	O
/	JJ	O
68.2	CD	O
and	CC	O
her	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
.	.	O

she	PRP	O
received	VBD	O
no	DT	O
coumadin	NN	B-TREATMENT
during	IN	O
her	PRP$	O
admission	NN	O
and	CC	O
by	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
her	PRP$	B-TEST
pt	NN	I-TEST
was	VBD	O
down	RB	O
to	TO	O
16.2	CD	O
.	.	O

she	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
per	IN	O
day	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
35.6	CD	O
showing	VBG	O
significant	JJ	O
bump	NN	O
in	IN	O
her	PRP$	B-TEST
count	NN	I-TEST
after	IN	O
her	PRP$	O
second	JJ	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
rbc	NN	I-TREATMENT
's	POS	I-TREATMENT
.	.	O

her	PRP$	B-TEST
pt	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
13.2	CD	O
and	CC	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
po	NN	O
q	NN	O
d	NN	O
as	IN	O
mentioned	VBN	O
.	.	O

on	IN	O
9-28-92	CD	O
,	,	O
the	DT	O
patient	NN	O
will	MD	O
return	VB	O
for	IN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
she	PRP	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
her	PRP$	O
primary	JJ	O
doctor	NN	O
,	,	O
dr.	NN	O
jescspald	NN	O
,	,	O
for	IN	O
repeat	NN	B-TEST
pt	NN	I-TEST
and	CC	O
coumadin	NN	B-TREATMENT
dosing	NN	I-TREATMENT
on	IN	O
monday	NN	O
,	,	O
9-14-02	CD	O
.	.	O

76-year-old	JJ	O
male	NN	O
with	IN	O
right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
pain	NN	I-PROBLEM
x	NNP	O
five	CD	O
years	NNS	O
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
is	VBZ	O
often	RB	O
severely	RB	O
and	CC	O
increasing	VBG	O
at	IN	O
night	NN	O
especially	RB	O
when	WRB	O
he	PRP	O
is	VBZ	O
lying	VBG	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
.	.	O

tonsillectomy	NN	B-TREATMENT
.	.	O

history	NN	O
of	IN	O
high	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
,	,	O
enlarged	VBD	B-PROBLEM
heart	NN	I-PROBLEM
.	.	O

zantac	NN	B-TREATMENT
.	.	O

furosemide	NN	B-TREATMENT
.	.	O

aerobid	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
non-tender	NN	B-PROBLEM
.	.	O

left	VBN	O
hip	NN	O
shows	VBZ	O
flexion	NN	B-TEST
and	CC	O
extension	NN	B-TEST
40	CD	O
.	.	O

right	JJ	B-TEST
hip	NN	I-TEST
flexion	NN	I-TEST
and	CC	O
extension	NN	B-TEST
40	CD	O
and	CC	O
0	CD	O
.	.	O

right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
pain	VBP	I-PROBLEM
degenerative	JJ	B-PROBLEM
joint	NN	I-PROBLEM
disease	NN	I-PROBLEM
for	IN	O
right	JJ	B-TREATMENT
total	JJ	I-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
as	IN	O
a	DT	O
postoperative	JJ	O
admit	NN	O
on	IN	O
december	NN	O
7	CD	O
for	IN	O
total	JJ	B-TREATMENT
hip	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

for	IN	O
further	JJ	O
details	NNS	O
of	IN	O
this	DT	B-TREATMENT
procedure	NN	I-TREATMENT
see	VBP	O
operative	JJ	O
note	NN	O
.	.	O

however	RB	O
he	PRP	O
had	VBD	O
a	DT	O
report	NN	O
of	IN	O
emesis	NN	B-PROBLEM
of	IN	I-PROBLEM
coffee	NN	I-PROBLEM
grounds	NNS	I-PROBLEM
on	IN	O
postoperative	JJ	O
night	NN	O
#1	NN	O
.	.	O

this	DT	O
with	IN	O
no	DT	O
electrocardiogram	NN	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

due	JJ	O
to	TO	O
this	DT	O
gi	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
felt	VBD	O
that	IN	O
he	PRP	O
would	MD	O
be	VB	O
a	DT	O
candidate	NN	O
for	IN	O
esophagogastroduodenoscopy	NN	B-TEST
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
nothing	NN	B-TREATMENT
by	IN	I-TREATMENT
mouth	NN	I-TREATMENT
and	CC	O
the	DT	B-TEST
esophagogastroduodenoscopy	NN	I-TEST
was	VBD	O
done	VBN	O
by	IN	O
the	DT	O
gi	NN	O
service	NN	O
.	.	O

findings	NNS	O
showed	VBD	O
a	DT	B-PROBLEM
mallory	NN	I-PROBLEM
weiss	JJ	I-PROBLEM
tear	NN	I-PROBLEM
,	,	O
nonspecific	JJ	B-PROBLEM
duodenitis	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
zantac	NN	B-TREATMENT
150	CD	O
mg.	NN	O
po	NN	O
b.i.d.	NN	O
and	CC	O
h	NN	B-TEST
pylori	NN	I-TEST
serology	NN	I-TEST
was	VBD	O
sent	VBN	O
.	.	O

post	NN	O
egd	VB	B-TEST
his	PRP$	O
diet	NN	O
was	VBD	O
advanced	JJ	O
slowly	RB	O
and	CC	O
he	PRP	O
did	VBD	O
exceptionally	RB	O
well	RB	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
he	PRP	O
was	VBD	O
tolerating	VBG	O
a	DT	O
full	JJ	O
diet	NN	O
,	,	O
out	IN	O
of	IN	O
bed	NN	O
with	IN	O
pain	NN	B-PROBLEM
,	,	O
tolerated	VBN	O
on	IN	O
po.	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
intact	JJ	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
lower	JJR	B-TEST
extremity	NN	I-TEST
arterial	JJ	I-TEST
non-invasive	JJ	I-TEST
studies	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
recurrent	NN	O
symptoms	NNS	O
of	IN	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
emesis	NN	I-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
79	CD	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
cataracts	NNS	B-PROBLEM
,	,	O
glaucoma	NN	B-PROBLEM
,	,	O
and	CC	O
diabetes	NNS	B-PROBLEM
,	,	O
who	WP	O
fell	VBD	O
and	CC	O
tripped	VBD	O
over	IN	O
a	DT	O
wheelchair	NN	O
of	IN	O
a	DT	O
friend	NN	O
with	IN	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
no	DT	O
dizziness	NN	B-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
77	CD	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
132/48	CD	O
.	.	O

respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
17	CD	O
.	.	O

sats	NNS	B-TEST
96%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
97.6	CD	O
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
front	JJ	I-PROBLEM
focal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
adjacent	NN	O
to	TO	O
the	DT	O
falx	NN	O
with	IN	O
intraparenchymal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
epidural	JJ	B-PROBLEM
or	CC	I-PROBLEM
subdural	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
near	IN	I-PROBLEM
the	DT	I-PROBLEM
falx	NN	I-PROBLEM
with	IN	O
no	DT	O
shift	NN	B-PROBLEM
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
c	JJ	I-TEST
spine	NN	I-TEST
was	VBD	O
negative	JJ	O
and	CC	O
her	PRP$	O
cervical	JJ	O
spine	NN	O
was	VBD	O
cleared	VBN	O
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
close	JJ	B-TEST
neurosurgical	JJ	I-TEST
and	CC	I-TEST
neurological	JJ	I-TEST
observation	NN	I-TEST
.	.	O

repeat	NN	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
showed	VBD	O
stable	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

she	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
followup	JJ	O
with	IN	O
dr.	JJ	O
wilson	NN	O
in	IN	O
two	CD	O
weeks	NNS	O
with	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
.	.	O

1.	CD	O
levofloxacin	JJ	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q.24h.	NN	O
x3	NNP	O
days	NNS	O
.	.	O

2.	CD	O
dilantin	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

3.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

4.	CD	O
timoptic	JJ	B-TREATMENT
0.25	CD	O
one	CD	O
drop	NN	O
o.u.	NN	O
b.i.d.	NN	O

5.	CD	O
lantoprost	JJS	B-TREATMENT
0.005	CD	O
ophthalmic	JJ	O
solution	NN	O
one	CD	O
drop	NN	O
o.u.	VBD	O
q.h.s.	NN	O

6.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

7.	CD	O
insulin-sliding	JJ	B-TREATMENT
scale	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
40	CD	O
units	NNS	O
of	IN	O
humalog	NN	B-TREATMENT
in	IN	O
the	DT	O
a.m.	NN	O
and	CC	O
20	CD	O
at	IN	O
night	NN	O
.	.	O

she	PRP	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
perez	NNS	O
in	IN	O
two	CD	O
weeks	NNS	O
with	IN	O
repeat	NN	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
.	.	O

1.	CD	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

2.	CD	O
alzheimer	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
87-year-old	JJ	O
male	NN	O
with	IN	O
stage	NN	B-PROBLEM
d	NN	I-PROBLEM
prostate	NN	I-PROBLEM
was	VBD	O
cancer	NN	B-PROBLEM
,	,	O
was	VBD	O
admitted	VBN	O
for	IN	O
fluid	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
on	IN	O
the	DT	O
10th	CD	O
of	IN	O
march	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
diagnosed	VBN	O
with	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
august	NN	O
of	IN	O
1989	CD	O
.	.	O

he	PRP	O
presented	VBD	O
with	IN	O
gross	JJ	B-PROBLEM
hematuria	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

subsequent	JJ	B-TEST
prostatic	JJ	I-TEST
biopsy	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
gleason	NN	I-PROBLEM
's	POS	I-PROBLEM
iv	NN	I-PROBLEM
,	,	I-PROBLEM
plus	CC	I-PROBLEM
v	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
and	CC	O
the	DT	B-TEST
ct	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
irregular	JJ	I-PROBLEM
large	JJ	I-PROBLEM
prostate	NN	I-PROBLEM
with	IN	O
tumor	NN	B-PROBLEM
invasion	NN	I-PROBLEM
into	IN	I-PROBLEM
the	DT	I-PROBLEM
bladder	NN	I-PROBLEM
and	CC	O
evidence	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
retroperitoneal	NN	I-PROBLEM
lymph	NN	I-PROBLEM
node	JJ	I-PROBLEM
spread	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
also	RB	O
evidence	NN	O
of	IN	O
bone	NN	B-PROBLEM
metastasis	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
in	IN	O
october	NN	O
of	IN	O
1991	CD	O
for	IN	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
and	CC	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
was	VBD	O
treated	VBN	O
with	IN	O
fluid	JJ	B-TREATMENT
rehydration	NN	I-TREATMENT
and	CC	O
foley	JJ	B-TREATMENT
catheter	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
past	JJ	O
one	CD	O
month	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
's	POS	O
wife	NN	O
has	VBZ	O
noticed	VBN	O
a	DT	B-PROBLEM
marked	JJ	I-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
p.o.	JJ	I-PROBLEM
intake	NN	I-PROBLEM
and	CC	O
also	RB	O
noted	VBD	O
a	DT	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
of	IN	O
approximately	RB	O
ten	JJ	O
pounds	NNS	O
in	IN	O
the	DT	O
preceding	VBG	O
two	CD	O
weeks	NNS	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
lethargic	JJ	B-PROBLEM
and	CC	O
bed	VBD	B-PROBLEM
ridden	NN	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
two	CD	O
weeks	NNS	O
,	,	O
although	IN	O
there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fever	NN	B-PROBLEM
or	CC	O
chills	NNS	B-PROBLEM
over	IN	O
this	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
now	RB	O
admitted	VBN	O
for	IN	O
fluid	JJ	B-TREATMENT
rehydration	NN	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
observation	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
with	IN	O
a	DT	B-TEST
recumbent	NN	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
128/16	CD	O
,	,	O
pulse	NN	B-TEST
of	IN	O
76	CD	O
,	,	O
and	CC	O
standing	VBG	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
110/60	CD	O
with	IN	O
a	DT	B-TEST
pulse	NN	I-TEST
of	IN	O
88	CD	O
.	.	O

respirations	NNS	B-TEST
are	VBP	O
unlabored	VBN	B-PROBLEM
at	IN	O
16	CD	O
.	.	O

noted	VBN	O
for	IN	O
nonicteric	JJ	B-PROBLEM
sclerae	NN	I-PROBLEM
and	CC	O
lungs	NNS	O
that	WDT	O
are	VBP	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

no	DT	O
cva	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
was	VBD	O
appreciated	VBN	O
in	IN	O
the	DT	O
heart	NN	O
and	CC	O
the	DT	O
heart	NN	O
appears	VBZ	O
to	TO	O
be	VB	O
in	IN	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

without	IN	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

decreased	VBN	B-PROBLEM
turgor	NN	I-PROBLEM
with	IN	O
dry	JJ	B-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
of	IN	O
7.75	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
46.2%	CD	O
,	,	O
sodium	NN	B-TEST
144	CD	O
,	,	O
potassium	NN	B-TEST
3.9	CD	O
,	,	O
creatinine	NN	B-TEST
25	CD	O
,	,	O
and	CC	O
bun	NN	B-TEST
was	VBD	O
1.4	CD	O
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
of	IN	O
88	CD	O
.	.	O

urinalysis	NN	B-TEST
demonstrated	VBD	O
30-50	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
with	IN	O
red	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
too	RB	O
numerous	JJ	O
to	TO	O
count	VB	O
and	CC	O
2+	CD	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	O
diagnosis	NN	O
of	IN	O
prostate	NN	B-PROBLEM
ca	MD	I-PROBLEM
,	,	O
for	IN	O
fluid	JJ	B-TREATMENT
rehydration	NN	I-TREATMENT
.	.	O

initially	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
bactrim	NN	B-TREATMENT
for	IN	O
presumptive	JJ	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
the	DT	O
initial	JJ	O
course	NN	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
,	,	O
he	PRP	O
took	VBD	O
p.o.'	NN	O
s	NN	O
poorly	RB	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
,	,	O
however	RB	O
,	,	O
and	CC	O
his	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

by	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
six	CD	O
,	,	O
however	RB	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
febrile	JJ	B-PROBLEM
to	TO	O
100.7	CD	O
and	CC	O
repeat	NN	B-TEST
urinalysis	NN	I-TEST
showed	VBD	O
20-30	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
and	CC	O
1+	CD	B-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

antibiotics	NNS	B-TREATMENT
were	VBD	O
switched	VBN	O
to	TO	O
iv	VB	B-TREATMENT
ciprofloxacin	NN	I-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
defervesced	VBD	O
;	:	O
however	RB	O
,	,	O
by	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
seven	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
passing	VBG	O
very	RB	O
little	JJ	O
urine	NN	O
through	IN	O
his	PRP$	B-TREATMENT
condom	NN	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
electrolyte	NN	B-TEST
screen	NN	I-TEST
and	CC	O
electrolytes	NNS	B-TEST
from	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
seven	CD	O
showed	VBD	O
a	DT	B-TEST
bun	NN	I-TEST
of	IN	O
27	CD	O
and	CC	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
2.7	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
vigorously	RB	B-TREATMENT
fluid	JJ	I-TREATMENT
rehydrated	VBD	I-TREATMENT
;	:	O
however	RB	O
,	,	O
by	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
nine	CD	O
,	,	O
bun	NN	B-TEST
was	VBD	O
22	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
3.5	CD	O
.	.	O

a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
that	DT	O
time	NN	O
with	IN	O
the	DT	O
recovery	NN	O
of	IN	O
approximately	RB	O
800	CD	O
cc	NN	O
of	IN	O
urine	NN	O
.	.	O

blood	NN	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
148	CD	O
and	CC	O
a	DT	B-TEST
potassium	NN	I-TEST
of	IN	O
5.1	CD	O
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
fluid	JJ	I-TREATMENT
hydration	NN	I-TREATMENT
from	IN	O
d5	JJ	B-TREATMENT
one-half	JJ	I-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
with	IN	O
20	CD	O
meq	NN	O
of	IN	O
k	NN	B-TREATMENT
to	TO	O
d5w	VB	B-TREATMENT
and	CC	O
acuchecks	VB	B-TEST
from	IN	O
this	DT	O
time	NN	O
showed	VBD	O
blood	NN	B-TEST
sugars	NNS	I-TEST
routinely	RB	O
between	IN	O
20	CD	O
and	CC	O
50	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
one	CD	O
amp	NN	O
of	IN	O
d50	NN	B-TREATMENT
for	IN	O
each	DT	B-TEST
acucheck	NN	I-TEST
for	IN	O
blood	NN	B-TEST
sugars	NNS	I-TEST
of	IN	O
less	JJR	O
than	IN	O
40	CD	O
.	.	O

gradually	RB	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
following	JJ	O
days	NNS	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
electrolytes	NNS	I-TEST
again	RB	O
normalized	VBD	O
;	:	O
however	RB	O
,	,	O
as	IN	O
the	DT	O
patient	NN	O
continues	VBZ	O
to	TO	O
take	VB	O
p.o.'	NN	O
s	NNS	O
poorly	RB	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
on	IN	O
iv	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
fourteen	NN	O
,	,	O
electrolytes	NNS	B-TEST
were	VBD	O
sodium	NN	B-TEST
of	IN	O
140	CD	O
,	,	O
potassium	NN	B-TEST
3.9	CD	O
,	,	O
bun	NN	B-TEST
of	IN	O
11	CD	O
,	,	O
creatinine	NN	B-TEST
1.3	CD	O
with	IN	O
a	DT	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
of	IN	O
125	CD	O
and	CC	O
a	DT	B-TEST
magnesium	NN	I-TEST
of	IN	O
1.9	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
transferred	VBN	O
to	TO	O
el	VB	O
hospital	NN	O
,	,	O
still	RB	O
receiving	VBG	O
iv	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
at	IN	O
a	DT	O
rate	NN	O
currently	RB	O
of	IN	O
50	CD	O
cc	NNS	O
an	DT	O
hour	NN	O
of	IN	O
d5	JJ	B-TREATMENT
one-half	JJ	I-TREATMENT
normal	JJ	I-TREATMENT
with	IN	O
20	CD	O
meq	NN	O
of	IN	O
k	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
in	IN	O
place	NN	O
and	CC	O
the	DT	B-TREATMENT
bacitracin	JJ	I-TREATMENT
ointment	NN	I-TREATMENT
should	MD	O
be	VB	O
applied	VBN	O
to	TO	O
the	DT	O
urethral	JJ	O
meatus	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

periodic	JJ	B-TEST
urinalysis	NN	I-TEST
should	MD	O
be	VB	O
conducted	VBN	O
to	TO	O
monitor	VB	O
the	DT	O
development	NN	O
of	IN	O
possible	JJ	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

it	PRP	O
should	MD	O
be	VB	O
noted	VBN	O
that	DT	O
while	NN	O
in	IN	O
the	DT	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ultrasound	NN	I-TEST
which	WDT	O
is	VBZ	O
significant	JJ	O
for	IN	O
a	DT	B-PROBLEM
grossly	RB	I-PROBLEM
enlarged	VBN	I-PROBLEM
liver	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
foci	NN	I-PROBLEM
of	IN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
discharged	VBN	O
on	IN	O
mylanta	NN	B-TREATMENT
30	CD	O
cc	NN	O
with	IN	O
meals	NNS	O
,	,	O
carafate	VBP	B-TREATMENT
1	CD	O
gm	NN	O
q.	NN	O
6	CD	O
,	,	O
heparin	NN	B-TREATMENT
5000	CD	O
units	NNS	O
subcutaneous	JJ	O
b.i.d.	NN	O
until	IN	O
the	DT	O
patient	NN	O
regains	VBZ	O
full	JJ	O
activity	NN	O
and	CC	O
iv	JJ	B-TREATMENT
hydration	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
foley	NN	I-TREATMENT
should	MD	O
be	VB	O
in	IN	O
place	NN	O
until	IN	O
a	DT	O
follow-up	JJ	O
appointment	NN	O
with	IN	O
dr.	JJ	O
aarhalt	NN	O
can	MD	O
be	VB	O
scheduled	VBN	O
in	IN	O
approximately	RB	O
one	CD	O
to	TO	O
two	CD	O
weeks	NNS	O
at	IN	O
which	WDT	O
time	NN	O
a	DT	O
decision	NN	O
regarding	VBG	O
the	DT	O
status	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
urinary	JJ	I-PROBLEM
obstruction	NN	I-PROBLEM
will	MD	O
be	VB	O
addressed	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
milton/haverhill	VB	O
per	IN	O
family	NN	O
request	NN	O
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
comfort	NN	B-TREATMENT
(	(	I-TREATMENT
hospice	NN	I-TREATMENT
)	)	I-TREATMENT
management	NN	I-TREATMENT
.	.	O

tylenol	NN	B-TREATMENT
(	(	I-TREATMENT
acetaminophen	NN	I-TREATMENT
)	)	I-TREATMENT
650	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
starting	VBG	O
today	NN	O
(	(	O
11/02	CD	O
)	)	O
prn	NN	O
headache	NN	B-PROBLEM

do	VB	O
not	RB	O
take	VB	O
more	JJR	O
than	IN	O
4gm	CD	O
/	JJ	O
day	NN	O
acetylsalicylic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
325	CD	O
mg	NNS	O
po	JJ	O
daily	JJ	O
phoslo	NN	B-TREATMENT
(	(	I-TREATMENT
calcium	JJ	I-TREATMENT
acetate	NN	I-TREATMENT
(	(	O
1	CD	O
gelcap	NN	O
=	VBD	O
667	CD	O
mg	NN	O
)	)	O
)	)	O
1,334	CD	O
mg	NN	O
po	NN	O
tid	NN	O

please	VB	O
give	VB	O
with	IN	O
meals	NNS	O
flovent	JJ	B-TREATMENT
hfa	NN	I-TREATMENT
(	(	I-TREATMENT
fluticasone	JJ	I-TREATMENT
propionate	NN	I-TREATMENT
)	)	I-TREATMENT
44	CD	O
mcg	JJ	O
inh	NN	O
bid	NN	O
labetalol	VBZ	B-TREATMENT
hcl	$	I-TREATMENT
300	CD	O

sbp	NN	B-TEST
&lt;	VBZ	O
100	CD	O
or	CC	O
hr	VB	B-TEST
&lt;	CD	O
55	CD	O

cozaar	NN	B-TREATMENT
(	(	I-TREATMENT
losartan	JJ	I-TREATMENT
)	)	I-TREATMENT
50	CD	O

sbp	NN	B-TEST
&lt;	VBZ	O
100	CD	O

nephrocaps	NNS	B-TREATMENT
(	(	I-TREATMENT
nephro-vit	JJ	I-TREATMENT
rx	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	JJ	O
po	NNS	O
daily	RB	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

simvastatin	NN	B-TREATMENT
and	CC	O
niacin	NN	B-TREATMENT
,	,	O
vit.	JJ	B-TREATMENT
b-3	NN	I-TREATMENT

zocor	NN	B-TREATMENT
(	(	I-TREATMENT
simvastatin	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
bedtime	NN	O

override	RB	O
added	VBD	O
on	IN	O
10/30/06	CD	O
by	IN	O
felsapprydefusc	NN	O
,	,	O
eri	JJ	O
n.	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
nephrocaps	NNS	B-TREATMENT
po	NNS	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
581988585	CD	O
)	)	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

simvastatin	NN	B-TREATMENT
and	CC	O
niacin	NN	B-TREATMENT
,	,	O
vit	NN	B-TREATMENT
.	.	I-TREATMENT

b-3	NN	B-TREATMENT

house	NN	O
/	VBD	O
2	CD	O
gm	NN	O
na	NNS	O
/	VBP	O
low	JJ	O
saturated	VBD	O
fat	JJ	O
low	JJ	O
cholesterol	NN	O
/	VBZ	O
2	CD	O
gram	NN	O
k+	NN	O
,	,	O
renal	JJ	B-TREATMENT
diet	JJ	I-TREATMENT
&lt;	NN	O
i	NN	O
&gt;	VBP	O
&lt;	JJ	O
fdi	NN	O
&gt;	NN	O

hemodialysis	NN	B-TREATMENT
mwf	NN	O
,	,	O
dr.	JJ	O
gaetz	JJ	O
220-871-6906	JJ	O
1-2	JJ	O
weeks	NNS	O
,	,	O
dr.	RB	O
clow	JJ	O
836-771-4924	JJ	O
1	CD	O
week	NN	O
,	,	O
cardiology	NN	O
clinic	JJ	O
452-860-1428	JJ	O
,	,	O
please	VB	O
call	NN	O
to	TO	O
make	VB	O
an	DT	O
appointment	NN	O
in	IN	O
1-2	JJ	O
weeks	NNS	O
with	IN	O
a	DT	O
cardiology	NN	O
fellow	NN	O
,	,	O

nka	NN	B-PROBLEM

ihss	NN	B-PROBLEM
af	NN	B-PROBLEM
esrd	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
,	,	O
iga	JJ	B-PROBLEM
nephropathy	NN	I-PROBLEM
on	IN	O
transplant	JJ	O
list	NN	O
,	,	O
copd	NN	B-PROBLEM
,	,	O
s	JJ	O
/	NNP	O
p	NN	O
pacemaker	NN	B-TREATMENT
for	IN	O
afib	NN	B-PROBLEM
,	,	O
bph	NN	B-PROBLEM
s	NN	O
/	NNP	O
p	NN	O
turp	NN	B-TREATMENT
,	,	O
htn	NN	B-PROBLEM
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
gout	NN	B-PROBLEM
,	,	O
h	NN	O
/	NNP	O
o	RB	O
positive	JJ	B-PROBLEM
ppd	NN	I-PROBLEM
mr	NN	B-PROBLEM

hemodialysis	NN	B-TREATMENT
s	NN	O
/	NNP	O
p	VBZ	O
abdominal	JJ	B-TEST
fat	JJ	I-TEST
pad	NN	I-TEST
biopsy	NN	I-TEST
11/2/06	CD	O

62	CD	O
yo	JJ	O
m	NN	O
w	NN	O
/	NNP	O
iga	NN	B-PROBLEM
nephropathy	NN	I-PROBLEM
,	,	O
developmental	JJ	B-PROBLEM
delay	NN	I-PROBLEM
,	,	O
began	VBD	O
hd	JJ	B-TREATMENT
7/31	CD	O
.	.	O

was	VBD	O
seen	VBN	O
in	IN	O
dialysis	NN	O
on	IN	O
day	NN	O
of	IN	O
admission	NN	O
and	CC	O
was	VBD	O
seen	VBN	O
to	TO	O
have	VB	O
&quot;	NNP	B-PROBLEM
raccoon	VB	I-PROBLEM
eyes	NNS	I-PROBLEM
&quot;	NNP	I-PROBLEM
and	CC	O
hd	JJ	O
staff	NN	O
was	VBD	O
worried	VBN	O
about	IN	O
sending	VBG	O
home	NN	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
w	NN	O
/	NNP	O
o	NN	O
bleed	NN	B-PROBLEM
.	.	O

trauma	JJ	B-TEST
series	NN	I-TEST
normal	JJ	O
.	.	O

pt	NN	O
denies	NNS	O
abuse	VBP	O
or	CC	O
loc	VBP	B-PROBLEM
associated	VBN	O
w	JJ	O
/	NNP	O
fall	NN	O
,	,	O
but	CC	O
has	VBZ	O
noticed	VBN	O
several	JJ	O
recent	JJ	O
falls	NNS	O
.	.	O

recent	JJ	B-TEST
neuro	NN	I-TEST
w	NN	I-TEST
/	NNP	I-TEST
u	JJ	I-TEST
including	VBG	O
eeg	NN	B-TEST
,	,	O
carotid	NN	B-TEST
u	JJ	I-TEST
/	NNP	I-TEST
s	NN	I-TEST
,	,	O
head	NN	B-TEST
ct	NN	I-TEST
(	(	O
old	JJ	B-PROBLEM
stroke	NN	I-PROBLEM
)	)	O
,	,	O
dobutamine-mibi	JJ	B-TEST
(	(	O
fixed	VBN	B-PROBLEM
defect	NN	I-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
inferolateral	JJ	I-PROBLEM
reversible	NN	I-PROBLEM
)	)	O
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

esrd	NN	B-PROBLEM
from	IN	O
iga	NN	B-PROBLEM
,	,	O
s	JJ	O
/	NNP	O
p	NN	O
ppi	NN	B-TREATMENT
after	IN	O
nodal	JJ	B-TREATMENT
ablation	NN	I-TREATMENT
,	,	O
htn	NN	B-PROBLEM
,	,	O
copd	NN	B-PROBLEM
,	,	O
hypothyroid	NN	B-PROBLEM
,	,	O
hypertrophic	JJ	B-PROBLEM

t	NN	B-TEST
96.5	CD	O
,	,	O
bp	NN	B-TEST
145/97	CD	O
,	,	O
p	NN	B-TEST
70	CD	O
,	,	O
pox	VBD	B-TEST
98%	CD	O
gen	NN	O
ao	NN	O
x	VBD	O
3	CD	O
,	,	O
raccoon	NN	B-PROBLEM
eyes	NNS	I-PROBLEM
,	,	O
large	JJ	B-PROBLEM
forehead	NN	I-PROBLEM
hematoma	NN	I-PROBLEM

soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM

1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
b	NN	I-PROBLEM
/	NN	I-PROBLEM
l	NN	I-PROBLEM

warm	NN	O
,	,	O
smooth	CC	O
,	,	O
no	DT	O
rashes	NNS	B-PROBLEM

clean	JJ	O
w	NN	O
/	NNP	O
o	VBZ	O
inflammation	NN	B-PROBLEM

k	NN	B-TEST
3.5	CD	O
,	,	O
creat	NN	B-TEST
3.8	CD	O
,	,	O
trop-i	JJ	B-TEST
0.45	CD	O
,	,	O
inr	NN	B-TEST
1.6	CD	O

the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
telemetry	NN	B-TEST
and	CC	O
had	VBD	O
no	DT	O
telemetry	NN	B-PROBLEM
events	NNS	I-PROBLEM
while	IN	O
an	DT	O
inpatient	NN	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
seen	VBN	O
by	IN	O
the	DT	O
electrophysiology	NN	O
service	NN	O
,	,	O
his	PRP$	B-TREATMENT
pacemaker	NN	I-TREATMENT
was	VBD	O
interrogated	VBN	O
and	CC	O
working	VBG	O
fine	NN	O
,	,	O
with	IN	O
no	DT	O
signs	NNS	O
of	IN	O
recent	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
arrhythmia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
his	PRP$	O
undergoing	VBG	O
a	DT	B-TEST
tte	NN	I-TEST
prior	RB	O
to	TO	O
discharge	VB	O
to	TO	O
rule	VB	O
out	RP	O
a	DT	B-PROBLEM
thrombus	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
tte	NN	I-TEST
showed	VBD	O
ef	JJ	B-TEST
45-50%	JJ	O
,	,	O
moderate	JJ	B-PROBLEM
clvh	NN	I-PROBLEM
,	,	O
abnormal	JJ	B-PROBLEM
diastolic	JJ	I-PROBLEM
function	NN	I-PROBLEM
,	,	O
moderate	JJ	B-PROBLEM
mr	NN	I-PROBLEM
,	,	O
moderate	JJ	B-PROBLEM
tr	NN	I-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
lae	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
ionfiltrative	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O
and	CC	O
the	DT	O
patient	JJ	O
underwent	JJ	O
abdominal	JJ	B-TEST
fat	NN	I-TEST
pad	NN	I-TEST
biopsy	NN	I-TEST
to	TO	O
assess	VB	O
for	IN	O
amyloidosis	NN	B-PROBLEM
.	.	O

he	PRP	O
also	RB	O
currently	RB	O
has	VBZ	O
an	DT	B-TEST
spep	NN	I-TEST
/	NN	O
upep/beta	JJ	B-TEST
2	CD	I-TEST
microglobulin	NN	I-TEST
/	NNP	O
ace	NN	B-TEST
test	NN	I-TEST
that	WDT	O
are	VBP	O
currently	RB	O
pending	VBG	O
.	.	O

he	PRP	O
had	VBD	O
carotid	VBN	B-TEST
ultrasound	JJ	I-TEST
studies	NNS	I-TEST
3	CD	O
months	NNS	O
ago	IN	O
that	DT	O
were	VBD	O
normal	JJ	O
without	IN	O
evidence	NN	O
for	IN	O
stenosis	NN	B-PROBLEM
.	.	O

2.	CD	O
renal	JJ	O
-	:	O
cont	NN	O
mwf	NN	O
hd	NN	B-TREATMENT
;	:	O
electrolytes	NNS	B-TEST
have	VBP	O
been	VBN	O
stable	JJ	O
.	.	O

perhaps	RB	O
his	PRP$	O
recent	JJ	O
falls	NNS	O
are	VBP	O
related	VBN	O
to	TO	O
orthostatic	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
after	IN	O
dialysis	NN	B-TREATMENT
.	.	O

3.	CD	O
cv	NN	O
-the	NN	O
pt	NN	O
has	VBZ	O
a	DT	O
small	JJ	O
area	NN	O
of	IN	O
reversible	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
on	IN	O
recent	JJ	B-TEST
mibi	NN	I-TEST
,	,	O
and	CC	O
has	VBZ	O
troponins	NNS	B-PROBLEM
persistently	RB	I-PROBLEM
elevated	VBN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
his	PRP$	B-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
troponins	NNS	I-TEST
remained	VBD	O
lower	JJR	O
than	IN	O
his	PRP$	O
baseline	NN	O
levels	NNS	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
suspicion	NN	O
of	IN	O
acs	NN	B-PROBLEM
causing	VBG	O
syncope	NN	B-PROBLEM
.	.	O

he	PRP	O
continued	VBD	O
on	IN	O
his	PRP$	B-TREATMENT
zocor	NN	I-TREATMENT
,	,	O
cozaar	NN	B-TREATMENT
and	CC	O
labetalol	NN	B-TREATMENT
.	.	O

we	PRP	O
will	MD	O
now	RB	O
hold	VB	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
given	VBN	O
his	PRP$	O
recent	JJ	O
falls	NNS	O
and	CC	O
bleeding	VBG	B-PROBLEM
risk	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
was	VBD	O
restarted	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

4.	CD	O
endo	SYM	O
-	:	O
tsh	NN	B-TEST
was	VBD	O
4.7	CD	O
and	CC	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
macrocytosis	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
b12	NN	I-TEST
level	NN	I-TEST
was	VBD	O
418	CD	O
and	CC	O
normal	JJ	O
.	.	O

he	PRP	O
does	VBZ	O
have	VB	O
a	DT	O
history	NN	O
of	IN	O
b12	JJ	B-PROBLEM
deficiency	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
,	,	O
and	CC	O
evidence	NN	O
for	IN	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
ble	JJ	I-PROBLEM
which	WDT	O
may	MD	O
also	RB	O
be	VB	O
contributing	VBG	O
to	TO	O
his	PRP$	O
recent	JJ	O
falls	NNS	O
.	.	O
?	.	O
etoh	NN	O

watch	NN	O
for	IN	O
etoh	JJ	B-PROBLEM
wd	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
signs	NNS	O
of	IN	O
alcohol	NN	B-PROBLEM
withdrawal	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
serum	NN	I-TEST
toxicology	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

copd	NN	B-PROBLEM
and	CC	O
r	VB	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
off	RB	O
oxygen	NN	B-TREATMENT
and	CC	O
stable	JJ	O
.	.	O

r	NN	B-PROBLEM
complex	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
,	,	O
bladder	NN	B-PROBLEM
diverticula	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
will	MD	O
need	VB	O
a	DT	B-TEST
follow	VB	I-TEST
up	RP	I-TEST
ultrasound	NN	I-TEST
to	TO	O
further	JJ	O
evaluate	VB	O
these	DT	B-PROBLEM
incidental	JJ	I-PROBLEM
findings	NNS	I-PROBLEM
seen	VBN	O
on	IN	O
imaging	VBG	B-TEST
upon	JJ	O
admission	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
urinalysis	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
fecal	JJ	B-PROBLEM
leukocytes	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
c.difficile	JJ	I-TEST
test	NN	I-TEST
is	VBZ	O
negative	JJ	O
on	IN	O
prelim	NN	O
read	NN	O
,	,	O
however	RB	O
very	RB	O
low	JJ	O
suspicion	NN	O
given	VBN	O
no	DT	O
recent	JJ	B-TREATMENT
antibiotic	JJ	I-TREATMENT
use	NN	I-TREATMENT
.	.	O

please	VB	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
if	IN	O
you	PRP	O
have	VBP	O
falls	NNS	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
visual	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
muscle	NN	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

1)	CD	O
hemodialysis	NN	B-TREATMENT

2)	CD	O
please	NN	O
do	VB	O
not	RB	O
take	VB	O
coumadin	NN	B-TREATMENT
.	.	O

3)	CD	O
please	NN	O
follow	VB	O
up	RP	O
with	IN	O
pcp	NN	O
to	TO	O
have	VB	O
ultrasound	NN	B-TEST
of	IN	I-TEST
right	JJ	I-TEST
kidney	NN	I-TEST
and	CC	I-TEST
bladder	NN	I-TEST
to	TO	O
assess	VB	O
right	JJ	B-PROBLEM
kidney	NN	I-PROBLEM
cyst	NN	I-PROBLEM
and	CC	O
bladder	NN	B-PROBLEM
diverticula	NN	I-PROBLEM
seen	VBN	O
incidentally	RB	O

4)	CD	O
please	NN	O
follow	VB	O
up	RP	O
with	IN	O
dr.	NNS	O
clow	VBP	O
to	TO	O
follow	VB	O
up	RP	O
results	NNS	O
of	IN	O
abdominal	JJ	B-TEST
fat	JJ	I-TEST
pad	NN	I-TEST
biopsy	NN	I-TEST
and	CC	O
blood	NN	B-TEST
tests	NNS	I-TEST
to	TO	O
assess	VB	O
for	IN	O
amyloid	NN	B-PROBLEM
.	.	O

readmitted	VBN	O
for	IN	O
hyperbilirubinemia	NN	B-PROBLEM
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#5	NN	O
.	.	O

prenatal	JJ	B-TEST
screens	NNS	I-TEST
were	VBD	O
o+	RB	O
,	,	O
antibody	NN	B-TEST
negative	JJ	O
,	,	O
hepatitis	JJ	B-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rapid	JJ	B-TEST
plasma	NN	I-TEST
reagin	NN	I-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
group	NN	B-TEST
b	VBD	I-TEST
strep	RB	I-TEST
positive	JJ	O
.	.	O

the	DT	O
infant	NN	O
delivered	VBD	O
vaginally	RB	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
9	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
9	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

alleyne	RB	B-TEST
blood	NN	I-TEST
type	NN	I-TEST
is	VBZ	O
o+	JJ	O
/	NNP	O
coombs	NN	B-TEST
negative	NN	O
.	.	O

he	PRP	O
was	VBD	O
readmitted	VBN	O
for	IN	O
phototherapy	NN	B-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
#5	NN	O
for	IN	O
a	DT	B-TEST
bilirubin	NN	I-TEST
of	IN	O
23.3	CD	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
thomas	NN	O
was	VBD	O
well-appearing	JJ	O
though	IN	O
slightly	RB	B-PROBLEM
sleepy	VBN	I-PROBLEM
with	IN	O
jaundice	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
regular	JJ	O
without	IN	O
murmur	NN	B-PROBLEM
,	,	O
and	CC	O
pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
and	CC	O
symmetrical	JJ	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
with	IN	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
weight	NN	I-TEST
was	VBD	O
3.505	CD	O
(	(	O
7	CD	O
pounds	NNS	O
/	JJ	O
12	CD	O
ounces	NNS	O
)	)	O
on	IN	O
readmission	NN	O
.	.	O

his	PRP$	B-TEST
tone	NN	I-TEST
was	VBD	O
normal	JJ	O
with	IN	O
normal	JJ	O
neonatal	JJ	O
reflexes	NNS	O
.	.	O

breath	NN	B-TEST
sounds	NNS	I-TEST
are	VBP	O
clear	JJ	O
and	CC	O
equal	JJ	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
regular	JJ	O
heart	NN	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
and	CC	O
pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
and	CC	O
symmetric	JJ	O
.	.	O

alleyne	JJ	O
birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
3.710	CD	O
kg	NN	O
(	(	O
8	CD	O
pounds	NNS	O
/	JJ	O
3	CD	O
ounces	NNS	O
).	VBP	O

his	PRP$	B-TEST
weight	NN	I-TEST
on	IN	O
this	DT	O
admission	NN	O
was	VBD	O
3.505	CD	O
kg	NN	O
(	(	O
7	CD	O
pounds	NNS	O
/	JJ	O
12	CD	O
ounces	NNS	O
).	VBP	O

his	PRP$	B-TEST
discharge	NN	I-TEST
weight	NN	I-TEST
is	VBZ	O
3585	CD	O
grams	NN	O
(	(	O
7	CD	O
pounds	NNS	O
13	CD	O
ounces	NNS	O
)	)	O
.	.	O

alleyne	RB	O
bilirubin	NN	B-TEST
on	IN	O
2018-05-09	JJ	O
was	VBD	O
10.4	CD	O
;	:	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
.	.	O

at	IN	O
the	DT	O
primary	JJ	O
pediatrician	NN	O
's	POS	O
office	NN	O
on	IN	O
2018-05-12	JJ	O
his	PRP$	B-TEST
bilirubin	NN	I-TEST
had	VBD	O
been	VBN	O
23	CD	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
was	VBD	O
readmitted	VBN	O
to	TO	O
the	DT	O
healthsouth	NN	O
rehab	JJ	O
hospital	NN	O
of	IN	O
western	JJ	O
mass.	NNS	O
and	CC	O
double	JJ	B-TREATMENT
phototherapy	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

his	PRP$	B-TEST
bilirubin	NN	I-TEST
on	IN	O
05-13	NN	O
was	VBD	O
18.4	CD	O
;	:	O
and	CC	O
on	IN	O
05-14	NN	O
it	PRP	O
was	VBD	O
14.7	CD	O
.	.	O

phototherapy	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
2018-05-14	JJ	O
,	,	O
and	CC	O
a	DT	B-TEST
rebound	NN	I-TEST
bilirubin	NN	I-TEST
will	MD	O
be	VB	O
checked	VBN	O
in	IN	O
the	DT	O
pediatrician	NN	O
's	POS	O
office	NN	O
.	.	O

the	DT	B-TEST
hematocrit	NN	I-TEST
on	IN	O
05-12	NN	O
was	VBD	O
48.7	CD	O
with	IN	O
a	DT	B-TEST
reticulocyte	NN	I-TEST
count	NN	I-TEST
of	IN	O
1.9	CD	O
,	,	O
and	CC	O
his	PRP$	B-TEST
blood	NN	I-TEST
type	NN	I-TEST
is	VBZ	O
o+	JJ	O
/	NNP	O
coombs	NN	B-TEST
negative	NN	O
.	.	O

auditory	NN	B-TEST
hearing	VBG	I-TEST
screening	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
,	,	O
and	CC	O
the	DT	O
infant	NN	O
passed	VBD	O
both	DT	O
ears	NNS	O
on	IN	O
his	PRP$	O
previous	JJ	O
admission	NN	O
.	.	O

hearing	VBG	B-TEST
screens	NNS	I-TEST
were	VBD	O
repeated	VBN	O
on	IN	O
2018-05-13	JJ	O
and	CC	O
he	PRP	O
passed	VBD	O
both	DT	O
ears	NNS	O
.	.	O

4.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
positioning	VBG	I-TEST
screen	NN	I-TEST
:	:	O

5.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screens	NNS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
2018-05-09	JJ	O
;	:	O
and	CC	O
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

on	IN	O
his	PRP$	O
previous	JJ	O
admission	NN	O
,	,	O
terrance	NN	O
received	VBD	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
2018-05-09	JJ	O
.	.	O

6.	CD	O
immunization	NN	B-TREATMENT
recommended	VBD	O
:	:	O

influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
(	(	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
child	NN	O
's	POS	O
life	NN	O
)	)	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

2.	CD	O
exaggerated	JJ	B-PROBLEM
physiologic	JJ	I-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
responsive	NN	O
to	TO	O
phototherapy	VB	B-TREATMENT
.	.	O

progressive	JJ	B-PROBLEM
acanthamoeba	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65-year-old	JJ	O
man	NN	O
with	IN	O
refractory	JJ	B-PROBLEM
cll	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
non-myeloblative	JJ	B-TREATMENT
stem	NN	I-TREATMENT
cell	NN	I-TREATMENT
transplant	NN	I-TREATMENT
approximately	RB	O
nine	CD	O
months	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
and	CC	O
status	NN	O
post	NN	O
prolonged	VBD	O
recent	JJ	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
stay	NN	O
for	IN	O
acanthamoeba	JJ	B-PROBLEM
infection	NN	I-PROBLEM
of	IN	I-PROBLEM
skin	NN	I-PROBLEM
and	CC	O
sinuses	NNS	O
,	,	O
complicated	VBN	O
by	IN	O
ars	NNS	B-PROBLEM
due	JJ	O
to	TO	O
medication	NN	B-PROBLEM
toxicity	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
gvhd	NN	B-PROBLEM
and	CC	O
recent	JJ	B-PROBLEM
cmv	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
readmitted	VBN	O
for	IN	O
new	JJ	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
creatinine	NN	I-PROBLEM
,	,	O
hepatomegaly	NN	B-PROBLEM
and	CC	O
fluid	NN	B-PROBLEM
surge	NN	I-PROBLEM
spacing	NN	I-PROBLEM
,	,	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
hyponatremia	NN	B-PROBLEM
.	.	O

patient	NN	O
initially	RB	O
presented	VBN	O
in	IN	O
1991	CD	O
with	IN	O
cervical	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
,	,	O
was	VBD	O
treated	VBN	O
with	IN	O
mace	NN	B-TREATMENT
/	NNP	O
cytabom	NN	B-TREATMENT
,	,	O
and	CC	O
did	VBD	O
well	RB	O
until	IN	O
1997	CD	O
,	,	O
when	WRB	O
he	PRP	O
received	VBD	O
six	CD	O
cycles	NNS	O
of	IN	O
fludarabine	NN	B-TREATMENT
for	IN	O
progressive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

in	IN	O
november	NNP	O
,	,	O
2001	CD	O
,	,	O
he	PRP	O
progressed	VBD	O
to	TO	O
leukemic	JJ	B-PROBLEM
phase	NN	I-PROBLEM
,	,	O
received	VBD	O
rituxan	NN	B-TREATMENT
and	CC	O
cvp	NN	B-TREATMENT
.	.	O

started	VBN	O
campath	NN	B-TREATMENT
in	IN	O
july	NN	O
,	,	O
2001	CD	O
,	,	O
complicated	VBN	O
by	IN	O
lymphopenia	NN	B-PROBLEM
/	NNP	O
neutropenia	NN	B-PROBLEM
and	CC	O
cmv	NN	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
and	CC	O
underwent	JJ	O
mud	NN	B-TREATMENT
stem	NN	I-TREATMENT
cell	NN	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
december	NN	O
,	,	O
2002	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
bone	VBN	B-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
,	,	O
august	RB	O
,	,	O
2003	CD	O
,	,	O
for	IN	O
persistent	JJ	B-PROBLEM
pancytopenia	NN	I-PROBLEM
,	,	O
revealing	VBG	O
mild	JJ	B-PROBLEM
hypercelluarity	NN	I-PROBLEM
with	IN	O
80%	CD	B-PROBLEM
leukemic	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
again	RB	O
treated	VBN	O
with	IN	O
campath	NN	B-TREATMENT
,	,	O
had	VBD	O
recurrent	VBN	B-PROBLEM
fever	RB	I-PROBLEM
in	IN	O
association	NN	O
with	IN	O
sinus	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
with	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
showing	NN	O
left	VBD	B-PROBLEM
maxillary	JJ	I-PROBLEM
sinusitis	NN	I-PROBLEM
in	IN	O
association	NN	O
with	IN	O
new	JJ	B-PROBLEM
skin	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
on	IN	I-PROBLEM
right	JJ	I-PROBLEM
elbow	NN	I-PROBLEM
and	CC	I-PROBLEM
buttocks	NNS	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
hospitalized	VBN	O
september	RB	O
26	CD	O
to	TO	O
november	VB	O
11	CD	O
for	IN	O
what	WP	O
was	VBD	O
diagnosed	VBN	O
by	IN	O
skin	NN	B-TEST
biopsy	NN	I-TEST
and	CC	O
sinus	JJ	B-TEST
washings	NNS	I-TEST
as	IN	O
acanthamoeba	JJ	B-PROBLEM
infection	NN	I-PROBLEM
of	IN	I-PROBLEM
skin	NN	I-PROBLEM
and	CC	O
sinuses	NNS	O
,	,	O
without	IN	O
any	DT	O
progression	NN	O
to	TO	O
neurologic	JJ	B-PROBLEM
infection	NN	I-PROBLEM
(	(	O
as	IN	O
assessed	VBN	O
by	IN	O
head	NN	B-TEST
ct	NN	I-TEST
and	CC	O
mri	NN	B-TEST
)	)	O
.	.	O

id	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
azithromycin	NN	B-TREATMENT
,	,	O
itraconazole	NN	B-TREATMENT
,	,	O
and	CC	O
pentamidine	NN	B-TREATMENT
,	,	O
with	IN	O
progression	NN	O
of	IN	O
skin	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

subsequent	JJ	O
discontinuance	NN	O
of	IN	O
azithromycin	NN	B-TREATMENT
,	,	O
trial	NN	B-TREATMENT
of	IN	I-TREATMENT
5-fc	JJ	I-TREATMENT
,	,	O
with	IN	O
increasing	VBG	B-PROBLEM
neutropenia	JJ	I-PROBLEM
requiring	VBG	O
discontinuance	NN	O
,	,	O
change	NN	O
if	IN	O
itraconazole	JJ	B-TREATMENT
to	TO	O
voriconazole	VB	B-TREATMENT
,	,	O
given	VBN	O
continued	VBD	B-PROBLEM
neutropenia	JJ	I-PROBLEM
,	,	O
and	CC	O
trial	NN	O
of	IN	O
sulfadiazine	NN	B-TREATMENT
,	,	O
discontinued	VBN	O
for	IN	O
increasing	VBG	B-PROBLEM
ars	NNS	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
p.o.	JJ	B-TREATMENT
voriconazole	NN	I-TREATMENT
and	CC	O
iv	JJ	B-TREATMENT
pentamidine	NN	I-TREATMENT
,	,	O
with	IN	O
pentamidine	JJ	B-TREATMENT
nasal	JJ	I-TREATMENT
washings	NNS	I-TREATMENT
,	,	O
with	IN	O
re-ct	NN	B-TEST
of	IN	I-TEST
sinuses	NNS	I-TEST
near	IN	O
end	NN	O
of	IN	O
stay	NN	O
showing	VBG	O
no	DT	O
change	NN	O
in	IN	O
disease	NN	B-PROBLEM
burden	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
recurrent	VBN	B-PROBLEM
cmb	JJ	I-PROBLEM
infection	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
campath	NN	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
requiring	VBG	O
iv	JJ	B-TREATMENT
foscarnet	NN	I-TREATMENT
therapy	NN	I-TREATMENT
during	IN	O
stay	NN	O
,	,	O
with	IN	O
inability	NN	O
to	TO	O
tolerate	VB	O
valganciclovir	JJ	B-TREATMENT
maintenance	NN	I-TREATMENT
suppression	NN	I-TREATMENT
subsequently	RB	O
due	JJ	O
to	TO	O
increasing	VBG	B-PROBLEM
ars	NNS	I-PROBLEM
.	.	O

hypercapture	NN	B-TEST
near	IN	O
end	NN	O
of	IN	O
stay	NN	O
was	VBD	O
negative	JJ	O
.	.	O

patient	NN	O
experienced	VBD	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
on	IN	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
with	IN	O
previous	JJ	B-TEST
baseline	NN	I-TEST
creatinine	NN	I-TEST
1.6	CD	O
,	,	O
felt	VBD	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
medication	NN	B-PROBLEM
toxicity	NN	I-PROBLEM
,	,	O
requiring	VBG	O
kayexalate	NN	B-TREATMENT
and	CC	O
phoslo	NN	B-TREATMENT
to	TO	O
manage	VB	O
electrolytes	NNS	B-TEST
,	,	O
but	CC	O
never	RB	O
any	DT	O
need	NN	O
for	IN	O
hemodialysis	NN	B-TREATMENT
,	,	O
with	IN	O
mild	JJ	O
improvement	NN	O
of	IN	O
creatinine	NN	B-TEST
by	IN	O
discharge	NN	O
,	,	O
with	IN	O
peak	JJ	B-TEST
creatinine	NN	I-TEST
3.4	CD	O
,	,	O
discharge	NN	B-TEST
creatinine	NN	I-TEST
2.6	CD	O
.	.	O

patient	NN	O
struggled	VBD	O
with	IN	O
gvhd	NN	B-PROBLEM
,	,	O
with	IN	O
extensive	JJ	B-PROBLEM
skin	NN	I-PROBLEM
involvement	NN	I-PROBLEM
,	,	O
taking	VBG	O
cellcept	NN	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
and	CC	O
cyclosporine	NN	B-TREATMENT
at	IN	O
time	NN	O
of	IN	O
last	JJ	O
admission	NN	O
.	.	O

cellcept	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
infection	NN	B-PROBLEM
,	,	O
but	CC	O
attempts	NNS	O
to	TO	O
decrease	VB	O
prednisone	NN	B-TREATMENT
or	CC	O
cyclosporine	NN	B-TREATMENT
were	VBD	O
unsuccessful	JJ	O
.	.	O

patient	JJ	O
returns	NNS	O
from	IN	O
rehabilitation	NN	B-TREATMENT
after	IN	O
discharge	NN	O
on	IN	O
november	JJ	O
11	CD	O
,	,	O
with	IN	O
new	JJ	B-PROBLEM
fever	NN	I-PROBLEM
up	RB	O
to	TO	O
102.0	CD	O
in	IN	O
dsci	NN	O
clinic	NN	O
,	,	O
increasing	VBG	B-PROBLEM
hepatomegaly	NN	I-PROBLEM
as	IN	O
assessed	VBN	O
by	IN	O
examination	NN	B-TEST
in	IN	O
clinic	NN	O
,	,	O
and	CC	O
increasing	VBG	B-PROBLEM
creatinine	NN	I-PROBLEM
.	.	O

denies	NNS	O
cough	VBP	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
neck	NN	B-PROBLEM
stiffness	NN	I-PROBLEM
,	,	O
new	JJ	B-PROBLEM
skin	NN	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
red	JJ	I-PROBLEM
petechiae	NN	I-PROBLEM
,	,	O
or	CC	O
increasing	VBG	B-PROBLEM
sinus	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

patient	NN	O
reports	NNS	O
persistent	JJ	B-PROBLEM
mild	RB	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
discomfort	NN	I-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
poor	JJ	I-PROBLEM
appetite	NN	I-PROBLEM
.	.	O

refractory	NN	B-PROBLEM
cll	NN	I-PROBLEM
with	IN	O
bone	NN	B-PROBLEM
marrow	NN	I-PROBLEM
involvement	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
mud	NN	B-TREATMENT
,	,	I-TREATMENT
mini-allo	JJ	I-TREATMENT
stem	NN	I-TREATMENT
cell	NN	I-TREATMENT
transplant	NN	I-TREATMENT
,	,	O
december	NN	O
,	,	O
2002	CD	O
,	,	O
acanthamoeba	JJ	B-PROBLEM
infection	NN	I-PROBLEM
of	IN	I-PROBLEM
skin	NN	I-PROBLEM
and	CC	I-PROBLEM
sinuses	NNS	I-PROBLEM
,	,	O
recently	RB	O
treated	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
pentamidine	NN	I-TREATMENT
and	CC	O
p.o.	JJ	B-TREATMENT
voriconazole	NN	I-TREATMENT
,	,	O
history	NN	O
of	IN	O
recurrent	NN	B-PROBLEM
cmb	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
ars	NNS	I-PROBLEM
on	IN	O
cri	NN	B-PROBLEM
,	,	O
thought	VBD	O
due	JJ	O
to	TO	O
medication	NN	B-PROBLEM
toxicity	NN	I-PROBLEM
(	(	O
creatinine	NN	B-TEST
on	IN	O
discharge	NN	O
from	IN	O
retelk	JJ	O
county	NN	O
medical	JJ	O
center	NN	O
on	IN	O
october	$	O
16	CD	O
was	VBD	O
2.6)	CD	O
.	.	O

no	DT	O
history	NN	O
of	IN	O
hemodialysis	NN	B-TREATMENT
.	.	O

graft	NN	B-PROBLEM
versus	NN	I-PROBLEM
host	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
recently	RB	O
on	IN	O
cyclosporine	NN	B-TREATMENT
50	CD	O
b.i.d.	NN	O
and	CC	O
prednisone	NN	B-TREATMENT
60	CD	O
q.d.	NN	O

history	NN	O
of	IN	O
svt	NN	B-PROBLEM
.	.	O

pentamidine	NN	B-TREATMENT
300	CD	O
mg	NN	O
iv	NN	O
q.	VBD	O
36	CD	O
hours	NNS	O
,	,	O
pentamidine	NN	B-TREATMENT
nasal	NN	I-TREATMENT
wash	VBZ	I-TREATMENT
60	CD	O
mg	NN	O
per	IN	O
6	CD	O
ml	NN	O
of	IN	O
sterile	JJ	B-TREATMENT
water	NN	I-TREATMENT
q.d.	NN	O
,	,	O
voriconazole	JJ	B-TREATMENT
200	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
acyclovir	RB	B-TREATMENT
400	CD	O
mg	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
cyclosporine	VBP	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
prednisone	NN	B-TREATMENT
60	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
gcsf	VBP	B-TREATMENT
480	CD	O
mcg	NN	O
iv	NN	O
q.d.	NN	O
,	,	O
epogen	VBZ	B-TREATMENT
40,000	CD	O
units	NNS	O
subcu	RB	O
q.	JJ	O
week	NN	O
,	,	O
protonix	VBP	B-TREATMENT
40	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
simethicone	NN	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
8	CD	O
,	,	O
nitroglycerin	JJ	B-TREATMENT
paste	NN	I-TREATMENT
1	CD	O
&quot;	NNP	O
q.	VBD	O
4	CD	O
h.	NN	O
p.r.n.	NN	O
,	,	O
flunisolide	RB	B-TREATMENT
nasal	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
,	,	O
2	CD	O
puffs	NNS	O
q.	RB	O
8	CD	O
,	,	O
oxycodone	CD	B-TREATMENT
10-15	JJ	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
6	CD	O
p.r.n.	NN	O
,	,	O
sudafed	VBD	B-TREATMENT
30	CD	O
mg	NN	O
q.	NN	O
6	CD	O
p.o.	NN	O
p.r.n.	NN	O
,	,	O
fluconazole	JJ	B-TREATMENT
2%	CD	I-TREATMENT
cream	NN	I-TREATMENT
b.i.d.	NN	O
to	TO	O
erythematous	JJ	B-PROBLEM
skin	NN	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
ditropan	VBP	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
tylenol	VBZ	B-TREATMENT
650	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
4	CD	O
h.	NN	O
p.r.n.	NN	O
,	,	O
ambien	JJ	B-TREATMENT
5-10	JJ	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
h.s.	NN	O
p.r.n.	NN	O
,	,	O
neurontin	RB	B-TREATMENT
100	CD	O
mg	NNS	O
q.	JJ	O
a.m.	RB	O
,	,	O
200	CD	O
mg	NN	O
q.	CD	O
p.m.	NN	O
,	,	O
aquaphor	NN	B-TREATMENT
cream	NN	I-TREATMENT
b.i.d.	NN	O
p.r.n.	NN	O
,	,	O
lotrimin	VBZ	B-TREATMENT
1%	CD	I-TREATMENT
cream	NN	I-TREATMENT
b.i.d.	NN	O
to	TO	O
feet	NNS	O
,	,	O
dulcolax	JJ	B-TREATMENT
5-10	JJ	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
p.r.n.	NN	O
,	,	O
phoslo	VBP	B-TREATMENT
667	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
,	,	O
peridex	NN	B-TREATMENT
0.12%	CD	O
,	,	O
15	CD	O
ml	NN	O
p.o.	NN	O
b.i.d.	NN	O
mouthwash	NN	O
,	,	O
benadryl	JJ	B-TREATMENT
25-50	JJ	O
mg	NN	O
q.	JJ	O
4-6	JJ	O
h.	NN	O
p.r.n.	NN	O
pruritus	NN	B-PROBLEM
,	,	O
sarna	JJ	B-TREATMENT
cream	NN	I-TREATMENT
q.d.	NN	O
p.r.n.	NN	O
pruritus	NN	B-PROBLEM
,	,	O
nystatin	RB	B-TREATMENT
5	CD	O
ml	NNS	O
p.o.	JJ	O
q.i.d.	JJ	O
swish	NN	O
and	CC	O
!	.	O

spit	NN	O
,	,	O
folate	VBP	O
1	CD	B-TREATMENT
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
vitamin	NN	O
e	VBD	B-TREATMENT
400	CD	I-TREATMENT
units	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
haldol	VBD	O
2	CD	B-TREATMENT
mg	NN	O
iv	NN	O
q.	VBD	O
6	CD	O
p.r.n.	NN	O
agitation	NN	O
,	,	B-PROBLEM
colace	NN	O
100	CD	B-TREATMENT
mg	NN	O
b.i.d.	NN	O
,	,	O
senna	VBD	O
2	CD	B-TREATMENT
tablets	NNS	O
p.o.	VBP	O
b.i.d.	NN	O

bactrim	NN	B-TREATMENT
(	(	O
severe	JJ	B-PROBLEM
rash	NN	I-PROBLEM
)	)	O
,	,	O
ganciclovir	FW	B-TREATMENT
(	(	O
rash	NN	B-PROBLEM
,	,	O
has	VBZ	O
been	VBN	O
desensitized	VBN	O
)	)	O
.	.	O

comfortable	JJ	O
,	,	O
conversational	JJ	O
,	,	O
appears	VBZ	O
same	JJ	O
as	IN	O
week	NN	O
prior	RB	O
,	,	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

pupils	NNS	O
were	VBD	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
anicteric	JJ	B-PROBLEM
.	.	O

regular	JJ	O
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
gallops	NNS	B-PROBLEM
or	CC	O
rubs	NNS	B-PROBLEM
.	.	O

jvp	NN	B-TEST
flat	NN	O
.	.	O

lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

normoactive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
mild	JJ	B-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
,	,	O
not	RB	O
dissimilar	JJ	O
from	IN	O
week	NN	O
prior	RB	O
,	,	O
pronounced	VBD	B-PROBLEM
hepatomegaly	NN	I-PROBLEM
with	IN	O
liver	NN	O
edge	VBP	O
7	CD	O
cm	NN	O
below	IN	O
costal	JJ	O
margin	NN	O
,	,	O
midclavicular	JJ	O
line	NN	O
,	,	O
no	DT	O
splenomegaly	NN	B-PROBLEM
,	,	O
no	DT	O
cva	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

slightly	RB	B-PROBLEM
cool	JJ	I-PROBLEM
,	,	O
3-4+	JJ	B-PROBLEM
edema	NN	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

erythematous	JJ	B-PROBLEM
eruption	NN	I-PROBLEM
on	IN	O
80%	CD	O
of	IN	O
body	NN	O
,	,	O
not	RB	O
much	JJ	O
change	NN	O
from	IN	O
week	NN	O
prior	RB	O
.	.	O

erythematous	JJ	B-PROBLEM
nodules	NNS	I-PROBLEM
on	IN	I-PROBLEM
arms	NNS	I-PROBLEM
at	IN	O
elbows	NNS	O
and	CC	O
on	IN	O
right	JJ	O
thigh	NN	O
,	,	O
as	IN	O
previous	JJ	O
.	.	O

sodium	NN	B-TEST
129	CD	O
,	,	O
creatinine	NN	B-TEST
3.0	CD	O
,	,	O
bun	NN	B-TEST
70	CD	O
,	,	O
potassium	NN	B-TEST
5.0	CD	O
,	,	O
bicarbonate	NN	B-TEST
23	CD	O
,	,	O
chloride	RB	B-TEST
99	CD	O
,	,	O
alt	RB	B-TEST
36	CD	O
,	,	O
ast	RB	B-TEST
30	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
215	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
1.1	CD	O
,	,	O
albumin	RB	B-TEST
2.6	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
2.0	CD	O
,	,	O
hematocrit	NN	B-TEST
30.5	CD	O
,	,	O
platelets	NNS	B-TEST
60	CD	O
.	.	O

patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
diagnosis	NN	O
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
new	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

workup	NN	B-TEST
on	IN	I-TEST
admission	NN	I-TEST
included	VBD	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	JJ	I-TEST
negative	NN	O
for	IN	O
pneumonia	NN	B-PROBLEM
,	,	O
an	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
liver	NN	I-TEST
to	TO	O
investigate	VB	O
for	IN	O
focal	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
with	IN	O
no	DT	O
evidence	NN	O
for	IN	O
abscess	NN	B-PROBLEM
or	CC	O
focal	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
on	IN	O
report	NN	O
.	.	O

blood	NN	B-TEST
and	CC	I-TEST
urine	JJ	I-TEST
cultures	NNS	I-TEST
with	IN	O
only	RB	O
positive	JJ	O
culture	NN	O
a	DT	B-TEST
blood	NN	I-TEST
culture	NN	I-TEST
on	IN	O
november	NN	O
20	CD	O
,	,	O
with	IN	O
one	CD	O
of	IN	O
two	CD	O
bottles	NNS	O
positive	JJ	O
for	IN	O
coagulase	NN	B-PROBLEM
negative	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
cmv	NN	I-TEST
hypercapture	NN	I-TEST
,	,	O
negative	JJ	O
for	IN	O
presence	NN	O
of	IN	O
cmv	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
cat	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
sinuses	NNS	I-TEST
with	IN	O
finding	NN	O
of	IN	O
progressive	JJ	B-PROBLEM
thickening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
maxillary	JJ	I-PROBLEM
sinus	NN	I-PROBLEM
and	CC	O
both	DT	O
sets	NNS	O
of	IN	O
ethmoid	JJ	O
air	NN	O
cells	NNS	O
since	IN	O
prior	JJ	O
study	NN	O
of	IN	O
november	$	O
9	CD	O
,	,	O
indicating	VBG	O
progressive	JJ	B-PROBLEM
infection	NN	I-PROBLEM
of	IN	I-PROBLEM
acanthamoeba	NN	I-PROBLEM
and	CC	O
any	DT	O
possible	JJ	O
superinfection	NN	B-PROBLEM
with	IN	O
bacterial	JJ	B-PROBLEM
sinusitis	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
days	NNS	O
following	VBG	O
admission	NN	O
,	,	O
there	EX	O
was	VBD	O
clear	JJ	O
evidence	NN	O
for	IN	O
progression	NN	O
of	IN	O
erythematous	JJ	B-PROBLEM
nodules	NNS	I-PROBLEM
over	IN	I-PROBLEM
both	DT	I-PROBLEM
arms	NNS	I-PROBLEM
and	CC	O
right	JJ	O
thigh	NN	O
at	IN	O
foci	NN	O
of	IN	O
acanthamoeba	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
suggesting	VBG	O
progressive	JJ	B-PROBLEM
skin	NN	I-PROBLEM
involvement	NN	I-PROBLEM
with	IN	O
acanthamoeba	NN	B-PROBLEM
.	.	O

infectious	JJ	O
disease	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
and	CC	O
recommendation	NN	O
was	VBD	O
to	TO	O
switch	VB	O
from	IN	O
voriconazole	NN	B-TREATMENT
to	TO	O
itraconazole	VB	B-TREATMENT
,	,	O
on	IN	O
which	WDT	O
there	EX	O
was	VBD	O
more	RBR	O
existing	JJ	O
data	NNS	O
on	IN	O
treatment	NN	B-TREATMENT
of	IN	O
acanthamoeba	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

pentamidine	NN	B-TREATMENT
intravenous	JJ	I-TREATMENT
and	CC	I-TREATMENT
nasal	JJ	I-TREATMENT
washings	NNS	I-TREATMENT
were	VBD	O
continued	VBN	O
.	.	O

clinical	JJ	O
progression	NN	O
of	IN	O
skin	NN	B-PROBLEM
and	CC	I-PROBLEM
sinus	JJ	I-PROBLEM
infection	NN	I-PROBLEM
on	IN	O
maximal	JJ	B-TREATMENT
antimicrobial	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
continued	VBD	O
,	,	O
with	IN	O
emergence	NN	O
on	IN	O
november	JJ	O
20	CD	O
of	IN	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
right-sided	JJ	I-PROBLEM
ptosis	NN	I-PROBLEM
in	IN	O
association	NN	O
with	IN	O
a	DT	B-PROBLEM
left	NN	I-PROBLEM
homonymous	JJ	I-PROBLEM
hemianopsia	NN	I-PROBLEM
,	,	O
and	CC	O
fleeting	VBG	B-PROBLEM
confusion	NN	I-PROBLEM
while	IN	O
febrile	NN	B-PROBLEM
,	,	O
prompting	VBG	O
head	NN	B-TEST
mri	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	O
large	JJ	O
5	CD	O
x	JJ	O
2	CD	O
x	JJ	O
4.3	CD	O
cm	JJ	O
region	NN	O
in	IN	O
the	DT	O
right	JJ	O
occipital	JJ	O
lobe	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
and	CC	O
edema	NN	B-PROBLEM
,	,	O
with	IN	O
dural	JJ	B-PROBLEM
and	CC	I-PROBLEM
,	,	I-PROBLEM
likely	RB	I-PROBLEM
,	,	I-PROBLEM
leptomeningeal	JJ	I-PROBLEM
enhancement	NN	I-PROBLEM
in	IN	O
association	NN	O
with	IN	O
small	JJ	B-PROBLEM
foci	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
cerebellum	NN	I-PROBLEM
and	CC	O
pons	NNS	O
,	,	O
concerning	VBG	O
for	IN	O
early	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
of	IN	O
similar	JJ	O
type	NN	O
.	.	O

idiosyncratic	JJ	B-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
cyclosporine	VB	B-TREATMENT
was	VBD	O
considered	VBN	O
as	IN	O
cause	NN	O
for	IN	O
cerebritis	NN	B-PROBLEM
,	,	O
and	CC	O
cyclosporine	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

however	RB	O
,	,	O
much	RB	O
more	RBR	O
likely	JJ	O
explanation	NN	O
is	VBZ	O
progressive	JJ	B-PROBLEM
infection	NN	I-PROBLEM
of	IN	O
acanthamoeba	NN	B-PROBLEM
with	IN	O
new	JJ	B-PROBLEM
neurologic	JJ	I-PROBLEM
involvement	NN	I-PROBLEM
.	.	O

most	RBS	O
likely	JJ	O
source	NN	O
of	IN	O
fevers	NNS	B-PROBLEM
was	VBD	O
judged	VBN	O
to	TO	O
be	VB	O
progressive	JJ	B-PROBLEM
acanthamoeba	JJ	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
even	RB	O
on	IN	O
maximal	JJ	B-TREATMENT
antimicrobial	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

a	DT	B-TEST
single	JJ	I-TEST
blood	NN	I-TEST
culture	NN	I-TEST
positive	JJ	O
for	IN	O
coagulase	NN	B-PROBLEM
negative	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
on	IN	O
november	$	O
20	CD	O
indicating	VBG	O
possible	JJ	O
developing	VBG	B-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
resulted	VBD	O
in	IN	O
a	DT	O
course	NN	O
of	IN	O
levofloxacin	NN	B-TREATMENT
,	,	O
for	IN	O
both	DT	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
treatment	NN	B-TREATMENT
of	IN	O
any	DT	B-PROBLEM
bacterial	JJ	I-PROBLEM
superinfection	NN	I-PROBLEM
of	IN	O
acanthamoeba	JJ	B-PROBLEM
sinusitis	NN	I-PROBLEM
.	.	O

patient	NN	O
experienced	VBD	O
steady	JJ	O
decline	NN	O
,	,	O
with	IN	O
persistent	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
despite	IN	O
all	DT	B-TREATMENT
above	IN	I-TREATMENT
measures	NNS	I-TREATMENT
,	,	O
progressive	JJ	O
areas	NNS	O
of	IN	O
skin	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
more	RBR	O
frequent	JJ	O
episodes	NNS	O
of	IN	O
confusion	NN	B-PROBLEM
,	,	O
and	CC	O
decreasing	VBG	B-PROBLEM
oxygen	NN	I-PROBLEM
saturation	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
fluid	NN	B-PROBLEM
surge	NN	I-PROBLEM
spacing	NN	I-PROBLEM
.	.	O

on	IN	O
november	JJ	O
30	CD	O
,	,	O
a	DT	O
family	NN	O
meeting	NN	O
with	IN	O
patient	NN	O
&apos;s	NN	O
daughter	NN	O
and	CC	O
spouse	NN	O
,	,	O
along	IN	O
with	IN	O
primary	JJ	O
oncologist	NN	O
,	,	O
dr.	NN	O
tomedankell	NN	O
bile	NN	O
,	,	O
attending	VBG	O
physician	NN	O
,	,	O
dr.	NN	O
mellerny	NN	O
close	RB	O
,	,	O
and	CC	O
house	NN	O
staff	NN	O
,	,	O
was	VBD	O
held	VBN	O
to	TO	O
discuss	VB	O
patient	JJ	B-PROBLEM
&apos;s	NNP	I-PROBLEM
critical	JJ	I-PROBLEM
condition	NN	I-PROBLEM
and	CC	O
inability	NN	O
to	TO	O
prevent	VB	O
progression	NN	O
of	IN	O
skin	NN	B-PROBLEM
,	,	I-PROBLEM
sinus	NN	I-PROBLEM
and	CC	I-PROBLEM
neurological	JJ	I-PROBLEM
acanthamoeba	NN	I-PROBLEM
infection	NN	I-PROBLEM
on	IN	O
maximal	JJ	B-TREATMENT
antimicrobial	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
withdraw	VB	O
aggressive	JJ	B-TREATMENT
measures	NNS	I-TREATMENT
of	IN	I-TREATMENT
care	NN	I-TREATMENT
,	,	O
with	IN	O
priority	NN	O
on	IN	O
patient	JJ	O
&apos;s	NN	O
comfort	NN	O
.	.	O

pentamidine	NN	B-TREATMENT
,	,	O
itraconazole	NN	B-TREATMENT
,	,	O
levaquin	NN	B-TREATMENT
,	,	O
acyclovir	NN	B-TREATMENT
and	CC	O
gcsf	NN	B-TREATMENT
were	VBD	O
discontinued	VBN	O
,	,	O
along	IN	O
with	IN	O
other	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
nonessential	JJ	O
to	TO	O
patient	VB	O
&apos;s	JJ	O
comfort	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
made	VBN	O
comfortable	JJ	O
with	IN	O
morphine	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
for	IN	O
air	NN	B-PROBLEM
hunger	NN	I-PROBLEM
,	,	O
and	CC	O
sinus	VBD	B-TREATMENT
suctioning	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
to	TO	O
relieve	VB	O
congestion	NN	B-PROBLEM
,	,	O
in	IN	O
conjunction	NN	O
with	IN	O
continuation	NN	O
of	IN	O
nasal	JJ	B-TREATMENT
sprays	NNS	I-TREATMENT
.	.	O

tylenol	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
to	TO	O
control	VB	O
fevers	NNS	B-PROBLEM
and	CC	O
prednisone	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
to	TO	O
control	VB	O
inflammation	NN	B-PROBLEM
and	CC	O
prevent	JJ	O
precipitation	NN	O
of	IN	O
adrenal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

end	NN	B-PROBLEM
stage	NN	I-PROBLEM
liver	JJ	I-PROBLEM
disease	NN	I-PROBLEM

piggyback	NN	B-TREATMENT
orthotopic	NN	I-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT

liver	NN	B-TEST
biopsy	NN	I-TEST

mr.	NN	O
reese	NN	O
is	VBZ	O
a	DT	O
70	CD	O
-	:	O
year-old	JJ	O
gentleman	NN	O
with	IN	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
liver	JJ	I-PROBLEM
disease	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
alcoholic	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
underwent	JJ	O
radiofrequency	NN	B-TREATMENT
ablation	NN	I-TREATMENT
of	IN	I-TREATMENT
two	CD	I-TREATMENT
small	JJ	I-TREATMENT
liver	NN	I-TREATMENT
nodules	NNS	I-TREATMENT
,	,	O
one	CD	O
in	IN	O
segment	NN	O
vi	NN	O
and	CC	O
the	DT	O
other	JJ	O
in	IN	O
the	DT	O
caudate	NN	O
lobe	NN	O
.	.	O

cytology	NN	B-TEST
on	IN	O
these	DT	B-PROBLEM
nodules	NNS	I-PROBLEM
was	VBD	O
suspicious	JJ	O
for	IN	O
hepatocellular	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
ablation	NN	I-TREATMENT
was	VBD	O
done	VBN	O
on	IN	O
2013-12-04	JJ	O
.	.	O

he	PRP	O
had	VBD	O
decompensation	NN	O
of	IN	O
his	PRP$	B-PROBLEM
cirrhosis	NN	I-PROBLEM
in	IN	O
2011	CD	O
with	IN	O
ascites	NNS	B-PROBLEM
and	CC	O
sbp	NN	B-PROBLEM
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
encephalopathy	CC	B-PROBLEM
during	IN	O
that	DT	O
period	NN	O
.	.	O

the	DT	O
liver	NN	O
was	VBD	O
from	IN	O
a	DT	O
62	CD	O
year-old	JJ	O
gentleman	NN	O
who	WP	O
had	VBD	O
died	VBN	O
from	IN	O
cva	NN	B-PROBLEM
with	IN	O
normal	JJ	O
liver	NN	O
function	NN	O
.	.	O

he	PRP	O
has	VBZ	O
no	DT	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
gi	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
or	CC	O
varices	NNS	B-PROBLEM
by	IN	O
endoscopy	NN	B-TEST
.	.	O

his	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
also	RB	O
remarkable	JJ	O
for	IN	O
non-insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	NNS	I-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
underwent	NN	O
a	DT	B-TREATMENT
cabg	NN	I-TREATMENT
in	IN	O
1998	CD	O
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
gastroesophageal	NN	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
anemia	NN	B-PROBLEM
.	.	O

he	PRP	O
also	RB	O
has	VBZ	O
had	VBD	O
a	DT	B-TREATMENT
prior	JJ	I-TREATMENT
inguinal	JJ	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

on	IN	O
pre-operative	JJ	B-TEST
exam	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
,	,	O
and	CC	O
oriented	VBD	O
x3	NNP	O
.	.	O

he	PRP	O
was	VBD	O
not	RB	O
in	IN	O
any	DT	B-PROBLEM
apparent	JJ	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
with	IN	O
normal	JJ	O
vitals	NNS	O
.	.	O

he	PRP	O
is	VBZ	O
6	CD	O
feet	NNS	O
1	CD	O
inches	NNS	O
tall	JJ	O
and	CC	O
has	VBZ	O
a	DT	B-TEST
pre-op	JJ	I-TEST
weight	NN	I-TEST
of	IN	O
181	CD	O
pounds	NNS	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
pallor	NN	B-PROBLEM
or	CC	O
obvious	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
asterixis	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
palmar	VBN	B-PROBLEM
erythema	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
clubbing	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

his	PRP$	O
chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
ascultation	NN	B-TEST
.	.	O

his	PRP$	B-TEST
heart	NN	I-TEST
sounds	VBZ	I-TEST
were	VBD	O
regular	JJ	O
rate	NN	O
rhythm	NN	O
.	.	O

his	PRP$	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
viscera	NN	B-PROBLEM
was	VBD	O
felt	VBN	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
pedal	JJ	B-PROBLEM
edema	NN	I-PROBLEM
or	CC	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
neurological	JJ	I-TEST
exam	NN	I-TEST
was	VBD	O
intact	JJ	O
.	.	O

2014-12-30	JJ	O
10:34	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
699	CD	O
*	NN	O
ast	NN	B-TEST
-	:	O
1434	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
65	CD	O
amylase	NN	B-TEST
-	:	O
46	CD	O
totbili	SYM	B-TEST
-	:	O
5.9	CD	O
*	NN	O

2015-01-01	JJ	O
11:46	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
1423	CD	O
*	NN	O
ast	IN	B-TEST
-	:	O
1066	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
72	CD	O
totbili	SYM	B-TEST
-	:	O
6.2	CD	O
*	NN	O

2015-01-19	JJ	O
04:47	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
355	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
90	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
352	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
3.2	CD	O
*	NN	O

mr.	NN	O
reese	JJ	O
jones	VBZ	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

within	IN	O
the	DT	O
fist	JJ	O
few	JJ	O
days	NNS	O
after	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
his	PRP$	B-TEST
liver	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
were	VBD	O
elevated	VBN	B-PROBLEM
to	TO	O
as	RB	O
high	JJ	O
as	IN	O
1484	CD	O
for	IN	O
alt	NN	B-TEST
,	,	O
915	CD	O
for	IN	O
ast	NN	B-TEST
,	,	O
and	CC	O
7.6	CD	O
for	IN	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
.	.	O

his	PRP$	B-TEST
alk	NN	I-TEST
phos	NN	I-TEST
were	VBD	O
inititially	RB	O
low	JJ	B-PROBLEM
a	DT	O
few	JJ	O
days	NNS	O
after	IN	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
but	CC	O
it	PRP	O
rised	VBD	O
up	RB	O
to	TO	O
422	CD	O
two	CD	O
weeks	NNS	O
after	IN	O
,	,	O
but	CC	O
down-trended	JJ	O
,	,	O
as	IN	O
with	IN	O
the	DT	O
rest	NN	O
of	IN	O
his	PRP$	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
test	NN	I-TEST
by	IN	O
the	DT	O
time	NN	O
he	PRP	O
left	VBD	O
the	DT	O
hospital	NN	O
.	.	O

several	JJ	O
tests	NNS	O
,	,	O
including	VBG	O
duplex	JJ	B-TEST
ultrasound	NN	I-TEST
,	,	O
ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
,	,	O
and	CC	O
abdominal	JJ	B-TEST
a-gram	NN	I-TEST
all	DT	O
showed	VBD	O
patent	NN	O
right	NN	O
and	CC	O
left	VBD	O
hepatic	JJ	O
arteries	NNS	O
arising	VBG	O
from	IN	O
the	DT	O
celiac	JJ	O
trunk	NN	O
.	.	O

an	DT	B-TEST
ercp	NN	I-TEST
was	VBD	O
also	RB	O
done	VBN	O
,	,	O
showing	VBG	O
a	DT	B-PROBLEM
filling	VBG	I-PROBLEM
defect	NN	I-PROBLEM
from	IN	O
a	DT	B-PROBLEM
narrowed	JJ	I-PROBLEM
donor	NN	I-PROBLEM
duct	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
strictures	NNS	B-PROBLEM
.	.	O

a	DT	B-TREATMENT
sphincterotomy	NN	I-TREATMENT
wss	NN	O
done	VBN	O
to	TO	O
drain	VB	O
the	DT	B-PROBLEM
sludge	NN	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
central	JJ	I-PROBLEM
common	JJ	I-PROBLEM
duct	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
resulting	VBG	O
from	IN	O
the	DT	B-TREATMENT
sphincterotomy	NN	I-TREATMENT
,	,	O
but	CC	O
it	PRP	O
was	VBD	O
controlled	VBN	O
by	IN	O
epinepherine	NN	B-TREATMENT
injections	NNS	I-TREATMENT
.	.	O

initial	JJ	B-TEST
biopsy	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
allograft	NN	I-TEST
three	CD	O
days	NNS	O
after	IN	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
consistent	JJ	O
with	IN	O
preservation	NN	B-PROBLEM
/	NNP	I-PROBLEM
ischemic	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

result	NN	O
of	IN	O
a	DT	B-TEST
second	JJ	I-TEST
biopsy	NN	I-TEST
,	,	O
which	WDT	O
was	VBD	O
done	VBN	O
three	CD	O
weeks	NNS	O
after	IN	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
is	VBZ	O
still	RB	O
pending	VBG	O
.	.	O

during	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
his	PRP$	B-TEST
blood	NN	I-TEST
glucose	NN	I-TEST
were	VBD	O
elevated	VBN	B-PROBLEM
and	CC	O
labile	JJ	B-PROBLEM
ranging	VBG	O
from	IN	O
below	IN	B-PROBLEM
normal	JJ	I-PROBLEM
values	NNS	I-PROBLEM
[	VBP	O
40-60	JJ	O
's]	CD	O
to	TO	O
the	DT	O
200-300	JJ	O
's	POS	O
.	.	O

he	PRP	O
was	VBD	O
completely	RB	O
assymptomatic	JJ	B-PROBLEM
while	IN	O
below	IN	B-PROBLEM
normal	JJ	I-PROBLEM
values	NNS	I-PROBLEM
.	.	O

at	IN	O
one	CD	O
point	NN	O
,	,	O
he	PRP	O
had	VBD	O
to	TO	O
be	VB	O
on	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

however	RB	O
with	IN	O
the	DT	O
help	NN	O
of	IN	O
albano	NN	O
,	,	O
his	PRP$	B-TEST
blood	NN	I-TEST
glucose	NN	I-TEST
began	VBD	O
to	TO	O
normalize	VB	O
.	.	O

also	RB	O
,	,	O
he	PRP	O
has	VBZ	O
been	VBN	O
afebrile	IN	B-PROBLEM
with	IN	O
stable	JJ	O
vitals	NNS	O
,	,	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
,	,	O
producing	VBG	O
good	JJ	O
urine	NN	O
and	CC	O
adequate	JJ	O
stool	NN	O
.	.	O

furthermore	RB	O
,	,	O
he	PRP	O
has	VBZ	O
had	VBN	O
no	DT	O
complaints	NNS	B-PROBLEM
,	,	O
including	VBG	O
pain	NN	B-PROBLEM
,	,	O
while	IN	O
his	PRP$	B-TEST
lab	NN	I-TEST
values	NNS	I-TEST
are	VBP	O
normalizing	VBG	O
.	.	O

he	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
to	TO	O
home	NN	O
,	,	O
in	IN	O
good	JJ	O
condition	NN	O
,	,	O
with	IN	O
very	RB	O
specific	JJ	O
intructions	NNS	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
albano	NN	O
for	IN	O
his	PRP$	B-TREATMENT
diabetic	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
the	DT	O
transplant	NN	O
clinic	NN	O
for	IN	O
his	PRP$	B-TREATMENT
transplant	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

1.	CD	O
trimethoprim	JJ	B-TREATMENT
-	:	I-TREATMENT
sulfamethoxazole	JJ	I-TREATMENT
80-400	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

3.	CD	O
mycophenolate	NN	B-TREATMENT
mofetil	NN	I-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

5.	CD	O
valganciclovir	JJ	B-TREATMENT
450	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
ursodiol	JJ	B-TREATMENT
300	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

9.	CD	O
fluconazole	JJ	B-TREATMENT
200	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

10.	CD	O
insulin	NN	B-TREATMENT
ss	NN	I-TREATMENT
and	CC	O
fixed	VBN	B-TREATMENT
dose	NN	I-TREATMENT

fingerstick	JJ	B-TEST
qachs	NN	O
,	,	O
3	CD	O
am	VBP	O
insulin	JJ	B-TREATMENT
sc	NN	I-TREATMENT
fixed	VBN	I-TREATMENT
dose	JJ	I-TREATMENT
orders	NNS	O

insulin	NN	B-TREATMENT
sc	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

11.	CD	O
tacrolimus	JJ	B-TREATMENT
0.5	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
capsule	NN	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

12.	CD	O
insulin	NN	B-TREATMENT
nph	JJ	I-TREATMENT
human	JJ	I-TREATMENT
recomb	NN	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
cartridge	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
subcutaneous	NN	O
at	IN	O
breakfast	NN	O
:	:	O
please	NN	O
take	VB	O
as	IN	O
prescribed	VBN	O
by	IN	O
albano	NN	O
/	NNP	O
transplant	NN	O
team	NN	O
.	.	O

13.	CD	O
insulin	NN	B-TREATMENT
regular	JJ	I-TREATMENT
human	JJ	I-TREATMENT
300	CD	O
unit	NN	O
/	VBD	O
3	CD	O
ml	JJ	O
insulin	NN	O
pen	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
subcutaneous	JJ	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
please	VB	O
take	VB	O
as	IN	O
prescribed	VBN	O
by	IN	O
albano	NN	O
/	NNP	O
transplant	NN	O
team	NN	O
.	.	O

14.	CD	O
insulin	NN	B-TREATMENT
syringe	NN	I-TREATMENT
needless	NN	I-TREATMENT
(	(	O
disp	NN	O
)	)	O
1	CD	O
ml	JJ	O
syringe	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
miscell.	NN	O
as	IN	O
directed	VBN	O
by	IN	O
albano	NN	O
/	NNP	O
trasplant	NN	O
.	.	O

end	NN	B-PROBLEM
stage	NN	I-PROBLEM
liver	JJ	I-PROBLEM
disease	NN	I-PROBLEM

please	VB	O
take	VB	O
medications	NNS	B-TREATMENT
as	IN	O
prescribed	JJ	O
and	CC	O
read	JJ	O
warning	NN	O
labels	NNS	O
carefully	RB	O
.	.	O

if	IN	O
symptoms	NNS	O
such	JJ	O
as	IN	O
fever	NN	B-PROBLEM
/	NNP	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
/	NNP	O
vomiting	NN	B-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
pain	NN	I-PROBLEM
/	NNP	O
redness	NN	B-PROBLEM
/	NNP	O
purulent	NN	B-PROBLEM
discharge	NN	I-PROBLEM
from	IN	O
incision	NN	B-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
jaundice	NN	I-PROBLEM
,	,	O
please	VB	O
call	NN	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
immediately	RB	O
.	.	O

pat	NN	O
incision	NN	B-PROBLEM
wounds	VBZ	I-PROBLEM
dry	JJ	O
,	,	O
do	VBP	O
not	RB	O
scrub	VB	O
wound	NN	B-PROBLEM
when	WRB	O
showering	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
weak	JJ	B-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
sapsclyss	JJ	O
,	,	O
leo	JJ	O
r	NN	O
and	CC	O
the	DT	O
preliminary	JJ	O
diagnosis	NN	O
is	VBZ	O
weakness	NN	B-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

fever	NN	B-PROBLEM
,	,	O
tachycardia	NN	B-PROBLEM

patient	NN	O
is	VBZ	O
a	DT	O
58	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
recent	JJ	O
admission	NN	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
s/p	JJ	O
negative	JJ	O
exploratory	NN	O
laparotomy	NN	O
for	IN	O
suspected	JJ	O
intussuception	NN	B-PROBLEM
now	RB	O
returns	VBZ	O
on	IN	O
day	NN	O
of	IN	O
discharge	NN	O
with	IN	O
fever	NN	B-PROBLEM
and	CC	O
tachycardia	NN	B-PROBLEM
.	.	O

patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
for	IN	O
terrible	JJ	B-PROBLEM
vasculopathy	JJ	I-PROBLEM
s/p	NN	O
recent	JJ	B-TREATMENT
right	JJ	I-TREATMENT
bka	NN	I-TREATMENT
with	IN	O
dry	JJ	B-PROBLEM
gangrene	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
stump	NN	I-PROBLEM
.	.	O

post-operatively	RB	O
,	,	O
his	PRP$	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
necessitating	VBG	O
an	DT	O
urgent	JJ	O
return	NN	O
to	TO	O
the	DT	O
icu	NN	O
and	CC	O
was	VBD	O
intubated	VBN	O
.	.	O

after	IN	O
multuple	NN	O
failed	VBD	O
attempts	NNS	O
at	IN	O
extubation	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
trached	VBN	O
.	.	O

patient	NN	O
then	RB	O
did	VBD	O
well	RB	O
on	IN	O
a	DT	B-TREATMENT
trach	NN	I-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
rehab	VB	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
but	CC	O
now	RB	O
returns	VBZ	O
with	IN	O
tachycardia	NN	B-PROBLEM
to	TO	O
the	DT	O
120	CD	O
's	POS	O
,	,	O
and	CC	O
fever	RB	B-PROBLEM
to	TO	O
102	CD	O
degrees	NNS	O
f	RB	O
.	.	O

pvd	NN	B-PROBLEM
s/p	NN	O
multiple	NN	B-PROBLEM
failed	VBD	I-PROBLEM
femoral	JJ	I-PROBLEM
distal	JJ	I-PROBLEM
bypass	NN	I-PROBLEM

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM

cad	NN	B-PROBLEM
s/p	NN	O
cabg	NN	B-TREATMENT
2003	CD	O
s/p	NN	O

ex	JJ	B-TEST
lap	CD	I-TEST
05-23	JJ	O

t	RB	B-TEST
101	CD	O
hr	NN	B-TEST
120	CD	O
bp	NN	B-TEST
144/90	CD	O
rr	NN	B-TEST
18	CD	O
spo2	NN	B-TEST
99%	CD	O
on	IN	O
70%	CD	O
tm	NN	B-TREATMENT

moderately	RB	B-PROBLEM
distressed	JJ	I-PROBLEM

coarse	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
b/l	VBP	I-PROBLEM

tachycardic	NN	B-PROBLEM
,	,	O
nl	JJ	O
s1	NN	O
and	CC	O
s2	NN	O

abd	NN	O
soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM

right	JJ	B-PROBLEM
aka	NN	I-PROBLEM
stump	NN	I-PROBLEM
with	IN	O
dry	JJ	B-PROBLEM
gangrene	NN	I-PROBLEM

mri	JJ	B-TEST
head	NN	I-TEST
:	:	O

the	DT	O
diffusion	NN	O
images	NNS	O
demonstrate	VBP	O
no	DT	O
evidence	NN	O
of	IN	O
slow	JJ	B-PROBLEM
diffusion	NN	I-PROBLEM
to	TO	O
indicate	VB	O
acute	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
prominence	NN	I-PROBLEM
of	IN	I-PROBLEM
ventricles	NNS	I-PROBLEM
and	CC	I-PROBLEM
sulci	NN	I-PROBLEM
,	,	O
inappropriate	NN	O
for	IN	O
the	DT	O
patient	NN	O
's	POS	O
age	NN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
midline	NN	B-PROBLEM
shift	NN	I-PROBLEM
,	,	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
,	,	O
hydrocephalus	NN	B-PROBLEM
,	,	O
or	CC	O
territorial	JJ	B-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

following	VBG	O
gadolinium	NN	B-TEST
,	,	O
no	DT	O
evidence	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
parenchymal	NN	I-PROBLEM
,	,	I-PROBLEM
vascular	JJ	I-PROBLEM
,	,	I-PROBLEM
or	CC	I-PROBLEM
meningeal	VB	I-PROBLEM
enhancement	JJ	I-PROBLEM
seen	VBN	O
.	.	O

gastric	JJ	B-TEST
biopsy	NN	I-TEST
:	:	O
negative	JJ	O
for	IN	O
h.	JJ	B-PROBLEM
pylori	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
on	IN	O
admission	NN	O
showed	VBD	O
effusions	NNS	B-PROBLEM
consistent	JJ	O
with	IN	O
chf	NN	B-PROBLEM
along	IN	O
with	IN	O
overlying	VBG	B-PROBLEM
pnumonia	NN	I-PROBLEM
.	.	O

urine	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
significant	JJ	O
for	IN	O
klebsiella	NN	B-PROBLEM
uti	NN	I-PROBLEM
and	CC	O
sputum	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
significant	JJ	O
for	IN	O
mrsa	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
levofloxacin	NN	B-TREATMENT
and	CC	O
fluconazole	NN	B-TREATMENT
.	.	O

he	PRP	O
underwent	JJ	O
picc	JJ	B-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT
on	IN	O
06-18	NN	O
.	.	O

a	DT	B-TREATMENT
trach	NN	I-TREATMENT
collar	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
on	IN	O
06-19	NN	O
.	.	O

gi	NN	O
was	VBD	O
consulted	VBN	O
for	IN	O
colonoscopy	NN	B-TEST
.	.	O

he	PRP	O
tolerated	VBD	O
his	PRP$	B-TREATMENT
trach	NN	I-TREATMENT
collar	NN	I-TREATMENT
,	,	O
and	CC	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
at	IN	O
goal	NN	O
.	.	O

the	DT	B-TREATMENT
fluconazole	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-PROBLEM
failed	JJ	I-PROBLEM
bedside	NN	I-PROBLEM
swallow	NN	I-PROBLEM
study	NN	I-PROBLEM
.	.	O

based	VBN	O
on	IN	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
that	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
hydro-pneumothorax	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	O
the	DT	O
lung	NN	O
,	,	O
a	DT	O
thoracic	NN	O
surgery	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
though	IN	O
no	DT	O
specific	JJ	B-TREATMENT
interventions	NNS	I-TREATMENT
were	VBD	O
warranted	VBN	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

on	IN	O
06-23	CD	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
tube	NN	I-TREATMENT
feed	NN	I-TREATMENT
were	VBD	O
changed	VBN	O
from	IN	O
respalor	NN	B-TREATMENT
to	TO	O
deliver	VB	B-TREATMENT
2.0	CD	I-TREATMENT
to	TO	O
give	VB	O
increased	JJ	O
calories	NNS	O
.	.	O

on	IN	O
06-25	NN	O
,	,	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
grew	VBD	O
out	RP	O
vre	NN	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-TEST
c	NN	I-TEST
diff	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

he	PRP	O
experienced	VBD	O
low	JJ	B-PROBLEM
grade	NN	I-PROBLEM
fevers	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
pan-cultured	JJ	O
on	IN	O
06-26	NN	O
for	IN	O
continued	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
.	.	O

on	IN	O
06-27	NN	O
,	,	O
his	PRP$	B-TREATMENT
nutrition	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
was	VBD	O
changed	VBN	O
to	TO	O
deliver	VB	B-TREATMENT
2.0	CD	I-TREATMENT
at	IN	O
70	CD	O
cc	NN	O
/	NNP	O
hr	NN	O
with	IN	O
15	CD	O
g	NNS	O
promod	NN	B-TREATMENT
.	.	O

on	IN	O
06-28	NN	O
,	,	O
the	DT	O
patient	NN	O
experienced	VBD	O
pvc	NN	B-PROBLEM
's	POS	I-PROBLEM
.	.	O

an	DT	B-TEST
ekg	NN	I-TEST
showed	VBD	O
st	JJ	B-PROBLEM
segment	NN	I-PROBLEM
depression	NN	I-PROBLEM
along	IN	O
the	DT	O
lateral	JJ	O
pre-cordial	JJ	O
leads	NNS	O
.	.	O

serial	JJ	B-TEST
enzymes	NNS	I-TEST
showed	VBD	O
mild	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
of	IN	O
troponins	NNS	B-TEST
.	.	O

the	DT	O
cardiology	NN	O
service	NN	O
simply	RB	O
recommended	VBD	O
increasing	VBG	O
the	DT	B-TREATMENT
beta-blockade	NN	I-TREATMENT
and	CC	O
maximizing	VBG	O
the	DT	O
patient	NN	O
's	POS	O
electrolyte	NN	O
status	NN	O
.	.	O

pt	NN	B-TREATMENT
's	POS	I-TREATMENT
vancomycin	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
after	IN	O
14	CD	O
days	NNS	O
of	IN	O
treatment	NN	B-TREATMENT
.	.	O

hiv	JJ	B-TEST
test	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

mri	NNS	B-TEST
head	NN	I-TEST
was	VBD	O
obtained	VBN	O
to	TO	O
further	RBR	O
w/u	VB	O
patient	NN	B-PROBLEM
's	POS	I-PROBLEM
apparent	JJ	I-PROBLEM
cognitive	JJ	I-PROBLEM
decline	NN	I-PROBLEM
.	.	O

mri	NN	B-TEST
showed	VBD	O
prominent	JJ	B-PROBLEM
sulci	NN	I-PROBLEM
and	CC	O
enlarged	VBD	B-PROBLEM
ventricles	NNS	I-PROBLEM
abnormal	JJ	O
for	IN	O
the	DT	O
patient	NN	O
's	POS	O
age	NN	O
.	.	O

due	JJ	O
to	TO	O
concerns	NNS	O
for	IN	O
dementia	NN	B-PROBLEM
,	,	O
neurology	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
.	.	O

neurology	NN	O
felt	VBD	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
cognitive	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
were	VBD	O
consistent	JJ	O
w/	JJ	O
metabolic	NN	B-PROBLEM
encephalopathy	NN	I-PROBLEM
due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
multiple	JJ	I-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

underlying	VBG	B-PROBLEM
dementia	NN	I-PROBLEM
was	VBD	O
possible	JJ	O
but	CC	O
difficult	JJ	O
to	TO	O
assess	VB	O
with	IN	O
an	DT	B-PROBLEM
overlying	VBG	I-PROBLEM
delerium	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
pull	VB	O
out	RP	O
his	PRP$	B-TREATMENT
doboff	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

pt	NN	O
had	VBD	O
egd	VBN	B-TEST
performed	VBN	O
to	TO	O
evaluate	VB	O
his	PRP$	B-PROBLEM
poor	JJ	I-PROBLEM
nutritional	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
high	JJ	B-TREATMENT
dose	NN	I-TREATMENT
ppi	NN	I-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

the	DT	B-TEST
gastric	JJ	I-TEST
biopsy	NN	I-TEST
and	CC	O
the	DT	B-TEST
serology	NN	I-TEST
were	VBD	O
both	DT	O
negative	JJ	O
for	IN	O
h.	JJ	B-PROBLEM
pylori	NN	I-PROBLEM
.	.	O

peg	JJ	B-TREATMENT
placement	NN	I-TREATMENT
was	VBD	O
unsuccessful	JJ	O
by	IN	O
gi	NNS	O
due	JJ	O
to	TO	O
the	DT	O
patient	NN	O
's	POS	O
anantomy	NN	O
.	.	O

07-05	CD	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
j	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBN	O
in	IN	O
interventional	JJ	O
radiology	NN	O
for	IN	O
nutritional	JJ	B-TREATMENT
support	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
re-started	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

07-06	JJ	O
patient	NN	O
failed	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
swallow	JJ	I-TEST
evaluation	NN	I-TEST
due	JJ	O
to	TO	O
discoordinated	VBN	B-PROBLEM
swallow	NN	I-PROBLEM
.	.	O

07-07	CD	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
for	IN	O
colonoscopy	NN	B-TEST
and	CC	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
normal	JJ	O
colon	NN	O
to	TO	O
cecum	VB	O
.	.	O

07-12	CD	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
c	JJ	B-PROBLEM
diff	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
14	CD	O
day	NN	O
course	NN	O
of	IN	O
flagyl	NN	B-TREATMENT
.	.	O

on	IN	O
07-18	NN	O
,	,	O
as	IN	O
his	PRP$	O
mental	JJ	O
status	NN	O
improved	VBD	O
,	,	O
he	PRP	O
did	VBD	O
well	RB	O
at	IN	O
the	DT	B-TEST
bed	JJ	I-TEST
side	NN	I-TEST
swall	NN	I-TEST
evaluation	NN	I-TEST
.	.	O

on	IN	O
07-19	NN	O
,	,	O
he	PRP	O
underwent	VBD	O
video	RB	B-TEST
swallow	JJ	I-TEST
evaluation	NN	I-TEST
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
tolerate	VB	O
ground	NN	B-TREATMENT
consistent	JJ	I-TREATMENT
food	NN	I-TREATMENT
and	CC	O
thin	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
meds	NNS	I-TREATMENT
should	MD	O
be	VB	O
crushed	VBN	O
and	CC	O
mixed	JJ	O
with	IN	O
puree	JJ	B-TREATMENT
thick	NN	I-TREATMENT
liquid	NN	I-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
gained	VBN	O
30	CD	B-PROBLEM
lb	JJ	I-PROBLEM
since	IN	O
the	DT	B-TREATMENT
tubefeed	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
(	(	O
70	CD	O
lb	NN	O
to	TO	O
100	CD	O
lb	NN	O
)	)	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

he	PRP	O
will	MD	O
still	RB	O
need	VB	O
to	TO	O
be	VB	O
on	IN	O
tubefeed	NN	B-TREATMENT
to	TO	O
support	VB	O
his	PRP$	O
nutrition	NN	O
until	IN	O
he	PRP	O
is	VBZ	O
cleared	VBN	O
by	IN	O
a	DT	O
nutritionist	NN	O
.	.	O

he	PRP	O
did	VBD	O
much	RB	O
better	RBR	O
with	IN	O
pt	NN	B-TREATMENT
and	CC	O
ot	NN	B-TREATMENT
at	IN	O
the	DT	O
end	NN	O
after	IN	O
his	PRP$	O
mental	JJ	O
status	NN	O
improved	VBN	O
.	.	O

as	IN	O
noted	VBN	O
above	IN	O
,	,	O
his	PRP$	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
change	NN	I-PROBLEM
was	VBD	O
likely	JJ	O
toxic-metabolic	JJ	B-PROBLEM
from	IN	O
acute	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
started	VBD	O
to	TO	O
develop	VB	O
more	JJR	B-PROBLEM
pain	NN	I-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
stump	NN	I-PROBLEM
since	IN	O
07-17	NN	O
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
vascular	JJ	O
surgery	NN	O
who	WP	O
felt	VBD	O
that	IN	O
he	PRP	O
is	VBZ	O
too	RB	O
medically	RB	B-PROBLEM
sick	JJ	I-PROBLEM
and	CC	O
malnourished	VBN	B-PROBLEM
to	TO	O
have	VB	O
surgery	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

initially	RB	O
,	,	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
titrating	VBG	O
up	RP	O
the	DT	B-TREATMENT
oxycontin	NN	I-TREATMENT
.	.	O

he	PRP	O
then	RB	O
developed	VBD	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
requiring	VBG	O
foley	JJ	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

after	IN	O
he	PRP	O
passed	VBD	O
the	DT	B-TEST
video	NN	I-TEST
swallowing	NN	I-TEST
,	,	O
he	PRP	O
was	VBD	O
tolerating	VBG	O
ground	NN	B-TREATMENT
consistent	JJ	I-TREATMENT
solids	NNS	I-TREATMENT
.	.	O

on	IN	O
07-24	NN	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	B-PROBLEM
emesis	NN	I-PROBLEM
x	NN	O
1	CD	O
,	,	O
and	CC	O
had	VBD	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
(	(	O
+	JJ	O
interstital	JJ	B-PROBLEM
markings	NNS	I-PROBLEM
on	IN	O
the	DT	O
left	NN	O
on	IN	O
cxr	NN	B-TEST
,	,	O
fever	NN	B-PROBLEM
,	,	O
leukocytosis	NN	B-PROBLEM
)	)	O
.	.	O

his	PRP$	B-TREATMENT
flagyl	JJ	I-TREATMENT
course	NN	I-TREATMENT
was	VBD	O
extended	VBN	O
,	,	O
and	CC	O
vanc	NN	B-TREATMENT
/	NN	O
levo	NN	B-TREATMENT
were	VBD	O
added	VBN	O
.	.	O

his	PRP$	B-TEST
sputum	NN	I-TEST
showed	VBD	O
many	JJ	B-PROBLEM
gpc	NN	I-PROBLEM
which	WDT	O
later	RB	O
grew	VBD	O
staph	JJ	B-PROBLEM
aureus	NN	I-PROBLEM
.	.	O

given	VBN	O
his	PRP$	B-PROBLEM
recent	JJ	I-PROBLEM
mrsa	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
he	PRP	O
will	MD	O
be	VB	O
treated	VBN	O
with	IN	O
2	CD	O
week	NN	O
course	NN	O
of	IN	O
vanc	NN	B-TREATMENT
/	NNP	O
levo	VBZ	B-TREATMENT
/	NNP	O
flagyl	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
pain	NN	O
service	NN	O
who	WP	O
recommended	VBD	O
to	TO	O
discontinue	VB	O
oxycontin	NN	B-TREATMENT
,	,	O
and	CC	O
start	VB	O
neurontin	NN	B-TREATMENT
,	,	O
msir	NN	B-TREATMENT
,	,	O
and	CC	O
lidocaine	JJ	B-TREATMENT
patch	NN	I-TREATMENT
in	IN	O
addition	NN	O
to	TO	O
the	DT	B-TREATMENT
standing	VBG	I-TREATMENT
tylenol	NN	I-TREATMENT
.	.	O

on	IN	O
07-25	NN	O
,	,	O
his	PRP$	B-TREATMENT
j-tube	NN	I-TREATMENT
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
obstructed	VBN	B-PROBLEM
but	CC	O
was	VBD	O
able	JJ	O
to	TO	O
be	VB	O
flushed	VBN	O
by	IN	O
ir	NN	O
on	IN	O
07-26	NN	O
.	.	O

tubefeed	NN	B-TREATMENT
was	VBD	O
resumed	VBN	O
without	IN	O
any	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
since	IN	O
.	.	O

since	IN	O
oxycontin	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
,	,	O
the	DT	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
07-27	NN	O
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
void	VB	O
without	IN	O
any	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
.	.	O

lopressor	NN	B-TREATMENT
50	CD	O
mg	NN	O
bid	NN	O

percocet	NN	B-TREATMENT

nebulizer	NN	B-TREATMENT

lipitor	NN	B-TREATMENT

klonopin	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
tid	NN	O

riss	NN	B-TREATMENT

heparin	NN	B-TREATMENT
sc	NN	I-TREATMENT

lasix	RB	B-TREATMENT
40	CD	O
mg	NNS	O
tid	NN	O

prevacid	NN	B-TREATMENT

milk	NN	B-TREATMENT
of	IN	I-TREATMENT
mag	NN	I-TREATMENT

multivitamin	NN	B-TREATMENT

papain	NN	B-TREATMENT

zinc	NN	B-TREATMENT

1.	CD	O
albuterol	SYM	B-TREATMENT
-	:	O
ipratropium	NN	B-TREATMENT
103-18	JJ	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
02-19	JJ	O
puffs	NNS	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
multivitamins	NNS	B-TREATMENT
tablet	NN	I-TREATMENT
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

3.	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
.	.	O

5.	CD	O
heparin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
atorvastatin	JJ	B-TREATMENT
calcium	NN	I-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

7.	CD	O
papain	NN	B-TREATMENT
-	:	I-TREATMENT
urea	JJ	I-TREATMENT
830,000-10	JJ	O
unit	NN	O
-%	NNP	O
spray	NN	O
,	,	O
non-aerosol	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
appl	RB	O
topical	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

8.	CD	O
insulin	NN	B-TREATMENT
regular	JJ	I-TREATMENT
human	JJ	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
injection	NN	I-TREATMENT
asdir	NN	O
(	(	O
as	IN	O
directed	VBN	O
)	)	O
:	:	O
see	VB	O
the	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

9.	CD	O
zinc	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
220	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

10.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

11.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

12.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

13.	CD	O
clopidogrel	NN	B-TREATMENT
bisulfate	NN	I-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

14.	CD	O
metronidazole	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
6	CD	O
days	NNS	O
:	:	O
last	JJ	O
day	NN	O
2017-07-25	JJ	O
.	.	O

15.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
.	.	O

16.	CD	O
olanzapine	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
confusion	NN	B-PROBLEM
.	.	O

17.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

18.	CD	O
morphine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
15	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

19.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
:	:	O
last	JJ	O
day	NN	O
08-07	NNP	O
.	.	O

20.	CD	O
vancomycin	JJ	B-TREATMENT
hcl	NN	I-TREATMENT
in	IN	O
dextrose	JJ	B-TREATMENT
1	CD	O
g	NN	O
/	VBD	O
200	CD	O
ml	NN	O
piggyback	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
intravenous	JJ	O
q	$	O
12h	CD	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
:	:	O
last	JJ	O
day	NN	O
08-07	NNP	O
.	.	O

21.	CD	O
gabapentin	NN	B-TREATMENT
300	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

22.	CD	O
lidocaine	JJ	B-TREATMENT
5	CD	O
%(	JJ	O
700	CD	O
mg	NN	O
/	NNP	O
patch	NN	O
)	)	O
adhesive	JJ	O
patch	NN	O
,	,	O
medicated	VBN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
adhesive	JJ	O
patch	NN	O
,	,	O
medicated	VBD	O
topical	JJ	O
qd	NN	O
(	(	O
)	)	O
.	.	O

23.	CD	O
morphine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
2	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
02-19	JJ	O
injection	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

24.	CD	O
prochlorperazine	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

1)	CD	O
gangrenous	JJ	B-PROBLEM
leg	NN	I-PROBLEM

2)	CD	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM

3)	CD	O
mrsa	NNS	B-PROBLEM
pneumonia	NN	I-PROBLEM

4)	CD	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
thrive	VB	I-PROBLEM
and	CC	O
weight	VB	B-PROBLEM
loss	NN	I-PROBLEM

5)	CD	O
altered	VBD	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

6)	CD	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM

7)	CD	O
c.diff	NN	B-PROBLEM
colitis	NN	I-PROBLEM

1)	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

2)	CD	O
anemia	NN	B-PROBLEM

3)	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM

4)	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM

5)	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM

6)	CD	O
hypertension	NN	B-PROBLEM

hemodynamically	RB	O
stable	JJ	O
,	,	O
pt	VB	O
doing	VBG	O
much	JJ	O
better	RBR	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
passed	VBD	O
video	NN	B-TEST
swallow	JJ	I-TEST
evaluation	NN	I-TEST
tolerating	VBG	O
po	NN	O
.	.	O

patient	NN	O
needs	VBZ	O
to	TO	O
take	VB	O
all	DT	O
of	IN	O
the	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
directed	VBN	O
.	.	O

patient	NN	O
needs	VBZ	O
to	TO	O
continue	VB	O
the	DT	B-TREATMENT
tube	NN	I-TREATMENT
feed	NN	I-TREATMENT
nutrition	NN	I-TREATMENT
until	IN	O
re-assessed	JJ	O
by	IN	O
the	DT	O
nutrionist	NN	O
.	.	O

he	PRP	O
needs	VBZ	O
to	TO	O
seek	VB	O
medical	JJ	O
attention	NN	O
if	IN	O
he	PRP	O
develops	VBZ	O
fever	RB	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
worsening	VBG	B-PROBLEM
wound	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM

no	DT	O
cpr	NN	B-TREATMENT
/	VBZ	O
no	DT	O
defib	NN	B-TREATMENT
/	VBZ	O
no	DT	O
intubation	NN	B-TREATMENT
/	VBZ	O
no	DT	O
pressors	NNS	B-TREATMENT

albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
2	CD	O
puff	NN	O
inh	NN	O
qid	NN	O
prn	NN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
wheezing	VBG	B-PROBLEM
vitamin	NN	B-TREATMENT
c	NN	I-TREATMENT
(	(	I-TREATMENT
ascorbic	JJ	I-TREATMENT
acid	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
miacalcin	NN	B-TREATMENT
(	(	I-TREATMENT
calcitonin	JJ	I-TREATMENT
-	:	I-TREATMENT
salmon	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
spray	NN	O
inh	NN	O
qd	NN	O

1mag	CD	B-TREATMENT
citrate	NN	I-TREATMENT
(	(	I-TREATMENT
citrate	NN	I-TREATMENT
of	IN	I-TREATMENT
magnesia	NN	I-TREATMENT
)	)	I-TREATMENT
300	CD	O
milliliters	NNS	O
po	VBP	O
qd	JJ	O
prn	NN	O
constipation	NN	B-PROBLEM
colace	NN	B-TREATMENT
(	(	I-TREATMENT
docusate	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
tid	VBD	O
glyburide	RB	B-TREATMENT
5	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
starting	VBG	O
in	IN	O
am	VBP	O
on	IN	O
12/21/04	CD	O
lactulose	JJ	B-TREATMENT
30	CD	O
milliliters	NNS	O
po	VBP	O
q6	NN	O

diarrhea	NN	B-PROBLEM

senna	JJ	B-TREATMENT
tablets	NNS	I-TREATMENT
2	CD	O
tab	JJ	O
po	RB	O
bid	VBD	O
simethicone	RB	B-TREATMENT
160	CD	O
mg	NNS	O
po	JJ	O
qid	NN	O
starting	VBG	O
today	NN	O
(	(	O
12/23	CD	O
)	)	O
prn	NN	O

gas	NN	B-PROBLEM
,	,	O
upset	JJ	B-PROBLEM
stomach	NN	I-PROBLEM
.	.	O

tamoxifen	RB	B-TREATMENT
20	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O

override	RB	O
added	VBD	O
on	IN	O
12/19/04	CD	O
by	IN	O
sapmoores	NNS	O
,	,	O
nell	RB	O
rilet	NN	O
,	,	O
m.d.	NN	O
on	IN	O
order	NN	O
for	IN	O
levofloxacin	NN	B-TREATMENT
po	NN	I-TREATMENT
(	(	O
ref	JJ	O
#	#	O
88006031	CD	O
)	)	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

tamoxifen	NN	B-TREATMENT
citrate	NN	I-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT

aware	JJ	O
mvi	RBR	B-TREATMENT
therapeutic	JJ	I-TREATMENT
w	NN	I-TREATMENT
/	NN	I-TREATMENT
minerals	NNS	I-TREATMENT
(	(	I-TREATMENT
therap	VB	I-TREATMENT
vits	NNS	I-TREATMENT
/	NNP	I-TREATMENT
minerals	NNS	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	NN	O
pilocarpine	NN	B-TREATMENT
4%	CD	I-TREATMENT
solution	NN	I-TREATMENT
1	CD	O
drop	NN	O
os	NN	O
qid	JJ	O
flonase	NN	B-TREATMENT
(	(	I-TREATMENT
fluticasone	JJ	I-TREATMENT
nasal	NN	I-TREATMENT
spray	NN	I-TREATMENT
)	)	I-TREATMENT
2	CD	O
spray	JJ	O
inh	NN	O
bid	NN	O

2	CD	B-TREATMENT
alphagan	NN	I-TREATMENT
(	(	I-TREATMENT
brimonidine	JJ	I-TREATMENT
tartrate	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
drop	NN	O
os	NN	O
bid	NN	O

2	CD	B-TREATMENT
levofloxacin	JJ	I-TREATMENT
250	CD	O
mg	NN	O
po	NN	O
qd	NN	O
x	$	O
1	CD	O
days	NNS	O
starting	VBG	O
today	NN	O
(	(	O
12/21	CD	O
)	)	O

administer	RB	O
iron	NN	B-TREATMENT
products	NNS	I-TREATMENT
a	DT	O
minimum	NN	O
of	IN	O
2	CD	O
hours	NNS	O
before	IN	O
or	CC	O
after	IN	O
a	DT	B-TREATMENT
levofloxacin	NN	I-TREATMENT
or	CC	O
ciprofloxacin	NN	B-TREATMENT
dose	VBP	O
dose	NN	O

if	IN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
,	,	O
please	VB	O
cycle	NN	O
(	(	O
hold	VB	O
1	CD	O
hr	NN	O
before	IN	O
to	TO	O
2	CD	O
hr	NNS	O
after	IN	O
)	)	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

tamoxifen	NN	B-TREATMENT
citrate	NN	I-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT

celexa	NN	B-TREATMENT
(	(	I-TREATMENT
citalopram	NN	I-TREATMENT
)	)	I-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
calcium	NN	B-TREATMENT
carb	NN	I-TREATMENT
+	NNP	I-TREATMENT
d	NN	I-TREATMENT
(	(	O
600mg	CD	O
elem	NN	B-TREATMENT
ca	MD	I-TREATMENT
+	VB	I-TREATMENT
vit	NN	I-TREATMENT
d/200	NN	I-TREATMENT
iu	NN	O
)	)	O
1	CD	O
tab	JJ	O
po	RB	O
bid	NN	O
lumigan	NN	B-TREATMENT
(	(	I-TREATMENT
bimatoprost	$	I-TREATMENT
0.03%	CD	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
drop	NN	O
ou	NN	O
qhs	NN	O

cefuroxime	JJ	B-TREATMENT
axetiladmit	NN	O
diagnosis	NN	O
:	:	O

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
abdominal	NN	B-PROBLEM
pain	NN	I-PROBLEM

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
allergies	NNS	B-PROBLEM
-	:	O
pcn	NN	B-TREATMENT
-	:	O
rash	NN	B-PROBLEM
-	:	O
bactrim	SYM	B-TREATMENT
-	:	O
hives	VBZ	B-PROBLEM
-	:	O
erythro	NN	B-TREATMENT
-	:	O
nausea	NN	B-PROBLEM
-	:	O
ceclor	NN	B-TREATMENT
-	:	O
nausea	NN	B-PROBLEM
-	:	O
clarythro	NN	B-TREATMENT
=	NN	O
rash	NN	B-PROBLEM

67	CD	O
y/o	JJ	O
f	NN	O
w/	NN	O
hx	NN	O
poliomyelitis	NN	B-PROBLEM
,	,	O
breast	NN	B-PROBLEM
ca	MD	I-PROBLEM
stable	VB	O
on	IN	O
tamoxifen	NN	B-TREATMENT
,	,	O
vent	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
in	IN	O
an	DT	B-TREATMENT
iron	NN	I-TREATMENT
lung	NN	I-TREATMENT
admitted	VBD	O
w/	JJ	O
1	CD	O
day	NN	O
hx	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
recently	RB	O
admitted	VBN	O
1	CD	O
week	NN	O
ago	RB	O
w/	VBD	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

pain	NN	B-PROBLEM
worse	NN	O
with	IN	O
movement	NN	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
brbpr	NN	B-PROBLEM
,	,	O
melena	NN	B-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
.	.	O

on	IN	O
admision	NN	O
,	,	O
t	NN	B-TEST
97.5	CD	O
,	,	O
hr	NN	B-TEST
86	CD	O
,	,	O
bp	NN	B-TEST
111/47	CD	O
,	,	O
r	NN	B-TEST
20	CD	O
.	.	O

sat	RB	B-TEST
94%	CD	O
on	IN	O
4l	CD	B-TREATMENT
.	.	O

exam	NN	B-TEST
notable	JJ	O
for	IN	O
hyperactive	JJ	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
with	IN	O
abd	JJ	B-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
tenderness	NN	B-PROBLEM
to	TO	O
palpation	NN	B-TEST
at	IN	I-TEST
llq	NN	I-TEST
and	CC	O
rlq	NN	O
.	.	O

no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

abd	NN	B-TEST
ct	NN	I-TEST
showed	VBD	O
stable	JJ	O
findings	NNS	O
compared	VBN	O
to	TO	O
12/10/04	CD	O
except	IN	O
for	IN	O
distended	JJ	B-PROBLEM
right	NN	I-PROBLEM
colon	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
ileus	NN	B-PROBLEM
.	.	O

pt	NN	O
&apos;s	NNP	O
clinical	JJ	O
picture	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
constipation-related	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
started	VBN	O
on	IN	O
bowel	NN	B-TREATMENT
regimen	NNS	I-TREATMENT
with	IN	O
senna	NN	B-TREATMENT
,	,	O
magcitrate	NN	B-TREATMENT
and	CC	O
lactulose	NN	B-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
abd	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
tenderness	NN	B-PROBLEM
improved	VBN	O
after	IN	O
bowel	NN	O
movement	NN	O
.	.	O

pt	NN	O
was	VBD	O
levo	JJ	B-TREATMENT
250mg	CD	O
x	JJ	O
3	CD	O
days	NNS	O
for	IN	O
uti	JJ	B-PROBLEM
(	(	O
pyuria	NNS	B-PROBLEM
on	IN	O
admisstion	NN	O
)	)	O
.	.	O

pt	NN	O
has	VBZ	O
been	VBN	O
using	VBG	O
iron	NN	B-TREATMENT
lung	NN	I-TREATMENT
for	IN	O
breathing	NN	O
and	CC	O
has	VBZ	O
been	VBN	O
satting	VBG	O
well	RB	O
duing	VBG	O
her	PRP$	O
hospital	NN	O
course	NN	O
.	.	O

1.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

2.	CD	O
dilated	VBN	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

3.	CD	O
a	DT	O
27	CD	O
week	NN	O
intrauterine	JJ	B-PROBLEM
pregnancy	NN	I-PROBLEM
.	.	O

4.	CD	O
chronic	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

5.	CD	O
asthma	NN	B-PROBLEM
.	.	O

6.	CD	O
history	NN	O
of	IN	O
atrioseptal	JJ	B-PROBLEM
defect	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
28	CD	O
-	:	O
year-old	NN	O
,	,	O
gravida	NN	O
3	CD	O
,	,	O
para	NN	O
1	CD	O
,	,	O
at	IN	O
approximately	RB	O
27	CD	O
weeks	NNS	O
gestation	NN	O
,	,	O
who	WP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2014-05-12	JJ	O
due	JJ	O
to	TO	O
increasing	VBG	O
symptoms	NNS	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
known	VBN	B-PROBLEM
dilated	VBN	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
baseline	NN	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
approximately	RB	O
25%	CD	O
.	.	O

she	PRP	O
had	VBD	O
been	VBN	O
managed	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
during	IN	O
her	PRP$	O
pregnancy	NN	O
and	CC	O
was	VBD	O
on	IN	O
multiple	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
daily	RB	O
,	,	O
hydralazine	PRP	B-TREATMENT
25	CD	O
mg	JJ	O
daily	RB	O
,	,	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
100	CD	O
mg	JJ	O
daily	RB	O
,	,	O
digoxin	NN	B-TREATMENT
0.5	CD	O
mg	JJ	O
daily	JJ	O
and	CC	O
lovenox	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
twice	RB	O
daily	RB	O
subcutaneously	RB	O
.	.	O

she	PRP	O
also	RB	O
took	VBD	O
albuterol	NN	B-TREATMENT
on	IN	O
a	DT	O
p.r.n.	JJ	O
basis	NN	O
for	IN	O
her	PRP$	B-PROBLEM
asthma	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
known	VBN	B-PROBLEM
allergy	NNS	I-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
,	,	O
vancomycin	FW	B-TREATMENT
and	CC	O
erythromycin	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
symptoms	NNS	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
decreased	VBN	B-PROBLEM
fetal	JJ	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

fetal	JJ	B-TEST
monitoring	NN	I-TEST
initially	RB	O
on	IN	O
admission	NN	O
was	VBD	O
appropriate	JJ	O
for	IN	O
gestational	JJ	O
age	NN	O
.	.	O

on	IN	O
physical	JJ	B-TEST
exam	NN	I-TEST
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
bilateral	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
mildly	RB	B-PROBLEM
elevated	VBD	I-PROBLEM
pressures	NNS	I-PROBLEM
in	IN	O
the	DT	O
140	CD	O
to	TO	O
150/90	CD	O
range	NN	O
,	,	O
and	CC	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distension	NN	I-PROBLEM
.	.	O

after	IN	O
consultation	NN	O
with	IN	O
cardiology	NN	O
as	RB	O
well	RB	O
as	IN	O
anesthesia	NN	O
on	IN	O
call	NN	O
that	IN	O
evening	NN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
transfer	VB	O
the	DT	O
patient	NN	O
to	TO	O
the	DT	O
icu	NN	O
for	IN	O
intensive	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

central	JJ	B-TREATMENT
iv	JJ	I-TREATMENT
access	NN	I-TREATMENT
was	VBD	O
obtained	VBN	O
.	.	O

symptoms	NNS	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
gradually	RB	O
abated	VBN	O
over	IN	O
the	DT	O
next	JJ	O
48	CD	O
to	TO	O
72	CD	O
hours	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
antenatal	JJ	B-TREATMENT
corticosteroids	NNS	I-TREATMENT
for	IN	O
fetal	JJ	O
lung	NN	O
maturity	NN	O
.	.	O

after	IN	O
discussion	NN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
attempt	VB	O
to	TO	O
obtain	VB	O
28	CD	O
weeks	NNS	O
gestation	NN	O
and	CC	O
then	RB	O
deliver	VB	O
electively	RB	O
by	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
given	VBN	O
the	DT	B-PROBLEM
decompensation	NN	I-PROBLEM
in	IN	O
the	DT	O
third	JJ	O
trimester	NN	O
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
primary	JJ	B-TREATMENT
low	JJ	I-TREATMENT
transverse	NN	I-TREATMENT
cesarean	NN	I-TREATMENT
section	NN	I-TREATMENT
on	IN	O
2014-05-19	JJ	O
at	IN	O
approximately	RB	O
28	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

the	DT	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
on	IN	O
the	DT	O
west	NN	O
campus	NN	O
in	IN	O
the	DT	O
cardiothoracic	NN	O
surgical	JJ	O
suite	NN	O
.	.	O

this	DT	O
was	VBD	O
performed	VBN	O
in	IN	O
this	DT	O
location	NN	O
in	IN	O
case	NN	O
any	DT	B-PROBLEM
acute	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
decompensation	NN	I-PROBLEM
occurred	VBD	O
during	IN	O
the	DT	O
time	NN	O
of	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

cardiothoracic	NN	O
surgery	NN	O
was	VBD	O
on	IN	O
standby	NN	O
during	IN	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

she	PRP	O
required	VBD	O
several	JJ	O
episodes	NNS	O
of	IN	O
diuresis	NN	B-TREATMENT
due	JJ	O
to	TO	O
increasing	VBG	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
on	IN	O
postoperative	JJ	O
day	NN	O
#1	NNP	O
and	CC	O
postoperative	JJ	O
day	NN	O
#2	VBD	O
due	JJ	O
to	TO	O
worsening	VBG	O
symptoms	NNS	O
of	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
from	IN	O
fluid	JJ	B-PROBLEM
shifts	NNS	I-PROBLEM
that	WDT	O
normally	RB	O
occur	VBP	O
during	IN	O
the	DT	O
postpartum	JJ	O
period	NN	O
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
during	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
postoperative	JJ	O
course	NN	O
and	CC	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
medication	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
that	IN	O
she	PRP	O
had	VBD	O
been	VBN	O
on	IN	O
during	IN	O
the	DT	O
antepartum	JJ	O
period	NN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
underwent	JJ	O
tubal	JJ	B-TREATMENT
ligation	NN	I-TREATMENT
at	IN	O
the	DT	O
time	NN	O
of	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
.	.	O

toprol	NN	B-TREATMENT
xl	VBZ	I-TREATMENT
100	CD	O
mg	JJ	O
daily	RB	O
,	,	O
hydralazine	PRP	B-TREATMENT
25	CD	O
mg	JJ	O
daily	RB	O
,	,	O
lasix	VBD	B-TREATMENT
40	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.75	CD	O
mg	JJ	O
daily	RB	O
,	,	O
lovenox	VBD	B-TREATMENT
40	CD	O
mg	JJ	O
twice	RB	O
daily	RB	O
subcutaneously	RB	O
and	CC	O
albuterol	VB	B-TREATMENT
p.r.n.	NN	O

acute	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

acute	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

percutaneous	JJ	B-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
,	,	O
4/9/95	CD	O
.	.	O

directional	JJ	B-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
,	,	I-TREATMENT
left	VBD	I-TREATMENT
main	JJ	I-TREATMENT
and	CC	I-TREATMENT
left	VBD	I-TREATMENT
anterior	RP	I-TREATMENT
descending	VBG	I-TREATMENT
vessels	NNS	I-TREATMENT
.	.	O

lanoxin	NN	B-TREATMENT
0.375	CD	O
mg.	JJ	O
daily	RB	O
.	.	O

coumadin	NN	B-TREATMENT
as	IN	O
adjusted	VBN	O
by	IN	O
prothrombin	NN	B-TEST
times	NNS	I-TEST
,	,	O
isordil	JJ	B-TREATMENT
20	CD	O
mg.	NN	O
tid	NN	O
,	,	O
micronase	NN	B-TREATMENT
1.25	CD	O
mg.	JJ	O
daily	RB	O
,	,	O
aspirin	VBZ	B-TREATMENT
81	CD	O
mg.	JJ	O
daily	RB	O
,	,	O
nitroglycerin	RB	B-TREATMENT
0.3	CD	O
mg.	NNS	O
sl	JJ	O
prn	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
seventy	NN	O
two	CD	O
year	NN	O
old	JJ	O
man	NN	O
who	WP	O
a	DT	O
number	NN	O
of	IN	O
years	NNS	O
ago	RB	O
underwent	JJ	O
coronary	JJ	B-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
at	IN	O
another	DT	O
institution	NN	O
.	.	O

in	IN	O
1992	CD	O
he	PRP	O
underwent	VBD	O
redo	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
.	.	O

in	IN	O
april	JJ	O
1994	CD	O
he	PRP	O
presented	VBD	O
with	IN	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
was	VBD	O
given	VBN	O
streptokinase	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
recurrent	NN	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
went	VBD	O
to	TO	O
the	DT	O
catheter	NN	O
laboratory	NN	O
where	WRB	O
a	DT	B-PROBLEM
proximal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
lesion	NN	I-PROBLEM
was	VBD	O
angioplastied	VBN	O
.	.	O

a	DT	O
relook	JJ	O
several	JJ	O
days	NNS	O
later	RB	O
led	VBD	O
to	TO	O
a	DT	B-TREATMENT
repeat	NN	I-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
has	VBZ	O
stable	VBN	B-PROBLEM
,	,	I-PROBLEM
mild	JJ	I-PROBLEM
angina	NN	I-PROBLEM
,	,	O
subsequently	RB	O
,	,	O
mostly	RB	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
stress	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
he	PRP	O
was	VBD	O
involved	VBN	O
in	IN	O
a	DT	O
minor	JJ	O
motor	NN	O
vehicle	NN	O
accident	NN	O
,	,	O
and	CC	O
there	EX	O
was	VBD	O
some	DT	O
apparent	JJ	O
controversy	NN	O
with	IN	O
the	DT	O
driver	NN	O
of	IN	O
the	DT	O
other	JJ	O
vehicle	NN	O
,	,	O
during	IN	O
the	DT	O
course	NN	O
of	IN	O
which	WDT	O
he	PRP	O
developed	VBD	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
the	DT	O
left	JJ	O
arm	NN	O
and	CC	O
shoulder	NN	O
.	.	O

this	DT	O
waxed	NN	O
and	CC	O
waned	VBD	O
for	IN	O
thirty	NN	O
to	TO	O
sixty	VB	O
minutes	NNS	O
,	,	O
and	CC	O
he	PRP	O
took	VBD	O
a	DT	O
number	NN	O
of	IN	O
nitroglycerins	NNS	B-TREATMENT
.	.	O

after	IN	O
returning	VBG	O
home	NN	O
after	IN	O
conferring	VBG	O
with	IN	O
his	PRP$	O
wife	NN	O
,	,	O
and	CC	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
lasted	VBD	O
another	DT	O
half	JJ	O
hour	NN	O
,	,	O
he	PRP	O
came	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

his	PRP$	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
increased	VBN	B-PROBLEM
t	NNS	I-PROBLEM
wave	VBP	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v3	NN	I-PROBLEM
and	CC	O
v4	NN	O
and	CC	O
1	CD	O
mm	NN	O
.	.	O

st	NN	B-PROBLEM
segment	NN	I-PROBLEM
depression	NN	I-PROBLEM
in	IN	I-PROBLEM
v3	NN	I-PROBLEM
through	IN	O
v6	NN	O
.	.	O

his	PRP$	B-TEST
examination	NN	I-TEST
was	VBD	O
largely	RB	O
benign	JJ	O
after	IN	O
he	PRP	O
was	VBD	O
made	VBN	O
pain	NN	B-PROBLEM
free	JJ	O
.	.	O

the	DT	B-TEST
pulse	NN	I-TEST
was	VBD	O
75	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
120/80	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

the	DT	O
jugular	NN	O
veins	NNS	O
were	VBD	O
not	RB	O
distended	VBN	B-PROBLEM
,	,	O
the	DT	B-TEST
carotid	NN	I-TEST
volume	NN	I-TEST
was	VBD	O
diminished	VBN	B-PROBLEM
.	.	O

there	EX	O
were	VBD	O
normal	JJ	B-TREATMENT
prothetic	JJ	I-TREATMENT
valves	NNS	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
grade	JJ	I-PROBLEM
ii-ii	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
and	CC	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
negative	JJ	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
edema	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
feet	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
demonstrated	VBD	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
poor	JJ	B-PROBLEM
r	NNS	I-PROBLEM
wave	VBP	I-PROBLEM
progression	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
and	CC	O
t	NN	B-PROBLEM
wave	VBP	I-PROBLEM
inversion	NN	I-PROBLEM
in	IN	I-PROBLEM
leads	VBZ	I-PROBLEM
v	RB	I-PROBLEM
4	CD	I-PROBLEM
,	,	I-PROBLEM
5	CD	I-PROBLEM
,	,	O
and	CC	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

intubation	NN	B-TREATMENT

central	JJ	B-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT

64	CD	O
f	NN	O
with	IN	O
breast	NN	B-PROBLEM
ca	MD	I-PROBLEM
s/p	VB	O
mastectomy	JJ	B-TREATMENT
17	CD	O
y	NN	O
ago	IN	O
with	IN	O
local	JJ	B-PROBLEM
recurrence	NN	I-PROBLEM
leading	VBG	O
to	TO	O
paralysis	NN	B-PROBLEM
of	IN	I-PROBLEM
l	NN	I-PROBLEM
arm	NN	I-PROBLEM
~	NNP	O
5-6	CD	O
y	NN	O
ago	RB	O
.	.	O

now	RB	O
declining	VBG	O
gradually	RB	O
since	IN	O
january	NN	O
(	(	O
30	CD	B-PROBLEM
lbs	NNS	I-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
,	,	O
becoming	VBG	O
more	RBR	B-PROBLEM
confused	JJ	I-PROBLEM
,	,	O
decreased	JJ	B-PROBLEM
appetite	NN	I-PROBLEM
).	NN	O

patient	NN	O
declined	VBD	O
workup	JJ	B-TEST
/	NNP	O
imaging	NN	B-TEST
for	IN	O
mets	NNS	B-PROBLEM
as	IN	O
outpatient	NN	O
.	.	O

over	IN	O
the	DT	O
last	JJ	O
2	CD	O
weeks	NNS	O
,	,	O
husband	NN	O
reports	NNS	O
patient	JJ	O
becoming	VBG	O
increasingly	RB	B-PROBLEM
weak	JJ	I-PROBLEM
,	,	O
unable	JJ	O
to	TO	O
leave	VB	O
bed	NN	O
,	,	O
confused	VBN	B-PROBLEM
,	,	O
unable	JJ	O
to	TO	O
feed	VB	O
herself	PRP	O
.	.	O

seen	VBN	O
by	IN	O
vna	NN	O
and	CC	O
noted	VBD	O
to	TO	O
be	VB	O
tachycardic	JJ	B-PROBLEM
and	CC	O
sent	VBD	O
to	TO	O
middleboroughfor	VB	O
evaluation	NN	B-TEST
.	.	O

now	RB	O
sent	VBN	O
in	IN	O
to	TO	O
amesbury	VB	O
by	IN	O
vna	NN	O
because	IN	O
of	IN	O
asymptomatic	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

transferred	VBN	O
here	RB	O
for	IN	O
workup	NN	B-TEST
for	IN	O
cns	JJ	B-PROBLEM
mets	NNS	I-PROBLEM
and	CC	O
admission	NN	O
.	.	O

in	IN	O
john	NN	O
,	,	O
vs	SYM	B-TEST
-	:	O
99.6	CD	O
,	,	O
135	CD	O
,	,	O
122/65	CD	O
,	,	O
20	CD	O
.	.	O

neurosurg	RB	O
evaluated	VBN	O
pt	NN	O
and	CC	O
felt	VBD	O
to	TO	O
not	RB	O
be	VB	O
surgical	JJ	O
candidate	NN	O
;	:	O
recommended	VBN	O
dilantin	NN	B-TREATMENT
load	NN	I-TREATMENT
and	CC	O
decadron	NN	B-TREATMENT
.	.	O

received	VBN	O
lorazepam	JJ	B-TREATMENT
prior	RB	O
to	TO	O
ct	VB	B-TEST
scan	JJ	I-TEST
.	.	O

intubated	VBN	O
for	IN	O
ms	NN	B-PROBLEM
changes	NNS	I-PROBLEM
and	CC	O
lethargy	NN	B-PROBLEM
and	CC	O
concern	NN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
.	.	O

post	NN	O
intubation	NN	B-TREATMENT
,	,	O
hypotensive	JJ	B-PROBLEM
and	CC	O
started	VBD	O
on	IN	O
dopamine	NN	B-TREATMENT
and	CC	O
transitioned	VBD	O
to	TO	O
levophed	VB	B-TREATMENT
.	.	O

received	VBN	O
vancomycin	JJ	B-TREATMENT
/	JJ	O
levafloxacin	NN	B-TREATMENT
at	IN	O
osh	NN	O
.	.	O

received	VBN	O
metronidazole	NN	B-TREATMENT
at	IN	O
ricky	NN	O
in	IN	O
mediplex	JJ	O
rehab	NN	O
hospital	NN	O
.	.	O

in	IN	O
cmed	JJ	O
ccu	NN	O
,	,	O
pt.	RB	O
responsive	JJ	O
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
only	RB	O
.	.	O

1.	CD	O
left	VBD	O
breast	NN	O
status	NN	O
post	NN	O
radical	JJ	B-TREATMENT
mastectomy	NN	I-TREATMENT
in	IN	O
2002	CD	O
with	IN	O
adjuvant	JJ	B-TREATMENT
tamoxifen	NN	I-TREATMENT
for	IN	O
five	CD	O
years	NNS	O
.	.	O

this	DT	O
was	VBD	O
followed	VBN	O
by	IN	O
later	RBR	O
development	NN	O
of	IN	O
lymphedema	NN	B-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
arm	NN	I-PROBLEM
(	(	I-PROBLEM
distal	JJ	I-PROBLEM
>	NNP	I-PROBLEM
proximal	NN	I-PROBLEM
)	)	I-PROBLEM
weakness	NN	I-PROBLEM
due	JJ	O
to	TO	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
left	JJ	I-PROBLEM
axilla	NN	I-PROBLEM
ensheathing	VBG	I-PROBLEM
nerve	NN	I-PROBLEM
plexus	NN	I-PROBLEM
.	.	O

treated	VBN	O
with	IN	O
course	NN	O
of	IN	O
local	JJ	B-TREATMENT
xrt	NN	I-TREATMENT
in	IN	O
springfield	NN	O
municipal	JJ	O
hospital	NN	O
and	CC	O
tamoxifen	NN	B-TREATMENT
.	.	O

switched	VBN	O
to	TO	O
arimedex	VB	B-TREATMENT
in	IN	O
2019-02-10	JJ	O
due	JJ	O
to	TO	O
vaginal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
on	IN	O
tamoxifen	NN	B-TREATMENT
.	.	O

self	NN	O
discontinued	VBN	O
arimedex	NN	B-TREATMENT
last	JJ	O
month	NN	O
.	.	O

no	DT	O
prior	JJ	O
history	NN	O
of	IN	O
intracranial	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
,	,	I-PROBLEM
brachial	JJ	I-PROBLEM
plexus	NN	I-PROBLEM
resulting	VBG	O
in	IN	O
left	JJ	B-PROBLEM
arm	NN	I-PROBLEM
paresis	NN	I-PROBLEM
,	,	O
as	IN	O
above	IN	O

maternal	JJ	O
aunt	NN	O
with	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

father	RB	O
deceased	VBN	O
from	IN	O
complications	NNS	B-PROBLEM
from	IN	O
ms	NN	B-PROBLEM
.	.	O

t	NN	B-TEST
99.8	CD	O

hr	NN	B-TEST
124	CD	O

sbp	NN	B-TEST
135/58	CD	O

rr	NN	B-TEST
16	CD	O

ox	RB	B-TEST
100	CD	O

cachectic	JJ	B-PROBLEM
,	,	O
lays	VBZ	O
with	IN	O
eyes	NNS	O
closed	VBD	O
.	.	O

temporal	JJ	B-PROBLEM
wasting	NN	I-PROBLEM
.	.	O

nc/at	NN	B-PROBLEM
.	.	O

anicteric	NN	B-PROBLEM
.	.	O

mucosa	NN	B-PROBLEM
dry	NN	I-PROBLEM
.	.	O

no	DT	O
r/r/w	NN	B-PROBLEM
.	.	O

tachycardic	NN	B-PROBLEM
,	,	O
regular	JJ	O
.	.	O

no	DT	O
m/r/g	NN	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
nd	JJ	B-PROBLEM
,	,	O
+	JJ	O
nabs	NN	O
.	.	O

no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

no	DT	O
hsm	NN	B-PROBLEM
.	.	O

wasted	VBN	B-PROBLEM
.	.	O

legs	NNS	O
are	VBP	O
rigid	JJ	B-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
there	EX	O
is	VBZ	O
diffuse	JJ	B-PROBLEM
metastatic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

three	CD	B-PROBLEM
discrete	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
within	IN	O
the	DT	O
left	JJ	O
frontal	NN	O
,	,	O
right	JJ	O
occipital	NN	O
,	,	O
and	CC	O
left	VBD	O
parietal	JJ	O
lobes	NNS	O
with	IN	O
significant	JJ	B-PROBLEM
surrounding	VBG	I-PROBLEM
vasogenic	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
largest	JJS	I-PROBLEM
single	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
measures	VBZ	O
3.7	CD	O
x	NN	O
3.4	CD	O
cm	NN	O
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
surrounding	VBG	I-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
10	CD	O
mm	NNS	O
rightward	JJ	B-PROBLEM
shift	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
with	IN	O
associated	JJ	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
ventricles	NNS	I-PROBLEM
.	.	O

the	DT	O
basilar	JJ	O
cistern	NN	O
is	VBZ	O
preserved	VBN	O
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
uncal	JJ	B-PROBLEM
herniation	NN	I-PROBLEM
.	.	O

ct	NN	B-TEST
torso	NN	I-TEST

1.	CD	O
right	JJ	B-PROBLEM
middle	NN	I-PROBLEM
lobe	NN	I-PROBLEM
lung	NN	I-PROBLEM
nodule	NN	I-PROBLEM
,	,	O
suspicious	JJ	O
for	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
lung	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
which	WDT	O
appear	VBP	O
confluent	NN	B-PROBLEM
,	,	O
most	RBS	O
suggestive	JJ	O
of	IN	O
infectious	JJ	B-PROBLEM
etiology	NN	I-PROBLEM
,	,	O
however	RB	O
,	,	O
cannot	VBP	O
entirely	RB	O
exclude	JJ	O
metastatic	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

recommend	NN	O
follow	VB	B-TEST
up	RP	I-TEST
ct	NN	I-TEST
to	TO	O
ensure	VB	O
resolution	NN	O
.	.	O

3.	CD	O
multiple	JJ	B-PROBLEM
hypodense	NN	I-PROBLEM
liver	NN	I-PROBLEM
lesions	NNS	I-PROBLEM
which	WDT	O
are	VBP	O
mildly	RB	B-PROBLEM
enhancing	VBG	I-PROBLEM
,	,	O
most	JJS	O
consistent	JJ	O
with	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

4.	CD	O
bilateral	JJ	B-PROBLEM
small	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
which	WDT	O
certainly	RB	O
could	MD	O
be	VB	O
malignant	JJ	B-PROBLEM
given	VBN	O
today	NN	B-TEST
's	POS	I-TEST
findings	NNS	I-TEST
and	CC	O
history	NN	O
of	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

5.	CD	O
no	DT	O
evidence	NN	O
of	IN	O
bony	NN	B-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

metastatic	JJ	B-PROBLEM
breast	NN	I-PROBLEM
ca	MD	I-PROBLEM
-	:	O
large	JJ	B-PROBLEM
brain	NN	I-PROBLEM
mets	NNS	I-PROBLEM
with	IN	O
midline	JJ	B-PROBLEM
shift	NN	I-PROBLEM
.	.	O

intubated	VBN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
.	.	O

treated	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
dilantin	NN	I-TREATMENT
and	CC	O
decadron	NN	B-TREATMENT
.	.	O

dilantin	NN	B-TREATMENT
was	VBD	O
stopped	VBN	O
.	.	O

will	MD	O
go	VB	O
home	NN	O
with	IN	O
prn	JJ	O
morphine	NN	B-TREATMENT
,	,	O
ativan	NN	B-TREATMENT
,	,	O
and	CC	O
pr	JJ	B-TREATMENT
decadron	NN	I-TREATMENT
.	.	O

pnuemonia	SYM	B-PROBLEM
-	:	O
possible	JJ	O
aspiration	NN	B-PROBLEM
.	.	O

completed	VBN	O
a	DT	O
7	CD	O
day	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
levofloxacin	NN	B-TREATMENT
.	.	O

1.	CD	O
morphine	JJ	B-TREATMENT
concentrate	NN	I-TREATMENT
20	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
2.5-20	JJ	O
mg	NN	O
po	NN	O
q1-2h	NN	O
(	(	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

2.	CD	O
lorazepam	JJ	B-TREATMENT
0.5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
0.5-2	JJ	O
mg	NN	O
po	NN	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
aggitation	NN	B-PROBLEM
/	JJ	O
seizure	NN	B-PROBLEM
:	:	O
please	NN	O
dispense	NN	O
liquid	NN	O
.	.	O

3.	CD	O
dexamethasone	NN	B-TREATMENT
4	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
:	:	O
please	VB	O
give	VB	O
8	CD	O
mg	JJ	O
suppository	NN	O
.	.	O

breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
75	CD	O
year	NN	O
old	JJ	O
hispanic	JJ	O
male	NN	O
with	IN	O
insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
above-knee	JJ	I-TREATMENT
amputation	NN	I-TREATMENT
about	IN	O
five	CD	O
years	NNS	O
ago	RB	O
,	,	O
who	WP	O
reportedly	RB	O
approximately	RB	O
four	CD	O
months	NNS	O
ago	RB	O
,	,	O
he	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ulceration	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
great	JJ	I-PROBLEM
toe	NN	I-PROBLEM
,	,	O
which	WDT	O
progressively	RB	O
worsened	VBD	O
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
a	DT	O
doctor	NN	O
in	IN	O
arizona	NN	O
and	CC	O
treated	VBN	O
with	IN	O
dressing	NN	B-TREATMENT
changes	NNS	I-TREATMENT
and	CC	O
debridement	NN	B-TREATMENT
until	IN	O
approximately	RB	O
six	CD	O
weeks	NNS	O
ago	RB	O
,	,	O
when	WRB	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
started	VBN	O
with	IN	O
ciprofloxacin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
suggested	VBN	O
that	IN	O
he	PRP	O
should	MD	O
have	VB	O
an	DT	B-TREATMENT
amputation	NN	I-TREATMENT
and	CC	O
he	PRP	O
decided	VBD	O
to	TO	O
come	VB	O
to	TO	O
fairm	VB	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NN	I-PROBLEM
for	IN	O
fifteen	JJ	O
years	NNS	O
.	.	O

right	JJ	B-TREATMENT
above-knee	JJ	I-TREATMENT
amputation	NN	I-TREATMENT
five	CD	O
years	NNS	O
ago	RB	O
,	,	O
status	NN	O
post	NN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
.	.	O

he	PRP	O
sustained	VBD	O
left	VBD	B-PROBLEM
humerus	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
tib-fib	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

tylenol	NN	B-TREATMENT
,	,	O
ciprofloxacin	NN	B-TREATMENT
and	CC	O
insulin	NN	B-TREATMENT
,	,	O
about	RB	O
16	CD	O
units	NNS	O
of	IN	O
nph	JJ	B-TREATMENT
qa.m.	NN	O

on	IN	O
review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
,	,	O
denies	VBZ	O
fevers	NNS	B-PROBLEM
,	,	O
has	VBZ	O
pain	VBN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
foot	NN	I-PROBLEM
,	,	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
reveals	VBZ	O
him	PRP	O
to	TO	O
be	VB	O
an	DT	O
elderly	JJ	O
gentleman	NN	O
who	WP	O
is	VBZ	O
alert	JJ	O
and	CC	O
oriented	JJ	O
and	CC	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
no	DT	O
visceromegaly	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
showed	VBD	O
normal	JJ	O
prostate	NN	O
,	,	O
guaiac	JJ	B-TEST
negative	NN	O
.	.	O

his	PRP$	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

pulses	NNS	B-TEST
remained	VBD	O
,	,	O
aside	RB	O
from	IN	O
the	DT	B-TREATMENT
above-knee	JJ	I-TREATMENT
amputation	NN	I-TREATMENT
on	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
side	NN	I-TREATMENT
,	,	O
they	PRP	O
remained	VBD	O
symmetrical	JJ	O
bilaterally	RB	O
with	IN	O
3+	CD	B-TEST
carotid	NNS	I-TEST
,	,	O
2+	CD	B-TEST
brachial	NN	I-TEST
,	,	O
1+	CD	B-TEST
radial	NN	I-TEST
,	,	O
3+	CD	B-TEST
femoral	NN	I-TEST
.	.	O

significant	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
6.0	CD	O
,	,	O
hematocrit	NN	B-TEST
35.9	CD	O
,	,	O
electrolytes	NNS	B-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
13	CD	O
and	CC	O
0.8	CD	O
,	,	O
amylase	NN	B-TEST
of	IN	O
56	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
electrocardiogram	NN	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
acute	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
change	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
ruled	VBD	O
out	RP	O
acute	JJ	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

left	JJ	B-PROBLEM
foot	NN	I-PROBLEM
changes	NNS	I-PROBLEM
consistent	VBP	O
with	IN	O
osteomyelitis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
great	JJ	I-PROBLEM
toe	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
a	DT	O
question	NN	O
of	IN	O
evaluation	NN	B-TEST
of	IN	I-TEST
circulation	NN	I-TEST
to	TO	O
the	DT	O
left	NN	O
great	JJ	O
toe	NN	O
and	CC	O
also	RB	O
possible	JJ	O
debridement	NN	B-TREATMENT
and	CC	O
possibly	RB	O
a	DT	B-TREATMENT
toe	NN	I-TREATMENT
amputation	NN	I-TREATMENT
.	.	O

08-27-92	NN	O
,	,	O
left	VBD	B-TEST
foot	NN	I-TEST
film	NN	I-TEST
,	,	O
correlation	NN	O
,	,	O
patient	JJ	O
consistent	NN	O
with	IN	O
osteomyelitis	NN	B-PROBLEM
involving	VBG	I-PROBLEM
the	DT	I-PROBLEM
first	JJ	I-PROBLEM
digit	NN	I-PROBLEM
and	CC	O
possibly	RB	O
the	DT	O
second	JJ	O
digit	NN	O
of	IN	O
the	DT	O
left	JJ	O
foot	NN	O
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
reveals	NNS	O
no	DT	O
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
lower	JJR	B-TEST
extremity	NN	I-TEST
arterial	JJ	I-TEST
non-invasive	JJ	I-TEST
study	NN	I-TEST
which	WDT	O
showed	VBD	O
good	JJ	O
arterial	JJ	O
hemodynamics	NNS	O
of	IN	O
the	DT	O
left	NN	O
lower	JJR	O
extremity	NN	O
,	,	O
perfusion	NN	O
to	TO	O
the	DT	O
tm	NN	O
level	NN	O
,	,	O
but	CC	O
there	EX	O
was	VBD	O
evidence	NN	O
of	IN	O
diabetic	JJ	B-PROBLEM
small	JJ	I-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
spasm	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
digits	NNS	I-PROBLEM
.	.	O

the	DT	O
arterial	JJ	O
circulation	NN	O
is	VBZ	O
adequate	JJ	O
for	IN	O
healing	VBG	O
of	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
great	JJ	I-PROBLEM
toe	NN	I-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
noncompressible	JJ	B-PROBLEM
left	VBD	I-PROBLEM
thigh	JJ	I-PROBLEM
and	CC	I-PROBLEM
calf	JJ	I-PROBLEM
pressures	NNS	I-PROBLEM
highly	RB	B-PROBLEM
calcified	VBN	I-PROBLEM
arterial	JJ	I-PROBLEM
system	NN	I-PROBLEM
.	.	O

on	IN	O
09-03-92	JJ	O
,	,	O
patient	JJ	O
underwent	NN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
great	JJ	I-TREATMENT
toe	NN	I-TREATMENT
buttontoe	NN	I-TREATMENT
amputation	NN	I-TREATMENT
under	IN	O
regional	JJ	B-TREATMENT
ankle	NN	I-TREATMENT
block	NN	I-TREATMENT
for	IN	O
chronic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
osteomyelitis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
great	JJ	I-PROBLEM
toe	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
during	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
a	DT	B-TREATMENT
small	JJ	I-TREATMENT
penrose	NN	I-TREATMENT
drain	NN	I-TREATMENT
postoperatively	RB	O
that	DT	O
was	VBD	O
placed	VBN	O
intraoperatively	RB	O
and	CC	O
discontinued	VBN	O
on	IN	O
approximately	RB	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
preoperatively	RB	O
treated	VBN	O
with	IN	O
about	IN	O
a	DT	O
seven	CD	O
day	NN	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
unasyn	NNS	I-TREATMENT
and	CC	O
postoperatively	RB	O
treated	VBN	O
for	IN	O
approximately	RB	O
four	CD	O
days	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
unasyn	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
incision	NN	I-PROBLEM
from	IN	O
buttontoe	JJ	B-TREATMENT
amputation	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
foot	NN	I-TREATMENT
healing	VBG	O
well	RB	O
,	,	O
without	IN	O
any	DT	O
further	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

included	VBD	O
his	PRP$	B-TREATMENT
pre-admission	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
55	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
critical	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
who	WP	O
was	VBD	O
referred	VBN	O
to	TO	O
dr.	VB	O
brenda	NN	O
hummer	NN	O
for	IN	O
discussion	NN	O
for	IN	O
surgical	JJ	B-TREATMENT
options	NNS	I-TREATMENT
to	TO	O
free	VB	O
this	DT	B-PROBLEM
condition	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reportedly	RB	O
had	VBD	O
been	VBN	O
experiencing	VBG	O
increasing	VBG	B-PROBLEM
fatigue	NN	I-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
with	IN	O
exertion	NN	O
for	IN	O
the	DT	O
year	NN	O
prior	RB	O
to	TO	O
his	PRP$	O
admission	NN	O
.	.	O

the	DT	O
patient	NN	O
reported	VBD	O
increasingly	RB	O
frequent	JJ	O
episodes	NNS	O
of	IN	O
dizziness	NN	B-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
accompanied	VBN	O
with	IN	O
coughing	VBG	B-PROBLEM
spells	NNS	I-PROBLEM
after	IN	O
walking	VBG	O
approximately	RB	O
a	DT	O
half	NN	O
a	DT	O
mile	NN	O
or	CC	O
climbing	VBG	O
three	CD	O
flights	NNS	O
of	IN	O
stairs	NNS	O
.	.	O

on	IN	O
2010-05-27	JJ	O
,	,	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
revealed	VBD	O
critical	JJ	B-PROBLEM
fibrocalcific	NN	I-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
125	CD	O
mmhg	NNS	O
,	,	O
a	DT	B-TEST
mean	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
74	CD	O
mmhg	NN	O
,	,	O
an	DT	B-TEST
oak	JJ	I-TEST
bluffs	NNS	I-TEST
of	IN	O
0.44	CD	O
,	,	O
and	CC	O
1+	CD	B-PROBLEM
aortic	JJ	I-PROBLEM
and	CC	I-PROBLEM
mitral	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
subsequently	RB	O
underwent	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
on	IN	O
2010-06-01	JJ	O
,	,	O
which	WDT	O
demonstrated	VBD	O
no	DT	O
hemodynamically	RB	B-PROBLEM
significant	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
but	CC	O
critical	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
consistent	NN	O
with	IN	O
his	PRP$	B-TEST
echocardiogram	NN	I-TEST
study	NN	I-TEST
results	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
scheduled	VBN	O
for	IN	O
a	DT	B-TREATMENT
mechanical	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
aortic	JJ	B-TREATMENT
replacement	NN	I-TREATMENT
on	IN	O
2010-06-07	JJ	O
.	.	O

1.	CD	O
diabetes	NNS	B-PROBLEM
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
seasonal	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

4.	CD	O
arthritis	NN	B-PROBLEM
.	.	O

1.	CD	O
metformin	NN	B-TREATMENT
.	.	O

2.	CD	O
celexa	NN	B-TREATMENT
.	.	O

3.	CD	O
lipitor	NN	B-TREATMENT
.	.	O

4.	CD	O
aspirin	NN	B-TREATMENT
.	.	O

5.	CD	O
toprol	NN	B-TREATMENT
xl	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
and	CC	O
shell	VB	O
fish	NN	O
.	.	O

on	IN	O
2010-06-07	JJ	O
,	,	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
mechanical	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
23	CD	I-TREATMENT
mm	NN	I-TREATMENT
carbomedics	NNS	I-TREATMENT
mechanical	JJ	I-TREATMENT
valve	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
supra	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
aortic	JJ	I-TREATMENT
graft	NN	I-TREATMENT
with	IN	O
gelweave	JJ	B-TREATMENT
28	CD	O
mm	NN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
with	IN	O
a	DT	B-TREATMENT
bypass	NN	I-TREATMENT
time	NN	I-TREATMENT
of	IN	O
155	CD	O
minutes	NNS	O
and	CC	O
a	DT	B-TREATMENT
crossclamp	JJ	I-TREATMENT
time	NN	I-TREATMENT
of	IN	O

the	DT	O
patient	NN	O
's	POS	O
pericardium	NN	O
was	VBD	O
left	VBN	O
open	JJ	O
;	:	O
lines	NNS	B-TREATMENT
placed	VBD	O
included	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
radial	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
ij	NN	I-TREATMENT
line	NN	I-TREATMENT
;	:	O
both	DT	O
ventricular	JJ	B-TREATMENT
and	CC	I-TREATMENT
atrial	JJ	I-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
;	:	O
two	CD	B-TREATMENT
mediastinal	JJ	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	NN	O
surgery	NN	O
recovery	NN	O
unit	NN	O
,	,	O
intubated	VBN	B-TREATMENT
,	,	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
and	CC	O
management	NN	O
.	.	O

on	IN	O
transfer	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
mean	JJ	I-TEST
arterial	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
76	CD	O
,	,	O
cvp	NN	B-TEST
12	CD	O
,	,	O
pad	NN	B-TEST
17	CD	O
,	,	O
and	CC	O
his	PRP$	B-TEST
bennie	NN	I-TEST
was	VBD	O
25	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
av	RB	B-TREATMENT
paced	VBN	I-TREATMENT
at	IN	O
a	DT	O
rate	NN	O
of	IN	O
88	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

active	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
included	VBD	O
milrinone	NN	B-TREATMENT
,	,	O
levophed	VBN	B-TREATMENT
,	,	O
propofol	NN	B-TREATMENT
,	,	O
and	CC	O
insulin	NN	B-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
successfully	RB	O
weaned	VBN	O
and	CC	O
extubated	VBN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
advanced	JJ	O
to	TO	O
oral	JJ	O
intake	NN	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
chest	JJS	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
without	IN	O
complication	NN	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
subsequently	RB	O
cleared	VBN	O
for	IN	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
physical	JJ	O
therapy	NN	O
,	,	O
who	WP	O
declared	VBD	O
him	PRP	O
a	DT	O
suitable	JJ	O
candidate	NN	O
for	IN	O
discharge	NN	O
directly	RB	O
to	TO	O
home	NN	O
following	VBG	O
resolution	NN	O
of	IN	O
his	PRP$	B-TREATMENT
medical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
advanced	VBN	O
to	TO	O
a	DT	O
full	JJ	O
regular	JJ	O
diet	NN	O
,	,	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
without	IN	O
complication	NN	B-PROBLEM
,	,	O
and	CC	O
had	VBD	O
adequate	JJ	B-TREATMENT
pain	NN	I-TREATMENT
control	NN	I-TREATMENT
provided	VBD	O
via	IN	O
oral	JJ	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
begun	VBN	O
on	IN	O
anticoagulation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
a	DT	B-TEST
target	NN	I-TEST
inr	NN	I-TEST
of	IN	O
2.5	CD	O
.	.	O

on	IN	O
the	DT	O
evening	NN	O
of	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
four	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
transient	JJ	O
episode	NN	O
of	IN	O
disorientation	NN	B-PROBLEM
and	CC	O
confusion	NN	B-PROBLEM
which	WDT	O
subsequently	RB	O
resolved	VBD	O
spontaneously	RB	O
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
afebrile	JJ	B-PROBLEM
and	CC	O
stable	JJ	O
.	.	O

his	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
clean	JJ	O
,	,	O
dry	JJ	O
,	,	O
and	CC	O
intact	JJ	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
cellulitis	NN	B-PROBLEM
or	CC	O
purulent	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
tolerant	NN	O
of	IN	O
a	DT	O
full	JJ	O
regular	JJ	O
diet	NN	O
and	CC	O
had	VBD	O
his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
well	RB	O
controlled	VBN	O
via	IN	O
oral	JJ	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
inr	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
2.3	CD	O
.	.	O

1.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

2.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
hours	NNS	O
times	RB	O
seven	CD	O
days	NNS	O
.	.	O

3.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
p.o.	NN	O
q.	VBD	O
12	CD	O
hours	NNS	O
times	RB	O
seven	CD	O
days	NNS	O
.	.	O

4.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5.	CD	O
metformin	NN	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

6.	CD	O
percocet	NN	B-TREATMENT
5/325	CD	O
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
q.	RB	O
four	CD	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

7.	CD	O
celexa	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
warfarin	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
times	NNS	O
four	CD	O
days	NNS	O
,	,	O
after	IN	O
which	WDT	O
point	VBP	O
the	DT	O
patient	NN	O
's	POS	O
dosage	NN	O
schedule	NN	O
is	VBZ	O
to	TO	O
be	VB	O
coordinated	VBN	O
by	IN	O
his	PRP$	O
pcp	NN	O
,	,	O
dr.	NN	O
jerold	NN	O
esqueda	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
maintain	VB	O
his	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
clean	VBP	O
and	CC	O
dry	JJ	O
at	IN	O
all	DT	O
times	NNS	O
.	.	O

the	DT	O
patient	NN	O
may	MD	O
shower	VB	O
but	CC	O
should	MD	O
pat	VB	O
dry	JJ	O
incisions	NNS	B-PROBLEM
afterwards	NNS	O
;	:	O
no	DT	O
bathing	NN	O
or	CC	O
swimming	NN	O
until	IN	O
further	JJ	O
notice	NN	O
.	.	O

the	DT	O
patient	NN	O
may	MD	O
resume	VB	O
a	DT	B-TREATMENT
heart	NN	I-TREATMENT
healthy	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

no	DT	O
driving	VBG	O
while	IN	O
taking	VBG	O
prescription	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
have	VB	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
managed	VBN	O
by	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
provider	NN	O
,	,	O
dr.	NN	O
jerold	NN	O
esqueda	NN	O
,	,	O
for	IN	O
a	DT	B-TEST
target	NN	I-TEST
inr	NN	I-TEST
of	IN	O
2.5	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
report	VB	O
to	TO	O
dr.	VB	O
jones	NNS	O
office	NN	O
on	IN	O
2010-06-14	NN	O
for	IN	O
an	DT	B-TEST
initial	JJ	I-TEST
blood	NN	I-TEST
draw	NN	I-TEST
and	CC	O
subsequent	JJ	B-TREATMENT
coumadin	NN	I-TREATMENT
titration	NN	I-TREATMENT
;	:	O
coumadin	NN	B-TEST
levels	NNS	I-TEST
are	VBP	O
to	TO	O
be	VB	O
monitored	VBN	O
per	IN	O
his	PRP$	O
pcp	NN	O
david	NN	O
.	.	O

mediastinal	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

mediastinal	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
obesity	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

january	JJ	O
3	CD	O
,	,	O
1994	CD	O
,	,	O
median	JJ	B-TEST
sternotomy	NN	I-TEST
with	IN	O
mediastinal	JJ	B-TEST
exploration	NN	I-TEST
,	,	O
radical	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	O
tumor	NN	B-PROBLEM
and	CC	O
aortopulmonary	JJ	B-PROBLEM
window	NN	I-PROBLEM
;	:	O
partial	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
adjacent	JJ	I-TREATMENT
lung	NN	I-TREATMENT
,	,	O
en	JJ	B-TREATMENT
bloc	NN	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
vagus	NN	I-TREATMENT
and	CC	I-TREATMENT
phrenic	JJ	I-TREATMENT
nerves	NNS	I-TREATMENT
;	:	O
partial	JJ	B-TREATMENT
pericardectomy	NN	I-TREATMENT
;	:	O
fiberoptic	JJ	B-TEST
bronchoscopy	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
66	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
colon	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
superhilar	JJ	I-PROBLEM
region	NN	I-PROBLEM
,	,	O
who	WP	O
presents	VBZ	O
for	IN	O
bronchoscopy	NN	B-TEST
,	,	O
mediastinal	JJ	B-TEST
exploration	NN	I-TEST
and	CC	O
resection	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
she	PRP	O
experienced	VBD	O
the	DT	O
onset	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
in	IN	O
early	JJ	O
1992	CD	O
.	.	O

in	IN	O
december	NN	O
of	IN	O
1992	CD	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
transverse	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
for	IN	O
colon	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
which	WDT	O
was	VBD	O
duke	JJ	B-PROBLEM
&apos;s	JJ	I-PROBLEM
grade	NN	I-PROBLEM
b-ii	NN	I-PROBLEM
,	,	O
lymph	NN	O
nodes	NNS	O
were	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
received	VBD	O
postoperative	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

in	IN	O
september	NN	O
of	IN	O
1992	CD	O
,	,	O
she	PRP	O
underwent	VBD	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
because	IN	O
of	IN	O
an	DT	B-PROBLEM
increased	JJ	I-PROBLEM
level	NN	I-PROBLEM
of	IN	I-PROBLEM
cea	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
blood	NN	I-TEST
with	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
liver	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
on	IN	O
computerized	JJ	B-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
.	.	O

the	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
rise	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TEST
cea	NN	I-TEST
level	NN	I-TEST
which	WDT	O
prompted	VBD	O
a	DT	B-TEST
further	JJ	I-TEST
work	NN	I-TEST
up	RB	I-TEST
.	.	O

in	IN	O
september	NN	O
of	IN	O
1993	CD	O
,	,	O
an	DT	B-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
pelvic	JJ	I-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
negative	JJ	O
and	CC	O
in	IN	O
june	NN	O
of	IN	O
1993	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-TEST
negative	JJ	I-TEST
bone	NN	I-TEST
scan	NN	I-TEST
.	.	O

in	IN	O
december	NN	O
of	IN	O
1994	CD	O
,	,	O
a	DT	B-TEST
thoracic	JJ	I-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
four	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
mass	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
suprahilar	JJ	I-PROBLEM
region	NN	I-PROBLEM
,	,	O
adjacent	JJ	O
to	TO	O
the	DT	B-PROBLEM
aortopulmonary	JJ	I-PROBLEM
window	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
experienced	VBD	O
increased	JJ	B-PROBLEM
hoarseness	NN	I-PROBLEM
over	IN	O
the	DT	O
preceding	JJ	O
months	NNS	O
,	,	O
which	WDT	O
was	VBD	O
due	JJ	O
to	TO	O
left	JJ	B-PROBLEM
vocal	JJ	I-PROBLEM
cord	NN	I-PROBLEM
paralysis	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
complains	VBZ	O
of	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
for	IN	O
the	DT	O
preceding	VBG	O
month	NN	O
and	CC	O
now	RB	O
presents	NNS	O
for	IN	O
mediastinal	JJ	B-TEST
exploration	NN	I-TEST
and	CC	O
resection	NN	B-TREATMENT
of	IN	O
her	PRP$	O
probable	JJ	O
metastatic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
previous	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
1983	CD	O
,	,	O
hypothyroidism	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
history	NN	O
of	IN	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
past	JJ	O
surgical	JJ	O
history	NN	O
is	VBZ	O
notable	JJ	O
for	IN	O
a	DT	O
1971	CD	O
mastectomy	NN	B-TREATMENT
on	IN	I-TREATMENT
the	DT	I-TREATMENT
right	NN	I-TREATMENT
,	,	O
1937	CD	O
appendectomy	NN	B-TREATMENT
,	,	O
1991	CD	O
cholecystectomy	NN	B-TREATMENT
,	,	O
1992	CD	O
transverse	NN	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
1992	CD	O
exploratory	NN	B-TEST
laparotomy	NN	I-TEST
,	,	O
1991	CD	O
bilateral	JJ	B-TREATMENT
cataract	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

levoxine	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O
vasotec	JJ	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
maxzide	RB	B-TREATMENT
75/50	CD	O
,	,	O
30	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
sulfa	VB	B-TREATMENT
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
she	PRP	O
is	VBZ	O
an	DT	O
obese	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
hoarse	JJ	I-PROBLEM
voice	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
shows	VBZ	O
that	IN	O
she	PRP	O
is	VBZ	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
,	,	O
extra	JJ	O
ocular	JJ	O
movements	NNS	O
are	VBP	O
intact	JJ	O
,	,	O
pupils	JJ	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
and	CC	O
the	DT	O
oropharynx	NN	O
was	VBD	O
clear	JJ	O
,	,	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
lymphadenopathy	NN	B-PROBLEM
,	,	O
either	DT	O
axillary	JJ	O
or	CC	O
supraclavicular	JJ	O
.	.	O

chest	NN	O
is	VBZ	O
clear	JJ	O
with	IN	O
decreased	JJ	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
previous	JJ	I-TREATMENT
right	JJ	I-TREATMENT
mastectomy	NN	I-TREATMENT
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
without	IN	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

obese	JJ	B-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
surgical	JJ	I-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

the	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
guaiac	JJ	B-TEST
negative	JJ	O
without	IN	O
masses	NNS	B-PROBLEM
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
nonfocal	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
january	JJ	O
3	CD	O
,	,	O
1994	CD	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
median	JJ	I-TREATMENT
sternotomy	NN	I-TREATMENT
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
mediastinal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

this	DT	B-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
situated	VBN	O
in	IN	O
the	DT	B-PROBLEM
aortopulmonary	JJ	I-PROBLEM
window	NN	I-PROBLEM
and	CC	O
was	VBD	O
sent	VBN	O
to	TO	O
pathology	NN	O
.	.	O

the	DT	B-TEST
frozen	JJ	I-TEST
section	NN	I-TEST
analysis	NN	I-TEST
revealed	VBD	O
this	DT	O
to	TO	O
be	VB	O
adenocarcinoma	RB	B-PROBLEM
,	,	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM
most	RBS	O
likely	JJ	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
intraoperatively	RB	O
and	CC	O
another	DT	O
placed	VBN	O
postoperatively	RB	O
in	IN	O
the	DT	O
recovery	NN	O
room	NN	O
,	,	O
for	IN	O
what	WP	O
was	VBD	O
presumed	VBN	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

this	DT	B-TREATMENT
tube	NN	I-TREATMENT
drained	VBD	O
only	RB	O
a	DT	O
small	JJ	O
amount	NN	O
of	IN	O
fluid	NN	O
and	CC	O
it	PRP	O
was	VBD	O
likely	JJ	O
that	IN	O
the	DT	B-PROBLEM
effusion	NN	I-PROBLEM
was	VBD	O
made	VBN	O
to	TO	O
look	VB	O
more	JJR	O
severe	JJ	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
left	JJ	B-PROBLEM
hemidiaphragm	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
.	.	O

this	DT	B-TREATMENT
additional	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
the	DT	O
following	JJ	O
day	NN	O
.	.	O

her	PRP$	B-TEST
postoperative	JJ	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
31	CD	O
,	,	O
compared	VBN	O
to	TO	O
a	DT	B-TEST
preoperative	JJ	I-TEST
level	NN	I-TEST
of	IN	O
43	CD	O
.	.	O

mediastinal	JJ	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
.	.	O

percocet	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
status	NN	O
post	NN	O
off	IN	B-TREATMENT
pump	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
three	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
63	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
who	WP	O
had	VBD	O
initially	RB	O
presented	VBN	O
with	IN	O
exertional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pressure	NN	I-PROBLEM
several	JJ	O
weeks	NNS	O
prior	RB	O
to	TO	O
this	DT	O
admission	NN	O
that	WDT	O
would	MD	O
resolve	VB	O
with	IN	O
rest	NN	O
.	.	O

stress	NN	B-TEST
echocardiogram	NN	I-TEST
demonstrated	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
40%	CD	O
,	,	O
hypokinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
distal	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
,	,	O
akinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
distal	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
and	CC	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
three	CD	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
now	RB	O
presents	VBZ	O
for	IN	O
elective	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

3.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

4.	CD	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

5.	CD	O
status	NN	O
post	NN	O
cadaveric	JJ	B-TREATMENT
kidney	NN	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
2012-09-21	JJ	O
.	.	O

6.	CD	O
chronic	JJ	B-PROBLEM
allograft	NN	I-PROBLEM
nephropathy	NN	I-PROBLEM
.	.	O

7.	CD	O
chronic	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
.	.	O

8.	CD	O
history	NN	O
of	IN	O
upper	JJ	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

9.	CD	O
depression	NN	B-PROBLEM
.	.	O

10.	CD	O
gout	NN	B-PROBLEM
.	.	O

11.	CD	O
question	NN	O
of	IN	O
transient	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
attack	NN	I-PROBLEM
.	.	O

12.	CD	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
av	JJ	I-TREATMENT
fistula	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
daily	RB	O
.	.	O

2.	CD	O
neoral	JJ	B-TREATMENT
25	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
diltiazem	JJ	B-TREATMENT
240	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

4.	CD	O
allopurinol	JJ	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
daily	RB	O
.	.	O

5.	CD	O
hydralazine	NN	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

6.	CD	O
enalapril	JJ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

7.	CD	O
avandia	JJ	B-TREATMENT
4	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

8.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

9.	CD	O
bactrim	JJ	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
once	RB	O
daily	JJ	O
.	.	O

10.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
25	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

11.	CD	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
25	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

12.	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

preoperative	JJ	O
laboratory	NN	O
values	NNS	O
showed	VBD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
6.8	CD	O
,	,	O
hematocrit	NN	B-TEST
33.3	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST

inr	RB	B-TEST
1.1	CD	O
.	.	O

chem7	NN	B-TEST
showed	VBD	O
sodium	JJ	B-TEST
138	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
107	CD	O
,	,	O
bicarbonate	NN	B-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
49	CD	O
,	,	O
creatinine	NN	B-TEST
2.5	CD	O
,	,	O
glucose	VBD	B-TEST
156	CD	O
.	.	O

calcium	NN	B-TEST
9.2	CD	O
,	,	O
magnesium	NN	B-TEST
1.8	CD	O
,	,	O
and	CC	O
phosphorus	RB	B-TEST
4.2	CD	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
in	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
comfortable	JJ	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
showed	VBD	O
temperature	NN	B-TEST
96.3	CD	O
,	,	O
pulse	RB	B-TEST
64	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
170/70	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
normocephalic	JJ	O
and	CC	O
atraumatic	JJ	B-PROBLEM
.	.	O

anicteric	NN	B-PROBLEM
.	.	O

the	DT	O
chest	NN	O
is	VBZ	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

neck	NN	O
was	VBD	O
supple	JJ	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

cardiovascular	NN	O
shows	NNS	O
grade	VBP	B-PROBLEM
ii/vi	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

the	DT	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
umbilical	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

extremities	NNS	O
are	VBP	O
warm	JJ	O
,	,	O
noncyanotic	JJ	B-PROBLEM
and	CC	O
nonedematous	JJ	B-PROBLEM
times	NNS	O
four	CD	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
service	NN	O
for	IN	O
optimization	NN	O
prior	RB	O
to	TO	O
his	PRP$	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
his	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
closely	RB	O
followed	VBN	O
from	IN	O
his	PRP$	O
admission	NN	O
through	IN	O
to	TO	O
his	PRP$	O
discharge	NN	O
by	IN	O
the	DT	O
renal	JJ	O
service	NN	O
for	IN	O
his	PRP$	B-PROBLEM
transplant	NN	I-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

on	IN	O
2016-02-15	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
and	CC	O
had	VBD	O
an	DT	B-TREATMENT
off	RP	I-TREATMENT
pump	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
performed	VBN	O
with	IN	O
the	DT	B-TREATMENT
left	JJ	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
left	VBN	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
obtuse	VB	I-TREATMENT
marginal	JJ	I-TREATMENT
and	CC	O
posterior	JJ	O
descending	NN	O
artery	NN	O
.	.	O

for	IN	O
details	NNS	O
of	IN	O
this	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
please	VB	O
see	VB	O
the	DT	O
previously	RB	O
dictated	VBN	O
operative	JJ	O
note	NN	O
.	.	O

postoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
csru	NN	O
for	IN	O
close	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

on	IN	O
the	DT	O
evening	NN	O
of	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
zero	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
decreased	VBN	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
and	CC	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
lasix	JJ	I-TREATMENT
drip	NN	I-TREATMENT
for	IN	O
diuresis	NN	B-TREATMENT
.	.	O

the	DT	O
renal	JJ	O
service	NN	O
continued	VBD	O
to	TO	O
follow	VB	O
close	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-TREATMENT
immunosuppression	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
and	CC	O
awakened	VBN	O
from	IN	O
sedation	NN	B-TREATMENT
.	.	O

he	PRP	O
did	VBD	O
well	RB	O
on	IN	O
this	DT	O
and	CC	O
his	PRP$	B-TREATMENT
levophed	JJ	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
to	TO	O
off	RP	O
as	IN	O
tolerated	VBN	O
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
six	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
hematocrit	NN	I-PROBLEM
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
four	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
platelet	NN	I-PROBLEM
level	NN	I-PROBLEM
of	IN	O
43,000	CD	O
.	.	O

heparin	NN	B-TEST
induced	VBD	I-TEST
thrombocytopenia	IN	I-TEST
antibody	NN	I-TEST
panel	NN	I-TEST
was	VBD	O
sent	VBN	O
.	.	O

chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
when	WRB	O
output	NN	B-TEST
was	VBD	O
low	JJ	O
.	.	O

pacing	VBG	B-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
.	.	O

ultimately	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
six	CD	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
,	,	O
adequate	JJ	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
on	IN	O
p.o.	NN	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
and	CC	O
ambulating	VBG	O
well	RB	O
with	IN	O
clearance	NN	O
of	IN	O
physical	JJ	O
therapy	NN	O
.	.	O

cardiac	NN	B-TREATMENT
and	CC	I-TREATMENT
diabetic	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

the	DT	O
chest	NN	O
is	VBZ	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
without	IN	O
sternal	JJ	B-PROBLEM
click	NN	I-PROBLEM
or	CC	O
discharge	NN	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

extremities	NNS	O
are	VBP	O
warm	JJ	O
,	,	O
noncyanotic	JJ	B-PROBLEM
,	,	O
minimal	JJ	B-PROBLEM
peripheral	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

1.	CD	O
percocet	NN	B-TREATMENT
5/325	CD	O
one	CD	O
to	TO	O
two	CD	O
q4hours	NNS	O
p.r.n.	VBP	O

2.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

3.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

4.	CD	O
bactrim	JJ	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
one	CD	O
tablet	NN	O
once	RB	O
daily	RB	O
.	.	O

5.	CD	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

6.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

7.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

8.	CD	O
hydralazine	NN	B-TREATMENT
75	CD	O
mg	NN	O
q6hours	NNS	O
.	.	O

9.	CD	O
cyclosporin	NN	B-TREATMENT
75	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

10.	CD	O
rosiglitazone	NN	B-TREATMENT
4	CD	O
mg	NN	O
once	RB	O
daily	RB	O
.	.	O

he	PRP	O
should	MD	O
follow-up	VB	O
with	IN	O
his	PRP$	O
cardiologist	NN	O
in	IN	O
one	CD	O
to	TO	O
two	CD	O
weeks	NNS	O
for	IN	O
optimization	NN	O
of	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
should	MD	O
return	VB	O
or	CC	O
contact	VB	O
the	DT	O
office	NN	O
if	IN	O
he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
,	,	O
sternal	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
significant	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

dementia	NN	B-PROBLEM
;	:	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
108-year-old	JJ	O
nursing	NN	O
home	NN	O
resident	NN	O
,	,	O
who	WP	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	O
two-day	JJ	O
history	NN	O
of	IN	O
increased	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
secretions	NNS	I-PROBLEM
and	CC	O
a	DT	O
24-hour	JJ	O
history	NN	O
of	IN	O
elevated	VBN	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

despite	IN	O
augmentin	NNS	B-TREATMENT
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
delirium	NN	I-PROBLEM
worsened	VBD	O
in	IN	O
the	DT	O
24	CD	O
hours	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
and	CC	O
her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
up	RB	O
to	TO	O
102	CD	O
.	.	O

recurrent	NN	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
most	JJS	O
recently	RB	O
on	IN	O
2/23/97	CD	O
;	:	O
recurrent	JJ	B-PROBLEM
aspiration	NN	I-PROBLEM
pneumonias	NN	I-PROBLEM
,	,	O
most	RBS	O
recently	RB	O
on	IN	O
2/21/97	CD	O
;	:	O
multi-infarct	JJ	B-PROBLEM
dementia	NN	I-PROBLEM
with	IN	O
associated	JJ	B-PROBLEM
dysphasia	NN	I-PROBLEM
;	:	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
;	:	O
history	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
;	:	O
pernicious	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
;	:	O
chronic	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
stasis	NN	I-PROBLEM
;	:	O
status	NN	O
post	NN	O
left	VBD	B-PROBLEM
femoral	JJ	I-PROBLEM
neck	NN	I-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

augmentin	RB	B-TREATMENT
500	CD	O
mg	NNS	O
t.i.d.	NN	O

senokot	VB	B-TREATMENT
one	CD	O
q.h.s.	NN	O

sertraline	NN	B-TREATMENT
75	CD	O
mg	NN	O
q.day	NN	O
.	.	O

aspirin	RB	B-TREATMENT
81	CD	O
mg	NN	O
q.day	NN	O
.	.	O

vitamin	NN	B-TREATMENT
b12	NN	I-TREATMENT
100	CD	O
mcg	NN	O
im	JJ	O
q.month	NN	O
.	.	O

urecholine	JJ	B-TREATMENT
25	CD	O
mg	NN	O
t.i.d.	NN	O
colace	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
resides	VBZ	O
in	IN	O
the	DT	O
pcaer,ter	NN	O
medical	JJ	O
center	NN	O
,	,	O
is	VBZ	O
nonambulatory	JJ	B-PROBLEM
,	,	O
and	CC	O
her	PRP$	O
code	NN	O
status	NN	O
is	VBZ	O
do	VBP	O
not	RB	O
resuscitate	VB	O
/	NNS	O
do	VBP	O
not	RB	O
intubate	VB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
nonverbal	JJ	B-PROBLEM
,	,	O
but	CC	O
was	VBD	O
able	JJ	O
to	TO	O
open	VB	O
her	PRP$	O
eyes	NNS	O
and	CC	O
nod	NN	O
.	.	O

no	DT	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
102.2	CD	O
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
135/64	CD	O
;	:	O
pulse	JJ	B-TEST
rate	NN	I-TEST
108	CD	O
;	:	O
respirations	NNS	B-TEST
24	CD	O
;	:	O
oxygen	NN	B-TEST
saturations	NNS	I-TEST
on	IN	I-TEST
room	NN	I-TEST
air	NN	I-TEST
94%	CD	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	VB	I-TEST
examination	NN	I-TEST
revealed	VBD	O
no	DT	O
ocular	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

neck	SYM	O
-	:	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
;	:	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	VBZ	I-PROBLEM
;	:	O
jugular	JJ	B-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
not	RB	O
elevated	VBN	B-PROBLEM
;	:	O
no	DT	O
goiter	NN	B-PROBLEM
.	.	O

chest	JJS	O
-	:	O
reduced	VBN	B-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
with	IN	O
faint	JJ	B-PROBLEM
inspiratory	NN	I-PROBLEM
rhonchi	VBD	I-PROBLEM
anteriorly	RB	I-PROBLEM
.	.	O

cardiac	JJ	O
-	:	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
frequent	JJ	B-PROBLEM
premature	NN	I-PROBLEM
beats	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
2/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
non-tender	JJ	B-PROBLEM
,	,	O
nondistended	JJ	B-PROBLEM
,	,	O
no	DT	O
hepatomegaly	NN	B-PROBLEM
,	,	O
normal	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
-	:	O
1+	CD	B-PROBLEM
edema	NN	I-PROBLEM
;	:	O
2+	CD	B-TEST
pulses	NNS	I-TEST
.	.	O

skin	SYM	O
-	:	O
intact	JJ	O
with	IN	O
diaper	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
sodium	NN	I-TEST
was	VBD	O
142	CD	O
;	:	O
potassium	NN	B-TEST
4.5	CD	O
;	:	O
chloride	JJ	B-TEST
105	CD	O
;	:	O
bicarbonate	NN	B-TEST
27	CD	O
;	:	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
31	CD	O
and	CC	O
1.3	CD	O
;	:	O
glucose	JJ	B-TEST
107	CD	O
;	:	O
total	JJ	B-TEST
protein	NN	I-TEST
7.7	CD	O
;	:	O
albumin	JJ	B-TEST
3.2	CD	O
;	:	O
globulin	NN	B-TEST
4.5	CD	O
;	:	O
uric	JJ	B-TEST
acid	NN	I-TEST
4.2	CD	O
;	:	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
114	CD	O
;	:	O
serum	JJ	B-TEST
glutamic	JJ	I-TEST
oxaloacetic	JJ	I-TEST
transaminase	NN	I-TEST
46	CD	O
;	:	O
lactic	JJ	B-TEST
acid	NN	I-TEST
dehydrogenase	NN	I-TEST
370	CD	O
;	:	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
11,000	CD	O
with	IN	O
83	CD	O
polymorphonuclear	JJ	B-TEST
leukocytes	NNS	I-TEST
;	:	O
hematocrit	VBZ	B-TEST
42	CD	O
;	:	O
platelet	NN	B-TEST
count	NN	I-TEST
227,000	CD	O
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
consolidation	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
lyin	NN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
lobes	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
a	DT	O
presumed	JJ	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
for	IN	O
rehydration	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
clindamycin	NN	B-TREATMENT
and	CC	O
ofloxacin	NN	B-TREATMENT
at	IN	O
renal	JJ	O
dose	NN	O
to	TO	O
cover	VB	O
the	DT	B-PROBLEM
aspiration	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
positive	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
culture	NN	I-PROBLEM
,	,	O
which	WDT	O
subsequently	RB	O
came	VBD	O
back	RB	O
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
wheezing	NN	I-PROBLEM
,	,	O
which	WDT	O
responded	VBD	O
well	RB	O
to	TO	O
albuterol	VB	B-TREATMENT
nebulizers	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
generally	RB	O
doing	VBG	O
well	RB	O
with	IN	O
resolution	NN	O
of	IN	O
her	PRP$	B-TEST
temperature	NN	I-TEST
until	IN	O
4/1/97	CD	O
at	IN	O
9:20	CD	O
p.m.	NN	O
,	,	O
when	WRB	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
unresponsive	JJ	B-PROBLEM
with	IN	O
fixed	JJ	B-PROBLEM
dilated	VBN	I-PROBLEM
pupils	NNS	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

altered	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

intubatation	NN	B-TREATMENT

central	JJ	B-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT

52	CD	O
y.o.	NNS	O
male	JJ	O
with	IN	O
esld	JJ	B-PROBLEM
due	JJ	O
to	TO	O
hcv	VB	B-PROBLEM
/	NNP	O
etoh	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
now	RB	O
with	IN	O
delta	JJ	B-PROBLEM
ms	NN	I-PROBLEM
.	.	O

recently	RB	O
d/c	VBZ	O
'd	MD	O
on	IN	O
05-15	NN	O
after	IN	O
admission	NN	O
for	IN	O
hepatic	JJ	B-PROBLEM
encephalopathy	JJ	I-PROBLEM
versus	NN	O
opiate	NN	B-PROBLEM
abuse	NN	I-PROBLEM
.	.	O

brought	VBN	O
in	IN	O
by	IN	O
family	NN	O
for	IN	O
ams	NNS	B-PROBLEM
.	.	O

no	DT	O
hx	NN	O
available	JJ	O
at	IN	O
youville	NNP	O
hospital	NN	O
katherine	NN	O
,	,	O
except	IN	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

increasing	VBG	B-PROBLEM
tachypnea	NN	I-PROBLEM
and	CC	O
tachycardia	NN	B-PROBLEM
in	IN	O
leola	NN	O
,	,	O
cxr	NN	B-TEST
with	IN	O
likely	JJ	O
aspiration	NN	B-PROBLEM
pna	NN	I-PROBLEM
versus	NN	O
chf	NN	B-PROBLEM
,	,	O
intubated	VBN	B-TREATMENT
.	.	O

started	VBN	O
on	IN	O
levo	NN	B-TREATMENT
/	NNP	O
flagyl	NN	B-TREATMENT
/	NNP	O
ceftriaxone	NN	B-TREATMENT
and	CC	O
lasix	NN	B-TREATMENT
for	IN	O
sbp	NN	B-PROBLEM
and	CC	O
questionable	JJ	O
meningitis	NN	B-PROBLEM
.	.	O

1.	CD	O
hcv/etoh	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM

2.	CD	O
h/o	NN	O
sbp	NN	B-PROBLEM

3.	CD	O
esoph	JJ	B-PROBLEM
varices	NNS	I-PROBLEM
(	(	I-PROBLEM
grade	VB	I-PROBLEM
i	NN	I-PROBLEM
)	)	I-PROBLEM

4.	CD	O
depression	NN	B-PROBLEM

6.	CD	O
recurrent	NN	B-PROBLEM
arf	NN	I-PROBLEM

7.	CD	O
h/o	JJ	O
seizure	NN	B-PROBLEM

8.	CD	O
chronic	JJ	B-PROBLEM
lbp	NN	I-PROBLEM

9.	CD	O
anemia	NN	B-PROBLEM

his	PRP$	O
father	NN	O
had	VBD	O
hemochromatosis	NN	B-PROBLEM
and	CC	O
dmii	NN	B-PROBLEM
.	.	O

101.8	CD	O
,	,	O
100	CD	O
,	,	O
144/92	CD	O
,	,	O
18	CD	O
,	,	O
98%	CD	O
3lnc	CD	O
lying	NN	O
in	IN	O
bed	NN	O
,	,	O
oriented	VBD	O
hospital	NN	O
only	RB	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
tachy	NN	B-PROBLEM
but	CC	O
reg	NN	B-PROBLEM
diffusely	RB	I-PROBLEM
ttp	JJ	I-PROBLEM
and	CC	O
guaiac	JJ	B-TEST
negative	JJ	O
non-pitting	JJ	B-PROBLEM
brawny	NN	I-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
lichenification	NN	B-PROBLEM

pertinent	JJ	O
results	NNS	O
:	:	O
wbc	JJ	B-TEST
6.7	CD	O
46%	CD	O
pmn	NN	O
40%	CD	O
bands	NNS	B-TEST
,	,	O
na	RB	B-TEST
128	CD	O
tbili	NN	B-TEST
9.1	CD	O
,	,	O
alb	RB	B-TEST
2.3	CD	O
,	,	O
inr	NN	B-TEST
2.1	CD	O
,	,	O
lactate	VBP	B-TEST
4.4	CD	O
ecg	NN	B-TEST
unremarkable	JJ	O

1st	CD	B-TEST
cxr	NN	I-TEST
normal	JJ	O
;	:	O
2nd	CD	O
prior	NN	O
to	TO	O
intubation	VB	B-TREATMENT
?	.	O
rll	JJ	B-PROBLEM
opacity	NN	I-PROBLEM
(	(	O
mild	JJ	B-PROBLEM
chf	NN	I-PROBLEM
?	.	O
)	)	O
ascites	VBZ	B-PROBLEM
:	:	O

2900	CD	B-TEST
wbc	NN	I-TEST
98%	CD	O
pmn	NN	O
,	,	O
suspcious	JJ	O
for	IN	O
intra	JJ	B-PROBLEM
/	NNP	I-PROBLEM
extracellular	NN	I-PROBLEM
bact	NN	I-PROBLEM

sbp	NN	B-PROBLEM
:	:	O

pt	NN	O
admitted	VBN	O
with	IN	O
e	JJ	B-PROBLEM
coli	NNS	I-PROBLEM
spb	NN	I-PROBLEM
and	CC	O
bacteremia	NN	B-PROBLEM
.	.	O

was	VBD	O
treated	VBN	O
with	IN	O
ceftriaxone	NN	B-TREATMENT
2	CD	O
gm	NN	O
iv	JJ	O
daily	JJ	O
with	IN	O
multiple	JJ	B-TREATMENT
repeat	NN	I-TREATMENT
paracenteses	NNS	I-TREATMENT
.	.	O

repeat	NN	B-TEST
taps	NNS	I-TEST
did	VBD	O
not	RB	O
revealed	VBN	O
evidence	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
14	CD	O
days	NNS	O
of	IN	O
levoflox	NN	B-TREATMENT
.	.	O

resp	JJ	B-PROBLEM
failure	NN	I-PROBLEM
:	:	O

unclear	JJ	O
etiology	NN	O
,	,	O
but	CC	O
likely	JJ	O
aspiration	NN	B-PROBLEM
event	NN	I-PROBLEM
in	IN	O
monica	NN	O
.	.	O

treated	VBN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

weaning	NN	O
and	CC	O
potential	JJ	B-TREATMENT
extubation	NN	I-TREATMENT
complicated	VBN	O
by	IN	O
mechanical	JJ	B-PROBLEM
disadvantage	NN	I-PROBLEM
from	IN	O
large	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
continued	VBN	B-PROBLEM
somnolence	NN	I-PROBLEM
(	(	O
off	IN	O
sedation	NN	B-TREATMENT
).	NN	O

we	PRP	O
performed	VBD	O
frequent	JJ	B-TREATMENT
large	JJ	I-TREATMENT
vol	NN	I-TREATMENT
taps	NNS	I-TREATMENT
and	CC	O
attempted	VBD	O
to	TO	O
give	VB	O
diuretics	NNS	B-TREATMENT
,	,	O
but	CC	O
were	VBD	O
limited	VBN	O
by	IN	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
ascites	NNS	I-PROBLEM
quickly	RB	O
accumulated	VBD	O
after	IN	O
each	DT	B-TREATMENT
tap	NN	I-TREATMENT
.	.	O

cirrhosis	NN	B-PROBLEM
:	:	O

end-stage	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
with	IN	O
refractory	NN	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

each	DT	O
time	NN	O
we	PRP	O
have	VBP	O
initiated	VBN	O
diuretics	NNS	B-TREATMENT
,	,	O
creatinine	NN	B-TEST
rose	VBD	O
.	.	O

patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
nadolol	NN	B-TREATMENT
(	(	O
as	IN	O
bp	NN	B-TEST
tolerated	VBN	O
)	)	O
and	CC	O
lactulose	$	B-TREATMENT
)	)	O

renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
:	:	O

creatinine	NN	B-PROBLEM
elevation	NN	I-PROBLEM
appears	VBZ	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
both	DT	O
elevated	VBN	B-PROBLEM
abdominal	JJ	I-PROBLEM
pressures	NNS	I-PROBLEM
from	IN	O
ascites	NNS	B-PROBLEM
as	RB	O
well	RB	O
as	IN	O
to	TO	O
attempts	NNS	O
at	IN	O
diuresis	NN	B-TREATMENT
.	.	O

ams	NNS	B-PROBLEM
:	:	O

likely	JJ	O
hepatic	JJ	B-PROBLEM
encepholopathy	NN	I-PROBLEM
initially	RB	O
,	,	O
and	CC	O
later	RBR	O
likely	RB	O
related	VBN	O
to	TO	O
sedation	NN	B-TREATMENT
and	CC	O
delayed	JJ	B-PROBLEM
clearance	NN	I-PROBLEM
from	IN	O
liver	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

patient	NN	O
became	VBD	O
increasingly	RB	O
hypotensive	JJ	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
rising	VBG	I-PROBLEM
cr	NN	I-PROBLEM
,	,	O
eventually	RB	O
becoming	VBG	O
pressor	NN	B-PROBLEM
dependent	NN	I-PROBLEM
.	.	O

family	NN	O
meeting	NN	O
was	VBD	O
held	VBN	O
to	TO	O
discuss	VB	O
grave	JJ	O
prognosis	NN	O
,	,	O
and	CC	O
patient	NN	O
was	VBD	O
made	VBN	O
cmo	NN	B-TREATMENT
.	.	O

atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

ecasa	NN	B-TREATMENT
(	(	I-TREATMENT
aspirin	JJ	I-TREATMENT
enteric	RB	I-TREATMENT
coated	VBN	I-TREATMENT
)	)	I-TREATMENT
81	CD	O
mg	NN	O
po	NN	O
qd	NN	O
levoxyl	NN	B-TREATMENT
(	(	I-TREATMENT
levothyroxine	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
)	)	I-TREATMENT
25	CD	O
mcg	NN	O
po	NN	O
qd	NN	O
synarel	NN	B-TREATMENT
(	(	I-TREATMENT
nafarelin	JJ	I-TREATMENT
acetate	NN	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
puff	JJ	O
na	TO	O
bid	VB	O
nitroglycerin	RB	B-TREATMENT
1/150	CD	O
(	(	O
0.4	CD	O
mg	NN	O
)	)	O
1	CD	O
tab	NN	O
sl	NN	O
q5min	NN	O
x	VBD	O
3	CD	O
doses	NNS	O
prn	JJ	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
multivitamin	NN	B-TREATMENT
therapeutic	JJ	I-TREATMENT
(	(	I-TREATMENT
therapeutic	JJ	I-TREATMENT
multivi	NN	I-TREATMENT
...	:	I-TREATMENT
)	)	I-TREATMENT
1	CD	O
tab	NN	O
po	NN	O
qd	NN	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

simvastatin	NN	B-TREATMENT
and	CC	O
niacin	NN	B-TREATMENT
,	,	O
vit	NN	O
.	.	O

ok	JJ	O
toprol	NN	B-TREATMENT
xl	NNP	I-TREATMENT
(	(	I-TREATMENT
metoprolol	NN	I-TREATMENT
(	(	I-TREATMENT
sust.	JJ	I-TREATMENT
rel.	NN	I-TREATMENT
)	)	I-TREATMENT
)	)	O
200	CD	O
mg	NN	O
po	NN	O
qd	NN	O

8	CD	O
plavix	NN	B-TREATMENT
(	(	I-TREATMENT
clopidogrel	NN	I-TREATMENT
)	)	I-TREATMENT
75	CD	O
mg	NN	O
po	NN	O
qd	NN	O
lipitor	NN	B-TREATMENT
(	(	I-TREATMENT
atorvastatin	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O

potentially	RB	O
serious	JJ	B-PROBLEM
interaction	NN	I-PROBLEM
:	:	O

niacin	RB	B-TREATMENT
,	,	O
vit	NN	O
.	.	O

b-3	NN	O
and	CC	O
atorvastatin	NN	B-TREATMENT
calcium	NN	I-TREATMENT

morphine	NN	B-TREATMENT
,	,	O

leuprolide	JJ	B-TREATMENT
admit	NN	O
diagnosis	NN	O
:	:	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

s	NN	O
/	NNP	O
p	NN	O
inferior	JJ	B-PROBLEM
stemi	NN	I-PROBLEM
(	(	O
2/17	CD	O
)	)	O
with	IN	O
stent	NN	B-TREATMENT
to	TO	I-TREATMENT
rca	VB	I-TREATMENT
;	:	O
tte	NN	B-TEST
(	(	O
2/17	CD	O
)	)	O
-	:	O
lvef	JJ	B-TEST
55-60%	JJ	O
,	,	O
inferobasal	JJ	B-PROBLEM
hk	NN	I-PROBLEM
;	:	O
cervical	JJ	B-PROBLEM
spinal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
;	:	O
hypothyroidism	NN	B-PROBLEM
;	:	O
gerd	NN	B-PROBLEM
;	:	O
endometriosis	CC	B-PROBLEM
s	VB	O
/	JJ	O
p	NN	O
laparotomy	NN	B-TEST
and	CC	O
l	JJ	B-TREATMENT
oophorectomy	NN	I-TREATMENT
.	.	O

ett	SYM	B-TEST
-	:	O
mibi	NN	B-TEST
5/27/05	CD	O
-	:	O
normal	JJ	O
,	,	O
no	DT	O
e	NN	O
/	VBZ	O
o	JJ	O
ischemia	NN	B-PROBLEM
.	.	O

45	CD	O
yo	JJ	O
f	NN	O
s	NN	O
/	NNP	O
p	NN	O
recent	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
stemi	NN	I-PROBLEM
(	(	O
2/17	CD	O
)	)	O
w/	NN	O
100%	CD	O
rca	NN	O
stented	VBD	O
-&gt;	JJ	O
0%	CD	O
,	,	O
and	CC	O
residual	JJ	B-PROBLEM
lad	NN	I-PROBLEM
/	NNP	I-PROBLEM
diag1/lcx	NN	I-PROBLEM
/	NNP	I-PROBLEM
om2	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

developed	VBN	O
burning	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
before	IN	O
bedtime	NN	O
the	DT	O
night	NN	O
pta	NN	O
.	.	O

no	DT	O
associated	JJ	O
sxs	NN	B-PROBLEM
/	NNP	O
radiation	NN	B-PROBLEM
.	.	O

slept	RB	O
well	RB	O
,	,	O
but	CC	O
on	IN	O
the	DT	O
am	VBP	O
of	IN	O
admission	NN	O
had	VBD	O
same	JJ	B-PROBLEM
burning	NN	I-PROBLEM
across	IN	I-PROBLEM
chest	NN	I-PROBLEM
(	(	O
&quot;	FW	O
deeper	JJR	O
than	IN	O
heartburn	VB	B-PROBLEM
&quot;	JJ	O
)	)	O
so	RB	O
went	VBD	O
to	TO	O
her	PRP$	O
md	NN	O
&apos;s	JJ	O
office	NN	O
.	.	O

transient	JJ	B-PROBLEM
diaphoresis	NN	I-PROBLEM
in	IN	O
md	NN	O
&apos;s	NNP	O
office	NN	O
that	WDT	O
patient	NN	O
attributed	VBD	O
to	TO	O
heat	VB	O
in	IN	O
room	NN	O
.	.	O

patient	NN	O
says	VBZ	O
pain	NN	B-PROBLEM
is	VBZ	O
similar	JJ	O
in	IN	O
location	NN	O
and	CC	O
quality	NN	O
to	TO	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
she	PRP	O
had	VBD	O
with	IN	O
her	PRP	B-PROBLEM
mi	NN	I-PROBLEM
,	,	O
although	IN	O
with	IN	O
her	PRP$	B-PROBLEM
mi	NN	I-PROBLEM
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
much	RB	O
more	JJR	O
intense	JJ	O
(	(	O
20x	CD	O
worse	NN	O
)	)	O
.	.	O

this	DT	O
is	VBZ	O
1st	CD	B-PROBLEM
pain	NN	I-PROBLEM
since	IN	O
mi	NN	B-PROBLEM
(	(	O
though	IN	O
patient	NN	O
reports	NNS	O
chronic	JJ	B-PROBLEM
baseline	NN	I-PROBLEM
chest	NN	I-PROBLEM
tightness	IN	I-PROBLEM
x8-10	JJ	O
years	NNS	O
of	IN	O
unclear	JJ	O
etiology	NN	O
)	)	O
.	.	O

cp	NN	B-PROBLEM
/	NN	O
burning	VBG	B-PROBLEM
lasted	VBD	O
several	JJ	O
hours	NNS	O
and	CC	O
was	VBD	O
relieved	VBN	O
after	IN	O
she	PRP	O
received	VBD	O
maalox	NN	B-TREATMENT
,	,	O
lidocaine	NN	B-TREATMENT
,	,	O
and	CC	O
ntg	RB	B-TREATMENT
in	IN	O
the	DT	O
ed	NN	O
.	.	O

she	PRP	O
reports	VBZ	O
compliance	NN	O
with	IN	O
her	PRP$	B-TREATMENT
asa	NN	I-TREATMENT
+	NN	O
plavix	NN	B-TREATMENT
.	.	O

she	PRP	O
is	VBZ	O
active	JJ	O
at	IN	O
baseline	NN	O
,	,	O
participating	VBG	O
in	IN	O
cardiac	JJ	B-TREATMENT
rehab	NN	I-TREATMENT
for	IN	O
2	CD	O
hrs	NNS	O
/	JJ	O
week	NN	O
and	CC	O
running	VBG	O
up	RB	O
and	CC	O
down	RB	O
stairs	NNS	O
at	IN	O
home	NN	O
without	IN	O
cp	JJ	B-PROBLEM
/	NNP	O
sob	NN	B-PROBLEM
.	.	O

in	IN	O
ed	JJ	O
vitals	NNS	B-TEST
p86	VBP	B-TEST
bp	RB	B-TEST
127/88	CD	O
sat	VBD	B-TEST
100%	CD	O
.	.	O

nad	NN	B-PROBLEM
.	.	O

no	DT	O
jvd	NN	B-PROBLEM
.	.	O

ctab.	NN	O
nl	NN	O
s1s2	NN	O
,	,	O
reg	NN	O
,	,	O
no	DT	O
m	NN	B-PROBLEM
/	NNP	O
r.	VBZ	B-PROBLEM
no	DT	O
chest	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

abd	NN	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
/	NNP	O
nd	NN	B-PROBLEM
,	,	O
nabs.	JJ	O
ext	NN	O
wwp	NN	O
,	,	O
no	DT	O
c	NN	B-PROBLEM
/	NNP	O
c/e	NN	B-PROBLEM
,	,	O
2+dp	CD	B-TEST
&apos;s	NN	O
b	NN	O
/	NNP	O
l.	NN	O

trop	NN	B-TEST
&lt;	NNP	I-TEST
assay	NN	I-TEST
,	,	O
ck	NN	B-TEST
67	CD	O
,	,	O
mb	VBD	B-TEST
0.2	CD	O
.	.	O

ekg	SYM	B-TEST
-	:	O
old	JJ	B-PROBLEM
twi	NN	I-PROBLEM
iii	NN	I-PROBLEM
.	.	O

a	DT	O
/	JJ	O
p	NN	B-TEST
:	:	O

45f	CD	O
with	IN	O
recent	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
stemi	NN	I-PROBLEM
s	NN	O
/	NNP	O
p	NN	O
stent	NN	B-TREATMENT
to	TO	I-TREATMENT
rca	VB	I-TREATMENT
.	.	O

(	(	O
i	NN	O
)	)	O
romi	NN	B-TEST
negative	JJ	O
.	.	O

ett	NN	B-TEST
mibi	NN	B-TEST
4/14	CD	O
without	IN	O
e	NN	O
/	NNP	O
o	NN	O
ischemia	NN	B-PROBLEM
.	.	O
?	.	O

gerd	NN	B-PROBLEM
as	IN	O
etiology	NN	O
of	IN	O
her	PRP$	B-PROBLEM
chest	NN	I-PROBLEM
burning	NN	I-PROBLEM
.	.	O

cont	NN	O
asa	NN	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
,	,	O
bblkr	NN	B-TREATMENT
.	.	O

(	(	O
p	NN	O
)	)	O
most	RBS	O
recent	JJ	O
echo	NN	B-TEST
:	:	O

ef	RB	B-TEST
55%	CD	O
and	CC	O
inf	JJ	B-PROBLEM
/	NNP	I-PROBLEM
post	NN	I-PROBLEM
hk	NN	I-PROBLEM
.	.	O

(	(	O
r	NN	O
)	)	O
patient	NN	O
had	VBD	O
no	DT	O
events	NNS	O
on	IN	O
tele	NN	B-TEST
.	.	O

continue	NN	O
levoxyl	NN	B-TREATMENT
for	IN	O
hypothyroidism	NN	B-PROBLEM
,	,	O
synarel	NN	B-TREATMENT
for	IN	O
endometriosis	NN	B-PROBLEM
.	.	O

cervical	JJ	B-PROBLEM
spondylosis	NN	I-PROBLEM
,	,	O
tylenol	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

h	NN	O
/	JJ	O
o	JJ	O
gerd-	JJ	B-PROBLEM
nexium	NN	B-TREATMENT
.	.	O

if	IN	O
you	PRP	O
develop	VBP	O
recurrent	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
call	VB	O
your	PRP$	O
doctor	NN	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
hospital	NN	O
.	.	O

continue	VB	O
taking	VBG	O
all	DT	O
of	IN	O
your	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

right	JJ	B-PROBLEM
parietal	NN	I-PROBLEM
wound	VBD	I-PROBLEM
dehiscence	NN	I-PROBLEM
.	.	O

csf	NN	B-PROBLEM
leak	NN	I-PROBLEM
.	.	O

perforated	VBN	B-PROBLEM
diverticulitis	NN	I-PROBLEM
.	.	O

lumbar	NN	B-TREATMENT
drain	NN	I-TREATMENT
placement	JJ	I-TREATMENT
2012-05-24	JJ	O

exploratory	JJ	B-TEST
laparotomy	JJ	I-TEST
2012-05-26	JJ	O

abdominal	JJ	B-TREATMENT
washtou	NN	I-TREATMENT
2012-05-26	JJ	O

sigmoid	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
and	CC	O
hartmans	NNS	B-TREATMENT
pouch	JJ	I-TREATMENT
2012-05-26	JJ	O

lumbar	NN	B-TREATMENT
drain	NN	I-TREATMENT
placement	JJ	I-TREATMENT
2012-05-29	JJ	O

ct-guided	JJ	B-TREATMENT
aspiration	NN	I-TREATMENT
06-01	NN	O
for	IN	O
pelvic	JJ	B-PROBLEM
abscess	NN	I-PROBLEM

reveision	NN	B-TREATMENT
right	RB	I-TREATMENT
craniotomy	VBZ	I-TREATMENT
06-03	JJ	O

revsion	NN	B-TREATMENT
of	IN	I-TREATMENT
bone	NN	I-TREATMENT
flap	NN	I-TREATMENT
06-03	NN	O

emergent	JJ	B-TREATMENT
intubation	NN	I-TREATMENT
06-04	NN	O

picc	JJ	B-TREATMENT
line	NN	I-TREATMENT
placement	NN	I-TREATMENT
2012-06-08	JJ	O

57	CD	O
yo	NN	O
right	RB	O
handed	VBD	O
male	NN	O
with	IN	O
seizure	NN	B-PROBLEM
history	NN	I-PROBLEM
since	IN	O
1988	CD	O
,	,	O
s/p	JJ	O
craniotomies	NNS	B-TREATMENT
x	VBP	O
3	CD	O
(	(	O
most	RBS	O
recently	RB	O
05-05	VBP	O
)	)	O
for	IN	O
oligodendroglioma	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
began	VBD	O
having	VBG	O
generalized	VBN	B-PROBLEM
tonic	JJ	I-PROBLEM
-	:	I-PROBLEM
clonic	NN	I-PROBLEM
seizures	NNS	I-PROBLEM
in	IN	O
1988	CD	O
,	,	O
which	WDT	O
at	IN	O
the	DT	O
time	NN	O
were	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
related	VBN	O
to	TO	O
asthma	VB	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
his	PRP$	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
negative	JJ	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
dilantin	NN	B-TREATMENT
and	CC	O
phenobarbital	NN	B-TREATMENT
.	.	O

however	RB	O
,	,	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
left	VBN	B-PROBLEM
arm	JJ	I-PROBLEM
focal	JJ	I-PROBLEM
motor	NN	I-PROBLEM
seizures	NNS	I-PROBLEM
and	CC	O
problems	NNS	B-PROBLEM
thinking	VBG	I-PROBLEM
.	.	O

in	IN	O
2001-08-31	JJ	O
he	PRP	O
stopped	VBD	O
his	PRP$	B-TREATMENT
medication	NN	I-TREATMENT
and	CC	O
had	VBD	O
a	DT	B-PROBLEM
generalized	VBN	I-PROBLEM
tonic	JJ	I-PROBLEM
-	:	I-PROBLEM
clonic	JJ	I-PROBLEM
seizure	NN	I-PROBLEM
in	IN	O
12/94	CD	O
.	.	O

he	PRP	O
was	VBD	O
diagnosed	VBN	O
by	IN	O
biopsy	NN	B-TEST
with	IN	O
oligodendroglioma	NN	B-PROBLEM
,	,	O
and	CC	O
gross	JJ	B-TREATMENT
total	JJ	I-TREATMENT
resection	NN	I-TREATMENT
by	IN	O
dr.	NN	O
redner	NN	O
in	IN	O

95	CD	O
revealed	VBD	O
a	DT	B-PROBLEM
low-grade	JJ	I-PROBLEM
oligodendroglioma	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
dr.	JJ	O
gregory	NN	O
dumas	NN	O
,	,	O
with	IN	O
serial	JJ	B-TEST
mri	NN	I-TEST
's.	NN	I-TEST

in	IN	O
2011-05-02	JJ	O
,	,	O
he	PRP	O
was	VBD	O
requiring	VBG	O
more	JJR	B-TREATMENT
ativan	NNS	I-TREATMENT
to	TO	O
control	VB	O
his	PRP$	B-PROBLEM
seizures	NNS	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
increasingly	RB	B-PROBLEM
disoriented	VBN	I-PROBLEM
and	CC	O
forgetful	JJ	B-PROBLEM
with	IN	O
headaches	NNS	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
repeat	NN	I-TREATMENT
total	JJ	I-TREATMENT
resection	NN	I-TREATMENT
in	IN	O
4/04	CD	O
by	IN	O
dr.	NN	O
peter	NN	O
hoadley	NN	O
at	IN	O
hallmark	NN	O
health	NN	O
system	NN	O
which	WDT	O
revealed	VBD	O
anaplastic	JJ	B-PROBLEM
oligodendroglioma	NN	I-PROBLEM
grade	NN	I-PROBLEM
iii	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
radiation	NN	B-TREATMENT
following	VBG	O
the	DT	B-TREATMENT
resection	NN	I-TREATMENT
and	CC	O
was	VBD	O
doing	VBG	O
well	RB	O
on	IN	O
monthly	JJ	B-TREATMENT
temodar	NN	I-TREATMENT
until	IN	O
2012-04-23	JJ	O
when	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
marked	JJ	I-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
behavior	NN	I-PROBLEM
,	,	O
his	PRP$	O
balance	NN	O
was	VBD	O
off	RB	O
,	,	O
speech	NN	B-PROBLEM
slurred	VBD	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
had	VBD	O
difficulty	NN	B-PROBLEM
using	VBG	I-PROBLEM
the	DT	I-PROBLEM
computer	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
head	NN	I-TEST
mri	NN	I-TEST
on	IN	O
2012-04-24	JJ	O
revealed	JJ	O
increasing	VBG	B-PROBLEM
tumor	NN	I-PROBLEM
infiltration	NN	I-PROBLEM
with	IN	O
increased	JJ	B-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
craniotomy	NN	I-TREATMENT
with	IN	O
resection	NN	B-TREATMENT
and	CC	O
gliadel	NN	B-TREATMENT
wafers	NNS	I-TREATMENT
on	IN	O
2012-05-02	JJ	O
at	IN	O
hallmark	NN	O
health	NN	O
system	NN	O
by	IN	O
dr.	JJ	O
ackley	NN	O
.	.	O

came	VBD	O
for	IN	O
neurosurgery	NN	O
follow	VBP	O
up	RP	O
on	IN	O
05-21	NN	O
,	,	O
and	CC	O
had	VBD	O
been	VBN	O
having	VBG	O
clear	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
leaking	VBG	O
from	IN	O
his	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
frontal	JJ	B-PROBLEM
headache	NN	I-PROBLEM
,	,	O
imbalance	NN	B-PROBLEM
,	,	O
bumping	VBG	O
into	IN	O
things	NNS	O
with	IN	O
his	PRP$	O
left	JJ	O
leg	NN	O
and	CC	O
worsening	VBG	B-PROBLEM
tremors	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
for	IN	O
lumbar	NN	B-TREATMENT
drain	NN	I-TREATMENT
placement	NN	I-TREATMENT

right	JJ	B-PROBLEM
parietal	NN	I-PROBLEM
oligodendroglioma	NN	I-PROBLEM
,	,	O
as	IN	O
above	IN	O
status	NN	O
post	NN	O
craniotomy	NN	B-TREATMENT
x	$	O
3	CD	O
(	(	O
'95	CD	O
,	,	O
'04	CD	O
,	,	O
'05	CD	O
)	)	O

hernia	NN	B-TREATMENT
surgery	NN	I-TREATMENT
x	CD	O
3	CD	O

right	JJ	B-PROBLEM
hand	NN	I-PROBLEM
ganglion	NN	I-PROBLEM
cyst	NN	I-PROBLEM
removed	VBD	O

asthma	NN	B-PROBLEM

abdomen	NNS	O
soft	JJ	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	VBD	B-PROBLEM

no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM

strength	NN	B-TEST
5/5	CD	O
throughout	IN	O

2+	CD	B-TEST
reflexes	NNS	I-TEST
throughout	IN	O

no	DT	O
dysmetria	NN	B-PROBLEM

wbc	SYM	B-TEST
-	:	O
6.3	CD	O
rbc	NN	B-TEST
-	:	O
4.17	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
13.7	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
40.2	CD	O
mcv	SYM	B-TEST
-	:	O
96	CD	O
mch	SYM	B-TEST
-	:	O
32.7	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
34.0	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
143	CD	O
*	NN	O
pt	NN	B-TEST
-	:	O
11.9	CD	O
ptt	NN	B-TEST
-	:	O
21.1	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
0.9	CD	O
glucose	JJ	B-TEST
-	:	O
207	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
17	CD	O
creat	NN	B-TEST
-	:	O
0.9	CD	O
na	SYM	B-TEST
-	:	O
134	CD	O
k	SYM	B-TEST
-	:	O
4.6	CD	O
cl	NN	B-TEST
-	:	O
93	CD	O
*	NN	O
hco3	NN	B-TEST
-	:	O
35	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
11	CD	O
calcium	NN	B-TEST
-	:	O
8.3	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
1.8	CD	O
*#	NN	O
mg	SYM	B-TEST
-	:	O
2.1	CD	O

wbc	SYM	B-TEST
-	:	O
6.5	CD	O
rbc	NN	B-TEST
-	:	O
3.20	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
30.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
96	CD	O
mch	SYM	B-TEST
-	:	O
32.8	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
34.2	CD	O
rdw	NN	B-TEST
-	:	O
14.3	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
227	CD	O
pt	NN	B-TEST
-	:	O
13.4	CD	O
ptt	NN	B-TEST
-	:	O
24.6	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	I-TEST
1.1	CD	O
glucose	JJ	B-TEST
-	:	O
117	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
12	CD	O
creat	NN	B-TEST
-	:	O
0.6	CD	O
na	SYM	B-TEST
-	:	O
140	CD	O
k	SYM	B-TEST
-	:	O
4.2	CD	O
cl	NN	B-TEST
-	:	O
102	CD	O
hco3	NN	B-TEST
-	:	O
32	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
10	CD	O
calcium	NN	B-TEST
-	:	O
9.0	CD	O
phos	NN	B-TEST
-	:	O
3.9	CD	O
mg	SYM	B-TEST
-	:	O
2.0	CD	O

diverticular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
colon	NN	I-PROBLEM
:	:	O

1.	CD	O
multiple	JJ	B-PROBLEM
diverticula	NN	I-PROBLEM
.	.	O

2.	CD	O
rupture	NN	B-PROBLEM
of	IN	I-PROBLEM
diverticulum	NN	I-PROBLEM
with	IN	O
pericolic	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
2012-06-11	CD	O
:	:	O

1)	CD	O
overall	JJ	O
,	,	O
a	DT	O
slight	JJ	O
decrease	NN	O
in	IN	O
the	DT	B-PROBLEM
mass	NN	I-PROBLEM
effect	NN	I-PROBLEM
and	CC	O
edema	NN	B-PROBLEM
associated	VBN	O
with	IN	O
the	DT	O
postoperative	JJ	O
changes	NNS	O
.	.	O

2)	CD	O
slight	JJ	O
increase	NN	O
in	IN	O
epidural	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
adjacent	NN	O
to	TO	O
the	DT	B-PROBLEM
craniotomy	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
abdomen	NNS	I-TEST
2012-06-18	CD	O
:	:	O

small	JJ	B-PROBLEM
residual	JJ	I-PROBLEM
collection	NN	I-PROBLEM
anterior	NN	O
to	TO	O
the	DT	O
rectum	NN	O
,	,	O
smaller	JJR	O
than	IN	O
on	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
,	,	O
and	CC	O
without	IN	O
substantial	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
components	NNS	I-PROBLEM
to	TO	O
allow	VB	O
drainage	NN	B-TREATMENT
.	.	O

wound	JJ	B-TEST
culture	NN	I-TEST
(	(	O
final	JJ	O
2012-06-05	NN	O
)	)	O
:	:	O

(	(	O
pelvic	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
)	)	O

due	JJ	O
to	TO	O
mixed	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
types	NNS	I-PROBLEM
(	(	O
>=	$	O
3	CD	O
colony	NN	O
types	NNS	O
)	)	O
an	DT	B-TEST
abbreviated	JJ	I-TEST
workup	NN	I-TEST
is	VBZ	O
performed	VBN	O
appropriate	JJ	O
to	TO	O
the	DT	O
isolates	NNS	O
recovered	VBD	O
from	IN	O
the	DT	O
site	NN	O
(	(	O
including	VBG	O
a	DT	B-TEST
screen	NN	I-TEST
for	IN	O
pseudomonas	NN	B-PROBLEM
aeruginosa	NN	I-PROBLEM
,	,	O
staphylococcus	VB	B-PROBLEM
aureus	NN	I-PROBLEM
and	CC	O
beta	NN	B-PROBLEM
streptococcus	NN	I-PROBLEM
)	)	O
.	.	O

enterococcus	NN	B-PROBLEM
sp.	NN	I-PROBLEM

sparse	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

pseudomonas	NNS	B-PROBLEM
aeruginosa	NN	I-PROBLEM
.	.	O

sparse	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

corynebacterium	NN	B-PROBLEM
species	NNS	I-PROBLEM
(	(	I-PROBLEM
diphtheroids	NNS	I-PROBLEM
)	)	I-PROBLEM
.	.	O

sparse	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

enterococcus	NN	B-PROBLEM
sp	NN	I-PROBLEM
.	.	O

pseudomonas	NNS	B-PROBLEM
aeruginosa	VBP	I-PROBLEM

ampicillin------------	NN	B-TREATMENT

cefepime--------------	NN	B-TREATMENT

ceftazidime-----------	NN	B-TREATMENT

ciprofloxacin---------	NN	B-TREATMENT

gentamicin------------	NN	B-TREATMENT

imipenem--------------	NN	B-TREATMENT

levofloxacin----------	NN	B-TREATMENT

meropenem-------------	NN	B-TREATMENT

penicillin------------	NN	B-TREATMENT

piperacillin----------	NN	B-TREATMENT

piperacillin/tazo-----	NN	B-TREATMENT

tobramycin------------	NN	B-TREATMENT

vancomycin------------	NN	B-TREATMENT

wound	JJ	B-TEST
culture	NN	I-TEST
(	(	O
final	JJ	O
2012-06-05	NN	O
)	)	O
:	:	O

(	(	O
from	IN	O
or	CC	B-TREATMENT
revision	VB	I-TREATMENT
craniotomy	NN	I-TREATMENT
)	)	O

staph	NN	B-PROBLEM
aureus	NN	I-PROBLEM
coag	NN	I-PROBLEM
+	NN	O
.	.	O

sparse	JJ	B-PROBLEM
growth	NN	I-PROBLEM
.	.	O

oxacillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococci	NN	I-PROBLEM
must	MD	O
be	VB	O
reported	VBN	O
as	IN	O
also	RB	O
resistant	VBP	B-PROBLEM
to	TO	O
other	JJ	O
penicillins	NNS	B-TREATMENT
,	,	O
cephalosporins	NNS	B-TREATMENT
,	,	O
carbacephems	NNS	B-TREATMENT
,	,	O
carbapenems	NNS	B-TREATMENT
,	,	O
and	CC	O
beta-lactamase	JJ	B-TREATMENT
inhibitor	NN	I-TREATMENT
combinations	NNS	I-TREATMENT
.	.	O

rifampin	NN	B-TREATMENT
should	MD	O
not	RB	O
be	VB	O
used	VBN	O
alone	RB	O
for	IN	O
therapy	NN	B-TREATMENT
.	.	O

please	VB	O
contact	VB	O
the	DT	O
microbiology	NN	O
laboratory	NN	O
(	(	O
2313-08-31	JJ	O
)	)	O
immediately	RB	O
if	IN	O
sensitivity	NN	O
to	TO	O
clindamycin	VB	B-TREATMENT
is	VBZ	O
required	VBN	O
on	IN	O
this	DT	O
patient	NN	O
's	POS	O
isolate	NN	O
.	.	O

staph	NN	B-PROBLEM
aureus	NN	I-PROBLEM
coag	NN	I-PROBLEM
+	NN	O

erythromycin----------	NN	B-TREATMENT

gentamicin------------	JJ	B-TREATMENT
<=0.5	NN	O
s	NN	O

levofloxacin----------	NN	B-TREATMENT

oxacillin-------------	NN	B-TREATMENT

penicillin------------	JJ	B-TREATMENT
=>0.5	NN	O
r	NN	O

rifampin--------------	JJ	B-TREATMENT
<=0.5	NN	O
s	NN	O

tetracycline----------	NN	B-TREATMENT

vancomycin------------	NN	B-TREATMENT

brief	JJ	O
hospital	JJ	O
course	NN	O
:	:	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
2012-05-24	JJ	O
after	IN	O
having	VBG	O
drainage	NN	B-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
for	IN	O
the	DT	O
last	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
the	DT	O
brain	NN	O
tumor	NN	O
clinic	NN	O
on	IN	O
05-21	JJ	O
and	CC	O
stitches	NNS	B-TREATMENT
were	VBD	O
placed	VBN	O
in	IN	O
the	DT	B-PROBLEM
incision	NN	I-PROBLEM
,	,	O
however	RB	O
it	PRP	O
continued	VBD	O
to	TO	O
leak	VB	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
lumbar	NN	I-TREATMENT
drain	NN	I-TREATMENT
placed	VBD	O
.	.	O

he	PRP	O
c/o	VBZ	O
of	IN	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
distension	NN	B-PROBLEM
on	IN	O
05-25	NN	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
kub	NN	I-TEST
done	VBN	O
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

on	IN	O
05-26	NN	O
he	PRP	O
continued	VBD	O
to	TO	O
c/o	VB	O
of	IN	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
had	VBD	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
done	VBN	O
to	TO	O
due	VB	O
to	TO	O
decreased	JJ	B-PROBLEM
lung	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
.	.	O

general	JJ	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
or	CC	O
for	IN	O
exploratory	JJ	B-TEST
laproratomy	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
perforated	VBN	I-PROBLEM
sigmoid	NN	I-PROBLEM
diverticulum	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
colostomy	NN	I-TREATMENT
and	CC	O
partial	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
.	.	O

patient	NN	O
recovered	VBN	O
well	RB	O
from	IN	O
colocetomy	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
abd	NN	I-PROBLEM
abcess	NN	I-PROBLEM
which	WDT	O
was	VBD	O
drained	VBN	O
via	IN	O
ct	NN	B-TEST
guidance	NN	I-TEST
on	IN	O
06-01	NN	O
.	.	O

on	IN	O
06-02	JJ	O
his	PRP$	B-TREATMENT
lumbar	NN	I-TREATMENT
drain	NN	I-TREATMENT
pulled	VBD	O
out	RP	O
.	.	O

he	PRP	O
had	VBD	O
to	TO	O
have	VB	O
it	PRP	O
replaced	VBN	O
,	,	O
however	RB	O
,	,	O
because	IN	O
his	PRP$	B-PROBLEM
head	NN	I-PROBLEM
incision	NN	I-PROBLEM
began	VBD	O
to	TO	O
leak	VB	O
again	RB	O
.	.	O

on	IN	O
06-03	NN	O
he	PRP	O
was	VBD	O
taken	VBN	O
back	RB	O
to	TO	O
the	DT	O
or	CC	O
for	IN	O
debridement	NN	B-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
head	NN	I-PROBLEM
wound	NN	I-PROBLEM
with	IN	O
removal	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
remaining	VBG	I-PROBLEM
gliadel	NN	I-PROBLEM
waffers	NNS	I-PROBLEM
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
,	,	O
postop	VB	O
however	RB	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
grand	JJ	I-PROBLEM
mal	JJ	I-PROBLEM
seizure	NN	I-PROBLEM
and	CC	O
was	VBD	O
intubated	VBN	O
and	CC	O
sent	VBN	O
to	TO	O
the	DT	O
icu	NN	O
.	.	O

id	NN	O
was	VBD	O
consulted	VBN	O
for	IN	O
both	DT	O
the	DT	B-PROBLEM
abd	NN	I-PROBLEM
abcess	NN	I-PROBLEM
and	CC	O
possible	JJ	O
meningitis	NN	B-PROBLEM
given	VBN	O
the	DT	B-PROBLEM
large	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
wbc	NN	I-PROBLEM
in	IN	O
the	DT	B-TEST
csf	NN	I-TEST
cultures	NNS	I-TEST
.	.	O

patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
q12	NN	O
and	CC	O
zosyn	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
kept	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
until	IN	O
06-17	NNP	O
.	.	O

neurologically	RB	O
he	PRP	O
slowly	RB	O
woke	VBD	O
up	RP	O
after	IN	O
the	DT	B-PROBLEM
seizures	NNS	I-PROBLEM
and	CC	O
was	VBD	O
extubated	VBN	O
on	IN	O
06-03	NN	O
.	.	O

he	PRP	O
was	VBD	O
transfered	VBN	O
to	TO	O
the	DT	O
step	NN	O
down	RB	O
unit	NN	O
and	CC	O
had	VBD	O
his	PRP$	B-TREATMENT
lumbar	NN	I-TREATMENT
drain	NN	I-TREATMENT
slowly	RB	O
weaned	VBD	O
.	.	O

the	DT	B-TREATMENT
lumbar	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
d/ced	VBN	O
on	IN	O
06-14	NN	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
which	WDT	O
remains	VBZ	O
stable	JJ	O
and	CC	O
head	NN	B-PROBLEM
wound	NN	I-PROBLEM
remain	VBP	O
dry	JJ	O
.	.	O

pt	NN	O
and	CC	O
ot	NN	O
are	VBP	O
recommending	VBG	O
rehab	NN	B-TREATMENT
.	.	O

he	PRP	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr	NN	O
fisher	VBP	O
the	DT	O
general	JJ	O
surgeon	NN	O
in	IN	O
two	CD	O
weeks	NNS	O
and	CC	O
follow	VB	O
up	RP	O
in	IN	O
the	DT	O
brain	NN	O
tumor	NN	O
clinic	NN	O
in	IN	O
two	CD	O
weeks	NNS	O
for	IN	O
stitch	NN	B-TREATMENT
removal	NN	I-TREATMENT
.	.	O

h	NN	O
ewas	NN	O
switched	VBN	O
to	TO	O
oral	JJ	B-TREATMENT
cipro	NN	I-TREATMENT
for	IN	O
the	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
abcess	NN	I-PROBLEM
and	CC	O
will	MD	O
continue	VB	O
it	PRP	O
until	IN	O
he	PRP	O
has	VBZ	O
his	PRP$	O
followup	NN	O
with	IN	O
infectious	JJ	O
disease	NN	O
in	IN	O
2	CD	O
weeks	NNS	O
.	.	O

neurontin	NN	B-TREATMENT
,	,	O
keppra	NN	B-TREATMENT
,	,	O
lamictal	JJ	B-TREATMENT
,	,	O
decadron	NN	B-TREATMENT
,	,	O
multivitamin	NN	B-TREATMENT
,	,	O
murray	NN	O
,	,	O
calcium	NN	B-TREATMENT

1.	CD	O
heparin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

2.	CD	O
diphenhydramine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
25	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

3.	CD	O
albuterol	SYM	B-TREATMENT
-	:	I-TREATMENT
ipratropium	NN	I-TREATMENT
103-18	JJ	O
mcg	NN	O
/	NNP	O
actuation	NN	O
aerosol	NN	O
sig	NN	O
:	:	O
03-04	JJ	O
puffs	NNS	O
inhalation	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

5.	CD	O
fluticasone	NN	B-TREATMENT
-	:	I-TREATMENT
salmeterol	NN	I-TREATMENT
250-50	JJ	O
mcg	NN	O
/	NNP	O
dose	JJ	O
disk	NN	O
with	IN	O
device	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
disk	NN	O
with	IN	O
device	JJ	O
inhalation	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

6.	CD	O
lamotrigine	JJ	B-TREATMENT
100	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1.5	CD	O
tablets	NNS	O
po	JJ	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

7.	CD	O
levetiracetam	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
ibuprofen	JJ	B-TREATMENT
400	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

9.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

11.	CD	O
ciprofloxacin	NN	B-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
2	CD	O
weeks.	JJ	O
tablet	NN	O
(	(	O
s	NN	O
)	)	O

12.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
0.5	CD	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

13.	CD	O
lorazepam	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
dexamethasone	NN	B-TREATMENT
2	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
.	.	O

15.	CD	O
insulin	NN	B-TREATMENT
regular	JJ	I-TREATMENT
human	JJ	I-TREATMENT
100	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
asdir	NN	O
(	(	O
as	IN	O
directed	VBN	O
)	)	O
:	:	O
51-150	JJ	O
0	CD	O
units	NNS	O

16.	CD	O
hydralazine	NN	B-TREATMENT
hcl	NN	I-TREATMENT
20	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
0.5	CD	O
syringe	NN	O
injection	NN	O
q4hr	NN	O
(	(	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
sbp	JJ	B-PROBLEM
>	JJ	O
150	CD	O
.	.	O

cerebrospinal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
leak	NN	I-PROBLEM

chronic	JJ	O
steroid	NN	O
use	NN	O
wound	NN	B-PROBLEM
infection	NN	I-PROBLEM

perforated	VBN	B-PROBLEM
sigmoid	JJ	I-PROBLEM
diverticulum	NN	I-PROBLEM
status	NN	O
post	NN	O
exploratory	NN	B-TEST
laparotomy	NN	I-TEST

status	NN	O
post	NN	O
sigmoid	NN	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
hartmans	NNS	B-TREATMENT
pouch	JJ	I-TREATMENT
and	CC	O
washout	NN	B-TREATMENT

post	NN	B-PROBLEM
operative	JJ	I-PROBLEM
fever	NN	I-PROBLEM
fever	NN	B-PROBLEM
status	NN	O
post	NN	O
reveision	NN	B-TREATMENT
right	RB	I-TREATMENT
craniotomy	NN	I-TREATMENT
and	CC	O
revsion	NN	B-TREATMENT
of	IN	I-TREATMENT
bone	NN	I-TREATMENT
flap	NN	I-TREATMENT
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

seizure	NN	B-PROBLEM

conant	JJ	B-PROBLEM
palsy	NN	I-PROBLEM
with	IN	O
left	NN	B-PROBLEM
sided	VBD	I-PROBLEM
weakness	NN	I-PROBLEM

respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
requiring	VBG	O
intubation	NN	B-TREATMENT

methicillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
staph	NN	I-PROBLEM
aureus	JJ	I-PROBLEM
infection	NN	I-PROBLEM
of	IN	I-PROBLEM
central	JJ	I-PROBLEM
nervous	JJ	I-PROBLEM
system	NN	I-PROBLEM

pelvic	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
oligodendroglioma	NN	B-PROBLEM

asthma	NN	B-PROBLEM

s/p	JJ	O
craniotomy	NN	B-TREATMENT
x	VBD	O
3	CD	O

hernia	NN	B-TREATMENT
surgery	NN	I-TREATMENT
x	CD	O
3	CD	O

call	NN	O
with	IN	O
any	DT	B-PROBLEM
spiking	VBG	I-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
leakage	NN	B-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
head	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
increase	NN	B-PROBLEM
in	IN	I-PROBLEM
headaches	NNS	I-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
,	,	O
blurry	JJ	B-PROBLEM
vision	NN	I-PROBLEM
severe	JJ	B-PROBLEM
neck	NN	I-PROBLEM
stiffness	NN	I-PROBLEM
,	,	O
redness	NN	B-PROBLEM
,	,	O
swelling	VBG	B-PROBLEM
,	,	O
or	CC	O
discharge	VB	B-PROBLEM
around	IN	O
your	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
site	NN	I-PROBLEM

call	VB	O
your	PRP$	O
general	JJ	O
surgeon	NN	O
if	IN	O
you	PRP	O
experience	VBP	O
increased	VBN	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
vomiting	NN	B-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
or	CC	I-PROBLEM
increased	VBD	I-PROBLEM
ostomy	JJ	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

ischemic	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O
orthotopic	JJ	B-TREATMENT
heart	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
graft	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
medical	JJ	B-PROBLEM
noncompliance	NN	I-PROBLEM
.	.	O

cardiac	JJ	B-TEST
echocardiogram	NN	I-TEST
.	.	O

mr.	NN	O
vessels	NNS	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
man	NN	O
status	NN	O
post	NN	O
orthotopic	IN	B-TREATMENT
heart	NN	I-TREATMENT
transplantation	NN	I-TREATMENT
in	IN	O
1991	CD	O
at	IN	O
dautenorwe	JJ	O
stuart	NN	O
erec	VBZ	O
hillpa	NN	O
of	IN	O
hospital	NN	O
who	WP	O
is	VBZ	O
admitted	VBN	O
with	IN	O
dyspnea	NN	B-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

mr.	NN	O
vessels	NNS	O
&apos;s	VBP	O
postoperative	JJ	O
course	NN	O
has	VBZ	O
been	VBN	O
marked	VBN	O
by	IN	O
cmv	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
poorly	RB	B-PROBLEM
controlled	VBN	I-PROBLEM
lipids	NNS	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
1.8	CD	O
or	CC	O
so	RB	O
.	.	O

recently	RB	O
he	PRP	O
had	VBD	O
documented	VBN	O
coronary	JJ	B-TEST
angiography	NN	I-TEST
based	VBN	O
on	IN	O
a	DT	B-TEST
catheterization	NN	I-TEST
performed	VBN	O
in	IN	O
january	JJ	O
1996	CD	O
with	IN	O
moderate	JJ	B-PROBLEM
to	TO	I-PROBLEM
diffuse	VB	I-PROBLEM
atherosclerosis	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
angiogram	NN	I-TEST
performed	VBD	O
a	DT	O
year	NN	O
later	RB	O
showed	VBD	O
marked	JJ	O
progression	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
allograft	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
biopsy	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
revealed	VBD	O
grade	JJ	B-PROBLEM
1b	CD	I-PROBLEM
rejection	NN	I-PROBLEM
with	IN	O
endothelialitis	NN	B-PROBLEM
and	CC	O
eosinophils	NNS	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
pulsed	JJ	B-TREATMENT
iv	NN	I-TREATMENT
steroids	NNS	I-TREATMENT
and	CC	O
imuran	NN	B-TREATMENT
,	,	O
was	VBD	O
augmented	VBN	O
with	IN	O
mycophenolate	NN	B-TREATMENT
mofetil	NN	I-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
cariogenic	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
faring	VBG	O
poorly	RB	O
.	.	O

prior	RB	O
to	TO	O
admission	NN	O
he	PRP	O
was	VBD	O
seen	VBN	O
approximately	RB	O
1	CD	O
week	NN	O
in	IN	O
the	DT	O
office	NN	O
with	IN	O
mild	JJ	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
then	RB	O
revealed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
40%	CD	O
and	CC	O
an	DT	B-TEST
endomyocardial	JJ	I-TEST
biopsy	NN	I-TEST
revealed	VBD	O
no	DT	O
ejection	NN	B-PROBLEM
.	.	O

notable	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
allograft	NN	I-PROBLEM
vasculopathy	NN	I-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
cmv	JJ	B-PROBLEM
infection	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
depression	NN	B-PROBLEM
,	,	O
and	CC	O
tricuspid	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

examination	NN	B-TEST
revealed	VBD	O
a	DT	O
tired	JJ	O
,	,	O
fatigued	VBN	O
man	NN	O
with	IN	O
cool	JJ	B-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
is	VBZ	O
130/80	CD	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
100.	CD	O
jugular	JJ	B-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
increasing	VBG	O
.	.	O

carotids	NNS	B-TEST
were	VBD	O
2+	CD	O
.	.	O

crackles	NNS	B-PROBLEM
were	VBD	O
increased	VBN	O
1/4	CD	O
of	IN	O
the	DT	O
way	NN	O
up	RP	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
ventricular	NN	I-PROBLEM
heave	NN	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
s3	NN	I-PROBLEM
galop	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
with	IN	O
a	DT	O
palpable	JJ	O
liver	NN	O
edge	NN	O
and	CC	O
the	DT	B-TEST
pulses	NNS	I-TEST
were	VBD	O
diminished	VBN	O
.	.	O

revealed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
136	CD	O
,	,	O
potassium	NN	B-TEST
4.5	CD	O
,	,	O
bun	NN	B-TEST
47	CD	O
,	,	O
creatinine	NN	B-TEST
2.4	CD	O
,	,	O
glucose	VBD	B-TEST
136.	CD	O
hematocrit	NN	B-TEST
40%	CD	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
revealed	VBD	O
poor	JJ	B-PROBLEM
r	NN	I-PROBLEM
wave	NN	I-PROBLEM
progression	NN	I-PROBLEM
and	CC	O
marked	VBD	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
all	DT	I-PROBLEM
volts	NNS	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
prominent	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
vessels	NNS	I-PROBLEM
and	CC	O
enlarged	JJ	B-PROBLEM
heart	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
via	IN	O
the	DT	O
emergency	NN	O
room	NN	O
where	WRB	O
a	DT	B-TEST
bedside	NN	I-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

the	DT	B-TEST
echocardiogram	NN	I-TEST
revealed	VBD	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
30%	CD	O
and	CC	O
worsening	VBG	B-PROBLEM
systolic	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

hydrocortisone	NN	B-TREATMENT
was	VBD	O
given	VBN	O
1	CD	O
g	NN	O
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
reverse	VB	O
what	WP	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
aggressive	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
allograft	NN	I-PROBLEM
vasculopathy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
diuresed	VBD	O
and	CC	O
responded	VBD	O
to	TO	O
lasix	VB	B-TREATMENT
100	CD	O
mg	NN	O
administered	VBN	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
and	CC	O
was	VBD	O
admitted	VBN	O
to	TO	O
a	DT	O
monitored	VBN	O
bed	NN	O
.	.	O

at	IN	O
4:30	CD	O
am	VBP	O
the	DT	O
following	JJ	O
morning	NN	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
in	IN	O
cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

despite	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
intravenous	JJ	B-TREATMENT
epinephrine	NN	I-TREATMENT
,	,	O
and	CC	O
multiple	JJ	O
attempts	NNS	O
at	IN	O
defibrillation	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
unable	JJ	O
to	TO	O
be	VB	O
resuscitated	VBN	O
.	.	O

upon	IN	O
arrival	NN	O
of	IN	O
the	DT	O
covering	VBG	O
access	NN	O
physician	IN	O
the	DT	O
patient	NN	O
was	VBD	O
being	VBG	O
ventilated	VBN	O
mechanically	RB	O
and	CC	O
cpr	NN	B-TREATMENT
was	VBD	O
being	VBG	O
performed	VBN	O
.	.	O

the	DT	B-TEST
rhythm	NN	I-TEST
revealed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
with	IN	O
no	DT	O
palpable	JJ	O
or	CC	O
measurable	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

there	EX	O
were	VBD	O
also	RB	O
runs	NNS	O
of	IN	O
ventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
which	WDT	O
generated	VBD	O
into	IN	O
ventricular	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
that	WDT	O
was	VBD	O
refractory	NN	O
to	TO	O
multiple	VB	B-TREATMENT
cardioversions	NNS	I-TREATMENT
.	.	O

a	DT	B-TEST
pericardiocentesis	NN	I-TEST
was	VBD	O
attempted	VBN	O
with	IN	O
no	DT	O
yield	NN	O
of	IN	O
pericardial	JJ	O
fluid	NN	O
.	.	O

a	DT	B-TREATMENT
transvenous	JJ	I-TREATMENT
pacing	NN	I-TREATMENT
wire	NN	I-TREATMENT
was	VBD	O
attempted	VBN	O
and	CC	O
a	DT	O
pacing	NN	O
rhythm	NN	O
was	VBD	O
obtained	VBN	O
but	CC	O
with	IN	O
no	DT	O
palpable	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

in	IN	O
total	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
defibrillated	VBN	O
10	CD	O
times	NNS	O
,	,	O
given	VBN	O
5	CD	O
courses	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
epinephrine	NN	I-TREATMENT
,	,	O
one	CD	O
course	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
atropine	NN	I-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
calcium	NN	I-TREATMENT
x	VBZ	O
1	CD	O
in	IN	O
addition	NN	O
to	TO	O
an	DT	B-TREATMENT
amp	NN	I-TREATMENT
of	IN	I-TREATMENT
bicarbonate	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
resuscitation	NN	I-TREATMENT
efforts	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
at	IN	O
4:15	CD	O
am	VBP	O
and	CC	O
were	VBD	O
begun	VBN	O
at	IN	O
3:38	CD	O
am	VBP	O
.	.	O

an	DT	B-TEST
autopsy	JJ	I-TEST
permission	NN	O
was	VBD	O
granted	VBN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
inr	NN	B-TEST
of	IN	O
3.2	CD	O
that	WDT	O
came	VBD	O
back	RB	O
on	IN	O
date	NN	O
of	IN	O
discharge	NN	O
.	.	O

please	NN	O
hold	VB	O
dose	NN	O
of	IN	O
warfarin	NN	B-TREATMENT
on	IN	O
the	DT	O
night	NN	O
of	IN	O
the	DT	O
16	CD	O
,	,	O
and	CC	O
please	VB	O
recheck	VB	O
inr	NN	B-TEST
on	IN	O
2016-11-16	JJ	O
and	CC	O
dose	JJ	O
warfarin	NNS	B-TREATMENT
appropriately	RB	O
for	IN	O
inr	NN	B-TEST
of	IN	O
2	CD	O
to	TO	O
2.5.	CD	O

wound	NN	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

incision	NN	B-TREATMENT
and	CC	O
drainage	NN	B-TREATMENT
of	IN	O
wound	JJ	B-PROBLEM
infection	NN	I-PROBLEM
on	IN	O
3/7/02	CD	O
.	.	O

abdominal	JJ	B-TEST
pelvic	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
on	IN	O
3/10/02	CD	O
.	.	O

fistulogram	NN	B-TEST
on	IN	O
3/11/02	CD	O
.	.	O

intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
79-year-old	JJ	O
man	NN	O
status	NN	O
postradical	JJ	B-TREATMENT
cystoprostatectomy	NN	I-TREATMENT
with	IN	I-TREATMENT
ileal	JJ	I-TREATMENT
loop	NN	I-TREATMENT
for	IN	O
locally	RB	B-PROBLEM
invasive	JJ	I-PROBLEM
prostate	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

this	DT	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
2/11/02	CD	O
by	IN	O
dr.	NN	O
doje	NN	O
para	NN	O
.	.	O

the	DT	O
postoperative	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
transfer	NN	O
to	TO	O
the	DT	O
cardiac	JJ	O
step-down	JJ	O
unit	NN	O
.	.	O

this	DT	O
transfer	NN	O
occurred	VBD	O
around	IN	O
postoperative	JJ	O
day	NN	O
8	CD	O
for	IN	O
anticoagulation	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
load	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
anticoagulation	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
due	RB	O
to	TO	O
concern	NN	O
for	IN	O
postoperative	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
fevers	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
on	IN	O
3/7/02	CD	O
,	,	O
complaining	VBG	O
of	IN	O
fevers	NNS	B-PROBLEM
since	IN	O
monday	NN	O
3/2/02	CD	O
.	.	O

he	PRP	O
developed	VBD	O
erythema	VB	B-PROBLEM
around	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
on	IN	O
wednesday	NN	O
and	CC	O
was	VBD	O
seen	VBN	O
by	IN	O
dr.	NN	O
para	NN	O
,	,	O
who	WP	O
started	VBD	O
keflex	NNP	B-TREATMENT
and	CC	O
obtained	VBD	O
a	DT	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
which	WDT	O
demonstrated	VBD	O
a	DT	B-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
at	IN	O
the	DT	O
site	NN	O
of	IN	O
erythema	NN	B-PROBLEM
.	.	O

the	DT	B-PROBLEM
fevers	NNS	I-PROBLEM
continued	VBD	O
as	RB	O
high	JJ	O
as	IN	O
102.5	CD	O
degrees	NNS	O
f	VBP	O
with	IN	O
chills	NNS	B-PROBLEM
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
.	.	O

he	PRP	O
was	VBD	O
draining	VBG	O
pus	NN	B-PROBLEM
from	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
site	NN	I-PROBLEM
with	IN	O
subsequent	JJ	O
relief	NN	O
of	IN	O
discomfort	NN	B-PROBLEM
at	IN	O
the	DT	O
site	NN	O
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
gout	NN	B-PROBLEM
.	.	O

cystoprostatectomy	NN	B-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
inguinal	JJ	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

keflex	JJ	B-TREATMENT
500	CD	O
mg	NN	O
qid	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
presentation	NN	O
,	,	O
temperature	NN	B-TEST
99.3	CD	O
degrees	NNS	O
f	RB	O
,	,	O
other	JJ	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

he	PRP	O
was	VBD	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
non-toxic	JJ	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdomen	NNS	O
soft	JJ	O
and	CC	O
there	EX	O
was	VBD	O
wound	NN	B-PROBLEM
erythema	NN	I-PROBLEM
with	IN	O
three	CD	B-PROBLEM
areas	NNS	I-PROBLEM
of	IN	I-PROBLEM
dehiscence	NN	I-PROBLEM
draining	VBG	O
foul-smelling	JJ	B-PROBLEM
,	,	I-PROBLEM
purulent	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

the	DT	O
fascia	NN	O
appeared	VBD	O
intact	JJ	O
by	IN	O
probing	VBG	B-TEST
.	.	O

the	DT	B-TREATMENT
stoma	NN	I-TREATMENT
was	VBD	O
pink	JJ	O
and	CC	O
functional	JJ	O
.	.	O

the	DT	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
a	DT	B-PROBLEM
midline	JJ	I-PROBLEM
incision	NN	I-PROBLEM
for	IN	O
his	PRP$	B-TREATMENT
radical	JJ	I-TREATMENT
cystoprostatectomy	NN	I-TREATMENT
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
16.9	CD	O
,	,	O
hematocrit	NN	B-TEST
32.2	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
418	CD	O
,	,	O
sodium	NN	B-TEST
131	CD	O
,	,	O
potassium	NN	B-TEST
3.4	CD	O
,	,	O
chloride	RB	B-TEST
102	CD	O
,	,	O
bicarbonate	NN	B-TEST
21.4	CD	O
,	,	O
bun27	NN	B-TEST
,	,	O
creatinine	NN	B-TEST
1.4	CD	O
,	,	O
glucose	VBD	B-TEST
150	CD	O
.	.	O

ct	NNS	B-TEST
scan	JJ	I-TEST
3/5/02	CD	O
:	:	O

a	DT	B-PROBLEM
fluid	JJ	I-PROBLEM
collection	NN	I-PROBLEM
external	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
fascia	JJ	I-PROBLEM
consistent	NN	O
with	IN	O
site	NN	O
of	IN	O
erythema	NN	B-PROBLEM
.	.	O

after	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
further	RBR	O
opened	VBN	O
,	,	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
bid	NN	I-TREATMENT
dressing	VBG	I-TREATMENT
change	NN	I-TREATMENT
and	CC	O
packing	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
and	CC	O
good	JJ	O
urine	NN	O
output	NN	O
.	.	O

the	DT	B-PROBLEM
wound	NN	I-PROBLEM
erythema	NN	I-PROBLEM
was	VBD	O
improving	VBG	O
and	CC	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
packed	VBN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

wound	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

we	PRP	O
continued	VBD	O
his	PRP$	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
.	.	O

by	IN	O
hospital	JJ	O
day	NN	O
4	CD	O
,	,	O
he	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
throughout	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
.	.	O

the	DT	B-TEST
wound	NN	I-TEST
cultures	VBZ	I-TEST
demonstrated	VBN	O
gram-positive	JJ	B-PROBLEM
cocci	NN	I-PROBLEM
in	IN	I-PROBLEM
clusters	NNS	I-PROBLEM
and	CC	O
gram-negative	JJ	B-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
and	CC	O
we	PRP	O
obtained	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
to	TO	O
check	VB	O
for	IN	O
an	DT	B-PROBLEM
enterocutaneous	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

we	PRP	O
discontinued	VBD	O
his	PRP$	B-TREATMENT
flagyl	NN	I-TREATMENT
on	IN	O
that	DT	O
day	NN	O
.	.	O

we	PRP	O
contacted	VBD	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	NN	O
aslinke	NN	O
______	NNP	O
,	,	O
regarding	VBG	O
his	PRP$	B-TREATMENT
cardiac	JJ	I-TREATMENT
medication	NN	I-TREATMENT
management	NN	I-TREATMENT
.	.	O

we	PRP	O
agreed	VBD	O
that	IN	O
he	PRP	O
should	MD	O
resume	VB	O
his	PRP$	B-TREATMENT
atenolol	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
.	.	O

we	PRP	O
changed	VBD	O
the	DT	B-TREATMENT
dressings	NNS	I-TREATMENT
tid	VBP	O
instead	RB	O
of	IN	O
bid	NN	O
for	IN	O
continued	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
scan	VBD	I-TEST
that	DT	O
was	VBD	O
obtained	VBN	O
on	IN	O
3/10/02	CD	O
demonstrated	JJ	O
no	DT	O
connection	NN	O
between	IN	O
bowel	NN	O
and	CC	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
drainage	NN	I-PROBLEM
had	VBD	O
been	VBN	O
decreasing	VBG	O
and	CC	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
be	VB	O
afebrile	JJ	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
following	JJ	O
day	NN	O
,	,	O
3/11/02	CD	O
,	,	O
a	DT	B-TEST
fistulogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
a	DT	B-PROBLEM
fistula	NN	I-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
bowel	NN	I-PROBLEM
to	TO	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

her	PRP$	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

he	PRP	O
was	VBD	O
comfortable	JJ	O
and	CC	O
erythema	JJ	B-PROBLEM
continued	VBN	O
to	TO	O
decrease	VB	O
with	IN	O
improvemeent	NN	O
in	IN	O
the	DT	O
appearance	NN	O
of	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

in	IN	O
consultation	NN	O
with	IN	O
infectious	JJ	O
disease	NN	O
,	,	O
it	PRP	O
was	VBD	O
agreed	VBN	O
to	TO	O
discharge	VB	O
the	DT	O
patient	NN	O
on	IN	O
augmentin	NN	B-TREATMENT
for	IN	O
coverage	NN	O
.	.	O

we	PRP	O
obtained	VBD	O
sensitivities	NNS	B-TEST
of	IN	O
his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

he	PRP	O
remaineda	VBZ	O
febrile	JJ	B-PROBLEM
with	IN	O
daily	JJ	O
improvement	NN	O
in	IN	O
the	DT	O
appearance	NN	O
of	IN	O
his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
7	CD	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
demonstrated	VBD	O
no	DT	O
erythema	NN	B-PROBLEM
with	IN	O
moderate	JJ	B-PROBLEM
dark	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
discharged	VBN	O
with	IN	O
wh	NN	O
and	CC	O
continued	VBD	B-TREATMENT
dressing	VBG	I-TREATMENT
changes	NNS	I-TREATMENT
bid	NN	O
.	.	O

1.	CD	O
the	DT	O
patient	NN	O
will	MD	O
be	VB	O
sent	VBN	O
home	NN	O
on	IN	O
7	CD	O
days	NNS	O
of	IN	O
augmentin	JJ	B-TREATMENT
po	NN	I-TREATMENT
.	.	O

percocet	NN	B-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

norvasc	RB	B-TREATMENT
2.5	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O
.	.	O

augmentin	RB	B-TREATMENT
500/125	CD	O
1	CD	O
tab	NN	O
po	NN	O
tid	NN	O
x	$	O
7	CD	O
days	NNS	O
.	.	O

morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
/	NNP	O
codeine	NN	B-TREATMENT
/	NNP	O
keflex	NNP	B-TREATMENT
/	NNP	O
sudafed	VBD	B-TREATMENT

fever	RB	B-PROBLEM
/	NNP	O
+	NNP	O
bc	NN	B-PROBLEM
w/	NN	O
h/o	NN	O
mv	NN	B-PROBLEM
endocarditis	NN	I-PROBLEM

mitral	JJ	B-TREATMENT
valve	NNS	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
31	CD	B-TREATMENT
mm	NNS	I-TREATMENT
sjm	JJ	I-TREATMENT
biocor	JJ	I-TREATMENT
tissue	NN	I-TREATMENT
valve	NN	I-TREATMENT
/	NNP	I-TREATMENT
della	NN	I-TREATMENT

copeland	NN	B-TREATMENT
resection	NN	I-TREATMENT
on	IN	O
2019-03-19	JJ	O

mr.	NN	O
pizano	NN	O
is	VBZ	O
a	DT	O
75	CD	O
y/o	NN	O
man	NN	O
who	WP	O
has	VBZ	O
a	DT	O
pmhx	NN	O
significant	JJ	O
for	IN	O
enterococcus	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
valve	NN	I-PROBLEM
endocarditis	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
been	VBN	O
treated	VBN	O
since	IN	O
09-19	NN	O
.	.	O

he	PRP	O
has	VBZ	O
had	VBD	O
2	CD	O
6	CD	O
week	NN	O
courses	NNS	O
of	IN	O
antibiotics	NNS	B-TREATMENT
with	IN	O
recurrent	JJ	B-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
tee	NN	I-TEST
on	IN	O
2019-01-22	JJ	O
which	WDT	O
revealed	VBD	O
thickened	VBD	B-PROBLEM
mitral	JJ	I-PROBLEM
leaflets	NNS	I-PROBLEM
with	IN	O
small	JJ	B-PROBLEM
vegetations	NNS	I-PROBLEM
on	IN	I-PROBLEM
both	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
and	CC	I-PROBLEM
posterior	JJ	I-PROBLEM
leaflets	NNS	I-PROBLEM
with	IN	O
moderate	JJ	B-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
preserved	VBN	O
lv	JJ	O
systolic	JJ	O
function	NN	O
with	IN	O
mild	JJ	B-PROBLEM
tr	NNS	I-PROBLEM
and	CC	O
ar	NN	B-PROBLEM
and	CC	O
lae	NN	B-PROBLEM
without	IN	O
abscess	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
tee	NN	I-TEST
on	IN	O
02-19	NN	O
which	WDT	O
revealed	VBD	O
4	CD	B-PROBLEM
+	JJ	I-PROBLEM
mr	NN	I-PROBLEM
.	.	O

thomasine	NN	O
was	VBD	O
tranferred	VBN	O
from	IN	O
mwmc	NN	O
(	(	O
where	WRB	O
he	PRP	O
was	VBD	O
admitted	VBN	O
on	IN	O
02-15	NN	O
with	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
)	)	O
to	TO	O
idmc	VB	O
for	IN	O
further	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
and	CC	O
possibly	RB	O
mvr	NNS	B-TREATMENT
.	.	O

past	JJ	O
medical	JJ	O
history	NN	O
:	:	O
h/o	JJ	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
endocarditis	NN	I-PROBLEM

hypertension	NN	B-PROBLEM

h/o	NN	O
cva	NN	B-PROBLEM

spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
s/p	NN	O
lumbar	NN	B-TREATMENT
laminectomy	NN	I-TREATMENT
x	VBD	O
3	CD	O

parkinson	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM

h/o	NN	O
paranoid	NN	B-PROBLEM
delusions	NNS	I-PROBLEM

mgus	NN	B-PROBLEM
vs	NN	O
mm	NN	B-PROBLEM

elderly	JJ	O
man	NN	O
in	IN	O
nad	JJ	B-PROBLEM
,	,	O
vss	NN	O

nc/at	RB	B-PROBLEM
,	,	O
perrla	NN	O
,	,	O
eomi	NN	O
,	,	O
poor	JJ	B-PROBLEM
dentition	NN	I-PROBLEM

supple	NN	O
,	,	O
from	IN	O
,	,	O
-	:	O
thyromegaly	NN	B-PROBLEM
,	,	O
-	:	O
lymphadenopathy	NN	B-PROBLEM
,	,	O
carotids	NNS	B-TEST
2	CD	O
+	NNS	O

bilat	NN	O
w/out	NN	O
bruits	NNS	B-PROBLEM

ctab	SYM	O
-	:	O
w/r/r	NN	B-PROBLEM

rrr	NN	O
,	,	O
+	NNP	O
s1s2	NN	O
,	,	O
02-18	CD	O
mumrmur	NN	B-PROBLEM

soft	JJ	O
nt/nd	NNS	B-PROBLEM
,	,	O
+	NNP	O
bs	NN	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
hepatomegaly	JJ	B-PROBLEM
/	CD	O
splenomegaly	NN	B-PROBLEM

warm	NN	O
,	,	O
dry	JJ	O
-	:	O
c/c/e	NN	B-PROBLEM
,	,	O
pulses	VBZ	B-TEST
2+	CD	O
throughout	IN	O

skin	NN	O
:	:	O
well-healed	JJ	B-PROBLEM
surgical	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
on	IN	I-PROBLEM
lower	JJR	I-PROBLEM
back	NN	I-PROBLEM

nad	JJ	B-PROBLEM
/	NNP	O
vss	NN	O

rrr	NN	O
,	,	O
sternum	NN	O
stable	JJ	O
,	,	O
incision	JJ	B-PROBLEM
clean	NN	O
and	CC	O
dry	JJ	O
,	,	O
no	DT	O
erythema	NN	B-PROBLEM
/	VBZ	O
drainage	NN	B-PROBLEM

abdm	NN	O
:	:	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
/	NNP	O
nd	NN	B-PROBLEM
/	NNP	O
nabs	NN	B-PROBLEM

ext	NN	O
:	:	O
warm	NN	O
well	NN	O
perfused	VBN	O
,	,	O
no	DT	O
c/c/e	NN	B-PROBLEM

glucose	JJ	B-TEST
-	:	O
94	CD	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
21	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
138	CD	O
potassium	NN	B-TEST
-	:	O
5.0	CD	O
chloride	NN	B-TEST
-	:	O
105	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
25	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
13	CD	O

alt	NN	B-TEST
(	(	I-TEST
sgpt	JJ	I-TEST
)-	JJ	I-TEST
6	CD	O
ast	NN	B-TEST
(	(	I-TEST
sgot	JJ	I-TEST
)-	JJ	I-TEST
20	CD	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	I-TEST
255	CD	O
*	JJ	O
alk	NN	B-TEST
phos	SYM	I-TEST
-	:	O
134	CD	O
*	JJ	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
0.4	CD	O

calcium	NN	B-TEST
-	:	O
9.3	CD	O
phosphate	NN	B-TEST
-	:	O
3.7	CD	O
magnesium	NN	B-TEST
-	:	O
2.3	CD	O

wbc	SYM	B-TEST
-	:	O
4.9	CD	O
rbc	NN	B-TEST
-	:	O
4.27	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
35.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
82	CD	O
mch	SYM	B-TEST
-	:	O
26.4	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
32.2	CD	O
rdw	NN	B-TEST
-	:	O
17.4	CD	O
*	NN	O

neuts	NNS	B-TEST
-	:	O
66.3	CD	O
lymphs	SYM	B-TEST
-	:	O
25.0	CD	O
monos	NNS	B-TEST
-	:	O
5.7	CD	O
eos	SYM	B-TEST
-	:	O
0.1	CD	O
basos	SYM	B-TEST
-	:	O
2.9	CD	O
*	NN	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
187	CD	O

pt	SYM	B-TEST
-	:	O
13.1	CD	O
ptt	NN	B-TEST
-	:	O
30.1	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.1	CD	O

2019-02-28	JJ	O
06:27	CD	O
pm	NN	O
urine	NN	B-TEST

color	NN	B-TEST
-	:	O
amber	NN	O
appear	JJ	B-TEST
-	:	O
clear	JJ	O
sp	NN	B-TEST
stickney	NN	I-TEST
-	:	O
1.015	CD	O

2019-03-23	JJ	O
05:31	CD	O
am	VBP	O
blood	NN	B-TEST

wbc	SYM	B-TEST
-	:	O
8.6	CD	O
rbc	NN	B-TEST
-	:	O
3.43	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
28.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
84	CD	O
mch	SYM	B-TEST
-	:	O
28.9	CD	O
mchc	SYM	B-TEST
-	:	O
34.5	CD	O
rdw	NN	B-TEST
-	:	O
17.8	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
120	CD	O
*	NN	O

2019-03-25	JJ	O
01:53	CD	O
am	VBP	O
blood	NN	B-TEST

glucose	JJ	B-TEST
-	:	O
95	CD	O
urean	JJ	B-TEST
-	:	O
35	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.4	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
136	CD	O
k	SYM	B-TEST
-	:	O
4.9	CD	O
cl	NN	B-TEST
-	:	O
105	CD	O
hco3	NN	B-TEST
-	:	O
21	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
15	CD	O

2019-03-25	JJ	O
04:47	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
14.1	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
29.4	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	JJ	O
1.3	CD	O
*	NN	O

as	IN	O
mentioned	VBN	O
in	IN	O
the	DT	O
hpi	NN	O
,	,	O
mr.	FW	O
mcculley	NNP	O
was	VBD	O
transferred	VBN	O
from	IN	O
mwmc	NN	O
to	TO	O
nantucket	VB	O
cottage	NN	O
hospital	NN	O
for	IN	O
ongoing	VBG	O
care	NN	O
(	(	O
?	.	O
mvr	NN	B-TREATMENT
).	NN	O

iv	NN	B-TREATMENT
daptomycin	NN	I-TREATMENT
was	VBD	O
continued	VBN	O
via	IN	O
picc	NN	B-TREATMENT
line	NN	I-TREATMENT
which	WDT	O
was	VBD	O
inserted	VBN	O
on	IN	O
02-20	NN	O
at	IN	O
mwmc	NN	O
.	.	O

mr	NN	O
stutts	NN	O
had	VBD	O
an	DT	B-TEST
extensive	JJ	I-TEST
preop	NN	I-TEST
evaluation	NN	I-TEST
including	VBG	O
cardiology	NN	O
,	,	O
infectious	JJ	O
diseases	NNS	O
,	,	O
orthopedics	NNS	O
,	,	O
psychiatry	NN	O
and	CC	O
ethics	NNS	O
services	NNS	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
aortoomy	NN	B-TREATMENT
,	,	O
and	CC	O
left	VBD	B-TREATMENT
atrial	JJ	I-TREATMENT
appendage	NN	I-TREATMENT
resection	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
bypass	NN	I-TREATMENT
time	NN	I-TREATMENT
was	VBD	O
103	CD	O
minutes	NNS	O
/	VBP	O
crossclamp	JJ	B-TREATMENT
89	CD	O
mins	NNS	O
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
or	CC	O
to	TO	O
the	DT	O
csru	NN	O
on	IN	O
epinephrinne	NN	B-TREATMENT
and	CC	O
propofol	JJ	B-TREATMENT
infusions	NNS	I-TREATMENT
.	.	O

following	VBG	O
surgery	NN	B-TREATMENT
his	PRP$	B-TREATMENT
anesthesia	NN	I-TREATMENT
was	VBD	O
reversed	VBN	O
,	,	O
he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
ventilator	NN	B-TREATMENT
and	CC	O
successfully	RB	O
extubated	VBN	O
.	.	O

his	PRP$	B-TREATMENT
iv	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
also	RB	O
weaned	VBN	O
to	TO	O
off	RP	O
.	.	O

on	IN	O
pod1	PDT	O
his	PRP$	B-TREATMENT
pa	NN	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
,	,	O
he	PRP	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
diuretics	NNS	B-TREATMENT
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
with	IN	O
the	DT	O
assisstance	NN	O
of	IN	O
the	DT	O
nursing	NN	O
staff	NN	O
and	CC	O
physical	JJ	O
therapy	NN	O
the	DT	O
patients	NNS	O
activity	NN	O
level	NN	O
was	VBD	O
advanced	JJ	O
,	,	O
he	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
all	DT	B-TREATMENT
oral	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
with	IN	O
the	DT	O
exception	NN	O
of	IN	O
his	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

it	PRP	O
should	MD	O
be	VB	O
noted	VBN	O
that	IN	O
the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
episodes	NNS	O
of	IN	O
postoperative	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O

electrophysiology	NN	O
service	NN	O
,	,	O
started	VBN	O
on	IN	O
procainamide	NN	B-TREATMENT
and	CC	O
coumadin	NN	B-TREATMENT
.	.	O

aricept	IN	B-TREATMENT
10	CD	O
mg	NN	O
qd	NN	O
,	,	O
aspirin	RB	B-TREATMENT
81	CD	O
mg	NN	O
qd	NN	O
,	,	O
folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
,	,	O
gabapentin	NN	B-TREATMENT
200	CD	O
mg	NN	O
tid	NN	O
,	,	O
lopressor	VBZ	B-TREATMENT
12.5	CD	O
mg	NN	O
bid	NN	O
,	,	O
lisinopril	VBZ	B-TREATMENT
5	CD	O
mg	NN	O
qd	NN	O
,	,	O
daptomycin	VBZ	B-TREATMENT
420	CD	O
mg	NN	O
iv	NN	O
qd	NN	O
,	,	O
protonix	VBP	B-TREATMENT
40	CD	O
mg	NN	O
qd	NN	O
,	,	O
seroquel	NN	B-TREATMENT
50	CD	O
mg	NN	O
tid	NN	O
,	,	O
heparin	JJ	B-TREATMENT
5000	CD	O
units	NNS	O
sq	VBD	O
tid	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
bid	NN	O
,	,	O
lactulose	VBP	B-TREATMENT
15	CD	O
mg	JJ	O
bid	NN	O
,	,	O
comtan	VBP	B-TREATMENT
200	CD	O
mg	NN	O
qd	NN	O
,	,	O
mirapex	FW	B-TREATMENT
1.5	CD	O
mg	NN	O
tid	NN	O
,	,	O
sinemet	VBD	B-TREATMENT
50	CD	O
/	JJ	O
200	CD	O
mg	NN	O
tid	NN	O

1.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

2.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
packet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
packet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

4.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
.	.	O

5.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

6.	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

7.	CD	O
entacapone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

8.	CD	O
pramipexole	JJ	B-TREATMENT
0.25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
six	CD	O
(	(	O
6	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

9.	CD	O
carbidopa	SYM	B-TREATMENT
-	:	I-TREATMENT
levodopa	NN	I-TREATMENT
50	CD	O
-	:	O
200	CD	O
mg	JJ	O
tablet	NN	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
.	.	O

10.	CD	O
quetiapine	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

11.	CD	O
procainamide	JJ	B-TREATMENT
250	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
capsule	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
:	:	O
x	$	O
6	CD	O
weeks	NNS	O
.	.	O

12.	CD	O
acetaminophen	SYM	B-TREATMENT
-	:	I-TREATMENT
codeine	NN	I-TREATMENT
300-30	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

13.	CD	O
warfarin	JJ	B-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
as	IN	O
directed	VBN	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
.	.	O

14.	CD	O
daptomycin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
recon	NN	O
soln	NN	O
sig	NN	O
:	:	O
four	CD	O
90y	CD	O
(	(	O
480	CD	O
)	)	O
mg	NN	O
intravenous	JJ	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
)	)	O
:	:	O
thru	JJ	O
05-02	NN	O
.	.	O

extended	VBN	B-TREATMENT
care	NN	I-TREATMENT

discharge	NN	O
diagnosis	NN	O
:	:	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
endocarditis	NN	I-PROBLEM
s/p	NN	O
mv	CD	B-TREATMENT
replacement	NN	I-TREATMENT

htn	NN	B-PROBLEM

s/p	NN	O
cva	NN	B-PROBLEM

spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
s/p	NN	O
lumbar	NN	B-TREATMENT
laminectomy	NN	I-TREATMENT

parkingson	NN	B-PROBLEM
's	POS	I-PROBLEM

h/o	NN	O
paranoid	NN	B-PROBLEM
delusions	NNS	I-PROBLEM

mgus	NN	B-PROBLEM
vs	NN	O
mm	NN	B-PROBLEM

wash	JJ	O
incisions	NNS	B-PROBLEM
with	IN	O
warm	JJ	O
water	NN	O
and	CC	O
gentle	JJ	O
soap	NN	O
.	.	O

do	VB	O
not	RB	O
apply	VB	O
lotions	NNS	B-TREATMENT
,	,	O
creams	NNS	B-TREATMENT
,	,	O
ointments	NNS	B-TREATMENT
or	CC	O
powders	NNS	B-TREATMENT
to	TO	O
incision	NN	B-PROBLEM
.	.	O

please	VB	O
contact	JJ	O
office	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
more	JJR	O
than	IN	O
101.5	CD	O
or	CC	O
notice	JJ	O
drainage	NN	B-PROBLEM
from	IN	O
chest	JJ	B-PROBLEM
incision	NN	I-PROBLEM
.	.	O

cervical	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
;	:	O
bilateral	JJ	B-PROBLEM
ureteral	JJ	I-PROBLEM
obstruction	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

uremia	NN	B-PROBLEM
.	.	O

ileus	NN	B-PROBLEM
.	.	O

bilateral	JJ	B-TREATMENT
ureteral	JJ	I-TREATMENT
stent	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

this	DT	O
78-year-old	JJ	O
woman	NN	O
had	VBD	O
stage	NN	B-PROBLEM
iiib	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cervix	NN	I-PROBLEM
and	CC	O
she	PRP	O
has	VBZ	O
known	VBN	B-PROBLEM
periaortic	JJ	I-PROBLEM
and	CC	I-PROBLEM
splenic	JJ	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

when	WRB	O
her	PRP$	B-PROBLEM
cancer	NN	I-PROBLEM
was	VBD	O
diagnosed	VBN	O
,	,	O
she	PRP	O
underwent	JJ	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
and	CC	O
pelvic	JJ	B-TREATMENT
lymphadenectomy	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
extensive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
uterus	NN	I-PROBLEM
,	,	I-PROBLEM
ovarian	JJ	I-PROBLEM
tubes	NN	I-PROBLEM
,	,	I-PROBLEM
omentum	NN	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
periaortic	JJ	I-PROBLEM
lymph	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

postoperatively	RB	O
,	,	O
she	PRP	O
developed	VBD	O
ileus	NN	B-PROBLEM
,	,	O
then	RB	O
finally	RB	O
she	PRP	O
recovered	VBD	O
and	CC	O
she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
the	DT	O
nursing	NN	O
home	NN	O
.	.	O

she	PRP	O
was	VBD	O
readmitted	VBN	O
because	IN	O
of	IN	O
a	DT	O
problem	NN	O
with	IN	O
uremia	NN	B-PROBLEM
and	CC	O
high	JJ	B-PROBLEM
bun	NN	I-PROBLEM
and	CC	I-PROBLEM
creatinine	NN	I-PROBLEM
when	WRB	O
she	PRP	O
seen	VBN	O
in	IN	O
the	DT	O
office	NN	O
and	CC	O
the	DT	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
was	VBD	O
ordered	VBN	O
.	.	O

the	DT	B-TEST
bun	NN	I-TEST
was	VBD	O
70	CD	O
and	CC	O
creatinine	NN	B-TEST
was	VBD	O
4.6	CD	O
and	CC	O
for	IN	O
this	DT	O
reason	NN	O
she	PRP	O
had	VBD	O
ultrasound	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
kidney	NN	I-TEST
which	WDT	O
showed	VBD	O
bilateral	JJ	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
ureteral	JJ	B-TREATMENT
stent	JJ	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
she	PRP	O
was	VBD	O
generally	RB	O
stable	JJ	O
and	CC	O
she	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
disease	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
pelvis	NN	I-PROBLEM
,	,	O
no	DT	O
bleeding	NN	B-PROBLEM
and	CC	O
no	DT	O
other	JJ	B-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

dr.	NN	O
jescdrig	NN	O
was	VBD	O
called	VBN	O
and	CC	O
a	DT	O
consultation	NN	O
was	VBD	O
done	VBN	O
and	CC	O
he	PRP	O
placed	VBD	O
bilateral	JJ	B-TREATMENT
ureteral	JJ	I-TREATMENT
stents	NNS	I-TREATMENT
in	IN	I-TREATMENT
her	PRP$	I-TREATMENT
kidneys	NNS	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
dropped	VBN	O
her	PRP$	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
to	TO	O
normal	JJ	O
and	CC	O
she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
may	MD	O
be	VB	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
to	TO	I-PROBLEM
her	PRP$	I-PROBLEM
skin	NN	I-PROBLEM
on	IN	O
the	DT	O
right	JJ	O
paraumbilical	JJ	O
area	NN	O
.	.	O

because	IN	O
of	IN	O
her	PRP$	O
age	NN	O
and	CC	O
mental	JJ	O
condition	NN	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
she	PRP	O
had	VBD	O
cerebral	JJ	B-PROBLEM
atrophy	NN	I-PROBLEM
,	,	O
the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
for	IN	O
comfort	NN	O
unless	IN	O
she	PRP	O
has	VBZ	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
problem	NN	I-PROBLEM
and	CC	O
no	DT	O
further	JJ	O
chemotherapy	NN	B-TREATMENT
or	CC	O
treatment	NN	B-TREATMENT
will	MD	O
be	VB	O
given	VBN	O
.	.	O

the	DT	O
possibility	NN	O
that	IN	O
she	PRP	O
may	MD	O
need	VB	O
to	TO	O
receive	VB	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
this	DT	O
area	NN	O
to	TO	O
prevent	VB	O
her	PRP	O
from	IN	O
getting	VBG	O
further	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
was	VBD	O
also	RB	O
brought	VBN	O
up	RP	O
.	.	O

indeed	RB	O
,	,	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
she	PRP	O
was	VBD	O
conscious	JJ	O
and	CC	O
she	PRP	O
was	VBD	O
cooperative	JJ	O
and	CC	O
she	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
communicate	VB	O
very	RB	O
nicely	RB	O
with	IN	O
everyone	NN	O
including	VBG	O
her	PRP$	O
family	NN	O
,	,	O
except	IN	O
for	IN	O
the	DT	B-PROBLEM
mental	JJ	I-PROBLEM
instability	NN	I-PROBLEM
that	IN	O
she	PRP	O
had	VBD	O
because	IN	O
of	IN	O
her	PRP$	B-PROBLEM
cerebral	JJ	I-PROBLEM
atrophy	NN	I-PROBLEM
due	JJ	O
to	TO	O
senility	NN	B-PROBLEM
.	.	O

morphine	NN	B-TREATMENT

major	JJ	O
surgical	JJ	O
or	CC	O
invasive	JJ	O
procedure	NN	O
:	:	O
s/p	NN	O
right	RB	B-TREATMENT
hip	NN	I-TREATMENT
orif	NN	I-TREATMENT

s/p	NN	O
intubation	NN	B-TREATMENT

75	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
cad	JJ	B-PROBLEM
s/p	NN	O
mi	NN	B-PROBLEM
x4	NNP	O
(	(	O
s/p	JJ	O
lad	NN	B-TREATMENT
stent	NN	I-TREATMENT
'09	POS	O
and	CC	O
rca	VB	B-TREATMENT
stent	JJ	I-TREATMENT
x	NN	O
2	CD	O
in	IN	O
'00	CD	O
and	CC	O
'04	PRP	O
)	)	O
,	,	O
chf	NN	B-PROBLEM
with	IN	O
ef	JJ	B-TEST
55%	CD	O
,	,	O
paf	NN	B-PROBLEM
,	,	O
inducible	JJ	B-PROBLEM
vtach	NN	I-PROBLEM
s/p	NN	O
aicd	JJ	B-TREATMENT
placement	NN	I-TREATMENT
,	,	O
sick	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
s/p	NN	O
pacer	NN	B-TREATMENT
and	CC	O
copd	NN	B-PROBLEM
with	IN	O
restrictive	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

per	IN	O
daughter	NN	O
,	,	O
pt	NN	O
was	VBD	O
in	IN	O
her	PRP$	O
usoh	JJ	O
until	IN	O
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
superficial	JJ	I-PROBLEM
ulcerations	NNS	I-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
foot	NN	I-PROBLEM
with	IN	O
erythema	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
bridgewater	VB	O
chelsea	NN	O
soldier	NN	O
's	POS	O
home	NN	O
hospital	NN	O
and	CC	O
started	VBD	O
on	IN	O
unasyn	JJ	B-TREATMENT
iv	NN	I-TREATMENT
.	.	O

pt	NN	O
awoke	NN	O
later	RB	O
that	IN	O
night	NN	O
and	CC	O
felt	VBD	O
unsteady	JJ	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
and	CC	O
sustained	VBD	O
a	DT	O
mechanical	JJ	O
fall	NN	O
.	.	O

per	IN	O
daughter	NN	O
,	,	O
pt	NN	O
did	VBD	O
not	RB	O
note	VB	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
tachycardia	NN	B-PROBLEM
,	,	O
had	VBD	O
a	DT	O
good	JJ	O
po	NN	O
intake	NN	O
and	CC	O
no	DT	O
noted	JJ	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
in	IN	O
severe	JJ	B-PROBLEM
"	NNP	I-PROBLEM
back	RB	I-PROBLEM
pain	VBP	I-PROBLEM
"	NN	I-PROBLEM
as	IN	O
per	IN	O
daughter	NN	O
which	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
dilaudid	NN	B-TREATMENT
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
neck	NN	I-TEST
revealed	VBD	O
a	DT	O
possible	JJ	O
c1	NN	B-PROBLEM
fracture	NN	I-PROBLEM
and	CC	O
the	DT	B-TEST
x-ray	NN	I-TEST
at	IN	O
the	DT	O
osh	NN	O
revealed	VBD	O
intratrochanteric	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
femur	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
hallmark	VB	O
health	NN	O
system	NN	O
for	IN	O
orthopaedic	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

in	IN	O
monica	NN	O
at	IN	O
hallmark	NN	O
health	NN	O
system	NN	O
,	,	O
pt	NN	O
was	VBD	O
seen	VBN	O
by	IN	O
the	DT	O
trauma	NN	O
service	NN	O
where	WRB	O
a	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
neck	NN	I-TEST
revealed	VBD	O
no	DT	O
fracture	NN	B-PROBLEM
(	(	O
however	RB	O
,	,	O
the	DT	B-TREATMENT
c-collar	NN	I-TREATMENT
was	VBD	O
maintained	VBN	O
secondary	JJ	O
to	TO	O
pain	VB	B-PROBLEM
)	)	O
.	.	O

the	DT	O
orthopaedic	JJ	O
service	NN	O
recommended	VBD	O
emergent	JJ	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
intratrochanteric	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
instability	NN	B-PROBLEM
.	.	O

the	DT	O
monica	NN	O
stay	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
runs	NNS	O
of	IN	O
afib	NN	B-PROBLEM
to	TO	O
133	CD	O
requiring	VBG	O
iv	NN	B-TREATMENT
lopressor	NN	I-TREATMENT
.	.	O

pt	NN	O
is	VBZ	O
very	RB	B-PROBLEM
sob	JJ	I-PROBLEM
at	IN	O
baseline	NN	O
,	,	O
not	RB	O
on	IN	O
home	NN	B-TREATMENT
ox	NN	I-TREATMENT
,	,	O
no	DT	O
cp	NN	B-PROBLEM
at	IN	O
rest	NN	O
,	,	O
no	DT	O
le	NN	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
no	DT	O
pnd	NN	B-PROBLEM
,	,	O
stable	JJ	B-PROBLEM
orthopnea	NN	I-PROBLEM
(	(	O
2	CD	O
pillows	NNS	O
)	)	O
.	.	O

pt	NN	O
ambulates	VBZ	O
10	CD	O
feet	NNS	O
with	IN	O
significant	JJ	B-PROBLEM
fatigue	NN	I-PROBLEM
as	IN	O
per	IN	O
daughter	NN	O
.	.	O

(	(	O
?	.	O
dec	NN	B-PROBLEM
in	IN	I-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
)	)	O
.	.	O

cmed	VBN	O
ccu	JJ	O
change	NN	O
include	VBP	O
discontinuation	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
secondary	JJ	O
to	TO	O
inc	VB	O
risk	NN	O
of	IN	O
upper	JJ	B-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

digoxin	NN	B-TREATMENT
,	,	O
norvasc	NN	B-TREATMENT
and	CC	O
imdur	NN	B-TREATMENT
was	VBD	O
also	RB	O
discontinued	VBN	O
.	.	O

75	CD	O
yo	NNS	O
f	JJ	O
with	IN	O
cad	JJ	B-PROBLEM
s/p	NN	O
stenting	NN	B-TREATMENT
,	,	O
vt	NN	B-PROBLEM
,	,	O
sss	JJ	B-PROBLEM
s/p	NN	O
pacer	NN	B-TREATMENT
,	,	O
copd	NN	B-PROBLEM
,	,	O
presented	VBN	O
to	TO	O
osh	VB	O
2016-03-21	JJ	O
with	IN	O
foot	JJ	B-PROBLEM
ulceration	NN	I-PROBLEM
.	.	O

started	VBN	O
on	IN	O
unasyn	NN	B-TREATMENT
,	,	O
in	IN	O
hospital	NN	O
suffered	VBD	O
mech.	JJ	O
fall	NN	O
with	IN	O
hip	NN	B-PROBLEM
fx	NN	I-PROBLEM
.	.	O

medically	RB	B-TEST
eval	JJ	I-TEST
not	RB	O
high	JJ	B-TREATMENT
risk	NN	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
preop	VBP	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
given	VBN	O
.	.	O

orif	NN	B-TREATMENT
with	IN	O
repair	NN	B-TREATMENT
of	IN	O
neck	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
2016-03-23	CD	O
.	.	O

expected	VBN	B-TREATMENT
prolonged	JJ	I-TREATMENT
extubation	NN	I-TREATMENT
course	NN	I-TREATMENT
given	VBN	O
copd	JJ	B-PROBLEM
history	NN	I-PROBLEM
,	,	O
as	IN	O
with	IN	O
colon	NN	B-TREATMENT
ca	MD	I-TREATMENT
resection	VB	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

late	JJ	O
03-23	NN	O
found	VBD	O
with	IN	O
afib	NN	B-PROBLEM
and	CC	O
rvr	NN	B-PROBLEM
,	,	O
given	VBN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
with	IN	O
min.	JJ	O
response	NN	O
,	,	O
started	VBD	O
dilt.	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

received	VBD	O
2	CD	B-TREATMENT
mg	NNS	I-TREATMENT
dilaudid	NN	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
o/n	NN	O
.	.	O

this	DT	O
am	VBP	O
with	IN	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
continued	VBD	B-PROBLEM
tachycardia	NN	I-PROBLEM
on	IN	O
dilt.	NN	B-TREATMENT
gtt	NN	I-TREATMENT
.	.	O

transferred	VBN	O
to	TO	O
unit	NN	O
and	CC	O
urgently	RB	O
intubated	VBN	O
(	(	O
labs	JJ	B-TEST
below.	NN	O
)	)	O

of	IN	O
note	NN	O
,	,	O
a	DT	B-TREATMENT
ngt	NN	I-TREATMENT
by	IN	O
xray	NN	B-TEST
was	VBD	O
not	RB	O
in	IN	O
correct	JJ	O
position	NN	O
?	.	O
lungs	NNS	O
->	VBD	O
possibly	RB	O
used	VBN	O
for	IN	O
medication	NN	B-TREATMENT
administration	NN	I-TREATMENT
this	DT	O
am	VBP	O
.	.	O

1.	CD	O
cad	NN	B-PROBLEM
s/p	NN	O
lad	JJ	B-TREATMENT
stent	NN	I-TREATMENT
in	IN	O
'	POS	O
98	CD	O
+	NNS	O
rca	JJ	B-TREATMENT
stet	NN	I-TREATMENT
in	IN	O
'	POS	O
00	CD	O
with	IN	O
repeat	NN	B-TREATMENT
rca	NN	I-TREATMENT
stent	NN	I-TREATMENT
in	IN	O
'	POS	O
04	CD	O
.	.	O

last	JJ	B-TEST
cath	NN	I-TEST
in	IN	O
9-04	CD	O

2.	CD	O
paf	NN	B-PROBLEM

3.	CD	O
dm	NN	B-PROBLEM

4.	CD	O
sick	JJ	B-PROBLEM
sinus	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
s/p	JJ	O
pacer	NN	B-TREATMENT
placement	NN	I-TREATMENT
in	IN	O
'	POS	O
98	CD	O

5.	CD	O
depression	NN	B-PROBLEM

6.	CD	O
copd	NN	B-PROBLEM
(	(	O
no	DT	O
pft	NN	B-TEST
available	JJ	O
)	)	O

7.	CD	O
chronic	JJ	B-PROBLEM
restrictive	JJ	I-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
(	(	O
no	DT	O
pft	NN	B-TEST
available	JJ	O
)	)	O

8.	CD	O
htn	NN	B-PROBLEM

9.	CD	O
hyperlipidemia	NN	B-PROBLEM

10.	CD	O
obesity	NN	B-PROBLEM

11.	CD	O
s/p	NN	O
tah	NN	B-TREATMENT

12.	CD	O
s/p	JJ	O
colonic	JJ	B-TREATMENT
resection	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
perforation	VB	B-PROBLEM
s/p	JJ	O
polypectomy	NN	B-TREATMENT

13.	CD	O
inducible	JJ	B-PROBLEM
vtach	NN	I-PROBLEM
on	IN	O
ep	NN	B-TEST
study	NN	I-TEST
with	IN	O
aicd	JJ	B-TREATMENT
placement	NN	I-TREATMENT
11-01	JJ	O

14.	CD	O
chf	NN	B-PROBLEM

15.	CD	O
upper	JJ	B-PROBLEM
gi	NNS	I-PROBLEM
bleed	VBD	I-PROBLEM

vs	NN	B-TEST
:	:	O

hr	NN	B-TEST
:	:	O
133	CD	O

bp	NN	B-TEST
:	:	O
110/80	CD	O

gen	NN	O
:	:	O
sedated	VBN	B-TREATMENT
but	CC	O
a+o	JJ	O
x3	NN	O

heent	NN	O
:	:	O
cervical	JJ	B-TREATMENT
collar	NN	I-TREATMENT
in	IN	O
place	NN	O

cv	NN	O
:	:	O
tachycardia	NN	B-PROBLEM

abd	NN	O
:	:	O
+	NN	O
bs	NN	O
,	,	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
nd	JJ	B-PROBLEM
,	,	O
bs	JJ	O
+	NN	O

ext	NN	O
:	:	O
no	DT	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
,	,	O
r	NN	B-PROBLEM
leg	NN	I-PROBLEM
shortened	VBD	I-PROBLEM
and	CC	I-PROBLEM
rotated	VBD	I-PROBLEM
,	,	O
+	NNP	O
cellulitis	NN	B-PROBLEM

wbc	SYM	B-TEST
-	:	O
12.7	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
4.32	CD	O
hgb	NN	B-TEST
-	:	O
10.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
33.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
77	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
24.2	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
31.5	CD	O
rdw	NN	B-TEST
-	:	O
15.4	CD	O

neuts	NNS	B-TEST
-	:	O
90.5	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
5.1	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
3.7	CD	O
eos	SYM	B-TEST
-	:	O
0.6	CD	O
basos	SYM	B-TEST
-	:	O
0.2	CD	O

hypochrom	SYM	B-TEST
-	:	O
3+	CD	O
poikilocy	NN	B-TEST
-	:	O
1+	CD	O
microcyt	SYM	B-TEST
-	:	O
2+	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
324	CD	O

pt	SYM	B-TEST
-	:	O
13.6	CD	O
ptt	NN	B-TEST
-	:	O
25.2	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.2	CD	O

glucose	JJ	B-TEST
-	:	O
191	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
14	CD	O
creat	NN	B-TEST
-	:	O
0.6	CD	O
sodium	NN	B-TEST
-	:	O
141	CD	O
potassium	NN	B-TEST
-	:	O
3.5	CD	O
chloride	NN	B-TEST
-	:	O
101	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
28	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
16	CD	O

calcium	NN	B-TEST
-	:	O
8.8	CD	O
phosphate	NN	B-TEST
-	:	O
4.4	CD	O
magnesium	NN	B-TEST
-	:	O
1.9	CD	O

2016-03-22	JJ	O
11:25	CD	O
am	VBP	O
urine	JJ	B-TEST

color	NN	B-TEST
-	:	O
yellow	NN	O
appear	VBP	B-TEST
-	:	O
clear	JJ	O
sp	NN	B-TEST
barajas	SYM	I-TEST
-	:	O
1.020	CD	O

2016-03-22	JJ	O
11:25	CD	O
am	VBP	O
urine	JJ	B-TEST

blood	NN	B-TEST
-	:	O
lg	NN	B-TEST
nitrite	JJ	I-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O
glucose	JJ	B-TEST
-	:	O
250	CD	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
6.5	CD	O

leuk	SYM	B-TEST
-	:	O
neg	NN	O

2016-03-22	JJ	O
11:25	CD	O
am	VBP	O
urine	JJ	B-TEST

rbc	LS	B-TEST
-	:	O
0-2	JJ	O
wbc	JJ	B-TEST
-	:	O
04-02	JJ	O
bacteria	NNS	B-TEST
-	:	O
occ	NN	B-TEST
yeast	SYM	I-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
0	CD	O

2016-03-22	JJ	O
11:25	CD	O
am	VBP	O
urine	JJ	B-TEST

hyaline	NN	B-TEST
-	:	O
3	CD	O
*	NN	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
178	CD	O
*	NN	O

ck-mb	JJ	B-TEST
-	:	O
7	CD	O

d-dimer	JJ	B-TEST
-	:	O
1748	CD	O
*	NN	O

ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
153	CD	O
*	NN	O

ck-mb	JJ	B-TEST
-	:	O
5	CD	O
ctropnt	NN	B-TEST
-<	CD	O
0.01	CD	O

'	POS	O
00	CD	O
tte	NN	B-TEST
:	:	O

ef	JJ	B-TEST
50-55%	JJ	O
;	:	O
mild	VB	B-PROBLEM
to	TO	I-PROBLEM
moderate	VB	I-PROBLEM
mr	NN	I-PROBLEM
,	,	O
left	VBD	O
atrium	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
,	,	O
trace	NN	B-PROBLEM
ar	NN	I-PROBLEM

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
:	:	O
inferior	JJ	B-PROBLEM
,	,	I-PROBLEM
posterobasilar	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
,	,	O
1	CD	B-PROBLEM
+	NN	I-PROBLEM
mr	NN	I-PROBLEM
,	,	O
ef	RB	B-TEST
48%	CD	O
,	,	O
mid	NN	O
rca	NN	O
50%	CD	O
,	,	O
distal	JJ	O
rca	NN	O
40%	CD	O
,	,	O
mid	NN	O
lad	JJ	O
50%	CD	O
,	,	O
om3	FW	B-PROBLEM
diffusely	RB	I-PROBLEM
diseased	VBN	I-PROBLEM
s/p	NN	O
stenting	NN	B-TREATMENT
of	IN	I-TREATMENT
rca	NN	I-TREATMENT
with	IN	O
drug	NN	B-TREATMENT
eluting	VBG	I-TREATMENT
stent	NN	I-TREATMENT
with	IN	O
10%	CD	B-TEST
residual	JJ	I-TEST
flow	NN	I-TEST
.	.	O

2016-03-22	JJ	O
cxr	NN	B-TEST
:	:	O
moderate	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
without	IN	O
chf	NN	B-PROBLEM
,	,	O
no	DT	O
effusions	NNS	B-PROBLEM
,	,	O
left	VBD	B-PROBLEM
retrocardiac	JJ	I-PROBLEM
opacity	NN	I-PROBLEM
consistent	NN	O
with	IN	O
atelectasis	NN	B-PROBLEM
vs.	FW	O
consolidation	NN	B-PROBLEM

2016-03-22	JJ	O
ct	JJ	B-TEST
c-spine	NN	I-TEST
:	:	O

1)	CD	O
no	DT	O
evidence	NN	O
of	IN	O
fracture	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cervical	JJ	I-PROBLEM
spine	NN	I-PROBLEM
.	.	O

no	DT	O
definite	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
c1	NN	I-PROBLEM
is	VBZ	O
identified	VBN	O
to	TO	O
correlate	VB	O
with	IN	O
the	DT	O
history	NN	O
of	IN	O
questioned	JJ	O
c1	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
from	IN	O
outside	JJ	O
hospital	NN	O
.	.	O

2)	CD	O
extensive	JJ	B-PROBLEM
degenerative	JJ	I-PROBLEM
change	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cervical	JJ	I-PROBLEM
spine	NN	I-PROBLEM
."	NN	O

2016-03-22	JJ	O
femur	NN	B-TEST
&	CC	I-TEST
r	NN	I-TEST
knee	NN	I-TEST
x-ray	NN	I-TEST
:	:	O

1)	CD	O
comminuted	JJ	B-PROBLEM
intertrochanteric	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
femur	NN	I-PROBLEM
,	,	O
with	IN	O
avulsion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lesser	JJR	I-PROBLEM
trochanter	NN	I-PROBLEM
,	,	O
displacement	NN	B-PROBLEM
and	CC	O
angulation	NN	B-PROBLEM
.	.	O

2)	CD	O
no	DT	O
other	JJ	B-PROBLEM
definite	JJ	I-PROBLEM
fractures	NNS	I-PROBLEM
identified.	VBP	O
degenerative	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lumbosacral	JJ	I-PROBLEM
spine	NN	I-PROBLEM
."	NN	O

2016-04-01	JJ	O
flexion	NN	B-TEST
extension	NN	I-TEST
xrays	NNS	I-TEST
of	IN	I-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
:	:	O

mild	JJ	O
degree	NN	O
of	IN	O
instability	NN	B-PROBLEM
at	IN	I-PROBLEM
level	JJ	I-PROBLEM
c3-c4	NN	I-PROBLEM
as	IN	O
described	NN	O
.	.	O

possibility	NN	O
of	IN	O
arch	JJ	B-PROBLEM
element	NN	I-PROBLEM
in	IN	I-PROBLEM
this	DT	I-PROBLEM
region	NN	I-PROBLEM
cannot	NN	O
be	VB	O
excluded	VBN	O
.	.	O

75	CD	O
yo	JJ	O
f	NN	O
s/p	NN	O
mix4	NN	B-PROBLEM
,	,	O
numerous	JJ	B-TEST
cath	NN	I-TEST
,	,	O
paf	NN	B-PROBLEM
,	,	O
inducible	JJ	B-PROBLEM
vtach	NN	I-PROBLEM
s/p	NN	O
aicd	NN	B-TREATMENT
and	CC	O
pacer	NN	B-TREATMENT
with	IN	O
severe	JJ	B-PROBLEM
copd	NN	I-PROBLEM
/	NNP	O
restrictive	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
s/p	VBD	O
fall	NN	O
with	IN	O
intertrochanteric	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
.	.	O

as	IN	O
per	NN	O
cmed	VBD	O
ccu	NN	O
,	,	O
pt	NN	O
requires	VBZ	O
emergent	JJ	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
intertrochanteric	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
to	TO	O
preserve	VB	O
neurovascular	JJ	O
function	NN	O
.	.	O

pt	NN	O
is	VBZ	O
a	DT	O
moderate	JJ	O
risk	NN	O
for	IN	O
a	DT	B-TREATMENT
needed	JJ	I-TREATMENT
emergent	NN	I-TREATMENT
non-cardiac	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

pt	NN	O
is	VBZ	O
medically	RB	O
cleared	VBN	O
for	IN	O
procedure	NN	B-TREATMENT
,	,	O
likely	RB	O
has	VBZ	O
some	DT	B-PROBLEM
mile	NN	I-PROBLEM
rate	NN	I-PROBLEM
related	VBN	I-PROBLEM
ischemia	NN	I-PROBLEM
.	.	O

---	JJ	O
pre-op	JJ	B-TREATMENT
b-blocker	NN	I-TREATMENT
with	IN	O
goal	NN	B-TEST
hr	NN	I-TEST
<	VBD	O
70	CD	O

---	RB	O
no	DT	O
real	JJ	O
utility	NN	O
in	IN	O
mibi	NN	B-TREATMENT
/	NNP	O
cath	NN	B-TEST
prior	RB	O
to	TO	O
procedure	VB	B-TREATMENT
gien	JJ	O
previous	JJ	B-TEST
caths	NNS	I-TEST
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
to	TO	O
be	VB	O
intervened	VBN	O
on	IN	O
.	.	O

---	JJ	O
v-tach	NN	B-PROBLEM
:	:	O
pt	NN	O
has	VBZ	O
aicd	VBN	B-TREATMENT
in	IN	O
place	NN	O
,	,	O
however	RB	O
b-blocker	NN	B-TREATMENT
should	MD	O
contorl	VB	O
vtach	NN	B-PROBLEM
for	IN	O
now	RB	O
.	.	O

---	JJ	O
b-blocker	NN	B-TREATMENT
iv	NN	I-TREATMENT
,	,	O
dilt	JJ	B-TREATMENT
prn	NN	O
for	IN	O
paf	NN	B-PROBLEM

---	NN	O
hold	VBP	O
coumadin	NN	B-TREATMENT
for	IN	O
afib	NN	B-PROBLEM
given	VBN	O
hx	NN	O
of	IN	O
upper	JJ	B-PROBLEM
gib	NN	I-PROBLEM
and	CC	O
surgery	NN	B-TREATMENT
in	IN	O
am	VBP	O

---	NN	O
continue	NN	O
asa	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT

---	NN	O
romi	NN	B-PROBLEM
,	,	O
check	VB	O
am	VBP	O
ecg	VB	B-TEST

2.	CD	O
copd	JJ	B-PROBLEM
/	NNP	O
restrictive	NN	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
:	:	O

---	JJ	O
nebs	JJ	B-TREATMENT
/	NN	O
mdi	NN	B-TREATMENT
prn	NN	O

---	NN	O
no	DT	O
need	NN	O
for	IN	O
steroids	NNS	B-TREATMENT
now	RB	O

---	NNS	O
expect	VBP	O
prolonged	JJ	B-PROBLEM
wean	JJ	I-PROBLEM
given	VBN	O
previous	JJ	O
history	NN	O
of	IN	O
prolonged	JJ	B-PROBLEM
wean	JJ	I-PROBLEM
s/p	NN	O
colonic	JJ	B-TREATMENT
resection	NN	I-TREATMENT

---	RB	O
incentive	JJ	B-TREATMENT
spirometry	NN	I-TREATMENT
for	IN	O
atelectasis	NN	B-PROBLEM

3.	CD	O
hip	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
:	:	O

---	JJ	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
with	IN	O
diluadid	NN	B-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT

---	JJ	O
lovenox	NN	B-TREATMENT
tonight	NN	O
x1	NN	O
,	,	O
hold	VBP	O
am	VBP	O
dose	JJ	O
per	IN	O
cmed	VBN	O
ccu	NN	O

4.	CD	O
anemia	NN	B-PROBLEM
:	:	O

---	NN	O
iron	NN	B-TEST
studies	NNS	I-TEST

---	NN	O
tsh	NN	B-TEST

---	NN	O
no	DT	O
need	NN	O
fortransfusion	NN	B-TREATMENT
currently	RB	O
,	,	O
keep	VB	O
hct	NN	B-TEST
>	CD	O
30	CD	O

5.	CD	O
hypokalemia	NN	B-PROBLEM
:	:	O

---	RB	O
60iv	CD	B-TREATMENT
k	NNS	I-TREATMENT
now	RB	O

---	NN	O
continue	VBP	O
po	NN	B-TREATMENT
k	NN	I-TREATMENT

---	RB	O
check	NN	O
lytes	NNS	B-TEST
in	IN	O
pm	NN	O

6.	CD	O
cellulitis	NN	B-PROBLEM
:	:	O

---	NN	O
continue	VBP	O
unasyn	NN	B-TREATMENT

---	NNS	O
hold	VBP	O
off	RP	O
on	IN	O
x-rays	NNS	B-TEST
for	IN	O
now	RB	O

7.	CD	O
dm	NN	B-PROBLEM
:	:	O

---	NN	O
riss	SYM	B-TREATMENT
-	:	O
tight	JJ	O
glucose	JJ	B-TREATMENT
control	NN	I-TREATMENT
pre-op	NN	O

8.	CD	O
ppx	NN	B-TREATMENT
:	:	O

---	JJ	O
protonix	NN	B-TREATMENT
,	,	O
lovenox	NN	B-TREATMENT
,	,	O
r	NN	B-TREATMENT
boot	NN	I-TREATMENT
as	IN	O
per	IN	O
cmed	NN	O
ccu	NN	O

npo	NN	B-TREATMENT

orif	NN	B-TREATMENT
with	IN	O
repair	NN	B-TREATMENT
of	IN	O
neck	JJ	B-PROBLEM
fracture	NN	I-PROBLEM
2016-03-23	CD	O
.	.	O

had	VBD	O
expected	VBN	O
prolonged	JJ	B-PROBLEM
post-op	JJ	I-PROBLEM
extubation	NN	I-PROBLEM
in	IN	O
pacu	NN	O
given	VBN	O
copd	JJ	B-PROBLEM
history	NN	I-PROBLEM
,	,	O
as	IN	O
with	IN	O
colon	NN	B-TREATMENT
ca	MD	I-TREATMENT
resection	VB	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

late	JJ	O
03-23	NN	O
found	VBD	O
with	IN	O
afib	NN	B-PROBLEM
and	CC	O
rvr	NN	B-PROBLEM
,	,	O
given	VBN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
with	IN	O
min.	JJ	O
response	NN	O
,	,	O
started	VBD	O
dilt.	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

received	VBD	O
2	CD	B-TREATMENT
mg	NNS	I-TREATMENT
dilaudid	NN	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
o/n	NN	O
.	.	O

on	IN	O
03-24	JJ	O
am	VBP	O
p/w	JJ	O
with	IN	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
continued	VBD	B-PROBLEM
tachycardia	NN	I-PROBLEM
on	IN	O
dilt.	NN	B-TREATMENT
gtt.	NN	I-TREATMENT

of	IN	O
note	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	O
question	NN	O
of	IN	O
misplaced	JJ	B-PROBLEM
ngt	NN	I-PROBLEM
.	.	O

when	WRB	O
ngt	JJ	B-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
pulled	VBN	O
out	RP	O
,	,	O
it	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
respiratory-like	JJ	O
secretions	NNS	O
.	.	O

concern	NN	O
for	IN	O
aspiration	NN	B-PROBLEM
of	IN	O
mediations	NNS	B-TREATMENT
to	TO	O
lungs	NNS	O
.	.	O

however	RB	O
,	,	O
evaluation	NN	O
of	IN	O
cxr	NN	B-TEST
revealed	VBN	O
ngt	RB	B-PROBLEM
coiled	VBN	I-PROBLEM
in	IN	I-PROBLEM
esophagus	NN	I-PROBLEM
.	.	O

pt	NN	B-PROBLEM
's	POS	I-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
is	VBZ	O
most	RBS	O
likely	JJ	O
on	IN	O
setting	VBG	O
of	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
vs.	FW	O
pneumonitis	NN	B-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
depressed	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
post-operative	JJ	B-TREATMENT
narcotics	NNS	I-TREATMENT
.	.	O

pt	NN	O
was	VBD	O
pan-cultured	JJ	O
and	CC	O
switched	VBD	O
from	IN	O
unasyn	NN	B-TREATMENT
(	(	O
started	VBN	O
at	IN	O
osh	NN	O
for	IN	O
foot	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
)	)	O
to	TO	O
zosyn	VB	B-TREATMENT
.	.	O

vanco	NN	B-TREATMENT
was	VBD	O
added	VBN	O
for	IN	O
possible	JJ	O
nosocomial	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

cta	NN	B-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
was	VBD	O
negative	JJ	O
for	IN	O
pe	NN	B-PROBLEM
,	,	O
but	CC	O
revealed	VBD	O
bilateral	JJ	B-PROBLEM
patchy	NN	I-PROBLEM
ground	NN	I-PROBLEM
glass	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
c/w	VBP	O
aspiration	NN	B-PROBLEM
vs.	FW	O
pneumonia	NN	B-PROBLEM
vs.	FW	O
edema	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
weaned	VBN	O
down	RP	O
on	IN	O
ventilator	NN	B-TREATMENT
,	,	O
minimal	JJ	B-PROBLEM
secretions	NNS	I-PROBLEM
noted	VBD	O
.	.	O

on	IN	O
03-27	JJ	O
,	,	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
depressed	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
off	IN	O
all	DT	B-TREATMENT
sedating	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
;	:	O
mental	JJ	O
status	NN	O
improved	VBN	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
day	NN	O
.	.	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
was	VBD	O
rate-controlled	VBN	O
on	IN	O
dilt	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

dilt	JJ	B-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
and	CC	O
metoprolol	RB	B-TREATMENT
titrated	VBD	O
up	RP	O
.	.	O

cardiac	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
cycled	VBN	O
in	IN	O
setting	NN	O
of	IN	O
rapid	JJ	B-PROBLEM
af	NNS	I-PROBLEM
and	CC	O
were	VBD	O
flat	JJ	O
.	.	O

initially	RB	O
,	,	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
dry	JJ	B-PROBLEM
with	IN	O
low	JJ	B-PROBLEM
fena	NN	I-PROBLEM
and	CC	O
given	VBN	O
ivf	NNS	B-TREATMENT
.	.	O

then	RB	O
,	,	O
noted	VBD	O
to	TO	O
be	VB	O
volume	NN	B-PROBLEM
overloaded	VBN	I-PROBLEM
and	CC	O
diuresed	VBN	O
with	IN	O
lasix	NN	B-TREATMENT
.	.	O

pt	NN	O
had	VBD	O
depressed	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
on	IN	O
transfer	NN	O
to	TO	O
cmed	VB	O
in	IN	O
setting	NN	O
of	IN	O
narcotics	NNS	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
started	VBN	O
on	IN	O
propofol	NN	B-TREATMENT
while	IN	O
intubated	VBN	B-TREATMENT
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
acute	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
,	,	O
or	CC	O
stroke	NN	B-PROBLEM
.	.	O

mental	JJ	O
status	NN	O
improved	VBD	O
during	IN	O
times	NNS	O
when	WRB	O
propofol	NN	B-TREATMENT
was	VBD	O
held	VBN	O
.	.	O

on	IN	O
03-27	JJ	O
,	,	O
pt	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
significantly	RB	B-PROBLEM
depressed	VBN	I-PROBLEM
m.s.	NN	I-PROBLEM
off	IN	O
propol	NN	B-TREATMENT
improved	VBD	O
off	RP	O
sedation	NN	B-TREATMENT
.	.	O

all	DT	B-TREATMENT
sedating	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
prn	NN	B-TREATMENT
narcotics	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
and	CC	O
mental	JJ	O
status	NN	O
cleared	VBD	O
somewhat	RB	O
.	.	O

s/p	JJ	O
hip	NN	B-TREATMENT
fx	JJ	I-TREATMENT
repair	NN	I-TREATMENT
:	:	O
started	VBN	O
on	IN	O
lovenox	NN	B-TREATMENT
for	IN	O
anti-coagulation	NN	B-TREATMENT
.	.	O

given	VBN	O
standing	VBG	B-TREATMENT
nsaid	NN	I-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

opiates	NNS	B-TREATMENT
used	VBD	O
very	RB	O
sparingly	RB	O
in	IN	O
setting	VBG	O
of	IN	O
ms	NNS	B-PROBLEM
change	VBP	I-PROBLEM

resp	JJ	B-PROBLEM
failure	NN	I-PROBLEM
/	JJ	O
copd	NN	B-PROBLEM
:	:	O

initially	RB	O
got	VBD	O
steroids	NNS	B-TREATMENT
upon	IN	O
intubation	NN	B-TREATMENT
.	.	O

still	RB	O
tachypneic	JJ	B-PROBLEM
and	CC	O
hypoxic	NN	B-PROBLEM
on	IN	O
room	NN	O
air	NN	O
.	.	O

?	.	O
copd	NN	B-PROBLEM
vs	NN	O
atelectasis	NN	B-PROBLEM
as	IN	O
cause	NN	O
of	IN	O
hypoxia	NN	B-PROBLEM
.	.	O

-	:	O
atrovent	NN	B-TREATMENT
standing	NN	O
.	.	O

prn	NN	O
albuterol	NN	B-TREATMENT
only	RB	O
given	VBN	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM
with	IN	O
rvr	NN	B-PROBLEM

-	:	O
inhaled	VBD	B-TREATMENT
steroids	NNS	I-TREATMENT

fever	NN	B-PROBLEM
:	:	O

had	VBD	O
received	VBN	O
unasyn	JJ	B-TREATMENT
,	,	O
vanc	NN	B-TREATMENT
,	,	O
zosyn	NN	B-TREATMENT
during	IN	O
hospital	JJ	O
course	NN	O
for	IN	O
cellulitis	NN	B-PROBLEM
and	CC	O
other	JJ	O
unclear	JJ	O
reasons	NNS	O
,	,	O
including	VBG	O
possible	JJ	O
vent	NN	B-PROBLEM
associated	VBN	I-PROBLEM
pna	NN	I-PROBLEM
.	.	O

afebrile	JJ	B-PROBLEM
>	$	O
24	CD	O
hours	NNS	O
off	IN	O
abx	NN	B-TREATMENT
.	.	O

-	:	O
culture	NN	B-TEST
if	IN	O
spikes	NNS	O
.	.	O

no	DT	O
abx	NN	B-TREATMENT
unless	IN	O
source	NN	O
found	VBD	O

a.fib	NN	B-PROBLEM
with	IN	O
rvr	NN	B-PROBLEM
-	:	O
has	VBZ	O
ppm	VBN	B-TREATMENT
,	,	O
so	RB	O
can	MD	O
have	VB	O
lot	NN	O
of	IN	O
nodal	JJ	B-TREATMENT
agents	NNS	I-TREATMENT
.	.	O

now	RB	O
rate	NN	O
controlled	VBN	O
on	IN	O
metop	NN	B-TREATMENT
125	CD	O
tid	NN	O
and	CC	O
dilt	NN	B-TREATMENT
.	.	O

-	:	O
continue	NN	O
nodal	JJ	B-TREATMENT
agents	NNS	I-TREATMENT

-	:	O
consider	NN	O
anti	NNS	B-TREATMENT
coag	NN	I-TREATMENT
for	IN	O
cva	NN	B-TREATMENT
prevention	NN	I-TREATMENT
,	,	O
but	CC	O
wait	VBP	O
until	IN	O
ambulating	VBG	O
better	JJR	O

cad	NN	B-PROBLEM
:	:	O
on	IN	O
asa	NN	B-TREATMENT
,	,	O
b	NN	B-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
ace	NN	B-TREATMENT
.	.	O

no	DT	O
statin	NN	B-TREATMENT
.	.	O

heme	NN	O
-	:	O
anemic	NN	B-PROBLEM
.	.	O

possible	JJ	O
anemia	NN	B-PROBLEM
03-02	JJ	O
operative	JJ	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
.	.	O

follow	JJ	O
hct	VBD	B-TEST
daily	JJ	O
goal	NN	O
>	VBD	O
28	CD	O

had	VBD	O
fall	NN	O
pta	NN	O
with	IN	O
?	.	O
fx	NN	B-PROBLEM
on	IN	O
initial	JJ	B-TEST
ct	NN	I-TEST
,	,	O
neg	JJ	O
fx	NN	B-PROBLEM
on	IN	O
f/u	JJ	B-TEST
ct	NN	I-TEST
.	.	O

-	:	O
flex	NN	B-TEST
/	NNP	I-TEST
ext	NN	I-TEST
films	NNS	I-TEST
done	VBN	O

-	:	O
will	MD	O
clear	VB	O
with	IN	O
neursurg	JJ	O
prior	JJ	O
to	TO	O
removing	VBG	O
hard	JJ	B-TREATMENT
collar	NN	I-TREATMENT

overnight	VBN	O
on	IN	O
pt	NN	O
's	POS	O
first	JJ	O
evening	NN	O
on	IN	O
the	DT	O
floor	NN	O
,	,	O
she	PRP	O
had	VBD	O
episode	NN	O
of	IN	O
desaturation	NN	B-PROBLEM
with	IN	O
inc	JJ	B-PROBLEM
o2	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
(	(	O
4l	CD	O
->	RB	O
6l	CD	O
->	JJ	O
sating	VBG	B-TEST
91%	CD	O
on	IN	O
nrb	NN	B-TREATMENT
)	)	O
-	:	O
cxr	NN	B-TEST
with	IN	O
worsening	VBG	B-PROBLEM
-	:	O
non	NN	O
responsive	NN	O
to	TO	O
lasix	VB	B-TREATMENT
.	.	O

family	NN	O
meeting	NN	O
held	VBD	O
and	CC	O
pt	NNS	O
made	VBD	O
clear	JJ	O
wishes	NNS	O
after	IN	O
extubation	NN	B-TREATMENT
that	IN	O
she	PRP	O
does	VBZ	O
not	RB	O
want	VB	O
to	TO	O
be	VB	O
intubated	VBN	O
again	RB	O
and	CC	O
made	VBD	O
dnr	NNS	B-TREATMENT
/	JJ	O
dni	NN	B-TREATMENT
.	.	O

no	DT	O
bipap	NN	B-TREATMENT
.	.	O

now	RB	O
pt	VBZ	O
lethargic	NN	B-PROBLEM
and	CC	O
min	NN	B-PROBLEM
responsive	NN	I-PROBLEM
.	.	O

all	DT	O
four	CD	O
children	NNS	O
in	IN	O
pts	NNS	O
room	NN	O
and	CC	O
agree	VB	O
on	IN	O
cmo	NNS	B-TREATMENT
-	:	O
want	VBP	O
to	TO	O
d/c	VB	O
c-collar	JJ	B-TREATMENT
and	CC	O
start	JJ	O
morphine	NN	B-TREATMENT
ggt	NN	I-TREATMENT
.	.	O

although	IN	O
dr.	JJ	O
ray	NN	O
will	MD	O
be	VB	O
covering	VBG	O
pt	JJ	O
today	NN	O
,	,	O
dr.	NN	O
stephanie	NN	O
wilson	NN	O
spoke	VBD	O
with	IN	O
family	NN	O
this	DT	O
morning	NN	O
and	CC	O
has	VBZ	O
noted	VBN	O
that	IN	O
pt	NN	O
is	VBZ	O
cmo	JJ	B-TREATMENT
.	.	O

ep	NN	O
was	VBD	O
called	VBN	O
to	TO	O
deactivate	VB	O
pt	JJ	O
dual	JJ	B-TREATMENT
chamber	NN	I-TREATMENT
icd	NN	I-TREATMENT
as	IN	O
per	IN	O
family	NN	O
wishes	NNS	O
.	.	O

on	IN	O
exam	NN	B-TEST
,	,	O
pt	NN	O
lethargic	NN	B-PROBLEM
,	,	O
responsive	JJ	O
to	TO	O
pain	VB	B-PROBLEM
but	CC	O
not	RB	O
voice	NN	O
,	,	O
with	IN	O
nrb	NN	B-TREATMENT
in	IN	O
place	NN	O
;	:	O
obvious	JJ	B-PROBLEM
inc	NN	I-PROBLEM
wob	NN	I-PROBLEM
.	.	O

iv	NN	B-TREATMENT
in	IN	I-TREATMENT
r	JJ	I-TREATMENT
foot	NN	I-TREATMENT
for	IN	O
access	NN	O
.	.	O

afebrile	NN	B-PROBLEM
;	:	O

bp	NN	B-TEST
:	:	O
159-161-139-98	JJ	O
(	(	O
after	IN	O
morphine	NN	B-TREATMENT
)/	NN	O
69	CD	O
hr	NN	B-TEST
:	:	O
148	CD	O
-->	$	O
88	CD	O
;	:	O
rr	NN	B-TEST
:	:	O
28-40	JJ	O
o2	NN	B-TEST
:	:	O
94%	CD	O
nrb	NN	B-TREATMENT

as	IN	O
above	NN	O
,	,	O
made	VBN	O
cmo	NN	B-TREATMENT
after	IN	O
meeting	VBG	O
with	IN	O
nf	JJ	O
team	NN	O
and	CC	O
family	NN	O
and	CC	O
reconfirmed	VBN	O
with	IN	O
primary	JJ	O
medical	JJ	O
team	NN	O
on	IN	O
04-02	NN	O
.	.	O

start	NN	O
morphine	NN	B-TREATMENT
ggt	NN	I-TREATMENT
and	CC	O
titrate	NN	O
to	TO	O
comfort	NN	O
.	.	O

d/c	NN	O
'ed	POS	O
all	DT	B-TEST
lab	NN	I-TEST
draws	VBZ	I-TEST
/	JJ	O
vitals	NNS	B-TEST
.	.	O

prn	NN	B-TREATMENT
nebs	NN	I-TREATMENT
for	IN	O
comfort	NN	O
.	.	O

morhpine	NN	B-TREATMENT
ggt	NN	I-TREATMENT
titrated	VBD	O
up	RB	O
to	TO	O
18	CD	O
mg	NNS	O
/	JJ	O
hr	NN	O
by	IN	O
monday	JJ	O
morning	NN	O
and	CC	O
pt	NN	O
expired	VBD	O
04-04	CD	O
at	IN	O
7:40	CD	O
am	VBP	O
.	.	O

1.	CD	O
coumadin	NN	B-TREATMENT
2	CD	O
mg	NN	O
once	RB	O
daily	JJ	O
(	(	O
stopped	VBN	O
recently	RB	O
due	JJ	O
to	TO	O
risk	NN	O
of	IN	O
gi	NNS	B-PROBLEM
bleed	VBN	I-PROBLEM
)	)	O

2.	CD	O
zoloft	JJ	B-TREATMENT
100	CD	O
mg	NN	O
once	RB	O
daily	JJ	O

3.	CD	O
toprol	NN	B-TREATMENT
100	CD	O
mg	NN	O
bid	NN	O

4.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NNS	O
bid	NN	O

5.	CD	O
as	IN	B-TREATMENT
81	CD	O
mg	NN	O
once	RB	O
daily	JJ	O

6.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
once	RB	O
daily	JJ	O

7.	CD	O
kcl	$	B-TREATMENT
40	CD	O
meq	NN	O
once	RB	O
daily	JJ	O

8.	CD	O
prandin	JJ	B-TREATMENT
0.5	CD	O
mg	NN	O
once	RB	O
daily	JJ	O

9.	CD	O
unasyn	JJ	B-TREATMENT
3	CD	O
giv	NN	O
q8hours	NNS	O

morphine	NN	B-TREATMENT
->	NNP	O
confusion	NN	B-PROBLEM
/	NNP	O
delerium	NN	B-PROBLEM
.	.	O

adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
72	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	VBD	O
a	DT	B-TREATMENT
four	CD	I-TREATMENT
vessel	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1983	CD	O
,	,	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
hepatitis	NN	B-PROBLEM
c	NNS	I-PROBLEM
positive	JJ	O
cirrhosis	NN	B-PROBLEM
history	NN	O
with	IN	O
history	NN	O
of	IN	O
portal	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
and	CC	O
status	NN	O
post	NN	O
an	DT	B-PROBLEM
upper	JJ	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
on	IN	O
4-10-98	JJ	O
,	,	O
who	WP	O
presents	VBZ	O
from	IN	O
sondi	JJ	O
memorial	NN	O
for	IN	O
work	NN	B-TEST
up	RB	I-TEST
of	IN	O
pulmonary	JJ	B-PROBLEM
infiltrates	NNS	I-PROBLEM
,	,	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
sondi	VB	O
memorial	JJ	O
on	IN	O
4-10-98	JJ	O
with	IN	O
fatigue	NN	B-PROBLEM
and	CC	O
fall	NN	O
,	,	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
29	CD	O
,	,	O
baseline	NN	O
37	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transfused	VBN	O
two	CD	B-TREATMENT
units	NNS	I-TREATMENT
and	CC	O
an	DT	B-TEST
esophagogastroduodenoscopy	NN	I-TEST
done	VBN	O
where	WRB	O
it	PRP	O
showed	VBD	O
gastritis	NN	B-PROBLEM
,	,	O
candidal	JJ	B-PROBLEM
esophagitis	NN	I-PROBLEM
and	CC	O
portal	JJ	B-PROBLEM
hypertensive	NN	I-PROBLEM
gastropathy	NN	I-PROBLEM
without	IN	O
varices	NNS	B-PROBLEM
.	.	O

a	DT	B-TEST
colonoscopy	NN	I-TEST
showed	VBD	O
anteriordysplasia	NN	B-PROBLEM
,	,	O
no	DT	O
bleeding	NN	B-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
after	IN	O
one	CD	O
week	NN	O
on	IN	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
.	.	O

on	IN	O
4-24	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
again	RB	O
at	IN	O
sondi	JJ	O
memorial	NN	O
when	WRB	O
he	PRP	O
experienced	VBD	O
at	IN	O
home	NN	O
a	DT	O
fall	NN	O
,	,	O
no	DT	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
positive	JJ	O
substernal	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
pleuritic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
cough	NN	B-PROBLEM
.	.	O

he	PRP	O
went	VBD	O
to	TO	O
sondi	VB	O
memorial	JJ	O
where	WRB	O
he	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
left	VBN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
/	NNP	O
pneumonia	NN	B-PROBLEM
,	,	O
started	VBD	O
on	IN	O
cefuroxime	NN	B-TREATMENT
.	.	O

his	PRP$	O
respiratory	NN	O
condition	NN	O
continued	VBD	O
to	TO	O
deteriorate	VB	O
despite	IN	O
aggressive	JJ	B-TREATMENT
chest	NN	I-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
possible	JJ	O
blood	NN	O
,	,	O
given	VBN	O
lasix	NN	B-TREATMENT
for	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
,	,	O
hypoxic	JJ	B-PROBLEM
and	CC	O
intubated	JJ	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
expanding	VBG	B-PROBLEM
pulmonary	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
on	IN	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
,	,	O
developed	VBD	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
minimal	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
less	JJR	O
than	IN	O
10	CD	O
cc	NNS	O
an	DT	O
hour	NN	O
,	,	O
started	VBD	O
on	IN	O
dopamine	NN	B-TREATMENT
for	IN	O
hemodynamic	JJ	B-PROBLEM
instability	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
obtained	VBN	O
on	IN	O
4-26	JJ	O
which	WDT	O
showed	VBD	O
concentric	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
with	IN	O
normal	JJ	O
_____	NN	O
left	VBD	O
ventricular	JJ	O
function	NN	O
,	,	O
severe	RB	B-PROBLEM
right	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
dilatation	NN	I-PROBLEM
with	IN	O
septal	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
and	CC	I-PROBLEM
flattening	VBG	I-PROBLEM
with	IN	O
a	DT	O
question	NN	O
of	IN	O
right	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
clot	NN	I-PROBLEM
raised	VBN	O
with	IN	O
mild	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
pressure	NN	I-PROBLEM
of	IN	O
approximately	RB	O
70	CD	O
millimeters	NNS	O
,	,	O
consistent	JJ	O
with	IN	O
fairly	RB	B-PROBLEM
severe	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
x	VBP	O
two	CD	O
sent	VBD	O
off	IN	O
with	IN	O
no	DT	O
growth	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
flat	JJ	O
creatine	NN	B-TEST
kinases	NNS	I-TEST
and	CC	O
he	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
oaksgekesser/	VB	O
memorial	JJ	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
work	NN	I-TEST
up	RB	I-TEST
.	.	O

at	IN	O
the	DT	O
oaksgekesser/	JJ	O
memorial	JJ	O
hospital	NN	O
he	PRP	O
was	VBD	O
quite	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
,	,	O
requiring	VBG	O
dopamine	NN	B-TREATMENT
at	IN	O
1,000	CD	O
,	,	O
levo	NN	B-TREATMENT
at	IN	O
12	CD	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	NN	O
diffuse	IN	B-PROBLEM
patchy	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
on	IN	I-PROBLEM
left	JJ	I-PROBLEM
lung	NN	I-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
lung	NN	I-PROBLEM
patchy	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
hemidiaphragm	NN	I-PROBLEM
elevated	VBD	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
adult	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
from	IN	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
urinalysis	NN	I-TEST
was	VBD	O
obtained	VBN	O
which	WDT	O
showed	VBD	O
blood	NN	B-PROBLEM
,	,	O
urine	JJ	B-PROBLEM
sediment	NN	I-PROBLEM
was	VBD	O
active	JJ	B-PROBLEM
with	IN	O
positive	JJ	O
dysmorphic	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
red	JJ	B-PROBLEM
cell	NN	I-PROBLEM
casts	NNS	I-PROBLEM
,	,	O
and	CC	O
1+	CD	B-PROBLEM
albumin	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
protein	NN	I-PROBLEM
uria	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
anca	VBN	B-TEST
,	,	O
anti-gbm	JJ	B-TEST
,	,	O
anti-streptolycin	JJ	B-TEST
,	,	O
ana	JJ	B-TEST
,	,	O
upep	JJ	B-TEST
,	,	O
spep	JJ	B-TEST
,	,	O
renal	JJ	B-TEST
ultrasound	NN	I-TEST
,	,	O
hepatitis	NN	B-TEST
c	NNS	I-TEST
cryoglobulin	VBP	I-TEST
sent	VBN	O
out	RP	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
bronchoscopy	NN	I-TEST
immediately	RB	O
done	VBN	O
which	WDT	O
showed	VBD	O
no	DT	O
fresh	JJ	B-PROBLEM
blood	NN	I-PROBLEM
,	,	O
just	RB	O
old	JJ	B-PROBLEM
clot	NN	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
pulmonary	JJ	I-TREATMENT
arterial	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
in	IN	O
the	DT	O
right	JJ	O
internal	JJ	O
jugular	NN	O
vein	NN	O
.	.	O

question	NN	O
of	IN	O
pulmonary-renal	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
was	VBD	O
raised	VBN	O
.	.	O

the	DT	O
patient	NN	O
subsequently	RB	O
deteriorated	VBN	O
over	IN	O
time	NN	O
,	,	O
was	VBD	O
started	VBN	O
on	IN	O
cvvh	NN	B-TREATMENT
and	CC	O
suffered	VBD	O
significant	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
without	IN	O
improvement	NN	O
of	IN	O
his	PRP$	O
pulmonary	JJ	O
/	NNP	O
renal	JJ	O
situation	NN	O
.	.	O

a	DT	O
family	NN	O
meeting	NN	O
was	VBD	O
held	VBN	O
on	IN	O
5-2-98	JJ	O
and	CC	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
be	VB	O
made	VBN	O
comfort	NN	B-TREATMENT
care	NN	I-TREATMENT
only	RB	O
.	.	O

all	DT	O
cvvh	NN	B-TREATMENT
and	CC	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
the	DT	O
patient	NN	O
spontaneously	RB	O
passed	VBN	O
away	RP	O
on	IN	O
5-2-98	JJ	O
,	,	O
at	IN	O
4:55	CD	O
p.m.	NN	O

this	DT	O
is	VBZ	O
a	DT	O
56	JJ	O
year-old	JJ	O
gentleman	NN	O
with	IN	O
severe	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
reports	NNS	O
having	VBG	O
been	VBN	O
told	VBN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
heart	NN	I-PROBLEM
murmur	VBZ	I-PROBLEM
many	JJ	O
years	NNS	O
ago	RB	O
but	CC	O
just	RB	O
recently	RB	O
diagnosed	VBN	O
with	IN	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
mild	VBN	B-PROBLEM
dyspnea	NNS	I-PROBLEM
on	IN	O
exertion	NN	O
increasing	VBG	O
over	IN	O
the	DT	O
past	JJ	O
couple	NN	O
of	IN	O
months	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
in	IN	O
2011-09-05	JJ	O
revealed	VBD	O
a	DT	B-TEST
left	JJ	I-TEST
ventricular	JJ	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
20	CD	O
to	TO	O
25%	CD	O
.	.	O

2.	CD	O
insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

3.	CD	O
proteinuria	NNS	B-PROBLEM
.	.	O

4.	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

5.	CD	O
cellulitis	NN	B-PROBLEM
.	.	O

6.	CD	O
gangrene	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
second	JJ	I-PROBLEM
toe	NN	I-PROBLEM
in	IN	O
2010-06-06	JJ	O
followed	VBN	O
by	IN	O
an	DT	B-TREATMENT
amputation	NN	I-TREATMENT
.	.	O

7.	CD	O
left	JJ	B-TREATMENT
common	JJ	I-TREATMENT
femoral	JJ	I-TREATMENT
dorsalis	NN	I-TREATMENT
pedis	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

8.	CD	O
right	JJ	B-TREATMENT
leg	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
1999	CD	O
.	.	O

9.	CD	O
right	RB	B-TREATMENT
below	IN	I-TREATMENT
the	DT	I-TREATMENT
knee	NN	I-TREATMENT
amputation	NN	I-TREATMENT
in	IN	O
2008	CD	O
.	.	O

the	DT	O
patient	NN	O
states	VBZ	O
he	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

2.	CD	O
vasotec	JJ	B-TREATMENT
7.5	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

3.	CD	O
humalog	NN	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
with	IN	O
meals	NNS	O
and	CC	O
at	IN	O
bedtime	NN	O
.	.	O

4.	CD	O
humulin	NN	B-TREATMENT
walters	NNS	I-TREATMENT
insulin	VBP	I-TREATMENT
24	CD	O
units	NNS	O
subcutaneous	JJ	O
q	JJ	O
a.m.	NN	O
and	CC	O
8	CD	O
to	TO	O
16	CD	O
in	IN	O
the	DT	O
evening	NN	O
depending	VBG	O
upon	IN	O
where	WRB	O
his	PRP$	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
has	VBZ	O
been	VBN	O
.	.	O

preoperative	JJ	B-TEST
laboratory	NN	I-TEST
values	NNS	I-TEST
were	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	O
patient	JJ	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
on	IN	O
2011-10-17	JJ	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
20%	CD	I-PROBLEM
left	VBD	I-PROBLEM
vein	NN	I-PROBLEM
osteal	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
70%	CD	B-PROBLEM
lad	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
80%	CD	I-PROBLEM
right	JJ	I-PROBLEM
coronary	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2011-10-18	JJ	O
where	WRB	O
he	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
aortic	JJ	I-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
#23	NNP	B-TREATMENT
mm	VBP	I-TREATMENT
pericardial	JJ	I-TREATMENT
valve	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
two	CD	O
with	IN	O
a	DT	O
lima	NN	O
to	TO	O
the	DT	O
lad	NN	O
and	CC	O
saphenous	JJ	O
vein	NN	O
to	TO	O
the	DT	O
acute	JJ	O
marginal	NN	O
.	.	O

postoperatively	RB	O
the	DT	O
patient	NN	O
was	VBD	O
transported	VBN	O
to	TO	O
the	DT	O
cardiac	NN	O
surgery	NN	O
recovery	NN	O
unit	NN	O
on	IN	O
milrinone	NN	B-TREATMENT
,	,	O
neo-synephrine	JJ	B-TREATMENT
and	CC	O
levophed	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
weaned	VBN	O
from	IN	O
mechanical	JJ	B-TREATMENT
ventilation	NN	I-TREATMENT
and	CC	O
subsequently	RB	O
extubated	VBN	O
on	IN	O
the	DT	O
night	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

he	PRP	O
remained	VBD	O
on	IN	O
levophed	VBN	B-TREATMENT
,	,	O
milrinone	NN	B-TREATMENT
and	CC	O
neo-synephrine	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
and	CC	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
.	.	O

n.	JJ	O
saez	NN	O
clinic	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
due	JJ	O
to	TO	O
hyperglycemia	VB	B-PROBLEM
and	CC	O
the	DT	O
need	NN	O
for	IN	O
insulin	NN	B-TREATMENT
drip	NN	I-TREATMENT
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
the	DT	B-TREATMENT
milrinone	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
down	RP	O
.	.	O

the	DT	B-TREATMENT
levophed	VBN	I-TREATMENT
had	VBD	O
been	VBN	O
discontinued	VBN	O
as	IN	O
the	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
beginning	VBG	O
to	TO	O
progress	VB	O
hemodynamically	RB	O
.	.	O

upon	IN	O
discontinuation	NN	O
of	IN	O
the	DT	B-TREATMENT
milrinone	NN	I-TREATMENT
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
sv02	NN	I-TEST
had	VBD	O
dropped	VBN	O
significantly	RB	O
in	IN	O
the	DT	O
low	JJ	O
50	CD	O
s.	NN	O

the	DT	O
patient	NN	O
had	VBD	O
decreased	VBN	B-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
and	CC	O
therefore	NN	O
was	VBD	O
placed	VBN	O
back	RP	O
on	IN	O
his	PRP$	B-TREATMENT
milrinone	NN	I-TREATMENT
to	TO	O
keep	VB	O
his	PRP$	B-TEST
cardiac	JJ	I-TEST
index	NN	I-TEST
greater	JJR	O
than	IN	O
2.0	CD	O
.	.	O

over	IN	O
the	DT	O
next	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
it	PRP	O
was	VBD	O
very	RB	O
slowly	RB	O
decreased	VBN	O
as	IN	O
his	PRP$	B-TREATMENT
ace	NN	I-TREATMENT
inhibitors	NNS	I-TREATMENT
were	VBD	O
increased	VBN	O
orally	RB	O
.	.	O

the	DT	O
patient	NN	O
ultimately	RB	O
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	B-TREATMENT
milrinone	NN	I-TREATMENT
,	,	O
transitioned	VBD	O
to	TO	O
captopril	VB	B-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
five	CD	O
and	CC	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
.	.	O

once	RB	O
the	DT	O
patient	NN	O
had	VBD	O
remained	VBN	O
off	IN	O
of	IN	O
inotropics	NNS	B-TREATMENT
for	IN	O
approximately	RB	O
24	CD	O
hours	NNS	O
,	,	O
he	PRP	O
had	VBD	O
been	VBN	O
given	VBN	O
diuretics	NNS	B-TREATMENT
and	CC	O
ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
and	CC	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
he	PRP	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
to	TO	O
the	DT	O
telemetry	NN	O
floor	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
six	CD	O
.	.	O

a	DT	B-TEST
physical	JJ	I-TEST
therapy	NN	I-TEST
evaluation	NN	I-TEST
was	VBD	O
obtained	VBN	O
for	IN	O
assistance	NN	O
and	CC	O
mobility	NN	O
.	.	O

cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

it	PRP	O
was	VBD	O
their	PRP$	O
recommendation	NN	O
to	TO	O
continue	VB	O
ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
,	,	O
to	TO	O
continue	VB	O
daily	JJ	B-TEST
weights	NNS	I-TEST
,	,	O
to	TO	O
switch	VB	O
the	DT	O
patient	NN	O
to	TO	O
a	DT	B-TREATMENT
long	JJ	I-TREATMENT
acting	JJ	I-TREATMENT
beta-blocker	NN	I-TREATMENT
and	CC	O
to	TO	O
enroll	VB	O
the	DT	O
patient	NN	O
in	IN	O
postoperative	JJ	B-TREATMENT
cardiac	JJ	I-TREATMENT
rehabilitation	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
to	TO	O
make	VB	O
sure	JJ	O
the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
statin	NN	B-TREATMENT
drugs	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
,	,	O
continued	VBD	O
to	TO	O
increase	VB	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
ambulation	NN	O
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
sugars	NNS	I-TEST
were	VBD	O
followed	VBN	O
by	IN	O
the	DT	O
cape	NN	O
cod	NN	O
hospital	NN	O
clinic	JJ	O
service	NN	O
and	CC	O
insulin	NN	B-TREATMENT
has	VBZ	O
been	VBN	O
adjusted	VBN	O
accordingly	RB	O
.	.	O

temperature	NN	B-TEST
96.9	CD	O
f	NN	O
,	,	O
pulse	RB	B-TEST
84	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
106/59	CD	O
.	.	O

most	RBS	B-TEST
recent	JJ	I-TEST
laboratory	NN	I-TEST
values	NNS	I-TEST
are	VBP	O
from	IN	O
2011-10-25	CD	O
which	WDT	O
revealed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
8.4000	CD	O
,	,	O
hematocrit	NN	B-TEST
35	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
202,000.	CD	O
sodium	NN	B-TEST
133	CD	O
,	,	O
potassium	NN	B-TEST
4.4	CD	O
,	,	O
chloride	RB	B-TEST
93	CD	O
,	,	O
co2	NN	B-TEST
30	CD	O
,	,	O
bun	NN	B-TEST
24	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	VBD	B-TEST
198	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
finger	NN	I-TEST
stick	VBD	I-TEST
blood	NN	I-TEST
glucose	NN	I-TEST
levels	NNS	I-TEST
range	VBP	O
from	IN	O
151	CD	O
to	TO	O
390	CD	O
over	IN	O
the	DT	O
past	JJ	O
24	CD	O
hours	NNS	O
and	CC	O
his	PRP$	B-TREATMENT
insulin	NN	I-TREATMENT
scale	NN	I-TREATMENT
has	VBZ	O
been	VBN	O
adjusted	VBN	O
upward	RB	O
to	TO	O
compensate	VB	O
for	IN	O
that	DT	O
.	.	O

pulmonary	JJ	B-TEST
exam	NN	I-TEST
he	PRP	O
is	VBZ	O
clear	JJ	O
upper	JJ	O
lobes	NN	O
,	,	O
diminished	VBD	B-PROBLEM
bilateral	JJ	I-PROBLEM
bases	NNS	I-PROBLEM
left	VBD	O
greater	JJR	O
than	IN	O
right	NN	O
.	.	O

coronary	JJ	B-TEST
exam	NN	I-TEST
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

his	PRP$	O
sternum	NN	O
is	VBZ	O
stable.	JJ	O
his	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
is	VBZ	O
clean	JJ	O
and	CC	O
dry	JJ	O
steri	NN	B-TREATMENT
strips	NNS	I-TREATMENT
intact	JJ	O
.	.	O

his	PRP$	O
extremities	NNS	O
are	VBP	O
warm	JJ	O
and	CC	O
well	RB	O
perfused	VBN	O
with	IN	O
minimal	JJ	B-PROBLEM
edema	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
foot	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
his	PRP$	O
right	JJ	O
stump	NN	O
.	.	O

he	PRP	O
is	VBZ	O
able	JJ	O
to	TO	O
apply	VB	O
his	PRP$	B-TREATMENT
prosthesis	NN	I-TREATMENT
and	CC	O
ambulate	NN	O
as	RB	O
well	RB	O
.	.	O

1.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

2.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
milliequivalents	NNS	O
po	JJ	O
bid	NN	O
.	.	O

3.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

4.	CD	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

5.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

6.	CD	O
captopril	NN	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

7.	CD	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

8.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

9.	CD	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
.	.	O

10.	CD	O
bollin	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
18	CD	O
units	NNS	O
subcutaneous	JJ	O
q	JJ	O
a.m.	NN	O
,	,	O
richard	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
14	CD	O
units	NNS	O
subcutaneous	JJ	O
q	CD	O
p.m.	NN	O

11.	CD	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
humalog	NN	I-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
for	IN	O
breakfast	NN	O
is	VBZ	O
blood	VBN	B-TEST
glucose	NN	I-TEST
of	IN	O
151	CD	O
to	TO	O
200	CD	O
equal	JJ	O
4	CD	O
units	NNS	O
,	,	O
201	CD	O
to	TO	O
250	CD	O
equal	JJ	O
6	CD	O
units	NNS	O
,	,	O
251	CD	O
to	TO	O
350	CD	O
equal	JJ	O
12	CD	O
units	NNS	O
,	,	O
greater	JJR	O
than	IN	O
350	CD	O
equals	NNS	O
15	CD	O
units	NNS	O
.	.	O

for	IN	O
lunch	NN	O
blood	NN	B-TEST
glucose	NN	I-TEST
of	IN	O
101	CD	O
to	TO	O
150	CD	O
equals	NNS	O
4	CD	O
units	NNS	O
,	,	O
151	CD	O
to	TO	O
200	CD	O
equals	NNS	O
7	CD	O
units	NNS	O
,	,	O
201	CD	O
to	TO	O
250	CD	O
equals	NNS	O
8	CD	O
units	NNS	O
,	,	O
251	CD	O
to	TO	O
350	CD	O
equals	NNS	O
12	CD	O
units	NNS	O
,	,	O
greater	JJR	O
than	IN	O
350	CD	O
equals	NNS	O
15	CD	O
units	NNS	O
.	.	O

dinner	NN	O
blood	NN	B-TEST
glucose	VBD	I-TEST
101	CD	O
to	TO	O
150	CD	O
equals	NNS	O
2	CD	O
units	NNS	O
,	,	O
151	CD	O
to	TO	O
200	CD	O
equals	NNS	O
3	CD	O
units	NNS	O
,	,	O
201	CD	O
to	TO	O
250	CD	O
equals	NNS	O
6	CD	O
units	NNS	O
,	,	O
251	CD	O
to	TO	O
350	CD	O
equals	NNS	O
12	CD	O
units	NNS	O
,	,	O
greater	JJR	O
than	IN	O
350	CD	O
equals	NNS	O
15	CD	O
units	NNS	O
.	.	O

1.	CD	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

2.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

3.	CD	O
type	NN	B-PROBLEM
i	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

4.	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
also	RB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
for	IN	O
diabetes	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	NNS	O
east	RB	O
here	RB	O
at	IN	O
the	DT	O
heart	NN	O
failure	NN	O
clinic	NN	O
to	TO	O
continue	VB	O
follow	VB	O
up	RP	O
with	IN	O
cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
and	CC	O
heart	NN	B-TREATMENT
failure	NN	I-TREATMENT
management	NN	I-TREATMENT
.	.	O

acute	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

gout	NN	B-PROBLEM
.	.	O

stent	JJ	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
rca	NN	I-TREATMENT
on	IN	O
october	$	O
15	CD	O
,	,	O
1999	CD	O
.	.	O

right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
coronary	JJ	B-TEST
angiography	NN	I-TEST
on	IN	O
october	$	O
15	CD	O
,	,	O
1999	CD	O
.	.	O

aspirin	RB	B-TREATMENT
325	CD	O
mg.	NN	O
qday	NN	O
.	.	O

plavix	NN	B-TREATMENT
75	CD	O
mg.	NN	O
qday	NN	O
for	IN	O
four	CD	O
weeks	NNS	O
.	.	O

atenolol	RB	B-TREATMENT
50	CD	O
mg.	NN	O
qday	NN	O
.	.	O

mr.	NN	O
factor	NN	O
is	VBZ	O
a	DT	O
76	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
acute	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
who	WP	O
was	VBD	O
urgently	RB	O
transferred	VBN	O
by	IN	O
dr.	JJ	O
lenni	NNS	O
factor	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
possible	JJ	O
angioplasty	NN	B-TREATMENT
.	.	O

his	PRP$	O
only	JJ	O
cardiac	JJ	O
risk	NN	O
factor	NN	O
includes	VBZ	O
hypertension	NN	B-PROBLEM
.	.	O

the	DT	O
night	NN	O
of	IN	O
oct	NN	O
14	CD	O
,	,	O
1999	CD	O
the	DT	O
patient	NN	O
developed	VBD	O
chest	JJS	B-PROBLEM
discomfort	NN	I-PROBLEM
associated	VBN	O
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
acute	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

due	JJ	O
to	TO	O
unknown	JJ	O
duration	NN	O
of	IN	O
the	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
the	DT	O
patient	NN	O
wastransferred	VBD	O
urgently	RB	O
to	TO	O
the	DT	O
tgcho	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

shortly	RB	O
after	IN	O
aggrastat	NN	B-TREATMENT
was	VBD	O
started	VBN	O
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
pain	JJ	B-PROBLEM
free	JJ	O
.	.	O

hypertension	NN	B-PROBLEM
and	CC	O
gout	NN	B-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
115/77	CD	O
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
64	CD	O
.	.	O

jvp	NN	B-TEST
6	CD	O
cm	NN	O
.	.	O

carotid	NN	B-TEST
upstroke	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
s4	NN	I-PROBLEM
.	.	O

femoral	JJ	B-TEST
and	CC	I-TEST
distal	JJ	I-TEST
pulses	NNS	I-TEST
were	VBD	O
full	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
pedaledema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
62	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
,	,	O
small	JJ	B-PROBLEM
qwaves	NNS	I-PROBLEM
in	IN	I-PROBLEM
3	CD	I-PROBLEM
and	CC	I-PROBLEM
f	NNS	I-PROBLEM
,	,	O
st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
2	CD	I-PROBLEM
,	,	I-PROBLEM
3	CD	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
f.	JJ	I-PROBLEM
st	NN	B-PROBLEM
depression	NN	I-PROBLEM
in	IN	I-PROBLEM
1	CD	I-PROBLEM
,	,	I-PROBLEM
l	NN	I-PROBLEM
and	CC	I-PROBLEM
v2	NN	I-PROBLEM
and	CC	I-PROBLEM
3	CD	I-PROBLEM
.	.	O

peak	NN	B-TEST
cpk	NN	I-TEST
1117	CD	O
.	.	O

total	JJ	B-TEST
cholesterol	NN	I-TEST
142	CD	O
.	.	O

ldl	RB	B-TEST
56	CD	O
.	.	O

hdl	NN	B-TEST
30	CD	O
.	.	O

triglycerides	NNS	B-TEST
281	CD	O
.	.	O

coronary	JJ	B-TEST
angiography	NN	I-TEST
,	,	O
right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
percutaneous	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
rca	NN	I-TREATMENT
were	VBD	O
performed	VBN	O
from	IN	O
the	DT	O
right	JJ	O
groin	NN	O
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

the	DT	O
proximal	JJ	O
rca	NN	O
was	VBD	O
totally	RB	B-PROBLEM
occluded	VBN	I-PROBLEM
with	IN	O
good	JJ	O
left	NN	O
to	TO	O
right	JJ	O
collaterals	NNS	O
.	.	O

the	DT	O
lad	NN	O
showed	VBD	O
a	DT	B-PROBLEM
40%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
segment	NN	I-PROBLEM
.	.	O

the	DT	O
circumflex	NN	O
showed	VBD	O
mild	JJ	B-PROBLEM
atherosclerotic	JJ	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
rca	NN	I-PROBLEM
occlusion	NN	I-PROBLEM
was	VBD	O
successfully	RB	O
dilated	VBN	O
and	CC	O
sent	VBN	O
using	VBG	O
a	DT	B-TREATMENT
3.0	CD	I-TREATMENT
x	NN	I-TREATMENT
23	CD	I-TREATMENT
mm	NN	I-TREATMENT
duet	NN	I-TREATMENT
with	IN	O
post	NN	B-TREATMENT
stent	NN	I-TREATMENT
dilatation	NN	I-TREATMENT
up	RB	O
to	TO	O
16	CD	O
atmospheres	NNS	O
.	.	O

following	VBG	O
intervention	NN	B-TREATMENT
right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
was	VBD	O
performed	VBN	O
to	TO	O
rule	VB	O
out	RP	O
rv	NN	B-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
ra	NN	I-TEST
was	VBD	O
5	CD	O
.	.	O

pa	NN	B-TEST
was	VBD	O
19/7	CD	O
with	IN	O
a	DT	B-TEST
mean	NN	I-TEST
of	IN	O
13	CD	O
.	.	O

pcw	NN	B-TEST
was	VBD	O
11	CD	O
.	.	O

of	IN	O
note	NN	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
clear	JJ	I-PROBLEM
a	DT	I-PROBLEM
wave	NN	I-PROBLEM
in	IN	O
the	DT	B-TEST
rv	NN	I-TEST
tracing	NN	I-TEST
,	,	O
suggestive	NN	O
of	IN	O
rv	NN	B-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

the	DT	O
next	JJ	O
day	NN	O
the	DT	O
patient	NN	O
was	VBD	O
quite	RB	B-PROBLEM
confused	JJ	I-PROBLEM
and	CC	O
disoriented	VBN	B-PROBLEM
,	,	O
which	WDT	O
gradually	RB	O
disappeared	VBD	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
performed	VBN	O
to	TO	O
evaluate	VB	O
the	DT	B-TEST
lv	NN	I-TEST
function	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
53%	CD	O
with	IN	O
inferoposteriorakinesis	NN	B-PROBLEM
/	JJ	O
hypokinesis	NN	B-PROBLEM
.	.	O

the	DT	O
next	JJ	O
day	NN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
mental	JJ	O
status	NN	O
came	VBD	O
back	RB	O
to	TO	O
baseline	NN	O
and	CC	O
he	PRP	O
remained	VBD	O
free	JJ	O
of	IN	O
angina	NN	B-PROBLEM
.	.	O

betalactams	NNS	B-TREATMENT
/	VBP	O
levofloxacin	NN	B-TREATMENT

chief	JJ	O
complaint	NN	O
:	:	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM

major	JJ	O
surgical	JJ	O
or	CC	O
invasive	JJ	O
procedure	NN	O
:	:	O
s/p	JJ	O
intracranial	JJ	B-TREATMENT
pressure	NN	I-TREATMENT
bolt	NN	I-TREATMENT
placement	NN	I-TREATMENT

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
58	JJ	O
-	:	O
year-old	JJ	O
man	NN	O
with	IN	O
history	NN	O
of	IN	O
iddm	NN	B-PROBLEM
,	,	O
pvd	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
toe	NN	B-TREATMENT
amputations	NNS	I-TREATMENT
,	,	O
diabetic	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
,	,	O
and	CC	O
retinopathy	VB	B-PROBLEM
recently	RB	O
admitted	VBN	O
to	TO	O
mclean	VB	O
hospital	NN	O
from	IN	O
2017-01-13	JJ	O
,	,	O
through	IN	O
2017-01-18	JJ	O
,	,	O
with	IN	O
a	DT	O
diagnosis	NN	O
of	IN	O
right	JJ	B-PROBLEM
heel	NN	I-PROBLEM
diabetic	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
with	IN	O
mssa	JJ	B-PROBLEM
osteomyelitis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
calcaneus	NN	I-PROBLEM
,	,	O
mssa	FW	B-PROBLEM
bacteremia	NN	I-PROBLEM
,	,	O
acute	JJ	B-PROBLEM
interstitial	JJ	I-PROBLEM
nephritis	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
oxacillin	VB	B-TREATMENT
,	,	O
and	CC	O
rll	VB	B-PROBLEM
pna	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
sent	VBN	O
home	NN	O
with	IN	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
and	CC	O
iv	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

he	PRP	O
returned	VBD	O
to	TO	O
the	DT	O
wing	VBG	O
memorial	JJ	O
&	CC	O
medical	JJ	O
center	NN	O
intubated	VBN	B-TREATMENT
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
on	IN	O
2017-02-04	JJ	O
,	,	O
for	IN	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
was	VBD	O
sent	VBN	O
to	TO	O
cmed	VB	O
csru	NN	O
.	.	O

prior	RB	O
to	TO	O
his	PRP$	O
re-admission	NN	O
,	,	O
his	PRP$	O
sister	NN	O
had	VBD	O
noted	VBN	O
that	IN	O
he	PRP	O
was	VBD	O
having	VBG	O
some	DT	B-PROBLEM
shaking	VBG	I-PROBLEM
chills	NNS	I-PROBLEM
and	CC	O
heavy	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
.	.	O

when	WRB	O
he	PRP	O
came	VBD	O
back	RB	O
to	TO	O
faulkner	VB	O
hospital	JJ	O
hospital	NN	O
for	IN	O
confusion	NN	B-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
,	,	O
his	PRP$	B-TEST
initial	JJ	I-TEST
oxygen	NN	I-TEST
sat	VBD	I-TEST
was	VBD	O
only	RB	O
80%	CD	O
with	IN	O
a	DT	B-TEST
fingerstick	NN	I-TEST
of	IN	O
29	CD	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
d50	NN	B-TREATMENT
,	,	O
but	CC	O
continued	VBD	O
to	TO	O
have	VB	O
progressive	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
was	VBD	O
therefore	RB	O
intubated	JJ	O
and	CC	O
transferred	VBD	O
to	TO	O
the	DT	O
austen	JJ	O
riggs	NN	O
center	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
multifocal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
bacteremia	NN	B-PROBLEM
with	IN	O
enterobacter	NN	B-PROBLEM
and	CC	O
mssa	NN	B-PROBLEM
.	.	O

past	JJ	O
medical	JJ	O
history	NN	O
:	:	O
diabetes	VBZ	B-PROBLEM
type	IN	I-PROBLEM
1	CD	I-PROBLEM
since	IN	O
age	NN	O
24	CD	O
after	IN	O
pancreatic	JJ	B-PROBLEM
trauma	NN	I-PROBLEM

diabetic	JJ	B-PROBLEM
retinopathy	NN	I-PROBLEM

direct	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM

pvd	NN	B-PROBLEM

status	NN	O
post	NN	O
multiple	NN	B-TREATMENT
toe	NN	I-TREATMENT
amputations	NNS	I-TREATMENT

recent	JJ	B-PROBLEM
right	JJ	I-PROBLEM
heel	NN	I-PROBLEM
osteomyelitis	NN	I-PROBLEM

recent	JJ	B-PROBLEM
mssa	NN	I-PROBLEM
bacteremia	NN	I-PROBLEM

multifocal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM

acute	JJ	B-PROBLEM
interstitial	JJ	I-PROBLEM
nephritis	NN	I-PROBLEM

cataract	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

on	IN	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
from	IN	O
the	DT	O
cmed	VBN	O
csru	NN	O
on	IN	O
2017-02-15	JJ	O
temp	NN	B-TEST
:	:	O

97.4	CD	O
hr	NN	B-TEST
:	:	O

78	CD	O
bp	NN	B-TEST
:	:	O

141/64	CD	O
rr	NN	B-TEST
:	:	O

20	CD	O
o2sat	NNS	B-TEST
:	:	O

94-95%	CD	O
on	IN	O
3l	CD	B-TREATMENT
nc	NNS	I-TREATMENT

gen	NN	O
:	:	O
somnolent	NN	B-PROBLEM
but	CC	O
arousable	JJ	O
to	TO	O
voice	VB	O

rrr	NN	O
,	,	O
no	DT	O
m/r/g	NN	B-PROBLEM

lungs	NNS	O
:	:	O
crackles	NNS	B-PROBLEM
bibasilar	VBP	I-PROBLEM

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
slightly	RB	B-PROBLEM
distended	VBN	I-PROBLEM
,	,	O
nontender	FW	B-PROBLEM
,	,	O
+bs	FW	O

2+	CD	B-PROBLEM
pitting	VBG	I-PROBLEM
edema	NN	I-PROBLEM
b	NN	I-PROBLEM
le	NN	I-PROBLEM
to	TO	I-PROBLEM
knee	VB	I-PROBLEM
,	,	O
nonpitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
in	IN	I-PROBLEM
b	NN	I-PROBLEM
hands	NNS	I-PROBLEM
and	CC	I-PROBLEM
arms	NNS	I-PROBLEM
.	.	O

1+	CD	B-TEST
dp	NN	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	I-TEST
.	.	O

missing	VBG	B-PROBLEM
r	NN	I-PROBLEM
1st	CD	I-PROBLEM
toe	NN	I-PROBLEM
and	CC	I-PROBLEM
l	NN	I-PROBLEM
2nd	CD	I-PROBLEM
toe	NN	I-PROBLEM
.	.	O

wound	NN	B-TREATMENT
vac	NN	I-TREATMENT
in	IN	O
place	NN	O
on	IN	O
r	JJ	O
foot	NN	O
.	.	O

l	NN	B-TREATMENT
picc	NN	I-TREATMENT
(	(	O
2017-02-14	JJ	O
)	)	O
.	.	O

not	RB	O
following	VBG	O
commands	NNS	O
but	CC	O
moves	VBZ	O
ue	VBP	O
's	POS	O
to	TO	O
try	VB	O
to	TO	O
pull	VB	O
out	RP	O
ng	JJ	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

ct	JJ	B-TEST
chest	JJS	I-TEST
2017-02-06	JJ	O

1.	CD	O
extensive	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
diffuse	NN	I-PROBLEM
ground	NN	I-PROBLEM
glass	NN	I-PROBLEM
and	CC	O
more	RBR	O
confluent	JJ	O
areas	NNS	O
of	IN	O
consolidation	NN	B-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lungs	NNS	I-PROBLEM
consistent	NN	O
with	IN	O
the	DT	B-TEST
recent	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
.	.	O

this	DT	B-PROBLEM
non	JJ	I-PROBLEM
-	:	I-PROBLEM
specific	JJ	I-PROBLEM
pattern	NN	I-PROBLEM
could	MD	O
represent	VB	O
diffuse	VB	B-PROBLEM
pneumonia	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
ards	NNS	B-PROBLEM
.	.	O

this	DT	O
would	MD	O
likely	RB	O
less	RBR	O
represent	JJ	O
asymmetric	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

2.	CD	O
small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

echo	JJ	B-TEST
2018-02-06	JJ	O

1.	CD	O
no	DT	O
spontaneous	JJ	B-PROBLEM
echo	NN	I-PROBLEM
contrast	NN	I-PROBLEM
or	CC	O
thrombus	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
left	JJ	O
atrium	NN	O
or	CC	O
left	VBN	O
atrial	JJ	O
appendage	NN	O
.	.	O

no	DT	O
atrial	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
by	IN	O
2d	CD	B-TEST
or	CC	I-TEST
color	NN	I-TEST
doppler	NN	I-TEST
.	.	O

2.	CD	O
left	VBD	B-TEST
ventricular	JJ	I-TEST
wall	NN	I-TEST
thickness	NN	I-TEST
,	,	O
cavity	NN	B-TEST
size	NN	I-TEST
,	,	O
and	CC	O
systolic	JJ	B-TEST
function	NN	I-TEST
are	VBP	O
normal	JJ	O
(	(	O
lvef	JJ	B-TEST
>	NNP	O
55%	CD	O
)	)	O
.	.	O

3.	CD	O
right	JJ	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
and	CC	O
free	JJ	B-TEST
wall	NN	I-TEST
motion	NN	I-TEST
are	VBP	O
normal	JJ	O
.	.	O

4.	CD	O
the	DT	O
ascending	NN	O
,	,	O
transverse	NN	O
and	CC	O
descending	VBG	O
thoracic	NN	O
aorta	NNS	O
are	VBP	O
normal	JJ	O
in	IN	O
diameter	NN	O
and	CC	O
free	JJ	O
of	IN	O
atherosclerotic	JJ	B-PROBLEM
plaque	NN	I-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
vegetations	NNS	B-PROBLEM
are	VBP	O
seen	VBN	O
on	IN	O
the	DT	O
aortic	JJ	O
valve	NN	O
.	.	O

trace	NN	B-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

6.	CD	O
the	DT	O
mitral	JJ	O
valve	NN	O
appears	VBZ	O
structurally	RB	O
normal	JJ	O
with	IN	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

no	DT	O
mass	NN	B-PROBLEM
or	CC	O
vegetation	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
mitral	JJ	O
valve	NN	O
.	.	O

7.	CD	O
no	DT	O
vegetation	NN	B-PROBLEM
/	FW	O
mass	NN	B-PROBLEM
is	VBZ	O
seen	VBN	O
on	IN	O
the	DT	O
pulmonic	JJ	O
valve	NN	O
.	.	O

8.	CD	O
there	EX	O
is	VBZ	O
a	DT	O
trivial	JJ	O
/	NN	O
physiologic	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
ct	VBD	I-TEST
2017-02-08	JJ	O

no	DT	O
intracranial	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
or	CC	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

no	DT	O
major	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
territorial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
is	VBZ	O
identified	VBN	O
.	.	O

no	DT	O
osseous	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
are	VBP	O
seen	VBN	O
.	.	O

no	DT	O
intracranial	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
ct	JJ	B-TEST
evidence	NN	O
of	IN	O
acute	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

eeg	JJ	B-TEST
2017-02-10	JJ	O

this	DT	O
is	VBZ	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
eeg	NN	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
voltage	NN	I-PROBLEM
and	CC	O
slow	VB	B-PROBLEM
background	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
encephalopathy	NN	I-PROBLEM
of	IN	O
toxic	NN	O
,	,	O
metabolic	JJ	O
,	,	O
or	CC	O
anoxic	JJ	O
etiology	NN	O
.	.	O

note	NN	O
that	IN	O
with	IN	O
the	DT	O
documented	JJ	O
movements	NNS	O
of	IN	O
the	DT	O
patient	NN	O
's	POS	O
head	NN	O
and	CC	O
mouth	NN	O
,	,	O
no	DT	O
change	NN	O
on	IN	O
the	DT	B-TEST
eeg	NN	I-TEST
was	VBD	O
seen	VBN	O
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
ongoing	VBG	B-PROBLEM
seizures	NNS	I-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

cultures	NNS	B-TEST
:	:	O

urine	NN	B-TEST
:	:	O

2017-02-04	JJ	O
and	CC	O
2017-02-07	JJ	O
and	CC	O
2017-02-11	JJ	O
:	:	O
yeast	NN	B-PROBLEM

sputum	NN	B-TEST
2017-02-04	JJ	O

enterobacter	NN	B-PROBLEM
cloacae	NN	I-PROBLEM

iv	NN	B-TREATMENT
catheter	NN	I-TREATMENT
tip	VBD	I-TREATMENT
2017-02-05:	JJ	O

staphylococcus	NN	B-PROBLEM
,	,	I-PROBLEM
coagulase	NN	I-PROBLEM
negative	JJ	I-PROBLEM
sensitive	JJ	O
to	TO	O
vanc	VB	B-TREATMENT

blood	NN	B-TEST
:	:	O

enterobacter	NN	B-PROBLEM
cloacae	NN	I-PROBLEM

enterococcus	NN	B-PROBLEM
faecium	NN	I-PROBLEM
.	.	O

staphylococcus	NN	B-PROBLEM
,	,	I-PROBLEM
coagulase	NN	I-PROBLEM
negative	JJ	I-PROBLEM
.	.	O

stool	JJ	B-TEST
2017-02-07	JJ	O
:	:	O
c.	NN	B-PROBLEM
diff	NN	I-PROBLEM
negative	JJ	O

1)	CD	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
:	:	O

on	IN	O
admission	NN	O
,	,	O
this	DT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
likely	JJ	O
03-15	JJ	O
worsening	VBG	B-PROBLEM
pna	NN	I-PROBLEM
.	.	O

pt	NN	O
remained	VBD	O
intubated	JJ	B-TREATMENT
until	IN	O
2017-02-14	JJ	O
.	.	O

he	PRP	O
had	VBD	O
difficulty	NN	O
weaning	VBG	O
from	IN	O
the	DT	B-TREATMENT
vent	NN	I-TREATMENT
due	JJ	O
to	TO	O
difficulties	NNS	B-PROBLEM
with	IN	I-PROBLEM
neurological	JJ	I-PROBLEM
status	NN	I-PROBLEM
(	(	O
he	PRP	O
remained	VBD	O
drowsy	JJ	B-PROBLEM
and	CC	O
unresponsive	JJ	B-PROBLEM
for	IN	O
many	JJ	O
days	NNS	O
)	)	O
but	CC	O
eventually	RB	O
awoke	VBD	O
enough	JJ	O
and	CC	O
was	VBD	O
extubated	VBN	O
without	IN	O
difficulty	NN	O
and	CC	O
remained	VBD	O
stable	JJ	O
on	IN	O
3l	CD	B-TREATMENT
nc	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
but	CC	O
a	DT	O
few	JJ	O
days	NNS	O
later	RB	O
began	VBD	O
to	TO	O
show	VB	O
signs	NNS	O
of	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
reintubation	NN	B-TREATMENT
for	IN	O
likely	JJ	O
aspiration	NN	B-PROBLEM
event	NN	I-PROBLEM
leading	VBG	O
to	TO	O
worsening	VBG	B-PROBLEM
pneumonia	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
some	DT	O
component	NN	O
of	IN	O
pulm	NN	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
extubated	VBN	O
a	DT	O
few	JJ	O
days	NNS	O
later	RB	O
and	CC	O
transferred	VBD	O
back	RB	O
to	TO	O
the	DT	O
floor	NN	O
where	WRB	O
his	PRP$	O
pulm	NN	O
status	NN	O
improved	VBD	O
dramatically	RB	O
with	IN	O
lasix	NN	B-TREATMENT
and	CC	O
continued	JJ	B-TREATMENT
nebulizer	NN	I-TREATMENT
treatments	NNS	I-TREATMENT
.	.	O

however	RB	O
,	,	O
on	IN	O
2017-03-01	JJ	O
at	IN	O
6	CD	O
am	VBP	O
the	DT	O
pt	NN	O
was	VBD	O
found	VBN	O
with	IN	O
labored	JJ	B-PROBLEM
respirations	NNS	I-PROBLEM
(	(	O
rr	VB	B-TEST
=	RB	O
24	CD	O
)	)	O
and	CC	O
sao2	$	B-TEST
89%	CD	O
,	,	O
which	WDT	O
improved	VBD	O
to	TO	O
only	RB	O
sao290	VB	B-TEST
-	:	O
91%	CD	O
on	IN	O
100%	CD	O
nrb	NNS	B-TREATMENT
.	.	O

abg	NN	B-TEST
(	(	O
7.42	CD	O
/	RB	O
38	CD	O
/	JJ	O
88	CD	O
)	)	O
was	VBD	O
performed	VBN	O
,	,	O
80	CD	O
mg	NN	O
lasix	NN	B-TREATMENT
was	VBD	O
given	VBN	O
and	CC	O
the	DT	O
patietn	NN	O
had	VBD	O
foley	NN	B-TREATMENT
placed	VBN	O
and	CC	O
had	VBD	O
good	JJ	O
urine	NN	O
output	NN	O
and	CC	O
good	JJ	O
mentation	NN	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
nebulizers	NNS	B-TREATMENT
without	IN	O
improvement	NN	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
radiograph	NN	I-TEST
had	VBD	O
fluffy	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
.	.	O

although	IN	O
the	DT	O
pt	NN	O
was	VBD	O
w/o	JJ	O
fever	NN	B-PROBLEM
,	,	O
he	PRP	O
had	VBD	O
chills	NNS	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
readmitted	VBN	O
tot	IN	O
he	PRP	O
cmed	VBD	O
csru	NN	O
for	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
recurrent	JJ	I-PROBLEM
aspiration	NN	I-PROBLEM
event	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
meropenem	NN	B-TREATMENT
,	,	O
started	VBD	O
on	IN	O
bipap	NN	B-TREATMENT
and	CC	O
aggressively	RB	O
suctioned	VBN	O
in	IN	O
an	DT	O
attempt	NN	O
to	TO	O
avoid	VB	O
intubation	NN	B-TREATMENT
.	.	O

on	IN	O
03-02	NN	O
at	IN	O
10	CD	O
am	VBP	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
acutechange	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
with	IN	O
bradycardia	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
pinpoint	NN	B-PROBLEM
pupils	NNS	I-PROBLEM
,	,	O
decerebrate	NN	B-PROBLEM
posturing	NN	I-PROBLEM
and	CC	O
increased	VBD	B-PROBLEM
tone	NN	I-PROBLEM
in	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremities	NNS	I-PROBLEM
and	CC	O
unresponsiveness	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
ct	VB	O
immediately	RB	O
for	IN	O
stat	JJ	B-TEST
scan	JJ	I-TEST
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
massive	JJ	I-PROBLEM
occipital	NN	I-PROBLEM
spontaneous	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
into	IN	I-PROBLEM
the	DT	I-PROBLEM
l	NN	I-PROBLEM
ventricle	NN	I-PROBLEM
requiring	VBG	O
ventricular	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

neurosurgery	NN	O
was	VBD	O
immediately	RB	O
called	VBN	O
for	IN	O
an	DT	B-TREATMENT
evd	NN	I-TREATMENT
and	CC	O
anesthesia	NN	O
was	VBD	O
called	VBN	O
stat	NN	O
to	TO	O
the	DT	O
bedside	NN	O
for	IN	O
intubation	NN	B-TREATMENT
at	IN	O
10:45	CD	O
am	VBP	O
in	IN	O
order	NN	O
to	TO	O
assist	VB	O
in	IN	O
hyperventilation	NN	B-TREATMENT
.	.	O

after	IN	O
endotracheal	JJ	B-TREATMENT
intubation	NN	I-TREATMENT
,	,	O
maps	NNS	B-TEST
were	VBD	O
maintained	VBN	O
between	IN	O
70	CD	O
and	CC	O
90	CD	O
,	,	O
dilantin	NN	B-TREATMENT
was	VBD	O
dose	JJ	O
to	TO	O
maintain	VB	O
an	DT	O
appropriate	JJ	O
level	NN	O
.	.	O

l	NN	B-TREATMENT
frontal	JJ	I-TREATMENT
icp	NN	I-TREATMENT
bolt	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
by	IN	O
neurosurgery	NN	O
under	IN	O
sterile	JJ	O
conditions	NNS	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

mannitol	NN	B-TREATMENT
75	CD	O
mg	NN	O
iv	NN	O
x	VBD	O
1	CD	O
then	RB	O
50	CD	O
gm	NNS	O
iv	JJ	O
tid	NN	O
was	VBD	O
begun	VBN	O
to	TO	O
maintain	VB	O
serum	JJ	B-TEST
osm	JJ	I-TEST
>	NN	O
320	CD	O
and	CC	O
na	JJ	B-TEST
>	NN	O
147	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
hyperventilated	VBN	B-TREATMENT
to	TO	O
goal	NN	B-TEST
pco2	VB	I-TEST
30-35	JJ	O
with	IN	O
icp	JJ	B-TEST
improvement	NN	O
.	.	O

serial	JJ	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
studies	NNS	I-TEST
and	CC	O
neurologic	JJ	B-TEST
exams	NNS	I-TEST
were	VBD	O
performed	VBN	O
but	CC	O
the	DT	O
patient	NN	O
was	VBD	O
unchaged	JJ	O
,	,	O
unresponsive	JJ	B-PROBLEM
with	IN	O
posturing	NN	B-PROBLEM
and	CC	O
no	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
movement	NN	I-PROBLEM
despite	IN	O
icp	JJ	B-TEST
being	VBG	O
maintained	VBN	O
in	IN	O
good	JJ	O
range	NN	O
(	(	O
<	JJ	O
20	CD	O
).	NN	O

on	IN	O
2017-03-03	JJ	O
,	,	O
a	DT	O
family	NN	O
meeting	NN	O
resulted	VBD	O
in	IN	O
the	DT	O
patient	NN	O
's	POS	O
code	NN	O
being	VBG	O
changed	VBN	O
to	TO	O
comfort	VB	B-TREATMENT
measures	NNS	I-TREATMENT
only	RB	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
terminally	RB	O
extubated	VBN	O
on	IN	O
a	DT	B-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
ativan	NN	B-TREATMENT
titrated	VBN	O
for	IN	O
agonal	JJ	B-PROBLEM
breathing	NN	I-PROBLEM
and	CC	O
discomfort	NN	B-PROBLEM
;	:	O
scopolamine	NN	B-TREATMENT
was	VBD	O
used	VBN	O
as	IN	O
an	DT	O
adjunct	JJ	O
to	TO	O
control	VB	O
secretions	NNS	B-PROBLEM
and	CC	O
appeared	VBD	O
comfortable	JJ	O
when	WRB	O
he	PRP	O
died	VBD	O
at	IN	O
12:27	CD	O
pm	NN	O
on	IN	O
2017-03-04	JJ	O
.	.	O

the	DT	O
family	NN	O
refused	VBD	O
autopsy	NN	B-TEST
or	CC	O
post-mortem	JJ	B-TEST
examination	NN	I-TEST
to	TO	O
deduce	VB	O
secondary	JJ	O
causes	NNS	O
of	IN	O
death	NN	O
.	.	O

2.	CD	O
id	JJ	O
-	:	O
bacteremia	NN	B-PROBLEM
and	CC	O
pna	NN	B-PROBLEM
:	:	O

pt	NN	B-TREATMENT
's	POS	I-TREATMENT
triple	JJ	I-TREATMENT
lumen	NNS	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
growing	VBG	O
coag	JJ	B-PROBLEM
neg	JJ	I-PROBLEM
staph	NN	I-PROBLEM
.	.	O
and	CC	O
picc	JJ	B-TREATMENT
tip	NN	I-TREATMENT
and	CC	O
sputum	NN	B-TEST
growing	VBG	O
enterobacter	JJ	B-PROBLEM
cloacae	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
picc	NN	I-TREATMENT
was	VBD	O
d/c	JJ	O
'ed	NNP	O
and	CC	O
pt	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
vancomycin	NN	B-TREATMENT
(	(	O
for	IN	O
course	NN	O
of	IN	O
6	CD	O
weeks	NNS	O
)	)	O
and	CC	O
meropenem	NN	B-TREATMENT
was	VBD	O
added	VBN	O
on	IN	O
02-09	NNP	O
(	(	O
for	IN	O
3	CD	O
week	NN	O
course	NN	O
).	NN	O

tee	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

pt	NN	O
finished	VBD	O
the	DT	O
3	CD	O
week	NN	O
course	NN	O
of	IN	O
meropenem	NN	B-TREATMENT
while	IN	O
in	IN	O
house	NN	O
and	CC	O
was	VBD	O
discharged	VBN	O
to	TO	O
rehab	VB	O
on	IN	O
day	NN	O
34/42	CD	O
of	IN	O
the	DT	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

3)	CD	O
ain	NN	B-PROBLEM
:	:	O

pt	NN	O
received	VBD	O
oxacillin	RP	B-TREATMENT
during	IN	O
his	PRP$	O
prior	JJ	O
hospitalization	NN	O
and	CC	O
had	VBD	O
ain	VBN	B-PROBLEM
from	IN	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

on	IN	O
this	DT	O
admission	NN	O
he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
.	.	O

fluoroquinolones	NNS	B-TREATMENT
and	CC	O
other	JJ	O
renal	JJ	O
toxins	NNS	O
were	VBD	O
avoided	VBN	O
.	.	O

renal	JJ	O
function	NN	O
gradually	RB	O
improved	VBN	O
and	CC	O
cr	NN	B-TEST
trended	VBD	O
down	RB	O
from	IN	O
peak	NN	O
of	IN	O
7.6	CD	O
to	TO	O
1.4	CD	O
.	.	O

before	IN	O
the	DT	O
patient	NN	O
acutely	RB	O
decompensated	VBD	O
as	IN	O
above	IN	O
,	,	O
the	DT	O
plan	NN	O
was	VBD	O
for	IN	O
steroid	JJ	B-TREATMENT
taper	NN	I-TREATMENT
:	:	O

4)	CD	O
foot	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
:	:	O
the	DT	O
pt	NN	O
was	VBD	O
followed	VBN	O
by	IN	O
podiatry	NN	O
and	CC	O
had	VBD	O
several	JJ	B-TREATMENT
further	JJ	I-TREATMENT
debridement	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
r	NN	I-PROBLEM
heel	NN	I-PROBLEM
wound	NN	I-PROBLEM
.	.	O

on	IN	O
abx	NN	B-TREATMENT
,	,	O
podiatry	NN	O
following	NN	O
,	,	O
changed	VBD	O
vac	JJ	B-TREATMENT
q3	JJ	O
days	NNS	O
.	.	O

5)	CD	O
encephalopathy	NN	B-PROBLEM
:	:	O
it	PRP	O
was	VBD	O
unclear	JJ	O
why	WRB	O
the	DT	O
pt	NN	O
's	POS	O
mental	JJ	O
status	NN	O
initially	RB	O
did	VBD	O
not	RB	O
improve	VB	O
more	RBR	O
quickly	RB	O
after	IN	O
all	DT	B-TREATMENT
sedatives	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
extubated	VBN	O
.	.	O

his	PRP$	O
ms	NN	O
waxed	NN	O
and	CC	O
waned	VBD	O
for	IN	O
many	JJ	O
days	NNS	O
and	CC	O
uremia	JJ	B-PROBLEM
vs.	FW	O
failure	NN	B-PROBLEM
to	TO	I-PROBLEM
clear	JJ	I-PROBLEM
sedatives	NNS	I-PROBLEM
were	VBD	O
considered	VBN	O
(	(	O
although	IN	O
pt	NN	O
was	VBD	O
making	VBG	O
urine	JJ	O
and	CC	O
lft	NN	B-TEST
's	POS	I-TEST
are	VBP	O
wnl	JJ	O
).	NN	O

the	DT	O
pt	NN	O
had	VBD	O
an	DT	B-TEST
eeg	NN	I-TEST
and	CC	O
2	CD	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
's	POS	I-TEST
which	WDT	O
did	VBD	O
not	RB	O
show	VB	O
anoxic	JJ	B-PROBLEM
brain	NN	I-PROBLEM
injury	NN	I-PROBLEM
or	CC	O
bleeding	NN	B-PROBLEM
.	.	O

he	PRP	O
gradually	RB	O
improved	VBD	O
and	CC	O
was	VBD	O
a&ox3	VBN	O
and	CC	O
near	JJ	O
baseline	NN	O
before	IN	O
amesbury	NN	O
hospital	NN	O
transferred	VBD	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
in	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

6)	CD	O
dm	NN	B-PROBLEM
:	:	O

pt	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
ssi	NN	B-TREATMENT
with	IN	O
small	JJ	O
amount	NN	O
of	IN	O
standing	VBG	B-TREATMENT
insulin	NN	I-TREATMENT
while	IN	O
he	PRP	O
was	VBD	O
npo	RB	B-TREATMENT
and	CC	O
then	RB	O
his	PRP$	B-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
gradually	RB	O
increased	VBN	O
as	IN	O
he	PRP	O
received	VBD	O
tube	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

the	DT	O
pt	NN	O
had	VBD	O
an	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
and	CC	O
received	VBD	O
tube	NNS	B-TREATMENT
feeds	NNS	I-TREATMENT
for	IN	O
the	DT	O
majority	NN	O
of	IN	O
his	PRP$	B-TREATMENT
hospitalization	NN	I-TREATMENT
.	.	O

upon	IN	O
extubation	NN	B-TREATMENT
and	CC	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
he	PRP	O
pulled	VBD	O
out	RP	O
the	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
time	NN	O
several	JJ	O
times	NNS	O
and	CC	O
required	JJ	O
restraints	NNS	B-TREATMENT
.	.	O

albumin	NN	B-TEST
was	VBD	O
very	RB	B-PROBLEM
low	JJ	I-PROBLEM
and	CC	O
pt	NN	O
had	VBD	O
significant	JJ	B-PROBLEM
edema	JJ	I-PROBLEM
likely	JJ	O
03-15	NN	O
this	DT	O
.	.	O

pump	NN	O
/	NN	O
htn	NN	B-PROBLEM
:	:	O
pt	NN	O
had	VBD	O
episodes	NNS	O
of	IN	O
both	DT	O
hypertension	NN	B-PROBLEM
and	CC	O
hypotension	NN	B-PROBLEM
during	IN	O
his	PRP$	O
stay	NN	O
.	.	O

he	PRP	O
was	VBD	O
managed	VBN	O
with	IN	O
metoprolol	NN	B-TREATMENT
,	,	O
hydralazine	NN	B-TREATMENT
,	,	O
and	CC	O
amlodipine	NN	B-TREATMENT
.	.	O

near	IN	O
discharge	NN	O
his	PRP$	B-TEST
bp	NN	I-TEST
was	VBD	O
controlled	VBN	O
with	IN	O
metoprolol	NN	B-TREATMENT
only	RB	O
.	.	O

9)	CD	O
hypernatremia	SYM	B-PROBLEM
-	:	O
while	NN	O
in	IN	O
the	DT	O
cmed	JJ	O
csru	NN	O
the	DT	O
pt	NN	O
developed	VBD	O
hypernatremia	NN	B-PROBLEM
.	.	O

this	DT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
likely	JJ	O
03-15	JJ	O
intravascular	JJ	B-PROBLEM
volume	NN	I-PROBLEM
depletion	NN	I-PROBLEM
since	IN	O
the	DT	B-TEST
pt	NN	I-TEST
's	POS	I-TEST
albumin	NN	I-TEST
was	VBD	O
so	RB	B-PROBLEM
low	JJ	I-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
third	JJ	O
spacing	VBG	O
all	DT	O
of	IN	O
his	PRP$	O
fluid	NN	O
.	.	O

he	PRP	O
was	VBD	O
volume	NN	O
resuscitated	VBN	O
and	CC	O
managed	VBN	O
with	IN	O
d5w	NN	B-TREATMENT
and	CC	O
lasix	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
receving	VBG	O
fw	JJ	B-TREATMENT
boluses	NNS	I-TREATMENT
with	IN	O
his	PRP$	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
hypernatremia	NN	I-PROBLEM
fully	RB	O
resolved	VBD	O
when	WRB	O
he	PRP	O
resumed	VBD	O
eating	VBG	O
on	IN	O
his	PRP$	O
own	JJ	O
and	CC	O
had	VBD	O
access	NN	O
to	TO	O
free	JJ	O
water	NN	O
.	.	O

10)	CD	O
anemia	NN	B-PROBLEM
:	:	O

pt	NN	B-TEST
's	POS	I-TEST
hct	NN	I-TEST
trended	VBD	O
down	RB	O
slowly	RB	O
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

labs	NNS	B-TEST
were	VBD	O
consistent	JJ	O
with	IN	O
anemia	NN	B-PROBLEM
of	IN	O
chronic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transfused	VBN	O
3	CD	B-TREATMENT
units	NNS	I-TREATMENT
prbc	VBP	I-TREATMENT
's	POS	I-TREATMENT
near	IN	O
the	DT	O
end	NN	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
and	CC	O
had	VBD	O
an	DT	O
appropriate	JJ	O
bump	NN	O
.	.	O

when	WRB	O
the	DT	O
pt	NN	O
's	POS	O
ms	NN	O
improved	VBD	O
to	TO	O
near	VB	O
baseline	NN	O
before	IN	O
again	RB	O
decompensating	NN	O
,	,	O
he	PRP	O
became	VBD	O
extremely	RB	B-PROBLEM
tearful	JJ	I-PROBLEM
and	CC	O
expressed	JJ	O
feelings	NNS	O
of	IN	O
depression	NN	B-PROBLEM
after	IN	O
being	VBG	O
in	IN	O
the	DT	O
hospital	NN	O
for	IN	O
so	RB	O
long	RB	O
.	.	O

he	PRP	O
expressed	VBD	O
interest	NN	O
in	IN	O
taking	VBG	O
an	DT	B-TREATMENT
anti-depressant	JJ	I-TREATMENT
for	IN	O
a	DT	O
short	JJ	O
time	NN	O
while	IN	O
he	PRP	O
was	VBD	O
recovering	VBG	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
celexa	NN	B-TREATMENT
.	.	O

medications	NNS	O
on	IN	O
admission	NN	O
:	:	O
vancomycin	NN	B-TREATMENT
1g	CD	O
iv	NN	O
q48	NN	O

mvi	NN	B-TREATMENT

neurontin	RB	B-TREATMENT
300	CD	O
qd	NN	O

riss	NN	B-TREATMENT

prednisone	NN	B-TREATMENT
taper	NN	I-TREATMENT
60	CD	O
qd	NN	O

prilosec	NN	B-TREATMENT
20	CD	O
qd	NN	O

metoprolol	RB	B-TREATMENT
25	CD	O
bid	NN	O

lantus	NN	B-TREATMENT
480	CD	O
qd	NN	O

calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
tid	NN	O
with	IN	O
meals	NNS	O

discharge	NN	O
diagnosis	NN	O
:	:	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM

diabetes	NNS	B-PROBLEM
mellitis	VBP	I-PROBLEM
(	(	O
pancreatic	JJ	B-PROBLEM
trauma	NN	I-PROBLEM
)	)	O

acute	JJ	B-PROBLEM
interstitial	JJ	I-PROBLEM
nephritis	NN	I-PROBLEM
(	(	O
oxacillin	NN	B-TREATMENT
)	)	O

peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM

peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM

digital	JJ	B-PROBLEM
necrosis	NN	I-PROBLEM

multiple	JJ	B-TREATMENT
toe	NN	I-TREATMENT
amputations	NNS	I-TREATMENT

diabetic	JJ	B-PROBLEM
nephropathy	NN	I-PROBLEM

hypertension	NN	B-PROBLEM

mssa	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM

enterococcal	JJ	B-PROBLEM
bacteremia	NN	I-PROBLEM

enterbactor	NN	B-PROBLEM
cloacae	NN	I-PROBLEM
bacteremia	NN	I-PROBLEM

multifocal	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM

respiratory	NN	B-PROBLEM
failure	NN	I-PROBLEM

mssa	NN	B-PROBLEM
osteomyelitis	NN	I-PROBLEM
of	IN	I-PROBLEM
calcaneous	JJ	I-PROBLEM

toxic	NN	B-PROBLEM
/	NNP	I-PROBLEM
metabolic	NN	I-PROBLEM
encephalopathy	NN	I-PROBLEM

hypernatremia	NN	B-PROBLEM

pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
mediastinal	JJ	B-PROBLEM
mass	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
bronchiectasis	NN	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

vq	JJ	B-TEST
scan	NN	I-TEST
,	,	O
lower	JJR	B-TEST
extremities	NNS	I-TEST
noninvasive	JJ	I-TEST
doppler	NN	I-TEST
studies	NNS	I-TEST
and	CC	O
overnight	JJ	B-TEST
oximetry	NN	I-TEST
saturation	NN	I-TEST
monitoring	NN	I-TEST
.	.	O

mr.	NN	O
state	NN	O
is	VBZ	O
an	DT	O
81-year-old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
restrictive	JJ	B-PROBLEM
and	CC	I-PROBLEM
obstructive	JJ	I-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
dilated	VBN	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O
inferior	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
and	CC	O
anterior	JJ	B-PROBLEM
mediastinal	JJ	I-PROBLEM
masses	NNS	I-PROBLEM
admitted	VBN	O
with	IN	O
acute	JJ	O
onset	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
setting	NN	O
of	IN	O
inadvertently	RB	O
decreasing	VBG	O
lasix	NN	B-TREATMENT
from	IN	O
80	CD	O
mg.	NNS	O
po	RB	O
40	CD	O
mg.	NNS	O
a	DT	O
day	NN	O
mr.	NN	O
state	NN	O
had	VBD	O
sudden	JJ	B-PROBLEM
onset	NN	I-PROBLEM
dyspnea	NN	I-PROBLEM
after	IN	O
approximate	JJ	O
day	NN	O
and	CC	O
a	DT	O
half	JJ	O
prodrome	JJ	B-PROBLEM
culminating	NN	O
in	IN	O
severe	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

upon	IN	O
arrival	NN	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
mr.	NN	B-TEST
state	NN	I-TEST
&apos;s	JJ	I-TEST
saturations	NNS	I-TEST
were	VBD	O
in	IN	O
the	DT	O
mid	NN	O
80s	CD	O
and	CC	O
he	PRP	O
was	VBD	O
promptly	RB	O
rendered	VBN	O
more	RBR	O
comfortable	JJ	O
with	IN	O
high	JJ	B-TREATMENT
flow	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
,	,	O
morphine	NN	B-TREATMENT
,	,	O
and	CC	O
nitrates	NNS	B-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
relatively	RB	O
unrevealing	JJ	O
for	IN	O
interstitial	JJ	B-PROBLEM
or	CC	I-PROBLEM
alveolar	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
with	IN	O
clinical	JJ	O
improvement	NN	O
ensued	VBN	O
with	IN	O
the	DT	O
immediate	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
as	IN	O
noted	JJ	O
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
angina	NN	B-PROBLEM
,	,	O
syncope	NN	B-PROBLEM
,	,	O
preceding	VBG	B-PROBLEM
worsening	VBG	I-PROBLEM
orthopnea	NN	I-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
hematemesis	NN	B-PROBLEM
or	CC	O
melena	NN	B-PROBLEM
.	.	O

is	VBZ	O
notable	JJ	O
for	IN	O
an	DT	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
restrictive	JJ	B-PROBLEM
and	CC	I-PROBLEM
obstructive	JJ	I-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
fev1	NN	I-TEST
of	IN	O
.9	NNP	O
and	CC	O
fvc	NN	B-TEST
of	IN	O
1.34	CD	O
and	CC	O
a	DT	O
moderate	JJ	O
at	IN	O
best	JJS	O
response	NN	O
to	TO	O
bronchodilators	NNS	B-TREATMENT
,	,	O
and	CC	O
a	DT	O
negative	JJ	O
sestamibi	NN	O
scan	JJ	O
in	IN	O
may	MD	O
,	,	O
1999	CD	O
apart	NN	O
from	IN	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
fixed	VBN	I-PROBLEM
inferolateral	JJ	I-PROBLEM
defect	NN	I-PROBLEM
,	,	O
systolic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
with	IN	O
recent	JJ	B-TEST
echocardiography	NN	I-TEST
revealing	VBG	O
an	DT	B-TEST
lvid	NN	I-TEST
of	IN	O
62	CD	O
mm.	NNS	O
and	CC	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
28	CD	O
percent	NN	O
,	,	O
moderate	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
mild-to-moderate	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
33	CD	O
and	CC	O
a	DT	B-TEST
mean	JJ	I-TEST
gradient	NN	I-TEST
of	IN	O
19	CD	O
and	CC	O
a	DT	B-TEST
valve	JJ	I-TEST
area	NN	I-TEST
of	IN	O
1.4	CD	O
cm.	NN	O
squared	VBN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
mr.	NN	O
state	NN	O
has	VBZ	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
mediastinal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
2x2x1.7	CD	O
cm.	NN	O
by	IN	O
recent	JJ	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
without	IN	O
surrounding	VBG	B-PROBLEM
or	CC	I-PROBLEM
adjacent	JJ	I-PROBLEM
adenopathy	NN	I-PROBLEM
or	CC	O
parenchymal	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
apart	RB	O
from	IN	O
bronchiectasis	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
cardiomyopathy	NN	I-TEST
work	NN	I-TEST
up	RB	I-TEST
entailed	VBD	O
a	DT	O
negative	JJ	O
ana	NN	O
,	,	O
negative	JJ	O
spep	NN	O
,	,	O
upep	JJ	B-TEST
and	CC	O
benz-jones	JJ	B-TEST
proteins	NNS	I-TEST
,	,	O
normal	JJ	O
ferritin	NN	O
,	,	O
thyroid	JJ	B-TEST
stimulating	VBG	I-TEST
hormone	NN	I-TEST
and	CC	O
a	DT	B-TEST
recent	JJ	I-TEST
work	NN	I-TEST
up	RB	I-TEST
for	IN	O
possible	JJ	O
bimomatous	JJ	B-PROBLEM
associated	VBN	O
myasthenia	NN	B-PROBLEM
gravis	NN	I-PROBLEM
that	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
155/60	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
70	CD	O
with	IN	O
occasional	JJ	B-PROBLEM
premature	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
contractions	NNS	I-PROBLEM
,	,	O
respirations	NNS	B-TEST
14	CD	O
.	.	O

mr.	NN	O
state	NN	O
was	VBD	O
dyspneic	JJ	B-PROBLEM
speaking	NN	O
in	IN	O
short	JJ	O
sentences	NNS	O
initially	RB	O
on	IN	O
high	JJ	B-TREATMENT
flow	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

jugular	JJ	B-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
8	CD	O
with	IN	O
a	DT	B-PROBLEM
brisk	JJ	I-PROBLEM
inspiratory	NN	I-PROBLEM
descent	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

carotids	NNS	B-TEST
were	VBD	O
2+	CD	O
.	.	O

breath	NN	O
sounds	NNS	O
were	VBD	O
decreased	VBN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
only	RB	O
with	IN	O
distant	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
2	CD	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	FW	I-PROBLEM
consistent	NN	O
with	IN	O
aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
gallavardin	NNS	B-PROBLEM
like	IN	I-PROBLEM
radiation	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
apex	NN	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
with	IN	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
or	CC	O
hepatojugular	JJ	B-PROBLEM
reflex	NN	I-PROBLEM
,	,	O
bruits	NNS	B-PROBLEM
or	CC	O
pulsations	NNS	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
rash	NN	B-PROBLEM
and	CC	O
no	DT	O
edema	NN	B-PROBLEM
and	CC	O
the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
non-focal	JJ	O
.	.	O

notable	JJ	O
for	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
145	CD	O
,	,	O
potassium	NN	B-TEST
3.6	CD	O
,	,	O
bun	NN	B-TEST
23	CD	O
,	,	O
creatinine	NN	B-TEST
1.3	CD	O
,	,	O
glucose	RB	B-TEST
104	CD	O
,	,	O
hematocrit	NN	B-TEST
42	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
8.7	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
235	CD	O
and	CC	O
a	DT	B-TEST
pt	NN	I-TEST
of	IN	O
12.9	CD	O
seconds	NNS	O
.	.	O

the	DT	B-TEST
urinalysis	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

the	DT	B-TEST
troponin	NN	I-TEST
i	NN	I-TEST
was	VBD	O
less	JJR	O
than	IN	O
.4	NN	O
and	CC	O
the	DT	B-TEST
creatine	NN	I-TEST
kinase	NN	I-TEST
was	VBD	O
114	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
moderate	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
with	IN	O
no	DT	O
clear	JJ	B-PROBLEM
interstitial	NN	I-PROBLEM
or	CC	I-PROBLEM
alveolar	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
chronic	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
and	CC	O
/	NN	O
or	CC	O
scarring	NN	B-PROBLEM
at	IN	I-PROBLEM
both	DT	I-PROBLEM
lung	NN	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
revealed	VBD	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
premature	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
complexes	NNS	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
with	IN	O
left	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
hemiblock	NN	I-PROBLEM
and	CC	O
old	JJ	B-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
underwent	NN	O
an	DT	B-TREATMENT
approximate	JJ	I-TREATMENT
1.5	CD	I-TREATMENT
liter	NN	I-TREATMENT
diuresis	NN	I-TREATMENT
within	IN	O
the	DT	O
first	JJ	O
24	CD	O
hours	NNS	O
with	IN	O
improvement	NN	O
in	IN	O
his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
improvement	NN	O
in	IN	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
.	.	O

after	IN	O
a	DT	O
long	JJ	O
discussion	NN	O
with	IN	O
the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
family	NN	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
would	MD	O
be	VB	O
prudent	JJ	O
.	.	O

prior	RB	O
to	TO	O
catheterization	VB	B-TEST
a	DT	B-TEST
vq	JJ	I-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
revealed	VBD	O
a	DT	O
moderate	JJ	O
probability	NN	O
for	IN	O
pe	NN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
subsegmental	JJ	I-PROBLEM
defect	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lingular	NN	I-PROBLEM
on	IN	O
the	DT	O
left	NN	O
lung	NN	O
.	.	O

subsequent	JJ	B-TEST
lower	JJR	I-TEST
extremities	NNS	I-TEST
noninvasive	JJ	I-TEST
studies	NNS	I-TEST
and	CC	O
d-dimer	JJ	B-TEST
test	NN	I-TEST
were	VBD	O
both	DT	O
negative	JJ	O
rendering	VBG	O
the	DT	O
probability	NN	O
of	IN	O
acute	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolism	NN	I-PROBLEM
less	JJR	O
than	IN	O
2	CD	O
percent	NN	O
.	.	O

it	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
would	MD	O
be	VB	O
in	IN	O
need	NN	O
of	IN	O
chronic	JJ	B-TREATMENT
coumadin	NN	I-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
lieu	NN	O
of	IN	O
this	DT	O
low	JJ	O
probability	NN	O
findings	NNS	O
in	IN	O
toto	NN	O
.	.	O

coronary	JJ	B-TEST
angiography	NN	I-TEST
revealed	VBD	O
occlusion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
proximally	RB	I-PROBLEM
with	IN	O
insignificant	JJ	B-PROBLEM
plaquing	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
circumflex	JJ	O
arteries	NNS	O
.	.	O

after	IN	O
a	DT	B-TREATMENT
approximate	JJ	I-TREATMENT
3	CD	I-TREATMENT
liter	NN	I-TREATMENT
total	JJ	I-TREATMENT
diuresis	NN	I-TREATMENT
the	DT	B-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
5	CD	O
,	,	O
pulmonary	JJ	B-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
14	CD	O
,	,	O
pulmonary	JJ	B-TEST
vacuolar	NN	I-TEST
resistance	NN	I-TEST
353	CD	O
and	CC	O
the	DT	B-TEST
cardiac	JJ	I-TEST
output	NN	I-TEST
depressed	VBD	O
at	IN	O
2.95	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
,	,	O
or	CC	O
a	DT	B-TEST
cardiac	JJ	I-TEST
index	NN	I-TEST
of	IN	O
1.7	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
.	.	O

based	VBN	O
upon	IN	O
these	DT	O
findings	NNS	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
mr.	NN	O
state	NN	O
most	RBS	O
likely	JJ	O
has	VBZ	O
multi-factorial	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
owing	VBG	O
to	TO	O
both	DT	O
his	PRP$	B-PROBLEM
ventilatory	NN	I-PROBLEM
limitation	NN	I-PROBLEM
and	CC	O
to	TO	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
low	JJ	I-PROBLEM
output	NN	I-PROBLEM
state	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
isordil	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
in	IN	O
hospital	NN	O
and	CC	O
blood	NN	B-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
was	VBD	O
relative	JJ	O
episodic	NN	O
with	IN	O
systolic	JJ	B-TEST
pressures	NNS	I-TEST
ranging	VBG	O
between	IN	O
100	CD	O
and	CC	O
160	CD	O
.	.	O

future	JJ	O
adjustments	NNS	O
will	MD	O
be	VB	O
made	VBN	O
at	IN	O
home	NN	O
pending	VBG	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
measures	NNS	I-TEST
.	.	O

at	IN	O
a	DT	O
goal	NN	O
weight	NN	B-TEST
of	IN	O
142	CD	O
pounds	NNS	O
,	,	O
mr.	NN	B-TEST
state	NN	I-TEST
&apos;s	VBD	I-TEST
filling	VBG	I-TEST
pressures	NNS	I-TEST
appeared	VBD	O
ideal	JJ	O
with	IN	O
a	DT	B-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
14	CD	O
and	CC	O
his	PRP$	O
goal	NN	O
weight	NN	O
range	NN	O
will	MD	O
be	VB	O
between	IN	O
142	CD	O
and	CC	O
44	CD	O
pounds	NNS	O
at	IN	O
home	NN	O
.	.	O

imdur	NN	B-TREATMENT
120	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O
captopril	NN	B-TREATMENT
100mg.	CD	O
po	NN	O
t.i.d.	NN	O
lasix	VBD	B-TREATMENT
80	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
40	CD	O
meq.	NN	O
po	NN	O
q.d.	NN	O
coreg	NN	B-TREATMENT
12.5	CD	O
mg.	NN	O
b.i.d.	NN	O
cozaar	NN	B-TREATMENT
100	CD	O
mg.	NN	O
b.i.d.	NN	O
plavix	NN	B-TREATMENT
75	CD	O
mg.	NN	O
q.d.	NN	O
allopurinol	VBD	B-TREATMENT
300	CD	O
mg.	NN	O
q.d.	NN	O
pulmacort	NN	B-TREATMENT
and	CC	O
serevent	NN	B-TREATMENT
inhalers	NNS	I-TREATMENT
2	CD	O
puffs	NNS	O
b.i.d.	VBD	O
zocor	$	B-TREATMENT
20	CD	O
mg.	NN	O
q.d.	NN	O
prilosec	NN	B-TREATMENT
20	CD	O
mg.	NN	O
q.d.	NN	O
colace	NN	B-TREATMENT
100	CD	O
mg.	NN	O
t.i.d.	NN	O

patient	NN	O
is	VBZ	O
a	DT	O
26	CD	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
nonischemic	JJ	B-PROBLEM
dilated	VBN	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
15-20%	JJ	O
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	O
one-week	JJ	O
history	NN	O
of	IN	O
progressive	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

she	PRP	O
reports	VBZ	O
orthopnea	NN	B-PROBLEM
with	IN	O
an	DT	B-PROBLEM
increasing	VBG	I-PROBLEM
pillow	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
of	IN	O
2-4	JJ	O
with	IN	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

patient	NN	O
also	RB	O
reports	VBZ	O
a	DT	B-PROBLEM
6-pound	JJ	I-PROBLEM
weight	NN	I-PROBLEM
gain	NN	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
four	CD	O
days	NNS	O
with	IN	O
associated	JJ	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
reports	VBZ	O
positional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
worse	JJR	O
with	IN	O
lying	VBG	O
down	RP	O
and	CC	O
relieved	VBN	O
with	IN	O
sitting	VBG	O
up	RP	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
activity	NN	O
.	.	O

she	PRP	O
also	RB	O
reports	VBZ	O
a	DT	B-PROBLEM
cough	JJ	I-PROBLEM
productive	NN	O
of	IN	O
green	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
for	IN	O
approximately	RB	O
one	CD	O
week	NN	O
.	.	O

she	PRP	O
does	VBZ	O
report	NN	O
chills	NNS	B-PROBLEM
,	,	O
but	CC	O
no	DT	O
fevers	NNS	B-PROBLEM
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
nesiritide	JJ	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
responded	VBD	O
well	RB	O
with	IN	O
2000	CD	O
cc	NN	O
urine	JJ	O
output	NN	O
.	.	O

1.	CD	O
nonischemic	JJ	B-PROBLEM
dilated	VBN	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
15-20%	JJ	O
.	.	O

2.	CD	O
status	NN	O
post	NN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
in	IN	O
2011-11-19	CD	O
which	WDT	O
showed	VBD	O
normal	JJ	O
coronaries	NNS	O
.	.	O

1.	CD	O
toprol	NN	B-TREATMENT
.	.	O

2.	CD	O
lasix	NN	B-TREATMENT
.	.	O

3.	CD	O
digoxin	NN	B-TREATMENT
.	.	O

4.	CD	O
coumadin	NN	B-TREATMENT
.	.	O

5.	CD	O
flovent	NN	B-TREATMENT
.	.	O

6.	CD	O
albuterol	NN	B-TREATMENT
.	.	O

7.	CD	O
lisinopril	NN	B-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
98.1	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
130/99	CD	O
,	,	O
pulse	NN	B-TEST
of	IN	O
111	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
16	CD	O
.	.	O

she	PRP	O
is	VBZ	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
obese	JJ	B-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
slightly	RB	B-PROBLEM
tachypneic	JJ	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
jvd	NN	B-PROBLEM
to	TO	O
angle	VB	O
of	IN	O
the	DT	O
jaw	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
got	VBD	O
bilateral	JJ	B-PROBLEM
basilar	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
,	,	O
no	DT	O
wheezing	NN	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
examination	NN	I-TEST
:	:	O

she	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
s1	NN	O
,	,	O
s2	NN	O
with	IN	O
a	DT	B-PROBLEM
2/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	O
positive	JJ	O
s4	NN	B-PROBLEM
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
.	.	O

2+	CD	B-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
9.3	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
37.7	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
293	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
ck	NN	I-TEST
of	IN	O
212	CD	O
and	CC	O
mb	NN	B-TEST
of	IN	O
21	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
troponin	NN	I-TEST
of	IN	O
0.56	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
chem-7	JJ	I-TEST
which	WDT	O
was	VBD	O
normal	JJ	O
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.5	CD	O
on	IN	O
her	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
right	JJ	B-PROBLEM
patchy	NN	I-PROBLEM
opacity	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

ekg	NN	B-TEST
showed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
borderline	NN	B-PROBLEM
left	VBD	I-PROBLEM
axis	RB	I-PROBLEM
,	,	O
normal	JJ	O
intervals	NNS	O
,	,	O
lvh	NN	B-PROBLEM
,	,	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
,	,	O
no	DT	O
q	NN	B-PROBLEM
waves	NNS	I-PROBLEM
,	,	O
no	DT	O
p-r	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
,	,	O
no	DT	O
st	NN	B-PROBLEM
segment	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
or	CC	O
depression	NN	B-PROBLEM
.	.	O

1.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
:	:	O

patient	NN	O
was	VBD	O
diuresed	VBN	O
effectively	RB	O
with	IN	O
nesiritide	JJ	B-TREATMENT
and	CC	O
lasix	NN	B-TREATMENT
.	.	O

patient	NN	B-TEST
's	POS	I-TEST
weight	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
250	CD	O
pounds	NNS	O
,	,	O
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
244	CD	O
pounds	NNS	O
which	WDT	O
was	VBD	O
back	RB	O
to	TO	O
her	PRP$	B-TEST
dry	JJ	I-TEST
weight	NN	I-TEST
.	.	O

patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP	B-TREATMENT
toprol	NN	I-TREATMENT
,	,	O
her	PRP	B-TREATMENT
lisinopril	NN	I-TREATMENT
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
digoxin	NN	I-TREATMENT
.	.	O

patient	NN	B-TREATMENT
's	POS	I-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
for	IN	O
right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
biopsy	NN	B-TEST
,	,	O
and	CC	O
then	RB	O
ep	VB	B-TEST
study	NN	I-TEST
with	IN	O
icd	JJ	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

patient	NN	O
did	VBD	O
have	VB	O
woodrow	NN	O
betty	NN	O
,	,	O
spep	NN	B-TEST
,	,	O
and	CC	O
anticardiolipin	VB	B-TEST
antibody	NN	I-TEST
sent	NN	O
for	IN	O
further	JJ	B-TEST
workup	NN	I-TEST
of	IN	O
the	DT	O
etiology	NN	O
of	IN	O
her	PRP$	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

the	DT	O
courtney	NN	O
,	,	O
spep	NN	B-TEST
,	,	O
and	CC	O
anticardiolipin	IN	B-TEST
antibody	NN	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

her	PRP$	B-TEST
cks	NNS	I-TEST
did	VBD	O
trend	NN	O
down	RP	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
and	CC	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
her	PRP$	O
known	JJ	O
clean	JJ	O
coronaries	NNS	O
on	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
in	IN	O
2011-11-19	JJ	O
,	,	O
it	PRP	O
was	VBD	O
believed	VBN	O
that	IN	O
a	DT	B-PROBLEM
myocarditis	NN	I-PROBLEM
might	MD	O
be	VB	O
the	DT	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
elevated	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
enzymes	NNS	I-PROBLEM
and	CC	O
also	RB	O
could	MD	O
have	VB	O
exacerbated	VBN	O
her	PRP$	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

patient	NN	O
did	VBD	O
receive	VB	O
a	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
elevated	VBD	B-PROBLEM
wedge	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
and	CC	O
biopsy	NN	B-TEST
specimens	NNS	I-TEST
were	VBD	O
obtained	VBN	O
of	IN	O
the	DT	O
right	JJ	O
ventricle	NN	O
.	.	O

the	DT	O
results	NNS	O
of	IN	O
these	DT	B-TEST
biopsies	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
in	IN	O
pathology	NN	O
.	.	O

post	NN	O
right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
right	JJ	B-TEST
ventricular	NN	I-TEST
biopsy	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
the	DT	O
ccu	NN	O
for	IN	O
a	DT	B-TREATMENT
swan	NN	I-TREATMENT
-	:	I-TREATMENT
guided	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
her	PRP$	B-PROBLEM
elevated	JJ	I-PROBLEM
wedge	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
and	CC	O
low	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
ccu	NN	O
,	,	O
she	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
milrinone	NN	B-TREATMENT
with	IN	O
good	JJ	O
results	NNS	O
.	.	O

patient	NN	O
was	VBD	O
also	RB	O
seen	VBN	O
by	IN	O
the	DT	O
pulmonary	JJ	O
service	NN	O
here	RB	O
and	CC	O
had	VBD	O
pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
done	VBN	O
as	IN	O
part	NN	O
of	IN	O
a	DT	B-TEST
pretransplant	JJ	I-TEST
workup	NN	I-TEST
.	.	O

patient	NN	O
did	VBD	O
receive	VB	O
an	DT	B-TREATMENT
icd	NN	I-TREATMENT
during	IN	O
this	DT	O
hospital	JJ	O
admission	NN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
in	IN	O
bigeminy	NN	B-PROBLEM
during	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
and	CC	O
did	VBD	O
have	VB	O
frequent	JJ	O
runs	NNS	O
of	IN	O
ectopy	NN	B-PROBLEM
as	IN	O
noted	VBN	O
on	IN	O
telemetry	NN	B-TEST
.	.	O

2.	CD	O
her	PRP$	B-PROBLEM
right	NN	I-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
:	:	O

patient	NN	O
did	VBD	O
report	VB	O
a	DT	B-PROBLEM
cough	JJ	I-PROBLEM
productive	NN	O
of	IN	O
green	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

she	PRP	O
received	VBD	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
azithromycin	NN	B-TREATMENT
for	IN	O
this	DT	O
with	IN	O
resolution	NN	O
of	IN	O
her	PRP$	B-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
sputum	NN	B-PROBLEM
production	NN	I-PROBLEM
.	.	O

on	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
her	PRP	B-TREATMENT
coumadin	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
held	VBN	O
for	IN	O
her	PRP$	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
,	,	O
and	CC	O
her	PRP$	B-TEST
biopsy	NN	I-TEST
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
icd	JJ	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
continued	VBN	O
on	IN	O
all	DT	B-TREATMENT
her	PRP$	I-TREATMENT
heart	NN	I-TREATMENT
failure	NN	I-TREATMENT
medications	NNS	I-TREATMENT
including	VBG	O
her	PRP$	B-TREATMENT
toprol	NN	I-TREATMENT
,	,	O
her	PRP	B-TREATMENT
lisinopril	NN	I-TREATMENT
,	,	O
her	PRP	B-TREATMENT
digoxin	NN	I-TREATMENT
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
lasix	NN	I-TREATMENT
.	.	O

nonischemic	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

1.	CD	O
digoxin	NN	B-TREATMENT
375	CD	O
mcg	NN	O
and	CC	O
250	CD	O
mcg	NN	O
alternating	VBG	O
doses	NNS	O
each	DT	O
day	NN	O
.	.	O

2.	CD	O
lisinopril	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
toprol	NN	B-TREATMENT
xl	VBD	I-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
flovent	JJ	B-TREATMENT
110	CD	O
mcg	NN	O
two	CD	O
puffs	NNS	O
b.i.d.	VBP	O

5.	CD	O
albuterol	JJ	B-TREATMENT
1-2	JJ	O
puffs	NNS	O
q.6h.	JJ	O
prn	NN	O
.	.	O

6.	CD	O
coumadin	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O

7.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
keflex	JJ	B-TREATMENT
500	CD	O
mg	NN	O
x6	NN	O
doses	NNS	O
.	.	O

patient	NN	O
will	MD	O
also	RB	O
followup	VB	O
with	IN	O
her	PRP	O
primary	JJ	O
care	NN	O
provider	NN	O
,	,	O
dr.	NN	O
sandra	NN	O
lamar	NN	O
for	IN	O
check	NN	O
of	IN	O
her	PRP$	B-TEST
inr	NN	I-TEST
in	IN	O
one	CD	O
week	NN	O
's	POS	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
pain	NN	B-PROBLEM
/	JJ	O
assault	NN	O
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
observation	NN	O
at	IN	O
ph	JJ	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
.	.	O

your	PRP$	O
patient	NN	O
was	VBD	O
admitted	VBN	O
under	IN	O
the	DT	O
care	NN	O
of	IN	O
shuffcuch	JJ	O
,	,	O
seysharmse	JJ	O
n	NN	O
with	IN	O
a	DT	O
preliminary	JJ	O
diagnosis	NN	O
of	IN	O
vertebral	JJ	B-PROBLEM
fractures	NNS	I-PROBLEM
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

hypoxia	NN	B-PROBLEM

cc	NN	O
:	:	O
dyspnea	NN	B-PROBLEM

86	CD	O
yo	JJ	O
man	NN	O
with	IN	O
h/o	JJ	O
cva	NN	B-PROBLEM
,	,	O
chf	NN	B-PROBLEM
,	,	O
recent	JJ	O
episodes	NNS	O
of	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
who	WP	O
p/w	VBP	O
dyspnea	NN	B-PROBLEM
from	IN	O
his	PRP$	O
nh	NN	O
.	.	O

per	IN	O
the	DT	O
pt	NN	O
's	POS	O
daughter	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
2-3	JJ	O
episodes	NNS	O
of	IN	O
asp	JJ	B-PROBLEM
pna	NN	I-PROBLEM
in	IN	O
the	DT	O
last	JJ	O
2	CD	O
months	NNS	O
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
has	VBZ	O
received	VBN	O
iv	JJ	B-TREATMENT
abx	NN	I-TREATMENT
at	IN	O
the	DT	O
nh	NN	O
with	IN	O
apparent	JJ	O
resolution	NN	O
of	IN	O
symptoms	NNS	B-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
's	POS	O
daughter	NN	O
and	CC	O
son-in-law	NN	O
confirm	NN	O
his	PRP$	O
desire	NN	O
to	TO	O
be	VB	O
dnr/dni	JJ	B-TREATMENT
,	,	O
stating	VBG	O
that	IN	O
they	PRP	O
want	VBP	O
him	PRP	O
to	TO	O
be	VB	O
comfortable	JJ	O
.	.	O

however	RB	O
,	,	O
when	WRB	O
asked	VBN	O
if	IN	O
she	PRP	O
thinks	VBZ	O
he	PRP	O
would	MD	O
want	VB	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
even	RB	O
if	IN	O
it	PRP	O
meant	VBD	O
that	IN	O
his	PRP$	O
respiratory	NN	O
status	NN	O
would	MD	O
worsen	VB	O
,	,	O
the	DT	O
pt	NN	O
's	POS	O
daughter	NN	O
says	VBZ	O
that	IN	O
he	PRP	O
would	MD	O
not	RB	O
.	.	O

in	IN	O
particular	JJ	O
,	,	O
she	PRP	O
feels	VBZ	O
that	IN	O
the	DT	O
pt	NN	O
would	MD	O
not	RB	O
want	VB	O
a	DT	B-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
if	IN	O
it	PRP	O
would	MD	O
negatively	RB	O
impact	VB	O
his	PRP$	O
respiratory	NN	O
function	NN	O
.	.	O

-	:	O
dm2	NN	B-PROBLEM
,	,	O
with	IN	O
mild	JJ	B-PROBLEM
background	NN	I-PROBLEM
diabetic	JJ	I-PROBLEM
retinopathy	NN	I-PROBLEM

-	:	O
cva	NN	B-PROBLEM
x	VBZ	O
2	CD	O
,	,	O
1970	CD	O
and	CC	O
1996	CD	O

-	:	O
htn	NN	B-PROBLEM

-	:	O
cad	NN	B-PROBLEM

-	:	O
chf	NN	B-PROBLEM
,	,	O
lvef	VBZ	B-TEST
unknown	JJ	O

-	:	O
pvd	NN	B-PROBLEM
,	,	O
s/p	JJ	O
femoral-popliteal	JJ	B-TREATMENT
bypass	NN	I-TREATMENT

-	:	O
renal	NN	B-PROBLEM
cell	NN	I-PROBLEM
ca	MD	I-PROBLEM
,	,	O
s/p	VB	O
left	VBN	B-TREATMENT
nephrectomy	JJ	I-TREATMENT
1992	CD	O

-	:	O
bph	NN	B-PROBLEM

-	:	O
dementia	NN	B-PROBLEM
,	,	O
since	IN	O
2000	CD	O
,	,	O
baseline	NN	B-TEST
mmse	NN	I-TEST
21/29	CD	O

-	:	O
s/p	NN	O
fall	NN	O
with	IN	O
right	JJ	B-PROBLEM
hip	NN	I-PROBLEM
fx	NN	I-PROBLEM
and	CC	O
orif	NN	B-TREATMENT

-	:	O
moderate	NN	B-PROBLEM
r	NN	I-PROBLEM
sided	VBD	I-PROBLEM
macular	JJ	I-PROBLEM
degeneration	NN	I-PROBLEM

-	:	O
depression	NN	B-PROBLEM

-	:	O
s/p	NN	O
right	JJ	B-TREATMENT
inguinal	JJ	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT

t	NN	B-TEST
102.8	CD	O

hr	NN	B-TEST
113	CD	O

bp	NN	B-TEST
157/85	CD	O

rr	NN	B-TEST
35	CD	O

sat	RB	B-TEST
97%	CD	O
on	IN	O
bipap	NN	B-TREATMENT

gen	NN	O
:	:	O
frail	NN	B-PROBLEM
,	,	O
elderly	JJ	O
caucasian	JJ	O
man	NN	O
lying	VBG	O
in	IN	O
stretcher	NN	O
,	,	O
hob	NN	O
at	IN	O
45	CD	O
degrees	NNS	O
,	,	O
breathing	VBG	O
in	IN	O
moderate	JJ	B-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
accessory	JJ	B-PROBLEM
muscle	NN	I-PROBLEM
use	NN	I-PROBLEM

bipap	NN	B-TREATMENT
mask	NN	I-TREATMENT
in	IN	O
place	NN	O
with	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
leak	NN	I-PROBLEM
,	,	O
eyes	NNS	O
closed	VBD	O
,	,	O
mouth	NN	O
open	JJ	O
,	,	O
no	DT	O
rhinorhea	NN	B-PROBLEM
or	CC	O
oral	JJ	B-PROBLEM
discharge	NN	I-PROBLEM
visible	JJ	O

jvp	NN	B-TEST
flat	JJ	O

cv	NN	O
:	:	O
difficult	JJ	O
to	TO	O
assess	VB	O
heart	NN	O
sounds	VBZ	O
over	IN	O
respiratory	JJ	O
sounds	NNS	O
,	,	O
but	CC	O
appears	VBZ	O
to	TO	O
have	VB	O
rrr	NN	O
,	,	O
nl	JJ	O
s1	NN	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM

r	VB	O
lower	JJR	O
01-20	NN	O
with	IN	O
coarse	JJ	B-PROBLEM
bs	NN	I-PROBLEM
and	CC	O
rales	NNS	B-PROBLEM
;	:	O
l	JJ	O
side	NN	O
clear	JJ	O
;	:	O
no	DT	O
wheezing	NN	B-PROBLEM

abd	NN	O
:	:	O
thin	JJ	O
,	,	O
nd	JJ	B-PROBLEM
,	,	O
nt	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
palpable	JJ	O

ext	NN	O
:	:	O
thin	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
multiple	JJ	B-PROBLEM
old	JJ	I-PROBLEM
well-healed	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
on	IN	I-PROBLEM
r	NN	I-PROBLEM
leg	NN	I-PROBLEM

skin	NN	O
:	:	O
warm	JJ	O
and	CC	O
dry	JJ	O
,	,	O
no	DT	O
rash	NN	B-PROBLEM
or	CC	O
breakdown	NN	B-PROBLEM
noted	VBD	O
though	RB	O
could	MD	O
not	RB	O
examine	VB	O
sacrum	NN	O

neuro	NN	O
:	:	O
reactive	NN	O
to	TO	O
pain	VB	B-TEST
,	,	O
otherwise	RB	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
10.9	CD	O
rbc	NN	B-TEST
-	:	O
4.63	CD	O
hgb	NN	B-TEST
-	:	O
13.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
40.3	CD	O
#	#	O
mcv	SYM	B-TEST
-	:	O
87	CD	O
mch	SYM	B-TEST
-	:	O
29.3	CD	O
mchc	SYM	B-TEST
-	:	O
33.7	CD	O
rdw	NN	B-TEST
-	:	O
14.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
393	CD	O
#	#	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
82.6	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
14.5	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
2.2	CD	O
eos	SYM	B-TEST
-	:	O
0.2	CD	O
baso	SYM	B-TEST
-	:	O
0.4	CD	O

2014-01-20	JJ	O
02:08	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
13.2	CD	O
ptt	NN	B-TEST
-	:	O
27.4	CD	O
inr	NN	B-TEST
(	(	I-TEST
pt	JJ	I-TEST
)-	CD	I-TEST
1.2	CD	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	B-TEST
ct	VBD	I-TEST
-	:	O
393	CD	O
#	#	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
334	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
22	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
0.9	CD	O
na	SYM	B-TEST
-	:	O
144	CD	O
k	SYM	B-TEST
-	:	O
5.0	CD	O
cl	NN	B-TEST
-	:	O
108	CD	O
hco3	NN	B-TEST
-	:	O
25	CD	O
angap	NN	B-TEST
-	:	O
16	CD	O

2014-01-20	JJ	O
02:08	CD	O
pm	NN	O
blood	NN	B-TEST
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
275	CD	O
*	NN	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
15	CD	O
ast	IN	B-TEST
-	:	O
22	CD	O
ld	NN	B-TEST
(	(	I-TEST
ldh	JJ	I-TEST
)-	JJ	I-TEST
254	CD	O
*	JJ	O
ck	NN	B-TEST
(	(	I-TEST
cpk	JJ	I-TEST
)-	JJ	I-TEST
398	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
125	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
0.5	CD	O

2014-01-20	JJ	O
02:08	CD	O
pm	JJ	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
9	CD	O
ctropnt	NN	B-TEST
-	:	O
0.08	CD	O
*	NN	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
ctropnt	NN	B-TEST
-	:	O
0.05	CD	O
*	NN	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
ck-mb	JJ	B-TEST
-	:	O
7	CD	O

2014-01-20	JJ	O
05:30	CD	O
am	VBP	O
blood	NN	B-TEST
albumin	NN	B-TEST
-	:	O
3.2	CD	O
*	JJ	O
calcium	NN	B-TEST
-	:	O
9.3	CD	O
phos	NN	B-TEST
-	:	O
4.2	CD	O
mg	SYM	B-TEST
-	:	O
1.8	CD	O

abg	NN	B-TEST
s:	NN	I-TEST

2014-01-20	JJ	O
10:46	CD	O
pm	NN	O
blood	NN	B-TEST
type	NN	O
-	:	O
art	NN	B-TEST
po2	VBZ	B-TEST
-	:	O
148	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
129	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.03	CD	O
*	NN	O
calhco3	NN	B-TEST
-	:	O
37	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
-1	NN	O

2014-01-20	JJ	O
11:49	CD	O
am	VBP	O
blood	NN	B-TEST
type	NN	O
-	:	O
art	NN	B-TEST
peep	VBZ	B-TREATMENT
-	:	O
5	CD	O
fio2	JJ	B-TREATMENT
-	:	O
60	CD	O
po2	NN	B-TEST
-	:	O
75	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
56	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.29	CD	O
*	NN	O
calhco3	NN	B-TEST
-	:	O
28	CD	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
0	CD	O
intubat	NN	O
-	:	O
not	RB	O
intuba	JJ	O
comment	NN	O
-	:	O
bipap	NN	B-TREATMENT

2014-01-20	JJ	O
10:46	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
114	CD	O
*	NN	O
lactate	NN	B-TEST
-	:	O
1.8	CD	O
k	SYM	B-TEST
-	:	O
4.8	CD	O

2014-01-20	JJ	O
11:49	CD	O
am	VBP	O
blood	NN	B-TEST
lactate	NN	B-TEST
-	:	O
3.0	CD	O
*	NN	O
k	SYM	B-TEST
-	:	O
5.1	CD	O

2014-01-20	JJ	O
11:49	CD	O
am	VBP	O
blood	NN	B-TEST
freeca	NN	B-TEST
-	:	O
1.19	CD	O

cxr	NN	B-TEST
:	:	O

focal	JJ	B-PROBLEM
consolidation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
medial	JJ	I-PROBLEM
aspect	NN	I-PROBLEM
of	IN	O
the	DT	O
right	NN	O
lower	RBR	O
lung	NN	O

this	DT	O
86	CD	O
yo	NN	O
man	NN	O
with	IN	O
h/o	JJ	O
cva	NN	B-PROBLEM
,	,	O
chf	NN	B-PROBLEM
,	,	O
recent	JJ	O
episodes	NNS	O
of	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
presented	VBN	O
with	IN	O
dyspnea	NN	B-PROBLEM
from	IN	O
his	PRP$	O
nh	NN	O
,	,	O
likely	RB	O
from	IN	O
new	JJ	O
rll	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
zosyn	NN	B-TREATMENT
and	CC	O
vanco	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
presumed	JJ	I-PROBLEM
aspiration	NN	I-PROBLEM
,	,	O
"	NNP	B-PROBLEM
hospital	NN	I-PROBLEM
"	NN	I-PROBLEM
aquired	VBD	I-PROBLEM
pna	NN	I-PROBLEM
.	.	O

pe	NN	B-PROBLEM
was	VBD	O
considered	VBN	O
but	CC	O
less	RBR	O
likely	JJ	O
given	VBN	O
his	PRP$	B-PROBLEM
fevers	NNS	I-PROBLEM
and	CC	O
clear	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
on	IN	O
cxr	NN	B-TEST
.	.	O

he	PRP	O
was	VBD	O
supported	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
for	IN	O
his	PRP$	O
respiratory	NN	O
status	NN	O
.	.	O

an	DT	B-TEST
abg	NN	I-TEST
was	VBD	O
attempted	VBN	O
in	IN	O
the	DT	O
deanna	NN	O
however	RB	O
it	PRP	O
was	VBD	O
limited	VBN	O
by	IN	O
pt	NN	B-PROBLEM
discomfort	NN	I-PROBLEM
.	.	O

abg	NN	B-TEST
on	IN	O
arrival	NN	O
to	TO	O
the	DT	O
icu	NN	O
was	VBD	O
7.29/56/75	CD	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
sputum	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
some	DT	B-TREATMENT
prn	JJ	I-TREATMENT
morphine	NN	I-TREATMENT
for	IN	O
comfort	NN	O
.	.	O

in	IN	O
the	DT	O
evening	NN	O
of	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
increasingly	RB	B-PROBLEM
somnolent	JJ	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
abg	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
was	VBD	O
7.03/129/148	CD	O
.	.	O

based	VBN	O
upon	IN	O
this	DT	O
wish	JJ	O
the	DT	B-TREATMENT
bipap	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
nasal	JJ	B-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
written	VBN	O
for	IN	O
a	DT	B-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
however	RB	O
he	PRP	O
expired	VBD	O
before	IN	O
this	DT	O
could	MD	O
be	VB	O
initiated	VBN	O
.	.	O

elevated	VBN	B-PROBLEM
lactate	NN	I-PROBLEM
:	:	O

this	DT	O
was	VBD	O
concerning	VBG	O
for	IN	O
early	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
given	VBN	O
rll	JJ	B-PROBLEM
pna	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
remained	VBD	O
elevated	JJ	B-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
hydrated	VBN	O
with	IN	O
ns	JJ	B-TREATMENT
conservatively	RB	O
,	,	O
given	VBN	O
h/o	NN	O
chf	NN	B-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
.	.	O

dm2	NN	B-PROBLEM
:	:	O

he	PRP	O
was	VBD	O
covered	VBN	O
with	IN	O
a	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
while	IN	O
unstable	JJ	O

cad	NN	B-PROBLEM
:	:	O

he	PRP	O
was	VBD	O
not	RB	O
taking	VBG	O
any	DT	B-TREATMENT
po	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
per	IN	O
hunt	NN	O
center	NN	O
rehab	NN	O
so	IN	O
all	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
.	.	O

-	:	O
paxil	NN	B-TREATMENT

-	:	O
terazosin	NN	B-TREATMENT

-	:	O
glucophage	NN	B-TREATMENT

-	:	O
glyburide	NN	B-TREATMENT

-	:	O
atenolol	NN	B-TREATMENT

-	:	O
imdur	NN	B-TREATMENT

pneumonia	NN	B-PROBLEM

bilateral	JJ	B-PROBLEM
lung	NN	I-PROBLEM
nodules	NNS	I-PROBLEM

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
50	CD	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
lung	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
dating	VBG	O
back	RB	O
to	TO	O
the	DT	O
july	NN	O
of	IN	O
1995	CD	O
discovered	VBD	O
on	IN	O
a	DT	B-TEST
work-up	NN	I-TEST
for	IN	O
an	DT	B-PROBLEM
adrenal	JJ	I-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

diffuse	NN	B-PROBLEM
adenopathy	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
at	IN	O
that	DT	O
time	NN	O
and	CC	O
an	DT	O
attempt	NN	O
was	VBD	O
made	VBN	O
at	IN	O
axillary	JJ	B-TEST
node	NN	I-TEST
biopsy	NN	I-TEST
which	WDT	O
was	VBD	O
aborted	VBN	O
secondary	JJ	O
to	TO	O
positioning	VBG	O
difficulty	NN	O
and	CC	O
difficult	JJ	B-PROBLEM
intubation	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
since	IN	O
then	RB	O
lost	VBN	O
to	TO	O
follow-up	JJ	B-TEST
with	IN	O
a	DT	O
recently	RB	O
re-establish	JJ	O
primary	NN	O
care	NN	O
practitioner	NN	O
contact	NN	O
.	.	O

follow-up	JJ	B-TEST
chest	NN	I-TEST
ct	NN	I-TEST
on	IN	O
october	$	O
26	CD	O
,	,	O
1997	CD	O
at	IN	O
the	DT	O
ver	NN	O
medical	JJ	O
center	NN	O
showed	VBD	O
multiple	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodules	NNS	I-PROBLEM
in	IN	O
abundant	JJ	O
number	NN	O
,	,	O
very	RB	B-PROBLEM
small	JJ	I-PROBLEM
nodes	NNS	I-PROBLEM
seen	VBN	O
in	IN	O
the	DT	O
mediastinum	NN	O
but	CC	O
no	DT	O
hilar	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
or	CC	O
adrenal	JJ	B-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
on	IN	O
august	JJ	O
6	CD	O
,	,	O
1997	CD	O
revealed	VBD	O
multiple	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodules	NNS	I-PROBLEM
increasing	VBG	O
in	IN	O
size	NN	O
since	IN	O
july	NN	O
22	CD	O
,	,	O
1995	CD	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
or	CC	O
diabetes	VBZ	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
an	DT	B-TREATMENT
open	JJ	I-TREATMENT
cholecystectomy	NN	I-TREATMENT
in	IN	O
1968	CD	O
,	,	O
status	NN	O
post	NN	O
hysterectomy	NN	B-TREATMENT
and	CC	O
axillary	JJ	B-TEST
node	NN	I-TEST
biopsy	NN	I-TEST
which	WDT	O
failed	VBD	O
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hiatal	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
and	CC	O
umbilical	JJ	B-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
an	DT	B-PROBLEM
adrenal	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
treated	VBN	O
with	IN	O
prednisone	NN	B-TREATMENT
in	IN	O
the	DT	O
past	JJ	O
,	,	O
but	CC	O
not	RB	O
currently	RB	O
.	.	O

1)	CD	O
spironolactone	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

2)	CD	O
advil	JJ	B-TREATMENT
p.r.n.	NN	O

3)	CD	O
topical	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
for	IN	O
eczema	NN	B-PROBLEM
p.r.n.	NN	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
140/80	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
86	CD	O
.	.	O

she	PRP	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
,	,	O
obese	JJ	O
,	,	O
black	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

her	PRP$	O
skin	NN	O
is	VBZ	O
intact	JJ	O
without	IN	O
lesions	NNS	B-PROBLEM
.	.	O

her	PRP$	B-TEST
heent	NN	I-TEST
examination	NN	I-TEST
is	VBZ	O
benign	JJ	O
.	.	O

her	PRP$	O
neck	NN	O
is	VBZ	O
slightly	RB	B-PROBLEM
tender	VBN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
firm	NN	I-PROBLEM
thyroid	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
.	.	O

her	PRP$	O
lungs	NNS	O
have	VBP	O
decreased	VBN	B-PROBLEM
sounds	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
lung	NN	I-PROBLEM
fields	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
umbilical	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
scar	NN	I-PROBLEM
for	IN	I-PROBLEM
approximately	RB	I-PROBLEM
2	CD	I-PROBLEM
1/2	CD	I-PROBLEM
cm	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

pulmonary	JJ	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
on	IN	O
september	NN	O
27	CD	O
,	,	O
1997	CD	O
revealed	VBD	O
an	DT	B-TEST
fvc	NN	I-TEST
of	IN	O
2.7	CD	O
which	WDT	O
is	VBZ	O
112%	CD	O
and	CC	O
fev1	NN	B-TEST
of	IN	O
2.23	CD	O
which	WDT	O
is	VBZ	O
123%	CD	O
.	.	O

her	PRP$	O
admission	NN	O
laboratory	NN	O
data	NNS	O
includes	VBZ	O
serum	JJ	B-TEST
chemistries	NNS	I-TEST
with	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
144	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
101	CD	O
,	,	O
bicarbonate	NN	B-TEST
28	CD	O
,	,	O
bun	NN	B-TEST
10	CD	O
,	,	O
creatinine	NN	B-TEST
0.9	CD	O
and	CC	O
glucose	VB	B-TEST
of	IN	O
93	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
7.65	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
42	CD	O
and	CC	O
platelets	NNS	B-TEST
of	IN	O
345	CD	O
.	.	O

her	PRP$	B-TEST
urinalysis	NN	I-TEST
shows	VBZ	O
2+	CD	B-PROBLEM
bacteria	NNS	I-PROBLEM
and	CC	O
2+	CD	B-PROBLEM
squamous	JJ	I-PROBLEM
epithelium	NN	I-PROBLEM
with	IN	O
greater	JJR	B-PROBLEM
than	IN	I-PROBLEM
10,000	CD	I-PROBLEM
mixed	JJ	I-PROBLEM
bacteria	NNS	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
on	IN	O
august	JJ	O
6	CD	O
,	,	O
1997	CD	O
revealed	VBD	O
multiple	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodules	NNS	I-PROBLEM
increased	VBN	O
in	IN	O
size	NN	O
as	IN	O
previously	RB	O
mentioned	VBN	O
.	.	O

pt	NN	B-TEST
was	VBD	O
11.7	CD	O
,	,	O
ptt	NN	B-TEST
26.7	CD	O
and	CC	O
inr	NN	B-TEST
of	IN	O
0.9	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
december	NN	O
5	CD	O
,	,	O
1997	CD	O
and	CC	O
underwent	JJ	O
left	NN	B-TREATMENT
lung	NN	I-TREATMENT
wedge	VBP	I-TREATMENT
thoracoscopic	NN	I-TREATMENT
resection	NN	I-TREATMENT
and	CC	O
bronchoscopy	NN	B-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
pulled	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
and	CC	O
the	DT	O
patient	NN	O
did	VBD	O
quite	RB	O
well	RB	O
and	CC	O
remained	VBD	O
inhouse	NN	O
for	IN	O
observation	NN	B-TEST
until	IN	O
december	NNP	O
7	CD	O
,	,	O
1997	CD	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

1)	CD	O
lac-hydrin	JJ	B-TREATMENT
12%	CD	O
topically	RB	O
b.i.d.	JJ	O

2)	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

3)	CD	O
tylenol	JJ	B-TREATMENT
#	#	I-TREATMENT
3	CD	I-TREATMENT
tablets	NNS	O
rather	RB	O
than	IN	O
percocet	VB	B-TREATMENT
,	,	O
1-2	JJ	O
tablets	NNS	O
p.o.	VBP	O
q.4-6h.	JJ	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

4)	CD	O
spironolactone	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

this	DT	O
is	VBZ	O
a	DT	O
64-year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
and	CC	O
dilated	VBD	B-PROBLEM
cardiomyopathy	NNS	I-PROBLEM
(	(	O
with	IN	O
a	DT	B-TEST
transthoracic	JJ	I-TEST
echocardiogram	NN	I-TEST
in	IN	O
2016-01-13	JJ	O
showing	VBG	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
40%	CD	O
,	,	O
posterior	NN	B-PROBLEM
and	CC	I-PROBLEM
inferior	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
,	,	O
and	CC	O
large	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
thrombus	NN	I-PROBLEM
).	NN	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
from	IN	O
2016-01-21	JJ	O
to	TO	O
2016-02-03	JJ	O
;	:	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
3-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
normal	JJ	O
left	NN	O
main	JJ	O
,	,	O
mid	JJ	O
left	VBD	O
anterior	JJ	O
descending	VBG	O
artery	NN	O
60%	CD	O
,	,	O
diffuse	RB	B-PROBLEM
90%	CD	I-PROBLEM
mid	JJ	I-PROBLEM
distal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
at	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
diagonal	JJ	O
,	,	O
serial	JJ	O
70%	CD	O
and	CC	O
90%	CD	B-PROBLEM
left	VBD	I-PROBLEM
circumflex	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
and	CC	O
90%	CD	O
first	JJ	O
obtuse	NN	O
marginal	NN	O
,	,	O
and	CC	O
mid	RB	O
right	JJ	O
coronary	JJ	O
artery	NN	O
60%	CD	O
.	.	O

during	IN	O
initial	JJ	B-TEST
evaluation	NN	I-TEST
for	IN	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
,	,	O
80%	CD	O
to	TO	O
90%	CD	O
of	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
was	VBD	O
found	VBN	O
;	:	O
for	IN	O
which	WDT	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
internal	JJ	I-TREATMENT
carotid	NN	I-TREATMENT
artery	NN	I-TREATMENT
stent	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
for	IN	O
a	DT	O
goal	NN	O
inr	NN	B-TEST
of	IN	O
2.5	CD	O
to	TO	O
3	CD	O
.	.	O

she	PRP	O
was	VBD	O
then	RB	O
admitted	VBN	O
again	RB	O
on	IN	O
2016-03-30	JJ	O
for	IN	O
an	DT	B-TREATMENT
elective	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

at	IN	O
surgery	NN	B-TREATMENT
,	,	O
the	DT	O
descending	VBG	O
aorta	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
calcified	VBN	B-PROBLEM
,	,	O
and	CC	O
an	DT	B-TEST
intraoperative	JJ	I-TEST
transesophageal	NN	I-TEST
echocardiogram	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
irregular	JJ	I-PROBLEM
intra-aortic	JJ	I-PROBLEM
pedunculated	VBN	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
stroke	NN	I-PROBLEM
risk	NN	I-PROBLEM
of	IN	O
aortic	JJ	B-TREATMENT
cross-clamping	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
this	DT	O
finding	NN	O
,	,	O
the	DT	O
plan	NN	O
for	IN	O
a	DT	B-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
was	VBD	O
aborted	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
service	NN	O
for	IN	O
medical	JJ	O
management	NN	O
in	IN	O
anticipation	NN	O
of	IN	O
possible	JJ	O
percutaneous	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
later	RBR	O
in	IN	O
the	DT	O
admission	NN	O
.	.	O

1.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

4.	CD	O
asthma	NN	B-PROBLEM
.	.	O

5.	CD	O
chronic	JJ	B-PROBLEM
low	JJ	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

6.	CD	O
cholelithiasis	NN	B-PROBLEM
.	.	O

7.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
(	(	O
as	IN	O
noted	VBN	O
previously	RB	O
).	JJ	O

8.	CD	O
dilated	VBN	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
(	(	O
also	RB	O
as	RB	O
noted	VBN	O
above	IN	O
).	NN	O

1.	CD	O
dopamine	JJ	B-TREATMENT
drip	NN	I-TREATMENT
at	IN	O
3	CD	O
.	.	O

2.	CD	O
insulin	NN	B-TREATMENT
drip	NN	I-TREATMENT
at	IN	O
2	CD	O
.	.	O

3.	CD	O
regular	JJ	B-TREATMENT
10	CD	O
units	NNS	O
intravenously	RB	O
q.6h.	RB	O
as	IN	O
needed	VBN	O
.	.	O

4.	CD	O
percocet	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

5.	CD	O
sucralfate	JJ	B-TREATMENT
1	CD	O
g	NN	O
via	IN	O
nasogastric	JJ	O
tube	NN	O
q.6h.	NN	O

6.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

7.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
per	IN	O
day	NN	O
.	.	O

8.	CD	O
flonase	NN	B-TREATMENT
2	CD	O
puffs	NNS	O
twice	RB	O
per	IN	O
day	NN	O
.	.	O

9.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

10.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

11.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
temperature	NN	B-TEST
was	VBD	O
99.3	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
66	CD	O
in	IN	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
132/51	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
22	CD	O
,	,	O
and	CC	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
was	VBD	O
100%	CD	O
on	IN	O
3	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

swan	NN	B-TEST
showed	VBD	O
a	DT	B-TEST
pa	NN	I-TEST
of	IN	O
29/11	CD	O
,	,	O
svr	NN	B-TEST
of	IN	O
14/9	CD	O
,	,	O
cardiac	JJ	B-TEST
output	NN	I-TEST
of	IN	O
3.86	CD	O
,	,	O
cardiac	JJ	B-TEST
index	NN	I-TEST
of	IN	O
2.14	CD	O
.	.	O

urine	JJ	B-TEST
output	NN	I-TEST
of	IN	O
30	CD	O
cc	NN	O
to	TO	O
100	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
over	IN	O
the	DT	O
last	JJ	O
four	CD	O
hours	NNS	O
.	.	O

chest	NN	B-TREATMENT
tube	NN	I-TREATMENT
showed	VBD	O
30	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
over	IN	O
the	DT	O
last	JJ	O
four	CD	O
hours	NNS	O
.	.	O

in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
denied	VBD	O
pain	NN	B-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
and	CC	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
anteriorly	RB	O
.	.	O

heart	NN	O
was	VBD	O
regular	JJ	O
in	IN	O
rate	NN	B-TEST
and	CC	O
rhythm	NN	B-TEST
.	.	O

normal	JJ	O
first	JJ	B-TEST
heart	NN	I-TEST
sounds	NNS	I-TEST
and	CC	O
second	JJ	B-TEST
heart	NN	I-TEST
sounds	VBZ	I-TEST
.	.	O

no	DT	O
audible	JJ	B-PROBLEM
murmurs	NNS	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
with	IN	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

lines	NNS	B-TREATMENT
included	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
antecubital	JJ	I-TREATMENT
peripheral	JJ	I-TREATMENT
intravenous	JJ	I-TREATMENT
.	.	O

chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
in	IN	O
place	NN	O
in	IN	O
left	JJ	O
internal	JJ	O
jugular	NN	O
an	DT	B-TREATMENT
pulmonary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

laboratories	NNS	B-TEST
revealed	VBD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
12.7	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
32.4	CD	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
140	CD	O
,	,	O
and	CC	O
mean	JJ	B-TEST
cell	NN	I-TEST
volume	NN	I-TEST
was	VBD	O
80	CD	O
.	.	O

patient	NN	O
was	VBD	O
4.4	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
was	VBD	O
14	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
0.6	CD	O
,	,	O
and	CC	O
glucose	NN	B-TEST
was	VBD	O
147	CD	O
.	.	O

inr	NN	B-TEST
was	VBD	O
1.2	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
was	VBD	O
23.7	CD	O
,	,	O
and	CC	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
was	VBD	O
13.4	CD	O
.	.	O

free	JJ	B-TEST
calcium	NN	I-TEST
was	VBD	O
0.95	CD	O
on	IN	O
03-30	NN	O
.	.	O

phosphate	NN	B-TEST
was	VBD	O
3.6	CD	O
and	CC	O
magnesium	NN	B-TEST
was	VBD	O
2.2	CD	O
.	.	O

arterial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
at	IN	O
3	CD	O
a.m.	RB	O
demonstrated	VBD	O
7.4/45/125	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
64-year-old	JJ	O
female	NN	O
with	IN	O
3-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
service	NN	O
for	IN	O
western	JJ	O
mass	NN	O
.	.	O

hospital	NN	O
medical	JJ	O
optimization	NN	O
and	CC	O
management	NN	O
following	VBG	O
an	DT	B-TREATMENT
aborted	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
when	WRB	O
a	DT	B-PROBLEM
mobile	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
atheroma	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
,	,	O
and	CC	O
statin	NN	B-TREATMENT
.	.	O

once	RB	O
the	DT	O
patient	NN	O
was	VBD	O
titrated	VBN	O
off	RP	O
dopamine	NN	B-TREATMENT
,	,	O
the	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
and	CC	O
ace	NN	B-TREATMENT
inhibitor	NN	I-TREATMENT
were	VBD	O
restarted	VBN	O
.	.	O

with	IN	O
regard	NN	O
to	TO	O
the	DT	B-PROBLEM
left	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
thrombus	NN	I-PROBLEM
,	,	O
her	PRP$	O
goal	NN	O
inr	NN	B-TEST
remained	VBD	O
2.5	CD	O
to	TO	O
3	CD	O
;	:	O
and	CC	O
the	DT	O
goal	NN	O
was	VBD	O
to	TO	O
start	VB	O
heparin	NN	B-TREATMENT
once	RB	O
the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
from	IN	O
a	DT	B-TREATMENT
thoracotomy	NN	I-TREATMENT
and	CC	O
chest	NN	B-TREATMENT
tube	NN	I-TREATMENT

by	IN	O
04-01	NNP	O
,	,	O
on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
doing	VBG	O
well	RB	O
and	CC	O
the	DT	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
still	RB	O
had	VBD	O
transcutaneous	JJ	B-TREATMENT
pacing	VBG	I-TREATMENT
wires	NNS	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

likewise	RB	O
,	,	O
on	IN	O
04-01	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
weaned	VBN	O
off	RP	O
surgery	NN	B-TREATMENT
without	IN	O
difficulty	NN	O
.	.	O

thus	RB	O
,	,	O
the	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
and	CC	O
ace	NN	B-TREATMENT
inhibitor	NN	I-TREATMENT
were	VBD	O
started	VBN	O
to	TO	O
be	VB	O
titrated	VBN	O
up	RP	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
wellbutrin	NN	B-TREATMENT
for	IN	O
smoking	VBG	O
cessation	NN	O
.	.	O

at	IN	O
this	DT	O
point	NN	O
,	,	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
the	DT	O
patient	NN	O
would	MD	O
not	RB	O
receive	VB	O
percutaneous	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
on	IN	O
this	DT	O
admission	NN	O
and	CC	O
would	MD	O
likely	RB	O
be	VB	O
discharged	VBN	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
stabilization	NN	O
with	IN	O
followup	NN	O
.	.	O

after	IN	O
evaluation	NN	B-TEST
and	CC	O
a	DT	O
discussion	NN	O
with	IN	O
dr.	JJ	O
gunter	NN	O
,	,	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
the	DT	O
patient	NN	O
no	RB	O
longer	RBR	O
needed	VBN	O
anticoagulation	NN	B-TREATMENT
since	IN	O
there	EX	O
was	VBD	O
no	DT	O
aortic	JJ	B-PROBLEM
thrombus	NN	I-PROBLEM
but	CC	O
only	RB	O
an	DT	B-PROBLEM
aortic	JJ	I-PROBLEM
plaque	NN	I-PROBLEM
,	,	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
anterior/apical	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
noted	VBD	O
.	.	O

at	IN	O
this	DT	O
point	NN	O
,	,	O
the	DT	B-PROBLEM
left	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
thrombus	NN	I-PROBLEM
(	(	O
for	IN	O
which	WDT	O
she	PRP	O
was	VBD	O
initially	RB	O
started	JJ	O
therapy	NN	B-TREATMENT
for	IN	O
)	)	O
was	VBD	O
no	DT	O
longer	RBR	O
present	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
hematocrit	NN	I-PROBLEM
drop	NN	I-PROBLEM
and	CC	O
was	VBD	O
transfused	VBN	O
one	CD	B-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
for	IN	O
a	DT	O
goal	NN	O
hematocrit	NN	B-TEST
of	IN	O
greater	JJR	O
than	IN	O
30	CD	O
.	.	O

by	IN	O
04-03	NNP	O
,	,	O
captopril	NN	B-TREATMENT
and	CC	O
atenolol	NN	B-TREATMENT
were	VBD	O
started	VBN	O
,	,	O
and	CC	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
leg	JJ	I-TREATMENT
bandage	NN	I-TREATMENT
from	IN	O
the	DT	B-TREATMENT
vein	NN	I-TREATMENT
harvest	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
do	VB	O
well	RB	O
on	IN	O
the	DT	B-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
was	VBD	O
without	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

with	IN	O
dr.	JJ	O
gunter	NN	O
for	IN	O
an	DT	B-TREATMENT
eventual	JJ	I-TREATMENT
percutaneous	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
,	,	O
and	CC	O
her	PRP$	O
surgeon	NN	O
(	(	O
dr.	JJ	O
halcomb	NN	O
)	)	O
following	VBG	O
her	PRP$	B-TREATMENT
thoracotomy	NN	I-TREATMENT
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O
3-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
aborted	VBD	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
due	JJ	O
to	TO	O
mobile	VB	B-PROBLEM
aortic	JJ	I-PROBLEM
atheroma	NN	I-PROBLEM
.	.	O

3.	CD	O
diabetes	NNS	B-PROBLEM
.	.	O

4.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

2.	CD	O
docusate	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
per	IN	O
day	NN	O
.	.	O

3.	CD	O
fluticasone	NN	B-TREATMENT
2	CD	O
puffs	NNS	O
inhaled	JJ	O
twice	RB	O
per	IN	O
day	NN	O
.	.	O

4.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

5.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

6.	CD	O
pravastatin	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

7.	CD	O
bupropion	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
per	IN	O
day	NN	O
(	(	O
for	IN	O
smoking	VBG	O
cessation	NN	O
).	NN	O

8.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

9.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
once	RB	O
per	IN	O
day	NN	O
.	.	O

right	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
papillary	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
papillary	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

1.	CD	O
pulmonary	JJ	B-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
iliac	NN	I-PROBLEM
bone	NN	I-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

2.	CD	O
eosinophilia	NNS	B-PROBLEM
.	.	O

3.	CD	O
chronic	JJ	B-PROBLEM
leg	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

4.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

5.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

6.	CD	O
left	VBD	B-PROBLEM
subclavian	JJ	I-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

7.	CD	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
74	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
metastatic	JJ	B-PROBLEM
papillary	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
thyroid	NN	I-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
on	IN	O
4/28/93	CD	O
with	IN	O
progressive	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
a	DT	O
good	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
january	NN	O
of	IN	O
1993	CD	O
when	WRB	O
she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
serious	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
associated	VBN	O
with	IN	O
weakness	NN	B-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
also	RB	O
reported	VBN	O
a	DT	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
15	CD	I-PROBLEM
pounds	NNS	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
two	CD	O
months	NNS	O
.	.	O

although	IN	O
her	PRP$	B-PROBLEM
upper	JJ	I-PROBLEM
respiratory	NN	I-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
seemed	VBD	O
to	TO	O
be	VB	O
resolving	VBG	O
,	,	O
her	PRP$	B-PROBLEM
weakness	NN	I-PROBLEM
persisted	VBN	O
.	.	O

a	DT	B-TEST
work	NN	I-TEST
up	RB	I-TEST
begun	VBN	O
by	IN	O
her	PRP$	O
internist	NN	O
,	,	O
dr.	NN	O
brain	NN	O
,	,	O
revealed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
49,000	CD	O
with	IN	O
50%	CD	B-TEST
eosinophils	NNS	I-TEST
.	.	O

she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
box	VB	O
memorial	JJ	O
hospital	NN	O
nursing	NN	O
home	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

data	NNS	O
collected	VBD	O
there	EX	O
included	VBD	O
a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
which	WDT	O
was	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	B-TEST
liver	NN	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
showed	VBD	O
an	DT	B-TEST
alkaline	JJ	I-TEST
phosphatase	NN	I-TEST
of	IN	O
303	CD	O
,	,	O
ldh	VBD	B-TEST
310	CD	O
,	,	O
sgot	VBD	B-TEST
66	CD	O
,	,	O
albumin	RB	B-TEST
2.5	CD	O
.	.	O

a	DT	B-TEST
peripheral	JJ	I-TEST
blood	NN	I-TEST
smear	NN	I-TEST
showed	VBD	O
mature	NN	O
eosinophils	NNS	O
in	IN	O
increased	JJ	B-PROBLEM
numbers	NNS	I-PROBLEM
.	.	O

chromosomal	JJ	B-TEST
studies	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

a	DT	B-TEST
bone	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
increased	JJ	B-PROBLEM
uptake	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
manubrium	NN	I-PROBLEM
at	IN	O
the	DT	O
site	NN	O
of	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
fracture	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
the	DT	O
right	JJ	O
supraclavicular	JJ	O
area	NN	O
.	.	O

a	DT	B-TEST
thyroid	NN	I-TEST
ultrasound	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
inferior	JJ	I-PROBLEM
thyroid	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
followed	VBN	O
by	IN	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
which	WDT	O
showed	VBD	O
an	DT	B-PROBLEM
enlarged	JJ	I-PROBLEM
spleen	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
lytic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
iliac	NN	I-PROBLEM
bone	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
benign	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
.	.	O

biopsy	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
lytic	JJ	I-TEST
lesion	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
metastases	NNS	B-PROBLEM
papillary	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
thyroid	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
upper	JJ	I-TEST
gastrointestinal	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	B-TEST
small	JJ	I-TEST
bowel	NN	I-TEST
follow	VBP	I-TEST
through	IN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

a	DT	B-TEST
thyroid	JJ	I-TEST
scan	NN	I-TEST
revealed	VBD	O
decreased	JJ	B-PROBLEM
function	NN	I-PROBLEM
and	CC	O
displacement	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
thyroid	NN	I-PROBLEM
by	IN	O
a	DT	B-PROBLEM
cold	JJ	I-PROBLEM
mass	NN	I-PROBLEM
located	VBN	O
inferiorly	RB	O
with	IN	O
calcifications	NNS	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
ct	NN	I-TEST
also	RB	O
revealed	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
necrotic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
involving	VBG	O
the	DT	O
right	NN	O
lung	NN	O
posteriorly	RB	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
profound	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
appetite	NN	I-PROBLEM
and	CC	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
developed	VBD	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
left	VBN	B-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
associated	VBN	O
with	IN	O
increased	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

a	DT	B-TEST
needle	JJ	I-TEST
biopsy	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	JJ	I-TEST
thyroid	NN	I-TEST
nodule	NN	I-TEST
showed	VBD	O
papillary	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reports	VBZ	O
no	DT	O
history	NN	O
of	IN	O
radiation	NN	B-PROBLEM
exposure	NN	I-PROBLEM
,	,	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
thyroid	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
no	DT	O
recent	JJ	O
travels	NNS	O
or	CC	O
exposure	NN	B-PROBLEM
to	TO	I-PROBLEM
tuberculosis	NN	I-PROBLEM
.	.	O

includes	VBZ	O
a	DT	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
good	JJ	O
heart	NN	B-TREATMENT
rate	NN	I-TREATMENT
control	NN	I-TREATMENT
on	IN	O
digoxin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
also	RB	O
reports	VBZ	O
no	DT	O
known	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergy	NN	I-PROBLEM
.	.	O

lanoxin	NN	B-TREATMENT
,	,	O
0.25	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O
lasix	CC	B-TREATMENT
,	,	O
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
,	,	O
elderly	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
showed	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
126/72	CD	O
,	,	O
pulse	RB	B-TEST
84	CD	O
,	,	O
respirations	NNS	B-TEST
22	CD	O
,	,	O
temperature	NN	B-TEST
98.6	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
3	CD	I-PROBLEM
x	NN	I-PROBLEM
4	CD	I-PROBLEM
cm	JJ	I-PROBLEM
firm	NN	I-PROBLEM
,	,	I-PROBLEM
nontender	RB	I-PROBLEM
right	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
mass	NN	I-PROBLEM
that	WDT	O
seemed	VBD	O
to	TO	O
be	VB	O
fixed	VBN	O
to	TO	O
the	DT	O
trachea	NN	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
exhibited	VBD	O
right	JJ	B-PROBLEM
basilar	NN	I-PROBLEM
dullness	VB	I-PROBLEM
one	CD	O
quarter	NN	O
of	IN	O
the	DT	O
way	NN	O
up	RP	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
definite	JJ	B-PROBLEM
s3	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
4+	CD	B-PROBLEM
edema	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
67.3	CD	O
with	IN	O
a	DT	B-TEST
differential	NN	I-TEST
of	IN	O
21%	CD	B-TEST
polys	NN	I-TEST
,	,	O
16%	CD	B-TEST
bands	NNS	I-TEST
,	,	O
3%	CD	B-TEST
lymphocytes	NNS	I-TEST
,	,	O
2%	CD	B-TEST
monocytes	NNS	I-TEST
,	,	O
57%	CD	B-TEST
eosinophils	NNS	I-TEST
and	CC	O
1%	CD	B-TEST
myelocytes	NNS	I-TEST
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
38.8	CD	O
,	,	O
hemoglobin	NN	B-TEST
13.7	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
155,000	CD	O
,	,	O
pt	NN	B-TEST
12.7/10.1	CD	O
,	,	O
ptt	NN	B-TEST
33.9	CD	O
,	,	O
erythrocyte	JJ	B-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
calcium	NN	B-TEST
7.5	CD	O
,	,	O
phosphorus	NN	B-TEST
3.5	CD	O
,	,	O
sodium	NN	B-TEST
136	CD	O
,	,	O
potassium	NN	B-TEST
3.7	CD	O
,	,	O
bun	NN	B-TEST
15	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
5.9	CD	O
,	,	O
albumin	RB	B-TEST
2.3	CD	O
,	,	O
globulin	NN	B-TEST
3.6	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
379	CD	O
,	,	O
sgot	VBD	B-TEST
37	CD	O
,	,	O
digoxin	NN	B-TEST
level	NN	I-TEST
0.7	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
dr.	VB	O
shatermivaet	JJ	O
s	NN	O
brain	NN	O
on	IN	O
4/28/93	CD	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
papillary	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
thyroid	NN	I-PROBLEM
with	IN	O
bone	NN	B-PROBLEM
involvement	NN	I-PROBLEM
and	CC	O
possible	JJ	O
lung	NN	B-PROBLEM
involvement	NN	I-PROBLEM
.	.	O

work	NN	B-TEST
up	RP	I-TEST
was	VBD	O
begun	VBN	O
for	IN	O
the	DT	O
possible	JJ	O
myeloproliferative	JJ	B-PROBLEM
/	NNP	I-PROBLEM
myelodysplastic	JJ	I-PROBLEM
disorder	NN	I-PROBLEM
associated	VBN	O
with	IN	O
the	DT	B-PROBLEM
hyper-eosinophilic	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

accordingly	RB	O
,	,	O
an	DT	O
oncology	NN	O
consult	NN	O
was	VBD	O
called	VBN	O
on	IN	O
4/29/93	CD	O
and	CC	O
a	DT	B-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
aspirate	NN	I-TEST
biopsy	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

this	DT	O
revealed	VBD	O
maturation	NN	O
of	IN	O
leukocytes	NNS	O
to	TO	O
all	DT	O
stages	NNS	O
with	IN	O
markedly	RB	B-PROBLEM
increased	VBN	I-PROBLEM
eosinophilic	JJ	I-PROBLEM
proliferation	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
lung	NN	I-TEST
biopsy	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
4/30/93	CD	O
without	IN	O
definitive	JJ	O
results	NNS	O
.	.	O

during	IN	O
this	DT	O
time	NN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
coagulation	NN	O
status	NN	O
had	VBD	O
improved	VBN	O
with	IN	O
vitamin	JJ	B-TREATMENT
k	NNS	I-TREATMENT
therapy	NN	I-TREATMENT
with	IN	O
pts	NNS	B-TEST
normalizing	VBG	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
suffer	VB	O
from	IN	O
edema	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
and	CC	O
a	DT	O
vascular	JJ	O
radiology	NN	O
consult	NN	O
revealed	VBD	O
a	DT	B-PROBLEM
thrombosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
subclavian	JJ	I-PROBLEM
vein	NN	I-PROBLEM
extending	VBG	O
into	IN	O
the	DT	O
axillary	JJ	O
vein	NN	O
.	.	O

there	EX	O
was	VBD	O
some	DT	B-PROBLEM
thrombosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
jugular	NN	I-PROBLEM
vein	NN	I-PROBLEM
as	RB	O
well	RB	O
.	.	O

a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
was	VBD	O
completely	RB	O
negative	JJ	O
for	IN	O
any	DT	B-PROBLEM
metastatic	JJ	I-PROBLEM
process	NN	I-PROBLEM
involving	VBG	O
the	DT	O
brain	NN	O
.	.	O

thus	RB	O
,	,	O
a	DT	B-TREATMENT
heparin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
was	VBD	O
begun	VBN	O
.	.	O

meanwhile	RB	O
,	,	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
eosinophilia	NN	I-PROBLEM
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
trial	NN	I-TREATMENT
of	IN	I-TREATMENT
prednisone	NN	I-TREATMENT
.	.	O

she	PRP	O
also	RB	O
developed	VBD	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
which	WDT	O
responded	VBD	O
to	TO	O
bactrim	VB	B-TREATMENT
,	,	O
but	CC	O
which	WDT	O
was	VBD	O
subsequently	RB	O
stopped	VBN	O
because	IN	O
of	IN	O
diarrhea	NN	B-PROBLEM
.	.	O

the	DT	O
conclusions	NNS	O
at	IN	O
this	DT	O
time	NN	O
of	IN	O
the	DT	O
thyroid	JJ	O
cytologist	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
bone	NN	O
pathologist	NN	O
,	,	O
were	VBD	O
that	IN	O
the	DT	O
findings	NNS	O
were	VBD	O
diagnostic	JJ	O
of	IN	O
papillary	JJ	B-PROBLEM
thyroid	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
with	IN	O
pulmonary	JJ	B-PROBLEM
metastases	NNS	I-PROBLEM
.	.	O

dr.	JJ	O
trial	NN	O
was	VBD	O
subsequently	RB	O
consulted	VBN	O
on	IN	O
5/5	CD	O
for	IN	O
surgical	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
.	.	O

on	IN	O
5/6/93	CD	O
the	DT	O
patient	NN	O
underwent	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
thyroidectomy	NN	I-TREATMENT
with	IN	O
sacrifice	NN	O
of	IN	O
the	DT	O
right	JJ	O
recurrent	NN	O
laryngeal	RB	O
nerve	RB	O
as	RB	O
well	RB	O
as	IN	O
the	DT	O
right	JJ	O
sternothyroid	NN	O
muscle	NN	O
and	CC	O
lower	JJR	O
parathyroid	NN	O
gland	NN	O
.	.	O

she	PRP	O
underwent	JJ	O
autotransplantation	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
parathyroid	NN	I-TREATMENT
gland	NN	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
repair	NN	B-TREATMENT
of	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
posterior	NN	I-TREATMENT
membranous	JJ	I-TREATMENT
tracheotomy	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
rate	NN	I-TEST
was	VBD	O
well	RB	O
controlled	VBN	O
on	IN	O
digoxin	NN	B-TREATMENT
.	.	O

on	IN	O
the	DT	O
ward	NN	O
she	PRP	O
continued	VBD	O
a	DT	B-TREATMENT
gentle	JJ	I-TREATMENT
diuresis	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
solu-medrol	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

calcium	NN	B-TEST
levels	NNS	I-TEST
remained	VBD	O
7.2	CD	O
to	TO	O
7.5	CD	O
postoperatively	RB	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
improve	VB	O
with	IN	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
hoarseness	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
voice	NN	I-PROBLEM
that	WDT	O
was	VBD	O
expected	VBN	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
exhibit	VB	O
asymptomatic	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

anticoagulation	NN	B-TREATMENT
was	VBD	O
begun	VBN	O
on	IN	O
the	DT	O
third	JJ	O
postoperative	JJ	O
day	NN	O
with	IN	O
coumadin	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
effectively	RB	B-TREATMENT
anticoagulated	VBN	I-TREATMENT
with	IN	O
a	DT	B-TEST
pt	NN	I-TEST
in	IN	O
the	DT	O
range	NN	O
between	IN	O
15	CD	O
and	CC	O
17	CD	O
over	IN	O
a	DT	O
control	NN	O
of	IN	O
10	CD	O
.	.	O

she	PRP	O
also	RB	O
received	VBD	O
a	DT	O
radiation	NN	O
therapy	NN	O
consult	NN	O
for	IN	O
local	JJ	B-TREATMENT
control	NN	I-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
invasive	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

metastatic	JJ	B-PROBLEM
papillary	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

coumadin	NN	B-TREATMENT
,	,	O
5	CD	O
mg	NN	O
po	NN	O
alternating	VBG	O
with	IN	O
2.5	CD	O
mg	NNS	O
po	VBP	O
;	:	O
prednisolone	NN	B-TREATMENT
,	,	O
30	CD	O
mg	NN	O
po	NN	O
bid	NN	O
;	:	O
hydrochlorothiazide	NN	B-TREATMENT
,	,	O
50	CD	O
mg	NN	O
po	NN	O
bid	NN	O
;	:	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
,	,	O
40	CD	O
meq	NN	O
po	NN	O
bid	NN	O
;	:	O
augmentin	NN	B-TREATMENT
,	,	O
500	CD	O
mg	NN	O
po	NN	O
tid	NN	O
;	:	O
digoxin	NN	B-TREATMENT
,	,	O
0.125	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O
tylenol	CC	B-TREATMENT
,	,	O
650	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
;	:	O
carafate	NN	B-TREATMENT
,	,	O
1	CD	O
gram	NN	O
po	NN	O
bid	NN	O
;	:	O
synthroid	NN	B-TREATMENT
,	,	O
0.125	CD	O
mg	NN	O
po	NN	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
home	NN	O
with	IN	O
terchestlumnesamp	JJ	O
medical	JJ	O
center	NN	O
referral	NN	O
for	IN	O
weekly	JJ	B-TEST
blood	NN	I-TEST
tests	NNS	I-TEST
,	,	O
potassium	NN	B-TEST
and	CC	O
pt	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
also	RB	O
to	TO	O
keep	VB	O
her	PRP$	B-TREATMENT
left	JJ	I-TREATMENT
arm	NN	I-TREATMENT
elevated	VBD	I-TREATMENT
and	CC	O
to	TO	O
remain	VB	O
on	IN	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
sodium	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
be	VB	O
maintained	VBN	O
on	IN	O
a	DT	B-TEST
pt	NN	I-TEST
between	IN	O
15	CD	O
and	CC	O
17	CD	O
with	IN	O
coumadin	NN	B-TREATMENT
.	.	O

arrangements	NNS	O
will	MD	O
be	VB	O
made	VBN	O
for	IN	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
neck	NN	I-TREATMENT
and	CC	I-TREATMENT
right	JJ	I-TREATMENT
iliac	NN	I-TREATMENT
crest	NN	I-TREATMENT
.	.	O

change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

per	IN	O
record	NN	O
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
multiple	JJ	O
episodes	NNS	O
in	IN	O
the	DT	O
last	JJ	O
week	NN	O
of	IN	O
changes	NNS	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

no	DT	O
localizing	VBG	O
etiology	NN	O
of	IN	O
delta	JJ	B-PROBLEM
ms	NN	I-PROBLEM
.	.	O

that	IN	O
evening	VBG	O
she	PRP	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
amesbury	VB	O
hospital	JJ	O
hospital	NN	O
.	.	O

there	EX	O
her	PRP$	B-TEST
oxygen	NN	I-TEST
she	PRP	O
was	VBD	O
sating	VBG	O
65%	CD	O
on	IN	O
room	NN	O
air	NN	O
,	,	O
increased	VBD	O
to	TO	O
98%	CD	O
with	IN	O
a	DT	B-TREATMENT
nonrebreather	JJ	I-TREATMENT
mask	NN	I-TREATMENT
.	.	O

there	EX	O
an	DT	B-TEST
abg	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
showed	VBD	O
an	DT	B-TEST
abg	NN	I-TEST
of	IN	O
7.42	CD	O
,	,	O
62	CD	O
,	,	O
and	CC	O
55	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
that	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
that	WDT	O
was	VBD	O
questionable	JJ	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
.	.	O

lumbar	NN	B-TEST
puncture	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
the	DT	B-TEST
micro	NN	I-TEST
cultures	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
psychiatry	NN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
but	CC	O
noted	VBD	O
there	EX	O
was	VBD	O
no	DT	O
psychoses	NNS	B-PROBLEM
,	,	O
but	CC	O
delirium	NN	B-PROBLEM
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
a	DT	B-TEST
k	NN	I-TEST
of	IN	O
6.0	CD	O
and	CC	O
given	VBN	O
30	CD	O
of	IN	O
kayexalate	NN	B-TREATMENT
,	,	O
5	CD	O
of	IN	O
haldol	NN	B-TREATMENT
,	,	O
2	CD	O
mg	NN	O
of	IN	O
ativan	NN	B-TREATMENT
given	VBN	O
for	IN	O

agitation	NN	B-PROBLEM
,	,	O
and	CC	O
2	CD	O
mg	NN	O
of	IN	O
ceftriaxone	NN	B-TREATMENT
was	VBD	O
given	VBN	O
for	IN	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
101.3	CD	O
with	IN	O
a	DT	O
concern	NN	O
for	IN	O
meningitis	NN	B-PROBLEM
as	IN	O
a	DT	B-TEST
lp	NN	I-TEST
was	VBD	O
done	VBN	O
prior	RB	O
.	.	O

on	IN	O
arrival	NN	O
to	TO	O
mass.	VB	O
eye	NN	O
&	CC	O
ear	JJ	O
infirmary	NN	O
,	,	O
she	PRP	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
with	IN	O
an	DT	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
of	IN	O
72%	CD	O
on	IN	O
6	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
50%	CD	B-TREATMENT
vent	NN	I-TREATMENT
mask	NN	I-TREATMENT
,	,	O
which	WDT	O
improved	VBD	O
her	PRP	B-TEST
oxygenation	NN	I-TEST
to	TO	O
97%	CD	O
.	.	O

patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
.	.	O

original	JJ	B-TEST
abg	NN	I-TEST
here	RB	O
before	IN	O
bipap	NN	B-TREATMENT
was	VBD	O
7.19	CD	O
,	,	O
102	CD	O
,	,	O
and	CC	O
92	CD	O
.	.	O

after	IN	O
being	VBG	O
placed	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
decreased	VBD	B-PROBLEM
to	TO	O
the	DT	O
80s	CD	O
.	.	O

she	PRP	O
responded	VBD	O
to	TO	O
1	CD	O
liter	NN	O
of	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
and	CC	O
blood	NN	B-TEST
pressure	NN	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

patient	NN	O
had	VBD	O
peripheral	JJ	B-TREATMENT
iv	NN	I-TREATMENT
x1	NN	O
placed	VBD	O
and	CC	O
right	JJ	B-TREATMENT
femoral	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
in	IN	O
the	DT	O
matthew	NN	O
.	.	O

when	WRB	O
laying	VBG	O
flat	JJ	O
,	,	O
her	PRP$	B-TEST
sats	NNS	I-TEST
decreased	VBD	B-PROBLEM
to	TO	O
50%	CD	O
on	IN	O
30%	CD	O
fio2	NN	B-TREATMENT
,	,	O
peep	NN	B-TREATMENT
of	IN	O
10	CD	O
,	,	O
and	CC	O
pressure	NN	B-TREATMENT
support	NN	I-TREATMENT
of	IN	O
5	CD	O
.	.	O

her	PRP$	B-TEST
abg	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
was	VBD	O
7.24	CD	O
,	,	O
91	CD	O
,	,	O
and	CC	O
38	CD	O
.	.	O

once	RB	O
the	DT	O
patient	NN	O
sat	VBD	O
up	RP	O
,	,	O
her	PRP$	B-TEST
sats	NNS	I-TEST
improved	VBN	O
and	CC	O
her	PRP$	O
airway	NN	O
was	VBD	O
no	RB	O
longer	RB	O
obstructed	VBN	O
.	.	O

after	IN	O
a	DT	O
history	NN	O
on	IN	O
bipap	NN	B-TREATMENT
about	IN	O
a	DT	O
half	NN	O
an	DT	O
hour	NN	O
,	,	O
her	PRP$	B-TEST
abg	NN	I-TEST
was	VBD	O
7.29	CD	O
,	,	O
79	CD	O
,	,	O
and	CC	O
106	CD	O
on	IN	O
30%	CD	O
pressure	NN	B-TREATMENT
support	NN	I-TREATMENT
of	IN	O
5	CD	O
and	CC	O
peep	NN	B-TREATMENT
of	IN	O
10	CD	O
.	.	O

she	PRP	O
denied	VBD	O
any	DT	O
pain	NN	B-PROBLEM
and	CC	O
was	VBD	O
not	RB	O
answering	VBG	O
questions	NNS	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

1.	CD	O
obstructive-sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
?	.	O

2.	CD	O
morbid	JJ	B-PROBLEM
obesity	NN	I-PROBLEM
.	.	O

3.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
unknown	JJ	O
ef	NN	B-TEST
.	.	O

4.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

5.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

6.	CD	O
depression	NN	B-PROBLEM
.	.	O

8.	CD	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

9.	CD	O
history	NN	O
of	IN	O
fibroids	NNS	B-PROBLEM
.	.	O

10.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

1.	CD	O
lasix	JJ	B-TREATMENT
40	CD	O
q.d.	NN	O

2.	CD	O
senna	JJ	B-TREATMENT
two	CD	O
tablets	NNS	O
q.6h.	VBP	O

3.	CD	O
metoprolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
b.i.d.	NN	O

4.	CD	O
metformin	NN	B-TREATMENT
1,000	CD	O
mg	NN	O
b.i.d.	NN	O

5.	CD	O
colace	NN	B-TREATMENT
.	.	O

6.	CD	O
niferex	JJ	B-TREATMENT
one	CD	O
tablet	NN	O
b.i.d.	NN	O

7.	CD	O
cozaar	NN	B-TREATMENT
25	CD	O
mg	NN	O
q.d.	NN	O

8.	CD	O
ranitidine	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
peroxetine	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

10.	CD	O
insulin	NN	B-TREATMENT
:	:	O

nph	RB	B-TREATMENT
70	CD	O
units	NNS	O
q.a.m.	RB	O
,	,	O
50	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
regular	JJ	B-TREATMENT
insulin-sliding	JJ	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

11.	CD	O
subq	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
5,000	CD	O
q.8h.	NN	O

12.	CD	O
lactulose	NN	B-TREATMENT
.	.	O

13.	CD	O
multivitamins	NNS	B-TREATMENT
.	.	O

14.	CD	O
albuterol	NN	B-TREATMENT
inhalers	NNS	I-TREATMENT
prn	VBP	O
.	.	O

penicillin	NN	B-TREATMENT
:	:	O

shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
108	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
140/82	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
96%	CD	O
,	,	O
respiratory	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
22	CD	O
on	IN	O
bipap	NN	B-TREATMENT
5/10/30%	CD	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
sleepy	JJ	B-PROBLEM
but	CC	O
arousable	JJ	O
.	.	O

arousable	JJ	O
intermittently	RB	O
to	TO	O
voice	NN	B-TEST
.	.	O

pupils	NNS	B-TEST
3	CD	O
mm	NNS	O
reactive	JJ	O
.	.	O

obese	JJ	B-PROBLEM
,	,	O
unable	JJ	O
to	TO	O
assess	VB	O
lymphadenopathy	JJ	B-PROBLEM
or	CC	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

poor	JJ	B-PROBLEM
effort	NN	I-PROBLEM
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
,	,	O
rales	NNS	B-PROBLEM
,	,	O
or	CC	O
rhonchi	NN	B-PROBLEM
.	.	O

distant	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
tachycardia	NN	B-PROBLEM
,	,	O
regular	JJ	O
rhythm	NN	B-TEST
.	.	O

abdomen	NNS	O
is	VBZ	O
obese	JJ	B-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
decreased	VBD	B-PROBLEM
bowel	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

obese	JJ	B-PROBLEM
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
2+	CD	O
pulses	NNS	B-TEST
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
12.8	CD	O
(	(	O
79%	CD	O
polys	NN	B-TEST
,	,	O
13%	CD	O
lymphocytes	NNS	B-TEST
,	,	O
8	CD	O
monocytes	NNS	B-TEST
,	,	O
nucleated	VBD	B-TEST
rbcs	JJ	I-TEST
1%	CD	O
),hematocrit	NN	B-TEST
31.7	CD	O
.	.	O

potassium	NN	B-TEST
5.2	CD	O
,	,	O
creatinine	NN	B-TEST
1.3	CD	O
,	,	O
bun	NN	B-TEST
35	CD	O
,	,	O
glucose	RB	B-TEST
152	CD	O
,	,	O
d	NN	B-TEST
dimer	NN	I-TEST
1636	CD	O
,	,	O
inr	VBZ	B-TEST
1.3	CD	O
.	.	O

urinalysis	NN	B-TEST
:	:	O

moderate	JJ	B-TEST
leukocytes	NNS	I-TEST
,	,	O
06-09	JJ	O
rbcs	NN	B-TEST
,	,	O
21-50	JJ	O
lymphocytes	NNS	B-TEST
,	,	O
many	JJ	B-PROBLEM
bacteria	NNS	I-PROBLEM
,	,	O
06-09	JJ	O
epithelial	JJ	B-TEST
cells	NNS	I-TEST
.	.	O

tox	NN	B-TEST
screen	NN	I-TEST
negative	JJ	O
.	.	O

urine	JJ	B-TEST
cultures	NNS	I-TEST
pending	VBG	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
11.8	CD	O
(	(	O
90%	CD	O
polys	NN	B-TEST
,	,	O
4%	CD	O
lymphocytes	NNS	B-TEST
,	,	O
5%	CD	O
monocytes	NNS	B-TEST
,	,	O
1%	CD	O
basophils	NNS	B-TEST
,	,	O
3%	CD	O
nucleated	JJ	B-TEST
rbcs	NN	I-TEST
).	NN	O

potassium	NN	B-TEST
6.6	CD	O
,	,	O
creatinine	NN	B-TEST
1.4	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
302	CD	O
,	,	O
t	EX	B-TEST
bilirubin	NN	I-TEST
0.6	CD	O
,	,	O
ast	RB	B-TEST
25	CD	O
,	,	O
alt	RB	B-TEST
84	CD	O
,	,	O
ck	NN	B-TEST
of	IN	O
15	CD	O
,	,	O
troponin	NN	B-TEST
0.01	CD	O
.	.	O

chest	JJ	B-TEST
x-ray	NN	I-TEST
:	:	O

left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
basal	NN	I-PROBLEM
opacity	NN	I-PROBLEM
.	.	O

ekg	NN	B-TEST
:	:	O

sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
106	CD	O
beats	NNS	B-TEST
per	IN	I-TEST
minute	NN	I-TEST
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
t-wave	JJ	B-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
leads	NNS	I-PROBLEM
i	NNS	I-PROBLEM
and	CC	I-PROBLEM
avl	NN	I-PROBLEM
that	WDT	O
are	VBP	O
old	JJ	O
.	.	O

no	DT	O
qrs	NN	B-PROBLEM
widening	NN	I-PROBLEM
and	CC	O
no	DT	O
peak	JJ	B-PROBLEM
t	NN	I-PROBLEM
waves	NNS	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
in	IN	O
comparison	NN	O
to	TO	O
2015-09-27	JJ	O
ekg	NN	B-TEST
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
rotated	VBD	O
low	JJ	B-PROBLEM
lung	NN	I-PROBLEM
volumes	NNS	I-PROBLEM
,	,	O
hazy	JJ	B-PROBLEM
opacities	NNS	I-PROBLEM
at	IN	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
in	IN	O
2010	CD	O
:	:	O

mild-to-moderate	JJ	B-PROBLEM
mr	NN	I-PROBLEM
,	,	O
tr	NN	B-PROBLEM
.	.	O

1.	CD	O
hypercarbic	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
failure	NN	I-PROBLEM
issues	NNS	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
changes	NNS	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
pco2	NN	B-TEST
of	IN	O
100	CD	O
,	,	O
ph	NN	B-TEST
of	IN	O
7.19	CD	O
,	,	O
decreasing	VBG	B-PROBLEM
sats	NNS	I-PROBLEM
on	IN	O
arrival	NN	O
likely	JJ	O
element	NN	O
of	IN	O
obstructive-sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	NN	O
and	CC	O
had	VBD	O
multiple	JJ	O
episodes	NNS	O
of	IN	O
apnea	NN	B-PROBLEM
throughout	IN	O
the	DT	O
night	NN	O
.	.	O

she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
pressure	NN	B-TREATMENT
support	NN	I-TREATMENT
,	,	O
which	WDT	O
improved	VBD	O
her	PRP	B-TEST
saturations	NNS	I-TEST
and	CC	O
decreased	VBD	O
her	PRP$	B-PROBLEM
hypercarbia	NN	I-PROBLEM
.	.	O

patient	NN	O
improved	VBD	O
that	IN	O
her	PRP$	B-TEST
mental	JJ	I-TEST
status	NN	I-TEST
with	IN	O
improvement	NN	O
of	IN	O
her	PRP$	B-TEST
oxygenation	NN	I-TEST
and	CC	O
ventilation	NN	O
as	RB	O
well	RB	O
as	IN	O
for	IN	O
correction	NN	O
of	IN	O
her	PRP$	B-PROBLEM
respiratory	JJ	I-PROBLEM
acidosis	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
eventually	RB	O
placed	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
on	IN	O
hospital	NN	O
day	NN	O
three	CD	O
,	,	O
on	IN	O
the	DT	O
date	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
of	IN	O
bipap	JJ	B-TREATMENT
settings	NNS	O
of	IN	O
12/8/5	CD	B-TREATMENT
liters	NNS	I-TREATMENT
of	IN	I-TREATMENT
oxygen	NN	I-TREATMENT
with	IN	O
saturations	NNS	B-TEST
of	IN	O
96%	CD	O
with	IN	O
a	DT	B-TEST
gas	NN	I-TEST
of	IN	O
7.38	CD	O
,	,	O
67	CD	O
,	,	O
and	CC	O
91	CD	O
with	IN	O
an	DT	O
aim	NN	O
of	IN	O
a	DT	O
goal	NN	O
pco2	NN	B-TEST
of	IN	O
67	CD	O
.	.	O

she	PRP	O
only	RB	O
had	VBD	O
one	CD	O
episode	NN	O
of	IN	O
apnea	NN	B-PROBLEM
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

2.	CD	O
delta	JJ	B-PROBLEM
ms/mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
issues	NNS	I-PROBLEM
:	:	O

most	RBS	O
likely	JJ	O
her	PRP$	B-PROBLEM
waxing	NN	I-PROBLEM
and	CC	I-PROBLEM
waning	VBG	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
hypercarbia/hypoxia	NN	B-PROBLEM
compounded	VBN	O
by	IN	O
infection	NN	B-PROBLEM
of	IN	I-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
uti	NN	B-PROBLEM
.	.	O

with	IN	O
improvements	NNS	O
of	IN	O
her	PRP$	B-TEST
ventilation	NN	I-TEST
and	CC	O
oxygenation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
with	IN	O
levofloxacin	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
uti	JJ	I-PROBLEM
and	CC	O
pneumonia	NN	B-PROBLEM
,	,	O
her	PRP$	O
mental	JJ	O
status	NN	O
greatly	RB	O
improved	VBN	O
on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
without	IN	O
further	JJ	B-PROBLEM
waxing	NN	I-PROBLEM
and	CC	I-PROBLEM
waning	NN	I-PROBLEM
.	.	O

b12	NN	B-TEST
,	,	O
folate	NN	B-TEST
,	,	O
rpr	NN	B-TEST
were	VBD	O
all	DT	O
sent	NN	O
that	WDT	O
were	VBD	O
unremarkable	JJ	O
as	IN	O
causes	NNS	O
for	IN	O
delta	JJ	B-PROBLEM
ms	NN	I-PROBLEM
.	.	O

we	PRP	O
are	VBP	O
awaiting	VBG	O
results	NNS	O
of	IN	O
the	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
from	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
but	CC	O
on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
.	.	O

those	DT	B-TEST
cultures	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
multivites	NNS	B-TREATMENT
.	.	O

3.	CD	O
fever	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
initially	RB	O
presented	VBN	O
with	IN	O
t	JJ	B-TEST
max	NN	I-TEST
of	IN	O
101.3	CD	O
at	IN	O
outside	JJ	O
hospital	NN	O
with	IN	O
increasing	VBG	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
counts	NNS	I-PROBLEM
and	CC	O
a	DT	O
positive	JJ	O
urinalysis	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
with	IN	O
bilateral	JJ	B-PROBLEM
patchy	NN	I-PROBLEM
infiltrates	NNS	I-PROBLEM
likely	JJ	O
pneumonia	NN	B-PROBLEM
and	CC	O
uti	NN	B-PROBLEM
.	.	O

upon	IN	O
calling	VBG	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
the	DT	O
urine	NN	O
was	VBD	O
growing	VBG	O
out	RP	O
klebsiella	NN	B-PROBLEM
,	,	O
and	CC	O
patient	NN	O
was	VBD	O
given	VBN	O
a	DT	O
10	CD	O
day	NN	O
course	NN	O
of	IN	O
levofloxacin	NN	B-TREATMENT
to	TO	O
cover	VB	O
both	DT	O
the	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
and	CC	O
uti	NN	B-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
and	CC	O
urine	JJ	B-TEST
cultures	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
at	IN	O
this	DT	O
hospital	NN	O
visit	NN	O
and	CC	O
the	DT	O
csf	NN	B-TEST
fluid	NN	I-TEST
from	IN	O
whitter	NN	O
rehabilitation	NN	O
hospital	NN	O
needs	NNS	O
to	TO	O
be	VB	O
further	RB	O
evaluated	VBN	O
.	.	O

patient	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
decreasing	VBG	I-PROBLEM
white	JJ	I-PROBLEM
count	NN	I-PROBLEM
x48	NN	O
hours	NNS	O
.	.	O

4.	CD	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
issues	NNS	I-PROBLEM
:	:	O

creatinine	NN	B-TEST
initially	RB	O
presented	VBD	O
at	IN	O
1.3	CD	O
.	.	O

patient	NN	O
is	VBZ	O
known	VBN	O
to	TO	O
have	VB	O
a	DT	O
baseline	NN	O
of	IN	O
1.0	CD	O
,	,	O
most	RBS	O
likely	JJ	O
hypovolemia	NN	B-PROBLEM
and	CC	O
prerenal	NN	O
.	.	O

a	DT	B-TEST
fena	NN	I-TEST
was	VBD	O
sent	VBN	O
,	,	O
was	VBD	O
0.3%	CD	O
.	.	O

patient	NN	O
was	VBD	O
gently	RB	O
hydrated	VBN	O
and	CC	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
started	VBD	O
up	RP	O
on	IN	O
a	DT	B-TREATMENT
p.o.	NN	I-TREATMENT
diet	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
,	,	O
her	PRP$	B-TEST
creatinine	NN	I-TEST
returned	VBN	O
to	TO	O
0.8	CD	O
,	,	O
and	CC	O
she	PRP	O
remained	VBD	O
with	IN	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
0.8	CD	O
for	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

patient's	NN	B-TEST
k	NN	I-TEST
was	VBD	O
followed	VBN	O
,	,	O
and	CC	O
trended	VBD	O
back	RB	O
down	RB	O
to	TO	O
normal	JJ	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
at	IN	O
3.9	CD	O
.	.	O

5.	CD	O
elevated	JJ	B-PROBLEM
transaminases	NNS	I-PROBLEM
:	:	O

patient	NN	O
had	VBD	O
no	DT	O
right	JJ	B-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

stewart	JJ	B-TEST
sign	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

a	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
that	IN	O
showed	VBD	O
no	DT	O
hepatic	JJ	B-PROBLEM
or	CC	I-PROBLEM
biliary	JJ	I-PROBLEM
pathology	NN	I-PROBLEM
likely	RB	O
due	JJ	O
to	TO	O
acute	VB	B-PROBLEM
phase	NN	I-PROBLEM
stress	NN	I-PROBLEM
changes	NNS	I-PROBLEM
given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
she	PRP	O
had	VBD	O
no	DT	O
clinical	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
need	NN	O
to	TO	O
followup	VB	O
these	DT	B-TEST
transaminases	NNS	I-TEST
.	.	O

6.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
history	NN	O
:	:	O

patient	NN	O
was	VBD	O
stable	JJ	O
without	IN	O
evidence	NN	O
of	IN	O
chf	NN	B-PROBLEM
on	IN	O
chest	JJ	B-TEST
x-ray	NN	I-TEST
.	.	O

followed	VBD	O
her	PRP	B-TEST
sats	NNS	I-TEST
likely	JJ	O
due	JJ	O
to	TO	O
obstructive-sleep	JJ	B-PROBLEM
apnea	NN	I-PROBLEM
and	CC	O
hypoventilation	NN	B-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
and	CC	O
.......-	JJ	O
receptor	NN	B-TREATMENT
blocker	NN	I-TREATMENT
on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
given	VBN	O
that	IN	O
her	PRP$	B-TEST
creatinine	NN	I-TEST
had	VBD	O
stabilized	VBN	O
.	.	O

patient	NN	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
cardiac	NN	I-PROBLEM
issues	NNS	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
on	IN	O
telemetry	NN	B-TEST
without	IN	O
any	DT	O
episodes	NNS	O
of	IN	O
any	DT	B-PROBLEM
rhythm	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
some	DT	B-PROBLEM
vaginal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
x2	JJ	O
days	NNS	O
.	.	O

patient	NN	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
fibroids	NNS	B-PROBLEM
during	IN	O
this	DT	O
hospitalization	NN	O
.	.	O

followed	VBD	O
her	PRP$	B-TEST
examination	NN	I-TEST
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
throughout	IN	O
this	DT	O
course	NN	O
.	.	O

patient	NN	O
is	VBZ	O
strongly	RB	O
encouraged	VBN	O
to	TO	O
followup	VB	O
with	IN	O
her	PRP	O
outside	JJ	O
primary	JJ	O
care	NN	O
provider	NN	O
to	TO	O
followup	VB	O
for	IN	O
the	DT	B-PROBLEM
vaginal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
given	VBN	O
her	PRP$	O
history	NN	O
of	IN	O
fibroids	NNS	B-PROBLEM
and	CC	O
question	NN	O
metaplasia	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrium	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
nucleated	JJ	B-PROBLEM
rbcs	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
stress	VB	B-PROBLEM
and	CC	O
hypoxia	VB	B-PROBLEM
during	IN	O
this	DT	O
admission	NN	O
.	.	O

hemolysis	NN	B-TEST
laboratories	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
iron	NN	I-TREATMENT
supplementation	NN	I-TREATMENT
.	.	O

reticulocyte	NN	B-TEST
count	NN	I-TEST
was	VBD	O
performed	VBN	O
that	IN	O
was	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
was	VBD	O
npo	RB	B-TREATMENT
with	IN	O
a	DT	B-PROBLEM
decrease	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

we	PRP	O
slowly	RB	O
advanced	VBD	O
her	PRP	O
diet	NN	O
as	IN	O
her	PRP$	O
mental	JJ	O
status	NN	O
improved	VBN	O
and	CC	O
repleted	VBD	O
her	PRP$	B-TEST
electrolytes	NNS	I-TEST
,	,	O
and	CC	O
started	VBD	O
on	IN	O
her	PRP	B-TREATMENT
p.o.	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
on	IN	O
hospital	JJ	O
day	NN	O
two	CD	O
.	.	O

10.	CD	O
diabetes	NNS	B-PROBLEM
:	:	O

patient	NN	O
had	VBD	O
q.i.d.	JJ	O
fingersticks	NNS	B-TEST
with	IN	O
a	DT	B-TREATMENT
humalog	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
and	CC	O
nph	JJ	B-TREATMENT
doses	NNS	I-TREATMENT
were	VBD	O
cut	VBN	O
in	IN	O
half	NN	O
while	IN	O
she	PRP	O
was	VBD	O
npo	RB	B-TREATMENT
,	,	O
and	CC	O
they	PRP	O
were	VBD	O
brought	VBN	O
back	RB	O
to	TO	O
her	PRP$	B-TREATMENT
normal	JJ	I-TREATMENT
doses	NNS	I-TREATMENT
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
with	IN	O
a	DT	O
full	JJ	O
diet	NN	O
.	.	O

12.	CD	O
prophylaxis	NN	B-TREATMENT
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
subq	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
for	IN	O
dvt	NN	B-PROBLEM
and	CC	O
ranitidine	NN	B-TREATMENT
for	IN	O
gi	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
be	VB	O
discharged	VBN	O
today	NN	O
to	TO	O
lahey	VB	O
clinic	JJ	O
-	:	O
north	NN	O
shore	VBP	O
hospital	NN	O
for	IN	O
long-term	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
........	NN	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
further	JJ	O
evaluation	NN	B-TEST
of	IN	O
her	PRP$	B-PROBLEM
obstructive-sleep	JJ	I-PROBLEM
apnea	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
,	,	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
remained	VBD	O
stable	JJ	O
,	,	O
and	CC	O
her	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
were	VBD	O
well	RB	O
above	IN	O
90%	CD	O
during	IN	O
the	DT	O
daytime	NN	O
on	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
at	IN	O
night	NN	O
on	IN	O
the	DT	B-TREATMENT
bipap	NN	I-TREATMENT
settings	NNS	O

1.	CD	O
nph	JJ	B-TREATMENT
70	CD	O
units	NNS	O
q.a.m.	RB	O
,	,	O
50	CD	O
units	NNS	O
q.p.m.	RB	O

2.	CD	O
humalog	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

3.	CD	O
subq	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
5,000	CD	O
units	NNS	O
t.i.d.	VBP	O

4.	CD	O
ranitidine	NN	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5.	CD	O
multivitamin	NN	B-TREATMENT
x1	NN	O
.	.	O

6.	CD	O
losartan	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
iron	NN	B-TREATMENT
supplementation	NN	I-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
levofloxacin	JJ	B-TREATMENT
day	NN	O
four	CD	O
of	IN	O
10	CD	O
to	TO	O
be	VB	O
completed	VBN	O
for	IN	O
a	DT	O
full	JJ	O
10-day	JJ	O
course	NN	O
,	,	O
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
metoprolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

10.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

papillary	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

papillary	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
flexible	JJ	I-TEST
bronchoscopy	NN	I-TEST
and	CC	O
extrapleural-pleural	JJ	B-TREATMENT
lobectomy	NN	I-TREATMENT
on	IN	O
12-4-93	JJ	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
emphysema	NN	B-PROBLEM
who	WP	O
presents	VBZ	O
for	IN	O
admission	NN	O
with	IN	O
a	DT	O
diagnosis	NN	O
of	IN	O
broncho-alveolar	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
and	CC	O
is	VBZ	O
scheduled	VBN	O
for	IN	O
flexible	JJ	B-TEST
bronchoscopy	NN	I-TEST
,	,	O
mediastinoscopy	NN	B-TEST
and	CC	O
thoracotomy	NN	B-TREATMENT
with	IN	O
questionable	JJ	O
pneumonectomy	NN	B-TREATMENT
by	IN	O
dr.	VBG	O
an	DT	O
on	IN	O
12-4-93	NNS	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
native	NN	O
of	IN	O
nahuter	NN	O
with	IN	O
a	DT	O
70+	CD	O
pack	NN	O
year	NN	O
smoking	VBG	O
history	NN	O
(	(	O
2	CD	O
1/2-3	JJ	O
pack	NN	O
per	IN	O
day	NN	O
x	$	O
35	CD	O
years	NNS	O
)	)	O
whose	WP$	O
symptoms	NNS	O
began	VBD	O
last	JJ	O
12/92	CD	O
when	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
fever	NN	B-PROBLEM
.	.	O

in	IN	O
six	CD	O
months	NNS	O
,	,	O
he	PRP	O
was	VBD	O
hospitalized	VBN	O
for	IN	O
pneumonia	NN	B-PROBLEM
x	NNP	O
four	CD	O
.	.	O

he	PRP	O
has	VBZ	O
had	VBD	O
worsening	VBG	B-PROBLEM
dyspnea	NN	I-PROBLEM
and	CC	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
,	,	O
though	IN	O
denies	NNS	O
orthopnea	VBP	B-PROBLEM
.	.	O

no	DT	O
hemoptysis	NN	B-PROBLEM
,	,	O
no	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
sweats	NNS	B-PROBLEM
,	,	O
when	WRB	O
pneumonia	NN	B-PROBLEM
resolved	VBD	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
noticed	VBD	O
a	DT	B-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
weight	NN	I-PROBLEM
of	IN	O
approximately	RB	O
25	CD	O
pounds	NNS	O
over	IN	O
a	DT	O
few	JJ	O
months	NNS	O
with	IN	O
increased	JJ	B-PROBLEM
fatigue	NN	I-PROBLEM
and	CC	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
&quot;	JJ	I-PROBLEM
spot	NN	I-PROBLEM
&quot;	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
on	IN	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
noted	VBN	O
in	IN	O
october	NN	O
of	IN	O
1993	CD	O
,	,	O
after	IN	O
his	PRP$	B-PROBLEM
pneumonia	NN	I-PROBLEM
cleared	VBD	O
.	.	O

a	DT	B-TEST
follow	JJ	I-TEST
up	RP	I-TEST
chest	JJS	I-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
led	VBD	O
to	TO	O
a	DT	B-TEST
tissue	NN	I-TEST
biopsy	NN	I-TEST
via	IN	O
flexible	JJ	B-TEST
bronchoscopy	NN	I-TEST
in	IN	O
07/93	CD	O
.	.	O

tissue	NN	O
returned	VBN	O
well	RB	B-PROBLEM
differentiated	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

his	PRP$	O
appetite	NN	O
has	VBZ	O
been	VBN	O
good	JJ	O
and	CC	O
he	PRP	O
has	VBZ	O
only	RB	O
complained	VBN	O
of	IN	O
occasional	JJ	B-PROBLEM
sharp	JJ	I-PROBLEM
pain	NN	I-PROBLEM
under	IN	I-PROBLEM
his	PRP$	I-PROBLEM
rib	NN	I-PROBLEM
cage	NN	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
percodan	VB	B-TREATMENT
,	,	O
which	WDT	O
gives	VBZ	O
him	PRP	O
itchiness	NN	B-PROBLEM
.	.	O

triamcinolone	NN	B-TREATMENT
,	,	O
one	CD	O
tablet	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
dosage	NN	O
unknown	JJ	O
,	,	O
xanax	JJ	B-TREATMENT
one	CD	O
tablet	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
prn	JJ	O
anxiety	NN	B-PROBLEM
,	,	O
dosage	NN	O
unknown	JJ	O
,	,	O
ms	JJ	B-TREATMENT
contin	NN	I-TREATMENT
prn	NN	O
.	.	O

distant	JJ	B-PROBLEM
peptic	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
thumb	NN	B-PROBLEM
and	CC	I-PROBLEM
middle	JJ	I-PROBLEM
finger	NN	I-PROBLEM
lost	VBD	I-PROBLEM
secondary	JJ	O
to	TO	O
lawnmower	VB	O
accident	NN	O
at	IN	O
age	NN	O
five	CD	O
years	NNS	O
,	,	O
no	DT	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
partial	JJ	B-TREATMENT
gastrectomy	NN	I-TREATMENT
for	IN	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	O
1965	CD	O
.	.	O

the	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
anxiety	NN	B-PROBLEM
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
he	PRP	O
is	VBZ	O
a	DT	O
cachectic	JJ	O
white	JJ	O
male	NN	O
looking	VBG	O
older	JJR	O
than	IN	O
his	PRP$	O
stated	JJ	O
age	NN	O
,	,	O
who	WP	O
is	VBZ	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
neck	NN	O
showed	VBD	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
x	NN	I-PROBLEM
1	CD	I-PROBLEM
centimeter	NN	I-PROBLEM
submaxillary	JJ	I-PROBLEM
right	JJ	I-PROBLEM
lymph	NN	I-PROBLEM
node	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
otherwise	RB	O
supple	JJ	O
,	,	O
with	IN	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

his	PRP$	O
chest	NN	O
and	CC	O
axillae	NN	O
showed	VBD	O
no	DT	O
supraclavicular	NN	B-PROBLEM
or	CC	I-PROBLEM
axillary	JJ	I-PROBLEM
adenopathy	NN	I-PROBLEM
.	.	O

the	DT	O
lung	NN	O
sounds	NNS	O
were	VBD	O
rhonchorous	JJ	B-PROBLEM
,	,	O
otherwise	RB	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

cardiovascular	JJ	B-TEST
exam	NN	I-TEST
:	:	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
normal	JJ	O
sl	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

scaphoid	NN	O
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
no	DT	O
palpable	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
parasagittal	JJ	I-PROBLEM
scar	NN	I-PROBLEM
right	NN	O
of	IN	O
the	DT	O
midline	NN	O
.	.	O

pulses	NNS	B-TEST
were	VBD	O
2+	CD	O
and	CC	O
symmetrical	JJ	O
,	,	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

admission	NN	B-TEST
sodium	NN	I-TEST
of	IN	O
136	CD	O
,	,	O
potassium	NN	B-TEST
3.8	CD	O
,	,	O
chloride	RB	B-TEST
99	CD	O
,	,	O
bicarbonate	NN	B-TEST
27.3	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
13	CD	O
and	CC	O
0.6	CD	O
,	,	O
glucose	RB	B-TEST
86	CD	O
,	,	O
calcium	NN	B-TEST
9.3	CD	O
,	,	O
liver	JJR	B-TEST
function	NN	I-TEST
tests	NNS	I-TEST
notable	JJ	O
for	IN	O
an	DT	O
albumin	NN	B-TEST
of	IN	O
2.5	CD	O
,	,	O
globulin	NN	B-TEST
4.5	CD	O
.	.	O

the	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
14.5	CD	O
,	,	O
hematocrit	NN	B-TEST
31.0	CD	O
,	,	O
hemoglobin	VBD	B-TEST
10.3	CD	O
and	CC	O
platelet	VB	B-TEST
count	NN	I-TEST
478,000	CD	O
.	.	O

the	DT	B-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
on	IN	O
room	NN	O
air	NN	O
were	VBD	O
7.46/70/41	CD	O
.	.	O

the	DT	B-TEST
pulmonary	JJ	I-TEST
function	NN	I-TEST
tests	NNS	I-TEST
revealed	VBD	O
an	DT	B-TEST
fev1	NN	I-TEST
of	IN	O
1.51	CD	O
,	,	O
fvc	RB	B-TEST
2.72	CD	O
,	,	O
and	CC	O
fev1/fvc	JJ	B-TEST
ratio	NN	I-TEST
of	IN	O
56%	CD	O
.	.	O

dlco	NN	B-TEST
was	VBD	O
2	CD	O
,	,	O
or	CC	O
19%	CD	O
of	IN	O
predicted	VBN	O
.	.	O

a	DT	B-TEST
quantitative	JJ	I-TEST
v	NN	I-TEST
/	NNP	I-TEST
q	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
also	RB	O
done	VBN	O
preoperatively	RB	O
and	CC	O
pulmonary	JJ	O
consult	NN	O
was	VBD	O
obtained	VBN	O
preoperatively	RB	O
.	.	O

pulmonary	NN	O
recommended	VBD	O
that	IN	O
he	PRP	O
just	RB	O
be	VB	O
started	VBN	O
on	IN	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	NN	B-TREATMENT
metered	VBD	I-TREATMENT
dose	JJ	I-TREATMENT
inhalers	NNS	I-TREATMENT
,	,	O
2	CD	O
puffs	NNS	O
q6h	RB	O
,	,	O
prior	RB	O
to	TO	O
surgery	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
underwent	VBD	O
his	PRP$	B-TREATMENT
procedure	NN	I-TREATMENT
on	IN	O
12-4-93	JJ	O
,	,	O
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

findings	NNS	O
included	VBD	O
thickened	JJ	B-PROBLEM
pleura	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
adhesions	NNS	I-PROBLEM
and	CC	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
near	IN	I-PROBLEM
the	DT	I-PROBLEM
margin	NN	I-PROBLEM
major	JJ	I-PROBLEM
fissure	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
firm	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
oxygen	JJ	B-TEST
saturations	NNS	I-TEST
of	IN	O
99%	CD	O
with	IN	O
an	DT	B-TEST
fi02	NN	I-TEST
of	IN	O
40%	CD	O
and	CC	O
had	VBD	O
no	DT	O
complaints	NNS	O
.	.	O

his	PRP$	B-TEST
left	VBD	I-TEST
lower	JJR	I-TEST
lobe	NN	I-TEST
micro	NN	I-TEST
results	NNS	O
revealed	VBD	O
alpha	JJ	B-PROBLEM
hemolytic	JJ	I-PROBLEM
streptococcus	NN	I-PROBLEM
on	IN	O
culture	NN	B-TEST
and	CC	O
he	PRP	O
was	VBD	O
then	RB	O
switched	VBN	O
to	TO	O
penicillin	VB	B-TREATMENT
and	CC	O
gentamicin	VB	B-TREATMENT
after	IN	O
being	VBG	O
started	VBN	O
on	IN	O
triples	NNS	O
of	IN	O
flagyl	NN	B-TREATMENT
,	,	O
ampicillin	NN	B-TREATMENT
,	,	O
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
low	JJ	B-PROBLEM
grade	NN	I-PROBLEM
temperatures	NNS	I-PROBLEM
,	,	O
though	RB	O
did	VBD	O
not	RB	O
spike	VB	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
temperature	NN	I-PROBLEM
during	IN	O
his	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

his	PRP$	O
hospital	NN	O
course	NN	O
was	VBD	O
otherwise	RB	O
uneventful	JJ	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
,	,	O
afebrile	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
unchanged	JJ	O
from	IN	O
the	DT	O
previous	JJ	O
day	NN	O
,	,	O
with	IN	O
slight	JJ	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	I-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
completed	VBN	O
six	CD	O
days	NNS	O
of	IN	O
penicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
and	CC	O
was	VBD	O
discharged	VBN	O
on	IN	O
ciprofloxacin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
for	IN	O
the	DT	O
next	JJ	O
seven	CD	O
days	NNS	O
.	.	O

tylenol	RB	B-TREATMENT
#	#	I-TREATMENT
3	CD	I-TREATMENT
,	,	O
xanax	NNP	B-TREATMENT
,	,	O
ciprofloxacin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
gravida	NN	O
iii	NN	O
,	,	O
para	NN	O
ii	NN	O
,	,	O
who	WP	O
was	VBD	O
sent	VBN	O
from	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
's	POS	O
office	NN	O
secondary	NN	O
to	TO	O
lower	VB	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
uterine	JJ	B-TREATMENT
artery	NN	I-TREATMENT
embolization	NN	I-TREATMENT
on	IN	O
2009-01-07	JJ	O
secondary	JJ	O
to	TO	O
fibroids	NNS	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
continuing	VBG	B-PROBLEM
vaginal	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
bacterial	JJ	B-PROBLEM
vaginosis	NN	I-PROBLEM
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
and	CC	O
was	VBD	O
given	VBN	O
a	DT	O
prescription	NN	O
for	IN	O
flagyl	NN	B-TREATMENT
.	.	O

she	PRP	O
noted	VBD	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
which	WDT	O
became	VBD	O
more	RBR	O
severe	JJ	O
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

she	PRP	O
went	VBD	O
to	TO	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
's	POS	O
office	NN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
complaining	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
which	WDT	O
she	PRP	O
stated	VBD	O
was	VBD	O
constant	JJ	O
but	CC	O
intermittently	RB	O
sharper	JJR	O
at	IN	O
times	NNS	O
.	.	O

she	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
loose	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
no	DT	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
temperature	NN	I-TEST
was	VBD	O
100.4	CD	O
in	IN	O
the	DT	O
office	NN	O
,	,	O
and	CC	O
she	PRP	O
had	VBD	O
no	DT	O
chills	NNS	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
sent	VBN	O
for	IN	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
abdomen	NNS	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
fluid	NN	B-PROBLEM
and	CC	O
question	NN	O
of	IN	O
gas	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
sent	VBN	O
to	TO	O
pinewood	VB	O
,	,	O
norfolk	FW	O
for	IN	O
treatment	NN	B-TREATMENT
and	CC	O
admission	NN	B-TREATMENT
.	.	O

cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
x	VBD	O
2	CD	O
,	,	O
spontaneous	JJ	B-PROBLEM
abortion	NN	I-PROBLEM
x	VBD	O
1	CD	O
.	.	O

some	DT	B-PROBLEM
spotting	NN	I-PROBLEM
on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
but	CC	O
not	RB	O
a	DT	O
normal	JJ	O
period	NN	O
.	.	O

lupron	NN	B-TREATMENT
x	NNP	O
three	CD	O
months	NNS	O
prior	RB	O
to	TO	O
embolization	NN	B-TREATMENT
.	.	O

fibroid	JJ	B-PROBLEM
uterus	NN	I-PROBLEM
status	NN	O
post	NN	O
embolization	NN	B-TREATMENT
on	IN	O
2009-01-07	JJ	O
.	.	O

dilatation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
x	VBP	O
1	CD	O
for	IN	O
sab	NN	B-PROBLEM
.	.	O

history	NN	O
of	IN	O
herpes	NNS	B-PROBLEM
simplex	JJ	I-PROBLEM
virus	NN	I-PROBLEM
,	,	O
last	JJ	O
outbreak	NN	O
in	IN	O
2000	CD	O
.	.	O

no	DT	O
history	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
pap	NN	I-PROBLEM
smears	NNS	I-PROBLEM
.	.	O

cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
x	VBD	O
2	CD	O
,	,	O
dilatation	NN	B-TREATMENT
and	CC	I-TREATMENT
curettage	NN	I-TREATMENT
x	NN	O
1	CD	O
,	,	O
neck	NN	B-TREATMENT
fusion	NN	I-TREATMENT
after	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
,	,	O
shoulder	NN	B-TREATMENT
surgery	NN	I-TREATMENT
after	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
.	.	O

flagyl	NN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
100.4	CD	O
,	,	O
pulse	RB	B-TEST
108	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
110/70	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
100%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
she	PRP	O
was	VBD	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
notable	JJ	O
for	IN	O
voluntary	JJ	B-PROBLEM
guarding	NN	I-PROBLEM
but	CC	O
no	DT	O
involuntary	JJ	B-PROBLEM
guarding	NN	I-PROBLEM
or	CC	O
rebound	NN	B-PROBLEM
,	,	O
mild	VB	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
greater	JJR	O
than	IN	O
left	VBD	O
lower	JJR	O
quadrant	NN	O
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
pelvic	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
some	DT	B-PROBLEM
brownish	JJ	I-PROBLEM
discharge	NN	I-PROBLEM
.	.	O

her	PRP$	O
uterus	NN	O
and	CC	O
adnexa	NN	O
were	VBD	O
difficult	JJ	O
to	TO	O
assess	VB	O
secondary	JJ	O
to	TO	O
voluntary	JJ	B-PROBLEM
tensing	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
49-year-old	JJ	O
gravida	NN	O
iii	NN	O
,	,	O
para	NN	O
ii	NN	O
,	,	O
status	NN	B-TREATMENT
post	NN	I-TREATMENT
uterine	JJ	I-TREATMENT
artery	NN	I-TREATMENT
embolization	NN	I-TREATMENT
on	IN	O
2009-01-07	JJ	O
due	JJ	O
to	TO	O
uterine	JJ	B-PROBLEM
fibroids	NNS	I-PROBLEM
,	,	O
with	IN	O
continued	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
ct	NN	B-TEST
scan	JJ	I-TEST
revealing	NN	O
fluid	NN	B-PROBLEM
and	CC	I-PROBLEM
gas	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
initial	JJ	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.3	CD	O
,	,	O
with	IN	O
a	DT	O
normal	JJ	O
differential	NN	O
.	.	O

her	PRP$	B-TEST
sedimentation	NN	I-TEST
rate	NN	I-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
at	IN	O
110	CD	O
.	.	O

her	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

she	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
her	PRP$	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
positive	JJ	B-PROBLEM
in	IN	O
the	DT	B-TEST
anaerobic	JJ	I-TEST
culture	NN	I-TEST
for	IN	O
gram-positive	JJ	B-PROBLEM
cocci	NN	I-PROBLEM
in	IN	I-PROBLEM
pairs	NNS	I-PROBLEM
and	CC	I-PROBLEM
clusters	NNS	I-PROBLEM
.	.	O

further	JJ	B-TEST
identification	NN	I-TEST
revealed	VBD	O
staphylococcus	JJ	B-PROBLEM
coag-negative	JJ	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
sensitive	JJ	O
to	TO	O
gentamicin	VB	B-TREATMENT
and	CC	O
clindamycin	VB	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
and	CC	O
was	VBD	O
afebrile	RB	B-PROBLEM
until	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
five	CD	O
,	,	O
when	WRB	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
temperature	NN	I-PROBLEM
spike	NN	I-PROBLEM
to	TO	O
102.3	CD	O
.	.	O

repeat	NN	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
were	VBD	O
sent	VBN	O
.	.	O

her	PRP$	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
12.8	CD	O
,	,	O
with	IN	O
a	DT	O
normal	JJ	O
differential	NN	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
an	DT	O
infectious	JJ	O
disease	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
,	,	O
and	CC	O
the	DT	O
recommendation	NN	O
was	VBD	O
to	TO	O
discontinue	VB	O
the	DT	B-TREATMENT
ampicillin	NN	I-TREATMENT
,	,	O
gentamicin	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
,	,	O
and	CC	O
start	VB	O
her	PRP$	O
on	IN	O
intravenous	JJ	B-TREATMENT
unasyn	NN	I-TREATMENT
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TEST
pelvic	JJ	I-TEST
ultrasound	NN	I-TEST
and	CC	O
an	DT	B-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NN	I-TEST
ct	NN	I-TEST
,	,	O
which	WDT	O
revealed	VBD	O
continued	VBD	B-PROBLEM
air	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
endometrial	JJ	I-PROBLEM
cavity	NN	I-PROBLEM
vs.	NN	O
in	IN	O
the	DT	B-PROBLEM
fundal	JJ	I-PROBLEM
fibroid	NN	I-PROBLEM
.	.	O

discussion	NN	O
was	VBD	O
had	VBN	O
at	IN	O
this	DT	O
time	NN	O
with	IN	O
the	DT	O
patient	NN	O
regarding	VBG	O
whether	IN	O
or	CC	O
not	RB	O
this	DT	O
represented	VBD	O
an	DT	B-PROBLEM
infected	JJ	I-PROBLEM
abscess	NN	I-PROBLEM
vs.	IN	O
post-surgical	JJ	B-PROBLEM
change	NN	I-PROBLEM
.	.	O

possible	JJ	O
drainage	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
abscess	NN	I-PROBLEM
vs.	FW	O
hysterectomy	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
requested	VBD	O
an	DT	O
outside	JJ	O
second	JJ	O
opinion	NN	O
,	,	O
as	IN	O
she	PRP	O
was	VBD	O
reluctant	JJ	O
to	TO	O
undergo	VB	O
hysterectomy	NN	B-TREATMENT
at	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
eight	CD	O
,	,	O
on	IN	O
oral	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
to	TO	O
have	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
in	IN	O
one	CD	O
week	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
to	TO	O
obtain	VB	O
a	DT	O
second	JJ	O
opinion	NN	O
regarding	VBG	O
the	DT	O
question	NN	O
of	IN	O
possible	JJ	O
surgical	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

post-infarction	NN	B-PROBLEM
unstable	JJ	I-PROBLEM
angina	JJ	I-PROBLEM
pectoris	NN	I-PROBLEM
.	.	O

post-infarction	NN	B-PROBLEM
unstable	JJ	I-PROBLEM
angina	JJ	I-PROBLEM
pectoris	NN	I-PROBLEM
.	.	O

inferior	JJ	B-PROBLEM
wall	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
ventricular	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
arrest	NN	I-PROBLEM
,	,	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
psychosis	NN	B-PROBLEM
.	.	O

3-27-93	JJ	O
,	,	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
coronary	JJ	B-TEST
and	CC	I-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
angiography	NN	I-TEST
;	:	O
4-2-93	JJ	O
,	,	O
exercise	JJ	B-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	I-TEST
thallium	NN	I-TEST
.	.	O

vasotec	JJ	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
isordil	JJ	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
,	,	O
ticlopidine	VB	B-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
metoprolol	FW	B-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
ciprofloxacin	VBP	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
q12h	NN	O
x	NNP	O
seven	CD	O
days	NNS	O
,	,	O
nitroglycerin	JJ	B-TREATMENT
0.3	CD	O
mg	NN	O
sublingually	RB	O
prn	JJ	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
73	CD	O
year	NN	O
old	JJ	O
female	NN	O
who	WP	O
was	VBD	O
transferred	VBN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
after	IN	O
ventricular	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
arrest	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
3-16-93	JJ	O
to	TO	O
diy	VB	O
hospital	NN	O
for	IN	O
an	DT	B-PROBLEM
e.	JJ	I-PROBLEM
coli	NNS	I-PROBLEM
urinary	JJ	I-PROBLEM
tract	JJ	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
readmitted	VBN	O
on	IN	O
3-20-93	JJ	O
because	IN	O
of	IN	O
fever	NN	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
and	CC	O
a	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
ventricular	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
arrest	NN	I-PROBLEM
,	,	O
successfully	RB	O
cardioverted	VBN	O
back	RB	O
to	TO	O
rapid	VB	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
finally	RB	O
to	TO	O
sinus	VB	O
rhythm	NN	O
,	,	O
where	WRB	O
an	DT	B-TEST
electrocardiogram	NN	I-TEST
then	RB	O
showed	VBD	O
st	JJ	B-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
inferior	JJ	I-PROBLEM
leads	NNS	I-PROBLEM
.	.	O

peak	NN	B-TEST
cpk	NN	I-TEST
was	VBD	O
2494	CD	O
with	IN	O
18%	CD	B-TEST
mb	NN	I-TEST
's	POS	I-TEST
.	.	O

she	PRP	O
required	VBD	O
intubation	NN	B-TREATMENT
for	IN	O
mild	NN	B-PROBLEM
to	TO	I-PROBLEM
moderate	VB	I-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
treated	VBN	O
with	IN	O
diuretics	NNS	B-TREATMENT
,	,	O
intravenous	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
and	CC	O
heparin	NN	B-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
post-infarction	NN	B-PROBLEM
angina	NN	I-PROBLEM
,	,	O
was	VBD	O
transferred	VBN	O
here	RB	O
for	IN	O
angiography	NN	B-TEST
and	CC	O
possible	JJ	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
is	VBZ	O
130/80	CD	O
,	,	O
pulse	RB	B-TEST
74	CD	O
and	CC	O
regular	JJ	O
,	,	O
respirations	NNS	B-TEST
14	CD	O
.	.	O

her	PRP$	O
chest	NN	O
demonstrated	VBD	O
bibasilar	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
jugular	JJ	I-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
seven	CD	O
centimeters	NNS	O
,	,	O
carotid	JJ	B-TEST
upstroke	NN	I-TEST
normal	JJ	O
.	.	O

the	DT	B-TEST
heart	NN	I-TEST
exam	NN	I-TEST
revealed	VBD	O
a	DT	O
normal	JJ	O
sl	NN	O
and	CC	O
s2	NN	O
was	VBD	O
normally	RB	O
split	VBN	O
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
s4	NN	I-PROBLEM
,	,	O
no	DT	O
s3	NN	B-PROBLEM
,	,	O
grade	VBD	B-PROBLEM
ii/vi	JJ	I-PROBLEM
apical	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
in	IN	I-PROBLEM
systole	NN	I-PROBLEM
,	,	O
no	DT	O
rubs	NN	B-PROBLEM
.	.	O

no	DT	O
calf	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
or	CC	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

peripheral	JJ	B-TEST
pulses	NNS	I-TEST
were	VBD	O
2+	CD	O
and	CC	O
symmetrical	JJ	O
bilaterally	RB	O
.	.	O

on	IN	O
3-27-93	JJ	O
,	,	O
patient	JJ	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
,	,	O
coronary	JJ	B-TEST
and	CC	I-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
angiography	NN	I-TEST
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

review	NN	O
of	IN	O
these	DT	B-TEST
angiograms	NNS	I-TEST
demonstrated	VBD	O
a	DT	O
dominant	JJ	O
right	JJ	O
coronary	JJ	O
artery	NN	O
with	IN	O
a	DT	B-PROBLEM
focal	JJ	I-PROBLEM
50%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid-portion	NN	I-PROBLEM
.	.	O

the	DT	O
left	JJ	O
anterior	JJ	O
descending	NN	O
had	VBD	O
moderate	JJ	B-PROBLEM
plaques	NNS	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
50%	CD	I-PROBLEM
proximal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
anterior	NN	I-PROBLEM
oblique	JJ	I-PROBLEM
caudal	JJ	I-PROBLEM
view	NN	O
.	.	O

the	DT	O
proximal	JJ	O
diagonal	JJ	O
d1	NN	O
had	VBD	O
a	DT	B-PROBLEM
50%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

the	DT	O
circumflex	NN	O
had	VBD	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
30%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
proximally	RB	O
and	CC	O
an	DT	B-PROBLEM
80%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
at	IN	O
the	DT	O
origin	NN	O
of	IN	O
the	DT	O
second	JJ	O
major	JJ	O
marginal	JJ	O
artery	NN	O
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
angiogram	NN	I-TEST
showed	VBD	O
akinesis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
posterobasal	NN	I-PROBLEM
walls	NNS	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
diaphragmatic	JJ	I-PROBLEM
wall	NN	I-PROBLEM
and	CC	O
trace	NN	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
heparin	JJ	B-TREATMENT
anticoagulation	NN	I-TREATMENT
.	.	O

an	DT	B-TEST
exercise	NN	I-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	I-TEST
thallium	NN	I-TEST
was	VBD	O
to	TO	O
be	VB	O
performed	VBN	O
in	IN	O
order	NN	O
to	TO	O
assess	VB	O
myocardial	JJ	O
viability	NN	O
in	IN	O
the	DT	B-PROBLEM
infarct	NN	I-PROBLEM
zone	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
lesion	NN	I-PROBLEM
was	VBD	O
complex	JJ	O
and	CC	O
there	EX	O
was	VBD	O
severe	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
obtuse	NN	I-PROBLEM
marginal	JJ	I-PROBLEM
1	CD	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
angina	NN	I-PROBLEM
.	.	O

on	IN	O
4-2-93	JJ	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
persantine	NN	I-TEST
thallium	NN	I-TEST
study	NN	I-TEST
.	.	O

this	DT	O
showed	VBD	O
no	DT	O
diagnostic	JJ	B-PROBLEM
electrocardiogram	NN	I-PROBLEM
changes	NNS	I-PROBLEM
for	IN	O
ischemia	NN	B-PROBLEM
and	CC	O
no	DT	O
angina	JJ	B-PROBLEM
pectoris	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
thallium	NN	I-TEST
images	VBZ	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
region	NN	I-PROBLEM
of	IN	I-PROBLEM
persistently	RB	I-PROBLEM
reduced	VBN	I-PROBLEM
blood	NN	I-PROBLEM
flow	NN	I-PROBLEM
involving	VBG	O
the	DT	O
apex	NN	O
and	CC	O
inferoposterior	JJ	O
segments	NNS	O
of	IN	O
the	DT	O
left	NN	O
ventricular	NN	O
wall	NN	O
.	.	O

this	DT	O
was	VBD	O
consistent	JJ	O
with	IN	O
scar	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
definite	JJ	B-PROBLEM
perfusion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
circumflex	JJ	I-PROBLEM
zone	NN	I-PROBLEM
.	.	O

large	JJ	B-PROBLEM
left	VBD	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stroke	VBD	I-PROBLEM
along	IN	O
with	IN	O
posterior	JJ	B-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
strokes	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
an	DT	O
86	CD	O
year	NN	O
old	JJ	O
woman	NN	O
who	WP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
history	NN	O
of	IN	O
atrial	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
who	WP	O
was	VBD	O
admitted	VBN	O
on	IN	O
2013-09-06	JJ	O
,	,	O
to	TO	O
the	DT	O
neurologic	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
service	NN	O
after	IN	O
collapsing	VBG	O
at	IN	O
home	NN	O
at	IN	O
8:30	CD	O
p.m	NN	O
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
right	RB	B-PROBLEM
sided	VBN	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
was	VBD	O
noted	VBN	O
by	IN	O
her	PRP$	O
husband	NN	O
to	TO	O
have	VB	O
vomited	VBN	O
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
comatose	RB	B-PROBLEM
at	IN	O
home	NN	O
by	IN	O
ems	NNS	O
and	CC	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

on	IN	O
arrival	NN	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
98.2	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
164/110	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
28	CD	O
,	,	O
and	CC	O
heart	NN	B-TEST
rate	NN	I-TEST
of	IN	O
74	CD	O
.	.	O

she	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
responsive	JJ	B-PROBLEM
only	RB	I-PROBLEM
to	TO	I-PROBLEM
painful	VB	I-PROBLEM
stimuli	NN	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
intubated	VBN	O
for	IN	O
airway	NN	B-TREATMENT
protection	NN	I-TREATMENT
and	CC	O
received	VBN	O
multiple	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
prior	RB	O
to	TO	O
her	PRP$	B-TEST
initial	JJ	I-TEST
neurologic	JJ	I-TEST
examination	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
cold	JJ	I-PROBLEM
distal	NN	I-PROBLEM
left	VBD	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
which	WDT	O
was	VBD	O
operated	VBN	O
on	IN	O
and	CC	O
she	PRP	O
is	VBZ	O
now	RB	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
brachial	JJ	I-TREATMENT
artery	NN	I-TREATMENT
embolectomy	NN	I-TREATMENT
.	.	O

throughout	IN	O
her	PRP$	O
course	NN	O
on	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
service	NN	O
,	,	O
she	PRP	O
has	VBZ	O
remained	VBN	O
unresponsive	JJ	B-PROBLEM
with	IN	O
imaging	VBG	B-TEST
studies	NNS	I-TEST
consistent	JJ	O
with	IN	O
a	DT	O
large	JJ	O
left	NN	O
middle	JJ	O
cerebral	JJ	O
artery	NN	O
and	CC	O
posterior	JJ	B-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
distribution	NN	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
and	CC	O
midline	NN	B-PROBLEM
shift	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
evidence	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
occipital	NN	I-PROBLEM
and	CC	I-PROBLEM
cerebellar	JJ	I-PROBLEM
infarctions	NNS	I-PROBLEM
as	IN	O
well	RB	O
.	.	O

discussion	NN	O
with	IN	O
the	DT	O
patient	NN	O
's	POS	O
family	NN	O
by	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
service	NN	O
has	VBZ	O
resulted	VBN	O
in	IN	O
focusing	VBG	O
on	IN	O
her	PRP$	B-TREATMENT
comfort	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

based	VBN	O
on	IN	O
this	DT	O
,	,	O
she	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
the	DT	O
neurology	NN	O
service	NN	O
for	IN	O
focus	NN	O
on	IN	O
comfort	NN	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

1.	CD	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
lumpectomy	NN	B-TREATMENT
.	.	O

2.	CD	O
mitral	JJ	B-TREATMENT
commissurectomy	NN	I-TREATMENT
.	.	O

3.	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
.	.	O

4.	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

5.	CD	O
arterial	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
,	,	I-PROBLEM
left	VBD	I-PROBLEM
femoral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

6.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

1.	CD	O
lopressor	NN	B-TREATMENT
intravenous	JJ	I-TREATMENT
q	NN	O
6	CD	O
hours	NNS	O
.	.	O

2.	CD	O
morphine	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
1	CD	O
mg	NN	O
intravenous	JJ	O
p.r.n.	NN	O

penicillin	NN	B-TREATMENT
,	,	O
sulfa	NN	B-TREATMENT
and	CC	O
quinidine	NN	B-TREATMENT
.	.	O

on	IN	O
the	DT	O
date	NN	O
of	IN	O
transfer	NN	O
,	,	O
temperature	NN	B-TEST
98.5	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
and	CC	O
irregular	JJ	B-PROBLEM
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
140/60	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
100%	CD	O
in	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
minimally	RB	B-PROBLEM
responsive	JJ	I-PROBLEM
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

head	NN	O
and	CC	O
neck	NN	O
-	:	O
normocephalic	NN	O
,	,	O
supple	NN	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

cardiovascular	JJ	O
-	:	O
irregular	JJ	B-PROBLEM
rhythm	NN	I-PROBLEM
,	,	O
normal	JJ	O
rate	NN	O
.	.	O

pulmonary	JJ	O
-	:	O
good	JJ	O
air	NN	O
movement	NN	O
,	,	O
but	CC	O
occasional	JJ	B-PROBLEM
rhonchi	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
reveals	NNS	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

extremities	NNS	O
-	:	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

neurologic	JJ	O
-	:	O
the	DT	O
patient	NN	O
is	VBZ	O
unresponsive	JJ	B-PROBLEM
to	TO	O
verbal	VB	B-TEST
stimuli	NN	I-TEST
,	,	O
withdrawals	VBZ	O
the	DT	O
left	JJ	O
extremities	NNS	O
to	TO	O
noxious	JJ	B-TEST
stimulation	NN	I-TEST
.	.	O

there	EX	O
is	VBZ	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
gaze	NN	I-PROBLEM
preference	NN	I-PROBLEM
.	.	O

the	DT	O
fundi	NN	O
belmont	NN	O
difficult	JJ	O
to	TO	O
visualize	VB	O
but	CC	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
papilledema	NN	B-PROBLEM
.	.	O

reflexes	NNS	B-TEST
are	VBP	O
down	RB	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.5	CD	O
,	,	O
hematocrit	NN	B-TEST
31.0	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
290,000	CD	O
.	.	O

inr	RB	B-TEST
3.0	CD	O
.	.	O

potassium	NN	B-TEST
was	VBD	O
3.0	CD	O
,	,	O
glucose	VBD	B-TEST
131	CD	O
.	.	O

mr	NN	B-TEST
studies	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
left	NN	I-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
smaller	JJR	I-PROBLEM
posterior	JJ	I-PROBLEM
circulation	NN	I-PROBLEM
infarctions	NNS	I-PROBLEM
.	.	O

briefly	NN	O
,	,	O
she	PRP	O
is	VBZ	O
an	DT	O
86	CD	O
year	NN	O
old	JJ	O
woman	NN	O
who	WP	O
has	VBZ	O
suffered	VBN	O
multiple	JJ	B-PROBLEM
cardioembolic	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarctions	NNS	I-PROBLEM
in	IN	I-PROBLEM
multiple	JJ	I-PROBLEM
arterial	JJ	I-PROBLEM
territories	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
remained	VBN	O
unresponsive	JJ	B-PROBLEM
throughout	IN	O
the	DT	O
hospitalization	NN	O
and	CC	O
currently	RB	O
only	RB	O
withdraws	VBZ	O
to	TO	O
pain	VB	B-PROBLEM
.	.	O

a	DT	B-TREATMENT
low	JJ	I-TREATMENT
dose	JJ	I-TREATMENT
morphine	NN	I-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
initiated	VBN	O
after	IN	O
further	RB	O
serious	JJ	O
discussion	NN	O
with	IN	O
her	PRP$	O
husband	NN	O
and	CC	O
nieces	NNS	O
and	CC	O
nephews	NNS	O
.	.	O

the	DT	O
family	NN	O
did	VBD	O
not	RB	O
want	VB	O
postmortem	NN	B-TEST
examination	NN	I-TEST
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

non-insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
and	CC	O
history	NN	O
of	IN	O
etoh	NN	O
abuse	NN	O
.	.	O

september	NN	O
11	CD	O
,	,	O
1994	CD	O
,	,	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
,	,	O
metoprolol	FW	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
baby	NN	B-TREATMENT
aspirin	VBD	I-TREATMENT
80	CD	O
mg	NN	O
po	NN	O
q.day	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
anticoagulation	NN	O
clinic	NN	O
for	IN	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
level	NN	I-TEST
evaluations	NNS	I-TEST
and	CC	O
appropriate	JJ	B-TREATMENT
coumadin	NN	I-TREATMENT
doses	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
66	CD	O
year	NN	O
old	JJ	O
portuguese	JJ	O
speaking	VBG	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
and	CC	O
history	NN	O
of	IN	O
tobacco	NN	O
use	NN	O
,	,	O
who	WP	O
is	VBZ	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
september	NN	O
of	IN	O
1993	CD	O
and	CC	O
february	NN	O
of	IN	O
1993	CD	O
,	,	O
who	WP	O
presented	VBD	O
with	IN	O
new	JJ	O
onset	NN	O
of	IN	O
left	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
arm	NN	B-PROBLEM
pain	NN	I-PROBLEM
for	IN	O
two	CD	O
days	NNS	O
.	.	O

apparently	RB	O
,	,	O
patient	NN	O
was	VBD	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
he	PRP	O
noted	VBD	O
new	JJ	O
onset	NN	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
arm	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
confined	VBN	O
to	TO	O
his	PRP$	O
left	JJ	O
side	NN	O
.	.	O

the	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
considered	VBN	O
mild	JJ	O
but	CC	O
persistent	JJ	O
with	IN	O
episodes	NNS	O
lasting	VBG	O
twenty	NN	O
minutes	NNS	O
.	.	O

he	PRP	O
came	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
july	NN	O
22	CD	O
,	,	O
1994	CD	O
,	,	O
relieved	VBN	O
with	IN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
.	.	O

no	DT	O
history	NN	O
of	IN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	NN	B-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

denies	NNS	O
fevers	NNS	B-PROBLEM
,	,	O
pleuritic	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
cough	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
pseudonormalization	NN	B-PROBLEM
of	IN	I-PROBLEM
t	NN	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	O
v1	NN	O
through	IN	O
v6	NN	O
and	CC	O
q	NN	B-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	O
v3	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
past	IN	O
cardiac	JJ	O
history	NN	O
is	VBZ	O
significant	JJ	O
for	IN	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
september	NN	O
of	IN	O
1993	CD	O
and	CC	O
a	DT	B-PROBLEM
non-q	JJ	I-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
february	NN	O
of	IN	O
1993	CD	O
.	.	O

the	DT	O
patient	NN	O
in	IN	O
september	NN	O
of	IN	O
1993	CD	O
had	VBD	O
3-4	JJ	B-PROBLEM
millimeter	NN	I-PROBLEM
st	NN	I-PROBLEM
segment	NN	I-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	O
v4	NN	O
and	CC	O
depression	NN	B-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
avf	NN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
,	,	O
patient	NN	O
had	VBD	O
bright	VBN	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	FW	I-PROBLEM
rectum	NN	I-PROBLEM
as	IN	O
well	RB	O
and	CC	O
patient	JJ	O
had	VBD	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
which	WDT	O
showed	VBD	O
95%	CD	O
left	VBD	O
anterior	JJ	O
descending	NN	O
,	,	O
which	WDT	O
was	VBD	O
percutaneous	JJ	O
transluminal	JJ	O
coronary	NN	O
angioplastied	VBD	O
and	CC	O
had	VBD	O
intra-aortic	JJ	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
cpk	NN	I-TEST
of	IN	O
over	IN	O
5000	CD	O
with	IN	O
mb	JJ	B-TEST
fraction	NN	I-TEST
of	IN	O
26.7	CD	O
.	.	O

the	DT	B-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
44%	CD	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
with	IN	O
anterior	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
and	CC	O
septal	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
positive	JJ	I-PROBLEM
exercise	NN	I-PROBLEM
tolerance	NN	I-PROBLEM
test	NN	I-PROBLEM
with	IN	O
thallium	NN	O
and	CC	O
repeat	NN	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
showed	VBD	O
left	JJ	O
anterior	JJ	O
descending	VBG	O
being	VBG	O
patent	NN	O
and	CC	O
distal	JJ	B-PROBLEM
posterior	NN	I-PROBLEM
descending	VBG	I-PROBLEM
artery	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
circumflex	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
after	IN	I-PROBLEM
the	DT	I-PROBLEM
obtuse	NN	I-PROBLEM
marginal	JJ	I-PROBLEM
1	CD	I-PROBLEM
.	.	O

in	IN	O
february	NN	O
of	IN	O
1993	CD	O
,	,	O
patient	NN	O
again	RB	O
presented	VBN	O
with	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
ruled	VBN	O
in	IN	O
for	IN	O
a	DT	B-PROBLEM
non-q	JJ	I-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
cpk	JJ	B-TEST
peak	NN	I-TEST
of	IN	O
219	CD	O
and	CC	O
mb	NN	B-TEST
of	IN	O
20.9	CD	O
.	.	O

repeat	NN	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
showed	VBD	O
re-stenosis	NN	B-PROBLEM
of	IN	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	NN	I-PROBLEM
that	WDT	O
had	VBD	O
been	VBN	O
percutaneous	JJ	O
transluminal	JJ	O
coronary	NN	O
angioplastied	VBD	O
and	CC	O
a	DT	B-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
first	JJ	I-PROBLEM
obtuse	NN	I-PROBLEM
marginal	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
moderate	JJ	I-PROBLEM
to	TO	I-PROBLEM
severe	VB	I-PROBLEM
left	VBN	I-PROBLEM
circumflex	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
after	IN	O
the	DT	O
third	JJ	O
obtuse	IN	O
marginal	JJ	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
an	DT	B-PROBLEM
akinetic	JJ	I-PROBLEM
anterolateral	NN	I-PROBLEM
and	CC	I-PROBLEM
apical	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

again	RB	O
,	,	O
patient	JJ	O
&apos;s	NN	O
cardiac	JJ	O
risk	NN	O
factors	NNS	O
include	VBP	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
increasing	VBG	B-PROBLEM
cholesterol	NN	I-PROBLEM
and	CC	O
a	DT	O
positive	JJ	O
family	NN	O
history	NN	O
and	CC	O
tobacco	NN	O
use	NN	O
.	.	O

in	IN	O
the	DT	O
past	JJ	O
,	,	O
patient	NN	O
had	VBD	O
been	VBN	O
noted	VBN	O
to	TO	O
be	VB	O
non-compliant	JJ	B-PROBLEM
with	IN	O
cardiac	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
continues	VBZ	O
to	TO	O
smoke	VB	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
non-insulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
diet-controlled	JJ	O
,	,	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarctions	NNS	I-PROBLEM
x	VBP	O
two	CD	O
as	IN	O
mentioned	VBN	O
above	IN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
.	.	O

lower	JJR	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
in	IN	O
february	NN	O
of	IN	O
1993	CD	O
which	WDT	O
was	VBD	O
not	RB	O
worked	VBN	O
up	RP	O
due	JJ	O
to	TO	O
patient	JJ	O
deferment	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
,	,	O
develops	VBZ	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

metoprolol	NN	B-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
isordil	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
ecotrin	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
q.day	NN	O
.	.	O

the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
revealed	VBD	O
him	PRP	O
to	TO	O
be	VB	O
afebrile	JJ	B-PROBLEM
,	,	O
blood	JJ	B-TEST
pressure	NN	I-TEST
of	IN	O
130/80	CD	O
with	IN	O
a	DT	B-TEST
pulse	JJ	I-TEST
rate	NN	I-TEST
of	IN	O
56	CD	O
and	CC	O
respirations	NNS	B-TEST
of	IN	O
24	CD	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
he	PRP	O
is	VBZ	O
a	DT	O
well	RB	O
developed	VBN	O
,	,	O
well	RB	O
nourished	JJ	O
man	NN	O
breathing	VBG	O
easily	RB	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

multiple	JJ	B-PROBLEM
stigmata	NN	I-PROBLEM
of	IN	O
burns	NNS	B-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

on	IN	O
head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
,	,	O
pupils	VBZ	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
fundus	NN	O
was	VBD	O
sharp	JJ	O
,	,	O
oral	JJ	O
mucosa	NN	O
was	VBD	O
clear	JJ	O
.	.	O

no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
at	IN	O
five	CD	O
centimeters	NNS	O
,	,	O
neck	NN	O
was	VBD	O
supple	JJ	O
,	,	O
full	JJ	O
range	NN	O
of	IN	O
movement	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
,	,	O
no	DT	O
adenopathy	NN	B-PROBLEM
.	.	O

lungs	NNS	O
had	VBD	O
bibasilar	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
1/4	CD	O
of	IN	O
the	DT	O
way	NN	O
up	IN	O
bilaterally	RB	O
,	,	O
otherwise	RB	O
clear	JJ	O
.	.	O

ii	NN	B-PROBLEM
/	NNP	I-PROBLEM
vi	VBZ	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
left	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
,	,	O
positive	JJ	O
s3	NN	B-PROBLEM
,	,	O
question	NN	O
of	IN	O
s4	NN	B-PROBLEM
,	,	O
otherwise	RB	O
point	NN	O
of	IN	O
maximal	JJ	B-TEST
impulse	NN	I-TEST
was	VBD	O
laterally	RB	B-PROBLEM
displaced	VBN	I-PROBLEM
.	.	O

surgical	JJ	B-PROBLEM
midline	NN	I-PROBLEM
incision	NN	I-PROBLEM
and	CC	O
previous	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
history	NN	O
of	IN	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
mildly	RB	B-PROBLEM
obese	JJ	I-PROBLEM
with	IN	O
liver	JJ	O
edge	NN	O
two	CD	O
centimeters	NNS	O
below	IN	O
the	DT	O
right	JJ	O
costal	NN	O
margin	NN	O
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
trace	JJ	B-PROBLEM
guaiac	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
pulses	NNS	B-TEST
distally	RB	I-TEST
,	,	O
1+	CD	B-TEST
femorals	NNS	I-TEST
,	,	O
1+	CD	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
otherwise	RB	O
nonfocal	JJ	O
with	IN	O
mentioned	JJ	O
left	VBD	O
upper	JJ	O
extremity	NN	O
3/5	CD	O
strength	NN	O
with	IN	O
pain	NN	B-PROBLEM
and	CC	O
5/5	CD	O
on	IN	O
the	DT	O
left	NN	O
lower	JJR	O
extremity	NN	O
.	.	O

admission	NN	B-TEST
hematocrit	NN	I-TEST
44	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
13	CD	O
and	CC	O
0.9	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
and	CC	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
which	WDT	O
showed	VBD	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
q	JJ	B-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	O
v6	NN	O
,	,	O
t	JJ	B-PROBLEM
wave	VBP	I-PROBLEM
pseudonormalization	NN	I-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	O
v6	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
rule	NN	O
out	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
ruled	VBD	O
in	IN	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
cpk	JJ	B-TEST
maximum	NN	O
on	IN	O
hospital	JJ	O
day	NN	O
number	NN	O
one	CD	O
peak	NN	B-TEST
of	IN	O
186	CD	O
and	CC	O
iso	NN	B-TEST
of	IN	O
23.8	CD	O
and	CC	O
index	NN	B-TEST
of	IN	O
12.8	CD	O
on	IN	O
september	NN	O
2	CD	O
,	,	O
1994	CD	O
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
the	DT	B-TREATMENT
appropriate	JJ	I-TREATMENT
protocol	NN	I-TREATMENT
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
,	,	O
aspirin	NN	B-TREATMENT
,	,	O
and	CC	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
for	IN	O
rate	NN	B-TREATMENT
and	CC	I-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
on	IN	O
the	DT	O
date	NN	O
of	IN	O
september	NN	O
5	CD	O
,	,	O
1994	CD	O
had	VBD	O
cardiac	VBN	B-TEST
catheterization	NN	I-TEST
which	WDT	O
showed	VBD	O
normal	JJ	O
resting	VBG	O
hemodynamics	NNS	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
small	JJ	O
non-dominant	JJ	O
right	JJ	O
coronary	NN	O
artery	NN	O
,	,	O
left	VBD	O
anterior	RP	O
descending	VBG	O
showed	VBD	O
severe	JJ	B-PROBLEM
proximal	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
with	IN	O
more	RBR	B-PROBLEM
distal	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
of	IN	I-PROBLEM
diagonal	JJ	I-PROBLEM
one	CD	I-PROBLEM
.	.	O

the	DT	O
left	NN	O
circumflex	NN	O
was	VBD	O
dominant	JJ	O
with	IN	O
severe	JJ	B-PROBLEM
disease	NN	I-PROBLEM
of	IN	I-PROBLEM
obtuse	IN	I-PROBLEM
marginal	JJ	I-PROBLEM
one	CD	I-PROBLEM
,	,	O
with	IN	O
moderate	JJ	B-PROBLEM
mid-circumflex	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
and	CC	O
moderate	JJ	B-PROBLEM
posterior	NN	I-PROBLEM
descending	VBG	I-PROBLEM
artery	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventriculography	NN	I-TEST
shows	VBZ	O
anterior	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
and	CC	O
apical	JJ	B-PROBLEM
severe	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
moderately	RB	I-PROBLEM
depressed	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
fraction	NN	I-PROBLEM
,	,	O
cardiac	JJ	B-TEST
output	NN	I-TEST
of	IN	O
3.9	CD	O
,	,	O
index	NN	B-TEST
of	IN	O
2.0	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
cardiac	JJ	O
surgery	NN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
stable	JJ	B-TEST
hematocrit	NN	I-TEST
of	IN	O
38%	CD	O
on	IN	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
carotid	NN	I-TEST
noninvasives	NNS	I-TEST
preoperatively	RB	O
were	VBD	O
negative	JJ	O
.	.	O

dental	JJ	B-TEST
consult	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

on	IN	O
the	DT	O
date	NN	O
of	IN	O
september	NN	O
11	CD	O
,	,	O
1994	CD	O
,	,	O
patient	JJ	O
underwent	NN	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
with	IN	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
posterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
artery	NN	I-TREATMENT
,	,	O
circumflex	NN	B-TREATMENT
and	CC	I-TREATMENT
diagonal	JJ	I-TREATMENT
and	CC	I-TREATMENT
left	VBD	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
left	VBN	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
bypass	NN	O
time	NN	O
of	IN	O
one	CD	O
hour	NN	O
and	CC	O
fifty	JJ	O
minutes	NNS	O
with	IN	O
good	JJ	O
urine	NN	O
output	NN	O
and	CC	O
pre-bypass	NN	B-TEST
cardiac	JJ	I-TEST
output	NN	I-TEST
of	IN	O
4.0	CD	O
,	,	O
post-chest	JJ	B-TEST
closure	NN	I-TEST
5.3	CD	O
,	,	O
arrived	VBN	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
on	IN	O
nipride	NN	B-TREATMENT
,	,	O
lidocaine	NN	B-TREATMENT
of	IN	O
1	CD	O
and	CC	O
fentanyl/	NNS	B-TREATMENT
versed	VBD	B-TREATMENT
of	IN	O
10	CD	O
.	.	O

the	DT	B-TEST
postoperative	JJ	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
26%	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
routine	JJ	O
postoperative	JJ	O
course	NN	O
in	IN	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
a	DT	B-TEST
postoperative	JJ	I-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
11	CD	O
and	CC	O
1.2	CD	O
with	IN	O
good	JJ	O
urine	JJ	O
output	NN	O
of	IN	O
over	IN	O
100	CD	O
an	DT	O
hour	NN	O
and	CC	O
patient	JJ	O
received	VBN	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
and	CC	O
platelets	NNS	B-TREATMENT
for	IN	O
increasing	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
tube	NN	I-PROBLEM
drainage	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
&apos;s	VBZ	O
only	RB	O
post-surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
was	VBD	O
remarkable	JJ	O
for	IN	O
hypertension	NN	B-PROBLEM
requiring	VBG	O
nipride	RB	B-TREATMENT
and	CC	O
bleeding	VBG	B-PROBLEM
which	WDT	O
was	VBD	O
controlled	VBN	O
with	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
,	,	O
platelets	NNS	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
stable	JJ	I-TEST
hematocrit	NN	I-TEST
of	IN	O
30%	CD	O
with	IN	O
cpk	NN	B-TEST
&apos;s	NNP	I-TEST
postoperatively	RB	O
maximum	JJ	B-TEST
mb	JJ	I-TEST
fraction	NN	I-TEST
of	IN	O
78	CD	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
,	,	O
patient	JJ	O
went	VBD	O
into	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
treated	VBN	O
appropriately	RB	O
with	IN	O
metoprolol	NN	B-TREATMENT
and	CC	O
digoxin	NN	B-TREATMENT
and	CC	O
converted	VBD	O
back	RB	O
to	TO	O
sinus	VB	O
rhythm	NN	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
need	VB	O
diuresis	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
postoperative	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
up	RP	O
on	IN	O
fih	NNS	O
were	VBD	O
coumadin	NNS	B-TREATMENT
,	,	O
baby	NN	B-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
isordil	JJ	B-TREATMENT
10	CD	O
po	NN	O
t.i.d.	NN	O
,	,	O
digoxin	NN	B-TREATMENT
.25	NN	O
q.day	NN	O
,	,	O
metoprolol	FW	B-TREATMENT
25	CD	O
po	NN	O
b.i.d.	NN	O
______________	NN	O

chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	O
wires	NNS	B-TREATMENT
were	VBD	O
all	DT	O
discontinued	VBN	O
according	VBG	O
to	TO	O
protocol	NN	B-TREATMENT
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
four	CD	O
.	.	O

the	DT	B-TREATMENT
isordil	NN	I-TREATMENT
was	VBD	O
also	RB	O
discontinued	VBN	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
incisions	NNS	I-PROBLEM
sternal	JJ	O
and	CC	O
right	JJ	O
leg	NN	O
were	VBD	O
clean	JJ	O
and	CC	O
healing	VBG	O
well	RB	O
,	,	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
70-80	JJ	O
,	,	O
with	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
98-110/60	CD	O
and	CC	O
patient	NN	O
was	VBD	O
doing	VBG	O
well	RB	O
,	,	O
recovering	VBG	O
,	,	O
ambulating	VBG	O
,	,	O
tolerating	VBG	O
regular	JJ	O
diet	NN	O
and	CC	O
last	JJ	B-TEST
hematocrit	NN	I-TEST
prior	RB	O
to	TO	O
discharge	VB	O
was	VBD	O
39%	CD	O
with	IN	O
a	DT	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
15	CD	O
and	CC	O
1.0	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
level	NN	I-TEST
of	IN	O
13.8	CD	O
,	,	O
chest	JJS	B-TEST
x-ray	JJ	I-TEST
prior	NN	O
to	TO	O
discharge	VB	O
showed	VB	O
small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
cardiomegaly	NNS	I-PROBLEM
and	CC	O
subsegmental	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
bibasilar	NN	I-PROBLEM
and	CC	O
electrocardiogram	NN	B-TEST
showed	VBD	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
left	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
enlargement	NN	I-PROBLEM
and	CC	O
no	DT	O
acute	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
on	IN	O
electrocardiogram	NN	B-TEST
.	.	O

patient	NN	O
needs	VBZ	O
anticoagulation	NN	B-TREATMENT
for	IN	O
large	JJ	B-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	O
prevent	VB	O
any	DT	O
possibility	NN	O
of	IN	O
thrombosis	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
32-year-old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
type	VBP	I-PROBLEM
1	CD	I-PROBLEM
and	CC	O
migraines	NNS	B-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
complaints	NNS	O
of	IN	O
nausea	NN	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
and	CC	O
vomiting	VBG	B-PROBLEM
for	IN	O
24	CD	O
hours	NNS	O
.	.	O

patient	NN	O
states	NNS	O
she	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
take	VB	O
her	PRP$	B-TREATMENT
usual	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
because	IN	O
she	PRP	O
was	VBD	O
vomiting	VBG	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
any	DT	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
or	CC	O
dysuria	NNS	B-PROBLEM
but	CC	O
does	VBZ	O
state	NN	O
she	PRP	O
had	VBD	O
her	PRP	B-PROBLEM
usual	JJ	I-PROBLEM
migraine	NN	I-PROBLEM
headache	NN	I-PROBLEM
the	DT	O
night	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
arterial	JJ	I-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
were	VBD	O
7.19	CD	O
,	,	O
22	CD	O
and	CC	O
109	CD	O
with	IN	O
a	DT	B-TEST
bicarbonate	NN	I-TEST
of	IN	O
9	CD	O
and	CC	O
a	DT	B-TEST
fingerstick	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
500	CD	O
.	.	O

patient	NN	O
was	VBD	O
given	VBN	O
two	CD	B-TREATMENT
boluses	NNS	I-TREATMENT
of	IN	I-TREATMENT
15	CD	I-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
of	IN	O
one	CD	O
unit	NN	O
per	IN	O
hour	NN	O
and	CC	O
given	VBN	O
a	DT	B-TREATMENT
total	NN	I-TREATMENT
of	IN	I-TREATMENT
five	CD	I-TREATMENT
liters	NNS	I-TREATMENT
of	IN	I-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
fingersticks	NNS	I-TEST
decreased	VBN	O
with	IN	O
the	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
an	DT	B-TREATMENT
insulin	NN	I-TREATMENT
drip	NN	I-TREATMENT
and	CC	O
frequent	JJ	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
monitoring	NN	I-TEST
and	CC	O
chem-7	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

her	PRP$	B-TEST
anion	NN	I-TEST
gap	NN	I-TEST
closed	VBD	O
and	CC	O
her	PRP$	B-TEST
fingersticks	NNS	I-TEST
were	VBD	O
less	JJR	O
than	IN	O
200	CD	O
.	.	O

her	PRP$	B-TREATMENT
nph	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
regular	JJ	I-TREATMENT
sliding	NN	I-TREATMENT
scale	NN	I-TREATMENT
were	VBD	O
started	VBN	O
and	CC	O
her	PRP$	B-TREATMENT
drip	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
any	DT	B-PROBLEM
more	RBR	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

includes	VBZ	O
diabetes	NNS	B-PROBLEM
,	,	O
diagnosed	VBN	O
at	IN	O
age	NN	O
14	CD	O
.	.	O

multiple	JJ	O
episodes	NNS	O
of	IN	O
diabetic	JJ	B-PROBLEM
ketoacidosis	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
,	,	O
migraine	NN	B-PROBLEM
headaches	NNS	I-PROBLEM
and	CC	O
attention	NN	B-PROBLEM
deficit	NN	I-PROBLEM
disorder	NN	I-PROBLEM
.	.	O

included	VBN	O
wellbutrin	NN	B-TREATMENT
,	,	O
imitrex	NN	B-TREATMENT
,	,	O
tylenol	NN	B-TREATMENT
,	,	O
humalog	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
and	CC	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
two	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
,	,	O
7	CD	O
units	NNS	O
at	IN	O
noon	NN	O
and	CC	O
13	CD	O
units	NNS	O
at	IN	O
bedtime	NN	O
.	.	O

patient	NN	O
has	VBZ	O
allergies	NNS	B-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
.	.	O

she	PRP	O
gets	VBZ	O
hives	NNS	B-PROBLEM
.	.	O

bactrim	NN	B-TREATMENT
,	,	O
she	PRP	O
gets	VBZ	O
hives	NNS	B-PROBLEM
.	.	O

percocet	NN	B-TREATMENT
and	CC	O
erythromycin	NN	B-TREATMENT
,	,	O
she	PRP	O
gets	VBZ	O
gastrointestinal	JJ	B-PROBLEM
upset	NN	I-PROBLEM
and	CC	O
keflex	VB	B-TREATMENT
she	PRP	O
gets	VBZ	O
hives	NNS	B-PROBLEM
.	.	O

patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
at	IN	O
eight	CD	O
months	NNS	O
.	.	O

hypertension	NN	B-PROBLEM
.	.	O

includes	VBZ	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
99.9	CD	O
.	.	O

pulse	NN	B-TEST
of	IN	O
94	CD	O
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
of	IN	O
138/49	CD	O
.	.	O

patient	NN	O
was	VBD	O
generally	RB	B-PROBLEM
ill-appearing	JJ	I-PROBLEM
and	CC	O
nauseated	JJ	B-PROBLEM
,	,	O
but	CC	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
.	.	O

neck	NN	O
supple	NN	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

chest	NN	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

neurological	JJ	B-TEST
exam	NN	I-TEST
:	:	O

cranial	JJ	B-TEST
nerves	NNS	I-TEST
ii	VBP	I-TEST
through	IN	I-TEST
xii	NNS	I-TEST
are	VBP	O
intact	JJ	O
,	,	O
nonfocal	JJ	O
,	,	O
moving	VBG	O
all	DT	O
extremities	NNS	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
22.8	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
42.1	CD	O
.	.	O

sodium	NN	B-TEST
of	IN	O
136	CD	O
,	,	O
chloride	RB	B-TEST
96	CD	O
,	,	O
bicarbonate	NN	B-TEST
8	CD	O
,	,	O
bun	NN	B-TEST
25	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
,	,	O
glucose	VBD	B-TEST
720	CD	O
.	.	O

arterial	JJ	B-TEST
blood	NN	I-TEST
gases	NNS	I-TEST
showed	VBD	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.19	CD	O
,	,	O
pco2	NN	B-TEST
of	IN	O
22	CD	O
and	CC	O
po2	NN	B-TEST
of	IN	O
102	CD	O
and	CC	O
a	DT	B-TEST
potassium	NN	I-TEST
of	IN	O
3.9	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
infiltrate	NN	B-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
was	VBD	O
normal	JJ	O
sinus	JJ	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
t	NN	I-PROBLEM
wave	NN	I-PROBLEM
inversion	NN	I-PROBLEM
in	IN	I-PROBLEM
v2	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
st	JJ	B-PROBLEM
segment	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
.	.	O

as	IN	O
above	NN	O
,	,	O
and	CC	O
once	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
,	,	O
patient	NN	O
had	VBD	O
fingersticks	NNS	B-TEST
monitored	VBN	O
every	DT	O
four	CD	O
hours	NNS	O
with	IN	O
a	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

patient	NN	O
reached	VBD	O
goal	NN	O
of	IN	O
fingersticks	NNS	B-TEST
between	IN	O
50	CD	O
and	CC	O
300	CD	O
,	,	O
which	WDT	O
is	VBZ	O
what	WP	O
she	PRP	O
maintains	VBZ	O
at	IN	O
home	NN	O
.	.	O

sliding	VBG	B-TREATMENT
scale	NN	I-TREATMENT
was	VBD	O
adjusted	VBN	O
as	IN	O
necessary	JJ	O
.	.	O

patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
until	IN	O
taking	VBG	O
good	JJ	O
po	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
white	JJ	I-PROBLEM
count	NN	I-PROBLEM
upon	IN	O
admission	NN	O
,	,	O
however	RB	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
came	VBD	O
down	RB	O
to	TO	O
7.1	CD	O
and	CC	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
patient	NN	O
was	VBD	O
afebrile	JJ	B-PROBLEM
and	CC	O
no	DT	O
clear	JJ	O
etiology	NN	O
for	IN	O
elevated	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
on	IN	O
admission	NN	O
,	,	O
questionably	RB	O
secondary	JJ	O
to	TO	O
short	JJ	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
however	RB	O
,	,	O
patient	NN	O
is	VBZ	O
completely	RB	O
symptom	JJ	O
free	JJ	O
upon	IN	O
discharge	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
electrolytes	NNS	I-TEST
were	VBD	O
repleted	VBN	O
as	IN	O
necessary	JJ	O
.	.	O

potassium	NN	B-TREATMENT
was	VBD	O
given	VBN	O
with	IN	O
her	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
phosphate	NN	B-TREATMENT
will	MD	O
be	VB	O
repleted	VBN	O
as	IN	O
patient	NN	O
increases	VBZ	O
her	PRP$	O
po	JJ	O
intake	NN	O
.	.	O

1.	CD	O
diabetic	JJ	B-PROBLEM
ketoacidosis	NN	I-PROBLEM
.	.	O

2.	CD	O
viral	JJ	B-PROBLEM
gastroenteritis	NN	I-PROBLEM
.	.	O

includes	VBZ	O
her	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
and	CC	O
her	PRP$	B-TREATMENT
nph	JJ	I-TREATMENT
fixed	JJ	O
scale	NN	O
of	IN	O
7	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
,	,	O
2	CD	O
units	NNS	O
at	IN	O
noon	NN	O
and	CC	O
13	CD	O
units	NNS	O
at	IN	O
bedtime	NN	O
.	.	O

patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
decrease	VB	O
her	PRP$	B-TREATMENT
evening	NN	I-TREATMENT
dose	NN	I-TREATMENT
if	IN	O
she	PRP	O
does	VBZ	O
not	RB	O
continue	VB	O
to	TO	O
take	VB	O
good	JJ	O
po	NN	O
.	.	O

patient	NN	O
will	MD	O
also	RB	O
continue	VB	O
on	IN	O
her	PRP	B-TREATMENT
wellbutrin	NN	I-TREATMENT
and	CC	O
imitrex	NN	B-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
migraines	NNS	B-PROBLEM
.	.	O

non-q	JJ	B-PROBLEM
wave	VBP	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

non-q	JJ	B-PROBLEM
wave	VBP	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
anterior	RB	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
05-93	NNP	O
,	,	O
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
left	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
in	IN	O
05-93	NNP	O
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

coronary	JJ	B-TREATMENT
angiography	NN	I-TREATMENT
,	,	O
exercise	NN	B-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	I-TEST
thallium	NN	I-TEST
.	.	O

metoprolol	NN	B-TREATMENT
50	CD	O
mg	NN	O
po	NN	O
bid	NN	O
,	,	O
isordil	VBP	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
tid	NN	O
,	,	O
enteric	RB	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	JJ	I-TREATMENT
1	CD	O
po	NN	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
65	CD	O
year	NN	O
old	JJ	O
portuguese	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
i	NN	O
may	MD	O
1993	CD	O
and	CC	O
is	VBZ	O
status	NN	O
post	NN	O
a	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
lad	NN	I-TREATMENT
who	WP	O
presented	VBD	O
on	IN	O
10-24-93	JJ	O
with	IN	O
crushing	VBG	B-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
prior	JJ	O
cardiac	JJ	O
history	NN	O
until	IN	O
may	MD	O
1993	CD	O
when	WRB	O
on	IN	O
5-24	NN	O
he	PRP	O
had	VBD	O
crushing	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
radiated	VBD	O
to	TO	O
his	PRP$	O
left	JJ	O
arm	NN	O
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
at	IN	O
that	DT	O
time	NN	O
to	TO	O
have	VB	O
3-4	JJ	B-PROBLEM
mm	NNS	I-PROBLEM
st	VBP	I-PROBLEM
segment	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	O
v4	NN	O
at	IN	O
pre	JJ	O
health	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
fairm	VB	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
and	CC	O
had	VBD	O
4-7	JJ	B-PROBLEM
mm	NNS	I-PROBLEM
st	VBP	I-PROBLEM
segment	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
across	IN	I-PROBLEM
the	DT	I-PROBLEM
precordium	NN	I-PROBLEM
with	IN	O
q&apos;s	NN	B-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
and	CC	I-PROBLEM
v2	NN	I-PROBLEM
,	,	O
2	CD	B-PROBLEM
mm	NN	I-PROBLEM
st	NN	I-PROBLEM
elevation	NN	I-PROBLEM
in	IN	I-PROBLEM
avl	NN	I-PROBLEM
,	,	O
and	CC	O
1-2	JJ	B-PROBLEM
mm	NN	I-PROBLEM
reciprocal	JJ	I-PROBLEM
st	NN	I-PROBLEM
depression	NN	I-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
f.	NN	I-PROBLEM

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
at	IN	O
that	DT	O
time	NN	O
he	PRP	O
had	VBD	O
bright	VBN	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
therefore	RB	O
lysis	NN	B-TREATMENT
was	VBD	O
deferred	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
taken	VBN	O
directly	RB	O
to	TO	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
lab	NN	O
.	.	O

the	DT	O
cardiac	JJ	O
catheterization	NN	O
results	NNS	O
at	IN	O
that	DT	O
time	NN	O
revealed	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
7	CD	O
,	,	O
pulmonary	JJ	B-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
29/16	CD	O
,	,	O
rv	NN	B-TEST
33/8	CD	O
,	,	O
pulmonary	JJ	B-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
16	CD	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
95%	CD	I-PROBLEM
proximal	NN	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
lesion	NN	I-PROBLEM
which	WDT	O
was	VBD	O
ptca	JJ	O
&apos;d	NN	O
to	TO	O
a	DT	O
residual	NN	O
of	IN	O
30%	CD	O
and	CC	O
an	DT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
mild	NNS	I-PROBLEM
to	TO	I-PROBLEM
moderate	VB	I-PROBLEM
disease	NN	I-PROBLEM
at	IN	O
the	DT	O
om1	NN	O
noted	VBD	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
care	NN	O
unit	NN	O
where	WRB	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
peak	JJ	I-TEST
cpk	NN	I-TEST
of	IN	O
5,042	CD	O
and	CC	O
26.7%	CD	O
mb&apos;s	NN	B-TEST
.	.	O

his	PRP$	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
without	IN	O
problems	NNS	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
hypotension	NN	B-PROBLEM
with	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
therefore	RB	O
they	PRP	O
were	VBD	O
not	RB	O
started	VBN	O
.	.	O

on	IN	O
day	NN	O
six	CD	O
,	,	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
44%	CD	O
with	IN	O
anterior	JJ	B-PROBLEM
akinesis	NN	I-PROBLEM
and	CC	O
septal	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

on	IN	O
day	NN	O
nine	CD	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
low	JJ	I-TEST
level	NN	I-TEST
exercise	NN	I-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	I-TEST
thallium	NN	I-TEST
which	WDT	O
was	VBD	O
positive	JJ	O
for	IN	O
2.5	CD	B-PROBLEM
mm	JJ	I-PROBLEM
horizontal	JJ	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
avf	NN	I-PROBLEM
,	,	O
and	CC	O
1.5	CD	B-PROBLEM
mm	NN	I-PROBLEM
downsloping	VBG	I-PROBLEM
st	JJ	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v5	NN	I-PROBLEM
and	CC	I-PROBLEM
v6	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
some	DT	B-PROBLEM
anteroseptal	JJ	I-PROBLEM
redistribution	NN	I-PROBLEM
on	IN	O
thallium	NN	B-TREATMENT
.	.	O

therefore	RB	O
,	,	O
he	PRP	O
went	VBD	O
to	TO	O
repeat	VB	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
that	IN	O
the	DT	O
left	JJ	O
anterior	JJ	O
descending	VBG	O
site	NN	O
was	VBD	O
patent	NN	O
and	CC	O
revealed	VBD	O
a	DT	B-PROBLEM
distal	JJ	I-PROBLEM
pda	NN	I-PROBLEM
lesion	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
circumflex	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
after	IN	O
the	DT	O
om	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
and	CC	O
is	VBZ	O
supposed	VBN	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
shuffburle	NN	O
of	IN	O
gastroenterology	NN	O
for	IN	O
work	NN	B-TEST
up	RB	I-TEST
of	IN	O
his	PRP$	B-PROBLEM
bright	JJ	I-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
is	VBZ	O
supposed	VBN	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
amesin	NN	O
of	IN	O
cardiology	NN	O
and	CC	O
dr.	JJ	O
shuffpasc	NN	O
of	IN	O
dingclearf	NN	O
alllirefaith	NN	O
memorial	JJ	O
hospital	NN	O
.	.	O

he	PRP	O
went	VBD	O
home	NN	O
and	CC	O
did	VBD	O
not	RB	O
take	VB	O
any	DT	O
of	IN	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
smoked	VBD	O
and	CC	O
drank	VBD	O
heavily	RB	O
throughout	IN	O
the	DT	O
several	JJ	O
months	NNS	O
.	.	O

on	IN	O
the	DT	O
a.m.	NN	O
of	IN	O
10-24-93	JJ	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
crushing	VBG	B-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
came	VBD	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
emergency	NN	O
ward	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
ashen	JJ	B-PROBLEM
and	CC	O
diaphoretic	JJ	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
oxygen	NN	B-TREATMENT
,	,	O
aspirin	NN	B-TREATMENT
,	,	O
five	CD	B-TREATMENT
sublingual	JJ	I-TREATMENT
nitroglycerins	NNS	I-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
,	,	O
and	CC	O
was	VBD	O
eventually	RB	O
made	VBN	O
pain	NN	O
free	JJ	O
with	IN	O
that	DT	B-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

his	PRP$	O
cardiac	JJ	O
risk	NN	O
factors	NNS	O
included	VBD	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
cigarette	NN	O
smoking	NN	O
,	,	O
and	CC	O
a	DT	O
positive	JJ	O
family	NN	O
history	NN	O
.	.	O

his	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
included	VBD	O
hypertension	NN	B-PROBLEM
and	CC	O
non-insulin	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
diet	JJ	O
controlled	VBN	O
.	.	O

his	PRP$	O
past	JJ	O
surgical	JJ	O
history	NN	O
had	VBD	O
included	VBN	O
gastric	JJ	B-TREATMENT
ulcer	NN	I-TREATMENT
surgery	NN	I-TREATMENT
and	CC	O
appendectomy	NN	B-TREATMENT
.	.	O

on	IN	O
admission	NN	O
,	,	O
he	PRP	O
was	VBD	O
on	IN	O
isordil	JJ	B-TREATMENT
10	CD	O
tid	NN	O
and	CC	O
enteric	JJ	B-TREATMENT
coated	VBN	I-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
but	CC	O
he	PRP	O
was	VBD	O
not	RB	O
taking	VBG	O
either	CC	O
of	IN	O
these	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
110/70	CD	O
,	,	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
66	CD	O
,	,	O
respirations	NNS	B-TEST
of	IN	O
24	CD	O
,	,	O
temperature	NN	B-TEST
of	IN	O
98	CD	O
.	.	O

the	DT	B-TEST
heent	NN	I-TEST
exam	NN	I-TEST
revealed	VBD	O
the	DT	O
extra	JJ	O
ocular	JJ	O
movements	NNS	O
intact	JJ	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
hypertensive	JJ	B-PROBLEM
or	CC	I-PROBLEM
diabetic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
suppled	VBN	O
,	,	O
with	IN	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
and	CC	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
carotids	NNS	I-TEST
were	VBD	O
1+	CD	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

the	DT	O
heart	NN	O
was	VBD	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s4	NN	O
,	,	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
i	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
,	,	O
except	IN	O
for	IN	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
dry	JJ	I-PROBLEM
crackles	NNS	I-PROBLEM
bibasilarly	RB	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
revealed	VBD	O
a	DT	B-PROBLEM
midline	NN	I-PROBLEM
scar	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
quadrant	NN	I-PROBLEM
scar	NN	I-PROBLEM
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	JJ	B-PROBLEM
wit	NN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

the	DT	O
liver	NN	O
edge	NN	O
was	VBD	O
2	CD	O
cm	NN	O
below	IN	O
the	DT	O
right	JJ	O
costal	NN	O
margin	NN	O
,	,	O
but	CC	O
smooth	CC	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
splenomegaly	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
were	VBD	O
diminished	VBN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
bilateral	JJ	B-PROBLEM
intertrigo	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
femoral	JJ	I-PROBLEM
region	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
his	PRP$	O
axillae	NN	O
.	.	O

the	DT	O
extremities	NNS	O
revealed	VBD	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
pulses	NNS	I-TEST
were	VBD	O
1+	CD	O
bilaterally	RB	O
.	.	O

the	DT	B-TEST
skin	NN	I-TEST
exam	NN	I-TEST
revealed	VBD	O
changes	NNS	O
consistent	JJ	O
with	IN	O
vitiligo	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

the	DT	O
laboratory	NN	O
data	NNS	O
revealed	VBD	O
normal	JJ	O
electrolytes	NNS	O
,	,	O
bun	NN	O
and	CC	O
creatinine	NN	O
,	,	O
normal	JJ	O
liver	NN	O
function	NN	O
tests	NNS	O
,	,	O
a	DT	B-TEST
first	JJ	I-TEST
cpk	NN	I-TEST
of	IN	O
140	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
43.1	CD	O
.	.	O

the	DT	B-TEST
portable	JJ	I-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
clear	JJ	O
lungs	NNS	O
,	,	O
slight	VBD	B-PROBLEM
enlarged	JJ	I-PROBLEM
heart	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
elevated	JJ	I-PROBLEM
hemidiaphragm	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
normal	JJ	O
sinus	JJ	O
rhythm	NN	O
at	IN	O
81	CD	O
,	,	O
with	IN	O
normal	JJ	O
intervals	NNS	O
and	CC	O
normal	JJ	O
axis	NN	O
,	,	O
had	VBD	O
poor	JJ	B-PROBLEM
r-wave	JJ	I-PROBLEM
progression	NN	I-PROBLEM
consistent	NN	O
with	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
had	VBD	O
flipped	VBN	B-PROBLEM
t-waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
v1	NN	I-PROBLEM
through	IN	O
v5	NN	O
,	,	O
which	WDT	O
were	VBD	O
of	IN	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
since	IN	O
his	PRP$	B-TEST
last	JJ	I-TEST
ekg	NN	I-TEST
on	IN	O
5-25-93	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
step	NN	O
down	RP	O
unit	NN	O
for	IN	O
a	DT	O
rule	NN	O
out	IN	O
mi	NN	B-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
aspirin	NN	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
,	,	O
and	CC	O
intravenous	JJ	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT
.	.	O

no	DT	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
was	VBD	O
started	VBN	O
because	IN	O
of	IN	O
his	PRP$	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
with	IN	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
and	CC	O
because	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
only	RB	O
110/70	CD	O
.	.	O

the	DT	O
patient	NN	O
ruled	VBD	O
in	IN	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
cpk	NN	I-TEST
of	IN	O
219	CD	O
and	CC	O
20.9%	CD	B-TEST
mb	NN	I-TEST
fraction	NN	I-TEST
.	.	O

this	DT	O
was	VBD	O
a	DT	B-PROBLEM
non-q	JJ	I-PROBLEM
wave	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
as	IN	O
there	EX	O
were	VBD	O
no	DT	O
diagnostic	JJ	B-PROBLEM
electrocardiogram	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

on	IN	O
10-27-93	JJ	O
,	,	O
the	DT	O
patient	NN	O
went	VBD	O
to	TO	O
the	DT	O
cath	NN	O
lab	NN	O
which	WDT	O
revealed	VBD	O
a	DT	O
small	JJ	O
nondominant	JJ	O
right	JJ	O
coronary	JJ	O
artery	NN	O
without	IN	O
any	DT	B-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
a	DT	B-PROBLEM
restenosis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
lesion	NN	I-PROBLEM
that	WDT	O
had	VBD	O
been	VBN	O
ptca	JJ	B-TREATMENT
&apos;d	NNP	I-TREATMENT
,	,	O
a	DT	B-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
first	JJ	I-PROBLEM
om	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
moderately	RB	I-PROBLEM
severe	JJ	I-PROBLEM
left	VBN	I-PROBLEM
circumflex	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
after	IN	I-PROBLEM
the	DT	I-PROBLEM
om3	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	JJ	I-TEST
ventriculogram	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
akinetic	JJ	I-PROBLEM
anterolateral	NN	I-PROBLEM
and	CC	I-PROBLEM
apical	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	O
results	NNS	O
of	IN	O
this	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
,	,	O
which	WDT	O
were	VBD	O
not	RB	O
significantly	RB	O
changed	VBN	O
from	IN	O
his	PRP$	B-TEST
previous	JJ	I-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
prior	RB	O
to	TO	O
the	DT	B-TREATMENT
ptca	NN	I-TREATMENT
,	,	O
it	PRP	O
was	VBD	O
elected	VBN	O
to	TO	O
attempt	VB	O
to	TO	O
medically	RB	O
manage	VB	O
the	DT	O
patient	NN	O
.	.	O

a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
was	VBD	O
started	VBN	O
with	IN	O
metoprolol	NN	B-TREATMENT
initially	RB	O
at	IN	O
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
and	CC	O
eventually	RB	O
increased	VBD	O
to	TO	O
50	CD	O
mg	NNS	O
po	JJ	O
bid	NN	O
.	.	O

the	DT	O
patient	NN	O
ambulated	VBD	O
extensively	RB	O
on	IN	O
the	DT	O
fih	JJ	O
20	CD	O
floor	NN	O
each	DT	O
day	NN	O
without	IN	O
any	DT	O
episodes	NNS	O
of	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

on	IN	O
11-2-93	JJ	O
,	,	O
the	DT	O
patient	NN	O
underwent	VBD	O
a	DT	B-TEST
low	JJ	I-TEST
level	NN	I-TEST
treadmill	NN	I-TEST
exercise	VBP	I-TEST
test	NN	I-TEST
with	IN	O
thallium	NN	B-TEST
imaging	NN	I-TEST
.	.	O

this	DT	B-TEST
treadmill	JJ	I-TEST
test	NN	I-TEST
was	VBD	O
done	VBN	O
on	IN	O
medications	NNS	B-TREATMENT
,	,	O
including	VBG	O
beta	NN	B-TREATMENT
blockers	NNS	I-TREATMENT
,	,	O
in	IN	O
hopes	NNS	O
to	TO	O
assess	VB	O
an	DT	O
amount	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
on	IN	O
treatment	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
able	JJ	O
to	TO	O
exercise	VB	O
for	IN	O
approximately	RB	O
nine	CD	O
minutes	NNS	O
on	IN	O
a	DT	B-TREATMENT
modified	VBN	I-TREATMENT
bruce	NN	I-TREATMENT
protocol	NN	I-TREATMENT
,	,	O
however	RB	O
,	,	O
he	PRP	O
did	VBD	O
not	RB	O
reach	VB	O
his	PRP$	O
predicted	JJ	O
maximal	JJ	O
heart	NN	O
rate	NN	O
while	IN	O
he	PRP	O
was	VBD	O
on	IN	O
the	DT	B-TREATMENT
beta	NN	I-TREATMENT
blockade	NN	I-TREATMENT
.	.	O

there	EX	O
were	VBD	O
no	DT	O
diagnostic	JJ	B-PROBLEM
electrocardiogram	NN	I-PROBLEM
changes	NNS	I-PROBLEM
during	IN	O
the	DT	B-TEST
treadmill	NN	I-TEST
exercise	NN	I-TEST
test	NN	I-TEST
,	,	O
although	IN	O
he	PRP	O
did	VBD	O
have	VB	O
0.5	CD	B-PROBLEM
to	TO	I-PROBLEM
1	CD	I-PROBLEM
mm	NNS	I-PROBLEM
st	JJ	I-PROBLEM
depression	NN	I-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
avf	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
study	NN	I-TEST
was	VBD	O
halted	VBN	O
for	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

thallium	NN	B-TEST
images	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
moderate	JJ	I-PROBLEM
sized	JJ	I-PROBLEM
region	NN	I-PROBLEM
of	IN	I-PROBLEM
ischemic	JJ	I-PROBLEM
but	CC	I-PROBLEM
viable	JJ	I-PROBLEM
myocardium	NN	I-PROBLEM
involving	VBG	O
the	DT	O
anteroseptal	NN	O
and	CC	O
lateral	JJ	O
segments	NNS	O
of	IN	O
the	DT	O
left	JJ	O
ventricle	NN	O
.	.	O

there	EX	O
was	VBD	O
also	RB	O
some	DT	O
evidence	NN	O
of	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
during	IN	O
the	DT	B-TEST
test	NN	I-TEST
.	.	O

these	DT	B-TEST
images	NNS	I-TEST
were	VBD	O
essentially	RB	O
unchanged	JJ	O
compared	VBN	O
with	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
thallium	NN	I-TEST
images	NNS	I-TEST
in	IN	O
may	MD	O
1993	CD	O
.	.	O

after	IN	O
extensive	JJ	O
discussion	NN	O
between	IN	O
myself	PRP	O
,	,	O
dr.	VBZ	O
amesin	NN	O
,	,	O
and	CC	O
dr.	JJ	O
scgach	NN	O
,	,	O
it	PRP	O
was	VBD	O
elected	VBN	O
to	TO	O
discharge	VB	O
the	DT	O
patient	NN	O
to	TO	O
home	NN	O
with	IN	O
medical	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
extremely	RB	O
reluctant	JJ	O
to	TO	O
undergo	VB	O
surgery	NN	B-TREATMENT
,	,	O
although	IN	O
he	PRP	O
understands	VBZ	O
that	IN	O
this	DT	O
may	MD	O
become	VB	O
necessary	JJ	O
in	IN	O
the	DT	O
future	NN	O
.	.	O

previously	RB	O
he	PRP	O
had	VBD	O
not	RB	O
taken	VBN	O
any	DT	O
of	IN	O
his	PRP$	B-TREATMENT
medicines	NNS	I-TREATMENT
and	CC	O
smoked	VBD	O
heavily	RB	O
on	IN	O
the	DT	O
outside	NN	O
and	CC	O
not	RB	O
kept	VB	O
any	DT	O
of	IN	O
his	PRP$	O
appointments	NNS	O
.	.	O

the	DT	O
importance	NN	O
of	IN	O
quitting	VBG	O
smoking	NN	O
as	RB	O
well	RB	O
as	IN	O
continuing	VBG	O
to	TO	O
follow	VB	O
his	PRP$	B-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
was	VBD	O
emphasized	VBN	O
to	TO	O
the	DT	O
daughter	NN	O
and	CC	O
to	TO	O
the	DT	O
patient	NN	O
.	.	O

she	PRP	O
will	MD	O
be	VB	O
actively	RB	O
involved	VBN	O
in	IN	O
encouraging	VBG	O
the	DT	O
patient	NN	O
to	TO	O
comply	VB	O
with	IN	O
this	DT	B-TREATMENT
medical	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
also	RB	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
amesin	NN	O
as	RB	O
well	RB	O
as	IN	O
dr.	NN	O
lfsquarc	NN	O
on	IN	O
the	DT	O
outside	NN	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
throughout	IN	O
the	DT	O
entire	JJ	O
hospitalization	NN	O
.	.	O

despite	IN	O
being	VBG	O
on	IN	O
heparin	NN	B-TREATMENT
for	IN	O
a	DT	O
short	JJ	O
time	NN	O
,	,	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
very	RB	O
stable	JJ	O
with	IN	O
only	RB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
dip	NN	I-PROBLEM
after	IN	O
the	DT	B-TREATMENT
catheterization	NN	I-TREATMENT
was	VBD	O
done	VBN	O
.	.	O

he	PRP	O
will	MD	O
need	VB	O
to	TO	O
be	VB	O
followed	VBN	O
up	RP	O
as	IN	O
an	DT	O
out	RP	O
patient	NN	O
for	IN	O
guaiac	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
stools	NNS	I-PROBLEM
and	CC	O
possibly	RB	O
worked	VBD	O
up	RP	O
for	IN	O
this	DT	O
in	IN	O
the	DT	O
future	NN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

hpi	NN	O
:	:	O
this	DT	O
is	VBZ	O
a	DT	O
79	CD	O
y/o	NN	O
m	NN	O
with	IN	O
h/o	NN	O
of	IN	O
htn	NN	B-PROBLEM
,	,	O
dm	NN	B-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
cva	NN	I-PROBLEM
theresa	NN	O
,	,	O
chronic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM
on	IN	O
vent	NN	B-TREATMENT
,	,	O
trached	VBN	B-TREATMENT
,	,	O
esrd	VB	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
who	WP	O
was	VBD	O
sent	VBN	O
from	IN	O
rehab	NN	O
facility	NN	O
for	IN	O
worsening	VBG	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

per	IN	O
refferal	JJ	O
notes	NNS	O
,	,	O
he	PRP	O
went	VBD	O
to	TO	O
hemodyalisis	VB	B-TREATMENT
today	NN	O
in	IN	O
the	DT	O
morning	NN	O
.	.	O

at	IN	O
about	RB	O
2:30	CD	O
pm	NN	O
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
worsening	VBG	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
.	.	O

in	IN	O
that	DT	O
setting	NN	O
he	PRP	O
was	VBD	O
hypotensive	JJ	B-PROBLEM
down	RB	O
to	TO	O
the	DT	O
92/45	CD	O
,	,	O
and	CC	O
was	VBD	O
given	VBN	O
1	CD	B-TREATMENT
l	JJ	I-TREATMENT
ns	NN	I-TREATMENT
.	.	O

fs	NN	B-TEST
was	VBD	O
also	RB	O
checked	JJ	O
179	CD	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
it	PRP	O
seems	VBZ	O
that	IN	O
he	PRP	O
had	VBD	O
been	VBN	O
on	IN	O
t	NN	B-TREATMENT
peace	NN	I-TREATMENT
since	IN	O
4	CD	O
am	VBP	O
today	NN	O
.	.	O

at	IN	O
2:30	CD	O
he	PRP	O
was	VBD	O
also	RB	O
found	VBN	O
with	IN	O
sats	NNS	B-TEST
in	IN	O
the	DT	O
90%	CD	O
.	.	O

abg	NN	B-TEST
done	VBN	O
7.1	CD	O
,	,	O
89/72	CD	O
-	:	O
he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
ac	JJ	B-TREATMENT
600	CD	O
/	JJ	O
0.4	CD	O
and	CC	O
6	CD	O
peep	JJ	B-TREATMENT
-	:	O
sats	VBZ	B-TEST
up	IN	O
to	TO	O
94%	CD	O
.	.	O

given	VBN	O
persistent	JJ	B-PROBLEM
lethargy	NN	I-PROBLEM
,	,	O
patient	NN	O
was	VBD	O
sent	VBN	O
to	TO	O
falkener	VB	O
amanda	NN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
after	IN	O
interview	NN	O
with	IN	O
hcp	NN	O
,	,	O
at	IN	O
around	IN	O
07-23	NNP	O
,	,	O
patient	NN	O
started	VBD	O
having	VBG	O
episodes	NNS	O
of	IN	O
dizziness	NN	B-PROBLEM
,	,	O
and	CC	O
had	VBD	O
unstable	JJ	B-PROBLEM
gait	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
peg	NN	I-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
tracheostomy	NN	B-TREATMENT
prior	RB	O
to	TO	O
d/c	VB	O
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
chronicallyl	JJ	B-PROBLEM
vent	JJ	I-PROBLEM
dependent	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
amanda	NN	O
:	:	O
vs	NN	B-TEST
t	VBZ	B-TEST
103	CD	O
rectal	JJ	O
bp90/44	NN	B-TEST
hr	NN	B-TEST
:	:	O
84	CD	O
rr	NN	B-TEST
16	CD	O
sats	NNS	B-TEST
:	:	O
98	CD	O
+	NN	B-PROBLEM
guiac	JJ	I-PROBLEM
stool	NN	I-PROBLEM
.	.	O

he	PRP	O
received	VBD	O
tylenol	NN	B-TREATMENT
,	,	O
levofloxacin	VBZ	B-TREATMENT
500	CD	O
mg	NN	O
iv	NN	O
,	,	O
flagyl	VBP	B-TREATMENT
500	CD	O
mg	NN	O
and	CC	O
vancomycin	NN	B-TREATMENT
and	CC	O
i	NN	B-TREATMENT
l	VBP	I-TREATMENT
ns	NN	I-TREATMENT
.	.	O

cva	NN	B-PROBLEM
theresa	NN	O
/	NN	O
2006	CD	O

htn	NN	B-PROBLEM

dm	NN	B-PROBLEM

cri	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
since	IN	O
theresa	NN	O
(	(	O
tu,	JJ	O
thurs,	NN	O
sat	VBD	O
)	)	O

neuropathy	RB	B-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM

s/p	NN	O
ccy	NN	B-TREATMENT

brother	NN	O
died	VBD	O
cerebral	JJ	B-PROBLEM
aneurysm	NN	I-PROBLEM

brother	NN	O
sabina	NN	B-PROBLEM
cancer	NN	I-PROBLEM

brother	NN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM

vitals	NNS	B-TEST
:	:	O
t	NN	B-TEST
:	:	O
99	CD	O
p	NN	B-TEST
:	:	O
84	CD	O
bp	NN	B-TEST
:	:	O
145/62	CD	O
ac	NN	B-TREATMENT
:	:	O
600	CD	O
,	,	O
x	VBD	O
12	CD	O
/	JJ	O
0.5	CD	O
/	JJ	O
5	CD	O
sao2	NN	B-TEST
:	:	O
100%	CD	O

heent	NN	O
:	:	O
peerla	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM
.	.	O
+	JJ	O
tracheostomy	NN	B-TREATMENT

decrease	NN	B-PROBLEM
breath	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

cardiac	NN	O
:	:	O
rrr	NN	O
,	,	O
nl	RB	O
.	.	O
s1s2	NN	O
,	,	O
soft	JJ	B-PROBLEM
holosytolic	NN	I-PROBLEM
murmur	NN	I-PROBLEM
apex	NN	I-PROBLEM

abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM
,	,	O
normoactive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
or	CC	O
organomegaly	RB	B-PROBLEM
noted	VBN	O
.	.	O

+	JJ	O
g	NN	B-TREATMENT
tube	NN	I-TREATMENT

extremities	NNS	O
:	:	O
left	VBD	B-TREATMENT
arm	NN	I-TREATMENT
avf	NN	I-TREATMENT

1+	CD	B-PROBLEM
trace	NN	I-PROBLEM
edemalymphadenopathy	NN	I-PROBLEM
noted	VBD	O
.	.	O

skin	NN	O
:	:	O
no	DT	O
rashes	NNS	B-PROBLEM
,	,	O
small	JJ	B-PROBLEM
decubit	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
back	NN	I-PROBLEM
.	.	O

decreased	VBN	B-PROBLEM
reflexes	NNS	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

agap	NN	B-TEST
=	VBZ	O
14	CD	O

ck	NN	B-TEST
:	:	O
29	CD	O
mb	NN	B-TEST
:	:	O
notdone	RB	O
trop	NN	B-TEST
-*	NNP	O
t	NN	O
*:	VBD	O
0.44	CD	O

ctropnt	NN	B-TEST
>	VBZ	O
0.10	CD	O
ng	JJ	O
/	NNP	O
ml	NN	O
suggests	VBZ	O
acute	VBP	B-PROBLEM
mi	NN	I-PROBLEM

ca	MD	B-TEST
:	:	O
8.6	CD	O
mg	NN	B-TEST
:	:	O
2.4	CD	O
p	NN	B-TEST
:	:	O
5.0	CD	O

probnp	NN	B-TEST
:	:	O
11065	CD	O

wbc	NN	B-TEST
15.2	CD	O
plat	NN	B-TEST
395	CD	O

hct	NN	B-TEST
:	:	O
28.4	CD	O

n	NNS	B-TEST
:	:	O
89.8	CD	O
band	NN	B-TEST
:	:	O
0	CD	O
l	NN	B-TEST
:	:	O
5.8	CD	O
m	NN	B-TEST
:	:	O
4.1	CD	O
e	NN	B-TEST
:	:	O
0.3	CD	O
bas	NN	B-TEST
:	:	O
0.1	CD	O
pt	NN	B-TEST
:	:	O
12.1	CD	O
ptt	NN	B-TEST
:	:	O
37.5	CD	O
inr	NN	B-TEST
:	:	O
1.0	CD	O

k	NN	B-TEST
:	:	O
5.5	CD	O
lactate	NN	B-TEST
:	:	O
1.3	CD	O

this	DT	O
is	VBZ	O
a	DT	O
79	CD	O
y/o	NN	O
m	NN	O
with	IN	O
h/o	NN	O
htn	NN	B-PROBLEM
,	,	O
dm	NN	B-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
cva	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
ventilatory	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
cri	NN	B-PROBLEM
on	IN	O
hd	NN	B-TREATMENT
who	WP	O
presents	VBZ	O
with	IN	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
ms	NN	I-PROBLEM
and	CC	O
febrile	NN	B-PROBLEM
in	IN	O
the	DT	O
amanda	NN	O
,	,	O
admitted	VBN	O
to	TO	O
cmed	VB	O
.	.	O

#	#	O
altered	VBD	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
:	:	O
ct	NNS	B-TEST
scan	VBP	I-TEST
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
new	JJ	B-PROBLEM
intracraneal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

patient	NN	O
febrile	NN	B-PROBLEM
in	IN	O
the	DT	O
amanda	NN	O
.	.	O

high	JJ	B-PROBLEM
wbc	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
it	PRP	O
could	MD	O
have	VB	O
been	VBN	O
a	DT	O
combination	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
,	,	O
hypercapnia	NN	B-PROBLEM
and	CC	O
infection	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

despite	IN	O
having	VBG	O
a	DT	B-PROBLEM
profund	NN	I-PROBLEM
limitation	NN	I-PROBLEM
communicating	VBG	I-PROBLEM
given	VBN	O
his	PRP$	B-PROBLEM
neurological	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
his	PRP$	B-PROBLEM
mental	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
seemed	VBD	O
to	TO	O
improved	VBN	O
initially	RB	O
.	.	O

however	RB	O
later	RB	O
on	IN	O
during	IN	O
his	PRP$	O
course	NN	O
,	,	O
his	PRP$	O
mental	JJ	O
status	NN	O
deteriorated	VBD	O
,	,	O
being	VBG	O
even	RB	O
less	RBR	B-PROBLEM
responsive	JJ	I-PROBLEM
.	.	O

patient	NN	O
febrile	NN	B-PROBLEM
and	CC	O
with	IN	O
a	DT	B-PROBLEM
high	JJ	I-PROBLEM
wbc	NN	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

after	IN	O
starting	VBG	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
-	:	O
cefepime	NN	B-TREATMENT
-	:	O
vancomycin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
(	(	O
for	IN	O
initial	JJ	O
concern	NN	O
of	IN	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
),	IN	O
he	PRP	O
responded	VBD	O
clinically	RB	O
.	.	O

urine	JJ	B-TEST
cx	NN	I-TEST
from	IN	O
rehab	NN	O
showed	VBD	O
gram	JJ	B-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
>	VBP	B-PROBLEM
100	CD	I-PROBLEM
k	NN	I-PROBLEM
enterobacter	NN	I-PROBLEM
cloacae	NN	I-PROBLEM
.	.	O

urine	JJ	B-TEST
cx	NN	I-TEST
in	IN	O
house	NN	O
grew	VBD	O
citrobacter	JJR	B-PROBLEM
freundi	NN	I-PROBLEM
and	CC	O
his	PRP$	B-TEST
sputum	NN	I-TEST
grew	VBD	O
acinetobacter	RB	B-PROBLEM
baummani	NN	I-PROBLEM
.	.	O

since	IN	O
there	EX	O
was	VBD	O
no	DT	O
more	JJR	O
evidence	NN	O
of	IN	O
gram	NN	B-PROBLEM
positive	JJ	I-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
vancomycin	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
and	CC	O
cefepime	NN	B-TREATMENT
was	VBD	O
kept	VBN	O
.	.	O

#	#	O
fevers	NNS	B-PROBLEM
:	:	O
in	IN	O
the	DT	O
amanda	NN	O
,	,	O
high	JJ	B-PROBLEM
wbc	NN	I-PROBLEM
,	,	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

also	RB	O
possible	JJ	O
source	NN	O
sinus	NN	B-PROBLEM
infections	NNS	I-PROBLEM
given	VBN	O
findings	NNS	O
on	IN	O
intial	JJ	B-TEST
ct	NN	I-TEST
(	(	O
see	VB	O
summary	JJ	O
in	IN	O
significant	JJ	O
studies	NNS	O
).	IN	O
he	PRP	O
did	VBD	O
not	RB	O
spike	VB	O
any	DT	O
fevers	NNS	B-PROBLEM
after	IN	O
being	VBG	O
transfer	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
from	IN	O
the	DT	O
amanda	NN	O
.	.	O

#	#	O
resp	NN	O
:	:	O
patient	NN	O
was	VBD	O
intermitentely	RB	O
switched	VBN	O
from	IN	O
ac	NN	B-TREATMENT
to	TO	O
pressure	VB	B-TREATMENT
support	NN	I-TREATMENT
trials	NNS	I-TREATMENT
.	.	O

then	RB	O
trach	NN	B-TREATMENT
mask	NN	I-TREATMENT
trials	NNS	I-TREATMENT
were	VBD	O
done	VBN	O
.	.	O

he	PRP	O
tolerated	VBD	O
this	DT	O
well	NN	O
,	,	O
although	IN	O
he	PRP	O
required	VBD	O
ps	JJ	B-TREATMENT
overnight	NN	O
.	.	O

#	#	O
esrd	NN	B-PROBLEM
on	IN	O
hemodyalisis	NN	B-TREATMENT
:	:	O
renal	JJ	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
hd	NN	B-TREATMENT
was	VBD	O
continued	VBN	O
.	.	O

rhythm	NN	B-TEST
:	:	O
nsr	NN	O
,	,	O
not	RB	O
tachycardic	JJ	B-PROBLEM
.	.	O

pump	NN	B-TEST
:	:	O
with	IN	O
trace	NN	O
of	IN	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

x	JJ	B-TEST
ray	NN	I-TEST
suggested	VBD	O
some	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
on	IN	O
admission	NN	O
.	.	O

despite	IN	O
this	DT	O
findings	NNS	O
,	,	O
he	PRP	O
was	VBD	O
supported	VBN	O
with	IN	O
40%	CD	B-TREATMENT
fio2	NNS	I-TREATMENT
most	RBS	O
of	IN	O
the	DT	O
time	NN	O
.	.	O

cad	NN	B-PROBLEM
:	:	O
on	IN	O
admission	NN	O
ck	NN	B-TEST
low	JJ	O
normal	JJ	O
,	,	O
mb	JJ	B-TEST
not	RB	O
done	VBN	O
.	.	O

troponin	NN	B-TEST
0.44.	CD	O

it	PRP	O
was	VBD	O
more	RBR	O
likely	JJ	O
due	JJ	O
to	TO	O
cri	VB	B-PROBLEM
.	.	O

second	JJ	O
set	VBD	O
12	CD	O
hours	NNS	O
apart	RB	O
,	,	O
showed	VBD	O
no	DT	O
changes	NNS	B-PROBLEM
.	.	O

s/p	JJ	O
stroke	NN	B-PROBLEM
:	:	O
continue	NN	O
aspirin	NN	B-TREATMENT
,	,	O
statin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT

#	#	O
hypotension	NN	B-PROBLEM
:	:	O
per	IN	O
referral	JJ	O
form	NN	O
.	.	O

intially	RB	O
concern	NN	O
for	IN	O
sepsis	NN	B-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
fevers	NNS	B-PROBLEM
and	CC	O
high	JJ	B-PROBLEM
blood	NN	I-PROBLEM
count	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
bp	NN	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
held	VBN	O
on	IN	O
admission	NN	O
.	.	O

patient	NN	O
did	VBD	O
not	RB	O
require	VB	O
pressors	NNS	B-TREATMENT
.	.	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
remained	VBD	O
stable	JJ	O
and	CC	O
bp	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
were	VBD	O
restarted	VBN	O
.	.	O

tube	NN	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
thorugh	IN	O
peg	NN	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

on	IN	O
2013-09-08	JJ	O
,	,	O
patient	NN	O
pulled	VBD	O
out	RP	O
peg	JJ	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

temporary	JJ	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
on	IN	O
2013-09-11	CD	O
,	,	O

on	IN	O
2013-09-12	JJ	O
after	IN	O
deterioration	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	I-PROBLEM
also	RB	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
,	,	O
goals	NNS	O
of	IN	O
care	NN	O
were	VBD	O
discussed	VBN	O
with	IN	O
his	PRP$	O
hcp	NN	O
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
to	TO	O
direct	JJ	O
goals	NNS	O
of	IN	O
care	NN	O
towards	NNS	O
confort	NN	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

novolin	RB	B-TREATMENT
16	CD	O
u	JJ	O
q	NN	O
12h	CD	O

aranesp	RB	B-TREATMENT
40	CD	O
mcg	NNS	O
sc	NN	O

prozac	NN	B-TREATMENT
liquid	VBD	I-TREATMENT
20	CD	O
mg	NN	O
q	NN	O
am	VBP	O

heparin	NN	B-TREATMENT
3000	CD	O
u	JJ	O
tu	NN	O
,	,	O
thursday	NN	O
saturday	NN	O

norvasc	RB	B-TREATMENT
10	CD	O
mg	JJ	O
daily	JJ	O
gt	NN	O

tylenol	NN	B-TREATMENT
prn	NN	O

reglan	NN	B-TREATMENT
5	CD	O
mg	NN	O
q	NN	O
6h	CD	O
,	,	O

fergon	NN	B-TREATMENT
300	CD	O
mg	NN	O
bid	NN	O

plavix	NN	B-TREATMENT
75	CD	O
mg	NN	O
gt	NN	O

nephrocaps	NNS	B-TREATMENT
1	CD	O
daily	JJ	O

novolin	RB	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

heparin	NN	B-TREATMENT
sc	NN	O
5000	CD	O
q	NN	O
8h	CD	O

protonix	NN	B-TREATMENT
40	CD	O
mg	JJ	O
daily	JJ	O
gt	NN	O

combivent	NN	B-TREATMENT
2	CD	O
puff	NN	O
qid	NN	O
inh	NN	O

zocor	NN	B-TREATMENT
10	CD	O
mg	NN	O
tab	NN	O
/	NNP	O
day	NN	O
gt	NN	O

aspirin	RB	B-TREATMENT
325	CD	O
mg	NNS	O
tab	NN	O

ferrlecit	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
ferric	JJ	I-TREATMENT
gluconate	NN	I-TREATMENT
mo-we	JJ	O
fr	NN	O
iv	NN	O

1.	CD	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

2.	CD	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM

3.	CD	O
chronic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM

1.	CD	O
hypertension	NN	B-PROBLEM

2.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM

3.	CD	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
on	IN	O
hd	NN	B-TREATMENT

ms.	NN	O
less	CC	O
is	VBZ	O
a	DT	O
79	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
non	NN	B-PROBLEM
small	JJ	I-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
diagnosed	VBN	O
in	IN	O
02/95	CD	O
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
resection	NN	I-TREATMENT
for	IN	O
stage	NN	B-PROBLEM
i	NN	I-PROBLEM
in	IN	O
10/95	CD	O
and	CC	O
treated	VBD	O
with	IN	O
xrt	NNP	B-TREATMENT
.	.	O

she	PRP	O
presented	VBD	O
to	TO	O
the	DT	O
hospital	NN	O
with	IN	O
a	DT	B-PROBLEM
numb	JJ	I-PROBLEM
right	NN	I-PROBLEM
leg	NN	I-PROBLEM
this	DT	O
morning	NN	O
and	CC	O
underwent	NN	O
an	DT	B-TREATMENT
emergent	JJ	I-TREATMENT
embolectomy	NN	I-TREATMENT
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
1990	CD	O
,	,	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
hypertension	NN	B-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
on	IN	I-TREATMENT
admission	NN	I-TREATMENT
were	VBD	O
coumadin	NNS	B-TREATMENT
,	,	O
digoxin	NN	B-TREATMENT
synthroid	NN	B-TREATMENT
,	,	O
lopressor	NN	B-TREATMENT
and	CC	O
zantac	NN	B-TREATMENT
.	.	O

on	IN	O
1/14/96	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
dialysis	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

on	IN	O
1/18/96	CD	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
acute	JJ	I-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
underwent	NN	O
an	DT	B-TEST
emergent	JJ	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
massive	JJ	I-PROBLEM
subarachnoid	NN	I-PROBLEM
hemorrhage	NN	I-PROBLEM
with	IN	O
bleeding	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
subarachnoid	JJ	I-PROBLEM
space	NN	I-PROBLEM
,	,	O
and	CC	O
throughout	IN	O
the	DT	O
ventricles	NNS	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
significant	JJ	B-PROBLEM
hydrocephalus	NN	I-PROBLEM
.	.	O

follow	VB	B-TEST
up	RP	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
worsening	NN	O
of	IN	O
her	PRP$	B-PROBLEM
hydrocephalus	NN	I-PROBLEM
and	CC	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
ventriculostomy	NN	I-TREATMENT
placed	VBN	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

she	PRP	O
failed	VBD	O
to	TO	O
improve	VB	O
following	VBG	O
placement	NN	O
of	IN	O
the	DT	B-TREATMENT
ventriculostomy	NN	I-TREATMENT
and	CC	O
her	PRP$	O
poor	JJ	O
prognosis	NN	O
was	VBD	O
discussed	VBN	O
with	IN	O
the	DT	O
family	NN	O
.	.	O

the	DT	O
family	NN	O
at	IN	O
that	DT	O
point	NN	O
considering	VBG	O
the	DT	O
multiple	NN	O
system	NN	O
involvement	NN	O
of	IN	O
her	PRP$	B-PROBLEM
diseases	NNS	I-PROBLEM
,	,	O
decided	VBD	O
to	TO	O
make	VB	O
the	DT	O
patient	NN	O
dnr	NN	B-TREATMENT
and	CC	O
withdraw	JJ	O
care	NN	B-TREATMENT
.	.	O

the	DT	O
medical	JJ	O
examiner	NN	O
was	VBD	O
called	VBN	O
and	CC	O
the	DT	O
case	NN	O
was	VBD	O
discussed	VBN	O
,	,	O
and	CC	O
he	PRP	O
declined	VBD	O
autopsy	NN	B-TEST
of	IN	O
the	DT	O
case	NN	O
.	.	O

status	NN	O
post	NN	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
.	.	O

1)	CD	O
menorrhagia	NN	B-PROBLEM
.	.	O

2)	CD	O
pelvic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

3)	CD	O
endometriosis	NN	B-PROBLEM
.	.	O

tah-bso	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
42	CD	O
year	NN	O
old	JJ	O
gravida	NN	O
ii	NN	O
,	,	O
para	NN	O
i	NNS	O
female	VBP	O
with	IN	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
menorrhagia	NN	B-PROBLEM
and	CC	O
pelvic	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
endometriosis	NN	B-PROBLEM
that	WDT	O
is	VBZ	O
symptomatic	JJ	B-PROBLEM
.	.	O

she	PRP	O
used	VBD	O
danocrine	NN	B-TREATMENT
for	IN	O
approximately	RB	O
nine	CD	O
months	NNS	O
and	CC	O
was	VBD	O
pain	RB	B-PROBLEM
free	JJ	O
,	,	O
but	CC	O
was	VBD	O
unable	JJ	O
to	TO	O
tolerate	VB	O
the	DT	B-PROBLEM
side	NN	I-PROBLEM
effects	NNS	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
status	NN	O
post	NN	O
several	JJ	B-TEST
laparoscopies	NNS	I-TEST
in	IN	O
the	DT	O
past	NN	O
with	IN	O
which	WDT	O
she	PRP	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
endometriosis	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
recently	RB	O
been	VBN	O
on	IN	O
depo-provera	NN	B-TREATMENT
and	CC	O
has	VBZ	O
had	VBN	O
episodes	NNS	O
of	IN	O
break-through	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
for	IN	O
six	CD	O
weeks	NNS	O
at	IN	O
a	DT	O
time	NN	O
.	.	O

she	PRP	O
desired	VBD	O
surgical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

on	IN	O
12/12/96	CD	O
she	PRP	O
had	VBD	O
an	DT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT
total	JJ	I-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
.	.	O

estimated	VBN	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
100	CD	O
cc	NN	O
and	CC	O
she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
number	NN	O
one	CD	O
she	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
and	CC	O
doing	VBG	O
well	RB	O
with	IN	O
a	DT	B-TREATMENT
pca	NN	I-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
number	NN	O
two	CD	O
she	PRP	O
was	VBD	O
also	RB	O
afebrile	JJ	B-PROBLEM
and	CC	O
had	VBD	O
not	RB	O
passed	VBN	O
any	DT	B-PROBLEM
flatus	NN	I-PROBLEM
yet	RB	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
34.2	CD	O
and	CC	O
stable	JJ	O
from	IN	O
her	PRP$	O
preoperative	JJ	O
value	NN	O
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
number	NN	O
three	CD	O
her	PRP$	O
abdomen	NNS	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
distended	VBN	B-PROBLEM
with	IN	O
a	DT	B-TEST
few	JJ	I-TEST
bowel	NN	I-TEST
sounds	NNS	I-TEST
and	CC	O
she	PRP	O
still	RB	O
had	VBD	O
not	RB	O
passed	VBN	O
gas	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
decreased	VBD	O
the	DT	O
amount	NN	O
of	IN	O
demerol	NN	B-TREATMENT
she	PRP	O
was	VBD	O
using	VBG	O
and	CC	O
supplemented	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
and	CC	O
continued	VBD	O
her	PRP$	O
frequent	JJ	O
ambulation	NN	O
.	.	O

on	IN	O
postop	JJ	O
day	NN	O
number	NN	O
four	CD	O
she	PRP	O
had	VBD	O
passed	VBN	O
flatus	NN	B-PROBLEM
and	CC	O
was	VBD	O
feeling	VBG	O
much	JJ	O
better	RBR	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
in	IN	O
good	JJ	O
condition	NN	O
on	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

demerol	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

motrin	NN	B-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

colace	NN	B-TREATMENT
stool	NN	I-TREATMENT
softener	NN	I-TREATMENT
.	.	O

mixed	JJ	B-PROBLEM
mesodermal	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

mixed	JJ	B-PROBLEM
mesodermal	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

(	(	O
1	CD	O
)	)	O
status	NN	O
post	NN	O
hysterectomy	NN	B-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
oophorectomy	NN	I-TREATMENT
.	.	O

(	(	O
2	CD	O
)	)	O
abdominal	NN	B-PROBLEM
wall	NN	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

(	(	O
3	CD	O
)	)	O
hypertension	NN	B-PROBLEM
.	.	O

on	IN	O
june	NN	O
26	CD	O
,	,	O
1994	CD	O
tumor	NN	B-TREATMENT
debulking	NN	I-TREATMENT
,	,	O
pelvic	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
abdominal	JJ	B-TREATMENT
wall	NN	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
81	CD	O
year	NN	O
old	JJ	O
female	NN	O
,	,	O
g2	NN	O
,	,	O
p2	NN	O
,	,	O
who	WP	O
status	NN	O
post	NN	O
total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy-bilateral	JJ	I-TREATMENT
salpingo-oophorectomy	JJ	I-TREATMENT
one	CD	O
years	NNS	O
ago	RB	O
for	IN	O
a	DT	B-PROBLEM
mixed	JJ	I-PROBLEM
mesodermal	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
vaginal	JJ	B-PROBLEM
apex	NN	I-PROBLEM
recurrence	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
a	DT	O
normal	JJ	O
pelvic	JJ	O
examination	NN	O
and	CC	O
ct	JJ	B-TEST
scan	NN	I-TEST
in	IN	O
february	NN	O
of	IN	O
1993	CD	O
but	CC	O
one	CD	O
month	NN	O
prior	RB	O
to	TO	O
this	DT	O
admission	NN	O
starting	VBG	O
bleeding	VBG	B-PROBLEM
per	IN	I-PROBLEM
vagina	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
examination	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
apicovaginal	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
consistent	NN	O
with	IN	O
recurrent	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
central	JJ	I-PROBLEM
recurrence	NN	I-PROBLEM
and	CC	O
biopsy	NN	B-TEST
of	IN	O
this	DT	B-PROBLEM
lesion	NN	I-PROBLEM
was	VBD	O
positive	JJ	O
.	.	O

she	PRP	O
presents	VBZ	O
now	RB	O
for	IN	O
excision	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
local	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
recurrence	NN	I-PROBLEM
.	.	O

halcion	NN	B-TREATMENT
0.25	CD	O
mg.	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O

valium	NN	B-TREATMENT
5	CD	O
mg.	NN	O
p.o.	NN	O
p.r.n	NN	O
and	CC	O
methyclothiazide	$	B-TREATMENT
5	CD	O
mg.	NN	O
q.d.	NN	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

her	PRP$	B-TEST
temperature	NN	I-TEST
is	VBZ	O
97.9	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
160/80	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
92	CD	O
,	,	O
her	PRP$	B-TEST
heent	JJ	I-TEST
examination	NN	I-TEST
reveals	NNS	O
anicteric	JJ	B-PROBLEM
sclerae	NN	I-PROBLEM
and	CC	O
her	PRP$	O
left	JJ	O
eye	NN	O
has	VBZ	O
slightly	RB	B-PROBLEM
relaxed	VBN	I-PROBLEM
inferoorbital	JJ	I-PROBLEM
wall	NN	I-PROBLEM
.	.	O

her	PRP$	O
chest	NN	O
is	VBZ	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

her	PRP$	O
heart	NN	O
has	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
i	JJ	B-PROBLEM
/	VBP	I-PROBLEM
vi	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
is	VBZ	O
obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
and	CC	O
without	IN	O
palpable	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
.	.	O

extremities	NNS	O
two	CD	B-TEST
plus	CC	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	I-TEST
and	CC	O
nonpitting	VBG	B-PROBLEM
edema	VB	I-PROBLEM
up	IN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
knees	NNS	I-PROBLEM
in	IN	O
both	DT	O
legs	NNS	O
.	.	O

sodium	NN	B-TEST
142	CD	O
,	,	O
potassium	NN	B-TEST
3.3	CD	O
,	,	O
chloride	RB	B-TEST
98	CD	O
,	,	O
bicarbonate	NN	B-TEST
34	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
14/0.9	CD	O
.	.	O

her	PRP$	B-TEST
alkaline	JJ	I-TEST
phosphatase	NN	I-TEST
is	VBZ	O
77	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
12.5	CD	O
,	,	O
hematocrit	NN	B-TEST
42.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
268	CD	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
patient	NN	O
with	IN	O
recurrence	NN	O
of	IN	O
a	DT	B-PROBLEM
mixed	JJ	I-PROBLEM
mesodermal	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
vaginal	JJ	I-PROBLEM
apex	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
for	IN	O
local	JJ	B-TREATMENT
excision	NN	I-TREATMENT
.	.	O

on	IN	O
that	DT	O
day	NN	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
an	DT	B-TEST
exam	NN	I-TEST
under	IN	O
anesthesia	NN	B-TREATMENT
,	,	O
an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
with	IN	O
lysis	NN	B-TREATMENT
of	IN	O
adhesions	NNS	B-PROBLEM
,	,	O
tumor	NN	B-TREATMENT
debulking	NN	I-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
pelvic	JJ	I-TREATMENT
lymph	NN	I-TREATMENT
node	DT	I-TREATMENT
dissection	NN	I-TREATMENT
.	.	O

an	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hernia	NN	I-PROBLEM
was	VBD	O
also	RB	O
repaired	VBN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
vaginal	JJ	I-TREATMENT
pack	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
second	JJ	O
postoperative	JJ	O
day	NN	O
as	RB	O
well	RB	O
as	IN	O
the	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
three	CD	O
she	PRP	O
had	VBD	O
return	NN	O
of	IN	O
normal	JJ	O
bowel	NN	O
function	NN	O
and	CC	O
was	VBD	O
able	JJ	O
to	TO	O
tolerate	VB	O
a	DT	O
regular	JJ	O
diet	NN	O
without	IN	O
any	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
june	NN	O
30	CD	O
,	,	O
1994	CD	O
,	,	O
postoperative	JJ	O
day	NN	O
four	CD	O
.	.	O

on	IN	O
that	DT	O
day	NN	O
she	PRP	O
was	VBD	O
feeling	VBG	O
well	RB	O
enough	RB	O
,	,	O
eating	VBG	O
well	RB	O
,	,	O
and	CC	O
voiding	VBG	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
only	JJ	I-TREATMENT
additional	JJ	I-TREATMENT
medication	NN	I-TREATMENT
on	IN	O
discharge	NN	O
is	VBZ	O
percocet	VBN	B-TREATMENT
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

in	IN	O
addition	NN	O
dr.	FW	O
blincarour	NN	O
from	IN	O
radiation	NN	O
oncology	NN	O
saw	VBD	O
the	DT	O
patient	NN	O
and	CC	O
recommended	VBD	O
pelvic	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
wishes	VBZ	O
to	TO	O
get	VB	O
her	PRP$	B-TREATMENT
radiation	NN	I-TREATMENT
in	IN	O
o	NN	O
and	CC	O
has	VBZ	O
spoken	VBN	O
to	TO	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	JJ	O
regarding	VBG	O
this	DT	O
.	.	O

of	IN	O
note	PDT	O
the	DT	O
pelvic	JJ	O
lymph	NN	O
nodes	NNS	O
which	WDT	O
were	VBD	O
dissected	VBN	O
were	VBD	O
positive	JJ	O
for	IN	O
tumor	NN	B-PROBLEM
by	IN	O
frozen	JJ	B-TEST
section	NN	I-TEST
analysis	NN	I-TEST
.	.	O

the	DT	B-TEST
permanent	JJ	I-TEST
pathology	NN	I-TEST
sections	NNS	I-TEST
are	VBP	O
still	RB	O
pending	VBG	O
.	.	O

renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
83-year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
steroid-treated	JJ	B-PROBLEM
polymyalgia	NN	I-PROBLEM
rheumatica	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
and	CC	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
who	WP	O
presented	VBD	O
for	IN	O
a	DT	B-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
peripheral	JJ	I-TEST
angiography	NN	I-TEST
for	IN	O
bilateral	JJ	B-PROBLEM
foot	NN	I-PROBLEM
ulcers	NNS	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
an	DT	B-PROBLEM
evaluated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
urea	JJ	I-PROBLEM
nitrogen	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
creatinine	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
potassium	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
notes	VBZ	O
he	PRP	O
developed	VBD	O
worsening	VBG	B-PROBLEM
foot	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
ulcers	NNS	B-PROBLEM
four	CD	O
months	NNS	O
ago	RB	O
.	.	O

due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
worsening	VBG	I-PROBLEM
blood	NN	I-PROBLEM
glucose	NN	I-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
insulin	NN	B-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
foot	NN	I-PROBLEM
ulcers	NNS	I-PROBLEM
continued	VBD	O
to	TO	O
develop	VB	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
feet	NNS	I-PROBLEM
;	:	O
primarily	RB	O
at	IN	O
night	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
for	IN	O
vascular	JJ	O
consultation	NN	O
because	IN	O
of	IN	O
the	DT	B-PROBLEM
ulcerations	NNS	I-PROBLEM
and	CC	O
pain	NN	B-PROBLEM
and	CC	O
scheduled	VBN	O
for	IN	O
a	DT	O
lower	JJR	O

extremity	NN	B-TEST
angiography	NN	I-TEST
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
,	,	O
but	CC	O
due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
the	DT	O
procedure	NN	O
was	VBD	O
cancelled	VBN	O
.	.	O

the	DT	O
patient	NN	O
showed	VBD	O
peaked	JJ	B-PROBLEM
t	NN	I-PROBLEM
waves	NNS	I-PROBLEM
on	IN	O
electrocardiogram	NN	B-TEST
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
medicine	VB	O
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
any	DT	O
oliguria	NN	B-PROBLEM
,	,	O
hematuria	NN	B-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
foamy	JJ	B-PROBLEM
urine	NN	I-PROBLEM
,	,	O
flank	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
or	CC	O
urinary	JJ	B-PROBLEM
hesitancy	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
complained	VBN	O
of	IN	O
fatigue	NN	B-PROBLEM
,	,	O
anorexia	NN	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
10-pound	JJ	I-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	O
the	DT	O
last	JJ	O
four	CD	O
months	NNS	O
.	.	O

he	PRP	O
gets	VBZ	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
one	CD	O
flight	NN	O
of	IN	O
stairs	NNS	O
.	.	O

he	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
fevers	NNS	I-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
,	,	O
recent	JJ	B-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
orthopnea	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
hematemesis	NN	B-PROBLEM
,	,	O
melena	NN	B-PROBLEM
,	,	O
or	CC	O
hematochezia	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
notes	VBZ	O
he	PRP	O
has	VBZ	O
had	VBD	O
hoarseness	VBN	B-PROBLEM
for	IN	O
the	DT	O
last	JJ	O
two	CD	O
to	TO	O
three	CD	O
weeks	NNS	O
.	.	O

1.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	JJ	I-PROBLEM
times	NNS	O
four	CD	O
years	NNS	O
;	:	O
recently	RB	O
started	VBD	O
insulin	NN	B-TREATMENT
and	CC	O
metformin	NN	B-TREATMENT
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
concurrent	NN	I-TREATMENT
steroid	NN	I-TREATMENT
use	NN	I-TREATMENT
.	.	O

last	JJ	O
hemoglobin	NN	B-TEST
a1c	NN	I-TEST
was	VBD	O
11.4	CD	O
.	.	O

2.	CD	O
polymyalgia	NN	B-PROBLEM
rheumatica	NN	I-PROBLEM
diagnosed	VBD	O
four	CD	O
years	NNS	O
ago	RB	O
;	:	O
on	IN	O
steroids	NNS	B-TREATMENT
.	.	O

3.	CD	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
transurethral	JJ	B-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
prostate	NN	I-TREATMENT
.	.	O

4.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

5.	CD	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
.	.	O

6.	CD	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

methylprednisolone	NN	B-TREATMENT
4	CD	O
mg	NN	O
q.	NN	O
a.m.	NN	O
and	CC	O
2	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
spironolactone	NN	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
metformin	NN	B-TREATMENT
1500	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
pravastatin	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
lisinopril	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
a.m.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
80	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
a.m.	NN	O
,	,	O
tylenol	NN	B-TREATMENT
as	IN	O
needed	VBN	O
,	,	O
insulin	JJ	B-TREATMENT
regular	JJ	I-TREATMENT
22	CD	O
units	NNS	O
in	IN	O
the	DT	O
morning	NN	O
and	CC	O
12	CD	O
units	NNS	O
at	IN	O
night	NN	O
(	(	O
lispro	JJ	B-TREATMENT
regular	NN	I-TREATMENT
).	NN	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

type	NN	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
in	IN	O
twin	NN	O
brother	NN	O
,	,	O
type	NN	B-PROBLEM
2	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
in	IN	O
mother	NN	O
and	CC	O
brother	NN	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
temperature	NN	B-TEST
was	VBD	O
98.1	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
140/70	CD	O
,	,	O
pulse	NN	B-TEST
was	VBD	O
95	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
was	VBD	O
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
thin	JJ	O
white	JJ	O
male	NN	O
,	,	O
lying	VBG	O
in	IN	O
bed	NN	O
,	,	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
hoarse	JJ	I-PROBLEM
voice	NN	I-PROBLEM
.	.	O

sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

neck	NN	O
revealed	VBD	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
.	.	O

a	DT	B-PROBLEM
2/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
with	IN	O
faint	NN	B-PROBLEM
lower	RBR	I-PROBLEM
lobe	NN	I-PROBLEM
crackles	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

back	RB	O
revealed	VBN	O
no	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

no	DT	O
rebound	NN	B-PROBLEM
or	CC	O
guarding	NN	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

extremities	NNS	O
revealed	VBD	O
2+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	I-TEST
,	,	O
1+	CD	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
pulses	VBZ	I-TEST
bilaterally	RB	I-TEST
.	.	O

no	DT	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

left	JJ	O
foot	NN	O
with	IN	O
a	DT	B-PROBLEM
dry	JJ	I-PROBLEM
crusted	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
over	IN	O
the	DT	O
medial	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
first	JJ	O
metatarsal	NN	O
head	NN	O
and	CC	O
the	DT	O
lateral	JJ	O
posterior	JJ	O
heel	NN	O
.	.	O

on	IN	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
dry	JJ	I-PROBLEM
crusted	VBD	I-PROBLEM
ulcer	NN	I-PROBLEM
over	IN	O
the	DT	O
medial	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
first	JJ	O
metatarsal	NN	O
head	NN	O
and	CC	O
medial	JJ	O
posterior	NN	O
heel	NN	O
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
grossly	RB	O
intact	JJ	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
30	CD	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
269	CD	O
.	.	O

sodium	NN	B-TEST
was	VBD	O
139	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
6.1	CD	O
,	,	O
chloride	NN	B-TEST
was	VBD	O
102	CD	O
,	,	O
bicarbonate	NN	B-TEST
was	VBD	O
18	CD	O
,	,	O
blood	NN	B-TEST
urea	JJ	I-TEST
nitrogen	NN	I-TEST
was	VBD	O
100	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
2.3	CD	O
,	,	O
and	CC	O
blood	NN	B-TEST
glucose	NN	I-TEST
was	VBD	O
189	CD	O
.	.	O

fena	NN	B-TEST
was	VBD	O
0.37	CD	O
.	.	O

renal	JJ	B-TEST
ultrasound	NN	I-TEST
was	VBD	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
83	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
,	,	O
steroid-treated	JJ	B-PROBLEM
polymyalgia	NN	I-PROBLEM
rheumatica	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
and	CC	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
without	IN	O
presented	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
for	IN	O
lower	JJR	B-TEST
extremity	NN	I-TEST
angiograph	NN	I-TEST
;	:	O
however	RB	O
,	,	O
that	DT	O
was	VBD	O
deferred	VBN	O
due	JJ	O
to	TO	O
new	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

1.	CD	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
thought	VBN	O
to	TO	O
be	VB	O
prerenal	JJ	B-PROBLEM
,	,	O
and	CC	O
his	PRP$	O
renal	JJ	O
status	NN	O
improved	VBN	O
after	IN	O
hydration	NN	B-TREATMENT
and	CC	O
increased	VBD	B-TREATMENT
oral	JJ	I-TREATMENT
intake	NN	I-TREATMENT
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
a	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
angiography	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
kidneys	NNS	I-TEST
which	WDT	O
showed	VBD	O
mild	JJ	B-PROBLEM
right-sided	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

his	PRP$	O
renal	JJ	O
function	NN	O
fluctuated	VBD	O
throughout	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
and	CC	O
when	WRB	O
he	PRP	O
was	VBD	O
in	IN	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
he	PRP	O
did	VBD	O
have	VB	O
decreased	VBN	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
cardiogenic	JJ	B-PROBLEM
shock	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
with	IN	O
severe	JJ	B-PROBLEM
peripheral	JJ	I-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

during	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
he	PRP	O
developed	VBD	O
some	DT	B-PROBLEM
nonsustained	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
on	IN	O
07-02	NN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
infection	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
and	CC	O
went	VBD	O
into	IN	O
sustained	VBN	B-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
that	WDT	O
was	VBD	O
treated	VBN	O
with	IN	O
lidocaine	NN	B-TREATMENT
.	.	O

after	IN	O
being	VBG	O
treated	VBN	O
with	IN	O
lidocaine	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
apneic	JJ	B-PROBLEM
requiring	VBG	O
intubation	NN	B-TREATMENT
and	CC	O
transfer	NN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
.	.	O

his	PRP$	B-PROBLEM
nonsustained	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
lidocaine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
he	PRP	O
had	VBD	O
elevated	VBN	B-PROBLEM
troponins	NNS	I-PROBLEM
and	CC	O
likely	JJ	O
an	DT	B-PROBLEM
ischemic	JJ	I-PROBLEM
event	NN	I-PROBLEM
on	IN	O
the	DT	O
07-02	NN	O
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
fraction	NN	I-PROBLEM
from	IN	O
prior	JJ	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
which	WDT	O
revealed	VBD	O
3-vessel	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

cardiothoracic	NN	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
,	,	O
and	CC	O
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
acute	JJ	I-PROBLEM
illness	NN	I-PROBLEM
,	,	O
they	PRP	O
wanted	VBD	O
to	TO	O
re-evaluate	VB	O
after	IN	O
the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
have	VB	O
intermittent	JJ	O
episodes	NNS	O
of	IN	O
ventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
lidocaine	NN	B-TREATMENT
and	CC	O
eventually	RB	O
changed	VBN	O
over	IN	O
to	TO	O
amiodarone	VB	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
cardiogenic	JJ	B-PROBLEM
shock	NN	I-PROBLEM
requiring	VBG	O
pressors	NNS	B-TREATMENT
.	.	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
likely	RB	O
suffered	VBD	O
a	DT	B-PROBLEM
second	JJ	I-PROBLEM
ischemic	JJ	I-PROBLEM
event	NN	I-PROBLEM
during	IN	O
his	PRP$	O
coronary	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
a	DT	B-TEST
swan-ganz	JJ	I-TEST
catheter	NN	I-TEST
in	IN	O
place	NN	O
and	CC	O
had	VBD	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
cardiac	NN	I-PROBLEM
output	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
treated	VBN	O
with	IN	O
levofloxacin	NN	B-TREATMENT
for	IN	O
a	DT	B-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
then	RB	O
developed	VBD	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
with	IN	O
staphylococcus	JJ	B-PROBLEM
aureus	NNS	I-PROBLEM
sensitive	JJ	O
to	TO	O
levofloxacin	VB	B-TREATMENT
,	,	O
and	CC	O
that	DT	O
was	VBD	O
continued	VBN	O
.	.	O

when	WRB	O
the	DT	O
patient	NN	O
became	VBD	O
hypotensive	JJ	B-PROBLEM
and	CC	O
required	JJ	O
intubation	NN	B-TREATMENT
and	CC	O
pressors	NNS	B-TREATMENT
,	,	O
his	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
broadened	VBN	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
stress-dose	JJ	B-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
bilateral	JJ	B-PROBLEM
staphylococcus	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
required	VBN	O
intubation	NN	B-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
and	CC	O
ventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
actually	RB	O
extubated	VBN	O
on	IN	O
07-09	JJ	O
,	,	O
but	CC	O
then	RB	O
reintubated	VBD	O
one	CD	O
hour	NN	O
later	RB	O
due	JJ	O
to	TO	O
hypoxia	VB	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
bilateral	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
occipital	NN	I-PROBLEM
,	,	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

right	JJ	B-PROBLEM
occipital	NN	I-PROBLEM
,	,	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

old	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
1984	CD	O
.	.	O

head	NN	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
angiogram	NN	I-TEST
with	IN	I-TEST
and	CC	I-TEST
without	IN	I-TEST
gadolinium	NN	I-TEST
.	.	O

head	NN	B-TEST
computerized	VBD	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
,	,	O
echocardiogram	NN	B-TEST
,	,	O
transcranial	JJ	B-TEST
dopplers	NNS	I-TEST
,	,	O
carotid	NN	B-TEST
noninvasives	NNS	I-TEST
,	,	O
holter	NN	B-TEST
electrocardiogram	NN	I-TEST
,	,	O
electroencephalogram	NN	B-TEST
,	,	O
and	CC	O
visual	JJ	B-TEST
field	NN	I-TEST
testing	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
72-year-old	JJ	O
right-handed	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
1984	CD	O
.	.	O

also	RB	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
noninsulin	JJ	B-PROBLEM
dependent	JJ	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
now	RB	O
presenting	VBG	O
with	IN	O
acute	JJ	B-PROBLEM
blurry	NN	I-PROBLEM
vision	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
,	,	O
which	WDT	O
is	VBZ	O
homonymous	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
sudden	JJ	O
onset	NN	O
of	IN	O
blurred	JJ	B-PROBLEM
vision	NN	I-PROBLEM
,	,	O
where	WRB	O
the	DT	O
right	JJ	O
side	NN	O
of	IN	O
his	PRP$	O
wife	NN	O
&apos;s	NNP	O
face	NN	O
looked	VBD	O
blurred	VBN	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
notice	JJ	O
change	NN	B-PROBLEM
of	IN	I-PROBLEM
vision	NN	I-PROBLEM
in	IN	O
the	DT	O
background	NN	O
.	.	O

the	DT	B-PROBLEM
blurred	JJ	I-PROBLEM
vision	NN	I-PROBLEM
was	VBD	O
homonymous	JJ	O
,	,	O
which	WDT	O
he	PRP	O
had	VBD	O
blurred	VBN	O
in	IN	O
each	DT	O
eye	NN	O
in	IN	O
the	DT	O
left	JJ	O
visual	JJ	O
field	NN	O
.	.	O

the	DT	B-PROBLEM
same	JJ	I-PROBLEM
blurred	JJ	I-PROBLEM
vision	NN	I-PROBLEM
was	VBD	O
also	RB	O
noticed	VBN	O
later	RB	O
when	WRB	O
the	DT	O
patient	NN	O
was	VBD	O
watching	VBG	O
television	NN	O
and	CC	O
also	RB	O
when	WRB	O
he	PRP	O
was	VBD	O
reading	VBG	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
ph	VB	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
for	IN	O
rule	NN	O
out	IN	O
transient	NN	B-PROBLEM
ischemic	JJ	I-PROBLEM
attack	NN	I-PROBLEM
and	CC	O
rule	NN	O
out	IN	O
stroke	NN	B-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	B-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
ataxia	NN	B-PROBLEM
,	,	O
motor	NN	B-PROBLEM
deficits	NNS	I-PROBLEM
,	,	O
speech	NN	B-PROBLEM
deficits	NNS	I-PROBLEM
or	CC	O
sensory	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
lightly	RB	O
bumped	VBD	O
his	PRP$	O
head	NN	O
on	IN	O
the	DT	O
top	JJ	O
three	CD	O
times	NNS	O
on	IN	O
the	DT	O
previous	JJ	O
night	NN	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
frontal	JJ	B-PROBLEM
headaches	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
tight	JJ	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

is	VBZ	O
significant	JJ	O
for	IN	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
1984	CD	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
on	IN	O
cardiac	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
since	IN	O
and	CC	O
has	VBZ	O
had	VBN	O
no	DT	O
new	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
diagnosed	VBN	O
with	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
since	IN	O
1991	CD	O
and	CC	O
has	VBZ	O
been	VBN	O
maintained	VBN	O
on	IN	O
glipizide	NN	B-TREATMENT
.	.	O

in	IN	O
1992	CD	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
diagnosed	VBN	O
with	IN	O
bladder	NN	B-PROBLEM
papilloma	NN	I-PROBLEM
and	CC	O
has	VBZ	O
been	VBN	O
cystoscoped	VBN	O
seven	CD	O
times	NNS	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
stroke	NN	B-PROBLEM
but	CC	O
no	DT	O
history	NN	O
of	IN	O
migraines	NNS	B-PROBLEM
.	.	O

lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
cardizem	VBP	B-TREATMENT
30	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
,	,	O
zantac	VBZ	B-TREATMENT
150	CD	O
mg	NN	O
po	NN	O
qd	NN	O
,	,	O
isordil	JJ	B-TREATMENT
60	CD	O
mg	NN	O
po	NN	O
q	NN	O
a.m.	NN	O
,	,	O
60	CD	O
mg	NN	O
po	NN	O
q	NN	O
noon	NN	O
,	,	O
30	CD	O
mg	NN	O
po	NN	O
q	CD	O
p.m.	NN	O
and	CC	O
30	CD	O
mg	NN	O
po	NN	O
q	NN	O
hs	NN	O
,	,	O
glipizide	JJ	B-TREATMENT
po	NN	O
5	CD	O
mg	NN	O
q	NN	O
a.m.	NN	O

the	DT	O
patient	NN	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	O
neck	NN	O
was	VBD	O
supple	JJ	O
and	CC	O
no	DT	O
goiter	NN	B-PROBLEM
was	VBD	O
noticed	VBN	O
,	,	O
no	DT	O
bruit	NN	B-PROBLEM
was	VBD	O
noticed	VBN	O
.	.	O

the	DT	O
heart	NN	O
had	VBD	O
normal	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
with	IN	O
normal	JJ	O
sl	NNS	O
and	CC	O
s2	NN	O
and	CC	O
no	DT	O
significant	JJ	B-PROBLEM
heart	NN	I-PROBLEM
murmur	NN	I-PROBLEM
was	VBD	O
heard	VBN	O
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
flat	JJ	O
,	,	O
nontender	FW	B-PROBLEM
,	,	O
with	IN	O
normal	JJ	O
bowel	NN	O
sounds	NNS	O
and	CC	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
was	VBD	O
noticed	VBN	O
.	.	O

no	DT	O
mass	NN	B-PROBLEM
was	VBD	O
noticed	VBN	O
.	.	O

capillary	JJ	B-TEST
refill	NN	I-TEST
was	VBD	O
normal	JJ	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

the	DT	O
calves	NNS	O
were	VBD	O
nontender	JJR	B-PROBLEM
.	.	O

on	IN	O
neurological	JJ	B-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
alert	JJ	O
,	,	O
oriented	VBN	O
to	TO	O
time	NN	O
,	,	O
place	NN	O
and	CC	O
person	NN	O
.	.	O

for	IN	O
cranial	JJ	O
nerves	NNS	O
the	DT	O
patient	NN	O
had	VBD	O
minimal	JJ	B-PROBLEM
blurred	VBN	I-PROBLEM
vision	NN	I-PROBLEM
in	IN	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
extra	JJ	I-TEST
ocular	JJ	I-TEST
movements	NNS	I-TEST
were	VBD	O
full	JJ	O
with	IN	O
mild	JJ	B-PROBLEM
terminal	JJ	I-PROBLEM
nystagmus	NN	I-PROBLEM
,	,	O
2-3	JJ	O
beats	NNS	O
,	,	O
in	IN	O
the	DT	O
right	JJ	O
lateral	JJ	O
gaze	NN	O
.	.	O

the	DT	B-TEST
light	JJ	I-TEST
reflex	NN	I-TEST
was	VBD	O
slightly	RB	B-PROBLEM
slow	JJ	I-PROBLEM
but	CC	O
equal	JJ	O
and	CC	O
intact	JJ	O
direct	JJ	O
and	CC	O
indirectly	RB	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
conduction	NN	B-PROBLEM
hearing	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
,	,	O
which	WDT	O
had	VBD	O
been	VBN	O
old	JJ	O
.	.	O

the	DT	B-TEST
motor	NN	I-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
tone	NN	O
and	CC	O
bulk	NN	O
were	VBD	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
mild	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
with	IN	O
the	DT	B-TEST
strength	NN	I-TEST
of	IN	O
5	CD	O
minus	NNS	O
on	IN	O
the	DT	O
upper	JJ	O
and	CC	O
lower	JJR	O
extremities	NNS	O
,	,	O
distally	RB	O
and	CC	O
proximally	RB	O
.	.	O

the	DT	O
coordination	NN	O
was	VBD	O
intact	JJ	O
for	IN	O
finger-nose-finger	JJ	B-TEST
test	NN	I-TEST
,	,	O
rapid	JJ	O
alternating	VBG	O
hand	NN	O
movements	NNS	O
.	.	O

the	DT	B-TEST
heel-shin-test	NN	I-TEST
was	VBD	O
slightly	RB	B-PROBLEM
clumsy	JJ	I-PROBLEM
bilaterally	RB	I-PROBLEM
but	CC	O
the	DT	O
knee	NN	O
tapping	NN	O
was	VBD	O
normal	JJ	O
bilaterally	RB	O
.	.	O

sensory	JJ	B-TEST
examination	NN	I-TEST
:	:	O

the	DT	O
patient	NN	O
had	VBD	O
decreased	VBN	B-PROBLEM
vibratory	JJ	I-PROBLEM
sense	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
,	,	O
worse	JJR	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
.	.	O

the	DT	B-TEST
babinski	NN	I-TEST
&apos;s	NN	I-TEST
were	VBD	O
negative	JJ	O
bilaterally	RB	O
.	.	O

the	DT	B-TEST
cross	NN	I-TEST
extension	NN	I-TEST
reflex	NN	I-TEST
was	VBD	O
positive	JJ	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

complete	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
:	:	O

white	JJ	B-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
7	CD	O
,	,	O
hematocrit	NN	B-TEST
42.7%	CD	O
,	,	O
hemoglobin	NN	B-TEST
14.3	CD	O
,	,	O
platelets	NNS	B-TEST
161	CD	O
.	.	O

69%	CD	B-TEST
polys	NN	I-TEST
,	,	O
60%	CD	B-TEST
lymphs	NN	I-TEST
,	,	O
10%	CD	B-TEST
monos	NNS	I-TEST
,	,	O
5%	CD	B-TEST
eos	NN	I-TEST
.	.	O

prothrombin	JJ	B-TEST
time	NN	I-TEST
11.7	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
30.4	CD	O
.	.	O

over	IN	B-TEST
100	CD	I-TEST
red	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
per	IN	O
high	JJ	O
powered	JJ	O
field	NN	O
,	,	O
20-50	JJ	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
per	IN	O
high	JJ	O
powered	JJ	O
field	NN	O
.	.	O

sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
4.7	CD	O
,	,	O
chloride	RB	B-TEST
106	CD	O
,	,	O
bicarbonate	NN	B-TEST
21.6	CD	O
,	,	O
bun	NN	B-TEST
22	CD	O
,	,	O
creatinine	NN	B-TEST
1.6	CD	O
,	,	O
glucose	RB	B-TEST
107	CD	O
,	,	O
amylase	NN	B-TEST
120	CD	O
,	,	O
calcium	NN	B-TEST
8.7	CD	O
,	,	O
phosphorus	NN	B-TEST
3.3	CD	O
,	,	O
magnesium	NN	B-TEST
1.9	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
7.5	CD	O
,	,	O
albumin	RB	B-TEST
3.9	CD	O
,	,	O
globulin	NN	B-TEST
3.6	CD	O
,	,	O
uric	JJ	B-TEST
acid	NN	I-TEST
5.6	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
43	CD	O
,	,	O
got	VBD	B-TEST
42	CD	O
,	,	O
ldh	VBD	B-TEST
549	CD	O
with	IN	O
hemolyzed	JJ	B-TEST
sample	NN	I-TEST
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
revealed	VBD	O
no	DT	O
pneumonia	NN	B-PROBLEM
,	,	O
no	DT	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
revealed	VBD	O
q-waves	NNS	B-PROBLEM
in	IN	I-PROBLEM
leads	NNS	I-PROBLEM
ii	RB	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
and	CC	I-PROBLEM
avf	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
revealed	VBD	O
right	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
occipital	JJ	I-PROBLEM
low-density	JJ	I-PROBLEM
area	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
and	CC	O
magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	VBG	I-TEST
angiogram	NN	I-TEST
obtained	VBN	O
on	IN	O
may	MD	O
11	CD	O
,	,	O
1995	CD	O
,	,	O
revealed	VBD	O
subacute	NN	B-PROBLEM
right	RB	I-PROBLEM
lateral	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
decreased	VBD	B-PROBLEM
flow	NN	I-PROBLEM
related	VBN	I-PROBLEM
enhancement	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
posterior	JJ	I-PROBLEM
communicating	VBG	I-PROBLEM
artery	NN	I-PROBLEM
with	IN	O
respect	NN	O
to	TO	O
that	DT	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

the	DT	O
right	NN	O
suggested	VBD	O
decreased	JJ	B-PROBLEM
flow	NN	I-PROBLEM
.	.	O

carotid	NN	B-TEST
noninvasives	NNS	I-TEST
revealed	VBD	O
minimal	JJ	B-PROBLEM
carotid	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

transcranial	JJ	B-TEST
dopplers	NNS	I-TEST
:	:	O

holter	NN	B-TEST
electrocardiogram	NN	I-TEST
:	:	O

no	DT	O
significant	JJ	B-PROBLEM
arrhythmias	NN	I-PROBLEM
.	.	O

electroencephalogram	NN	B-TEST
:	:	O

visual	JJ	B-TEST
field	NN	I-TEST
testing	NN	I-TEST
:	:	O

small	JJ	B-PROBLEM
wedge-shaped	JJ	I-PROBLEM
visual	JJ	I-PROBLEM
field	NN	I-PROBLEM
defect	NN	I-PROBLEM
in	IN	I-PROBLEM
right	JJ	I-PROBLEM
eye	NN	I-PROBLEM
,	,	O
suggesting	VBG	O
retinal	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

echocardiogram	NN	B-TEST
revealing	VBG	O
segmental	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
involving	VBG	O
inferoseptal	JJ	O
,	,	O
inferior	JJ	O
and	CC	O
posterior	JJ	O
segments	NNS	O
at	IN	O
the	DT	O
base	NN	O
and	CC	O
mid	JJ	O
ventricular	JJ	O
level	NN	O
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricle	NN	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
moderately	RB	B-PROBLEM
impaired	JJ	I-PROBLEM
with	IN	O
and	CC	B-TEST
estimated	VBN	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
35%	CD	O
.	.	O

otherwise	RB	O
,	,	O
there	EX	O
was	VBD	O
pulmonary	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
tricuspid	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
,	,	O
mitral	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
and	CC	O
aortic	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
clots	NNS	B-PROBLEM
seen	VBN	O
on	IN	O
the	DT	B-TEST
echocardiogram	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
and	CC	O
had	VBD	O
the	DT	B-TEST
studies	NNS	I-TEST
as	IN	O
described	VBN	O
above	IN	O
for	IN	O
rule	NN	O
out	IN	O
source	NN	O
of	IN	O
embolic	JJ	B-PROBLEM
strokes	NNS	I-PROBLEM
including	VBG	O
carotid	NN	B-TEST
noninvasives	NNS	I-TEST
,	,	O
transcranial	JJ	B-TEST
dopplers	NNS	I-TEST
,	,	O
holter	NN	B-TEST
electrocardiogram	NN	I-TEST
and	CC	O
echocardiogram	NN	B-TEST
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
serial	JJ	B-TEST
electrocardiogram	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
no	DT	O
change	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
serial	JJ	B-TEST
creatinine	NN	I-TEST
kinase	NN	I-TEST
with	IN	I-TEST
mb	JJ	I-TEST
fractions	NNS	I-TEST
studied	VBN	O
,	,	O
which	WDT	O
revealed	VBD	O
mb	NNS	B-TEST
fraction	NN	I-TEST
too	RB	B-PROBLEM
low	JJ	I-PROBLEM
to	TO	O
be	VB	O
tested	VBN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
experienced	VBD	O
a	DT	O
feeling	NN	O
of	IN	O
moving	VBG	O
back	RB	O
and	CC	O
forth	NN	O
when	WRB	O
lying	VBG	O
down	RP	O
with	IN	O
neck	NN	O
extended	VBN	O
during	IN	O
the	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
and	CC	O
also	RB	O
in	IN	O
bed	NN	O
.	.	O

this	DT	B-PROBLEM
moving	VBG	I-PROBLEM
sense	NN	I-PROBLEM
,	,	O
with	IN	O
normal	JJ	O
electroencephalogram	NN	O
,	,	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
vestibular	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
or	CC	O
from	IN	O
the	DT	O
acute	JJ	O
episode	NN	O
of	IN	O
the	DT	B-PROBLEM
stroke	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
will	MD	O
have	VB	O
these	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
only	RB	O
when	WRB	O
the	DT	O
eyes	NNS	O
are	VBP	O
closed	VBN	O
.	.	O

our	PRP$	O
opinion	NN	O
was	VBD	O
not	RB	O
to	TO	O
intervene	VB	O
or	CC	O
have	VB	O
any	DT	B-TEST
further	JJ	I-TEST
studies	NNS	I-TEST
for	IN	O
acute	JJ	O
period	NN	O
and	CC	O
to	TO	O
continued	VB	O
to	TO	O
observe	VB	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
hypotensive	JJ	I-PROBLEM
episode	NN	I-PROBLEM
and	CC	O
the	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
80	CD	O
,	,	O
after	IN	O
the	DT	O
patient	NN	O
received	VBD	O
his	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
cardiac	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
off	RP	O
his	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
since	IN	O
during	IN	O
the	DT	O
admission	NN	O
and	CC	O
will	MD	O
be	VB	O
discharged	VBN	O
off	RP	O
his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

otherwise	RB	O
,	,	O
there	EX	O
were	VBD	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
blurred	JJ	B-PROBLEM
vision	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
with	IN	O
an	DT	O
unchanged	JJ	O
neurological	JJ	B-TEST
and	CC	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
and	CC	O
was	VBD	O
discharged	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
qd	NN	O
,	,	O
on	IN	O
may	MD	O
14	CD	O
,	,	O
1995	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
with	IN	O
the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
as	IN	O
described	VBN	O
above	IN	O
.	.	O

medications	NNS	B-TREATMENT
-	:	O
aspirin	NN	B-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
qd	NN	O
,	,	O
glipizide	RB	B-TREATMENT
25	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
discharged	VBN	O
home	NN	O
without	IN	O
his	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
cardiac	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
will	MD	O
also	RB	O
be	VB	O
followed	VBN	O
by	IN	O
his	PRP$	O
regular	JJ	O
urologist	NN	O
at	IN	O
ochtuheihugh	IN	O
put	NN	O
university	NN	O
medical	JJ	O
center	NN	O
within	IN	O
one	CD	O
week	NN	O
after	IN	O
discharge	NN	O
for	IN	O
his	PRP$	B-PROBLEM
continuing	VBG	I-PROBLEM
hematuria	NNS	I-PROBLEM
.	.	O

in	IN	O
brief	NN	O
,	,	O
the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
64	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
significant	JJ	O
history	NN	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
three	CD	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarctions	NNS	I-PROBLEM
and	CC	O
also	RB	O
status	NN	O
post	NN	O
five	CD	B-TREATMENT
vessel	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
'	POS	O
89	CD	O
and	CC	O
status	NN	O
post	NN	O
multiple	RB	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasties	NNS	I-TREATMENT
who	WP	O
recently	RB	O
had	VBD	O
a	DT	B-TEST
catheterization	NN	I-TEST
done	VBN	O
in	IN	O
mississippi	NN	O
and	CC	O
stent	NN	B-TREATMENT
placed	VBN	O
in	IN	O
2013-03-24	JJ	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
until	IN	O
approximately	RB	O
three	CD	O
to	TO	O
four	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
presentation	NN	O
when	WRB	O
he	PRP	O
began	VBD	O
to	TO	O
experience	VB	O
increased	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
on	IN	O
exertion	NN	O
.	.	O

one	CD	O
week	NN	O
prior	RB	O
to	TO	O
presentation	NN	O
,	,	O
he	PRP	O
had	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
leading	VBG	O
to	TO	O
a	DT	B-TEST
repeat	NN	I-TEST
catheterization	NN	I-TEST
at	IN	O
springfield	NN	O
on	IN	O
07-30	NN	O
which	WDT	O
showed	VBD	O
narrowing	NN	B-PROBLEM
of	IN	O
the	DT	B-TREATMENT
stent	NN	I-TREATMENT
and	CC	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
approximately	RB	O
20%	CD	O
.	.	O

no	DT	O
intervention	NN	B-TREATMENT
was	VBD	O
done	VBN	O
at	IN	O
that	DT	O
point	NN	O
.	.	O

on	IN	O
the	DT	O
evening	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
awoken	VBN	O
with	IN	O
chest	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
radiating	VBG	O
to	TO	O
the	DT	O
neck	NN	O
anginal	JJ	O

equivalent	NN	O
which	WDT	O
was	VBD	O
relieved	VBN	O
by	IN	O
sublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
.	.	O

this	DT	O
episode	NN	O
happened	VBD	O
three	CD	O
times	NNS	O
that	WDT	O
night	NN	O
and	CC	O
finally	RB	O
on	IN	O
the	DT	O
fourth	JJ	O
re-awakening	NN	O
,	,	O
the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
at	IN	O
springfield	NN	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
faulkner	NN	O
hospital	NN	O
for	IN	O
coronary	JJ	B-TREATMENT
revascularization	NN	I-TREATMENT
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

2.	CD	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
x3	NN	I-PROBLEM

3.	CD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT

4.	CD	O
systemic	JJ	B-PROBLEM
lupus	NN	I-PROBLEM
erythematosus	NN	I-PROBLEM
in	IN	O
remission	NN	O

1.	CD	O
coreg	NN	B-TREATMENT
6.25	CD	O
mg	NN	O
po	NN	O
bid	NN	O

2.	CD	O
lasix	JJ	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
qd	NN	O

3.	CD	O
imdur	JJ	B-TREATMENT
30	CD	O
mg	NN	O
po	NN	O
qd	NN	O

4.	CD	O
k-dur	JJ	B-TREATMENT
10	CD	O
milliequivalents	NNS	O
po	JJ	O
qd	NN	O

5.	CD	O
zestril	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
po	NN	O
bid	NN	O

6.	CD	O
multivitamin	NN	B-TREATMENT

7.	CD	O
folate	NN	B-TREATMENT

he	PRP	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
2	CD	I-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	FW	I-PROBLEM
heard	NN	O
loudest	NN	O
at	IN	O
the	DT	O
apex	NN	O
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
44	CD	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
8	CD	O
.	.	O

potassium	NN	B-TEST
was	VBD	O
3.9	CD	O
.	.	O

bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
was	VBD	O
18	CD	O
and	CC	O
0.9	CD	O
.	.	O

his	PRP$	B-TEST
troponin	NN	I-TEST
was	VBD	O
29.7	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
medically	RB	O
managed	VBN	O
initially	RB	O
and	CC	O
then	RB	O
underwent	JJ	O
on	IN	O
2013-08-09	JJ	O
,	,	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
x2	NNP	O
and	CC	O
a	DT	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
annuloplasty	NN	I-TREATMENT
with	IN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#1	NNP	O
,	,	O
his	PRP$	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
at	IN	O
2	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

he	PRP	O
also	RB	O
began	VBD	O
to	TO	O
wean	VB	O
off	RP	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#1	NNP	O
in	IN	O
the	DT	O
evening	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
go	VB	O
into	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
for	IN	O
which	WDT	O
he	PRP	O
was	VBD	O
controlled	VBN	O
and	CC	O
started	VBN	O
on	IN	O
amiodarone	NN	B-TREATMENT
,	,	O
after	IN	O
which	WDT	O
he	PRP	O
converted	VBD	O
again	RB	O
to	TO	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

his	PRP$	B-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
had	VBD	O
already	RB	O
been	VBN	O
removed	VBN	O
and	CC	O
on	IN	O
postoperative	JJ	O
day	NN	O
#3	NNP	O
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
on	IN	O
lopressor	NN	B-TREATMENT
and	CC	O
amiodarone	NN	B-TREATMENT
in	IN	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#4	NNP	O
,	,	O
he	PRP	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
on	IN	O
lopressor	NN	B-TREATMENT
at	IN	O
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
and	CC	O
an	DT	B-TREATMENT
amiodarone	NN	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
left	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
at	IN	O
this	DT	O
time	NN	O
and	CC	O
his	PRP$	B-TREATMENT
right	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
the	DT	O
following	JJ	O
day	NN	O
on	IN	O

he	PRP	O
remains	VBZ	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
and	CC	O
the	DT	O
patient	NN	O
is	VBZ	O
ambulating	VBG	O
to	TO	O
a	DT	O
level	NN	O
5	CD	O
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
wishes	NNS	O
to	TO	O
be	VB	O
discharged	VBN	O
home	NN	O
today	NN	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

2.	CD	O
mitral	JJ	B-PROBLEM
valve	NN	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
x2	NN	O
and	CC	O
mitral	JJ	B-TREATMENT
valve	NN	I-TREATMENT
annuloplasty	NN	I-TREATMENT

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

2.	CD	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
x3	NN	O

3.	CD	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT

1.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
bid	NN	O

2.	CD	O
amiodarone	NN	B-TREATMENT
taper	NN	I-TREATMENT
400	CD	O
mg	NN	O
po	NN	O
tid	NN	O
x4	NNP	O
days	NNS	O
,	,	O
then	RB	O
bid	VB	O
x7	NNP	O
days	NNS	O
,	,	O
qd	JJ	O
x7	NNP	O
days	NNS	O
,	,	O
then	RB	O
200	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O

3.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O

4.	CD	O
k-dur	JJ	B-TREATMENT
20	CD	O
milliequivalents	NNS	O
po	JJ	O
qd	NN	O

5.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
po	NN	O
qd	NN	O

6.	CD	O
percocet	JJ	B-TREATMENT
1	CD	O
to	TO	O
2	CD	O
po	NNS	O
q	RB	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
prn	NN	O

7.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O

8.	CD	O
percocet	NN	B-TREATMENT

9.	CD	O
protonix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qd	NN	O

ho	NN	B-TEST
evaluation	NN	I-TEST

nka	NN	B-PROBLEM

pp	NN	B-PROBLEM
/	CD	O
pps	NN	B-PROBLEM

principal	JJ	O
discharge	NN	O
diagnosis	NN	O
;	:	O
responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
pp	NN	B-PROBLEM

other	JJ	O
diagnosis	NN	O
;	:	O
conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
pp	NN	B-PROBLEM

epidural	JJ	B-TREATMENT

pps	NN	B-PROBLEM
,	,	O

bilateral	JJ	B-TREATMENT
tubal	JJ	I-TREATMENT
ligation	NN	I-TREATMENT

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
73	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
a	DT	O
recent	JJ	O
history	NN	O
of	IN	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
and	CC	O
hypercholesterolemia	NN	B-PROBLEM
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
department	NN	O
with	IN	O
the	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
syncope	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
from	IN	O
the	DT	O
hospital	NN	O
for	IN	O
orthopedics	NNS	O
with	IN	O
the	DT	O
diagnosis	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
about	IN	O
six	CD	O
months	NNS	O
prior	RB	O
to	TO	O
the	DT	O
current	JJ	O
admission	NN	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
warfarin	NN	B-TREATMENT
.	.	O

one	CD	O
month	NN	O
prior	RB	O
to	TO	O
this	DT	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
reports	VBZ	O
not	RB	O
feeling	VBG	O
well	RB	O
with	IN	O
worsening	VBG	B-PROBLEM
gastric	JJ	I-PROBLEM
distress	NN	I-PROBLEM
.	.	O

a	DT	O
few	JJ	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
he	PRP	O
fell	VBD	O
down	RB	O
on	IN	O
his	PRP$	O
back	NN	O
and	CC	O
started	VBD	O
taking	VBG	O
ibuprofen	NN	B-TREATMENT
1000	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
pain	NN	B-PROBLEM
and	CC	O
vioxx	NN	B-TREATMENT
in	IN	O
addition	NN	O
to	TO	O
his	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
and	CC	O
coumadin	JJ	B-TREATMENT
regimen	NNS	I-TREATMENT
.	.	O

the	DT	O
night	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
by	IN	O
his	PRP$	O
wife	NN	O
on	IN	O
the	DT	O
bathroom	NN	O
floor	NN	O
in	IN	O
a	DT	O
pool	NN	O
of	IN	O
urine	NN	O
,	,	O
unresponsive	JJ	B-PROBLEM
without	IN	O
any	DT	O
body	NN	O
movements	NNS	O
,	,	O
post-ictal	JJ	B-PROBLEM
state	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reports	VBZ	O
some	DT	B-PROBLEM
nausea	NN	I-PROBLEM
and	CC	O
epigastric	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
post-prandial	JJ	O
.	.	O

he	PRP	O
denies	VBZ	O
any	DT	O
emesis	NN	B-PROBLEM
,	,	O
melena	NN	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
or	CC	O
constipation	NN	B-PROBLEM
.	.	O

denies	NNS	O
incontinence	NN	B-PROBLEM
.	.	O

he	PRP	O
does	VBZ	O
have	VB	O
diaphoresis	NN	B-PROBLEM
and	CC	O
weakness	NN	B-PROBLEM
with	IN	O
orthostatic	JJ	O
changes	NNS	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
stool	NN	B-TEST
guaiac	NN	I-TEST
was	VBD	O
trace	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
24.8	CD	O
,	,	O
with	IN	O
a	DT	O
baseline	NN	O
of	IN	O
46	CD	O
.	.	O

gastric	JJ	B-TREATMENT
lavage	NN	I-TREATMENT
was	VBD	O
grossly	RB	O
positive	JJ	O
for	IN	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
material	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
inr	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
4.4	CD	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
vitamin	JJ	B-TREATMENT
k	NN	I-TREATMENT
10	CD	O
mg	NN	O
subcutaneously	RB	O
,	,	O
2.5	CD	O
liters	NNS	O
of	IN	O
normal	JJ	B-TREATMENT
saline	NN	I-TREATMENT
,	,	O
two	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
two	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
and	CC	O
transferred	VBD	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
further	JJ	O
management	NN	O
.	.	O

1.	CD	O
hyperthyroid	JJ	B-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
radioactive	JJ	B-TREATMENT
iodine	NN	I-TREATMENT
ablation	NN	I-TREATMENT
,	,	O
now	RB	O
hypothyroid	VBZ	B-PROBLEM
on	IN	O
levoxyl	NN	B-TREATMENT
.	.	O

2.	CD	O
history	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
,	,	O
etiology	NN	O
unknown	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
coumadin	NN	B-TREATMENT
five	CD	O
months	NNS	O
prior	RB	O
to	TO	O
this	DT	O
admission	NN	O
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

well	RB	O
controlled	VBN	O
on	IN	O
lipitor	NN	B-TREATMENT
.	.	O

last	JJ	B-TEST
total	JJ	I-TEST
cholesterol	NN	I-TEST
was	VBD	O
168	CD	O
in	IN	O
2015-08-24	JJ	O
.	.	O

4.	CD	O
paroxysmal	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
fibrillation	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

1.	CD	O
only	RB	O
significant	JJ	O
for	IN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
inguinal	JJ	I-TREATMENT
hernia	NN	I-TREATMENT
repair	NN	I-TREATMENT
.	.	O

penicillin	NN	B-TREATMENT
.	.	O

1.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
week	NN	O
.	.	O

2.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
.	.	O

3.	CD	O
propranolol	JJ	B-TREATMENT
10	CD	O
mg	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

4.	CD	O
coumadin	NN	B-TREATMENT
6.25	CD	O
mg	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

5.	CD	O
levoxyl	JJ	B-TREATMENT
100	CD	O
meq	JJ	O
q.	JJ	O
day	NN	O
.	.	O

6.	CD	O
ambien	JJ	B-TREATMENT
p.r.n.	NN	O

7.	CD	O
vitamins	NNS	B-TREATMENT
.	.	O

8.	CD	O
vioxx	NN	B-TREATMENT
times	NNS	O
three	CD	O
weeks	NNS	O
.	.	O

significant	JJ	O
for	IN	O
mother	NN	O
who	WP	O
has	VBZ	O
hypertension	NN	B-PROBLEM
and	CC	O
stroke	NN	B-PROBLEM
at	IN	O
the	DT	O
age	NN	O
of	IN	O
70	CD	O
.	.	O

temperature	NN	B-TEST
was	VBD	O
100.3	CD	O
f.	NN	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
115	CD	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

pupils	NNS	O
equally	RB	O
round	VBP	O
and	CC	O
reactive	VBP	O
to	TO	O
light	NN	B-TEST
and	CC	O
accommodation	NN	B-TEST
bilaterally	RB	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
normal	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

pulmonary	JJ	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
anteriorly	RB	O
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
with	IN	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
one	CD	O
to	TO	O
two	CD	O
pulses	NNS	O
in	IN	O
all	DT	O
four	CD	O
extremities	NNS	O
.	.	O

sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.4	CD	O
,	,	O
chloride	RB	B-TEST
108	CD	O
,	,	O
bicarbonate	NN	B-TEST
23	CD	O
,	,	O
bun	NN	B-TEST
57	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	VBD	B-TEST
115	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.0	CD	O
,	,	O
differential	NN	B-TEST
with	IN	O
76	CD	O
neutrophils	NNS	B-TEST
,	,	O
2	CD	O
monos	NNS	B-TEST
,	,	O
21	CD	O
lymphocytes	NNS	B-TEST
,	,	O
and	CC	O
no	DT	O
eosinophils	NNS	B-TEST
.	.	O

hematocrit	NN	B-TEST
24.8	CD	O
,	,	O
platelets	NNS	B-TEST
223	CD	O
,	,	O
inr	NN	B-TEST
2.4	CD	O
,	,	O
ck	NN	B-TEST
234	CD	O
.	.	O

ct	JJ	B-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
showed	VBD	O
no	DT	O
hemorrhage	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

ekg	RB	B-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
90	CD	O
with	IN	O
normal	JJ	O
intervals	NNS	O
and	CC	O
st	NNS	B-PROBLEM
wave	VBP	I-PROBLEM
inversions	NNS	I-PROBLEM
and	CC	O
early	JJ	B-PROBLEM
r	NN	I-PROBLEM
wave	NN	I-PROBLEM
progression	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
further	JJ	O
management	NN	O
for	IN	O
acute	NN	B-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

1.	CD	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
receive	VB	O
blood	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
on	IN	O
the	DT	O
floor	NN	O
and	CC	O
serial	JJ	B-TEST
hematocrits	NNS	I-TEST
with	IN	O
serial	JJ	B-TEST
inr	NN	I-TEST
checks	NNS	I-TEST
were	VBD	O
drawn	VBN	O
.	.	O

as	IN	O
he	PRP	O
was	VBD	O
receiving	VBG	O
his	PRP$	O
third	JJ	O
unit	NN	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
became	VBD	O
tachycardic	JJ	B-PROBLEM
and	CC	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
temperature	NN	I-TEST
raised	VBD	O
from	IN	O
98.6	CD	O
f.	NN	O
,	,	O
to	TO	O
101.0	CD	O
f.	NNS	O

he	PRP	O
was	VBD	O
shown	VBN	O
to	TO	O
have	VB	O
rigors	NNS	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
tylenol	RB	B-TREATMENT
1	CD	O
mg	NN	O
with	IN	O
epinephrine	NN	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
of	IN	O
hydrocortisone	NN	B-TREATMENT
,	,	O
25	CD	O
mg	NN	O
of	IN	O
benadryl	NN	B-TREATMENT
and	CC	O
demerol	NN	B-TREATMENT
15	CD	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
pepcid	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
emesis	NN	B-PROBLEM
times	NNS	O
three	CD	O
of	IN	O
75	CD	O
cc	NN	O
of	IN	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
material	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
desaturated	VBD	O
to	TO	O
the	DT	O
low	JJ	O
80	CD	O
s	NN	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
non-rebreather	JJ	I-TREATMENT
mask	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
saturations	NNS	I-TEST
improved	VBN	O
quickly	RB	O
on	IN	O
100%	CD	B-TREATMENT
non-rebreather	JJ	I-TREATMENT
mask	NN	I-TREATMENT
within	IN	O
15	CD	O
to	TO	O
20	CD	O
minutes	NNS	O
.	.	O

shortly	RB	O
after	IN	O
his	PRP$	O
mental	JJ	O
status	NN	O
changed	VBD	O
;	:	O
he	PRP	O
became	VBD	O
disoriented	JJ	B-PROBLEM
and	CC	O
euphoric	JJ	B-PROBLEM
and	CC	O
continued	VBD	O
to	TO	O
be	VB	O
in	IN	O
this	DT	O
state	NN	O
for	IN	O
two	CD	O
more	JJR	O
hours	NNS	O
.	.	O

after	IN	O
that	DT	O
period	NN	O
of	IN	O
time	NN	O
,	,	O
his	PRP$	O
mental	JJ	O
status	NN	O
gradually	RB	O
improved	VBN	O
and	CC	O
he	PRP	O
continued	VBD	O
to	TO	O
receive	VB	O
his	PRP$	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
requiring	VBG	O
a	DT	O
total	NN	O
of	IN	O
ten	JJ	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
four	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
to	TO	O
reach	VB	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
30.0	CD	O
,	,	O
which	WDT	O
remained	VBD	O
stable	JJ	O
for	IN	O
the	DT	O
duration	NN	O
of	IN	O
his	PRP$	O
stay	NN	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
high	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
proton	NN	I-TREATMENT
pump	NN	I-TREATMENT
inhibitors	NNS	I-TREATMENT
for	IN	O
prophylaxis	NN	B-TREATMENT
.	.	O

on	IN	O
wednesday	NN	O
,	,	O
11-25	JJ	O
,	,	O
an	DT	B-TEST
esophagogastroduodenoscopy	NN	I-TEST
was	VBD	O
performed	VBN	O
and	CC	O
was	VBD	O
significant	JJ	O
for	IN	O
the	DT	O
following	JJ	O
findings	NNS	O
:	:	O

medium	NN	B-PROBLEM
hiatal	NN	I-PROBLEM
hernia	NN	I-PROBLEM
,	,	O
barrett's	NN	B-PROBLEM
esophagus	NN	I-PROBLEM
,	,	O
erosion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
gastroesophageal	JJ	I-PROBLEM
junction	NN	I-PROBLEM
,	,	O
granularity	NN	B-PROBLEM
,	,	O
erythema	NN	B-PROBLEM
and	CC	O
congestion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
antrum	NN	I-PROBLEM
in	IN	O
the	DT	O
pre-pyloric	JJ	O
region	NN	O
compatible	JJ	O
with	IN	O
gastritis	NN	B-PROBLEM
.	.	O

erosions	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
antrum	NN	I-PROBLEM
and	CC	I-PROBLEM
pre-pyloric	JJ	I-PROBLEM
region	NN	I-PROBLEM
,	,	O
granularity	NN	B-PROBLEM
,	,	O
erythema	NN	B-PROBLEM
and	CC	O
congestion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
bulb	NN	I-PROBLEM
and	CC	I-PROBLEM
posterior	JJ	I-PROBLEM
bulb	NN	I-PROBLEM
compatible	JJ	O
with	IN	O
duodenitis	NN	B-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
recommended	VBN	O
by	IN	O
gastroenterology	NN	O
that	IN	O
the	DT	O
patient	NN	O
is	VBZ	O
to	TO	O
stay	VB	O
off	RP	O
aspirin	NN	B-TREATMENT
for	IN	O
at	IN	O
least	JJS	O
four	CD	O
to	TO	O
six	CD	O
weeks	NNS	O
at	IN	O
discharge	NN	O
to	TO	O
prevent	VB	O
further	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

during	IN	O
transfusion	NN	B-PROBLEM
reaction	NN	I-PROBLEM
episode	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
tachycardia	NN	B-PROBLEM
ranging	VBG	O
from	IN	O
134	CD	O
to	TO	O
158	CD	O
,	,	O
for	IN	O
one	CD	O
to	TO	O
two	CD	O
hours	NNS	O
.	.	O

ekg	NN	B-TEST
during	IN	O
this	DT	O
episode	NN	O
was	VBD	O
taken	VBN	O
and	CC	O
showed	VBN	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
serial	JJ	B-TEST
enzymes	NNS	I-TEST
were	VBD	O
significant	JJ	O
for	IN	O
ck	NN	B-TEST
peaking	NN	O
at	IN	O
1075	CD	O
,	,	O
mb	FW	B-TEST
peaking	VBG	O
at	IN	O
114	CD	O
and	CC	O
mb	JJ	B-TEST
index	NN	I-TEST
peaking	VBG	O
at	IN	O
10.8	CD	O
,	,	O
consistent	NN	O
with	IN	O
myocardial	JJ	B-PROBLEM
damage	NN	I-PROBLEM
.	.	O

the	DT	O
day	NN	O
following	VBG	O
this	DT	O
episode	NN	O
,	,	O
ekg	NN	B-TEST
showed	VBD	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
r	NN	I-PROBLEM
wave	VBP	I-PROBLEM
progression	NN	I-PROBLEM
in	IN	O
anterior	JJ	O
leads	NNS	O
and	CC	O
q	NN	B-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
leads	NNS	I-PROBLEM
iii	NNS	I-PROBLEM
and	CC	O
avf	JJ	B-PROBLEM
consistent	NN	O
with	IN	O
anteroseptal	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
remained	VBD	O
stable	JJ	O
during	IN	O
his	PRP$	O
stay	NN	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
episodes	NNS	O
of	IN	O
arrhythmia	NN	B-PROBLEM
on	IN	O
telemetry	NN	B-TEST
.	.	O

the	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
was	VBD	O
attributed	VBN	O
to	TO	O
demand	VB	B-PROBLEM
ischemia	JJ	I-PROBLEM
secondary	JJ	O
to	TO	O
acute	VB	B-PROBLEM
hematocrit	JJ	I-PROBLEM
drop	NN	I-PROBLEM
exacerbated	VBN	O
by	IN	O
tachycardia	NN	B-PROBLEM
secondary	JJ	O
to	TO	O
blood	VB	B-PROBLEM
transfusion	NN	I-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

further	JJ	B-TEST
cardiologic	VBD	I-TEST
work-up	NN	I-TEST
was	VBD	O
suggested	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
at	IN	O
four	CD	O
to	TO	O
six	CD	O
weeks	NNS	O
post	RB	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
lopressor	NN	B-TREATMENT
,	,	O
lipitor	NN	B-TREATMENT
and	CC	O
lisinopril	NN	B-TREATMENT
.	.	O

3.	CD	O
after	IN	O
ten	JJ	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
four	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
at	IN	O
above	IN	O
30	CD	O
.	.	O

his	PRP$	B-TEST
inr	NN	I-TEST
decreased	VBD	O
to	TO	O
1.3	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

he	PRP	O
required	VBD	O
no	DT	O
blood	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
for	IN	O
four	CD	O
days	NNS	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

4.	CD	O
history	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
likely	RB	O
secondary	JJ	O
to	TO	O
frequent	JJ	O
flying	NN	O
.	.	O

the	DT	O
need	NN	O
for	IN	O
further	JJ	B-TREATMENT
anti-coagulation	NN	I-TREATMENT
was	VBD	O
discussed	VBN	O
with	IN	O
the	DT	O
patient	NN	O
's	POS	O
attending	NN	O
,	,	O
dr.	JJ	O
coleman	NN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
decided	VBN	O
not	RB	O
to	TO	O
continue	VB	O
anti-coagulation	NN	B-TREATMENT
due	JJ	O
to	TO	O
increased	VBN	O
risk	NN	B-PROBLEM
of	IN	I-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
levothyroxine	NN	B-TREATMENT
soon	RB	O
after	IN	O
admission	NN	O
.	.	O

his	PRP$	B-TEST
hemoglobin	NN	I-TEST
a1c	NN	I-TEST
was	VBD	O
sent	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

6.	CD	O
single	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
change	NN	I-PROBLEM
times	NNS	O
two	CD	O
hours	NNS	O
during	IN	O
episode	NN	O
of	IN	O
blood	NN	B-PROBLEM
transfusion	NN	I-PROBLEM
reaction	NN	I-PROBLEM
.	.	O

was	VBD	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
multiple	VB	B-TREATMENT
drugs	NNS	I-TREATMENT
administered	VBN	O
during	IN	O
the	DT	O
episode	NN	O
including	VBG	O
demerol	NN	B-TREATMENT
.	.	O

7.	CD	O
prophylaxis	NN	B-TREATMENT
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
home	NN	O
on	IN	O
proton	NN	B-TREATMENT
pump	NN	I-TREATMENT
inhibitors	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TEST
helicobacter	NN	I-TEST
pylori	NN	I-TEST
serology	NN	I-TEST
was	VBD	O
sent	VBN	O
and	CC	O
was	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
the	DT	B-TREATMENT
following	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

1.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2.	CD	O
metoprolol	JJ	B-TREATMENT
37.5	CD	O
mg	NN	O
p.o.	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

5.	CD	O
levothyroxine	JJ	B-TREATMENT
100	CD	O
micrograms	NNS	O
p.o.	JJ	O
q.	JJ	O
day	NN	O
.	.	O

metastatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
.	.	O

metastatic	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
.	.	O

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
,	,	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
,	,	O
rectal	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
premature	NN	B-PROBLEM
ventricular	JJ	I-PROBLEM
contractions	NNS	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM
paralysis	NN	I-PROBLEM
.	.	O

10-02-94	JJ	O
left	VBD	B-TREATMENT
hepatectomy	NN	I-TREATMENT
,	,	O
10-01-94	JJ	O
celiac	NN	B-TEST
and	CC	I-TEST
superior	JJ	I-TEST
mesenteric	JJ	I-TEST
angiogram	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
60	CD	O
year	NN	O
old	JJ	O
diabetic	NN	O
who	WP	O
underwent	VBD	O
an	DT	B-TREATMENT
apr	NN	I-TREATMENT
in	IN	O
1989	CD	O
for	IN	O
rectal	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
and	CC	O
has	VBZ	O
been	VBN	O
doing	VBG	O
following	VBG	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
5fu	CD	B-TREATMENT
.	.	O

he	PRP	O
recently	RB	O
developed	VBD	O
fatigue	NN	B-PROBLEM
and	CC	O
dyspnea	NN	B-PROBLEM
and	CC	O
workup	NN	B-TEST
disclosed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
liver	NN	I-PROBLEM
mass	NN	I-PROBLEM
which	WDT	O
was	VBD	O
biopsied	VBN	O
and	CC	O
revealed	VBN	O
to	TO	O
be	VB	O
poorly	RB	B-PROBLEM
differentiated	VBN	I-PROBLEM
neoplasm	NN	I-PROBLEM
most	RBS	O
consistent	JJ	O
with	IN	O
metastatic	JJ	B-PROBLEM
rectal	NN	I-PROBLEM
discontinued	VBN	I-PROBLEM
.	.	O

remarkable	JJ	O
for	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
,	,	O
premature	NN	B-PROBLEM
ventricular	JJ	I-PROBLEM
contractions	NNS	I-PROBLEM
,	,	O
rectal	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
diabetic	JJ	B-PROBLEM
neuropathy	JJ	I-PROBLEM
both	DT	O
peripherally	RB	O
and	CC	O
involving	VBG	O
the	DT	O
right	JJ	O
diaphragm	NN	O
.	.	O

diabeta	NN	B-TREATMENT
10	CD	O
mg.	NN	O
po.	NN	O
bid	NN	O
.	.	O

serax	NN	B-TREATMENT
20	CD	O
mg.	NN	O
po.	NN	O
qhs	NN	O
.	.	O

sudafed	RB	B-TREATMENT
30	CD	O
mg.	JJ	O
po.	NN	O
bid	NN	O
.	.	O

theo-dur	JJ	B-TREATMENT
300	CD	O
mg.	JJ	O
po.	NN	O
bid	NN	O
.	.	O

betoptic	JJ	B-TREATMENT
0.5%	CD	O
one	CD	O
drop	NN	O
ou	NN	O
bid	NN	O
,	,	O
propene	NN	B-TREATMENT
0.1%	CD	O
one	CD	O
drop	NN	O
ou	NN	O
bid	NN	O
,	,	O
pred-forte	JJ	B-TREATMENT
1%	CD	O
one	CD	O
drop	NN	O
os	NN	O
bid	NN	O
,	,	O
percocet	VBP	B-TREATMENT
two	CD	O
tabs.	JJ	O
po.	NN	O
q4hours	NNS	O
prn	VBP	O
.	.	O

proventil	NN	B-TREATMENT
2	CD	O
puffs	NNS	O
q6hours	RB	O
prn	VBP	O
.	.	O

includes	VBZ	O
and	CC	O
abdominoperineal	JJ	B-TREATMENT
resection	NN	I-TREATMENT
in	IN	O
1989	CD	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM

demonstrated	VBD	O
an	DT	O
obese	JJ	O
man	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
140/75	CD	O
,	,	O
pulse	RB	B-TEST
90	CD	O
and	CC	O
irregular	JJ	B-PROBLEM
,	,	O
respirations	NNS	B-TEST
20	CD	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
examinations	NNS	I-TEST
were	VBD	O
unremarkable	JJ	O
.	.	O

cardiac	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
remarkable	JJ	O
for	IN	O
frequent	JJ	B-PROBLEM
ectopic	NN	I-PROBLEM
beats	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
lung	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
clear	JJ	O
but	CC	O
breath	JJ	B-TEST
sounds	NNS	I-TEST
were	VBD	O
more	RBR	O
pronounced	JJ	O
on	IN	O
the	DT	O
left	NN	O
than	IN	O
the	DT	O
right	NN	O
.	.	O

soft	JJ	O
,	,	O
obese	JJ	B-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
epigastric	JJ	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

an	DT	B-TREATMENT
intact	JJ	I-TREATMENT
colostomy	NN	I-TREATMENT
was	VBD	O
present	JJ	O
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
could	MD	O
be	VB	O
palpated	VBN	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
extreme	JJ	I-PROBLEM
obesity	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	B-PROBLEM
peripheral	JJ	I-PROBLEM
neuropathy	JJ	I-PROBLEM
including	VBG	O
decreased	JJ	B-PROBLEM
sensation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
with	IN	O
decreased	JJ	B-PROBLEM
strength	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
upper	JJ	I-PROBLEM
and	CC	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
most	RBS	O
pronounced	VBN	O
in	IN	O
the	DT	O
legs	NNS	O
and	CC	O
feet	NNS	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
demonstrated	VBD	O
right	JJ	B-PROBLEM
hemidiaphragmatic	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
remarkable	JJ	O
for	IN	O
trigeminy	NN	B-PROBLEM
at	IN	O
91	CD	O
per	IN	O
minute	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
underwent	JJ	O
celiac	NN	B-TEST
and	CC	I-TEST
superior	JJ	I-TEST
mesenteric	JJ	I-TEST
artery	NN	I-TEST
angiography	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
a	DT	O
patent	NN	O
celiac	NN	O
and	CC	O
superior	JJ	O
mesenteric	JJ	O
artery	NN	O
with	IN	O
normal	JJ	O
branching	VBG	O
pattern	NN	O
.	.	O

his	PRP$	B-TEST
preoperative	JJ	I-TEST
workup	NN	I-TEST
was	VBD	O
completed	VBN	O
and	CC	O
included	VBD	O
a	DT	O
normal	JJ	O
white	JJ	O
count	NN	O
,	,	O
hematocrit	NN	B-TEST
42	CD	O
.	.	O

on	IN	O
10-02-94	CD	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
he	PRP	O
underwent	JJ	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
and	CC	O
left	VBD	B-TREATMENT
hepatectomy	NN	I-TREATMENT
and	CC	O
cholecystectomy	NN	B-TREATMENT
by	IN	O
dr.	NN	O
duhenile	NN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
with	IN	O
a	DT	B-PROBLEM
2000	CD	I-PROBLEM
cc.	NN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
and	CC	O
was	VBD	O
autotransfused	VBN	O
two	CD	O
units	NNS	O
of	IN	O
blood	NN	B-TREATMENT
.	.	O

in	IN	O
the	DT	O
postoperative	JJ	O
course	NN	O
mr.	NN	O
fyfe	NN	O
did	VBD	O
surprisingly	RB	O
well	RB	O
given	VBN	O
his	PRP$	B-PROBLEM
underlying	VBG	I-PROBLEM
medical	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O
,	,	O

he	PRP	O
did	VBD	O
require	VB	O
two	CD	O
units	NNS	O
of	IN	O
transfused	JJ	B-TREATMENT
blood	NN	I-TREATMENT
but	CC	O
otherwise	RB	O
did	VBD	O
quite	RB	O
well	RB	O
and	CC	O
was	VBD	O
extubated	VBN	O
on	IN	O
the	DT	O
night	NN	O
of	IN	O
surgery	NN	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
manifest	VB	O
occasional	JJ	B-PROBLEM
premature	NN	I-PROBLEM
ventricular	JJ	I-PROBLEM
contractions	NNS	I-PROBLEM
,	,	O
but	CC	O
these	DT	O
were	VBD	O
unchanged	JJ	O
from	IN	O
preoperatively	RB	O
and	CC	O
the	DT	O
patient	JJ	O
otherwise	NN	O
did	VBD	O
well	RB	O
.	.	O

his	PRP$	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
begun	VBN	O
on	IN	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
and	CC	O
subsequently	RB	O
advanced	VBD	O
to	TO	O
a	DT	O
regular	JJ	O
diet	NN	O
without	IN	O
difficulty	NN	O
.	.	O

both	DT	O
of	IN	O
his	PRP$	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
without	IN	O
incident	NN	O
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
#	#	O
7	CD	O
,	,	O
mr.	FW	O
fyfe	NN	O
was	VBD	O
tolerating	VBG	O
a	DT	B-TREATMENT
regular	JJ	I-TREATMENT
ada	NN	I-TREATMENT
1800	CD	I-TREATMENT
kilocalorie	NN	I-TREATMENT
diet	NN	I-TREATMENT
without	IN	O
difficulty	NN	O
with	IN	O
all	DT	O
of	IN	O
his	PRP$	B-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	O
drains	NNS	B-TREATMENT
removed	VBN	O
.	.	O

his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
healing	VBG	O
well	RB	O
and	CC	O
his	PRP$	B-TREATMENT
colostomy	NN	I-TREATMENT
functioning	VBG	O
appropriately	RB	O
without	IN	O
significant	JJ	O
difficulty	NN	O
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
per	NN	O
naplesspecrycet	NN	O
hospital	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
on	IN	O
the	DT	B-TREATMENT
same	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
which	WDT	O
he	PRP	O
was	VBD	O
on	IN	O
preoperatively	RB	O
.	.	O

these	DT	O
include	VBP	O
diabeta	NN	B-TREATMENT
10	CD	O
mg.	NN	O
po.	NN	O
bid	NN	O
.	.	O

serax	NN	B-TREATMENT
20	CD	O
mg.	NN	O
po.	NN	O
qhs	NN	O
.	.	O

sudafed	RB	B-TREATMENT
30	CD	O
po.	JJ	O
bid	NN	O
.	.	O

theo-dur	JJ	B-TREATMENT
300	CD	O
mg.	JJ	O
po.	NN	O
bid	NN	O
.	.	O

betoptic	JJ	B-TREATMENT
0.5%	CD	O
one	CD	O
drop	NN	O
ou	NN	O
bid	NN	O
,	,	O
propene	NN	B-TREATMENT
0.1%	CD	O
one	CD	O
drop	NN	O
ou	NN	O
bid	NN	O
.	.	O

pred-forte	JJ	B-TREATMENT
1%	CD	O
one	CD	O
drop	NN	O
os	NN	O
bid	NN	O
.	.	O

percocet	NN	B-TREATMENT
two	CD	O
tabs	NN	O
po.	NN	O
q4h	NN	O
prn	NN	O
.	.	O

proventil	NN	B-TREATMENT
2	CD	O
puffs	NNS	O
q6hours	RB	O
prn	VBP	O
..	NNS	O

baby	NN	O
barbara	NN	O
stead	NN	O
is	VBZ	O
a	DT	O
term	NN	O
infant	NN	O
admitted	VBN	O
with	IN	O
increasing	VBG	B-PROBLEM
head	NN	I-PROBLEM
circumference	NN	I-PROBLEM
and	CC	O
bruising	NN	B-PROBLEM
.	.	O

o	RB	B-TEST
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	I-TEST

pregnancy	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
oligohydramnios	NNS	B-PROBLEM
with	IN	O
an	DT	B-TEST
afi	NN	I-TEST
of	IN	O
3.5	CD	O
and	CC	O
by	IN	O
multiple	JJ	B-TEST
evaluations	NNS	I-TEST
for	IN	O
decreased	JJ	B-PROBLEM
fetal	JJ	I-PROBLEM
movement	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
spontaneous	JJ	B-PROBLEM
onset	NN	I-PROBLEM
of	IN	I-PROBLEM
labor	NN	I-PROBLEM
progressing	VBG	O
through	IN	O
vacuum	NN	B-TREATMENT
assisted	VBN	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
under	IN	O
epidural	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

clear	JJ	O
amniotic	JJ	O
fluid	NN	O
,	,	O
no	DT	O
antepartum	JJ	B-PROBLEM
maternal	JJ	I-PROBLEM
fever	NN	I-PROBLEM
or	CC	O
fetal	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
no	DT	O
antepartum	NN	B-TREATMENT
antibiotic	JJ	I-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

baby	NN	O
was	VBD	O
vigorous	JJ	O
at	IN	O
delivery	NN	O
,	,	O
was	VBD	O
bulb	JJ	B-TREATMENT
suction	NN	I-TREATMENT
,	,	O
dried	VBN	O
,	,	O
and	CC	O
had	VBD	O
free	JJ	B-TREATMENT
flow	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
administered	VBD	O
briefly	NN	O
.	.	O

apgars	NNS	B-TEST
were	VBD	O
nine	CD	O
and	CC	O
nine	CD	O
.	.	O

in	IN	O
the	DT	O
newborn	JJ	O
nursery	NN	O
,	,	O
he	PRP	O
initially	RB	O
had	VBD	O
a	DT	B-PROBLEM
caput	NN	I-PROBLEM
which	WDT	O
increased	VBD	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
swelling	VBG	B-PROBLEM
and	CC	O
bruising	VBG	B-PROBLEM
in	IN	O
the	DT	O
subsequent	JJ	O
24	CD	O
hours	NNS	O
.	.	O

he	PRP	O
was	VBD	O
then	RB	O
referred	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
for	IN	O
assessment	NN	B-TEST
and	CC	O
management	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
increased	VBN	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
3850	CD	O
grams	NNS	O
.	.	O

head	NN	B-TEST
circumference	NN	I-TEST
was	VBD	O
41	CD	O
cm	NN	O
.	.	O

heent	NN	B-TEST
was	VBD	O
significant	JJ	O
for	IN	O
swelling	VBG	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
scalp	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
in	IN	O
generalized	JJ	O
distribution	NN	O
with	IN	O
ecchymosis	NN	B-PROBLEM
extending	VBG	O
from	IN	O
the	DT	O
occiput	NN	O
to	TO	O
the	DT	O
posterior	JJ	O
auricular	JJ	O
area	NN	O
and	CC	O
dorsal	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
neck	NN	O
to	TO	O
the	DT	O
mid	JJ	O
cervical	JJ	O
level	NN	O
.	.	O

no	DT	O
nasal	JJ	B-PROBLEM
flaring	NN	I-PROBLEM
.	.	O

no	DT	O
retractions	NNS	B-PROBLEM
,	,	O
good	JJ	O
breath	NN	O
sounds	NNS	O
bilaterally	RB	O
,	,	O
no	DT	O
crackles	NNS	B-PROBLEM
.	.	O

femoral	JJ	B-TEST
pulses	NNS	I-TEST
normal	JJ	O
,	,	O
s1	JJ	O
,	,	O
s2	JJ	O
were	VBD	O
normal	JJ	O
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
1/6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
in	IN	O
the	DT	O
upper	JJ	O
left	VBD	O
sternal	JJ	O
border	NN	O
without	IN	O
radiation	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
no	DT	O
organomegaly	NN	B-PROBLEM
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
.	.	O

bowel	NN	B-TEST
sounds	NNS	I-TEST
are	VBP	O
active	JJ	O
and	CC	O
patent	NN	O
.	.	O

cns	NN	O
active	JJ	O
,	,	O
responsive	JJ	O
to	TO	O
stimulation	NN	B-TEST
.	.	O

tone	NN	B-TEST
is	VBZ	O
normal	JJ	O
,	,	O
moving	VBG	O
all	DT	O
limbs	NNS	O
symmetrically	RB	O
,	,	O
irritable	JJ	B-PROBLEM
with	IN	O
palpation	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
scalp	NN	I-TEST
.	.	O

suck	NN	B-TEST
,	,	O
root	NN	B-TEST
,	,	O
gag	NN	B-TEST
,	,	O
grasp	NN	B-TEST
,	,	O
and	CC	O
morrow	NN	B-TEST
were	VBD	O
normal	JJ	O
.	.	O

pale	NN	O
as	IN	O
above	IN	O
,	,	O
nonicteric	JJ	B-PROBLEM
.	.	O

normal	JJ	O
spine	NN	O
,	,	O
hip	NN	O
,	,	O
clavicles	NNS	O
,	,	O
small	JJ	B-PROBLEM
mass	NN	I-PROBLEM
at	IN	O
the	DT	O
site	NN	O
of	IN	O
previous	JJ	B-TREATMENT
right	JJ	I-TREATMENT
quadriceps	NNS	I-TREATMENT
intramuscular	JJ	I-TREATMENT
injection	NN	I-TREATMENT
.	.	O

an	DT	B-TEST
initial	JJ	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
had	VBD	O
revealed	VBN	O
extracranial	JJ	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
swelling	VBG	I-PROBLEM
most	JJS	O
prominently	RB	O
at	IN	O
the	DT	O
right	JJ	O
frontal-parietal-occipital	JJ	O
area	NN	O
extending	VBG	O
to	TO	O
the	DT	O
left	NN	O
and	CC	O
to	TO	O
the	DT	O
upper	JJ	O
cervical	JJ	O
region	NN	O
.	.	O

no	DT	O
gross	JJ	B-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

but	CC	O
upon	IN	O
further	JJ	O
radiology	NN	O
attending	VBG	O
stoughton	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
occipital	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
noted	VBD	O
.	.	O

the	DT	B-TEST
initial	JJ	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
21.2	CD	O
,	,	O
platelets	NNS	B-TEST
186	CD	O
.	.	O

pt	NN	B-TEST
was	VBD	O
14.6	CD	O
,	,	O
ptt	VBD	B-TEST
77	CD	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.4	CD	O
.	.	O

fibrinogen	NN	B-TEST
was	VBD	O
192	CD	O
.	.	O

d-dimer	NN	B-TEST
was	VBD	O
negative	JJ	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
term	NN	O
infant	NN	O
with	IN	O
significant	JJ	B-PROBLEM
subgaleal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
with	IN	O
apparent	JJ	O
extension	NN	O
over	IN	O
the	DT	O
past	JJ	O
six	CD	O
hours	NNS	O
.	.	O

there	EX	O
was	VBD	O
also	RB	O
elevation	NN	B-PROBLEM
of	IN	O
the	DT	B-TEST
ptt	NN	I-TEST
suggesting	VBG	O
possible	JJ	O
inborn	JJ	B-PROBLEM
coagulopathy	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
also	RB	O
critical	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
subgaleal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

patient	NN	O
has	VBZ	O
been	VBN	O
on	IN	O
room	NN	O
air	NN	O
maintaining	VBG	O
sats	NNS	B-TEST
above	IN	O
95%	CD	O
.	.	O

no	DT	O
apnea	NN	B-PROBLEM
or	CC	O
bradycardia	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
initial	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
on	IN	O
admission	NN	O
likely	RB	O
secondary	JJ	O
to	TO	O
severe	VB	B-PROBLEM
anemia	NN	I-PROBLEM
which	WDT	O
has	VBZ	O
since	IN	O
resolved	VBN	O
.	.	O

patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
po	NN	O
feeds	NNS	O
as	IN	O
of	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
after	IN	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
had	VBD	O
stabilized	VBN	O
.	.	O

his	PRP$	B-TEST
admission	NN	I-TEST
weight	NN	I-TEST
was	VBD	O
3850	CD	O
grams	NNS	O
.	.	O

his	PRP$	B-TEST
weight	NN	I-TEST
on	IN	I-TEST
discharge	NN	I-TEST
was	VBD	O
4055	CD	O
.	.	O

given	VBN	O
the	DT	O
significant	JJ	O
amount	NN	O
of	IN	O
bleeding	NN	B-PROBLEM
,	,	O
baby	NN	O
was	VBD	O
started	VBN	O
prophylactically	RB	O
on	IN	O
phototherapy	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
bilirubin	NN	I-TEST
peaked	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
at	IN	O
5.4	CD	O
with	IN	O
a	DT	B-TEST
subsequent	JJ	I-TEST
bilirubin	NN	I-TEST
of	IN	O
4.6	CD	O
at	IN	O
which	WDT	O
time	NN	O
phototherapy	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

given	VBN	O
the	DT	O
rapid	JJ	O
extension	NN	O
of	IN	O
the	DT	B-PROBLEM
subgaleal	NN	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
coagulopathy	JJ	B-TEST
workup	NN	I-TEST
was	VBD	O
initiated	VBN	O
revealing	VBG	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
ptt	NN	I-PROBLEM
level	NN	I-PROBLEM
of	IN	O
77	CD	O
as	RB	O
well	RB	O
as	IN	O
factor	NN	B-TEST
8	CD	I-TEST
level	NN	I-TEST
that	WDT	O
was	VBD	O
below	IN	O
detection	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
normal	JJ	O
factors	NNS	O
5	CD	O
,	,	O
9	CD	O
,	,	O
10	CD	O
,	,	O
and	CC	O
11	CD	O
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
50	CD	I-TREATMENT
units	NNS	I-TREATMENT
/	VBP	I-TREATMENT
kg	JJ	I-TREATMENT
bolus	NN	I-TREATMENT
of	IN	I-TREATMENT
factor	NN	I-TREATMENT
8	CD	I-TREATMENT
followed	VBN	O
by	IN	O
continuous	JJ	B-TREATMENT
factor	NN	I-TREATMENT
8	CD	I-TREATMENT
infusions	NNS	I-TREATMENT
at	IN	O
50	CD	O
units	NNS	O
/	VBP	O
kg	JJ	O
/	NNP	O
day	NN	O
divided	VBD	O
until	IN	O
hourly	JJ	O
infusion	NN	O
rates	NNS	O
at	IN	O
05-10	NNP	O
.	.	O

subsequent	JJ	B-TEST
factor	NN	I-TEST
8	CD	I-TEST
levels	NNS	I-TEST
varied	VBN	O
with	IN	O
an	DT	B-TEST
initial	JJ	I-TEST
factor	NN	I-TEST
8	CD	I-TEST
level	NN	I-TEST
of	IN	O
18	CD	O
after	IN	O
the	DT	B-TREATMENT
bolus	NN	I-TREATMENT
with	IN	O
which	WDT	O
he	PRP	O
received	VBD	O
another	DT	O
bolus	NN	O
of	IN	O
factor	NN	B-TREATMENT
8	CD	I-TREATMENT
of	IN	O
50	CD	O
units	NNS	O
/	NNP	O
kg	NN	O
and	CC	O
increased	VBD	B-TREATMENT
factor	NN	I-TREATMENT
8	CD	I-TREATMENT
infusion	NN	I-TREATMENT
rate	NN	I-TREATMENT
to	TO	O
65	CD	O
units	NNS	O
/	VBP	O
kg	JJ	O
/	NNP	O
day	NN	O
.	.	O

as	IN	O
of	IN	O
05-17	NN	O
,	,	O
he	PRP	O
was	VBD	O
switched	VBN	O
over	IN	O
to	TO	O
bolus	VB	B-TREATMENT
infusion	NN	I-TREATMENT
in	IN	O
preparation	NN	O
of	IN	O
continued	JJ	B-TREATMENT
home	NN	I-TREATMENT
factor	NN	I-TREATMENT
8	CD	I-TREATMENT
administration	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
peak	NN	I-TEST
level	NN	I-TEST
after	IN	O
a	DT	O
bolus	NN	O
of	IN	O
75	CD	O
units	NNS	O
/	NNP	O
kg	NN	O
of	IN	O
factor	NN	B-TREATMENT
8	CD	I-TREATMENT
was	VBD	O
131	CD	O
.	.	O

a	DT	B-TEST
trough	JJ	I-TEST
level	NN	I-TEST
at	IN	O
20	CD	O
hours	NNS	O
after	IN	O
the	DT	B-TREATMENT
bolus	NN	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
29	CD	O
.	.	O

he	PRP	O
will	MD	O
continue	VB	O
to	TO	O
receive	VB	O
factor	NN	B-TREATMENT
8	CD	I-TREATMENT
bolus	JJ	I-TREATMENT
q	NNS	O
day	NN	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
2-3	JJ	O
weeks	NNS	O
in	IN	O
light	NN	O
of	IN	O
the	DT	B-PROBLEM
intracranial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
and	CC	O
will	MD	O
be	VB	O
followed	VBN	O
by	IN	O
hematology	NN	O
visiting	VBG	O
nurse	JJ	O
michael	NN	O
edwards	NNS	O
level	NN	O
checks	NNS	O
at	IN	O
home	NN	O
.	.	O

currently	RB	O
,	,	O
the	DT	B-TREATMENT
infusion	NN	I-TREATMENT
of	IN	O
factor	NN	B-TREATMENT
8	CD	I-TREATMENT
are	VBP	O
going	VBG	O
through	IN	O
a	DT	B-TREATMENT
jugular	NN	I-TREATMENT
broviac	NN	I-TREATMENT
which	WDT	O
was	VBD	O
placed	VBN	O
on	IN	O
05-15	NN	O
for	IN	O
administration	NN	O
of	IN	O
factor	NN	B-TREATMENT
.	.	O

his	PRP$	B-TEST
last	JJ	I-TEST
ptt	NN	I-TEST
on	IN	O
05-16	NN	O
was	VBD	O
68.3	CD	O
.	.	O

the	DT	B-TEST
last	JJ	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
on	IN	O
05-16	NN	O
of	IN	O
54.5	CD	O
.	.	O

baby	NN	O
mary	JJ	O
stead	NN	O
initially	RB	O
presented	VBN	O
with	IN	O
significant	JJ	B-PROBLEM
subgaleal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ct	VBP	I-TEST
scan	JJ	I-TEST
on	IN	O
05-15	NN	O
had	VBD	O
shown	VBN	O
the	DT	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
subdural	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
significant	JJ	O
improvement	NN	O
of	IN	O
the	DT	B-PROBLEM
subgaleal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
head	NN	I-TEST
ultrasound	NN	I-TEST
on	IN	O
05-14	NN	O
reveals	NNS	O
no	DT	O
interventricular	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
head	NN	I-TEST
circumference	NN	I-TEST
on	IN	O
05-18	NN	O
was	VBD	O
36.5	CD	O
cm	NN	O
with	IN	O
a	DT	B-TEST
maximum	JJ	I-TEST
head	NN	I-TEST
circumference	NN	I-TEST
on	IN	O

teaching	NN	O
has	VBZ	O
been	VBN	O
completed	VBN	O
on	IN	O
the	DT	O
care	NN	O
of	IN	O
the	DT	B-TREATMENT
boviak	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
administration	NN	O
of	IN	O
factor	NN	B-TREATMENT
8	CD	I-TREATMENT
.	.	O

hearing	VBG	B-TEST
screen	NN	I-TEST
was	VBD	O
performed	VBN	O
automated	JJ	O
auditory	NN	O
brain	NN	O
stem	NN	O
responses	NNS	O
and	CC	O
baby	NN	O
david	NNS	O
stead	VBP	O

baby	NN	O
julian	JJ	O
stead	NN	O
had	VBD	O
been	VBN	O
stable	JJ	O
with	IN	O
improvement	NN	O
of	IN	O
the	DT	B-PROBLEM
subgaleal	NN	I-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
good	JJ	O
peak	NN	O
and	CC	O
trough	JJ	O
factor	NN	O
8	CD	O
levels	NNS	O
after	IN	O
the	DT	B-TREATMENT
bolus	JJ	I-TREATMENT
infusion	NN	I-TREATMENT
.	.	O

factor	NN	B-TREATMENT
8	CD	I-TREATMENT
boluses	NNS	I-TREATMENT
at	IN	O
75	CD	O
units	NNS	O
/	VBP	O
kg	JJ	O
/	NNP	O
day	NN	O
.	.	O

3.	CD	O
car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	VBG	I-TEST
passed	VBN	O
.	.	O

4.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
sent	NN	O
.	.	O

received	VBN	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccination	NN	I-TREATMENT
on	IN	O
05-16	NN	O
.	.	O

1.	CD	O
factor	NN	B-PROBLEM
8	CD	I-PROBLEM
deficiency	NN	I-PROBLEM
.	.	O

2.	CD	O
subgaleal	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
resolved	VBN	O
.	.	O

3.	CD	O
small	JJ	B-PROBLEM
occipital	JJ	I-PROBLEM
subdural	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
resolved	VBD	O

right	JJ	B-PROBLEM
shoulder	NN	I-PROBLEM
instability	NN	I-PROBLEM
.	.	O

in	IN	O
1989	CD	O
the	DT	O
patient	NN	O
was	VBD	O
dunking	VBG	O
a	DT	O
basketball	NN	O
and	CC	O
injured	VBD	O
his	PRP$	O
right	JJ	O
shoulder	NN	O
with	IN	O
abduction	NN	B-PROBLEM
external	JJ	I-PROBLEM
rotation	NN	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
persistent	JJ	B-PROBLEM
pain	NN	I-PROBLEM
over	IN	O
the	DT	O
years	NNS	O
which	WDT	O
has	VBZ	O
worsened	VBN	O
in	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
including	VBG	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
sleep	VB	I-PROBLEM
.	.	O

knee	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

in	IN	O
clinic	JJ	O
his	PRP$	B-TEST
cervical	JJ	I-TEST
spine	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

shoulder	NN	B-TEST
elevation	NN	I-TEST
is	VBZ	O
170	CD	O
degrees	NNS	O
with	IN	O
70	CD	O
degrees	NNS	O
of	IN	O
external	JJ	O
rotation	NN	O
and	CC	O
internal	JJ	O
rotation	NN	O
of	IN	O
the	DT	O
right	JJ	O
shoulder	NN	O
to	TO	O
t9	VB	O
vertebra	JJ	O
versus	NN	O
t7	NN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

mild	JJ	B-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
resistive	JJ	B-TEST
test	NN	I-TEST
and	CC	O
his	PRP$	B-TEST
pigott	NN	I-TEST
sign	NN	I-TEST
is	VBZ	O
mildly	RB	O
positive	JJ	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
negative	JJ	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

laxity	NN	B-PROBLEM
is	VBZ	O
noted	VBN	O
as	RB	O
well	RB	O
as	IN	O
markedly	RB	B-PROBLEM
positive	JJ	I-PROBLEM
apprehension	NN	I-PROBLEM
sign	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
an	DT	B-TREATMENT
open	JJ	I-TREATMENT
bankart	NN	I-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
biceps	NNS	B-TREATMENT
tenodesis	NN	I-TREATMENT
(	(	O
please	VB	O
see	VB	O
the	DT	O
operative	JJ	O
note	NN	O
for	IN	O
full	JJ	O
details	NNS	O
)	)	O
.	.	O

his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
intact	JJ	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
and	CC	O
it	PRP	O
was	VBD	O
covered	VBN	O
with	IN	O
perioperative	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
on	IN	O
percocet	NN	B-TREATMENT
.	.	O

percocet	JJ	B-TREATMENT
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q.4-6	JJ	O
hours	NNS	O
prn	VBP	O
pain	NN	B-PROBLEM
.	.	O

continuing	VBG	O
throughout	IN	O
his	PRP$	O
course	NN	O
he	PRP	O
had	VBD	O
multiple	JJ	B-PROBLEM
infectious	JJ	I-PROBLEM
disease	NN	I-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

he	PRP	O
developed	VBD	O
zoster	NN	B-PROBLEM
for	IN	O
which	WDT	O
he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
acyclovir	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
cultures	NNS	I-TEST
came	VBD	O
back	RB	O
as	IN	O
noted	VBN	O
with	IN	O
klebsiella	NN	B-PROBLEM
ultimately	RB	O
in	IN	O
his	PRP$	B-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
,	,	O
mrsa	NN	B-PROBLEM
in	IN	O
his	PRP$	O
sputum	NN	O
.	.	O

he	PRP	O
had	VBD	O
multiple	JJ	B-PROBLEM
sources	NNS	I-PROBLEM
of	IN	I-PROBLEM
yeast	NN	I-PROBLEM
.	.	O

currently	RB	O
his	PRP$	B-PROBLEM
only	JJ	I-PROBLEM
yeast	NN	I-PROBLEM
source	NN	I-PROBLEM
is	VBZ	O
urine	JJ	O
.	.	O

also	RB	O
in	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
month	NN	O
that	IN	O
he	PRP	O
was	VBD	O
in	IN	O
the	DT	O
icu	NN	O
he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
left	VBN	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
for	IN	O
fluid	NN	B-PROBLEM
and	CC	O
then	RB	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
ultimately	RB	O
for	IN	O
fluid	NN	B-PROBLEM
.	.	O

he	PRP	O
developed	VBD	O
another	DT	O
round	NN	O
of	IN	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
atn	NN	B-PROBLEM
and	CC	O
casts	NNS	B-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
urine	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
started	VBD	O
treatment	NN	B-TREATMENT
for	IN	O
gallstones	NNS	B-PROBLEM
with	IN	O
cholestasis	NN	B-PROBLEM
on	IN	O
the	DT	O
medication	NN	O
ursodiol	NN	B-TREATMENT
.	.	O

he	PRP	O
received	VBD	O
a	DT	O
course	NN	O
of	IN	O
cefepime	NN	B-TREATMENT
also	RB	O
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
multiple	JJ	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
after	IN	O
his	PRP$	B-TREATMENT
split	NN	I-TREATMENT
thickness	NN	I-TREATMENT
skin	JJ	I-TREATMENT
grafts	NNS	I-TREATMENT
,	,	O
which	WDT	O
he	PRP	O
does	VBZ	O
to	TO	O
this	DT	O
day	NN	O
.	.	O

in	IN	O
early	JJ	O
november	NN	O
he	PRP	O
started	VBD	O
dialysis	NN	B-TREATMENT
after	IN	O
a	DT	B-TREATMENT
permcath	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

his	PRP$	B-TREATMENT
dobbhoff	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
use	VB	O
a	DT	B-TREATMENT
passy-muir	JJ	I-TREATMENT
valve	NN	I-TREATMENT
intermittently	RB	O
for	IN	O
his	PRP$	B-TREATMENT
trach	NN	I-TREATMENT
.	.	O

on	IN	O
12-23	NNS	O
he	PRP	O
went	VBD	O
back	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
open	JJ	B-PROBLEM
jejunostomy	NN	I-PROBLEM
tube	NN	I-PROBLEM
dehiscence	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
j	NN	I-TREATMENT
tube	NN	I-TREATMENT
is	VBZ	O
now	RB	O
functioning	VBG	O
.	.	O

this	DT	O
was	VBD	O
repaired	VBN	O
and	CC	O
stay	VB	B-TREATMENT
sutures	NNS	I-TREATMENT
are	VBP	O
in	IN	O
place	NN	O
.	.	O

on	IN	O
11-24	JJ	O
he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
permanent	JJ	I-TREATMENT
ddd	NN	I-TREATMENT
pacemaker	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
lead	NN	I-TREATMENT
that	WDT	O
was	VBD	O
externally	RB	O
placed	VBN	O
on	IN	O
his	PRP$	O
chest	JJS	O
wall	NN	O
due	JJ	O
to	TO	O
his	PRP$	O
healing	NN	O
and	CC	O
infected	JJ	B-PROBLEM
chest	NN	I-PROBLEM
wound	NN	I-PROBLEM
.	.	O

from	IN	O
the	DT	O
point	NN	O
of	IN	O
discharge	NN	O
today	NN	O
on	IN	O
12-31	JJ	O
his	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
labs	NNS	I-TEST
are	VBP	O
as	IN	O
follows	VBZ	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
13.9	CD	O
,	,	O
hematocrit	NN	B-TEST
35.9	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
81,000	CD	O
.	.	O

sodium	NN	B-TEST
139	CD	O
,	,	O
k	VBD	B-TEST
4.8	CD	O
,	,	O
chloride	RB	B-TEST
109	CD	O
,	,	O
co2	NN	B-TEST
31	CD	O
,	,	O
bun	NN	B-TEST
33	CD	O
,	,	O
creatinine	NN	B-TEST
2.2	CD	O
,	,	O
blood	NN	B-TEST
sugar	NN	I-TEST
164	CD	O
.	.	O

albumin	RB	B-TEST
2.5	CD	O
.	.	O

vancomycin	JJ	B-TEST
level	NN	I-TEST
was	VBD	O
21	CD	O
.	.	O

he	PRP	O
occasionally	RB	O
gets	VBZ	O
agitated	VBN	B-PROBLEM
.	.	O

he	PRP	O
does	VBZ	O
have	VB	O
his	PRP$	B-TREATMENT
pacing	VBG	I-TREATMENT
lead	NN	I-TREATMENT
with	IN	O
his	PRP$	B-TREATMENT
external	JJ	I-TREATMENT
pacemaker	NN	I-TREATMENT
ddd	NN	I-TREATMENT
available	JJ	O
to	TO	O
him	PRP	O
and	CC	O
is	VBZ	O
being	VBG	O
followed	VBN	O
by	IN	O
the	DT	O
ep	JJ	O
service	NN	O
and	CC	O
dr.	JJ	O
janet	NN	O
gutkin	NN	O
for	IN	O
further	JJ	O
outpatient	JJ	O
treatment	NN	O
of	IN	O
this	DT	O

from	IN	O
a	DT	O
respiratory	JJ	O
point	NN	O
of	IN	O
view	NN	O
,	,	O
he	PRP	O
is	VBZ	O
on	IN	O
cpap	NN	B-TREATMENT
and	CC	O
pressure	NN	B-TREATMENT
support	NN	I-TREATMENT
at	IN	O
5	CD	O
and	CC	O
5	CD	O
at	IN	O
40%	CD	O
.	.	O

he	PRP	O
does	VBZ	O
use	VB	O
the	DT	B-TREATMENT
passy-muir	JJ	I-TREATMENT
valve	NN	I-TREATMENT
intermittently	RB	O
for	IN	O
his	PRP$	B-TREATMENT
trach	NN	I-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
on	IN	O
a	DT	B-TREATMENT
trach	NN	I-TREATMENT
collar	NN	I-TREATMENT
this	DT	O
week	NN	O
during	IN	O
the	DT	O
day	NN	O
only	RB	O
and	CC	O
rested	VBN	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
at	IN	O

abdominally	RB	O
,	,	O
he	PRP	O
does	VBZ	O
have	VB	O
his	PRP$	B-PROBLEM
midabdominal	JJ	I-PROBLEM
incision	NN	I-PROBLEM
with	IN	O
good	JJ	O
approximated	VBN	O
margins	NNS	O
and	CC	O
stay	NN	B-TREATMENT
sutures	NNS	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

from	IN	O
a	DT	O
gi	JJ	O
point	NN	O
of	IN	O
view	NN	O
,	,	O
he	PRP	O
is	VBZ	O
receiving	VBG	O
promote	JJ	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
through	IN	O
his	PRP$	B-TREATMENT
jejunostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

his	PRP$	B-PROBLEM
chest	JJS	I-PROBLEM
incision	NN	I-PROBLEM
is	VBZ	O
granulating	VBG	O
in	IN	O
well	RB	O
.	.	O

he	PRP	O
currently	RB	O
receives	VBZ	O
saline	JJ	B-TREATMENT
washes	NNS	I-TREATMENT
and	CC	O
adaptic	JJ	B-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
twice	RB	O
a	DT	O
day	NN	O
.	.	O

from	IN	O
a	DT	O
cmed	JJ	O
ccu	NN	O
point	NN	O
of	IN	O
view	NN	O
,	,	O
he	PRP	O
gets	VBZ	O
straight	RB	B-TREATMENT
cathed	VBN	I-TREATMENT
every	DT	O
other	JJ	O
day	NN	O
.	.	O

he	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
subclavian	JJ	I-TREATMENT
permcath	NN	I-TREATMENT
access	NN	O
for	IN	O
his	PRP$	B-TREATMENT
dialysis	NN	I-TREATMENT
which	WDT	O
takes	VBZ	O
place	NN	O
on	IN	O
monday	NN	O
,	,	O
wednesday	JJ	O
and	CC	O
friday	JJ	O
.	.	O

he	PRP	O
is	VBZ	O
hitt	JJ	B-TEST
negative	JJ	O
.	.	O

he	PRP	O
has	VBZ	O
received	VBN	O
no	DT	O
transfusions	NNS	B-TREATMENT
in	IN	O
the	DT	O
past	JJ	O
week	NN	O
or	CC	O
so	RB	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
has	VBZ	O
been	VBN	O
stable	JJ	O
in	IN	O
the	DT	O
mid-30s	NN	O
.	.	O

he	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
picc	JJ	I-TREATMENT
line	NN	I-TREATMENT
in	IN	O
place	NN	O
for	IN	O
his	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
which	WDT	O
are	VBP	O
as	IN	O
follows	VBZ	O
.	.	O

the	DT	B-TREATMENT
picc	NN	I-TREATMENT
line	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
on	IN	O
12-29	JJ	O
.	.	O

his	PRP$	B-TREATMENT
antibiotics	NNS	I-TREATMENT
currently	RB	O
are	VBP	O
vancomycin	JJ	B-TREATMENT
,	,	O
ceftazidime	NN	B-TREATMENT
,	,	O
fluconazole	NN	B-TREATMENT
and	CC	O
caspofungin	NN	B-TREATMENT
.	.	O

i	NN	O
will	MD	O
give	VB	O
doses	NNS	O
and	CC	O
administration	NN	O
information	NN	O
in	IN	O
his	PRP$	O
list	NN	O
of	IN	O
discharge	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
his	PRP$	B-TEST
albumin	NN	I-TEST
today	NN	O
is	VBZ	O
2.5	CD	O
.	.	O

he	PRP	O
is	VBZ	O
being	VBG	O
covered	VBN	O
by	IN	O
regular	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

exam	NN	B-TEST
today	NN	O
shows	VBZ	O
he	PRP	O
is	VBZ	O
neurologically	RB	O
alert	JJ	O
.	.	O

he	PRP	O
had	VBD	O
coarse	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
graft	NN	I-TREATMENT
is	VBZ	O
granulating	VBG	O
in	IN	O
.	.	O

1.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

2.	CD	O
ursodiol	JJ	B-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3.	CD	O
ascorbic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
500	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O

4.	CD	O
zinc	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
220	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
lansoprazole	JJ	B-TREATMENT
oral	JJ	I-TREATMENT
solution	NN	I-TREATMENT
30	CD	O
mg	NN	O
per	IN	O
gastric	JJ	O
tube	NN	O
q.d.	NN	O

6.	CD	O
caspofungin	NN	B-TREATMENT
acetate	NN	I-TREATMENT
50	CD	O
mg	NN	O
iv	NN	O
q.d.	NN	O
,	,	O
day	NN	O
23	CD	O
of	IN	O
treatment	NN	B-TREATMENT
and	CC	O
patient	NN	O
should	MD	O
remain	VB	O
on	IN	O
it	PRP	O
indefinitely	RB	O
.	.	O

7.	CD	O
nephrocaps	NNS	B-TREATMENT
one	CD	O
cap	NN	O
p.o.	NN	O
q.d.	NN	O

if	IN	O
on	IN	O
dialysis,	NN	B-TREATMENT
please	NN	O
take	VB	O
after	IN	O
dialysis	NN	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

8.	CD	O
metoclopramide	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
take	VBP	O
30	CD	O
minutes	NNS	O
before	IN	O
meals	NNS	O
.	.	O

9.	CD	O
fluconazole	JJ	B-TREATMENT
200	CD	O
mg	NN	O
p.o.	NN	O
q.h.d.	NN	O

patient	NN	O
should	MD	O
remain	VB	O
on	IN	O
this	DT	O
medication	NN	B-TREATMENT
.	.	O

10.	CD	O
magnesium	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
2	CD	O
gm	NN	O
in	IN	O
100	CD	O
ml	NN	O
of	IN	O
d5w	NN	B-TREATMENT
iv	NN	O
as	IN	O
needed	VBN	O
for	IN	O
repletion	NN	O
p.r.n.	NN	O

11.	CD	O
miconazole	JJ	B-TREATMENT
powder	NN	I-TREATMENT
2%	CD	O
one	CD	O
application	NN	O
t.p.	NN	O
t.i.d.	NN	O
p.r.n.	NN	O

12.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	NN	O
to	TO	O
650	CD	O
mg	NNS	O
p.o.	RB	O
q.four	VBP	O
to	TO	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

13.	CD	O
albuterol	NN	B-TREATMENT
one	CD	O
to	TO	O
two	CD	O
puffs	NNS	O
inhaled	VBD	O
q.	RB	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O

14.	CD	O
bisacodyl	NN	B-TREATMENT
10	CD	O
mg	NN	O
per	IN	O
rectum	NN	O
h.s.	NN	O
as	IN	O
needed	VBN	O
p.r.n.	NN	O

15.	CD	O
hydralazine	JJ	B-TREATMENT
hydrochloride	RB	I-TREATMENT
10	CD	O
mg	NNS	O
iv	JJ	O
q.	RB	O
six	CD	O
hours	NNS	O
p.r.n.	VBP	O
systolic	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
greater	JJR	O
than	IN	O
140	CD	O
.	.	O

16.	CD	O
vancomycin	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
as	IN	O
needed	VBN	O
for	IN	O
vancomycin	JJ	B-TEST
level	NN	I-TEST
less	JJR	O
than	IN	O
15	CD	O
.	.	O

this	DT	O
is	VBZ	O
day	NN	O
23	CD	O
of	IN	O
treatment	NN	B-TREATMENT
for	IN	O
an	DT	O
approximate	JJ	O
six	CD	O
week	NN	O
course	NN	O
.	.	O

17.	CD	O
ceftazidime	NN	B-TREATMENT
1	CD	O
gm	NN	O
iv	NN	O
q.h.d.	NN	O
after	IN	O
dialysis	NN	B-TREATMENT
.	.	O

18.	CD	O
alteplase	NN	B-TREATMENT
for	IN	O
catheter	NN	O
clearance	NN	O
2	CD	O
mg	NN	O
iv	NN	O
once	RB	O
times	VBZ	O
one	CD	O
dose	NN	O
for	IN	O
indwelling	VBG	B-TREATMENT
permcath	NN	I-TREATMENT
.	.	O

1.	CD	O
status	NN	O
post	NN	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
and	CC	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
times	NNS	O
four	CD	O
.	.	O

2.	CD	O
status	NN	O
post	NN	O
sternal	JJ	B-TREATMENT
debridement	NN	I-TREATMENT
.	.	O

3.	CD	O
status	NN	O
post	NN	O
skin	NN	B-TREATMENT
graft	NN	I-TREATMENT
to	TO	O
chest	VB	B-PROBLEM
incision	NN	I-PROBLEM
.	.	O

4.	CD	O
status	NN	O
post	NN	O
open	JJ	B-TREATMENT
jejunostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
,	,	O
open	JJ	B-TREATMENT
left	VBD	I-TREATMENT
subclavian	JJ	I-TREATMENT
permcath	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

5.	CD	O
status	NN	O
post	NN	O
ddd	NN	B-TREATMENT
pacer	NN	I-TREATMENT
placement	NN	I-TREATMENT
with	IN	O
external	JJ	B-TREATMENT
generator	NN	I-TREATMENT
.	.	O

6.	CD	O
status	NN	O
post	NN	O
abdominal	JJ	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
wound	JJ	B-PROBLEM
dehiscence	NN	I-PROBLEM
of	IN	I-PROBLEM
jejunostomy	NN	I-PROBLEM
site	NN	I-PROBLEM
.	.	O

7.	CD	O
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
tracheostomy	NN	I-TREATMENT
.	.	O

8.	CD	O
status	NN	O
post	NN	O
acute	VBP	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

9.	CD	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

10.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

11.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

12.	CD	O
asthma	NN	B-PROBLEM
.	.	O

13.	CD	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
status	NN	O
post	NN	O
gastrectomy	NN	B-TREATMENT
30	CD	O
years	NNS	O
ago	RB	O
.	.	O

14.	CD	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
status	NN	O
post	NN	O
colectomy	NN	B-TREATMENT
with	IN	O
xrt	NNP	B-TREATMENT
four	CD	O
years	NNS	O
ago	RB	O
.	.	O

15.	CD	O
peripheral	JJ	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
claudication	NN	I-PROBLEM
.	.	O

16.	CD	O
copd	NN	B-PROBLEM
with	IN	O
asbestosis	NN	B-PROBLEM
on	IN	O
chest	NN	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
.	.	O

small	JJ	B-PROBLEM
cell	NN	I-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

chemotherapy	NN	B-TREATMENT
.	.	O

briefly	NN	O
this	DT	O
is	VBZ	O
a	DT	O
hispanic	JJ	O
patient	NN	O
with	IN	O
history	NN	O
of	IN	O
advanced	JJ	B-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
small	JJ	O
cell	NN	O
in	IN	O
histology	NN	O
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
with	IN	O
almost	RB	B-PROBLEM
a	DT	I-PROBLEM
stridor	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
mediastinal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
with	IN	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
oncology	NN	O
service	NN	O
after	IN	O
discussions	NNS	O
about	IN	O
the	DT	O
utility	NN	O
of	IN	O
chemotherapy	NN	B-TREATMENT
.	.	O

in	IN	O
the	DT	O
oncology	NN	O
floor	NN	O
he	PRP	O
received	VBD	O
carboplatin	NN	B-TREATMENT
and	CC	O
etoposide	NN	B-TREATMENT
to	TO	O
which	WDT	O
he	PRP	O
reacted	VBD	O
well	RB	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
35-year-old	JJ	O
gentleman	NN	O
with	IN	O
hiv	NN	B-PROBLEM
on	IN	O
haart	NN	B-TREATMENT
with	IN	O
last	JJ	B-TEST
cd4	JJ	I-TEST
count	NN	I-TEST
of	IN	O
268	CD	O
and	CC	O
undetectable	JJ	O
viral	JJ	B-TEST
load	NN	I-TEST
who	WP	O
was	VBD	O
referred	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
via	IN	O
his	PRP$	O
pcp	NN	O
for	IN	O
progressive	JJ	B-PROBLEM
throat	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
edema	NN	B-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
throat	NN	I-PROBLEM
pain	NN	I-PROBLEM
began	VBD	O
2	CD	O
to	TO	O
3	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
initially	RB	O
treated	VBN	O
with	IN	O
ibuprofen	NN	B-TREATMENT
,	,	O
seen	VBN	O
in	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
where	WRB	O
he	PRP	O
received	VBD	O
iv	JJ	B-TREATMENT
penicillin	NN	I-TREATMENT
and	CC	O
was	VBD	O
sent	VBN	O
home	NN	O
.	.	O

in	IN	O
clinic	JJ	O
today	NN	O
,	,	O
the	DT	O
patient	NN	O
desaturated	VBD	O
to	TO	O
low	VB	O
90	CD	O
s	NN	O
with	IN	O
ambulation	NN	O
and	CC	O
also	RB	O
had	VBD	O
complaints	NNS	O
of	IN	O
progressive	JJ	B-PROBLEM
swelling	VBG	I-PROBLEM
"	NN	O
like	IN	O
my	PRP$	O
throat	NN	O
is	VBZ	O
going	VBG	O
to	TO	O
close	VB	O
up	RP	O
"	NN	O
with	IN	O
increasing	VBG	B-PROBLEM
drooling	NN	I-PROBLEM
,	,	O
unable	JJ	O
to	TO	O
swallow	VB	O
the	DT	B-TREATMENT
hiv	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

also	RB	O
noted	VBN	O
to	TO	O
have	VB	O
low-grade	JJ	B-PROBLEM
temperature	NN	I-PROBLEM
of	IN	O
99	CD	O
to	TO	O
100	CD	O
degrees	NNS	O
with	IN	O
productive	JJ	B-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
yellow	JJ	B-PROBLEM
sputum	NN	I-PROBLEM
times	NNS	O
1	CD	O
day	NN	O
with	IN	O

right	JJ	B-PROBLEM
ear	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

no	DT	O
subjective	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
describes	VBZ	O
whole	JJ	B-PROBLEM
body	NN	I-PROBLEM
numbness	NN	I-PROBLEM
.	.	O

he	PRP	O
currently	RB	O
notes	VBZ	O
improvement	NN	O
in	IN	O
his	PRP$	B-PROBLEM
throat	NN	I-PROBLEM
pain	NN	I-PROBLEM
after	IN	O
some	DT	B-TREATMENT
decadron	NN	I-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
cmed	JJ	O
csru	NN	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
and	CC	O
the	DT	B-TEST
exam	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
supraglottitis	NN	B-PROBLEM
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
history	NN	O
of	IN	O
opportunistic	JJ	B-PROBLEM
infections	NNS	I-PROBLEM
or	CC	O
prior	JJ	O
hospitalizations	NNS	O
.	.	O

of	IN	O
note	NN	O
,	,	O
his	PRP$	B-TEST
cd4	NN	I-TEST
count	NN	I-TEST
was	VBD	O
less	JJR	O
than	IN	O
200	CD	O
last	JJ	O
winter	NN	O
.	.	O

he	PRP	O
believes	VBZ	O
he	PRP	O
is	VBZ	O
up-to-date	JJ	O
on	IN	O
all	PDT	O
his	PRP$	B-TREATMENT
vaccines	NNS	I-TREATMENT
.	.	O

hiv	NN	B-PROBLEM
times	NNS	O
13	CD	O
years	NNS	O
.	.	O

last	JJ	B-TEST
cd4	NN	I-TEST
count	NN	I-TEST
of	IN	O
268	CD	O
,	,	O
viral	JJ	B-TEST
load	NN	I-TEST
undetectable	JJ	O
,	,	O
followed	VBD	O
at	IN	O
the	DT	O
boston	NN	O
regional	JJ	O
medical	JJ	O
centerr	NN	O
clinic	NN	O
by	IN	O
dr.	JJ	O
taylor	NN	O
.	.	O

history	NN	O
of	IN	O
anal	JJ	B-PROBLEM
warts	NNS	I-PROBLEM
and	CC	O
rectal	JJ	B-PROBLEM
abscesses	NNS	I-PROBLEM
and	CC	O
fistula	NN	B-PROBLEM
.	.	O

positive	JJ	O
for	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

negative	JJ	O
for	IN	O
cad	NN	B-PROBLEM
.	.	O

mother	NN	O
with	IN	O
throat	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

1.	CD	O
atazanavir	JJ	B-TREATMENT
300	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
ritonavir	NN	B-TREATMENT
100	CD	O
mg	NN	O
q.d.	NN	O

3.	CD	O
tenofovir	JJ	B-TREATMENT
300	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
didanosine	JJ	B-TREATMENT
250	CD	O
mg	NN	O
q.d.	NN	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

temperature	NN	B-TEST
100.1	CD	O
degrees	NNS	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
134/79	CD	O
,	,	O
pulse	RB	B-TEST
100	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
17	CD	O
,	,	O
and	CC	O
saturations	NNS	B-TEST
95	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

heent	NN	O
:	:	O
positive	JJ	O
hoarse	NN	B-PROBLEM
whisper	NN	I-PROBLEM
.	.	O

positive	JJ	O
drooling	NN	B-PROBLEM
.	.	O

negative	JJ	O
trismus	NN	B-PROBLEM
or	CC	O
stridor	NN	B-PROBLEM
.	.	O

bilateral	JJ	B-PROBLEM
tonsillar	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

no	DT	O
white	JJ	B-PROBLEM
exudate	NN	I-PROBLEM
.	.	O

right	JJ	O
external	JJ	O
auditory	NN	O
canal	NN	O
was	VBD	O
occluded	VBN	B-PROBLEM
bycerumen	NNS	I-PROBLEM
and	CC	O
left	VBD	O
external	JJ	O
auditory	JJ	O
canal	JJ	O
clear	JJ	O
with	IN	O
tympanic	JJ	O
membrane	NN	O
intact	NN	O
.	.	O

positive	JJ	O
anterior	JJ	B-PROBLEM
cervical	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

regular	JJ	O
and	CC	O
tachycardic	JJ	B-PROBLEM
.	.	O

bilateral	JJ	B-PROBLEM
coarse	NN	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
.	.	O

negative	JJ	O
rhonchi	NN	B-PROBLEM
,	,	O
rales	NNS	B-PROBLEM
,	,	O
or	CC	O
wheezes	NNS	B-PROBLEM
.	.	O

soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
18.3	CD	O
,	,	O
neutrophils	VBZ	B-TEST
89	CD	O
percent	NN	O
,	,	O
hematocrit	NN	B-TEST
41	CD	O
,	,	O
platelets	NNS	B-TEST
261	CD	O
,	,	O
inr	NN	B-TEST
1.2	CD	O
,	,	O
and	CC	O
chem-7	JJ	B-TEST
otherwise	NN	O
normal	JJ	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
effusions	NNS	B-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM
,	,	O
or	CC	O
pneumothorax	NN	B-PROBLEM
.	.	O

neck	NN	O
with	IN	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
prominence	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
epiglottitis	NN	I-PROBLEM
and	CC	I-PROBLEM
uvula	JJ	I-PROBLEM
consistent	NN	O
with	IN	O
epiglottitis	NN	B-PROBLEM
.	.	O

fiberoptic	JJ	B-TEST
scope	NN	I-TEST
showed	VBD	O
swelling	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
epiglottitis	NN	I-PROBLEM
extending	VBG	O
down	RP	O
to	TO	O
the	DT	O
right	JJ	O
aryepiglottic	JJ	O
fold	NN	O
obscuring	VBG	O
view	NN	O
of	IN	O
the	DT	O
right	JJ	O
vocal	JJ	O
cord	NN	O
.	.	O

left	RB	O
vocal	JJ	O
cord	NN	O
with	IN	O
glottic	JJ	O
airway	NN	O
visible	JJ	O
but	CC	O
narrow	JJ	B-PROBLEM
.	.	O

positive	JJ	O
edema	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
supraglottitis	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
35-year-old	JJ	O
gentleman	NN	O
with	IN	O
hiv	NN	B-PROBLEM
on	IN	O
haart	NN	B-TREATMENT
,	,	O
last	JJ	B-TEST
cd4	NN	I-TEST
count	VBD	I-TEST
268	CD	O
with	IN	O
undetectable	JJ	O
viral	JJ	B-TEST
load	NN	I-TEST
who	WP	O
was	VBD	O
initially	RB	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
supraglottitis	NN	B-PROBLEM
with	IN	O
significant	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

1.	CD	O
epiglottitis	NN	B-PROBLEM
/	NNP	O
supraglottitis	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
cmed	JJ	O
csru	NN	O
for	IN	O
48	CD	O
hours	NNS	O
and	CC	O
noted	VBD	O
to	TO	O
have	VB	O
decrease	NN	O
in	IN	O
swelling	VBG	B-PROBLEM
on	IN	O
serial	JJ	B-TEST
exams	NNS	I-TEST
.	.	O

he	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
the	DT	O
cmed	JJ	O
csru	NN	O
service	NN	O
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
iv	NN	B-TREATMENT
decadron	NN	I-TREATMENT
initially	RB	O
in	IN	O
addition	NN	O
to	TO	O
iv	VB	B-TREATMENT
unasyn	NN	I-TREATMENT
,	,	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
well	RB	O
.	.	O

his	PRP$	B-PROBLEM
edema	NN	I-PROBLEM
was	VBD	O
improving	VBG	O
and	CC	O
was	VBD	O
starting	VBG	O
to	TO	O
tolerate	VB	O
p.o.	NN	O

his	PRP$	O
airway	NN	O
and	CC	O
symptoms	NNS	B-PROBLEM
continued	VBD	O
to	TO	O
improve	VB	O
and	CC	O
remained	VBD	O
stable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
stable	JJ	O
for	IN	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
,	,	O
was	VBD	O
treated	VBN	O
with	IN	O
over	IN	O
72	CD	O
hours	NNS	O
of	IN	O
iv	JJ	B-TREATMENT
unasyn	NN	I-TREATMENT
,	,	O
and	CC	O
then	RB	O
transitioned	VBD	O
to	TO	O
oral	JJ	O
regimen	NNS	O
of	IN	O
augmentin	NN	B-TREATMENT
to	TO	O
be	VB	O
continued	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

eventually	RB	O
,	,	O
his	PRP$	B-TREATMENT
iv	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
transitioned	VBN	O
to	TO	O
a	DT	B-TREATMENT
p.o.	NN	I-TREATMENT
steroid	NN	I-TREATMENT
taper	NN	I-TREATMENT
,	,	O
which	WDT	O
he	PRP	O
tolerated	VBD	O
well	RB	O
,	,	O
and	CC	O
was	VBD	O
discharged	VBN	O
on	IN	O
a	DT	B-TREATMENT
steroid	JJ	I-TREATMENT
taper	NN	I-TREATMENT
also	RB	O
with	IN	O
cmed	JJ	O
csru	JJ	O
follow-up	NN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

his	PRP$	O
oxygenation	NN	O
and	CC	O
symptoms	NNS	B-PROBLEM
remained	VBD	O
stable	JJ	O
and	CC	O
again	RB	O
tolerated	JJ	O
p.o.	NN	O
without	IN	O
difficulty	NN	O
.	.	O

eventually	RB	O
,	,	O
as	IN	O
the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
,	,	O
his	PRP$	O
airway	NN	O
remained	VBD	O
stable	JJ	O
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
tolerating	VBG	O
po	NN	O
s,	NN	O
he	PRP	O
was	VBD	O
transitioned	VBN	O
to	TO	O
the	DT	O
floor	NN	O
where	WRB	O
he	PRP	O
remained	VBD	O
otherwise	RB	O
stable	JJ	O
and	CC	O
asymptomatic	JJ	B-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
during	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
stay	NN	O
after	IN	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
and	CC	O
per	IN	O
cmed	VBN	O
csru	NN	O
was	VBD	O
to	TO	O
be	VB	O
discharged	VBN	O
on	IN	O
a	DT	O
2-week	JJ	O
course	NN	O
of	IN	O
augmentin	NN	B-TREATMENT
with	IN	O
follow-up	JJ	O
with	IN	O
dr.	JJ	O
thibodeau	NN	O
in	IN	O
2	CD	O
weeks	NNS	O
'	POS	O
time	NN	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	B-TREATMENT
medrol	NN	I-TREATMENT
dosepak	NN	I-TREATMENT
.	.	O

1.	CD	O
hiv	NN	B-PROBLEM
.	.	O

once	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
p.o.	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
haart	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
and	CC	O
remained	VBD	O
stable	JJ	O
from	IN	O
that	DT	O
perspective	NN	O
.	.	O

epiglottitis	NN	B-PROBLEM
/	NNP	O
supraglottitis	NN	B-PROBLEM
.	.	O

hiv	NN	B-PROBLEM
.	.	O

1.	CD	O
menthol	SYM	B-TREATMENT
-	:	I-TREATMENT
cetylpyridinium	NN	I-TREATMENT
lozenges	VBZ	I-TREATMENT
1	CD	O
as	IN	O
needed	VBN	O
.	.	O

2.	CD	O
tenofovir	JJ	B-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
didanosine	JJ	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
atazanavir	JJ	B-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
ritonavir	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

6.	CD	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
methylprednisolone	NN	B-TREATMENT
4	CD	O
mg	NN	O
tablets	NNS	O
per	IN	O
taper	NN	O
regimen	NNS	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
discharged	VBN	O
on	IN	O
augmentin	NN	B-TREATMENT
xr	NN	I-TREATMENT
1000	CD	O
mg	NN	O
/	VBD	O
62.5	CD	O
mg	NN	O
sustained	VBD	O
release	NN	O
1	CD	O
tablet	NN	O
q.	NN	O
12h	CD	O
.	.	O
for	IN	O
2	CD	O
weeks	NNS	O
.	.	O

sob	NN	B-PROBLEM

copd	NN	B-PROBLEM
exacerbation	NN	I-PROBLEM
(	(	I-PROBLEM
emphysema	NN	I-PROBLEM
)	)	I-PROBLEM

prednisone	NN	B-TREATMENT
,	,	O
nebulizers	NNS	B-TREATMENT
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
shows	NNS	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
nodule	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
which	WDT	O
may	MD	O
be	VB	O
cancer	NN	B-PROBLEM
.	.	O

prednisone	NN	B-TREATMENT
60	CD	O
mg	JJ	O
daily	RB	O
for	IN	O
4	CD	O
days	NNS	O
.	.	O

continue	NN	O
inhalers	NNS	B-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

call	NN	O
dr.	NN	O
linketerf	NN	O
tomorrow	NN	O
and	CC	O
make	VB	O
an	DT	O
appointment	NN	O
for	IN	O
follow-up	NN	O
on	IN	O
the	DT	B-PROBLEM
lung	NN	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52	JJ	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
no	DT	O
known	JJ	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM
history	NN	I-PROBLEM
who	WP	O
presented	VBD	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
as	RB	O
well	RB	O
as	IN	O
exertional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
tightness	NN	I-PROBLEM
which	WDT	O
was	VBD	O
acute-on-chronic	JJ	O
.	.	O

the	DT	O
patient	NN	O
stated	VBD	O
her	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
began	VBD	O
in	IN	O
2011	CD	O
and	CC	O
have	VBP	O
increased	VBN	O
in	IN	O
intensity	NN	O
and	CC	O
frequency	NN	O
every	DT	O
since	IN	O
then	RB	O
.	.	O

she	PRP	O
reports	VBZ	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
and	CC	O
chest	JJS	B-PROBLEM
tightness	NN	I-PROBLEM
daily	RB	O
which	WDT	O
worsened	VBD	O
significantly	RB	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

says	VBZ	O
that	IN	O
she	PRP	O
could	MD	O
not	RB	O
walk	VB	O
a	DT	O
few	JJ	O
yards	NNS	O
without	IN	O
developing	VBG	O
symptoms	NNS	B-PROBLEM
.	.	O

she	PRP	O
describes	VBZ	O
the	DT	B-PROBLEM
chest	NN	I-PROBLEM
tightness	NN	I-PROBLEM
as	IN	O
substernal	JJ	O
and	CC	O
epigastric	JJ	O
.	.	O

she	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
associated	JJ	I-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
lightheadedness	NN	B-PROBLEM
,	,	O
or	CC	O
dizziness	NN	B-PROBLEM
.	.	O

she	PRP	O
does	VBZ	O
have	VB	O
radiation	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
pain	NN	I-PROBLEM
to	TO	O
her	PRP$	O
neck	NN	O
and	CC	O
jaw	NN	O
bilaterally	RB	O
.	.	O

she	PRP	O
also	RB	O
describes	VBZ	O
a	DT	B-PROBLEM
fast	JJ	I-PROBLEM
heart	NN	I-PROBLEM
rate	NN	I-PROBLEM
and	CC	O
palpitations	NNS	B-PROBLEM
.	.	O

she	PRP	O
stated	VBD	O
her	PRP	B-PROBLEM
symptoms	NNS	I-PROBLEM
improved	VBN	O
with	IN	O
rest	NN	O
,	,	O
and	CC	O
she	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
beginning	VBG	O
when	WRB	O
she	PRP	O
was	VBD	O
at	IN	O
rest	NN	O
.	.	O

the	DT	O
patient	NN	O
reports	VBZ	O
a	DT	B-TEST
previous	JJ	I-TEST
workup	NN	I-TEST
which	WDT	O
included	VBD	O
a	DT	O
negative	JJ	O
exercise	NN	O
treadmill	NN	O
test	NN	O
,	,	O
a	DT	O
normal	JJ	O
mibi	NN	O
in	IN	O
2011-04-10	JJ	O
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
echocardiogram	NN	O
in	IN	O
2012	CD	O
(	(	O
except	IN	O
some	DT	B-PROBLEM
borderline	NN	I-PROBLEM
mild	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
)	)	O
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
55%	CD	O
.	.	O

review	NN	B-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
significant	JJ	O
for	IN	O
menopausal	NN	B-PROBLEM
symptoms	NNS	I-PROBLEM
(	(	O
for	IN	O
which	WDT	O
she	PRP	O
has	VBZ	O
attempted	VBN	O
hormone	CD	B-TREATMENT
replacement	NN	I-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
discontinued	VBN	O
in	IN	O
2014	CD	O
).	NN	O

she	PRP	O
also	RB	O
reports	VBZ	O
difficulty	NN	B-PROBLEM
sleeping	VBG	I-PROBLEM
,	,	O
daytime	JJ	B-PROBLEM
sleepiness	NN	I-PROBLEM
.	.	O

she	PRP	O
sleeps	VBZ	O
on	IN	O
elevated	JJ	B-TREATMENT
pillows	NNS	I-TREATMENT
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
gastroesophageal	JJ	I-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

occasional	JJ	B-PROBLEM
paroxysmal	JJ	I-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
in	IN	O
the	DT	O
past	JJ	O
but	CC	O
none	NN	O
recently	RB	O
.	.	O

occasional	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
left	VBD	O
greater	JJR	O
than	IN	O
right	NN	O
.	.	O

no	DT	O
abdominal	JJ	B-PROBLEM
or	CC	I-PROBLEM
urinary	JJ	I-PROBLEM
complaints	NNS	I-PROBLEM
.	.	O

1.	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
grave's	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
radiation	NN	B-TREATMENT
resulting	VBG	O
in	IN	O
hypothyroidism	NN	B-PROBLEM
.	.	O

3.	CD	O
migraines	NNS	B-PROBLEM
.	.	O

synthroid	NN	B-TREATMENT
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
,	,	O
fioricet	NN	B-TREATMENT
,	,	O
celebrex	NN	B-TREATMENT
.	.	O

penicillin	NN	B-TREATMENT
causes	VBZ	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

diabetes	NNS	B-PROBLEM
,	,	O
grave's	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
history	NN	O
of	IN	O
cardiopulmonary	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
does	VBZ	O
use	VB	O
herbal	JJ	B-TREATMENT
remedies	NNS	I-TREATMENT
including	VBG	O
primrose	JJ	B-TREATMENT
oil	NN	I-TREATMENT
,	,	O
siberian	JJ	B-TREATMENT
ginseng	NN	I-TREATMENT
,	,	O
and	CC	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
use	NN	O
of	IN	O
wallerian	JJ	B-TREATMENT
root	NN	I-TREATMENT
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
temperature	NN	B-TEST
of	IN	O
98.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
74	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
130/91	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
21	CD	O
,	,	O
satting	VBG	O
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

neck	NN	O
was	VBD	O
supple	JJ	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
,	,	O
no	DT	O
thyromegaly	NN	B-PROBLEM
,	,	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
,	,	O
and	CC	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
had	VBD	O
scant	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
base	NN	I-PROBLEM
and	CC	I-PROBLEM
middle	JJ	I-PROBLEM
field	NN	I-PROBLEM
;	:	O
otherwise	RB	O
clear	JJ	O
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

no	DT	O
parasternal	JJ	B-PROBLEM
heave	NN	I-PROBLEM
.	.	O

gastrointestinal	JJ	O
revealed	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

no	DT	O
masses	NNS	B-PROBLEM
.	.	O

no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

extremities	NNS	O
had	VBD	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
2+	CD	B-TEST
distal	JJ	I-TEST
pedis	NN	I-TEST
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.1	CD	O
,	,	O
hematocrit	NN	B-TEST
37.7	CD	O
,	,	O
platelets	NNS	B-TEST
326	CD	O
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
4	CD	O
,	,	O
chloride	RB	B-TEST
105	CD	O
,	,	O
bicarbonate	NN	B-TEST
28	CD	O
,	,	O
bun	NN	B-TEST
17	CD	O
,	,	O
creatinine	NN	B-TEST
0.8	CD	O
,	,	O
glucose	VBD	B-TEST
76	CD	O
.	.	O

creatine	NN	B-TEST
kinase	NN	I-TEST
100	CD	O
,	,	O
mb	FW	B-TEST
4	CD	O
,	,	O
troponin	NN	B-TEST
of	IN	O
less	JJR	O
than	IN	O
0.3	CD	O
.	.	O

electrocardiogram	NN	B-TEST
revealed	VBD	O
left	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
hypertrophy	NN	I-PROBLEM
,	,	O
and	CC	O
poor	JJ	B-PROBLEM
r	NN	I-PROBLEM
wave	NN	I-PROBLEM
progression	NN	I-PROBLEM
which	WDT	O
were	VBD	O
new	JJ	O
.	.	O

also	RB	O
,	,	O
t	NNS	B-PROBLEM
wave	VBP	I-PROBLEM
inversions	NNS	I-PROBLEM
in	IN	I-PROBLEM
ii	NN	I-PROBLEM
,	,	I-PROBLEM
iii	NN	I-PROBLEM
,	,	I-PROBLEM
avf	NN	I-PROBLEM
,	,	I-PROBLEM
v1	VBP	I-PROBLEM
through	IN	I-PROBLEM
v5	NN	I-PROBLEM
;	:	O
new	JJ	B-PROBLEM
evolving	VBG	I-PROBLEM
right	JJ	I-PROBLEM
bundle-branch	JJ	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
52	JJ	O
-	:	O
year-old	JJ	O
female	NN	O
with	IN	O
no	DT	O
known	JJ	O
history	NN	O
of	IN	O
cardiac	JJ	B-PROBLEM
disease	NN	I-PROBLEM
presenting	VBG	O
with	IN	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
and	CC	O
chest	NN	B-PROBLEM
tightness	NN	I-PROBLEM
,	,	O
who	WP	O
was	VBD	O
admitted	VBN	O
for	IN	O
evaluation	NN	B-TEST
and	CC	O
management	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
complaints	NNS	O
of	IN	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
and	CC	O
chest	NN	B-PROBLEM
pressure	NN	I-PROBLEM
which	WDT	O
could	MD	O
be	VB	O
consistent	JJ	O
with	IN	O
angina	NN	B-PROBLEM
.	.	O

however	RB	O
,	,	O
given	VBN	O
the	DT	O
long	JJ	O
duration	NN	O
of	IN	O
the	DT	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
negative	JJ	O
workup	NN	O
in	IN	O
the	DT	O
past	NN	O
,	,	O
it	PRP	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
unlikely	JJ	O
.	.	O

however	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
an	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
and	CC	O
a	DT	B-TEST
rule	NN	I-TEST
out	IN	I-TEST
myocardial	JJ	I-TEST
infarction	NN	I-TEST
protocol	NN	I-TEST
was	VBD	O
initiated	VBN	O
.	.	O

a	DT	B-TEST
stress	NN	I-TEST
thallium	NN	I-TEST
was	VBD	O
planned	VBN	O
for	IN	O
the	DT	O
day	NN	O
following	VBG	O
admission	NN	O
.	.	O

however	RB	O
,	,	O
on	IN	O
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
lying	VBG	O
in	IN	O
her	PRP$	O
bed	NN	O
diaphoretic	JJ	B-PROBLEM
and	CC	O
obtunded	VBD	B-PROBLEM
,	,	O
and	CC	O
a	DT	O
code	NN	O
was	VBD	O
called	VBN	O
.	.	O

further	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
a	DT	O
strong	JJ	O
palpable	JJ	O
pulse	NN	O
with	IN	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
the	DT	O
130	CD	O
s	NN	O
and	CC	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
in	IN	O
the	DT	O
80	CD	O
s.	NN	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
fluid	NN	I-TREATMENT
bolus	NN	I-TREATMENT
.	.	O

the	DT	O
patient	JJ	O
quickly	RB	O
responded	VBD	O
to	TO	O
a	DT	B-TREATMENT
fluid	NN	I-TREATMENT
bolus	NN	I-TREATMENT
and	CC	O
became	VBD	O
interactive	JJ	O
.	.	O

she	PRP	O
reported	VBD	O
that	IN	O
she	PRP	O
was	VBD	O
sitting	VBG	O
on	IN	O
the	DT	O
commode	NN	O
urinating	NN	O
and	CC	O
began	VBD	O
to	TO	O
feel	VB	O
nauseous	JJ	B-PROBLEM
and	CC	O
presyncopal	JJ	B-PROBLEM
.	.	O

she	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
pressure	NN	B-PROBLEM
,	,	O
and	CC	O
no	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
during	IN	O
this	DT	O
event	NN	O
.	.	O

a	DT	B-TEST
rhythm	NN	I-TEST
check	NN	I-TEST
obtained	VBD	O
during	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
event	NN	O
demonstrated	VBD	O
a	DT	B-PROBLEM
pause	NN	I-PROBLEM
of	IN	I-PROBLEM
six	CD	I-PROBLEM
seconds	NNS	I-PROBLEM
followed	VBN	O
by	IN	O
a	DT	B-PROBLEM
junctional	JJ	I-PROBLEM
escape	NN	I-PROBLEM
rhythm	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
electrocardiogram	NN	I-TEST
obtained	VBN	O
after	IN	O
the	DT	O
code	NN	O
demonstrated	VBD	O
no	DT	O
acute	NN	B-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
acute	JJ	I-PROBLEM
bradycardic	JJ	I-PROBLEM
event	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
likely	RB	O
secondary	JJ	O
to	TO	O
her	PRP$	B-TREATMENT
new	JJ	I-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
in	IN	O
conjunction	NN	O
with	IN	O
a	DT	B-PROBLEM
vagal	JJ	I-PROBLEM
response	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
determined	VBN	O
to	TO	O
stop	VB	O
the	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
and	CC	O
atropine	NN	B-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
the	DT	O
bedside	NN	O
.	.	O

on	IN	O
the	DT	O
following	JJ	O
day	NN	O
the	DT	O
patient	NN	O
underwent	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
dilated	VBD	B-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
chronic	JJ	B-PROBLEM
dysfunction	NN	I-PROBLEM
and	CC	O
a	DT	B-TEST
pulmonary	JJ	I-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
100	CD	O
.	.	O

her	PRP$	B-TEST
stress	JJ	I-TEST
test	NN	I-TEST
was	VBD	O
cancelled	VBN	O
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
angiogram	NN	I-TEST
was	VBD	O
ordered	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
chronic	JJ	B-PROBLEM
thromboembolic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
as	IN	O
a	DT	O
potential	JJ	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
three	CD	O
sets	NNS	O
of	IN	O
normal	JJ	O
enzymes	NNS	O
and	CC	O
continued	VBD	O
to	TO	O
be	VB	O
monitored	VBN	O
on	IN	O
telemetry	NN	B-TEST
.	.	O

a	DT	O
pulmonary	JJ	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
possible	JJ	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
hypotension	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
little	JJ	O
evidence	NN	O
to	TO	O
suggest	VB	O
any	DT	B-PROBLEM
cardiac	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
grave's	NN	I-PROBLEM
disease	NN	I-PROBLEM
an	DT	B-PROBLEM
autoimmune	JJ	I-PROBLEM
process	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
possible	JJ	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
consideration	NN	O
was	VBD	O
given	VBN	O
to	TO	O
sarcoidosis	VB	B-PROBLEM
,	,	O
human	JJ	B-PROBLEM
immunodeficiency	NN	I-PROBLEM
virus	NN	I-PROBLEM
,	,	O
and	CC	O
drug-induced	JJ	O
given	VBN	O
her	PRP$	O
history	NN	O
of	IN	O
herbal	JJ	B-TREATMENT
medication	NN	I-TREATMENT
use	NN	O
.	.	O

it	PRP	O
was	VBD	O
recommended	VBN	O
that	IN	O
the	DT	O
patient	NN	O
begin	NN	O
anticoagulation	NN	B-TREATMENT
given	VBN	O
the	DT	O
severity	NN	O
of	IN	O
her	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
also	RB	O
planned	VBN	O
to	TO	O
undergo	VB	O
a	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
with	IN	O
a	DT	B-TEST
vasodilation	NN	I-TEST
trial	NN	I-TEST
by	IN	O
the	DT	O
catheterization	NN	O
laboratory	NN	O
.	.	O

a	DT	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2014-12-05	JJ	O
.	.	O

a	DT	B-TEST
pharmacologic	JJ	I-TEST
pulmonary	JJ	I-TEST
vasodilator	NN	I-TEST
challenge	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
a	DT	O
positive	JJ	O
response	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
a	DT	B-TEST
ct	JJ	I-TEST
angiogram	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
with	IN	O
pulmonary	JJ	B-TEST
embolism	NN	I-TEST
protocol	NN	I-TEST
showed	VBD	O
no	DT	O
intravascular	JJ	B-PROBLEM
filling	NN	I-PROBLEM
defect	NN	I-PROBLEM
but	CC	O
did	VBD	O
show	VB	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
ground-glass	NN	I-PROBLEM
and	CC	O
scattered	VBD	B-PROBLEM
adenopathy	NNS	I-PROBLEM
.	.	O

therefore	RB	O
,	,	O
in	IN	O
the	DT	O
end	NN	O
left	VBD	B-PROBLEM
atrial	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
was	VBD	O
essentially	RB	O
ruled	VBN	O
out	RP	O
as	IN	O
a	DT	O
primary	JJ	O
cause	NN	O
.	.	O

chronic	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
embolus	NN	I-PROBLEM
was	VBD	O
less	RBR	O
likely	JJ	O
given	VBN	O
her	PRP$	O
negative	JJ	O
ct	NN	O
angiogram	NN	O
.	.	O

chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
was	VBD	O
unlikely	JJ	O
given	VBN	O
the	DT	O
patient	NN	O
's	POS	O
normal	JJ	O
pulmonary	JJ	O
function	NN	O
tests	NNS	O
and	CC	O
dlco	NN	B-TEST
in	IN	O
2012	CD	O
as	RB	O
well	RB	O
as	IN	O
a	DT	O
normal	JJ	O
ct	NN	O
angiogram	NN	O
.	.	O

collagen	NN	B-PROBLEM
vascular	JJ	I-PROBLEM
disease	NN	I-PROBLEM
could	MD	O
not	RB	O
be	VB	O
definitively	RB	O
ruled	VBN	O
out	RP	O
;	:	O
however	RB	O
,	,	O
given	VBN	O
the	DT	O
patient	NN	O
's	POS	O
lack	NN	O
of	IN	O
connective	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
disorder	NN	I-PROBLEM
stigmata	VBD	I-PROBLEM
it	PRP	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
less	RBR	O
likely	JJ	O
,	,	O
and	CC	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
human	JJ	I-TEST
immunodeficiency	NN	I-TEST
virus	NN	I-TEST
test	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

therefore	RB	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
most	RBS	O
likely	JJ	O
experiencing	VBG	O
a	DT	B-PROBLEM
primary	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

consideration	NN	O
was	VBD	O
given	VBN	O
to	TO	O
treating	VBG	O
the	DT	O
patient	NN	O
with	IN	O
a	DT	O
course	NN	O
of	IN	O
calcium	NN	B-TREATMENT
channel	NN	I-TREATMENT
blocker	NN	I-TREATMENT
;	:	O
however	RB	O
,	,	O
given	VBN	O
the	DT	O
patient	NN	O
's	POS	O
poor	JJ	O
response	NN	O
to	TO	O
lopressor	NN	B-TREATMENT
,	,	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
this	DT	O
would	MD	O
not	RB	O
be	VB	O
optimal	JJ	O
treatment	NN	O
for	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

therefore	RB	O
,	,	O
her	PRP	O
insurance	NN	O
company	NN	O
was	VBD	O
contacted	VBN	O
regarding	VBG	O
the	DT	O
potential	NN	O
of	IN	O
flolan	NN	B-TREATMENT
as	IN	O
a	DT	O
treatment	NN	O
.	.	O

plans	NNS	O
were	VBD	O
made	VBN	O
for	IN	O
placement	NN	O
of	IN	O
a	DT	B-TREATMENT
hickman	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
initiation	NN	O
of	IN	O
flolan	NN	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
on	IN	O
12-07	JJ	O
,	,	O
the	DT	O
patient	NN	O
once	RB	O
again	RB	O
experienced	VBD	O
an	DT	O
episode	NN	O
of	IN	O
unresponsiveness	NN	B-PROBLEM
.	.	O

upon	IN	O
arrival	NN	O
by	IN	O
the	DT	O
physician	NN	O
the	DT	O
patient	NN	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
,	,	O
and	CC	O
oriented	VBN	O
with	IN	O
a	DT	B-TEST
pulse	NN	I-TEST
in	IN	O
the	DT	O
80	CD	O
s,	NN	O
with	IN	O
pressure	NN	B-TEST
in	IN	O
the	DT	O
80	CD	O
s,	NN	O
and	CC	O
satting	VBG	O
100%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

she	PRP	O
described	VBD	O
this	DT	O
episode	NN	O
as	IN	O
an	DT	B-PROBLEM
uncomfortable	JJ	I-PROBLEM
feeling	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
2	CD	O
liters	NNS	O
of	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
with	IN	O
a	DT	O
bump	NN	O
in	IN	O
her	PRP$	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
to	TO	O
the	DT	O
90	CD	O
s.	NN	O

review	NN	O
of	IN	O
telemetry	NN	B-TEST
revealed	VBD	O
an	DT	O
8	CD	O
to	TO	O
9	CD	O
beat	NN	O
episode	NN	O
of	IN	O
nonsustained	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
followed	VBN	O
by	IN	O
an	DT	O
episode	NN	O
of	IN	O
bradycardia	NN	B-PROBLEM
to	TO	O
60	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

the	DT	O
etiology	NN	O
of	IN	O
these	DT	B-PROBLEM
cardiovascular	JJ	I-PROBLEM
episodes	NNS	I-PROBLEM
was	VBD	O
unclear	JJ	O
,	,	O
but	CC	O
was	VBD	O
felt	VBN	O
likely	RB	O
secondary	JJ	O
to	TO	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
tenuous	JJ	I-PROBLEM
cardiovascular	JJ	I-PROBLEM
status	NN	I-PROBLEM
given	VBN	O
the	DT	O
fact	NN	O
that	IN	O
she	PRP	O
had	VBD	O
clear	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
was	VBD	O
very	RB	B-PROBLEM
preload	JJ	I-PROBLEM
dependent	NN	I-PROBLEM
,	,	O
and	CC	O
had	VBD	O
an	DT	O
intact	JJ	O
left	VBD	O
ventricular	JJ	O
function	NN	O
but	CC	O
with	IN	O
cardiac	JJ	B-PROBLEM
output	NN	I-PROBLEM
limited	VBD	I-PROBLEM
due	JJ	O
to	TO	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
compression	NN	I-PROBLEM
by	IN	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
left	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
.	.	O

given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
persistent	JJ	I-PROBLEM
hypotensive	JJ	I-PROBLEM
episodes	NNS	I-PROBLEM
,	,	O
and	CC	O
decreased	VBD	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
management	NN	O
prior	RB	O
to	TO	O
initiation	NN	O
of	IN	O
flolan	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

on	IN	O
12-08	JJ	O
,	,	O
the	DT	B-TREATMENT
hickman	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
preparation	NN	O
of	IN	O
flolan	JJ	B-TREATMENT
administration	NN	O
.	.	O

during	IN	O
the	DT	O
mass.	JJ	O
mental	JJ	O
health	NN	O
center	NN	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
exquisitely	RB	B-PROBLEM
preload	VB	I-PROBLEM
dependent	NN	I-PROBLEM
and	CC	O
responded	VBD	O
well	RB	O
to	TO	O
aggressive	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
as	IN	O
needed	VBN	O
to	TO	O
maintain	VB	O
her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
with	IN	O
a	DT	B-TEST
systolic	NN	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
90	CD	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
during	IN	O
her	PRP$	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
urine	JJ	I-TEST
output	NN	I-TEST
improved	VBD	O
dramatically	RB	O
with	IN	O
hydration	NN	B-TREATMENT
therapy	NN	I-TREATMENT
,	,	O
suggesting	VBG	O
her	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
was	VBD	O
secondary	JJ	O
to	TO	O
decreased	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
output	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
low	JJ	B-PROBLEM
preload	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
electrophysiology	NN	O
service	NN	O
,	,	O
who	WP	O
determined	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
demonstrating	VBG	O
severe	JJ	B-PROBLEM
vasal	NN	I-PROBLEM
sensitivity	NN	I-PROBLEM
with	IN	O
bradycardia	NN	B-PROBLEM
necessitating	VBG	O
pacemaker	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
to	TO	O
be	VB	O
deferred	VBN	O
until	IN	O
after	IN	O
the	DT	O
patient	NN	O
had	VBD	O
her	PRP$	B-TREATMENT
hickman	NN	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

because	IN	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
pulmonary	JJ	I-TEST
pressures	NNS	I-TEST
responded	VBD	O
so	RB	O
well	RB	O
to	TO	O
adenosine	VB	B-TREATMENT
during	IN	O
right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
,	,	O
it	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
the	DT	O
patient	NN	O
would	MD	O
be	VB	O
a	DT	O
good	JJ	O
candidate	NN	O
for	IN	O
flolan	NN	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

flolan	NN	B-TREATMENT
was	VBD	O
initiated	VBN	O
on	IN	O
12-08	NNS	O
at	IN	O
5	CD	O
nanograms	NNS	O
per	IN	O
kilogram	NN	O
per	IN	O
minute	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
monitored	VBN	O
for	IN	O
symptoms	NNS	B-PROBLEM
of	IN	O
flolan	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
including	VBG	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
first	RB	B-PROBLEM
bite	JJ	I-PROBLEM
jaw	NN	I-PROBLEM
claudication	NN	I-PROBLEM
,	,	O
or	CC	O
hypotension	NN	B-PROBLEM
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
hospital	NN	O
stay	VBD	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
flolan	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
titrated	VBN	O
to	TO	O
receive	VB	O
maximum	JJ	O
benefit	NN	O
without	IN	O
precipitating	VBG	O
symptoms	NNS	O
of	IN	O
flolan	NN	B-PROBLEM
overdose	VBP	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
stable	JJ	O
on	IN	O
her	PRP$	B-TREATMENT
current	JJ	I-TREATMENT
flolan	NN	I-TREATMENT
dose	NN	I-TREATMENT
and	CC	O
was	VBD	O
therefore	RB	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

a	DT	B-TEST
high	JJ	I-TEST
resolution	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
requested	VBN	O
to	TO	O
further	RBR	O
evaluate	VB	O
for	IN	O
possible	JJ	O
secondary	JJ	O
cause	NN	O
of	IN	O
her	PRP$	B-PROBLEM
primary	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
the	DT	O
patient	NN	O
refused	VBD	O
it	PRP	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

plans	NNS	O
for	IN	O
placement	NN	O
of	IN	O
a	DT	B-TREATMENT
pacemaker	NN	I-TREATMENT
were	VBD	O
initiated	VBN	O
.	.	O

however	RB	O
,	,	O
on	IN	O
the	DT	O
night	NN	O
prior	RB	O
to	TO	O
the	DT	O
planned	VBN	O
surgical	JJ	O
date	NN	O
the	DT	O
patient	NN	O
suffered	VBD	O
an	DT	O
episode	NN	O
of	IN	O
bleeding	VBG	B-PROBLEM
from	IN	O
her	PRP$	B-TREATMENT
hickman	NN	I-TREATMENT
catheter	NN	I-TREATMENT
site	NN	O
.	.	O

surgery	NN	O
was	VBD	O
notified	VBN	O
and	CC	O
pressure	NN	B-TREATMENT
was	VBD	O
applied	VBN	O
;	:	O
however	RB	O
,	,	O
it	PRP	O
did	VBD	O
not	RB	O
stop	VB	O
oozing	NN	O
.	.	O

a	DT	B-TREATMENT
surgicel	NN	I-TREATMENT
dressing	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
prolonged	JJ	B-TREATMENT
pressure	NN	I-TREATMENT
resulted	VBD	O
in	IN	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
an	DT	B-TREATMENT
extra	JJ	I-TREATMENT
stitch	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
an	DT	O
effort	NN	O
to	TO	O
stop	VB	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

following	VBG	O
this	DT	O
episode	VBZ	O
the	DT	O
patient	NN	O
felt	VBD	O
like	IN	O
she	PRP	O
was	VBD	O
"	RB	O
too	RB	B-PROBLEM
stressed	JJ	I-PROBLEM
"	NN	O
for	IN	O
pacemaker	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

therefore	RB	O
,	,	O
she	PRP	O
was	VBD	O
monitored	VBN	O
over	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
for	IN	O
any	DT	B-PROBLEM
further	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
events	NNS	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
next	JJ	O
few	JJ	O
days	NNS	O
the	DT	O
patient	NN	O
became	VBD	O
more	RBR	O
accustomed	JJ	O
to	TO	O
her	PRP$	B-TREATMENT
flolan	NN	I-TREATMENT
,	,	O
and	CC	O
flolan	NN	B-TREATMENT
teaching	NN	O
was	VBD	O
continued	VBN	O
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
occasional	JJ	O
episodes	NNS	O
of	IN	O
dizziness	NN	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
and	CC	O
hypotension	NN	B-PROBLEM
whenever	WRB	O
the	DT	O
alarm	NN	O
sounded	VBD	O
suggesting	VBG	O
that	IN	O
the	DT	B-TREATMENT
flolan	NN	I-TREATMENT
bag	NN	I-TREATMENT
needed	VBN	O
to	TO	O
be	VB	O
changed	VBN	O
.	.	O

on	IN	O
12-15	CD	O
,	,	O
the	DT	O
patient	NN	O
went	VBD	O
for	IN	O
placement	NN	O
of	IN	O
a	DT	B-TREATMENT
pacemaker	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
dual-mode	NN	B-TREATMENT
,	,	I-TREATMENT
dual-pacing	JJ	I-TREATMENT
,	,	I-TREATMENT
dual-sensing	JJ	I-TREATMENT
pacemaker	NN	I-TREATMENT
placed	VBN	O
with	IN	O
a	DT	B-TEST
lower	JJR	I-TEST
rate	NN	I-TEST
at	IN	O
60	CD	O
ppm	NN	O
,	,	O
and	CC	O
upper	JJ	B-TEST
rate	NN	I-TEST
of	IN	O
120	CD	O
ppm	NN	O
with	IN	O
a	DT	B-TEST
paced	JJ	I-TEST
av	NN	I-TEST
of	IN	O
150	CD	O
msec	NN	O
.	.	O

the	DT	O
patient	NN	O
recovered	VBD	O
well	RB	O
from	IN	O
her	PRP$	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
pacemaker	NN	B-TREATMENT
placement	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
her	PRP$	B-TREATMENT
flolan	NN	I-TREATMENT
therapy	NN	I-TREATMENT
well	RB	O
.	.	O

she	PRP	O
had	VBD	O
received	VBN	O
a	DT	O
full	JJ	O
course	NN	O
of	IN	O
flolan	NN	B-TREATMENT
teaching	NN	I-TREATMENT
and	CC	O
reported	VBD	O
that	IN	O
she	PRP	O
and	CC	O
her	PRP$	O
husband	NN	O
felt	VBD	O
comfortable	JJ	O
with	IN	O
the	DT	O
administration	NN	O
of	IN	O
the	DT	B-TREATMENT
medication	NN	I-TREATMENT
at	IN	O
home	NN	O
.	.	O

she	PRP	O
was	VBD	O
set	VBN	O
up	RP	O
with	IN	O
a	DT	B-TREATMENT
primary	JJ	I-TREATMENT
pulmonary	JJ	I-TREATMENT
hypertension	NN	I-TREATMENT
support	NN	I-TREATMENT
group	NN	I-TREATMENT
,	,	O
and	CC	O
home	NN	B-TREATMENT
services	NNS	I-TREATMENT
were	VBD	O
arranged	VBN	O
to	TO	O
help	VB	O
her	PRP	O
in	IN	O
the	DT	O
initiation	NN	O
of	IN	O
flolan	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

following	VBG	O
pacemaker	NN	B-TREATMENT
placement	VBD	I-TREATMENT
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
further	JJ	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
on	IN	O
telemetry	NN	B-TEST
,	,	O
and	CC	O
therefore	RB	O
she	PRP	O
was	VBD	O
discharged	VBN	O
in	IN	O
satisfactory	JJ	O
condition	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
signs	NNS	O
or	CC	O
symptoms	NNS	O
of	IN	O
infection	NN	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

however	RB	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
relatively	RB	I-PROBLEM
elevated	JJ	I-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
count	NN	I-PROBLEM
that	WDT	O
remained	VBD	O
stable	JJ	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

however	RB	O
,	,	O
near	IN	O
the	DT	O
end	NN	O
of	IN	O
her	PRP$	O
hospitalization	NN	O
the	DT	O
patient	NN	O
began	VBD	O
describing	VBG	O
increased	VBN	B-PROBLEM
urinary	JJ	I-PROBLEM
frequency	NN	I-PROBLEM
which	WDT	O
persisted	VBD	O
once	RB	O
her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

a	DT	B-TEST
urinalysis	NN	I-TEST
was	VBD	O
positive	JJ	B-PROBLEM
and	CC	O
urine	JJ	B-TEST
culture	NN	I-TEST
grew	VBD	O
enterococcus	NN	B-PROBLEM
which	WDT	O
was	VBD	O
pan	RB	O
sensitive	JJ	O
.	.	O

therefore	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
therapy	NN	I-TREATMENT
to	TO	O
complete	VB	O
a	DT	O
10	CD	O
-	:	O
day	NN	O
course	NN	O
.	.	O

following	VBG	O
initiation	NN	O
of	IN	O
the	DT	B-TREATMENT
antibiotic	JJ	I-TREATMENT
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
quickly	RB	O
came	VBD	O
down	RB	O
,	,	O
and	CC	O
she	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
still	RB	O
had	VBD	O
a	DT	B-PROBLEM
mildly	RB	I-PROBLEM
elevated	JJ	I-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cell	NN	I-PROBLEM
count	NN	I-PROBLEM
but	CC	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
with	IN	O
a	DT	O
normal	JJ	O
temperature	NN	O
.	.	O

she	PRP	O
will	MD	O
complete	VB	O
two	CD	O
more	JJR	O
days	NNS	O
of	IN	O
levaquin	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
were	VBD	O
followed	VBN	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	B-PROBLEM
decreased	JJ	I-PROBLEM
urine	NN	I-PROBLEM
output	NN	I-PROBLEM
was	VBD	O
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
preload	NN	I-PROBLEM
dependence	NN	I-PROBLEM
,	,	O
and	CC	O
that	IN	O
her	PRP$	B-TEST
urine	JJ	I-TEST
output	NN	I-TEST
increased	VBD	O
significantly	RB	O
when	WRB	O
she	PRP	O
was	VBD	O
adequately	RB	O
hydrated	VBN	O
in	IN	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
gastroesophageal	NN	B-PROBLEM
reflux	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
protonix	NN	B-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
and	CC	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
hospital	NN	O
stay	NN	O
.	.	O

despite	IN	O
bleeding	VBG	B-PROBLEM
from	IN	O
the	DT	B-TREATMENT
hickman	NN	I-TREATMENT
site	NN	I-TREATMENT
,	,	O
she	PRP	O
did	VBD	O
not	RB	O
require	VB	O
any	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
electrolytes	NNS	I-TEST
were	VBD	O
checked	VBN	O
on	IN	O
a	DT	O
daily	JJ	O
basis	NN	O
and	CC	O
remained	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
,	,	O
being	VBG	O
replaced	VBN	O
as	IN	O
needed	VBN	O
.	.	O

the	DT	O
patient	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypothyroidism	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
her	PRP$	B-TREATMENT
regular	JJ	I-TREATMENT
synthroid	NN	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

she	PRP	O
will	MD	O
need	VB	O
a	DT	B-TEST
tsh	NN	I-TEST
and	CC	O
t4	NN	B-TEST
checked	VBD	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
code	NN	I-TREATMENT
.	.	O

9.	CD	O
flolan	JJ	B-TREATMENT
administration	NN	I-TREATMENT
:	:	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
a	DT	B-TREATMENT
flolan	NN	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
5	CD	O
nanograms	NNS	O
per	IN	O
kilogram	NN	O
per	IN	O
minute	NN	O
.	.	O

a	DT	O
physical	JJ	O
therapy	NN	O
consultation	NN	O
was	VBD	O
obtained	VBN	O
to	TO	O
initiate	VB	O
a	DT	B-TEST
6	CD	I-TEST
-	:	I-TEST
minute	NN	I-TEST
walk	VBP	I-TEST
test	NN	I-TEST
.	.	O

on	IN	O
room	NN	O
air	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
was	VBD	O
95%	CD	O
and	CC	O
dropped	VBD	O
to	TO	O
88%	CD	O
following	VBG	O
a	DT	O
6	CD	O
-	:	O
minute	NN	O
walk	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
appropriate	JJ	O
flolan	NN	B-TREATMENT
teaching	VBG	I-TREATMENT
and	CC	O
supplies	NNS	O
.	.	O

she	PRP	O
has	VBZ	O
follow	VBN	O
up	RP	O
with	IN	O
dr.	NN	O
schwartz	NN	O
in	IN	O
the	DT	O
clinic	NN	O
on	IN	O
monday	NN	O
,	,	O
12-22	JJ	O
,	,	O
at	IN	O
2:30	CD	O
p.m.	NN	O
to	TO	O
check	VB	O
her	PRP$	B-TEST
inr	NN	I-TEST
and	CC	O
digoxin	NN	B-TEST
level	NN	I-TEST
.	.	O

she	PRP	O
also	RB	O
has	VBZ	O
follow	VBN	O
up	RP	O
with	IN	O
dr.	JJ	O
savage	NN	O
in	IN	O
the	DT	O
pulmonary	JJ	O
clinic	NN	O
on	IN	O
12-25	NNS	O
at	IN	O
12:15	CD	O
p.m.	NN	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
her	PRP$	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

1.	CD	O
coumadin	NN	B-TREATMENT
2	CD	O
mg	NN	O
p.o.	NN	O
q.6h.	NN	O

2.	CD	O
tylenol	JJ	B-TREATMENT
no.	NN	I-TREATMENT
3	CD	I-TREATMENT
one	CD	O
to	TO	O
two	CD	O
tablets	NNS	O
p.o.	VBP	O
q.4h.	JJ	O
p.r.n.	NN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

3.	CD	O
digoxin	NN	B-TREATMENT
0.125	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	JJ	O
times	NNS	O
two	CD	O
days	NNS	O
.	.	O

5.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

6.	CD	O
tylenol	JJ	B-TREATMENT
650	CD	O
mg	JJ	O
p.o.	JJ	O
q.4-6h.	JJ	O
p.r.n.	NN	O
for	IN	O
fever	NN	B-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
.	.	O

7.	CD	O
synthroid	JJ	B-TREATMENT
125	CD	O
mcg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

9.	CD	O
lactulose	JJ	B-TREATMENT
30	CD	O
cc	NN	O
p.o.	NN	O
q.6h.	NN	O
p.r.n.	NN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

10.	CD	O
flolan	JJ	B-TREATMENT
5	CD	O
nanograms	NNS	O
per	IN	O
kilograms	NNS	O
per	IN	O
minute	NN	O
,	,	O
continuous	JJ	O
infusion	NN	O
.	.	O

11.	CD	O
oxygen	NN	B-TREATMENT
per	IN	O
nasal	NN	B-TREATMENT
cannula	NN	I-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

cellulitis	NN	B-PROBLEM

attending	VBG	B-TEST
evaluation	NN	I-TEST

levofloxacin	RB	B-TREATMENT
500	CD	O
mg	NNS	O
po	JJ	O
qd	JJ	O
x	$	O
14	CD	O
days	NNS	O

administer	RB	O
iron	NN	B-TREATMENT
products	NNS	I-TREATMENT
a	DT	O
minimum	NN	O
of	IN	O
2	CD	O
hours	NNS	O
before	IN	O
or	CC	O
after	IN	O
a	DT	B-TREATMENT
levofloxacin	NN	I-TREATMENT
or	CC	O
ciprofloxacin	NN	B-TREATMENT
dose	VBP	I-TREATMENT
dose	JJ	O
if	IN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
,	,	O
please	VB	O
cycle	NN	O
(	(	O
hold	VB	O
1	CD	O
hr	NN	O
before	IN	O
to	TO	O
2	CD	O
hr	NNS	O
after	IN	O
)	)	O
take	VB	O
2	CD	O
hours	NNS	O
before	IN	O
or	CC	O
2	CD	O
hours	NNS	O
after	IN	O
dairy	NN	O
products	NNS	O
.	.	O

penicillins	NNS	B-TREATMENT

cellulitis	NN	B-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
cellulitis	NN	B-PROBLEM

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
cellulitis	NN	B-PROBLEM

ct	NN	B-TEST
of	IN	I-TEST
neck	NN	I-TEST
with	IN	I-TEST
contrast	NN	I-TEST

pt	NN	O
is	VBZ	O
22	CD	O
y	NN	O
/	NNP	O
o	VBZ	O
female	JJ	O
with	IN	O
hx	NN	O
of	IN	O
hiv	NN	B-PROBLEM
and	CC	O
cd4	NN	B-TEST
ct	NN	I-TEST
of	IN	O
297	CD	O
who	WP	O
presented	VBD	O
to	TO	O
ed	VB	O
on	IN	O
01/14	CD	O
with	IN	O
sebaceous	JJ	B-PROBLEM
cyst	NN	I-PROBLEM
that	WDT	O
was	VBD	O
infected	VBN	B-PROBLEM
.	.	O

cyst	NN	B-PROBLEM
was	VBD	O
drained	VBN	O
and	CC	O
pt	NN	O
was	VBD	O
sent	VBN	O
home	NN	O
with	IN	O
duracef	NN	B-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
fill	VB	O
script	NN	B-TREATMENT
for	IN	O
2	CD	O
days	NNS	O
and	CC	O
even	RB	O
then	RB	O
was	VBD	O
not	RB	B-PROBLEM
compliant	JJ	I-PROBLEM
with	IN	O
her	PRP$	B-TREATMENT
meds	NNS	I-TREATMENT
.	.	O

she	PRP	O
now	RB	O
returns	VBZ	O
to	TO	O
ed	VB	O
with	IN	O
pain	NN	B-PROBLEM
and	CC	O
erythema	NN	B-PROBLEM
from	IN	I-PROBLEM
the	DT	I-PROBLEM
midline	NN	I-PROBLEM
posterior	JJ	I-PROBLEM
neck	NN	I-PROBLEM
to	TO	O
her	PRP$	O
submental	JJ	O
area	NN	O
and	CC	O
2-3	JJ	O
d	NN	O
of	IN	O
intermittent	JJ	B-PROBLEM
fevers	NNS	I-PROBLEM
and	CC	O
chills	NNS	B-PROBLEM
.	.	O
+	JJ	O
nausea	NN	B-PROBLEM
.	.	O

no	DT	O
dysphagia	NN	B-PROBLEM
,	,	O
trouble	NN	O
hearing	NN	O
.	.	O

hiv	NN	B-PROBLEM
,	,	O
viral	JJ	B-TEST
load	NN	I-TEST
954	CD	O
,	,	O
7/03	CD	O
-	:	O
h.	NN	B-PROBLEM
pylori	NN	I-PROBLEM
pos.	NN	O
,	,	O
asthma	NN	B-PROBLEM

smokes	NNS	O
2-3	JJ	O
cig	JJ	O
/	NNP	O
day	NN	O
,	,	O
occ	NN	O
etoh	NN	O
,	,	O
and	CC	O
no	DT	O
drugs	NNS	O
except	IN	O
marijuana	NN	O
exam	NN	B-TEST
:	:	O

exam	NN	B-TEST
sig.	NN	O
for	IN	O
erthyema	NN	B-PROBLEM
as	IN	O
described	VBN	O
previously	RB	O
and	CC	O
tenderness	VB	B-PROBLEM
to	TO	O
minimal	JJ	B-TEST
palpation	NN	I-TEST
.	.	O

neck	NN	B-TEST
ct	NN	I-TEST
neg	NN	O
for	IN	O
abcess	NN	B-PROBLEM
.	.	O

pt	NN	O
with	IN	O
wbc	NN	B-TEST
of	IN	O
15.4	CD	O
with	IN	O
70%	CD	B-TEST
seg	NNS	I-TEST
.	.	O

(1)	NN	O
id	SYM	O
-	:	O
pt	NN	O
received	VBD	O
clinda	NNS	B-TREATMENT
and	CC	O
ancef	NN	B-TREATMENT
in	IN	O
ed	NN	O
.	.	O

will	MD	O
cont	VB	O
ancef	RB	B-TREATMENT
1q8	CD	O
overnight	JJ	O
and	CC	O
trans	NNS	O
to	TO	O
keflex	VB	B-TREATMENT
.	.	O

cd4	NN	B-TEST
ct	NN	I-TEST
.	.	O

bacitracin	NN	B-TREATMENT
oint	NN	I-TREATMENT
.	.	O

percocet	NN	B-TREATMENT
and	CC	O
morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
for	IN	O
pain	NN	B-PROBLEM
.	.	O

(2)	NN	O
gi	SYM	O
-	:	O
nexium	NN	B-TREATMENT

(3)	NN	O
fen	SYM	O
-	:	O
ns	NN	B-TREATMENT
overnight	NN	O

(4)	NN	O
pulm	SYM	O
-	:	O
albuterol	NN	B-TREATMENT
inhalers	NNS	I-TREATMENT
prn	VBP	O
patient	JJ	O
seems	VBZ	O
to	TO	O
be	VB	O
improving	VBG	O
and	CC	O
afebrile	JJ	B-PROBLEM
and	CC	O
resting	VBG	O
comfortably	RB	O
.	.	O

the	DT	B-PROBLEM
erythematous	JJ	I-PROBLEM
region	NN	I-PROBLEM
is	VBZ	O
retreating	VBG	O
and	CC	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
cleaned	VBD	O
.	.	O

she	PRP	O
is	VBZ	O
ready	JJ	O
to	TO	O
be	VB	O
sent	VBN	O
home	NN	O
with	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

repeat	NN	B-TEST
ct	NN	I-TEST
was	VBD	O
neg.	JJ	O
for	IN	O
abcess	NN	B-PROBLEM
or	CC	O
fascitis	NN	B-PROBLEM
.	.	O

1	CD	O
-	:	O
be	VB	O
sure	JJ	O
to	TO	O
finish	VB	O
all	DT	O
antibiotic	JJ	B-TREATMENT
even	RB	O
if	IN	O
pain	NN	B-PROBLEM
subsides	NNS	O
adn	VBP	O
inflammation	NN	B-PROBLEM
goes	VBZ	O
down	RB	O
.	.	O

2	CD	O
-	:	O
clean	NN	O
wound	NN	B-PROBLEM

1	CD	O
-	:	O
fill	NN	O
rx	NN	O
for	IN	O
antibiotics	NNS	B-TREATMENT
today	NN	O
and	CC	O
take	VB	O
until	IN	O
finished	VBN	O
even	RB	O
if	IN	O
neck	NN	B-PROBLEM
pain	NN	I-PROBLEM
subsides	NNS	O
x	VBP	O
14	CD	O
days	NNS	O

2	CD	O
-	:	O
clean	NN	O
wound	NN	B-PROBLEM

3	LS	O
-	:	O
return	NN	O
to	TO	O
ed	VB	O
or	CC	O
call	VB	O
pcp	NN	O
if	IN	O
neck	DT	B-PROBLEM
inflammation	NN	I-PROBLEM
and	CC	O
red	JJ	B-PROBLEM
swollen	JJ	I-PROBLEM
area	NN	I-PROBLEM
does	VBZ	O
not	RB	O
continue	VB	O
to	TO	O
get	VB	O
better	JJR	O
or	CC	O
if	IN	O
temperature	JJ	B-PROBLEM
returns	NNS	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
56	JJ	O
-	:	O
year-old	JJ	O
man	NN	O
without	IN	O
any	DT	O
significant	JJ	O
past	JJ	O
medical	JJ	O
history	NN	O
who	WP	O
presented	VBD	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
after	IN	O
the	DT	O
sudden	JJ	O
onset	NN	O
of	IN	O
headache	NN	B-PROBLEM
while	IN	O
he	PRP	O
was	VBD	O
riding	VBG	O
a	DT	O
bicycle	NN	O
.	.	O

he	PRP	O
characterized	VBD	O
this	DT	B-PROBLEM
headache	NN	I-PROBLEM
as	IN	O
the	DT	B-PROBLEM
worst	JJS	I-PROBLEM
headache	NN	I-PROBLEM
of	IN	O
his	PRP$	O
life	NN	O
and	CC	O
had	VBD	O
associated	VBN	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	VBG	B-PROBLEM
times	NNS	O
one	CD	O
.	.	O

he	PRP	O
also	RB	O
complained	VBD	O
of	IN	O
dizziness	NN	B-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
headache	NN	B-PROBLEM
onset	NN	O
.	.	O

he	PRP	O
presented	VBD	O
to	TO	O
the	DT	O
edith	JJ	O
nourse	JJ	O
rogers	NNS	O
memorial	JJ	O
va	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
,	,	O
where	WRB	O
an	DT	B-TEST
initial	JJ	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
read	VBN	O
as	IN	O
negative	JJ	O
.	.	O

however	RB	O
,	,	O
a	DT	B-TEST
lumbar	NN	I-TEST
puncture	NN	I-TEST
was	VBD	O
done	VBN	O
,	,	O
in	IN	O
which	WDT	O
tube	NN	O
1	CD	O
showed	VBD	O
4800	CD	B-TEST
red	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
and	CC	O
tube	NN	O
4	CD	O
showed	VBD	O
4000	CD	B-TEST
red	JJ	I-TEST
blood	NN	I-TEST
cells	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
sent	VBN	O
for	IN	O
an	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
,	,	O
which	WDT	O
raised	VBD	O
the	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
posterior	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
was	VBD	O
revealed	VBN	O
and	CC	O
,	,	O
on	IN	O
second	JJ	O
analysis	NN	O
,	,	O
it	PRP	O
was	VBD	O
thought	VBN	O
that	IN	O
it	PRP	O
was	VBD	O
suspicious	JJ	O
for	IN	O
a	DT	B-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
suprasellar	JJ	I-PROBLEM
cistern	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
admitted	VBN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

the	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
was	VBD	O
significant	JJ	O
for	IN	O
left	JJ	B-TREATMENT
shoulder	NN	I-TREATMENT
surgery	NN	I-TREATMENT
in	IN	O
2014-03-06	JJ	O
for	IN	O
repair	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
"	NNP	I-PROBLEM
minor	JJ	I-PROBLEM
rotator	NN	I-PROBLEM
cuff	NN	I-PROBLEM
tear	JJ	I-PROBLEM
"	NN	O
and	CC	O
removal	NN	B-TREATMENT
of	IN	O
osteophytes	NNS	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
on	IN	O
no	DT	O
medications	NNS	B-TREATMENT
.	.	O

there	EX	O
were	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
father	NN	O
had	VBD	O
leukemia	NN	B-PROBLEM
and	CC	O
the	DT	O
mother	NN	O
had	VBD	O
gastrointestinal	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
aneurysms	NNS	B-PROBLEM
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
resting	VBG	O
comfortably	RB	O
when	WRB	O
seen	VBN	O
,	,	O
slightly	RB	B-PROBLEM
sleepy	NN	I-PROBLEM
at	IN	O
first	JJ	O
but	CC	O
readily	RB	O
arousable	JJ	O
,	,	O
awake	VB	O
,	,	O
alert	VB	O
,	,	O
oriented	VBN	O
and	CC	O
conversant	JJ	O
.	.	O

of	IN	O
note	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
given	VBN	O
2	CD	O
mg	NN	O
of	IN	O
ativan	NN	B-TREATMENT
before	IN	O
the	DT	B-TEST
examination	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
no	DT	O
rigidity	NN	B-PROBLEM
,	,	O
but	CC	O
the	DT	O
neck	NN	O
was	VBD	O
slightly	RB	B-PROBLEM
painful	JJ	I-PROBLEM
at	IN	O
extreme	JJ	B-TEST
flexion	NN	I-TEST
.	.	O

the	DT	B-TEST
general	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
essentially	RB	O
unremarkable	JJ	O
,	,	O
as	IN	O
per	IN	O
previous	JJ	O
notes	NNS	O
.	.	O

on	IN	O
examination	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
extremities	NNS	I-TEST
,	,	O
the	DT	O
patient	NN	O
moved	VBD	O
all	DT	O
extremities	NNS	O
and	CC	O
had	VBD	O
strength	NN	O
of	IN	O
5/5	CD	O
in	IN	O
all	DT	O
of	IN	O
the	DT	O
muscle	NN	O

the	DT	B-TEST
sensory	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
slight	JJ	I-PROBLEM
inward	NN	I-PROBLEM
pronator	NN	I-PROBLEM
drift	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
hand	NN	I-PROBLEM
.	.	O

finger	NN	B-TEST
-	:	I-TEST
nose	JJ	I-TEST
-	:	I-TEST
finger	NN	I-TEST
testing	VBG	I-TEST
and	CC	O
heel	VB	B-TEST
-	:	I-TEST
to	TO	I-TEST
-	:	I-TEST
shin	JJ	I-TEST
testing	VBG	I-TEST
were	VBD	O
normal	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
ataxia	NN	B-PROBLEM
noted	VBD	O
.	.	O

laboratory	NN	B-TEST
values	NNS	I-TEST
were	VBD	O
as	IN	O
per	IN	O
the	DT	O
history	NN	O
of	IN	O
present	JJ	O
illness	NN	O
.	.	O

neurological	JJ	B-TEST
imaging	NN	I-TEST
data	NNS	O
was	VBD	O
as	IN	O
per	IN	O
the	DT	O
history	NN	O
of	IN	O
present	JJ	O
illness	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
where	WRB	O
a	DT	B-TEST
continued	JJ	I-TEST
cerebral	JJ	I-TEST
angiogram	NN	I-TEST
was	VBD	O
done	VBN	O
that	DT	O
was	VBD	O
essentially	RB	O
normal	JJ	O
,	,	O
without	IN	O
evidence	NN	O
of	IN	O
any	DT	B-PROBLEM
obvious	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
observed	VBN	O
for	IN	O
two	CD	O
days	NNS	O
with	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
ct	JJ	I-TEST
scan	JJ	I-TEST
showing	VBG	O
no	DT	O
changes	NNS	B-PROBLEM
from	IN	O
the	DT	B-TEST
previous	JJ	I-TEST
examination	NN	I-TEST
.	.	O

the	DT	B-PROBLEM
headache	NN	I-PROBLEM
stabilized	VBN	O
after	IN	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
with	IN	O
strict	JJ	O
instructions	NNS	O
to	TO	O
return	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
,	,	O
should	MD	O
there	RB	O
be	VB	O
an	DT	O
exacerbation	NN	O
of	IN	O
symptoms	NNS	B-PROBLEM
.	.	O

ruled	VBN	O
out	RP	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

2.	CD	O
ventricular	JJ	B-PROBLEM
ectopy	NN	I-PROBLEM
.	.	O

3.	CD	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

4.	CD	O
cardiomegaly	NN	B-PROBLEM
.	.	O

5.	CD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

6.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

7.	CD	O
paraphimosis	NN	B-PROBLEM
.	.	O

8.	CD	O
right	JJ	B-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

9.	CD	O
pericarditis	NN	B-PROBLEM
.	.	O

heparin	NN	B-TREATMENT
,	,	O
consisting	VBG	O
of	IN	O
thrombocytopenia	NN	B-PROBLEM
;	:	O
pronestyl	CC	B-TREATMENT
,	,	O
consisting	VBG	O
of	IN	O
nausea	NN	B-PROBLEM
.	.	O

coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
x	JJ	I-TREATMENT
3	CD	I-TREATMENT
.	.	O

insertion	NN	B-TREATMENT
of	IN	I-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
.	.	O

bilateral	JJ	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
.	.	O

left	VBN	B-TEST
ventriculography	NN	I-TEST
.	.	O

bilateral	JJ	B-TEST
coronary	JJ	I-TEST
angiography	NN	I-TEST
.	.	O

signal	JJ	B-TEST
average	JJ	I-TEST
ekg	NN	I-TEST
.	.	O

digoxin	NN	B-TREATMENT
,	,	O
.25	NNP	O
mg	NNP	O
po	NN	O
qd	NN	O
;	:	O
ecotrin	CC	B-TREATMENT
,	,	O
325	CD	O
mg	NN	O
qd	NN	O
;	:	O
coumadin	NN	B-TREATMENT
,	,	O
2.5	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O
lisinopril	CC	B-TREATMENT
,	,	O
2.5	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O
micronase	NN	B-TREATMENT
,	,	O
5	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
47	CD	O
year	NN	O
old	JJ	O
patient	NN	O
of	IN	O
dr.	NN	O
laymie	NN	O
fournier	NN	O
and	CC	O
dr.	NN	O
leebjescobe	NN	O
in	IN	O
co	NN	O
in	IN	O
saorlirv	NN	O
frea	NN	O
,	,	O
west	JJS	O
virginia	NN	O
who	WP	O
was	VBD	O
well	RB	O
until	IN	O
a	DT	O
bout	NN	O
of	IN	O
double	JJ	B-PROBLEM
pneumonia	NN	I-PROBLEM
in	IN	O
may	MD	O
1992	CD	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
was	VBD	O
hospitalized	VBN	O
at	IN	O
centdick	NN	O
naco	FW	O
hospital	JJ	O
medical	JJ	O
center	NN	O
.	.	O

he	PRP	O
also	RB	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
and	CC	O
diabetes	VBZ	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
transient	JJ	O
episode	NN	O
of	IN	O
headache	NN	B-PROBLEM
and	CC	O
disorientation	NN	B-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
and	CC	O
mri	JJ	B-TEST
scan	JJ	I-TEST
corroborated	VBN	O
multiple	JJ	B-PROBLEM
cerebral	JJ	I-PROBLEM
infarcts	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
family	NN	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
as	IN	O
well	RB	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
placed	VBN	O
on	IN	O
vasotec	NN	B-TREATMENT
.	.	O

a	DT	B-TEST
holter	NN	I-TEST
monitor	NN	I-TEST
showed	VBD	O
ventricular	JJ	B-PROBLEM
ectopy	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
thallium	NN	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
showed	VBD	O
tachycardia	NN	B-PROBLEM
and	CC	O
severe	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
fall	NN	I-PROBLEM
in	IN	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
with	IN	O
low	JJ	O
level	NN	O
exercise	NN	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
global	JJ	B-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

accordingly	RB	O
he	PRP	O
was	VBD	O
referred	VBN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
140/100	CD	O
,	,	O
phosphorus	NN	B-TEST
94	CD	O
,	,	O
weight	VBD	B-TEST
181	CD	O
lb	NN	O
.	.	O

loud	JJ	B-PROBLEM
s4	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
ii	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
regurgitant	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

peripheral	JJ	B-TEST
pulses	NNS	I-TEST
intact	JJ	O
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
104	CD	O
,	,	O
co2	NN	B-TEST
28	CD	O
,	,	O
bun	NN	B-TEST
14	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
,	,	O
glucose	VBD	B-TEST
243	CD	O
.	.	O

cholesterol	NN	B-TEST
197	CD	O
,	,	O
triglycerides	NNS	B-TEST
118	CD	O
,	,	O
hdl	NN	B-TEST
31	CD	O
,	,	O
ldl	VBD	B-TEST
142	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
6.2	CD	O
,	,	O
bilirubin	NN	B-TEST
1.0	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
72	CD	O
,	,	O
sgot	VBD	B-TEST
23	CD	O
.	.	O

hematocrit	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
43%	CD	O
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
6600	CD	O
.	.	O

mcv	NN	B-TEST
was	VBD	O
85	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
catheterization	NN	O
laboratory	NN	O
,	,	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
initially	RB	O
to	TO	O
have	VB	O
a	DT	B-TEST
pulmonary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
45	CD	O
with	IN	O
a	DT	B-TEST
pulmonary	JJ	I-TEST
artery	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
82/40	CD	O
.	.	O

this	DT	O
lowered	VBD	O
with	IN	O
iv	JJ	B-TREATMENT
nitroglycerin	NNS	I-TREATMENT
.	.	O

selective	JJ	B-TEST
coronary	NN	I-TEST
angiography	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
occluded	JJ	I-PROBLEM
right	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
in	IN	I-PROBLEM
its	PRP$	I-PROBLEM
midportion	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
an	DT	O
80%	CD	O
distal	NN	O
left	VBD	O
main	JJ	O
,	,	O
a	DT	O
90%	CD	O
proximal	NN	O
circumflex	NN	O
,	,	O
and	CC	O
multiple	JJ	B-PROBLEM
significant	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lad	NN	I-PROBLEM
.	.	O

his	PRP$	O
left	JJ	O
ventricle	NN	O
ejection	NN	O
showed	VBD	O
diffuse	IN	B-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
,	,	O
because	IN	O
of	IN	O
the	DT	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
critical	JJ	I-PROBLEM
left	NN	I-PROBLEM
main	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
he	PRP	O
should	MD	O
be	VB	O
admitted	VBN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

indeed	RB	O
,	,	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
diuretics	NNS	B-TREATMENT
and	CC	O
nitrates	NNS	B-TREATMENT
along	IN	O
with	IN	O
cessation	NN	O
of	IN	O
his	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
iv	NN	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
some	DT	B-PROBLEM
ventricular	JJ	I-PROBLEM
ectopy	NN	I-PROBLEM
on	IN	O
holter	NN	B-TEST
monitor	NN	I-TEST
.	.	O

he	PRP	O
developed	VBD	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
07/31	CD	O
which	WDT	O
previously	RB	O
had	VBD	O
been	VBN	O
ignored	VBN	O
but	CC	O
in	IN	O
retrospect	NN	O
was	VBD	O
probably	RB	O
his	PRP$	B-PROBLEM
anginal	JJ	I-PROBLEM
equivalent	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
multifocal	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
ectopy	NN	I-PROBLEM
at	IN	O
that	DT	O
time	NN	O
.	.	O

he	PRP	O
had	VBD	O
some	DT	B-PROBLEM
further	JJ	I-PROBLEM
anterolateral	JJ	I-PROBLEM
st	NN	I-PROBLEM
segment	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

therefore	RB	O
,	,	O
he	PRP	O
did	VBD	O
have	VB	O
unstable	JJ	B-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
his	PRP$	B-PROBLEM
critical	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
anatomy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
electrophysiology	NN	O
service	NN	O
,	,	O
dr.	NN	O
slusslashgodle	NN	O
,	,	O
who	WP	O
said	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
no	DT	O
indication	NN	O
for	IN	O
patch	NN	B-TREATMENT
placement	NN	I-TREATMENT
at	IN	O
the	DT	O
time	NN	O
of	IN	O
surgery	NN	B-TREATMENT
.	.	O

on	IN	O
08/02/93	CD	O
,	,	O
an	DT	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
;	:	O
then	RB	O
,	,	O
dr.	JJ	O
thorebreutz	NN	O
took	VBD	O
him	PRP	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
,	,	O
where	WRB	O
he	PRP	O
had	VBD	O
quadruple	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
left	VBN	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
graft	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
lad	NN	I-TREATMENT
,	,	O
a	DT	O
single	JJ	O
saphenous	JJ	O
vein	NN	O
to	TO	O
the	DT	O
right	JJ	O
coronary	JJ	O
artery	NN	O
with	IN	O
280	CD	O
cc	NNS	O
per	IN	O
minute	NN	O
flow	NN	O
,	,	O
and	CC	O
a	DT	B-TREATMENT
saphenous	JJ	I-TREATMENT
vein	NN	I-TREATMENT
snake	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
diagonal	JJ	I-TREATMENT
and	CC	O
circumflex	JJ	O
with	IN	O
150	CD	O
cc	NNS	O
per	IN	O
minute	NN	O
flow	NN	O
.	.	O

a	DT	B-PROBLEM
paraphimosis	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
and	CC	O
treated	VBN	O
by	IN	O
dr.	NN	O
ryna	NN	O
jescdrig	NN	O
.	.	O

after	IN	O
surgery	NN	B-TREATMENT
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
ongoing	JJ	I-PROBLEM
sinus	NN	I-PROBLEM
tachycardia	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
occasional	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
and	CC	I-PROBLEM
ventricular	JJ	I-PROBLEM
premature	NN	I-PROBLEM
beats	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
intra-aortic	JJ	I-TREATMENT
balloon	NN	I-TREATMENT
pump	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
the	DT	O
following	JJ	O
day	NN	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
out	IN	O
of	IN	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

he	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
nutrition	NN	O
service	NN	O
,	,	O
who	WP	O
followed	VBD	O
him	PRP	O
for	IN	O
dietary	JJ	O
management	NN	O
of	IN	O
his	PRP$	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
.	.	O

on	IN	O
08/05	CD	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
his	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
had	VBD	O
fallen	VBN	O
from	IN	O
171,000	CD	O
to	TO	O
54,000	CD	O
;	:	O
this	DT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
associated	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
heparin	NNS	I-TREATMENT
and	CC	O
indeed	RB	O
,	,	O
when	WRB	O
heparin	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
,	,	O
since	IN	O
it	PRP	O
had	VBD	O
been	VBN	O
restarted	VBN	O
after	IN	O
surgery	NN	O
,	,	O
his	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
rebounded	VBD	O
to	TO	O
normal	JJ	O
.	.	O

therefore	RB	O
,	,	O
he	PRP	O
does	VBZ	O
have	VB	O
a	DT	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
to	TO	O
heparin	VB	B-TREATMENT
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
runs	NNS	O
of	IN	O
nonsustained	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
clinically	RB	O
stable	JJ	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
at	IN	O
increased	VBN	O
risk	NN	O
for	IN	O
future	JJ	O
events	NNS	O
because	IN	O
of	IN	O
his	PRP$	B-PROBLEM
low	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
fraction	NN	I-PROBLEM
,	,	O
but	CC	O
he	PRP	O
is	VBZ	O
clinically	RB	O
stable	JJ	O
on	IN	O
ace	NN	B-TREATMENT
inhibitors	NNS	I-TREATMENT
,	,	O
digoxin	NN	B-TREATMENT
,	,	O
coumadin	NN	B-TREATMENT
,	,	O
and	CC	O
aspirin	NN	B-TREATMENT
.	.	O

he	PRP	O
understands	VBZ	O
that	IN	O
he	PRP	O
does	VBZ	O
have	VB	O
significant	JJ	B-PROBLEM
left	VBN	I-PROBLEM
ventricle	NN	I-PROBLEM
dysfunction	NN	I-PROBLEM
and	CC	O
requires	VBZ	O
monitoring	NN	B-TEST
of	IN	I-TEST
his	PRP$	I-TEST
prothrombin	NN	I-TEST
times	NNS	I-TEST
and	CC	I-TEST
his	PRP$	I-TEST
arrhythmias	NN	I-TEST
;	:	O
these	DT	O
will	MD	O
be	VB	O
done	VBN	O
in	IN	O
grovea	NN	O
co	NN	O
terburgperv	NN	O
portnew	NN	O
.	.	O

lamictal	JJ	B-TREATMENT
/	NNP	O
keflex	NNP	B-TREATMENT
/	NNP	O
navane	NN	B-TREATMENT
/	NNP	O
inderal	JJ	B-TREATMENT
/	NNP	O
depakote	NN	B-TREATMENT

transfer	NN	O
from	IN	O
osh	NN	O
,	,	O
seizure	NN	B-PROBLEM

lumbar	NN	B-TEST
puncture	NN	I-TEST

ms.	NN	O
swanson	NN	O
is	VBZ	O
a	DT	O
53	JJ	O
yo	NN	O
woman	NN	O
with	IN	O
pmh	NN	O
significant	JJ	O
for	IN	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
brain	NN	B-PROBLEM
injury	NN	I-PROBLEM
,	,	O
and	CC	O
?	.	O
atypical	JJ	B-PROBLEM
multiple	JJ	I-PROBLEM
sclerosis	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
right	JJ	B-PROBLEM
face	NN	I-PROBLEM
twitch	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
arm	NN	I-PROBLEM
shaking	NN	I-PROBLEM
.	.	O

she	PRP	O
lives	VBZ	O
in	IN	O
an	DT	O
assisted	JJ	O
living	NN	O
,	,	O
and	CC	O
was	VBD	O
noted	VBN	O
yesterday	NN	O
to	TO	O
have	VB	O
generalized	VBN	B-PROBLEM
tonic-clonic	JJ	I-PROBLEM
activity	NN	I-PROBLEM
beginning	VBG	O
on	IN	O
the	DT	O
right	JJ	O
side	NN	O
and	CC	O
lasting	JJ	O
90	CD	O
minutes	NNS	O
.	.	O

ems	NNS	O
gave	VBD	O
her	PRP	O
valium	NN	B-TREATMENT
5	CD	O
mg	NN	O
pr	NN	O
at	IN	O
the	DT	O
facility	NN	O
and	CC	O
brought	VBD	O
her	PRP	O
to	TO	O
barnstable	JJ	O
county	NN	O
hospital	NN	O
.	.	O

she	PRP	O
persisted	VBD	O
with	IN	O
right	NN	B-PROBLEM
sided	VBN	I-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
there	RB	O
and	CC	O
was	VBD	O
given	VBN	O
valium	NN	B-TREATMENT
10	CD	O
mg	NN	O
and	CC	O
ativan	$	B-TREATMENT
1	CD	O
mg	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
loaded	VBN	O
with	IN	O
dilantin	NN	B-TREATMENT
1000	CD	O
mg	NN	O
.	.	O

here	RB	O
she	PRP	O
was	VBD	O
given	VBN	O
an	DT	B-TREATMENT
additional	JJ	I-TREATMENT
valium	NN	I-TREATMENT
5	CD	O
mg	NN	O
x	NN	O
2	CD	O
and	CC	O
ativan	$	B-TREATMENT
1	CD	O
mg	NN	O
x	VBD	O
3	CD	O
for	IN	O
persistent	JJ	B-PROBLEM
twitching	NN	I-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
face	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
hand	NN	I-PROBLEM
.	.	O

since	IN	O
the	DT	B-TREATMENT
ativan	NN	I-TREATMENT
,	,	O
her	PRP$	B-PROBLEM
facial	JJ	I-PROBLEM
twitching	NN	I-PROBLEM
has	VBZ	O
apparently	RB	O
improved	VBN	O
,	,	O
but	CC	O
she	PRP	O
continues	VBZ	O
to	TO	O
have	VB	O
hand	NN	B-PROBLEM
twitches	NNS	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
an	DT	B-TEST
eeg	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
left	VBD	B-PROBLEM
sided	VBN	I-PROBLEM
slowing	VBG	I-PROBLEM
on	IN	O
preliminary	JJ	O
read	NN	O
.	.	O

apparently	RB	O
she	PRP	O
has	VBZ	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
possibly	RB	O
from	IN	O
a	DT	O
history	NN	O
of	IN	O
traumatic	JJ	B-PROBLEM
brain	NN	I-PROBLEM
injury	NN	I-PROBLEM
(	(	O
though	IN	O
per	IN	O
dr.	NN	O
paula	NN	O
,	,	O

records	NNS	O
from	IN	O
that	DT	O
hospitalization	NN	O
indicate	VB	O
she	PRP	O
may	MD	O
have	VB	O
only	RB	O
had	VBD	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
mild	JJ	I-PROBLEM
injury	NN	I-PROBLEM
)	)	O
and	CC	O
has	VBZ	O
been	VBN	O
managed	VBN	O
on	IN	O
dilantin	NN	B-TREATMENT
and	CC	O
keppra	NN	B-TREATMENT
.	.	O

since	IN	O
she	PRP	O
has	VBZ	O
seen	VBN	O
dr.	NNS	O
ollie	RB	O
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
at	IN	O
least	JJS	O
two	CD	O
episodes	NNS	O
of	IN	O
status	NN	B-PROBLEM
epilepticus	NN	I-PROBLEM
and	CC	O
one	CD	B-PROBLEM
generalized	JJ	I-PROBLEM
seizure	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
some	DT	B-PROBLEM
less	RBR	I-PROBLEM
significant	JJ	I-PROBLEM
seizures	NNS	I-PROBLEM
which	WDT	O
are	VBP	O
characterized	VBN	O
by	IN	O
left	NN	B-PROBLEM
gaze	NN	I-PROBLEM
preference	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
sided	VBN	I-PROBLEM
tonic-clonic	JJ	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
dilantin	NN	I-TEST
levels	NNS	I-TEST
had	VBD	O
been	VBN	O
somewhat	RB	O
difficult	JJ	O
to	TO	O
control	VB	O
.	.	O

he	PRP	O
tried	VBD	O
adding	VBG	O
lamictal	JJ	B-TREATMENT
,	,	O
but	CC	O
this	DT	O
caused	VBD	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
her	PRP$	O
last	JJ	O
visit	NN	O
(	(	O
2015-03-18	JJ	O
)	)	O
dr.	NN	O
bradley	NN	O
had	VBD	O
discussed	VBN	O
the	DT	O
addition	NN	O
of	IN	O
a	DT	B-TREATMENT
third	JJ	I-TREATMENT
castelluccio	NN	I-TREATMENT
,	,	O
possibly	RB	O
zonegran	NN	B-TREATMENT
(	(	O
less	RBR	O
likely	RB	O
topamax	JJ	B-TREATMENT
),	NNS	O
to	TO	O
the	DT	B-TREATMENT
dilantin	NN	I-TREATMENT
200	CD	O
mg	NN	O
bid	NN	O
and	CC	O
keppra	NN	B-TREATMENT
1500	CD	O
mg	NN	O
bid	NN	O
.	.	O

however	RB	O
,	,	O
she	PRP	O
had	VBD	O
several	JJ	B-TEST
dilantin	NN	I-TEST
levels	NNS	I-TEST
drawn	VBN	O
since	IN	O
her	PRP$	O
last	JJ	O
visit	NN	O
,	,	O
with	IN	O
15.4	CD	O
in	IN	O
05	CD	O
-	:	O
23.5	CD	O
in	IN	O
theresa	NN	O
,	,	O
and	CC	O
3.09	CD	O
-	:	O
18	CD	O
.	.	O

her	PRP$	O
sister	NN	O
reports	NNS	O
that	IN	O
the	DT	B-TREATMENT
medication	NN	I-TREATMENT
dose	NN	I-TREATMENT
had	VBD	O
been	VBN	O
changed	VBN	O
to	TO	O
200	CD	O
mg	NNS	O
qam	RB	O
and	CC	O
100	CD	O
mg	NN	O
qpm	NN	O
in	IN	O
theresa	NN	O
,	,	O
and	CC	O
a	DT	O
review	NN	O
of	IN	O
her	PRP$	O
union	NN	O
hospital	NN	O
-	:	O
north	NN	O
shore	RB	O
medical	JJ	O
center	NN	O
records	NNS	O
indicates	VBZ	O
that	IN	O
this	DT	O
may	MD	O
have	VB	O
occurred	VBN	O
in	IN	O
an	DT	O
urgent	JJ	O
care	NN	O
appointment	NN	O
secondary	JJ	O
to	TO	O
slurred	VB	B-PROBLEM
speech	NN	I-PROBLEM
and	CC	O
a	DT	O
recent	JJ	O
fall	NN	O
and	CC	O
a	DT	B-PROBLEM
non-trough	JJ	I-PROBLEM
level	NN	I-PROBLEM
of	IN	O
15.9	CD	O
.	.	O

according	VBG	O
to	TO	O
her	PRP$	O
sister	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
no	DT	B-PROBLEM
short-term	JJ	I-PROBLEM
memory	NN	I-PROBLEM
.	.	O

the	DT	O
patient	JJ	O
walks	NNS	O
with	IN	O
a	DT	B-TREATMENT
walker	NN	I-TREATMENT
at	IN	O
baseline	NN	O
and	CC	O
goes	VBZ	O
out	RP	O
for	IN	O
dinner	NN	O
and	CC	O
shopping	NN	O
with	IN	O
her	PRP$	O
sister	NN	O
.	.	O

ms.	NN	O
swanson	NN	O
also	RB	O
carries	VBZ	O
a	DT	O
diagnosis	NN	O
of	IN	O
"	NNP	O
atypical	JJ	B-PROBLEM
ms	NN	I-PROBLEM
",	NN	O
which	WDT	O
she	PRP	O
brought	VBD	O
with	IN	O
her	PRP	O
to	TO	O
dr.	VB	O
billie	NN	O
.	.	O

according	VBG	O
to	TO	O
dr.	JJ	O
nicole	NN	O
,	,	O
she	PRP	O
has	VBZ	O
had	VBN	O
stable	JJ	B-PROBLEM
deficits	NNS	I-PROBLEM
for	IN	O
many	JJ	O
years	NNS	O
without	IN	O
any	DT	B-PROBLEM
flare-like	JJ	I-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TEST
mri	NN	I-TEST
in	IN	O
2014	CD	O
that	WDT	O
showed	VBD	O
multiple	JJ	B-PROBLEM
plaque-like	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
but	CC	O
these	DT	O
were	VBD	O
entirely	RB	O
stable	JJ	O
since	IN	O
2010	CD	O
.	.	O

she	PRP	O
is	VBZ	O
not	RB	O
undergoing	JJ	O
any	DT	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
not	RB	O
had	VBN	O
an	DT	B-TEST
lp	NN	I-TEST
as	RB	O
far	RB	O
as	IN	O
dr.	JJ	O
ginger	NN	O
knows	NNS	O
.	.	O

h/o	JJ	O
head	NN	B-PROBLEM
trauma	NN	I-PROBLEM

atypical	JJ	B-PROBLEM
ms	NN	I-PROBLEM

seizures	NNS	B-PROBLEM

depression	NN	B-PROBLEM

hypercholesterolemia	NN	B-PROBLEM

vs	NN	B-TEST
:	:	O
t99.5	NN	O
,	,	O
bp	NN	B-TEST
126/72	CD	O
,	,	O
hr	NN	B-TEST
99	CD	O
,	,	O
rr	NN	B-TEST
15	CD	O
,	,	O
sao2	VBD	B-TEST
99%	CD	O
/	NNS	O
ra	NN	O

genl	NN	O
:	:	O
lying	NN	O
in	IN	O
bed	NN	O
,	,	O
right	JJ	O
hand	NN	O
moving	VBG	O
rhythmically	RB	O
,	,	O
ngt	NNS	B-TREATMENT
in	IN	O
place	NN	O

ms	NN	O
:	:	O
not	RB	B-PROBLEM
following	VBG	I-PROBLEM
commands	NNS	I-PROBLEM
,	,	O
withdraws	NNS	O
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
,	,	O
making	VBG	O
incomprehensible	JJ	B-PROBLEM
vocalizations	NNS	I-PROBLEM

motor	NN	O
:	:	O
moving	VBG	O
right	JJ	O
hand	NN	O
rhythmically	RB	O
with	IN	O
occasional	JJ	B-PROBLEM
right	JJ	I-PROBLEM
face	NN	I-PROBLEM
twitching	VBG	I-PROBLEM
as	RB	O
well	RB	O
.	.	O

moves	NNS	O
all	DT	O
extremities	NNS	O
to	TO	O
stimuli	VB	B-TEST
,	,	O
l	FW	O
>	CD	O
r	NN	O

sensation	NN	O
:	:	O
intact	JJ	O
to	TO	O
noxious	JJ	B-TEST
stimuli	NNS	I-TEST
in	IN	O
all	DT	O
four	CD	O
extremities	NNS	O

afebrile	NN	B-PROBLEM
,	,	O
vss	NN	O

no	DT	O
dysarthria	NN	B-PROBLEM
,	,	O
speech	JJ	O
fluent	NN	O
.	.	O

2015-09-20	JJ	O
03:54	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
11.4	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
3.96	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
12.1	CD	O
hct	NN	B-TEST
-	:	O
35.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
30.6	CD	O
mchc	SYM	B-TEST
-	:	O
34.6	CD	O
rdw	NN	B-TEST
-	:	O
13.1	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
152	CD	O

2015-09-28	JJ	O
07:50	CD	O
am	VBP	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
83.3	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
10.1	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
5.3	CD	O
eos	SYM	B-TEST
-	:	O
1.1	CD	O
baso	SYM	B-TEST
-	:	O
0.2	CD	O

2015-09-20	JJ	O
03:54	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
12.3	CD	O
ptt	NN	B-TEST
-	:	O
26.7	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.1	CD	O

2015-09-20	JJ	O
03:54	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
97	CD	O
urean	JJ	B-TEST
-	:	O
12	CD	O
creat	NN	B-TEST
-	:	O
0.4	CD	O
na	SYM	B-TEST
-	:	O
137	CD	O
k	SYM	B-TEST
-	:	O
3.8	CD	O
cl	NN	B-TEST
-	:	O
101	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
14	CD	O

2015-09-20	JJ	O
03:54	CD	O
am	VBP	O
blood	NN	B-TEST
albumin	NN	B-TEST
-	:	O
4.0	CD	O
calcium	NN	B-TEST
-	:	O
8.0	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
2.9	CD	O
mg	SYM	B-TEST
-	:	O
2.0	CD	O

2015-09-20	JJ	O
03:54	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
14	CD	O
ast	IN	B-TEST
-	:	O
18	CD	O
alkphos	SYM	B-TEST
-	:	O
92	CD	O
totbili	SYM	B-TEST
-	:	O
0.3	CD	O

2015-09-20	JJ	O
03:54	CD	O
am	VBP	O
blood	NN	B-TEST
phenyto	NN	B-TEST
-	:	O
18.4	CD	O

2015-09-29	JJ	O
07:25	CD	O
am	VBP	O
blood	NN	B-TEST
phenyto	NN	B-TEST
-	:	O
5.1	CD	O
*	NN	O

2015-09-22	JJ	O
03:04	CD	O
pm	NN	O
urine	NN	B-TEST
color	NN	B-TEST
-	:	O
straw	NN	O
appear	VBP	B-TEST
-	:	O
clear	JJ	O
sp	NN	O
dixon	SYM	B-TEST
-	:	O
1.010	CD	O

2015-09-22	JJ	O
03:04	CD	O
pm	JJ	O
urine	JJ	B-TEST
blood	NN	B-TEST
-	:	O
sm	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
neg	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
15	CD	O
bilirub	SYM	B-TEST
-	:	O
neg	NN	O
urobiln	JJ	B-TEST
-	:	O
neg	NN	O
ph	SYM	B-TEST
-	:	O
5.0	CD	O
leuks	SYM	B-TEST
-	:	O
mod	NN	O

2015-09-22	JJ	O
03:04	CD	O
pm	JJ	O
urine	JJ	B-TEST
rbc	NN	B-TEST
-	:	O
6	CD	O
*	NN	O
wbc	SYM	B-TEST
-	:	O
29	CD	O
*	NN	O
bacteri	SYM	B-TEST
-	:	O
occ	NN	B-TEST
yeast	SYM	I-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
<	NN	O
1	CD	O

2015-09-28	JJ	O
03:04	CD	O
pm	NN	O
urine	NN	B-TEST
color	NN	B-TEST
-	:	O
yellow	NN	O
appear	VBP	B-TEST
-	:	O
clear	JJ	O
sp	NN	B-TEST
brown	SYM	I-TEST
-	:	O
1.015	CD	O

2015-09-28	JJ	O
03:04	CD	O
pm	JJ	O
urine	JJ	B-TEST
blood	NN	B-TEST
-	:	O
lg	NN	B-TEST
nitrite	JJ	I-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
tr	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
neg	NN	O
bilirub	SYM	B-TEST
-	:	O
neg	NN	O
urobiln	JJ	B-TEST
-	:	O
0.2	CD	O
ph	NN	B-TEST
-	:	O
6.5	CD	O
leuks	SYM	B-TEST
-	:	O
neg	NN	O

2015-09-28	JJ	O
03:04	CD	O
pm	JJ	O
urine	JJ	B-TEST
rbc	NN	B-TEST
-	:	O
01-04	JJ	O
*	NN	O
wbc	SYM	B-TEST
-	:	O
04-19	JJ	O
bacteri	NN	B-TEST
-	:	O
few	JJ	O
yeast	JJ	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
0-2	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
wbc	VBD	B-TEST
-	:	O
6	CD	O
rbc	NN	B-TEST
-	:	O
2	CD	O
*	NN	O
polys	NN	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
92	CD	O
monos	NNS	B-TEST
-	:	O
8	CD	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
wbc	VBD	B-TEST
-	:	O
6	CD	O
rbc	NN	B-TEST
-	:	O
0	CD	O
polys	NN	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
95	CD	O
monos	NNS	B-TEST
-	:	O
5	CD	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
totprot	NN	B-TEST
-	:	O
56	CD	O
*	NN	O
glucose	VBD	B-TEST
-	:	O
77	CD	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
angiotensin	VBZ	B-TEST
1	CD	I-TEST
converting	VBG	I-TEST
enzyme	SYM	I-TEST
-	:	O
pnd	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
vdrl	FW	B-TEST
-	:	O
pnd	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
ernest	JJS	B-TEST
virus	NN	I-TEST
(	(	I-TEST
jcv	NN	I-TEST
)	)	I-TEST
dna	NN	I-TEST
detection	NN	I-TEST
by	IN	I-TEST
polymerase	NN	I-TEST
chain	NN	I-TEST
reaction	NN	I-TEST
(	(	I-TEST
pcr	JJ	I-TEST
)-	CD	O
pnd	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
varicella	NN	B-TEST
dna	NN	I-TEST
(	(	I-TEST
pcr	JJ	I-TEST
)-	CD	O
pnd	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
herpes	VBZ	B-TEST
simplex	JJ	I-TEST
virus	NN	I-TEST
pcr	SYM	I-TEST
-	:	O
pnd	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	O
ebv	VBZ	B-TEST
-	:	I-TEST
pcr	NN	I-TEST
-	:	O
pnd	NN	O

2015-09-25	JJ	O
02:20	CD	O
pm	JJ	O
cerebrospinal	JJ	B-TEST
fluid	NN	I-TEST
(	(	I-TEST
csf	NN	I-TEST
)	)	I-TEST
cytomegalovirus	NN	B-TEST
-	:	I-TEST
pcr	NN	I-TEST
-	:	O
negative	JJ	O

cryptococcus	NN	B-PROBLEM
:	:	O
negative	JJ	O

csf	NNS	B-TEST
negative	JJ	O

blood	NN	B-TEST
cx	NN	I-TEST
ngtd	NN	O

urine	JJ	B-TEST
cx	NN	I-TEST
lactobacillus	NN	B-PROBLEM

csf	JJ	B-TEST
cytology	NN	I-TEST
:	:	O
negative	JJ	O
for	IN	O
malignant	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

reactive	JJ	B-PROBLEM
lymphoid	NN	I-PROBLEM
cells	NNS	I-PROBLEM
.	.	O

immunotyping	VBG	B-TEST
negative	JJ	O
.	.	O

cxr	JJ	B-TEST
09-28	NN	O
:	:	O
no	DT	O
evidence	NN	O
for	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

no	DT	O
change	NN	O
since	IN	O
prior	JJ	B-TEST
study	NN	I-TEST
of	IN	O
2015-09-24	JJ	O
.	.	O

ct	JJ	B-TEST
head	NN	I-TEST
findings	NNS	O
:	:	O
there	EX	O
is	VBZ	O
moderately	RB	B-PROBLEM
severe	JJ	I-PROBLEM
,	,	I-PROBLEM
confluent	JJ	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
hypodensity	NN	I-PROBLEM
surrounding	VBG	O
the	DT	O
frontal	JJ	O
horns	NNS	O
,	,	O
posterior	JJ	O
horns	NNS	O
,	,	O
and	CC	O
more	JJR	O
superiorly	RB	O
,	,	O
involving	VBG	O
the	DT	O
centra	JJ	O
semiovale	NN	O
.	.	O

these	DT	O
findings	NNS	O
are	VBP	O
unchanged	JJ	O
from	IN	O
prior	JJ	B-TEST
studies	NNS	I-TEST
,	,	O
and	CC	O
may	MD	O
relate	VB	O
to	TO	O
the	DT	B-PROBLEM
"	NNP	I-PROBLEM
atypical	JJ	I-PROBLEM
"	NNP	I-PROBLEM
demyelinating	NN	I-PROBLEM
process	NN	I-PROBLEM
,	,	O
suggested	VBN	O
in	IN	O
the	DT	O
indication	NN	O
on	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
mri	NN	I-TEST
;	:	O
however	RB	O
,	,	O
they	PRP	O
are	VBP	O
non-specific	JJ	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
acute	NN	B-PROBLEM
intra	JJ	I-PROBLEM
-	:	I-PROBLEM
or	CC	I-PROBLEM
extra	JJ	I-PROBLEM
-	:	I-PROBLEM
axial	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
shift	NN	B-PROBLEM
of	IN	I-PROBLEM
normally	RB	I-PROBLEM
midline	JJ	I-PROBLEM
structures	NNS	I-PROBLEM
.	.	O

the	DT	O
ventricles	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
prominent	JJ	I-PROBLEM
,	,	O
but	CC	O
are	VBP	O
unchanged	JJ	O
from	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
interval	JJ	B-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
focal	JJ	I-PROBLEM
gray	JJ	I-PROBLEM
-	:	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
differentiation	NN	I-PROBLEM
to	TO	O
suggest	VB	O
acute	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
though	IN	O
ct	NN	B-TEST
is	VBZ	O
not	RB	O
sensitive	JJ	O
in	IN	O
the	DT	O
early	JJ	O
stages	NNS	O
.	.	O

no	DT	O
focal	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

1)	CD	O
no	DT	O
intracranial	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM
or	CC	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
;	:	O
no	DT	O
significant	JJ	B-PROBLEM
interval	JJ	I-PROBLEM
change	NN	I-PROBLEM
from	IN	O
ct	NN	B-TEST
of	IN	O
2015-07-20	JJ	O
.	.	O

2)	CD	O
diffuse	NN	B-PROBLEM
,	,	I-PROBLEM
confluent	JJ	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
hypodensity	NN	I-PROBLEM
,	,	O
which	WDT	O
may	MD	O
relate	VB	O
to	TO	O
an	DT	B-PROBLEM
underlying	VBG	I-PROBLEM
demyelinating	NN	I-PROBLEM
process	NN	I-PROBLEM
(	(	O
as	IN	O
suggested	VBN	O
in	IN	O
the	DT	O
indication	NN	O
provided	VBD	O
for	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
mri	NN	I-TEST
).	NN	O

the	DT	B-PROBLEM
markedly	RB	I-PROBLEM
low	JJ	I-PROBLEM
-	:	I-PROBLEM
attenation	NN	I-PROBLEM
(	(	O
14-15	JJ	O
hu	NN	O
)	)	O
centered	VBD	O
within	IN	O
this	DT	O
process	NN	O
suggests	VBZ	O
either	CC	O
irreversible	JJ	B-PROBLEM
demyelination	NN	I-PROBLEM
with	IN	O
cavitation	NN	B-PROBLEM
("	NNP	I-PROBLEM
black	JJ	I-PROBLEM
hole	NN	I-PROBLEM
"),	NN	O
or	CC	O
lacunar	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
on	IN	I-PROBLEM
a	DT	I-PROBLEM
vascular	JJ	I-PROBLEM
basis	NN	I-PROBLEM
.	.	O

generalized	VBN	O
and	CC	O
marked	VBN	B-PROBLEM
callosal	NN	I-PROBLEM
atrophy	NN	I-PROBLEM
(	(	O
on	IN	O
the	DT	B-TEST
mr	NN	I-TEST
)	)	O
also	RB	O
suggest	VBP	O
advanced	JJ	B-PROBLEM
,	,	I-PROBLEM
irreversible	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

3)	CD	O
no	DT	O
mass	NN	B-PROBLEM
is	VBZ	O
appreciated	VBN	O
on	IN	O
this	DT	B-TEST
limited	JJ	I-TEST
non-contrast	JJ	I-TEST
study	NN	I-TEST
;	:	O
if	IN	O
clinically	RB	O
concerned	VBN	O
,	,	O
an	DT	B-TEST
mri	NN	I-TEST
with	IN	I-TEST
gadolinium	NN	I-TEST
is	VBZ	O
recommended	VBN	O
.	.	O

mri	NN	B-TEST
:	:	O
there	EX	O
is	VBZ	O
a	DT	O
similar	JJ	O
configuration	NN	O
of	IN	O
increased	JJ	B-PROBLEM
t2	JJ	I-PROBLEM
signal	NN	I-PROBLEM
in	IN	O
the	DT	O
periventricular	JJ	O
white	JJ	O
matter	NN	O
of	IN	O
both	DT	O
cerebral	JJ	O
hemispheres	NNS	O
,	,	O
suggesting	VBG	O
demyelinating	VBG	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

as	IN	O
previously	RB	O
noted	VBN	O
,	,	O
there	EX	O
is	VBZ	O
associated	JJ	B-PROBLEM
volume	NN	I-PROBLEM
loss	NN	I-PROBLEM
,	,	O
thinning	VBG	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
corpus	NN	I-PROBLEM
callosum	NN	I-PROBLEM
,	,	O
and	CC	O
slight	VBD	B-PROBLEM
widening	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
ventricles	NNS	I-PROBLEM
.	.	O

on	IN	O
post-contrast	JJ	B-TEST
images	NNS	I-TEST
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
probably	RB	O
stable	JJ	O
appearance	NN	O
of	IN	O
a	DT	B-PROBLEM
5	CD	I-PROBLEM
mm	NN	I-PROBLEM
linear	NN	I-PROBLEM
,	,	I-PROBLEM
focal	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
enhancement	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
centrum	NN	I-PROBLEM
semiovale	NN	I-PROBLEM
,	,	O
of	IN	O
uncertain	JJ	O
etiology	NN	O
.	.	O

also	RB	O
ehancing	VBG	O
is	VBZ	O
3	CD	B-PROBLEM
mm	NN	I-PROBLEM
linear	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
hippocampal	JJ	I-PROBLEM
cortex	NN	I-PROBLEM
anteriorly	RB	I-PROBLEM
,	,	O
not	RB	O
seen	VBN	O
on	IN	O
the	DT	O
08-20	JJ	O
mr	NN	B-TEST
,	,	O
but	CC	O
that	IN	B-TEST
study	NN	I-TEST
was	VBD	O
very	RB	O
motion	JJ	O
-	:	O
degraded	VBN	O
.	.	O

the	DT	O
hippocampus	NN	O
would	MD	O
be	VB	O
a	DT	O
most	RBS	O
unusual	JJ	O
site	NN	O
for	IN	O
involvement	NN	O
by	IN	O
multiple	JJ	B-PROBLEM
sclerosis	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
apparent	JJ	B-PROBLEM
mass	NN	I-PROBLEM
lesion	NN	I-PROBLEM
or	CC	O
mass	NN	B-PROBLEM
effect	NN	I-PROBLEM
.	.	O

no	DT	O
changes	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
overall	JJ	I-PROBLEM
morphology	NN	I-PROBLEM
of	IN	O
the	DT	O
brain	NN	O
are	VBP	O
identified	VBN	O
.	.	O

1.	CD	O
stable	JJ	O
appearance	NN	O
of	IN	O
confluent	JJ	O
areas	NNS	O
of	IN	O
increased	JJ	B-PROBLEM
t2	JJ	I-PROBLEM
signal	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
periventricular	JJ	I-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
severe	JJ	B-PROBLEM
demyelinating	VBG	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

2.	CD	O
enhancing	VBG	B-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
centrum	NN	I-PROBLEM
semiovale	NN	I-PROBLEM
and	CC	O
also	RB	O
left	VBD	O
hippocampal	JJ	O
cortex	NN	O
.	.	O

this	DT	B-PROBLEM
former	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
was	VBD	O
evident	JJ	O
on	IN	O
mr	NN	B-TEST
dating	VBG	O
back	RB	O
to	TO	O
2014-08-15	CD	O
,	,	O
though	EX	O
is	VBZ	O
more	RBR	O
prominent	JJ	O
at	IN	O
this	DT	O
time	NN	O
,	,	O
likely	RB	O
due	JJ	O
to	TO	O
less	JJR	O
motion	JJ	O
degradation	NN	O
of	IN	O
the	DT	B-TEST
current	JJ	I-TEST
scan	NN	I-TEST
.	.	O

etiology	NN	O
of	IN	O
these	DT	B-PROBLEM
enhancing	VBG	I-PROBLEM
lesions	NNS	I-PROBLEM
is	VBZ	O
uncertain	JJ	O
,	,	O
but	CC	O
could	MD	O
be	VB	O
atypical	JJ	B-PROBLEM
manifestations	NNS	I-PROBLEM
of	IN	I-PROBLEM
demyelination	NN	I-PROBLEM
.	.	O

eeg	NN	B-TEST
:	:	O

abnormality	NN	O
#1:	NN	O
throughout	IN	O
the	DT	O
recording	NN	O
there	EX	O
were	VBD	O
frequent	JJ	O
bursts	NNS	O
of	IN	O
generalized	JJ	B-PROBLEM
theta	NN	I-PROBLEM
and	CC	I-PROBLEM
delta	NN	I-PROBLEM
slowing	NN	I-PROBLEM
.	.	O

facial	JJ	B-PROBLEM
twitching	NN	I-PROBLEM
was	VBD	O
described	VBN	O
by	IN	O
the	DT	O
technologist	NN	O
and	CC	O
seen	VBN	O
on	IN	O
the	DT	B-TEST
video	NN	I-TEST
.	.	O

this	DT	O
is	VBZ	O
primarily	RB	O
right-sided	JJ	B-PROBLEM
,	,	I-PROBLEM
facial	JJ	I-PROBLEM
movement	NN	I-PROBLEM
clinically	RB	O
and	CC	O
did	VBD	O
not	RB	O
appear	VB	O
to	TO	O
involve	VB	O
the	DT	O
forehead	NN	O
or	CC	O
cmed	VBN	O
csru	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
clear	JJ	O
eeg	NN	B-TEST
correlate	NN	O
.	.	O

abnormality	NN	O
#2:	VBZ	O
the	DT	B-TEST
background	NN	I-TEST
voltages	NNS	I-TEST
were	VBD	O
occasionally	RB	B-PROBLEM
lower	JJR	I-PROBLEM
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
,	,	O
and	CC	O
there	EX	O
were	VBD	O
additional	JJ	B-PROBLEM
bursts	NNS	I-PROBLEM
of	IN	I-PROBLEM
delta	NN	I-PROBLEM
slowing	VBG	I-PROBLEM
seen	VBN	O
broadly	RB	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
alone	RB	O
.	.	O

abnormality	NN	O
#3:	VBZ	O
the	DT	O
background	NN	O
rhythms	NN	O
were	VBD	O
dominated	VBN	O
by	IN	O
much	JJ	B-PROBLEM
faster	JJR	I-PROBLEM
beta	NN	I-PROBLEM
rhythm	NN	I-PROBLEM
.	.	O

hyperventilation	NN	B-TREATMENT
:	:	O
could	MD	O
not	RB	O
be	VB	O
performed	VBN	O
.	.	O

intermittent	JJ	B-TEST
photic	JJ	I-TEST
stimulation	NN	I-TEST
:	:	O
could	MD	O
not	RB	O
be	VB	O
performed	VBN	O
.	.	O

cardiac	JJ	B-TEST
monitor	NN	I-TEST
:	:	O
showed	VBD	O
a	DT	O
generally	RB	O
regular	JJ	O
rhythm	NN	O
.	.	O

impression	NN	O
:	:	O
abnormal	JJ	B-PROBLEM
portable	JJ	I-PROBLEM
eeg	NN	I-PROBLEM
due	JJ	O
to	TO	O
the	DT	B-PROBLEM
bursts	NNS	I-PROBLEM
of	IN	I-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
and	CC	O
additional	JJ	B-PROBLEM
left-sided	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
and	CC	O
voltage	NN	B-PROBLEM
dimunition	NN	I-PROBLEM
,	,	O
along	IN	O
with	IN	O
some	DT	B-PROBLEM
slowing	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
background	NN	I-PROBLEM
.	.	O

the	DT	O
generalized	JJ	O
and	CC	O
background	NN	O
features	NNS	O
indicate	VBP	O
a	DT	B-PROBLEM
wide-spread	JJ	I-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
left	NN	I-PROBLEM
sided	VBD	I-PROBLEM
slowing	NN	I-PROBLEM
and	CC	O
voltage	NN	B-PROBLEM
reduction	NN	I-PROBLEM
surpassed	VBD	O
an	DT	B-PROBLEM
additional	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
,	,	O
possibly	RB	O
wide-spread	JJ	B-PROBLEM
cortical	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
a	DT	O
possibility	NN	O
of	IN	O
a	DT	B-PROBLEM
structural	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
,	,	O
but	CC	O
the	DT	B-PROBLEM
encephalopathy	NN	I-PROBLEM
dominated	VBD	O
the	DT	O
overall	JJ	O
picture	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
clear	JJ	B-PROBLEM
epileptiform	NN	I-PROBLEM
discharges	NNS	I-PROBLEM
.	.	O

no	DT	O
eeg	NN	O
correlate	NN	O
was	VBD	O
established	VBN	O
for	IN	O
the	DT	B-PROBLEM
facial	JJ	I-PROBLEM
twitching	NN	I-PROBLEM
.	.	O

the	DT	O
lack	NN	O
of	IN	O
eeg	JJ	O
correlate	NN	O
to	TO	O
the	DT	B-PROBLEM
facial	JJ	I-PROBLEM
twitching	NN	I-PROBLEM
does	VBZ	O
not	RB	O
exclude	VB	O
a	DT	O
central	JJ	O
cause	NN	O
(	(	O
and	CC	O
,	,	O
indeed	RB	O
,	,	O
this	DT	O
appeared	VBD	O
most	RBS	O
likely	JJ	O
based	VBN	O
on	IN	O
the	DT	O
clinical	JJ	O
and	CC	O
video	JJ	B-TEST
observations	NNS	I-TEST
).	VBP	O

53	CD	O
yo	JJ	O
woman	NN	O
with	IN	O
h/o	JJ	O
seizure	NN	B-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
demyelinating	VBG	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
brain	NN	B-PROBLEM
injury	NN	I-PROBLEM
,	,	O
presents	NNS	O
with	IN	O
prolonged	JJ	B-PROBLEM
seizure	NN	I-PROBLEM
,	,	O
now	RB	O
unresponsive	JJ	B-PROBLEM
with	IN	O
persistent	JJ	B-PROBLEM
twitching	NN	I-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
face	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
most	RBS	O
consistent	JJ	O
with	IN	O
complex	JJ	B-PROBLEM
partial	JJ	I-PROBLEM
seizures	NNS	I-PROBLEM
with	IN	O
a	DT	O
focus	NN	O
in	IN	O
the	DT	O
left	NN	O
hemisphere	RB	O
,	,	O
most	JJS	O
likely	JJ	O
the	DT	O
motor	NN	O
strip	NN	O
.	.	O

in	IN	O
the	DT	O
past	NN	O
,	,	O
her	PRP$	B-PROBLEM
seizures	NNS	I-PROBLEM
were	VBD	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
,	,	O
which	WDT	O
implies	VBZ	O
that	IN	O
she	PRP	O
now	RB	O
has	VBZ	O
a	DT	O
new	JJ	O
focus	NN	O
.	.	O

it	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
this	DT	O
is	VBZ	O
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
underlying	JJ	I-PROBLEM
demyelinating	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
but	CC	O
per	IN	O
report	NN	O
this	DT	O
has	VBZ	O
not	RB	O
been	VBN	O
very	RB	O
active	JJ	O
.	.	O

other	JJ	O
possibilities	NNS	O
include	VBP	O
infection	NN	B-PROBLEM
,	,	O
including	VBG	O
her	PRP$	B-PROBLEM
uti	NN	I-PROBLEM
.	.	O

it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
these	DT	B-PROBLEM
seizures	NNS	I-PROBLEM
began	VBD	O
due	JJ	O
to	TO	O
subtherapeutic	JJ	B-PROBLEM
dilantin	NN	I-PROBLEM
levels	NNS	I-PROBLEM
on	IN	O
her	PRP$	B-TREATMENT
new	JJ	I-TREATMENT
dose	NN	I-TREATMENT
of	IN	O
200	CD	O
mg	NNS	O
/	VBD	O
100	CD	O
mg	NN	O
.	.	O

her	PRP$	B-TREATMENT
seizure	NN	I-TREATMENT
management	NN	I-TREATMENT
is	VBZ	O
difficult	JJ	O
,	,	O
given	VBN	O
the	DT	B-TREATMENT
higher	JJR	I-TREATMENT
doses	NNS	I-TREATMENT
were	VBD	O
causing	VBG	O
her	PRP$	O
to	TO	O
fall	VB	O
and	CC	O
slur	VB	O
her	PRP$	O
speech	NN	O
.	.	O

discussed	VBN	O
with	IN	O
dr.	NN	O
joaquin	NN	O
the	DT	O
addition	NN	O
of	IN	O
an	DT	B-TREATMENT
alternate	NN	I-TREATMENT
castelluccio	NN	I-TREATMENT
with	IN	O
the	DT	O
possibility	NN	O
of	IN	O
tapering	VBG	O
down	RP	O
the	DT	B-TREATMENT
dilantin	NN	I-TREATMENT
in	IN	O
the	DT	O
future	NN	O
,	,	O
and	CC	O
he	PRP	O
agreed	VBD	O
that	IN	O
she	PRP	O
may	MD	O
benefit	VB	O
from	IN	O
zonegran	NN	B-TREATMENT
.	.	O

cannot	NN	O
use	NN	O
lamictal	NN	B-TREATMENT
or	CC	O
depakote	NN	B-TREATMENT
due	JJ	O
to	TO	O
reactions	NNS	B-PROBLEM
.	.	O

topamax	NN	B-TREATMENT
is	VBZ	O
another	DT	O
possibility	NN	O
,	,	O
but	CC	O
not	RB	O
ideal	VB	O
in	IN	O
a	DT	O
patient	NN	O
with	IN	O
preexisting	VBG	B-PROBLEM
cognitive	JJ	I-PROBLEM
deficits	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
zonegran	NN	B-TREATMENT
at	IN	O
50	CD	O
mg	NNS	O
daily	RB	O
with	IN	O
plans	NNS	O
to	TO	O
increase	VB	O
by	IN	O
50	CD	O
mg	NNS	O
every	DT	O
other	JJ	O
week	NN	O
to	TO	O
a	DT	O
goal	NN	O
dose	NN	O
of	IN	O
200	CD	O
mg	NNS	O
/	JJ	O
day	NN	O
;	:	O
she	PRP	O
was	VBD	O
on	IN	O
100	CD	O
mg	JJ	O
daily	RB	O
at	IN	O
discharge	NN	O
and	CC	O
should	MD	O
have	VB	O
her	PRP$	O
dose	NN	O
increased	VBN	O
on	IN	O
10-12	JJ	O
and	CC	O
again	RB	O
on	IN	O
10-26	NNS	O
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
keppra	NN	B-TREATMENT
and	CC	O
dilantin	NN	B-TREATMENT
with	IN	O
trough	NN	B-TEST
checked	VBN	O
frequently	RB	O
and	CC	O
adjustment	NN	O
as	IN	O
needed	VBN	O
.	.	O

ativan	NN	B-TREATMENT
was	VBD	O
used	VBN	O
for	IN	O
breakthrough	NN	B-PROBLEM
seizures	NNS	I-PROBLEM
(	(	O
facial	JJ	B-PROBLEM
twitching	NN	I-PROBLEM
).	NN	O

mri/mra	NN	B-TEST
showed	VBD	O
new	JJ	B-PROBLEM
temporal	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
but	CC	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
if	IN	O
these	DT	O
are	VBP	O
the	DT	O
cause	NN	O
or	CC	O
effect	NN	O
of	IN	O
her	PRP$	B-PROBLEM
seizures	NNS	I-PROBLEM
.	.	O

she	PRP	O
will	MD	O
need	VB	O
to	TO	O
have	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
mri	NN	I-TEST
in	IN	O
several	JJ	O
months	NNS	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

lp	NN	B-TEST
was	VBD	O
done	VBN	O
and	CC	O
had	VBD	O
no	DT	O
changes	NNS	O
to	TO	O
suggest	VB	O
a	DT	O
different	JJ	O
etiology	NN	O
(	(	O
ie	JJ	O
negative	JJ	O
cytology	NN	O
and	CC	O
negative	JJ	O
immunophenotyping	NN	O
).	NN	O

oligoclonal	JJ	B-TEST
bands	NNS	I-TEST
were	VBD	O
not	RB	O
assessed	VBN	O
as	IN	O
there	EX	O
was	VBD	O
not	RB	O
enough	JJ	O
csf	NN	B-TEST
per	IN	O
the	DT	O
laboratory	NN	O
.	.	O

she	PRP	O
will	MD	O
need	VB	O
repeated	VBN	B-TEST
dilantin	JJ	I-TEST
troughs	NNS	I-TEST
with	IN	O
one	CD	O
time	NN	O
dose	NN	O
when	WRB	O
trough	NN	O
is	VBZ	O
subtherapeutic	JJ	O
.	.	O

angiotensin	RB	B-TEST
1	CD	I-TEST
converting	VBG	I-TEST
enzyme	NN	I-TEST

ebv-pcr	NN	B-TEST

herpes	NNS	B-TEST
simplex	JJ	I-TEST
virus	NN	I-TEST
pcr	NN	I-TEST

ernest	JJS	B-TEST
virus	NN	I-TEST
(	(	I-TEST
jcv	NN	I-TEST
)	)	I-TEST
dna	NN	B-TEST
pcr	NN	I-TEST

lyme	NN	B-TEST
,	,	O
total	JJ	B-TEST
eia	NN	I-TEST
with	IN	O
reflex	NN	B-TEST
to	TO	I-TEST
csf	VB	I-TEST
ratio	NN	I-TEST

varicella	NN	B-TEST
dna	NN	I-TEST
(	(	I-TEST
pcr	NN	I-TEST
)	)	I-TEST

vdrl	NN	B-TEST

2.	CD	O
atypical	JJ	B-PROBLEM
ms	NN	I-PROBLEM
:	:	O
discussed	VBN	O
with	IN	O
her	PRP$	O
outpt	JJ	O
neurologist	NN	O
(	(	O
dr.	JJ	O
ford	NN	O
in	IN	O
boston	NNP	O
medical	JJ	O
center	NN	O
);	VBZ	O
no	DT	O
current	JJ	O
role	NN	O
for	IN	O
ms	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

mri	NN	B-TEST
was	VBD	O
performed	VBN	O
and	CC	O
showed	VBD	O
new	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
vs	VBP	O
sz	JJ	B-PROBLEM
effects	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
last	JJ	I-TEST
mri	NN	I-TEST
in	IN	O
the	DT	O
centrum	NN	O
semiovale	NN	O
.	.	O

lp	NN	B-TEST
was	VBD	O
done	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
malignancy	NN	B-PROBLEM
,	,	O
and	CC	O
no	DT	O
malignant	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
were	VBD	O
seen	VBN	O
.	.	O

immunotyping	NN	B-TEST
was	VBD	O
negative	JJ	O
as	RB	O
well	RB	O
(	(	O
per	IN	O
verbal	FW	O
report	NN	O
).	NN	O

unfortunately	RB	O
,	,	O
oligoclonal	JJ	B-TEST
bands	NNS	I-TEST
could	MD	O
not	RB	O
be	VB	O
sent	VBN	O
from	IN	O
the	DT	O
csf	NN	O
(	(	O
lab	JJ	O
sent	NN	O
csf	NN	O
for	IN	O
other	JJ	B-TEST
studies	NNS	I-TEST
and	CC	O
there	EX	O
was	VBD	O
not	RB	O
enough	JJ	O
left	NN	O
over	IN	O
for	IN	O
ocb	JJ	B-TEST
s).	NN	I-TEST

given	VBN	O
that	IN	O
she	PRP	O
does	VBZ	O
have	VB	O
new	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
on	IN	O
mri	NN	B-TEST
,	,	O
if	IN	O
ocb	JJ	B-TEST
s	NN	I-TEST
were	VBD	O
sent	VBN	O
this	DT	O
would	MD	O
have	VB	O
weighed	VBN	O
in	IN	O
in	IN	O
her	PRP$	O
dx	NN	O
of	IN	O
ms	NN	B-PROBLEM
,	,	O
and	CC	O
it's	NN	O
possible	JJ	O
she	PRP	O
could	MD	O
benefit	VB	O
from	IN	O
ms	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

the	DT	O
family	NN	O
is	VBZ	O
confident	JJ	O
in	IN	O
any	DT	O
decision	NN	O
dr.	NN	O
ford	NN	O
would	MD	O
make	VB	O
re	NN	O
:	:	O
therapy	NN	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
ms	NN	I-PROBLEM
.	.	O

3.	CD	O
fevers	NNS	B-PROBLEM
on	IN	O
admission	NN	O
:	:	O
pt	NN	O
w/	WRB	O
positive	JJ	B-PROBLEM
u/a	NN	I-PROBLEM
,	,	O
treated	VBN	O
with	IN	O
bactrim	JJ	B-TREATMENT
x	JJ	O
3	CD	O
days	NNS	O
with	IN	O
defervescence	NN	O
.	.	O

4.	CD	O
depression	NN	B-PROBLEM
:	:	O
continue	NN	O
escitalopram	NN	B-TREATMENT
;	:	O
assess	CC	O
need	VBP	O
to	TO	O
change	VB	O
medication	NN	B-TREATMENT
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

5.	CD	O
fen	NN	O
:	:	O
ngt	NN	B-TREATMENT
was	VBD	O
placed	VBN	O
given	VBN	O
her	PRP$	B-PROBLEM
altered	JJ	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
has	VBZ	O
been	VBN	O
unable	JJ	O
to	TO	O
pass	VB	O
a	DT	B-TEST
swallow	JJ	I-TEST
evaluation	NN	I-TEST
,	,	O
but	CC	O
has	VBZ	O
improved	VBN	O
.	.	O

dilantin	NN	B-TREATMENT
200/100	CD	O

keppra	NN	B-TREATMENT
1500	CD	O
mg	NN	O
bid	NN	O

lexapro	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
q	NNS	O
day	NN	O

folate	NN	B-TREATMENT
1	CD	O
mg	NN	O
q	NN	O
day	NN	O

calcium	NN	B-TREATMENT
1	CD	O
tab	NN	O
bid	NN	O

1.	CD	O
zonisamide	NN	B-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
):	NNP	O
increase	NN	O
by	IN	O
50	CD	O
mg	NNS	O
every	DT	O
other	JJ	O
week	NN	O
(	(	O
next	JJ	O
increase	NN	O
2015-10-12	JJ	O
).	NN	O

2.	CD	O
phenytoin	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
four	CD	O
(	(	O
4	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
qam	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
morning	NN	O
)).	NN	O

3.	CD	O
phenytoin	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
three	CD	O
(	(	O
3	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
qpm	NN	O
(	(	O
once	RB	O
a	DT	O
day	NN	O
(	(	O
in	IN	O
the	DT	O
evening	NN	O
)).	NN	O

4.	CD	O
phenytoin	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
,	,	O
chewable	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
chewable	JJ	O
po	NN	O
every	DT	O
other	JJ	O
day	NN	O
(	(	O
every	DT	O
other	JJ	O
day	NN	O
).	VB	O

5.	CD	O
levetiracetam	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
four	CD	O
(	(	O
4	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
escitalopram	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

7.	CD	O
folic	JJ	B-TREATMENT
acid	RB	I-TREATMENT
1	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
lansoprazole	JJ	B-TREATMENT
30	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
rapid	JJ	O
dissolve	NN	O
,	,	O
dr	JJ	O
turner	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
rapid	JJ	O
dissolve	NN	O
,	,	O
dr	JJ	O
hughes	NNS	O
daily	RB	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
150	CD	O
mg	NN	O
/	VBD	O
15	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
one	CD	O
hundred	VBD	O
(	(	O
100	CD	O
)	)	O
mg	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

11.	CD	O
bisacodyl	NN	B-TREATMENT
10	CD	O
mg	NN	O
suppository	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
suppository	NN	O
rectal	JJ	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

12.	CD	O
heparin	NN	B-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	O
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
5000	CD	O
(	(	O
5000	CD	O
)	)	O
units	NNS	O
injection	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

seizure	NN	B-PROBLEM

history	NN	O
of	IN	O
atypical	JJ	B-PROBLEM
multiple	JJ	I-PROBLEM
sclerosis	NN	I-PROBLEM

memory	NN	B-PROBLEM
loss	NN	I-PROBLEM

status	NN	O
post	NN	O
brain	NN	B-PROBLEM
injury	NN	I-PROBLEM

urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM

take	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
as	IN	O
prescribed	NN	O
.	.	O

please	VB	O
increase	NN	O
zonegran	NN	B-TREATMENT
dose	NN	I-TREATMENT
by	IN	O
50	CD	O
every	DT	O
other	JJ	O
week	NN	O
until	IN	O
it	PRP	O
reaches	VBZ	O
200	CD	O
mg	JJ	O
daily	RB	O
,	,	O
with	IN	O
first	JJ	O
dose	JJ	O
change	NN	O
10-12	CD	O
to	TO	O
150	CD	O
mg	NNS	O
daily	RB	O
and	CC	O
second	JJ	O
dose	JJ	O
change	NN	O
10-26	JJ	O
to	TO	O
200	CD	O
mg	NNS	O
daily	RB	O
.	.	O

call	VB	O
the	DT	O
doctor	NN	O
or	CC	O
go	VB	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
with	IN	O
increased	JJ	B-PROBLEM
seizure	NN	I-PROBLEM
frequency	NN	I-PROBLEM
,	,	O
unresponsiveness	RB	B-PROBLEM
,	,	O
new	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
or	CC	O
numbness	NN	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

please	NN	O
follow	VB	O
up	RP	O
with	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
mri	NN	I-TEST
in	IN	O
several	JJ	O
months	NNS	O
to	TO	O
evaluate	VB	O
new	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
brain	NN	I-PROBLEM
.	.	O

vulvar	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
43-year-old	JJ	O
gravida	NN	O
ii	NN	O
para	NN	O
ii	JJ	O
white	JJ	O
female	NN	O
referred	VBN	O
by	IN	O
dr.	NN	O
ca	MD	O
shuff	VB	O
for	IN	O
evaluation	NN	B-TEST
.	.	O

she	PRP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
good	JJ	O
health	NN	O
until	IN	O
december	NN	O
when	WRB	O
she	PRP	O
was	VBD	O
seen	VBN	O
emergently	RB	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
perforated	JJ	I-PROBLEM
colon	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

that	DT	O
area	NN	O
was	VBD	O
resected	VBN	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBN	O
subsequent	VBN	B-TEST
cea&apos;s	NN	I-TEST
and	CC	O
scans	NNS	B-TEST
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

a	DT	B-PROBLEM
tumor	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
on	IN	O
her	PRP$	O
vulva	NN	O
which	WDT	O
was	VBD	O
biopsied	VBN	O
and	CC	O
revealed	VBN	O
squamous	JJ	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
in	IN	I-PROBLEM
situ	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

as	IN	O
above	IN	O
with	IN	O
colostomy	NN	B-TREATMENT
.	.	O

on	IN	O
admission	NN	O
included	VBD	O
heent	NN	B-TEST
exam	NN	I-TEST
which	WDT	O
was	VBD	O
normal	JJ	O
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

vulva	NN	O
and	CC	O
right	JJ	O
labia	NN	O
replaced	VBN	O
by	IN	O
reddish	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
somewhat	RB	O
raised	VBD	O
in	IN	O
the	DT	O
center	NN	O
extending	VBG	O
from	IN	O
adjacent	JJ	O
to	TO	O
the	DT	O
cuterus	NN	O
to	TO	O
the	DT	O
posterior	JJ	O
forchette	NN	O
.	.	O

otherwise	RB	O
,	,	O
her	PRP	B-TEST
pelvic	JJ	I-TEST
exam	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

stage	NN	B-PROBLEM
ii	RB	I-PROBLEM
squamous	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
vulva	NN	I-PROBLEM
.	.	O

the	DT	O
plan	NN	O
was	VBD	O
for	IN	O
right	JJ	B-TREATMENT
radical	JJ	I-TREATMENT
vulvectomy	NN	I-TREATMENT
.	.	O

1.	CD	O
vulvectomy	NN	B-TREATMENT
:	:	O

the	DT	O
patient	NN	O
on	IN	O
2/8/90	CD	O
underwent	NN	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
radical	JJ	I-TREATMENT
vulvectomy	NN	I-TREATMENT
with	IN	O
excellent	JJ	O
results	NNS	O
and	CC	O
negative	JJ	O
margins	NNS	O
on	IN	O
frozen	JJ	B-TEST
section	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
kept	VBN	O
on	IN	O
bedrest	JJS	B-TREATMENT
for	IN	O
two	CD	O
days	NNS	O
and	CC	O
then	RB	O
was	VBD	O
ambulating	VBG	O
and	CC	O
voiding	VBG	O
well	RB	O
without	IN	O
trouble	NN	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
three	CD	O
when	WRB	O
the	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
doing	VBG	O
betadine	JJ	B-TREATMENT
paint	NN	I-TREATMENT
and	CC	O
blow	NN	O
drying	VBG	O
the	DT	O
area	NN	O
several	JJ	O
times	NNS	O
a	DT	O
day	NN	O
and	CC	O
after	IN	O
each	DT	O
bowel	NN	O
movement	NN	O
and	CC	O
urine	NN	O
without	IN	O
incident	NN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

2014-04-18	CD	O
off	IN	B-TREATMENT
pump	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
utilizing	VBG	O
the	DT	O
left	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
to	TO	O
left	VB	O
anterior	RP	O
descending	VBG	O
artery	NN	O
,	,	O
free	JJ	O
right	NN	O
internal	JJ	O
mammary	NN	O
to	TO	O
obtuse	VB	O
marginal	JJ	O
and	CC	O
vein	JJ	B-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
diagonal	VB	I-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
60	CD	O
year	NN	O
old	JJ	O
male	NN	O
with	IN	O
new	JJ	B-PROBLEM
onset	VBN	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

nuclear	JJ	B-TEST
myocardial	JJ	I-TEST
perfusion	NN	I-TEST
study	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-PROBLEM
moderate	JJ	I-PROBLEM
fixed	VBN	I-PROBLEM
defect	NN	I-PROBLEM
within	IN	I-PROBLEM
the	DT	I-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
and	CC	O
cardiac	JJ	O
apex	NN	O
.	.	O

his	PRP$	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
however	RB	O
appeared	VBD	O
preserved	VBN	O
at	IN	O
73%	CD	O
with	IN	O
mild	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
wall	NN	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

subsequent	JJ	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
at	IN	O
nantucket	JJ	O
cottage	NN	O
hospital	NN	O
hospital	NN	O
on	IN	O
2014-04-16	JJ	O
was	VBD	O
significant	JJ	O
for	IN	O
severe	JJ	B-PROBLEM
two	CD	I-PROBLEM
vessel	NN	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

angiography	NN	B-TEST
revealed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
dominant	NN	I-PROBLEM
system	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
40%	CD	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	NN	I-PROBLEM
left	VBD	I-PROBLEM
main,	JJ	I-PROBLEM
several	JJ	B-PROBLEM
tight	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	NN	I-PROBLEM
and	CC	I-PROBLEM
mid	NN	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
descending	VBG	I-PROBLEM
artery	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	B-PROBLEM
90%	CD	I-PROBLEM
stenosis	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
circumflex	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
coronary	JJ	O
artery	NN	O
had	VBD	O
mild	VBN	B-PROBLEM
diffuse	IN	I-PROBLEM
plaquing	VBG	I-PROBLEM
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
focal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

based	VBN	O
upon	IN	O
the	DT	O
above	JJ	O
results	NNS	O
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
mediplex	NN	O
rehab	NN	O
hospital	NN	O
for	IN	O
surgical	JJ	B-TREATMENT
revascularization	NN	I-TREATMENT
.	.	O

asthma	NN	B-PROBLEM

benign	JJ	B-PROBLEM
prostatic	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM

history	NN	O
of	IN	O
nephrolithiasis	NN	B-PROBLEM

hemorrhoids	NNS	B-PROBLEM

mother	NN	O
suffer	NN	O
mi	NN	B-PROBLEM
in	IN	O
her	PRP$	O
50	CD	O
's,	POS	O
died	VBN	O
at	IN	O
age	NN	O
59	CD	O
.	.	O

father	RB	O
died	VBN	O
from	IN	O
mi	NN	B-PROBLEM
at	IN	O
age	NN	O
72	CD	O
.	.	O

vitals	NNS	B-TEST
:	:	O
t	NN	B-TEST
98.9	CD	O
,	,	O
bp	NN	B-TEST
148/70	CD	O
,	,	O
hr	NN	B-TEST
57	CD	O
,	,	O
rr	NN	B-TEST
20	CD	O
,	,	O
sat	VBD	B-TEST
95	CD	O
on	IN	O
room	NN	O
air	NN	O

general	JJ	O
:	:	O
well	RB	O
developed	VB	O
male	NN	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM

neck	NN	O
:	:	O
supple	NN	O
,	,	O
no	DT	O
jvd	NN	B-PROBLEM
,	,	O

heart	NN	O
:	:	O
regular	JJ	O
rate	NN	O
,	,	O
normal	JJ	O
s1s2	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
or	CC	O
rub	NN	B-PROBLEM

abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
normoactive	JJ	O
bowel	NN	O
sounds	NNS	O

ext	NN	O
:	:	O
warm	NN	O
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
no	DT	O
varicosities	NNS	B-PROBLEM

pulses	NNS	B-TEST
:	:	O
2+	CD	O
distally	RB	O
,	,	O
no	DT	O
carotid	NN	B-PROBLEM
or	CC	I-PROBLEM
femoral	JJ	I-PROBLEM
bruits	NNS	I-PROBLEM

2014-04-17	JJ	O
03:58	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
6.3	CD	O
rbc	NN	B-TEST
-	:	O
4.60	CD	O
hgb	NN	B-TEST
-	:	O
15.4	CD	O
hct	NN	B-TEST
-	:	O
42.9	CD	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
33.4	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
35.8	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
12.8	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
168	CD	O

2014-04-17	JJ	O
03:58	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
13.2	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
30.3	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.2	CD	O
*	NN	O

2014-04-17	JJ	O
03:58	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
92	CD	O
urean	JJ	B-TEST
-	:	O
15	CD	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
142	CD	O
k	SYM	B-TEST
-	:	O
4.5	CD	O
cl	NN	B-TEST
-	:	O
104	CD	O
hco3	NN	B-TEST
-	:	O
26	CD	O
angap	NN	B-TEST
-	:	O
17	CD	O

2014-04-17	JJ	O
03:58	CD	O
pm	NN	O
blood	NN	B-TEST
alt	SYM	B-TEST
-	:	O
18	CD	O
ast	IN	B-TEST
-	:	O
20	CD	O
alkphos	SYM	B-TEST
-	:	O
53	CD	O
amylase	NN	B-TEST
-	:	O
98	CD	O
totbili	SYM	B-TEST
-	:	O
0.6	CD	O

2014-04-17	JJ	O
03:58	CD	O
pm	NN	O
blood	NN	B-TEST
%hba1c	NNP	B-TEST
-	:	O
5.8	CD	O
[hgb]	SYM	B-TEST
-	:	O
done	VBN	O
[a1c]	SYM	B-TEST
-	:	O
done	VBN	O

2014-04-22	JJ	O
07:10	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
6.5	CD	O
rbc	NN	B-TEST
-	:	O
2.89	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.4	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
92	CD	O
mch	SYM	B-TEST
-	:	O
32.3	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
35.2	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
13.8	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
155	CD	O

2014-04-22	JJ	O
07:10	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
97	CD	O
urean	JJ	B-TEST
-	:	O
11	CD	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
142	CD	O
k	SYM	B-TEST
-	:	O
4.4	CD	O
cl	NN	B-TEST
-	:	O
103	CD	O
hco3	NN	B-TEST
-	:	O
34	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
9	CD	O

2014-04-22	JJ	O
07:10	CD	O
am	VBP	O
blood	NN	B-TEST
mg	NN	B-TEST
-	:	O
2.0	CD	O

2014-04-22	JJ	O
chest	JJS	B-TEST
x-ray	JJ	I-TEST
:	:	O
no	DT	O
evidence	NN	O
of	IN	O
pneumothorax	NN	B-PROBLEM
.	.	O

persistent	JJ	B-PROBLEM
bibasilar	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
and	CC	O
tiny	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

stable	JJ	B-PROBLEM
postoperative	JJ	I-PROBLEM
cardiac	NN	I-PROBLEM
and	CC	I-PROBLEM
mediastinal	JJ	I-PROBLEM
widening	NN	I-PROBLEM
.	.	O

2014-04-24	JJ	O
06:35	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
6.7	CD	O
rbc	NN	B-TEST
-	:	O
2.96	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.1	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
28.0	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
94	CD	O
mch	SYM	B-TEST
-	:	O
30.9	CD	O
mchc	SYM	B-TEST
-	:	O
32.7	CD	O
rdw	NN	B-TEST
-	:	O
13.6	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
234	CD	O
#	#	O

2014-04-25	JJ	O
06:45	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
93	CD	O
urean	JJ	B-TEST
-	:	O
13	CD	O
creat	NN	B-TEST
-	:	O
1.4	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
141	CD	O
k	SYM	B-TEST
-	:	O
4.6	CD	O
cl	NN	B-TEST
-	:	O
102	CD	O
hco3	NN	B-TEST
-	:	O
31	CD	O
angap	NN	B-TEST
-	:	O
13	CD	O

2014-04-24	JJ	O
06:35	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
96	CD	O
urean	JJ	B-TEST
-	:	O
13	CD	O
creat	NN	B-TEST
-	:	O
1.4	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
143	CD	O
k	SYM	B-TEST
-	:	O
4.8	CD	O
cl	NN	B-TEST
-	:	O
104	CD	O
hco3	NN	B-TEST
-	:	O
33	CD	O
*	NN	O
angap	NN	B-TEST
-	:	O
11	CD	O

mr.	NN	O
chester	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cardiac	JJ	O
surgical	JJ	O
service	NN	O
and	CC	O
underwent	JJ	O
routine	JJ	B-TEST
preoperative	JJ	I-TEST
evaluation	NN	I-TEST
.	.	O

he	PRP	O
remained	VBD	O
pain	RB	B-PROBLEM
free	JJ	O
on	IN	O
medical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

workup	NN	B-TEST
was	VBD	O
unremarkable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
cleared	VBN	O
for	IN	O
surgery	NN	B-TREATMENT
.	.	O

on	IN	O
04-18	NNP	O
,	,	O
dr.	NN	O
oneill	NN	O
performed	VBD	O
off	RP	B-TREATMENT
pump	NN	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

following	VBG	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
he	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
csru	NN	O
for	IN	O
invasive	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

given	VBN	O
hypotension	NN	B-PROBLEM
and	CC	O
bradycardia	NN	B-PROBLEM
,	,	O
he	PRP	O
was	VBD	O
slow	JJ	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM
from	IN	O
neosynephrine	NN	B-TREATMENT
.	.	O

low	JJ	B-TREATMENT
dose	NN	I-TREATMENT
beta	NN	I-TREATMENT
blockade	NN	I-TREATMENT
was	VBD	O
eventually	RB	O
resumed	VBN	O
.	.	O

chest	NN	B-TREATMENT
tubes	NNS	I-TREATMENT
and	CC	O
pacing	VBG	B-TREATMENT
wires	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

he	PRP	O
maintained	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
without	IN	O
atrial	JJ	B-PROBLEM
or	CC	I-PROBLEM
ventricular	JJ	I-PROBLEM
arrhythmias	NNS	I-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
in	IN	O
sinus	NN	B-PROBLEM
bradycardia	NN	I-PROBLEM
(	(	O
rate	NN	O
50-60	NN	O
)	)	O
and	CC	O
tolerated	VBD	O
low	JJ	B-TREATMENT
dose	JJ	I-TREATMENT
beta	NN	I-TREATMENT
blockade	NN	I-TREATMENT
.	.	O

on	IN	O
pod	NN	O
#6	IN	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
became	VBD	O
slightly	RB	B-PROBLEM
elevated	VBN	I-PROBLEM
at	IN	O
1.4	CD	O
,	,	O
his	PRP$	B-TREATMENT
lasix	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
and	CC	O
the	DT	O
following	JJ	O
day	NN	O
his	PRP$	B-TEST
creatinine	NN	I-TEST
was	VBD	O
stable	JJ	O
at	IN	O
1.4	CD	O
.	.	O

his	PRP$	B-TEST
discharge	NN	I-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
persistent	JJ	B-PROBLEM
bibasilar	JJ	I-PROBLEM
atelectasis	NN	I-PROBLEM
with	IN	O
only	JJ	O
tiny	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
will	MD	O
need	VB	O
to	TO	O
remain	VB	O
on	IN	O
plavix	NN	B-TREATMENT
for	IN	O
three	CD	O
months	NNS	O
postop	VB	O
given	VBN	O
the	DT	B-TREATMENT
off	RP	I-TREATMENT
pump	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
will	MD	O
need	VB	O
to	TO	O
remain	VB	O
on	IN	O
imdur	NN	B-TREATMENT
given	VBN	O
use	NN	O
of	IN	O
his	PRP$	O
right	JJ	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
as	IN	O
a	DT	B-TREATMENT
"	NNP	I-TREATMENT
free	JJ	I-TREATMENT
"	NNP	I-TREATMENT
arterial	NN	I-TREATMENT
graft	NN	I-TREATMENT
in	IN	O
preventing	VBG	O

vasospasm	NN	B-PROBLEM
.	.	O

lopressor	NN	B-TREATMENT
?	.	O
dose	VB	O

aspirin	RB	B-TREATMENT
325	CD	O
qd	NN	O

zocor	NN	B-TREATMENT
40	CD	O
qd	NN	O

iv	NN	B-TREATMENT
heparin	NN	I-TREATMENT

1.	CD	O
furosemide	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
5	CD	O
days	NNS	O
.	.	O

2.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq	NN	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
,	,	O
sustained	VBD	O
release	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
for	IN	O
5	CD	O
days	NNS	O
.	.	O

3.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

5.	CD	O
oxycodone	CD	B-TREATMENT
-	:	I-TREATMENT
acetaminophen	NN	I-TREATMENT
5-325	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
every	DT	O
4-6	JJ	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
simvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

7.	CD	O
fluticasone	NN	B-TREATMENT
-	:	I-TREATMENT
salmeterol	NN	I-TREATMENT
250-50	JJ	O
mcg	NN	O
/	NNP	O
dose	JJ	O
disk	NN	O
with	IN	O
device	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
disk	NN	O
with	IN	O
device	JJ	O
inhalation	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
isosorbide	JJ	B-TREATMENT
mononitrate	NN	I-TREATMENT
30	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

9.	CD	O
clopidogrel	NN	B-TREATMENT
75	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

10.	CD	O
metoprolol	JJ	B-TREATMENT
succinate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
0.5	CD	O
(	(	O
half	NN	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
-	:	O
s/p	NN	O
off	IN	B-TREATMENT
pump	NN	I-TREATMENT
cabg	NN	I-TREATMENT

sinus	NN	B-PROBLEM
bradycardia	NN	I-PROBLEM

asthma	NN	B-PROBLEM

bph	NN	B-PROBLEM

nephrolithiasis	NN	B-PROBLEM

follow	JJ	O
medications	NNS	B-TREATMENT
on	IN	O
discharge	NN	O
instructions	NNS	O
.	.	O

shower	JJR	O
daily	RB	O
,	,	O
let	VB	O
water	NN	O
flow	NN	O
over	IN	O
wounds	NNS	B-PROBLEM
,	,	O
pat	NN	O
dry	NN	O
with	IN	O
a	DT	O
towel	NN	O
.	.	O

do	VB	O
not	RB	O
use	VB	O
creams	NNS	O
,	,	O
lotions	NNS	O
,	,	O
or	CC	O
powders	NNS	O
on	IN	O
wounds	NNS	B-PROBLEM
.	.	O

call	VB	O
our	PRP$	O
office	NN	O
for	IN	O
sternal	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
,	,	O
temp	EX	B-PROBLEM
.>	CD	O
101.5	CD	O

the	DT	O
patient	NN	O
presented	VBN	O
with	IN	O
a	DT	O
chief	JJ	O
complaint	NN	O
of	IN	O
rlq	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

following	VBG	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
&apos;s	JJ	O
disposition	NN	O
at	IN	O
the	DT	O
end	NN	O
of	IN	O
the	DT	O
visit	NN	O
was	VBD	O
admitted	VBN	O
as	IN	O
an	DT	O
inpatient	NN	O
to	TO	O
ro	VB	O
woodma	NN	O
healthcare	NN	O
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
preliminary	JJ	O
admitting	VBG	O
physician	NN	O
is	VBZ	O
dalejesc	JJ	O
,	,	O
oie	JJ	O
and	CC	O
the	DT	O
preliminary	JJ	O
admitting	NN	O
diagnosis	NN	O
is	VBZ	O
cholecystitis	NN	B-PROBLEM
.	.	O

penicillins	NNS	B-TREATMENT

dyspnea	NN	B-PROBLEM

this	DT	O
is	VBZ	O
an	DT	O
83	CD	O
y/o	NNS	O
female	JJ	O
with	IN	O
moderate	JJ	B-PROBLEM
as	IN	I-PROBLEM
,	,	O
s/p	VBD	O
mvr	JJ	B-TREATMENT
27	CD	O
years	NNS	O
ago	RB	O
,	,	O
s/p	NN	O
ppm	NN	B-TREATMENT
,	,	O
dm	NN	B-PROBLEM
,	,	O
chf	NN	B-PROBLEM
,	,	O
p/w	JJ	O
dsypnea	NN	B-PROBLEM
and	CC	O
increased	JJ	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	VBG	I-PROBLEM
x	JJ	O
4-5	JJ	O
days	NNS	O
.	.	O

per	IN	O
family	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
worsening	VBG	B-PROBLEM
chf/volume	JJ	I-PROBLEM
overload	NN	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
several	JJ	O
weeks	NNS	O
,	,	O
requiring	VBG	O
supplemental	JJ	B-TREATMENT
o2	NN	I-TREATMENT
at	IN	O
rehab	NN	O
.	.	O

over	IN	O
the	DT	O
last	JJ	O
few	JJ	O
days	NNS	O
,	,	O
she	PRP	O
has	VBZ	O
been	VBN	O
noted	VBN	O
to	TO	O
be	VB	O
more	JJR	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
having	VBG	O
sats	NNS	B-TEST
to	TO	O
60%	CD	O
on	IN	O
ra	NN	O
.	.	O

her	PRP$	B-TREATMENT
lasix	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
60	CD	O
mg	NNS	O
bid	NN	O
.	.	O

beginning	VBG	O
today	NN	O
,	,	O
she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
in	IN	O
hypoxic	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
,	,	O
87-91%	JJ	O
on	IN	O
2l/nc	CD	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
increased	VBN	O
to	TO	O
5l	CD	O
,	,	O
with	IN	O
her	PRP$	B-TEST
sats	NNS	I-TEST
going	VBG	O
up	RB	O
to	TO	O
97%	CD	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
noted	VBN	O
to	TO	O
be	VB	O
more	JJR	B-PROBLEM
confused	JJ	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
few	JJ	O
days	NNS	O
and	CC	O
especially	RB	O
today	NN	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
lasix	NN	B-TREATMENT
and	CC	O
2	CD	B-TREATMENT
mg	NN	I-TREATMENT
iv	NN	I-TREATMENT
morphine	NN	I-TREATMENT
at	IN	O
new	JJ	O
england	NN	O
sinai	NN	O
hospital	NN	O
&	CC	O
rehab	NN	O
center	NN	O
rehab	NN	O
,	,	O
and	CC	O
sent	VBD	O
to	TO	O
nantucket	JJ	O
cottage	NN	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
.	.	O

en	IN	O
route	NN	O
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
additional	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
of	IN	O
60	CD	O
mg	NNS	O
iv	JJ	O
and	CC	O
nitro	JJ	B-TREATMENT
spray	NN	I-TREATMENT
x	VBD	O
2	CD	O
.	.	O

in	IN	O
the	DT	O
deanna	NN	O
,	,	O
her	PRP$	B-TEST
vs	NN	I-TEST
were	VBD	O
tc	JJ	B-TEST
97.2	CD	O
,	,	O
bp	NN	B-TEST
146/25	CD	O
,	,	O
hr	NN	B-TEST
70	CD	O
,	,	O
rr	NN	B-TEST
27	CD	O
,	,	O
sao2	VBD	B-TEST
95%/nrb	CD	B-TREATMENT
.	.	O

foley	NN	B-TREATMENT
was	VBD	O
placed	VBN	O
in	IN	O
deanna	NN	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
40	CD	O
mg	JJ	O
iv	NN	B-TREATMENT
lasix	NN	I-TREATMENT
and	CC	O
325	CD	O
mg	NN	O
asa	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
for	IN	O
comfort	NN	O
at	IN	O
30%	CD	O
fio2	NN	B-TREATMENT
,	,	O
5	CD	O
peep	NN	B-TREATMENT
,	,	O
12	CD	O
ps	NN	B-TREATMENT
.	.	O

admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

per	IN	O
family	NN	O
,	,	O
besides	IN	O
the	DT	B-PROBLEM
dyspnea	NN	I-PROBLEM
and	CC	O
sob	NN	B-PROBLEM
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
no	DT	O
other	JJ	B-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
including	VBG	O
f/c/s	NN	B-PROBLEM
,	,	O
cp	NN	B-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
abd	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
n/v/diarrhea	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
decreased	VBN	B-PROBLEM
appetite	RB	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
few	JJ	O
days	NNS	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
increasing	VBG	B-PROBLEM
confusion	NN	I-PROBLEM
.	.	O

1.	CD	O
moderate	JJ	B-PROBLEM
as	IN	I-PROBLEM

2.	CD	O
s/p	NN	O
mvr	NN	B-TREATMENT

3.	CD	O
s/p	NN	O
ppm	NN	B-TREATMENT

4.	CD	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM

5.	CD	O
dm	JJ	B-PROBLEM
2	CD	I-PROBLEM
on	IN	O
insulin	NN	B-TREATMENT

6.	CD	O
hypercholesterolemia	NN	B-PROBLEM

7.	CD	O
gout	NN	B-PROBLEM

8.	CD	O
depression	NN	B-PROBLEM

9.	CD	O
?	.	O
pulmonary	JJ	B-PROBLEM
fibrosis	NN	I-PROBLEM

10.	CD	O
chf/cad	NN	B-PROBLEM
,	,	O
last	JJ	B-TEST
ef	NN	I-TEST
55%	CD	O
4/06	CD	O

mother	NN	O
with	IN	O
h/o	NN	O
emphysema	NN	B-PROBLEM
,	,	O
cad	NN	B-PROBLEM

on	IN	O
bipap	NN	B-TREATMENT
,	,	O
nad	NN	B-PROBLEM

neck	NN	O
:	:	O
+	NN	O
elevated	VBD	B-PROBLEM
jvd	NN	I-PROBLEM
to	TO	O
earlobe	VB	O
,	,	O
supple	VB	O

chest	NN	O
:	:	O
decreased	VBN	B-PROBLEM
bs	NN	I-PROBLEM
at	IN	O
bases	NNS	O
with	IN	O
few	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
b/l	VBP	I-PROBLEM

cv	NN	O
:	:	O
rrr	NN	O
3/6	CD	O
hsm	NN	B-PROBLEM
,	,	O
loudest	JJS	O
at	IN	O
lusb	NN	O

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt/nd	JJ	B-PROBLEM
,	,	O
nabs	JJ	O

ext	NN	O
:	:	O
2	CD	O
+	NN	O
pitting	VBG	B-PROBLEM
edema	NN	I-PROBLEM
b/l	NN	I-PROBLEM
,	,	O
warm	JJ	O
with	IN	O
faint	NN	O
dp	NN	O

wbc	SYM	B-TEST
-	:	O
9.6	CD	O
rbc	NN	B-TEST
-	:	O
4.02	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.4	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
36.3	CD	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
28.4	CD	O
mchc	SYM	B-TEST
-	:	O
31.4	CD	O
rdw	NN	B-TEST
-	:	O
17.8	CD	O
*	NN	O

neuts	NNS	B-TEST
-	:	O
87.0	CD	O
*	NN	O
lymphs	SYM	B-TEST
-	:	O
6.7	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
5.0	CD	O
eos	SYM	B-TEST
-	:	O
0.9	CD	O
basos	SYM	B-TEST
-	:	O
0.4	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
161	CD	O

pt	SYM	B-TEST
-	:	O
23.2	CD	O
*	JJ	O
inr	NN	B-TEST
(	(	O
pt	NN	O
)	)	O
-	:	O
2.3	CD	O
*	NN	O

ctropnt	SYM	B-TEST
-	:	O
0.08	CD	O
*	NN	O

ck	NN	B-TEST
(	(	I-TEST
cpk	NN	I-TEST
)	)	I-TEST
-	:	O
37	CD	O

ctropnt	SYM	B-TEST
-	:	O
0.08	CD	O
*	NN	O

ck-mb	JJ	B-TEST
-	:	O
notdone	NN	O
probnp	NN	B-TEST
-	:	O
5313	CD	O
*	NN	O

glucose	JJ	B-TEST
-	:	O
173	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
52	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.5	CD	O
*	JJ	O
sodium	NN	B-TEST
-	:	O
145	CD	O
potassium	NN	B-TEST
-	:	O
4.8	CD	O
chloride	NN	B-TEST
-	:	O
100	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
40	CD	O
*	JJ	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
10	CD	O

type	NN	O
-	:	O
art	NN	B-TEST
po2	VBZ	I-TEST
-	:	O
249	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
99	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.28	CD	O
*	JJ	O
total	NN	B-TEST
co2	NN	I-TEST
-	:	O
49	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
15	CD	O
intubated	JJ	O
-	:	O
not	RB	O
intuba	VB	O

type	NN	O
-	:	O
art	NN	B-TEST
temp	SYM	I-TEST
-	:	O
37.0	CD	O
o2-90	JJ	O
o2	NN	B-TREATMENT
flow	NN	I-TREATMENT
-	:	O
5	CD	O
po2	NN	B-TEST
-	:	O
63	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
81	CD	O
*	NN	O
ph	NN	B-TEST
-	:	O
7.39	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
51	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
19	CD	O
aado2	SYM	B-TEST
-	:	O
513	CD	O
req	NN	B-TEST
o2	SYM	I-TEST
-	:	O
84	CD	O

echo	NN	B-TEST
:	:	O
the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
left	NN	I-TEST
ventricular	JJ	I-TEST
cavity	NN	I-TEST
size	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

overall	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
normal	JJ	O
(	(	O
lvef	JJ	B-TEST
70%	CD	O
).	NN	O

there	EX	O
is	VBZ	O
no	DT	O
ventricular	JJ	B-PROBLEM
septal	NN	I-PROBLEM
defect	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
ventricular	NN	O
free	JJ	O
wall	NN	O
is	VBZ	O
hypertrophied	VBN	B-PROBLEM
.	.	O

the	DT	O
right	JJ	O
ventricular	NN	O
cavity	NN	O
is	VBZ	O
dilated	VBN	B-PROBLEM
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
appears	VBZ	O
depressed	JJ	B-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
arch	NN	O
is	VBZ	O
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
focal	JJ	B-PROBLEM
calcifications	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
aortic	JJ	I-PROBLEM
arch	NN	I-PROBLEM
.	.	O

there	EX	O
are	VBP	O
three	CD	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
leaflets	NNS	I-PROBLEM
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
moderately	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
at	IN	O
least	JJS	O
moderate	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
bileaflet	NN	I-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
prosthesis	NN	I-TREATMENT
is	VBZ	O
present	JJ	O
.	.	O

the	DT	B-TEST
gradients	NNS	I-TEST
are	VBP	O
higher	JJR	O
than	IN	O
expected	VBN	O
for	IN	O
this	DT	O
type	NN	O
of	IN	O
prosthesis	NN	B-TREATMENT
.	.	O

the	DT	O
tricuspid	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
end-diastolic	JJ	I-TEST
pulmonic	JJ	I-TEST
regurgitation	NN	I-TEST
velocity	NN	I-TEST
is	VBZ	O
increased	VBN	B-PROBLEM
suggesting	VBG	O
pulmonary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
diastolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

compared	VBN	O
with	IN	O
the	DT	O
findings	NNS	O
of	IN	O
the	DT	B-TEST
prior	JJ	I-TEST
study	NN	I-TEST
(	(	O
images	NNS	O
reviewed	VBN	O
)	)	O
of	IN	O
2013-06-18	JJ	O
,	,	O
the	DT	B-TEST
pressure	NN	I-TEST
gradient	NN	I-TEST
across	IN	O
the	DT	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
prosthesis	NN	I-TREATMENT
is	VBZ	O
increased	VBN	B-PROBLEM
.	.	O

impression	NN	O
:	:	O
ap	NN	B-TEST
chest	NN	I-TEST
compared	VBN	O
to	TO	O
07-30	CD	O
through	IN	O
26	CD	O
:	:	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
.	.	O

bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
small	JJ	O
on	IN	O
the	DT	O
right	NN	O
and	CC	O
moderate	VB	O
on	IN	O
the	DT	O
left	NN	O
is	VBZ	O
stable	JJ	O
.	.	O

severe	JJ	B-PROBLEM
cardiomegaly	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
atelectasis	NN	I-PROBLEM
unchanged	JJ	O
.	.	O

no	DT	O
pneumothorax	NN	B-PROBLEM
.	.	O

transvenous	JJ	B-TREATMENT
right	JJ	I-TREATMENT
ventricular	NN	I-TREATMENT
pacer	NN	I-TREATMENT
lead	NN	I-TREATMENT
in	IN	O
standard	JJ	O
placement	NN	O
.	.	O

ecg	NN	B-TEST
:	:	O
ventricular	NN	O
paced	VBD	O
rhythm	NN	O
.	.	O

compared	VBN	O
to	TO	O
the	DT	B-TEST
previous	JJ	I-TEST
tracing	NN	I-TEST
of	IN	O
2014-07-30	JJ	O
no	DT	O
significant	JJ	O
change	NN	O
.	.	O

rate	NN	B-TEST
pr	NNS	B-TEST
qrs	VBP	B-TEST
qt/qtc	JJ	B-TEST
p	NN	B-TEST
qrs	NN	B-TEST
t	VBD	B-TEST
70	CD	O
0	CD	O
160	CD	O
466/486.42	CD	O
0	CD	O
-71	NNS	O
112	CD	O

a/p	SYM	O
-	:	O
83yo	CD	O
f	NN	O
with	IN	O
valvular	JJ	B-PROBLEM
disorder	NN	I-PROBLEM
,	,	O
af	NN	B-PROBLEM
,	,	O
and	CC	O
h/o	NN	O
cad	NN	B-PROBLEM
a/w	NN	O
hypercarbic	JJ	B-PROBLEM
respiratory	JJ	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

#	#	O
respiratory	NN	B-PROBLEM
failure	NN	I-PROBLEM
-	:	O
she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
csru	NN	O
for	IN	O
her	PRP$	B-PROBLEM
repiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM
which	WDT	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
secondary	JJ	O
to	TO	O
chf	VB	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
diuresed	VBN	O
with	IN	O
iv	JJ	B-TREATMENT
lasix	NN	I-TREATMENT
/	NNP	O
acetazolamide	NN	B-TREATMENT
and	CC	O
given	VBN	O
iv	JJ	B-TREATMENT
morphine	NN	I-TREATMENT
/	NNP	O
prn	NN	O
for	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
bipap	NN	B-TREATMENT
was	VBD	O
tried	VBN	O
.	.	O

however	RB	O
,	,	O
hypercarbia	NN	B-PROBLEM
(	(	O
04-11	JJ	O
metabolic	JJ	B-PROBLEM
alkalosis	NN	I-PROBLEM
)	)	O
remained	VBD	O
in	IN	O
the	DT	O
90s	CD	O
.	.	O

pt	NN	O
was	VBD	O
mentating	VBG	O
okay	NN	O
,	,	O
having	VBG	O
conversations	NNS	O
with	IN	O
intermittent	JJ	B-PROBLEM
somnolence	NN	I-PROBLEM
despite	IN	O
hypercarbia	NN	B-PROBLEM
.	.	O

tte	NN	B-TEST
showed	VBD	O
preserved	JJ	O
ef	NN	O
with	IN	O
moderate	JJ	B-PROBLEM
as	IN	I-PROBLEM
and	CC	O
moderate	VB	B-PROBLEM
ms	NN	I-PROBLEM
and	CC	O
mod	NN	B-PROBLEM
pulm	NN	I-PROBLEM
htn	NN	I-PROBLEM
.	.	O

cardiology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
thought	VBN	O
ms	NNS	B-PROBLEM
harold	VBD	O
holcomb	NN	O
to	TO	O
her	PRP$	B-PROBLEM
pulm	NN	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
pulm	NN	B-PROBLEM
htn	NN	I-PROBLEM
.	.	O

cardiology	NN	O
recommended	VBD	O
d/cing	VBG	O
digoxin	NN	B-TREATMENT
and	CC	O
starting	VBG	O
amiodarone	NN	B-TREATMENT
.	.	O

family	NN	O
declined	VBD	O
valvuloplasty	NN	B-TREATMENT
.	.	O

for	IN	O
possible	JJ	O
copd	NN	B-PROBLEM
,	,	O
pt	NN	O
was	VBD	O
started	VBN	O
on	IN	O
steroids	NNS	B-TREATMENT
and	CC	O
nebs	NNS	B-TREATMENT
on	IN	O
08-03	NN	O
.	.	O

pt	NN	O
is	VBZ	O
currently	RB	O
satting	VBG	B-TEST
90s	CD	O
on	IN	O
1	CD	O
l	NN	O
nc	NN	B-TREATMENT
while	IN	O
sitting	VBG	O
in	IN	O
a	DT	O
chair	NN	O
but	CC	O
needs	VBZ	O
more	RBR	B-TREATMENT
o2	JJ	I-TREATMENT
when	WRB	O
supine	NN	O
.	.	O

pt	NN	O
is	VBZ	O
a	DT	O
mouth	NN	O
breather	NN	O
and	CC	O
occasionally	RB	O
needs	VBZ	O
a	DT	B-TREATMENT
face	NN	I-TREATMENT
mask	NN	I-TREATMENT
.	.	O

pt	NN	O
will	MD	O
need	VB	O
i/os	RB	B-TEST
monitored	VBN	O
to	TO	O
goal	NN	O
even	RB	O
to	TO	O
slightly	RB	O
negative	JJ	O
as	IN	O
she	PRP	O
was	VBD	O
diursed	VBN	O
4.8	CD	O
l	NN	O
during	IN	O
her	PRP$	O
cmed	JJ	O
stay	NN	O
.	.	O

depending	VBG	O
on	IN	O
her	PRP	B-TEST
i/o	NN	I-TEST
,	,	O
lasix	NN	B-TREATMENT
and	CC	O
acetazolamide	NN	B-TREATMENT
can	MD	O
be	VB	O
decreased	VBN	O
or	CC	O
discontinued	VBN	O
.	.	O

#	#	O
h/o	NN	O
cad	SYM	B-PROBLEM
-	:	O
there	EX	O
were	VBD	O
new	JJ	O
changes	NNS	O
on	IN	O
ekg	NN	B-TEST
but	CC	O
pt	NN	O
was	VBD	O
ruled	VBN	O
out	RP	O
with	IN	O
3	CD	O
sets	NNS	O
of	IN	O
negative	JJ	O
cardiac	JJ	O
enzymes	NNS	O
.	.	O

pt	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
bb	NN	B-TREATMENT
,	,	O
asa	NN	B-TREATMENT
,	,	O
and	CC	O
nitrates	NNS	B-TREATMENT
.	.	O

#	#	O
acid	NN	O
/	NNP	O
base	NN	O
status	NN	O
-	:	O
respiratory	NN	B-PROBLEM
acidosis	NN	I-PROBLEM
with	IN	O
metabolic	JJ	O
compensation	NN	O
.	.	O

pt	NN	O
failed	VBD	O
bipap	NN	B-TREATMENT
and	CC	O
pco2	NN	B-TEST
remained	VBN	O
in	IN	O
the	DT	O
90s	CD	O
but	CC	O
maintaining	VBG	O
mentation	NN	O
.	.	O

#	#	O
renal	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
-	:	O
baseline	NN	B-TEST
cr	NN	I-TEST
unknown	JJ	O
,	,	O
may	MD	O
have	VB	O
cri	NN	B-PROBLEM
from	IN	O
dm	NN	B-PROBLEM
.	.	O

creatinine	NN	B-TEST
stayed	VBD	O
stable	JJ	O
from	IN	O
1.3-1.5	JJ	O
.	.	O

will	MD	O
need	VB	O
to	TO	O
renally	VB	O
dose	VB	O
all	DT	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

#	#	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM
-	:	O
continued	VBN	O
bb	NN	B-TREATMENT
.	.	O

per	IN	O
cardiology	NN	O
consult	NN	O
recs	NN	O
,	,	O
discontinued	VBN	O
digoxin	NN	B-TREATMENT
and	CC	O
started	VBD	O
amiodarone	NN	B-TREATMENT
.	.	O

due	JJ	O
to	TO	O
elevated	JJ	B-PROBLEM
inr	NN	I-PROBLEM
,	,	O
coumadin	NN	B-TREATMENT
was	VBD	O
held	VBN	O
.	.	O

pt	NN	O
needs	NNS	O
to	TO	O
be	VB	O
on	IN	O
amiodarone	JJ	B-TREATMENT
400mg	CD	O
bid	NN	O
x	VBD	O
7	CD	O
days	NNS	O
(	(	O
loading	VBG	O
dose	NN	O
)	)	O
and	CC	O
then	RB	O
400mg	CD	O
daily	RB	O
for	IN	O
maintenance	NN	O
.	.	O

#	#	O
dm	SYM	B-PROBLEM
-	:	O
insulin	NN	B-TREATMENT
standing	VBG	O
+	NNP	O
hiss	NN	O
,	,	O
fs	NN	O
qid	NN	O

#	#	O
depression	NN	B-PROBLEM
-	:	O
continued	VBD	B-TREATMENT
home	NN	I-TREATMENT
regimen	NNS	I-TREATMENT

#	#	O
f/e/n	SYM	O
-	:	O
npo	NN	O
initially	RB	O
while	IN	O
on	IN	O
bipap	NNS	B-TREATMENT
and	CC	O
now	RB	O
low	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
cardiac	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

#	#	O
ppx	SYM	O
-	:	O
supratherpeutic	JJ	B-PROBLEM
inr	NN	I-PROBLEM

#	#	O
access	NN	O
-	:	O
piv	NN	B-TREATMENT

no	DT	O
pressors	NNS	B-TREATMENT
or	CC	O
central	JJ	B-TREATMENT
line	NN	I-TREATMENT
per	IN	O
hcp	NN	O
.	.	O

coumadin	NN	B-TREATMENT
2.5	CD	O
mg	NN	O
/	VBD	O
3	CD	O
mg	NN	O

insulin	NN	B-TREATMENT
-	:	O
humulin	NN	B-TREATMENT
n	RB	I-TREATMENT
36	CD	O
u	JJ	O
daily	JJ	O
/	$	O
14	CD	O
u	JJ	O
qhs	NN	O

lasix	RB	B-TREATMENT
40	CD	O
mg	NNS	O
bid	NN	O

venlafaxine	NN	B-TREATMENT
xr	$	O
75	CD	O
mg	NN	O
qd	NN	O

sorbitol	NN	B-TREATMENT

metoprolol	NN	B-TREATMENT
25	CD	O
mg	NN	O
bid	NN	O

imdur	NN	B-TREATMENT
30	CD	O
mg	NN	O
qd	NN	O

hydralazine	NN	B-TREATMENT
50	CD	O
mg	NN	O
bid	NN	O

digoxin	NN	B-TREATMENT
0.125	CD	O
qd	NN	O

oscal	JJ	B-TREATMENT
250	CD	O
mg	NN	O
+	NNP	O
d	NN	O

tylenol	NN	B-TREATMENT
prn	NN	O

morphine	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
4	CD	O
mg	NN	O
q2	NN	O
hrs	NN	O
prn	NN	O

1.	CD	O
nph	NN	B-TREATMENT

2.	CD	O
humalog	NN	B-TREATMENT

3.	CD	O
venlafaxine	JJ	B-TREATMENT
37.5	CD	O
mg	NN	O
capsule	NN	O
,	,	O
sust	NN	O
.	.	O
release	VB	O
24	CD	O
hr	JJ	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
,	,	O
sust	NN	O
.	.	O
release	VB	O
24	CD	O
hr	JJ	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

4.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

5.	CD	O
isosorbide	JJ	B-TREATMENT
mononitrate	NN	I-TREATMENT
30	CD	O
mg	NN	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
sustained	VBD	O
release	NN	O
24	CD	O
hr	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

6.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
albuterol	NN	B-TREATMENT
sulfate	VB	I-TREATMENT
0.083	CD	O
%	NN	O
(	(	O
0.83	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
)	)	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

8.	CD	O
ipratropium	NN	B-TREATMENT
bromide	RB	I-TREATMENT
0.02	CD	O
%	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
).	VBP	O

9.	CD	O
albuterol	NN	B-TREATMENT
sulfate	VB	I-TREATMENT
0.083	CD	O
%	NN	O
(	(	O
0.83	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
)	)	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
inhalation	NN	O
q2h	NN	O
(	(	O
every	DT	O
2	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
.	.	O

11.	CD	O
furosemide	JJ	B-TREATMENT
10	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
forty	NN	O
(	(	O
40	CD	O
)	)	O
mg	NN	O
injection	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

12.	CD	O
acetazolamide	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
500	CD	O
mg	NN	O
recon	NN	O
soln	NN	O
sig	NN	O
:	:	O
two	CD	O
hundred	VBD	O
fifty	NNS	O
(	(	O
250	CD	O
)	)	O
recon	NN	O
soln	NN	O
injection	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

13.	CD	O
morphine	NN	B-TREATMENT
2	CD	O
mg	NN	O
/	NNP	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
mg	NN	O
injection	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

14.	CD	O
amiodarone	NN	B-TREATMENT
200	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
7	CD	O
days	NNS	O
.	.	O

15.	CD	O
amiodarone	NN	B-TREATMENT
400	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
:	:	O
after	IN	O
finishing	VBG	O
400mg	CD	O
bid	NN	O
x	VBD	O
6	CD	O
days	NNS	O
.	.	O

diastolic	JJ	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM

aortic	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

mitral	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM

possible	JJ	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

chronic	JJ	B-PROBLEM
kidney	NN	I-PROBLEM
disease	NN	I-PROBLEM

depression	NN	B-PROBLEM

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM

stable	JJ	O
,	,	O
satting	VBG	O
98%	CD	O
on	IN	O
1l	CD	B-TREATMENT
via	IN	I-TREATMENT
nc	NN	I-TREATMENT
,	,	O
sitting	VBG	O
up	RP	O
in	IN	O
a	DT	O
chair	NN	O

please	VB	O
call	VB	O
your	PRP$	O
doctor	NN	O
at	IN	O
the	DT	O
rehabilitation	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
any	DT	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
concerning	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

please	VB	O
take	VB	O
medications	NNS	B-TREATMENT
as	IN	O
instructed	VBN	O
.	.	O

gastric	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM

gastric	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM

hypothyroidism	NN	B-PROBLEM
following	VBG	O
near	IN	B-TREATMENT
total	JJ	I-TREATMENT
thyroidectomy	NN	I-TREATMENT
.	.	O

on	IN	O
1/12/92	CD	O
near	IN	B-TREATMENT
total	JJ	I-TREATMENT
gastrectomy	NN	I-TREATMENT
with	IN	O
retrocolic	JJ	B-TREATMENT
bill-roth	JJ	I-TREATMENT
ii	NN	I-TREATMENT
gastrojejunostomy	NN	I-TREATMENT
,	,	O
portal	JJ	B-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
repair	NN	B-TREATMENT
of	IN	O
ventral	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
,	,	O
and	CC	O
needle	JJ	B-TREATMENT
jejunostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

ms.	NN	O
tikrhalt	NN	O
is	VBZ	O
an	DT	O
86	CD	O
year	NN	O
old	JJ	O
female	NN	O
,	,	O
previously	RB	O
healthy	JJ	O
,	,	O
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	O
3	CD	O
month	NN	O
history	NN	O
of	IN	O
dysphagia	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
subsequent	JJ	I-TEST
workup	NN	I-TEST
including	VBG	O
upper	JJ	B-TEST
gastrointestinal	JJ	I-TEST
series	NN	I-TEST
and	CC	O
abdominal	JJ	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
suggested	VBD	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

endoscopy	NN	B-TEST
with	IN	O
biopsy	NN	B-TEST
revealed	VBN	O
gastric	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
poorly	RB	O
differentiated	VBN	O
,	,	O
within	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
stomach	NN	O
along	IN	O
the	DT	O
greater	JJR	O
curvature	NN	O
.	.	O

she	PRP	O
was	VBD	O
subsequently	RB	O
referred	VBN	O
to	TO	O
dr.	VB	O
ko	NN	O
for	IN	O
a	DT	O
possible	JJ	O
resection	NN	B-TREATMENT
of	IN	O
this	DT	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

she	PRP	O
reports	VBZ	O
a	DT	B-PROBLEM
10	CD	I-PROBLEM
pound	NN	I-PROBLEM
weight	VBD	I-PROBLEM
loss	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
an	DT	B-TREATMENT
appendectomy	NN	I-TREATMENT
in	IN	O
the	DT	O
distant	JJ	O
past	NN	O
,	,	O
cholecystectomy	NN	B-TREATMENT
in	IN	O
the	DT	O
past	JJ	O
,	,	O
history	NN	O
of	IN	O
of	IN	O
cesarean	JJ	B-TREATMENT
section	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
and	CC	O
a	DT	O
history	NN	O
of	IN	O
near	JJ	B-TREATMENT
total	JJ	I-TREATMENT
thyroidectomy	NN	I-TREATMENT
for	IN	O
nodular	JJ	B-PROBLEM
goiter	NN	I-PROBLEM
in	IN	O
the	DT	O
past	NN	O
.	.	O

her	PRP$	B-TREATMENT
only	JJ	I-TREATMENT
medication	NN	I-TREATMENT
is	VBZ	O
thyrolar	JJ	B-TREATMENT
for	IN	O
her	PRP$	B-PROBLEM
relative	JJ	I-PROBLEM
hypothyroidism	NN	I-PROBLEM
following	VBG	O
resection	NN	B-TREATMENT
.	.	O

there	EX	O
is	VBZ	O
a	DT	O
question	NN	O
of	IN	O
an	DT	B-PROBLEM
allergy	NN	I-PROBLEM
to	TO	O
tylenol	VB	B-TREATMENT
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

interestingly	RB	O
,	,	O
she	PRP	O
reports	VBZ	O
that	IN	O
both	DT	O
her	PRP$	O
mother	NN	O
and	CC	O
father	NN	O
died	VBD	O
of	IN	O
stomach	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
she	PRP	O
is	VBZ	O
an	DT	O
elderly	JJ	O
but	CC	O
spry	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	O
sclera	NN	O
were	VBD	O
nonicteric	JJ	B-PROBLEM
.	.	O

her	PRP$	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
masses	NNS	B-PROBLEM
or	CC	O
bruits	NNS	B-PROBLEM
noted	VBN	O
.	.	O

her	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

her	PRP$	B-TEST
cardiac	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

examination	NN	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
abdomen	NNS	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
flat	JJ	I-PROBLEM
nontender	NN	I-PROBLEM
abdomen	NNS	I-PROBLEM
without	IN	O
palpable	JJ	B-PROBLEM
masses	NNS	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
multiple	JJ	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
surgical	JJ	I-PROBLEM
scars	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
cva	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
or	CC	O
spinal	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
noted	VBD	O
.	.	O

her	PRP$	B-TEST
pulses	NNS	I-TEST
were	VBD	O
intact	JJ	O
throughout	IN	O
.	.	O

sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
3.7	CD	O
and	CC	O
bun	NN	B-TEST
of	IN	O
19	CD	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
37.2	CD	O
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
of	IN	O
6.6	CD	O
.	.	O

her	PRP$	B-TEST
bilirubin	NN	I-TEST
direct	NN	I-TEST
and	CC	O
total	JJ	B-TEST
were	VBD	O
0.1	CD	O
and	CC	O
0.3	CD	O
respectively	RB	O
.	.	O

her	PRP$	B-TEST
alkaline	JJ	I-TEST
phosphatase	NN	I-TEST
was	VBD	O
134	CD	O
.	.	O

her	PRP$	B-TEST
electrocardiogram	NN	I-TEST
demonstrated	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
without	IN	O
acute	JJ	B-PROBLEM
ischemic	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	B-TEST
assessment	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
was	VBD	O
that	IN	O
of	IN	O
an	DT	O
86	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
poorly	RB	B-PROBLEM
differentiated	VBN	I-PROBLEM
gastric	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
,	,	O
admitted	VBN	O
for	IN	O
resection	NN	B-TREATMENT
.	.	O

on	IN	O
1/12/92	CD	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
neart	JJ	I-TREATMENT
total	JJ	I-TREATMENT
gastrectomy	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
retrocolic	JJ	I-TREATMENT
bill-roth	JJ	I-TREATMENT
ii	NN	I-TREATMENT
gastrojejunostomy	NN	I-TREATMENT
reconstruction	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
ventral	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
upon	IN	O
abdominal	JJ	B-TEST
exploration	NN	I-TEST
within	IN	O
a	DT	B-TREATMENT
previous	JJ	I-TREATMENT
surgical	JJ	I-TREATMENT
incision	NN	I-TREATMENT
.	.	O

this	DT	O
was	VBD	O
repaired	VBN	B-TREATMENT
.	.	O

a	DT	B-TREATMENT
needle	JJ	I-TREATMENT
jejunostomy	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
her	PRP$	B-TREATMENT
operation	NN	I-TREATMENT
to	TO	O
facilitate	VB	O
postoperative	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
.	.	O

with	IN	O
regards	NNS	O
to	TO	O
the	DT	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
mass	NN	I-PROBLEM
along	IN	O
the	DT	O
greater	JJR	O
curvature	NN	O
in	IN	O
the	DT	O
body	NN	O
of	IN	O
the	DT	O
stomach	NN	O
,	,	O
and	CC	O
several	JJ	O
perigastric	JJ	O
lymph	NN	O
nodes	NNS	O
which	WDT	O
were	VBD	O
taken	VBN	O
with	IN	O
the	DT	B-TEST
specimen	NNS	I-TEST
.	.	O

in	IN	O
addition	NN	O
,	,	O
there	EX	O
were	VBD	O
at	IN	O
least	JJS	O
two	CD	O
lymph	JJ	O
nodes	NNS	O
within	IN	O
the	DT	O
porta	NN	O
hepatis	NN	O
which	WDT	O
were	VBD	O
dissected	VBN	B-TREATMENT
free	JJ	I-TREATMENT
and	CC	O
taken	VBN	O
en	JJ	O
bloc	NN	O
with	IN	O
the	DT	B-TEST
specimen	NNS	I-TEST
.	.	O

the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
abdomen	NNS	O
was	VBD	O
unremarkable	JJ	O
without	IN	O
evidence	NN	O
of	IN	O
metastatic	JJ	B-PROBLEM
spread	NN	I-PROBLEM
elsewhere	RB	O
,	,	O
including	VBG	O
the	DT	O
liver	NN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
recovery	NN	O
room	NN	O
in	IN	O
good	JJ	O
condition	NN	O
.	.	O

her	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
healed	VBN	O
well	RB	O
without	IN	O
incident	NN	O
and	CC	O
the	DT	B-TREATMENT
needle	JJ	I-TREATMENT
jejunostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
utilized	VBN	O
on	IN	O
the	DT	O
first	JJ	O
postoperative	JJ	O
day	NN	O
right	VBD	O
up	RB	O
until	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
infusing	VBG	O
vivonex	NNS	B-TREATMENT
t.e.n.	NN	I-TREATMENT

the	DT	O
patient	NN	O
tolerated	VBD	O
this	DT	O
without	IN	O
difficulty	NN	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
's	POS	I-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
3rd	CD	O
postoperative	JJ	O
day	NN	O
,	,	O
and	CC	O
with	IN	O
the	DT	O
passage	NN	O
of	IN	O
flatus	NN	O
and	CC	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
noted	VBD	O
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
liquid	NN	I-TREATMENT
diet	NN	I-TREATMENT
which	WDT	O
was	VBD	O
advanced	JJ	O
slowly	RB	O
.	.	O

as	IN	O
mentioned	VBN	O
,	,	O
her	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
healed	VBN	O
well	RB	O
without	IN	O
incident	NN	O
and	CC	O
the	DT	B-TREATMENT
staples	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
10th	JJ	O
postoperative	JJ	O
day	NN	O
just	RB	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
difficulties	NNS	I-PROBLEM
with	IN	O
confusion	NN	B-PROBLEM
in	IN	O
the	DT	O
early	JJ	O
postoperative	NN	O
period	NN	O
which	WDT	O
were	VBD	O
attributable	JJ	O
to	TO	O
her	PRP$	O
advanced	JJ	O
age	NN	O
and	CC	O
a	DT	B-PROBLEM
sundowning	JJ	I-PROBLEM
effect	NN	I-PROBLEM
.	.	O

surgical	JJ	O
pathology	NN	O
report	NN	O
was	VBD	O
completed	VBN	O
prior	JJ	O
to	TO	O
discharge	VB	O
which	WDT	O
revealed	VBD	O
poorly	RB	B-PROBLEM
differentiated	VBN	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
ulcerating	NN	O
and	CC	O
extending	VBG	O
through	IN	O
the	DT	O
wall	NN	O
into	IN	O
the	DT	O
serosa	NN	O
of	IN	O
the	DT	O
stomach	NN	O
.	.	O

metastatic	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
was	VBD	O
present	JJ	O
in	IN	O
3	CD	O
of	IN	O
3	CD	O
lymph	NN	O
nodes	NNS	O
.	.	O

the	DT	O
gastric	JJ	O
resection	NN	O
margins	NNS	O
were	VBD	O
free	JJ	O
of	IN	O
carcinoma	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
she	PRP	O
complained	VBD	O
of	IN	O
some	DT	B-PROBLEM
dysuria	NNS	I-PROBLEM
,	,	O
a	DT	B-TEST
urine	JJ	I-TEST
specimen	NN	I-TEST
was	VBD	O
obtained	VBN	O
,	,	O
which	WDT	O
showed	VBD	O
numerous	JJ	B-PROBLEM
white	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
empirically	RB	O
on	IN	O
bactrim	NNS	B-TREATMENT
,	,	O
while	IN	O
culture	NN	B-TEST
and	CC	O
sensitivity	NN	B-TEST
results	NNS	O
were	VBD	O
pending	VBG	O
and	CC	O
remained	VBD	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
.	.	O

bactrim	NN	B-TREATMENT
,	,	I-TREATMENT
single	JJ	I-TREATMENT
strength	NN	I-TREATMENT
,	,	O
one	CD	O
p.o.	NN	O
b.i.d.	NN	O
times	NNS	O
10	CD	O
days	NNS	O
,	,	O
initiated	VBD	O
9/27/92	CD	O
,	,	O
synthroid	VBD	B-TREATMENT
0.1	CD	O
mg	NN	O
p.o.	NN	O
q.day	NN	O
,	,	O
ferrous	JJ	B-TREATMENT
gluconate	NN	I-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
and	CC	O
folate	VB	B-TREATMENT
1	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

she	PRP	O
will	MD	O
be	VB	O
seen	VBN	O
by	IN	O
visiting	VBG	O
nurses	NNS	O
association	NN	O
to	TO	O
help	VB	O
with	IN	O
general	JJ	O
aspects	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
as	RB	O
well	RB	O
as	IN	O
adequate	JJ	O
diet	JJ	O
planning	NN	O
following	VBG	O
her	PRP$	B-TREATMENT
gastric	JJ	I-TREATMENT
resection	NN	I-TREATMENT
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

on	IN	O
2019-04-12	JJ	O
he	PRP	O
was	VBD	O
transfused	VBN	O
with	IN	O
2	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
due	JJ	O
to	TO	O
post-operative	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
.	.	O

mr.	JJ	O
minton	NNP	O
did	VBD	O
not	RB	O
get	VB	O
his	PRP$	B-TREATMENT
ivig	NN	I-TREATMENT
until	IN	O
2019-04-14	JJ	O
.	.	O

the	DT	B-TREATMENT
infusion	NN	I-TREATMENT
was	VBD	O
completed	VBN	O
without	IN	O
incidence	NN	O
.	.	O

he	PRP	O
remained	VBD	O
stable	JJ	O
with	IN	O
his	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
and	CC	O
lab	NN	B-TEST
data	NNS	I-TEST
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

2019-04-15	JJ	O
09:25	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
3.8	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
2.88	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
25.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
30.9	CD	O
mchc	SYM	B-TEST
-	:	O
34.3	CD	O
rdw	NN	B-TEST
-	:	O
16.4	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
194	CD	O

2019-04-14	JJ	O
08:50	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
6.5	CD	O
rbc	NN	B-TEST
-	:	O
3.02	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.4	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.1*	CD	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
31.0	CD	O
mchc	SYM	B-TEST
-	:	O
34.6	CD	O
rdw	NN	B-TEST
-	:	O
16.3	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
169	CD	O

2019-04-13	JJ	O
08:40	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
6.7	CD	O
rbc	NN	B-TEST
-	:	O
3.07	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
30.4	CD	O
mchc	SYM	B-TEST
-	:	O
34.5	CD	O
rdw	NN	B-TEST
-	:	O
16.2	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
144	CD	O
*	NN	O

2019-04-12	JJ	O
08:00	CD	O
pm	NN	O
blood	NN	B-TEST
hct	SYM	I-TEST
-	:	O
26.5	CD	O
*	NN	O

2019-04-12	JJ	O
06:35	CD	O
am	VBP	O
blood	NN	B-TEST
hct	NN	I-TEST
-	:	O
23.6	CD	O
*	NN	O

2019-04-11	JJ	O
12:55	CD	O
pm	NN	O
blood	NN	B-TEST
hct	SYM	I-TEST
-	:	O
27.1	CD	O
*	NN	O

2019-04-11	JJ	O
09:50	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
4.8	CD	O
rbc	NN	B-TEST
-	:	O
3.02	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
89	CD	O
mch	SYM	B-TEST
-	:	O
31.4	CD	O
mchc	SYM	B-TEST
-	:	O
35.5	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.2	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
103	CD	O
*	NN	O

2019-04-11	JJ	O
06:27	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
4.4	CD	O
rbc	NN	B-TEST
-	:	O
3.03	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
26.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
31.2	CD	O
mchc	SYM	B-TEST
-	:	O
35.4	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
14.7	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
94	CD	O
*	NN	O

2019-04-10	JJ	O
06:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
4.6	CD	O
rbc	NN	B-TEST
-	:	O
2.81	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
8.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
24.8	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
31.7	CD	O
mchc	SYM	B-TEST
-	:	O
36.0	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.2	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
95	CD	O
*	NN	O

2019-04-09	JJ	O
06:45	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
5.0	CD	O
rbc	NN	B-TEST
-	:	O
3.33	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.4	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
29.2	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
31.2	CD	O
mchc	SYM	B-TEST
-	:	O
35.5	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
72	CD	O
*	NN	O

2019-04-08	JJ	O
12:27	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
4.9	CD	O
rbc	NN	B-TEST
-	:	O
3.11	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
27.1	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
87	CD	O
mch	SYM	B-TEST
-	:	O
32.0	CD	O
mchc	SYM	B-TEST
-	:	O
36.6	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
15.5	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
107	CD	O
*	NN	O

2019-04-07	JJ	O
04:53	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	I-TEST
-	:	O
4.4	CD	O
rbc	NN	B-TEST
-	:	O
2.92	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.6	CD	O
*#	NN	O
hct	NN	B-TEST
-	:	O
25.8	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
88	CD	O
mch	SYM	B-TEST
-	:	O
32.8	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
37.1	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
14.9	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
81	CD	O
*	NN	O

2019-04-07	JJ	O
11:00	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
4.4	CD	O
rbc	NN	B-TEST
-	:	O
2.34	CD	O
*#	NN	O
hgb	NN	B-TEST
-	:	O
7.5	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
21.2	CD	O
*#	NN	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
32.1	CD	O
*	NN	O
mchc	SYM	B-TEST
-	:	O
35.4	CD	O
*	NN	O
rdw	NN	B-TEST
-	:	O
14.5	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
94	CD	O
*	NN	O

2019-04-07	JJ	O
06:00	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
3.2	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
3.14	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.0	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
28.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
92	CD	O
mch	SYM	B-TEST
-	:	O
32.0	CD	O
mchc	SYM	B-TEST
-	:	O
34.8	CD	O
rdw	NN	B-TEST
-	:	O
14.1	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
82	CD	O
*#	NN	O

2019-04-06	JJ	O
10:40	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	I-TEST
-	:	O
2.1	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.51	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
10.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
31.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
90	CD	O
mch	SYM	B-TEST
-	:	O
31.1	CD	O
mchc	SYM	B-TEST
-	:	O
34.5	CD	O
rdw	NN	B-TEST
-	:	O
14.3	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
50	CD	O
*	NN	O

2019-04-15	JJ	O
09:25	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	I-TEST
ct	VBD	I-TEST
-	:	O
194	CD	O

2019-04-14	JJ	O
08:50	CD	O
am	VBP	O
blood	NN	B-TEST
plt	NN	I-TEST
ct	VBD	I-TEST
-	:	O
169	CD	O

2019-04-14	JJ	O
08:50	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	I-TEST
-	:	O
12.0	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.0	CD	O

2019-04-15	JJ	O
09:25	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	I-TEST
-	:	O
134	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
19	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
na	SYM	B-TEST
-	:	O
135	CD	O
k	SYM	B-TEST
-	:	O
3.5	CD	O
cl	NN	B-TEST
-	:	O
100	CD	O
hco3	NN	B-TEST
-	:	O
28	CD	O
angap	NN	B-TEST
-	:	O
11	CD	O

1.	CD	O
cholecalciferol	NN	B-TREATMENT
(	(	I-TREATMENT
vitamin	JJ	I-TREATMENT
d3	NN	I-TREATMENT
)	)	I-TREATMENT
400	CD	O
unit	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

3.	CD	O
lorazepam	JJ	B-TREATMENT
0.5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
anxiety	NN	B-PROBLEM
.	.	O

4.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
).	VBP	O

5.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

8.	CD	O
enoxaparin	JJ	B-TREATMENT
30	CD	O
mg	NN	O
/	VBD	O
0.3	CD	O
ml	NN	O
syringe	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
subcutaneous	JJ	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
4	CD	O
weeks	NNS	O
.	.	O

9.	CD	O
oxycodone	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
q4-6h	NN	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

10.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
daily	JJ	O
(	(	O
daily	RB	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

11.	CD	O
magnesium	NN	B-TREATMENT
hydroxide	NN	I-TREATMENT
400	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	JJ	O
suspension	NN	O
sig	NN	O
:	:	O
thirty	NN	O
(	(	O
30	CD	O
)	)	O
ml	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

12.	CD	O
trazodone	NN	B-TREATMENT
50	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
hs	NN	O
(	(	O
at	IN	O
bedtime	NN	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
insomnia	NN	B-PROBLEM
.	.	O

end-stage	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

end-stage	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
right	JJ	B-TREATMENT
nephrectomy	NN	I-TREATMENT
.	.	O

2.	CD	O
cadaveric	JJ	B-TREATMENT
renal	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

3.	CD	O
acute	JJ	B-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

4.	CD	O
transplant	JJ	B-TREATMENT
nephrectomy	NN	I-TREATMENT
.	.	O

5.	CD	O
pulmonary	JJ	B-PROBLEM
emboli	NN	I-PROBLEM
.	.	O

6.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

7.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

8.	CD	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

9.	CD	O
hypercoagulable	JJ	B-PROBLEM
state	NN	I-PROBLEM
.	.	O

10.	CD	O
perforated	JJ	B-PROBLEM
viscus	NN	I-PROBLEM
.	.	O

11.	CD	O
abdominal	JJ	B-PROBLEM
abscesses	NNS	I-PROBLEM
.	.	O

12.	CD	O
sepsis	NN	B-PROBLEM
.	.	O

13.	CD	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
53-year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
longstanding	JJ	O
history	NN	O
of	IN	O
renal	JJ	B-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
and	CC	O
problems	NNS	B-PROBLEM
related	VBN	O
to	TO	O
vascular	JJ	O
access	NN	O
and	CC	O
hypercoagulable	JJ	B-PROBLEM
state	NN	I-PROBLEM
.	.	O

these	DT	O
culminated	VBN	O
in	IN	O
an	DT	B-TREATMENT
attempted	JJ	I-TREATMENT
cadaveric	NN	I-TREATMENT
kidney	NN	I-TREATMENT
transplant	NN	I-TREATMENT
undertaken	VBN	O
on	IN	O
12/16/97	CD	O
,	,	O
which	WDT	O
was	VBD	O
complicated	VBN	O
by	IN	O
thrombosis	NN	B-PROBLEM
and	CC	O
necrosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
cadaveric	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
within	IN	O
24	CD	O
hours	NNS	O
.	.	O

this	DT	O
required	VBD	O
a	DT	B-TREATMENT
transplant	JJ	I-TREATMENT
nephrectomy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
&apos;s	NNP	O
course	NN	O
was	VBD	O
subsequently	RB	O
characterized	VBN	O
by	IN	O
recurrent	NN	B-PROBLEM
pneumonias	NN	I-PROBLEM
,	,	O
possibly	RB	O
due	JJ	O
to	TO	O
aspiration	NN	B-PROBLEM
,	,	O
and	CC	O
by	IN	O
hemodynamic	JJ	B-PROBLEM
instability	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
from	IN	O
the	DT	O
transplant	NN	O
service	NN	O
for	IN	O
ventilatory	JJ	B-TREATMENT
management	NN	I-TREATMENT
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
hypotension	NN	B-PROBLEM
.	.	O

on	IN	O
transfer	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
not	RB	O
sedated	VBN	B-TREATMENT
,	,	O
but	CC	O
was	VBD	O
unresponsive	JJ	B-PROBLEM
and	CC	O
extremely	RB	B-PROBLEM
dyssynchronous	JJ	I-PROBLEM
with	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
substantial	JJ	B-PROBLEM
auto	NN	I-PROBLEM
peep	NN	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
elevated	VBN	I-PROBLEM
dead	JJ	I-PROBLEM
space	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
pulmonary	JJ	I-TEST
arteriogram	NN	I-TEST
on	IN	O
01/03/98	CD	O
demonstrated	JJ	O
multiple	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
emboli	NN	I-PROBLEM
,	,	O
likely	RB	O
less	JJR	O
than	IN	O
one	CD	O
week	NN	O
old	JJ	O
,	,	O
possibly	RB	O
introduced	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
the	DT	B-PROBLEM
renal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
of	IN	O
12/19/97	CD	O
.	.	O

an	DT	B-TREATMENT
inferior	JJ	I-TREATMENT
vena	NN	I-TREATMENT
cava	NN	I-TREATMENT
filter	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
;	:	O
lower	JJR	B-TEST
extremity	NN	I-TEST
noninvasive	JJ	I-TEST
studies	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
required	VBN	O
high	JJ	B-TREATMENT
pressures	NNS	I-TREATMENT
to	TO	O
ventilate	VB	O
adequately	RB	O
,	,	O
possibly	RB	O
related	VBN	O
to	TO	O
an	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
compartment	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
undergone	JJ	O
two	CD	B-TREATMENT
abdominal	JJ	I-TREATMENT
procedures	NNS	I-TREATMENT
following	VBG	O
explantation	NN	O
.	.	O

the	DT	O
physiology	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
septic	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

ct	JJ	B-TEST
scan	JJ	I-TEST
demonstrated	VBN	O
retroperitoneal	JJ	B-PROBLEM
collection	NN	I-PROBLEM
containing	VBG	O
both	DT	O
free	JJ	B-PROBLEM
air	NN	I-PROBLEM
and	CC	O
extravasated	VBD	B-PROBLEM
contrast	NN	I-PROBLEM
material	NN	I-PROBLEM
.	.	O

for	IN	O
the	DT	O
concern	NN	O
of	IN	O
a	DT	B-PROBLEM
perforated	JJ	I-PROBLEM
viscus	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
on	IN	O
01/06/98	CD	O
,	,	O
during	IN	O
which	WDT	O
the	DT	O
bowel	NN	O
was	VBD	O
run	VBN	O
without	IN	O
evidence	NN	O
of	IN	O
perforation	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
unstable	JJ	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
fluoroscopy	VB	B-TEST
,	,	O
where	WRB	O
oral	JJ	B-TEST
contrast	NN	I-TEST
was	VBD	O
demonstrated	VBN	O
to	TO	O
be	VB	O
extravasating	VBG	O
through	IN	O
a	DT	O
posterior	JJ	O
duodenum	NN	O
.	.	O

for	IN	O
this	DT	O
reason	NN	O
,	,	O
he	PRP	O
was	VBD	O
taken	VBN	O
again	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
01/08/98	CD	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
a	DT	B-TREATMENT
gastrojejunostomy	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
with	IN	O
stapling	VBG	B-TREATMENT
across	IN	I-TREATMENT
the	DT	I-TREATMENT
gastroduodenal	JJ	I-TREATMENT
junction	NN	I-TREATMENT
,	,	O
introduction	NN	O
of	IN	O
five	CD	B-TREATMENT
jackson-pratt	JJ	I-TREATMENT
drains	NNS	I-TREATMENT
into	IN	O
the	DT	B-PROBLEM
retroperitoneal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
cholecystotomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
,	,	O
gastrostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
,	,	O
and	CC	O
jejunostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
extensive	JJ	I-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
requiring	VBG	O
multiple	JJ	B-TREATMENT
blood	NN	I-TREATMENT
products	NNS	I-TREATMENT
and	CC	O
fluid	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

accompanying	VBG	O
this	DT	O
during	IN	O
this	DT	O
period	NN	O
were	VBD	O
elevations	NNS	B-PROBLEM
in	IN	O
liver	NN	B-TEST
function	NN	I-TEST
studies	NNS	I-TEST
and	CC	O
amylase	NN	B-TEST
and	CC	O
lipase	NN	B-TEST
consistent	NN	O
with	IN	O
pancreatic	JJ	B-PROBLEM
inflammation	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
aggressively	RB	O
treated	VBN	O
with	IN	O
fluid	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
and	CC	O
pressors	NNS	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
septic	JJ	I-PROBLEM
physiology	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
cardiac	JJ	B-PROBLEM
tamponade	NN	I-PROBLEM
or	CC	O
specific	JJ	B-PROBLEM
underlying	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
appropriate	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
serratia	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
for	IN	O
his	PRP$	B-PROBLEM
abdominal	JJ	I-PROBLEM
process	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
felt	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
underlying	VBG	I-PROBLEM
hypercoagulable	JJ	I-PROBLEM
state	NN	I-PROBLEM
,	,	O
thought	VBD	O
to	TO	O
be	VB	O
the	DT	O
source	NN	O
for	IN	O
the	DT	B-PROBLEM
repeated	JJ	I-PROBLEM
clots	NNS	I-PROBLEM
.	.	O

because	IN	O
of	IN	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
however	RB	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
full	JJ	B-TREATMENT
heparinization	NN	I-TREATMENT
would	MD	O
not	RB	O
be	VB	O
prudent	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
pneumo-boots	NNS	B-TREATMENT
and	CC	O
subcutaneous	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

attention	NN	O
was	VBD	O
paid	VBN	O
to	TO	O
a	DT	O
variety	NN	O
of	IN	O
metabolic	JJ	B-PROBLEM
and	CC	I-PROBLEM
electrolyte	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
which	WDT	O
were	VBD	O
corrected	VBN	O
appropriately	RB	O
.	.	O

nonetheless	RB	O
,	,	O
mr.	NN	O
less	JJR	O
continued	VBD	O
to	TO	O
remain	VB	O
critically	RB	B-PROBLEM
ill	VB	I-PROBLEM
with	IN	O
only	JJ	O
very	RB	O
transient	JJ	O
mild	NN	O
improvement	NN	O
with	IN	O
drainage	NN	B-TREATMENT
of	IN	O
additional	JJ	B-PROBLEM
retroperitoneal	NN	I-PROBLEM
fluid	NN	I-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
pressor	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
dependent	JJ	B-PROBLEM
upon	IN	O
mechanical	JJ	B-TREATMENT
ventilatory	NN	I-TREATMENT
assistance	NN	I-TREATMENT
.	.	O

his	PRP$	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
requiring	VBG	O
cardioversion	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
an	DT	B-PROBLEM
ongoing	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
for	IN	O
high	JJ	B-TREATMENT
volume	NN	I-TREATMENT
resuscitation	NN	I-TREATMENT
and	CC	O
was	VBD	O
persistently	RB	B-PROBLEM
acidotic	JJ	I-PROBLEM
despite	IN	O
cv-vvh	NN	B-TREATMENT
in	IN	O
the	DT	O
face	NN	O
of	IN	O
bicarbonate	JJ	B-TREATMENT
replenishment	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
also	RB	O
appeared	VBD	O
to	TO	O
have	VB	O
stool	NN	O
from	IN	O
his	PRP$	B-PROBLEM
jackson-pratt	JJ	I-PROBLEM
site	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
oblique	NN	I-PROBLEM
incision	NN	I-PROBLEM
.	.	O

bloody	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
his	PRP$	B-PROBLEM
increasingly	RB	I-PROBLEM
distended	VBN	I-PROBLEM
abdomen	NNS	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
continued	VBN	O
massive	JJ	B-PROBLEM
retroperitoneal	NN	I-PROBLEM
contamination	NN	I-PROBLEM
and	CC	O
probable	JJ	O
multiple	JJ	B-PROBLEM
enteric	JJ	I-PROBLEM
fistulae	NN	I-PROBLEM
from	IN	O
an	DT	B-PROBLEM
ischemic	JJ	I-PROBLEM
bowel	NN	I-PROBLEM
.	.	O

dr.	NN	O
cantsleddjesc	NN	O
felt	VBD	O
that	IN	O
no	DT	O
surgical	JJ	B-TREATMENT
approach	NN	I-TREATMENT
to	TO	O
this	DT	B-PROBLEM
problem	NN	I-PROBLEM
or	CC	O
further	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
or	CC	O
radiologic	NN	B-TREATMENT
procedures	NNS	I-TREATMENT
would	MD	O
be	VB	O
helpful	JJ	O
.	.	O

all	DT	O
physicians	NNS	O
and	CC	O
the	DT	O
family	NN	O
were	VBD	O
in	IN	O
agreement	NN	O
that	IN	O
the	DT	O
most	RBS	O
appropriate	JJ	O
approach	NN	O
was	VBD	O
to	TO	O
institute	VB	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
.	.	O

+loc	NN	B-PROBLEM
,	,	O
gcs:14	NN	B-TEST
.	.	O

she	PRP	O
brought	VBD	O
by	IN	O
ems	NNS	O
to	TO	O
nantucket	VB	O
cottage	NN	O
hospital	NN	O
for	IN	O
furher	JJR	B-TEST
evaluation	NN	I-TEST
.	.	O

2.	CD	O
h/o	NN	O
depression	NN	B-PROBLEM

3.	CD	O
?	.	O
h/o	NN	O
hypomania	NN	B-PROBLEM

4.	CD	O
l5-s1	JJ	B-PROBLEM
spondylolisthesis	NN	I-PROBLEM

all	DT	O
:	:	O
no	DT	O
known	JJ	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM

o	NN	O
:	:	O
t	NN	B-TEST
:	:	O
100.1	CD	O
bp	NN	B-TEST
:	:	O
162/84	CD	O
hr	NN	B-TEST
:	:	O
80	CD	O
rr	NN	B-TEST
:	:	O
20	CD	O
o2sats	NNS	B-TEST
:	:	O
100	CD	O

gen	NN	O
:	:	O
lying	NN	O
in	IN	O
strecther	NN	O
,	,	O
nad	RB	B-PROBLEM
,	,	O
shaking	VBG	B-PROBLEM
om	JJ	I-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

heent	NN	O
:	:	O
neck	NN	O
supple	NN	O
,	,	O
right	RB	O
cmed	VBN	O
ccu	JJ	O
ecchymotic	JJ	B-PROBLEM
and	CC	O
edematous	JJ	B-PROBLEM
,	,	O
c-collor	NN	B-TREATMENT
in	IN	O
place	NN	O
.	.	O

abd	NN	O
:	:	O
soft	JJ	O
,	,	O
nt	JJ	B-PROBLEM
,	,	O
bs+	NN	O

extrem	NN	O
:	:	O
cool	NN	O
,	,	O
no	DT	O
c/c/e	NN	B-PROBLEM
.	.	O

mental	JJ	O
status	NN	O
:	:	O
awake	NN	O
and	CC	O
alert	NN	O
,	,	O
cooperative	JJ	O
with	IN	O
exam	JJ	B-TEST
,	,	O
normal	JJ	O
affect	NN	O
.	.	O

no	DT	O
dysarthria	NN	B-PROBLEM
or	CC	O
paraphasic	JJ	B-PROBLEM
errors	NNS	I-PROBLEM
.	.	O

visual	JJ	O
fields	NNS	O
are	VBP	O
full	JJ	O
to	TO	O
confrontation	NN	B-TEST
.	.	O

iii	NN	O
,	,	O
iv	NN	O
,	,	O
vi:	FW	O
extraocular	JJ	O
movements	NNS	O
intact	JJ	O
bilaterally	RB	O
without	IN	O
nystagmus	NN	B-PROBLEM
.	.	O

viii:	NN	O
hearing	VBG	O
intact	JJ	O
to	TO	O
finger	VB	B-TEST
rub	VB	I-TEST
bilaterally	RB	O
.	.	O

xii:	JJ	O
tongue	NN	O
midline	NN	O
without	IN	O
fasciculations	NNS	B-PROBLEM
.	.	O

no	DT	O
abnormal	JJ	B-PROBLEM
movements	NNS	I-PROBLEM
,	,	O
tremors	NNS	B-PROBLEM
.	.	O

strength	NN	B-TEST
full	JJ	O
power	NN	O
05-31	JJ	O
execept	NN	O
right	JJ	O
dubord	NN	O
03-31	NN	O
.	.	O

no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM

sensation	NN	B-TEST
:	:	O
intact	JJ	O
to	TO	O
light	JJ	B-TEST
touch	NN	I-TEST
,	,	O
propioception	NN	B-TEST
,	,	O
pinprick	JJ	B-TEST
execept	NN	O
decreased	VBN	B-PROBLEM
sensation	NN	I-PROBLEM
l5-s1	JJ	I-PROBLEM
distrubution	NN	I-PROBLEM
.	.	O

reflexes	NNS	B-TEST
:	:	O

right	NN	O
:	:	O
b	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
t	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
br	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
pa	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
ac	SYM	B-TEST
-	:	O
2	CD	O

left	NN	O
:	:	O
b	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
t	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
br	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
pa	SYM	B-TEST
-	:	O
2	CD	O
;	:	O
ac	SYM	B-TEST
-	:	O
2	CD	O

coordination	NN	O
:	:	O
normal	JJ	O
finger-nose-finger	NN	B-TEST

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
urine	JJ	B-TEST
color	NN	I-TEST
-	:	O
yellow	NN	O
appear	VBP	B-TEST
-	:	O
clear	JJ	O
sp	NN	B-TEST
stickney	NN	I-TEST
-	:	O
1.032	CD	O

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
urine	JJ	B-TEST
blood	NN	I-TEST
-	:	O
neg	NN	O
nitrite	JJ	B-TEST
-	:	O
neg	NN	O
protein	SYM	B-TEST
-	:	O
tr	NN	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
50	CD	O
bilirubin	SYM	B-TEST
-	:	O
neg	NN	O
urobilngn	JJ	B-TEST
-	:	O
1	CD	O
ph	NN	B-TEST
-	:	O
7.0	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
urine	JJ	B-TEST
rbc-	JJ	I-TEST
0-2	JJ	O
wbc	NN	B-TEST
-	:	O
0	CD	O
bacteria	NNS	B-TEST
-	:	O
none	NN	O
yeast	SYM	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
0-2	NN	O

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
wbc	JJ	B-TEST
-	:	O
5.0	CD	O
rbc	NN	B-TEST
-	:	O
4.23	CD	O
hgb	NN	B-TEST
-	:	O
13.4	CD	O
hct	NN	B-TEST
-	:	O
38.5	CD	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
31.8	CD	O
mchc	SYM	B-TEST
-	:	O
34.9	CD	O
rdw	NN	B-TEST
-	:	O
12.7	CD	O

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
plt	JJ	B-TEST
count	NN	I-TEST
-	:	O
213	CD	O

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
urine	JJ	B-TEST
bnzodzpn	NN	I-TEST
-	:	O
neg	NN	O
barbitrt	SYM	B-TEST
-	:	O
neg	NN	O
opiates	VBZ	B-TEST
-	:	O
neg	NN	O
cocaine	NN	B-TEST
-	:	O
neg	NN	O
amphetmn	SYM	B-TEST
-	:	O
pos	NN	O
mthdone	NN	B-TEST
-	:	O
neg	NN	O

2013-03-27	JJ	O
01:09	CD	O
am	VBP	O
hgb	JJ	B-TEST
-	:	O
13.4	CD	O
calchct	NN	B-TEST
-	:	O
40	CD	O
o2	NN	B-TEST
sat	VBD	I-TEST
-	:	O
95	CD	O
carboxyhb	NN	B-TEST
-	:	O
1.2	CD	O
met	VBD	B-TEST
hgb	NN	I-TEST
-	:	O
0.2	CD	O

2013-03-27	JJ	O
12:59	CD	O
am	VBP	O
urea	JJ	B-TEST
n	JJ	I-TEST
-	:	O
21	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
0.8	CD	O

2013-03-27	JJ	O
02:25	CD	O
am	VBP	O
pt	JJ	B-TEST
-	:	O
13.2	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
22.9	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.2	CD	O
*	NN	O

chest	NN	B-TEST
and	CC	I-TEST
pelvis	JJ	I-TEST
x-rays	NNS	I-TEST
were	VBD	O
negative	JJ	O
for	IN	O
fractures	NNS	B-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
head	NN	I-TEST
demonstrated	VBD	O
intraparenchymal	JJ	B-PROBLEM
and	CC	I-PROBLEM
extraaxial	JJ	I-PROBLEM
blood	NN	I-PROBLEM
(	(	I-PROBLEM
mostly	RB	I-PROBLEM
subarachnoid	VBN	I-PROBLEM
)	)	I-PROBLEM
in	IN	I-PROBLEM
bilateral	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
hemispheres	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	JJR	O
,	,	O
in	IN	O
a	DT	O
pattern	NN	O
indicating	VBG	O
contrecoup	JJ	B-PROBLEM
injury	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
c-spine	NN	I-TEST
revealed	VBD	O
a	DT	O
possible	JJ	O
fracture	NN	B-PROBLEM
of	IN	I-PROBLEM
right	JJ	I-PROBLEM
c7	NN	I-PROBLEM
pedicle	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
chest	NN	I-TEST
revealed	VBD	O
bliateral	JJ	B-PROBLEM
lung	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
sinues	NNS	I-TEST
revealed	VBD	O
no	DT	O
fractures	NNS	B-PROBLEM
.	.	O

x-rays	NNS	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
right	JJ	I-TEST
lower	JJR	I-TEST
extremity	NN	I-TEST
were	VBD	O
negative	JJ	O
for	IN	O
any	DT	B-PROBLEM
acute	JJ	I-PROBLEM
injury	NN	I-PROBLEM
.	.	O

our	PRP$	O
recommendations	NNS	O
were	VBD	O
to	TO	O
load	VB	O
her	PRP$	O
with	IN	O
dilantin	NN	B-TREATMENT
and	CC	O
then	RB	O
continue	VB	O
at	IN	O
100	CD	O
mg	NN	O
po	NN	O
tid	NN	O
.	.	O

the	DT	O
orthopedics	NNS	O
spine	JJ	O
service	NN	O
saw	VBD	O
her	PRP$	O
and	CC	O
put	VB	O
her	PRP$	O
in	IN	O
a	DT	B-TREATMENT
c-collar	JJ	I-TREATMENT
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ct	VBD	I-TEST
12	CD	O
hours	NNS	O
after	IN	O
the	DT	O
first	JJ	O
was	VBD	O
largely	RB	O
unchanged	JJ	O
.	.	O

she	PRP	O
was	VBD	O
having	VBG	O
some	DT	B-PROBLEM
pain	NN	I-PROBLEM
issues	NNS	I-PROBLEM
and	CC	O
morphine	NN	B-TREATMENT
was	VBD	O
making	VBG	O
her	PRP$	O
"	JJ	O
jittery	NN	B-PROBLEM
."	NN	O

on	IN	O
hd	NN	O
2	CD	O
she	PRP	O
was	VBD	O
switched	VBN	O
to	TO	O
fioricet	VB	B-TREATMENT
,	,	O
which	WDT	O
helped	VBD	O
with	IN	O
her	PRP$	B-PROBLEM
headaches	NNS	I-PROBLEM
.	.	O

a	DT	B-TEST
repeact	JJ	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
unchanged	JJ	O
.	.	O

an	DT	B-TEST
mri	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
c-spine	NN	I-TEST
was	VBD	O
done	VBN	O
to	TO	O
evaluate	VB	O
for	IN	O
ligamentous	JJ	B-PROBLEM
injury	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
was	VBD	O
extremely	RB	B-TEST
limited	JJ	I-TEST
examination	NN	I-TEST
due	JJ	O
to	TO	O
patient	JJ	O
motion	NN	O
and	CC	O
the	DT	O
signal	NN	O
in	IN	O
the	DT	O
spinal	JJ	O
cord	NN	O
could	MD	O
not	RB	O
be	VB	O
adequately	RB	O
assessed	VBN	O
for	IN	O
edema	NN	B-PROBLEM
.	.	O

as	IN	O
per	NN	O
cmed	VBD	O
csru	JJ	O
spine	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
instructed	VBN	O
to	TO	O
follow-up	NN	O
in	IN	O
2	CD	O
weeks	NNS	O
for	IN	O
repeat	NN	B-TEST
x-rays	NNS	I-TEST
.	.	O

on	IN	O
discharge	NN	O
she	PRP	O
was	VBD	O
awake	RB	O
,	,	O
alert	NN	O
and	CC	O
orientated	VBD	O
x3	NNS	O
with	IN	O
c/o	JJ	O
mild	JJ	B-PROBLEM
headache	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
full	JJ	B-TEST
strength	NN	I-TEST
motor	NN	I-TEST
exam	NN	I-TEST
,	,	O
no	DT	O
pronator	NN	B-PROBLEM
drift	NN	I-PROBLEM
and	CC	O
perrla	NN	O
with	IN	O
full	JJ	O
eom	NN	O
s.	NN	O

she	PRP	O
was	VBD	O
ambulating	VBG	O
without	IN	O
difficulties	NNS	B-PROBLEM
.	.	O

on	IN	O
04-01	JJ	O
she	PRP	O
was	VBD	O
seen	VBN	O
by	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
thought	VBN	O
to	TO	O
benefit	VB	O
from	IN	O
acute	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
head	NN	I-TEST
ct	NN	I-TEST
prior	RB	O
to	TO	O
discharge	VB	O
that	DT	O
showed	VBD	O
resolution	NN	O
of	IN	O
the	DT	B-PROBLEM
subarachnoid	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

follow-up	NN	O
in	IN	O
1	CD	O
month	NN	O
with	IN	O
neurosurgery	NN	O
for	IN	O
a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
arranged	VBN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
on	IN	O
fioricet	NN	B-TREATMENT
and	CC	O
dilantin	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
counseled	VBN	O
to	TO	O
follow-up	JJ	O
with	IN	O
her	PRP$	O
pcp	JJ	O
f	JJ	O
6-12	JJ	O
months	NNS	O
regading	VBG	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
nodule	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
bilateral	JJ	I-PROBLEM
small	JJ	I-PROBLEM
lung	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
seen	VBN	O
on	IN	O
her	PRP$	B-TEST
chest	NN	I-TEST
ct	NN	I-TEST
.	.	O

1.	CD	O
celexa	NN	B-TREATMENT

2.	CD	O
premarin	NN	B-TREATMENT

3.	CD	O
trazodone	NN	B-TREATMENT

4.	CD	O
6-mp	JJ	B-TREATMENT

5.	CD	O
prednisone	NN	B-TREATMENT

1.	CD	O
phenytoin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
extended	VBD	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
1	CD	O
months	NNS	O
.	.	O

2.	CD	O
acetaminophen	SYM	B-TREATMENT
-	:	O
caff	NN	B-TREATMENT
-	:	O
butalbital	JJ	B-TREATMENT
504-61-78	JJ	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
01-28	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
1	CD	O
months	NNS	O
.	.	O

3.	CD	O
citalopram	NN	B-TREATMENT
20	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

4.	CD	O
metoprolol	JJ	B-TREATMENT
tartrate	NN	I-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

5.	CD	O
hydromorphone	NN	B-TREATMENT
2	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q4h	NN	O
(	(	O
every	DT	O
4	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

6.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
):	NNP	O
use	NN	O
while	IN	O
taking	VBG	O
narcotics	NNS	B-TREATMENT
.	.	O

7.	CD	O
phenytoin	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
extended	VBD	I-TREATMENT
100	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

head	NN	B-PROBLEM
trauma	NN	I-PROBLEM
with	IN	O
subarachnoid	JJ	B-PROBLEM
hemorrhage	NN	I-PROBLEM

c7	NN	B-PROBLEM
fracture	NN	I-PROBLEM

call	NN	O
for	IN	O
severe	JJ	B-PROBLEM
headache	NN	I-PROBLEM
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

please	VB	O
take	VB	O
fioricet	NN	B-TREATMENT
as	IN	O
directed	VBN	O
for	IN	O
headaches	NNS	B-PROBLEM
.	.	O

please	VB	O
do	VB	O
not	RB	O
drive	VB	O
while	IN	O
on	IN	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

please	NN	O
continue	VB	O
to	TO	O
wear	VB	O
your	PRP$	B-TREATMENT
c-collar	JJ	I-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
.	.	O

please	NN	O
continue	VB	O
dilantin	NN	B-TREATMENT
as	IN	O
directed	VBN	O
for	IN	O
seizure	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
kelley	NN	O
in	IN	O
4	CD	O
weeks	NNS	O
with	IN	O
head	NN	B-TEST
ct	SYM	I-TEST
-	:	O
call	NN	O
716	CD	O
3268	CD	O

please	NN	O
also	RB	O
follow-up	JJ	O
with	IN	O
dr.	JJ	O
obrecht	NN	O
of	IN	O
cmed	JJ	O
ccu	JJ	O
spine	NN	O
in	IN	O
2	CD	O
weeks	NNS	O
for	IN	O
flexion	NN	B-TEST
/	CD	I-TEST
extension	NN	I-TEST
x-rays	NNS	I-TEST
((	VBP	O
228	CD	O
)	)	O
411-7660	CD	O
)	)	O

please	VB	O
follow-up	JJ	O
with	IN	O
your	PRP$	O
pcp	NN	O
n	IN	O
6-12	JJ	O
months	NNS	O
reguading	VBG	O
the	DT	B-PROBLEM
right	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
nodule	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
bilateral	JJ	I-PROBLEM
small	JJ	I-PROBLEM
lung	NN	I-PROBLEM
nodules	NNS	I-PROBLEM
seen	VBN	O
on	IN	O
your	PRP$	B-TEST
chest	JJS	I-TEST
ct	NN	I-TEST
.	.	O

hepatocellular	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
and	CC	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
.	.	O

hepatocellular	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
and	CC	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
.	.	O

liver	NN	B-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

native	JJ	B-TREATMENT
hepatectomy	NN	I-TREATMENT
.	.	O

re-exploration	NN	B-TEST
for	IN	O
bleeding	NN	B-PROBLEM
.	.	O

mr.	NN	O
villesatelkscurb	NN	O
is	VBZ	O
a	DT	O
fifty	JJ	O
year	NN	O
old	JJ	O
black	JJ	O
gentleman	NN	O
with	IN	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
,	,	O
believed	VBN	O
to	TO	O
be	VB	O
contracted	VBN	O
during	IN	O
transfusions	NNS	B-TREATMENT
in	IN	O
a	DT	B-PROBLEM
previous	JJ	I-PROBLEM
trauma	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
recently	RB	O
prior	RB	O
to	TO	O
this	DT	O
admission	NN	O
,	,	O
had	VBD	O
a	DT	B-PROBLEM
rise	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
alpha	NN	I-PROBLEM
feta	NN	I-PROBLEM
protein	NN	I-PROBLEM
and	CC	O
a	DT	B-TEST
biopsy	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
liver	NN	I-TEST
had	VBD	O
shown	VBN	O
hepatocellular	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
liver	NN	B-TEST
transplant	NN	I-TEST
workup	NN	I-TEST
and	CC	O
to	TO	O
await	VB	O
liver	NN	B-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

significant	JJ	O
for	IN	O
motor	NN	O
vehicle	NN	O
accident	NN	O
in	IN	O
1966	CD	O
,	,	O
requiring	VBG	O
exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
and	CC	O
splenectomy	NN	B-TREATMENT
,	,	O
tonsillectomy	NN	B-TREATMENT
as	IN	O
a	DT	O
child	NN	O
,	,	O
pneumonia	NN	B-PROBLEM
in	IN	O
the	DT	O
past	NN	O
,	,	O
hepatitis	NN	B-PROBLEM
c	NN	I-PROBLEM
and	CC	O
recent	JJ	O
diagnosis	NN	O
of	IN	O
hepatocellular	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
medications	NNS	B-TREATMENT
included	VBD	O
lasix	NN	B-TREATMENT
and	CC	O
iron	NN	B-TREATMENT
.	.	O

significant	JJ	O
for	IN	O
normal	JJ	O
head	NN	O
,	,	O
eyes	NNS	O
,	,	O
ears	NNS	O
,	,	O
nose	RB	O
,	,	O
throat	NN	O
exam	NN	O
with	IN	O
no	DT	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
appreciable	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
clubbing	NN	B-PROBLEM
and	CC	O
palmar	NN	B-PROBLEM
erythema	NN	I-PROBLEM
with	IN	O
bilateral	JJ	B-PROBLEM
ankle	NN	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

bilirubin	NN	B-TEST
to	TO	O
be	VB	O
.6	VBN	O
.	.	O

sgot	NN	B-TEST
of	IN	O
80	CD	O
.	.	O

preoperatively	RB	O
,	,	O
the	DT	O
patient	JJ	O
underwent	JJ	O
chemo-embolization	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
hepatocellular	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

on	IN	O
july	NN	O
15	CD	O
,	,	O
1992	CD	O
,	,	O
a	DT	O
liver	NN	O
became	VBD	O
available	JJ	O
,	,	O
and	CC	O
the	DT	O
patient	JJ	O
underwent	JJ	O
hepatectomy	NN	B-TREATMENT
and	CC	O
orthotopic	NN	B-TREATMENT
liver	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
complicated	VBN	O
by	IN	O
severe	JJ	B-PROBLEM
coagulopathy	JJ	I-PROBLEM
requiring	VBG	O
fifty-nine	JJ	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
64	CD	O
units	NNS	O
of	IN	O
ffp	NN	B-TREATMENT
and	CC	O
34	CD	O
units	NNS	O
of	IN	O
platelets	NNS	B-TREATMENT
.	.	O

postoperatively	RB	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
coagulopathy	JJ	I-PROBLEM
requiring	VBG	O
re-exploration	NN	B-TEST
on	IN	O
postoperatively	RB	O
day	NN	O
2	CD	O
,	,	O
with	IN	O
findings	NNS	O
only	RB	O
of	IN	O
hematoma	NN	B-PROBLEM
and	CC	O
no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

initially	RB	O
,	,	O
the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
,	,	O
mentally	RB	O
alert	JJ	O
,	,	O
and	CC	O
oriented	VBD	O
,	,	O
however	RB	O
,	,	O
he	PRP	O
continued	VBD	O
to	TO	O
be	VB	O
coagulopathic	JJ	B-PROBLEM
and	CC	O
was	VBD	O
requiring	VBG	O
large	JJ	B-TREATMENT
amounts	NNS	I-TREATMENT
of	IN	I-TREATMENT
blood	NN	I-TREATMENT
and	CC	O
ffp	JJ	B-TREATMENT
transfusions	NNS	I-TREATMENT
,	,	O
with	IN	O
a	DT	B-PROBLEM
resultant	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
developed	VBD	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
felt	VBD	O
to	TO	O
be	VB	O
atn	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
ischemia	VB	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
kidneys	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
intubated	VBN	B-TREATMENT
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
twelve	JJ	O
days	NNS	O
prior	RB	O
to	TO	O
his	PRP$	O
death	NN	O
.	.	O

he	PRP	O
had	VBD	O
daily	JJ	B-TREATMENT
transfusions	NNS	I-TREATMENT
of	IN	O
ffp	NN	B-TREATMENT
and	CC	O
blood	NN	B-TREATMENT
,	,	O
and	CC	O
continued	VBD	O
coagulopathy	NNS	B-PROBLEM
.	.	O

he	PRP	O
also	RB	O
developed	VBD	O
thrombocytopenia	NN	B-PROBLEM
,	,	O
requiring	VBG	O
persistent	JJ	B-TREATMENT
platelet	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
on	IN	O
a	DT	O
daily	JJ	O
basis	NN	O
.	.	O

his	PRP$	B-TREATMENT
immunosuppression	NN	I-TREATMENT
was	VBD	O
okt3	JJ	B-TREATMENT
and	CC	O
solu	JJ	B-TREATMENT
medrol	NN	I-TREATMENT
,	,	O
and	CC	O
he	PRP	O
underwent	JJ	O
hemodialysis	NN	B-TREATMENT
and	CC	O
ultra	JJ	B-TREATMENT
filtration	NN	I-TREATMENT
to	TO	O
remove	VB	O
fluid	NN	O
.	.	O

while	IN	O
in	IN	O
the	DT	O
icu	NN	O
he	PRP	O
developed	VBD	O
seizures	NNS	B-PROBLEM
,	,	O
requiring	VBG	O
large	JJ	B-TREATMENT
amounts	NNS	I-TREATMENT
of	IN	I-TREATMENT
intravenous	JJ	I-TREATMENT
valium	NN	I-TREATMENT
to	TO	O
break	VB	O
his	PRP$	B-PROBLEM
seizures	NNS	I-PROBLEM
,	,	O
and	CC	O
he	PRP	O
was	VBD	O
maintained	VBN	O
on	IN	O
tegretol	NN	B-TREATMENT
and	CC	O
dilantin	NN	B-TREATMENT
.	.	O

however	RB	O
,	,	O
he	PRP	O
became	VBD	O
progressively	RB	O
more	RBR	O
mentally	RB	B-PROBLEM
obtunded	VBN	I-PROBLEM
.	.	O

during	IN	O
the	DT	B-PROBLEM
seizure	NN	I-PROBLEM
,	,	O
he	PRP	O
bit	VBD	O
his	PRP$	O
tongue	NN	O
,	,	O
resulting	VBG	O
in	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
from	IN	I-PROBLEM
his	PRP$	I-PROBLEM
tongue	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
sutured	VBN	B-TREATMENT
by	IN	O
the	DT	O
ent	NN	O
service	NN	O
,	,	O
however	RB	O
,	,	O
his	PRP$	B-PROBLEM
continued	VBN	I-PROBLEM
coagulopathy	NN	I-PROBLEM
resulted	VBD	O
in	IN	O
bleeding	VBG	B-PROBLEM
from	IN	I-PROBLEM
his	PRP$	I-PROBLEM
nasopharynx	NN	I-PROBLEM
,	,	O
which	WDT	O
could	MD	O
never	RB	O
be	VB	O
identified	VBN	O
,	,	O
and	CC	O
also	RB	O
upper	JJ	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

endoscopy	NN	B-TEST
never	RB	O
revealed	VBD	O
specific	JJ	O
sources	NNS	O
of	IN	O
bleeding	NN	B-PROBLEM
,	,	O
although	IN	O
he	PRP	O
appeared	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
diffuse	NN	I-PROBLEM
duodenitis	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
pitressin	NN	B-TREATMENT
to	TO	O
try	VB	O
to	TO	O
control	VB	O
the	DT	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
but	CC	O
he	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
severe	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
and	CC	O
became	VBD	O
progressively	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
,	,	O
with	IN	O
eventual	JJ	B-PROBLEM
bradycardia	NN	I-PROBLEM
and	CC	O
cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

mr.	NN	O
bruno	NN	O
is	VBZ	O
a	DT	O
60	CD	O
year	NN	O
old	JJ	O
gentleman	NN	O
who	WP	O
initially	RB	O
presented	VBN	O
with	IN	O
hematemesis	NN	B-PROBLEM
,	,	O
hemoptysis	NN	B-PROBLEM
and	CC	O
on	IN	O
work-up	NN	B-TEST
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
left	VBN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

he	PRP	O
previously	RB	O
underwent	JJ	O
bronchoscopy	NN	B-TEST
with	IN	I-TEST
washings	NNS	I-TEST
which	WDT	O
showed	VBD	O
to	TO	O
be	VB	O
negative	JJ	O
for	IN	O
malignant	JJ	B-PROBLEM
cells	NNS	I-PROBLEM
and	CC	O
showed	VBD	O
atypical	JJ	B-PROBLEM
bronchial	JJ	I-PROBLEM
epithelial	JJ	I-PROBLEM
cells	NNS	I-PROBLEM
,	,	O
likely	RB	O
to	TO	O
be	VB	O
reactive	JJ	B-TEST
.	.	O

1.	CD	O
rectal	JJ	B-PROBLEM
fissure	NN	I-PROBLEM
.	.	O

2.	CD	O
lumpectomy	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
left	NN	I-PROBLEM
breast	NN	I-PROBLEM
nodule	NN	I-PROBLEM
.	.	O

3.	CD	O
knee	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

4.	CD	O
hand	NN	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
home	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

the	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
was	VBD	O
essentially	RB	O
negative	JJ	O
.	.	O

on	IN	O
admission	NN	O
,	,	O
showed	VBD	O
a	DT	O
gentleman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
;	:	O
afebrile	NN	B-PROBLEM
.	.	O

chest	NN	O
was	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdomen	NNS	O
is	VBZ	O
benign	JJ	O
,	,	O
no	DT	O
mass	NN	B-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
bronchoscopy	NN	I-TREATMENT
and	CC	O
lower	JJR	B-TREATMENT
lobectomy	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
side	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
operation	NN	I-TREATMENT
was	VBD	O
subsequently	RB	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
postoperative	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
to	TO	O
be	VB	O
taken	VBN	O
back	RB	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
where	WRB	O
a	DT	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
pulmonary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
was	VBD	O
performed	VBN	O
.	.	O

during	IN	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
13	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
four	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
and	CC	O
one	CD	O
unit	NN	O
of	IN	O
platelets	NNS	B-TREATMENT
with	IN	O
an	DT	B-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
of	IN	O
1500	CD	O
cc	NN	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
to	TO	O
be	VB	O
stable	JJ	O
on	IN	O
the	DT	O
floor	NN	O
with	IN	O
subsequent	JJ	O
monitoring	NN	O
of	IN	O
hematocrit	NN	B-TEST
within	IN	O
a	DT	O
normal	JJ	O
stable	JJ	O
range	NN	O
.	.	O

he	PRP	O
is	VBZ	O
successfully	RB	O
extubated	VBN	O
on	IN	O
08-12	NN	O
and	CC	O
hypertension	NN	B-PROBLEM
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
where	WRB	O
the	DT	O
pain	NN	O
service	NN	O
is	VBZ	O
managing	VBG	O
his	PRP$	B-TREATMENT
epidural	JJ	I-TREATMENT
with	IN	O
very	RB	O
good	JJ	O
effect	NN	O
and	CC	O
he	PRP	O
is	VBZ	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
p.o.	NN	O
diet	NN	O
and	CC	O
is	VBZ	O
making	VBG	O
adequate	JJ	O
amount	NN	O
of	IN	O
urine	NN	O
.	.	O

his	PRP$	B-TREATMENT
epidural	NN	I-TREATMENT
was	VBD	O
successfully	RB	O
discontinued	VBN	O
and	CC	O
he	PRP	O
is	VBZ	O
discharged	VBN	O
to	TO	O
home	VB	O
on	IN	O
08-15	JJ	O
with	IN	O
instructions	NNS	O
to	TO	O
follow-up	JJ	O
with	IN	O
dr.	JJ	O
cordova	NN	O
in	IN	O
the	DT	O
office	NN	O
within	IN	O
the	DT	O
next	JJ	O
one	CD	O
to	TO	O
two	CD	O
weeks	NNS	O
.	.	O

he	PRP	O
is	VBZ	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
pain	NN	B-TREATMENT
medication	NN	I-TREATMENT
which	WDT	O
is	VBZ	O
percocet	NN	B-TREATMENT
.	.	O

left	VBN	B-PROBLEM
lung	JJ	I-PROBLEM
mass	NN	I-PROBLEM
status	NN	O
post	NN	O
resection	NN	B-TREATMENT
.	.	O

cp	NNS	B-PROBLEM
standardized	VBD	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
english	JJ	O
)	)	O
.	.	O

lt	NN	B-PROBLEM
arm/	NN	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM

ekg	RB	B-TEST
=	NNP	O
normal	JJ	O
,	,	O
cxr	JJ	B-TEST
normal	JJ	O
,	,	O
ddimer	JJ	B-TEST
/	NNP	O
cardiac	NN	B-TEST
enzymes	NNS	I-TEST
negative	JJ	O

ibuprofen	NN	B-TREATMENT
as	IN	O
needed	VBN	O

the	DT	O
infant	NN	O
is	VBZ	O
a	DT	O
32	CD	O
and	CC	O
03-05	JJ	O
week	NN	O
male	NN	O
,	,	O
twin	VB	O
a	DT	O
,	,	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
management	NN	B-TREATMENT
of	IN	O
prematurity	NN	B-PROBLEM
.	.	O

serologies	NNS	B-TEST
:	:	O

a	DT	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
gbs	JJ	B-TEST
unknown	NN	O
.	.	O

pregnancy	NN	B-PROBLEM
notable	JJ	O
for:	NN	O

2.	CD	O
ivf	NN	B-TREATMENT
with	IN	O
diamniotic	JJ	O
,	,	O
dichorionic	JJ	O
twins	NNS	O
.	.	O

3.	CD	O
at	IN	O
29-30	JJ	O
week	NN	O
gestation	NN	O
concern	NN	O
for	IN	O
fetal	JJ	B-PROBLEM
decelerations	NNS	I-PROBLEM
of	IN	O
twin	NN	O
a	DT	O
,	,	O
admitted	VBN	O
to	TO	O
cambridge	VB	O
health	NN	O
alliance	NN	O
,	,	O
completed	VBD	O
a	DT	O
course	NN	O
of	IN	O
betamethasone	NN	B-TREATMENT
,	,	O
discharged	VBD	O
to	TO	O
home	NN	O
.	.	O

4.	CD	O
elevated	VBD	B-PROBLEM
one	CD	I-PROBLEM
hour	NN	I-PROBLEM
glucose	JJ	I-PROBLEM
tolerance	NN	I-PROBLEM
test	NN	I-PROBLEM
,	,	O
normal	JJ	O
three	CD	O
hour	NN	O
glucose	JJ	O
tolerance	NN	O
test	NN	O
.	.	O

5.	CD	O
declined	VBD	O
triple	JJ	B-TEST
screen	NN	I-TEST
and	CC	O
amniocentesis	NN	B-TEST
.	.	O

presented	VBN	O
with	IN	O
spontaneous	JJ	B-PROBLEM
,	,	I-PROBLEM
premature	JJ	I-PROBLEM
rupture	NN	I-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

no	DT	O
maternal	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

delivery	NN	B-TREATMENT
by	IN	I-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
secondary	JJ	O
to	TO	O
twin	VB	B-PROBLEM
b	NN	I-PROBLEM
breech	NN	I-PROBLEM
presentation	NN	I-PROBLEM
.	.	O

apgars	NNS	B-TEST
eight	CD	O
at	IN	O
one	CD	O
minute	NN	O
and	CC	O
eight	CD	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
1865	CD	O
grams	NN	O
.	.	O

1.	CD	O
respiratory	NN	O
-	:	O
the	DT	O
infant	NN	O
has	VBZ	O
remained	VBN	O
in	IN	O
room	NN	O
air	NN	O
throughout	IN	O
this	DT	O
hospitalization	NN	O
with	IN	O
respiratory	JJ	B-TEST
rates	NNS	I-TEST
40	CD	O
s	NN	O
to	TO	O
50	CD	O
s,	NNS	O
oxygen	JJ	B-TEST
saturation	NN	I-TEST
greater	JJR	O
than	IN	O
94%	CD	O
.	.	O

one	CD	B-PROBLEM
apnea	NN	I-PROBLEM
and	CC	I-PROBLEM
bradycardia	NN	I-PROBLEM
event	NN	I-PROBLEM
which	WDT	O
was	VBD	O
self	PRP	O
resolved	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
four	CD	O
.	.	O

2.	CD	O
cardiovascular	JJ	O
-	:	O
the	DT	O
infant	NN	O
was	VBD	O
noted	VBN	O
on	IN	O
cr-monitor	NN	B-TEST
to	TO	O
have	VB	O
premature	NN	B-PROBLEM
ventricular	NN	I-PROBLEM
contractions	NNS	I-PROBLEM
which	WDT	O
resolved	VBD	O
spontaneously	RB	O
.	.	O

a	DT	B-TEST
twelve	JJ	I-TEST
lead	NN	I-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
recommended	VBN	O
if	IN	O
this	DT	O
persists	VBZ	O
.	.	O

no	DT	O
murmur	NN	B-PROBLEM
.	.	O

heart	NN	B-TEST
rates	NNS	I-TEST
140	CD	O
s	NN	O
to	TO	O
150	CD	O
s.	NN	O

mean	JJ	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
has	VBZ	O
been	VBN	O
46	CD	O
to	TO	O
54	CD	O
.	.	O

3.	CD	O
fluid	NN	O
,	,	O
electrolytes	NNS	O
and	CC	O
nutrition	NN	O
-	:	O
the	DT	O
infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
one	CD	O
and	CC	O
advanced	VBD	O
to	TO	O
full	JJ	B-TREATMENT
volume	NN	I-TREATMENT
feedings	NNS	I-TREATMENT
by	IN	O
day	NN	O
of	IN	O
life	NN	O
four	CD	O
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
initially	RB	O
started	VBN	O
on	IN	O
80	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
fluid	NN	I-TREATMENT
d10w	NN	I-TREATMENT
and	CC	O
advanced	VBD	O
to	TO	O
150	CD	O
cc	NNS	O
/	JJ	O
kg	JJ	O
/	NNP	O
day	NN	O
by	IN	O
day	NN	O
of	IN	O
life	NN	O
four	CD	O
.	.	O

the	DT	O
infant	NN	O
did	VBD	O
not	RB	O
receive	VB	O
parenteral	JJ	B-TREATMENT
nutrition	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
electrolytes	NNS	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
showed	VBD	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
145	CD	O
,	,	O
chloride	RB	B-TEST
111	CD	O
,	,	O
potassium	NN	B-TEST
3.8	CD	O
,	,	O
bicarbonate	NN	B-TEST
21	CD	O
.	.	O

the	DT	O
infant	NN	O
is	VBZ	O
currently	RB	O
receiving	VBG	O
breast	NN	O
milk	NN	O
22	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
or	CC	O
premature	NN	O
enfamil	VBP	O
22	CD	O
calories	NNS	O
per	IN	O
ounce	NN	O
,	,	O
150	CD	O
cc	NN	O
/	NNP	O
kg	NN	O
/	NNP	O
day	NN	O
p.o.	NN	O
and	CC	O
gavage	NN	B-TREATMENT
.	.	O

the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
weight	NN	I-TEST
today	NN	O
is	VBZ	O
1810	CD	O
grams	NN	O
which	WDT	O
was	VBD	O
no	DT	O
change	NN	O
from	IN	O
the	DT	O
previous	JJ	O
day	NN	O
.	.	O

4.	CD	O
gastrointestinal	JJ	O
-	:	O
the	DT	O
infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
single	JJ	B-TREATMENT
phototherapy	NN	I-TREATMENT
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
for	IN	O
a	DT	B-TEST
maximum	JJ	I-TEST
bilirubin	JJ	I-TEST
level	NN	I-TEST
of	IN	O
9.1	CD	O
with	IN	O
a	DT	B-TEST
direct	NN	I-TEST
of	IN	O
0.3	CD	O
.	.	O

phototherapy	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
five	CD	O
and	CC	O
the	DT	B-TEST
rebound	NN	I-TEST
bilirubin	VBD	I-TEST
level	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
six	CD	O
is	VBZ	O
7.7	CD	O
with	IN	O
a	DT	B-TEST
direct	NN	I-TEST
of	IN	O
0.2	CD	O
.	.	O

5.	CD	O
hematology	NN	O
-	:	O
the	DT	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
hematocrit	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
was	VBD	O
45.8%	CD	O
.	.	O

hematocrit	NN	B-TEST
on	IN	I-TEST
admission	NN	I-TEST
was	VBD	O
54.0%	CD	O
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
blood	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
this	DT	O
hospitalization	NN	O
.	.	O

6.	CD	O
infectious	JJ	O
disease	NN	O
-	:	O
the	DT	O
infant	NN	O
received	VBD	O
48	CD	O
hours	NNS	O
of	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
for	IN	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
on	IN	I-TEST
admission	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
8.0	CD	O
,	,	O
hematocrit	NN	B-TEST
54.0%	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
190,000	CD	O
,	,	O
11	CD	O

neutrophils	NNS	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
6.3	CD	O
,	,	O
hematocrit	NN	B-TEST
45.8%	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
199,000	CD	O
,	,	O
37	CD	O
neutrophils	NNS	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
,	,	O
53	CD	O
lymphocytes	NNS	B-TEST
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

the	DT	O
infant	NN	O
does	VBZ	O
not	RB	O
meet	VB	O
criteria	NNS	O
for	IN	O
head	NN	B-TEST
ultrasound	NN	I-TEST
.	.	O

8.	CD	O
sensory	JJ	O
-	:	O
hearing	NN	B-TEST
screening	NN	I-TEST
is	VBZ	O
recommended	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
infants	NNS	O
are	VBP	O
legally	RB	O
under	IN	O
the	DT	O
parents	NNS	O
'	POS	O
names	NNS	O
and	CC	O
they	PRP	O
are	VBP	O
involved	VBN	O
with	IN	O
the	DT	B-TREATMENT
infant	NN	I-TREATMENT
's	POS	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

car	NN	B-TEST
seat	NN	I-TEST
position	NN	I-TEST
screening	NN	I-TEST
:	:	O

state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
:	:	O

screens	NNS	B-TEST
have	VBP	O
been	VBN	O
sent	VBN	O
and	CC	O
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

immunizations	NNS	B-TREATMENT
:	:	O

the	DT	O
infant	NN	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
immunizations	NNS	I-TREATMENT
this	DT	O
hospitalization	NN	O
.	.	O

synagis	NN	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
october	VBN	O
through	IN	O
april	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
:	:	O

c.	NN	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O

d.	NN	O
airway	NN	B-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O

3.	CD	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

1.	CD	O
prematurity	NN	B-PROBLEM
32	CD	I-PROBLEM
and	CC	I-PROBLEM
4/7	CD	I-PROBLEM
weeks	NNS	I-PROBLEM
,	,	O
twin	JJ	O
#1	NN	O
.	.	O

2.	CD	O
rule	NN	O
out	IN	O
sepsis	NN	B-PROBLEM
,	,	O
ruled	VBD	O
out	RP	O
.	.	O

3.	CD	O
apnea	NN	B-PROBLEM
of	IN	I-PROBLEM
prematurity	NN	I-PROBLEM
.	.	O

4.	CD	O
indirect	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
.	.	O

pelvic	JJ	B-PROBLEM
mass	NN	I-PROBLEM

pelvic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
,	,	O
benign	JJ	B-PROBLEM
mucinous	JJ	I-PROBLEM
cystadenoma	NN	I-PROBLEM
.	.	O

total	JJ	B-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
right	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
appendectomy	NN	B-TREATMENT
,	,	O
omental	JJ	B-TEST
biopsy	NN	I-TEST
,	,	O
and	CC	O
pelvic	JJ	B-TREATMENT
washings	NNS	I-TREATMENT
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
56-year-old	JJ	O
menopausal	NN	O
female	JJ	O
g3	NN	O
,	,	O
p3	NN	O
who	WP	O
presented	VBD	O
initially	RB	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
a	DT	B-PROBLEM
pelvic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
while	IN	O
recently	RB	O
vacationing	VBG	O
in	IN	O
an	DT	O
saintcafield	NN	O
terland	NN	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
physical	JJ	I-TEST
over	IN	O
there	RB	O
,	,	O
and	CC	O
the	DT	B-TEST
evaluation	NN	I-TEST
included	VBD	O
an	DT	B-TEST
ultrasound	NN	I-TEST
which	WDT	O
showed	VBD	O
an	DT	B-PROBLEM
ovarian	JJ	I-PROBLEM
mass	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
seen	VBN	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
here	RB	O
on	IN	O
08/31/04	CD	O
where	WRB	O
they	PRP	O
performed	VBD	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
that	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
14	CD	I-PROBLEM
x	NN	I-PROBLEM
14	CD	I-PROBLEM
x	JJ	I-PROBLEM
10	CD	I-PROBLEM
cm	JJ	I-PROBLEM
pelvic	JJ	I-PROBLEM
mass	NN	I-PROBLEM
with	IN	O
multiple	JJ	B-PROBLEM
enlarged	JJ	I-PROBLEM
lymph	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
thus	RB	O
sent	VBN	O
to	TO	O
gyn	VB	O
for	IN	O
further	JJ	B-TEST
workup	NN	I-TEST
and	CC	O
is	VBZ	O
now	RB	O
here	RB	O
for	IN	O
surgical	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
pelvic	JJ	B-PROBLEM
mass	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
ca-125	NN	I-TEST
is	VBZ	O
9	CD	O
.	.	O

tubal	JJ	B-TREATMENT
ligation	NN	I-TREATMENT
.	.	O

g3	NN	O
,	,	O
p3	NN	O
,	,	O
spontaneous	JJ	B-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
x3	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

no	DT	O
history	NN	O
of	IN	O
gyn	NN	B-PROBLEM
,	,	O
cancers	NNS	B-PROBLEM
,	,	O
or	CC	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
hospital	JJ	O
day	NN	O
#	#	O
1	CD	O
where	WRB	O
she	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT
total	JJ	I-TREATMENT
abdominal	JJ	I-TREATMENT
hysterectomy	NN	I-TREATMENT
,	,	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
,	,	O
right	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	JJ	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
appendectomy	NN	B-TREATMENT
,	,	O
omental	JJ	B-TEST
biopsy	NN	I-TEST
,	,	O
pelvic	JJ	B-TREATMENT
washings	NNS	I-TREATMENT
,	,	O
and	CC	O
pap	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
diaphragm	NN	I-TREATMENT
.	.	O

an	DT	B-PROBLEM
estimated	VBN	I-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
was	VBD	O
100	CD	O
cc	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
surgery	NN	B-TREATMENT
,	,	O
frozen	JJ	B-TEST
section	NN	I-TEST
revealed	VBD	O
benign	RB	B-PROBLEM
mucinous	JJ	I-PROBLEM
cystadenoma	NN	I-PROBLEM
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
#3	NNP	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
p.o.&apos;	NN	O
s	NN	O
,	,	O
tolerating	VBG	O
oral	JJ	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
,	,	O
ambulating	VBG	O
,	,	O
passing	VBG	O
flatus	NN	O
,	,	O
and	CC	O
having	VBG	O
a	DT	O
bowel	NN	O
movement	NN	O
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
preoperatively	RB	O
was	VBD	O
36	CD	O
and	CC	O
postoperatively	RB	O
was	VBD	O
33	CD	O
and	CC	O
then	RB	O
32	CD	O
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
have	VB	O
some	DT	B-PROBLEM
tachycardia	NN	I-PROBLEM
postoperatively	RB	I-PROBLEM
;	:	O
however	RB	O
,	,	O
her	PRP	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

she	PRP	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
,	,	O
and	CC	O
her	PRP$	B-TEST
ekg	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

her	PRP$	B-PROBLEM
tachycardia	NN	I-PROBLEM
improved	NN	O
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
home	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
with	IN	O
prescriptions	NNS	O
for	IN	O
colace	NN	B-TREATMENT
,	,	O
motrin	NN	B-TREATMENT
and	CC	O
percocet	NN	B-TREATMENT
as	IN	O
needed	VBN	O
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
58	JJ	O
-	:	O
year-old	JJ	O
woman	NN	O
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
shaugnessy-kaplan	JJ	O
rehab	NN	O
hospital	NN	O
hospital	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
long	JJ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
tobacco	NN	O
abuse	NN	O
,	,	O
and	CC	O
family	NN	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
who	WP	O
was	VBD	O
in	IN	O
the	DT	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
saturday	JJ	O
previous	JJ	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
experienced	VBD	O
bilateral	JJ	B-PROBLEM
arm	NN	I-PROBLEM
and	CC	I-PROBLEM
chest	JJS	I-PROBLEM
discomfort	NN	I-PROBLEM
while	IN	O
carrying	VBG	O
groceries	NNS	O
.	.	O

her	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
resolved	VBN	O
with	IN	O
rest	NN	B-TREATMENT
.	.	O

the	DT	B-PROBLEM
same	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
occurred	VBD	O
again	RB	O
the	DT	O
same	JJ	O
evening	NN	O
with	IN	O
exertion	NN	O
and	CC	O
then	RB	O
were	VBD	O
again	RB	O
relieved	VBN	O
with	IN	O
rest	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
the	DT	O
outside	JJ	O
hospital	NN	O
emergency	NN	O
room	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
lovenox	NN	B-TREATMENT
and	CC	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
.	.	O

she	PRP	O
ruled	VBD	O
out	RP	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
by	IN	O
cpk	NN	B-TEST
and	CC	O
troponin	NN	B-TEST
and	CC	O
had	VBD	O
non	VBN	B-PROBLEM
diagnostic	JJ	I-PROBLEM
ekg	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
being	VBG	O
transferred	VBN	O
to	TO	O
arbour-fuller	JJ	O
hospital	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

results	NNS	O
of	IN	O
the	DT	B-TEST
catheterization	NN	I-TEST
indicated	VBD	O
the	DT	O
patient	NN	O
had	VBD	O
three	CD	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
was	VBD	O
a	DT	O
candidate	NN	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

her	PRP$	O
risk	NN	O
factors	NNS	O
:	:	O
hypertension	NN	B-PROBLEM
,	,	O
tobacco	NN	O
abuse	NN	O
(	(	O
one	CD	O
pack	NN	O
per	IN	O
day	NN	O
times	NNS	O
45	CD	O
years	NNS	O
),	JJ	O
family	NN	O
history	NN	O
(	(	O
father	NN	O
diagnosed	VBN	O
with	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	O
his	PRP$	O
50	CD	O
's,	POS	O
patient	NN	O
's	POS	O
mother	NN	O
had	VBD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
patient	NN	O
's	POS	O
brother	NN	O
has	VBZ	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
).	NN	O

hypercholesterolemia	NN	B-PROBLEM
(	(	O
total	JJ	B-TEST
cholesterol	NN	I-TEST
on	IN	O
admission	NN	O
300	CD	O
's	POS	O
several	JJ	O
years	NNS	O
ago	RB	O
).	VBD	O

the	DT	O
patient	JJ	O
denies	VBZ	O
any	DT	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

status	NN	O
post	NN	O
cva	NN	B-PROBLEM
times	NNS	O
two	CD	O
in	IN	O
2010	CD	O
,	,	O
arthritis	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
remote	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
remote	NN	B-PROBLEM
pleurisy	NN	I-PROBLEM
,	,	O
psoriasis	NN	B-PROBLEM
.	.	O

status	NN	O
post	NN	O
tubal	JJ	B-TREATMENT
ligation	NN	I-TREATMENT
.	.	O

at	IN	O
home	NN	O
,	,	O
aggrenox	RB	B-TREATMENT
250	CD	O
mg	NNS	O
po	JJ	O
q	JJ	O
day	NN	O
.	.	O

sulfa	NN	B-TREATMENT
causes	VBZ	O
rash	NN	B-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
son	NN	O
who	WP	O
is	VBZ	O
mentally	RB	B-PROBLEM
handicapped	VBN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
vital	JJ	B-TEST
signs	NNS	I-TEST
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
71	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
134/75	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
20	CD	O
.	.	O

neck	NN	O
,	,	O
no	DT	O
jugulovenous	JJ	B-PROBLEM
distension	NN	I-PROBLEM
,	,	O
carotids	NNS	B-PROBLEM
,	,	O
no	DT	O
bruit	NN	B-PROBLEM
in	IN	I-PROBLEM
either	CC	I-PROBLEM
right	JJ	I-PROBLEM
or	CC	I-PROBLEM
left	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

heart	NN	O
,	,	O
s1	NN	B-TEST
and	CC	O
s2	NN	B-TEST
appreciated	VBD	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
soft	JJ	O
,	,	O
non	RB	B-PROBLEM
distended	VBD	I-PROBLEM
,	,	O
nontender	NN	B-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
ecchymosis	NN	B-PROBLEM
in	IN	I-PROBLEM
mid	JJ	I-PROBLEM
abdomen	NNS	I-PROBLEM
,	,	O
left	VBD	O
of	IN	O
midline	NN	O
,	,	O
likely	RB	O
secondary	JJ	O
to	TO	O
lovenox	VB	B-TREATMENT
injections	NNS	I-TREATMENT
.	.	O

extremities	NNS	O
,	,	O
no	DT	O
bruit	NN	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
or	CC	I-PROBLEM
right	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
arteries	NNS	I-PROBLEM
.	.	O

dp	NN	B-TEST
and	CC	I-TEST
pt	NN	I-TEST
pulses	NNS	I-TEST
are	VBP	O
2+	CD	O
bilaterally	RB	O
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pedal	JJ	B-PROBLEM
edema	NN	I-PROBLEM
but	CC	O
there	EX	O
is	VBZ	O
evidence	NN	O
of	IN	O
some	DT	B-PROBLEM
psoriasis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	NN	O
.	.	O

cardiac	JJ	B-TEST
catheterization	NN	I-TEST
performed	VBN	O
on	IN	O
2013-01-03	JJ	O
:	:	O
three	CD	B-PROBLEM
vessel	NN	I-PROBLEM
disease	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
dominant	NN	I-PROBLEM
system	NN	I-PROBLEM
.	.	O

left	VBN	O
main	JJ	O
coronary	JJ	O
artery	NN	O
with	IN	O
short	JJ	O
vessel	NN	O
without	IN	O
significant	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

the	DT	B-PROBLEM
lad	NN	I-PROBLEM
diffusely	RB	I-PROBLEM
diseased	VBD	I-PROBLEM
proximal	JJ	I-PROBLEM
section	NN	I-PROBLEM
up	RB	O
to	TO	O
50%	CD	O
with	IN	O
focal	JJ	O
70%	CD	B-PROBLEM
mid	NN	I-PROBLEM
segment	NN	I-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

d1	NN	O
was	VBD	O
mildly	RB	B-PROBLEM
diseased	VBN	I-PROBLEM
diffusely	RB	I-PROBLEM
.	.	O

left	VBN	O
circumflex	NN	O
had	VBD	O
80%	CD	B-PROBLEM
stenosis	NN	I-PROBLEM
in	IN	I-PROBLEM
a	DT	I-PROBLEM
large	JJ	I-PROBLEM
om1	NN	I-PROBLEM
branch	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
coronary	JJ	O
artery	NN	O
was	VBD	O
diffusely	RB	B-PROBLEM
diseased	VBN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
mid	NN	I-PROBLEM
segment	NN	I-PROBLEM
with	IN	O
serial	JJ	B-PROBLEM
80-90%	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

limited	JJ	B-TEST
hemodynamics	NNS	I-TEST
showed	VBD	O
elevated	JJ	B-PROBLEM
lv	NN	I-PROBLEM
and	CC	I-PROBLEM
diastolic	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
(	(	O
21	CD	O
mmhg	NN	O
).	NN	O

left	VBN	B-TEST
ventriculogram	NN	I-TEST
demonstrates	VBZ	O
a	DT	B-PROBLEM
mild	JJ	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
and	CC	O
left	VBD	B-TEST
ventricular	JJ	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
58%	CD	O
with	IN	O
normal	JJ	O
regional	JJ	B-TEST
wall	NN	I-TEST
motion	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
edith	VB	O
nourse	JJ	O
rogers	NNS	O
memorial	JJ	O
va	JJ	O
hospital	NN	O
and	CC	O
brought	VBD	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2013-01-04	JJ	O
by	IN	O
dr.	JJ	O
van	NN	O
der	NN	O
talbot	NN	O
where	WRB	O
she	PRP	O
received	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
three	CD	O
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TREATMENT
anastomosis	NN	I-TREATMENT
between	IN	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
internal	JJ	I-TREATMENT
mammary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
and	CC	I-TREATMENT
the	DT	I-TREATMENT
left	JJ	I-TREATMENT
anterior	JJ	I-TREATMENT
descending	VBG	I-TREATMENT
artery	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
rca	VB	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
om	VB	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transported	VBN	O
to	TO	O
the	DT	O
cardiac	NN	O
surgery	NN	O
recovery	NN	O
room	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
extubated	VBN	O
on	IN	O
arrival	NN	O
in	IN	O
the	DT	O
cardiac	NN	O
surgery	NN	O
recovery	NN	O
room	NN	O
but	CC	O
was	VBD	O
on	IN	O
no	DT	O
drips	NNS	B-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#2	VBD	O
her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
chest	JJS	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
#3	NNP	O
she	PRP	O
began	VBD	O
ambulating	VBG	O
with	IN	O
some	DT	B-PROBLEM
great	JJ	I-PROBLEM
hesitancy	NN	I-PROBLEM
.	.	O

foley	NN	B-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
.	.	O

by	IN	O
postoperative	JJ	O
day	NN	O
#5	IN	O
she	PRP	O
was	VBD	O
ambulating	VBG	O
at	IN	O
level	NN	O
iv	NN	O
,	,	O
was	VBD	O
tolerating	VBG	O
po	NN	O
,	,	O
was	VBD	O
able	JJ	O
to	TO	O
void	VB	O
and	CC	O
felt	VB	O
comfortable	JJ	O
to	TO	O
go	VB	O
to	TO	O
rehab	VB	B-TREATMENT
.	.	O

1.	CD	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
three	CD	O
on	IN	O
2013-01-04	JJ	O
.	.	O

toprol	NN	B-TREATMENT
75	CD	O
mg	NN	O
po	NN	O
bid	NN	O
,	,	O
furosemide	RB	B-TREATMENT
20	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
times	NNS	O
one	CD	O
week	NN	O
,	,	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
po	NNS	O
bid	VBP	O
while	IN	O
on	IN	O
lasix	NN	B-TREATMENT
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NNS	O
bid	VBP	O
while	IN	O
on	IN	O
percocet	NN	B-TREATMENT
,	,	O
enteric	RB	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	JJ	I-TREATMENT
325	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
indocin	VB	B-TREATMENT
25	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
,	,	O
sarna	JJ	B-TREATMENT
cream	NN	I-TREATMENT
applied	VBD	O
to	TO	O
affected	JJ	O
area	NN	O
prn	NN	O
,	,	O
percocet	JJ	B-TREATMENT
1-2	JJ	O
tabs	NN	O
po	NN	O
q	VBD	O
4-6	JJ	O
hours	NNS	O
prn	NN	O
,	,	O
ibuprofen	JJ	B-TREATMENT
400	CD	O
mg	NN	O
po	NN	O
q	VBD	O
6	CD	O
hours	NNS	O
prn	RB	O
,	,	O
tylenol	VBD	B-TREATMENT
650	CD	O
mg	NN	O
po	NN	O
q	VBD	O
4-6	JJ	O
hours	NNS	O
prn	NN	O
,	,	O
ativan	RB	B-TREATMENT
0.5	CD	O
mg	NNS	O
po	JJ	O
q	RB	O
8	CD	O
hours	NNS	O
prn	NN	O
.	.	O

right	RB	B-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
e.	JJ	B-PROBLEM
coli	NNS	I-PROBLEM
.	.	O

mri	NN	B-TEST
/	NNP	O
mra	NN	B-TEST
.	.	O

echocardiogram	NN	B-TEST
,	,	O
neurovascular	JJ	B-TEST
ultrasound	NN	I-TEST
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
73-year-old	JJ	O
retired	JJ	O
cook	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
cervical	JJ	B-PROBLEM
myelopathy	NN	I-PROBLEM
,	,	O
who	WP	O
is	VBZ	O
admitted	VBN	O
for	IN	O
new	JJ	B-PROBLEM
left	JJ	I-PROBLEM
hemiparesis	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
undergone	JJ	O
c-spine	JJ	B-TREATMENT
surgery	NN	I-TREATMENT
for	IN	O
spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
with	IN	O
a	DT	O
question	NN	O
of	IN	O
myelopathy	NN	B-PROBLEM
and	CC	O
radiculopathy	NN	B-PROBLEM
in	IN	O
1992	CD	O
with	IN	O
residual	JJ	B-PROBLEM
spastic	JJ	I-PROBLEM
paresis	NN	I-PROBLEM
and	CC	O
monoparesis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
,	,	O
but	CC	O
was	VBD	O
ambulatory	JJ	O
until	IN	O
a	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

he	PRP	O
also	RB	O
at	IN	O
baseline	NN	O
has	VBZ	O
had	VBN	O
urinary	JJ	B-PROBLEM
and	CC	I-PROBLEM
fecal	JJ	I-PROBLEM
urgencies	NNS	I-PROBLEM
/	VBP	O
incontinence	NN	B-PROBLEM
.	.	O

his	PRP$	O
history	NN	O
is	VBZ	O
now	RB	O
that	IN	O
he	PRP	O
has	VBZ	O
had	VBD	O
a	DT	O
week	NN	O
of	IN	O
progressive	JJ	B-PROBLEM
left	VBN	I-PROBLEM
upper	JJ	I-PROBLEM
extremity	NN	I-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
to	TO	O
the	DT	O
point	NN	O
of	IN	O
being	VBG	O
unable	JJ	O
to	TO	O
move	VB	O
the	DT	O
left	JJ	O
hand	NN	O
and	CC	O
one	CD	O
day	NN	O
of	IN	O
being	VBG	O
unable	JJ	O
to	TO	O
walk	VB	O
secondary	JJ	O
to	TO	O
left	VB	B-PROBLEM
leg	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
with	IN	O
a	DT	O
marked	JJ	O
tendency	NN	O
to	TO	O
fall	VB	O
leftward	NN	O
.	.	O

notable	JJ	O
for	IN	O
anemia	NN	B-PROBLEM
,	,	O
hypercholesterolemia	NN	B-PROBLEM
,	,	O
narcolepsy	NN	B-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
6	CD	O
years	NNS	O
on	IN	O
dexedrine	NN	B-TREATMENT
,	,	O
impotence	NN	B-PROBLEM
with	IN	O
decreased	JJ	B-PROBLEM
testosterone	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
implant	NN	B-TREATMENT
,	,	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
duodenal	JJ	B-TREATMENT
resection	NN	I-TREATMENT
,	,	O
cervical	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
decompression	NN	B-TREATMENT
&apos;92	NNP	O
,	,	O
hernia	NN	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
herniorrhaphy	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

medications	NNS	B-TREATMENT
on	IN	O
admission	NN	O
:	:	O

dexedrine	NN	B-TREATMENT
5	CD	O
mg	NN	O
per	IN	O
day	NN	O
and	CC	O
motrin	$	B-TREATMENT
600	CD	O
mg	NN	O
tid	NN	O
.	.	O

physical	JJ	B-TEST
examination	NN	I-TEST
:	:	O

on	IN	O
admission	NN	O
,	,	O
older	JJR	O
,	,	O
black	JJ	O
gentleman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
with	IN	O
left	JJ	B-TEST
upper	JJ	I-TEST
extremity	NN	I-TEST
flex	NN	I-TEST
across	IN	O
his	PRP$	O
chest	NN	O
.	.	O

his	PRP$	B-TEST
temperatureis	NN	I-TEST
98.9	CD	O
.	.	O

his	PRP$	B-TEST
pressure	NN	I-TEST
is	VBZ	O
150/90	CD	O
.	.	O

rate	NN	B-TEST
76	CD	O
.	.	O

respirations	NNS	B-TEST
16	CD	O
.	.	O

he	PRP	O
was	VBD	O
edentulous	JJ	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
mild	VBN	B-PROBLEM
copper	NN	I-PROBLEM
wiring	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	B-PROBLEM
i	JJ	I-PROBLEM
/	NN	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
sternal	JJ	I-PROBLEM
border	NN	I-PROBLEM
.	.	O

heart	NN	B-TEST
sounds	VBZ	I-TEST
were	VBD	O
normal	JJ	O
and	CC	O
regular	JJ	O
.	.	O

breath	NN	B-TEST
sounds	NNS	I-TEST
were	VBD	O
equal	JJ	O
bilaterally	RB	O
with	IN	O
course	NN	B-PROBLEM
rhonchi	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
midline	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
scar	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
reducible	JJ	I-PROBLEM
umbilical	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
otherwise	RB	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
2+	CD	B-TEST
carotids	NNS	I-TEST
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
gynecomastia	NN	B-PROBLEM
.	.	O

1+	CD	B-TEST
right	JJ	I-TEST
posterior	NN	I-TEST
tibialis	NNS	I-TEST
,	,	O
2+	CD	B-TEST
left	VBD	I-TEST
posterior	JJ	I-TEST
tibialis	NNS	I-TEST
,	,	O
no	DT	O
edema	NN	B-PROBLEM
,	,	O
ichthyotic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
were	VBD	O
present	JJ	O
.	.	O

his	PRP$	B-TEST
hip	NN	I-TEST
flexion	NN	I-TEST
was	VBD	O
4+	CD	O
on	IN	O
the	DT	O
right	NN	O
and	CC	O
4-	JJ	O
on	IN	O
the	DT	O
left	NN	O
;	:	O
extension	NN	B-TEST
5	CD	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
4+	CD	O
on	IN	O
the	DT	O
left	NN	O
;	:	O
knee	CC	B-TEST
flexion	NN	I-TEST
evidently	RB	O
trace	VBZ	O
on	IN	O
the	DT	O
right	NN	O
and	CC	O
4-	JJ	O
on	IN	O
the	DT	O
left	NN	O
with	IN	O
knee	JJ	B-TEST
extension	NN	I-TEST
5-	NN	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
5	CD	O
on	IN	O
the	DT	O
right	NN	O
;	:	O
knee	VB	B-TEST
flexion	NN	I-TEST
4-	CD	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
trace	NN	O
on	IN	O
the	DT	O
right	NN	O
;	:	O
ankle	CC	B-TEST
dorsi	VB	I-TEST
flexion	NN	I-TEST
4-	CD	O
on	IN	O
the	DT	O
left	NN	O
,	,	O
trace	NN	O
on	IN	O
the	DT	O
right	NN	O
.	.	O

reflexes	NNS	B-TEST
4+	CD	O
overall	JJ	O
in	IN	O
the	DT	O
upper	JJ	O
extremities	NNS	O
and	CC	O
3+	CD	O
overall	JJ	O
in	IN	O
the	DT	O
lower	JJR	O
extremities	NNS	O
,	,	O
an	DT	O
upgoing	JJ	O
left	NN	O
toe	NN	O
and	CC	O
a	DT	O
down	RP	O
going	VBG	O
right	JJ	O
toe	NN	O
.	.	O

he	PRP	O
was	VBD	O
mildly	RB	B-PROBLEM
perseverative	JJ	I-PROBLEM
and	CC	O
inattentive	JJ	B-PROBLEM
.	.	O

laboratory	NN	B-TEST
data	NNS	I-TEST
:	:	O

sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
3.6	CD	O
,	,	O
bun	NN	B-TEST
14	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
,	,	O
hematocrit	NN	B-TEST
37%	CD	O
,	,	O
platelets	NNS	B-TEST
177	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
4.1	CD	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
degenerative	JJ	B-PROBLEM
joint	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
an	DT	B-PROBLEM
ill	NN	I-PROBLEM
defined	VBD	I-PROBLEM
left	VBD	I-PROBLEM
hemi-diaphragm	NN	I-PROBLEM
without	IN	O
air	NN	B-PROBLEM
space	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

on	IN	O
the	DT	O
lateral	JJ	O
view	NN	O
,	,	O
surgical	JJ	B-TREATMENT
clips	NNS	I-TREATMENT
in	IN	I-TREATMENT
the	DT	I-TREATMENT
abdomen	NNS	I-TREATMENT
.	.	O

ekg	RB	B-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
,	,	O
no	DT	O
st	NN	B-PROBLEM
or	CC	I-PROBLEM
t	NN	I-PROBLEM
wave	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

hospital	NN	O
course	NN	O
and	CC	O
treatment	NN	B-TREATMENT
:	:	O

mr.	NN	O
finger	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
what	WP	O
appeared	VBD	O
to	TO	O
be	VB	O
a	DT	B-PROBLEM
stroke	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
involving	VBG	O
his	PRP$	O
left	JJ	O
middle	JJ	O
cerebral	JJ	O
artery	NN	O
territory	NN	O
.	.	O

he	PRP	O
underwent	VBD	O
neurovascular	JJ	B-TEST
doppler	NN	I-TEST
studies	NNS	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
significant	JJ	O
change	NN	O
in	IN	O
either	DT	O
common	JJ	O
carotid	NN	O
or	CC	O
in	IN	O
the	DT	O
left	JJ	O
common	JJ	O
internal	JJ	O
ophthalmic	JJ	O
system	NN	O
.	.	O

however	RB	O
,	,	O
there	EX	O
were	VBD	O
hemodynamic	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
which	WDT	O
raised	VBD	O
the	DT	O
question	NN	O
of	IN	O
right	JJ	B-PROBLEM
siphon	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

transcranial	JJ	B-TEST
dopplers	NNS	I-TEST
showed	VBD	O
no	DT	O
abnormalities	NNS	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
ophthalmic	JJ	I-PROBLEM
siphon	NN	I-PROBLEM
systems	NNS	I-PROBLEM
,	,	O
distal	JJ	O
vertebrals	NNS	O
,	,	O
or	CC	O
proximal	JJ	O
basilar	JJ	O
artery	NN	O
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
first	JJ	O
hospital	NN	O
day	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
exam	NN	I-TEST
deteriorated	VBN	O
in	IN	O
a	DT	O
manner	NN	O
that	WDT	O
appeared	VBD	O
to	TO	O
be	VB	O
blood	JJ	O
pressure	NN	O
dependent	NN	O
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
started	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
from	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
admission	NN	O
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
had	VBD	O
showed	VBN	O
multiple	JJ	B-PROBLEM
lacunes	NNS	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	VBN	O
,	,	O
and	CC	O
the	DT	O
deep	JJ	O
gray	NN	O
and	CC	O
white	JJ	O
matters	NNS	O
suspicious	JJ	O
for	IN	O
proximal	JJ	B-PROBLEM
middle	JJ	I-PROBLEM
cerebral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
stem	NN	I-PROBLEM
occlusion	NN	I-PROBLEM
or	CC	O
stenosis	NN	B-PROBLEM
.	.	O

mri	NN	B-TEST
/	NNP	O
mra	NN	B-TEST
was	VBD	O
performed	VBN	O
with	IN	O
diffusion	NN	O
weighted	VBN	O
images	NNS	O
,	,	O
showing	VBG	O
subcortical	JJ	B-PROBLEM
white	JJ	I-PROBLEM
matter	NN	I-PROBLEM
and	CC	O
basal	NN	B-PROBLEM
ganglia	NN	I-PROBLEM
infarcts	NNS	I-PROBLEM
,	,	O
but	CC	O
preserved	VBD	O
middle	JJ	O
cerebral	JJ	O
artery	NN	O
territory	NN	O
cortex	NN	O
.	.	O

because	IN	O
of	IN	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
,	,	O
dependence	NN	O
of	IN	O
his	PRP$	O
left	NN	O
sided	VBD	O
extremities	NNS	O
,	,	O
the	DT	O
lower	JJR	O
leg	NN	O
specifically	RB	O
,	,	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
where	WRB	O
he	PRP	O
underwent	JJ	O
hypertensive	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
for	IN	O
several	JJ	O
days	NNS	O
.	.	O

his	PRP$	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
goal	NN	O
was	VBD	O
initially	RB	O
170-190	JJ	O
,	,	O
which	WDT	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
achieve	VB	O
spontaneously	RB	O
for	IN	O
the	DT	O
most	JJS	O
part	NN	O
.	.	O

however	RB	O
,	,	O
due	JJ	O
to	TO	O
the	DT	O
absence	NN	O
of	IN	O
clear	JJ	O
benefit	NN	O
at	IN	O
this	DT	O
level	NN	O
,	,	O
and	CC	O
further	JJ	B-PROBLEM
deterioration	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	NN	I-PROBLEM
sided	VBD	I-PROBLEM
strength	NN	I-PROBLEM
,	,	O
this	DT	O
goal	NN	O
was	VBD	O
increased	VBN	O
and	CC	O
neo-synephrine	JJ	B-TREATMENT
was	VBD	O
added	VBN	O
to	TO	O
his	PRP$	O
regimen	NNS	O
to	TO	O
achieve	VB	O
mean	JJ	B-TEST
arterial	JJ	I-TEST
pressures	NNS	I-TEST
in	IN	O
the	DT	O
110-120	JJ	O
range	NN	O
.	.	O

this	DT	O
strategy	NN	O
and	CC	O
its	PRP$	O
incumbent	JJ	O
risks	NNS	O
,	,	O
particularly	RB	O
in	IN	O
a	DT	O
patient	NN	O
on	IN	O
heparin	NN	B-TREATMENT
,	,	O
were	VBD	O
discussed	VBN	O
at	IN	O
length	NN	O
with	IN	O
both	DT	O
the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
family	NN	O
,	,	O
who	WP	O
were	VBD	O
very	RB	O
clear	JJ	O
in	IN	O
wanting	VBG	O
to	TO	O
proceed	VB	O
with	IN	O
all	DT	O
possible	JJ	O
efforts	NNS	O
to	TO	O
save	VB	O
the	DT	O
use	NN	O
of	IN	O
his	PRP$	O
left	JJ	O
leg	NN	O
.	.	O

he	PRP	O
also	RB	O
,	,	O
as	IN	O
neo-synephrinewas	JJ	B-TREATMENT
tapered	NN	O
,	,	O
developed	VBD	O
mild	JJ	B-PROBLEM
sensory	JJ	I-PROBLEM
findings	NNS	I-PROBLEM
,	,	O
in	IN	O
particular	JJ	O
diminished	VBD	B-PROBLEM
large	JJ	I-PROBLEM
fiber	JJ	I-PROBLEM
sensibility	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
hand	NN	I-PROBLEM
,	,	O
although	IN	O
he	PRP	O
at	IN	O
times	NNS	O
,	,	O
including	VBG	O
near	IN	O
the	DT	O
end	NN	O
of	IN	O
his	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
had	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
gaze	NN	I-PROBLEM
preference	NN	I-PROBLEM
.	.	O

in	IN	O
terms	NNS	O
of	IN	O
exploring	VBG	O
his	PRP$	O
visual	JJ	O
space	NN	O
,	,	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
look	VB	O
to	TO	O
the	DT	O
left	NN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
not	RB	O
possible	JJ	O
to	TO	O
elicit	VB	O
clear	JJ	O
evidence	NN	O
for	IN	O
a	DT	B-PROBLEM
field	NN	I-PROBLEM
deficit	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
followed	VBN	O
by	IN	O
speech	NN	O
and	CC	O
swallowing	VBG	O
service	NN	O
,	,	O
who	WP	O
assisted	VBD	O
in	IN	O
the	DT	B-TREATMENT
management	NN	I-TREATMENT
of	IN	I-TREATMENT
po	NNS	I-TREATMENT
intake	VBP	I-TREATMENT
which	WDT	O
gradually	RB	O
improved	VBD	O
,	,	O
although	IN	O
he	PRP	O
clearly	RB	O
had	VBD	O
problems	NNS	O
with	IN	O
manipulation	NN	O
of	IN	O
food	NN	O
in	IN	O
the	DT	O
left	JJ	O
side	NN	O
of	IN	O
his	PRP$	O
mouth	NN	O
and	CC	O
would	MD	O
tend	VB	O
to	TO	O
accumulate	VB	O
a	DT	O
pouch	NN	O
of	IN	O
food	NN	O
in	IN	O
his	PRP$	O
left	JJ	O
cheek	NN	O
.	.	O

i	NN	O
should	MD	O
mention	VB	O
that	IN	O
his	PRP$	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
therapy	NN	I-TREATMENT
was	VBD	O
at	IN	O
times	NNS	O
limited	VBN	O
by	IN	O
a	DT	B-PROBLEM
severe	JJ	I-PROBLEM
headache	NN	I-PROBLEM
,	,	O
although	IN	O
he	PRP	O
also	RB	O
had	VBD	O
this	DT	O
off	RP	O
the	DT	B-TREATMENT
pressor	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
several	JJ	B-TEST
repeat	NN	I-TEST
imaging	VBG	I-TEST
studies	NNS	I-TEST
during	IN	O
his	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
stay	NN	O
which	WDT	O
showed	VBD	O
further	JJ	B-PROBLEM
demarcation	NN	I-PROBLEM
,	,	O
but	CC	O
not	RB	O
extension	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
prior	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
both	DT	O
on	IN	O
computerized	JJ	B-TEST
tomography	NN	I-TEST
scan	JJ	I-TEST
and	CC	O
dwi	JJ	B-TEST
images	NNS	I-TEST
.	.	O

additionally	RB	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
perfusion	NN	I-TEST
,	,	I-TEST
diffusion	NN	I-TEST
mr	NN	I-TEST
study	NN	I-TEST
earlier	RBR	O
on	IN	O
,	,	O
which	WDT	O
suggested	VBD	O
the	DT	O
presence	NN	O
of	IN	O
viable	JJ	B-PROBLEM
penumbra	NN	I-PROBLEM
,	,	O
including	VBG	O
the	DT	O
overlying	NN	O
cortex	NN	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
regular	JJ	O
neurology	NN	O
floor	NN	O
once	IN	O
it	PRP	O
became	VBD	O
clear	JJ	O
that	IN	O
he	PRP	O
was	VBD	O
not	RB	O
receiving	VBG	O
any	DT	O
significant	JJ	O
benefit	NN	O
from	IN	O
hypertensive	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
his	PRP$	B-TEST
neurologic	JJ	I-TEST
exam	NN	I-TEST
is	VBZ	O
notable	JJ	O
for	IN	O
hemiplegia	NN	B-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
hemiparesis	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
leg	NN	I-PROBLEM
,	,	O
mild	VB	B-PROBLEM
large	JJ	I-PROBLEM
fiber	NNP	I-PROBLEM
sensory	JJ	I-PROBLEM
loss	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
left	JJ	I-PROBLEM
arm	NN	I-PROBLEM
,	,	O
and	CC	O
otherwise	RB	O
fairly	RB	O
intact	JJ	O
mental	JJ	O
status	NN	O
,	,	O
cranial	JJ	O
nerve	NN	O
function	NN	O
,	,	O
and	CC	O
right	RB	O
sided	VBD	O
motor	NN	O
and	CC	O
sensory	JJ	O
function	NN	O
.	.	O

he	PRP	O
will	MD	O
be	VB	O
discharged	VBN	O
to	TO	O
rehab	VB	O
on	IN	O
a	DT	O
regimen	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
today	NN	O
then	RB	O
daily	RB	O
for	IN	O
an	DT	O
inr	JJ	B-TEST
goal	NN	O
of	IN	O
2-3	JJ	O
,	,	O
ofloxacin	JJ	B-TREATMENT
400	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
to	TO	O
be	VB	O
discontinued	VBN	O
on	IN	O
11/05/96	CD	O
,	,	O
dexedrine	NN	B-TREATMENT
5	CD	O
mg	NN	O
po	NN	O
qd	NN	O
,	,	O
omeprazole	JJ	B-TREATMENT
20mg	CD	O
po	NN	O
qd	NN	O
,	,	O
erythromycin	FW	B-TREATMENT
eye	NN	I-TREATMENT
ointment	JJ	I-TREATMENT
ou	JJ	O
bid	NN	O
,	,	O
heparin	NN	B-TREATMENT
at	IN	O
its	PRP$	O
present	JJ	O
rate	NN	O
adjusting	VBG	O
per	IN	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
bid	NN	O
,	,	O
and	CC	O
discontinuing	VBG	O
when	WRB	O
the	DT	B-TREATMENT
coumadin	NN	I-TREATMENT
is	VBZ	O
therapeutic	JJ	O
,	,	O
tylenol	JJ	B-TREATMENT
650	CD	O
mg	NN	O
po	NN	O
q4	NN	O
prn	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
po	NN	O
bid	NN	O
.	.	O

mrs.	NN	O
gonzalez	NN	O
is	VBZ	O
a	DT	O
patient	NN	O
with	IN	O
a	DT	O
prior	JJ	O
medical	JJ	O
history	NN	O
including	VBG	O
hypothyroidism	NN	B-PROBLEM
,	,	O
iron-deficiency	NN	B-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
osteoporosis	NN	B-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
constipation	NN	I-PROBLEM
,	,	O
and	CC	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
status	NN	O
post	NN	O
hysterectomy	NN	B-TREATMENT
and	CC	O
bilateral	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
for	IN	O
evaluation	NN	B-TEST
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
adenocarcinoma	NN	B-PROBLEM
involving	VBG	O
the	DT	O
transverse	NN	O
colon	NN	O
and	CC	O
gallbladder	NN	O
.	.	O

at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
the	DT	O
patient	NN	O
had	VBD	O
already	RB	O
seemed	VBN	O
some	DT	B-TEST
workup	NN	I-TEST
for	IN	O
a	DT	O
couple	JJ	O
weeks	NNS	O
duration	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
occasionally	RB	O
radiated	VBD	O
to	TO	O
her	PRP$	O
back	NN	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
complaining	VBG	O
of	IN	O
fatigue	NN	B-PROBLEM
for	IN	O
two	CD	O
weeks	NNS	O
but	CC	O
a	DT	O
good	JJ	O
appetite	NN	O
and	CC	O
the	DT	O
patient	NN	O
denied	VBD	O
weight	JJ	B-PROBLEM
loss	NN	I-PROBLEM
,	,	O
melena	NN	B-PROBLEM
,	,	O
or	CC	O
bright	RB	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
cat	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
showed	VBD	O
air-fluid	JJ	B-PROBLEM
levels	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
gallbladder	NN	I-PROBLEM
.	.	O

it	PRP	O
also	RB	O
showed	VBD	O
a	DT	B-PROBLEM
thickened	JJ	I-PROBLEM
gallbladder	NN	I-PROBLEM
wall	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
common	JJ	I-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
.	.	O

incidentally	RB	O
,	,	O
it	PRP	O
also	RB	O
showed	VBD	O
diverticulosis	NN	B-PROBLEM
.	.	O

a	DT	B-TEST
hida	JJ	I-TEST
scan	NN	I-TEST
at	IN	O
the	DT	O
other	JJ	O
hospital	NN	O
did	VBD	O
not	RB	O
show	VB	O
filling	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
gallbladder	NN	I-PROBLEM
indicating	VBG	O
some	DT	O
sort	NN	O
of	IN	O

cystic	JJ	B-PROBLEM
duct	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
first	JJ	I-TEST
imaging	NN	I-TEST
study	NN	I-TEST
that	WDT	O
was	VBD	O
done	VBN	O
at	IN	O
hahnemann	NN	O
general	JJ	O
hospital	NN	O
was	VBD	O
a	DT	B-TEST
mrcp	NN	I-TEST
which	WDT	O
revealed	VBD	O
an	DT	B-PROBLEM
enhanced	JJ	I-PROBLEM
thickened	JJ	I-PROBLEM
gallbladder	NN	I-PROBLEM
wall	NN	I-PROBLEM
consistent	NN	O
with	IN	O
chronic	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
.	.	O

a	DT	O
differential	JJ	O
according	VBG	O
to	TO	O
the	DT	B-TEST
imaging	NN	I-TEST
included	VBD	O
a	DT	B-PROBLEM
fistula	NN	I-PROBLEM
with	IN	O
adjacent	JJ	B-PROBLEM
inflammatory	JJ	I-PROBLEM
change	NN	I-PROBLEM
but	CC	O
also	RB	O
carcinoma	VBD	B-PROBLEM
or	CC	O
adenomatosis	NN	B-PROBLEM
.	.	O

in	IN	O
addition,	NN	O
also	RB	O
the	DT	B-TEST
mrcp	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
mass	NN	I-PROBLEM
near	IN	O
the	DT	O
region	NN	O
of	IN	O
the	DT	O
neck	NN	O
of	IN	O
the	DT	O
gallbladder	NN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
,	,	O
an	DT	B-TEST
endoscopy	NN	I-TEST
and	CC	O
colonoscopy	NN	B-TEST
were	VBD	O
performed	VBN	O
.	.	O

the	DT	B-TEST
colonoscopy	NN	I-TEST
showed	VBD	O
two	CD	B-PROBLEM
polyps	NNS	I-PROBLEM
and	CC	O
also	RB	O
a	DT	O
region	NN	O
in	IN	O
the	DT	O
transverse	NN	O
colon	NN	O
that	WDT	O
was	VBD	O
biopsied	VBN	O
.	.	O

this	DT	B-TEST
biopsy	NN	I-TEST
came	VBD	O
back	RB	O
as	IN	O
positive	JJ	O
for	IN	O
adenocarcinoma	NN	B-PROBLEM
.	.	O

the	DT	O
diagnosis	NN	O
of	IN	O
adenocarcinoma	NN	B-PROBLEM
was	VBD	O
already	RB	O
established	VBN	O
prior	RB	O
to	TO	O
her	PRP$	O
admission	NN	O
at	IN	O
this	DT	O
hospital	NN	O
.	.	O

given	VBN	O
a	DT	B-TREATMENT
low-residual	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
her	PRP	O
belly	RB	O
cleaned	VBD	O
with	IN	O
hibiclens	NNS	B-TREATMENT
one	CD	O
a	DT	O
day	NN	O
and	CC	O
once	RB	O
an	DT	B-TEST
adequate	JJ	I-TEST
preoperative	JJ	I-TEST
evaluation	NN	I-TEST
was	VBD	O
performed	VBN	O
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
a	DT	B-TREATMENT
bowel	NN	I-TREATMENT
prep	NN	I-TREATMENT
on	IN	O
monday	JJ	O
afternoon	NN	O
and	CC	O
evening	NN	O
in	IN	O
preparation	NN	O
for	IN	O
an	DT	O

exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
on	IN	O
tuesday	NN	O
,	,	O
2014-07-29	JJ	O
.	.	O

on	IN	O
the	DT	O
morning	NN	O
of	IN	O
2014-07-29	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
and	CC	O
underwent	NN	O
a	DT	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
,	,	O
partial	JJ	B-TREATMENT
hepatectomy	NN	I-TREATMENT
,	,	O
partial	JJ	B-TREATMENT
lymph	NN	I-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
a	DT	B-TREATMENT
colocolostomy	NN	I-TREATMENT
,	,	O
partial	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
and	CC	O
in	IN	O
addition	NN	O
a	DT	B-TREATMENT
gastrostomy	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
feeding	JJ	I-TREATMENT
jejunostomy	NN	I-TREATMENT
were	VBD	O
also	RB	O
put	VBN	O
in	IN	O
place	NN	O
.	.	O

please	NN	O
refer	NN	O
to	TO	O
the	DT	O
previously	RB	O
dictated	VBN	O
operative	JJ	O
notes	NNS	O
for	IN	O
the	DT	O
details	NNS	O
of	IN	O
this	DT	B-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

briefly	NN	O
,	,	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
on	IN	O
2014-07-29	JJ	O
revealed	VBD	O
a	DT	B-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
gallbladder	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
cholecystocolonic	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
which	WDT	O
crossed	VBD	O
into	IN	O
the	DT	O
liver	NN	O
as	RB	O
well	RB	O
as	IN	O
metastatic	JJ	B-PROBLEM
adenopathy	NN	I-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
portal	JJ	I-PROBLEM
nodes	NNS	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
retroperitoneal	NN	B-PROBLEM
nodes	NNS	I-PROBLEM
around	IN	I-PROBLEM
the	DT	I-PROBLEM
inferior	JJ	I-PROBLEM
vena	NN	I-PROBLEM
cava	NN	I-PROBLEM
and	CC	I-PROBLEM
the	DT	I-PROBLEM
hepatic	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
to	TO	O
the	DT	B-TREATMENT
gastrostomy	NN	I-TREATMENT
and	CC	O
feeding	VBG	B-TREATMENT
jejunostomy	NN	I-TREATMENT
tube	NN	I-TREATMENT
,	,	O
two	CD	B-TREATMENT
belmont-gardner	NN	I-TREATMENT
drains	NNS	I-TREATMENT
were	VBD	O
placed	VBN	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
pain	NN	I-PROBLEM
postoperatively	RB	O
was	VBD	O
controlled	VBN	O
with	IN	O
an	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
the	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
had	VBD	O
the	DT	O
consequence	NN	O
of	IN	O
causing	VBG	O
a	DT	O
bit	NN	O
of	IN	O
a	DT	B-PROBLEM
hypotension	NN	I-PROBLEM
in	IN	O
the	DT	O
patient	NN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
surgical	JJ	O
icu	NN	O
for	IN	O
the	DT	O
first	JJ	O
postoperative	JJ	O
day	NN	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
low	JJ	B-PROBLEM
hematocrits	NNS	I-PROBLEM
which	WDT	O
required	VBD	O
a	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
out	RP	O
to	TO	O
the	DT	O
floor	NN	O
and	CC	O
she	PRP	O
was	VBD	O
doing	VBG	O
better	RBR	O
in	IN	O
terms	NNS	O
of	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
on	IN	O
a	DT	B-TREATMENT
dilaudid	JJ	I-TREATMENT
pca	NN	I-TREATMENT
machine	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
two	CD	O
,	,	O
interestingly	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
complaining	VBG	O
of	IN	O
sensitivity	NN	B-PROBLEM
to	TO	I-PROBLEM
light	NN	I-PROBLEM
from	IN	O
an	DT	O
unknown	JJ	O
etiology	NN	O
.	.	O

the	DT	O
patient	NN	O
's	POS	O
postoperative	JJ	O
course	NN	O
was	VBD	O
unremarkable	JJ	O
aside	RB	O
from	IN	O
the	DT	B-PROBLEM
photophobia	NN	I-PROBLEM
.	.	O

following	VBG	O
that	IN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
slowly	RB	O
advanced	JJ	O
to	TO	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
and	CC	O
to	TO	O
a	DT	O
regular	JJ	O
diet	NN	O
once	IN	O
her	PRP$	O
bowels	NNS	O
began	VBD	O
working	VBG	O
when	WRB	O
she	PRP	O
began	VBD	O
having	VBG	O
flatus	NN	O
.	.	O

her	PRP$	O
bowel	NN	O
function	NN	O
was	VBD	O
slow	JJ	O
to	TO	O
develop	VB	O
and	CC	O
she	PRP	O
needed	VBD	O
to	TO	O
remain	VB	O
n.p.o.	JJ	B-TREATMENT
until	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
six	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
given	VBN	O
supplemental	JJ	B-TREATMENT
tube	NN	I-TREATMENT
feedings	NNS	I-TREATMENT
to	TO	O
supplement	VB	O
her	PRP$	O
calories	NNS	O
and	CC	O
caloric	JJ	O
intake	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
seven	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
her	PRP$	B-TREATMENT
clear	JJ	I-TREATMENT
liquid	JJ	I-TREATMENT
diet	NN	I-TREATMENT
and	CC	O
her	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
p.o.	NN	B-TREATMENT
medicines	NNS	I-TREATMENT
and	CC	O
her	PRP$	B-TREATMENT
first	JJ	I-TREATMENT
belmont-gardner	NN	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
pulled	VBN	O
due	JJ	O
to	TO	O
scant	JJ	O
output	NN	O
.	.	O

by	IN	O
2014-08-09	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
tolerating	VBG	O
a	DT	O
full	JJ	O
solid	JJ	O
diet	NN	O
as	RB	O
well	RB	O
as	IN	O
her	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
discharged	VBN	O
to	TO	O
home	NN	O
with	IN	O
services	NNS	O
including	VBG	O
tube	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
for	IN	O
her	PRP$	O
home	NN	O
care	NN	O
.	.	O

1.	CD	O
metastatic	JJ	B-PROBLEM
gallbladder	NN	I-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

2.	CD	O
status	NN	O
post	NN	O
cholecystectomy	NN	B-TREATMENT
.	.	O

3.	CD	O
status	NN	O
post	NN	O
transverse	NN	B-TREATMENT
colectomy	NN	I-TREATMENT
with	IN	O
anastomosis	NN	B-PROBLEM
.	.	O

4.	CD	O
g	JJ	B-TREATMENT
tube	NN	I-TREATMENT
placement	NN	I-TREATMENT
.	.	O

5.	CD	O
feeding	VBG	B-TREATMENT
jejunostomy	NN	I-TREATMENT
.	.	O

6.	CD	O
hypothyroidism	NN	B-PROBLEM
.	.	O

7.	CD	O
blood	NN	B-PROBLEM
loss	NN	I-PROBLEM
requiring	VBG	O
transfusion	NN	B-TREATMENT
.	.	O

1.	CD	O
levothyroxine	JJ	B-TREATMENT
100	CD	O
micrograms	NNS	O
orally	RB	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

2.	CD	O
pantoprazole	JJ	B-TREATMENT
one	CD	O
tablet	NN	O
once	IN	O
a	DT	O
day	NN	O
.	.	O

3.	CD	O
ambien	JJ	B-TREATMENT
10	CD	O
mg	NNS	O
orally	RB	O
before	IN	O
bed	NN	O
.	.	O

4.	CD	O
tylenol	JJ	B-TREATMENT
#	#	O
3	CD	O
one	CD	O
tablet	NN	O
every	DT	O
four	CD	O
hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

5.	CD	O
reglan	NN	B-TREATMENT
10	CD	O
mg	NN	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
before	IN	O
meals	NNS	O
and	CC	O
at	IN	O
bedtime	NN	O
.	.	O

6.	CD	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

follow-up	NN	O
with	IN	O
the	DT	O
visiting	VBG	O
nurses	NNS	O
association	NN	O
to	TO	O
arrange	VB	O
assistance	NN	O
with	IN	O
her	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feeding	NN	I-TREATMENT
and	CC	O

necrotizing	VBG	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

necrotizing	VBG	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

1.	CD	O
wegener	NN	B-PROBLEM
&apos;s	JJ	I-PROBLEM
granulomatosis	NN	I-PROBLEM
.	.	O

2.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
anterior	RB	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
1993	CD	O
.	.	O

3.	CD	O
left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

4.	CD	O
dementia	NN	B-PROBLEM
.	.	O

5.	CD	O
gallstone	NN	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

6.	CD	O
fungal	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
.	.	O

7.	CD	O
intra-abdominal	JJ	B-PROBLEM
infection	NN	I-PROBLEM
.	.	O

8.	CD	O
total	JJ	B-PROBLEM
parenteral	JJ	I-PROBLEM
nutrition	NN	I-PROBLEM
dependent	NN	I-PROBLEM
.	.	O

exploratory	JJ	B-TEST
laparotomy	NN	I-TEST
,	,	O
left	VBD	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
end-transverse	JJ	B-TREATMENT
colostomy	NN	I-TREATMENT
,	,	O
drainage	NN	B-TREATMENT
of	IN	O
pancreatic	JJ	B-PROBLEM
necrosis	NN	I-PROBLEM
.	.	O

mr.	JJ	O
mass	NN	O
was	VBD	O
a	DT	O
56	CD	O
year	NN	O
old	JJ	O
white	JJ	O
male	NN	O
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
vassdiysey	JJ	O
medical	JJ	O
center	NN	O
for	IN	O
rule	NN	O
out	IN	O
pancreatic	JJ	B-PROBLEM
pseudocyst	NN	I-PROBLEM
.	.	O

mr.	JJ	O
mass	NNP	O
had	VBD	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
which	WDT	O
included	VBD	O
wegener	NN	B-PROBLEM
&apos;s	NNP	I-PROBLEM
granulomatosis	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
and	CC	O
gallstone	NN	B-PROBLEM
pancreatitis	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
vassdiysey	VB	O
medical	JJ	O
center	NN	O
with	IN	O
severe	JJ	B-PROBLEM
recurrent	NN	I-PROBLEM
pancreatitis	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	NN	B-PROBLEM
,	,	O
and	CC	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
amylase	NN	I-TEST
on	IN	O
admission	NN	O
there	EX	O
was	VBD	O
1,961	CD	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
two	CD	O
recent	JJ	O
admissions	NNS	O
for	IN	O
pancreatitis	NN	B-PROBLEM
in	IN	O
january	JJ	O
1994	CD	O
,	,	O
and	CC	O
august	JJ	O
1994	CD	O
.	.	O

his	PRP$	B-TEST
amylase	NN	I-TEST
decreased	VBD	O
to	TO	O
51	CD	O
,	,	O
and	CC	O
the	DT	O
increased	VBN	O
back	RB	O
to	TO	O
151	CD	O
on	IN	O
hospital	JJ	O
day	NN	O
#10	NNP	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
he	PRP	O
spiked	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
to	TO	O
103	CD	O
.	.	O

he	PRP	O
also	RB	O
became	VBD	O
increasingly	RB	B-PROBLEM
confused	VBN	I-PROBLEM
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	JJ	I-TEST
done	VBN	O
on	IN	O
4/16/95	CD	O
showed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
&quot;	NNP	I-PROBLEM
pseudocyst	NN	I-PROBLEM
&quot;	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
ph	VB	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
for	IN	O
further	JJ	B-TEST
surgical	JJ	I-TEST
evaluation	NN	I-TEST
.&apos;	NN	O

2.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
anterior	RB	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
in	IN	O
1993	CD	O
.	.	O

ejection	NN	B-TEST
fraction	NN	I-TEST
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
35%	CD	O
in	IN	O
1993	CD	O
.	.	O

recent	JJ	B-TEST
echocardiogram	NN	I-TEST
suggests	VBZ	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
15%	CD	O
.	.	O

3.	CD	O
wegener	NN	B-PROBLEM
&apos;s	JJ	I-PROBLEM
granulomatosis	NN	I-PROBLEM
,	,	O
with	IN	O
associated	VBN	B-PROBLEM
chronic	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

4.	CD	O
mild	JJ	B-PROBLEM
dementia	NN	I-PROBLEM
.	.	O

vitamin	NN	B-TREATMENT
k	NN	I-TREATMENT
,	,	O
10	CD	O
mg.	NN	O
,	,	O
im	NN	O
,	,	O
q-week	JJ	O
.	.	O

2.	CD	O
pepcid	NN	B-TREATMENT
,	,	O
20	CD	O
mg.	NN	O
,	,	O
intravenously	RB	O
,	,	O
q12h.	NN	O

3.	CD	O
digoxin	NN	B-TREATMENT
,	,	O
0.125	CD	O
mg.	NN	O
,	,	O
intravenously	RB	O
,	,	O
qd	NN	O
.	.	O

4.	CD	O
imipenem	NN	B-TREATMENT
,	,	O
500	CD	O
mg.	NN	O
,	,	O
intravenously	RB	O
,	,	O
q6h.	NN	O

5.	CD	O
nitropaste	NN	B-TREATMENT
,	,	O
one-half	JJ	O
inch	NN	O
to	TO	O
chest	VB	O
wall	NN	O
,	,	O
q6h.	NN	O

6.	CD	O
vasotec	NN	B-TREATMENT
.	.	O

7.	CD	O
alterajel	NN	B-TREATMENT
.	.	O

8.	CD	O
lasix	NN	B-TREATMENT
,	,	O
20	CD	O
mg.	NN	O
,	,	O
po	NN	O
,	,	O
qd	NN	O
.	.	O

9.	CD	O
haldol	NN	B-TREATMENT
.	.	O

10.	CD	O
demerol	NN	B-TREATMENT
,	,	O
prn	NN	O
.	.	O

ativan	NN	B-TREATMENT
.	.	O

in	IN	O
general	JJ	O
,	,	O
confused	JJ	O
white	JJ	O
man	NN	O
,	,	O
in	IN	O
mild	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

temperature	NN	B-TEST
was	VBD	O
102	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
110	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
22	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
113/63	CD	O
.	.	O

rales	NNS	B-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
,	,	O
bilateral	JJ	B-PROBLEM
decreased	VBN	I-PROBLEM
breath	NN	I-PROBLEM
sounds	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
no	DT	O
extra	JJ	B-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
,	,	O
abdomen	NNS	B-PROBLEM
distended	VBD	I-PROBLEM
with	IN	O
an	DT	B-PROBLEM
epigastric	JJ	I-PROBLEM
mass	NN	I-PROBLEM
noted	VBD	O
,	,	O
mildly	RB	B-PROBLEM
tender	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
,	,	O
no	DT	O
guarding	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
14.4	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
36.2	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
was	VBD	O
217	CD	O
,	,	O
sodium	NN	B-TEST
was	VBD	O
135	CD	O
,	,	O
potassium	NN	B-TEST
was	VBD	O
3.3	CD	O
,	,	O
chloride	NN	B-TEST
was	VBD	O
99	CD	O
,	,	O
bicarbonate	NN	B-TEST
was	VBD	O
25	CD	O
,	,	O
bun	NN	B-TEST
was	VBD	O
40	CD	O
,	,	O
creatinine	NN	B-TEST
was	VBD	O
1.9	CD	O
,	,	O
glucose	NN	B-TEST
was	VBD	O
124	CD	O
,	,	O
urinalysis	NN	B-TEST
was	VBD	O
negative	JJ	O
,	,	O
pt	NN	B-TEST
was	VBD	O
12.2	CD	O
,	,	O
ptt	NN	B-TEST
was	VBD	O
24.5	CD	O
,	,	O
calcium	NN	B-TEST
was	VBD	O
7.8	CD	O
,	,	O
phosphorus	NN	B-TEST
was	VBD	O
3.7	CD	O
,	,	O
albumin	NN	B-TEST
was	VBD	O
2.3	CD	O
,	,	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
1.3	CD	O
,	,	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
was	VBD	O
202	CD	O
,	,	O
sgpt	NN	B-TEST
was	VBD	O
32	CD	O
,	,	O
sgot	VBD	B-TEST
was	VBD	O
64	CD	O
,	,	O
ldh	NN	B-TEST
was	VBD	O
998	CD	O
,	,	O
amylase	NN	B-TEST
was	VBD	O
150	CD	O
.	.	O

ekg	NN	B-TEST
revealed	VBD	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
at	IN	O
107	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

evidence	NN	O
of	IN	O
old	JJ	B-PROBLEM
left	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
septal	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

chest	JJ	B-TEST
x-ray	NN	I-TEST
:	:	O

large	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ventricle	NN	I-PROBLEM
,	,	O
bilateral	JJ	B-PROBLEM
atelectasis	NN	I-PROBLEM
or	CC	O
effusion	NN	B-PROBLEM
.	.	O

abdominal	JJ	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
:	:	O

pancreatitis	NN	B-PROBLEM
,	,	O
fluid	NN	B-PROBLEM
collection	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lesser	JJR	I-PROBLEM
sac	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
perisplenic	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
which	WDT	O
appeared	VBD	O
to	TO	O
communicate	VB	O
with	IN	O
the	DT	B-PROBLEM
lesser	JJR	I-PROBLEM
sac	NN	I-PROBLEM
collection	NN	I-PROBLEM
.	.	O

gallbladder	NN	O
was	VBD	O
visualized	VBN	O
with	IN	O
stones	NNS	B-PROBLEM
.	.	O

in	IN	O
summary	JJ	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
considered	VBN	O
to	TO	O
have	VB	O
severe	JJ	B-PROBLEM
necrotizing	VBG	I-PROBLEM
pancreatitis	NN	I-PROBLEM
,	,	O
with	IN	O
severe	JJ	B-PROBLEM
cardiac	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
,	,	O
placed	VBN	O
on	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
imipenem	NN	I-TREATMENT
,	,	I-TREATMENT
intravenously	RB	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
total	JJ	B-TREATMENT
parenteral	JJ	I-TREATMENT
nutrition	NN	I-TREATMENT
.	.	O

on	IN	O
4/17/95	CD	O
,	,	O
gi	FW	O
interventional	JJ	O
radiology	NN	O
performed	VBD	O
drainage	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
peripancreatic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
.	.	O

approximately	RB	O
one	CD	O
liter	NN	O
of	IN	O
brownish	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
was	VBD	O
obtained	VBN	O
and	CC	O
sent	VBN	O
for	IN	O
culture	NN	B-TEST
.	.	O

the	DT	B-TREATMENT
drainage	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
left	VBN	O
in	IN	O
a	DT	B-PROBLEM
pseudocyst	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
persantine	NN	I-TEST
thallium	NN	I-TEST
study	NN	I-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
involving	VBG	O
the	DT	O
posteroseptal	NN	O
,	,	O
anteroseptal	JJ	O
areas	NNS	O
.	.	O

left	VBD	B-PROBLEM
ventricular	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
was	VBD	O
also	RB	O
noted	VBN	O
;	:	O
however	RB	O
,	,	O
no	DT	O
ischemia	NN	B-PROBLEM
was	VBD	O
seen	VBN	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
was	VBD	O
done	VBN	O
.	.	O

the	DT	B-TEST
echocardiogram	NN	I-TEST
showed	VBD	O
terrible	JJ	B-PROBLEM
left	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
function	NN	I-PROBLEM
,	,	O
with	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
drainage	NN	I-TREATMENT
catheter	NN	I-TREATMENT
continued	VBD	O
to	TO	O
have	VB	O
high	JJ	O
output	NN	O
.	.	O

the	DT	O
fluid	NN	O
was	VBD	O
sent	VBN	O
for	IN	O
amylase	NN	B-TEST
,	,	O
which	WDT	O
came	VBD	O
back	RB	O
53,230	CD	O
.	.	O

on	IN	O
4/28/95	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
new	JJ	O
onset	NN	O
of	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

his	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
had	VBD	O
bumped	VBN	O
from	IN	O
8.3	CD	O
on	IN	O
admission	NN	O
to	TO	O
18.5	CD	O
,	,	O
on	IN	O
4/27	CD	O
.	.	O

a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

approximately	RB	O
100	CD	O
cc.&apos;s	NN	O
of	IN	O
thick	JJ	B-PROBLEM
brownish	JJ	I-PROBLEM
material	NN	I-PROBLEM
was	VBD	O
aspirated	VBN	O
through	IN	O
the	DT	B-TREATMENT
indwelling	NN	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
showed	VBD	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
tip	NN	I-TREATMENT
in	IN	O
good	JJ	O
position	NN	O
.	.	O

because	IN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
deteriorating	VBG	I-PROBLEM
state	NN	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
4/28/95	CD	O
.	.	O

an	DT	B-TEST
exploratory	JJ	I-TEST
laparotomy	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

the	DT	O
splenic	JJ	O
flexure	NN	O
had	VBD	O
a	DT	B-PROBLEM
purulent	JJ	I-PROBLEM
exudative	JJ	I-PROBLEM
process	NN	I-PROBLEM
along	IN	I-PROBLEM
the	DT	I-PROBLEM
antimesenteric	JJ	I-PROBLEM
surface	NN	I-PROBLEM
.	.	O

thus	RB	O
,	,	O
the	DT	O
splenic	JJ	O
flexure	NN	O
and	CC	O
a	DT	O
portion	NN	O
of	IN	O
the	DT	O
descending	VBG	O
colon	NN	O
were	VBD	O
resected	VBN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
with	IN	O
end	JJ	B-TREATMENT
transverse	NN	I-TREATMENT
colostomy	NN	I-TREATMENT
,	,	O
and	CC	O
oversewing	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
descending	NN	I-TREATMENT
colon	NN	I-TREATMENT
.	.	O

drainage	NN	B-TREATMENT
of	IN	O
the	DT	B-PROBLEM
pancreatic	JJ	I-PROBLEM
necrosis	NN	I-PROBLEM
was	VBD	O
also	RB	O
done	VBN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
fairly	RB	O
well	RB	O
,	,	O
and	CC	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
extubated	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#2	NNP	O
,	,	O
but	CC	O
remained	VBD	O
pressor-dependent	NN	B-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
on	IN	O
imipenem	NN	B-TREATMENT
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
was	VBD	O
also	RB	O
started	VBN	O
.	.	O

thereafter	RB	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
long	JJ	I-PROBLEM
and	CC	I-PROBLEM
complicated	JJ	I-PROBLEM
postoperative	JJ	I-PROBLEM
course	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
repeated	VBN	O
episodes	NNS	O
of	IN	O
hypotension	NN	B-PROBLEM
to	TO	O
80-90	JJ	B-TEST
systolic/40-50	JJ	I-TEST
diastolic	NN	I-TEST
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
repeated	VBN	B-PROBLEM
temperature	NN	I-PROBLEM
spikes	NNS	I-PROBLEM
.	.	O

after	IN	O
repeated	VBN	B-TEST
work	NN	I-TEST
ups	RB	I-TEST
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
these	DT	O
were	VBD	O
probably	RB	O
due	JJ	O
to	TO	O
remaining	VBG	B-PROBLEM
infection	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
peripancreatic	JJ	I-PROBLEM
area	NN	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
drainage	NN	I-TREATMENT
tube	NN	I-TREATMENT
from	IN	I-TREATMENT
the	DT	I-TREATMENT
peripancreatic	JJ	I-TREATMENT
area	NN	I-TREATMENT
was	VBD	O
gradually	RB	O
advanced	JJ	O
,	,	O
and	CC	O
eventually	RB	O
discontinued	VBN	O
.	.	O

mr.	JJ	O
mass	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
multiple	JJ	O
courses	NNS	O
of	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

most	RBS	O
recently	RB	O
,	,	O
he	PRP	O
was	VBD	O
on	IN	O
a	DT	O
28	CD	O
day	NN	O
course	NN	O
of	IN	O
vancomycin	NN	B-TREATMENT
,	,	O
ofloxacin	NN	B-TREATMENT
,	,	O
and	CC	O
flagyl	NN	B-TREATMENT
,	,	O
for	IN	O
blood	NN	B-TEST
cultures	NNS	I-TEST
that	WDT	O
were	VBD	O
positive	JJ	O
for	IN	O
gram	JJ	B-PROBLEM
positive	JJ	I-PROBLEM
cocci	NN	I-PROBLEM
and	CC	O
enteric	JJ	B-PROBLEM
and	CC	I-PROBLEM
non-enteric	JJ	I-PROBLEM
gram	NN	I-PROBLEM
negative	JJ	I-PROBLEM
rods	NNS	I-PROBLEM
.	.	O

this	DT	B-TREATMENT
28	CD	I-TREATMENT
day	NN	I-TREATMENT
course	NN	I-TREATMENT
was	VBD	O
completed	VBN	O
on	IN	O
07/15/95	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
treated	VBN	O
initially	RB	O
with	IN	O
amphotericin-b	JJ	B-TREATMENT
and	CC	O
then	RB	O
with	IN	O
fluconazole	NN	B-TREATMENT
for	IN	O
a	DT	B-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
guided	VBD	I-TEST
aspirate	NN	I-TEST
of	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
around	IN	I-PROBLEM
his	PRP$	I-PROBLEM
pancreas	NN	I-PROBLEM
,	,	O
which	WDT	O
grew	VBD	O
candida	NNS	B-PROBLEM
albicans	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
several	JJ	O
episodes	NNS	O
of	IN	O
fungal	JJ	B-PROBLEM
cystitis	NN	I-PROBLEM
with	IN	O
torulopsis	NN	B-PROBLEM
glabrata	NN	I-PROBLEM
,	,	O
going	VBG	O
from	IN	O
his	PRP$	B-TEST
urine	NN	I-TEST
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
amphotericin-b	JJ	B-TREATMENT
bladder	NN	I-TREATMENT
washes	NNS	I-TREATMENT
for	IN	O
this	DT	O
.	.	O

mr.	JJ	O
mass	NN	O
was	VBD	O
initially	RB	O
anticoagulated	VBN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
left	JJ	I-PROBLEM
ventricular	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
problems	NNS	B-PROBLEM
with	IN	O
po	JJ	O
intake	NN	O
.	.	O

he	PRP	O
had	VBD	O
repeated	VBN	O
bouts	NNS	O
of	IN	O
small-volume	JJ	B-PROBLEM
emesis	NN	I-PROBLEM
that	WDT	O
may	MD	O
have	VB	O
been	VBN	O
secondary	JJ	O
to	TO	O
reflux	VB	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	O
variety	NN	O
of	IN	O
anti-emetics	NNS	B-TREATMENT
,	,	O
most	JJS	O
recently	RB	O
granisetron	NN	B-TREATMENT
,	,	O
with	IN	O
only	JJ	O
mild	JJ	O
success	NN	O
.	.	O

he	PRP	O
remained	VBD	O
total	JJ	B-PROBLEM
parenteral	JJ	I-PROBLEM
nutrition-dependent	NN	I-PROBLEM
throughout	IN	O
his	PRP$	O
hospital	NN	O
course	NN	O
.	.	O

by	IN	O
the	DT	O
end	NN	O
of	IN	O
june	NN	O
,	,	O
it	PRP	O
became	VBD	O
clear	JJ	O
that	IN	O
mr.	JJ	O
mass	NNP	O
would	MD	O
require	VB	O
aggressive	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
in	IN	O
order	NN	O
to	TO	O
eradicate	VB	O
his	PRP$	B-PROBLEM
intra-abdominal	JJ	I-PROBLEM
bursts	NNS	I-PROBLEM
of	IN	I-PROBLEM
intermittent	JJ	I-PROBLEM
sepsis	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
long	JJ	O
discussions	NNS	O
with	IN	O
the	DT	O
patient	NN	O
and	CC	O
his	PRP$	O
wife	NN	O
,	,	O
who	WP	O
was	VBD	O
his	PRP$	O
health-care	JJ	O
proxy	NN	O
,	,	O
revealed	VBD	O
that	IN	O
they	PRP	O
felt	VBD	O
that	IN	O
no	DT	O
further	JJ	B-TREATMENT
aggressive	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
be	VB	O
attempted	VBN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
given	VBN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
do	VBP	O
not	RB	O
resuscitate	VB	O
status	NN	O
and	CC	O
the	DT	B-PROBLEM
risk	NN	I-PROBLEM
for	IN	I-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
stopped	VBN	O
without	IN	O
incident	JJ	O
several	JJ	O
weeks	NNS	O
before	IN	O
transfer	NN	O
.	.	O

1.	CD	O
heparin	NN	B-TREATMENT
,	,	O
5,000	CD	O
units	NNS	O
,	,	O
sc.	NN	O
,	,	O
b.i.d.	NN	O

2.	CD	O
lisinopril	NN	B-TREATMENT
,	,	O
20	CD	O
mg.	NN	O
,	,	O
po	NN	O
,	,	O
qd	NN	O
.	.	O

3.	CD	O
isordil	NN	B-TREATMENT
,	,	O
10	CD	O
mg.	NN	O
,	,	O
po	NN	O
,	,	O
t.i.d.	NN	O

4.	CD	O
nitropaste	NN	B-TREATMENT
,	,	O
1	CD	O
inch	NN	O
to	TO	O
chest	VB	O
wall	NN	O
,	,	O
q8h.	NN	O

5.	CD	O
carafate	NN	B-TREATMENT
,	,	O
one	CD	O
gram	NN	O
,	,	O
po	NN	O
or	CC	O
per	IN	O
nasogastric	JJ	B-TREATMENT
tube	NN	I-TREATMENT
,	,	O
q.i.d.	NN	O
,	,	O
cardizem	NN	B-TREATMENT
,	,	O
30	CD	O
mg.	NN	O
,	,	O
po	NN	O
,	,	O
q6h	NN	O
,	,	O
digoxin	NN	B-TREATMENT
,	,	O
0.25	CD	O
mg.	NN	O
,	,	O
po	NN	O
or	CC	O
intravenously	RB	O
,	,	O
qd	NN	O
,	,	O
fluconazole	NN	B-TREATMENT
,	,	O
200	CD	O
mg.	NN	O
,	,	O
qd	NN	O
,	,	O
for	IN	O
five	CD	O
more	JJR	O
days	NNS	O
,	,	O
after	IN	O
transfer	NN	O
,	,	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
a	DT	O
14	CD	O
day	NN	O
course	NN	O
,	,	O
total	JJ	B-TREATMENT
parenteral	JJ	I-TREATMENT
nutrition	NN	I-TREATMENT
to	TO	O
meet	VB	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
nutritional	JJ	O
needs	NNS	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
an	DT	B-TREATMENT
ostomy	JJ	I-TREATMENT
appliance	NN	I-TREATMENT
around	IN	O
the	DT	O
former	JJ	O
site	NN	O
of	IN	O
his	PRP$	B-TREATMENT
pancreatic	JJ	I-TREATMENT
fistula	NN	I-TREATMENT
drain	NN	I-TREATMENT
.	.	O

this	DT	O
area	NN	O
has	VBZ	O
continued	VBN	O
to	TO	O
drain	VB	O
and	CC	O
it	PRP	O
is	VBZ	O
felt	VBN	O
that	IN	O
it	PRP	O
could	MD	O
be	VB	O
best	RB	O
managed	VBN	O
by	IN	O
an	DT	B-TREATMENT
ostomy	JJ	I-TREATMENT
appliance	NN	I-TREATMENT
and	CC	O
stoma	NN	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
also	RB	O
treated	VBN	O
with	IN	O
shots	NNS	B-TREATMENT
of	IN	I-TREATMENT
morphine	NN	I-TREATMENT
for	IN	O
intermittent	NN	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

mr.	NN	O
olander	NN	O
had	VBD	O
acute	JJ	B-PROBLEM
blood	NN	I-PROBLEM
loss	NN	I-PROBLEM
anemia	NN	I-PROBLEM
from	IN	O
the	DT	O
combination	NN	O
of	IN	O
the	DT	B-PROBLEM
gunshot	NN	I-PROBLEM
wound	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
distal	NN	I-PROBLEM
femur	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
requirements	NNS	O
for	IN	O
urgent	JJ	B-TREATMENT
open	JJ	I-TREATMENT
reduction	NN	I-TREATMENT
,	,	O
internal	JJ	B-TREATMENT
fixation	NN	I-TREATMENT
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
dropped	VBD	O
down	RB	O
to	TO	O
the	DT	O
level	NN	O
of	IN	O
20	CD	O
.	.	O

although	IN	O
he	PRP	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
,	,	O
we	PRP	O
elected	VBD	O
to	TO	O
move	VB	O
ahead	RB	O
and	CC	O
transfuse	VB	O
him	PRP	O
with	IN	O
nonautologous	JJ	B-TREATMENT
prbc	NN	I-TREATMENT
.	.	O

left	VBN	B-TREATMENT
axillary	JJ	I-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
status	NN	O
post	NN	O
breast	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
49	CD	O
year	NN	O
old	JJ	O
previously	RB	O
healthy	JJ	O
female	NN	O
,	,	O
who	WP	O
was	VBD	O
diagnosed	VBN	O
in	IN	O
june	NN	O
,	,	O
1992	CD	O
,	,	O
with	IN	O
a	DT	B-PROBLEM
breast	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
after	IN	O
she	PRP	O
presented	VBD	O
with	IN	O
some	DT	B-PROBLEM
breast	NN	I-PROBLEM
discomfort	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
wide	JJ	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
breast	NN	I-PROBLEM
mass	NN	I-PROBLEM
by	IN	O
dr.	NN	O
ausguall	NN	O
on	IN	O
8/17/93	CD	O
.	.	O

pathology	NN	B-TEST
of	IN	O
this	DT	B-TREATMENT
resection	NN	I-TREATMENT
revealed	VBD	O
a	DT	B-PROBLEM
grade	NN	I-PROBLEM
iii	NN	I-PROBLEM
/	NNP	I-PROBLEM
iii	NN	I-PROBLEM
infiltrating	VBG	I-PROBLEM
ductal	JJ	I-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

she	PRP	O
now	RB	O
presents	VBZ	O
for	IN	O
left	JJ	B-TREATMENT
axillary	JJ	I-TREATMENT
node	NN	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
to	TO	O
complete	VB	O
her	PRP$	O
staging	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

is	VBZ	O
negative	JJ	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
breast	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
female	NN	O
,	,	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
are	VBP	O
stable	JJ	O
,	,	O
she	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
.	.	O

reveals	NNS	O
no	DT	O
adenopathy	NN	B-PROBLEM
,	,	O
extra	JJ	O
ocular	JJ	O
movements	NNS	O
intact	JJ	O
,	,	O
pupils	JJ	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
normal	JJ	O
first	JJ	O
and	CC	O
second	JJ	O
heart	NN	O
sounds	VBZ	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
or	CC	O
gallop	NN	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
and	CC	O
percussion	NN	B-TEST
.	.	O

soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
there	EX	O
is	VBZ	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

reveals	NNS	O
a	DT	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
incision	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
side	NN	I-PROBLEM
,	,	O
there	EX	O
are	VBP	O
no	DT	O
axillary	JJ	O
lymph	NN	O
nodes	NNS	O
palpable	JJ	O
on	IN	O
both	DT	O
sides	NNS	O
.	.	O

reveal	NN	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

sodium	NN	B-TEST
140	CD	O
,	,	O
potassium	NN	B-TEST
4.4	CD	O
,	,	O
bun	NN	B-TEST
and	CC	O
creatinine	NN	B-TEST
14/.9	CD	O
,	,	O
glucose	RB	B-TEST
95	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
10.0	CD	O
,	,	O
with	IN	O
a	DT	O
control	NN	O
of	IN	O
10.2	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
26.9	CD	O
,	,	O
urinalysis	NN	B-TEST
negative	JJ	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
count	NN	I-TEST
5.8	CD	O
,	,	O
hematocrit	NN	B-TEST
37.5	CD	O
,	,	O
hemoglobin	NN	B-TEST
13.4	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
274,000	CD	O
.	.	O

the	DT	B-TEST
electrocardiogram	NN	I-TEST
reveals	NNS	O
normal	JJ	O
sinus	JJ	O
rhythm	NN	O
at	IN	O
66	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
,	,	O
with	IN	O
no	DT	O
st	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
there	EX	O
is	VBZ	O
r	JJ	B-PROBLEM
wave	JJ	I-PROBLEM
progression	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
9/14/93	CD	O
,	,	O
and	CC	O
underwent	NN	O
on	IN	O
that	DT	O
same	JJ	O
day	NN	O
,	,	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
axillary	JJ	I-TREATMENT
lymph	NN	I-TREATMENT
nodes	NNS	I-TREATMENT
dissection	NN	I-TREATMENT
,	,	O
by	IN	O
dr.	NN	O
ausguall	NN	O
.	.	O

the	DT	O
patient	NN	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
,	,	O
there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
her	PRP$	B-TREATMENT
jp	NN	I-TREATMENT
was	VBD	O
still	RB	O
in	IN	O
place	NN	O
.	.	O

patient	NN	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
dr.	NN	O
ausguall	NN	O
,	,	O
in	IN	O
about	IN	O
4-5	JJ	O
days	NNS	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
the	DT	B-TREATMENT
jp	NN	I-TREATMENT
drain	NN	I-TREATMENT
will	MD	O
be	VB	O
removed	VBN	O
.	.	O

percocet	JJ	B-TREATMENT
1-2	JJ	O
tablets	NNS	O
po	VBP	O
q3-4	JJ	O
prn	NN	O
.	.	O

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	O
drugs	NNS	B-TREATMENT

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM

intubation	NN	B-TREATMENT

ercp	NN	B-TEST
with	IN	O
stent	NN	B-TREATMENT

blood	NN	B-TREATMENT
transfusion	NN	I-TREATMENT

pt	NN	O
is	VBZ	O
a	DT	O
78	CD	O
yo	NN	O
male	NN	O
with	IN	O
h/o	PDT	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM
,	,	O
s/p	JJ	O
multiple	JJ	B-PROBLEM
cva	NN	I-PROBLEM
s,	NN	I-PROBLEM
chf	NN	B-PROBLEM
,	,	O
htn	NN	B-PROBLEM
,	,	O
dm2	RB	B-PROBLEM
admitted	VBN	O
to	TO	O
mediplex	VB	O
rehab	JJ	O
hospital	NN	O
robert	NN	O
on	IN	O
02-01	JJ	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
n/v	NN	B-PROBLEM
since	IN	O
that	DT	O
morning	NN	O
.	.	O

pt	NN	B-TEST
's	POS	I-TEST
vitals	NNS	I-TEST
on	IN	O
admission	NN	O
wer	NN	O
significant	JJ	O
for	IN	O
t	NN	B-TEST
104	CD	O
,	,	O
sbp	VBD	B-TEST
100	CD	O
s,	NN	O
hr	NN	B-TEST
in	IN	O
the	DT	O
120	CD	O
s.	NN	O

ruq	NN	B-TEST
u/s	NN	I-TEST
demonstrated	VBD	O
multiple	JJ	B-PROBLEM
small	JJ	I-PROBLEM
gallstones	NNS	I-PROBLEM
with	IN	O
sludges	NNS	B-PROBLEM
without	IN	O
evidence	NN	O
of	IN	O
pericholecystic	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
or	CC	O
significant	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
gallbladder	NN	I-PROBLEM
.	.	O

surgery	NN	O
was	VBD	O
consulted	VBN	O
for	IN	O
concern	NN	O
of	IN	O
cholangitis	NN	B-PROBLEM
with	IN	O
probable	JJ	O
sepsis	NN	B-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
ccu	NN	O
,	,	O
intubated	VBD	B-TREATMENT
overnight	JJ	O
for	IN	O
ercp	JJ	B-TEST
procedure	NN	I-TEST
and	CC	O
fluid	JJ	B-TREATMENT
resuscitation	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
zosyn	NN	B-TREATMENT
.	.	O

pt	NN	B-TEST
's	POS	I-TEST
inr	NN	I-TEST
was	VBD	O
eleveted	VBN	B-PROBLEM
as	IN	O
he	PRP	O
was	VBD	O
on	IN	O
home	NN	B-TREATMENT
coumadin	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
4	CD	B-TREATMENT
units	NNS	I-TREATMENT
ffp	VBN	I-TREATMENT
in	IN	O
anticipation	NN	O
of	IN	O
ercp	FW	B-TEST
the	DT	O
following	JJ	O
day	NN	O
.	.	O

on	IN	O
02-02	JJ	O
ercp	NN	B-TEST
demonstrated	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
filling	NN	I-PROBLEM
defect	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
duct	NN	I-PROBLEM
representing	VBG	O
a	DT	B-PROBLEM
stone	NN	I-PROBLEM
with	IN	O
cbd	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
.	.	O

a	DT	B-TREATMENT
biliary	JJ	I-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
after	IN	O
the	DT	B-TREATMENT
removal	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
stone	NN	I-PROBLEM
.	.	O

1)	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM

2)	CD	O
s/p	JJ	O
mvr	NN	B-TREATMENT
(	(	I-TREATMENT
mechanical	JJ	I-TREATMENT
)	)	I-TREATMENT

3)	CD	O
chf	NN	B-PROBLEM
ef	NN	B-TEST
15%	CD	O

4)	CD	O
htn	NN	B-PROBLEM

5)	CD	O
multiple	JJ	B-PROBLEM
cva	NN	I-PROBLEM
s	NN	I-PROBLEM
(	(	O
last	JJ	O
1998	CD	O
)	)	O

6)	CD	O
hypercholesterolemia	NN	B-PROBLEM

7)	CD	O
type	NN	B-PROBLEM
ii	NN	I-PROBLEM
dm	NN	I-PROBLEM

8)	CD	O
multiple	JJ	B-PROBLEM
prior	RB	I-PROBLEM
uti	JJ	I-PROBLEM

t	NN	B-TEST
:	:	O
99.0	CD	O
;	:	O
bp	CC	B-TEST
142/61	CD	O
;	:	O
pulse	JJ	B-TEST
65	CD	O
;	:	O
resp	VB	B-TEST
20	CD	O
;	:	O
o2	PRP	B-TEST
sat	VBD	I-TEST
96%	CD	O
ra	NN	O

gen	NN	O
-	:	O
alert	NN	O
,	,	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM

heent	NN	O
-	:	O
mucous	JJ	B-PROBLEM
membranes	NNS	I-PROBLEM
slightly	RB	I-PROBLEM
dry	VBP	I-PROBLEM

neck	SYM	O
-	:	O
no	DT	O
jvd	NN	B-PROBLEM
,	,	O
no	DT	O
cervical	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM

cv	SYM	O
-	:	O
normal	JJ	O
s1/s2	NN	O
,	,	O
irreg	NN	B-PROBLEM
irreg	NN	I-PROBLEM

abd	SYM	O
-	:	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
distension	NN	I-PROBLEM
,	,	O
normoactive	JJ	O
bowel	NN	O
sounds	NNS	O

extr	SYM	O
-	:	O
no	DT	O
edema	NN	B-PROBLEM
.	.	O

2+	CD	O
dp	NN	B-TEST
pulses	NNS	I-TEST
bilaterally	RB	O

neur	NN	O
:	:	O
a	DT	O
&	CC	O
o	NN	O
x3	NN	O
,	,	O
dysarthric	JJ	B-PROBLEM
speech	NN	I-PROBLEM
,	,	O

cn	NN	O
:	:	O
mild	NN	B-PROBLEM
left	VBD	I-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
,	,	O
o/w	JJ	O
appears	VBZ	O
intact	JJ	O
;	:	O
4/5	CD	O
strength	NN	O
on	IN	O
flex	NN	O
at	IN	O
elbows	NNS	O
b/l	VBP	O
,	,	O
legs	JJ	O
06-22	JJ	O
strength	NN	O
,	,	O
dtr	NN	O
s	NN	O
intact	JJ	O
,	,	O
sensation	NN	O
intact	JJ	O

skin	SYM	O
-	:	O
no	DT	O
rash	NN	B-PROBLEM

ercp	JJ	O
report	NN	O
:	:	O
four	CD	B-TEST
fluoroscopic	NN	I-TEST
images	NNS	I-TEST
and	CC	O
ercp	NNS	B-TEST
are	VBP	O
provided	VBN	O
.	.	O

a	DT	B-PROBLEM
large	JJ	I-PROBLEM
filling	NN	I-PROBLEM
defect	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
distal	JJ	O
duct	NN	O
representing	VBG	O
a	DT	B-PROBLEM
stone	NN	I-PROBLEM
.	.	O

the	DT	O
common	JJ	O
duct	NN	O
is	VBZ	O
dilated	VBN	B-PROBLEM
.	.	O

subsequent	JJ	B-TREATMENT
biliary	JJ	I-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
after	IN	O
the	DT	B-TREATMENT
removal	NN	I-TREATMENT
of	IN	O
the	DT	B-PROBLEM
stone	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
:	:	O

2019-02-01	JJ	O
(	(	O
4	CD	O
of	IN	O
4	CD	O
bottles	NNS	O
)	)	O
e.coli	VBP	B-PROBLEM

cxr	NN	B-TEST
:	:	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

echo	NN	B-TEST
:	:	O

the	DT	O
left	JJ	O
atrium	NN	O
is	VBZ	O
markedly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
symmetric	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
.	.	O

the	DT	O
left	NN	O
ventricular	JJ	O
cavity	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
moderate	JJ	B-PROBLEM
global	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricular	JJ	I-PROBLEM
hypokinesis	NN	I-PROBLEM
.	.	O

overall	JJ	O
left	VBD	O
ventricular	JJ	O
systolic	JJ	O
function	NN	O
is	VBZ	O
moderately	RB	B-PROBLEM
depressed	JJ	I-PROBLEM
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
chamber	NN	I-TEST
size	NN	I-TEST
and	CC	O
free	JJ	O
wall	NN	O
motion	NN	O
are	VBP	O
normal	JJ	O
.	.	O

right	RB	B-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
normal	JJ	O
.	.	O

[	NN	O
intrinsic	JJ	B-TEST
right	JJ	I-TEST
ventricular	NN	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
is	VBZ	O
likely	JJ	O
more	RBR	B-PROBLEM
depressed	JJ	I-PROBLEM
given	VBN	O
the	DT	O
severity	NN	O
of	IN	O
tricuspid	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
.]	NN	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
(	(	O
3	CD	O
)	)	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
aortic	JJ	B-PROBLEM
valve	NN	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

mild	NN	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
aortic	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

a	DT	B-TREATMENT
bileaflet	NN	I-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
prosthesis	NN	I-TREATMENT
is	VBZ	O
present	JJ	O
.	.	O

the	DT	B-TEST
transmitral	JJ	I-TEST
gradient	NN	I-TEST
is	VBZ	O
normal	JJ	O
for	IN	O
this	DT	B-TREATMENT
prosthesis	NN	I-TREATMENT
.	.	O

no	DT	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

mild	NN	B-PROBLEM
(	(	I-PROBLEM
1+	CD	I-PROBLEM
)	)	I-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

[	NNS	O
due	JJ	O
to	TO	O
acoustic	JJ	O
shadowing	NN	O
,	,	O
the	DT	O
severity	NN	O
of	IN	O
mitral	JJ	B-PROBLEM
regurgitation	NN	I-PROBLEM
may	MD	O
be	VB	O
significantly	RB	O
underestimated	JJ	O
.]	NN	O

the	DT	O
tricuspid	JJ	O
valve	NN	O
leaflets	NNS	O
are	VBP	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

moderate	JJ	B-PROBLEM
[	$	I-PROBLEM
2+	CD	I-PROBLEM
]	NNP	I-PROBLEM
tricuspid	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

there	EX	O
is	VBZ	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
pericardial	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

2019-02-01	JJ	O
03:20	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
11.7	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
4.72	CD	O
hgb	NN	B-TEST
-	:	O
14.1	CD	O
hct	NN	B-TEST
-	:	O
42.7	CD	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
29.9	CD	O
mchc	SYM	B-TEST
-	:	O
33.1	CD	O
rdw	NN	B-TEST
-	:	O
14.9	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
91	CD	O
*	NN	O

2019-02-01	JJ	O
03:20	CD	O
pm	NN	O
blood	NN	B-TEST
neuts	NNS	B-TEST
-	:	O
94.6	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
2.7	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
1.9	CD	O
*	NN	O
eos	SYM	B-TEST
-	:	O
0.4	CD	O
baso	SYM	B-TEST
-	:	O
0.4	CD	O

2019-02-01	JJ	O
03:20	CD	O
pm	NN	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
28.0	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
26.7	CD	O
inr(pt)	JJ	B-TEST
-	:	O
2.9	CD	O
*	NN	O

2019-02-01	JJ	O
03:20	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
202	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
31	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.3	CD	O
*	NN	O
na	SYM	B-TEST
-	:	O
141	CD	O
k	SYM	B-TEST
-	:	O
4.0	CD	O
cl	NN	B-TEST
-	:	O
102	CD	O
hco3	NN	B-TEST
-	:	O
27	CD	O
angap	NN	B-TEST
-	:	O
16	CD	O

2019-02-01	JJ	O
03:20	CD	O
pm	NN	O
blood	NN	B-TEST
alt	SYM	B-TEST
-	:	O
167	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
218	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
108	CD	O
amylase	NN	B-TEST
-	:	O
117	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
3.6	CD	O
*	NN	O

2019-02-02	JJ	O
03:54	CD	O
pm	NN	O
blood	NN	B-TEST
lipase	NN	B-TEST
-	:	O
992	CD	O
*	NN	O

2019-02-01	JJ	O
03:20	CD	O
pm	NN	O
blood	NN	B-TEST
albumin	SYM	B-TEST
-	:	O
4.8	CD	O
calcium	NN	B-TEST
-	:	O
9.4	CD	O
phos	NN	B-TEST
-	:	O
1.9	CD	O
*	NN	O
mg	SYM	B-TEST
-	:	O
2.0	CD	O

2019-02-01	JJ	O
04:15	CD	O
pm	NN	O
blood	NN	B-TEST
digoxin	NN	B-TEST
-	:	O
0.3	CD	O
*	NN	O

2019-02-01	JJ	O
11:43	CD	O
pm	NN	O
blood	NN	B-TEST
type	NN	I-TEST
-	:	O
art	NN	O
temp	SYM	B-TEST
-	:	O
38.3	CD	O
peep	JJ	B-TREATMENT
-	:	O
5	CD	O
po2	NN	B-TEST
-	:	O
115	CD	O
*	NN	O
pco2	NN	B-TEST
-	:	O
36	CD	O
ph	NN	B-TEST
-	:	O
7.33	CD	O
*	NN	O
caltco2	NN	B-TEST
-	:	O
20	CD	O
*	JJ	O
base	NN	B-TEST
xs	NNP	I-TEST
-	:	O
-6	NN	O
intubat	NN	O
-	:	O
intubated	VBN	B-TREATMENT

2019-02-01	JJ	O
04:06	CD	O
pm	NN	O
blood	NN	B-TEST
lactate	NN	B-TEST
-	:	O
3.4	CD	O
*	NN	O

2019-02-01	JJ	O
08:00	CD	O
pm	NN	O
blood	NN	B-TEST
lactate	NN	B-TEST
-	:	O
6.4	CD	O
*	NN	O

2019-02-06	JJ	O
06:30	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
7.4	CD	O
rbc	NN	B-TEST
-	:	O
3.82	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
11.3	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
34.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
91	CD	O
mch	SYM	B-TEST
-	:	O
29.5	CD	O
mchc	SYM	B-TEST
-	:	O
32.5	CD	O
rdw	NN	B-TEST
-	:	O
15.1	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
92	CD	O
*	NN	O

2019-02-09	JJ	O
04:45	CD	O
am	VBP	O
blood	NN	B-TEST
pt	NN	B-TEST
-	:	O
19.6	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
74.9	CD	O
*	NN	O
inr(pt)	NN	B-TEST
-	:	O
1.9	CD	O
*	NN	O

2019-02-07	JJ	O
09:00	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
124	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
26	CD	O
*	NN	O
creat	NN	B-TEST
-	:	O
1.2	CD	O
na	SYM	B-TEST
-	:	O
140	CD	O
k	SYM	B-TEST
-	:	O
3.7	CD	O
cl	NN	B-TEST
-	:	O
102	CD	O
hco3	NN	B-TEST
-	:	O
29	CD	O
angap	NN	B-TEST
-	:	O
13	CD	O

2019-02-07	JJ	O
09:00	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
62	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
45	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
105	CD	O
totbili	SYM	B-TEST
-	:	O
2.2	CD	O
*	NN	O

2019-02-04	JJ	O
02:40	CD	O
am	VBP	O
blood	NN	B-TEST
lipase	NN	B-TEST
-	:	O
74	CD	O
*	NN	O

2019-02-07	JJ	O
09:00	CD	O
am	VBP	O
blood	NN	B-TEST
mg	NN	B-TEST
-	:	O
2.0	CD	O

2019-02-04	JJ	O
02:50	CD	O
am	VBP	O
blood	NN	B-TEST
lactate	NN	B-TEST
-	:	O
1.0	CD	O

pt	NN	O
is	VBZ	O
a	DT	O
78	CD	O
yo	NN	O
male	NN	O
with	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
s/p	JJ	O
multiple	JJ	B-PROBLEM
cva	NN	I-PROBLEM
s,	NN	I-PROBLEM
chf	NN	B-PROBLEM
,	,	O
htn	NN	B-PROBLEM
,	,	O
dm2	NN	B-PROBLEM
transferred	VBD	O
from	IN	O
the	DT	O
cmed	VBN	O
ccu	NN	O
s/p	NN	O
intervention	NN	B-TREATMENT
for	IN	O
cholangitis	NN	B-PROBLEM
.	.	O

1)	CD	O
acute	JJ	B-PROBLEM
cholangitis	NN	I-PROBLEM
:	:	O
pt	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
icu	NN	O
,	,	O
intubated	VBN	O
,	,	O
and	CC	O
ercp	NN	B-TEST
performed	NN	O
,	,	O
likely	RB	O
stone	NN	B-PROBLEM
obstructing	VBG	O
cbd	NN	O
.	.	O

stent	NN	B-TREATMENT
was	VBD	O
placed	VBN	O
and	CC	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
antibiotics	NNS	B-TREATMENT
(	(	O
zosyn	SYM	B-TREATMENT
-	:	O
>	NN	O
ciprofloxacin	NN	B-TREATMENT
).	NN	O

per	IN	O
ercp	NN	O
fellow	NN	O
,	,	O
plan	NN	O
is	VBZ	O
for	IN	O
patient	NN	O
to	TO	O
return	VB	O
in	IN	O
four	CD	O
weeks	NNS	O
to	TO	O
see	VB	O
dr.	JJ	O
suzanne	NN	O
davis	NN	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
will	MD	O
likely	RB	O
have	VB	O
repeat	NN	B-TEST
cholangiogram	NN	I-TEST
and	CC	O
removal	NN	B-TREATMENT
of	IN	O
stent	NN	B-TREATMENT
and	CC	O
stone	NN	B-PROBLEM
.	.	O

if	IN	O
this	DT	O
is	VBZ	O
still	RB	O
problematic	JJ	O
,	,	O
pt	NN	O
may	MD	O
also	RB	O
need	VB	O
a	DT	B-TREATMENT
sphincterotomy	NN	I-TREATMENT
.	.	O

pt	NN	O
is	VBZ	O
to	TO	O
continue	VB	O
ciprofloxacin	NN	B-TREATMENT
for	IN	O
a	DT	O
complete	JJ	O
14	CD	O
day	NN	O
course	NN	O
.	.	O

2)	CD	O
mechanical	JJ	B-TREATMENT
mitral	JJ	I-TREATMENT
valve	NN	I-TREATMENT
:	:	O
anticoagulation	NN	B-TREATMENT
was	VBD	O
reversed	VBN	O
for	IN	O
ercp	NN	B-TEST
.	.	O

after	IN	O
this	DT	O
he	PRP	O
was	VBD	O
anticoagulated	VBN	O
with	IN	O
heparin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

inr	NN	B-TEST
was	VBD	O
1.9	CD	O
on	IN	O
discharge	NN	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
sc	JJ	B-TREATMENT
lovenox	NN	I-TREATMENT
x	VBD	O
1	CD	O
and	CC	O
will	MD	O
continue	VB	O
this	DT	O
the	DT	O
day	NN	O
after	IN	O
discharge	NN	O
bid	NN	O
for	IN	O
one	CD	O
day	NN	O
.	.	O

vna	NN	O
will	MD	O
check	VB	O
his	PRP$	B-TEST
inr	NN	I-TEST
at	IN	O
home	NN	O
and	CC	O
page	VB	O
his	PRP$	O
pcp	NN	O
with	IN	O
the	DT	O
results	NNS	O
.	.	O

3)	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
:	:	O
rate	NN	O
controlled	VBN	O
and	CC	O
on	IN	O
warfarin	NN	B-TREATMENT
.	.	O

while	IN	O
in	IN	O
the	DT	O
hospital	NN	O
he	PRP	O
had	VBD	O
several	JJ	O
episodes	NNS	O
of	IN	O
pauses	NNS	B-PROBLEM
,	,	O
none	NN	O
longer	JJR	O
than	IN	O
2.5	CD	O
seconds	NNS	O
.	.	O

his	PRP$	B-TREATMENT
digoxin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
and	CC	O
his	PRP$	B-TREATMENT
metoprolol	NN	I-TREATMENT
was	VBD	O
titrated	VBN	O
down	RP	O
from	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
dose	NN	I-TREATMENT
.	.	O

once	RB	O
the	DT	B-TREATMENT
digoxin	NN	I-TREATMENT
was	VBD	O
no	RB	O
longer	RB	O
having	VBG	O
effect	NN	O
,	,	O
metoprolol	NN	B-TREATMENT
was	VBD	O
titrated	VBN	O
back	RB	O
to	TO	O
home	NN	O
dose	NN	O
.	.	O

4)	CD	O
chf	NN	B-PROBLEM
:	:	O
pt	NN	O
was	VBD	O
oxygen	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
for	IN	O
most	JJS	O
of	IN	O
the	DT	O
hospital	NN	O
course	NN	O
,	,	O
cxr	NN	B-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
diuresed	VBN	O
with	IN	O
lasix	NN	B-TREATMENT
with	IN	O
good	JJ	O
effect	NN	O
.	.	O

volume	NN	B-PROBLEM
overload	NN	I-PROBLEM
likely	RB	O
ocurred	VBN	O
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
given	VBN	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

did	VBD	O
not	RB	O
require	VB	O
lasix	NN	B-TREATMENT
on	IN	O
discharge	NN	O
.	.	O

5)	CD	O
e.	JJ	B-PROBLEM
coli	NNS	I-PROBLEM
bacteremia	VBP	I-PROBLEM
/	JJ	O
sepsis	NN	B-PROBLEM
:	:	O
source	NN	O
of	IN	O
acute	JJ	B-PROBLEM
cholangitis	NN	I-PROBLEM
as	IN	O
above	NN	O
.	.	O

pt	NN	O
required	VBD	O
3	CD	O
day	NN	O
stay	VB	O
in	IN	O
the	DT	O
surgical	JJ	O
icu	NN	O
and	CC	O
intubation	NN	B-TREATMENT
as	IN	O
above	NN	O
.	.	O

6)	CD	O
intubation	NN	B-TREATMENT
:	:	O
pt	NN	O
was	VBD	O
97%	CD	O
on	IN	O
room	NN	O
air	NN	O
on	IN	O
arrival	NN	O
to	TO	O
cindy	VB	O
,	,	O
developed	VBN	O
rapid	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
reponse	NN	I-PROBLEM
to	TO	O
a	DT	B-PROBLEM
fib	NN	I-PROBLEM
which	WDT	O
was	VBD	O
treated	VBN	O
,	,	O
but	CC	O
after	IN	O
that	DT	O
period	NN	O
of	IN	O
time	NN	O
required	VBN	O
oxygen	NN	B-TREATMENT
,	,	O
presumably	RB	O
for	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
lori	JJ	O
pt	NN	O
was	VBD	O
given	VBN	O
3l	CD	B-TREATMENT
ns	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
1	CD	O
unit	NN	O
of	IN	O
ffp	NN	B-TREATMENT
,	,	O
and	CC	O
oxygen	NN	B-PROBLEM
requirements	NNS	I-PROBLEM
contimued	VBN	O
to	TO	O
climb	VB	O
.	.	O

in	IN	O
the	DT	O
cmed	JJ	O
ccu	NN	O
pt	NN	O
was	VBD	O
intubated	VBN	O
for	IN	O
ercp	JJ	B-TEST
procedure	NN	I-TEST
.	.	O

lisinopril	RB	B-TREATMENT
2.5	CD	O
qday	NN	O
,	,	O
buspiron	NN	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
qday	NN	O
,	,	O
digoxin	NN	B-TREATMENT
,	,	O
doxasozin	VBZ	B-TREATMENT
8	CD	O
mg	NN	O
qhs	NN	O
,	,	O
glyburide	RB	B-TREATMENT
2.5	CD	O
mg	NN	O
qday	NN	O
,	,	O
metoprolol	FW	B-TREATMENT
bid	NN	O
,	,	O
atorvastatin	VBZ	B-TREATMENT
20	CD	O
mg	NN	O
qday	NN	O
,	,	O
warfarin	WP	B-TREATMENT
5	CD	O
mg	NN	O
qday	NN	O

1.	CD	O
ciprofloxacin	NN	B-TREATMENT
500	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
)	)	O
for	IN	O
6	CD	O
days	NNS	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT

continue	VB	O
all	DT	B-TREATMENT
other	JJ	I-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
except	IN	O
do	VBP	O
not	RB	O
take	VB	O
digoxin	NN	B-TREATMENT
.	.	O

acute	NN	B-PROBLEM
cholangitis	NN	I-PROBLEM

anticoagulation	NN	B-TREATMENT
with	IN	O
a	DT	B-TREATMENT
mechanical	JJ	I-TREATMENT
valve	NN	I-TREATMENT

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM

congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM

please	NN	O
continue	VB	O
ciprofloxacin	JJ	B-TREATMENT
antibiotic	JJ	I-TREATMENT
until	IN	O
2019-02-14	JJ	O
.	.	O

dr.	NN	O
mcfarlane	NN	O
is	VBZ	O
the	DT	O
doctor	NN	O
who	WP	O
performed	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
to	TO	O
place	VB	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
in	IN	I-TREATMENT
your	PRP$	I-TREATMENT
bile	NN	I-TREATMENT
duct	NN	I-TREATMENT
(	(	O
a	DT	O
tube	NN	O
that	WDT	O
drains	VBZ	O
the	DT	O
liver	NN	O
).	NN	O

his	PRP$	O
nurse	NN	O
is	VBZ	O
going	VBG	O
to	TO	O
contact	VB	O
you	PRP	O
at	IN	O
home	NN	O
to	TO	O
schedule	VB	O
a	DT	O
time	NN	O
for	IN	O
a	DT	B-TREATMENT
repeat	NN	I-TREATMENT
procedure	NN	I-TREATMENT
to	TO	O
remove	VB	O
that	DT	B-TREATMENT
stent	NN	I-TREATMENT
.	.	O

it	PRP	O
will	MD	O
be	VB	O
called	VBN	O
in	IN	O
to	TO	O
dr.	VB	O
hamasaki	JJ	O
office	NN	O
and	CC	O
he	PRP	O
will	MD	O
call	VB	O
you	PRP	O
to	TO	O
see	VB	O
how	WRB	O
to	TO	O
change	VB	O
your	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
.	.	O

you	PRP	O
will	MD	O
also	RB	O
take	VB	O
lovenox	NN	B-TREATMENT
subcutaneous	JJ	I-TREATMENT
injections	NNS	I-TREATMENT
tomorrow	NN	O
,	,	O
2019-02-10	JJ	O
.	.	O

continue	VB	O
all	DT	O
of	IN	O
your	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
except	IN	O
for	IN	O
digoxin	NN	B-TREATMENT
.	.	O

dr.	NN	O
mcfarlane	NN	O
is	VBZ	O
the	DT	O
doctor	NN	O
who	WP	O
performed	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
to	TO	O
place	VB	O
a	DT	B-TREATMENT
stent	NN	I-TREATMENT
in	IN	I-TREATMENT
your	PRP$	I-TREATMENT
bile	NN	I-TREATMENT
duct	NN	I-TREATMENT
(	(	O
a	DT	O
tube	NN	O
that	WDT	O
drains	VBZ	O
the	DT	O
liver	NN	O
).	NN	O

his	PRP$	O
nurse	NN	O
is	VBZ	O
going	VBG	O
to	TO	O
contact	VB	O
you	PRP	O
at	IN	O
home	NN	O
to	TO	O
schedule	VB	O
a	DT	O
time	NN	O
for	IN	O
a	DT	B-TREATMENT
repeat	NN	I-TREATMENT
procedure	NN	I-TREATMENT
to	TO	O
remove	VB	O
that	DT	B-TREATMENT
stent	NN	I-TREATMENT
.	.	O

before	IN	O
you	PRP	O
have	VBP	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
with	IN	O
dr.	JJ	O
morris	NN	O
you	PRP	O
will	MD	O
need	VB	O
to	TO	O
talk	VB	O
to	TO	O
dr.	VB	O
moya	NN	O
to	TO	O
see	VB	O
if	IN	O
you	PRP	O
need	VBP	O
to	TO	O
stop	VB	O
your	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
/	NN	O
warfarin	NN	B-TREATMENT
for	IN	O
a	DT	O
few	JJ	O
days	NNS	O
.	.	O

ampullary	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM

ampullary	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
50	CD	O
year	NN	O
old	JJ	O
man	NN	O
in	IN	O
his	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
the	DT	O
patient	NN	O
developed	VBD	O
epigastric	JJ	B-PROBLEM
pain	NN	I-PROBLEM
after	IN	O
meals	NNS	O
.	.	O

the	DT	O
next	JJ	O
morning	NN	O
,	,	O
the	DT	O
patient	NN	O
felt	VBD	O
dizzy	NN	B-PROBLEM
and	CC	O
went	VBD	O
to	TO	O
his	PRP$	O
private	JJ	O
medical	JJ	O
doctor	NN	O
at	IN	O
eifro	JJ	O
medical	JJ	O
center	NN	O
,	,	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
bilirubins	NNS	I-PROBLEM
,	,	I-PROBLEM
alkaline	JJ	I-PROBLEM
phosphatase	NN	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
transaminases	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
reported	VBD	O
fatigue	JJ	B-PROBLEM
and	CC	O
nausea	NN	B-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
noted	VBN	O
coca	NN	B-PROBLEM
cola	NN	I-PROBLEM
colored	VBD	I-PROBLEM
urine	JJ	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
constipated	VBN	B-PROBLEM
with	IN	O
hard	JJ	B-PROBLEM
stool	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
reported	VBD	O
an	DT	B-PROBLEM
18	CD	I-PROBLEM
lb	NN	I-PROBLEM
weight	NN	I-PROBLEM
loss	NN	I-PROBLEM
over	IN	O
the	DT	O
last	JJ	O
4-5	JJ	O
months	NNS	O
.	.	O

significant	JJ	O
only	RB	O
for	IN	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
.	.	O

serax	NN	B-TREATMENT
p.r.n.	NN	O
insomnia	NN	B-PROBLEM
;	:	O
iron	NN	B-TREATMENT
;	:	O
mvi	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

bp	NN	B-TEST
120/80	CD	O
,	,	O
temp	RB	B-TEST
96	CD	O
,	,	O
pulse	RB	B-TEST
78	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
.	.	O

no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	O
skin	NN	O
is	VBZ	O
jaundiced	VBN	B-PROBLEM
.	.	O

notable	JJ	O
for	IN	O
scleral	JJ	B-PROBLEM
icterus	NN	I-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
,	,	O
rales	NNS	B-PROBLEM
,	,	O
or	CC	O
rhonchi	NN	B-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

soft	JJ	O
,	,	O
bowel	JJ	O
sounds	NNS	O
present	JJ	O
,	,	O
tenderness	JJ	B-PROBLEM
present	NN	O
in	IN	O
epigastrium	NN	O
to	TO	O
moderate	VB	B-TEST
palpation	NN	I-TEST
.	.	O

there	EX	O
was	VBD	O
no	DT	O
rebound	NN	B-PROBLEM
and	CC	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

no	DT	O
incisional	JJ	B-PROBLEM
scars	NNS	I-PROBLEM
.	.	O

warm	NN	O
,	,	O
with	IN	O
no	DT	O
edema	NN	B-PROBLEM
and	CC	O
palpable	JJ	O
pulses	NNS	O
bilaterally	RB	O
.	.	O

na	RB	B-TEST
134	CD	O
,	,	O
k	VBD	B-TEST
4.2	CD	O
,	,	O
cl	NN	B-TEST
98	CD	O
,	,	O
bicarb	NN	B-TEST
26	CD	O
,	,	O
bun	NN	B-TEST
11	CD	O
,	,	O
creatinine	NN	B-TEST
0.5	CD	O
,	,	O
glucose	VBD	B-TEST
119	CD	O
.	.	O

cbc	SYM	B-TEST
-	:	O
white	JJ	B-TEST
count	NN	I-TEST
7.5	CD	O
,	,	O
hematocrit	NN	B-TEST
28.5	CD	O
,	,	O
platelets	NNS	B-TEST
452	CD	O
.	.	O

pt	NN	B-TEST
16.2	CD	O
,	,	O
ptt	NN	B-TEST
34.7	CD	O
,	,	O
inr	RB	B-TEST
1.8	CD	O
.	.	O

ldh	NN	B-TEST
254	CD	O
,	,	O
amylase	NN	B-TEST
727	CD	O
,	,	O
lipase	NN	B-TEST
8600	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
preoperatively	RB	O
for	IN	O
surgery	NN	B-TREATMENT
on	IN	O
7/4/98	CD	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NN	I-TEST
workup	VBD	I-TEST
up	RB	I-TEST
until	IN	O
that	DT	O
time	NN	O
included	VBD	O
a	DT	O
diagnosis	NN	O
of	IN	O
periampullary	JJ	B-PROBLEM
adenocarcinoma	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
proven	VBN	O
by	IN	O
egd	NN	B-TEST
directed	VBN	I-TEST
biopsy	NN	I-TEST
,	,	O
and	CC	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
,	,	O
which	WDT	O
was	VBD	O
biopsied	VBN	O
and	CC	O
found	VBN	O
to	TO	O
be	VB	O
an	DT	B-PROBLEM
oncocytoma	NN	I-PROBLEM
.	.	O

on	IN	O
7/4/98	CD	O
,	,	O
the	DT	O
patient	NN	O
underwent	NN	O
a	DT	B-TREATMENT
whipple	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
,	,	O
which	WDT	O
proceeded	VBD	O
without	IN	O
complications	NNS	B-PROBLEM
.	.	O

the	DT	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
d/c&apos;d	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
#2	NNP	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
#4	NNP	O
,	,	O
the	DT	O
patient	NN	O
began	VBD	O
tolerating	VBG	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
and	CC	O
his	PRP$	O
diet	NN	O
was	VBD	O
advanced	VBN	O
as	IN	O
tolerated	VBN	O
by	IN	O
postoperative	JJ	O
day	NN	O
#6	NNP	O
and	CC	O
7	CD	O
.	.	O

sandostatin	NN	B-TREATMENT
100	CD	O
mcg	NN	O
subcu.	NN	O
b.i.d.	NN	O
;	:	O
percocet	CC	B-TREATMENT
1-2	JJ	O
tabs	JJ	O
q.3-4h.	JJ	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
;	:	O
axid	CC	B-TREATMENT
150	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
;	:	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
54	JJ	O
year-old	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
with	IN	O
known	VBN	B-PROBLEM
brain	NN	I-PROBLEM
mets	NNS	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
pe	NN	B-PROBLEM
,	,	O
recent	JJ	B-TREATMENT
radiation	NN	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
steroids	NNS	B-TREATMENT
who	WP	O
presented	VBD	O
in	IN	O
2012-04-23	JJ	O
with	IN	O
myopathy	NN	B-PROBLEM
presumed	VBN	O
secondary	JJ	O
to	TO	O
sterids	NNS	B-TREATMENT
,	,	O
which	WDT	O
have	VBP	O
been	VBN	O
given	VBN	O
for	IN	O
her	PRP$	B-PROBLEM
brain	NN	I-PROBLEM
mets	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
later	RB	O
sent	VBN	O
to	TO	O
rehab	VB	O
,	,	O
but	CC	O
returned	VBD	O
early	RB	O
in	IN	O
april	NN	O
with	IN	O
increased	JJ	B-PROBLEM
cough	NN	I-PROBLEM
with	IN	O
exertion	NN	O
with	IN	O
fever	NN	B-PROBLEM
to	TO	O
101	CD	O
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
levaquin	JJ	B-TREATMENT
given	VBN	O
her	PRP$	B-TEST
temperatures	NNS	I-TEST
and	CC	O
differential	JJ	O
diagnosis	NN	O
of	IN	O
increased	JJ	B-PROBLEM
pe	NN	I-PROBLEM
burden	NN	I-PROBLEM
load	NN	I-PROBLEM
,	,	O
infections	NNS	B-PROBLEM
or	CC	O
pneumonia	NN	B-PROBLEM
and	CC	O
questionable	JJ	O
lymphangitic	JJ	B-PROBLEM
spread	NN	I-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
experience	VB	O
improvement	NN	O
in	IN	O
her	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
and	CC	O
was	VBD	O
readmitted	VBN	O
on	IN	O
06-11	NN	O
with	IN	O
continued	JJ	B-PROBLEM
dyspnea	NN	I-PROBLEM
and	CC	O
fevers	NNS	B-PROBLEM
.	.	O

review	NN	O
of	IN	O
cta	NN	B-TEST
showed	VBD	O
no	DT	O
pe	NN	B-PROBLEM
,	,	O
but	CC	O
there	RB	O
was	VBD	O
ground	NN	B-PROBLEM
glass	NN	I-PROBLEM
opacities	NNS	I-PROBLEM
on	IN	O
ct	NN	B-TEST
,	,	O
so	RB	O
pcp	NN	B-PROBLEM
was	VBD	O
considered	VBN	O
highly	RB	O
unlikely	JJ	O
given	VBN	O
her	PRP$	O
recent	JJ	O
history	NN	O
of	IN	O
steroid	NN	B-TREATMENT
use	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
induced	JJ	I-TEST
sputum	NN	I-TEST
was	VBD	O
negative	JJ	O
and	CC	O
bol	NN	B-TEST
was	VBD	O
done	VBN	O
and	CC	O
also	RB	O
negative	JJ	O
.	.	O

sputum	NN	B-TEST
cultures	NNS	I-TEST
were	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
was	VBD	O
given	VBN	O
bactrim	NN	B-TREATMENT
and	CC	O
she	PRP	O
had	VBD	O
improvement	NN	O
in	IN	O
the	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
after	IN	O
her	PRP$	B-TREATMENT
bactrim	NN	I-TREATMENT
was	VBD	O
started	VBN	O
and	CC	O
improved	VBN	O
room	NN	O
air	NN	O
sats	NNS	O
and	CC	O
was	VBD	O
sent	VBN	O
home	NN	O
on	IN	O
bactrim	NN	B-TREATMENT
.	.	O

she	PRP	O
presented	VBD	O
on	IN	O
clinic	NN	O
on	IN	O
06-20	JJ	O
with	IN	O
hypotension	NN	B-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
was	VBD	O
given	VBN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

she	PRP	O
spiked	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
to	TO	O
103	CD	O
with	IN	O
blood	NN	B-TEST
pressures	NNS	I-TEST
hypertensive	VBP	B-PROBLEM
into	IN	O
the	DT	B-TEST
systolic	JJ	I-TEST
80	CD	O
s	NN	O
and	CC	O
with	IN	O
rigors	NNS	B-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
a	DT	O
question	NN	O
of	IN	O
left	NN	B-PROBLEM
lung	NN	I-PROBLEM
opacity	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
vancomycin	NNS	B-TREATMENT
and	CC	O
a	DT	O
gram	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

today	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
bathroom	NN	O
and	CC	O
became	VBD	O
hypoxic	NN	B-PROBLEM
with	IN	O
saturations	NNS	B-TEST
in	IN	O
the	DT	O
80	CD	O
s	NN	O
and	CC	O
was	VBD	O
responsive	JJ	O
to	TO	O
oxygen	VB	B-TREATMENT
,	,	O
but	CC	O
was	VBD	O
still	RB	O
tachypneic	VBN	B-PROBLEM
without	IN	O
improvement	NN	O
and	CC	O
was	VBD	O
placed	VBN	O
on	IN	O
nonrebreather	NN	B-TREATMENT
.	.	O

currently	RB	O
the	DT	O
patient	NN	O
is	VBZ	O
admitted	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
further	JJ	B-TREATMENT
medical	JJ	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

currently	RB	O
the	DT	O
patient	NN	O
is	VBZ	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
without	IN	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
dysphagia	NN	B-PROBLEM
.	.	O

1.	CD	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
left	VBD	I-PROBLEM
side	NN	I-PROBLEM
diagnosed	VBN	O
in	IN	O
1982	CD	O
status	NN	O
post	NN	O
1995	CD	O
mastectomy	NN	B-TREATMENT
with	IN	O
5	CD	O
out	IN	O
of	IN	O
9	CD	O
positive	JJ	B-PROBLEM
lymph	NN	I-PROBLEM
nodes	NNS	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
bone	NN	B-TREATMENT
marrow	NN	I-TREATMENT
transplant	NN	I-TREATMENT
and	CC	O
then	RB	O
later	RB	O
with	IN	O
tamoxifen	NN	B-TREATMENT
from	IN	O
2004	CD	O
to	TO	O
2001	CD	O
.	.	O

in	IN	O
2011	CD	O
she	PRP	O
had	VBD	O
mediastinal	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
treated	VBN	O
with	IN	O
taxol	NN	B-TREATMENT
and	CC	O
changed	VBD	O
to	TO	O
navelbine	VB	B-TREATMENT
on	IN	O
03-28	NN	O
.	.	O

she	PRP	O
had	VBD	O
diagnosed	VBN	O
brain	NN	B-PROBLEM
mets	NNS	I-PROBLEM
in	IN	O
2012-03-25	JJ	O
right	JJ	O
side	NN	O
cerebella	NN	O
and	CC	O
parietal	NN	O
for	IN	O
which	WDT	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
chemotherapy	NN	B-TREATMENT
,	,	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
decadron	NN	B-TREATMENT
.	.	O

2.	CD	O
history	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
in	IN	O
2012-04-23	JJ	O
treated	VBN	O
with	IN	O
only	RB	O
aspirin	JJ	B-TREATMENT
secondary	JJ	O
to	TO	O
brain	NN	B-PROBLEM
mets	NNS	I-PROBLEM
.	.	O

3.	CD	O
asthma	NN	B-PROBLEM
.	.	O

4.	CD	O
gastritis	NN	B-PROBLEM
.	.	O

1.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
q	JJ	O
day	NN	O
.	.	O

2.	CD	O
megace	NN	B-TREATMENT
400	CD	O
q	JJ	O
day	NN	O
.	.	O

3.	CD	O
colace	NN	B-TREATMENT
200	CD	O
b.i.d.	NN	O

4.	CD	O
aspirin	NN	B-TREATMENT
.	.	O

5.	CD	O
heparin	NN	B-TREATMENT
subq.	NN	O

6.	CD	O
prednisone	NN	B-TREATMENT
40	CD	O
q	JJ	O
day	NN	O
.	.	O

8.	CD	O
clindamycin	NN	B-TREATMENT
900	CD	O
q	NN	O
8	CD	O
.	.	O

9.	CD	O
levaquin	JJ	B-TREATMENT
500	CD	O
q	JJ	O
day	NN	O
.	.	O

penicillin	NN	B-TREATMENT
.	.	O

on	IN	O
examination	NN	B-TEST
on	IN	O
transfer	NN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
she	PRP	O
is	VBZ	O
febrile	JJ	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
grade	NN	I-PROBLEM
temperature	NN	I-PROBLEM
of	IN	O
100.1	CD	O
,	,	O
tachycardic	NN	B-PROBLEM
to	TO	O
110	CD	O
,	,	O
hypotensive	JJ	B-PROBLEM
85/49	CD	O
,	,	O
tachypneic	NN	B-PROBLEM
into	IN	O
the	DT	O
50	CD	O
s	NN	O
and	CC	O
60	CD	O
s,	NN	O
95%	CD	O
on	IN	O
nonrebreather	NN	B-TREATMENT
.	.	O

in	IN	O
general	JJ	O
,	,	O
she	PRP	O
is	VBZ	O
extremely	RB	B-PROBLEM
tachypneic	JJ	I-PROBLEM
,	,	O
difficulty	NN	B-PROBLEM
in	IN	I-PROBLEM
speaking	VBG	I-PROBLEM
words	NNS	I-PROBLEM
.	.	O

her	PRP$	O
heart	NN	O
is	VBZ	O
regular	JJ	O
without	IN	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
,	,	O
slightly	RB	B-PROBLEM
tachycardic	JJ	I-PROBLEM
.	.	O

her	PRP$	B-TEST
pulmonary	JJ	I-TEST
examination	NN	I-TEST
shows	VBZ	O
she	PRP	O
has	VBZ	O
bronchial	JJ	O
breath	NN	O
sounds	VBZ	O
with	IN	O
dry	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
benign	JJ	O
.	.	O

extremities	NNS	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
3.2	CD	O
,	,	O
hematocrit	NN	B-TEST
26.6	CD	O
,	,	O
platelets	NNS	B-TEST
130	CD	O
,	,	O
chemistry	NN	B-TEST
is	VBZ	O
131	CD	O
,	,	O
potassium	NN	B-TEST
3.0	CD	O
,	,	O
chloride	RB	B-TEST
105	CD	O
,	,	O
bicarb	NN	B-TEST
17	CD	O
,	,	O
bun	NN	B-TEST
10	CD	O
,	,	O
creatinine	NN	B-TEST
0.5	CD	O
,	,	O
glucose	VBD	B-TEST
105	CD	O
.	.	O

calcium	NN	B-TEST
7.3	CD	O
,	,	O
phos	NN	B-TEST
1.8	CD	O
,	,	O
magnesium	NN	B-TEST
1.5	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
gas	NN	I-TEST
showing	VBG	O
7.36	CD	O
,	,	O
31	CD	O
,	,	O
96	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-TEST
ct	NN	I-TEST
from	IN	O
the	DT	O
29th	CD	O
of	IN	O
her	PRP$	O
abdomen	NNS	O
and	CC	O
pelvis	NN	O
showing	NN	O
marked	VBD	B-PROBLEM
increased	JJ	I-PROBLEM
consolidations	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lung	NN	I-PROBLEM
base	NN	I-PROBLEM
and	CC	O
question	NN	O
of	IN	O
new	JJ	B-PROBLEM
left	NN	I-PROBLEM
sided	VBD	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
febrile	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
with	IN	O
a	DT	O
question	NN	O
of	IN	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
infiltrate	NN	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
.	.	O

the	DT	O
exact	JJ	O
etiology	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
was	VBD	O
presumed	VBN	O
to	TO	O
be	VB	O
questionable	JJ	O
multifactorial	JJ	O
.	.	O

there	EX	O
was	VBD	O
concern	NN	O
about	IN	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
.	.	O

also	RB	O
she	PRP	O
had	VBD	O
a	DT	O
history	NN	O
of	IN	O
pe	NN	B-PROBLEM
and	CC	O
also	RB	O
there	EX	O
was	VBD	O
concern	NN	O
about	IN	O
possible	JJ	O
lymphangitic	JJ	B-PROBLEM
spread	NN	I-PROBLEM
of	IN	O
her	PRP$	B-PROBLEM
breast	NN	I-PROBLEM
ca	MD	I-PROBLEM
.	.	O

given	VBN	O
her	PRP$	B-PROBLEM
fevers	NNS	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
initially	RB	O
started	VBD	O
on	IN	O
ceptaz	NN	B-TREATMENT
,	,	O
levaquin	NN	B-TREATMENT
and	CC	O
__________	NN	O
and	CC	O
clindamycin	NN	B-TREATMENT
.	.	O

lab	NN	O
two	CD	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
added	VBN	O
considering	VBG	O
the	DT	O
patient	NN	O
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
a	DT	O
relatively	RB	O
high	JJ	O
risk	NN	O
for	IN	O
pcp	JJ	B-PROBLEM
douglas	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
trialed	VBN	O
on	IN	O
bipap	NN	B-TREATMENT
,	,	O
but	CC	O
the	DT	O
patient	NN	O
was	VBD	O
increasingly	RB	B-PROBLEM
dyspneic	JJ	I-PROBLEM
,	,	O
increased	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
stress	NN	I-PROBLEM
and	CC	O
ultimately	RB	O
needed	VBN	O
to	TO	O
be	VB	O
intubated	VBN	O
on	IN	O
06-22	NN	O
.	.	O

earlier	RBR	O
during	IN	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
she	PRP	O
underwent	JJ	O
bronchoscopy	NN	B-TEST
,	,	O
which	WDT	O
was	VBD	O
sent	VBN	O
for	IN	O
cytology	NN	B-TEST
and	CC	O
multiple	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
pathogens	NNS	I-PROBLEM
all	DT	O
of	IN	O
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

ultimately	RB	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
continued	VBD	O
and	CC	O
she	PRP	O
began	VBD	O
to	TO	O
defervesce	VB	O
and	CC	O
her	PRP$	B-TEST
bacterial	JJ	I-TEST
studies	NNS	I-TEST
particulaly	VBP	O
from	IN	O
bal	JJ	B-TEST
lavage	NN	I-TEST
were	VBD	O
found	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
multiple	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
withdrawn	NN	O
.	.	O

clindamycin	NN	B-TREATMENT
and	CC	O
_______________	NN	O
was	VBD	O
discontinued	VBN	O
early	RB	O
in	IN	O
hospital	JJ	O
course	NN	O
.	.	O

her	PRP$	B-TEST
pcp	NN	I-TEST
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
negative	JJ	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
vancomycin	NN	B-TREATMENT
,	,	O
levaquin	NN	B-TREATMENT
were	VBD	O
also	RB	O
discontinued	VBN	O
.	.	O

she	PRP	O
was	VBD	O
later	RB	O
continued	VBN	O
on	IN	O
ceftazidine	NN	B-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
for	IN	O
possible	JJ	O
gram	NN	B-PROBLEM
negative	JJ	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
also	RB	O
for	IN	O
possible	JJ	O
post	NN	B-PROBLEM
obstructive	JJ	I-PROBLEM
picture	NN	I-PROBLEM
that	IN	O
she	PRP	O
would	MD	O
be	VB	O
at	IN	O
risk	NN	O
for	IN	O
given	VBN	O
her	PRP$	O
pulmonary	JJ	O
anatomy	NN	O
.	.	O

as	IN	O
the	DT	O
hubbard	NN	O
regional	JJ	O
hospital	NN	O
hospital	NN	O
course	NN	O
went	VBD	O
on	IN	O
the	DT	O
patient	NN	O
's	POS	O
respiratory	NN	O
did	VBD	O
not	RB	O
show	VB	O
mild	JJ	O
improvement	NN	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

unfortunately	RB	O
her	PRP$	O
mental	JJ	O
status	NN	O
failed	VBD	O
to	TO	O
improve	VB	O
despite	IN	O
having	VBG	O
been	VBN	O
off	IN	O
all	DT	B-TREATMENT
sedative	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
for	IN	O
several	JJ	O
days	NNS	O
.	.	O

later	RB	O
in	IN	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
family	NN	O
meetings	NNS	O
took	VBD	O
place	NN	O
and	CC	O
given	VBN	O
the	DT	O
patient	NN	O
's	POS	O
overall	JJ	O
poor	JJ	O
prognosis	NN	O
with	IN	O
decreased	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
the	DT	O
patient	NN	O
would	MD	O
become	VB	O
cmo	NN	B-TREATMENT
.	.	O

however	RB	O
,	,	O
she	PRP	O
is	VBZ	O
cmo	JJ	B-TREATMENT
and	CC	O
will	MD	O
not	RB	O
be	VB	O
intubated	VBN	O
for	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
thought	VBD	O
to	TO	O
be	VB	O
exhibiting	VBG	O
septic	JJ	B-PROBLEM
physiology	NN	I-PROBLEM
,	,	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
hypotensive	NN	B-PROBLEM
.	.	O

she	PRP	O
required	VBD	O
aggressive	JJ	B-TREATMENT
intravenous	JJ	I-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
later	RB	O
required	VBN	O
pressor	NN	B-TREATMENT
support	NN	I-TREATMENT
with	IN	O
neo-synephrine	JJ	B-TREATMENT
.	.	O

later	RB	O
during	IN	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
she	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
somewhat	RB	B-PROBLEM
overloaded	JJ	I-PROBLEM
and	CC	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
were	VBD	O
cut	VBN	O
back	RB	O
.	.	O

it	PRP	O
was	VBD	O
quite	RB	O
difficult	JJ	O
weaning	VBG	O
her	PRP$	O
off	NN	O
of	IN	O
neo-synephrine	NN	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
given	VBN	O
stress	NN	B-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

later	RB	O
in	IN	O
her	PRP$	O
hospital	NN	O
course	NN	O
she	PRP	O
also	RB	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
for	IN	O
question	NN	O
of	IN	O
new	JJ	O
ecg	JJ	O
findings	NNS	O
in	IN	O
her	PRP$	O
inferior	JJ	O
leads	NNS	O
.	.	O

her	PRP$	B-TEST
echocardiogram	NN	I-TEST
,	,	O
however	RB	O
,	,	O
was	VBD	O
essentially	RB	O
normal	JJ	O
with	IN	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
55%	CD	O
without	IN	O
any	DT	B-PROBLEM
gross	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
or	CC	O
valvular	JJ	B-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

as	IN	O
mentioned	VBN	O
above	IN	O
the	DT	O
patient	NN	O
's	POS	O
hemodynamic	JJ	O
status	NN	O
was	VBD	O
tenuous	JJ	B-PROBLEM
throughout	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
as	IN	O
it	PRP	O
was	VBD	O
difficult	JJ	O
to	TO	O
wean	VB	O
the	DT	O
patient	NN	O
off	IN	O
of	IN	O
neo-synephrine	NN	B-TREATMENT
.	.	O

by	IN	O
06-28	NNP	O
,	,	O
however	RB	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
off	RB	O
of	IN	O
neo-synephrine	JJ	B-TREATMENT
,	,	O
but	CC	O
at	IN	O
this	DT	O
time	NN	O
as	IN	O
mentioned	VBN	O
above	IN	O
the	DT	O
patient	NN	O
was	VBD	O
deemed	VBN	O
to	TO	O
be	VB	O
cmo	JJ	B-TREATMENT
per	IN	O
discussion	NN	O
with	IN	O
physicians	NNS	O
and	CC	O
her	PRP$	O
husband	NN	O
/	NNP	O
health	NN	O
care	NN	O
proxy	NN	O
.	.	O

patient	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
known	JJ	B-PROBLEM
malignancy	NN	I-PROBLEM
and	CC	O
also	RB	O
a	DT	O
history	NN	O
of	IN	O
pulmonary	JJ	B-PROBLEM
embolisms	NNS	I-PROBLEM
from	IN	O
2012-04-23	CD	O
.	.	O

earlier	RBR	O
in	IN	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
the	DT	O
team	NN	O
was	VBD	O
concerned	VBN	O
about	IN	O
possible	JJ	O
pulmonary	JJ	B-PROBLEM
embolisms	NNS	I-PROBLEM
as	IN	O
a	DT	O
possible	JJ	O
source	NN	O
of	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
respiratory	JJ	I-PROBLEM
decompensation	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
brain	NN	B-PROBLEM
metastasis	NN	I-PROBLEM
and	CC	O
at	IN	O
this	DT	O
point	NN	O
anticoagulation	NN	B-TREATMENT
was	VBD	O
thought	VBN	O
to	TO	O
be	VB	O
a	DT	O
contraindication	NN	O
given	VBN	O
risk	NN	O
for	IN	O
hemorrhage	NN	B-PROBLEM
into	IN	O
these	DT	B-PROBLEM
tumors	NNS	I-PROBLEM
.	.	O

she	PRP	O
did	VBD	O
have	VB	O
lower	JJR	B-TEST
extremity	NN	I-TEST
doppler	NN	I-TEST
ultrasounds	NNS	I-TEST
,	,	O
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

as	IN	O
mentioned	VBN	O
above	IN	O
patient	NN	O
initially	RB	O
hypotension	NN	B-PROBLEM
,	,	O
febrile	NN	B-PROBLEM
and	CC	O
in	IN	O
respiratory	JJ	B-PROBLEM
distress	NN	I-PROBLEM
presumed	VBN	O
to	TO	O
be	VB	O
septic	JJ	B-PROBLEM
source	NN	I-PROBLEM
likely	JJ	O
pulmonary	NN	O
.	.	O

initially	RB	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
broad	JJ	B-TREATMENT
spectrum	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
including	VBG	O
vancomycin	NN	B-TREATMENT
,	,	O
ceptaz	NN	B-TREATMENT
,	,	O
levaquin	NN	B-TREATMENT
,	,	O
clindamycin	NN	B-TREATMENT
and	CC	O
_________.	NN	O

all	DT	O
of	IN	O
her	PRP$	B-TEST
cultures	NNS	I-TEST
are	VBP	O
negative	JJ	O
to	TO	O
date	NN	O
.	.	O

she	PRP	O
was	VBD	O
negative	JJ	O
for	IN	O
pcp	NN	B-PROBLEM
and	CC	O
subsequently	RB	O
_____________	NNP	O
was	VBD	O
continued	VBN	O
and	CC	O
clindamycin	NN	B-TREATMENT
was	VBD	O
changed	VBN	O
for	IN	O
anaerobic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
her	PRP$	B-TREATMENT
vancomycin	NN	I-TREATMENT
and	CC	O
levaquin	NN	B-TREATMENT
were	VBD	O
also	RB	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
afebrile	JJ	B-PROBLEM
during	IN	O
the	DT	O
majority	NN	O
of	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

by	IN	O
virtue	NN	O
of	IN	O
discussions	NNS	O
on	IN	O
06-28	JJ	O
the	DT	O
patient	NN	O
was	VBD	O
deemed	VBN	O
to	TO	O
be	VB	O
cmo	VBN	B-TREATMENT
and	CC	O
all	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
withdrawn	VBN	O
at	IN	O
this	DT	O
point	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
earlier	RBR	O
in	IN	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
,	,	O
which	WDT	O
was	VBD	O
essentially	RB	O
negative	JJ	O
for	IN	O
an	DT	B-PROBLEM
intraabdominal	JJ	I-PROBLEM
pathology	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
initially	RB	O
supported	VBN	O
with	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
during	IN	O
her	PRP$	O
intensive	JJ	O
care	NN	O
unit	NN	O
course	NN	O
,	,	O
but	CC	O
at	IN	O
this	DT	O
point	NN	O
the	DT	O
patient	NN	O
is	VBZ	O
cmo	JJ	B-TREATMENT
and	CC	O
tube	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
subsequently	RB	O
discontinued	VBN	O
.	.	O

ultimately	RB	O
it	PRP	O
was	VBD	O
decided	VBN	O
by	IN	O
06-28	NN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
shown	VBN	O
minimal	JJ	O
improvement	NN	O
and	CC	O
minimal	JJ	O
evidence	NN	O
of	IN	O
improvement	NN	O
status	NN	O
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
at	IN	O
this	DT	O
point	NN	O
for	IN	O
the	DT	O
patient	NN	O
to	TO	O
be	VB	O
extubated	VBN	O
and	CC	O
to	TO	O
move	VB	O
toward	IN	O
cmo	NN	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

subsequently	RB	O
all	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
,	,	O
blood	NN	B-TEST
draws	NNS	I-TEST
and	CC	O
supportive	JJ	B-TREATMENT
blood	NN	I-TREATMENT
pressure	NN	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
withdrawn	VBN	O
.	.	O

currently	RB	O
she	PRP	O
is	VBZ	O
comfortable	JJ	O
with	IN	O
morphine	NN	B-TREATMENT
and	CC	O
ativan	NN	B-TREATMENT
prn.	NN	O

currently	RB	O
plans	NNS	O
are	VBP	O
in	IN	O
the	DT	O
making	NN	O
for	IN	O
arranging	VBG	O
for	IN	O
the	DT	O
patient	NN	O
to	TO	O
have	VB	O
home	NN	B-TREATMENT
hospice	NN	I-TREATMENT
care	NN	I-TREATMENT
.	.	O

1.	CD	O
metastatic	JJ	B-PROBLEM
breast	NN	I-PROBLEM
cancer	NN	I-PROBLEM
end	NN	I-PROBLEM
stage	NN	I-PROBLEM
.	.	O

2.	CD	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
unclear	JJ	O
etiology	NN	O
,	,	O
presumed	VBD	O
secondary	JJ	O
to	TO	O
possible	JJ	O
pneumonia	NN	B-PROBLEM
,	,	O
questionable	JJ	O
lymphangitic	JJ	B-PROBLEM
spread	NN	I-PROBLEM
.	.	O

3.	CD	O
sepsis	NN	B-PROBLEM
presumed	VBD	O
pulmonary	JJ	O
source	NN	O
.	.	O

1.	CD	O
morphine	NN	B-TREATMENT
prn	NN	O
.	.	O

2.	CD	O
ativan	JJ	B-TREATMENT
prn	NN	O
.	.	O

3.	CD	O
tylenol	JJ	B-TREATMENT
prn	NN	O
.	.	O

4.	CD	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	JJ	B-TREATMENT
nebs	NN	I-TREATMENT
prn	NN	O
.	.	O

left	JJ	B-PROBLEM
parietal	JJ	I-PROBLEM
glioblastoma	NN	I-PROBLEM
multiforme	NN	I-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
an	DT	O
88	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
fatigue	NN	B-PROBLEM
and	CC	O
decreased	VBN	B-PROBLEM
short	JJ	I-PROBLEM
term	NN	I-PROBLEM
memory	NN	I-PROBLEM
for	IN	O
the	DT	O
past	JJ	O
six	CD	O
months	NNS	O
.	.	O

the	DT	O
past	JJ	O
six	CD	O
weeks	NNS	O
,	,	O
she	PRP	O
has	VBZ	O
also	RB	O
been	VBN	O
complaining	VBG	O
of	IN	O
hot	JJ	B-PROBLEM
sensation	NN	I-PROBLEM
and	CC	O
tingling	VBG	B-PROBLEM
sensation	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
hands	NNS	I-PROBLEM
bilaterally	RB	I-PROBLEM
.	.	O

for	IN	O
the	DT	O
past	JJ	O
five	CD	O
weeks	NNS	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
experienced	VBN	O
dragging	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
leg	NN	I-PROBLEM
with	IN	O
weakness	NN	B-PROBLEM
throughout	IN	O
that	DT	O
side	NN	O
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
patient	NN	O
reported	VBD	O
demonstrated	JJ	O
three	CD	B-PROBLEM
lesions	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
parietal	JJ	I-PROBLEM
region	NN	I-PROBLEM
of	IN	O
the	DT	O
brain	NN	O
.	.	O

bone	NN	B-TEST
scan	JJ	I-TEST
,	,	O
ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
,	,	O
chest	JJS	B-TEST
x-ray	NN	I-TEST
,	,	O
and	CC	O
mammogram	NNS	B-TEST
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

patient	NN	O
noted	VBD	O
the	DT	B-PROBLEM
foot	NN	I-PROBLEM
dragging	VBG	I-PROBLEM
to	TO	O
have	VB	O
worsened	VBN	O
over	IN	O
the	DT	O
past	JJ	O
few	JJ	O
weeks	NNS	O
but	CC	O
improved	VBN	O
since	IN	O
on	IN	O
decadron	IN	B-TREATMENT
the	DT	O
past	JJ	O
week	NN	O
before	IN	O
admission	NN	O
.	.	O

patient	NN	O
is	VBZ	O
now	RB	O
admitted	VBN	O
for	IN	O
elective	JJ	B-TEST
left	JJ	I-TEST
parietal	JJ	I-TEST
stereotactic	JJ	I-TEST
biopsy	NN	I-TEST
of	IN	O
the	DT	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

significant	JJ	O
for	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
basal	NN	B-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
nose	JJ	I-PROBLEM
six	CD	O
years	NNS	O
ago	RB	O
,	,	O
cataracts	NNS	B-PROBLEM
,	,	O
and	CC	O
a	DT	B-TREATMENT
hysterectomy	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

hydrochlorothiazide	RB	B-TREATMENT
25	CD	O
mg	NNS	O
q.d.	NN	O
and	CC	O
decadron	NN	B-TREATMENT
25	CD	O
mg	NN	O
b.i.d.	NN	O

on	IN	O
admission	NN	O
demonstrated	VBD	O
a	DT	O
well-developed	JJ	O
,	,	O
well-nourished	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
dragging	VBG	O
her	PRP$	O
right	JJ	O
foot	NN	O
.	.	O

head	NN	O
was	VBD	O
atraumatic	JJ	B-PROBLEM
and	CC	O
normocephalic	JJ	O
with	IN	O
pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	NN	O
.	.	O

clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

examination	NN	B-TEST
demonstrated	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
without	IN	O
any	DT	B-PROBLEM
murmurs	NNS	I-PROBLEM
noted	VBN	O
.	.	O

benign	NN	O
with	IN	O
a	DT	B-PROBLEM
hysterectomy	NN	I-PROBLEM
scar	NN	I-PROBLEM
which	WDT	O
was	VBD	O
well	RB	O
healed	VBN	O
.	.	O

examination	NN	B-TEST
showed	VBD	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
alert	JJ	O
and	CC	O
oriented	VBD	O
times	NNS	O
three	CD	O
,	,	O
short	JJ	O
term	NN	O
memory	NN	O
was	VBD	O
deficient	JJ	B-PROBLEM
,	,	O
patient	JJ	O
remembered	VBD	O
zero	CD	O
out	IN	O
of	IN	O
three	CD	O
things	NNS	O
to	TO	O
remember	VB	O
at	IN	O
one	CD	O
minute	NN	O
,	,	O
speech	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
fluent	JJ	O
,	,	O
and	CC	O
cranial	JJ	O
nerves	NNS	O
ii-xii	JJ	O
were	VBD	O
intact	JJ	O
.	.	O

on	IN	O
motor	NN	B-TEST
examination	NN	I-TEST
,	,	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
of	IN	O
normal	JJ	O
motor	NN	O
function	NN	O
throughout	IN	O
except	IN	O
for	IN	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
dorsi	NN	I-PROBLEM
flexion	NN	I-PROBLEM
and	CC	I-PROBLEM
plantar	NN	I-PROBLEM
flexion	NN	I-PROBLEM
,	,	O
both	DT	O
noted	VBD	O
to	TO	O
be	VB	O
about	IN	O
4/5	CD	O
and	CC	O
sensory	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
intact	JJ	O
throughout	IN	O
.	.	O

patient	NN	O
's	POS	O
gait	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
drag	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
right	JJ	B-PROBLEM
foot	NN	I-PROBLEM
drop	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
april	NN	O
21	CD	O
where	WRB	O
patient	JJ	O
underwent	NN	O
a	DT	B-TEST
left	JJ	I-TEST
parietal	JJ	I-TEST
stereotactic	NN	I-TEST
guided	VBD	I-TEST
brain	NN	I-TEST
biopsy	NN	I-TEST
.	.	O

patient	NN	O
tolerated	VBD	O
the	DT	B-TEST
procedure	NN	I-TEST
well	RB	O
without	IN	O
any	DT	B-PROBLEM
complications	NNS	I-PROBLEM
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
recovery	NN	O
room	NN	O
awake	NN	O
and	CC	O
stable	JJ	O
then	RB	O
subsequently	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

patient	NN	O
did	VBD	O
well	RB	O
post-operatively	RB	O
,	,	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
right	NN	I-PROBLEM
sided	VBN	I-PROBLEM
deficit	NN	I-PROBLEM
,	,	O
and	CC	O
physical	JJ	O
therapy	NN	O
and	CC	O
occupational	JJ	O
therapy	NN	O
visited	VBD	O
the	DT	O
patient	NN	O
,	,	O
worked	VBD	O
with	IN	O
the	DT	O
patient	NN	O
,	,	O
and	CC	O
determined	VBD	O
that	IN	O
patient	NN	O
needed	VBN	O
rehabilitation	NN	B-TREATMENT
with	IN	O
physical	JJ	O
therapy	NN	O
.	.	O

she	PRP	O
is	VBZ	O
to	TO	O
receive	VB	O
rehabilitation	NN	B-TREATMENT
to	TO	O
increase	VB	O
her	PRP$	O
mobility	NN	O
and	CC	O
strength	NN	O
,	,	O
rehabilitation	NN	B-TREATMENT
potential	NN	O
is	VBZ	O
good	JJ	O
,	,	O
and	CC	O
she	PRP	O
is	VBZ	O
to	TO	O
receive	VB	O
the	DT	O
following	JJ	O
medications	NNS	O
at	IN	O
that	DT	O
facility	NN	O
:	:	O

decadron	NN	B-TREATMENT
3	CD	O
mg	NN	O
p.o.	NN	O
q.6h.	NN	O
times	NNS	O
one	CD	O
week	NN	O
then	RB	O
2	CD	O
mg	NNS	O
p.o.q.6h.	JJ	O
thereafter	RB	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
heparin	JJ	B-TREATMENT
5000	CD	O
units	NNS	O
subcutaneously	RB	O
b.i.d.	VBP	O
until	IN	O
ambulating	VBG	O
well	RB	O
,	,	O
hydrochlorothiazide	RB	B-TREATMENT
25mg	CD	O
q.d.	NN	O
,	,	O
dilantin	VBZ	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
zantac	VBZ	B-TREATMENT
150	CD	O
mg	NN	O
b.i.d.	NN	O
,	,	O
and	CC	O
percocet	NN	B-TREATMENT
p.r.n.	NN	O

pathology	NN	O
of	IN	O
the	DT	B-TEST
biopsy	NN	I-TEST
demonstrated	VBD	O
glioblastoma	JJ	B-PROBLEM
multiforme	NN	I-PROBLEM
,	,	I-PROBLEM
grade	NN	I-PROBLEM
iii/iii	NN	I-PROBLEM
.	.	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
back	RB	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

mr.	NN	O
hohlt	NN	O
is	VBZ	O
a	DT	O
76	CD	O
-	:	O
year-old	JJ	O
man	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
and	CC	O
prior	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
with	IN	O
a	DT	B-TREATMENT
percutaneous	JJ	I-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
in	IN	O
2005	CD	O
at	IN	O
the	DT	O
cambridge	NN	O
health	NN	O
alliance	NN	O
.	.	O

he	PRP	O
states	VBZ	O
that	IN	O
he	PRP	O
has	VBZ	O
experienced	VBN	O
pain	NN	B-PROBLEM
and	CC	O
tightness	NN	B-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
back	NN	I-PROBLEM
radiating	NN	O
into	IN	O
both	DT	O
shoulders	NNS	O
starting	VBG	O
on	IN	O
2016-09-02	JJ	O
.	.	O

the	DT	O
patient	NN	O
denies	VBZ	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
or	CC	O
nausea	NN	B-PROBLEM
.	.	O

the	DT	B-PROBLEM
pain	NN	I-PROBLEM
lasted	VBD	O
for	IN	O
30	CD	O
seconds	NNS	O
following	VBG	O
pushing	VBG	O
a	DT	O
wheelbarrow	NN	O
and	CC	O
resolved	VBN	O
with	IN	O
rest	NN	O
.	.	O

the	DT	O
patient	NN	O
denied	VBD	O
any	DT	O
prior	JJ	O
episodes	NNS	O
of	IN	O
pain	NN	B-PROBLEM
or	CC	O
any	DT	O
since	IN	O
2005	CD	O
following	VBG	O
the	DT	O
initial	JJ	O
episode	NN	O
of	IN	O
pain	NN	B-PROBLEM
.	.	O

he	PRP	O
then	RB	O
presented	VBD	O
to	TO	O
mass.	VB	O
mental	JJ	O
health	NN	O
center	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
ruled	VBN	O
out	RP	O
for	IN	O
an	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
by	IN	O
enzymes	NNS	B-TEST
and	CC	O
electrocardiograms	NNS	B-TEST
.	.	O

the	DT	O
patient	NN	O
also	RB	O
underwent	VBD	O
a	DT	O
negative	JJ	O
evaluation	NN	O
for	IN	O
dissecting	VBG	B-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

on	IN	O
2016-09-03	JJ	O
,	,	O
the	DT	O
patient	NN	O
began	VBD	O
experiencing	VBG	O
continuing	VBG	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
of	IN	O
increasing	VBG	O
intensity	NN	O
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
nitroglycerin	JJ	B-TREATMENT
paste	NN	I-TREATMENT
and	CC	O
iv	JJ	B-TREATMENT
integrelin	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
plavix	NN	B-TREATMENT
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
he	PRP	O
ruled	VBD	O
in	IN	O
for	IN	O
an	DT	B-PROBLEM
nst	JJ	I-PROBLEM
emi	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
peak	JJ	I-TEST
ck	NN	I-TEST
of	IN	O
412	CD	O
and	CC	O
a	DT	B-TEST
troponin	NN	I-TEST
of	IN	O
6.23	CD	O
.	.	O

electrocardiograms	NNS	B-TEST
progressed	VBD	O
to	TO	O
inverted	VB	B-PROBLEM
t	NN	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
v5	NN	I-PROBLEM
and	CC	I-PROBLEM
v6	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
now	RB	O
transferred	VBN	O
to	TO	O
cambridge	VB	O
health	NN	O
alliance	NN	O
for	IN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

hypertension	NN	B-PROBLEM
,	,	O
hyperlipidemia	NN	B-PROBLEM
,	,	O
imi	NN	B-PROBLEM
in	IN	O
2005	CD	O
.	.	O

partial	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
,	,	O
herniorrhaphy	NN	B-TREATMENT
,	,	O
percutaneous	JJ	B-TREATMENT
transluminal	JJ	I-TREATMENT
coronary	JJ	I-TREATMENT
angioplasty	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
rca	NN	I-TREATMENT
in	IN	O
2005	CD	O
,	,	O
left	VBD	B-TREATMENT
knee	NN	I-TREATMENT
surgery	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
tonsil	NN	B-TREATMENT
and	CC	I-TREATMENT
adenoid	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
flomax	JJ	B-TREATMENT
0.4	CD	O
q.d.	NN	O

2.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
q.d.	NN	O

3.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
q.d.	NN	O

4.	CD	O
naproxen	JJ	B-TREATMENT
p.r.n.	NN	O
as	RB	O
well	RB	O
as	IN	O
several	JJ	B-TREATMENT
vitamins	NNS	I-TREATMENT
and	CC	O
supplements	NNS	B-TREATMENT
.	.	O

5.	CD	O
zestoretic	JJ	B-TREATMENT
with	IN	O
an	DT	O
unknown	JJ	O
dose	NN	O
.	.	O

1.	CD	O
captopril	NN	B-TREATMENT
25	CD	O
t.i.d.	NN	O

2.	CD	O
protonix	JJ	B-TREATMENT
q.d.	RB	O
40	CD	O
.	.	O

3.	CD	O
nitroglycerin	JJ	B-TREATMENT
paste	NN	I-TREATMENT
1	CD	O
inch	NN	O
q.	RB	O
6	CD	O
hours	NNS	O
.	.	O

4.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
b.i.d.	NN	O

5.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
q.d.	NN	O

6.	CD	O
lovenox	JJ	B-TREATMENT
90	CD	O
b.i.d.	NN	O

7.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
q.d.	NN	O

8.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
q.d.	NN	O

father	RB	O
died	VBN	O
in	IN	O
his	PRP$	O
80	CD	O
's	POS	O
of	IN	O
pacemaker	NN	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
his	PRP$	O
70	CD	O
's.	NNS	O

heart	NN	B-TEST
rate	NN	I-TEST
is	VBZ	O
55	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
is	VBZ	O
129/79	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
is	VBZ	O
22	CD	O
,	,	O
o2	JJR	B-TEST
sat	NN	I-TEST
is	VBZ	O
96	CD	O
percent	NN	O
on	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

in	IN	O
general	JJ	O
,	,	O
well-appearing	JJ	O
man	NN	O
,	,	O
lying	VBG	O
on	IN	O
a	DT	O
stretcher	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

2	CD	B-TEST
plus	CC	I-TEST
carotids	NNS	I-TEST
with	IN	O
no	DT	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
and	CC	O
no	DT	O
bruits	NNS	B-PROBLEM
and	CC	O
no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

fine	JJ	B-PROBLEM
crackles	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
bases	NNS	I-PROBLEM
,	,	O
otherwise	RB	O
clear	JJ	O
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
s1	NN	O
and	CC	O
s2	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	O
:	:	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
and	CC	O
nondistended	JJ	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
and	CC	O
no	DT	O
bruits	NNS	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
are	VBP	O
2	CD	O
plus	JJ	O
femoral	JJ	O
bilaterally	RB	O
,	,	O
2	CD	O
plus	CC	O
dorsalis	JJ	O
pedis	NN	O
as	RB	O
well	RB	O
as	IN	O
posterior	JJ	O
tibial	JJ	O
bilaterally	RB	O
.	.	O

no	DT	O
edema	NN	B-PROBLEM
.	.	O

chest	NN	B-TEST
ct	NN	I-TEST
done	VBN	O
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
showed	VBD	O
no	DT	O
gallstones	NNS	B-PROBLEM
.	.	O

left	VBN	O
kidney	NN	O
with	IN	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
splenic	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
and	CC	O
no	DT	O
triple	NN	B-PROBLEM
a	DT	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
has	VBZ	O
sinus	VBN	O
rhythm	NN	O
with	IN	O
q	JJ	B-PROBLEM
wave	NN	I-PROBLEM
in	IN	I-PROBLEM
2	CD	I-PROBLEM
,	,	I-PROBLEM
3	CD	I-PROBLEM
,	,	I-PROBLEM
and	CC	I-PROBLEM
f	NN	I-PROBLEM
,	,	O
flattened	VBD	B-PROBLEM
t	JJ	I-PROBLEM
waves	NNS	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
lateral	JJ	I-PROBLEM
leads	NNS	I-PROBLEM
,	,	O
sinus	NN	O
rhythm	NN	O
at	IN	O
a	DT	O
rate	NN	O
of	IN	O
56	CD	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
is	VBZ	O
8.3	CD	O
,	,	O
hematocrit	NN	B-TEST
42.7	CD	O
,	,	O
platelets	NNS	B-TEST
180	CD	O
,	,	O
inr	NN	B-TEST
was	VBD	O
1.1	CD	O
,	,	O
sodium	NN	B-TEST
135	CD	O
,	,	O
potassium	NN	B-TEST
4.0	CD	O
,	,	O
chloride	RB	B-TEST
99	CD	O
,	,	O
co2	NN	B-TEST
33	CD	O
,	,	O
bun	NN	B-TEST
13	CD	O
,	,	O
creatinine	NN	B-TEST
1.0	CD	O
,	,	O
glucose	VBD	B-TEST
96	CD	O
.	.	O

while	IN	O
on	IN	O
transfer	NN	O
,	,	O
the	DT	O
patient	JJ	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
.	.	O

in	IN	O
summary	JJ	O
,	,	O
the	DT	B-TEST
catheterization	NN	I-TEST
showed	VBD	O
left	VBD	O
main	JJ	O
with	IN	O
no	DT	O
obstructive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
lad	VBZ	O
with	IN	O
70	CD	B-PROBLEM
percent	NN	I-PROBLEM
serial	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
,	,	O
left	VBD	O
circumflex	NN	O
with	IN	O
70	CD	O
percent	NN	O
proximal	NN	O
,	,	O
om1	NN	O
and	CC	O
om2	VB	O
both	DT	O
70	CD	B-PROBLEM
percent	NN	I-PROBLEM
lesions	NNS	I-PROBLEM
,	,	O
rca	NN	O
with	IN	O
nonobstructive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
ejection	NN	O

fraction	NN	B-TEST
of	IN	O
25	CD	O
percent	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
referred	VBN	O
to	TO	O
ct	VB	O
surgery	NN	O
who	WP	O
was	VBD	O
seen	VBN	O
and	CC	O
accepted	VBN	O
for	IN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	NN	I-TREATMENT
.	.	O

in	IN	O
summary	JJ	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
4	CD	O
with	IN	O
a	DT	B-TREATMENT
lima	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
lad	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
om1	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
om2	NN	I-TREATMENT
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
diagonal	NN	I-TREATMENT
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
operation	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
operating	NN	O
room	NN	O
to	TO	O
the	DT	O
cardiothoracic	NN	O
icu	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
,	,	O
he	PRP	O
was	VBD	O
av	RB	B-TREATMENT
paced	VBN	I-TREATMENT
at	IN	O
a	DT	O
rate	NN	O
of	IN	O
88	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

he	PRP	O
had	VBD	O
propofol	VBN	B-TREATMENT
at	IN	O
30	CD	O
mc	NNS	O
per	IN	O
kg	NN	O
per	IN	O
minute	NN	O
and	CC	O
neo-synephrine	JJ	B-TREATMENT
to	TO	O
maintain	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
.	.	O

his	PRP$	B-TREATMENT
anesthesia	NN	I-TREATMENT
was	VBD	O
reversed	VBN	O
.	.	O

he	PRP	O
was	VBD	O
weaned	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
and	CC	O
successfully	RB	O
extubated	VBN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
1	CD	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
on	IN	O
a	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
to	TO	O
maintain	VB	O
an	DT	O
adequate	JJ	O
blood	NN	O

he	PRP	O
remained	VBD	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
as	IN	O
he	PRP	O
was	VBD	O
unable	JJ	O
to	TO	O
be	VB	O
weaned	VBN	O
off	IN	O
of	IN	O
his	PRP$	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
drip	NN	I-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
1	CD	O
,	,	O
his	PRP$	B-TREATMENT
swan-ganz	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
as	RB	O
well	RB	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
2	CD	O
,	,	O
another	DT	O
attempt	NN	O
was	VBD	O
made	VBN	O
to	TO	O
wean	VB	O
the	DT	O
patient	NN	O
off	IN	O
of	IN	O
neo-synephrine	JJ	B-TREATMENT
unsuccessfully	RB	O
.	.	O

his	PRP$	B-TREATMENT
chest	JJS	I-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
.	.	O

however	RB	O
,	,	O
because	IN	O
he	PRP	O
could	MD	O
not	RB	O
be	VB	O
weaned	VBN	O
from	IN	O
the	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
,	,	O
he	PRP	O
again	RB	O
remained	VBD	O
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
3	CD	O
,	,	O
an	DT	O
additional	JJ	O
attempt	NN	O
was	VBD	O
made	VBN	O
to	TO	O
wean	VB	O
the	DT	O
patient	NN	O
from	IN	O
his	PRP$	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
unsuccessfully	RB	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
received	VBD	O
a	DT	B-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
in	IN	O
an	DT	O
additional	JJ	O
attempt	NN	O
to	TO	O
wean	VB	O
from	IN	O
neo-synephrine	JJ	B-TREATMENT
.	.	O

this	DT	O
also	RB	O
did	VBD	O
not	RB	O
help	VB	O
in	IN	O
the	DT	O
attempt	NN	O
to	TO	O
wean	VB	O
from	IN	O
neo-synephrine	JJ	B-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
and	CC	O
he	PRP	O
remained	VBD	O
again	RB	O
in	IN	O
the	DT	O
icu	NN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
4	CD	O
,	,	O
additional	JJ	O
attempts	NNS	O
were	VBD	O
made	VBN	O
to	TO	O
wean	VB	O
the	DT	O
patient	NN	O
off	IN	O
of	IN	O
his	PRP$	B-TREATMENT
neo-synephrine	NN	I-TREATMENT
,	,	O
however	RB	O
,	,	O
he	PRP	O
continued	VBD	O
to	TO	O
drop	VB	O
his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
whenever	WRB	O
an	DT	O
attempt	NN	O
was	VBD	O
made	VBN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
5	CD	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
finally	RB	O
weaned	VBN	O
off	IN	O
of	IN	O
his	PRP$	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
and	CC	O
diuresis	NN	B-TREATMENT
was	VBD	O
begun	VBN	O
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
6	CD	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
floor	NN	O
for	IN	O
continuing	VBG	B-TREATMENT
postoperative	JJ	I-TREATMENT
care	NN	I-TREATMENT
and	CC	O
cardiac	JJ	B-TREATMENT
rehabilitation	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
as	IN	O
follows	VBZ	O
:	:	O
vital	JJ	B-TEST
signs	NNS	I-TEST
were	VBD	O
temperature	JJ	B-TEST
99	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
84	CD	O
in	IN	O
sinus	NN	O
rhythm	NN	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
114/63	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
18	CD	O
,	,	O
o2	FW	B-TEST
sat	VBD	I-TEST
was	VBD	O
94	CD	O
percent	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

weight	NN	B-TEST
preoperatively	RB	O
was	VBD	O
88.5	CD	O
kilos	NN	O
,	,	O
at	IN	O
discharge	NN	O
was	VBD	O
90.4	CD	O
kilos	NN	O
.	.	O

white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
8.8	CD	O
,	,	O
hematocrit	NN	B-TEST
29.7	CD	O
,	,	O
platelets	NNS	B-TEST
367	CD	O
,	,	O
sodium	NN	B-TEST
139	CD	O
,	,	O
potassium	NN	B-TEST
4.7	CD	O
,	,	O
chloride	RB	B-TEST
102	CD	O
,	,	O
co2	NN	B-TEST
27	CD	O
,	,	O
bun	NN	B-TEST
17	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
,	,	O
glucose	VBD	B-TEST
95	CD	O
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

sternum	NN	O
is	VBZ	O
stable	JJ	O
,	,	O
incision	NN	B-PROBLEM
with	IN	O
staples	NNS	B-TREATMENT
,	,	O
opened	VBD	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

abdomen	NNS	O
:	:	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBD	B-PROBLEM
with	IN	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

warm	NN	O
and	CC	O
well	RB	O
profuse	VB	O
with	IN	O
1	CD	B-PROBLEM
to	TO	I-PROBLEM
2	CD	I-PROBLEM
plus	CC	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
saphenous	JJ	I-PROBLEM
vein	NN	I-PROBLEM
graft	NN	I-PROBLEM
site	NN	I-PROBLEM
with	IN	O
steri-strips	NNS	B-TREATMENT
,	,	O
open	JJ	O
to	TO	O
air	NN	O
,	,	O
clean	JJ	O
and	CC	O
dry	JJ	O
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
grafting	VBG	I-TREATMENT
times	NNS	O
4	CD	O
with	IN	O
lima	NN	B-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
lad	NN	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
om1	VB	I-TREATMENT
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
om2	VB	I-TREATMENT
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
diagonal	NN	I-TREATMENT
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

4.	CD	O
status	NN	O
post	NN	O
partial	JJ	B-TREATMENT
thyroidectomy	NN	I-TREATMENT
.	.	O

5.	CD	O
status	NN	O
post	NN	O
hernia	NN	B-TREATMENT
repair	NN	I-TREATMENT
.	.	O

6.	CD	O
status	NN	O
post	NN	O
left	VBD	B-TREATMENT
knee	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

7.	CD	O
status	NN	O
post	NN	O
tonsil	NN	B-TREATMENT
and	CC	I-TREATMENT
adenoid	JJ	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

1.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O

2.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
q.d.	NN	O
times	NNS	O
3	CD	O
months	NNS	O
.	.	O

3.	CD	O
aspirin	JJ	B-TREATMENT
325	CD	O
mg	NN	O
q.d.	NN	O

4.	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	JJ	O
times	NNS	O
two	CD	O
weeks	NNS	O
.	.	O

5.	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
q.d.	JJ	O
times	NNS	O
two	CD	O
weeks	NNS	O
.	.	O

6.	CD	O
metoprolol	JJ	B-TREATMENT
12.5	CD	O
mg	NN	O
b.i.d.	NN	O

7.	CD	O
percocet	JJ	B-TREATMENT
1	CD	O
to	TO	O
2	CD	O
tabs	NNS	O
q.	RB	O
4	CD	O
hours	NNS	O
p.r.n.	NN	O

gastrointestinal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM

gi	NNS	B-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

patient	NN	O
is	VBZ	O
an	DT	O
84-year-old	JJ	O
male	NN	O
who	WP	O
was	VBD	O
transferred	VBN	O
from	IN	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
hematocrit	NN	I-PROBLEM
of	IN	O
21	CD	O
and	CC	O
with	IN	O
guaiac-positive	JJ	B-PROBLEM
stool	NN	I-PROBLEM
.	.	O

the	DT	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
he	PRP	O
experienced	VBD	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
,	,	O
and	CC	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
admission	NN	O
he	PRP	O
collapsed	VBD	O
and	CC	O
complained	VBD	O
of	IN	O
substantial	JJ	B-PROBLEM
weakness	NN	I-PROBLEM
.	.	O

he	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
melana	NN	I-PROBLEM
,	,	O
any	DT	B-PROBLEM
hematemesis	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
at	IN	O
the	DT	O
time	NN	O
at	IN	O
which	WDT	O
time	NN	O
it	PRP	O
was	VBD	O
found	VBN	O
that	IN	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
21	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
90/60	CD	O
,	,	O
and	CC	O
his	PRP$	B-TEST
inr	NN	I-TEST
was	VBD	O
3.3	CD	O
.	.	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
is	VBZ	O
anti-coagulated	JJ	B-TREATMENT
for	IN	O
an	DT	B-TREATMENT
artificial	JJ	I-TREATMENT
heart	NN	I-TREATMENT
valve	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
at	IN	O
that	DT	O
point	NN	O
given	VBN	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

on	IN	O
further	JJ	O
questioning	NN	O
,	,	O
the	DT	O
patient	NN	O
reported	VBD	O
that	IN	O
he	PRP	O
started	VBD	O
to	TO	O
feel	VB	O
&quot;	JJ	O
different	JJ	O
&quot;	JJ	O
several	JJ	O
days	NNS	O
ago	RB	O
with	IN	O
slowing	VBG	B-PROBLEM
and	CC	I-PROBLEM
difficult	JJ	I-PROBLEM
ambulation	NN	I-PROBLEM
progressing	VBG	O
to	TO	O
complete	VB	O
inability	NN	O
to	TO	O
ambulate	VB	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
ambulation	NN	O
,	,	O
but	CC	O
he	PRP	O
does	VBZ	O
have	VB	O
baseline	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
exertion	NN	O
.	.	O

he	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
dysuria	NN	B-PROBLEM
,	,	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
or	CC	O
any	DT	O
history	NN	O
of	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
last	JJ	O
admitted	JJ	O
to	TO	O
padrugmoff	VB	O
hospital	NN	O
with	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
24.5	CD	O
,	,	O
and	CC	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
he	PRP	O
had	VBD	O
guaiac-positive	JJ	B-PROBLEM
and	CC	O
had	VBD	O
a	DT	B-TEST
small	JJ	I-TEST
bowel	NN	I-TEST
follow	VBP	I-TEST
through	IN	I-TEST
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

he	PRP	O
was	VBD	O
transfused	VBN	O
4	CD	B-TREATMENT
units	NNS	I-TREATMENT
during	IN	O
that	DT	O
admission	NN	O
and	CC	O
discharged	VBN	O
with	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
34	CD	O
on	IN	O
vitamin	NN	B-TREATMENT
c	NN	I-TREATMENT
and	CC	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
97.4	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
65	CD	O
,	,	O
pressure	NN	B-TEST
107/52	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
22	CD	O
and	CC	O
saturating	VBG	B-TEST
100%	CD	O
on	IN	O
2	CD	O
l	NN	O
of	IN	O
a	DT	B-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

general	JJ	B-TEST
exam	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
was	VBD	O
notable	JJ	O
for	IN	O
pale	JJ	B-PROBLEM
mucous	JJ	I-PROBLEM
membranes	NNS	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
lateral	JJ	I-PROBLEM
eye	NN	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
clear	JJ	O
lungs	NNS	O
,	,	O
2/6	CD	B-PROBLEM
holosystolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
,	,	O
best	JJS	O
heard	NN	O
at	IN	O
the	DT	O
apex	NN	O
,	,	O
abdomen	NNS	O
was	VBD	O
mildly	RB	B-PROBLEM
distended	JJ	I-PROBLEM
but	CC	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
and	CC	O
his	PRP$	O
extremities	NNS	O
were	VBD	O
without	IN	O
edema	NN	B-PROBLEM
and	CC	O
skin	NN	O
without	IN	O
any	DT	B-PROBLEM
rashes	NNS	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
status	NN	O
post	NN	O
two-vessel	JJ	B-TREATMENT
cabg	NN	I-TREATMENT
in	IN	O
1986	CD	O
,	,	O
also	RB	O
he	PRP	O
was	VBD	O
treated	VBN	O
for	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
aortic	JJ	B-TREATMENT
valve	NN	I-TREATMENT
replacement	NN	I-TREATMENT
,	,	O
and	CC	O
mitral	JJ	B-TREATMENT
valve	NNS	I-TREATMENT
replacement	NN	I-TREATMENT
with	IN	O
st.	JJ	B-TREATMENT
jude	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
valve	NN	I-TREATMENT
in	IN	O
09/2001	CD	O
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
history	NN	O
of	IN	O
prior	JJ	B-PROBLEM
gi	NNS	I-PROBLEM
bleed	VBP	I-PROBLEM
requiring	VBG	O
blood	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
during	IN	O
which	WDT	O
he	PRP	O
also	RB	O
had	VBD	O
a	DT	B-TEST
colonoscopy	NN	I-TEST
on	IN	O
05/2003	CD	O
which	WDT	O
demonstrated	VBD	O
no	DT	O
neoplasia	NN	B-PROBLEM
and	CC	O
scattered	VBD	B-PROBLEM
diverticuli	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
,	,	O
following	VBG	O
his	PRP$	B-PROBLEM
first	JJ	I-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
had	VBD	O
an	DT	B-TEST
eeg	NN	I-TEST
done	VBN	O
in	IN	O
07/2003	CD	O
which	WDT	O
showed	VBD	O
gastritis	NN	B-PROBLEM
with	IN	O
oozing	VBG	B-PROBLEM
and	CC	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
recent	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

included	VBN	O
lasix	NN	B-TREATMENT
,	,	O
lopressor	NN	B-TREATMENT
,	,	O
coumadin	NN	B-TREATMENT
,	,	O
diovan	NN	B-TREATMENT
,	,	O
torsemide	NN	B-TREATMENT
,	,	O
flomax	NN	B-TREATMENT
,	,	O
protonix	NN	B-TREATMENT
,	,	O
senekot	NN	B-TREATMENT
,	,	O
potassium	NN	B-TREATMENT
,	,	O
vitamin	FW	B-TREATMENT
c	NN	I-TREATMENT
,	,	O
iron	NN	B-TREATMENT
,	,	O
and	CC	O
a	DT	B-TREATMENT
multivitamin	NN	I-TREATMENT
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
wife	NN	O
with	IN	O
alzheimer	JJ	B-PROBLEM
&apos;s	NNS	I-PROBLEM
who	WP	O
lives	VBZ	O
in	IN	O
a	DT	O
skilled-nursing	JJ	O
facility	NN	O
.	.	O

notable	JJ	O
for	IN	O
a	DT	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
of	IN	O
78	CD	O
,	,	O
1.7	CD	O
;	:	O
for	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
,	,	O
potassium	NN	B-TEST
139	CD	O
and	CC	O
3.6	CD	O
;	:	O
chloride	NN	B-TEST
and	CC	O
bicarb	NN	B-TEST
108	CD	O
,	,	O
21	CD	O
.	.	O

white	JJ	B-TEST
count	NN	I-TEST
7	CD	O
,	,	O
hematocrit	NN	B-TEST
24.2	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
was	VBD	O
183	CD	O
.	.	O

his	PRP$	B-TEST
inr	NN	I-TEST
was	VBD	O
also	RB	O
3.4	CD	O
.	.	O

ptt	NN	B-TEST
was	VBD	O
55	CD	O
.	.	O

his	PRP$	B-TEST
ekg	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
right	JJ	B-PROBLEM
bundle	NN	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
axis	JJ	I-PROBLEM
deviation	NN	I-PROBLEM
,	,	O
but	CC	O
was	VBD	O
in	IN	O
sinus	JJ	O
rhythm	NN	O
.	.	O

his	PRP$	B-TEST
ua	NN	I-TEST
had	VBD	O
10-17	JJ	B-PROBLEM
white	JJ	I-PROBLEM
blood	NN	I-PROBLEM
cells	NNS	I-PROBLEM
;	:	O
trace	NN	B-PROBLEM
leukocyte	NN	I-PROBLEM
esterase	NN	I-PROBLEM
hyaline	NN	B-PROBLEM
casts	VBZ	I-PROBLEM
numbering	VBG	O
60-70	JJ	O
.	.	O

his	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
clear	JJ	O
lungs	NNS	O
with	IN	O
no	DT	O
edema	NN	B-PROBLEM
or	CC	O
infiltrates	NNS	B-PROBLEM
and	CC	O
small	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

patient	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
troponin	NN	I-TEST
of	IN	O
0.71	CD	O
on	IN	O
admission	NN	O
with	IN	O
a	DT	B-TEST
ck	NN	I-TEST
of	IN	O
46	CD	O
and	CC	O
ckmb	NN	B-TEST
of	IN	O
3.4	CD	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
patient	NN	O
was	VBD	O
likely	JJ	O
having	VBG	O
a	DT	B-PROBLEM
repeat	NN	I-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
and	CC	O
while	IN	O
he	PRP	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
,	,	O
he	PRP	O
had	VBD	O
evidently	RB	O
lost	VBN	O
a	DT	O
substantial	JJ	O
amount	NN	O
of	IN	O
blood	NN	O
.	.	O

patient	NN	O
was	VBD	O
transfused	VBN	O
2	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
overnight	RB	O
,	,	O
the	DT	O
first	JJ	O
night	NN	O
after	IN	O
admission	NN	O
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
bumped	VBD	O
up	RP	O
appropriately	RB	O
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
a	DT	B-TREATMENT
proton	NN	I-TREATMENT
pump	NN	I-TREATMENT
inhibitor	NN	I-TREATMENT
and	CC	O
on	IN	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
and	CC	O
vitamin	NN	B-TREATMENT
c	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
held	VBN	O
at	IN	O
the	DT	O
time	NN	O
given	VBN	O
the	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
even	RB	O
though	IN	O
it	PRP	O
was	VBD	O
important	JJ	O
to	TO	O
keep	VB	O
his	PRP$	B-TEST
inr	JJ	I-TEST
2.5-3.5	JJ	O
,	,	O
given	VBN	O
his	PRP$	B-TREATMENT
artificial	JJ	I-TREATMENT
valve	NN	I-TREATMENT
it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
the	DT	O
risk	NN	O
of	IN	O
continued	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
was	VBD	O
to	TO	O
great	JJ	O
to	TO	O
continue	VB	O
the	DT	B-TREATMENT
coumadin	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
subsequently	RB	O
seen	VBN	O
by	IN	O
the	DT	O
gi	NN	O
team	NN	O
who	WP	O
performed	VBD	O
an	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
which	WDT	O
demonstrated	VBD	O
the	DT	O
following	NN	O
:	:	O

in	IN	O
the	DT	O
esophagus	NN	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
hiatal	NN	I-PROBLEM
hernia	NN	I-PROBLEM
and	CC	O
in	IN	O
the	DT	O
stomach	NN	O
there	EX	O
is	VBZ	O
evidence	NN	O
of	IN	O
erosive	JJ	B-PROBLEM
gastritis	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
body	NN	I-PROBLEM
of	IN	O
the	DT	O
stomach	NN	O
and	CC	O
the	DT	O
antrum	NN	O
,	,	O
the	DT	O
mucous	JJ	O
appeared	VBD	O
edematous	JJ	B-PROBLEM
.	.	O

a	DT	B-PROBLEM
small	JJ	I-PROBLEM
polyp	NN	I-PROBLEM
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
fundus	NN	O
which	WDT	O
stigmata	NN	B-PROBLEM
of	IN	O
old	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
;	:	O
an	DT	B-TREATMENT
endoclip	NN	I-TREATMENT
was	VBD	O
applied	VBN	O
to	TO	O
this	DT	O
.	.	O

another	DT	B-PROBLEM
polyp	NN	I-PROBLEM
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
antrum	NN	O
and	CC	O
cold	JJ	B-TEST
biopsies	NNS	I-TEST
were	VBD	O
obtained	VBN	O
there	RB	O
.	.	O

in	IN	O
the	DT	O
duodenum	NN	O
,	,	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
avm	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
the	DT	O
second	JJ	O
portion	NN	O
of	IN	O
the	DT	O
duodenum	NN	O
and	CC	O
was	VBD	O
cauterized	VBN	O
.	.	O

the	DT	B-TEST
biopsy	NN	I-TEST
subsequently	RB	O
demonstrated	VBD	O
a	DT	B-PROBLEM
hyperplastic	JJ	I-PROBLEM
polyp	NN	I-PROBLEM
with	IN	O
acute	NN	B-PROBLEM
and	CC	I-PROBLEM
chronic	JJ	I-PROBLEM
inflammation	NN	I-PROBLEM
and	CC	O
erosion	NN	B-PROBLEM
and	CC	O
reactive	JJ	B-PROBLEM
epithelial	JJ	I-PROBLEM
changes	NNS	I-PROBLEM
but	CC	O
no	DT	O
dysplasia	NN	B-PROBLEM
.	.	O

also	RB	O
of	IN	O
note	NN	O
,	,	O
prior	RB	O
to	TO	O
the	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
received	VBD	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
to	TO	O
reverse	VB	O
his	PRP$	B-TREATMENT
anticoagulation	NN	I-TREATMENT
.	.	O

patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
during	IN	O
and	CC	O
after	IN	O
the	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
and	CC	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
above	IN	O
30	CD	O
following	VBG	O
this	DT	O
until	IN	O
the	DT	O
point	NN	O
of	IN	O
discharge	NN	O
.	.	O

his	PRP$	B-TEST
last	JJ	I-TEST
recorded	JJ	I-TEST
hematocrit	NN	I-TEST
on	IN	O
discharge	NN	O
was	VBD	O
31.3	CD	O
.	.	O

his	PRP$	B-TEST
last	JJ	I-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
were	VBD	O
42	CD	O
and	CC	O
1.5	CD	O
with	IN	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
2.5	CD	O
.	.	O

consideration	NN	O
was	VBD	O
given	VBN	O
to	TO	O
performing	VBG	O
a	DT	B-TEST
repeat	NN	I-TEST
colonoscopy	NN	I-TEST
.	.	O

this	DT	O
was	VBD	O
discussed	VBN	O
with	IN	O
the	DT	O
gi	NN	O
service	NN	O
who	WP	O
felt	VBD	O
that	IN	O
this	DT	O
was	VBD	O
not	RB	O
necessary	JJ	O
given	VBN	O
the	DT	B-TEST
recent	JJ	I-TEST
colonoscopy	NN	I-TEST
that	IN	O
he	PRP	O
had	VBD	O
had	VBN	O
in	IN	O
05/2003	CD	O
.	.	O

ischemia	NN	B-PROBLEM
:	:	O

patient	JJ	B-PROBLEM
&apos;s	NNP	I-PROBLEM
troponin	NN	I-PROBLEM
bump	NN	I-PROBLEM
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
likely	JJ	O
to	TO	O
demand	VB	B-PROBLEM
ischemia	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
his	PRP$	B-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
not	RB	O
felt	VBD	O
that	IN	O
he	PRP	O
was	VBD	O
having	VBG	O
acute	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

on	IN	O
discharge	NN	O
,	,	O
he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
aspirin	NN	I-TREATMENT
,	,	O
simvastatin	NN	B-TREATMENT
and	CC	O
his	PRP$	B-TREATMENT
lopressor	NN	I-TREATMENT
which	WDT	O
was	VBD	O
initially	RB	O
held	VBN	O
,	,	O
and	CC	O
subsequently	RB	O
restarted	VBN	O
.	.	O

patient	NN	O
continued	VBD	O
to	TO	O
be	VB	O
in	IN	O
a-fib.	JJ	B-PROBLEM
throughout	IN	O
the	DT	O
admission	NN	O
and	CC	O
was	VBD	O
restarted	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
concurrently	RB	O
with	IN	O
heparin	NN	B-TREATMENT
.	.	O

heparin	NN	B-TREATMENT
was	VBD	O
subsequently	RB	O
dcd	JJ	O
once	RB	O
his	PRP$	B-TEST
inr	NN	I-TEST
reached	VBD	O
a	DT	O
therapeutic	JJ	O
level	NN	O
between	IN	O
2.5-3.5	JJ	O
.	.	O

his	PRP$	B-TEST
last	JJ	I-TEST
reported	JJ	I-TEST
inr	NN	I-TEST
on	IN	O
discharge	NN	O
was	VBD	O
2.5	CD	O
.	.	O

patient	NN	O
had	VBD	O
,	,	O
as	IN	O
noted	VBN	O
above	IN	O
,	,	O
his	PRP$	B-TREATMENT
anticoagulation	NN	I-TREATMENT
was	VBD	O
initially	RB	O
reversed	VBN	O
despite	IN	O
his	PRP$	O
having	VBG	O
artificial	JJ	B-TREATMENT
valves	NNS	I-TREATMENT
.	.	O

however	RB	O
,	,	O
his	PRP$	B-TREATMENT
coumadin	NN	I-TREATMENT
was	VBD	O
subsequently	RB	O
restarted	VBN	O
and	CC	O
he	PRP	O
achieved	VBD	O
therapeutic	JJ	O
inr	NN	B-TEST
levels	NNS	I-TEST
before	IN	O
discharge	NN	O
.	.	O

patient	NN	O
,	,	O
during	IN	O
this	DT	O
hospital	JJ	O
course	NN	O
,	,	O
became	VBD	O
hypervolemic	JJ	B-PROBLEM
likely	JJ	O
due	JJ	O
to	TO	O
his	PRP$	B-TREATMENT
diuretics	NNS	I-TREATMENT
being	VBG	O
held	VBN	O
and	CC	O
due	JJ	O
to	TO	O
his	PRP$	O
receiving	VBG	O
blood	NN	B-TREATMENT
products	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
diuresed	VBN	O
initially	RB	O
with	IN	O
one	CD	O
dose	NN	O
of	IN	O
lasix	NN	B-TREATMENT
and	CC	O
subsequently	RB	O
with	IN	O
one	CD	O
dose	NN	O
of	IN	O
torsemide	NN	B-TREATMENT
after	IN	O
it	PRP	O
was	VBD	O
discovered	VBN	O
that	IN	O
he	PRP	O
developed	VBD	O
thrombocytopenia	VB	B-PROBLEM
on	IN	O
a	DT	O
prior	JJ	O
admission	NN	O
in	IN	O
reaction	NN	O
to	TO	O
lasix	VB	B-TREATMENT
.	.	O

of	IN	O
note	NN	O
,	,	O
he	PRP	O
did	VBD	O
not	RB	O
become	VB	O
thrombocytopenic	JJ	B-PROBLEM
on	IN	O
this	DT	O
admission	NN	O
.	.	O

was	VBD	O
discharged	VBN	O
on	IN	O
11/16/2003	CD	O
in	IN	O
stable	JJ	O
condition	NN	O
with	IN	O
the	DT	B-TEST
last	JJ	I-TEST
recorded	JJ	I-TEST
hematocrit	NN	I-TEST
of	IN	O
31.3	CD	O
.	.	O

he	PRP	O
was	VBD	O
asked	VBN	O
to	TO	O
continue	VB	O
on	IN	O
his	PRP$	B-TREATMENT
nexium	NN	I-TREATMENT
,	,	O
iron	NN	B-TREATMENT
and	CC	O
vitamin	NN	B-TREATMENT
c	NN	I-TREATMENT
and	CC	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
other	JJ	I-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
final	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
on	IN	O
discharge	NN	O
were	VBD	O
as	IN	O
follows	VBZ	O
:	:	O

aspirin	RB	B-TREATMENT
325	CD	O
,	,	O
he	PRP	O
was	VBD	O
restarted	VBN	O
on	IN	O
a	DT	B-TREATMENT
ppi	NN	I-TREATMENT
,	,	O
also	RB	O
on	IN	O
iron	NN	B-TREATMENT
,	,	O
vitamin	FW	B-TREATMENT
c	NN	I-TREATMENT
,	,	O
lopressor	VBZ	B-TREATMENT
12.5	CD	O
b.i.d	NN	O
.	.	O

of	IN	O
note	NN	O
,	,	O
this	DT	O
was	VBD	O
at	IN	O
a	DT	O
decreased	JJ	O
dose	NN	O
compared	VBN	O
to	TO	O
that	DT	O
which	WDT	O
he	PRP	O
came	VBD	O
in	IN	O
on	IN	O
,	,	O
coumadin	NN	B-TREATMENT
7.5	CD	O
,	,	O
mg	NN	O
,	,	O
torsemide	RB	B-TREATMENT
100	CD	O
q.d.	NN	O
,	,	O
sucralfate	NN	B-TREATMENT
,	,	O
simvastatin	NN	B-TREATMENT
,	,	O
diovan	NN	B-TREATMENT
.	.	O

cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
49	CD	O
year	NN	O
old	JJ	O
man	NN	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
status	NN	O
post	NN	O
cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

information	NN	O
was	VBD	O
very	RB	O
limited	JJ	O
regarding	VBG	O
the	DT	O
circumstances	NNS	O
of	IN	O
his	PRP$	B-PROBLEM
cardiac	JJ	I-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

reportedly	RB	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
at	IN	O
a	DT	O
local	JJ	O
restaurant	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
unresponsive	JJ	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
asystolic	JJ	B-PROBLEM
but	CC	O
regained	VBD	O
a	DT	O
perfusing	NN	O
rhythm	NN	O
after	IN	O
2	CD	O
mg	NN	O
of	IN	O
epinephrine	NN	B-TREATMENT
and	CC	O
2	CD	O
mg	NN	O
of	IN	O
atropine	NN	B-TREATMENT
.	.	O

he	PRP	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
despite	IN	O
the	DT	O
administration	NN	O
of	IN	O
narcan	JJ	B-TREATMENT
.	.	O

ct	JJ	B-TEST
examinations	NNS	I-TEST
of	IN	I-TEST
the	DT	I-TEST
head	NN	I-TEST
,	,	I-TEST
chest	NN	I-TEST
,	,	I-TEST
abdomen	NNS	I-TEST
and	CC	I-TEST
pelvis	NNS	I-TEST
were	VBD	O
all	DT	O
unremarkable	JJ	O
.	.	O

initial	JJ	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
retrocardiac	NN	I-PROBLEM
opacity	NN	I-PROBLEM
and	CC	O
prominent	JJ	B-PROBLEM
interstitium	NN	I-PROBLEM
though	IN	O
his	PRP$	O
lung	NN	O
volumes	NNS	O
were	VBD	O
low	JJ	B-PROBLEM
.	.	O

subsequent	JJ	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
right	JJ	B-TREATMENT
main	JJ	I-TREATMENT
stem	NN	I-TREATMENT
intubation	NN	I-TREATMENT
with	IN	O
left	JJ	B-PROBLEM
lung	NN	I-PROBLEM
collapse	NN	I-PROBLEM
which	WDT	O
had	VBD	O
corrected	VBN	O
with	IN	O
withdrawal	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
endotracheal	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
transferred	VBN	O
to	TO	O
the	DT	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
induced	JJ	B-TREATMENT
hypothermia	NN	I-TREATMENT
given	VBN	O
his	PRP$	O
hemodynamic	JJ	O
stability	NN	O
,	,	O
ongoing	VBG	B-PROBLEM
unresponsiveness	NN	I-PROBLEM
and	CC	O
recent	JJ	B-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
hospital	NN	I-PROBLEM
cardiac	JJ	I-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

1)	CD	O
hypertension	NN	B-PROBLEM
.	.	O

2)	CD	O
chronic	JJ	B-PROBLEM
low	JJ	I-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
s/p	JJ	O
lumbar	NN	B-TREATMENT
discectomy	NN	I-TREATMENT
x	VBD	O
2	CD	O
.	.	O

3)	CD	O
cirrhosis	NN	B-PROBLEM
.	.	O

4)	CD	O
h/o	JJ	O
stab	NN	B-PROBLEM
wound	NN	I-PROBLEM
complicated	VBN	O
by	IN	O
pneumothorax	NN	B-PROBLEM
.	.	O

5)	CD	O
h/o	NNS	O
lower	JJR	B-PROBLEM
extremity	NN	I-PROBLEM
cellulitis	NN	I-PROBLEM
.	.	O

6)	CD	O
s/p	JJ	O
cholecystectomy	NN	B-TREATMENT
.	.	O

7)	CD	O
peripheral	JJ	B-PROBLEM
neuropathy	NN	I-PROBLEM
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1.	CD	O
oxycontin	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q	VBD	O
12hours	CD	O
.	.	O

2.	CD	O
percocet	NN	B-TREATMENT
.	.	O

3.	CD	O
nortriptyline	NN	B-TREATMENT
.	.	O

4.	CD	O
neurontin	JJ	B-TREATMENT
1800	CD	O
mg	NN	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O

he	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
abuse	NN	O
of	IN	O
percocet	NN	B-TREATMENT
according	VBG	O
to	TO	O
his	PRP$	O
brother	NN	O
.	.	O

he	PRP	O
had	VBD	O
recently	RB	O
filled	VBN	O
a	DT	O
prescription	NN	O
for	IN	O
560	CD	O
tablets	NNS	O
of	IN	O
percocet	NN	B-TREATMENT
as	RB	O
well	RB	O
as	IN	O
60	CD	O
tablets	NNS	O
of	IN	O
oxycontin	NN	B-TREATMENT
early	JJ	O
last	JJ	O
month	NN	O
.	.	O

negative	JJ	O
for	IN	O
any	DT	O
history	NN	O
of	IN	O
sudden	JJ	B-PROBLEM
death	NN	I-PROBLEM
or	CC	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

on	IN	O
admission	NN	O
,	,	O
temperature	NN	B-TEST
was	VBD	O
96.2	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
150/80	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
92	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
16	CD	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
he	PRP	O
was	VBD	O
unarousible	JJ	B-PROBLEM
,	,	O
intubated	VBN	B-TREATMENT
,	,	O
not	RB	O
on	IN	O
any	DT	B-TREATMENT
sedation	NN	I-TREATMENT
.	.	O

they	PRP	O
were	VBD	O
minimally	RB	B-PROBLEM
reactive	JJ	I-PROBLEM
.	.	O

his	PRP$	O
sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
without	IN	O
murmurs	NNS	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

his	PRP$	O
abdomen	NNS	O
had	VBD	O
normal	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

extremities	NNS	O
had	VBD	O
multiple	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
excoriations	NNS	I-PROBLEM
.	.	O

neurologic	JJ	B-TEST
examination	NN	I-TEST
-	:	O
he	PRP	O
was	VBD	O
unarousible	JJ	B-PROBLEM
and	CC	O
without	IN	O
sedation	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
no	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
movements	NNS	I-PROBLEM
.	.	O

flaccid	NN	B-PROBLEM
.	.	O

extremities	NNS	O
-	:	O
babinski	NN	B-TEST
reflex	NN	I-TEST
was	VBD	O
equivocal	JJ	O
bilaterally	RB	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
,	,	O
laboratories	NNS	B-TEST
were	VBD	O
remarkable	JJ	O
for	IN	O
a	DT	B-TEST
partial	JJ	I-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
of	IN	O
31.7	CD	O
,	,	O
inr	NN	B-TEST
1.4	CD	O
,	,	O
potassium	NN	B-TEST
3.2	CD	O
,	,	O
glucose	RB	B-TEST
182	CD	O
,	,	O
lactate	NN	B-TEST
was	VBD	O
initially	RB	O
6.6	CD	O
.	.	O

urine	JJ	B-TEST
toxicology	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
negative	JJ	O
.	.	O

serum	NN	B-TEST
toxicology	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
positive	JJ	O
for	IN	O
tca	NN	B-TREATMENT
s.	NN	I-TREATMENT

tylenol	JJ	B-TEST
level	NN	I-TEST
was	VBD	O
15	CD	O
.	.	O

alcohol	NN	B-TEST
level	NN	I-TEST
was	VBD	O
199	CD	O
.	.	O

initial	JJ	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
7.31/46/500/77	CD	O
.	.	O

cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
-	:	O
his	PRP$	B-PROBLEM
arrest	NN	I-PROBLEM
was	VBD	O
of	IN	O
unknown	JJ	O
etiology	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
admission	NN	O
.	.	O

no	DT	O
further	JJ	O
history	NN	O
was	VBD	O
ever	RB	O
gained	VBN	O
about	IN	O
his	PRP$	B-PROBLEM
cardiac	NN	I-PROBLEM
arrest	NN	I-PROBLEM
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

ct	NN	B-TEST
angiogram	NN	I-TEST
had	VBD	O
been	VBN	O
negative	JJ	O
for	IN	O
pulmonary	JJ	B-PROBLEM
embolism	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
2013-04-26	JJ	O
,	,	O
which	WDT	O
showed	VBD	O
a	DT	O
normal	JJ	O
ejection	NN	O
fraction	NN	O
and	CC	O
trivial	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
;	:	O
otherwise	RB	O
no	DT	O
obvious	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM
were	VBD	O
seen	VBN	O
.	.	O

given	VBN	O
the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
out	NN	I-PROBLEM
of	IN	I-PROBLEM
hospital	NN	I-PROBLEM
arrest	NN	I-PROBLEM
,	,	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
despite	IN	O
hemodynamic	JJ	O
stability	NN	O
,	,	O
he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
induced	JJ	B-TREATMENT
hypothermia	NN	I-TREATMENT
and	CC	O
with	IN	O
cold	JJ	B-TREATMENT
packs	NNS	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
cooling	NN	I-TREATMENT
blanket	NN	I-TREATMENT
were	VBD	O
placed	VBN	O
with	IN	O
goals	NNS	O
of	IN	O
reducing	VBG	O
his	PRP$	B-TEST
core	NN	I-TEST
body	NN	I-TEST
temperature	NN	I-TEST
to	TO	O
32	CD	O
degrees	NNS	O
celsius	VBP	O
for	IN	O
a	DT	O
period	NN	O
of	IN	O
twelve	NN	O
hours	NNS	O
at	IN	O
which	WDT	O
point	NN	O
he	PRP	O
would	MD	O
be	VB	O
rewarmed	VBN	O
over	IN	O
the	DT	O
subsequent	JJ	O
six	CD	O
hours	NNS	O
.	.	O

neurology	NN	O
-	:	O
the	DT	O
patient	NN	O
remained	VBD	O
unresponsive	JJ	B-PROBLEM
after	IN	O
the	DT	B-TREATMENT
induced	JJ	I-TREATMENT
hypothermia	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noticed	VBN	O
to	TO	O
develop	VB	O
myoclonic	JJ	B-PROBLEM
jerks	NNS	I-PROBLEM
and	CC	O
occasional	JJ	O
fluttering	NN	O
of	IN	O
his	PRP$	O
eyelids	NNS	O
.	.	O

electroencephalogram	NN	B-TEST
revealed	VBD	O
the	DT	O
patient	NN	O
was	VBD	O
experiencing	VBG	O
persistent	JJ	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

neurology	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
very	RB	O
aggressively	RB	O
,	,	O
loaded	VBD	O
with	IN	O
multiple	JJ	B-TREATMENT
drugs	NNS	I-TREATMENT
,	,	O
including	VBG	O
ativan	NN	B-TREATMENT
and	CC	O
propofol	JJ	B-TREATMENT
drips	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
demonstrate	VB	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
despite	IN	O
this	DT	O
.	.	O

he	PRP	O
was	VBD	O
loaded	VBN	O
with	IN	O
dilantin	NN	B-TREATMENT
and	CC	O
ultimately	RB	O
was	VBD	O
treated	VBN	O
with	IN	O
a	DT	B-TREATMENT
pentobarb	NN	I-TREATMENT
coma	NN	I-TREATMENT
.	.	O

after	IN	O
multiple	JJ	O
attempts	NNS	O
of	IN	O
weaning	VBG	O
the	DT	B-TREATMENT
pentobarb	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
continually	RB	O
reverting	VBG	O
to	TO	O
status	NN	B-PROBLEM
epilepticus	NN	I-PROBLEM
which	WDT	O
was	VBD	O
never	RB	O
able	JJ	O
to	TO	O
be	VB	O
suppressed	VBN	O
.	.	O

infectious	JJ	O
disease	NN	O
-	:	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
rose	VBD	O
to	TO	O
a	DT	O
peak	NN	O
of	IN	O
17	CD	O
.	.	O

multiple	JJ	B-TEST
cultures	NNS	I-TEST
were	VBD	O
done	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
ultimately	RB	O
found	VBN	O
to	TO	O
have	VB	O
methicillin	VBN	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
bacteremia	NN	I-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM
,	,	O
and	CC	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

for	IN	O
all	PDT	O
these	DT	B-PROBLEM
infections	NNS	I-PROBLEM
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
also	RB	O
on	IN	O
levofloxacin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
for	IN	O
presumed	JJ	O
aspiration	NN	B-PROBLEM
pneumonia	NN	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	O
admission	NN	O
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
cleared	VBN	O
by	IN	O
2013-05-03	JJ	O
.	.	O

sputum	JJ	B-TEST
culture	NN	I-TEST
as	RB	O
late	RB	O
as	IN	O
2013-05-10	JJ	O
,	,	O
however	RB	O
was	VBD	O
still	RB	O
positive	JJ	O
for	IN	O
coagulase	NN	B-PROBLEM
positive	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
which	WDT	O
was	VBD	O
methicillin	RBS	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
gravely	RB	B-PROBLEM
ill	JJ	I-PROBLEM
throughout	IN	O
his	PRP$	O
hospital	NN	O
stay	NN	O
and	CC	O
had	VBD	O
multiple	JJ	O
meetings	NNS	O
were	VBD	O
held	VBN	O
with	IN	O
his	PRP$	O
family	NN	O
with	IN	O
his	PRP$	O
son	NN	O
being	VBG	O
his	PRP$	O
next	NN	O
of	IN	O
kin	NN	O
.	.	O

ultimately	RB	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
the	DT	O
patient	NN	O
's	POS	O
wishes	NNS	O
would	MD	O
be	VB	O
to	TO	O
not	RB	O
be	VB	O
maintained	VBN	O
in	IN	O
a	DT	O
vegetative	JJ	O
state	NN	O
and	CC	O
given	VBN	O
his	PRP$	O
poor	JJ	O
prognosis	NN	O
ultimately	RB	O
the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
pursue	VB	O
comfort	NN	B-TREATMENT
measures	NNS	I-TREATMENT
only	RB	O
.	.	O

the	DT	O
family	NN	O
did	VBD	O
consent	NN	O
to	TO	O
a	DT	B-TEST
postmortem	NN	I-TEST
examination	NN	I-TEST
.	.	O

cardiac	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

anoxic	NN	B-PROBLEM
brain	NN	I-PROBLEM
injury	NN	I-PROBLEM

status	NN	B-PROBLEM
epilepticus	NN	I-PROBLEM

methicillin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
aureus	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

mrsa	NN	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

mrsa	NN	B-PROBLEM
bacteremia	NN	I-PROBLEM
.	.	O

respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM

1	CD	O
)	)	O
thrombotic	JJ	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM
purpura	NN	I-PROBLEM
.	.	O

2	CD	O
)	)	O
bronchiolitis	NN	B-PROBLEM
obliterans	NNS	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

3	LS	O
)	)	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
requiring	VBG	O
chronic	JJ	B-TREATMENT
dialysis	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
63	JJ	O
year-old	JJ	O
woman	NN	O
transferred	VBD	O
from	IN	O
pre	JJ	O
health	NN	O
on	IN	O
june	NN	O
19	CD	O
,	,	O
1998	CD	O
to	TO	O
the	DT	O
verg	NNP	O
medical	JJ	O
center	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
thrombotic	JJ	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM
purpura	NN	I-PROBLEM
and	CC	O
bronchiolitis	NN	B-PROBLEM
obliterans	NNS	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

on	IN	O
may	MD	O
12	CD	O
,	,	O
1998	CD	O
,	,	O
the	DT	O
patient	NN	O
presented	VBD	O
to	TO	O
pre	VB	O
health	NN	O
with	IN	O
fever	NN	B-PROBLEM
,	,	O
cough	NN	B-PROBLEM
,	,	O
dyspnea	NN	B-PROBLEM
and	CC	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
revealing	VBG	O
a	DT	B-PROBLEM
patchy	NN	I-PROBLEM
infiltrate	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lung	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
clindamycin	NN	B-TREATMENT
and	CC	O
erythromycin	NN	B-TREATMENT
which	WDT	O
were	VBD	O
changed	VBN	O
to	TO	O
trovan	VB	B-TREATMENT
and	CC	O
then	RB	O
transferred	VBD	O
to	TO	O
a	DT	O
hospital	NN	O
.	.	O

on	IN	O
may	MD	O
27	CD	O
,	,	O
1998	CD	O
,	,	O
the	DT	O
patient	NN	O
desaturated	VBD	O
to	TO	O
40%	CD	O
with	IN	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
100.5	CD	O
degrees	NNS	O
.	.	O

her	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
improved	VBN	O
to	TO	O
only	RB	O
92%	CD	O
on	IN	O
100%	CD	B-TREATMENT
face	NN	I-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
pre	VB	O
health	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
there	RB	O
revealed	VBD	O
bilateral	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
with	IN	O
increasing	VBG	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
vq	JJ	I-TEST
scan	NN	I-TEST
was	VBD	O
high	JJ	O
probability	NN	O
,	,	O
but	CC	O
no	DT	O
pulmonary	JJ	B-TEST
angiogram	NN	I-TEST
was	VBD	O
done	VBN	O
and	CC	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
revealed	VBD	O
a	DT	O
normal	JJ	O
left	JJ	O
ventricle	NN	O
with	IN	O
no	DT	O
wall	NN	B-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
and	CC	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
75%	CD	O
.	.	O

on	IN	O
may	MD	O
24	CD	O
,	,	O
1998	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	JJS	I-TEST
which	WDT	O
revealed	VBD	O
diffuse	NN	B-PROBLEM
alveolar	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
at	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
base	NN	I-PROBLEM
,	,	O
mediastinal	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
and	CC	O
bilateral	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusions	NNS	I-PROBLEM
.	.	O

at	IN	O
this	DT	O
point	NN	O
,	,	O
a	DT	O
diagnosis	NN	O
of	IN	O
lupus	NN	B-PROBLEM
was	VBD	O
considered	VBN	O
and	CC	O
her	PRP$	B-TEST
ana	NN	I-TEST
was	VBD	O
1:640	CD	O
and	CC	O
her	PRP$	B-TEST
rheumatoid	JJ	I-TEST
factor	NN	I-TEST
and	CC	O
anca	NN	B-TEST
were	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
a	DT	B-TREATMENT
steroid	JJ	I-TREATMENT
trial	NN	I-TREATMENT
at	IN	O
that	DT	O
point	NN	O
.	.	O

her	PRP$	O
pleural	JJ	O
fluid	NN	O
was	VBD	O
tapped	VBN	O
and	CC	O
it	PRP	O
was	VBD	O
negative	JJ	O
for	IN	O
malignancy	NN	B-PROBLEM
.	.	O

on	IN	O
june	NN	O
11	CD	O
,	,	O
1998	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
video	NN	I-TEST
assisted	VBN	I-TEST
thoracoscopic	NN	I-TEST
study	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
right	NN	I-TEST
lung	NN	I-TEST
which	WDT	O
revealed	VBD	O
chronic	JJ	B-PROBLEM
interstitial	JJ	I-PROBLEM
pneumonitis	NN	I-PROBLEM
with	IN	O
a	DT	B-PROBLEM
bronchiolitis	NN	I-PROBLEM
obliterans	VBZ	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia-like	JJ	I-PROBLEM
reaction	NN	I-PROBLEM
and	CC	O
a	DT	B-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
then	RB	O
started	VBN	O
on	IN	O
40	CD	O
mg	NN	O
of	IN	O
prednisone	NN	B-TREATMENT
q.	JJ	O
day	NN	O
.	.	O

from	IN	O
may	MD	O
27	CD	O
,	,	O
1998	CD	O
through	IN	O
june	NN	O
19	CD	O
,	,	O
1998	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
decline	NN	O
in	IN	O
her	PRP$	B-TEST
platelets	NNS	I-TEST
from	IN	O
394	CD	O
to	TO	O
28	CD	O
with	IN	O
a	DT	O
stable	JJ	O
hematocrit	NN	O
of	IN	O
32	CD	O
to	TO	O
33	CD	O
and	CC	O
a	DT	B-PROBLEM
rise	NN	I-PROBLEM
in	IN	O
creatinine	NN	B-TEST
from	IN	O
1.0	CD	O
to	TO	O
3.8	CD	O
.	.	O

on	IN	O
june	NN	O
19	CD	O
,	,	O
1998	CD	O
,	,	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
verg	NNP	O
medical	JJ	O
center	NN	O
medical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
possible	JJ	O
thrombotic	JJ	B-PROBLEM
thrombocytopenic	NN	I-PROBLEM
purpura	NN	I-PROBLEM
.	.	O

1	CD	O
)	)	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
in	IN	O
1995	CD	O
in	IN	O
the	DT	O
pontine	JJ	O
region	NN	O
secondary	JJ	O
to	TO	O
hypertension	NN	B-PROBLEM
.	.	O

2	CD	O
)	)	O
hypertension	NN	B-PROBLEM
.	.	O

3	LS	O
)	)	O
status	NN	O
post	NN	O
hysterectomy	NN	B-TREATMENT
.	.	O

4	CD	O
)	)	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
.	.	O

1	CD	O
)	)	O
albuterol	NN	B-TREATMENT
inhaler	$	I-TREATMENT
4	CD	O
puffs	NNS	O
q.i.d.	NN	O

2	CD	O
)	)	O
lasix	NN	B-TREATMENT
p.r.n.	NN	O

3	LS	O
)	)	O
prednisone	NN	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4	CD	O
)	)	O
inderal	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O

5	CD	O
)	)	O
thiamine	NN	B-TREATMENT
.	.	O

6	CD	O
)	)	O
lasix	NN	B-TREATMENT
p.r.n.	NN	O

7	CD	O
)	)	O
atrovent	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
4	CD	O
puffs	NNS	O
q.i.d.	NN	O

8	CD	O
)	)	O
folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
.	.	O

9	CD	O
)	)	O
premarin	NN	B-TREATMENT
0.625	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

10	CD	O
)	)	O
omeprazole	VBD	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

11	CD	O
)	)	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

father	RB	O
died	VBN	O
at	IN	O
age	NN	O
56	CD	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

mother	NN	O
died	VBD	O
at	IN	O
age	NN	O
68	CD	O
of	IN	O
pancreatic	JJ	B-PROBLEM
carcinoma	NN	I-PROBLEM
.	.	O

brother	NN	O
has	VBZ	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
family	NN	O
history	NN	O
of	IN	O
hematologic	NN	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

laboratory	NN	B-TEST
studies	NNS	I-TEST
on	IN	O
admission	NN	O
were	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
of	IN	O
131	CD	O
,	,	O
potassium	NN	B-TEST
6.2	CD	O
,	,	O
bun	NN	B-TEST
111	CD	O
,	,	O
creatinine	NN	B-TEST
3.9	CD	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
23	CD	O
,	,	O
hematocrit	VBD	B-TEST
27	CD	O
with	IN	O
2+	CD	B-PROBLEM
schistocytes	NNS	I-PROBLEM
and	CC	O
2+	CD	B-PROBLEM
spherocytes	NNS	I-PROBLEM
on	IN	O
the	DT	B-TEST
smear	NN	I-TEST
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
92	CD	O
and	CC	O
ldh	$	B-TEST
496	CD	O
.	.	O

1	CD	O
)	)	O
bronchiolitis	NN	B-PROBLEM
obliterans	NNS	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia	NN	I-PROBLEM
:	:	O

the	DT	B-TEST
video	NN	I-TEST
assisted	VBD	I-TEST
thoracoscopic	NN	I-TEST
study	NN	I-TEST
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
was	VBD	O
consistent	JJ	O
with	IN	O
bronchiolitis	NN	B-PROBLEM
obliterans	NNS	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
continued	VBN	O
on	IN	O
steroids	NNS	B-TREATMENT
throughout	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
stay	NN	O
.	.	O

this	DT	O
was	VBD	O
changed	VBN	O
to	TO	O
solu-medrol	JJ	B-TREATMENT
part	NN	O
way	NN	O
through	IN	O
the	DT	O
course	NN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
hematologic	NN	I-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
see	VBP	O
below	IN	O
.	.	O

by	IN	O
discharge	NN	O
,	,	O
she	PRP	O
was	VBD	O
returned	VBN	O
to	TO	O
40	CD	O
mg	NN	O
of	IN	O
prednisone	NN	B-TREATMENT
q.	NN	O
day	NN	O
times	NNS	O
one	CD	O
month	NN	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
slow	JJ	I-TREATMENT
taper	NN	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
bronchiolitis	NN	I-PROBLEM
obliterans	NNS	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia	NN	I-PROBLEM
appeared	VBD	O
to	TO	O
improve	VB	O
slowly	RB	O
throughout	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
,	,	O
however	RB	O
on	IN	O
july	NN	O
12	CD	O
,	,	O
1998	CD	O
,	,	O
after	IN	O
starting	VBG	O
dialysis	NN	B-TREATMENT
(	(	O
see	VB	O
below	IN	O
)	)	O
,	,	O
the	DT	O
patient	NN	O
desaturated	VBD	O
and	CC	O
required	VBD	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

repeat	NN	B-TEST
chest	RBS	I-TEST
x-rays	NNS	I-TEST
and	CC	O
chest	JJS	B-TEST
ct	NN	I-TEST
scans	NNS	I-TEST
appeared	VBD	O
consistent	JJ	O
with	IN	O
pulmonary	JJ	B-PROBLEM
edema	NN	I-PROBLEM
from	IN	O
volume	NN	B-PROBLEM
overload	NN	I-PROBLEM
given	VBN	O
her	PRP$	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
eventually	RB	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
pulmonary	JJ	O
status	NN	O
did	VBD	O
improve	VB	O
after	IN	O
significant	JJ	B-TREATMENT
volume	NN	I-TREATMENT
removal	NN	I-TREATMENT
with	IN	O
dialysis	NN	B-TREATMENT
for	IN	O
several	JJ	O
weeks	NNS	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
her	PRP$	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
still	RB	O
requiring	VBG	O
two	CD	O
liters	NNS	O
of	IN	O
supplemental	JJ	B-TREATMENT
oxygen	NN	I-TREATMENT
to	TO	O
maintain	VB	O
her	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
in	IN	O
the	DT	O
mid	NN	O
90%	CD	O
.	.	O

2	CD	O
)	)	O
thrombotic	JJ	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM
purpura	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
admitted	VBN	O
with	IN	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
28	CD	O
,	,	O
hematocrit	NN	B-TEST
of	IN	O
32	CD	O
,	,	O
ldh	NN	B-TEST
of	IN	O
496	CD	O
with	IN	O
2+	CD	B-PROBLEM
schistocytes	NNS	I-PROBLEM
and	CC	O
2+	CD	B-PROBLEM
spherocytes	NNS	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
smear	NN	I-TEST
.	.	O

this	DT	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
consistent	JJ	O
with	IN	O
thrombotic	JJ	B-PROBLEM
thrombocytopenic	JJ	I-PROBLEM
purpura	NN	I-PROBLEM
and	CC	O
on	IN	O
june	NN	O
20	CD	O
,	,	O
1998	CD	O
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
daily	JJ	B-TREATMENT
plasma	NN	I-TREATMENT
exchange	NN	I-TREATMENT
which	WDT	O
continued	VBD	O
through	IN	O
july	NN	O
27	CD	O
,	,	O
1999	CD	O
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
changed	VBN	O
to	TO	O
intravenous	JJ	B-TREATMENT
solu-medrol	JJ	I-TREATMENT
50	CD	O
mg	JJ	O
q.	NNS	O
day	NN	O
which	WDT	O
was	VBD	O
changed	VBN	O
back	RB	O
to	TO	O
40	CD	O
mg	NN	O
of	IN	O
prednisone	NN	B-TREATMENT
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

her	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
initially	RB	O
rose	VBD	O
to	TO	O
a	DT	O
maximum	NN	O
of	IN	O
159	CD	O
on	IN	O
july	NN	O
3	CD	O
,	,	O
1998	CD	O
,	,	O
then	RB	O
they	PRP	O
steadily	RB	O
fell	VBD	O
to	TO	O
a	DT	O
low	NN	O
of	IN	O
60	CD	O
on	IN	O
july	NN	O
20	CD	O
,	,	O
1999	CD	O
.	.	O

her	PRP$	B-TEST
ldh	NN	I-TEST
which	WDT	O
peaked	VBD	O
at	IN	O
1255	CD	O
decreased	VBD	O
to	TO	O
the	DT	O
mid	NN	O
200s	CD	O
,	,	O
but	CC	O
remained	VBD	O
elevated	VBN	B-PROBLEM
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
schistocytes	NNS	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
smear	NN	I-TEST
,	,	O
but	CC	O
it	PRP	O
was	VBD	O
much	RB	O
decreased	VBN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
required	VBN	O
red	JJ	B-TREATMENT
blood	NN	I-TREATMENT
cell	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
,	,	O
approximately	RB	O
two	CD	O
units	NNS	O
every	DT	O
seven	CD	O
to	TO	O
ten	VB	O
days	NNS	O
to	TO	O
maintain	VB	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
.	.	O

eventually	RB	O
,	,	O
her	PRP	B-TREATMENT
plasma	VBP	I-TREATMENT
exchange	NN	I-TREATMENT
was	VBD	O
tapered	VBN	O
to	TO	O
a	DT	O
smaller	JJR	O
and	CC	O
smaller	JJR	O
dose	JJ	O
each	DT	O
day	NN	O
and	CC	O
then	RB	O
discontinued	VBD	O
altogether	RB	O
after	IN	O
july	NN	O
27	CD	O
,	,	O
1999	CD	O
.	.	O

after	IN	O
this	DT	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
platelet	NN	I-TEST
count	NN	I-TEST
rose	VBD	O
to	TO	O
a	DT	O
maximum	NN	O
of	IN	O
177	CD	O
on	IN	O
discharge	NN	O
.	.	O

it	PRP	O
is	VBZ	O
felt	VBN	O
that	IN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
thrombotic	JJ	I-PROBLEM
thrombocytopenic	NN	I-PROBLEM
purpura	NN	I-PROBLEM
has	VBZ	O
resolved	VBN	O
.	.	O

she	PRP	O
will	MD	O
continue	VB	O
on	IN	O
her	PRP	B-TREATMENT
prednisone	NN	I-TREATMENT
for	IN	O
one	CD	O
month	NN	O
as	IN	O
above	IN	O
for	IN	O
the	DT	B-PROBLEM
bronchiolitis	NN	I-PROBLEM
obliterans	VBZ	I-PROBLEM
organizing	VBG	I-PROBLEM
pneumonia	NN	I-PROBLEM
with	IN	O
a	DT	B-TREATMENT
very	RB	I-TREATMENT
slow	JJ	I-TREATMENT
taper	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
presented	VBN	O
in	IN	O
acute	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
bun	NN	I-TEST
of	IN	O
101	CD	O
and	CC	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
3.7	CD	O
.	.	O

throughout	IN	O
the	DT	O
month	NN	O
of	IN	O
june	NN	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
rising	VBG	I-PROBLEM
potassium	NN	I-PROBLEM
phosphate	NN	I-PROBLEM
and	CC	O
increasing	VBG	B-PROBLEM
volume	NN	I-PROBLEM
overload	NN	I-PROBLEM
with	IN	O
decreasing	VBG	O
response	NN	O
to	TO	O
diuretics	NNS	B-TREATMENT
and	CC	O
she	PRP	O
was	VBD	O
finally	RB	O
initiated	VBN	O
on	IN	O
dialysis	NN	B-TREATMENT
with	IN	O
ultrafiltration	NN	B-TREATMENT
on	IN	O
july	NN	O
12	CD	O
,	,	O
1998	CD	O
.	.	O

the	DT	O
opinion	NN	O
of	IN	O
the	DT	O
renal	JJ	O
consult	NN	O
was	VBD	O
that	IN	O
this	DT	O
was	VBD	O
permanent	JJ	B-PROBLEM
and	CC	I-PROBLEM
non-reversible	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
failure	NN	I-PROBLEM
since	IN	O
it	PRP	O
did	VBD	O
not	RB	O
improve	VB	O
with	IN	O
dialysis	NN	B-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
will	MD	O
continue	VB	O
on	IN	O
dialysis	NN	B-TREATMENT
three	CD	O
times	NNS	O
per	IN	O
week	NN	O
.	.	O

she	PRP	O
required	VBD	O
approximately	RB	O
five	CD	O
liters	NNS	O
of	IN	O
ultrafiltration	NN	B-TREATMENT
fluid	NN	I-TREATMENT
removal	NN	I-TREATMENT
at	IN	O
each	DT	O
dialysis	NN	O
session	NN	O
due	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
significant	JJ	I-PROBLEM
volume	NN	I-PROBLEM
overload	NN	I-PROBLEM
.	.	O

during	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	B-TREATMENT
dialysis	NN	I-TREATMENT
,	,	O
she	PRP	O
had	VBD	O
a	DT	O
great	JJ	O
improvement	NN	O
in	IN	O
her	PRP$	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
and	CC	O
her	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
multiple	JJ	B-PROBLEM
line	NN	I-PROBLEM
infections	NNS	I-PROBLEM
during	IN	O
her	PRP$	O
admission	NN	O
including	VBG	O
a	DT	B-PROBLEM
confirmed	JJ	I-PROBLEM
coag.	NN	I-PROBLEM
negative	JJ	I-PROBLEM
staphylococcus	NN	I-PROBLEM
line	NN	I-PROBLEM
infection	NN	I-PROBLEM
with	IN	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
on	IN	O
june	NN	O
23	CD	O
,	,	O
1998	CD	O
,	,	O
july	RB	O
4	CD	O
,	,	O
1998	CD	O
,	,	O
july	RB	O
8	CD	O
,	,	O
1998	CD	O
and	CC	O
july	RB	O
9	CD	O
,	,	O
1998	CD	O
.	.	O

the	DT	O
patient	NN	O
eventually	RB	O
had	VBD	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
subclavian	JJ	I-TREATMENT
tesio	NN	I-TREATMENT
catheter	NN	I-TREATMENT
placed	VBN	O
and	CC	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
brachial	NN	I-TREATMENT
picc	NN	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
on	IN	O
july	NN	O
10	CD	O
,	,	O
1998	CD	O
which	WDT	O
remained	VBD	O
patent	NN	O
and	CC	O
uninfected	JJ	B-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
a	DT	B-TREATMENT
full	JJ	I-TREATMENT
three	CD	I-TREATMENT
week	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
vancomycin	NN	I-TREATMENT
and	CC	O
also	RB	O
received	VBD	O
a	DT	B-TREATMENT
three	CD	I-TREATMENT
week	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
ceftazidime	NN	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
fungal	JJ	I-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
treated	VBN	O
with	IN	O
amphojel	JJ	B-TREATMENT
bladder	NN	I-TREATMENT
irrigation	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
followed	VBN	O
by	IN	O
a	DT	B-PROBLEM
klebsiella	NN	I-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
for	IN	O
which	WDT	O
she	PRP	O
received	VBD	O
levofloxacin	JJ	B-TREATMENT
times	NNS	O
fourteen	JJ	O
days	NNS	O
.	.	O

she	PRP	O
also	RB	O
received	VBD	O
a	DT	B-TREATMENT
fourteen	JJ	I-TREATMENT
day	NN	I-TREATMENT
course	NN	I-TREATMENT
of	IN	I-TREATMENT
acyclovir	NN	I-TREATMENT
which	WDT	O
was	VBD	O
begun	VBN	O
on	IN	O
june	NN	O
21	CD	O
,	,	O
1998	CD	O
for	IN	O
perianal	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
consistent	JJ	O
with	IN	O
herpes	NNS	B-PROBLEM
simplex	JJ	I-PROBLEM
virus	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
on	IN	O
fluconazole	NN	B-TREATMENT
for	IN	O
some	DT	B-PROBLEM
oral	JJ	I-PROBLEM
thrush	NN	I-PROBLEM
which	WDT	O
was	VBD	O
inadvertently	RB	O
continued	VBN	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
thirty	JJ	O
days	NNS	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
also	RB	O
started	VBN	O
on	IN	O
bactrim	NN	B-TREATMENT
one	CD	I-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
tablet	NN	O
q.o.d.	NN	O
as	IN	O
prophylaxis	NN	O
for	IN	O
pneumocystis	NN	B-PROBLEM
carinii	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
while	IN	O
on	IN	O
her	PRP$	B-TREATMENT
high	JJ	I-TREATMENT
dose	JJ	I-TREATMENT
steroids	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
with	IN	O
a	DT	O
question	NN	O
of	IN	O
lupus	NN	B-PROBLEM
given	VBN	O
her	PRP$	B-TEST
ana	NN	I-TEST
of	IN	O
1:640	CD	O
although	IN	O
her	PRP$	B-TEST
rheumatoid	JJ	I-TEST
factor	NN	I-TEST
and	CC	O
anca	NN	B-TEST
were	VBD	O
negative	JJ	O
.	.	O

unfortunately	RB	O
throughout	IN	O
her	PRP$	O
admission	NN	O
,	,	O
we	PRP	O
were	VBD	O
unable	JJ	O
to	TO	O
test	VB	O
any	DT	B-TEST
more	JJR	I-TEST
titers	NNS	I-TEST
since	IN	O
she	PRP	O
was	VBD	O
receiving	VBG	O
daily	RB	B-TREATMENT
plasma	JJ	I-TREATMENT
exchange	NN	I-TREATMENT
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
ana	NN	I-TEST
,	,	O
rheumatoid	JJ	B-TEST
factor	NN	I-TEST
and	CC	O
anca	NN	B-TEST
may	MD	O
be	VB	O
repeated	VBN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

1	CD	O
)	)	O
the	DT	O
patient	NN	O
will	MD	O
follow-up	VB	O
with	IN	O
her	PRP$	O
primary	JJ	O
care	NN	O
physician	NN	O
,	,	O
dr.	NN	O
tamarg	NN	O
study	NN	O
,	,	O
in	IN	O
arvus	NN	O
after	IN	O
she	PRP	O
is	VBZ	O
discharged	VBN	O
from	IN	O
rehabilitation	NN	B-TREATMENT
.	.	O

2	CD	O
)	)	O
the	DT	O
patient	NN	O
is	VBZ	O
being	VBG	O
discharged	VBN	O
to	TO	O
a	DT	O
hospital	NN	O
where	WRB	O
she	PRP	O
will	MD	O
receive	VB	O
onsite	JJ	B-TREATMENT
hemodialysis	NN	I-TREATMENT
three	CD	O
times	NNS	O
per	IN	O
week	NN	O
on	IN	O
monday	NN	O
,	,	O
wednesday	JJ	O
and	CC	O
friday	JJ	O
.	.	O

3	LS	O
)	)	O
the	DT	O
patient	NN	O
will	MD	O
continue	VB	O
to	TO	O
have	VB	O
her	PRP$	B-TEST
cbc	NN	I-TEST
,	,	O
ldh	NN	B-TEST
,	,	O
bilirubin	NN	B-TEST
,	,	O
chem-7	JJ	B-TEST
and	CC	O
magnesium	NN	B-TEST
and	CC	O
calcium	NN	B-TEST
checked	VBN	O
with	IN	O
each	DT	B-TREATMENT
dialysis	NN	I-TREATMENT
and	CC	O
the	DT	O
results	NNS	O
will	MD	O
be	VB	O
faxed	VBN	O
to	TO	O
dr.	VB	O
ian	JJ	O
zineisfreierm	NN	O
,	,	O
the	DT	O
hematology	NN	O
attending	VBG	O
at	IN	O
fax	JJ	O
number	NN	O
751-329-8840	JJ	O
.	.	O

4	CD	O
)	)	O
the	DT	O
patient	NN	O
will	MD	O
eventually	RB	O
need	VB	O
a	DT	B-TREATMENT
permanent	JJ	I-TREATMENT
dialysis	NN	I-TREATMENT
fistula	NN	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
left	NN	I-TREATMENT
subclavian	JJ	I-TREATMENT
tesio	NN	I-TREATMENT
which	WDT	O
she	PRP	O
has	VBZ	O
in	IN	O
place	NN	O
will	MD	O
last	JJ	O
for	IN	O
several	JJ	O
months	NNS	O
in	IN	O
the	DT	O
mean	JJ	O
time	NN	O
.	.	O

she	PRP	O
would	MD	O
like	VB	O
to	TO	O
arrange	VB	O
to	TO	O
have	VB	O
her	PRP$	B-TREATMENT
fistula	NN	I-TREATMENT
placed	VBN	O
at	IN	O
pre	JJ	O
health	NN	O
and	CC	O
the	DT	O
vascular	JJ	O
surgeons	NNS	O
there	EX	O
should	MD	O
be	VB	O
contacted	VBN	O
regarding	VBG	O
this	DT	O
.	.	O

5	CD	O
)	)	O
the	DT	O
patient	NN	O
will	MD	O
need	VB	O
packed	NNS	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cell	NN	I-TREATMENT
transfusions	NNS	I-TREATMENT
with	IN	O
dialysis	NN	B-TREATMENT
when	WRB	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
falls	VBZ	O
below	IN	O
26	CD	O
.	.	O

6	CD	O
)	)	O
the	DT	O
patient	NN	O
will	MD	O
continue	VB	O
her	PRP$	B-TREATMENT
prednisone	NN	I-TREATMENT
at	IN	O
40	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
one	CD	O
month	NN	O
(	(	O
this	DT	O
was	VBD	O
started	VBN	O
on	IN	O
july	NN	O
27	CD	O
,	,	O
1999	CD	O
)	)	O
and	CC	O
then	RB	O
she	PRP	O
will	MD	O
begin	VB	O
a	DT	B-TREATMENT
slow	JJ	I-TREATMENT
taper	NN	I-TREATMENT
as	IN	O
guided	VBN	O
by	IN	O
pulmonary	NN	O
.	.	O

1	CD	O
)	)	O
calcitriol	NN	B-TREATMENT
0.25	CD	O
mcg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

2	CD	O
)	)	O
tums	NN	B-TREATMENT
1250	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

3	LS	O
)	)	O
premarin	NN	B-TREATMENT
0.625	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

4	CD	O
)	)	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

5	CD	O
)	)	O
humulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
q.a.c.	NN	O
and	CC	O
q.h.s.	NN	O

6	CD	O
)	)	O
labetalol	NN	B-TREATMENT
400	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

7	CD	O
)	)	O
omeprazole	VBD	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

8	CD	O
)	)	O
serax	NN	B-TREATMENT
15	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
p.r.n.	NN	O
insomnia	NN	B-PROBLEM
.	.	O

9	CD	O
)	)	O
prednisone	NN	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.	NN	O
day	NN	O
times	NNS	O
thirty	JJ	O
days	NNS	O
beginning	VBG	O
on	IN	O
july	NN	O
27	CD	O
,	,	O
1999	CD	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
a	DT	B-TREATMENT
slow	JJ	I-TREATMENT
taper	NN	I-TREATMENT
as	IN	O
directed	VBN	O
by	IN	O
the	DT	O
pulmonologist	NN	O
.	.	O

10	CD	O
)	)	O
metamucil	NN	B-TREATMENT
one	CD	O
packet	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

11	CD	O
)	)	O
amlodipine	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

12	CD	O
)	)	O
bactrim	NN	B-TREATMENT
double	JJ	I-TREATMENT
strength	NN	I-TREATMENT
one	CD	O
tablet	NN	O
p.o.	NN	O
q.o.d.	NN	O

13	CD	O
)	)	O
nephrocaps	FW	B-TREATMENT
one	CD	O
tablet	NN	O
p.o.	NN	O
q.	JJ	O
day	NN	O
.	.	O

14	CD	O
)	)	O
epogen	NN	B-TREATMENT
1,000	CD	O
units	NNS	O
subcutaneously	RB	O
three	CD	O
times	NNS	O
per	IN	O
week	NN	O
.	.	O

15	CD	O
)	)	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O

surgery	NN	B-TREATMENT

tetracycline	NN	B-TREATMENT

s/p	NN	O
i&d	NN	B-TREATMENT
(	(	O
03-17	CD	O
)	)	O

s/p	JJ	O
debridement	NN	B-TREATMENT
(	(	O
03-18	CD	O
)	)	O

he	PRP	O
developed	VBD	O
right	JJ	B-PROBLEM
foot	NN	I-PROBLEM
pain	VBP	I-PROBLEM
the	DT	O
sunday	NN	O
prior	RB	O
to	TO	O
admission	NN	O
and	CC	O
was	VBD	O
seen	VBN	O
by	IN	O
his	PRP$	O
podiatrist	NN	O
,	,	O
who	WP	O
diagnosed	VBD	O
him	PRP	O
with	IN	O
gout	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
colchicine	NN	B-TREATMENT
and	CC	O
prednisone	NN	B-TREATMENT
.	.	O

mr.	NNS	O
morton	NNP	O
then	RB	O
developed	VBD	O
more	JJR	B-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
warmth	NN	B-PROBLEM
to	TO	I-PROBLEM
his	PRP$	I-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
later	RB	O
in	IN	O
the	DT	O
week	NN	O
and	CC	O
presented	VBN	O
to	TO	O
the	DT	O
youville	NNP	O
hospital	NN	O
-	:	O
woody	NN	O
monica	NN	O
.	.	O

at	IN	O
this	DT	O
hospital	NN	O
he	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
i&d	NN	I-TREATMENT
(	(	O
03-17	JJ	O
)	)	O
of	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
foot	NN	I-PROBLEM
infection	NN	I-PROBLEM
and	CC	O
subsequently	RB	O
underwent	JJ	O

re-exploration	NN	B-TEST
(	(	O
03-18	CD	O
)	)	O
for	IN	O
developing	VBG	B-PROBLEM
necrotizing	JJ	I-PROBLEM
fascitis	NN	I-PROBLEM
.	.	O

pmh	NN	O
:	:	O
prostate	NN	B-PROBLEM
ca	MD	I-PROBLEM
,	,	O
glaucoma	VB	B-PROBLEM

psh	NN	O
:	:	O
rih	NN	B-TREATMENT
repair	NN	I-TREATMENT
,	,	O
s/p	NN	O
turp	NN	B-TREATMENT
,	,	O
s/p	JJ	O
thyroid	NN	B-TREATMENT
excision	NN	I-TREATMENT

heent	NN	O
:	:	O
eomi	NN	O
,	,	O
anicteric,	JJ	B-PROBLEM
op	NN	O
pink	NN	O

neck	NN	O
:	:	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
supple	NN	O

cv	NN	O
:	:	O
rrr	NN	O
,	,	O
no	DT	O
m/r	NN	B-PROBLEM

gi	NN	O
:	:	O
soft/nt/nd	NN	B-PROBLEM

ext	NN	O
:	:	O
r	JJ	O
foot	NN	O
with	IN	O
erythema	JJ	B-PROBLEM
/	NNP	O
swelling	NN	B-PROBLEM
;	:	O
muscle	NN	O
and	CC	O
tendons	NNS	O
exposed	VBN	O
,	,	O
with	IN	O
necrotic	JJ	B-PROBLEM
edges	NNS	I-PROBLEM
,	,	O
some	DT	B-PROBLEM
fibrinous	JJ	I-PROBLEM
exudate	NN	I-PROBLEM

mri	JJ	B-TEST
rle	VBZ	I-TEST
03-21	NN	O

"	RB	O
1.	CD	B-PROBLEM
7	CD	I-PROBLEM
cm	NN	I-PROBLEM
linear	JJ	I-PROBLEM
fluid	JJ	I-PROBLEM
collection	NN	I-PROBLEM
running	VBG	O
between	IN	O
the	DT	O
anterior	NN	O
and	CC	O
lateral	JJ	O
muscle	NN	O
compartments	NNS	O
,	,	O
extending	VBG	O
from	IN	O
a	DT	O
large	JJ	O
area	NN	O
of	IN	O
soft	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
loss	NN	I-PROBLEM
seen	VBN	O
in	IN	O
the	DT	O
distal	JJ	O
lateral	JJ	O
foreleg	NN	O
to	TO	O
roughly	RB	O
the	DT	O
mid	NN	O
tibia	NN	O
/	NNP	O
fibula	NN	O
,	,	O
18	CD	O
cm	NN	O
distal	NN	O
to	TO	O
the	DT	O
knee	NN	O
joint	JJ	O
line	NN	O
.	.	O

the	DT	B-PROBLEM
collection	NN	I-PROBLEM
is	VBZ	O
largest	JJS	O
at	IN	O
its	PRP$	O
most	JJS	O
proximal	JJ	O
extent	NN	O
,	,	O
measuring	VBG	O
1.4	CD	O
x	JJ	O
0.7	CD	O
cm	NN	O
in	IN	O
the	DT	O
transverse	JJ	O
dimension	NN	O
.	.	O

2.	CD	O
non-specific	JJ	B-PROBLEM
myositis	NN	I-PROBLEM
involving	VBG	O
multiple	JJ	O
muscle	NN	O
groups	NNS	O
in	IN	O
the	DT	O
foreleg	NN	O
,	,	O
most	JJS	O
severe	JJ	O
in	IN	O
the	DT	O
anterior	NN	O
,	,	O
lateral	JJ	O
,	,	O
and	CC	O
posterior	JJ	O
deep	JJ	O
compartments	NNS	O
.	.	O

3.	CD	O
tendinosis	NN	B-PROBLEM
of	IN	O
the	DT	O
posterior	JJ	O
tibialis	NN	O
and	CC	O
peroneus	NN	O
brevis	NN	O
tendons	NNS	O
.	.	O

no	DT	O
tendon	NN	B-PROBLEM
tear	NN	I-PROBLEM
.	.	O

4.	CD	O
no	DT	O
evidence	NN	O
of	IN	O
abnormal	JJ	B-PROBLEM
bone	NN	I-PROBLEM
marrow	VBD	I-PROBLEM
signal	JJ	I-PROBLEM
intensity	NN	I-PROBLEM
or	CC	O
intraosseous	JJ	B-PROBLEM
abscess	NN	I-PROBLEM
."	NN	O

rle	JJ	B-TEST
angio	VBZ	I-TEST
03-21	NN	O

"	RB	O
1.	CD	O
mild	NNS	B-PROBLEM
but	CC	I-PROBLEM
multifocal	JJ	I-PROBLEM
atherosclerotic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
involving	VBG	O
the	DT	O
infrarenal	JJ	O
aorta	NN	O
and	CC	O
iliac	JJ	O
arteries	NNS	O
,	,	O
with	IN	O
no	DT	O
significant	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
gradient	NN	I-PROBLEM
associated	VBN	O
.	.	O

2.	CD	O
significant	JJ	B-PROBLEM
segmental	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
(	(	O
approx.	JJ	O
5-6	JJ	O
cm	NN	O
long	RB	O
)	)	O
in	IN	O
the	DT	O
mid	NN	O
right	JJ	O
superficial	JJ	O
femoral	JJ	O
artery	NN	O
.	.	O

3.	CD	O
high	JJ	B-PROBLEM
bifurcation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
popliteal	JJ	I-PROBLEM
artery	NN	I-PROBLEM
at	IN	O
the	DT	O
knee	NN	O
level	NN	O
.	.	O

4.	CD	O
in	IN	O
the	DT	O
proximal	JJ	O
calf	NN	O
,	,	O
severe	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
or	CC	O
occlusion	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
two	CD	I-PROBLEM
terminal	JJ	I-PROBLEM
branches	NNS	I-PROBLEM
arising	VBG	O
from	IN	O
this	DT	O
popliteal	JJ	O
bifurcation	NN	O
(	(	O
likely	JJ	O
the	DT	O
anterior	JJ	O
tibial	NN	O
and	CC	O
the	DT	O
peroneal	NN	O
arteries	NNS	O
).	VBP	O

two	CD	B-PROBLEM
significant	JJ	I-PROBLEM
focal	JJ	I-PROBLEM
stenoses	NNS	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
anterior	JJ	I-PROBLEM
tibial	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

right	RB	O
posterior	JJ	O
tibial	JJ	O
artery	NN	O
completely	RB	B-PROBLEM
occluded	VBD	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
penicillin	NN	B-TREATMENT
g	NN	I-TREATMENT
,	,	O
clindamycin	NN	B-TREATMENT
,	,	O
for	IN	O
empiric	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
,	,	O
with	IN	O
group	NN	B-PROBLEM
a	DT	I-PROBLEM
strep	JJ	I-PROBLEM
growth	NN	I-PROBLEM
from	IN	O
the	DT	B-TEST
new	JJ	I-TEST
england	NN	I-TEST
baptist	NN	I-TEST
hospital-bryce	JJ	I-TEST
cultures	NNS	I-TEST
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
undergo	VB	O
bid	NN	B-TREATMENT
dressing	VBG	I-TREATMENT
changes	NNS	I-TREATMENT
.	.	O

per	IN	O
their	PRP$	O
recommendations	NNS	O
,	,	O
silvadine	NN	B-TREATMENT
was	VBD	O
applied	VBN	O
to	TO	O
the	DT	O
tendons	NNS	O
to	TO	O
prevent	VB	O
dessication	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
angiogram	NN	I-TEST
on	IN	O
hd#4	NN	O
showed	VBD	O
severe	JJ	B-PROBLEM
tibial	JJ	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
moderate	JJ	B-PROBLEM
sfa	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
no	DT	O
dp	NN	O
artery	NN	O
was	VBD	O
seen	VBN	O
.	.	O

the	DT	O
vascular	JJ	O
team	NN	O
recommended	VBD	O
a	DT	B-TREATMENT
femoral-peroneal	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
for	IN	O
revascularization	NN	B-TREATMENT
and	CC	O
performed	VBD	O
this	DT	B-TREATMENT
operation	NN	I-TREATMENT
on	IN	O
hd#5	NN	O
.	.	O

he	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
,	,	O
please	VB	O
see	VB	O
dr.	JJ	O
allgood	NN	O
operative	JJ	O
note	NN	O
for	IN	O
detail	NN	O
.	.	O

on	IN	O
pod#1	NN	O
,	,	O
mr.	JJ	O
morton	NNP	O
received	VBD	O
2	CD	O
units	NNS	O
of	IN	O
prbcs	NN	B-TREATMENT
for	IN	O
post-op	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
(	(	O
hct	JJ	B-TEST
25	CD	O
).	NN	O

mr.	NN	O
morton	NNP	O
continued	VBD	O
to	TO	O
be	VB	O
followed	VBN	O
by	IN	O
infectious	JJ	O
disease	NN	O
,	,	O
whose	WP$	O
recommendations	NNS	O
were	VBD	O
to	TO	O
complete	VB	O
a	DT	O
01-28	JJ	O
week	NN	O
course	NN	O
of	IN	O
penicillin	NN	B-TREATMENT
g	NN	I-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
after	IN	O
the	DT	O
foot	NN	O
was	VBD	O
completely	RB	O
debrided	VBN	O
and	CC	O
the	DT	B-TREATMENT
skin	NN	I-TREATMENT
flaps	NNS	I-TREATMENT
completed	VBN	O
.	.	O

his	PRP$	B-PROBLEM
wound	NN	I-PROBLEM
continued	VBD	O
to	TO	O
heal	VB	O
well	RB	O
and	CC	O
by	IN	O
pod	NN	O
#6	FW	O
a	DT	B-TREATMENT
vac	NN	I-TREATMENT
dressing	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

he	PRP	O
received	VBD	O
a	DT	B-TREATMENT
picc	NN	I-TREATMENT
on	IN	O
pod#7	NN	O
for	IN	O
his	PRP$	B-TREATMENT
long-term	JJ	I-TREATMENT
antibiotic	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
mr.	JJ	O
morton	NNP	O
had	VBD	O
good	JJ	O
pain	NN	O
control	NN	O
,	,	O
was	VBD	O
tolerating	VBG	O
a	DT	O
regular	JJ	O
diet	NN	O
,	,	O
had	VBD	O
a	DT	B-PROBLEM
well-healing	JJ	I-PROBLEM
wound	NN	I-PROBLEM
treated	VBD	O
with	IN	O
a	DT	B-TREATMENT
vac	NN	I-TREATMENT
dressing	NN	I-TREATMENT
,	,	O
and	CC	O
was	VBD	O
to	TO	O
continue	VB	O
his	PRP$	B-TREATMENT
iv	NN	I-TREATMENT
pcn	NN	I-TREATMENT
g	NN	I-TREATMENT
and	CC	O
clindamycin	NN	B-TREATMENT
.	.	O

timolol	NN	B-TREATMENT
.5%	NN	O

right	RB	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
necrosing	VBG	I-PROBLEM
fascitis	JJ	I-PROBLEM
history	NN	O
of	IN	O
prostate	NN	B-PROBLEM
cancer	NN	I-PROBLEM
s/p	NN	O
turp	NN	B-TREATMENT
glaucoma	NN	B-PROBLEM

if	IN	O
you	PRP	O
have	VBP	O
any	DT	B-PROBLEM
fevers/chills	NNS	I-PROBLEM
,	,	O
nausea/vomiting	VBG	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
foot	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
please	VB	O
seek	JJ	O
medical	JJ	O
attention	NN	O
.	.	O

mevacor	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
;	:	O
colace	NN	B-TREATMENT
100	CD	O
t.i.d.	NN	O
;	:	O
carafate	VB	B-TREATMENT
1	CD	O
gram	JJ	O
q.i.d.	NN	O
;	:	O
serax	CC	B-TREATMENT
15	CD	O
mg	NN	O
p.o.	NN	O
q.6.h.	NN	O
to	TO	O
hold	VB	O
for	IN	O
somnolence	NN	B-PROBLEM
;	:	O
thiamine	CC	B-TREATMENT
100	CD	O
mg	NN	O
im	NN	O
q.d.	NN	O
,	,	O
folate	VBP	B-TREATMENT
1	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
multivitamin	FW	B-TREATMENT
1	CD	O
q.d.	NN	O
,	,	O
percocet	JJ	B-TREATMENT
1-2	JJ	O
tabs	NN	O
p.o.	NN	O
q.4.h.	NN	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
,	,	O
dulcolax	VBZ	B-TREATMENT
2	CD	O
tabs	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
p.r.n.	VBZ	O
no	DT	B-PROBLEM
stool	NN	I-PROBLEM
x	RB	O
48	CD	O
hours	NNS	O
;	:	O
tylenol	CC	B-TREATMENT
650	CD	O
p.o.	NN	O
q.4.h.	NN	O
p.r.n.	NN	O
and	CC	O
heparin	NN	B-TREATMENT
7500	CD	O
units	NNS	O
subcu.	VBD	O
b.i.d.	NN	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
61	JJ	O
-	:	O
year-old	JJ	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
5-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
on	IN	O
2009-09-11	JJ	O
,	,	O
who	WP	O
presents	VBZ	O
for	IN	O
elective	JJ	B-TEST
right	JJ	I-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
and	CC	O
pericardiocentesis	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
well	RB	O
after	IN	O
his	PRP$	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

on	IN	O
10-14	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
,	,	I-PROBLEM
moderate-to-large	JJ	I-PROBLEM
sized	VBN	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
asymptomatic	JJ	B-PROBLEM
at	IN	O
this	DT	O
time	NN	O
,	,	O
and	CC	O
the	DT	O
decision	NN	O
was	VBD	O
made	VBN	O
to	TO	O
monitor	VB	O
him	PRP	O
and	CC	O
to	TO	O
start	VB	O
him	PRP	O
on	IN	O
lasix	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
follow-up	JJ	B-TEST
transthoracic	JJ	I-TEST
echocardiogram	NN	I-TEST
on	IN	O
11-04	JJ	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
slightly	RB	I-PROBLEM
large	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

a	DT	O
few	JJ	O
days	NNS	O
later	RB	O
,	,	O
on	IN	O
11-07	JJ	O
,	,	O
the	DT	O
patient	NN	O
began	VBD	O
to	TO	O
develop	VB	O
dyspnea	NN	B-PROBLEM
on	IN	O
exertion	NN	O
with	IN	O
normal	JJ	O
activity	NN	O
.	.	O

he	PRP	O
also	RB	O
noted	VBD	O
a	DT	B-PROBLEM
new	JJ	I-PROBLEM
two	CD	I-PROBLEM
to	TO	I-PROBLEM
three-pillow	JJ	I-PROBLEM
orthopnea	NN	I-PROBLEM
and	CC	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
.	.	O

on	IN	O
11-08	JJ	O
,	,	O
he	PRP	O
had	VBD	O
an	DT	O
episode	NN	O
of	IN	O
acute	JJ	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
chest	NN	B-PROBLEM
pressure	NN	I-PROBLEM
which	WDT	O
he	PRP	O
describes	VBZ	O
as	IN	O
different	JJ	O
from	IN	O
his	PRP$	B-PROBLEM
typical	JJ	I-PROBLEM
angina	NN	I-PROBLEM
with	IN	O
minimal	JJ	O
exertion	NN	O
.	.	O

the	DT	O
patient	JJ	O
spoke	NN	O
with	IN	O
his	PRP$	O
cardiologist	NN	O
who	WP	O
referred	VBD	O
him	PRP	O
for	IN	O
pericardiocentesis	NN	B-TREATMENT
for	IN	O
persistent	NN	B-PROBLEM
and	CC	I-PROBLEM
symptomatic	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

on	IN	O
right	JJ	B-TEST
heart	NN	I-TEST
catheterization	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
elevated	VBN	B-PROBLEM
right-sided	JJ	I-PROBLEM
and	CC	I-PROBLEM
left-sided	JJ	I-PROBLEM
filling	NN	I-PROBLEM
pressures	NNS	I-PROBLEM
with	IN	O
a	DT	B-TEST
pulmonary	JJ	I-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
19	CD	O
and	CC	O
a	DT	B-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
16	CD	O
.	.	O

after	IN	O
600	CD	O
cc	NN	O
of	IN	O
serosanguineous	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
was	VBD	O
removed	VBN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
pulmonary	JJ	I-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
9	CD	O
and	CC	O
a	DT	B-TEST
right	JJ	I-TEST
atrial	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
2	CD	O
;	:	O
indicating	VBG	O
resolution	NN	O
of	IN	O
tamponade	JJ	B-PROBLEM
physiology	NN	I-PROBLEM
.	.	O

1.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
5-vessel	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
on	IN	O
2009-09-11	JJ	O
.	.	O

left	VBN	O
internal	JJ	O
mammary	JJ	O
artery	NN	O
to	TO	O
left	VB	O
anterior	RP	O
descending	VBG	O
artery	NN	O
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	O
left	VB	O
anterior	RP	O
descending	VBG	O
artery	NN	O
to	TO	O
diagonal	VB	O
,	,	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	O
right	VB	O
posterior	JJ	O
descending	VBG	O
artery	NN	O
,	,	O
and	CC	O
saphenous	JJ	B-TREATMENT
vein	NN	I-TREATMENT
graft	NN	I-TREATMENT
to	TO	O
first	JJ	O
obtuse	IN	O
marginal	JJ	O
.	.	O

2.	CD	O
type	NN	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
for	IN	O
50	CD	O
years	NNS	O
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

4.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

5.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
baseline	JJ	I-TEST
creatinine	NN	I-TEST
of	IN	O
1.1	CD	O
to	TO	O
1.4	CD	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

atenolol	RB	B-TREATMENT
50	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
baby	NN	B-TREATMENT
aspirin	VBD	I-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
accupril	RB	B-TREATMENT
40	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
hydrochlorothiazide	RB	B-TREATMENT
12.5	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
18	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
10	CD	O
units	NNS	O
q.p.m.	RB	O
,	,	O
humalog	VBD	B-TREATMENT
sliding-scale	JJ	I-TREATMENT
q.a.m.	NN	O
and	CC	O
q.p.m.	NN	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
100.9	CD	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
148	CD	O
to	TO	O
162/45	CD	O
to	TO	O
54	CD	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
85	CD	O
to	TO	O
87	CD	O
,	,	O
breathing	VBG	O
at	IN	O
17	CD	O
to	TO	O
23	CD	O
,	,	O
satting	VBG	O
100%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

in	IN	O
general	JJ	O
,	,	O
he	PRP	O
was	VBD	O
alert	JJ	O
and	CC	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

his	PRP$	O
neck	NN	O
was	VBD	O
supple	RB	O
without	IN	O
any	DT	B-PROBLEM
jugular	JJ	I-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
.	.	O

heent	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
his	PRP$	O
pupils	NNS	O
were	VBD	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	NN	O
.	.	O

his	PRP$	O
sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

cardiovascular	NN	O
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
heart	NN	B-PROBLEM
sounds	VBZ	I-PROBLEM
muffled	VBN	I-PROBLEM
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

respiratory	NN	O
revealed	VBD	O
bibasilar	JJ	B-PROBLEM
rales	NNS	I-PROBLEM
.	.	O

abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
and	CC	O
nondistended	VBD	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

extremities	NNS	O
revealed	VBD	O
trace	NN	B-PROBLEM
lower	RBR	I-PROBLEM
extremity	NN	I-PROBLEM
edema	NN	I-PROBLEM
,	,	O
right	RB	O
greater	JJR	O
than	IN	O
left	VBD	O
,	,	O
2+	CD	B-TEST
dorsalis	NN	I-TEST
pedis	NN	I-TEST
and	CC	I-TEST
posterior	JJ	I-TEST
tibialis	NN	I-TEST
pulses	NNS	I-TEST
.	.	O

he	PRP	O
had	VBD	O
2+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	O
.	.	O

no	DT	O
hematomas	NN	B-PROBLEM
were	VBD	O
noted	VBN	O
,	,	O
but	CC	O
a	DT	B-PROBLEM
soft	JJ	I-PROBLEM
right	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
bruit	NN	I-PROBLEM
was	VBD	O
heard	VBN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
9.5	CD	O
,	,	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
34.5	CD	O
,	,	O
a	DT	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
of	IN	O
194	CD	O
.	.	O

his	PRP$	B-TEST
chem-7	NN	I-TEST
revealed	VBD	O
sodium	NN	B-TEST
of	IN	O
132	CD	O
,	,	O
potassium	NN	B-TEST
of	IN	O
43	CD	O
,	,	O
chloride	NN	B-TEST
of	IN	O
97	CD	O
,	,	O
bicarbonate	NN	B-TEST
of	IN	O
28	CD	O
,	,	O
bun	NN	B-TEST
of	IN	O
25	CD	O
,	,	O
creatinine	NN	B-TEST
of	IN	O
1.3	CD	O
,	,	O
glucose	NN	B-TEST
of	IN	O
220	CD	O
.	.	O

he	PRP	O
had	VBD	O
an	DT	B-TEST
inr	NN	I-TEST
of	IN	O
1.1	CD	O
.	.	O

a	DT	B-TEST
calcium	NN	I-TEST
of	IN	O
8.4	CD	O
,	,	O
phosphate	NN	B-TEST
of	IN	O
2.5	CD	O
,	,	O
magnesium	NN	B-TEST
of	IN	O
1.9	CD	O
.	.	O

pericardial	JJ	B-TEST
fluid	NN	I-TEST
analysis	NN	I-TEST
was	VBD	O
consistent	JJ	O
with	IN	O
an	DT	B-PROBLEM
exudative	JJ	I-PROBLEM
etiology	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
electrocardiogram	NN	I-TEST
with	IN	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
at	IN	O
70	CD	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
normal	JJ	O
intervals	NNS	O
,	,	O
low	JJ	B-PROBLEM
voltage	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
limb	NN	I-PROBLEM
leads	VBZ	I-PROBLEM
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
on	IN	O
admission	NN	O
revealed	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
on	IN	O
11-10	JJ	O
which	WDT	O
revealed	VBD	O
the	DT	O
following	NN	O
:	:	O

global	JJ	B-TEST
left	VBD	I-TEST
ventricular	JJ	I-TEST
systolic	JJ	I-TEST
function	NN	I-TEST
appeared	VBD	O
grossly	RB	O
preserved	VBN	O
.	.	O

due	JJ	O
to	TO	O
technical	JJ	O
quality	NN	O
a	DT	B-PROBLEM
focal	JJ	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
abnormality	NN	I-PROBLEM
could	MD	O
not	RB	O
be	VB	O
fully	RB	O
excluded	VBN	O
.	.	O

the	DT	O
aortic	JJ	O
valve	NN	O
leaflets	NNS	O
were	VBD	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

the	DT	O
mitral	JJ	O
valve	NN	O
leaflets	NNS	O
were	VBD	O
mildly	RB	B-PROBLEM
thickened	VBN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
(	(	O
up	IN	O
to	TO	O
greater	JJR	O
than	IN	O
6	CD	O
cm	JJ	O
wide	JJ	O
anterior	NN	O
to	TO	O
the	DT	O
right	JJ	O
ventricle	NN	O
).	NN	O

the	DT	O
right	JJ	O
ventricle	NN	O
was	VBD	O
compressed	VBN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
after	IN	O
his	PRP$	B-TREATMENT
therapeutic	JJ	I-TREATMENT
pericardiocentesis	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
his	PRP$	B-TREATMENT
home	NN	I-TREATMENT
cardiac	NN	I-TREATMENT
regimen	NNS	I-TREATMENT
,	,	O
but	CC	O
was	VBD	O
started	VBN	O
on	IN	O
indomethacin	NN	B-TREATMENT
for	IN	O
post	NN	B-PROBLEM
pericardiotomy	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
night	NN	O
the	DT	O
patient	NN	O
drained	VBD	O
an	DT	O
additional	JJ	O
400	CD	O
cc	NN	O
of	IN	O
serosanguineous	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
from	IN	O
his	PRP$	B-TREATMENT
pericardial	JJ	I-TREATMENT
drain	NN	I-TREATMENT
pouch	NN	I-TREATMENT
.	.	O

by	IN	O
the	DT	O
next	JJ	O
morning	NN	O
,	,	O
the	DT	O
degree	NN	O
of	IN	O
drainage	NN	B-PROBLEM
had	VBD	O
decreased	VBN	O
considerably	RB	O
with	IN	O
only	RB	O
60	CD	O
cc	NNS	O
drained	VBN	O
over	IN	O
six	CD	O
hours	NNS	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
transthoracic	NN	I-TEST
echocardiogram	NN	I-TEST
prior	RB	O
to	TO	O
drain	VB	B-TREATMENT
removal	NN	I-TREATMENT
which	WDT	O
revealed	VBD	O
the	DT	O
following	NN	O
:	:	O

a	DT	B-PROBLEM
trivial	JJ	I-PROBLEM
/	NN	I-PROBLEM
physiologic	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
one	CD	O
day	NN	O
post	VB	O
pericardiocentesis	NN	B-TREATMENT
with	IN	O
no	DT	O
change	NN	O
from	IN	O
the	DT	B-TEST
study	NN	I-TEST
immediately	RB	O
post	JJ	O
pericardiocentesis	NN	B-TREATMENT
.	.	O

the	DT	B-TREATMENT
pericardial	JJ	I-TREATMENT
drain	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
without	IN	O
any	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
pericardial	JJ	I-TREATMENT
fluid	NN	I-TREATMENT
bag	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
without	IN	O
any	DT	B-PROBLEM
difficulty	NN	I-PROBLEM
with	IN	O
the	DT	O
decision	NN	O
to	TO	O
monitor	VB	O
the	DT	O
patient	NN	O
overnight	NN	O
and	CC	O
repeat	VB	O
the	DT	B-TEST
echocardiogram	NN	I-TEST
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
enlarged	VBN	I-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
which	WDT	O
was	VBD	O
noted	VBN	O
to	TO	O
layer	VB	O
on	IN	O
a	DT	B-TEST
lateral	JJ	I-TEST
decubitus	NN	I-TEST
film	NN	I-TEST
.	.	O

we	PRP	O
decided	VBD	O
to	TO	O
perform	VB	O
a	DT	B-TREATMENT
therapeutic	JJ	I-TREATMENT
thoracentesis	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
prepped	VBN	O
and	CC	O
draped	VBN	O
in	IN	O
a	DT	O
sterile	JJ	O
fashion	NN	O
,	,	O
and	CC	O
1150	CD	O
cc	NN	O
of	IN	O
fluid	NN	B-PROBLEM
were	VBD	O
drained	VBN	B-TREATMENT
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
was	VBD	O
obtained	VBN	O
post	NN	O
thoracentesis	NN	B-TREATMENT
which	WDT	O
revealed	VBD	O
a	DT	O
significant	JJ	O
decrease	NN	O
in	IN	O
the	DT	O
size	NN	O
of	IN	O
the	DT	B-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
pneumothorax	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
markedly	RB	I-TEST
improved	VBN	I-TEST
lung	NN	I-TEST
examination	NN	I-TEST
with	IN	O
increased	JJ	O
air	NN	O
movement	NN	O
in	IN	O
the	DT	O
left	JJ	O
base	NN	O
.	.	O

he	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
had	VBD	O
oxygen	VBN	B-TEST
saturations	NNS	I-TEST
in	IN	O
the	DT	O
90	CD	O
s	NN	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
echocardiogram	NN	I-TEST
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
trivial	JJ	I-PROBLEM
/	NN	I-PROBLEM
physiologic	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

1.	CD	O
post	NN	B-PROBLEM
pericardiotomy	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

2.	CD	O
status	NN	O
post	NN	O
pericardiocentesis	NN	B-TREATMENT
.	.	O

3.	CD	O
status	NN	O
post	NN	O
thoracentesis	NN	B-TREATMENT
.	.	O

4.	CD	O
type	NN	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	VBP	I-PROBLEM
for	IN	O
50	CD	O
years	NNS	O
.	.	O

5.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

6.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

7.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

8.	CD	O
chronic	JJ	B-PROBLEM
renal	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

1.	CD	O
indomethacin	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
t.i.d.	NN	O
for	IN	O
seven	CD	O
days.	NNS	O

2.	CD	O
atenolol	JJ	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

3.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
baby	NN	B-TREATMENT
aspirin	VBD	I-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
iron	NN	B-TREATMENT
sulfate	NN	I-TREATMENT
81	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

6.	CD	O
accupril	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

7.	CD	O
hydrochlorothiazide	JJ	B-TREATMENT
12.5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

8.	CD	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
18	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
10	CD	O
units	NNS	O
q.p.m.	RB	O

9.	CD	O
humalog	NN	B-TREATMENT
sliding-scale	JJ	I-TREATMENT
q.a.m.	NN	O
and	CC	O
q.p.m.	NN	O

vaginal	JJ	B-TREATMENT
delivery	NN	I-TREATMENT
with	IN	O
first	JJ	B-PROBLEM
degree	NN	I-PROBLEM
laceration	NN	I-PROBLEM

advanced	JJ	B-PROBLEM
maternal	JJ	I-PROBLEM
age	NN	I-PROBLEM
;	:	O
depression	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
;	:	O
hepatitis	NN	B-PROBLEM
c	VBZ	I-PROBLEM
antibody	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
;	:	O
polyneuropathy	JJ	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
;	:	O
problems	NNS	O
with	IN	O
abuse	NN	O
,	,	O
history	NN	O
of	IN	O
;	:	O
rh	JJ	O
nonsensitization	NN	O
;	:	O
stopped	VBD	O
smoking	VBG	O
this	DT	O
pregnancy	NN	O
,	,	O
history	NN	O
of	IN	O

spontaneous	JJ	B-TREATMENT
vertex	NNS	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM

height	NN	B-TEST
normal	JJ	O
66	CD	O
heent	NN	O
normal	JJ	O
mouth	NN	O
normal	JJ	O
neck	NN	O
normal	JJ	O
breasts	NNS	O
normal	JJ	O
nipples	NNS	O
normal	JJ	O
chest	JJS	O
normal	JJ	O
cor	NN	O
normal	JJ	O
abdomen	NNS	O
normal	JJ	O
extrem	JJ	O
normal	JJ	O
skin	NN	B-PROBLEM
mottled	VBN	I-PROBLEM
on	IN	I-PROBLEM
both	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

nodes	NNS	O
normal	JJ	O
vulva	NN	O
normal	JJ	O
vagina	NN	O
normal	JJ	O
cervix	NN	O
normal	JJ	O
os	NN	O
normal	JJ	O
adnexae	NN	O
normal	JJ	O
uterus	JJ	O
normal	JJ	O
uterine	JJ	B-TEST
size	NN	I-TEST
in	IN	O
weeks	NNS	O
15	CD	O
hospital	JJ	O
course	NN	O
(	(	O
include	VBP	O
complications	NNS	O
if	IN	O
any	DT	O
)	)	O
:	:	O

active	JJ	B-PROBLEM
labor	NN	I-PROBLEM
.	.	O

she	PRP	O
delivered	VBD	O
a	DT	O
2809	CD	O
gram	NN	O
male	NN	O
infant	NN	O
on	IN	O
03/16/2002	CD	O
at	IN	O
02:50	CD	O
am	VBP	O
with	IN	O
apgar	JJ	B-TEST
scores	NNS	I-TEST
of	IN	O
7	CD	O
and	CC	O
9	CD	O
at	IN	O
one	CD	O
and	CC	O
five	CD	O
minutes	NNS	O
respectively	RB	O
at	IN	O
38.0	CD	O
weeks	NNS	O
gestation	NN	O
via	IN	O
spontaneous	JJ	B-TREATMENT
vertex	FW	I-TREATMENT
vaginal	JJ	I-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

depression	NN	B-PROBLEM
.	.	O

postpartum	NN	B-TREATMENT
rh	NN	I-TREATMENT
immune	JJ	I-TREATMENT
globulin	NN	I-TREATMENT
:	:	O

postpartum	NN	B-TREATMENT
measles	NNS	I-TREATMENT
/	VBP	I-TREATMENT
mumps/rubella	JJ	I-TREATMENT
vaccine	NN	I-TREATMENT
:	:	O

multivitamins	NNS	B-TREATMENT
and	CC	O
folate	NN	B-TREATMENT
(	(	O
stuart	JJ	B-TREATMENT
prenatal	NN	I-TREATMENT
with	IN	O
folate	NN	B-TREATMENT
)	)	O
;	:	O
fluoxetine	NN	B-TREATMENT
(	(	I-TREATMENT
prozac	NN	I-TREATMENT
)	)	I-TREATMENT

patient	NN	O
recorded	VBD	O
as	IN	O
having	VBG	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM
to	TO	I-PROBLEM
drugs	NNS	I-PROBLEM

altered	VBN	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM

diaphoresis	NN	B-PROBLEM

abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM

lap	RB	B-TREATMENT
converted	VBN	O
to	TO	O
open	VB	B-TREATMENT
cholecystectomy	NN	I-TREATMENT

her	PRP$	O
family	NN	O
memebers	NNS	O
stated	VBD	O
that	IN	O
she	PRP	O
was	VBD	O
found	VBN	O
at	IN	O
home	NN	O
with	IN	O
altered	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
diaphoresis	NN	B-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
diabetic	JJ	B-PROBLEM
.	.	O

mental	JJ	O
status	NN	O
improved	VBN	O
after	IN	O
binasal	NN	B-TREATMENT
cannula	NN	I-TREATMENT
oxygen	NN	I-TREATMENT
applied	VBN	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
localized	VBD	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

she	PRP	O
developed	VBD	O
leukocytosis	NN	B-PROBLEM
and	CC	O
transaminasemia	NN	B-PROBLEM
.	.	O

dm	NN	B-PROBLEM
on	IN	O
insulin	NN	B-TREATMENT

htn	NN	B-PROBLEM

gerd	NN	B-PROBLEM

pvd	NN	B-PROBLEM

osteo-arthritis	NN	B-PROBLEM

osteoporosis	NN	B-PROBLEM

anemia	NN	B-PROBLEM

cholelithiasis	NN	B-PROBLEM

left	JJ	B-PROBLEM
humeral	JJ	I-PROBLEM
fracture	NN	I-PROBLEM

b/l	NN	B-PROBLEM
cataracts	NNS	I-PROBLEM
s/p	VBP	O
surgery	NN	B-TREATMENT

s/p	JJ	O
uterine	JJ	B-TREATMENT
myomectomy	NN	I-TREATMENT

walks	NNS	O
without	IN	O
cane	NN	B-TREATMENT

denies	NNS	O
cad	VBP	B-PROBLEM

t	NN	B-TEST
:	:	O
99.2	CD	O
hr	NN	B-TEST
97	CD	O
bp	NN	B-TEST
131/68	CD	O
rr	NN	B-TEST
:	:	O
20	CD	O
spo2	NN	B-TEST
100%	CD	O
on	IN	O
ra	NN	O

no	DT	O
mumur	NN	B-PROBLEM
/	VBZ	O
regurgiation	NN	B-PROBLEM
/	NNP	O
gallop	NN	B-PROBLEM

+	NN	O
haskell	NN	B-TEST
sign	NN	I-TEST
,	,	O
right	JJ	B-PROBLEM
upper	NN	I-PROBLEM
quadrant	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
rebounding	NN	B-PROBLEM

skin	NN	O
:	:	O
no	DT	O
c/c/e	NN	B-PROBLEM

neuro	NN	O
:	:	O
cn	JJ	O
ii-xii	JJ	O
intact	NN	O
,	,	O
no	DT	O
dysdiadokinesis	NN	B-PROBLEM
.	.	O

decreased	VBN	B-PROBLEM
babinski	NN	I-PROBLEM
's	POS	I-PROBLEM

2015-04-16	JJ	O
07:10	CD	O
pm	NN	O
blood	NN	B-TEST
albumin	SYM	B-TEST
-	:	O
3.8	CD	O
calcium	NN	B-TEST
-	:	O
9.0	CD	O
phos	NN	B-TEST
-	:	O
2.6	CD	O
*#	NN	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

2015-04-16	JJ	O
07:10	CD	O
pm	NN	O
blood	NN	B-TEST
alt	SYM	B-TEST
-	:	O
295	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
56	CD	O
*	NN	O
ck(cpk)	NN	B-TEST
-	:	O
60	CD	O
alkphos	SYM	B-TEST
-	:	O
208	CD	O
*	JJ	O
amylase	NN	B-TEST
-	:	O
23	CD	O
totbili	SYM	B-TEST
-	:	O
1.6	CD	O
*	NN	O

2015-04-16	JJ	O
07:10	CD	O
pm	NN	O
blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
280	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
18	CD	O
creat	NN	B-TEST
-	:	O
1.0	CD	O
na	SYM	B-TEST
-	:	O
135	CD	O
k	SYM	B-TEST
-	:	O
4.2	CD	O
cl	NN	B-TEST
-	:	O
98	CD	O
hco3	NN	B-TEST
-	:	O
22	CD	O
angap	NN	B-TEST
-	:	O
19	CD	O

2015-04-16	JJ	O
07:10	CD	O
pm	NN	O
blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
18.4	CD	O
*#	NN	O
rbc	NN	B-TEST
-	:	O
4.27	CD	O
hgb	NN	B-TEST
-	:	O
11.9	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
34.8	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
82	CD	O
mch	SYM	B-TEST
-	:	O
27.9	CD	O
mchc	SYM	B-TEST
-	:	O
34.1	CD	O
rdw	NN	B-TEST
-	:	O
15.0	CD	O
plt	NN	B-TEST
ct	NN	I-TEST
-	:	O
317	CD	O

2015-04-24	JJ	O
06:35	CD	O
am	VBP	O
blood	NN	B-TEST
alt	NN	B-TEST
-	:	O
82	CD	O
*	NN	O
ast	VBD	B-TEST
-	:	O
62	CD	O
*	NN	O
alkphos	SYM	B-TEST
-	:	O
145	CD	O
*	JJ	O
amylase	NN	B-TEST
-	:	O
51	CD	O
totbili	SYM	B-TEST
-	:	O
0.4	CD	O

2015-04-24	JJ	O
06:35	CD	O
am	VBP	O
blood	NN	B-TEST
glucose	JJ	B-TEST
-	:	O
134	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
8	CD	O
creat	NN	B-TEST
-	:	O
0.6	CD	O
na	SYM	B-TEST
-	:	O
144	CD	O
k	SYM	B-TEST
-	:	O
3.7	CD	O
cl	NN	B-TEST
-	:	O
106	CD	O
hco3	NN	B-TEST
-	:	O
31	CD	O
angap	NN	B-TEST
-	:	O
11	CD	O

2015-04-24	JJ	O
06:35	CD	O
am	VBP	O
blood	NN	B-TEST
wbc	NN	B-TEST
-	:	O
10.5	CD	O
rbc	NN	B-TEST
-	:	O
3.49	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
28.0	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
80	CD	O
*	NN	O
mch	SYM	B-TEST
-	:	O
27.5	CD	O
mchc	SYM	B-TEST
-	:	O
34.3	CD	O
rdw	NN	B-TEST
-	:	O
15.8	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
504	CD	O
*	NN	O

gb	JJ	B-TEST
us	PRP	I-TEST
2015-04-16	JJ	O

1.	CD	O
distended	VBD	B-PROBLEM
gallbladder	NN	I-PROBLEM
with	IN	O
impacted	JJ	B-PROBLEM
1.6	CD	I-PROBLEM
cm	NN	I-PROBLEM
gallstone	NN	I-PROBLEM
,	,	O
focal	JJ	B-PROBLEM
wall	NN	I-PROBLEM
thickening	NN	I-PROBLEM
,	,	O
and	CC	O
positive	JJ	B-PROBLEM
sonallan	NN	I-PROBLEM
stephens	VBZ	I-PROBLEM
sign	JJ	I-PROBLEM
-	:	O
findings	NNS	O
consistent	JJ	O
with	IN	O
acute	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
.	.	O

2.	CD	O
right	JJ	B-PROBLEM
renal	NN	I-PROBLEM
cysts	NNS	I-PROBLEM
-	:	O
lower	JJR	B-PROBLEM
pole	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
is	VBZ	O
unchanged	JJ	O
from	IN	O
prior	JJ	B-TEST
exam	NN	I-TEST
of	IN	O
2010-10-25	JJ	O
and	CC	O
upper	JJ	B-PROBLEM
pole	NN	I-PROBLEM
exophytic	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
was	VBD	O
not	RB	O
previously	RB	O
seen	VBN	O
sonstacy	NN	O
.	.	O

ercp	JJ	B-TEST
report	NN	O
2015-04-21	JJ	O

1.	CD	O
successful	JJ	O
removal	NN	B-TREATMENT
of	IN	O
cbd	NN	B-PROBLEM
stone	NN	I-PROBLEM
and	CC	O
placement	NN	O
of	IN	O
plastic	NN	B-TREATMENT
biliary	JJ	I-TREATMENT
stent	NN	I-TREATMENT
for	IN	O
confirmed	VBN	B-PROBLEM
cystic	JJ	I-PROBLEM
duct	NN	I-PROBLEM
leak	NN	I-PROBLEM
.	.	O

ms	NN	O
malek	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
2015-04-16	JJ	O
due	JJ	O
to	TO	O
altered	JJ	B-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
acute	VB	B-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

gallbladder	NN	B-TEST
ultra	JJ	I-TEST
sound	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
distended	JJ	I-PROBLEM
1.6	CD	I-PROBLEM
cm	NN	I-PROBLEM
non	NN	I-PROBLEM
mobile	JJ	I-PROBLEM
stone	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

on	IN	O
2015-04-17	JJ	O
she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
or	CC	O
for	IN	O
lap	RB	B-TREATMENT
converted	VBN	O
to	TO	O
open	VB	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
,	,	O
see	VBP	O
op	JJ	O
report	NN	O
for	IN	O
details	NNS	O
.	.	O

she	PRP	O
was	VBD	O
extubated	VBN	B-TREATMENT
and	CC	O
recovered	VBN	O
well	RB	O
in	IN	O
pacu	NN	O
.	.	O

she	PRP	O
remained	VBD	O
npo	JJ	B-TREATMENT
with	IN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
foley	VBP	B-TREATMENT
catheter	NN	I-TREATMENT
and	CC	O
dilaudid	JJ	B-TREATMENT
iv	NN	I-TREATMENT
for	IN	O
pain	NN	B-TREATMENT
control	NN	I-TREATMENT
,	,	O
unasyn	NN	B-TREATMENT
for	IN	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

she	PRP	O
returned	VBD	O
to	TO	O
cmed	VB	O
for	IN	O
further	JJ	B-TEST
monitoring	NN	I-TEST
.	.	O

she	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
low	JJ	B-PROBLEM
urine	JJ	I-PROBLEM
output	NN	I-PROBLEM
at	IN	O
times	NNS	O
.	.	O

she	PRP	O
responded	VBD	O
well	RB	O
to	TO	O
fluid	VB	B-TREATMENT
bolusing	NN	I-TREATMENT
.	.	O

she	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
ice	JJ	O
chips	NNS	O
.	.	O

pod#2	NN	O
her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
somewhat	RB	O
uncontrolled	JJ	O
,	,	O
she	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
dilaudid	JJ	B-TREATMENT
pca	NN	I-TREATMENT
with	IN	O
fair	JJ	O
effect	NN	O
.	.	O

urine	JJ	B-TEST
output	NN	I-TEST
remained	VBD	O
adequate	JJ	O
.	.	O

she	PRP	O
was	VBD	O
monitored	VBN	O
on	IN	O
telemetry	NN	B-TEST
for	IN	O
mild	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
and	CC	O
recieved	VBD	O
iv	JJ	B-TREATMENT
beta	NN	I-TREATMENT
blockers	NNS	I-TREATMENT
.	.	O

pod#3	NN	O
she	PRP	O
was	VBD	O
advanced	VBN	O
to	TO	O
sips	NNS	B-TREATMENT
and	CC	I-TREATMENT
clears	NNS	I-TREATMENT
,	,	O
foley	VBP	B-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
.	.	O

pod#4	NN	O
,	,	O
bilious	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
in	IN	O
her	PRP$	B-TREATMENT
jp	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
worsening	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
on	IN	O
exam	NN	B-TEST
.	.	O

she	PRP	O
was	VBD	O
held	VBN	O
npo	RB	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
ercp	VB	B-TEST
where	WRB	O
sphincterotomy	NN	B-TREATMENT
was	VBD	O
performed	VBN	O
and	CC	O
biliary	JJ	B-TREATMENT
stent	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
returned	VBN	O
to	TO	O
cc6	VB	O
post-procedure	NN	O
.	.	O

jp	NN	B-TREATMENT
remained	VBD	O
intact	JJ	O
with	IN	O
serosainguinous	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
.	.	O

pod#5	NN	O
she	PRP	O
c/o	VBD	O
difficulty	NN	B-PROBLEM
voiding	NN	I-PROBLEM
,	,	O
pt	NN	O
was	VBD	O
straight	VBN	B-TREATMENT
cathed	VBN	I-TREATMENT
after	IN	O
bladder	NN	B-TEST
scan	NN	I-TEST
was	VBD	O
obtained	VBN	O
and	CC	O
revealed	VBN	O
>	$	O
600	CD	O
ccs	NN	O
urine	NN	O
.	.	O

pod#	NN	O
05-25	CD	O
she	PRP	O
continued	VBD	O
with	IN	O
intermittent	JJ	O
complaints	NNS	O
of	IN	O
urinary	JJ	B-PROBLEM
retention	NN	I-PROBLEM
.	.	O

renal	JJ	B-TEST
function	NN	I-TEST
remained	VBD	O
normal	JJ	O
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
require	VB	O
further	JJ	B-TREATMENT
straight	JJ	I-TREATMENT
catheterization	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
advanced	VBN	O
to	TO	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
again	RB	O
without	IN	O
nausea	NN	B-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
well	RB	O
controlled	VBN	O
by	IN	O
tylenol	NN	B-TREATMENT
.	.	O

her	PRP$	O
home	NN	O
regimen	NN	O
of	IN	O
lantus	NN	B-TREATMENT
was	VBD	O
resumed	VBN	O
for	IN	O
elevated	JJ	B-PROBLEM
blood	NN	I-PROBLEM
glucose	NN	I-PROBLEM
.	.	O

she	PRP	O
required	VBD	O
disimpaction	NN	B-TREATMENT
and	CC	O
had	VBD	O
hard	JJ	B-PROBLEM
stool	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
rectum	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
initiated	VBN	O
on	IN	O
a	DT	B-TREATMENT
bowel	NN	I-TREATMENT
regimen	NN	I-TREATMENT
and	CC	O
had	VBD	O
no	DT	O
further	JJ	O
incidents	NNS	O
of	IN	O
diarrhea	NN	B-PROBLEM
or	CC	O
constipation	NN	B-PROBLEM
.	.	O

appropriate	NN	O
follow	VB	O
up	IN	O
appointments	NNS	O
are	VBP	O
recommended	VBN	O
as	RB	O
well	RB	O
as	IN	O
prescriptions	NNS	B-TREATMENT
.	.	O

she	PRP	O
should	MD	O
return	VB	O
in	IN	O
6	CD	O
weeks	NNS	O
for	IN	O
removal	NN	B-TREATMENT
of	IN	O
biliary	JJ	B-TREATMENT
stent	NN	I-TREATMENT
.	.	O

tramadol	RB	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day)	NN	O
.	.	O

2.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

3.	CD	O
nortriptyline	JJ	B-TREATMENT
25	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

5.	CD	O
buspirone	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
clonazepam	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
cholecalciferol	NN	B-TREATMENT
(	(	I-TREATMENT
vitamin	JJ	I-TREATMENT
d3	NN	I-TREATMENT
)	)	I-TREATMENT
400	CD	O
unit	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

9.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
50	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
ten	NN	O
(	(	O
10	CD	O
)	)	O
ml	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
hexavitamin	JJ	B-TREATMENT
tablet	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

11.	CD	O
dicyclomine	JJ	B-TREATMENT
10	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

12.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

15.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

16.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

17.	CD	O
ibuprofen	JJ	B-TREATMENT
600	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

18.	CD	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	B-TREATMENT
sc	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
q6h	NN	B-TREATMENT
regular	JJ	I-TREATMENT
glucose	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
dose	VBD	I-TREATMENT
0-60	JJ	O
mg	NN	O
/	NNP	O
dl	VBZ	O
01-20	JJ	O
amp	JJ	O
d50	NN	O
61-120	JJ	O
mg	NN	O
/	NNP	O
dl	VBZ	O
0	CD	O
units	NNS	O
121-140	JJ	O
mg	NN	O
/	NNP	O
dl	VBZ	O
3	CD	O
units	NNS	O
141-160	JJ	O
mg/dl	JJ	O
5	CD	O
units	NNS	O
161-180	JJ	O
mg/dl	NN	O
7	CD	O

19.	CD	O
lantus	JJ	B-TREATMENT
30	CD	O
units	NNS	O
lantus	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
with	IN	O
breakfast	NN	O

1.	CD	O
tramadol	JJ	B-TREATMENT
50	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

2.	CD	O
senna	JJ	B-TREATMENT
8.6	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

3.	CD	O
nortriptyline	JJ	B-TREATMENT
25	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

5.	CD	O
buspirone	NN	B-TREATMENT
10	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
clonazepam	NN	B-TREATMENT
0.5	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

7.	CD	O
cholecalciferol	NN	B-TREATMENT
(	(	I-TREATMENT
vitamin	JJ	I-TREATMENT
d3	NN	I-TREATMENT
)	)	I-TREATMENT
400	CD	O
unit	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

8.	CD	O
pantoprazole	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

9.	CD	O
docusate	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
50	CD	O
mg	NN	O
/	VBD	O
5	CD	O
ml	NN	O
liquid	NN	O
sig	NN	O
:	:	O
ten	NN	O
(	(	O
10	CD	O
)	)	O
ml	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

10.	CD	O
hexavitamin	JJ	B-TREATMENT
tablet	NN	I-TREATMENT
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
cap	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

11.	CD	O
dicyclomine	JJ	B-TREATMENT
10	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
capsule	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

12.	CD	O
atorvastatin	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	JJ	O
daily	JJ	O
(	(	O
daily	JJ	O
).	NN	O

13.	CD	O
amoxicillin-pot	JJ	B-TREATMENT
clavulanate	NN	I-TREATMENT
875-125	JJ	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
for	IN	O
4	CD	O
days	NNS	O
.	.	O

14.	CD	O
heparin	NN	B-TREATMENT
(	(	I-TREATMENT
porcine	NN	I-TREATMENT
)	)	I-TREATMENT
5,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
solution	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
injection	NN	O
injection	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

15.	CD	O
bisacodyl	NN	B-TREATMENT
5	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
two	CD	O
(	(	O
2	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

16.	CD	O
acetaminophen	JJ	B-TREATMENT
325	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
1-2	JJ	O
tablets	NNS	O
po	JJ	O
q4-6h	JJ	O
(	(	O
every	DT	O
4	CD	O
to	TO	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

17.	CD	O
ibuprofen	JJ	B-TREATMENT
600	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q8h	NN	O
(	(	O
every	DT	O
8	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

18.	CD	O
insulin	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

insulin	NN	B-TREATMENT
sc	NN	I-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT

glucose	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
dose	NN	I-TREATMENT

30	CD	O
units	NNS	O
lantus	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
with	IN	O
breakfast	NN	O

acute	NN	B-PROBLEM
cholecystitis	NN	I-PROBLEM

gangrenous	JJ	B-PROBLEM
cholecystitis	NN	I-PROBLEM
with	IN	O
perforation	NN	B-PROBLEM

please	VB	O
call	VB	O
your	PRP$	O
surgeon	NN	O
if	IN	O
you	PRP	O
develop	VBP	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fever	RB	B-PROBLEM
greater	JJR	O
than	IN	O
101.5	CD	O
,	,	O
foul	JJ	B-PROBLEM
smelling	NN	I-PROBLEM
or	CC	I-PROBLEM
colorful	JJ	I-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
redness	NN	B-PROBLEM
or	CC	O
swelling	NN	B-PROBLEM
,	,	O
severe	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
distention	NN	B-PROBLEM
,	,	O
persistent	JJ	B-PROBLEM
nausea	NN	I-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
,	,	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
eat	VB	I-PROBLEM
or	CC	I-PROBLEM
drink	VB	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
which	WDT	O
are	VBP	O
concerning	VBG	O
to	TO	O
you	PRP	O
.	.	O

if	IN	O
there	EX	O
is	VBZ	O
clear	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
from	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
,	,	O
cover	NN	O
with	IN	O
a	DT	B-TREATMENT
dry	JJ	I-TREATMENT
dressing	NN	I-TREATMENT
.	.	O

leave	VB	O
white	JJ	B-TREATMENT
strips	NNS	I-TREATMENT
above	IN	O
your	PRP$	B-PROBLEM
incisions	NNS	I-PROBLEM
in	IN	O
place	NN	O
,	,	O
allow	VB	O
them	PRP	O
to	TO	O
fall	VB	O
off	RP	O
on	IN	O
their	PRP$	O
own	JJ	O
.	.	O

medications	NNS	O
:	:	O
resume	VB	O
your	PRP$	B-TREATMENT
home	NN	I-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

you	PRP	O
should	MD	O
take	VB	O
a	DT	B-TREATMENT
stool	NN	I-TREATMENT
softener	NN	I-TREATMENT
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
daily	RB	O
as	IN	O
needed	VBN	O
for	IN	O
constipation	NN	B-PROBLEM
.	.	O

you	PRP	O
will	MD	O
be	VB	O
given	VBN	O
pain	JJ	B-TREATMENT
medication	NN	I-TREATMENT
which	WDT	O
may	MD	O
make	VB	O
you	PRP	O
drowsy	VB	B-PROBLEM
.	.	O

no	DT	O
driving	VBG	O
while	IN	O
taking	VBG	O
pain	JJ	B-TREATMENT
medicine	NN	I-TREATMENT
.	.	O

you	PRP	O
will	MD	O
be	VB	O
contacted	VBN	O
by	IN	O
the	DT	O
gastrointestinal	JJ	O
doctors	NNS	O
pat	VBP	O
barrow	VB	O
the	DT	B-TREATMENT
removal	NN	I-TREATMENT
of	IN	O
your	PRP$	B-TREATMENT
biliary	JJ	I-TREATMENT
stent	NN	I-TREATMENT
in	IN	O
6	CD	O
weeks	NNS	O
.	.	O

ruptured	VBN	B-PROBLEM
aortic	JJ	I-PROBLEM
aneurism	NN	I-PROBLEM

ruptured	VBN	B-PROBLEM
parathyroid	JJ	I-PROBLEM
adenoma	NN	I-PROBLEM
.	.	O

she	PRP	O
arrived	VBD	O
intubated	JJ	B-TREATMENT
and	CC	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
despite	IN	O
concerns	NNS	O
of	IN	O
a	DT	B-PROBLEM
dissecting	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
arch	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

she	PRP	O
initially	RB	O
presented	VBD	O
to	TO	O
brottlake	VB	O
medical	JJ	O
center	NN	O
on	IN	O
9/15/00	CD	O
complaining	NN	O
of	IN	O
acute	JJ	B-PROBLEM
onset	NN	I-PROBLEM
dysphasia	NN	I-PROBLEM
to	TO	O
liquids	NNS	O
and	CC	O
solids	NNS	O
.	.	O

while	IN	O
she	PRP	O
was	VBD	O
in	IN	O
brottlake	JJ	O
medical	JJ	O
center	NN	O
,	,	O
she	PRP	O
developed	VBD	O
new	JJ	B-PROBLEM
onset	NN	I-PROBLEM
stridor	NN	I-PROBLEM
,	,	O
and	CC	O
an	DT	O
ent	NN	O
consult	NN	O
was	VBD	O
obtained	VBN	O
.	.	O

they	PRP	O
attempted	VBD	O
a	DT	B-TREATMENT
fiberoptic	JJ	I-TREATMENT
intubation	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
#	#	I-TREATMENT
6	CD	I-TREATMENT
endotracheal	JJ	I-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
found	VBD	O
a	DT	B-PROBLEM
5	CD	I-PROBLEM
mm	NN	I-PROBLEM
severely	RB	I-PROBLEM
compressed	VBD	I-PROBLEM
airway	RB	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
differential	JJ	I-PROBLEM
systolic	JJ	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
ecchymosis	NN	B-PROBLEM
on	IN	I-PROBLEM
her	PRP$	I-PROBLEM
anterior	JJ	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

given	VBN	O
these	DT	O
findings	NNS	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
ct	NN	I-TEST
scan	NN	I-TEST
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
retrotracheal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
that	WDT	O
appeared	VBD	O
to	TO	O
obliterate	VB	O
the	DT	O
esophagus	NN	O
.	.	O

this	DT	O
raised	VBD	O
concerns	NNS	O
for	IN	O
a	DT	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
verg	VB	O
medical	JJ	O
center	NN	O
emergently	RB	O
.	.	O

at	IN	O
the	DT	O
ingree	NN	O
and	CC	O
ot	NN	O
of	IN	O
weamanshy	JJ	O
medical	JJ	O
center	NN	O
,	,	O
she	PRP	O
underwent	VBD	O
an	DT	B-TEST
emergent	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
with	IN	O
iv	JJ	B-TEST
contrast	NN	I-TEST
.	.	O

this	DT	O
revealed	VBD	O
no	DT	O
extravasation	NN	B-PROBLEM
of	IN	I-PROBLEM
contrast	NN	I-PROBLEM
and	CC	O
no	DT	O
aortic	JJ	B-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
it	PRP	O
did	VBD	O
show	VB	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
mediastinal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
compressing	VBG	O
the	DT	O
trachea	NN	O
with	IN	O
a	DT	O
density	NN	O
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

severe	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
,	,	O
angina	NN	B-PROBLEM
,	,	O
gerd	NN	B-PROBLEM
,	,	O
peptic	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
billroth	DT	B-TREATMENT
ii	NN	I-TREATMENT
,	,	O
ovarian	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
tah-bso	NN	B-TREATMENT
in	IN	O
1987	CD	O
with	IN	O
a	DT	O
negative	JJ	O
second	JJ	O
look	NN	O
laparotomy	NN	O
in	IN	O
1988	CD	O
,	,	O
chronic	JJ	B-PROBLEM
anemia	NN	I-PROBLEM
,	,	O
chronic	JJ	B-PROBLEM
left	VBD	I-PROBLEM
ear	JJ	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

celexa	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.;	NN	O
lasix	VBD	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.;	NN	O
capoten	VBD	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.;	NN	O
pepcid	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.;	NN	O
cardizem	VBD	B-TREATMENT
180	CD	O
mg	NN	O
p.o.	NN	O
q.d.;	NN	O
xanax	VBD	B-TREATMENT
0.5	CD	O
mg	NN	O
tabs	NN	O
.	.	O

on	IN	O
transfer	NN	O
,	,	O
she	PRP	O
was	VBD	O
on	IN	O
her	PRP$	B-TREATMENT
preadmission	NN	I-TREATMENT
medications	NNS	I-TREATMENT
plus	CC	O
unasyn	JJ	B-TREATMENT
and	CC	O
tigan	JJ	B-TREATMENT
250	CD	O
mg	NN	O
p.o.	NN	O
q.6h.	NN	O
p.r.n.	NN	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
intubated	VBN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
98.6	CD	O
,	,	O
66	CD	O
.	.	O

right	JJ	B-TEST
arm	NN	I-TEST
was	VBD	O
180/80	CD	O
,	,	O
left	VBD	B-TEST
188/72	CD	O
,	,	O
and	CC	O
a-line	NN	B-TEST
was	VBD	O
151/61	CD	O
.	.	O

tidal	JJ	B-TREATMENT
volume	NN	I-TREATMENT
is	VBZ	O
700	CD	O
with	IN	O
a	DT	B-TREATMENT
rate	NN	I-TREATMENT
of	IN	O
10	CD	O
,	,	O
10	CD	O
of	IN	O
pressure	NN	B-TREATMENT
support	NN	I-TREATMENT
,	,	O
and	CC	O
10	CD	O
of	IN	O
peep	NN	B-TREATMENT
,	,	O
and	CC	O
100%	CD	B-TREATMENT
fio2	NN	I-TREATMENT
,	,	O
satting	VBG	O
100%	CD	O
.	.	O

she	PRP	O
was	VBD	O
sedated	VBN	B-TREATMENT
and	CC	O
spontaneously	RB	O
moving	VBG	O
all	DT	O
four	CD	O
extremities	NNS	O
.	.	O

edematous	JJ	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
bilateral	JJ	B-PROBLEM
crepitus	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
anterior	JJ	I-PROBLEM
neck	NN	I-PROBLEM
.	.	O

the	DT	O
superior	JJ	O
clavicular	JJ	O
area	NN	O
showed	VBD	O
no	DT	O
signs	NNS	O
of	IN	O
central	JJ	B-TREATMENT
line	NN	I-TREATMENT
access	NN	I-TREATMENT
attempts	NNS	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
3	CD	I-PROBLEM
cm	NN	I-PROBLEM
mobile	RB	I-PROBLEM
gelatinous	JJ	I-PROBLEM
well-circumscribed	JJ	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
supraclavicular	JJ	I-PROBLEM
region	NN	I-PROBLEM
.	.	O

her	PRP$	O
anterior	JJ	O
neck	NN	O
and	CC	O
chest	NN	O
had	VBD	O
a	DT	B-PROBLEM
1	CD	I-PROBLEM
cm	NN	I-PROBLEM
to	TO	I-PROBLEM
2	CD	I-PROBLEM
cm	JJ	I-PROBLEM
area	NN	I-PROBLEM
of	IN	I-PROBLEM
ecchymosis	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
bilateral	JJ	B-PROBLEM
expiratory	NN	I-PROBLEM
wheezes	NNS	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
nontender	NN	B-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
obese	JJ	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
midline	NN	I-PROBLEM
defect	NN	I-PROBLEM
consistent	NN	O
with	IN	O
a	DT	B-PROBLEM
ventral	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
a	DT	B-PROBLEM
smaller	JJR	I-PROBLEM
anterior	JJ	I-PROBLEM
defect	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	RBR	I-PROBLEM
quadrant	NN	I-PROBLEM
.	.	O

on	IN	O
the	DT	O
right	JJ	O
side	NN	O
,	,	O
2+	CD	B-TEST
femoral	JJ	I-TEST
,	,	O
popliteal	JJ	B-TEST
,	,	O
dp	NN	B-TEST
,	,	O
pt	NN	B-TEST
,	,	O
and	CC	O
radial	JJ	B-TEST
;	:	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
,	,	O
2+	CD	B-TEST
femoral	JJ	I-TEST
,	,	O
popliteal	JJ	B-TEST
,	,	O
dp	NN	B-TEST
,	,	O
pt	NN	B-TEST
,	,	O
and	CC	O
radial	NN	B-TEST
.	.	O

cbc	NN	B-TEST
was	VBD	O
8.7	CD	O
,	,	O
25.3	CD	O
,	,	O
and	CC	O
184	CD	O
.	.	O

coags	NNS	B-TEST
12.2	CD	O
,	,	O
24.8	CD	O
,	,	O
and	CC	O
1.0	CD	O
.	.	O

her	PRP$	B-TEST
gas	NN	I-TEST
was	VBD	O
7.47/40/332	CD	O
.	.	O

electrolytes	NNS	B-TEST
were	VBD	O
143	CD	O
,	,	O
3.4	CD	O
,	,	O
105	CD	O
,	,	O
28	CD	O
,	,	O
24	CD	O
,	,	O
3	CD	O
,	,	O
and	CC	O
131	CD	O
.	.	O

ekg	RB	B-TEST
showed	VBD	O
normal	JJ	O
sinus	NNS	O
rhythm	VBP	O
with	IN	O
left	JJ	B-PROBLEM
ventricular	JJ	I-PROBLEM
hypertrophy	NN	I-PROBLEM
and	CC	O
incomplete	JJ	B-PROBLEM
left	VBD	I-PROBLEM
bundle	JJ	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

ct	NN	B-TEST
scan	NN	I-TEST
showed	VBD	O
an	DT	B-PROBLEM
anterior	JJ	I-PROBLEM
mediastinal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
compressing	VBG	O
the	DT	O
trachea	NN	O
with	IN	O
air	NN	O
.	.	O

it	PRP	O
was	VBD	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
.	.	O

ms.	NN	O
shuffa	NN	O
underwent	VBD	O
an	DT	B-TEST
egd	NN	I-TEST
and	CC	O
flexible	JJ	B-TEST
bronchoscopy	NN	I-TEST
on	IN	O
9/16/00	CD	O
shortly	RB	O
after	IN	O
she	PRP	O
arrived	VBD	O
.	.	O

this	DT	O
showed	VBD	O
tracheal	JJ	B-PROBLEM
compressions	NNS	I-PROBLEM
but	CC	O
no	DT	O
other	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
that	WDT	O
were	VBD	O
obvious	JJ	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

she	PRP	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
remained	VBD	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

the	DT	O
differential	JJ	O
diagnoses	NNS	O
at	IN	O
this	DT	O
point	NN	O
consisted	VBD	O
of	IN	O
hematoma	NN	B-PROBLEM
vs.	FW	O
neoplasm	NN	B-PROBLEM
vs.	FW	O
an	DT	B-PROBLEM
abscess	NN	I-PROBLEM
vs.	FW	O
a	DT	B-PROBLEM
thyroid	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

on	IN	O
9/22/00	CD	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
cervical	JJ	I-TEST
mediastinoscopy	NN	I-TEST
.	.	O

a	DT	B-TEST
biopsy	NN	I-TEST
of	IN	O
this	DT	B-PROBLEM
mass	NN	I-PROBLEM
was	VBD	O
consistent	JJ	O
with	IN	O
hematoma	NN	B-PROBLEM
.	.	O

the	DT	O
operative	JJ	O
report	NN	O
shows	VBZ	O
that	IN	O
there	EX	O
was	VBD	O
an	DT	B-PROBLEM
abnormal	JJ	I-PROBLEM
area	NN	I-PROBLEM
below	IN	I-PROBLEM
the	DT	I-PROBLEM
trachea	NN	I-PROBLEM
to	TO	O
the	DT	O
left	NN	O
which	WDT	O
represented	VBD	O
a	DT	O
cavity	NN	O
between	IN	O
the	DT	O
esophagus	NN	O
,	,	O
trachea	NN	O
,	,	O
aorta	NN	O
,	,	O
and	CC	O
spine	NN	O
that	WDT	O
was	VBD	O
full	JJ	O
of	IN	O
clot	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
.	.	O

over	IN	O
the	DT	O
next	JJ	O
several	JJ	O
days	NNS	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
on	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-PROBLEM
elevated	JJ	I-PROBLEM
calcium	NN	I-PROBLEM
level	NN	I-PROBLEM
that	WDT	O
raised	VBD	O
the	DT	O
suspicion	NN	O
that	IN	O
this	DT	B-PROBLEM
mass	NN	I-PROBLEM
could	MD	O
be	VB	O
a	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
coming	VBG	O
from	IN	O
a	DT	B-PROBLEM
ruptured	VBN	I-PROBLEM
parathyroid	NN	I-PROBLEM
adenoma	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
ionized	JJ	I-TEST
calcium	NN	I-TEST
was	VBD	O
elevated	VBN	B-PROBLEM
as	IN	O
was	VBD	O
the	DT	B-TEST
parathormone	NN	I-TEST
level	NN	I-TEST
.	.	O

given	VBN	O
these	DT	O
findings	NNS	O
,	,	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
sestamibi	JJ	I-TEST
scan	NN	I-TEST
.	.	O

the	DT	B-TEST
sestamibi	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
findings	NNS	O
that	WDT	O
were	VBD	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
parathyroid	JJ	I-PROBLEM
adenoma	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
of	IN	O
the	DT	O
thyroid	NN	O
.	.	O

at	IN	O
this	DT	O
time	NN	O
,	,	O
it	PRP	O
was	VBD	O
believed	VBN	O
that	IN	O
her	PRP$	B-PROBLEM
clot	NN	I-PROBLEM
was	VBD	O
due	JJ	O
to	TO	O
a	DT	B-PROBLEM
rupture	NN	I-PROBLEM
of	IN	O
this	DT	B-PROBLEM
parathyroid	JJ	I-PROBLEM
adenoma	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
a	DT	B-TEST
parathyroid	JJ	I-TEST
exploration	NN	I-TEST
with	IN	O
resection	NN	B-TREATMENT
of	IN	O
a	DT	B-PROBLEM
ruptured	JJ	I-PROBLEM
ectopic	NN	I-PROBLEM
right	RB	I-PROBLEM
upper	JJ	I-PROBLEM
parathyroid	NN	I-PROBLEM
adenoma	NN	I-PROBLEM
,	,	O
a	DT	B-TEST
biopsy	NN	I-TEST
of	IN	I-TEST
a	DT	I-TEST
normal	JJ	I-TEST
left	NN	I-TEST
and	CC	I-TEST
right	JJ	I-TEST
lower	JJR	I-TEST
parathyroids	NNS	I-TEST
,	,	O
resection	NN	B-TREATMENT
of	IN	I-TREATMENT
a	DT	I-TREATMENT
left	JJ	I-TREATMENT
upper	JJ	I-TREATMENT
parathyroid	NN	I-TREATMENT
,	,	O
and	CC	O
tracheostomy	NN	B-TREATMENT
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
well	RB	O
and	CC	O
was	VBD	O
transferred	VBN	O
back	RB	O
to	TO	O
the	DT	O
surgical	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
with	IN	O
her	PRP$	B-TREATMENT
new	JJ	I-TREATMENT
tracheostomy	NN	I-TREATMENT
working	VBG	O
well	RB	O
.	.	O

her	PRP$	O
postoperative	JJ	O
course	NN	O
was	VBD	O
complicated	VBN	O
by	IN	O
serosanguineous	JJ	B-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
.	.	O

this	DT	O
required	VBD	O
a	DT	B-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
continued	VBD	O
to	TO	O
drop	VB	O
over	IN	O
the	DT	O
next	JJ	O
couple	NN	O
of	IN	O
days	NNS	O
despite	IN	O
normal	JJ	O
platelet	NN	O
count	NN	O
,	,	O
normal	JJ	O
coags	NNS	O
,	,	O
and	CC	O
no	DT	O
obvious	JJ	O
source	NN	O
of	IN	O
bleeding	NN	B-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
believed	VBN	O
that	IN	O
she	PRP	O
was	VBD	O
continuing	VBG	O
to	TO	O
bleed	VB	B-PROBLEM
in	IN	I-PROBLEM
her	PRP$	I-PROBLEM
chest	NN	I-PROBLEM
.	.	O

she	PRP	O
underwent	VBD	O
an	DT	B-TEST
extensive	JJ	I-TEST
workup	NN	I-TEST
by	IN	O
hematology	NN	O
that	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
bleeding	NN	I-PROBLEM
diatheses	NNS	I-PROBLEM
of	IN	O
unknown	JJ	O
etiology	NN	O
.	.	O

it	PRP	O
turns	VBZ	O
out	RP	O
that	IN	O
several	JJ	O
people	NNS	O
in	IN	O
her	PRP$	O
family	NN	O
have	VBP	O
a	DT	B-PROBLEM
similar	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
diathesis	NN	I-PROBLEM
of	IN	O
unknown	JJ	O
etiology	NN	O
.	.	O

the	DT	O
patient	NN	O
became	VBD	O
intermittently	RB	B-PROBLEM
agitated	VBN	I-PROBLEM
.	.	O

we	PRP	O
have	VBP	O
been	VBN	O
giving	VBG	O
her	PRP$	B-TREATMENT
haldol	NN	I-TREATMENT
at	IN	O
bedtime	NN	O
as	RB	O
well	RB	O
as	IN	O
ativan	NN	B-TREATMENT
p.r.n.	NN	O
throughout	IN	O
the	DT	O
day	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
has	VBZ	O
been	VBN	O
ranging	VBG	O
from	IN	O
approximately	RB	O
140	CD	O
to	TO	O
160	CD	O
systolic	NN	O
.	.	O

this	DT	O
is	VBZ	O
on	IN	O
a	DT	O
current	JJ	O
regimen	NN	O
of	IN	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
t.i.d.	NN	O
as	RB	O
well	RB	O
as	IN	O
diltiazem	NN	B-TREATMENT
60	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
t.i.d.	NN	O
,	,	O
and	CC	O
lisinopril	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
q.d.	IN	O
she	PRP	O
occasionally	RB	O
gets	VBZ	O
hypertensive	JJ	B-PROBLEM
when	WRB	O
she	PRP	O
is	VBZ	O
agitated	VBN	B-PROBLEM
.	.	O

for	IN	O
this	DT	O
,	,	O
we	PRP	O
have	VBP	O
given	VBN	O
her	PRP$	O
10	CD	O
mg	NN	O
of	IN	O
hydralazine	NN	B-TREATMENT
.	.	O

her	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
responds	VBZ	O
well	RB	O
to	TO	O
this	DT	O
.	.	O

the	DT	O
patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
femoral	JJ	I-PROBLEM
artery	NN	I-PROBLEM
pseudoaneurysm	NN	I-PROBLEM
after	IN	O
placement	NN	B-TREATMENT
of	IN	I-TREATMENT
a	DT	I-TREATMENT
greenfield	NN	I-TREATMENT
filter	NN	I-TREATMENT
.	.	O

the	DT	B-PROBLEM
aneurysm	NN	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
is	VBZ	O
approximately	RB	O
2.5	CD	O
cm	NNS	O
.	.	O

they	PRP	O
elected	VBD	O
not	RB	O
to	TO	O
inject	VB	O
it	PRP	O
with	IN	O
thrombin	NN	B-TREATMENT
.	.	O

they	PRP	O
asked	VBD	O
that	IN	O
the	DT	O
patient	JJ	O
follow-up	NN	O
with	IN	O
dr.	JJ	O
ear	NN	O
in	IN	O
approximately	RB	O
three	CD	O
to	TO	O
four	CD	O
weeks	NNS	O
so	RB	O
that	IN	O
this	DT	B-PROBLEM
aneurysm	NN	I-PROBLEM
can	MD	O
be	VB	O
assessed	VBN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
remained	VBD	O
on	IN	O
cpap	NN	B-TREATMENT
with	IN	O
a	DT	B-TREATMENT
peep	NN	I-TREATMENT
of	IN	O
7.5	CD	O
and	CC	O
a	DT	B-TREATMENT
pressure	NN	I-TREATMENT
support	NN	I-TREATMENT
of	IN	O
9	CD	O
.	.	O

she	PRP	O
seems	VBZ	O
to	TO	O
be	VB	O
tolerating	VBG	O
this	DT	O
well	NN	O
as	IN	O
she	PRP	O
has	VBZ	O
an	DT	B-TEST
o2	JJ	I-TEST
sat	NN	I-TEST
of	IN	O
100%	CD	O
on	IN	O
40%	CD	B-TREATMENT
fio2	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
shows	VBZ	O
a	DT	B-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
that	WDT	O
had	VBD	O
greatly	RB	O
improved	VBN	O
in	IN	O
the	DT	O
last	JJ	O
few	JJ	O
days	NNS	O
.	.	O

her	PRP$	B-TREATMENT
tracheostomy	NN	I-TREATMENT
is	VBZ	O
functioning	VBG	O
well	RB	O
,	,	O
and	CC	O
we	PRP	O
have	VBP	O
had	VBD	O
no	DT	O
problems	NNS	B-PROBLEM
with	IN	O
it	PRP	O
.	.	O

we	PRP	O
had	VBD	O
her	PRP	O
down	RP	O
to	TO	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
pressure	NN	I-TREATMENT
support	NN	I-TREATMENT
of	IN	O
7	CD	O
in	IN	O
the	DT	O
last	JJ	O
week	NN	O
.	.	O

with	IN	O
the	DT	B-TREATMENT
pressure	NN	I-TREATMENT
support	NN	I-TREATMENT
at	IN	O
7	CD	O
,	,	O
she	PRP	O
became	VBD	O
tachypneic	JJ	B-PROBLEM
and	CC	O
had	VBD	O
to	TO	O
be	VB	O
brought	VBN	O
back	RB	O
up	IN	O
to	TO	O
10	CD	O
.	.	O

her	PRP$	B-TEST
oxygen	NN	I-TEST
saturation	NN	I-TEST
has	VBZ	O
always	RB	O
been	VBN	O
good	JJ	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
getting	VBG	O
tube	JJ	B-TREATMENT
feeds	NNS	I-TREATMENT
via	IN	O
her	PRP$	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
of	IN	O
full	JJ	B-TREATMENT
strength	NN	I-TREATMENT
jevity	NN	I-TREATMENT
of	IN	O
75	CD	O
cc	NNS	O
per	IN	O
hour	NN	O
.	.	O

last	JJ	O
week	NN	O
,	,	O
she	PRP	O
had	VBD	O
copious	JJ	B-PROBLEM
amounts	NNS	I-PROBLEM
of	IN	I-PROBLEM
stool	NN	I-PROBLEM
in	IN	O
the	DT	O
range	NN	O
of	IN	O
500	CD	O
cc	NN	O
to	TO	O
1000	CD	O
cc	NN	O
of	IN	O
liquid	JJ	O
stool	NN	O
per	IN	O
day	NN	O
.	.	O

stool	NN	B-TEST
cultures	NNS	I-TEST
have	VBP	O
been	VBN	O
sent	VBN	O
numerous	JJ	O
times	NNS	O
as	RB	O
well	RB	O
as	IN	O
analysis	NN	B-TEST
for	IN	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
toxin	NN	I-PROBLEM
.	.	O

we	PRP	O
believe	VBP	O
the	DT	O
this	DT	O
was	VBD	O
an	DT	B-PROBLEM
osmotic	JJ	I-PROBLEM
diarrhea	NN	I-PROBLEM
.	.	O

since	IN	O
her	PRP$	B-TREATMENT
tube	NN	I-TREATMENT
feeds	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
changed	VBN	O
from	IN	O
full	JJ	B-TREATMENT
strength	NN	I-TREATMENT
nephro	NN	I-TREATMENT
to	TO	O
jevity	NN	B-TREATMENT
,	,	O
her	PRP$	B-PROBLEM
diarrhea	NN	I-PROBLEM
has	VBZ	O
resolved	VBN	O
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
taking	VBG	O
zantac	NN	B-TREATMENT
,	,	O
and	CC	O
the	DT	B-TEST
ph	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
ng	JJ	I-TEST
tube	NN	I-TEST
residuals	NNS	I-TEST
have	VBP	O
been	VBN	O
in	IN	O
the	DT	O
5	CD	O
to	TO	O
8	CD	O
range	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
hypernatremia	VBN	B-PROBLEM
.	.	O

we	PRP	O
believe	VBP	O
her	PRP	O
to	TO	O
still	RB	O
be	VB	O
total	JJ	B-PROBLEM
body	NN	I-PROBLEM
overloaded	VBD	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
last	JJ	O
several	JJ	O
days	NNS	O
,	,	O
we	PRP	O
have	VBP	O
been	VBN	O
giving	VBG	O
her	PRP$	O
approximately	RB	O
500	CD	O
cc	NNS	O
to	TO	O
1000	CD	O
cc	NN	O
of	IN	O
free	JJ	B-TREATMENT
water	NN	I-TREATMENT
through	IN	O
her	PRP$	B-TREATMENT
ng	JJ	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

we	PRP	O
also	RB	O
have	VBP	O
been	VBN	O
diuresing	VBG	O
her	PRP$	O
with	IN	O
bumex	NN	B-TREATMENT
.	.	O

this	DT	O
seems	VBZ	O
to	TO	O
trend	NN	O
her	PRP$	B-TEST
sodium	NN	I-TEST
down	RP	O
.	.	O

her	PRP$	B-TEST
bun	NN	I-TEST
and	CC	O
creatinine	NN	B-TEST
have	VBP	O
been	VBN	O
normal	JJ	O
,	,	O
and	CC	O
she	PRP	O
has	VBZ	O
always	RB	O
made	VBN	O
good	JJ	O
urine	NN	O
.	.	O

as	IN	O
stated	VBN	O
before	IN	O
,	,	O
the	DT	O
patient	NN	O
continued	VBD	O
to	TO	O
ooze	VB	O
into	IN	O
her	PRP$	O
pleural	JJ	O
space	NN	O
well	RB	O
after	IN	O
her	PRP$	B-TREATMENT
definitive	JJ	I-TREATMENT
operation	NN	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TEST
extensive	JJ	I-TEST
workup	NN	I-TEST
by	IN	O
hematology	NN	O
which	WDT	O
revealed	VBD	O
a	DT	B-PROBLEM
bleeding	JJ	I-PROBLEM
diathesis	NN	I-PROBLEM
of	IN	O
unknown	JJ	O
origin	NN	O
.	.	O

before	IN	O
we	PRP	O
removed	VBD	O
her	PRP	B-TREATMENT
chest	JJS	I-TREATMENT
tube	NN	I-TREATMENT
,	,	O
we	PRP	O
had	VBD	O
to	TO	O
give	VB	O
her	PRP$	B-TREATMENT
platelets	NNS	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
problems	NNS	B-PROBLEM
with	IN	O
this	DT	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
is	VBZ	O
stable	JJ	O
in	IN	O
the	DT	O
28	CD	O
to	TO	O
33	CD	O
range	NN	O
.	.	O

i	NN	O
stress	NN	O
that	IN	O
she	PRP	O
cannot	VBD	O
be	VB	O
anticoagulated	VBN	B-TREATMENT
.	.	O

we	PRP	O
have	VBP	O
given	VBN	O
her	PRP$	B-TREATMENT
lovenox	NN	I-TREATMENT
in	IN	O
the	DT	O
past	NN	O
,	,	O
and	CC	O
she	PRP	O
continues	VBZ	O
to	TO	O
bleed	VB	O
.	.	O

therefore	RB	O
,	,	O
she	PRP	O
is	VBZ	O
on	IN	O
no	DT	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

she	PRP	O
does	VBZ	O
have	VB	O
a	DT	B-PROBLEM
left	JJ	I-PROBLEM
iliac	JJ	I-PROBLEM
deep	JJ	I-PROBLEM
vein	NN	I-PROBLEM
thrombosis	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
greenfield	NN	I-TREATMENT
filter	NN	I-TREATMENT
in	IN	O
place	NN	O
,	,	O
and	CC	O
this	DT	O
is	VBZ	O
her	PRP$	O
only	JJ	O
dvt	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
growing	VBG	O
enterobacter	RBR	B-PROBLEM
cloacae	NN	I-PROBLEM
that	WDT	O
is	VBZ	O
sensitive	JJ	O
only	RB	O
to	TO	O
macrodantin	VB	B-TREATMENT
from	IN	O
her	PRP$	B-TEST
urine	JJ	I-TEST
cultures	NNS	I-TEST
.	.	O

interestingly	RB	O
enough	RB	O
,	,	O
she	PRP	O
also	RB	O
has	VBZ	O
enterobacter	NN	B-PROBLEM
cloacae	NN	I-PROBLEM
growing	VBG	O
out	IN	O
of	IN	O
her	PRP$	O
sputum	NN	O
.	.	O

this	DT	O
is	VBZ	O
also	RB	O
sensitive	JJ	O
only	RB	O
to	TO	O
macrodantin	VB	B-TREATMENT
.	.	O

we	PRP	O
do	VBP	O
not	RB	O
believe	VB	O
that	IN	O
she	PRP	O
has	VBZ	O
any	DT	B-PROBLEM
respiratory	JJ	I-PROBLEM
process	NN	I-PROBLEM
going	VBG	O
on	IN	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

she	PRP	O
is	VBZ	O
just	RB	O
begun	VBN	O
on	IN	O
macrodantin	NN	B-TREATMENT
at	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
and	CC	O
should	MD	O
continue	VB	O
100	CD	O
mg	NNS	O
per	IN	O
ng	NN	B-TREATMENT
tube	NN	I-TREATMENT
q.i.d.	NN	O
for	IN	O
a	DT	O
ten	JJ	O
day	NN	O
course	NN	O
.	.	O

her	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
was	VBD	O
changed	VBN	O
the	DT	O
day	NN	O
before	IN	O
discharge	NN	O
.	.	O

8.	CD	O
tubes	NNS	B-TREATMENT
,	,	O
lines	NNS	B-TREATMENT
,	,	O
and	CC	O
drains	NNS	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-TREATMENT
tracheostomy	NN	I-TREATMENT
,	,	O
ng	JJ	B-TREATMENT
tube	NN	I-TREATMENT
,	,	O
and	CC	O
a	DT	B-TREATMENT
foley	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
central	JJ	I-TREATMENT
line	NN	I-TREATMENT
,	,	O
which	WDT	O
was	VBD	O
left	VBN	B-TREATMENT
subclavian	JJ	I-TREATMENT
quad	NN	I-TREATMENT
lumen	NNS	I-TREATMENT
,	,	O
was	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

albuterol	NN	B-TREATMENT
nebulizers	NNS	I-TREATMENT
2.5	CD	O
mg	NN	O
q.4h.	NN	O
and	CC	O
atrovent	NN	B-TREATMENT
nebulizers	NNS	I-TREATMENT
0.5	CD	O
mg	NN	O
q.4h.	NN	O
,	,	O
please	VB	O
alternate	VB	O
albuterol	NN	B-TREATMENT
and	CC	O
atrovent	NN	B-TREATMENT
;	:	O
rocaltrol	CC	B-TREATMENT
0.25	CD	O
mcg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
q.d.;	NN	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
1250	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
q.i.d.;	NN	O
vitamin	NN	B-TREATMENT
b12	NN	I-TREATMENT
1000	CD	O
mcg	NN	O
im	NN	O
q.	JJ	O
month	NN	O
,	,	O
next	JJ	O
dose	NN	O
is	VBZ	O
due	JJ	O
nov	RB	O
18	CD	O
;	:	O
diltiazem	CC	B-TREATMENT
60	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
t.i.d.;	VBP	O
ferrous	JJ	B-TREATMENT
sulfate	NN	I-TREATMENT
300	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
t.i.d.;	NN	O
haldol	NN	B-TREATMENT
5	CD	O
mg	NN	O
iv	NN	O
q.h.s.;	NN	O
hydralazine	NN	B-TREATMENT
10	CD	O
mg	NN	O
iv	NN	O
q.6h.	NN	O
p.r.n.	JJ	O
hypertension	NN	B-PROBLEM
;	:	O
lisinopril	CC	B-TREATMENT
10	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
q.d.;	NN	O
ativan	VBD	B-TREATMENT
1	CD	O
mg	NNS	O
per	IN	O
ng	NN	B-TREATMENT
tube	NN	I-TREATMENT
q.h.s.;	NN	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
t.i.d.;	NN	O
zantac	NN	B-TREATMENT
150	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
b.i.d.;	NN	O
multivitamin	VBD	B-TREATMENT
10	CD	O
ml	NNS	O
per	IN	O
ng	NN	B-TREATMENT
tube	NN	I-TREATMENT
q.d.;	VBD	O
macrodantin	$	B-TREATMENT
100	CD	O
mg	NN	O
per	IN	O
ng	FW	B-TREATMENT
tube	NN	I-TREATMENT
q.i.d.	NN	O
x	$	O
10	CD	O
days	NNS	O
beginning	VBG	O
on	IN	O
11/3/00	CD	O
.	.	O

stable	JJ	O
,	,	O
with	IN	O
active	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
being	VBG	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
and	CC	O
bleeding	VBG	B-PROBLEM
diathesis	NN	I-PROBLEM
.	.	O

on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
,	,	O
sodium	NN	B-TEST
145	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
109	CD	O
,	,	O
bicarb	NN	B-TEST
31	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
bun	NN	B-TEST
43	CD	O
,	,	O
glucose	VBD	B-TEST
116	CD	O
.	.	O

cbc	NN	B-TEST
14.9	CD	O
,	,	O
29.2	CD	O
(	(	O
which	WDT	O
is	VBZ	O
stable	JJ	O
)	)	O
,	,	O
and	CC	O
398	CD	O
.	.	O

pt	NN	B-TEST
12	CD	O
,	,	O
ptt	NN	B-TEST
27	CD	O
,	,	O
and	CC	O
inr	RB	B-TEST
1.0	CD	O
.	.	O

magnesium	NN	B-TEST
of	IN	O
1.9	CD	O
.	.	O

calcium	NN	B-TEST
8.1	CD	O
.	.	O

discharge	NN	O
summary	JJ	O
addendum	NN	O
:	:	O
the	DT	O
patient	NN	O
during	IN	O
her	PRP$	O
admission	NN	O
from	IN	O
2015-01-19	JJ	O
to	TO	O
2015-01-22	JJ	O
during	IN	O
that	DT	O
admission	NN	O
she	PRP	O
had	VBD	O
an	DT	B-TEST
echocardiogram	NN	I-TEST
which	WDT	O
revealed	VBD	O
essentially	RB	O
an	DT	B-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
40%	CD	O
with	IN	O
a	DT	B-PROBLEM
patent	NN	I-PROBLEM
foramen	NNS	I-PROBLEM
ovale	VBP	I-PROBLEM
mildly	RB	B-PROBLEM
dilated	VBN	I-PROBLEM
left	JJ	I-PROBLEM
atrium	NN	I-PROBLEM
.	.	O

it	PRP	O
also	RB	O
showed	VBD	O
intraseptal	JJ	B-PROBLEM
and	CC	I-PROBLEM
inferior	JJ	I-PROBLEM
akinesis	NN	I-PROBLEM
.	.	O

additionally	RB	O
because	IN	O
of	IN	O
her	PRP$	O
history	NN	O
of	IN	O
contrast	NN	B-PROBLEM
allergy	NN	I-PROBLEM
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
solu-medrol	JJ	B-TREATMENT
40	CD	O
milligrams	NNS	O
iv	JJ	O
prior	RB	O
to	TO	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
have	VB	O
any	DT	B-PROBLEM
untoward	JJ	I-PROBLEM
affects	NNS	I-PROBLEM
or	CC	O
allergic	JJ	B-PROBLEM
reactions	NNS	I-PROBLEM
to	TO	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
68	CD	O
year	NN	O
old	JJ	O
male	NN	O
status	NN	O
post	NN	O
three	CD	O
and	CC	O
a	DT	O
half	JJ	O
cycles	NNS	O
of	IN	O
adjuvant	JJ	B-TREATMENT
eap	JJ	I-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	O
good	JJ	O
response	NN	O
to	TO	O
preoperative	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
negative	JJ	O
nodes	NNS	O
,	,	O
and	CC	O
is	VBZ	O
admitted	VBN	O
for	IN	O
the	DT	O
final	JJ	O
portion	NN	O
of	IN	O
his	PRP$	B-TREATMENT
postoperative	JJ	I-TREATMENT
cycles	NNS	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
chemotherapy	NN	I-TREATMENT
the	DT	O
week	NN	O
before	IN	O
was	VBD	O
decreased	VBN	O
because	IN	O
the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
dropped	VBD	O
to	TO	O
2.8	CD	O
.	.	O

in	IN	O
the	DT	O
interim	NN	O
,	,	O
the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
rose	VBD	O
again	RB	O
to	TO	O
4.2	CD	O
with	IN	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
30.5	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
196	CD	O
thousand	NN	O
.	.	O

on	IN	O
physical	JJ	B-TEST
examination	NN	I-TEST
on	IN	O
admission	NN	O
,	,	O
the	DT	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
146/80	CD	O
,	,	O
weight	VBD	B-TEST
146	CD	O
,	,	O
temperature	NN	B-TEST
98.6	CD	O
,	,	O
and	CC	O
pulse	NN	B-TEST
of	IN	O
92	CD	O
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
examination	NN	I-TEST
demonstrated	VBD	O
single	JJ	O
s1	NN	O
,	,	O
s2	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
abdominal	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	B-TEST
neurological	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
nonfocal	JJ	O
.	.	O

the	DT	B-TEST
creatinine	NN	I-TEST
was	VBD	O
1.3	CD	O
and	CC	O
dropping	VBG	O
to	TO	O
1.1	CD	O
.	.	O

the	DT	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
0.2	CD	O
,	,	O
sgot	VBD	B-TEST
20	CD	O
,	,	O
magnesium	NN	B-TEST
of	IN	O
1.4	CD	O
.	.	O

the	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
4.0	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
190	CD	O
,	,	O
with	IN	O
62%	CD	O
polys	NNS	B-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
adriamycin	JJ	B-TREATMENT
25	CD	O
mg	NN	O
,	,	O
cis-platinum	JJ	B-TREATMENT
40	CD	O
mg	NN	O
,	,	O
preceded	VBN	O
by	IN	O
mannitol	NN	B-TREATMENT
12.5	CD	O
grams	NNS	O
intravenous	JJ	O
bolus	NN	O
,	,	O
and	CC	O
zofran	VBD	B-TREATMENT
11	CD	O
mg	NNS	O
on	IN	O
two	CD	O
occasions	NNS	O
given	VBN	O
as	IN	O
an	DT	B-TREATMENT
antiemetic	JJ	I-TREATMENT
.	.	O

the	DT	B-TREATMENT
chemotherapy	NN	I-TREATMENT
was	VBD	O
well	RB	O
tolerated	VBN	O
.	.	O

1.	CD	O
intravenous	JJ	B-TREATMENT
chemotherapy	NN	I-TREATMENT
,	,	O

2.	CD	O
adenocarcinoma	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
esophagus	NN	I-PROBLEM
,	,	O

3.	CD	O
mild	JJ	B-PROBLEM
hypomagnesemia	NN	I-PROBLEM
.	.	O

intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
chemotherapy	NN	I-TREATMENT
.	.	O

slow-mag	JJ	B-TREATMENT
2	CD	O
tablets	NNS	O
po	JJ	O
bid	NN	O
,	,	O
ativan	VBZ	B-TREATMENT
1	CD	O
mg	NN	O
sublingually	RB	O
q4h	JJ	O
prn	NN	O
nausea	NN	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
5235	CD	O
-	:	O
gram	NN	O
full-term	JJ	O
male	JJ	O
infant	NN	O
of	IN	O
a	DT	O
diabetic	JJ	O
mother	NN	O
born	VBN	O
by	IN	O
repeat	NN	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
to	TO	O
a	DT	O
29-year-old	JJ	O
gravida	NN	O
1	CD	O
,	,	O
para	NN	O
2	CD	O
,	,	O
woman	NN	O
.	.	O

prenatal	JJ	B-TEST
screens	NNS	I-TEST
benign	NN	O
.	.	O

group	NN	B-TEST
b	VBD	I-TEST
strep	JJ	I-TEST
status	NN	I-TEST
negative	JJ	O
.	.	O

pregnancy	NN	O
complicated	VBN	O
by	IN	O
insulin-dependent	JJ	B-PROBLEM
gestational	JJ	I-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

apgar	NN	B-TEST
scores	NNS	I-TEST
were	VBD	O
8	CD	O
at	IN	O
1	CD	O
minute	NN	O
and	CC	O
9	CD	O
at	IN	O
5	CD	O
minutes	NNS	O
.	.	O

the	DT	O
infant	NN	O
admitted	VBD	O
to	TO	O
the	DT	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
a	DT	B-TEST
dextrose	JJ	I-TEST
stick	NN	I-TEST
of	IN	O
20	CD	O
in	IN	O
the	DT	O
delivery	NN	O
room	NN	O
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
was	VBD	O
5235	CD	O
grams	NNS	O
,	,	O
length	NN	B-TEST
was	VBD	O
56	CD	O
cm	NN	O
,	,	O
and	CC	O
head	NN	B-TEST
circumference	NN	I-TEST
was	VBD	O
37.5	CD	O
cm	NN	O
.	.	O

bilateral	JJ	B-TEST
breath	NN	I-TEST
sounds	NNS	I-TEST
were	VBD	O
clear	JJ	O
and	CC	O
equal	JJ	O
.	.	O

no	DT	O
grunting	NN	B-PROBLEM
,	,	O
flaring	NN	B-PROBLEM
,	,	O
or	CC	O
retracting	VBG	B-PROBLEM
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
and	CC	O
nondistended	JJ	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
remained	VBN	O
on	IN	O
room	NN	O
air	NN	O
throughout	IN	O
his	PRP$	O
hospitalization	NN	O
with	IN	O
oxygen	JJ	B-TEST
saturations	NNS	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
95	CD	O
percent	NN	O
.	.	O

respiratory	NN	B-TEST
rates	NNS	I-TEST
have	VBP	O
been	VBN	O
40	CD	O
s	NN	O
to	TO	O
60	CD	O
s.	NN	O

the	DT	O
infant	NN	O
has	VBZ	O
had	VBN	O
two	CD	B-PROBLEM
spontaneous	JJ	I-PROBLEM
desaturations	NNS	I-PROBLEM
which	WDT	O
quickly	RB	O
self-resolved	VBD	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
one	CD	O
.	.	O

no	DT	O
apnea	NN	B-PROBLEM
or	CC	O
bradycardia	NN	B-PROBLEM
.	.	O

the	DT	O
infant	NN	O
has	VBZ	O
remained	VBN	O
hemodynamically	RB	O
stable	JJ	O
with	IN	O
heart	NN	B-TEST
rates	NNS	I-TEST
in	IN	O
the	DT	O
120	CD	O
s	NN	O
to	TO	O
140	CD	O
s	NNS	O
and	CC	O
mean	VB	B-TEST
blood	NN	I-TEST
pressures	NNS	I-TEST
of	IN	O
57	CD	O
to	TO	O
60	CD	O
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neonatal	JJ	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
treatment	NN	B-TREATMENT
of	IN	O
hypoglycemia	NN	B-PROBLEM
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
of	IN	O
enfamil	JJ	B-TREATMENT
20	CD	I-TREATMENT
calories	NNS	I-TREATMENT
per	IN	I-TREATMENT
ounce	NN	I-TREATMENT
by	IN	O
mouth	NN	O
ad	NN	O
lib	NN	O
and	CC	O
maintained	VBD	O
glucoses	NNS	B-TEST
in	IN	O
the	DT	O
middle	NN	O
to	TO	O
high	VB	O
40	CD	O
s	NNS	O
taking	VBG	O
by	IN	B-TREATMENT
mouth	JJ	I-TREATMENT
feedings	NNS	I-TREATMENT
every	DT	O
two	CD	O
to	TO	O
three	CD	O
hours	NNS	O
by	IN	O
mouth	NN	O
ad	NN	O
lib	NN	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
one	CD	O
,	,	O
the	DT	O
infant	NN	O
had	VBD	O
a	DT	B-TEST
dextrose	JJ	I-TEST
stick	NN	I-TEST
of	IN	O
34	CD	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
an	DT	B-TREATMENT
intravenous	JJ	I-TREATMENT
of	IN	O
d-10-w	NN	B-TREATMENT
was	VBD	O
started	VBN	O
at	IN	O
80	CD	O
cc	NN	O
/	NNP	O
kilogram	FW	O
per	IN	O
day	NN	O
.	.	O

on	IN	O
day	NN	O
of	IN	O
life	NN	O
two	CD	O
,	,	O
the	DT	O
infant	NN	O
began	VBD	O
to	TO	O
wean	VB	O
off	RP	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
,	,	O
and	CC	O
this	DT	O
was	VBD	O
completed	VBN	O
by	IN	O
day	NN	O
of	IN	O
life	NN	O
four	CD	O
.	.	O

calories	NNS	O
were	VBD	O
increased	VBN	O
to	TO	O
similac	VB	B-TREATMENT
24	CD	I-TREATMENT
calories	NNS	I-TREATMENT
per	IN	I-TREATMENT
ounce	NN	I-TREATMENT
.	.	O

before	IN	O
discharge	NN	O
to	TO	O
the	DT	O
newborn	JJ	O
nursery	NN	O
,	,	O
the	DT	O
infant	NN	O
was	VBD	O
taking	VBG	O
similac	JJ	B-TREATMENT
22	CD	I-TREATMENT
calories	NNS	I-TREATMENT
per	IN	I-TREATMENT
ounce	NN	I-TREATMENT
by	IN	O
mouth	NN	O
ad	NN	O
lib	NN	O
and	CC	O
maintaining	VBG	O
dextrose	JJ	B-TEST
sticks	NNS	I-TEST
in	IN	O
the	DT	O
60	CD	O
s.	NN	O

weight	NN	B-TEST
on	IN	O
discharge	NN	O
was	VBD	O
5200	CD	O
grams	NNS	O
.	.	O

a	DT	B-TEST
hearing	NN	I-TEST
screen	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	B-TEST
auditory	NN	I-TEST
brain	NN	I-TEST
stem	NN	I-TEST
responses	NNS	I-TEST
and	CC	O
the	DT	O
infant	NN	O
passed	VBN	O
on	IN	O
both	DT	O
ears	NNS	O
.	.	O

similac	NN	B-TREATMENT
22	CD	I-TREATMENT
calories	NNS	I-TREATMENT
per	IN	I-TREATMENT
ounce	NN	I-TREATMENT
by	IN	O
mouth	NN	O
ad	NN	O
lib	NN	O
with	IN	O
a	DT	O
goal	NN	O
of	IN	O
decreasing	VBG	O
to	TO	O
20	CD	B-TREATMENT
calories	NNS	I-TREATMENT
per	IN	I-TREATMENT
ounce	NN	I-TREATMENT
for	IN	O
dextrose	JJ	B-TEST
sticks	NNS	I-TEST
of	IN	O
greater	JJR	O
than	IN	O
60	CD	O
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
:	:	O

3.	CD	O
a	DT	B-TEST
state	NN	I-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
three	CD	O
;	:	O
the	DT	O
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

4.	CD	O
received	VBD	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
on	IN	O
2012-09-30	JJ	O
.	.	O

1.	CD	O
large	JJ	B-PROBLEM
for	IN	I-PROBLEM
gestational	JJ	I-PROBLEM
age	NN	I-PROBLEM
.	.	O

3.	CD	O
hypoglycemia	NN	B-PROBLEM
.	.	O

primary	JJ	B-TREATMENT
c	NNS	I-TREATMENT
/	VBP	I-TREATMENT
s	NN	I-TREATMENT
for	IN	O
breech	NN	B-PROBLEM

attending	VBG	B-TEST
evaluation	NN	I-TEST

ibuprofen	JJ	B-TREATMENT
400-600	JJ	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

oxycodone	RB	B-TREATMENT
5-10	JJ	O
mg	NN	O
po	NN	O
q3h	NN	O
prn	NN	O
pain	NN	B-PROBLEM

if	IN	O
pt	VBN	O
received	VBD	O
post	NN	B-TREATMENT
partum	NN	I-TREATMENT
spinal	JJ	I-TREATMENT
morphine	NN	I-TREATMENT
,	,	O
do	VBP	O
not	RB	O
administer	VB	O
oxycodone	NN	B-TREATMENT
for	IN	O
18	CD	O
hours	NNS	O
after	IN	O
morphine	JJ	B-TREATMENT
administration	NN	I-TREATMENT
.	.	O

prenatal	JJ	B-TREATMENT
multivitamins	NNS	I-TREATMENT
(	(	I-TREATMENT
stuartnatal	JJ	I-TREATMENT
)	)	I-TREATMENT
1	CD	O

penicillins	NNS	B-TREATMENT

breech	NN	B-PROBLEM
failed	VBD	I-PROBLEM
version	NN	I-PROBLEM
pregnancy	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
primary	JJ	B-TREATMENT
c	JJ	I-TREATMENT
/	NN	I-TREATMENT
s	NN	I-TREATMENT
for	IN	O
breech	NN	B-PROBLEM

scheduled	VBN	B-TREATMENT
c	NNS	I-TREATMENT
/	VBP	I-TREATMENT
s	NN	I-TREATMENT
for	IN	O
breech	NN	B-PROBLEM

vaginal	JJ	B-TREATMENT
delivery	NN	I-TREATMENT
:	:	O

undelivered	JJ	B-PROBLEM

breech	NN	B-PROBLEM
,	,	O

uterine	JJ	B-TREATMENT
incision	NN	I-TREATMENT
type	NN	I-TREATMENT
:	:	O

initial	JJ	B-TEST
newborn	JJ	I-TEST
exam	NN	I-TEST
:	:	O

no	DT	O
observed	JJ	B-PROBLEM
abnormalities	NNS	I-PROBLEM

prenatal	JJ	B-TEST
screens	NNS	I-TEST
:	:	O
blood	NN	B-TEST
type	NN	I-TEST
a	DT	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
,	,	O
rpr	NN	B-TEST
nonreactive	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
gbs	JJ	B-TEST
unknown	NN	O
.	.	O

he	PRP	O
was	VBD	O
born	VBN	O
by	IN	O
repeat	NN	B-TREATMENT
c-section	NN	I-TREATMENT
.	.	O

there	EX	O
was	VBD	O
artificial	JJ	B-TREATMENT
rupture	NN	I-TREATMENT
of	IN	I-TREATMENT
membranes	NNS	I-TREATMENT
was	VBD	O
performed	VBN	O
at	IN	O
the	DT	B-TREATMENT
delivery	NN	I-TREATMENT
.	.	O

mother	RB	O
received	VBN	O
epidural	JJ	B-TREATMENT
and	CC	O
spinal	JJ	B-TREATMENT
anesthesia	NN	I-TREATMENT
.	.	O

apgars	NNS	B-TEST
were	VBD	O
9	CD	O
and	CC	O
9	CD	O
at	IN	O
1	CD	O
and	CC	O
5	CD	O
minutes	NNS	O
.	.	O

he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
newborn	JJ	O
nursery	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

in	IN	O
the	DT	O
newborn	JJ	O
nursery	NN	O
he	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
po	NN	B-TREATMENT
feedings	NNS	I-TREATMENT
on	IN	O
demand	NN	O
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
large	JJ	B-PROBLEM
for	IN	I-PROBLEM
gestational	JJ	I-PROBLEM
age	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
weight	NN	I-TEST
of	IN	O
4525	CD	O
grams	NNS	O
.	.	O

his	PRP$	B-TEST
d-sticks	NNS	I-TEST
were	VBD	O
greater	JJR	O
than	IN	O
80	CD	O
.	.	O

at	IN	O
5	CD	O
hours	NNS	O
of	IN	O
life	NN	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
grunting	NN	B-PROBLEM
and	CC	O
flaring	NN	B-PROBLEM
and	CC	O
e.c.	NN	O
bovell	NN	O
consult	NN	O
was	VBD	O
done	VBN	O
.	.	O

he	PRP	O
was	VBD	O
in	IN	O
mild	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
a	DT	O
diagnosis	NN	O
of	IN	O
transient	JJ	B-PROBLEM
tachypnea	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
newborn	NN	I-PROBLEM
was	VBD	O
made	VBN	O
.	.	O

he	PRP	O
was	VBD	O
observed	VBN	O
in	IN	O
the	DT	O
nursery	NN	O
for	IN	O
progression	NN	B-PROBLEM
of	IN	I-PROBLEM
symptoms	NNS	I-PROBLEM
.	.	O

at	IN	O
16	CD	O
hours	NNS	O
of	IN	O
life	NN	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
increased	VBN	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	VBG	I-PROBLEM
with	IN	O
tachypnea	NN	B-PROBLEM
,	,	O
flaring	VBG	B-PROBLEM
and	CC	O
grunting	VBG	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
noted	VBN	O
to	TO	O
have	VB	O
axillary	JJ	B-TEST
temperature	NN	I-TEST
of	IN	O
100.4	CD	O
and	CC	O
a	DT	B-TEST
rectal	JJ	I-TEST
temperature	NN	I-TEST
of	IN	O
100.9	CD	O
.	.	O

at	IN	O
this	DT	O
point	NN	O
cmed	VBD	O
was	VBD	O
consulted	VBN	O
again	RB	O
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
cmed	VBN	O
triage	NN	O
for	IN	O
further	JJ	B-TREATMENT
care	NN	I-TREATMENT
.	.	O

birth	NN	B-TEST
weight	NN	I-TEST
of	IN	O
4525	CD	O
grams	NNS	O
which	WDT	O
is	VBZ	O
greater	JJR	O
than	IN	O
90th	CD	O
percentile	NN	O
;	:	O
length	CC	B-TEST
54	CD	O
cm	NN	O
which	WDT	O
is	VBZ	O
greater	JJR	O
than	IN	O
90th	CD	O
percentile	NN	O
;	:	O
head	NN	B-TEST
circumference	NN	I-TEST
37	CD	O
cm	NN	O
which	WDT	O
is	VBZ	O
greater	JJR	O
than	IN	O
90th	CD	O
percentile	NN	O
.	.	O

d-sticks	NNS	B-TEST
of	IN	O
117	CD	O
.	.	O

large	JJ	B-PROBLEM
for	IN	I-PROBLEM
gestational	JJ	I-PROBLEM
age	NN	I-PROBLEM
appearance	NN	I-PROBLEM
of	IN	O
an	DT	O
infant	NN	O
with	IN	O
tachypnea	NN	B-PROBLEM
,	,	O
grunting	VBG	B-PROBLEM
and	CC	O
flaring	NN	B-PROBLEM
.	.	O

bilateral	JJ	B-TEST
red	JJ	I-TEST
reflexes	NNS	I-TEST
.	.	O

mild	JJ	B-PROBLEM
flaring	NN	I-PROBLEM
.	.	O

respiratory	NN	O
:	:	O
tachypneic	NN	B-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
retractions	NNS	I-PROBLEM
,	,	O
increased	VBD	B-PROBLEM
work	NN	I-PROBLEM
of	IN	I-PROBLEM
breathing	NN	I-PROBLEM
,	,	O
clear	JJ	O
and	CC	O
equal	JJ	O
breath	NN	O
sounds	NNS	O
.	.	O

normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

brachial	JJ	B-TEST
pulses	NNS	I-TEST
equal	JJ	O
femoral	JJ	B-TEST
pulses	NNS	I-TEST
and	CC	O
are	VBP	O
2+	CD	O
.	.	O

abdomen	NNS	O
:	:	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
.	.	O

normal	JJ	O
tone	NN	O
and	CC	O
neonatal	JJ	B-TEST
reflexes	NNS	I-TEST
.	.	O

skin	NN	O
pink	NN	O
and	CC	O
capillary	JJ	B-TEST
refill	NN	I-TEST
less	JJR	O
than	IN	O
2	CD	O
seconds	NNS	O
.	.	O

spine	NN	O
straight	NN	O
and	CC	O
no	DT	O
abnormalities	NNS	B-PROBLEM
.	.	O

respiratory	NN	O
:	:	O
the	DT	O
infant	NN	O
was	VBD	O
placed	VBN	O
on	IN	O
cpap	NN	B-TREATMENT
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	VBN	O
and	CC	O
remained	VBN	O
on	IN	O
cpap	NN	B-TREATMENT
until	IN	O
day	NN	O
of	IN	O
life	NN	O
2	CD	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
weaned	VBD	O
to	TO	O
nasal	VB	B-TREATMENT
cannula	NN	I-TREATMENT
and	CC	O
then	RB	O
subsequently	RB	O
to	TO	O
room	NN	O
air	NN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
3	CD	O
.	.	O

he	PRP	O
has	VBZ	O
remained	VBN	O
on	IN	O
room	NN	O
air	NN	O
since	IN	O
that	DT	O
time	NN	O
and	CC	O
has	VBZ	O
had	VBN	O
no	DT	O
issues	NNS	O
with	IN	O
apnea	NN	B-PROBLEM
or	CC	O
desaturation	NN	B-PROBLEM
since	IN	O
being	VBG	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

initial	JJ	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
in	IN	O
the	DT	O
cmed	NN	O
showed	VBD	O
haziness	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
left	NN	I-PROBLEM
lower	JJR	I-PROBLEM
lobe	NN	I-PROBLEM
and	CC	O
patchy	JJ	B-PROBLEM
areas	NNS	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
consistent	JJ	O
with	IN	O
concerns	NNS	O
for	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
treated	VBN	O
for	IN	O
pneumonia	NN	B-PROBLEM
from	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	NN	O
.	.	O

cardiovascular	NN	O
:	:	O
the	DT	O
infant	NN	O
has	VBZ	O
maintained	VBN	O
stable	JJ	O
cardiovascular	JJ	O
status	NN	O
with	IN	O
normal	JJ	O
heart	NN	O
rates	NNS	O
and	CC	O
blood	NN	B-TEST
pressures	NNS	I-TEST
and	CC	O
no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

fluids	NNS	O
,	,	O
electrolytes	NNS	O
and	CC	O
nutrition	NN	O
:	:	O
the	DT	O
infant	NN	O
was	VBD	O
started	VBN	O
on	IN	O
iv	NN	B-TREATMENT
fluids	NNS	I-TREATMENT
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	NN	O
.	.	O

electrolytes	NNS	B-TEST
were	VBD	O
measured	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
2	CD	O
and	CC	O
were	VBD	O
stable	JJ	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

no	DT	O
further	JJ	B-TEST
electrolytes	NNS	I-TEST
have	VBP	O
been	VBN	O
measured	VBN	O
.	.	O

enteral	JJ	B-TREATMENT
feedings	NNS	I-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
3	CD	O
and	CC	O
the	DT	O
infant	NN	O
has	VBZ	O
been	VBN	O
ad	NN	B-TREATMENT
lib	NN	I-TREATMENT
po	NN	I-TREATMENT
feeding	VBG	I-TREATMENT
on	IN	O
demand	NN	O
since	IN	O
that	DT	O
time	NN	O
.	.	O

his	PRP$	B-TEST
discharge	NN	I-TEST
weight	NN	I-TEST
is	VBZ	O
4180	CD	O
grams	NN	O
.	.	O

bilirubin	NN	B-TEST
level	NN	I-TEST
was	VBD	O
peaked	VBN	O
on	IN	O
day	NN	O
of	IN	O
life	NN	O
4	CD	O
to	TO	O
10.9/0.3	CD	O
.	.	O

he	PRP	O
has	VBZ	O
required	VBN	O
no	DT	O
phototherapy	NN	B-TREATMENT
.	.	O

hematology	NN	O
:	:	O
hematocrit	NN	B-TEST
was	VBD	O
done	VBN	O
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	NN	O
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
41	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
404,000	CD	O
.	.	O

no	DT	O
further	JJ	O
hematocrit	NN	B-TEST
or	CC	O
platelets	NNS	B-TEST
have	VBP	O
been	VBN	O
measured	VBN	O
.	.	O

blood	NN	B-TEST
typing	NN	I-TEST
has	VBZ	O
been	VBN	O
done	VBN	O
on	IN	O
this	DT	O
infant	NN	O
.	.	O

the	DT	B-TEST
baby	NN	I-TEST
's	POS	I-TEST
blood	NN	I-TEST
type	NN	I-TEST
is	VBZ	O
b	JJ	O
negative	JJ	O
,	,	O
antibody	JJ	B-TEST
negative	JJ	O
.	.	O

infectious	JJ	O
disease	NN	O
:	:	O
cbc	NN	B-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
were	VBD	O
screened	VBN	O
on	IN	O
admission	NN	O
.	.	O

cbc	NN	B-TEST
was	VBD	O
benign	JJ	O
with	IN	O
22,000	CD	O
whites	NNS	B-TEST
,	,	O
80	CD	O
poly	NN	B-TEST
's,	POS	I-TEST
0	CD	O
bands	NNS	B-TEST
,	,	O
15	CD	O
lymphs	NN	B-TEST
.	.	O

ampicillin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
were	VBD	O
initiated	VBN	O
on	IN	O
admission	NN	O
and	CC	O
an	DT	B-TEST
lp	NN	I-TEST
was	VBD	O
done	VBN	O
due	JJ	O
to	TO	O
the	DT	O
clinical	JJ	O
issues	NNS	O
of	IN	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
and	CC	O
fever	NN	B-PROBLEM
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
cmed	NN	O
.	.	O

csf	NN	B-TEST
showed	VBD	O
white	JJ	B-TEST
count	NN	I-TEST
of	IN	O
7	CD	O
,	,	O
reds	VBZ	B-TEST
4	CD	O
,	,	O
protein	RB	B-TEST
119	CD	O
,	,	O
glucose	VBD	B-TEST
69	CD	O
.	.	O

the	DT	O
infant	NN	O
was	VBD	O
treated	VBN	O
for	IN	O
7	CD	O
days	NNS	O
of	IN	O
presumed	JJ	O
pneumonia	NN	B-PROBLEM
with	IN	O
ampicillin	NN	B-TREATMENT
and	CC	O
gentamycin	NN	B-TREATMENT
.	.	O

antibiotics	NNS	B-TREATMENT
were	VBD	O
discontinued	VBN	O
on	IN	O
the	DT	O
evening	NN	O
of	IN	O
2015-04-28	JJ	O
.	.	O

sensory	NN	O
:	:	O
hearing	NN	B-TEST
screen	NN	I-TEST
was	VBD	O
performed	VBN	O
with	IN	O
automated	JJ	B-TEST
auditory	NN	I-TEST
brain	NN	I-TEST
stem	NN	I-TEST
responses	NNS	I-TEST
and	CC	O
the	DT	O
results	NNS	O
was	VBD	O
the	DT	O
infant	JJ	O
passing	NN	O
in	IN	O
both	DT	O
ears	NNS	O
.	.	O

there	EX	O
are	VBP	O
no	DT	O
active	JJ	B-PROBLEM
ongoing	NN	I-PROBLEM
issues	NNS	I-PROBLEM
at	IN	O
this	DT	O
time	NN	O
.	.	O

1.	CD	O
ad	NN	B-TREATMENT
lib	NN	I-TREATMENT
po	JJ	I-TREATMENT
feedings	NNS	I-TREATMENT
of	IN	O
similac	NN	B-TREATMENT
20	CD	I-TREATMENT
cal	JJ	I-TREATMENT
/	NN	I-TREATMENT
oz	NN	I-TREATMENT
with	IN	I-TREATMENT
iron	NN	I-TREATMENT
.	.	O

2.	CD	O
medications	NNS	B-TREATMENT
:	:	O
none	NN	O
.	.	O

3.	CD	O
state	NN	B-TEST
newborn	JJ	I-TEST
screen	NN	I-TEST
was	VBD	O
sent	VBN	O
on	IN	O
2015-04-24	JJ	O
and	CC	O
results	NNS	O
are	VBP	O
pending	VBG	O
.	.	O

4.	CD	O
immunizations	NNS	B-TREATMENT
received	VBD	O
:	:	O
hepatitis	NN	B-TREATMENT
b	NN	I-TREATMENT
vaccine	NN	I-TREATMENT
was	VBD	O
given	VBN	O
on	IN	O
2015-04-25	JJ	O
.	.	O

5.	CD	O
immunizations	NNS	B-TREATMENT
recommended	VBD	O
:	:	O

6.	CD	O
synagis	JJ	B-TREATMENT
rsv	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
should	MD	O
be	VB	O
considered	VBN	O
from	IN	O
november	CC	O
through	IN	O
march	NN	O
for	IN	O
infants	NNS	O
who	WP	O
meet	VBP	O
any	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
criteria	NNS	O
.	.	O

daycare	NN	O
during	IN	O
the	DT	O
rsv	NN	O
season	NN	O
a	DT	O
smoker	NN	O
in	IN	O
the	DT	O
household	NN	O
,	,	O
neuromuscular	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
airway	NN	B-PROBLEM
abnormalities	NNS	I-PROBLEM
,	,	O
or	CC	O
school	NN	O
age	NN	O
siblings	NNS	O

c.	NN	O
with	IN	O
chronic	JJ	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

7.	CD	O
influenza	JJ	B-TREATMENT
immunization	NN	I-TREATMENT
is	VBZ	O
recommended	VBN	O
annually	RB	O
in	IN	O
the	DT	O
fall	NN	O
for	IN	O
all	DT	O
infants	NNS	O
once	IN	O
they	PRP	O
reach	VBP	O
6	CD	O
months	NNS	O
of	IN	O
age	NN	O
.	.	O

before	IN	O
this	DT	O
age	NN	O
and	CC	O
for	IN	O
the	DT	O
first	JJ	O
24	CD	O
months	NNS	O
of	IN	O
the	DT	O
child	NN	O
's	POS	O
life	NN	O
,	,	O
immunization	NN	B-TREATMENT
against	IN	O
influenza	NN	B-PROBLEM
is	VBZ	O
recommended	VBN	O
for	IN	O
household	NN	O
contacts	NNS	O
and	CC	O
out	IN	O
of	IN	O
home	NN	O
caregivers	NNS	O
.	.	O

1.	CD	O
presumed	JJ	O
pneumonia	NN	B-PROBLEM
,	,	O
treated	VBN	O
.	.	O

2.	CD	O
large	JJ	B-PROBLEM
for	IN	I-PROBLEM
gestational	JJ	I-PROBLEM
age	NN	I-PROBLEM
term	NN	O
male	NN	O
.	.	O

3.	CD	O
respiratory	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
resolved	VBN	O
.	.	O

4.	CD	O
mild	JJ	B-PROBLEM
hyperbilirubinemia	NN	I-PROBLEM
,	,	O
resolving	VBG	O
.	.	O

infrarenal	JJ	B-PROBLEM
abdominal	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
;	:	O

2.	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O

3.	CD	O
osteoarthritis	NN	B-PROBLEM
.	.	O

endovascular	JJ	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
abdominal	JJ	B-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
with	IN	O
bifurcated	JJ	B-TREATMENT
device	NN	I-TREATMENT
on	IN	O
september	NN	O
9	CD	O
,	,	O
2003	CD	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
an	DT	O
84	CD	O
year	NN	O
old	JJ	O
male	NN	O
,	,	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
who	WP	O
was	VBD	O
discovered	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
asymptomatic	JJ	I-PROBLEM
7	CD	I-PROBLEM
cm	JJ	I-PROBLEM
abdominal	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
on	IN	O
ct	JJ	B-TEST
scan	JJ	I-TEST
obtained	VBN	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
back	RB	O
in	IN	O
may	MD	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
he	PRP	O
had	VBD	O
presented	VBN	O
with	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
acute	JJ	B-PROBLEM
cholecystectomy	NN	I-PROBLEM
.	.	O

he	PRP	O
underwent	VBD	O
an	DT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT
laparoscopic	NN	I-TREATMENT
cholecystectomy	NN	I-TREATMENT
.	.	O

he	PRP	O
presents	VBZ	O
at	IN	O
this	DT	O
time	NN	O
for	IN	O
endovascular	JJ	B-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
this	DT	B-PROBLEM
abdominal	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
.	.	O

1.	CD	O
hypertension	NN	B-PROBLEM
;	:	O

2.	CD	O
gastroesophageal	JJ	B-PROBLEM
reflux	JJ	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O

3.	CD	O
h.	NN	B-PROBLEM
pylori	NN	I-PROBLEM
positive	JJ	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
therapy	NN	B-TREATMENT
;	:	O

4.	CD	O
osteoarthritis	NN	B-PROBLEM
.	.	O

1.	CD	O
craniotomy	NN	B-TREATMENT
for	IN	O
meningoma	NN	B-PROBLEM
,	,	O
february	JJ	O
,	,	O
1994	CD	O
;	:	O

2.	CD	O
laparoscopic	JJ	B-TREATMENT
cholecystectomy	NN	I-TREATMENT
in	IN	O
may	MD	O
,	,	O
2002	CD	O
.	.	O

1.	CD	O
aspirin	JJ	B-TREATMENT
81	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O

2.	CD	O
atenolol	JJ	B-TREATMENT
25	CD	O
mg	NN	O
po	NN	O
qd	NN	O
;	:	O

3.	CD	O
protonics	NNS	B-TREATMENT
40	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
152/74	CD	O
,	,	O
pulse	RB	B-TEST
60	CD	O
,	,	O
respirations	NNS	B-TEST
16	CD	O
.	.	O

he	PRP	O
has	VBZ	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
.	.	O

heart	NN	O
is	VBZ	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
without	IN	O
murmur	NN	B-PROBLEM
.	.	O

abdomen	NNS	O
is	VBZ	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
with	IN	O
a	DT	B-PROBLEM
pulsatile	JJ	I-PROBLEM
mass	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
epigastrium	NN	I-PROBLEM
.	.	O

extremities	NNS	O
reveals	VBZ	O
a	DT	B-TEST
2+	CD	I-TEST
femoral	JJ	I-TEST
and	CC	I-TEST
pedal	JJ	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
vascular	VB	O
surgery	NN	O
service	NN	O
as	IN	O
a	DT	O
same	JJ	O
day	NN	O
admission	NN	O
,	,	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
for	IN	O
an	DT	B-TREATMENT
uncomplicated	JJ	I-TREATMENT
endovascular	JJ	I-TREATMENT
repair	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
abdominal	JJ	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
,	,	O
and	CC	O
anurx	RB	B-TREATMENT
modular	JJ	I-TREATMENT
bifurcated	VBD	I-TREATMENT
graft	NN	I-TREATMENT
was	VBD	O
placed	VBN	O
,	,	O
and	CC	O
both	DT	O
common	JJ	O
femoral	JJ	O
arteries	NNS	O
were	VBD	O
repaired	VBN	O
in	IN	O
the	DT	O
usual	JJ	O
fashion	NN	O
.	.	O

he	PRP	O
had	VBD	O
pulsatile	JJ	B-TEST
pulse	JJ	I-TEST
volume	NN	I-TEST
recordings	NNS	I-TEST
,	,	O
in	IN	O
both	DT	O
lower	JJR	O
extremities	NNS	O
,	,	O
and	CC	O
both	DT	O
renal	JJ	O
arteries	NNS	O
were	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
patent	NN	O
,	,	O
as	IN	O
were	VBD	O
both	DT	O
internal	JJ	O
iliac	NN	O
arteries	NNS	O
.	.	O

his	PRP$	B-TEST
angiogram	NN	I-TEST
in	IN	O
the	DT	O
operating	NN	O
room	NN	O
,	,	O
revealed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
endo	JJ	I-PROBLEM
leak	NN	I-PROBLEM
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
an	DT	O
episode	NN	O
of	IN	O
a	DT	B-PROBLEM
prolonged	JJ	I-PROBLEM
sinus	NN	I-PROBLEM
pause	NN	I-PROBLEM
in	IN	O
the	DT	O
recovery	NN	O
room	NN	O
,	,	O
which	WDT	O
resulted	VBD	O
in	IN	O
transient	JJ	B-PROBLEM
loss	NN	I-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
.	.	O

he	PRP	O
responded	VBD	O
to	TO	O
a	DT	B-TREATMENT
neo-synephrine	JJ	I-TREATMENT
bolus	NN	I-TREATMENT
,	,	O
and	CC	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
complications	NNS	I-PROBLEM
from	IN	O
this	DT	O
standpoint	NN	O
.	.	O

dr.	JJ	O
rosean	NN	O
fletcher	NN	O
,	,	O
of	IN	O
the	DT	O
cardiology	NN	O
department	NN	O
was	VBD	O
consulted	VBN	O
,	,	O
and	CC	O
it	PRP	O
was	VBD	O
his	PRP$	O
opinion	NN	O
that	IN	O
the	DT	B-PROBLEM
sinus	NN	I-PROBLEM
pause	NN	I-PROBLEM
was	VBD	O
related	VBN	O
to	TO	O
increased	VBN	B-PROBLEM
vagal	JJ	I-PROBLEM
tone	NN	I-PROBLEM
postoperatively	RB	O
,	,	O
perhaps	RB	O
secondary	JJ	O
to	TO	O
the	DT	B-TREATMENT
epidural	JJ	I-TREATMENT
,	,	O
as	RB	O
well	RB	O
as	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
atenolol	NN	I-TREATMENT
use	NN	I-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
atenolol	NN	I-TREATMENT
was	VBD	O
held	VBN	O
,	,	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
further	JJ	B-PROBLEM
pauses	NNS	I-PROBLEM
during	IN	O
his	PRP$	O
stay	NN	O
.	.	O

his	PRP$	B-TEST
postoperative	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
endo	JJ	B-PROBLEM
leak	NN	I-PROBLEM
,	,	O
or	CC	O
graft	NN	B-PROBLEM
kinking	NN	I-PROBLEM
.	.	O

however	RB	O
,	,	O
he	PRP	O
did	VBD	O
develop	VB	O
significant	JJ	B-PROBLEM
ecchymosis	NN	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
groins	NNS	I-PROBLEM
,	,	O
extending	VBG	O
down	RP	O
into	IN	O
his	PRP$	O
scrotum	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
significant	JJ	B-PROBLEM
groin	NN	I-PROBLEM
hematomas	NN	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
adequately	RB	O
controlled	VBN	O
with	IN	O
oral	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

he	PRP	O
will	MD	O
be	VB	O
visited	VBN	O
by	IN	O
ldamc	NN	O
for	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
and	CC	O
incision	NN	B-TEST
checks	NNS	I-TEST
.	.	O

admission	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

acute	JJ	B-PROBLEM
inferior	JJ	I-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
61	JJ	O
-	:	O
year-old	JJ	O
caucasian-speaking	JJ	O
woman	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
hypercholesterolemia	NN	B-PROBLEM
and	CC	O
tobacco	NN	O
use	NN	O
who	WP	O
developed	VBD	O
waxing	VBG	B-PROBLEM
and	CC	I-PROBLEM
waning	VBG	I-PROBLEM
left	VBD	I-PROBLEM
substernal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
left	JJ	I-PROBLEM
shoulder	NN	I-PROBLEM
on	IN	O
2011-11-17	JJ	O
which	WDT	O
lasted	VBD	O
that	IN	O
entire	JJ	O
day	NN	O
.	.	O

upon	IN	O
waking	VBG	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
,	,	O
she	PRP	O
had	VBD	O
10/10	CD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
associated	VBN	O
with	IN	O
nausea	NN	B-PROBLEM
.	.	O

she	PRP	O
presented	VBD	O
to	TO	O
charlton	VB	O
memorial	JJ	O
hospital	NN	O
hospital	NN	O
emergency	NN	O
department	NN	O
with	IN	O
inferior	JJ	B-PROBLEM
st	JJ	I-PROBLEM
elevations	NNS	I-PROBLEM
;	:	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
became	VBD	O
acutely	RB	B-PROBLEM
hypotensive	JJ	I-PROBLEM
to	TO	O
a	DT	B-TEST
systolic	JJ	I-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
70	CD	O
to	TO	O
80	CD	O
after	IN	O
receiving	VBG	O
one	CD	O
ublingual	JJ	B-TREATMENT
nitroglycerin	NN	I-TREATMENT
.	.	O

she	PRP	O
then	RB	O
became	VBD	O
bradycardic	JJ	B-PROBLEM
which	WDT	O
responded	VBD	O
to	TO	O
atropine	VB	B-TREATMENT
and	CC	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

in	IN	O
addition	NN	O
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
aspirin	RB	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
,	,	O
heparin	NN	B-TREATMENT
,	,	O
and	CC	O
morphine	NN	B-TREATMENT
.	.	O

immediately	RB	O
prior	JJ	O
to	TO	O
transfer	VB	O
to	TO	O
worcester	VB	O
state	NN	O
hospital	NN	O
,	,	O
she	PRP	O
went	VBD	O
into	IN	O
ventricular	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
arrest	NN	I-PROBLEM
at	IN	O
12:30	CD	O
p.m.	NN	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
and	CC	O
defibrillated	VBN	B-TREATMENT
back	RB	O
to	TO	O
sinus	VB	O
rhythm	NN	O
after	IN	O
five	CD	B-TREATMENT
shocks	NNS	I-TREATMENT
.	.	O

she	PRP	O
received	VBD	O
an	DT	B-TREATMENT
amiodarone	NN	I-TREATMENT
bolus	NN	I-TREATMENT
of	IN	O
150	CD	O
mg	NNS	O
intravenously	RB	O
and	CC	O
was	VBD	O
continued	VBN	O
on	IN	O
an	DT	B-TREATMENT
amiodarone	NN	I-TREATMENT
drip	NN	I-TREATMENT
while	IN	O
cmed	VBN	O
csru-flighted	JJ	O
to	TO	O
boston	VB	O
regional	JJ	O
medical	JJ	O
centerr	NN	O
where	WRB	O
she	PRP	O
underwent	VBD	O
a	DT	B-TEST
catheterization	NN	I-TEST
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
total	JJ	I-PROBLEM
occlusion	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
proximal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
and	CC	O
diffuse	VB	B-PROBLEM
right	JJ	I-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
three	CD	B-TREATMENT
stents	NNS	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
coronary	NN	I-TREATMENT
artery	NN	I-TREATMENT
which	WDT	O
was	VBD	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
proximal	JJ	I-PROBLEM
dissection	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
good	JJ	O
post	NN	B-TEST
percutaneous	JJ	I-TEST
coronary	JJ	I-TEST
intervention	NN	I-TEST
angiographic	JJ	I-TEST
results	NNS	I-TEST
.	.	O

incidentally	RB	O
,	,	O
an	DT	B-TEST
aortogram	NN	I-TEST
during	IN	O
the	DT	B-TEST
catheterization	NN	I-TEST
revealed	VBD	O
a	DT	B-PROBLEM
debakey	JJ	I-PROBLEM
class	NN	I-PROBLEM
i	NN	I-PROBLEM
aortic	JJ	I-PROBLEM
ascending	VBG	I-PROBLEM
aneurysm	NN	I-PROBLEM
,	,	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
pulmonary	JJ	I-TEST
capillary	JJ	I-TEST
wedge	NN	I-TEST
pressure	NN	I-TEST
of	IN	O
20	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
catheterization	NN	B-TEST
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
in	IN	O
stable	JJ	O
condition	NN	O
and	CC	O
still	RB	O
intubated	VBN	B-TREATMENT
.	.	O

hypercholesterolemia	NN	B-PROBLEM
.	.	O

"	NN	O
flumaran	NN	B-TREATMENT
"	NN	O
for	IN	O
circulatory	NN	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

she	PRP	O
receives	VBZ	O
this	DT	B-TREATMENT
medication	NN	I-TREATMENT
by	IN	O
mail	NN	O
from	IN	O
her	PRP$	O
relatives	NNS	O
in	IN	O
jill	NN	O
.	.	O

amiodarone	NN	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

2.	CD	O
integrilin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

3.	CD	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
.	.	O

a	DT	O
question	NN	O
of	IN	O
a	DT	B-TREATMENT
sulfa	NN	I-TREATMENT
allergy	NN	B-PROBLEM
.	.	O

family	NN	O
history	NN	O
is	VBZ	O
not	RB	O
significant	JJ	O
for	IN	O
any	DT	O
early	JJ	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

examination	NN	B-TEST
on	IN	O
admission	NN	O
to	TO	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
revealed	VBD	O
blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
100/57	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
mean	JJ	I-TEST
arterial	JJ	I-TEST
pressure	NN	I-TEST
of	IN	O
75	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
sinus	VBN	O
rhythm	NN	O
at	IN	O
75	CD	O
,	,	O
temperature	NN	B-TEST
was	VBD	O
97.6	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
was	VBD	O
99%	CD	O
on	IN	O
assist	NN	B-TREATMENT
control	NN	I-TREATMENT
with	IN	O
a	DT	B-TREATMENT
tidal	JJ	I-TREATMENT
volume	NN	I-TREATMENT
of	IN	O
600	CD	O
on	IN	O
60%	CD	O
fio2	NN	B-TREATMENT
,	,	O
5	CD	O
of	IN	O
positive	JJ	B-TREATMENT
end-expiratory	JJ	I-TREATMENT
pressure	NN	I-TREATMENT
.	.	O

in	IN	O
general	JJ	O
,	,	O
she	PRP	O
was	VBD	O
sedated	VBN	B-TREATMENT
at	IN	O
the	DT	O
time	NN	O
,	,	O
responsive	JJ	O
to	TO	O
stimuli	VB	O
,	,	O
and	CC	O
was	VBD	O
following	VBG	O
commands	NNS	O
.	.	O

her	PRP$	B-TEST
carotids	NNS	I-TEST
were	VBD	O
2+	CD	O
bilaterally	RB	O
.	.	O

her	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
anteriorly	RB	O
.	.	O

her	PRP$	O
heart	NN	O
revealed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
a	DT	B-PROBLEM
faint	JJ	I-PROBLEM
second	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sound	NN	I-PROBLEM
and	CC	O
second	JJ	O
heart	NN	O
sound	NN	O
.	.	O

no	DT	O
audible	JJ	B-PROBLEM
extra	JJ	I-PROBLEM
heart	NN	I-PROBLEM
sounds	VBZ	I-PROBLEM
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
obese	JJ	B-PROBLEM
and	CC	O
had	VBD	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

it	PRP	O
was	VBD	O
soft	JJ	O
and	CC	O
nontender	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
peripheral	JJ	B-PROBLEM
edema	NN	I-PROBLEM
with	IN	O
2+	CD	B-TEST
peripheral	JJ	I-TEST
pulses	NNS	I-TEST
bilaterally	RB	I-TEST
.	.	O

her	PRP$	B-TEST
laboratories	NNS	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
transfer	NN	O
to	TO	O
saint	VB	O
vincent	JJ	O
hospital	NN	O
revealed	VBD	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
was	VBD	O
11.5	CD	O
,	,	O
hematocrit	NN	B-TEST
was	VBD	O
42	CD	O
on	IN	O
admission	NN	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
242	CD	O
.	.	O

chemistry-7	NN	B-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

creatine	NN	B-TEST
kinase	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
309	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
mb	NN	I-TEST
of	IN	O
19.6	CD	O
,	,	O
an	DT	B-TEST
index	NN	I-TEST
of	IN	O
6.3	CD	O
,	,	O
and	CC	O
an	DT	B-TEST
initial	JJ	I-TEST
troponin	NN	I-TEST
of	IN	O
0.73	CD	O
.	.	O

a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
revealed	VBD	O
an	DT	B-PROBLEM
enlarged	JJ	I-PROBLEM
mediastinum	NN	I-PROBLEM
with	IN	O
clear	JJ	O
lung	NN	O
fields	NNS	O
bilaterally	RB	O
.	.	O

initial	JJ	B-TEST
electrocardiogram	NN	I-TEST
showed	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
65	CD	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
2-mm	JJ	B-PROBLEM
st	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
lead	JJ	I-PROBLEM
iii	NN	I-PROBLEM
,	,	O
1-mm	JJ	B-PROBLEM
st	NN	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
avf	NN	I-PROBLEM
and	CC	I-PROBLEM
v1	NN	I-PROBLEM
,	,	O
1-mm	JJ	B-PROBLEM
st	NN	I-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
i	NN	I-PROBLEM
and	CC	I-PROBLEM
avl	NN	I-PROBLEM
;	:	O
consistent	JJ	O
with	IN	O
an	DT	B-PROBLEM
inferior	JJ	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
ventricular	NN	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

right-sided	JJ	B-TEST
electrocardiograms	NNS	I-TEST
showed	VBD	O
1-mm	JJ	B-PROBLEM
st	JJ	I-PROBLEM
elevations	NNS	I-PROBLEM
in	IN	I-PROBLEM
v4	NN	I-PROBLEM
;	:	O
consistent	JJ	O
with	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
ventricular	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

electrocardiogram	NN	B-TEST
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
revealed	VBD	O
a	DT	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
84	CD	O
,	,	O
with	IN	O
a	DT	O

normal	JJ	O
axis	NN	O
,	,	O
and	CC	O
normalizing	NN	O
of	IN	O
the	DT	B-PROBLEM
inferior	JJ	I-PROBLEM
st	NN	I-PROBLEM
segments	NNS	I-PROBLEM
,	,	O
with	IN	O
q	JJ	O
waves	NNS	O
evolving	VBG	O
in	IN	O
leads	NNS	O
iii	NNS	O
and	CC	O
avf	NN	O
.	.	O

an	DT	B-TEST
echocardiogram	NN	I-TEST
status	NN	O
post	NN	O
percutaneous	JJ	B-TREATMENT
coronary	JJ	I-TREATMENT
intervention	NN	I-TREATMENT
revealed	VBD	O
an	DT	B-PROBLEM
akinetic	JJ	I-PROBLEM
inferior	NN	I-PROBLEM
wall	NN	I-PROBLEM
and	CC	I-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
and	CC	O
ascending	VBG	O
aorta	NN	O
measuring	VBG	O
5	CD	O
cm	NN	O
.	.	O

there	EX	O
was	VBD	O
no	DT	O
effusion	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
night	NN	O
of	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
experienced	VBD	O
post	NN	B-PROBLEM
catheterization	NN	I-PROBLEM
hypotension	NN	I-PROBLEM
which	WDT	O
required	VBD	O
intravenous	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
dopamine	NN	B-TREATMENT
.	.	O

electrocardiogram	VB	B-TEST
the	DT	O
following	JJ	O
morning	NN	O
revealed	VBD	O
normalization	NN	O
of	IN	O
her	PRP$	O
st	JJ	O
segments	NNS	O
with	IN	O
evolution	NN	B-PROBLEM
of	IN	I-PROBLEM
q	NN	I-PROBLEM
waves	NNS	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
dopamine	NN	I-TREATMENT
was	VBD	O
weaned	VBN	O
off	RP	O
the	DT	O
following	JJ	O
day	NN	O
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
heparin	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
secondary	JJ	O
to	TO	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
groin	NN	I-PROBLEM
hematoma	NN	I-PROBLEM
which	WDT	O
had	VBD	O
developed	VBN	O
after	IN	O
the	DT	B-TREATMENT
sheath	NN	I-TREATMENT
had	VBD	O
been	VBN	O
pulled	VBN	O
out	RP	O
by	IN	O
the	DT	O
fellow	NN	O
.	.	O

her	PRP$	B-TEST
creatine	NN	I-TEST
kinases	NNS	I-TEST
climbed	VBD	O
;	:	O
reaching	VBG	O
a	DT	O
peak	NN	O
of	IN	O
3523	CD	O
,	,	O
which	WDT	O
was	VBD	O
down	RB	O
to	TO	O
1500	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

for	IN	O
her	PRP$	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
catheterization	NN	B-TEST
,	,	O
she	PRP	O
was	VBD	O
given	VBN	O
integrilin	NN	B-TREATMENT
for	IN	O
18	CD	O
hours	NNS	O
.	.	O

she	PRP	O
was	VBD	O
continued	VBN	O
on	IN	O
aspirin	NN	B-TREATMENT
,	,	O
plavix	NN	B-TREATMENT
,	,	O
and	CC	O
lipitor	NN	B-TREATMENT
.	.	O

for	IN	O
her	PRP$	O
rhythm	NN	O
,	,	O
amiodarone	NN	B-TREATMENT
was	VBD	O
discontinued	VBN	O
as	IN	O
she	PRP	O
was	VBD	O
maintained	VBN	O
in	IN	O
sinus	NN	O
rhythm	NN	O
after	IN	O
moving	VBG	O
to	TO	O
the	DT	O
floor	NN	O
.	.	O

for	IN	O
pump	NN	O
,	,	O
once	RB	O
transferred	VBN	O
out	IN	O
of	IN	O
the	DT	O
coronary	JJ	O
care	NN	O
unit	NN	O
on	IN	O
2011-11-20	JJ	O
,	,	O
a	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
was	VBD	O
begun	VBN	O
at	IN	O
12.5	CD	O
mg	NN	O
of	IN	O
lopressor	NN	B-TREATMENT
p.o.	NN	O
b.i.d.	NN	O
which	WDT	O
was	VBD	O
titrated	VBN	O
to	TO	O
25	CD	O
mg	NN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

also	RB	O
,	,	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
,	,	O
for	IN	O
increased	VBN	B-TREATMENT
afterload	NN	I-TREATMENT
reduction	NN	I-TREATMENT
,	,	O
she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
lisinopril	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

on	IN	O
2011-11-21	JJ	O
,	,	O
the	DT	O
patient	NN	O
experienced	VBD	O
atypical	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
which	WDT	O
was	VBD	O
made	VBN	O
worse	NN	O
with	IN	O
inspiration	NN	O
and	CC	O
movement	NN	O
.	.	O

it	PRP	O
was	VBD	O
not	RB	O
associated	VBN	O
with	IN	O
any	DT	B-PROBLEM
nausea	NN	I-PROBLEM
or	CC	O
vomiting	NN	B-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
pain	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
her	PRP$	B-PROBLEM
self-extubation	NN	I-PROBLEM
and	CC	O
noncardiac	JJ	B-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
checked	VBN	O
which	WDT	O
revealed	VBD	O
no	DT	O
st	NN	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
and	CC	O
there	EX	O
was	VBD	O
no	DT	O
increase	NN	O
in	IN	O
her	PRP$	O
downward	JJ	O
trending	NN	O
creatine	NN	B-TEST
phosphokinases	NNS	I-TEST
.	.	O

no	DT	O
further	JJ	B-TREATMENT
intervention	NN	I-TREATMENT
was	VBD	O
done	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
treated	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
orally	RB	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
ativan	NN	B-TREATMENT
for	IN	O
anxiety	NN	B-PROBLEM
that	IN	O
she	PRP	O
had	VBD	O
about	IN	O
going	VBG	O
home	NN	O
.	.	O

she	PRP	O
was	VBD	O
pain	RB	B-PROBLEM
free	JJ	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

regarding	VBG	O
her	PRP$	B-PROBLEM
aortic	JJ	I-PROBLEM
ascending	NN	I-PROBLEM
aneurysm	NN	I-PROBLEM
,	,	O
cardiothoracic	NN	O
surgery	NN	O
was	VBD	O
consulted	VBN	O
regarding	VBG	O
further	JJ	B-TEST
workup	NN	I-TEST
.	.	O

at	IN	O
their	PRP$	O
request	NN	O
,	,	O
a	DT	B-TEST
ct	JJ	I-TEST
scan	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
chest	NN	I-TEST
with	IN	O
contrast	NN	B-TEST
was	VBD	O
performed	VBN	O
on	IN	O
the	DT	O
day	NN	O
of	IN	O
discharge	NN	O
.	.	O

dr.	NN	O
streeter	NN	O
from	IN	O
cardiothoracic	NN	O
surgery	NN	O
will	MD	O
follow	VB	O
up	RP	O
with	IN	O
the	DT	O
patient	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
in	IN	O
approximately	RB	O
one	CD	O
month	NN	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

she	PRP	O
complained	VBD	O
of	IN	O
a	DT	B-PROBLEM
sore	NN	I-PROBLEM
throat	NN	I-PROBLEM
which	WDT	O
was	VBD	O
likely	RB	O
the	DT	O
etiology	NN	O
of	IN	O
her	PRP$	B-PROBLEM
atypical	JJ	I-PROBLEM
chest	NN	I-PROBLEM
complaints	NNS	I-PROBLEM
.	.	O

this	DT	O
resolved	VBN	O
with	IN	O
tylenol	NN	B-TREATMENT
and	CC	O
as	IN	O
needed	JJ	O
doses	NNS	O
of	IN	O
oxycodone	NN	B-TREATMENT
.	.	O

her	PRP$	O
lungs	NNS	O
remained	VBD	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
throughout	IN	O
the	DT	O
remainder	NN	O
of	IN	O
her	PRP$	O
hospital	JJ	O
course	NN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
of	IN	O
this	DT	O
dictation	NN	O
,	,	O
the	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
her	PRP$	I-TEST
chest	NN	I-TEST
was	VBD	O
still	RB	O
pending	VBG	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
electrolytes	NNS	I-TEST
sere	RB	O
managed	VBN	O
daily	RB	O
and	CC	O
repleted	VBN	O
on	IN	O
an	DT	O
as	IN	O
needed	JJ	O
basis	NN	O
.	.	O

she	PRP	O
did	VBD	O
receive	VB	O
intravenous	JJ	B-TREATMENT
k-phos	NNS	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
phosphorous	NN	I-PROBLEM
of	IN	O
1.5	CD	O
.	.	O

her	PRP$	B-TEST
phosphorous	JJ	I-TEST
rose	VBD	O
appropriately	RB	O
to	TO	O
3.6	CD	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

2.	CD	O
in	IN	O
addition	NN	O
,	,	O
as	IN	O
stated	VBN	O
above	IN	O
,	,	O
dr.hastings	NNS	O
office	NN	O
from	IN	O
cardiothoracic	NN	O
surgery	NN	O
will	MD	O
be	VB	O
in	IN	O
contact	NN	O
with	IN	O
ms.	JJ	O
williams	NNS	O
to	TO	O
arrange	VB	O
followup	NN	O
for	IN	O
her	PRP$	B-PROBLEM
ascending	VBG	I-PROBLEM
aortic	JJ	I-PROBLEM
aneurysm	NN	I-PROBLEM
in	IN	O
approximately	RB	O
one	CD	O
month	NN	O
.	.	O

1.	CD	O
lisinopril	JJ	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

2.	CD	O
lopressor	NN	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O

3.	CD	O
plavix	JJ	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

4.	CD	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

5.	CD	O
protonix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

6.	CD	O
enteric-coated	JJ	B-TREATMENT
aspirin	NN	I-TREATMENT
325	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

1.	CD	O
inferior	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
ventricular	NN	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
and	CC	O
stents	NNS	B-TREATMENT
times	NNS	O
three	CD	O
of	IN	O
the	DT	O
right	JJ	O
coronary	JJ	O
artery	NN	O
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM
.	.	O

3.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	O
75	CD	O
year	NN	O
old	JJ	O
righthanded	VBD	O
caucasian	JJ	O
female	NN	O
who	WP	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
fairm	NN	O
of	IN	O
ijordcompmac	JJ	O
hospital	NN	O
because	IN	O
of	IN	O
left	JJ	B-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
and	CC	O
hand	NN	B-PROBLEM
weakness	NN	I-PROBLEM
after	IN	O
glaucoma	NN	B-TREATMENT
laser	NN	I-TREATMENT
surgery	NN	I-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
sas	NN	O
general	JJ	O
hospital	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
of	IN	O
some	DT	B-PROBLEM
weakness	NN	I-PROBLEM
in	IN	O
the	DT	O
setting	NN	O
of	IN	O
multiple	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
o.d.	VBN	B-TREATMENT
glaucoma	NN	I-TREATMENT
surgery	NN	I-TREATMENT
,	,	O
1400	CD	O
hours	NNS	O
,	,	O
on	IN	O
may	MD	O
12th	CD	O
,	,	O
1992	CD	O
.	.	O

soon	RB	O
after	IN	O
surgery	NN	B-TREATMENT
,	,	O
the	DT	O
patient	NN	O
noted	VBD	O
her	PRP$	O
left	JJ	O
lower	JJR	O
face	NN	O
and	CC	O
hand	NN	O
were	VBD	O
weak	JJ	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
where	WRB	O
she	PRP	O
was	VBD	O
evaluated	VBN	O
and	CC	O
determined	VBN	O
to	TO	O
have	VB	O
had	VBN	O
a	DT	B-PROBLEM
cerebrovascular	JJ	I-PROBLEM
accident	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
absolutely	RB	O
no	DT	O
neurologic	JJ	B-PROBLEM
disease	NN	I-PROBLEM
in	IN	O
past	NN	O
.	.	O

the	DT	B-TEST
review	NN	I-TEST
of	IN	I-TEST
systems	NNS	I-TEST
is	VBZ	O
negative	JJ	O
.	.	O

however	RB	O
,	,	O
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
one	CD	O
family	NN	O
member	NN	O
noted	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-PROBLEM
transient	NN	I-PROBLEM
left	VBD	I-PROBLEM
facial	JJ	I-PROBLEM
droop	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
potassium	NN	I-TEST
three	CD	O
days	NNS	O
prior	RB	O
to	TO	O
surgery	NN	B-TREATMENT
was	VBD	O
2.8	CD	O
,	,	O
the	DT	B-TEST
level	NN	I-TEST
being	VBG	O
normalized	VBN	O
with	IN	O
p.o.	JJ	B-TREATMENT
kay	NN	I-TREATMENT
ciel	NN	I-TREATMENT
prior	RB	O
to	TO	O
admission	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
mi	NN	B-PROBLEM
in	IN	O
1989	CD	O
,	,	O
no	DT	O
angina	NN	B-PROBLEM
before	IN	O
or	CC	O
after	IN	O
.	.	O

#	#	O
2.	CD	O
history	NN	O
of	IN	O
m.	NN	B-PROBLEM
kansasaii	NN	I-PROBLEM
with	IN	O
workup	NN	B-TEST
by	IN	O
dr.	NN	O
screen	NN	O
at	IN	O
sas	JJ	O
general	JJ	O
hospital	NN	O
proceeding	VBG	O
currently	RB	O
.	.	O

#	#	O
3.	CD	O
history	NN	O
of	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

in	IN	O
december	NN	O
1990	CD	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
lumpectomy	NN	I-TREATMENT
,	,	I-TREATMENT
from	IN	I-TREATMENT
left	VBN	I-TREATMENT
breast	NN	I-TREATMENT
,	,	O
and	CC	O
xrt	NNP	B-TREATMENT
x	NNP	O
35	CD	O
.	.	O

no	DT	O
axillary	JJ	B-TREATMENT
dissection	NN	I-TREATMENT
was	VBD	O
done	VBN	O
because	IN	O
she	PRP	O
was	VBD	O
status	NN	O
post	NN	O
mi	NN	B-PROBLEM
.	.	O

she	PRP	O
received	VBD	O
tamoxifen	JJ	B-TREATMENT
briefly	NN	O
.	.	O

mammogram	NN	B-TEST
was	VBD	O
normal	JJ	O
7/92	CD	O
,	,	O
and	CC	O
5/92	CD	O
.	.	O

she	PRP	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
amoxicillin	VB	B-TREATMENT
,	,	O
having	VBG	O
developed	VBN	O
a	DT	B-PROBLEM
rash	NN	I-PROBLEM
,	,	O
does	VBZ	O
not	RB	O
smoke	VB	O
,	,	O
does	VBZ	O
not	RB	O
drink	VB	O
.	.	O

dyazide	RB	B-TREATMENT
one	CD	O
p.o.	NN	O
q.d.	NN	O
propanolol	NN	B-TREATMENT
5	CD	O
mg.	NN	O
p.o.	NN	O
t.i.d.	NN	O
isordil	NN	B-TREATMENT
5	CD	O
mg.	NN	O
p.o.	NN	O
t.i.d.	NN	O
glaucoma	NN	B-TREATMENT
drops	NNS	I-TREATMENT
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
118/75	CD	O
,	,	O
pulse	RB	B-TEST
88	CD	O
,	,	O
respirations	NNS	B-TEST
20	CD	O
,	,	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
and	CC	I-TEST
neck	NN	I-TEST
exam	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
,	,	O
except	IN	O
for	IN	O
the	DT	O
right	NN	O
eye	NN	O
being	VBG	O
patched	VBN	O
over	IN	O
.	.	O

back	RB	O
was	VBD	O
nontender	NN	B-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
jugular	JJ	B-TEST
venous	JJ	I-TEST
pressure	NN	I-TEST
was	VBD	O
normal	JJ	O
,	,	O
no	DT	O
carotid	NN	B-PROBLEM
bruit	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
;	:	O
murmur	NNS	B-PROBLEM
,	,	O
rub	NN	B-PROBLEM
,	,	O
gallop	NN	B-PROBLEM
,	,	O
click	NN	B-PROBLEM
and	CC	O
ectopy	NN	B-PROBLEM
were	VBD	O
absent	JJ	O
.	.	O

rectal	JJ	B-TEST
tone	NN	I-TEST
was	VBD	O
normal	JJ	O
,	,	O
guaiac	JJ	B-TEST
negative	JJ	O
stool	NN	O
.	.	O

without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
or	CC	O
stigmata	NN	B-PROBLEM
of	IN	O
subacute	JJ	B-PROBLEM
bacterial	JJ	I-PROBLEM
endocarditis	NN	I-PROBLEM
.	.	O

extensive	JJ	B-TEST
mental	NN	I-TEST
status	NN	I-TEST
testing	VBG	I-TEST
was	VBD	O
normal	JJ	O
,	,	O
except	IN	O
for	IN	O
recalling	VBG	O
only	RB	O
one	CD	O
out	NN	O
of	IN	O
three	CD	O
objects	NNS	O
at	IN	O
five	CD	O
minutes	NNS	O
.	.	O

there	EX	O
was	VBD	O
a	DT	O
touch	JJ	O
an	DT	B-PROBLEM
anosognosia	NN	I-PROBLEM
.	.	O

visual	JJ	O
fields	NNS	O
were	VBD	O
full	JJ	O
o.s.	NN	O
,	,	O
visual	JJ	B-TEST
acuity	NN	I-TEST
was	VBD	O
20/70	CD	O
o.s.	NN	O

pupil	JJ	B-TEST
o.s.	RB	I-TEST
reacted	VBD	O
to	TO	O
light	NN	O
.	.	O

eoms	NNS	O
with	IN	O
full	JJ	O
range	NN	O
of	IN	O
movement	NN	O
,	,	O
no	DT	O
nystagmus	NN	B-PROBLEM
.	.	O

inferior	JJ	B-PROBLEM
left	VBD	I-PROBLEM
weak	JJ	I-PROBLEM
.	.	O

no	DT	O
gag	NN	B-PROBLEM
was	VBD	O
present	JJ	O
.	.	O

dtrs	NN	B-TEST
showed	VBD	O
a	DT	O
mild	JJ	O
decrease	NN	O
in	IN	O
left	JJ	B-PROBLEM
biceps	NNS	I-PROBLEM
and	CC	I-PROBLEM
brachioradialis	NN	I-PROBLEM
reflexes	NNS	I-PROBLEM
,	,	O
otherwise	RB	O
normal	JJ	O
tone	NN	O
,	,	O
symmetrical	JJ	O
reflexes	NNS	O
,	,	O
downgoing	VBG	O
toes	NNS	O
.	.	O

no	DT	O
atrophy	NN	B-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

sensory	NN	B-TEST
exam	NN	I-TEST
showed	VBD	O
some	DT	O
leftsided	JJ	B-PROBLEM
errors	NNS	I-PROBLEM
with	IN	O
pinprick	NN	O
and	CC	O
proprioception	NN	O
.	.	O

finger	NN	B-TEST
/	VBD	I-TEST
to/nose	NN	I-TEST
was	VBD	O
with	IN	O
mild	JJ	B-PROBLEM
dysmetria	NNS	I-PROBLEM
,	,	O
exaggerated	VBN	O
on	IN	O
tracking	VBG	O
;	:	O
rapid	JJ	O
alternating	VBG	O
movements	NNS	O
normal	JJ	O
,	,	O
heel-to-shin	JJ	B-TEST
was	VBD	O
good	JJ	O
with	IN	O
few	JJ	B-PROBLEM
errors	NNS	I-PROBLEM
.	.	O

chest	NN	B-TEST
xray	NN	I-TEST
showed	VBD	O
expanded	JJ	O
lungs	NNS	O
with	IN	O
biapical	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
opacities	NNS	I-PROBLEM
.	.	O

ekg	NN	B-TEST
:	:	O

left	VBN	B-PROBLEM
bundle	JJ	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

bun	NN	B-TEST
27	CD	O
,	,	O
with	IN	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
.9	NNP	O
,	,	O
glucose	NN	B-TEST
was	VBD	O
182	CD	O
,	,	O
but	CC	O
otherwise	RB	O
electrolytes	NNS	B-TEST
were	VBD	O
normal	JJ	O
.	.	O

her	PRP$	B-TEST
admitting	VBG	I-TEST
hematocrit	NN	I-TEST
was	VBD	O
45%	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
7,700	CD	O
,	,	O
with	IN	O
an	DT	B-TEST
mcv	NN	I-TEST
of	IN	O
92	CD	O
,	,	O
platelets	NNS	B-TEST
were	VBD	O
normal	JJ	O
at	IN	O
263,000	CD	O
.	.	O

albumin	RB	B-TEST
2.5	CD	O
.	.	O

#	#	O
1.	CD	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
suffered	VBD	O
some	DT	B-PROBLEM
mild	NN	I-PROBLEM
weakness	NN	I-PROBLEM
which	WDT	O
was	VBD	O
attributed	VBN	O
to	TO	O
stenosis	NN	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
right	JJ	I-PROBLEM
internal	JJ	I-PROBLEM
carotid	NN	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
determined	VBN	O
by	IN	O
head	NN	B-TEST
ct	NN	I-TEST
,	,	O
head	NN	B-TEST
mri	NN	I-TEST
,	,	O
head	NN	B-TEST
mra	NN	I-TEST
,	,	O
carotid	VBP	B-TEST
noninvasive	JJ	I-TEST
studies	NNS	I-TEST
,	,	O
transcranial	JJ	B-TEST
dopplers	NNS	I-TEST
.	.	O

the	DT	O
possibility	NN	O
of	IN	O
a	DT	O
cardiac	JJ	O
origin	NN	O
was	VBD	O
evaluated	VBN	O
by	IN	O
echocardiogram	NN	B-TEST
and	CC	O
holter	NN	B-TEST
monitor	NN	I-TEST
.	.	O

her	PRP$	B-TEST
echocardiogram	NN	I-TEST
curiously	RB	O
showed	VBD	O
a	DT	O
normal	JJ	O
left	JJ	O
ventricular	JJ	O
size	NN	O
and	CC	O
systolic	JJ	O
function	NN	O
,	,	O
a	DT	B-PROBLEM
patent	NN	I-PROBLEM
foramen	NNS	I-PROBLEM
ovale	JJ	I-PROBLEM
,	,	O
with	IN	O
a	DT	B-PROBLEM
trace	NN	I-PROBLEM
right	NN	I-PROBLEM
to	TO	I-PROBLEM
left	VB	I-PROBLEM
shunt	NN	I-PROBLEM
,	,	O
as	IN	O
determined	VBN	O
by	IN	O
bubble	JJ	B-TEST
study	NN	I-TEST
,	,	O
trace	NN	B-PROBLEM
mr	NN	I-PROBLEM
was	VBD	O
present	JJ	O
.	.	O

previous	JJ	B-TEST
echoes	NNS	I-TEST
have	VBP	O
shown	VBN	O
mvp	NNS	B-PROBLEM
at	IN	O
the	DT	O
ona	JJ	O
hospital	NN	O
.	.	O

her	PRP$	B-TEST
holter	NN	I-TEST
showed	VBD	O
up	IN	O
to	TO	O
12	CD	O
beats	NNS	O
of	IN	O
svt	NN	B-PROBLEM
,	,	O
but	CC	O
was	VBD	O
otherwise	RB	O
unremarkable	JJ	O
.	.	O

she	PRP	O
was	VBD	O
anticoagulated	VBN	O
with	IN	O
heparin	NN	B-TREATMENT
and	CC	O
after	IN	O
several	JJ	O
days	NNS	O
coumadin	NN	B-TREATMENT
was	VBD	O
started	VBN	O
.	.	O

her	PRP$	B-TREATMENT
exact	JJ	I-TREATMENT
coumadin	NN	I-TREATMENT
dose	NN	I-TREATMENT
is	VBZ	O
undetermined	VBN	O
at	IN	O
this	DT	O
point	NN	O
,	,	O
however	RB	O
it	PRP	O
looks	VBZ	O
like	IN	O
it	PRP	O
will	MD	O
be	VB	O
something	NN	O
around	IN	O
5	CD	O
mg	NNS	O
a	DT	O
day	NN	O
.	.	O

her	PRP$	B-TEST
pro	JJ	I-TEST
time	NN	I-TEST
and	CC	O
ptt	NNS	B-TEST
have	VBP	O
normalized	VBN	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

she	PRP	O
needs	VBZ	O
to	TO	O
be	VB	O
given	VBN	O
5	CD	O
mg	NN	O
of	IN	O
coumadin	NN	B-TREATMENT
tonight	NN	O
,	,	O
5/22/92	CD	O
.	.	O

in	IN	O
addition	NN	O
heparin	NN	B-TREATMENT
should	MD	O
be	VB	O
started	VBN	O
to	TO	O
drip	VB	O
on	IN	O
arrival	NN	O
at	IN	O
400	CD	O
units	NNS	O
an	DT	O
hour	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
received	VBN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
her	PRP$	O
recovery	NN	O
is	VBZ	O
near	IN	O
complete	JJ	O
.	.	O

during	IN	O
evaluation	NN	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
neurologic	JJ	I-TEST
status	NN	I-TEST
,	,	O
it	PRP	O
was	VBD	O
determined	VBN	O
that	IN	O
for	IN	O
several	JJ	O
months	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
been	VBN	O
too	RB	B-PROBLEM
unsteady	JJ	I-PROBLEM
to	TO	I-PROBLEM
ambulate	VB	I-PROBLEM
.	.	O

on	IN	B-TEST
our	PRP$	I-TEST
exam	NN	I-TEST
she	PRP	O
is	VBZ	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
significant	JJ	O
amount	NN	O
of	IN	O
ataxia	NN	B-PROBLEM
,	,	O
especially	RB	O
in	IN	O
the	DT	O
midline	NN	O
and	CC	O
the	DT	O
exact	JJ	O
cause	NN	O
of	IN	O
this	DT	O
is	VBZ	O
unknown	JJ	O
.	.	O

there	EX	O
are	VBP	O
multiple	JJ	O
possible	JJ	O
contributions	NNS	O
and	CC	O
this	DT	O
is	VBZ	O
where	WRB	O
her	PRP$	O
need	NN	O
for	IN	O
careful	JJ	B-TEST
internal	JJ	I-TEST
medical	JJ	I-TEST
evaluation	NN	I-TEST
has	VBZ	O
arisen	VBN	O
.	.	O

at	IN	O
the	DT	O
time	NN	O
we	PRP	O
were	VBD	O
to	TO	O
embark	VB	O
on	IN	O
this	DT	B-TEST
evaluation	NN	I-TEST
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
family	NN	O
strongly	RB	O
requested	VBD	O
that	IN	O
she	PRP	O
be	VB	O
transferred	VBN	O
to	TO	O
the	DT	O
sas	NN	O
general	JJ	O
hospital	NN	O
.	.	O

what	WP	O
follows	VBZ	O
is	VBZ	O
a	DT	O
summary	NN	O
of	IN	O
her	PRP$	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
and	CC	O
their	PRP$	O
possible	JJ	O
relationship	NN	O
to	TO	O
her	PRP$	B-PROBLEM
ataxia	NN	I-PROBLEM
.	.	O

her	PRP$	B-PROBLEM
ataxia	NN	I-PROBLEM
is	VBZ	O
likely	JJ	O
due	JJ	O
to	TO	O
some	DT	O
cerebellar	JJ	O
function	NN	O
,	,	O
though	IN	O
this	DT	O
is	VBZ	O
not	RB	O
certain	JJ	O
.	.	O

moreover	RB	O
her	PRP$	B-TEST
mri	NN	I-TEST
did	VBD	O
not	RB	O
show	VB	O
any	DT	B-PROBLEM
discrete	JJ	I-PROBLEM
cerebellar	JJ	I-PROBLEM
lesions	NNS	I-PROBLEM
.	.	O

our	PRP$	O
leading	VBG	O
theory	NN	O
at	IN	O
this	DT	O
point	NN	O
is	VBZ	O
that	IN	O
her	PRP$	B-PROBLEM
cerebellar	JJ	I-PROBLEM
dysfunction	NN	I-PROBLEM
relates	VBZ	O
to	TO	O
perineoplastic	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
relating	VBG	O
to	TO	O
her	PRP$	O
history	NN	O
of	IN	O
breast	NN	B-PROBLEM
ca	MD	I-PROBLEM
.	.	O

as	IN	O
i	NN	O
mentioned	VBD	O
above	IN	O
,	,	O
her	PRP$	B-TEST
evaluation	NN	I-TEST
was	VBD	O
limited	VBN	O
by	IN	O
her	PRP$	O
cardiologic	NN	O
status	NN	O
at	IN	O
the	DT	O
time	NN	O
.	.	O

while	IN	O
mammogram	NNS	B-TEST
and	CC	O
ca-15.3	NN	B-TEST
and	CC	O
breast	NN	B-TEST
exam	NNS	I-TEST
are	VBP	O
all	DT	O
normal	JJ	O
,	,	O
the	DT	O
idea	NN	O
of	IN	O
a	DT	B-PROBLEM
perineoplastic	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
or	CC	O
without	IN	O
concomitant	JJ	B-PROBLEM
breast	NN	I-PROBLEM
ca	MD	I-PROBLEM
has	VBZ	O
reared	VBN	O
its	PRP$	O
head	NN	O
.	.	O

two	CD	O
possible	JJ	O
markers	NNS	O
are	VBP	O
anti-hu	JJ	B-PROBLEM
syndrome	JJ	I-PROBLEM
and	CC	O
anti-yo	JJ	B-TEST
antibody	NN	I-TEST
.	.	O

these	DT	B-TEST
tests	NNS	I-TEST
were	VBD	O
sent	VBN	O
on	IN	O
the	DT	O
18th	CD	O
and	CC	O
are	VBP	O
pending	VBG	O
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
.	.	O

the	DT	B-TEST
results	NNS	I-TEST
can	MD	O
be	VB	O
obtained	VBN	O
by	IN	O
paging	VBG	O
me	PRP	O
,	,	O
do	VBP	O
a.	JJ	O
joasscchird	NN	O
,	,	O
m.d.	NN	O
at	IN	O
834-364-2251	JJ	O
.	.	O

i	NN	O
will	MD	O
be	VB	O
happy	JJ	O
to	TO	O
furnish	VB	O
the	DT	B-TEST
results	NNS	I-TEST
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
mi	NN	B-PROBLEM
in	IN	O
1989	CD	O
.	.	O

echocardiogram	NN	B-TEST
no	RB	O
longer	RBR	O
shows	VBZ	O
wall	DT	B-PROBLEM
motion	NN	I-PROBLEM
abnormalities	NNS	I-PROBLEM
.	.	O

ekg	NN	B-TEST
,	,	O
when	WRB	O
the	DT	O
patient	NN	O
goes	VBZ	O
out	IN	O
of	IN	O
left	JJ	B-PROBLEM
bundle	JJ	I-PROBLEM
branch	NN	I-PROBLEM
block	NN	I-PROBLEM
transiently	RB	O
shows	VBZ	O
an	DT	B-PROBLEM
anterolateral	JJ	I-PROBLEM
q/wave	NN	I-PROBLEM
inversion	NN	I-PROBLEM
.	.	O

we	PRP	O
would	MD	O
like	VB	O
to	TO	O
discontinue	VB	O
her	PRP$	B-TREATMENT
isordil	NN	I-TREATMENT
to	TO	O
improve	VB	O
upon	IN	O
some	DT	B-PROBLEM
orthostatic	JJ	I-PROBLEM
hypotension	NN	I-PROBLEM
,	,	O
but	CC	O
we	PRP	O
are	VBP	O
not	RB	O
certain	JJ	O
whether	IN	O
her	PRP$	O
heart	NN	O
will	MD	O
tolerate	VB	O
this	DT	O
.	.	O

persantine	NN	B-TEST
thallium	NN	I-TEST
is	VBZ	O
scheduled	VBN	O
at	IN	O
this	DT	O
time	NN	O
,	,	O
but	CC	O
is	VBZ	O
yet	RB	O
to	TO	O
be	VB	O
performed	VBN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
orthostatic	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
x	NNP	O
many	JJ	O
years	NNS	O
.	.	O

during	IN	O
her	PRP$	O
hospitalization	NN	O
,	,	O
we	PRP	O
confirmed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
this	DT	O
,	,	O
even	RB	O
when	WRB	O
she	PRP	O
was	VBD	O
hydrated	VBN	O
with	IN	O
saline	NN	B-TREATMENT
,	,	O
to	TO	O
a	DT	B-TEST
fractional	JJ	I-TEST
excretion	NN	I-TEST
of	IN	I-TEST
sodium	NN	I-TEST
of	IN	O
2%	CD	O
.	.	O

studies	NNS	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
autonomic	JJ	I-TEST
system	NN	I-TEST
did	VBD	O
not	RB	O
document	VB	O
any	DT	B-PROBLEM
dysautonomia	NN	I-PROBLEM
.	.	O

studies	NNS	B-TEST
of	IN	I-TEST
skin	NN	I-TEST
galvanic	JJ	I-TEST
conduction	NN	I-TEST
were	VBD	O
normal	JJ	O
and	CC	O
her	PRP$	B-TEST
rr	NN	I-TEST
interval	JJ	I-TEST
evaluation	NN	I-TEST
was	VBD	O
not	RB	O
abnormal	JJ	B-PROBLEM
.	.	O

this	DT	O
is	VBZ	O
a	DT	B-PROBLEM
chronic	JJ	I-PROBLEM
problem	NN	I-PROBLEM
but	CC	O
may	MD	O
be	VB	O
contributing	VBG	O
to	TO	O
her	PRP$	B-PROBLEM
current	JJ	I-PROBLEM
weakness	NN	I-PROBLEM
and	CC	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
walk	VB	I-PROBLEM
.	.	O

florinef	NN	B-TREATMENT
is	VBZ	O
to	TO	O
be	VB	O
considered	VBN	O
,	,	O
however	RB	O
stopping	VBG	O
the	DT	B-TREATMENT
isordil	NN	I-TREATMENT
is	VBZ	O
one	CD	O
goal	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
bronchiectasis	NN	B-PROBLEM
from	IN	O
a	DT	B-PROBLEM
childhood	NN	I-PROBLEM
pneumonia	NN	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
there	EX	O
is	VBZ	O
a	DT	O
distant	JJ	O
history	NN	O
of	IN	O
m.	NN	B-PROBLEM
kansasaii	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

this	DT	O
has	VBZ	O
been	VBN	O
evaluated	VBN	O
by	IN	O
dr.	NN	O
screen	NN	O
at	IN	O
sas	JJ	O
general	JJ	O
hospital	NN	O
and	CC	O
probably	RB	O
relates	VBZ	O
to	TO	O
her	PRP$	B-TEST
lung	NN	I-TEST
xray	NN	I-TEST
.	.	O

ct	NN	B-TEST
at	IN	O
the	DT	O
ona	JJ	O
hospital	NN	O
in	IN	O
1989	CD	O
showed	VBD	O
similar	JJ	O
findings	NNS	O
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
ct	NN	I-TEST
was	VBD	O
to	TO	O
be	VB	O
performed	VBN	O
and	CC	O
may	MD	O
be	VB	O
yielding	VBG	O
.	.	O

a	DT	B-TEST
ppd	NN	I-TEST
was	VBD	O
placed	VBN	O
and	CC	O
is	VBZ	O
to	TO	O
be	VB	O
read	VBN	O
on	IN	O
saturday	NN	O
,	,	O
4	CD	O
26th	CD	O
.	.	O

the	DT	O
left	NN	O
volar	JJ	O
forearm	NN	O
has	VBZ	O
the	DT	B-TEST
ppd	NN	I-TEST
just	RB	O
proximal	JJ	O
to	TO	O
the	DT	O
wrist	NN	O
crease	NN	O
and	CC	O
a	DT	B-TEST
candida	NN	I-TEST
albicans	VBZ	I-TEST
placed	VBN	O
just	RB	O
distal	JJ	O
to	TO	O
the	DT	O
antecubital	JJ	O
fossa	NN	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
in	IN	O
1990	CD	O
,	,	O
for	IN	O
which	WDT	O
she	PRP	O
received	VBD	O
6	CD	O
months	NNS	O
of	IN	O
coumadin	NN	B-TREATMENT
.	.	O

dopplers	NNS	B-TEST
of	IN	I-TEST
her	PRP$	I-TEST
lower	JJR	I-TEST
extremities	NNS	I-TEST
were	VBD	O
negative	JJ	O
on	IN	O
this	DT	O
admission	NN	O
.	.	O

it	PRP	O
is	VBZ	O
doubtful	JJ	O
that	IN	O
she	PRP	O
has	VBZ	O
chronic	JJ	B-PROBLEM
pe	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
is	VBZ	O
one	CD	O
consideration	NN	O
.	.	O

it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
she	PRP	O
has	VBZ	O
pulmonary	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
from	IN	O
her	PRP$	B-PROBLEM
lung	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
and	CC	O
so	RB	O
this	DT	O
is	VBZ	O
a	DT	O
consideration	NN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
mild	JJ	B-PROBLEM
hyponatremia	NN	I-PROBLEM
during	IN	O
this	DT	O
hospitalization	NN	O
with	IN	O
a	DT	B-TEST
sodium	NN	I-TEST
as	RB	O
low	JJ	O
as	IN	O
131	CD	O
.	.	O

we	PRP	O
think	VBP	O
this	DT	O
is	VBZ	O
likely	JJ	O
due	JJ	O
to	TO	O
an	DT	B-PROBLEM
siadh	NN	I-PROBLEM
as	IN	O
she	PRP	O
is	VBZ	O
euvolemic	JJ	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
glaucoma	VBN	B-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
are	VBP	O
as	IN	O
listed	VBN	O
below	IN	O
.	.	O

propanolol	NN	B-TREATMENT
5	CD	O
mg.	NN	O
p.o.	NN	O
t.i.d.	NN	O
[	NNP	O
hold	NN	O
for	IN	O
sbp	NN	B-TEST
less	JJR	O
than	IN	O
110	CD	O
]	NNS	O
,	,	O
isosorbide	RB	B-TREATMENT
5	CD	O
mg.	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
,	,	O
hold	NN	O
for	IN	O
sbp	NN	B-TEST
less	JJR	O
than	IN	O
110	CD	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg.	NN	O
p.o.	NN	O
b.i.d.	NN	O
pilocarpine	NN	B-TREATMENT
4%	CD	O
one	CD	O
drop	NN	O
q.i.d.	NN	O
o.d.	JJ	O
pilocarpine	NN	B-TREATMENT
2%	CD	O
one	CD	O
drop	NN	O
b.i.d.	VBD	O
o.s.	JJ	O
betasan	JJ	B-TREATMENT
0.5%	CD	O
one	CD	O
drop	NN	O
b.i.d.	NN	O
o.d.	NN	O
.	.	O

bacitracin	NN	B-TREATMENT
ointment	NN	I-TREATMENT
one	CD	O
drop	NN	O
o.d.	VBD	O
q.h.s.	JJ	O
ciprofloxacin	NN	B-TREATMENT
500	CD	O
mg.	NN	O
one	CD	O
p.o.	NN	O
b.i.d.	NN	O
x	VBD	O
four	CD	O
more	JJR	O
days	NNS	O
[	VBP	O
until	IN	O
5/25/92	CD	O
]	NNS	O
,	,	O
for	IN	O
recently	RB	B-PROBLEM
discovered	VBN	I-PROBLEM
siderobacter	NN	I-PROBLEM
uti	NN	I-PROBLEM
.	.	O

coumadin	NN	B-TREATMENT
5	CD	O
mg.	NN	O
p.o.	NN	O
q.h.s.	NN	O

she	PRP	O
needs	VBZ	O
her	PRP	B-TREATMENT
dose	NN	I-TREATMENT
on	IN	O
5/22/92	CD	O
.	.	O

heparin	NN	B-TREATMENT
i.v.	NN	I-TREATMENT
drip	NN	I-TREATMENT
at	IN	O
400	CD	O
units	NNS	O
per	IN	O
hour	NN	O
,	,	O
on	IN	O
her	PRP$	O
arrival	NN	O
.	.	O

in	IN	O
addition	NN	O
the	DT	O
patient	NN	O
requires	VBZ	O
occupational	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

amoxicillin	NN	B-PROBLEM
rash	NN	I-PROBLEM
.	.	O

small	JJ	B-PROBLEM
stroke	NN	I-PROBLEM
,	,	O
nearly	RB	O
recovered	VBN	O
,	,	O
likely	JJ	O
embolic	NN	B-PROBLEM
from	IN	I-PROBLEM
carotid	JJ	I-PROBLEM
artery	NN	I-PROBLEM
.	.	O

glaucoma	NN	B-PROBLEM
,	,	O
under	IN	O
therapy	NN	B-TREATMENT
,	,	O
status	NN	O
post	NN	O
laser	NN	B-TREATMENT
surgery	NN	I-TREATMENT
o.d.	NN	I-TREATMENT

orthostatic	JJ	B-PROBLEM
hypotension	NN	I-PROBLEM
.	.	O

ataxia	NN	B-PROBLEM
with	IN	O
gait	JJ	B-PROBLEM
abnormality	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
breast	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
atypical	JJ	B-PROBLEM
mycobacterial	JJ	I-PROBLEM
colonization	NN	I-PROBLEM
.	.	O

history	NN	O
of	IN	O
dvt	NN	B-PROBLEM
.	.	O

hyponatremia	NN	B-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
with	IN	O
mi	NN	B-PROBLEM
in	IN	O
1989	CD	O
.	.	O

medicine	NN	B-TREATMENT

morphine	NN	B-TREATMENT
/	CD	O
latex	NN	B-TREATMENT

gib	NN	B-PROBLEM
,	,	O
hematemesis	NN	B-PROBLEM

egd	NN	B-TEST
with	IN	O
esophageal	JJ	B-TREATMENT
varices	NNS	I-TREATMENT
sclerosis	NN	I-TREATMENT

42	CD	O
year	NN	O
old	JJ	O
female	NN	O
with	IN	O
h/o	JJ	O
cholangiocarcinoma	NN	B-PROBLEM
dx	NN	O
in	IN	O
2009	CD	O
s/p	NN	O
resection	NN	B-TREATMENT
,	,	O
with	IN	O
recent	JJ	B-TEST
ct	NNS	I-TEST
showing	VBG	O
met	VBD	B-PROBLEM
cholangiocarcinoma	NN	I-PROBLEM
in	IN	O
9/2004	CD	O
.	.	O

pt	NN	O
was	VBD	O
recently	RB	O
admitted	VBN	O
for	IN	O
fever	NN	B-PROBLEM
due	JJ	O
to	TO	O
cholangitis	VB	B-PROBLEM
on	IN	O
10-18	JJ	O
and	CC	O
had	VBD	O
chemo	NN	B-TREATMENT
(	(	O
cddp	NN	B-TREATMENT
and	CC	O
gemcitabine	NN	B-TREATMENT
)	)	O
on	IN	O
monday	NN	O
,	,	O
10-21	JJ	O
.	.	O

since	IN	O
chemo	NN	B-TREATMENT
pt	NN	O
has	VBZ	O
intermittent	VBN	B-PROBLEM
nausea	RB	I-PROBLEM
adequately	RB	O
controlled	VBN	O
by	IN	O
zofran	NN	B-TREATMENT
and	CC	O
compazine	NN	B-TREATMENT
.	.	O

pt	NN	O
was	VBD	O
doing	VBG	O
well	RB	O
till	VB	O
night	NN	O
of	IN	O
admission	NN	O
when	WRB	O
she	PRP	O
developed	VBD	O
nausea	NN	B-PROBLEM
/	NN	O
vomitting	NN	B-PROBLEM
and	CC	O
sizable	JJ	O
amount	NN	O
of	IN	O
hemoptysis	NN	B-PROBLEM
and	CC	O
clots	NNS	B-PROBLEM
.	.	O

has	VBZ	O
low	JJ	B-PROBLEM
grade	VBN	I-PROBLEM
fever	NN	I-PROBLEM
since	IN	O
chemo	NN	B-TREATMENT
but	CC	O
otherwise	RB	O
ros	NN	B-TEST
was	VBD	O
neg	JJ	O
for	IN	O
shaking	VBG	B-PROBLEM
chills	NNS	I-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
sob	NN	B-PROBLEM
,	,	O
coughing	VBG	B-PROBLEM
,	,	O
constipation	NN	B-PROBLEM
,	,	O
diarrhea	NN	B-PROBLEM
,	,	O
tarry	NN	B-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
abd	RB	B-PROBLEM
pain	NN	I-PROBLEM
.	.	O

pt	NN	O
has	VBZ	O
reported	VBN	O
gaining	VBG	O
30	CD	O
lbs	JJ	O
since	IN	O
08-31	JJ	O
due	JJ	O
to	TO	O
ascites	NNS	B-PROBLEM
.	.	O

in	IN	O
monica	NN	O
:	:	O
vitals	NNS	B-TEST
:	:	O
t	NN	B-TEST
98.8	CD	O
p	NN	B-TEST
98	CD	O
bp	NN	B-TEST
136/68	CD	O
r	NN	B-TEST
29	CD	O
sat	VBD	B-TEST
98%	CD	O
rapt	NN	O
had	VBD	O
ng	VBN	B-TREATMENT
lavage	NN	I-TREATMENT
which	WDT	O
evantually	RB	O
cleared	VBD	O
up	RP	O
,	,	O
also	RB	O
was	VBD	O
transfused	VBN	O
1u	CD	B-TREATMENT
prbc	NN	I-TREATMENT
,	,	O
gi	NN	O
consult	NN	O
called	VBN	O
,	,	O
also	RB	O
got	VBD	O
zofran	NN	B-TREATMENT
and	CC	O
iv	JJ	B-TREATMENT
protonix	NN	I-TREATMENT
.	.	O

1.	CD	O
ca	MD	O
hx-klatskin	JJ	B-PROBLEM
tumor	NN	I-PROBLEM
originally	RB	O
diagnosed	VBD	O
2010-08-28	JJ	O
after	IN	O
presenting	VBG	O
with	IN	O
painless	JJ	B-PROBLEM
jaundice	NN	I-PROBLEM
.	.	O

2010-10-01	JJ	O
pt	NN	O
underwent	JJ	O
ex.	NN	B-TEST
lap	NN	I-TEST
with	IN	O
en	JJ	B-TREATMENT
bloc	NN	I-TREATMENT
resection	NN	I-TREATMENT
of	IN	I-TREATMENT
l	NN	I-TREATMENT
liver	NN	I-TREATMENT
lobe	NN	I-TREATMENT
,	,	I-TREATMENT
biliary	JJ	I-TREATMENT
tree	NN	I-TREATMENT
,	,	I-TREATMENT
and	CC	I-TREATMENT
portal	JJ	I-TREATMENT
vein	NN	I-TREATMENT
.	.	O

reconstructed	VBN	B-TREATMENT
portal	JJ	I-TREATMENT
vein	NN	I-TREATMENT
followed	VBN	O
by	IN	O
roux-en-y	JJ	B-TREATMENT
hepaticojejunostomy	NN	I-TREATMENT
.	.	O

per	IN	O
notes	NNS	O
,	,	O
pathology	NN	B-TEST
demonstrated	VBD	O
biliary	JJ	B-PROBLEM
ductal	JJ	I-PROBLEM
adenocarcinoma	NN	I-PROBLEM
(	(	O
t3n0m0	NN	B-PROBLEM
)	)	O
stage	NN	O
margit	NN	O
.	.	O

since	IN	O
presentation	NN	O
,	,	O
patient	NN	O
had	VBD	O
multiple	JJ	O
episodes	NNS	O
of	IN	O
cholangitis	NN	B-PROBLEM
(	(	O
08-06	JJ	O
in	IN	O
past	JJ	O
3	CD	O
years	NNS	O
with	IN	O
last	JJ	O
on	IN	O
10-18	JJ	O
),	NNP	O
always	RB	O
short	RB	O
lived	VBD	O
and	CC	O
treated	VBD	O
with	IN	O
antimicrobial	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
ciprofloxacin	NN	B-TREATMENT
proph	NN	I-TREATMENT
for	IN	O
about	RB	O
1	CD	O
year	NN	O
.	.	O

followed	VBN	O
with	IN	O
yearly	JJ	B-TEST
abdominal	JJ	I-TEST
ct	NN	I-TEST
without	IN	O
radiographic	JJ	B-PROBLEM
progression	NN	I-PROBLEM
.	.	O

cat	NN	B-TEST
scan	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
2013-09-20	JJ	O
at	IN	O
kindred	VBN	O
park	NN	O
view	NN	O
specialty	NN	O
hospital	NN	O
of	IN	O
springfield	NN	O
,	,	O
which	WDT	O
revealed	VBD	O
that	IN	O
she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
recurrence	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
tumor	NN	I-PROBLEM
with	IN	O
occlusion	NN	B-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
portal	JJ	I-PROBLEM
vein	NN	I-PROBLEM
occluding	VBG	B-PROBLEM
bile	JJ	I-PROBLEM
ducts	NNS	I-PROBLEM
,	,	O
hepatic	JJ	B-PROBLEM
artery	NN	I-PROBLEM
nearly	RB	I-PROBLEM
completely	RB	I-PROBLEM
occluded	VBN	I-PROBLEM
,	,	O
and	CC	O
much	JJ	B-PROBLEM
ascites	NNS	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
diuretics	NNS	B-TREATMENT
.	.	O

she	PRP	O
was	VBD	O
was	VBD	O
seen	VBN	O
at	IN	O
hallmark	NN	O
health	NN	O
system	NN	O
heme	JJ	O
/	NN	O
on	IN	O
clinic	JJ	O
10-09	JJ	O
and	CC	O
had	VBD	O
repeat	NN	B-TEST
ct	NNS	I-TEST
scan	JJ	I-TEST
which	WDT	O
revealed	VBD	O
metastatic	JJ	B-PROBLEM
cholangiocarcinoma	NN	I-PROBLEM
with	IN	O
mets	NNS	B-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
ovaries	NNS	I-PROBLEM
,	,	O
with	IN	O
tremendous	JJ	B-PROBLEM
increase	NN	I-PROBLEM
in	IN	I-PROBLEM
metastatic	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

there	RB	O
was	VBD	O
there	EX	O
was	VBD	O
obstructive	JJ	B-PROBLEM
uropathy	JJ	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
side	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
questionable	JJ	O
gastric	JJ	B-PROBLEM
outlet	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
and	CC	O
peritoneal	JJ	B-PROBLEM
carcinomatosis	NN	I-PROBLEM
.	.	O

2.	CD	O
cholecystectomy	NN	B-TREATMENT
at	IN	O
age	NN	O
25	CD	O

3.	CD	O
mva-multiple	JJ	B-TREATMENT
orthopedic	NN	I-TREATMENT
procedures	NNS	I-TREATMENT

4.	CD	O
strabismus	NN	B-PROBLEM

her	PRP$	O
maternal	JJ	O
grandmother	NN	O
had	VBD	O
breast	VBN	B-PROBLEM
cancer	NN	I-PROBLEM
in	IN	O
her	PRP$	O
80	CD	O
s	NN	O
and	CC	O
her	PRP$	O
dad	NN	O
's	POS	O
grandmother	NN	O
had	VBD	O
stomach	NN	B-PROBLEM
cancer	NN	I-PROBLEM
and	CC	O
died	VBD	O
in	IN	O
her	PRP$	O
50	CD	O
s.	NN	O

on	IN	O
her	PRP$	O
mom	NN	O
's	POS	O
side	NN	O
is	VBZ	O
an	DT	B-PROBLEM
extensive	JJ	I-PROBLEM
family	NN	I-PROBLEM
cardiac	JJ	I-PROBLEM
history	NN	I-PROBLEM
.	.	O

vital	NN	B-TEST
:	:	O
afebrile	NN	B-PROBLEM
,	,	O
96	CD	O
,	,	O
108/51	CD	O
,	,	O
o2sat99%ra	NN	B-TEST

general	JJ	O
:	:	O
pleasant	JJ	O
female	NN	O
in	IN	O
no	DT	O
apparent	JJ	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
jaundiced	VBD	B-PROBLEM
skin	NN	I-PROBLEM
.	.	O

heent	NN	O
:	:	O
sclera	NN	B-PROBLEM
icteric	NN	I-PROBLEM
,	,	O
op	JJ	O
clear	JJ	O
,	,	O
eomi	RB	O
,	,	O
perrl	NN	O
.	.	O

nodes	NNS	O
:	:	O
no	DT	O
supraclavicular	NN	B-PROBLEM
,	,	I-PROBLEM
submandibular	JJ	I-PROBLEM
,	,	I-PROBLEM
axillary	JJ	I-PROBLEM
or	CC	I-PROBLEM
inguinal	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

lungs	NNS	O
:	:	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

abdomen	NNS	O
:	:	O
soft	JJ	O
and	CC	O
distended	JJ	B-PROBLEM
,	,	O
but	CC	O
no	DT	O
actual	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

guaiac	NN	B-TEST
neg	NN	O
by	IN	O
monica	NN	O

back	RB	O
:	:	O
no	DT	O
cva	NN	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

extremities	NNS	O
:	:	O
no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
but	CC	O
+	NNP	O
edema	NN	B-PROBLEM
.	.	O

glucose	JJ	B-TEST
-	:	O
112	CD	O
*	JJ	O
urea	JJ	B-TEST
n	SYM	I-TEST
-	:	O
14	CD	O
creat	NN	B-TEST
-	:	O
0.8	CD	O
sodium	NN	B-TEST
-	:	O
133	CD	O
potassium	NN	B-TEST
-	:	O
4.0	CD	O
chloride	NN	B-TEST
-	:	O
97	CD	O
total	JJ	B-TEST
co2	NN	I-TEST
-	:	O
23	CD	O
anion	NN	B-TEST
gap	NN	I-TEST
-	:	O
17	CD	O

alt(sgpt)	SYM	B-TEST
-	:	O
149	CD	O
*	NN	O
ast(sgot)	SYM	B-TEST
-	:	O
83	CD	O
*	JJ	O
alk	NN	B-TEST
phos	SYM	I-TEST
-	:	O
663	CD	O
*	JJ	O
amylase	NN	B-TEST
-	:	O
37	CD	O
tot	NN	B-TEST
bili	SYM	I-TEST
-	:	O
8.2	CD	O
*	NN	O

lipase	NN	B-TEST
-	:	O
42	CD	O

iron	NN	B-TEST
-	:	O
52	CD	O

caltibc	SYM	B-TEST
-	:	O
230	CD	O
*	NN	O
ferritin	NN	B-TEST
-	:	O
197	CD	O
*	NN	O
trf	SYM	B-TEST
-	:	O
177	CD	O
*	NN	O

wbc	SYM	B-TEST
-	:	O
3.0	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
2.25	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
7.2	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
20.9	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
31.8	CD	O
mchc	SYM	B-TEST
-	:	O
34.3	CD	O
rdw	NN	B-TEST
-	:	O
14.7	CD	O

neuts	NNS	B-TEST
-	:	O
79.7	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
13.3	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
4.6	CD	O
eos	SYM	B-TEST
-	:	O
2.2	CD	O
basos	SYM	B-TEST
-	:	O
0.2	CD	O

hypochrom	SYM	B-TEST
-	:	O
1+	CD	O
anisocyt	JJ	B-TEST
-	:	O
normal	JJ	O
poikilocy	JJ	B-TEST
-	:	O
1+	CD	O
macrocyt	SYM	B-TEST
-	:	O
normal	JJ	O
microcyt	JJ	B-TEST
-	:	O
normal	JJ	O
polychrom	JJ	B-TEST
-	:	O
normal	JJ	O
ovalocyt	JJ	B-TEST
-	:	O
1+	CD	O

plt	NN	B-TEST
count	NN	I-TEST
-	:	O
88	CD	O
*	NN	O

pt	SYM	B-TEST
-	:	O
13.4	CD	O
ptt	NN	B-TEST
-	:	O
25.9	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.1	CD	O

ret	NN	B-TEST
aut	SYM	I-TEST
-	:	O
0.3	CD	O
*	NN	O

2013-10-27	JJ	O
01:30	CD	O
am	VBP	O
urine	JJ	B-TEST

color	NN	B-TEST
-	:	O
amber	NN	O
appear	VBP	B-TEST
-	:	O
slhazy	JJ	O
sp	NN	B-TEST
barajas	SYM	I-TEST
-	:	O
1.025	CD	O

2013-10-27	JJ	O
01:30	CD	O
am	VBP	O
urine	JJ	B-TEST

blood	NN	B-TEST
-	:	O
neg	NN	O
nitrite	JJ	B-TEST
-	:	O
pos	NN	O
protein	SYM	B-TEST
-	:	O
30	CD	O
glucose	JJ	B-TEST
-	:	O
neg	NN	O
ketone	NN	B-TEST
-	:	O
tr	NN	O
bilirubin	SYM	B-TEST
-	:	O
lg	NN	O
urobilngn	JJ	B-TEST
-	:	O
0.2	CD	O
ph	NN	B-TEST
-	:	O
5.5	CD	O
leuk	SYM	B-TEST
-	:	O
neg	NN	O

2013-10-27	JJ	O
01:30	CD	O
am	VBP	O
urine	JJ	B-TEST

rbc	LS	B-TEST
-	:	O
0-2	JJ	O
wbc	JJ	B-TEST
-	:	O
0-2	JJ	O
bacteria	NNS	B-TEST
-	:	O
mod	NN	O
yeast	SYM	B-TEST
-	:	O
none	NN	O
epi	SYM	B-TEST
-	:	O
03-01	JJ	O
renal	JJ	B-TEST
epi	NN	I-TEST
-	:	O
0-2	NN	O

2013-10-27	JJ	O
01:30	CD	O
am	VBP	O
urine	JJ	B-TEST

hyaline	JJ	B-TEST
-	:	O
0-2	NN	O

ct	NN	B-TEST
abd	NN	I-TEST
on	IN	O
2013-10-17	JJ	O
showed	NN	O
:	:	O

1.	CD	O
recurrent	NN	B-PROBLEM
cholangiocarcinoma	NN	I-PROBLEM
,	,	O
with	IN	O
intrahepatic	JJ	B-PROBLEM
bile	NN	I-PROBLEM
duct	NN	I-PROBLEM
dilatation	NN	I-PROBLEM
and	CC	O
gastric	JJ	B-PROBLEM
outlet	NN	I-PROBLEM
obstruction	NN	I-PROBLEM
;	:	O
exact	JJ	O
extent	NN	O
of	IN	O
disease	NN	B-PROBLEM
is	VBZ	O
unclear	JJ	O
,	,	O
but	CC	O
likely	RB	O
extensive	JJ	O
.	.	O

no	DT	O
evidence	NN	O
of	IN	O
portal	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
is	VBZ	O
seen	VBN	O
.	.	O

2.	CD	O
large	JJ	B-PROBLEM
,	,	I-PROBLEM
cystic	JJ	I-PROBLEM
,	,	I-PROBLEM
multiseptated	JJ	I-PROBLEM
mass	NN	I-PROBLEM
arising	VBG	O
from	IN	O
the	DT	O
adnexa	NN	O
,	,	O
worrisome	NN	O
for	IN	O
second	JJ	B-PROBLEM
primary	JJ	I-PROBLEM
malignancy	NN	I-PROBLEM
.	.	O

3.	CD	O
ascites	NNS	B-PROBLEM
,	,	O
and	CC	O
intraperitoneal	JJ	B-PROBLEM
carcinomatosis	NN	I-PROBLEM
,	,	O
which	WDT	O
can	MD	O
arise	VB	O
from	IN	O
either	DT	O
of	IN	O
the	DT	O
two	CD	O
processes	NNS	O
described	VBN	O
above	IN	O
.	.	O

4.	CD	O
hiatal	JJ	B-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

blood	NN	B-TEST
wbc	SYM	B-TEST
-	:	O
2.2	CD	O
*	NN	O
rbc	NN	B-TEST
-	:	O
3.09	CD	O
*	NN	O
hgb	NN	B-TEST
-	:	O
9.6	CD	O
*	NN	O
hct	NN	B-TEST
-	:	O
28.7	CD	O
*	NN	O
mcv	SYM	B-TEST
-	:	O
93	CD	O
mch	SYM	B-TEST
-	:	O
31.2	CD	O
mchc	SYM	B-TEST
-	:	O
33.6	CD	O
rdw	NN	B-TEST
-	:	O
17.0	CD	O
*	JJ	O
plt	NN	B-TEST
ct	SYM	I-TEST
-	:	O
89	CD	O
*	NN	O

blood	NN	B-TEST
neuts	NNS	I-TEST
-	:	O
89.7	CD	O
*	NN	O
bands	NNS	B-TEST
-	:	O
0	CD	O
lymphs	SYM	B-TEST
-	:	O
6.9	CD	O
*	JJ	O
monos	NNS	B-TEST
-	:	O
2.6	CD	O
eos	SYM	B-TEST
-	:	O
0.2	CD	O
baso	SYM	B-TEST
-	:	O
0.7	CD	O

blood	NN	B-TEST
pt	SYM	I-TEST
-	:	O
15.2	CD	O
*	NN	O
ptt	NN	B-TEST
-	:	O
29.7	CD	O
inr(pt)	JJ	B-TEST
-	:	O
1.5	CD	O

blood	NN	B-TEST
glucose	VB	B-TEST
-	:	O
117	CD	O
*	JJ	O
urean	JJ	B-TEST
-	:	O
11	CD	O
creat	NN	B-TEST
-	:	O
0.9	CD	O
na	SYM	B-TEST
-	:	O
135	CD	O
k	SYM	B-TEST
-	:	O
3.5	CD	O
cl	NN	B-TEST
-	:	O
97	CD	O
hco3	NN	B-TEST
-	:	O
28	CD	O
angap	NN	B-TEST
-	:	O
14	CD	O

blood	NN	B-TEST
alkphos	SYM	B-TEST
-	:	O
431	CD	O
*	NN	O
totbili	SYM	B-TEST
-	:	O
7.8	CD	O
*	NN	O

blood	NN	B-TEST
calcium	NN	B-TEST
-	:	O
8.3	CD	O
*	NN	O
phos	NN	B-TEST
-	:	O
3.5	CD	O
mg	SYM	B-TEST
-	:	O
1.9	CD	O

blood	NN	B-TEST
caltibc	SYM	B-TEST
-	:	O
230	CD	O
*	NN	O
ferritn	SYM	B-TEST
-	:	O
197	CD	O
*	NN	O
trf	SYM	B-TEST
-	:	O
177	CD	O
*	NN	O

1)	CD	O
gi	JJ	O
-	:	O
in	IN	O
the	DT	O
monica	NN	O
pt	NN	O
had	VBD	O
hct	NN	B-TEST
of	IN	O
20	CD	O
and	CC	O
bloody	JJ	B-PROBLEM
ng	NN	I-PROBLEM
lavage	NN	I-PROBLEM
which	WDT	O
did	VBD	O
not	RB	O
clear	JJ	O
.	.	O

she	PRP	O
was	VBD	O
transfused	VBN	O
1u	CD	B-TREATMENT
prbc	NN	I-TREATMENT
,	,	O
gi	NN	O
consult	NN	O
called	VBN	O
,	,	O
also	RB	O
got	VBD	O
zofran	NN	B-TREATMENT
and	CC	O
iv	JJ	B-TREATMENT
protonix	NN	I-TREATMENT
and	CC	O
admitted	VBN	O
to	TO	O
the	DT	O
ficu	NN	O
.	.	O

on	IN	O
arrival	NN	O
to	TO	O
unit	NN	O
pt	NN	O
had	VBD	O
egd	CC	B-TEST
which	WDT	O
revealed	VBD	O
grade	NN	B-PROBLEM
iii	NN	I-PROBLEM
esophageal	NN	I-PROBLEM
varices	NNS	I-PROBLEM
with	IN	O
signs	NNS	O
of	IN	O
old	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
octreotide	NN	B-TREATMENT
and	CC	O
nadolol	NN	B-TREATMENT
to	TO	O
control	VB	O
portal	JJ	B-PROBLEM
htn	NN	I-PROBLEM
.	.	O

pt	NN	O
was	VBD	O
stable	JJ	O
and	CC	O
had	VBD	O
appropriate	JJ	O
hct	NNS	B-PROBLEM
bump	VBP	I-PROBLEM
to	TO	O
25	CD	O
after	IN	O
2u	CD	B-TREATMENT
prbc	NN	I-TREATMENT
's.	NN	I-TREATMENT

she	PRP	O
also	RB	O
had	VBD	O
climbing	VBG	B-PROBLEM
bilirubin	NN	I-PROBLEM
and	CC	O
low	JJ	B-PROBLEM
grade	NN	I-PROBLEM
temp	NN	I-PROBLEM
and	CC	O
was	VBD	O
started	VBN	O
on	IN	O
zosyn	NN	B-TREATMENT
for	IN	O
suspected	JJ	O
biliary	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM
and	CC	O
ascending	VBG	B-PROBLEM
cholangitis	NN	I-PROBLEM
coverage	NN	O
.	.	O

she	PRP	O
was	VBD	O
rescoped	VBN	O
on	IN	O
10-28	JJ	O
and	CC	O
varices	NNS	B-PROBLEM
were	VBD	O
sclerosed	VBN	O
(	(	O
no	DT	O
banding	NN	B-TREATMENT
due	JJ	O
to	TO	O
latex	VB	B-PROBLEM
allergy	NN	I-PROBLEM
)	)	O
and	CC	O
diuretics	NNS	B-TREATMENT
of	IN	O
lasix	NN	B-TREATMENT
and	CC	O
aldactone	NN	B-TREATMENT
were	VBD	O
readded	VBN	O
for	IN	O
ascites	NNS	B-PROBLEM
since	IN	O
bp	NN	B-TEST
stable	NN	O
.	.	O

10-29	JJ	O
she	PRP	O
was	VBD	O
transfused	VBN	O
another	DT	O
3u	CD	B-TREATMENT
prbc	NN	I-TREATMENT
's	POS	I-TREATMENT
with	IN	O
hct	JJ	B-PROBLEM
bump	NN	I-PROBLEM
to	TO	O
31.9	CD	O
and	CC	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
broadend	NN	O
to	TO	O
unasyn	VB	B-TREATMENT
,	,	O
ceftriaxone	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
because	IN	O
she	PRP	O
continued	VBD	O
to	TO	O
spike	VB	O
,	,	O
and	CC	O
for	IN	O
sbp	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

preprocedure	NN	O
of	IN	O
ptc	NN	B-TEST
on	IN	O
10-30	JJ	O
she	PRP	O
was	VBD	O
transfused	VBN	O
1	CD	B-TREATMENT
unit	NN	I-TREATMENT
prbc	NN	I-TREATMENT
's,	POS	I-TREATMENT
2	CD	B-TREATMENT
platelets	NNS	I-TREATMENT
and	CC	O
2u	CD	B-TREATMENT
ffp	NN	I-TREATMENT
and	CC	O
procedure	NN	B-TEST
went	VBD	O
without	IN	O
complication	NN	B-PROBLEM
.	.	O

on	IN	O
transfer	NN	O
to	TO	O
the	DT	O
floor	NN	O
she	PRP	O
remained	VBD	O
hemodynamically	RB	O
stable	JJ	O
with	IN	O
stable	JJ	O
hct	NN	O
and	CC	O
declining	VBG	B-PROBLEM
bilirubin	NN	I-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
afebrile	RB	B-PROBLEM
so	RB	O
on	IN	O
11-02	JJ	O
antibiotic	JJ	B-TREATMENT
regimen	NNS	I-TREATMENT
was	VBD	O
weaned	VBN	O
to	TO	O
only	RB	O
levofloxacin	VB	B-TREATMENT
.	.	O

liver	RB	O
teams	NNS	O
recommended	VBD	O
to	TO	O
repeat	VB	B-TEST
egd	NN	I-TEST
with	IN	O
non	JJ	B-TREATMENT
latex	NNS	I-TREATMENT
banding	VBG	I-TREATMENT
in	IN	O
7-10	JJ	O
days	NNS	O
.	.	O

she	PRP	O
also	RB	O
went	VBD	O
home	NN	O
on	IN	O
naldolol	JJ	B-TREATMENT
20	CD	O
mg	NN	O
qd	NN	O
for	IN	O
portal	JJ	B-PROBLEM
htn	NN	I-PROBLEM
,	,	O
and	CC	O
her	PRP$	B-TREATMENT
home	NN	I-TREATMENT
doses	NNS	I-TREATMENT
of	IN	O
diuretics	NNS	B-TREATMENT
to	TO	O
control	VB	O
her	PRP$	B-PROBLEM
ascites	NNS	I-PROBLEM
.	.	O

2.	CD	O
us	PRP	B-TEST
finding	VBG	O
-	:	O
pt	NN	O
was	VBD	O
incidentally	RB	O
found	VBN	O
to	TO	O
have	VB	O
r	VBN	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
r	NN	I-PROBLEM
adenexal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
on	IN	O
her	PRP$	B-TEST
us	PRP	I-TEST
.	.	O

the	DT	B-PROBLEM
hydronephrosis	NN	I-PROBLEM
was	VBD	O
likely	RB	O
caused	VBN	O
by	IN	O
blockage	NN	B-PROBLEM
by	IN	O
her	PRP$	B-PROBLEM
tumor	NN	I-PROBLEM
.	.	O

given	VBN	O
her	PRP$	O
disease	NN	O
prognosis	NN	O
and	CC	O
the	DT	O
fact	NN	O
that	IN	O
her	PRP$	O
other	JJ	O
kidney	NN	O
is	VBZ	O
functioning	VBG	O
well	RB	O
,	,	O
no	DT	O
intervention	NN	B-TREATMENT
was	VBD	O
done	VBN	O
.	.	O

also	RB	O
the	DT	B-PROBLEM
adenexal	JJ	I-PROBLEM
mass	NN	I-PROBLEM
may	MD	O
represent	VB	O
a	DT	B-PROBLEM
second	JJ	I-PROBLEM
primary	JJ	I-PROBLEM
maligancy	NN	I-PROBLEM
.	.	O

this	DT	O
was	VBD	O
seen	VBN	O
on	IN	O
a	DT	B-TEST
prior	JJ	I-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
and	CC	O
her	PRP$	O
oncologist	NN	O
is	VBZ	O
aware	JJ	O
.	.	O

again	RB	O
given	VBN	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
's	POS	I-PROBLEM
poor	JJ	I-PROBLEM
disease	NN	I-PROBLEM
prognosis	NN	I-PROBLEM
,	,	O
there	EX	O
was	VBD	O
no	DT	O
intervention	NN	B-TREATMENT
made	VBD	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

medications	NNS	O
:	:	O
she	PRP	O
is	VBZ	O
on	IN	O
lasix	JJ	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
aldactone	RB	B-TREATMENT
25	CD	O
mg	NNS	O
p.o.	JJ	O
b.i.d.	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
mg	NNS	O
p.o.	JJ	O
daily	RB	O
,	,	O
ciprofloxacin	VBD	B-TREATMENT
250	CD	O
mg	NNS	O
p.o.	JJ	O
daily	RB	O
,	,	O
this	DT	O
is	VBZ	O
for	IN	O
prophylaxis	NN	B-TREATMENT
for	IN	O
cholangitis	NN	B-PROBLEM
and	CC	O
iron	NN	B-TREATMENT
.	.	O

1.	CD	O
pantoprazole	JJ	B-TREATMENT
sodium	NN	I-TREATMENT
40	CD	O
mg	NN	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
,	,	O
delayed	VBN	O
release	NN	O
(	(	O
e.c.	NN	O
)	)	O
po	NN	O
q12h	NN	O
(	(	O
every	DT	O
12	CD	O
hours	NNS	O
).	VBP	O

2.	CD	O
furosemide	JJ	B-TREATMENT
40	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

3.	CD	O
spironolactone	NN	B-TREATMENT
25	CD	O
mg	NN	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
bid	NN	O
(	(	O
2	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

4.	CD	O
levofloxacin	JJ	B-TREATMENT
500	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q24h	NN	O
(	(	O
every	DT	O
24	CD	O
hours	NNS	O
).	VBP	O

5.	CD	O
ursodiol	JJ	B-TREATMENT
300	CD	O
mg	NN	O
capsule	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
capsule	NN	O
po	NN	O
tid	NN	O
(	(	O
3	CD	O
times	NNS	O
a	DT	O
day	NN	O
).	NN	O

6.	CD	O
prochlorperazine	JJ	B-TREATMENT
10	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
q6h	NN	O
(	(	O
every	DT	O
6	CD	O
hours	NNS	O
)	)	O
as	IN	O
needed	VBN	O
.	.	O

7.	CD	O
nystatin	JJ	B-TREATMENT
100,000	CD	O
unit	NN	O
/	NNP	O
ml	NN	O
suspension	NN	O
sig	NN	O
:	:	O
five	CD	O
(	(	O
5	CD	O
)	)	O
ml	NN	O
po	RB	O
four	CD	O
times	NNS	O
a	DT	O
day	NN	O
:	:	O
swish	JJ	O
and	CC	O
swallow	JJ	O
.	.	O

8.	CD	O
nadolol	JJ	B-TREATMENT
20	CD	O
mg	JJ	O
tablet	NN	O
sig	NN	O
:	:	O
one	CD	O
(	(	O
1	CD	O
)	)	O
tablet	NN	O
po	NN	O
once	RB	O
a	DT	O
day	NN	O
.	.	O

please	NN	O
have	VB	O
cbc	VBN	B-TEST
and	CC	O
alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
and	CC	O
total	JJ	B-TEST
bilirubin	NN	I-TEST
checked	VBD	O
on	IN	O
monday	JJ	O
11-04	JJ	O

cholangiocarcinoma	NN	B-PROBLEM

biliary	JJ	B-PROBLEM
obstruction	NN	I-PROBLEM

grade	NN	B-PROBLEM
iii	NN	I-PROBLEM
esophageal	NN	I-PROBLEM
varices	NNS	I-PROBLEM

call	VB	O
your	PRP$	O
primary	JJ	O
care	NN	O
doctor	NN	O
,	,	O
oncologist	NN	O
,	,	O
or	CC	O
return	NN	O
to	TO	O
the	DT	O
emergency	NN	O
room	NN	O
if	IN	O
you	PRP	O
have	VBP	O
increasing	VBG	B-PROBLEM
nausea	NN	I-PROBLEM
,	,	O
vomiting	VBG	B-PROBLEM
,	,	O
leg	NN	B-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
,	,	O
or	CC	O
pain	NN	B-PROBLEM
.	.	O

you	PRP	O
will	MD	O
have	VB	O
a	DT	B-TREATMENT
banding	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
in	IN	O
9	CD	O
days	NNS	O
.	.	O

1.	CD	O
myelodysplastic	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
with	IN	O
symptomatic	JJ	B-PROBLEM
anemia	NN	I-PROBLEM

2.	CD	O
rheumatoid	NN	B-PROBLEM
arthritis	NN	I-PROBLEM

3.	CD	O
diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM

4.	CD	O
history	NN	O
of	IN	O
multiple	JJ	B-PROBLEM
focal	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
tachycardia	NN	I-PROBLEM

5.	CD	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
with	IN	O
dilated	JJ	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
,	,	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
30%	CD	O

6.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM

7.	CD	O
chronic	JJ	B-PROBLEM
bronchiectasis	NN	I-PROBLEM
on	IN	O
home	NN	B-TREATMENT
o2	NN	I-TREATMENT

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
69-year-old	JJ	O
male	NN	O
with	IN	O
multiple	JJ	B-PROBLEM
medical	JJ	I-PROBLEM
problems	NNS	I-PROBLEM
and	CC	O
known	VBN	B-PROBLEM
transfusion	NN	I-PROBLEM
dependent	NN	I-PROBLEM
secondary	JJ	O
to	TO	O
myelodysplastic	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
admitted	VBN	O
with	IN	O
decreased	JJ	B-PROBLEM
hematocrit	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
multiple	VBN	O
previous	JJ	O
admissions	NNS	O
for	IN	O
cardiac	NN	B-PROBLEM
and	CC	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
had	VBN	O
chronic	VBN	B-PROBLEM
anemia	NN	I-PROBLEM
since	IN	O
1990	CD	O
,	,	O
but	CC	O
a	DT	B-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
in	IN	O
07-92	JJ	O
,	,	O
was	VBD	O
consistent	JJ	O
with	IN	O
myelodysplastic	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
past	JJ	O
several	JJ	O
months	NNS	O
,	,	O
the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
increasing	VBG	B-PROBLEM
transfusing	NN	I-PROBLEM
requirements	NNS	I-PROBLEM
.	.	O

his	PRP$	B-TREATMENT
transfusions	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
complicated	VBN	O
by	IN	O
fluid	NN	B-PROBLEM
overload	NN	I-PROBLEM
and	CC	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
,	,	O
secondary	JJ	O
to	TO	O
ischemia	VB	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

his	PRP$	O
last	JJ	O
admission	NN	O
was	VBD	O
9-14-93	CD	O
,	,	O
for	IN	O
a	DT	B-TREATMENT
transfusion	NN	I-TREATMENT
without	IN	O
complications	NNS	B-PROBLEM
,	,	O
and	CC	O
prior	RB	O
to	TO	O
admission	VB	O
the	DT	O
patient	NN	O
reports	NNS	O
having	VBG	O
several	JJ	O
days	NNS	O
of	IN	O
increasing	VBG	B-PROBLEM
weakness	NN	I-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
.	.	O

apparently	RB	O
,	,	O
he	PRP	O
had	VBD	O
had	VBN	O
a	DT	B-PROBLEM
low	JJ	I-PROBLEM
hematocrit	NN	I-PROBLEM
as	IN	O
an	DT	O
outpatient	NN	O
and	CC	O
was	VBD	O
checked	VBN	O
two	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
but	CC	O
was	VBD	O
not	RB	O
given	VBN	O
transfusion	NN	B-TREATMENT
because	IN	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
want	VB	O
to	TO	O
come	VB	O
in	IN	O
at	IN	O
that	DT	O
time	NN	O
.	.	O

aside	RB	O
from	IN	O
the	DT	O
above	NN	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
felt	VBN	O
that	IN	O
baseline	NN	O
without	IN	O
fever	NN	B-PROBLEM
and	CC	O
chills	NNS	B-PROBLEM
or	CC	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
chronic	JJ	I-PROBLEM
cough	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
increase	NN	O
in	IN	O
his	PRP$	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
symptoms	NNS	I-PROBLEM
,	,	O
no	DT	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
and	CC	O
no	DT	O
hemoptysis	NN	B-PROBLEM
or	CC	O
changed	VBN	O
in	IN	O
arthritis	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
did	VBD	O
report	VB	O
taking	VBG	O
a	DT	B-TREATMENT
po	NN	I-TREATMENT
antibiotic	JJ	I-TREATMENT
(	(	I-TREATMENT
ciprofloxacin	NN	I-TREATMENT
)	)	I-TREATMENT
for	IN	O
right	JJ	B-PROBLEM
great	JJ	I-PROBLEM
toe	JJ	I-PROBLEM
infection	NN	I-PROBLEM
(	(	O
question	NN	O
of	IN	O
cellulitis	NN	B-PROBLEM
vs.	FW	O
paronychia	NN	B-PROBLEM
)	)	O
.	.	O

1.	CD	O
myelodysplastic	JJ	B-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

2.	CD	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
/	NNP	O
ischemiccardiomyopathy	NN	B-PROBLEM
with	IN	O
ejection	NN	B-TEST
fraction	NN	I-TEST
of	IN	O
30%	CD	O
.	.	O

3.	CD	O
history	NN	O
of	IN	O
mat	NN	B-PROBLEM
for	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
/	NNP	O
chronic	NN	B-PROBLEM
bronchi	NN	I-PROBLEM
ectasis	NN	I-PROBLEM
,	,	O
on	IN	O
home	NN	B-TREATMENT
oxygen	NN	I-TREATMENT
.	.	O

4.	CD	O
non	JJ	B-PROBLEM
insulin	NN	I-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

5.	CD	O
rheumatoid	JJ	B-PROBLEM
arthritis	NN	I-PROBLEM
.	.	O

7.	CD	O
history	NN	O
of	IN	O
peptic	JJ	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

8.	CD	O
cataracts	NNS	B-PROBLEM
,	,	O
status	NN	O
post	NN	O
bilateral	JJ	B-TREATMENT
repair	NN	I-TREATMENT
.	.	O

9.	CD	O
c3	NN	B-PROBLEM
radiculopathy	NN	I-PROBLEM
.	.	O

10.	CD	O
psoriasis	NN	B-PROBLEM
.	.	O

11.	CD	O
history	NN	O
of	IN	O
hemoptysis	NN	B-PROBLEM
,	,	O
on	IN	O
coumadin	NN	B-TREATMENT
.	.	O

12.	CD	O
status	NN	O
post	NN	O
turp	NN	B-TREATMENT
.	.	O

quinine	NN	B-TREATMENT
,	,	O
quinidine	NN	B-TREATMENT
,	,	O
bactrim	NN	B-TREATMENT
,	,	O
plaquenil	NN	B-TREATMENT
.	.	O

temperature	NN	B-TEST
98.8	CD	O
;	:	O
heart	NN	B-TEST
rate	NN	I-TEST
88-120	CD	O
and	CC	O
irregular	JJ	B-PROBLEM
;	:	O
blood	NN	B-TEST
pressure	NN	I-TEST
118/78	CD	O
;	:	O
o2	JJ	B-TEST
saturation	NN	I-TEST
96%	CD	O
on	IN	O
2	CD	B-TREATMENT
liters	NNS	I-TREATMENT
.	.	O

bilateral	JJ	B-PROBLEM
cataracts	NNS	I-PROBLEM
;	:	O
neck	RB	O
appeared	VBD	O
to	TO	O
be	VB	O
somewhat	RB	B-PROBLEM
asymmetric	JJ	I-PROBLEM
thyroid	NN	I-PROBLEM
with	IN	O
small	JJ	B-PROBLEM
nodule	NN	I-PROBLEM
barely	RB	O
palpable	JJ	O
on	IN	O
the	DT	O
left	NN	O
lobe	NN	O
with	IN	O
the	DT	O
thyroid	NN	O
,	,	O
otherwise	RB	O
negative	JJ	O
.	.	O

no	DT	O
lymphadenopathy	NN	B-PROBLEM
was	VBD	O
palpated	VBN	O
.	.	O

rales	NNS	B-PROBLEM
1/3	CD	O
of	IN	O
the	DT	O
way	NN	O
upbilaterally	RB	O
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
revealed	VBD	O
jugular	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
distention	NN	I-PROBLEM
at	IN	O
12	CD	O
cm	NN	O
,	,	O
no	DT	O
carotid	NN	B-PROBLEM
bruits	NNS	I-PROBLEM
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
was	VBD	O
tachycardic	JJ	B-PROBLEM
and	CC	O
regular	JJ	O
,	,	O
normal	JJ	O
s1	NN	O
and	CC	O
s2	NN	O
,	,	O
palpable	JJ	B-PROBLEM
s4	NN	I-PROBLEM
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
was	VBD	O
auscultated	VBN	O
.	.	O

obese	JJ	B-PROBLEM
,	,	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
bowel	JJ	O
sounds	NNS	O
were	VBD	O
present	JJ	O
.	.	O

heme	NN	B-TEST
negative	JJ	O
.	.	O

joint	JJ	B-PROBLEM
deformities	NNS	I-PROBLEM
consistent	VBP	O
with	IN	O
rheumatoid	JJ	B-PROBLEM
arthritis	NN	I-PROBLEM
,	,	O
right	JJ	O
mtp	NN	O
/	NNP	O
toe	NN	O
with	IN	O
minimal	JJ	B-PROBLEM
erythema	NN	I-PROBLEM
.	.	O

diffuse	NN	B-PROBLEM
psoriasis	NN	I-PROBLEM
over	IN	I-PROBLEM
trunk	NN	I-PROBLEM
and	CC	I-PROBLEM
arms	NNS	I-PROBLEM
.	.	O

neurological	JJ	B-TEST
examination	NN	I-TEST
was	VBD	O
non-focal	JJ	O
.	.	O

sma-7	NN	B-TEST
was	VBD	O
unremarkable	JJ	O
aside	RB	O
form	VBP	O
a	DT	B-TEST
creatinine	NN	I-TEST
of	IN	O
1.6	CD	O
and	CC	O
a	DT	B-TEST
glucose	NN	I-TEST
of	IN	O
207	CD	O
;	:	O
otherwise	RB	O
,	,	O
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

hematocrit	NN	B-TEST
was	VBD	O
22.4	CD	O
;	:	O
white	JJ	B-TEST
count	NN	I-TEST
.59	NN	O
;	:	O
platelets	NNS	B-TEST
84.	CD	O

the	DT	O
patient	NN	O
had	VBD	O
an	DT	B-PROBLEM
absolute	JJ	I-PROBLEM
neutropenia	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
anc	NN	I-TEST
of	IN	O
318	CD	O
;	:	O
differential	NN	B-TEST
revealed	VBD	O
48	CD	O
segs	NNS	B-TEST
,	,	O
6	CD	O
bands	NNS	B-TEST
,	,	O
40	CD	O
lymphs	NN	B-TEST
,	,	O
4	CD	O
monos	NNS	B-TEST
.	.	O

digoxin	NN	B-TEST
level	NN	I-TEST
was	VBD	O
1.4	CD	O
.	.	O

theo-dur	JJ	B-TEST
level	NN	I-TEST
was	VBD	O
15	CD	O
.	.	O

pt	NN	B-TEST
was	VBD	O
12.5	CD	O
;	:	O
ptt	NN	B-TEST
27.0	CD	O
.	.	O

urinalysis	NN	B-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

chest	JJS	B-TEST
x-ray	NN	I-TEST
showed	VBD	O
enlarged	JJ	B-PROBLEM
heart	NN	I-PROBLEM
with	IN	O
mild	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
vascular	NN	I-PROBLEM
redistribution	NN	I-PROBLEM
,	,	O
no	DT	O
gross	JJ	B-PROBLEM
congestive	JJ	I-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
.	.	O

ekg	NN	B-TEST
showed	VBD	O
question	NN	O
of	IN	O
mat	NN	B-PROBLEM
vs.	FW	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
ventricular	JJ	I-TEST
response	NN	I-TEST
of	IN	O
118	CD	O
,	,	O
axis	NN	B-TEST
was	VBD	O
0	CD	O
degrees	NNS	O
.	.	O

there	EX	O
was	VBD	O
st	JJ	B-PROBLEM
scooping	NN	I-PROBLEM
in	IN	O
the	DT	O
lateral	JJ	O
leads	NNS	O
consistent	JJ	O
with	IN	O
dig	NN	B-TREATMENT
vs.	FW	O
a	DT	O
question	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
ischemia	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
from	IN	O
his	PRP$	B-TEST
baseline	NN	I-TEST
ekg	NN	I-TEST
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
and	CC	O
placed	VBN	O
in	IN	O
isolation	NN	B-TREATMENT
on	IN	O
neutropenic	JJ	B-TREATMENT
precautions	NNS	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
transfused	VBN	O
with	IN	O
1/2	CD	B-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
packed	JJ	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
and	CC	O
given	VBN	O
lasix	NNS	B-TREATMENT
periodically	RB	O
to	TO	O
prevent	VB	O
him	PRP	O
from	IN	O
going	VBG	O
into	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
has	VBZ	O
he	PRP	O
had	VBD	O
on	IN	O
his	PRP$	B-TREATMENT
prior	JJ	I-TREATMENT
transfusion	NN	I-TREATMENT
.	.	O

because	IN	O
his	PRP$	O
need	NN	O
for	IN	O
multiple	JJ	B-TREATMENT
transfusionsm	NN	I-TREATMENT
he	PRP	O
was	VBD	O
transfused	VBN	O
with	IN	O
radiated	JJ	B-TREATMENT
leuco	JJ	I-TREATMENT
four	CD	O
units	NNS	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	O
good	JJ	O
bump	NN	O
in	IN	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
,	,	O
more	JJR	O
than	IN	O
expected	VBN	O
from	IN	O
22	CD	O
to	TO	O
high	JJ	O
20	CD	O
&apos;s	JJ	O
range	NN	O
next	JJ	O
day	NN	O
after	IN	O
3	CD	O
1/2	CD	O
units	NNS	O
,	,	O
but	CC	O
later	RB	O
that	IN	O
evening	VBG	O
had	VBD	O
a	DT	B-PROBLEM
drop	NN	I-PROBLEM
in	IN	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
so	RB	O
was	VBD	O
given	VBN	O
4	CD	O
more	JJR	O
1/2	CD	O
units	NNS	O
at	IN	O
this	DT	O
point	NN	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
4	CD	B-TREATMENT
units	NNS	I-TREATMENT
packed	VBD	I-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

he	PRP	O
again	RB	O
did	VBD	O
not	RB	O
bump	VB	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
sufficiently	RB	O
and	CC	O
remained	VBD	O
in	IN	O
the	DT	O
high	JJ	O
20	CD	O
&apos;s	NN	O
after	IN	O
a	DT	O
total	NN	O
of	IN	O
4	CD	O
units	NNS	O
,	,	O
so	IN	O
he	PRP	O
was	VBD	O
given	VBN	O
2	CD	O
more	JJR	O
total	JJ	O
units	NNS	O
in	IN	O
1/2	CD	O
units	NNS	O
segments	VBZ	O
the	DT	O
following	JJ	O
day	NN	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
subsequently	RB	O
bumped	VBD	O
to	TO	O
greater	JJR	O
than	IN	O
30	CD	O
and	CC	O
was	VBD	O
discharged	VBN	O
with	IN	O
hematocrit	NN	B-TEST
of	IN	O
32	CD	O
on	IN	O
11-7-93	NNS	O
.	.	O

the	DT	O
patient	NN	O
remained	VBD	O
asymptomatic	JJ	B-PROBLEM
from	IN	O
a	DT	B-PROBLEM
chf	NN	I-PROBLEM
stand	NN	I-PROBLEM
point	NN	I-PROBLEM
and	CC	O
felt	VBD	O
much	RB	O
better	RBR	O
after	IN	O
the	DT	B-TREATMENT
transfusions	NNS	I-TREATMENT
.	.	O

it	PRP	O
is	VBZ	O
unclear	JJ	O
why	WRB	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
bump	VB	O
his	PRP$	B-TEST
hematocrit	NN	I-TEST
more	RBR	O
but	CC	O
he	PRP	O
did	VBD	O
not	RB	O
appear	VB	O
to	TO	O
be	VB	O
hemolyzing	VBG	O
from	IN	O
laboratory	NN	O
data	NNS	O
,	,	O
that	DT	O
is	VBZ	O
his	PRP$	B-TEST
ldh	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

in	IN	O
addition	NN	O
,	,	O
multiple	JJ	O
stools	NNS	O
were	VBD	O
guaiaced	VBN	O
and	CC	O
were	VBD	O
all	DT	O
guaiac	JJ	B-TEST
negative	JJ	O
.	.	O

prednisone	NN	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
verapamil	FW	B-TREATMENT
80	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
,	,	O
isordil	VB	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
,	,	O
theo-dur	JJ	B-TREATMENT
200	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
lasix	VBZ	B-TREATMENT
80mg	CD	O
q	NN	O
am	VBP	O
,	,	O
40	CD	O
mg	NN	O
po	NN	O
q	NN	O
pm	NN	O
,	,	O
enalapril	VBZ	B-TREATMENT
2.5	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
,	,	O
pepcid	VBP	B-TREATMENT
20	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O

prenatal	NN	B-TEST
screens	NNS	I-TEST
-	:	O
blood	NN	B-TEST
type	NN	I-TEST
o	NN	O
positive	JJ	O
,	,	O
antibody	JJ	B-TEST
screen	JJ	I-TEST
negative	JJ	O
,	,	O
hepatitis	NN	B-TEST
b	NN	I-TEST
surface	NN	I-TEST
antigen	NN	I-TEST
negative	JJ	O
,	,	O
rpr	JJ	B-TEST
nonreactive	JJ	O
,	,	O
rubella	NN	B-TEST
immune	NN	O
.	.	O

gbs	NN	B-PROBLEM
negative	JJ	O
.	.	O

maternal	JJ	O
history	NN	O
notable	JJ	O
for	IN	O
hypothyroidism	NN	B-PROBLEM
on	IN	O
levoxyl	NN	B-TREATMENT
.	.	O

primary	JJ	B-TREATMENT
cesarean	JJ	I-TREATMENT
section	NN	I-TREATMENT
with	IN	O
previous	JJ	O
pregnancy	NN	O
for	IN	O
arrest	NN	B-PROBLEM
of	IN	I-PROBLEM
descent	NN	I-PROBLEM
.	.	O

other	JJ	B-TREATMENT
meds	NNS	I-TREATMENT
:	:	O
paxil	NN	B-TREATMENT
.	.	O

this	DT	O
pregnancy	NN	O
is	VBZ	O
complicated	VBN	O
by	IN	O
a	DT	B-PROBLEM
cyst	NN	I-PROBLEM
noted	VBD	O
on	IN	O
the	DT	O
umbilical	JJ	O
cord	NN	O
on	IN	O
fetal	JJ	B-TEST
ultrasound	NN	I-TEST
study	NN	I-TEST
at	IN	O
18	CD	O
weeks	NNS	O
gestation	NN	O
.	.	O

no	DT	O
perineal	JJ	B-PROBLEM
sepsis	NN	I-PROBLEM
risk	NN	I-PROBLEM
factors	NNS	I-PROBLEM
.	.	O

no	DT	O
maternal	JJ	B-PROBLEM
fever	NN	I-PROBLEM
.	.	O

no	DT	O
prolonged	JJ	B-PROBLEM
rupture	NN	I-PROBLEM
of	IN	I-PROBLEM
membranes	NNS	I-PROBLEM
.	.	O

anesthesia	NN	B-TREATMENT
by	IN	O
epidural	JJ	B-TREATMENT
.	.	O

apgars	NNS	B-TEST
were	VBD	O
8	CD	O
and	CC	O
9	CD	O
.	.	O

weight	NN	B-TEST
3.325	CD	O
kg	NN	O
,	,	O
length	NN	B-TEST
was	VBD	O
20	CD	O
inches	NNS	O
i.e.	JJ	O
51	CD	O
cm	NN	O
,	,	O
head	NN	B-TEST
circumference	NN	I-TEST
34.5	CD	O
cm	NN	O
.	.	O

nondysmorphic	JJ	B-PROBLEM
infant	NN	O
.	.	O

active	JJ	O
,	,	O
pink	VBP	O
newborn	VBN	O
in	IN	O
no	DT	O
distress	NN	B-PROBLEM
on	IN	O
radiate	NN	B-TREATMENT
warmer	NN	I-TREATMENT
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
.	.	O

2+	CD	B-TEST
femoral	JJ	I-TEST
pulses	NNS	I-TEST
.	.	O

umbilical	JJ	O
cord	NN	O
with	IN	O
braintree	JJ	O
jelly	NN	B-PROBLEM
cysts	NNS	I-PROBLEM
but	CC	O
also	RB	O
with	IN	O
pink	JJ	B-PROBLEM
tubular	JJ	I-PROBLEM
discoloration	NN	I-PROBLEM
at	IN	I-PROBLEM
base	NN	I-PROBLEM
.	.	O

no	DT	O
sacral	JJ	B-PROBLEM
anomalies	NNS	I-PROBLEM
.	.	O

cardiovascular	NN	O
:	:	O
no	DT	O
cardiovascular	JJ	B-PROBLEM
issues	NNS	I-PROBLEM
.	.	O

fluids	NNS	O
,	,	O
electrolytes	NNS	O
and	CC	O
nutrition	NN	O
:	:	O
infant	NN	O
initiated	VBD	O
on	IN	O
60	CD	O
cc	NNS	O
per	IN	O
kg	FW	O
per	IN	O
day	NN	O
of	IN	O
d10w	NN	B-TREATMENT
.	.	O

d-sticks	NNS	B-TEST
have	VBP	O
been	VBN	O
stable	JJ	O
.	.	O
infant	NN	O
is	VBZ	O
allowed	VBN	O
to	TO	O
ad	NN	O
lib	NN	O
breast	NN	O
feed	NN	O
which	WDT	O
he	PRP	O
is	VBZ	O
doing	VBG	O
vigorously	RB	O
.	.	O

an	DT	B-TEST
abdominal	JJ	I-TEST
ultrasound	NN	I-TEST
was	VBD	O
performed	VBN	O
.	.	O

initial	JJ	O
impression	NN	O
included	VBD	O
omphalocele	NN	B-PROBLEM
with	IN	O
further	JJ	B-TEST
imaging	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
bowel	NN	I-TEST
to	TO	O
be	VB	O
done	VBN	O
.	.	O

surgery	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
dr.	JJ	O
boston	NN	O
took	VBD	O
patient	NN	O
to	TO	O
or	CC	O
for	IN	O
exploration	NN	B-TEST
of	IN	I-TEST
cord	NN	I-TEST
on	IN	O
04-01	NN	O
.	.	O

urachal	JJ	B-PROBLEM
duct	NN	I-PROBLEM
remnanr	NN	I-PROBLEM
found	VBD	O
,	,	O
removed	VBN	O
and	CC	O
bladder	NN	O
repaired	VBN	O
.	.	O

hematology	NN	O
:	:	O
hematocrit	NN	B-TEST
on	IN	O
admission	NN	O
was	VBD	O
52.8	CD	O
.	.	O

the	DT	O
infant	NN	O
does	VBZ	O
not	RB	O
require	VB	O
a	DT	B-TREATMENT
new	JJ	I-TREATMENT
blood	NN	I-TREATMENT
transfusion	NN	I-TREATMENT
.	.	O

infectious	JJ	O
disease	NN	O
:	:	O
cbc	NN	B-TEST
and	CC	O
blood	NN	B-TEST
culture	NN	I-TEST
obtained	VBN	O
on	IN	O
admission	NN	O
.	.	O

initial	JJ	B-TEST
cbc	NN	I-TEST
had	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
20	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
386	CD	O
,	,	O
63	CD	O
polys	NN	B-TEST
,	,	O
2	CD	O
bands	NNS	B-TEST
,	,	O
23	CD	O
lymphs	NN	B-TEST
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
remained	VBD	O
negative	JJ	O
at	IN	O
this	DT	O
time	NN	O
.	.	O

infant	NN	O
has	VBZ	O
not	RB	O
received	VBN	O
any	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

sensory	NN	O
:	:	O
hearing	NN	B-TEST
screen	NN	I-TEST
has	VBZ	O
not	RB	O
yet	RB	O
been	VBN	O
performed	VBN	O
but	CC	O
should	MD	O
be	VB	O
done	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

urachal	JJ	B-PROBLEM
duct	NN	I-PROBLEM
remnant	NN	I-PROBLEM
.	.	O

1.	CD	O
dressing	VBG	B-TREATMENT
to	TO	O
remain	VB	O
in	IN	O
place	NN	O
for	IN	O
10	CD	O
days	NNS	O
unless	IN	O
signs	NNS	O
of	IN	O
bleeding	NN	B-PROBLEM
,	,	O
infection	NN	B-PROBLEM
or	CC	O
is	VBZ	O
soiled	VBN	O
.	.	O

gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM

sepsis	NN	B-PROBLEM
.	.	O

1	CD	O
)	)	O
gastrointestinal	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

2	CD	O
)	)	O
hepatic	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

3	LS	O
)	)	O
end	NN	B-PROBLEM
stage	NN	I-PROBLEM
renal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
on	IN	O
dialysis	NN	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
dark	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
per	IN	I-PROBLEM
rectum	NN	I-PROBLEM
and	CC	O
to	TO	O
be	VB	O
somewhat	RB	B-PROBLEM
fluid	JJ	I-PROBLEM
overloaded	VBN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
admitted	VBN	O
and	CC	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	O
significant	JJ	O
hematocrit	NN	B-PROBLEM
drop	NN	I-PROBLEM
from	IN	O
33.8	CD	O
to	TO	O
24.3	CD	O
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
operation	NN	O
be	VB	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
dialysis	VB	B-TREATMENT
for	IN	O
apparent	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
overload	NN	I-PROBLEM
.	.	O

his	PRP$	B-PROBLEM
gastrointestinal	JJ	I-PROBLEM
bleeding	NN	I-PROBLEM
issues	NNS	I-PROBLEM
were	VBD	O
investigated	VBN	O
with	IN	O
an	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
which	WDT	O
revealed	VBD	O
multiple	JJ	O
superficial	JJ	O
gastric	JJ	B-PROBLEM
ulcerations	NNS	I-PROBLEM
consistent	NN	O
with	IN	O
an	DT	B-PROBLEM
non-steroidal	JJ	I-PROBLEM
anti-inflammatory	JJ	I-PROBLEM
drugs	NNS	I-PROBLEM
gastropathy	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
discharged	VBN	O
on	IN	O
one	CD	B-TREATMENT
aspirin	NN	I-TREATMENT
a	DT	O
day	NN	O
with	IN	O
20	CD	O
of	IN	O
prilosec	NN	B-TREATMENT
b.i.d.	NN	O

the	DT	B-TREATMENT
aspirin	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
and	CC	O
he	PRP	O
had	VBD	O
no	DT	O
further	JJ	O
problems	NNS	O
with	IN	O
gastrointestinal	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
a	DT	O
stable	JJ	O
hematocrit	NN	B-TEST
the	DT	O
rest	NN	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
.	.	O

during	IN	O
the	DT	O
course	NN	O
of	IN	O
his	PRP$	O
hospitalization	NN	O
,	,	O
he	PRP	O
became	VBD	O
increasingly	RB	B-PROBLEM
lethargic	JJ	I-PROBLEM
.	.	O

an	DT	B-TEST
extensive	JJ	I-TEST
work-up	NN	I-TEST
was	VBD	O
done	VBN	O
for	IN	O
any	DT	B-PROBLEM
metabolic	JJ	I-PROBLEM
abnormalities	NNS	I-PROBLEM
which	WDT	O
was	VBD	O
unrevealing	VBG	O
.	.	O

he	PRP	O
responded	VBD	O
somewhat	RB	O
to	TO	O
lactulose	VB	B-TREATMENT
for	IN	O
hepatic	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
one	CD	B-PROBLEM
positive	JJ	I-PROBLEM
blood	NN	I-PROBLEM
culture	NN	I-PROBLEM
for	IN	O
vancomycin	NN	B-PROBLEM
resistant	JJ	I-PROBLEM
enterococcus	NN	I-PROBLEM
.	.	O

in	IN	O
the	DT	O
few	JJ	O
days	NNS	O
prior	RB	O
to	TO	O
his	PRP$	O
demise	NN	O
,	,	O
he	PRP	O
was	VBD	O
intermittently	RB	O
somewhat	RB	B-PROBLEM
lethargic	JJ	I-PROBLEM
buton	IN	O
the	DT	O
morning	NN	O
of	IN	O
june	NN	O
25	CD	O
,	,	O
1999	CD	O
,	,	O
his	PRP$	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
was	VBD	O
noted	VBN	O
to	TO	O
have	VB	O
increased	VBN	O
from	IN	O
8	CD	O
to	TO	O
13,000	CD	O
.	.	O

that	DT	O
day	NN	O
,	,	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
acutely	RB	B-PROBLEM
short	JJ	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
a	DT	B-TEST
respiratory	JJ	I-TEST
rate	NN	I-TEST
of	IN	O
40	CD	O
and	CC	O
oxygen	JJ	B-TEST
saturations	NNS	I-TEST
in	IN	O
the	DT	O
mid	NN	O
seventies	NNS	O
.	.	O

he	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
100%	CD	B-TREATMENT
nonrebreather	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
oxygen	NN	I-TEST
saturations	NNS	I-TEST
improved	VBN	O
to	TO	O
the	DT	O
low	JJ	O
nineties	NNS	O
.	.	O

nasal	JJ	B-TREATMENT
trumpet	NN	I-TREATMENT
suction	NN	I-TREATMENT
was	VBD	O
done	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
food	NN	O
like	IN	O
material	NN	O
that	WDT	O
was	VBD	O
easily	RB	O
suctioned	VBN	O
out	RP	O
.	.	O

blood	NN	B-TEST
gases	NNS	I-TEST
were	VBD	O
done	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-TEST
ph	NN	I-TEST
of	IN	O
7.2	CD	O
with	IN	O
a	DT	B-TEST
pco2	NN	I-TEST
of	IN	O
21	CD	O
.	.	O

fingerstick	NN	B-TEST
glucose	NN	I-TEST
revealed	VBD	O
a	DT	B-TEST
sugar	NN	I-TEST
of	IN	O
12	CD	O
.	.	O

a	DT	B-TEST
stat	JJ	I-TEST
panel	NN	I-TEST
7	CD	I-TEST
confirmed	VBD	O
that	IN	O
the	DT	B-TEST
sugar	NN	I-TEST
was	VBD	O
23	CD	O
and	CC	O
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
new	JJ	I-TEST
anion	NN	I-TEST
gap	NN	I-TEST
of	IN	O
40	CD	O
.	.	O

repeat	NN	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
was	VBD	O
done	VBN	O
which	WDT	O
was	VBD	O
almost	RB	O
identical	JJ	O
to	TO	O
the	DT	O
first	JJ	O
.	.	O

in	IN	O
the	DT	O
acute	NN	O
setting	NN	O
,	,	O
he	PRP	O
had	VBD	O
been	VBN	O
started	VBN	O
on	IN	O
levofloxacin	NN	B-TREATMENT
,	,	O
flagyl	NN	B-TREATMENT
,	,	O
and	CC	O
vancomycin	NN	B-TREATMENT
.	.	O

these	DT	B-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
continued	VBN	O
but	CC	O
the	DT	O
family	NN	O
decided	VBD	O
that	IN	O
they	PRP	O
wanted	VBD	O
us	PRP	O
to	TO	O
emphasize	VB	O
the	DT	O
comfort	NN	O
of	IN	O
the	DT	O
patient	NN	O
and	CC	O
pursue	VB	O
no	DT	O
further	JJ	B-TREATMENT
invasive	JJ	I-TREATMENT
measures	NNS	I-TREATMENT
.	.	O

the	DT	O
family	NN	O
declined	VBD	O
an	DT	B-TEST
autopsy	NN	I-TEST
saying	VBG	O
that	IN	O
they	PRP	O
felt	VBD	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
through	IN	O
enough	RB	O
.	.	O

medicine	NN	B-TREATMENT

this	DT	O
is	VBZ	O
a	DT	O
33	CD	O
-	:	O
year-old	JJ	O
asian-caucasian	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
type	NN	B-PROBLEM
1	CD	I-PROBLEM
diabetes	NNS	I-PROBLEM
,	,	O
asthma	NN	B-PROBLEM
,	,	O
alcohol	NN	O
abuse	NN	O
,	,	O
and	CC	O
personality	NN	B-PROBLEM
disorder	NN	I-PROBLEM
/	NNP	O
depression	NN	B-PROBLEM
admitted	VBD	O
on	IN	O
2010-08-28	JJ	O
for	IN	O
persistent	JJ	B-PROBLEM
hypoglycemia	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
complained	VBD	O
of	IN	O
diaphoresis	NN	B-PROBLEM
,	,	O
confusion	NN	B-PROBLEM
,	,	O
dizziness	NN	B-PROBLEM
,	,	O
lightheadedness	NN	B-PROBLEM
after	IN	O
drinking	VBG	O
a	DT	O
24	CD	O
ounce	NN	O
beer	NN	O
and	CC	O
taking	VBG	O
at	IN	O
least	JJS	O
an	DT	O
extra	JJ	O
15	CD	O
units	NNS	O
of	IN	O
nph	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
the	DT	O
evening	NN	O
of	IN	O
2010-08-27	JJ	O
(	(	O
later	RB	O
reported	VBN	O
over	IN	O
70	CD	O
u	JJ	O
insulin	NN	B-TREATMENT
administered	VBD	O
from	IN	O
2.30	CD	O
pm	NN	O
until	IN	O
time	NN	O
of	IN	O
presentation	NN	O
)	)	O
followed	VBN	O
by	IN	O
not	RB	O
eating	VBG	O
dinner	NN	O
.	.	O

his	PRP$	B-PROBLEM
symptoms	NNS	I-PROBLEM
mildly	RB	O
improved	VBN	O
after	IN	O
eating	VBG	O
a	DT	O
candy	NN	O
bar	NN	O
.	.	O

the	DT	O
ems	NN	O
was	VBD	O
called	VBN	O
and	CC	O
found	VBD	O
his	PRP$	B-TEST
blood	NN	I-TEST
sugar	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
to	TO	O
be	VB	O
61	CD	O
and	CC	O
noted	VBD	O
to	TO	O
be	VB	O
41	CD	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
.	.	O

he	PRP	O
denied	VBD	O
any	DT	B-PROBLEM
seizure	NN	I-PROBLEM
activity	NN	I-PROBLEM
,	,	O
loss	NN	B-PROBLEM
of	IN	I-PROBLEM
consciousness	NN	I-PROBLEM
,	,	O
incontinence	NN	B-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
fevers	NNS	B-PROBLEM
,	,	O
or	CC	O
chills	NNS	B-PROBLEM
,	,	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
change	NN	B-PROBLEM
in	IN	I-PROBLEM
urinary	JJ	I-PROBLEM
or	CC	I-PROBLEM
bowel	JJ	I-PROBLEM
habits	NNS	I-PROBLEM
,	,	O
or	CC	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
depressed	VBN	B-PROBLEM
recently	RB	O
regarding	VBG	O
stress	NN	O
with	IN	O
his	PRP$	O
home	NN	O
life	NN	O
and	CC	O
on	IN	O
the	DT	O
night	NN	O
of	IN	O
his	PRP$	B-TREATMENT
extra	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
doses	NNS	I-TREATMENT
,	,	O
his	PRP$	O
wife	NN	O
had	VBD	O
just	RB	O
kicked	VBN	O
him	PRP	O
out	IN	O
of	IN	O
the	DT	O
house	NN	O
.	.	O

he	PRP	O
has	VBZ	O
had	VBD	O
four	CD	O
past	JJ	O
hospitalizations	NNS	O
for	IN	O
attempted	JJ	B-PROBLEM
suicide	NN	I-PROBLEM
with	IN	O
insulin	NN	B-PROBLEM
overdosing	VBG	I-PROBLEM
,	,	O
usually	RB	O
denied	VBN	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
he	PRP	O
received	VBD	O
3.5	CD	O
amps	NNS	O
of	IN	O
d50	NN	B-TREATMENT
and	CC	O
then	RB	O
d5	VB	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
and	CC	O
d10	NN	B-TREATMENT
normal	JJ	I-TREATMENT
saline	NN	I-TREATMENT
with	IN	O
blood	NN	B-TEST
sugars	NNS	I-TEST
that	WDT	O
were	VBD	O
slow	JJ	B-PROBLEM
to	TO	I-PROBLEM
increase	VB	I-PROBLEM
leading	VBG	O
the	DT	O
icu	NN	O
team	NN	O
to	TO	O
suspect	VB	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
taken	VBN	O
more	RBR	O
insulin	JJ	B-TREATMENT
than	IN	O
he	PRP	O
admitted	VBD	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
a	DT	O
very	RB	O
positive	JJ	O
tox	NN	B-TEST
screen	NN	I-TEST
for	IN	O
alcohol	NN	O
.	.	O

his	PRP$	B-TEST
fingersticks	NNS	I-TEST
are	VBP	O
currently	RB	O
in	IN	O
the	DT	O
200	CD	O
s	NN	O
and	CC	O
his	PRP$	O
normal	JJ	O
blood	NN	O
glucose	NN	O
at	IN	O
home	NN	O
ranges	NNS	O
between	IN	O
90-200	CD	O
per	IN	O
the	DT	O
patient	NN	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
now	RB	O
complains	VBZ	O
of	IN	O
increased	VBN	B-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
/	NN	I-PROBLEM
right	JJ	I-PROBLEM
rib	NN	I-PROBLEM
cage	NN	I-PROBLEM
pain	NN	I-PROBLEM
and	CC	O
new	JJ	B-PROBLEM
headache	NN	I-PROBLEM
.	.	O

he	PRP	O
also	RB	O
complains	VBZ	O
of	IN	O
chronic	NN	B-PROBLEM
photophobia	NN	I-PROBLEM
which	WDT	O
is	VBZ	O
unchanged	JJ	O
.	.	O

he	PRP	O
denied	VBD	O
visual	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
lightheadedness	NN	B-PROBLEM
of	IN	O
dizziness	NN	B-PROBLEM
currently	RB	O
,	,	O
neck	NN	B-PROBLEM
stiffness	NN	I-PROBLEM
,	,	O
or	CC	O
pain	NN	B-PROBLEM
in	IN	I-PROBLEM
any	DT	I-PROBLEM
other	JJ	I-PROBLEM
area	NN	I-PROBLEM
.	.	O

1.	CD	O
insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
.	.	O

2.	CD	O
depression	NN	B-PROBLEM
.	.	O

3.	CD	O
asthma	NN	B-PROBLEM
.	.	O

5.	CD	O
hypercholesterolemia	NN	B-PROBLEM
.	.	O

humalog	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
.	.	O

2.	CD	O
nph	JJ	B-TREATMENT
12	CD	O
units	NNS	O
q.a.m.	RB	O
,	,	O
7	CD	O
units	NNS	O
q.p.m.	RB	O
with	IN	O
normal	JJ	B-TREATMENT
home	NN	I-TREATMENT
dose	NN	I-TREATMENT
being	VBG	O
30	CD	O
units	NNS	O
q.a.m.	RB	O
and	CC	O
15	CD	O
units	NNS	O
q.p.m.	RB	O

3.	CD	O
thiamine	NN	B-TREATMENT
.	.	O

4.	CD	O
folate	NN	B-TREATMENT
.	.	O

5.	CD	O
multivitamin	NN	B-TREATMENT
.	.	O

6.	CD	O
fluticasone	NN	B-TREATMENT
.	.	O

7.	CD	O
albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
p.r.n.	NN	O

8.	CD	O
neutra-phos	JJ	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

grandmother	NN	O
with	IN	O
diabetes	NNS	B-PROBLEM
.	.	O

mother	NN	O
with	IN	O
asthma	NN	B-PROBLEM
.	.	O

physical	JJ	O
examination	NN	O
on	IN	O
transfer	NN	O
:	:	O
vital	JJ	B-TEST
signs	NNS	I-TEST
:	:	O

t	NN	B-TEST
maximum	NN	I-TEST
98.6	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
90s-130s	CD	O
/	JJ	O
80s-90s	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
70s	CD	O
to	TO	O
80s	CD	O
,	,	O
respirations	NNS	B-TEST
18	CD	O
,	,	O
oxygen	NN	B-TEST
saturation	NN	I-TEST
98%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
soft-spoken	JJ	O
male	NN	O
resting	NN	O
in	IN	O
his	PRP$	O
bed	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

sclerae	NN	O
were	VBD	O
anicteric	JJ	B-PROBLEM
.	.	O

supple	NN	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
,	,	O
no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

normoactive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
soft	JJ	O
,	,	O
mildly	RB	B-PROBLEM
tender	NN	I-PROBLEM
at	IN	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
just	RB	O
inferior	RB	O
to	TO	O
the	DT	O
lower	JJR	O
ribs	NN	O
,	,	O
no	DT	O
epigastric	JJ	B-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

depressed	JJ	B-PROBLEM
affect	NN	I-PROBLEM
.	.	O

denied	VBN	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
.	.	O

cbc	NN	B-TEST
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
6.2	CD	O
,	,	O
hemoglobin	NN	B-TEST
13.3	CD	O
,	,	O
hematocrit	NN	B-TEST
39.4	CD	O
,	,	O
platelet	NN	B-TEST
307,000	CD	O
.	.	O

sodium	NN	B-TEST
142	CD	O
,	,	O
potassium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
104	CD	O
,	,	O
bicarbonate	NN	B-TEST
30	CD	O
,	,	O
bun	NN	B-TEST
7	CD	O
,	,	O
creatinine	NN	B-TEST
0.7	CD	O
,	,	O
glucose	VBD	B-TEST
41	CD	O
.	.	O

calcium	NN	B-TEST
9.6	CD	O
,	,	O
magnesium	NN	B-TEST
2.2	CD	O
,	,	O
phosphorus	NN	B-TEST
7.4	CD	O
,	,	O
vitamin	FW	B-TEST
b12	VBP	I-TEST
level	NN	I-TEST
320	CD	O
,	,	O
folate	NN	B-TEST
9.5	CD	O
,	,	O
tsh	NN	B-TEST
1.4	CD	O
,	,	O
acetone	RB	B-TEST
negative	JJ	O
.	.	O

serum	NN	B-TEST
tox	NN	I-TEST
screen	NN	I-TEST
,	,	O
alcohol	NN	O
32	CD	O
mg	NN	O
per	IN	O
deciliter	NN	O
,	,	O
negative	JJ	O
for	IN	O
aspirin	NN	B-TREATMENT
,	,	O
benzos	NN	B-TREATMENT
,	,	O
barbiturates	NNS	B-TREATMENT
,	,	O
and	CC	O
tca	NN	B-TREATMENT
.	.	O

urine	JJ	B-TEST
tox	NN	I-TEST
screen	NN	I-TEST
negative	JJ	O
for	IN	O
benzos	NN	B-TREATMENT
,	,	O
barbiturates	NNS	B-TREATMENT
,	,	O
opiates	NNS	B-TREATMENT
,	,	O
cocaine	NN	B-TREATMENT
,	,	O
amphetamines	NNS	B-TREATMENT
,	,	O
and	CC	O
methadone	NN	B-TREATMENT
.	.	O

telemetry	NN	B-TEST
was	VBD	O
notable	JJ	O
for	IN	O
episodes	NNS	O
of	IN	O
sinus	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
to	TO	O
120s	CD	O
to	TO	O
140s	CD	O
only	RB	O
.	.	O

1.	CD	O
hypoglycemia	NN	B-PROBLEM
:	:	O

the	DT	O
patient	NN	O
had	VBD	O
been	VBN	O
initially	RB	O
very	RB	B-PROBLEM
hypoglycemic	JJ	I-PROBLEM
on	IN	O
admission	NN	O
secondary	JJ	O
to	TO	O
overdosing	VBG	B-PROBLEM
on	IN	I-PROBLEM
insulin	NN	I-PROBLEM
;	:	O
however	RB	O
,	,	O
with	IN	O
glucose	JJ	B-TREATMENT
repletion	NN	I-TREATMENT
both	DT	O
in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
and	CC	O
in	IN	O
the	DT	O
icu	NN	O
,	,	O
this	DT	O
resolved	VBN	O
and	CC	O
the	DT	O
patient	NN	O
also	RB	O
began	VBD	O
to	TO	O
eat	VB	O
.	.	O

we	PRP	O
checked	VBD	O
fingerstick	JJ	B-TEST
glucoses	NNS	I-TEST
q.i.d.	NN	O
and	CC	O
at	IN	O
3:00	CD	O
a.m.	NN	O

his	PRP$	B-TEST
glucose	NN	I-TEST
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
discharge	NN	O
was	VBD	O
about	RB	O
60	CD	O
so	IN	O
we	PRP	O
opted	VBD	O
to	TO	O
decrease	VB	O
his	PRP$	B-TREATMENT
p.m.	NN	I-TREATMENT
nph	RB	I-TREATMENT
dose	VBZ	I-TREATMENT
slightly	RB	O
for	IN	O
discharge	NN	O
and	CC	O
continue	VB	O
covering	VBG	O
him	PRP	O
with	IN	O
sliding	VBG	B-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
.	.	O

it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
he	PRP	O
required	VBD	O
a	DT	O
much	RB	O
greater	JJR	O
amount	NN	O
of	IN	O
insulin	NN	B-TREATMENT
as	IN	O
an	DT	O
outpatient	NN	O
due	JJ	O
to	TO	O
poor	JJ	B-PROBLEM
compliance	NN	I-PROBLEM
with	IN	O
richard	NN	B-TREATMENT
natalie	NN	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
on	IN	O
a	DT	B-TREATMENT
diazepam	NN	I-TREATMENT
ciwa	NN	I-TREATMENT
scale	NN	I-TREATMENT
prophylaxis	NN	I-TREATMENT
against	IN	O
dt	NN	B-PROBLEM
s;	NN	I-PROBLEM
however	RB	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-TEST
very	RB	I-TEST
low	JJ	I-TEST
ciwa	NN	I-TEST
scale	NN	I-TEST
during	IN	O
his	PRP$	O
entire	JJ	O
admission	NN	O
and	CC	O
did	VBD	O
not	RB	O
need	VB	O
any	DT	B-TREATMENT
benzodiazepines	NNS	I-TREATMENT
.	.	O

3.	CD	O
depression	NN	B-PROBLEM
vs.	FW	O
borderline	NN	B-PROBLEM
personality	NN	I-PROBLEM
disorder	NN	I-PROBLEM
:	:	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
several	JJ	O
admissions	NNS	O
in	IN	O
the	DT	O
past	NN	O
for	IN	O
attempted	JJ	B-PROBLEM
suicide	NN	I-PROBLEM
with	IN	O
overdose	NN	B-PROBLEM
of	IN	O
his	PRP$	B-TREATMENT
insulin	NN	I-TREATMENT
and	CC	O
though	IN	O
he	PRP	O
denied	VBD	O
at	IN	O
this	DT	O
time	NN	O
attempting	VBG	O
to	TO	O
end	VB	O
his	PRP$	O
life	NN	O
,	,	O
it	PRP	O
appears	VBZ	O
that	IN	O
the	DT	O
social	JJ	O
situation	NN	O
of	IN	O
increased	JJ	B-PROBLEM
stressors	NNS	I-PROBLEM
corresponding	VBG	O
to	TO	O
this	DT	O
time	NN	O
suggest	VB	O
that	IN	O
this	DT	O
is	VBZ	O
not	RB	O
the	DT	O
truth	NN	O
.	.	O

he	PRP	O
received	VBD	O
a	DT	O
one-to-one	JJ	B-TREATMENT
sitter	NN	I-TREATMENT
during	IN	O
his	PRP$	O
admission	NN	O
and	CC	O
will	MD	O
be	VB	O
transferred	VBN	O
to	TO	O
the	DT	O
psychiatry	NN	O
healthsouth	VBD	O
new	JJ	O
england	NN	O
rehab	NN	O
hospital	NN	O
to	TO	O
ensure	VB	O
the	DT	O
patient	NN	O
's	POS	O
safety	NN	O
and	CC	O
initiate	VB	O
further	JJ	B-TREATMENT
antidepressant	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

he	PRP	O
will	MD	O
need	VB	O
close	RB	O
follow-up	JJ	O
regarding	VBG	O
his	PRP$	B-PROBLEM
depression	NN	I-PROBLEM
as	IN	O
an	DT	O
outpatient	NN	O
,	,	O
although	IN	O
apparently	RB	O
this	DT	O
has	VBZ	O
been	VBN	O
set	VBN	O
up	RP	O
for	IN	O
him	PRP	O
in	IN	O
the	DT	O
past	NN	O
and	CC	O
he	PRP	O
had	VBD	O
not	RB	O
followed	VBN	O
through	IN	O
.	.	O

4.	CD	O
history	NN	O
of	IN	O
high	JJ	B-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
:	:	O

his	PRP$	B-TEST
blood	NN	I-TEST
pressure	NN	I-TEST
was	VBD	O
fairly	RB	O
low	JJ	O
with	IN	O
a	DT	O
maximum	NN	O
of	IN	O
130s	CD	O
systolic	NN	O
during	IN	O
his	PRP$	O
admission	NN	O
,	,	O
thus	RB	O
we	PRP	O
did	VBD	O
not	RB	O
continue	VB	O
his	PRP$	B-TREATMENT
lisinopril	NN	I-TREATMENT
which	WDT	O
he	PRP	O
had	VBD	O
been	VBN	O
on	IN	O
in	IN	O
the	DT	O
past	NN	O
.	.	O

5.	CD	O
right	JJ	B-PROBLEM
upper	JJ	I-PROBLEM
quadrant	NN	I-PROBLEM
pain	NN	I-PROBLEM
:	:	O

we	PRP	O
obtained	VBD	O
a	DT	B-TEST
right	JJ	I-TEST
upper	NN	I-TEST
quadrant	NN	I-TEST
ultrasound	NN	I-TEST
as	RB	O
well	RB	O
as	IN	O
lfts	NNS	B-TEST
,	,	O
amylase	NN	B-TEST
,	,	O
and	CC	O
lipase	NN	B-TEST
which	WDT	O
were	VBD	O
all	DT	O
normal	JJ	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
cholecystitis	NN	B-PROBLEM
or	CC	O
gallstones	NNS	B-PROBLEM
or	CC	O
any	DT	B-PROBLEM
abnormalities	NNS	I-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
liver	NN	I-PROBLEM
or	CC	I-PROBLEM
kidneys	NNS	I-PROBLEM
.	.	O

it	PRP	O
is	VBZ	O
possible	JJ	O
that	IN	O
he	PRP	O
has	VBZ	O
had	VBD	O
a	DT	B-PROBLEM
muscle	NN	I-PROBLEM
strain	NN	I-PROBLEM
or	CC	O
other	JJ	B-PROBLEM
musculoskeletal	JJ	I-PROBLEM
cause	NN	I-PROBLEM
.	.	O

6.	CD	O
prophylaxis	NN	B-TREATMENT
:	:	O

he	PRP	O
was	VBD	O
put	VBN	O
on	IN	O
pepcid	NN	B-TREATMENT
for	IN	O
gi	NN	B-TREATMENT
prophylaxis	NN	I-TREATMENT
.	.	O

he	PRP	O
complied	VBD	O
with	IN	O
linda	NN	B-TREATMENT
chad	VBD	I-TREATMENT
diet	JJ	I-TREATMENT
while	IN	O
hospitalized	VBN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
hyperphosphatemic	JJ	B-PROBLEM
secondary	JJ	O
to	TO	O
overadministration	NN	O
of	IN	O
neutra-phos	JJ	B-TREATMENT
during	IN	O
his	PRP$	O
icu	JJ	O
stay	NN	O
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
two	CD	O
doses	NNS	O
of	IN	O
calcium	NN	B-TREATMENT
carbonate	NN	I-TREATMENT
1	CD	O
gram	NN	O
,	,	O
and	CC	O
will	MD	O
most	RBS	O
likely	JJ	O
normalize	JJ	O
secondary	JJ	O
to	TO	O
both	DT	O
calcium	NN	O
binding	NN	O
and	CC	O
urinary	JJ	O
excretion	NN	O
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
asymptomatic	JJ	B-PROBLEM
.	.	O

1.	CD	O
depression	NN	B-PROBLEM
.	.	O

2.	CD	O
insulin-dependent	JJ	B-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

3.	CD	O
asthma	NN	B-PROBLEM
.	.	O

1.	CD	O
insulin	NN	B-TREATMENT
nph	RB	I-TREATMENT
10	CD	O
units	NNS	O
q.a.m.	RB	O
,	,	O
5	CD	O
units	NNS	O
q.p.m.	RB	O

2.	CD	O
humalog	NN	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	JJ	I-TREATMENT
insulin	NN	I-TREATMENT
for	IN	O
fingerstick	JJ	B-TEST
blood	NN	I-TEST
glucose	VBD	I-TEST
151-200	JJ	O
2	CD	O
units	NNS	O
;	:	O
201-250	JJ	O
4	CD	O
units	NNS	O
;	:	O
251-300	JJ	O
6	CD	O
units	NNS	O
;	:	O
301-350	JJ	O
8	CD	O
units	NNS	O
;	:	O
351-400	JJ	O
10	CD	O
units	NNS	O
;	:	O
greater	JJR	O
than	IN	O
400	CD	O
12	CD	O
units	NNS	O
.	.	O

3.	CD	O
multivitamin	NN	B-TREATMENT
.	.	O

4.	CD	O
fluticasone	NN	B-TREATMENT
.	.	O

5.	CD	O
albuterol	NN	B-TREATMENT
p.r.n.	NN	O

6.	CD	O
pepcid	JJ	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O

the	DT	O
patient	NN	O
will	MD	O
be	VB	O
transferred	VBN	O
to	TO	O
the	DT	O
inpatient	JJ	O
psychiatry	NN	O
unit	NN	O
on	IN	O
springfield	NN	O
municipal	JJ	O
hospital	NN	O
iv	NN	O
for	IN	O
further	JJ	B-TEST
evaluation	NN	I-TEST
and	CC	O
treatment	NN	B-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
depression	NN	I-PROBLEM
and	CC	O
possible	JJ	O
suicidal	JJ	B-PROBLEM
ideation	NN	I-PROBLEM
.	.	O

he	PRP	O
will	MD	O
follow-up	VB	O
with	IN	O
his	PRP$	O
primary	JJ	O
care	NN	O
doctor	NN	O
,	,	O
dr.	NN	O
gillis	NN	O
,	,	O
after	IN	O
discharge	NN	O
,	,	O
johannes	NNS	O
for	IN	O
diabetes	NNS	B-TREATMENT
management	NN	I-TREATMENT
,	,	O
and	CC	O
psychiatry	NN	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
of	IN	O
his	PRP$	B-PROBLEM
impulsive	JJ	I-PROBLEM
behaviors	NNS	I-PROBLEM
.	.	O

increased	VBN	O
acid	NN	B-PROBLEM
reflux	NN	I-PROBLEM

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
printed	JJ	O
instructions	NNS	O
for	IN	O
abdominal	JJ	B-PROBLEM
pain	NN	I-PROBLEM
(	(	O
spanish	JJ	O
)	)	O
.	.	O

gerd	NN	B-PROBLEM

h	NN	O
,	,	O
p,	NN	B-TEST
labs	NNS	B-TEST
,	,	O
mylanta	FW	B-TREATMENT
/	FW	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT

mylanta	NN	B-TREATMENT
15	CD	O
cc	NN	O
mixed	JJ	O
with	IN	O
viscous	JJ	B-TREATMENT
lidocaine	NN	I-TREATMENT
every	DT	O
8	CD	O
hours	NNS	O
if	IN	O
needed	VBN	O
for	IN	O
severe	JJ	O
pain	NN	B-PROBLEM
only	RB	O
can	MD	O
use	VB	O
mylanta	NN	B-TREATMENT
without	IN	O
lidocaine	NN	B-TREATMENT
more	RBR	O
frequently	RB	O
bland	VBP	B-TREATMENT
diet	JJ	I-TREATMENT
,	,	O
no	DT	O
caffeine	NN	O
,	,	O
chilli	NN	O
,	,	O
or	CC	O
alcohol	NN	O
...	:	O

return	NN	O
to	TO	O
ed	VB	O
if	IN	O
worsening	VBG	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
black	JJ	B-PROBLEM
stools	NNS	I-PROBLEM
,	,	O
blood	NN	B-PROBLEM
in	IN	I-PROBLEM
stool	NN	I-PROBLEM

this	DT	O
is	VBZ	O
a	DT	O
44	CD	O
-	:	O
year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
9/02	CD	O
,	,	O
status	NN	O
post	NN	O
stent	NN	B-TREATMENT
proximal	NN	B-PROBLEM
and	CC	I-PROBLEM
mid-rca	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
and	CC	O
om	JJ	B-PROBLEM
lesion	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
myoview	NN	I-TEST
on	IN	O
05-04	NN	O
which	WDT	O
showed	VBD	O
fixed	VBN	B-PROBLEM
inferior	RB	I-PROBLEM
wall	JJ	I-PROBLEM
defect	NN	I-PROBLEM
but	CC	O
no	DT	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
getting	VBG	O
short	JJ	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
with	IN	O
exertion	NN	O
times	NNS	O
one	CD	O
month	NN	O
and	CC	O
also	RB	O
has	VBZ	O
occasional	JJ	B-PROBLEM
chest	NN	I-PROBLEM
tightness	NN	I-PROBLEM
.	.	O

he	PRP	O
denies	VBZ	O
orthopnea	NN	B-PROBLEM
,	,	O
edema	NN	B-PROBLEM
,	,	O
paroxysmal	JJ	B-PROBLEM
nocturnal	JJ	I-PROBLEM
dyspnea	NN	I-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
,	,	O
claudication	NN	B-PROBLEM
.	.	O

he	PRP	O
also	RB	O
has	VBZ	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
and	CC	O
noninsulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

he	PRP	O
underwent	JJ	O
cardiac	JJ	B-TEST
catheterization	NN	I-TEST
today	NN	O
which	WDT	O
revealed	VBD	O
om	NNS	O
,	,	O
no	DT	O
obstructive	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
anterior	RP	I-PROBLEM
descending	VBG	I-PROBLEM
minimal	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
left	VBD	B-PROBLEM
circumflex	JJ	I-PROBLEM
40%	CD	I-PROBLEM
mid-stenosis	NN	I-PROBLEM
.	.	O

right	RB	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	RB	I-PROBLEM
100%	CD	I-PROBLEM
mid-stenosis	NN	I-PROBLEM
.	.	O

echo	NN	B-TEST
in	IN	O
9/02	CD	O
showed	VBD	O
lvf	NN	B-TEST
of	IN	O
75%	CD	O
with	IN	O
moderate	JJ	B-PROBLEM
dilatation	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
descending	NN	I-PROBLEM
aorta	NN	I-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
now	RB	O
preop	JJ	O
for	IN	O
a	DT	B-TREATMENT
coronary	JJ	I-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
.	.	O

noninsulin	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	RBS	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
high	JJ	B-PROBLEM
cholesterol	NN	I-PROBLEM
,	,	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
in	IN	O
9/02	CD	O
.	.	O

status	NN	O
post	NN	O
stent	NN	B-TREATMENT
.	.	O

1.	CD	O
folic	JJ	B-TREATMENT
acid	NN	I-TREATMENT
.	.	O

2.	CD	O
metformin	NN	B-TREATMENT
.	.	O

3.	CD	O
norvasc	NN	B-TREATMENT
.	.	O

4.	CD	O
aspirin	NN	B-TREATMENT
.	.	O

5.	CD	O
lopressor	NN	B-TREATMENT
.	.	O

6.	CD	O
lipitor	NN	B-TREATMENT
.	.	O

7.	CD	O
diovan	NN	B-TREATMENT
.	.	O

8.	CD	O
hydrochlorothiazide	NN	B-TREATMENT
.	.	O

penicillin	NN	B-TREATMENT
,	,	O
sulfa	NN	B-TREATMENT
and	CC	O
codeine	NN	B-TREATMENT
.	.	O

strong	JJ	B-PROBLEM
coronary	JJ	I-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
in	IN	O
no	DT	O
acute	NN	B-PROBLEM
distress	NN	I-PROBLEM
,	,	O
vital	JJ	B-TEST
signs	NNS	I-TEST
stable	JJ	O
.	.	O

normocephalic	JJ	B-PROBLEM
,	,	O
atraumatic	JJ	B-PROBLEM
.	.	O

full	JJ	O
range	NN	O
of	IN	O
motion	NN	O
,	,	O
no	DT	O
lymphadenopathy	NN	B-PROBLEM
.	.	O

no	DT	O
thyromegaly	NN	B-PROBLEM
.	.	O

carotids	NNS	B-TEST
2+	CD	O
bilaterally	RB	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	O
.	.	O

no	DT	O
murmurs	NN	B-PROBLEM
,	,	O
rubs	NN	B-PROBLEM
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdomen	NNS	B-PROBLEM
obese	JJ	I-PROBLEM
,	,	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
without	IN	O
masses	NNS	B-PROBLEM
,	,	O
no	DT	O
hepatosplenomegaly	NN	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	VBZ	O
without	IN	O
cyanosis	NN	B-PROBLEM
,	,	O
clubbing	VBG	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

pulses	NNS	B-TEST
2+	CD	O
bilaterally	RB	O
throughout	IN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
hospital	NN	O
on	IN	O
2015-06-10	JJ	O
and	CC	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
2015-06-11	JJ	O
where	WRB	O
coronary	JJ	B-TREATMENT
artery	NN	I-TREATMENT
bypass	NN	I-TREATMENT
graft	NN	I-TREATMENT
times	NNS	O
four	CD	O
was	VBD	O
performed	VBN	O
.	.	O

he	PRP	O
initially	RB	O
required	VBD	O
nitroglycerin	JJ	B-TREATMENT
drip	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
chest	VBN	B-TREATMENT
tube	NN	I-TREATMENT
and	CC	O
pacing	NN	B-TREATMENT
wires	NNS	I-TREATMENT
in	IN	O
place	NN	O
.	.	O

received	VBN	O
perioperative	JJ	B-TREATMENT
vancomycin	NN	I-TREATMENT
.	.	O

postoperative	JJ	O
day	NN	O
one	CD	O
the	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
collapsed	JJ	I-PROBLEM
left	NN	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

peep	NN	B-TREATMENT
was	VBD	O
increased	VBN	O
and	CC	O
a	DT	B-TEST
chest	JJ	I-TEST
x-ray	NN	I-TEST
checked	VBD	O
the	DT	O
following	JJ	O
morning	NN	O
.	.	O

the	DT	O
patient	NN	O
subsequently	RB	O
did	VBD	O
well	RB	O
,	,	O
chest	JJS	B-TREATMENT
tubes	NNS	I-TREATMENT
were	VBD	O
removed	VBN	O
at	IN	O
the	DT	O
appropriate	JJ	O
time	NN	O
,	,	O
pacing	VBG	B-TREATMENT
wires	NNS	I-TREATMENT
removed	VBN	O
at	IN	O
the	DT	O
appropriate	JJ	O
time	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
discharged	VBN	O
to	TO	O
the	DT	O
regular	JJ	O
cardiothoracic	NN	O
floor	NN	O
where	WRB	O
his	PRP$	B-TREATMENT
anti-hypertensives	NNS	I-TREATMENT
were	VBD	O
manipulated	VBN	O
to	TO	O
improve	VB	O
his	PRP$	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
and	CC	O
blood	NN	B-TEST
pressure	NN	I-TEST
.	.	O

should	MD	O
not	RB	O
drive	VB	O
while	IN	O
on	IN	O
pain	NN	B-TREATMENT
medication	NN	I-TREATMENT
.	.	O

he	PRP	O
is	VBZ	O
on	IN	O
lopressor	NN	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

metformin	NN	B-TREATMENT
500	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
.	.	O

lasix	RB	B-TREATMENT
20	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
times	VB	O
seven	CD	O
days	NNS	O
.	.	O

potassium	NN	B-TREATMENT
20	CD	O
meq	NN	O
twice	RB	O
a	DT	O
day	NN	O
times	VB	O
seven	CD	O
days	NNS	O
.	.	O

potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
20	CD	O
meq	NN	O
times	NNS	O
seven	CD	O
days	NNS	O
,	,	O
plavix	VBP	B-TREATMENT
75	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
,	,	O
isosorbide	RB	B-TREATMENT
60	CD	O
mg	NNS	O
q	JJ	O
day	NN	O
,	,	O
percocet	NN	B-TREATMENT
p.r.n.	NN	O
,	,	O
entericoated	VBD	B-TREATMENT
aspirin	RB	I-TREATMENT
325	CD	O
mg	NNS	O
q	JJ	O
day	NN	O
.	.	O

colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
twice	RB	O
a	DT	O
day	NN	O
p.r.n.	NN	O

lipitor	NN	B-TREATMENT
20	CD	O
mg	NN	O
p.o.	NN	O
q	JJ	O
day	NN	O
.	.	O

folate	NN	B-TREATMENT
1	CD	O
mg	NN	O
q	JJ	O
day	NN	O
.	.	O

rule	NN	O
out	IN	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM

rule	NN	O
out	IN	O
for	IN	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM

1	CD	O
)	)	O
aortic	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
;	:	O
2	CD	O
)	)	O
parkinson	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O
3	CD	O
)	)	O
a	DT	O
history	NN	O
of	IN	O
colon	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
;	:	O
4	CD	O
)	)	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
.	.	O

an	DT	B-TEST
exercise	NN	I-TEST
tolerance	NN	I-TEST
test	NN	I-TEST
with	IN	O
imaging	NN	B-TEST
.	.	O

right	RB	B-PROBLEM
sided	VBN	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
by	IN	O
several	JJ	O
hours	NNS	O
.	.	O

miss	NN	O
siehjesc	NN	O
is	VBZ	O
an	DT	O
85-year-old	JJ	O
woman	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
significant	JJ	O
for	IN	O
parkinson	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
of	IN	O
ten	JJ	O
years	NNS	O
duration	NN	O
,	,	O
supraventricular	JJ	B-PROBLEM
tachycardia	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
history	NN	O
of	IN	O
colon	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
,	,	O
who	WP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
11:30	CD	O
on	IN	O
the	DT	O
morning	NN	O
of	IN	O
admission	NN	O
when	WRB	O
she	PRP	O
felt	VBD	O
the	DT	O
acute	NN	O
on	IN	O
set	NN	O
of	IN	O
5	CD	O
out	IN	O
of	IN	O
10	CD	O
right	NN	B-PROBLEM
sided	VBD	I-PROBLEM
chest	JJS	I-PROBLEM
pain	NN	I-PROBLEM
with	IN	O
radiation	NN	B-PROBLEM
to	TO	I-PROBLEM
her	PRP$	I-PROBLEM
sternum	NN	I-PROBLEM
but	CC	O
not	RB	O
to	TO	O
her	PRP$	O
neck	NN	O
or	CC	O
arms	NNS	O
or	CC	O
back	RB	O
.	.	O

it	PRP	O
was	VBD	O
not	RB	O
relieved	VBN	O
by	IN	O
2	CD	B-TREATMENT
sublingual	JJ	I-TREATMENT
nitroglycerins	NNS	I-TREATMENT
.	.	O

she	PRP	O
did	VBD	O
state	NN	O
that	IN	O
she	PRP	O
experienced	VBD	O
some	DT	B-PROBLEM
shortness	NN	I-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
(	(	O
her	PRP$	O
usual	JJ	O
anginal	JJ	O
equivalent	NN	O
)	)	O
and	CC	O
believes	VBZ	O
she	PRP	O
did	VBD	O
experience	VB	O
some	DT	B-PROBLEM
lightheadedness	NN	I-PROBLEM
as	RB	O
well	RB	O
,	,	O
but	CC	O
denies	VBZ	O
blacking	VBG	O
out	RP	O
or	CC	O
falling	VBG	O
.	.	O

while	IN	O
the	DT	B-PROBLEM
pain	NN	I-PROBLEM
was	VBD	O
initially	RB	O
intermittent	JJ	O
,	,	O
it	PRP	O
became	VBD	O
steady	JJ	O
at	IN	O
about	IN	O
1:00	CD	O
p.m.	NN	O
at	IN	O
which	WDT	O
time	NN	O
she	PRP	O
presented	VBD	O
to	TO	O
the	DT	O
tecal	JJ	O
galecounxopt	NN	O
community	NN	O
hospital	NN	O
emergency	NN	O
room	NN	O
and	CC	O
following	VBG	O
this	DT	O
experience	NN	O
a	DT	O
spontaneous	JJ	O
remission	NN	O
of	IN	O
her	PRP$	B-PROBLEM
right	NN	I-PROBLEM
sided	VBD	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

since	IN	O
that	DT	O
time	NN	O
she	PRP	O
has	VBZ	O
experience	NN	O
occasional	JJ	O
episodes	NNS	O
of	IN	O
the	DT	B-PROBLEM
same	JJ	I-PROBLEM
focal	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pain	NN	I-PROBLEM
but	CC	O
finds	VBZ	O
that	IN	O
it	PRP	O
spontaneously	RB	O
remits	VBZ	O
.	.	O

it	PRP	O
is	VBZ	O
made	VBN	O
better	RB	O
by	IN	O
direct	JJ	B-TREATMENT
pressure	NN	I-TREATMENT
to	TO	I-TREATMENT
the	DT	I-TREATMENT
point	NN	I-TREATMENT
and	CC	O
she	PRP	O
recalls	VBZ	O
no	DT	O
factors	NNS	O
which	WDT	O
worsened	VBD	O
it	PRP	O
.	.	O

she	PRP	O
is	VBZ	O
admitted	VBN	O
to	TO	O
rule	VB	O
out	RP	O
myocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

1	CD	O
)	)	O
parkinson	NN	B-PROBLEM
's	POS	I-PROBLEM
disease	NN	I-PROBLEM
;	:	O

2	CD	O
)	)	O
hypertension	NN	B-PROBLEM
;	:	O

3	LS	O
)	)	O
aorticsclerosis	NN	B-PROBLEM
;	:	O

4	CD	O
)	)	O
history	NN	O
of	IN	O
colon	NN	B-PROBLEM
carcinoma	NN	I-PROBLEM
;	:	O

5	CD	O
)	)	O
severe	JJ	B-PROBLEM
kyphosis	NN	I-PROBLEM
.	.	O

codeine	NN	B-TREATMENT
.	.	O

1	CD	O
)	)	O
lasix	NN	B-TREATMENT
20	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

2	CD	O
)	)	O
sinemet	VBD	B-TREATMENT
25/100	CD	O
1	CD	O
t.i.d.	NN	O

3	LS	O
)	)	O
cogentin	NN	B-TREATMENT
0.5	CD	O
mg.	NN	O
1	CD	O
tabs	NN	O
po	NN	O
q.a.m.	NN	O
and	CC	O
1	CD	O
q.noon	NN	O
as	RB	O
well	RB	O
as	IN	O
1	CD	O
q.h.s.	NN	O

4	CD	O
)	)	O
eldepryl	NN	B-TREATMENT
5	CD	O
mg.	NN	O
po	NN	O
b.i.d.	NN	O

5	CD	O
)	)	O
enteric	NN	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	RB	I-TREATMENT
325	CD	O
mg.	NNS	O
po	JJ	O
q.d.	NN	O

6	CD	O
)	)	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq.	NN	O
po	NN	O
q.d.	NN	O

is	VBZ	O
significant	JJ	O
for	IN	O
a	DT	O
father	NN	O
who	WP	O
had	VBD	O
a	DT	B-PROBLEM
stroke	NN	I-PROBLEM
and	CC	O
also	RB	O
suffered	VBD	O
from	IN	O
hypertension	NN	B-PROBLEM
.	.	O

she	PRP	O
denies	VBZ	O
any	DT	O
family	NN	O
history	NN	O
of	IN	O
diabetes	NNS	B-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
vital	JJ	I-TEST
signs	NNS	I-TEST
showed	VBD	O
a	DT	B-TEST
temperature	NN	I-TEST
of	IN	O
96.8	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
180/78	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
18	CD	O
,	,	O
and	CC	O
she	PRP	O
was	VBD	O
satting	VBG	B-TEST
95	CD	O
percent	NN	O
on	IN	O
two	CD	B-TREATMENT
liters	NNS	I-TREATMENT
nasal	JJ	I-TREATMENT
cannula	NN	I-TREATMENT
.	.	O

in	IN	O
general	JJ	O
the	DT	O
patient	NN	O
was	VBD	O
resting	VBG	O
comfortably	RB	O
in	IN	O
bed	NN	O
with	IN	O
a	DT	B-PROBLEM
visible	JJ	I-PROBLEM
tremor	NN	I-PROBLEM
of	IN	I-PROBLEM
her	PRP$	I-PROBLEM
right	JJ	I-PROBLEM
hand	NN	I-PROBLEM
and	CC	I-PROBLEM
foot	NN	I-PROBLEM
.	.	O

the	DT	O
head	NN	O
,	,	O
eyes	NNS	O
,	,	O
ears	NNS	O
,	,	O
nose	RB	O
and	CC	O
throat	NN	O
,	,	O
normocephalic	JJ	O
,	,	O
atraumatic	JJ	B-PROBLEM
,	,	O
pupils	JJ	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
reactive	JJ	O
to	TO	O
light	JJ	O
and	CC	O
accommodation	NN	O
,	,	O
extraocular	JJ	O
muscles	NNS	O
intact	JJ	O
,	,	O
sclera	JJ	B-PROBLEM
anicteric	NN	I-PROBLEM
.	.	O

supple	NN	O
,	,	O
no	DT	O
bruits	NNS	B-PROBLEM
,	,	O
nodes	NNS	B-PROBLEM
or	CC	O
thyromegaly	NN	B-PROBLEM
.	.	O

crackles	NNS	B-PROBLEM
at	IN	I-PROBLEM
both	DT	I-PROBLEM
bases	NNS	I-PROBLEM
,	,	O
kyphotic	JJ	B-PROBLEM
,	,	O
no	DT	O
costovertebral	JJ	B-PROBLEM
angle	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
1	CD	B-PROBLEM
out	IN	I-PROBLEM
of	IN	I-PROBLEM
6	CD	I-PROBLEM
systolic	JJ	I-PROBLEM
ejection	NN	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

soft	JJ	O
,	,	O
well	RB	B-PROBLEM
healed	VBN	I-PROBLEM
scar	NN	I-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
no	DT	O
tenderness	NN	B-PROBLEM
or	CC	O
organomegaly	NN	B-PROBLEM
noted	VBN	O
.	.	O

without	IN	O
clubbing	VBG	B-PROBLEM
,	,	O
claudication	NN	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

tremors	NNS	B-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
hand	NN	I-PROBLEM
and	CC	I-PROBLEM
foot	NN	I-PROBLEM
at	IN	O
rest	NN	O
.	.	O

equivocal	JJ	B-PROBLEM
cogwheeling	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
right	NN	I-PROBLEM
,	,	O
normal	JJ	O
tone	NN	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
's	POS	I-TEST
sma	JJ	I-TEST
7	CD	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
bun	NN	I-TEST
of	IN	O
28	CD	O
,	,	O
creatinine	NN	B-TEST
1.3	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
glucose	NN	I-TEST
of	IN	O
102	CD	O
.	.	O

extended	JJ	O
chemistries	NNS	B-TEST
were	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
with	IN	O
a	DT	B-TEST
creatine	JJ	I-TEST
kinase	NN	I-TEST
of	IN	O
122	CD	O
and	CC	O
no	DT	O
measured	JJ	B-TEST
methylene	NN	I-TEST
blue	JJ	I-TEST
fraction	NN	I-TEST
given	VBN	O
the	DT	O
low	JJ	O
value	NN	O
.	.	O

the	DT	B-TEST
complete	JJ	I-TEST
blood	NN	I-TEST
count	NN	I-TEST
was	VBD	O
notable	JJ	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
count	NN	I-TEST
of	IN	O
5.3,000	CD	O
,	,	O
hematocrit	VBD	B-TEST
39	CD	O
1/2	CD	O
and	CC	O
platelet	NN	B-TEST
count	NN	I-TEST
of	IN	O
180,000	CD	O
and	CC	O
normal	JJ	O
coags	NNS	O
were	VBD	O
measured	VBN	O
.	.	O

portable	JJ	B-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
was	VBD	O
without	IN	O
evidence	NN	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
or	CC	O
pneumonia	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
proceeded	VBD	O
to	TO	O
rule	VB	O
out	RP	O
formyocardial	JJ	B-PROBLEM
infarction	NN	I-PROBLEM
by	IN	O
enzymes	NNS	B-TEST
.	.	O

additionally	RB	O
,	,	O
the	DT	O
patient	NN	O
underwent	VBD	O
a	DT	B-TEST
exercise	NN	I-TEST
stress	NN	I-TEST
test	NN	I-TEST
on	IN	O
8/6/98	CD	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
proceeding	VBG	O
from	IN	O
76	CD	O
to	TO	O
93	CD	O
beats	NNS	O
per	IN	O
minute	NN	O
.	.	O

there	EX	O
were	VBD	O
no	DT	O
electrocardiogram	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
noted	VBD	O
and	CC	O
there	EX	O
were	VBD	O
no	DT	O
arrhythmias	NN	B-PROBLEM
noted	VBD	O
as	RB	O
well	RB	O
.	.	O

during	IN	O
the	DT	B-TEST
test	NN	I-TEST
the	DT	O
patient	NN	O
experienced	VBD	O
no	DT	O
chest	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
or	CC	O
pain	NN	B-PROBLEM
or	CC	O
dyspnea	NN	B-PROBLEM
and	CC	O
nuclear	JJ	B-TEST
medical	JJ	I-TEST
imaging	NN	I-TEST
was	VBD	O
without	IN	O
evidence	NN	O
of	IN	O
ischemia	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
in	IN	O
this	DT	O
fashion	NN	O
discharged	VBD	O
from	IN	O
the	DT	O
service	NN	O
to	TO	O
continue	VB	O
on	IN	O
her	PRP	B-TREATMENT
current	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
and	CC	O
to	TO	O
call	VB	O
in	IN	O
oneweek	NN	O
to	TO	O
follow	VB	O
up	RP	O
with	IN	O
dr.	NN	O
sterpbreutzsterp	NN	O
and	CC	O
cardiology	NN	O
.	.	O

1)	CD	O
lasix	JJ	B-TREATMENT
20	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

2)	CD	O
sinemet	VBD	B-TREATMENT
25/100	CD	O
po	NN	O
t.i.d.	NN	O

3)	CD	O
cogentin	NN	B-TREATMENT
0.5	CD	O
mg.	NN	O
2	CD	O
tabs	NN	O
q.a.m.	NN	O
,	,	O
1	CD	O
q.lunch	JJ	O
time	NN	O
,	,	O
1	CD	O
q.bed	JJ	O
time	NN	O
.	.	O

4)	CD	O
eldepryl	JJ	B-TREATMENT
5	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

5)	CD	O
enteric	JJ	B-TREATMENT
coated	VBD	I-TREATMENT
aspirin	JJ	I-TREATMENT
325	CD	O
mg.	NN	O
po	NN	O
q.d.	NN	O

6)	CD	O
potassium	NN	B-TREATMENT
chloride	NN	I-TREATMENT
10	CD	O
meq.	NN	O
po	NN	O
q.d.	NN	O

7)	CD	O
metoprolol	JJ	B-TREATMENT
25	CD	O
mg.	NN	O
po	NN	O
b.i.d.	NN	O

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

lopressor	NN	B-TREATMENT
(	(	I-TREATMENT
metoprolol	JJ	I-TREATMENT
tartrate	NN	I-TREATMENT
)	)	I-TREATMENT
12.5	CD	O
mg	JJ	O
po	NN	O
bid	NN	O

enalapril	JJ	B-TREATMENT
maleate	NN	I-TREATMENT
20	CD	O

dr.	NN	O
hashimoto	NN	O
,	,	O
no	DT	O
known	JJ	B-PROBLEM
allergies	NNS	I-PROBLEM

chest	JJ	B-PROBLEM
pressure	NN	I-PROBLEM
;	:	O
r	CC	O
/	VB	O
o	JJ	O
mi	NN	B-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM

chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
;	:	O
r	NN	O
/	CD	O
o	NN	O

mi	NN	B-PROBLEM

echocardiogram	NN	B-TEST
mra	NN	B-TEST
kidney	NN	I-TEST

51	CD	O
yo	JJ	O
f	NN	O
h	NN	O
/	NNP	O
o	NN	O
htn	NN	B-PROBLEM
,	,	O
hyperchol	NN	B-PROBLEM
,	,	O
p	NN	O
/	NNP	O
w	NN	O
ss	NN	B-PROBLEM
chest	NN	I-PROBLEM
pressure	NN	I-PROBLEM
x	VBZ	O
3	CD	O
days	NNS	O
.	.	O

usoh	JJ	O
until	IN	O
3	CD	O
day	NN	O
pta	NN	O
,	,	O
dev	VB	O
new	JJ	B-PROBLEM
ss	JJ	I-PROBLEM
chest	NN	I-PROBLEM
pressure	NN	I-PROBLEM
sometimes	RB	O
rad	VBZ	O
to	TO	O
back	VB	O
and	CC	O
l	VB	O
neck	NN	O
/	NNP	O
jaw	NN	O
.	.	O

pressure	NN	B-PROBLEM
lasted	VBN	O
for	IN	O
hours	NNS	O
at	IN	O
a	DT	O
time	NN	O
.	.	O

variably	RB	O
assoc	NN	O
with	IN	O
sob	NN	B-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
palpitations	NNS	B-PROBLEM
,	,	O
tremulousness	NN	B-PROBLEM
,	,	O
diaphoresis	NN	B-PROBLEM
.	.	O

pt	NN	O
has	VBZ	O
htn	VBN	B-PROBLEM
,	,	O
measured	VBN	O
bp	NN	B-TEST
home	NN	O
200/100	CD	O
.	.	O

reported	VBN	O
to	TO	O
a	DT	O
local	JJ	O
ed	NN	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
bp	VBN	B-TEST
up	RP	O
to	TO	O
200/100	CD	O
.	.	O

put	NN	O
on	IN	O
ntg	NN	B-TREATMENT
drip	NN	I-TREATMENT
without	IN	O
relief	NN	O
.	.	O

pain	NN	B-PROBLEM
2/10	CD	O
persisted	VBN	O
,	,	O
relieved	VBN	O
by	IN	O
mso4	NN	B-TREATMENT
.	.	O

at	IN	O
elmvh	JJ	O
ed	NN	O
,	,	O
bp	VBD	B-TEST
160/87	CD	O
.	.	O

now	RB	O
adm	VBZ	O
for	IN	O
r	NN	O
/	NNP	O
o	NN	O
mi	NN	B-PROBLEM
,	,	O
eval	NN	B-TEST
of	IN	O
?	.	O
demand	NN	B-PROBLEM
ischemia	NN	I-PROBLEM
,	,	O
plus	CC	O
w	JJ	B-TEST
/	NNP	I-TEST
u	NN	I-TEST
of	IN	O
htn	NN	B-PROBLEM
urgency	NN	I-PROBLEM
(	(	O
which	WDT	O
may	MD	O
be	VB	O
very	RB	O
new	JJ	O
in	IN	O
onset	NN	O
)	)	O
.	.	O

pe	NN	B-TEST
t97.5	NN	B-TEST
p59	NN	B-TEST
bp	NN	B-TEST
(	(	O
l	NN	O
)	)	O
180/86	CD	O
(	(	O
r	NN	O
)	)	O
186/98	CD	O
rr20	NN	B-TEST
98%	CD	O
2l	CD	B-TREATMENT
.	.	O

exam	NN	B-TEST
only	RB	O
notable	JJ	O
for	IN	O
ii	JJ	B-PROBLEM
/	NNP	I-PROBLEM
vi	NN	I-PROBLEM
systolic	JJ	I-PROBLEM
murmur	NN	I-PROBLEM
.	.	O

labs	NNS	B-TEST
only	RB	O
notable	JJ	O
for	IN	O
ck	NN	B-TEST
54	CD	O
(	(	O
nl	NN	O
)	)	O
,	,	O
trop	$	B-TEST
0.03	CD	O
,	,	O
hct	VBD	B-TEST
35.6	CD	O
mcv	NN	B-TEST
79	CD	O
.	.	O

ekg	NN	B-TEST
lbbb	NN	B-PROBLEM
nsr	NN	O
.	.	O

cxr	NN	B-TEST
negative	JJ	O
.	.	O

plan	NN	O
romi	VBZ	B-TEST
protocol	NN	I-TEST
.	.	O

cp	NN	B-TREATMENT
protocol	NN	I-TREATMENT
.	.	O

captopril	NN	B-TREATMENT
and	CC	O
nitropaste	NN	B-TREATMENT
to	TO	O
control	VB	O
pressure	NN	B-PROBLEM
.	.	O

mso4	NN	B-TREATMENT
for	IN	O
cp	NN	B-PROBLEM
.	.	O

echo	NN	B-TEST
,	,	O
mra	NN	B-TEST
(	(	O
r	JJ	O
/	NNP	O
o	MD	O
dissection	NN	B-PROBLEM
)	)	O
,	,	O
urine	JJ	B-TEST
catecholamines	NNS	I-TEST
and	CC	O
vma	NN	B-TEST
.	.	O

guaiac	NN	B-TEST
all	DT	I-TEST
stools	NNS	I-TEST
,	,	O
check	VB	O
iron	NN	B-TEST
studies	NNS	I-TEST
.	.	O

1.	CD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM

-	:	O
pt	NN	O
placed	VBN	O
on	IN	O
captopril	NN	B-TREATMENT
25	CD	O
tid	NN	O
,	,	O
lopressor	VBZ	B-TREATMENT
12.5	CD	O
bid	NN	O
and	CC	O
ntg	JJ	B-TREATMENT
paste	NN	I-TREATMENT
ss	NN	O
,	,	O
achieving	VBG	O
normal	JJ	O
bp	NN	O
w	NN	O
/	NNP	O
in	IN	O
5	CD	O
hrs	NN	O
of	IN	O
adm	NN	O
to	TO	O
floor	NN	O
.	.	O

her	PRP$	B-PROBLEM
cpress	NN	I-PROBLEM
dissappeared	VBD	O
over	IN	O
the	DT	O
same	JJ	O
timeframe	NN	O
.	.	O

-	:	O
pt	NN	O
r&apos;d	NN	O
/	NNP	O
o	NN	O
for	IN	O
mi	NN	B-PROBLEM
by	IN	O
cpk	NN	B-TEST
(	(	O
54-&gt;	JJ	O
38-&gt;	JJ	O
33	CD	O
)	)	O
and	CC	O
tpn	NN	B-TEST
(	(	O
0.03	CD	O
)	)	O
,	,	O
and	CC	O
stable	JJ	O
ekg	NN	O
.	.	O

2.	CD	O
hypertension	NN	B-PROBLEM

-	:	O
controlled	VBN	O
on	IN	O
captopril	NN	B-TREATMENT
+	NN	O
lopressor	NN	B-TREATMENT
to	TO	O
110-130s	CD	O
;	:	O
ntg	CC	B-TREATMENT
paste	NN	I-TREATMENT
causing	VBG	O
30	CD	O
pt	JJ	O
drop	NN	O
so	RB	O
d	JJ	O
/	NNP	O
c&apos;d	NN	O
.	.	O

-	:	O
mra	NN	B-TEST
kidney	NN	I-TEST
:	:	O

no	DT	O
stenosis	NN	B-PROBLEM
;	:	O
no	DT	O
parenchymal	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM

-	:	O
cxr	NN	B-TEST
:	:	O

no	DT	O
obvious	JJ	B-PROBLEM
mediastinal	JJ	I-PROBLEM
widening	NN	I-PROBLEM
,	,	O
but	CC	O
no	DT	O
comp	NN	B-TEST
arison	NN	I-TEST
film	NN	I-TEST
;	:	O
wnl	NN	O

-	:	O
echo	NN	B-TEST
:	:	O

ef	JJ	B-TEST
55-60	CD	O
,	,	O
?	.	O
septal	JJ	B-PROBLEM
flattening	NN	I-PROBLEM
,	,	O
mild	JJ	B-PROBLEM
tr	NN	I-PROBLEM
and	CC	O
mr	NN	B-PROBLEM
,	,	O
trace	NN	B-PROBLEM
effusion	NN	I-PROBLEM
-24h	NNP	B-TEST
urine	NN	I-TEST
study	NN	I-TEST
:	:	O

sternal	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

status	NN	O
post	NN	O
orthotopic	NN	B-TREATMENT
cardiac	NN	I-TREATMENT
transplant	NN	I-TREATMENT
.	.	O

insulin	NN	B-PROBLEM
dependent	NN	I-PROBLEM
diabetes	VBZ	I-PROBLEM
mellitus	NNS	I-PROBLEM
.	.	O

dilated	VBN	B-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
48-year-old	JJ	O
white	JJ	O
man	NN	O
who	WP	O
is	VBZ	O
20	CD	O
days	NNS	O
status	NN	O
post	NN	O
orthotopic	NN	B-TREATMENT
cardiac	NN	I-TREATMENT
transplant	NN	I-TREATMENT
who	WP	O
was	VBD	O
readmitted	VBN	O
for	IN	O
sternal	JJ	B-PROBLEM
wound	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
insulin	VBN	B-PROBLEM
dependent	JJ	I-PROBLEM
diabetes	NNS	I-PROBLEM
mellitus	NNS	I-PROBLEM
and	CC	O
a	DT	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
dilated	JJ	I-PROBLEM
cardiomyopathy	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
progressive	JJ	O
symptoms	NNS	O
of	IN	O
congestive	JJ	B-PROBLEM
heart	NN	I-PROBLEM
failure	NN	I-PROBLEM
which	WDT	O
led	VBD	O
to	TO	O
his	PRP$	B-TEST
evaluation	NN	I-TEST
of	IN	O
his	PRP$	B-TREATMENT
cardiac	JJ	I-TREATMENT
transplant	NN	I-TREATMENT
in	IN	O
march	NN	O
of	IN	O
1991	CD	O
.	.	O

preoperatively	RB	O
,	,	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
severely	RB	I-PROBLEM
dilated	JJ	I-PROBLEM
left	VBD	I-PROBLEM
ventricle	NN	I-PROBLEM
with	IN	O
markedly	RB	B-PROBLEM
diminished	VBN	I-PROBLEM
function	NN	I-PROBLEM
.	.	O

his	PRP$	O
post	NN	O
transplant	NN	O
course	NN	O
was	VBD	O
initially	RB	O
complicated	VBN	O
by	IN	O
hyperglycemia	NN	B-PROBLEM
and	CC	O
seizure	NN	B-PROBLEM
on	IN	O
postoperative	JJ	O
day	NN	O
number	NN	O
one	CD	O
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
predischarge	NN	I-TEST
biopsy	NN	I-TEST
.	.	O

he	PRP	O
felt	VBD	O
well	RB	O
at	IN	O
home	NN	O
without	IN	O
fevers	NNS	B-PROBLEM
,	,	O
chills	NNS	B-PROBLEM
or	CC	O
rigors	NNS	B-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
rashes	NNS	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
or	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

when	WRB	O
he	PRP	O
was	VBD	O
seen	VBN	O
on	IN	O
2/3	CD	O
in	IN	O
the	DT	O
transplant	NN	O
clinic	NN	O
,	,	O
his	PRP$	B-PROBLEM
incision	NN	I-PROBLEM
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
more	RBR	B-PROBLEM
erythematous	JJ	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
referred	VBN	O
to	TO	O
the	DT	O
surgical	JJ	O
clinic	NN	O
where	WRB	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
was	VBD	O
opened	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
for	IN	O
intravenous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

on	IN	O
admission	NN	O
revealed	VBD	O
a	DT	O
middle	JJ	O
aged	VBN	O
man	NN	O
in	IN	O
no	DT	O
distress	NN	B-PROBLEM
.	.	O

blood	NN	B-TEST
pressure	NN	I-TEST
was	VBD	O
152/88	CD	O
.	.	O

heart	NN	B-TEST
rate	NN	I-TEST
90	CD	O
.	.	O

respiratory	NN	B-TEST
rate	NN	I-TEST
14	CD	O
.	.	O

heent	NN	B-TEST
exam	NN	I-TEST
was	VBD	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

neck	NN	O
was	VBD	O
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

cardiac	JJ	B-TEST
exam	NN	I-TEST
showed	VBD	O
a	DT	O
normal	JJ	O
pmi	NN	O
,	,	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
,	,	O
normal	JJ	O
s1	NN	O
,	,	O
physiologically	RB	B-PROBLEM
split	JJ	I-PROBLEM
s2	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
s4	NN	I-PROBLEM
.	.	O

there	EX	O
were	VBD	O
no	DT	O
murmurs	NN	B-PROBLEM
or	CC	O
rubs	NN	B-PROBLEM
.	.	O

extremities	NNS	O
were	VBD	O
2+	CD	B-PROBLEM
pedal	JJ	I-PROBLEM
edema	NN	I-PROBLEM
to	TO	O
the	DT	O
knees	NNS	O
.	.	O

examination	NN	B-TEST
of	IN	O
the	DT	B-PROBLEM
sternal	JJ	I-PROBLEM
wound	NN	I-PROBLEM
showed	VBD	O
an	DT	O
opened	JJ	O
area	NN	O
in	IN	O
the	DT	O
mid	JJ	O
region	NN	O
of	IN	O
the	DT	B-PROBLEM
wound	NN	I-PROBLEM
with	IN	O
serosanguineous	JJ	B-PROBLEM
drainage	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
scant	JJ	I-PROBLEM
amount	NN	I-PROBLEM
of	IN	I-PROBLEM
thick	NN	I-PROBLEM
,	,	I-PROBLEM
yellow	JJ	I-PROBLEM
pus	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
induration	NN	B-PROBLEM
.	.	O

on	IN	O
admission	NN	O
revealed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
9.46	CD	O
with	IN	O
89%	CD	O
polys	NNS	B-TEST
,	,	O
2%	CD	O
bands	NNS	B-TEST
,	,	O
7%	CD	O
lymphocytes	NNS	B-TEST
,	,	O
2%	CD	O
monocytes	NNS	B-TEST
.	.	O

cyclosporin	NN	B-TEST
a	DT	I-TEST
level	NN	I-TEST
on	IN	O
admission	NN	O
was	VBD	O
179	CD	O
.	.	O

microscopic	NN	B-TEST
exam	NN	I-TEST
showed	VBD	O
4+	CD	B-PROBLEM
staph	NN	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
vancomycin	NN	B-TREATMENT
and	CC	O
ceftazidime	NN	B-TREATMENT
while	IN	O
awaiting	VBG	O
wound	NN	B-TEST
cultures	NNS	I-TEST
.	.	O

he	PRP	O
had	VBD	O
dressing	VBG	B-TREATMENT
changes	NNS	I-TREATMENT
twice	RB	O
a	DT	O
day	NN	O
.	.	O

cyclosporin	NN	B-TEST
levels	NNS	I-TEST
were	VBD	O
followed	VBN	O
and	CC	O
his	PRP$	B-TEST
sugars	NNS	I-TEST
were	VBD	O
followed	VBN	O
with	IN	O
a	DT	B-TREATMENT
sliding	VBG	I-TREATMENT
scale	NN	I-TREATMENT
.	.	O

during	IN	O
the	DT	O
first	JJ	O
two	CD	O
days	NNS	O
,	,	O
he	PRP	O
required	VBD	O
14	CD	B-TREATMENT
and	CC	I-TREATMENT
22	CD	I-TREATMENT
units	NNS	I-TREATMENT
of	IN	I-TREATMENT
additional	JJ	I-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

however	RB	O
,	,	O
by	IN	O
day	NN	O
three	CD	O
he	PRP	O
required	VBD	O
no	DT	O
additional	JJ	B-TREATMENT
insulin	NN	I-TREATMENT
coverage	NN	I-TREATMENT
.	.	O

on	IN	O
the	DT	O
day	NN	O
prior	RB	O
to	TO	O
discharge	VB	O
,	,	O
his	PRP$	B-TREATMENT
intravenous	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
and	CC	O
he	PRP	O
was	VBD	O
begun	VBN	O
on	IN	O
tetracycline	NN	B-TREATMENT
.	.	O

on	IN	O
discharge	NN	O
included	VBD	O
tetracycline	NN	B-TREATMENT
,	,	O
250	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
;	:	O
cyclosporin	NN	B-TREATMENT
,	,	O
325	CD	O
mg	NN	O
po	NN	O
b.i.d.	NN	O
;	:	O
prednisone	NN	B-TREATMENT
,	,	O
30	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
;	:	O
bactrim	JJ	B-TREATMENT
ds	NN	I-TREATMENT
,	,	O
one	CD	O
po	NN	O
q.o.d.	NN	O
;	:	O
diltiazem	NN	B-TREATMENT
,	,	O
30	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
;	:	O
mycostatin	NN	B-TREATMENT
,	,	O
15	CD	O
cc	NN	O
swish	NN	O
and	CC	O
swallow	JJ	O
q.i.d.	NN	O
;	:	O
lasix	CC	B-TREATMENT
,	,	O
40	CD	O
mg	NN	O
po	NN	O
q	JJ	O
day	NN	O
;	:	O
colace	NN	B-TREATMENT
,	,	O
100	CD	O
mg	NN	O
po	NN	O
q.i.d.	NN	O
;	:	O
carafate	NN	B-TREATMENT
,	,	O
1	CD	O
gram	NN	O
po	NN	O
q.i.d.	NN	O
;	:	O
imuran	NN	B-TREATMENT
,	,	O
50	CD	O
mg	NN	O
po	NN	O
t.i.d.	NN	O
;	:	O
nph	CC	B-TREATMENT
insulin	NN	I-TREATMENT
,	,	O
44	CD	O
units	NNS	O
and	CC	O
10	CD	O
units	NNS	O
of	IN	O
regular	JJ	O
q	NN	O
a.m.	NN	O
;	:	O
nph	CC	B-TREATMENT
,	,	O
22	CD	O
units	NNS	O
and	CC	O
8	CD	O
units	NNS	O
of	IN	O
regular	JJ	O
q	CD	O
p.m.	NN	O

lumbar	NN	B-PROBLEM
spinal	JJ	I-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

l2	NN	B-TREATMENT
to	TO	I-TREATMENT
l5	VB	I-TREATMENT
laminectomy	NN	I-TREATMENT
,	,	O
l2	CC	B-TREATMENT
through	IN	I-TREATMENT
l5	JJ	I-TREATMENT
posterior	JJ	I-TREATMENT
fusion	NN	I-TREATMENT
with	IN	O
segmental	JJ	B-TREATMENT
instrumentation	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
50-year-old	JJ	O
female	NN	O
with	IN	O
history	NN	O
of	IN	O
low	JJ	B-PROBLEM
back	RB	I-PROBLEM
pain	NN	I-PROBLEM
radiating	NN	B-PROBLEM
to	TO	I-PROBLEM
both	DT	I-PROBLEM
legs	NNS	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
increasing	VBG	B-PROBLEM
symptoms	NNS	I-PROBLEM
overtime	RB	O
,	,	O
not	RB	O
controlled	VBN	O
by	IN	O
conservative	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

she	PRP	O
therefore	RB	O
elected	VBD	O
to	TO	O
undergo	VB	O
surgical	JJ	B-TREATMENT
treatment	NN	I-TREATMENT
.	.	O

her	PRP$	O
past	JJ	O
medical	JJ	O
history	NN	O
is	VBZ	O
notable	JJ	O
for	IN	O
bilateral	JJ	B-PROBLEM
lower	JJR	I-PROBLEM
extremity	NN	I-PROBLEM
venous	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
with	IN	O
edema	NN	B-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
.	.	O

she	PRP	O
takes	VBZ	O
lisinopril	JJ	B-TREATMENT
/	NNP	O
hydrochlorothiazide	NN	B-TREATMENT
20/25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
vioxx	FW	B-TREATMENT
50	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
lipitor	NN	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
nortriptyline	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
neurontin	RB	B-TREATMENT
300	CD	O
mg	NNS	O
p.o.	JJ	O
t.i.d.	NN	O

she	PRP	O
has	VBZ	O
nausea	NN	B-PROBLEM
with	IN	O
codeine	JJ	B-TREATMENT
otherwise	RB	O
no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

past	JJ	O
surgical	JJ	O
history	NN	O
is	VBZ	O
notable	JJ	O
of	IN	O
d	NN	B-TEST
and	CC	O
c	NN	B-TEST
in	IN	O
1980	CD	O
and	CC	O
cyst	JJ	B-TREATMENT
excision	NN	I-TREATMENT
.	.	O

on	IN	O
examination	NN	B-TEST
,	,	O
her	PRP$	O
lungs	NNS	O
were	VBD	O
clear	JJ	O
.	.	O

she	PRP	O
had	VBD	O
2+	CD	B-TEST
bilateral	JJ	I-TEST
dp	NN	I-TEST
and	CC	O
radial	JJ	B-TEST
pulses	NNS	I-TEST
.	.	O

she	PRP	O
has	VBZ	O
mild	JJ	B-PROBLEM
swelling	VBG	I-PROBLEM
in	IN	I-PROBLEM
both	DT	I-PROBLEM
lower	JJR	I-PROBLEM
extremities	NNS	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
pain	NN	B-PROBLEM
with	IN	O
straight	JJ	O
leg	NN	O
raise	NN	O
,	,	O
left	VBD	O
greater	JJR	O
than	IN	O
right	NN	O
and	CC	O
5/5	CD	O
strength	NN	O
in	IN	O
right	JJ	O
quads	NNS	O
compared	VBN	O
to	TO	O
4/5	CD	O
on	IN	O
the	DT	O
left	NN	O
.	.	O

she	PRP	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
01/16/2003	CD	O
for	IN	O
decompression	NN	B-TREATMENT
at	IN	I-TREATMENT
l2	NN	I-TREATMENT
,	,	I-TREATMENT
l5	NN	I-TREATMENT
and	CC	O
laminectomy	NN	B-TREATMENT
with	IN	O
posterior	JJ	B-TREATMENT
instrumented	VBN	I-TREATMENT
fusion	NN	I-TREATMENT
at	IN	I-TREATMENT
l3	NN	I-TREATMENT
to	TO	I-TREATMENT
l5	VB	I-TREATMENT
.	.	O

she	PRP	O
tolerated	VBD	O
the	DT	B-TREATMENT
surgery	NN	I-TREATMENT
well	RB	O
.	.	O

she	PRP	O
received	VBD	O
blood	NN	B-TREATMENT
transfusions	NNS	I-TREATMENT
intraoperatively	RB	O
and	CC	O
postoperatively	RB	O
in	IN	O
addition	NN	O
to	TO	O
autologous	JJ	B-TREATMENT
blood	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
stable	JJ	O
postoperatively	RB	O
.	.	O

her	PRP$	B-TEST
neurologic	JJ	I-TEST
exam	NN	I-TEST
was	VBD	O
stable	JJ	O
postoperatively	RB	O
with	IN	O
5/5	CD	O
bilaterally	RB	O
,	,	O
tibial	JJ	O
,	,	O
ehl	JJ	O
,	,	O
fhl	JJ	O
,	,	O
gastroc	JJ	O
soleus	NN	O
,	,	O
and	CC	O
intact	JJ	O
quadriceps	NNS	O
.	.	O

she	PRP	O
was	VBD	O
fitted	VBN	O
for	IN	O
verholl	NN	B-TREATMENT
aet	NN	I-TREATMENT
over	IN	I-TREATMENT
leg	JJ	I-TREATMENT
brace	NN	I-TREATMENT
and	CC	O
mobilized	VBN	O
out	IN	O
of	IN	O
the	DT	O
bed	NN	O
in	IN	O
the	DT	B-TREATMENT
brace	NN	I-TREATMENT
with	IN	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
wounds	NNS	I-PROBLEM
were	VBD	O
stable	JJ	O
without	IN	O
any	DT	B-PROBLEM
erythema	NN	I-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
.	.	O

she	PRP	O
reported	VBD	O
nausea	NN	B-PROBLEM
on	IN	O
pain	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TREATMENT
pain	NN	I-TREATMENT
medications	NNS	I-TREATMENT
were	VBD	O
changed	VBN	O
around	IN	O
until	IN	O
an	DT	O
acceptable	JJ	O
regime	NN	O
was	VBD	O
accomplished	VBN	O
.	.	O

she	PRP	O
should	MD	O
continue	VB	O
to	TO	O
wear	VB	O
the	DT	B-TREATMENT
brace	NN	I-TREATMENT
when	WRB	O
out	IN	O
of	IN	O
bed	NN	O
and	CC	O
there	EX	O
should	MD	O
be	VB	O
no	DT	O
heavy	JJ	O
lifting	NN	O
,	,	O
twisting	VBG	O
or	CC	O
bending	VBG	O
activities	NNS	O
.	.	O

tylenol	RB	B-TREATMENT
650	CD	O
mg	NNS	O
p.o.	JJ	O
q.4h.	JJ	O
p.r.n.	NN	O
,	,	O
benadryl	VBD	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
p.r.n.	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
,	,	O
nortriptyline	JJ	B-TREATMENT
25	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
simvastatin	VBD	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
metamucil	VB	B-TREATMENT
one	CD	O
packet	NN	O
p.o.	NN	O
b.i.d.	NN	O
p.r.n.	NN	O
,	,	O
neurontin	RB	B-TREATMENT
300	CD	O
mg	NNS	O
p.o.	JJ	O
t.i.d.	NN	O
,	,	O
levsinex	VBZ	B-TREATMENT
0.375	CD	O
mg	NN	O
p.o.	NN	O
q.12h.	NN	O
,	,	O
lisinopril	JJ	B-TREATMENT
/	NNP	O
hydrochlorothiazide	NN	B-TREATMENT
20/25	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
hydrocortisone	NN	B-TREATMENT
topical	JJ	I-TREATMENT
ointment	NN	I-TREATMENT
to	TO	O
affected	JJ	B-PROBLEM
areas	NNS	I-PROBLEM
,	,	O
ms	NN	B-TREATMENT
contin	NN	I-TREATMENT
30	CD	O
mg	NN	O
p.o.	NN	O
b.i.d.	NN	O
,	,	O
msir	RB	B-TREATMENT
15	CD	O
to	TO	O
30	CD	O
mg	NNS	O
p.o.	JJ	O
q.4h.	JJ	O
p.r.n.	NN	O
pain	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
should	MD	O
continue	VB	O
to	TO	O
have	VB	O
dry	JJ	B-TREATMENT
sterile	JJ	I-TREATMENT
dressings	NNS	I-TREATMENT
to	TO	O
her	PRP$	B-PROBLEM
back	NN	I-PROBLEM
and	CC	I-PROBLEM
iliac	NN	I-PROBLEM
crest	NN	I-PROBLEM
wounds	VBZ	I-PROBLEM
until	IN	O
follow	VB	O
up	RP	O
with	IN	O
dr.	JJ	O
uph	NN	O
.	.	O

should	MD	O
there	RB	O
be	VB	O
any	DT	B-PROBLEM
wound	JJ	I-PROBLEM
erythema	NN	I-PROBLEM
or	CC	O
drainage	NN	B-PROBLEM
,	,	O
please	VB	O
contact	JJ	O
dr.	NN	O
uph	JJ	O
&apos;s	NNP	O
office	NN	O
immediately	RB	O
.	.	O

abdominal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM

ho	NN	B-TEST
evaluation	NN	I-TEST

motrin	NN	B-TREATMENT
(	(	I-TREATMENT
ibuprofen	NN	I-TREATMENT
)	)	I-TREATMENT
600	CD	O
mg	NN	O
po	NN	O
q6h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
,	,	O
headache	NN	B-PROBLEM
,	,	O
temperature	NN	B-TEST
greater	JJR	O
than	IN	O
:	:	O

take	VB	O
with	IN	O
food	NN	O
flagyl	NN	B-TREATMENT
(	(	I-TREATMENT
metronidazole	NN	I-TREATMENT
)	)	I-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
q8h	NN	O
x	$	O
10	CD	O
days	NNS	O
starting	VBG	O
today	NN	O
(	(	O
04/12	CD	O
)	)	O

take	VB	O
for	IN	O
10	CD	O
days	NNS	O
or	CC	O
until	IN	O
drains	NNS	B-TREATMENT
come	VBP	O
out	RP	O
;	:	O
whichever	WDT	O
is	VBZ	O
of	IN	O
longer	JJR	O
duration	NN	O
.	.	O

take	VB	O
with	IN	O
food	NN	O
oxycodone	NN	B-TREATMENT
10	CD	O
mg	NN	O
po	NN	O
q4h	NN	O
prn	NN	O
pain	NN	B-PROBLEM
levofloxacin	VBD	B-TREATMENT
500	CD	O
mg	NN	O
po	NN	O
qd	NN	O
x	$	O
10	CD	O
days	NNS	O
starting	VBG	O
today	NN	O
(	(	O
04/12	CD	O
)	)	O

take	VB	O
for	IN	O
10	CD	O
days	NNS	O
or	CC	O
until	IN	O
drains	NNS	B-TREATMENT
come	VBP	O
out	RP	O
;	:	O
whichever	WDT	O
is	VBZ	O
of	IN	O
longer	JJR	O
duration	NN	O
.	.	O

administer	RB	O
iron	NN	B-TREATMENT
products	NNS	I-TREATMENT
a	DT	O
minimum	NN	O
of	IN	O
2	CD	O
hours	NNS	O
before	IN	O
or	CC	O
after	IN	O
a	DT	B-TREATMENT
levofloxacin	NN	I-TREATMENT
or	CC	O
ciprofloxacin	NN	B-TREATMENT
dose	VBP	I-TREATMENT
dose	JJ	O
if	IN	O
on	IN	O
tube	NN	B-TREATMENT
feeds	NNS	I-TREATMENT
,	,	O
please	VB	O
cycle	NN	O
(	(	O
hold	VB	O
1	CD	O
hr	NN	O
before	IN	O
to	TO	O
2	CD	O
hr	NNS	O
after	IN	O
)	)	O

maalox-tablets	NNS	B-TREATMENT
quick	JJ	I-TREATMENT
dissolve	NN	I-TREATMENT
/	NNP	I-TREATMENT
chewable	JJ	I-TREATMENT
2	CD	O
tab	NN	O
po	NN	O
q6h	NN	O
protonix	NN	B-TREATMENT
(	(	I-TREATMENT
pantoprazole	NN	I-TREATMENT
)	)	I-TREATMENT
40	CD	O
mg	NN	O
po	NN	O
qd	NN	O

house	NN	B-TREATMENT
/	VBD	I-TREATMENT
low	JJ	I-TREATMENT
residue	JJ	I-TREATMENT
&lt;	NN	O
fdi	NN	O
&gt;	NN	O

dr.	NN	O
liley	NN	O
,	,	O
call	VB	O
asap	NN	O
to	TO	O
schedule	VB	O
1-2	JJ	O
weeks	NNS	O
,	,	O
your	PRP$	O
primary	JJ	O
care	NN	O
physician	JJ	O
1-2	JJ	O
weeks	NNS	O
,	,	O
interventional	JJ	O
radiology	NN	O
,	,	O
call	VB	O
329-125-0028	JJ	O
to	TO	O
schedule	VB	O
an	DT	O
appointment	NN	O
when	WRB	O
drain	NN	B-TEST
outputs	NNS	I-TEST
are	VBP	O
less	JJR	O
than	IN	O
10cc	CD	O
/	JJ	O
day	NN	O
.	.	O
,	,	O

nka	NN	B-PROBLEM

abdominal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM

responsible	JJ	O
after	IN	O
study	NN	O
for	IN	O
causing	VBG	O
admission	NN	O
)	)	O
abdominal	JJ	B-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM

conditions	NNS	O
,	,	O
infections	NNS	O
,	,	O
complications	NNS	O
,	,	O
affecting	VBG	O
treatment	NN	O
/	NNP	O
stay	NN	O
liver	RB	B-PROBLEM
hemangioma	NN	I-PROBLEM
,	,	O
bph	NN	B-PROBLEM
,	,	O
gout	NN	B-PROBLEM
,	,	O
meningioma	NN	B-PROBLEM
,	,	O
gerd	NN	B-PROBLEM
,	,	O
episodic	JJ	B-PROBLEM
vertigo	NN	I-PROBLEM
,	,	O
s	JJ	O
/	NNP	O
p	NN	O
r	NN	B-TREATMENT
colectomy	NN	I-TREATMENT
,	,	O
subtotal	JJ	B-TREATMENT
colectomy	NN	I-TREATMENT

ir	JJ	B-TREATMENT
drainage	NN	I-TREATMENT
x2	NN	O

hpi	NN	O
this	DT	O
is	VBZ	O
a	DT	O
60	CD	O
yo	NN	O
gentleman	NN	O
who	WP	O
previously	RB	O
had	VBD	O
an	DT	B-TREATMENT
ileocolic	JJ	I-TREATMENT
resection	NN	I-TREATMENT
for	IN	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
colon	NN	I-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
and	CC	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
recurrent	JJ	B-PROBLEM
disease	NN	I-PROBLEM
on	IN	O
colonoscopy	NN	B-TEST
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
malignant	JJ	I-PROBLEM
lesion	NN	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
descending	NN	I-PROBLEM
colon	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
subtotal	JJ	I-TREATMENT
colectomy	NN	I-TREATMENT
on	IN	O
03/22/05	CD	O
which	WDT	O
was	VBD	O
uncomplicated	VBN	O
.	.	O

postop	NN	O
he	PRP	O
has	VBZ	O
had	VBN	O
numerous	JJ	O
visits	NNS	O
to	TO	O
the	DT	O
ed	NN	O
for	IN	O
co	NN	O
fevers	NNS	B-PROBLEM
,	,	O
sweats	NNS	B-PROBLEM
,	,	O
and	CC	O
sob	NN	B-PROBLEM
.	.	O

cts	NNS	B-TEST
chest	VBP	I-TEST
was	VBD	O
negative	JJ	O
for	IN	O
pe	NN	B-PROBLEM
,	,	O
however	RB	O
it	PRP	O
did	VBD	O
reveal	VB	O
pulmonary	JJ	B-PROBLEM
nodules	NNS	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
rml	NN	I-PROBLEM
which	WDT	O
need	VBP	O
fu	NNS	B-TEST
imaging	VBG	I-TEST
in	IN	O
3	CD	O
months	NNS	O
.	.	O

he	PRP	O
also	RB	O
had	VBD	O
bl	VBN	B-PROBLEM
atelectasis	NN	I-PROBLEM
on	IN	O
cxr	NN	B-TEST
.	.	O

ct	NN	B-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
collection	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
rlq	NN	I-PROBLEM
which	WDT	O
appears	VBZ	O
to	TO	O
be	VB	O
amenable	JJ	O
to	TO	O
ir	VB	B-TREATMENT
drainage	NN	I-TREATMENT
.	.	O

he	PRP	O
also	RB	O
has	VBZ	O
had	VBN	O
urine	JJ	B-TEST
and	CC	I-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
sent	VBD	O
from	IN	O
the	DT	O
ed	NN	O
on	IN	O
04/05	CD	O
and	CC	O
was	VBD	O
empirically	RB	O
started	VBN	O
on	IN	O
avalox	NN	B-TREATMENT
last	JJ	O
pm	NN	O
.	.	O

pmh	NN	O
gerd	NN	B-PROBLEM
,	,	O
htn	NN	B-PROBLEM
,	,	O
gout	NN	B-PROBLEM
,	,	O
meningioma	NN	B-PROBLEM
,	,	O
liver	RB	B-PROBLEM
hemangioma	NN	I-PROBLEM
,	,	O
episodic	JJ	B-PROBLEM
vertigo	NN	I-PROBLEM
,	,	O
colon	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

meds	NNS	B-TREATMENT

protonix	NN	B-TREATMENT
40	CD	O
qd	NN	O
,	,	O
colchicine	VBP	B-TREATMENT
6	CD	O
mg	JJ	O
bid	NN	O
,	,	O
meclizine	NN	B-TREATMENT
25	CD	O
mg	NN	O
qid	NN	O
prn	NN	O
,	,	O
glucosamine	NN	B-TREATMENT
and	CC	O
oxycodone	NN	B-TREATMENT
prn	NN	O
,	,	O
tessalon	NN	B-TREATMENT
prn	NN	O
.	.	O

all	DT	O
nkda	JJ	B-PROBLEM
sh	NN	O
no	DT	O
smoking	NN	O
pe	NN	O

gen	NN	O
-	:	O
nad	NN	B-PROBLEM

heent	NN	O
--	:	O
perrla	NN	O
,	,	O
eomi	NN	O
,	,	O
mmm	NN	O
,	,	O
tongue	NN	O
midline	NN	O
,	,	O
op	JJ	O
clear	JJ	O
,	,	O
no	DT	O
masses	NNS	B-PROBLEM

neck	NN	O
--	:	O
no	DT	O
jvd	NN	B-PROBLEM
/	VBZ	O
lad/	NN	B-PROBLEM
;	:	O
trachea	CC	O
midline	VB	O
card	NN	O
-	:	O
rrr	NN	O
,	,	O
s1/s2	NN	O
,	,	O
no	DT	O
m	NN	B-PROBLEM
/	VBZ	O
r/g	NN	B-PROBLEM

pulm	SYM	O
-	:	O
ctab	NN	O
no	DT	O
w	NN	B-PROBLEM
/	VBZ	I-PROBLEM
r	NN	I-PROBLEM
/	NNP	I-PROBLEM
r	NN	I-PROBLEM
abd	NN	O
-nt	NNP	B-PROBLEM
/	NNP	O
nd	NN	B-PROBLEM
;	:	O
incision	NN	B-PROBLEM
c	VBZ	O
/	NNP	O
d	NN	O
/	NN	O
i	NN	O
;	:	O
discrete	JJ	B-PROBLEM
3x3	CD	I-PROBLEM
cm	NN	I-PROBLEM
slightly	RB	I-PROBLEM
firm	JJ	I-PROBLEM
protuberant	NN	I-PROBLEM
mass	NN	I-PROBLEM
to	TO	I-PROBLEM
the	DT	I-PROBLEM
r	NN	I-PROBLEM
of	IN	I-PROBLEM
umbilicus	NN	I-PROBLEM
;	:	O
no	DT	O
rebound	NN	B-PROBLEM
,	,	O
no	DT	O
guarding	NN	B-PROBLEM
.	.	O

back	RB	O
-	:	O
no	DT	O
flank	NN	B-PROBLEM
tenderness	NN	I-PROBLEM

ext	JJ	O
-	:	O
wwp	NN	O
;	:	O
no	DT	O
edema	NN	B-PROBLEM

at	IN	O
that	DT	O
time	NN	O
he	PRP	O
was	VBD	O
made	VBN	O
npo	NN	B-TREATMENT
with	IN	O
ivf	NN	B-TREATMENT
,	,	O
placed	VBN	O
on	IN	O
ampicillin	NN	B-TREATMENT
/	NNP	O
levofloxacin	VBZ	B-TREATMENT
/	NNP	O
flagyl	NN	B-TREATMENT
and	CC	O
underwent	JJ	O
ir	JJ	B-TREATMENT
placement	NN	I-TREATMENT
of	IN	I-TREATMENT
a	DT	I-TREATMENT
drainage	NN	I-TREATMENT
catheter	NN	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
abdominopelvic	JJ	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
.	.	O

overnight	RB	O
he	PRP	O
spiked	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
to	TO	O
103	CD	O
and	CC	O
his	PRP$	B-TEST
wbc	NN	I-TEST
climbed	VBD	O
from	IN	O
11	CD	O
to	TO	O
13	CD	O
.	.	O

as	IN	O
a	DT	O
result	NN	O
,	,	O
ir	NN	O
reviewed	VBD	O
the	DT	B-TEST
patient	JJ	I-TEST
&apos;s	JJ	I-TEST
post-procedure	NN	I-TEST
imaging	NN	I-TEST
and	CC	O
felt	VBD	O
that	IN	O
the	DT	B-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
not	RB	O
adequately	RB	O
draining	VBG	O
the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NNP	I-PROBLEM
fluid	NN	I-PROBLEM
collection	NN	I-PROBLEM
.	.	O

on	IN	O
04/07	CD	O
they	PRP	O
took	VBD	O
the	DT	O
patient	NN	O
back	RB	O
to	TO	O
the	DT	O
ir	NN	O
suite	NN	O
and	CC	O
placed	VBD	O
a	DT	B-TREATMENT
second	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
.	.	O

the	DT	O
location	NN	O
of	IN	O
the	DT	B-TREATMENT
second	JJ	I-TREATMENT
catheter	NN	I-TREATMENT
was	VBD	O
confirmed	VBN	O
that	IN	O
evening	NN	O
by	IN	O
a	DT	B-TEST
follow-up	JJ	I-TEST
scan	NN	I-TEST
which	WDT	O
revealed	VBD	O
good	JJ	O
placement	NN	O
.	.	O

the	DT	B-PROBLEM
patient	NN	I-PROBLEM
&apos;s	NN	I-PROBLEM
pain	NN	I-PROBLEM
from	IN	O
his	PRP$	B-TREATMENT
catheters	NNS	I-TREATMENT
was	VBD	O
controlled	VBN	O
with	IN	O
oxycodone	NN	B-TREATMENT
and	CC	O
motrin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
received	VBD	O
chest	JJ	B-TREATMENT
pt	NN	I-TREATMENT
and	CC	O
was	VBD	O
encouraged	VBN	O
to	TO	O
ambulate	VB	O
frequently	RB	O
.	.	O

after	IN	O
catheter	NN	B-TREATMENT
placement	NN	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
sips	NNS	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
advanced	VBN	O
to	TO	O
clears	NNS	B-TREATMENT
which	WDT	O
he	PRP	O
tolerated	VBD	O
and	CC	O
was	VBD	O
restarted	VBN	O
on	IN	O
a	DT	B-TREATMENT
low	JJ	I-TREATMENT
residue	JJ	I-TREATMENT
diet	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
3	CD	B-TEST
specimens	NNS	I-TEST
sent	VBD	O
for	IN	O
c.	NN	B-PROBLEM
difficile	NN	I-PROBLEM
which	WDT	O
were	VBD	O
negative	JJ	O
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
wbc	NN	I-TEST
trended	VBD	O
down	RB	O
to	TO	O
10.7	CD	O
at	IN	O
discharge	NN	O
from	IN	O
a	DT	O
peak	NN	O
of	IN	O
13	CD	O
on	IN	O
04/07	CD	O
.	.	O

his	PRP$	B-TEST
hematocrit	NN	I-TEST
remained	VBD	O
stable	JJ	O
.	.	O

he	PRP	O
received	VBD	O
dvt	JJ	B-TREATMENT
prophylaxis	NN	I-TREATMENT
with	IN	O
sc	JJ	B-TREATMENT
heparin	NN	I-TREATMENT
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
04/05	CD	O
revealed	VBD	O
bacteroides	NNS	B-PROBLEM
fragilis	VBP	I-PROBLEM
;	:	O
04/06	CD	O
fluid	NN	B-TEST
collection	NN	I-TEST
drainage	NN	I-TEST
from	IN	I-TEST
ir	NN	I-TEST
revealed	VBD	O

1)	CD	O
4+	CD	B-PROBLEM
alpha	JJ	I-PROBLEM
hemolytic	JJ	I-PROBLEM
strep	NN	I-PROBLEM
,	,	O

2)	CD	O
2+	CD	B-PROBLEM
e.	NN	I-PROBLEM
coli	NNS	I-PROBLEM
sensitive	VBP	O
to	TO	O
ampicillin	VB	B-TREATMENT
and	CC	O
levofloxacin	VB	B-TREATMENT
,	,	O

3)	CD	O
3+	CD	B-PROBLEM
enterococci	RB	I-PROBLEM
sensitive	JJ	O
to	TO	O
ampicillin	VB	B-TREATMENT
and	CC	O
levofloxacin	VB	B-TREATMENT
,	,	O

4)	CD	O
bacteroides	NNS	B-PROBLEM
fragilis	JJ	I-PROBLEM
and	CC	O
clostridium	NN	B-PROBLEM
perfringens	NNS	I-PROBLEM
.	.	O

blood	NN	B-TEST
cultures	NNS	I-TEST
from	IN	O
04/07	CD	O
showed	VBD	O
ngtd	NN	B-PROBLEM
.	.	O

cdiff	NN	B-TEST
from	IN	O
04/08	CD	O
,	,	O
04/09	CD	O
,	,	O
04/10	CD	O
were	VBD	O
negative	JJ	O
.	.	O

mr.	NN	O
liley	NN	O
was	VBD	O
discharged	VBN	O
in	IN	O
stable	JJ	O
condition	NN	O
,	,	O
ambulating	VBG	O
and	CC	O
voiding	VBG	O
independently	RB	O
,	,	O
and	CC	O
with	IN	O
adequate	JJ	B-TREATMENT
pain	NN	I-TREATMENT
control	NN	I-TREATMENT
.	.	O

ldamc	NN	O
services	NNS	O
were	VBD	O
set-up	JJ	O
for	IN	O
care	NN	B-TREATMENT
of	IN	O
his	PRP$	B-TREATMENT
ir	NN	I-TREATMENT
drains	NNS	I-TREATMENT
.	.	O

an	DT	B-TEST
abscessogram	NN	I-TEST
was	VBD	O
performed	VBN	O
on	IN	O
04/12/05	CD	O
and	CC	O
revealed	VBD	O
no	DT	O
fistula	NN	B-PROBLEM
.	.	O

-	:	O
seek	NN	O
medical	JJ	O
attention	NN	O
for	IN	O
fevers	NNS	B-PROBLEM
(	(	O
temp	JJ	B-TEST
&gt;	NNP	O
101.5	CD	O
)	)	O
,	,	O
worsening	VBG	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
drainage	NN	B-PROBLEM
or	CC	O
excessive	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
from	IN	O
incision	NN	B-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
or	CC	O
any	DT	B-PROBLEM
other	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
of	IN	O
concern	NN	O
.	.	O

-	:	O
follow	VB	O
up	RP	O
with	IN	O
your	PRP$	O
surgeon	NN	O
in	IN	O
1-2	JJ	O
weeks	NNS	O
for	IN	O
wound	NN	B-TEST
check	NN	I-TEST
.	.	O

-	:	O
please	NN	O
do	VB	O
not	RB	O
drive	VB	O
or	CC	O
consume	VB	O
alcohol	NN	O
while	IN	O
taking	VBG	O
pain	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

-	:	O
resume	NN	O
home	NN	B-TREATMENT
medications	NNS	I-TREATMENT
.	.	O

tracheoesophageal	JJ	B-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

tracheoesophageal	JJ	B-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

diabetes	NNS	B-PROBLEM
mellitus	VBP	I-PROBLEM
,	,	O
pneumonia	NN	B-PROBLEM
,	,	O
sepsis	NN	B-PROBLEM
,	,	O
respiratory	JJ	B-PROBLEM
failure	NN	I-PROBLEM
,	,	O
pleural	JJ	B-PROBLEM
effusion	NN	I-PROBLEM
,	,	O
postoperative	JJ	B-PROBLEM
encephalopathy	NN	I-PROBLEM
,	,	O
postoperative	JJ	B-PROBLEM
myocardial	JJ	I-PROBLEM
infarction	NN	I-PROBLEM
,	,	O
and	CC	O
thrombocytopenia	NN	B-PROBLEM
.	.	O

february	JJ	O
6	CD	O
,	,	O
1994	CD	O
,	,	O
rigid	JJ	B-TEST
bronchoscopy	NN	I-TEST
with	IN	O
biopsy	NN	B-TEST
and	CC	O
upper	JJ	B-TEST
gastrointestinal	JJ	I-TEST
endoscopy	NN	I-TEST
.	.	O

on	IN	O
february	JJ	O
10	CD	O
,	,	O
1994	CD	O
,	,	O
flexible	JJ	B-TEST
bronchoscopy	NN	I-TEST
,	,	O
flexible	JJ	B-TEST
esophagoscopy	NN	I-TEST
,	,	O
rigid	JJ	B-TEST
bronchoscopy	NN	I-TEST
,	,	O
transhiatal	JJ	B-TREATMENT
esophagectomy	NN	I-TREATMENT
(	(	I-TREATMENT
partial	JJ	I-TREATMENT
)	)	I-TREATMENT
,	,	O
substernal	JJ	B-TREATMENT
gastric	JJ	I-TREATMENT
interposition	NN	I-TREATMENT
and	CC	O
jejunostomy	NN	B-TREATMENT
.	.	O

multiple	JJ	B-TEST
bronchoscopies	NNS	I-TEST
,	,	O
chest	JJS	B-TREATMENT
tube	NN	I-TREATMENT
insertion	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
a	DT	O
71	CD	O
year	NN	O
old	JJ	O
white	JJ	O
female	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
carcinoid	NN	B-PROBLEM
lung	NN	I-PROBLEM
cancer	NN	I-PROBLEM
who	WP	O
presented	VBD	O
for	IN	O
evaluation	NN	B-TEST
of	IN	O
a	DT	B-PROBLEM
tracheoesophageal	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
initially	RB	O
diagnosed	VBN	O
in	IN	O
1978	CD	O
with	IN	O
atypical	JJ	B-PROBLEM
small	JJ	I-PROBLEM
cell	NN	I-PROBLEM
carcinoma	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
lung	NN	I-PROBLEM
and	CC	O
treated	VBN	O
with	IN	O
chemotherapy	NN	B-TREATMENT
and	CC	O
radiation	NN	B-TREATMENT
therapy	NN	I-TREATMENT
until	IN	O
1980	CD	O
.	.	O

she	PRP	O
did	VBD	O
well	RB	O
for	IN	O
approximately	RB	O
twelve	JJ	O
years	NNS	O
until	IN	O
she	PRP	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
carcinoid	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
same	JJ	I-PROBLEM
right	JJ	I-PROBLEM
upper	NN	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

this	DT	O
may	MD	O
have	VB	O
been	VBN	O
the	DT	B-PROBLEM
initial	JJ	I-PROBLEM
primary	JJ	I-PROBLEM
cancer	NN	I-PROBLEM
although	IN	O
it	PRP	O
is	VBZ	O
unclear	JJ	O
at	IN	O
present	NN	O
.	.	O

bronchoscopy	NN	B-TEST
at	IN	O
that	DT	O
time	NN	O
showed	VBD	O
an	DT	B-PROBLEM
endobronchial	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
of	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
bronchus	NN	I-PROBLEM
and	CC	O
it	PRP	O
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
unresectable	JJ	O
.	.	O

she	PRP	O
underwent	VBD	O
four	CD	B-TREATMENT
treatments	NNS	I-TREATMENT
of	IN	O
brachytherapy	NN	B-TREATMENT
in	IN	O
march	NN	O
through	IN	O
may	MD	O
of	IN	O
1993	CD	O
.	.	O

she	PRP	O
had	VBD	O
been	VBN	O
doing	VBG	O
reasonably	RB	O
well	RB	O
until	IN	O
december	NNS	O
of	IN	O
1993	CD	O
when	WRB	O
she	PRP	O
presented	VBD	O
with	IN	O
persistent	JJ	B-PROBLEM
and	CC	I-PROBLEM
worsening	JJ	I-PROBLEM
cough	NN	I-PROBLEM
and	CC	O
near	JJ	B-PROBLEM
strangulation	NN	I-PROBLEM
on	IN	O
attempts	NNS	O
at	IN	O
eating	VBG	O
solids	NNS	O
or	CC	O
drinking	NN	O
liquids	NNS	O
.	.	O

a	DT	B-TEST
bronchoscopy	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
tracheoesophageal	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
with	IN	O
an	DT	O
opening	NN	O
into	IN	O
the	DT	O
trachea	NN	O
above	IN	O
the	DT	O
carina	NN	O
and	CC	O
no	DT	O
tumor	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
right	JJ	I-PROBLEM
upper	JJ	I-PROBLEM
lobe	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
been	VBN	O
on	IN	O
total	JJ	B-TREATMENT
parenteral	JJ	I-TREATMENT
nutrition	NN	I-TREATMENT
and	CC	O
has	VBZ	O
been	VBN	O
nothing	NN	B-TREATMENT
by	IN	I-TREATMENT
mouth	NN	I-TREATMENT
since	IN	O
then	RB	O
.	.	O

a	DT	B-TEST
barium	NN	I-TEST
swallow	NN	I-TEST
prior	RB	O
to	TO	O
admission	NN	O
showed	VBD	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	B-PROBLEM
tracheoesophageal	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
with	IN	O
entrance	NN	O
into	IN	O
the	DT	O
right	JJ	O
mainstem	NN	O
bronchus	RB	O
below	IN	O
the	DT	O
carina	NN	O
.	.	O

bronchitis	NN	B-PROBLEM
,	,	O
asthma	NN	B-PROBLEM
,	,	O
carcinoid	JJ	B-PROBLEM
cancer	NN	I-PROBLEM
,	,	O
no	DT	O
history	NN	O
of	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
cerebrovascular	JJ	B-PROBLEM
accident	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
appendectomy	NN	B-TREATMENT
,	,	O
hysterectomy	NN	B-TREATMENT
and	CC	O
right	JJ	B-TREATMENT
salpingo-oophorectomy	NN	I-TREATMENT
,	,	O
bladder	NN	B-TREATMENT
suspension	NN	I-TREATMENT
and	CC	O
a	DT	B-TREATMENT
tumor	NN	I-TREATMENT
removal	NN	I-TREATMENT
from	IN	I-TREATMENT
the	DT	I-TREATMENT
right	JJ	I-TREATMENT
neck	NN	I-TREATMENT
.	.	O

cefuroxime	NN	B-TREATMENT
1.5	CD	O
grams	NNS	O
intravenously	RB	O
q8h	RB	O
,	,	O
solu-medrol	JJ	B-TREATMENT
62.5	CD	O
mg	NN	O
intravenously	RB	O
q8h	RB	O
,	,	O
ventolin	NN	B-TREATMENT
metered	VBD	I-TREATMENT
dose	JJ	I-TREATMENT
inhaler	NN	I-TREATMENT
,	,	O
2	CD	O
puffs	NNS	O
po	JJ	O
q.i.d.	NN	O
,	,	O
pepcid	VBP	B-TREATMENT
20	CD	O
mg	NN	O
intravenously	RB	O
b.i.d.	VBD	O

the	DT	O
patient	NN	O
is	VBZ	O
allergic	JJ	B-PROBLEM
to	TO	O
penicillin	VB	B-TREATMENT
,	,	O
morphine	NN	B-TREATMENT
,	,	O
codeine	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
pleasant	JJ	O
white	JJ	O
female	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
afebrile	JJ	B-PROBLEM
with	IN	O
stable	JJ	O
vital	JJ	O
signs	NNS	O
.	.	O

the	DT	B-TEST
head	NN	I-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
,	,	I-TEST
throat	NN	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

neck	NN	O
shows	VBZ	O
a	DT	B-PROBLEM
well	RB	I-PROBLEM
healed	VBN	I-PROBLEM
low	JJ	I-PROBLEM
collar	JJ	I-PROBLEM
incision	NN	I-PROBLEM
without	IN	O
adenopathy	JJ	B-PROBLEM
or	CC	O
bruit	NN	B-PROBLEM
.	.	O

the	DT	O
lungs	NNS	O
showed	VBD	O
mild	JJ	B-PROBLEM
inspiratory	NN	I-PROBLEM
wheeze	NN	I-PROBLEM
and	CC	O
moderate	JJ	B-PROBLEM
expiratory	NN	I-PROBLEM
wheezes	NNS	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
soft	JJ	O
,	,	O
nontender	NN	B-PROBLEM
,	,	O
nondistended	VBN	B-PROBLEM
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
or	CC	O
edema	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
is	VBZ	O
guaiac	JJ	B-TEST
negative	JJ	O
with	IN	O
a	DT	O
minimal	JJ	O
amount	NN	O
of	IN	O
stool	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
on	IN	O
february	JJ	O
5	CD	O
,	,	O
1994	CD	O
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
central	JJ	I-TREATMENT
venous	JJ	I-TREATMENT
line	NN	I-TREATMENT
placed	VBN	O
in	IN	O
her	PRP$	O
right	JJ	O
subclavian	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
february	JJ	O
6	CD	O
,	,	O
1994	CD	O
where	WRB	O
she	PRP	O
underwent	JJ	O
rigid	JJ	B-TEST
and	CC	I-TEST
flexible	JJ	I-TEST
bronchoscopy	NN	I-TEST
and	CC	O
upper	JJ	B-TEST
gastrointestinal	JJ	I-TEST
endoscopy	NN	I-TEST
.	.	O

findings	NNS	O
included	VBD	O
necrotic	JJ	B-PROBLEM
debris	NN	I-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
distal	JJ	I-PROBLEM
trachea	NN	I-PROBLEM
at	IN	O
the	DT	O
carina	NN	O
and	CC	O
right	JJ	O
mainstem	NN	O
bronchus	NN	O
.	.	O

her	PRP$	B-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
weaned	VBN	O
and	CC	O
the	DT	O
patient	NN	O
was	VBD	O
brought	VBN	O
to	TO	O
the	DT	O
operating	NN	O
room	NN	O
on	IN	O
february	JJ	O
10	CD	O
,	,	O
1994	CD	O
where	WRB	O
she	PRP	O
underwent	VBD	O
once	RB	O
again	RB	O
flexible	JJ	B-TEST
bronchoscopy	NN	I-TEST
and	CC	O
flexible	JJ	B-TEST
esophagoscopy	NN	I-TEST
,	,	O
as	RB	O
well	RB	O
as	IN	O
rigid	JJ	B-TEST
bronchoscopy	NN	I-TEST
.	.	O

she	PRP	O
then	RB	O
had	VBD	O
a	DT	B-TREATMENT
transhiatal	JJ	I-TREATMENT
esophagectomy	NN	I-TREATMENT
which	WDT	O
was	VBD	O
partial	JJ	O
,	,	O
and	CC	O
a	DT	B-TREATMENT
substernal	JJ	I-TREATMENT
gastric	JJ	I-TREATMENT
interposition	NN	I-TREATMENT
as	RB	O
well	RB	O
as	IN	O
a	DT	B-TREATMENT
jejunostomy	NN	I-TREATMENT
.	.	O

the	DT	B-TEST
pathology	NN	I-TEST
report	NN	I-TEST
suggested	VBD	O
that	IN	O
the	DT	O
area	NN	O
was	VBD	O
involved	VBN	O
with	IN	O
radiation	NN	B-PROBLEM
esophagitis	NN	I-PROBLEM
and	CC	O
focal	JJ	B-PROBLEM
ulceration	NN	I-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
ventilator	JJ	B-PROBLEM
dependent	NN	I-PROBLEM
postoperatively	RB	O
and	CC	O
was	VBD	O
taken	VBN	O
to	TO	O
the	DT	O
respiratory	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
triple	NN	B-TREATMENT
antibiotics	NNS	I-TREATMENT
which	WDT	O
included	VBD	O
vancomycin	NN	B-TREATMENT
,	,	O
ceftazidime	NN	B-TREATMENT
and	CC	O
gentamicin	NN	B-TREATMENT
.	.	O

on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
,	,	O
she	PRP	O
had	VBD	O
an	DT	B-TEST
electroencephalogram	NN	I-TEST
which	WDT	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
but	CC	O
some	DT	B-PROBLEM
generalized	JJ	I-PROBLEM
slowing	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
the	DT	O
neurology	NN	O
service	NN	O
for	IN	O
her	PRP$	B-PROBLEM
apparent	JJ	I-PROBLEM
postoperative	JJ	I-PROBLEM
encephalopathy	NN	I-PROBLEM
and	CC	O
episodes	NNS	O
of	IN	O
shaking	NN	B-PROBLEM
.	.	O

an	DT	B-TEST
endoscopy	NN	I-TEST
was	VBD	O
also	RB	O
performed	VBN	O
on	IN	O
postoperative	JJ	O
day	NN	O
two	CD	O
which	WDT	O
showed	VBD	O
clean	JJ	O
anastomosis	NN	B-TREATMENT
.	.	O

she	PRP	O
received	VBD	O
multiple	JJ	B-TEST
bronchoscopies	NNS	I-TEST
for	IN	O
pulmonary	JJ	B-TREATMENT
toilet	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
maintained	VBN	O
on	IN	O
tube	NN	B-TREATMENT
feedings	NNS	I-TREATMENT
and	CC	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
.	.	O

a	DT	B-TEST
repeat	NN	I-TEST
echocardiogram	NN	I-TEST
on	IN	O
february	JJ	O
18	CD	O
showed	VBD	O
no	DT	O
significant	JJ	B-PROBLEM
change	NN	I-PROBLEM
of	IN	O
her	PRP$	B-TEST
previous	JJ	I-TEST
echocardiogram	NN	I-TEST
on	IN	O
february	JJ	O
11	CD	O
,	,	O
which	WDT	O
showed	VBD	O
only	RB	O
a	DT	B-PROBLEM
small	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
pelvic	JJ	I-TEST
and	CC	I-TEST
abdominal	JJ	I-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
on	IN	O
february	JJ	O
18	CD	O
also	RB	O
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
a	DT	B-PROBLEM
focal	JJ	I-PROBLEM
collection	NN	I-PROBLEM
or	CC	O
abscess	NN	B-PROBLEM
.	.	O

she	PRP	O
remained	VBD	O
intermittently	RB	B-PROBLEM
febrile	JJ	I-PROBLEM
despite	IN	O
numerous	JJ	B-TREATMENT
antibiotics	NNS	I-TREATMENT
.	.	O

her	PRP$	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
showed	VBD	O
bilateral	JJ	B-PROBLEM
air	NN	I-PROBLEM
space	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
consistent	JJ	O
with	IN	O
pneumonia	NN	B-PROBLEM
or	CC	O
adult	NN	B-PROBLEM
respiratory	JJ	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

she	PRP	O
suffered	VBD	O
an	DT	O
episode	NN	O
of	IN	O
renal	JJ	B-PROBLEM
failure	NN	I-PROBLEM
which	WDT	O
was	VBD	O
felt	RBR	O
attributable	JJ	O
to	TO	O
aminoglycoside	VB	B-PROBLEM
toxicity	NN	I-PROBLEM
.	.	O

her	PRP$	B-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
weaned	VBN	O
.	.	O

because	IN	O
of	IN	O
her	PRP$	B-TREATMENT
prolonged	JJ	I-TREATMENT
intubation	NN	I-TREATMENT
and	CC	O
inability	NN	B-PROBLEM
to	TO	I-PROBLEM
wean	VB	I-PROBLEM
,	,	O
on	IN	O
february	JJ	O
24	CD	O
,	,	O
1994	CD	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-TREATMENT
tracheostomy	NN	I-TREATMENT
placed	VBN	O
.	.	O

she	PRP	O
remained	VBD	O
in	IN	O
a	DT	B-PROBLEM
coma	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
cultures	NNS	I-TEST
on	IN	O
february	JJ	O
26	CD	O
,	,	O
1994	CD	O
grew	VBD	O
out	RP	O
staphylococcus	NN	B-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
treated	VBN	O
for	IN	O
septicemia	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
sputum	NN	I-TEST
grew	VBD	O
out	RP	O
pseudomonas	JJ	B-PROBLEM
aeruginosa	NN	I-PROBLEM
as	RB	O
well	RB	O
.	.	O

the	DT	B-TEST
urine	NN	I-TEST
contained	VBN	O
yeast	NN	B-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
amphotericin	NN	B-TREATMENT
.	.	O

on	IN	O
march	NN	O
3	CD	O
,	,	O
1994	CD	O
,	,	O
a	DT	B-TEST
repeat	NN	I-TEST
chest	NN	I-TEST
and	CC	I-TEST
abdominal	JJ	I-TEST
and	CC	I-TEST
pelvis	JJ	I-TEST
computerized	JJ	I-TEST
tomography	NN	I-TEST
scan	NN	I-TEST
showed	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
fluid	JJ	B-PROBLEM
collections	NNS	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
left	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
however	RB	O
.	.	O

this	DT	O
was	VBD	O
drained	VBN	O
with	IN	O
a	DT	B-TREATMENT
left	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

her	PRP$	B-TEST
sputum	NN	I-TEST
then	RB	O
grew	VBD	O
out	RP	O
klebsiella	NN	B-PROBLEM
and	CC	O
she	PRP	O
was	VBD	O
treated	VBN	O
with	IN	O
amikacin	NN	B-TREATMENT
and	CC	O
imipenem	NN	B-TREATMENT
.	.	O

she	PRP	O
developed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
pleural	JJ	I-PROBLEM
effusion	NN	I-PROBLEM
and	CC	O
had	VBD	O
a	DT	B-TREATMENT
right	JJ	I-TREATMENT
chest	NN	I-TREATMENT
tube	NN	I-TREATMENT
placed	VBD	O
.	.	O

attempts	NNS	O
were	VBD	O
made	VBN	O
to	TO	O
facilitate	VB	O
her	PRP$	B-TREATMENT
wean	JJ	I-TREATMENT
by	IN	O
resting	VBG	O
her	PRP$	O
overnight	NN	O
with	IN	O
a	DT	O
combination	NN	O
of	IN	O
propafol	NN	B-TREATMENT
and	CC	O
fentanyl	NN	B-TREATMENT
.	.	O

this	DT	O
was	VBD	O
tried	VBN	O
for	IN	O
approximately	RB	O
seven	CD	O
days	NNS	O
with	IN	O
no	DT	O
real	JJ	O
progress	NN	O
made	VBD	O
toward	IN	O
facilitating	VBG	O
her	PRP$	B-TREATMENT
vent	JJ	I-TREATMENT
wean	NN	I-TREATMENT
.	.	O

she	PRP	O
continued	VBD	O
to	TO	O
require	VB	O
pressor	JJ	B-TREATMENT
support	NN	I-TREATMENT
in	IN	O
the	DT	O
high	JJ	O
30	CD	O
&apos;s	NN	O
.	.	O

she	PRP	O
also	RB	O
fell	VBD	O
into	IN	O
a	DT	B-PROBLEM
coma	NN	I-PROBLEM
once	RB	O
again	RB	O
.	.	O

on	IN	O
march	NN	O
31	CD	O
,	,	O
1994	CD	O
,	,	O
her	PRP$	B-PROBLEM
pressor	JJ	I-PROBLEM
support	NN	I-PROBLEM
requirement	NN	I-PROBLEM
increased	VBD	O
and	CC	O
she	PRP	O
continued	VBD	O
to	TO	O
have	VB	O
tachypneic	JJ	B-PROBLEM
episodes	NNS	I-PROBLEM
.	.	O

on	IN	O
april	JJ	O
2	CD	O
,	,	O
1994	CD	O
,	,	O
she	PRP	O
had	VBD	O
several	JJ	O
episodes	NNS	O
of	IN	O
bradycardia	NN	B-PROBLEM
and	CC	O
asystole	NN	B-PROBLEM
,	,	O
which	WDT	O
responded	VBD	O
only	RB	O
to	TO	O
manual	JJ	B-TREATMENT
ventilation	NN	I-TREATMENT
.	.	O

discussions	NNS	O
were	VBD	O
held	VBN	O
with	IN	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
family	NN	O
with	IN	O
regard	NN	O
to	TO	O
her	PRP$	O
previously	RB	O
expressed	VBN	O
wishes	NNS	O
not	RB	O
to	TO	O
be	VB	O
maintained	VBN	O
on	IN	O
artificial	JJ	B-TREATMENT
life	NN	I-TREATMENT
support	NN	I-TREATMENT
for	IN	O
extended	JJ	O
period	NN	O
of	IN	O
time	NN	O
with	IN	O
little	JJ	O
or	CC	O
no	DT	O
hope	NN	O
for	IN	O
recovery	NN	O
.	.	O

decision	NN	O
was	VBD	O
made	VBN	O
in	IN	O
conjunction	NN	O
with	IN	O
the	DT	O
family	NN	O
and	CC	O
dr.	NN	O
caslighlourdes	NNS	O
to	TO	O
terminate	VB	O
artificial	JJ	B-TREATMENT
respiratory	NN	I-TREATMENT
support	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
removed	VBN	O
from	IN	O
the	DT	B-TREATMENT
ventilator	NN	I-TREATMENT
and	CC	O
placed	VBN	O
on	IN	O
a	DT	B-TREATMENT
t-piece	NN	I-TREATMENT
in	IN	I-TREATMENT
her	PRP$	I-TREATMENT
trachea	NN	I-TREATMENT
only	RB	O
and	CC	O
was	VBD	O
made	VBN	O
comfortable	JJ	O
with	IN	O
narcotics	NNS	B-TREATMENT
.	.	O

they	PRP	O
have	VBP	O
declined	VBN	O
a	DT	B-TEST
post-mortem	JJ	I-TEST
examination	NN	I-TEST
.	.	O

adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	JJ	I-PROBLEM
syndrome	NN	I-PROBLEM
.	.	O

urinary	JJ	B-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
,	,	O
tracheostomy	NN	B-TREATMENT
status	NN	O
,	,	O
diabetes	VBZ	B-PROBLEM
mellitus	NN	I-PROBLEM
.	.	O

mr.	NN	O
stain	NN	O
was	VBD	O
transferred	VBN	O
from	IN	O
the	DT	O
oreiewlefell	NN	O
merkane	NN	O
i	NN	O
penaltbridgesgreat	VBP	O
university	NN	O
medical	JJ	O
center	NN	O
for	IN	O
progressive	JJ	B-PROBLEM
respiratory	NN	I-PROBLEM
failure	NN	I-PROBLEM
and	CC	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
superimposed	VBN	O
on	IN	O
a	DT	O
history	NN	O
of	IN	O
chronic	JJ	B-PROBLEM
obstructive	JJ	I-PROBLEM
pulmonary	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
perhaps	RB	O
asthma	NN	B-PROBLEM
,	,	O
and	CC	O
ulcerative	JJ	B-PROBLEM
colitis	NN	I-PROBLEM
.	.	O

his	PRP$	O
only	RB	O
positive	JJ	O
result	NN	O
was	VBD	O
a	DT	B-TEST
sputum	JJ	I-TEST
culture	NN	I-TEST
for	IN	O
pseudomonas	NN	B-PROBLEM
and	CC	O
this	DT	O
came	VBD	O
after	IN	O
he	PRP	O
had	VBD	O
already	RB	O
been	VBN	O
on	IN	O
antibiotics	NNS	B-TREATMENT
.	.	O

the	DT	B-TEST
physical	JJ	I-TEST
examination	NN	I-TEST
on	IN	O
transfer	NN	O
showed	VBD	O
an	DT	O
alert	JJ	O
male	NN	O
with	IN	O
temperature	NN	B-TEST
100	CD	O
degrees	NNS	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
120/64	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
80	CD	O
.	.	O

he	PRP	O
was	VBD	O
intubated	VBN	B-TREATMENT
with	IN	O
pressor	JJ	B-TREATMENT
support	NN	I-TREATMENT
of	IN	O
25	CD	O
,	,	O
and	CC	O
peep	NN	B-TREATMENT
of	IN	O
12.5	CD	O
with	IN	O
70%	CD	O
fio2	NNS	B-TREATMENT
.	.	O

tracheostomy	NN	B-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
in	IN	O
good	JJ	O
position	NN	O
.	.	O

there	EX	O
was	VBD	O
an	DT	B-PROBLEM
audible	JJ	I-PROBLEM
air	NN	I-PROBLEM
leak	NN	I-PROBLEM
.	.	O

his	PRP$	O
chest	NN	O
showed	VBD	O
bilateral	JJ	B-PROBLEM
rhonchi	NN	I-PROBLEM
.	.	O

the	DT	O
abdomen	NNS	O
was	VBD	O
distended	VBN	B-PROBLEM
with	IN	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

the	DT	B-TEST
rectal	JJ	I-TEST
examination	NN	I-TEST
was	VBD	O
unremarkable	JJ	O
.	.	O

extremities	NNS	O
showed	VBD	O
trace	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
chest	NN	I-TEST
x-ray	NN	I-TEST
showed	VBD	O
diffuse	IN	B-PROBLEM
bilateral	JJ	I-PROBLEM
alveolar	JJ	I-PROBLEM
infiltrates	NNS	I-PROBLEM
,	,	O
greater	JJR	O
in	IN	O
the	DT	O
lower	JJR	O
lung	NN	O
fields	NNS	O
than	IN	O
in	IN	O
the	DT	O
upper	NN	O
.	.	O

the	DT	B-TEST
ekg	NN	I-TEST
showed	VBD	O
normal	JJ	O
sinus	NN	O
rhythm	NN	O
at	IN	O
83	CD	O
,	,	O
with	IN	O
an	DT	O
11	CD	O
degree	NN	O
axis	NN	O
,	,	O
non-specific	JJ	B-PROBLEM
st-t	JJ	I-PROBLEM
wave	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
sputum	NN	I-TEST
gram	NN	I-TEST
stain	NN	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
few	JJ	I-PROBLEM
polys	NN	I-PROBLEM
and	CC	O
no	DT	O
organisms	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
blood	NN	I-TEST
gas	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
po2	NN	I-TEST
of	IN	O
56	CD	O
,	,	O
pco2	NN	B-TEST
of	IN	O
48	CD	O
and	CC	O
ph	NN	B-TEST
of	IN	O
7.47	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
in	IN	O
consultation	NN	O
by	IN	O
dr.	NN	O
wire	NN	O
who	WP	O
felt	VBD	O
that	DT	O
manipulation	NN	B-TREATMENT
of	IN	I-TREATMENT
the	DT	I-TREATMENT
tracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
the	DT	O
best	JJS	O
approach	NN	O
to	TO	O
the	DT	B-PROBLEM
air	NN	I-PROBLEM
leak	NN	I-PROBLEM
since	IN	O
it	PRP	O
was	VBD	O
a	DT	B-TREATMENT
new	JJ	I-TREATMENT
trach	NN	I-TREATMENT
and	CC	O
he	PRP	O
was	VBD	O
requiring	VBG	O
such	JJ	O
high	JJ	B-TREATMENT
ventilator	NN	I-TREATMENT
support	NN	I-TREATMENT
that	IN	O
it	PRP	O
was	VBD	O
risky	JJ	O
to	TO	O
change	VB	O
it	PRP	O
.	.	O

he	PRP	O
also	RB	O
felt	VBD	O
that	IN	O
lung	NN	B-TEST
biopsy	NN	I-TEST
at	IN	O
this	DT	O
time	NN	O
was	VBD	O
rather	RB	O
risky	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
therefore	RB	O
completely	RB	B-TEST
cultured	VBN	I-TEST
again	RB	O
and	CC	O
begun	VBN	O
on	IN	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
which	WDT	O
would	MD	O
take	VB	O
care	NN	O
of	IN	O
the	DT	B-PROBLEM
pseudomonas	NN	I-PROBLEM
he	PRP	O
was	VBD	O
known	VBN	O
to	TO	O
have	VB	O
.	.	O

the	DT	B-TREATMENT
steroids	NNS	I-TREATMENT
were	VBD	O
tapered	VBN	O
.	.	O

he	PRP	O
was	VBD	O
also	RB	O
begun	VBN	O
on	IN	O
anti-candida	JJ	B-TREATMENT
regimen	NNS	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
urinary	JJ	I-PROBLEM
tract	NN	I-PROBLEM
infection	NN	I-PROBLEM
with	IN	O
yeast	NN	B-PROBLEM
being	VBG	O
seen	VBN	O
.	.	O

because	IN	O
of	IN	O
the	DT	O
story	NN	O
of	IN	O
hemoptysis	NN	B-PROBLEM
,	,	O
he	PRP	O
also	RB	O
underwent	VBD	O
an	DT	B-TEST
exotic	JJ	I-TEST
bleeding	NN	I-TEST
work	NN	I-TEST
up	RB	I-TEST
for	IN	O
such	JJ	O
things	NNS	O
as	IN	O
wegner	NN	B-PROBLEM
&apos;s	NN	I-PROBLEM
and	CC	O
goodpasture	NN	B-PROBLEM
&apos;s	NN	I-PROBLEM
.	.	O

he	PRP	O
continued	VBD	O
to	TO	O
require	VB	O
very	RB	B-TREATMENT
high	JJ	I-TREATMENT
fio2	NN	I-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
dvt	NN	I-PROBLEM
by	IN	O
ultrasound	NN	B-TEST
.	.	O

he	PRP	O
underwent	VBD	O
a	DT	B-TREATMENT
trial	NN	I-TREATMENT
of	IN	I-TREATMENT
tpa	NN	I-TREATMENT
followed	VBN	O
by	IN	O
heparin	NN	B-TREATMENT
.	.	O

this	DT	O
produced	VBN	O
substantially	RB	B-PROBLEM
further	JJ	I-PROBLEM
hemoptysis	NN	I-PROBLEM
and	CC	O
the	DT	O
need	NN	O
for	IN	O
transfusion	NN	B-TREATMENT
.	.	O

he	PRP	O
stabilized	VBD	O
from	IN	O
this	DT	O
,	,	O
but	CC	O
on	IN	O
the	DT	O
fifth	NN	O
while	IN	O
continuing	VBG	O
to	TO	O
have	VB	O
extremely	RB	B-PROBLEM
ventilator	JJ	I-PROBLEM
requirement	NN	I-PROBLEM
.	.	O

at	IN	O
that	DT	O
time	NN	O
,	,	O
therefore	RB	O
,	,	O
ventilator	NN	B-TREATMENT
support	NN	I-TREATMENT
was	VBD	O
withdrawn	VBN	O
under	IN	O
the	DT	B-TREATMENT
comfort	NN	I-TREATMENT
measures	NNS	I-TREATMENT
of	IN	O
morphine	NN	B-TREATMENT
.	.	O

left	VBN	B-PROBLEM
anterior	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

left	VBN	B-PROBLEM
anterior	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
.	.	O

atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
deep	RB	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
,	,	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
,	,	O
right	JJ	B-PROBLEM
frontal	NN	I-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
hypertension	NN	B-PROBLEM
,	,	O
and	CC	O
question	NN	O
progressive	JJ	B-PROBLEM
supranuclear	NN	I-PROBLEM
palsy	NN	I-PROBLEM
.	.	O

magnetic	JJ	B-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
brain	NN	I-TEST
on	IN	O
10/18/96	CD	O
.	.	O

arterial	JJ	B-TEST
catheterization	NN	I-TEST
on	IN	O
10/14/96	CD	O
,	,	O
head	NN	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
on	IN	O
10/14/96	CD	O

granrivern	JJ	O
call	NN	O
is	VBZ	O
a	DT	O
79-year-old	JJ	O
right	NN	O
handed	VBD	O
white	JJ	O
male	NN	O
with	IN	O
a	DT	O
history	NN	O
of	IN	O
questionable	JJ	O
progressive	JJ	B-PROBLEM
supranuclear	NN	I-PROBLEM
palsy	NN	I-PROBLEM
,	,	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
deep	RB	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
,	,	O
and	CC	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
who	WP	O
presents	VBZ	O
with	IN	O
a	DT	B-PROBLEM
change	NN	I-PROBLEM
in	IN	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
a	DT	O
fall	NN	O
at	IN	O
home	NN	O
.	.	O

his	PRP$	O
family	NN	O
stated	VBD	O
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
progressive	JJ	I-PROBLEM
mental	JJ	I-PROBLEM
decline	NN	I-PROBLEM
over	IN	O
the	DT	O
past	JJ	O
three	CD	O
years	NNS	O
and	CC	O
was	VBD	O
initially	RB	O
diagnosed	VBN	O
with	IN	O
parkinson	NN	B-PROBLEM
&apos;s	JJ	I-PROBLEM
disease	NN	I-PROBLEM
or	CC	O
features	NNS	B-PROBLEM
consistent	JJ	O
with	IN	O
parkinsonism	NN	B-PROBLEM
.	.	O

this	DT	O
was	VBD	O
poorly	RB	O
responsive	JJ	O
to	TO	O
eldopa	VB	B-TREATMENT
.	.	O

he	PRP	O
was	VBD	O
later	RB	O
seen	VBN	O
by	IN	O
dr.	JJ	O
flo	JJ	O
cuchkote	NN	O
at	IN	O
the	DT	O
ph	NN	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
and	CC	O
diagnosed	VBN	O
with	IN	O
progressive	JJ	B-PROBLEM
supranuclear	JJ	I-PROBLEM
palsy	NN	I-PROBLEM
.	.	O

over	IN	O
the	DT	O
five	CD	O
to	TO	O
six	CD	O
weeks	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
drop	NN	I-PROBLEM
off	RP	I-PROBLEM
in	IN	I-PROBLEM
his	PRP$	I-PROBLEM
mental	JJ	I-PROBLEM
functioning	NN	I-PROBLEM
with	IN	O
more	RBR	O
frequent	JJ	O
episodes	NNS	O
of	IN	O
confusion	NN	B-PROBLEM
and	CC	O
disorientation	NN	B-PROBLEM
and	CC	O
requiring	VBG	O
more	JJR	O
assistance	NN	B-TREATMENT
with	IN	O
his	PRP$	O
activities	NNS	O
of	IN	O
daily	JJ	O
living	NN	O
.	.	O

he	PRP	O
also	RB	O
developed	VBD	O
a	DT	B-PROBLEM
urinary	JJ	I-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
definite	JJ	B-PROBLEM
clonic	JJ	I-PROBLEM
activity	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
known	JJ	B-PROBLEM
incontinence	NN	I-PROBLEM
.	.	O

a	DT	B-TEST
trauma	JJ	I-TEST
evaluation	NN	I-TEST
was	VBD	O
negative	JJ	O
and	CC	O
thus	RB	O
he	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
neurology	NN	O
service	NN	O
.	.	O

coumadin	NN	B-TREATMENT
4	CD	O
mgs	NN	O
po	NN	O
qhs	NN	O
,	,	O
vasotec	JJ	B-TREATMENT
5	CD	O
mgs	NN	O
po	NN	O
qd	NN	O
,	,	O
lasix	JJ	B-TREATMENT
prn	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mgs	NN	O
poqd	NN	O
,	,	O
proscar	NN	B-TREATMENT
and	CC	O
sinemet	NN	B-TREATMENT
.	.	O

no	DT	O
known	VBN	B-PROBLEM
drug	NN	I-PROBLEM
allergies	NNS	I-PROBLEM
.	.	O

1)	CD	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
on	IN	O
coumadin	NN	B-TREATMENT
,	,	O

2)	CD	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
;	:	O
the	DT	O
wife	NN	O
states	NNS	O
since	IN	O
he	PRP	O
was	VBD	O
in	IN	O
the	DT	O
infantry	NN	O
in	IN	O
world	NN	O
war	NN	O
ii	NN	O
.	.	O

3)	CD	O
question	NN	O
progressive	JJ	B-PROBLEM
supranuclear	NN	I-PROBLEM
palsy	NN	I-PROBLEM
.	.	O

4)	CD	O
old	JJ	B-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
infarct	NN	I-PROBLEM
.	.	O

5)	CD	O
hypertension	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
a	DT	O
father	NN	O
who	WP	O
had	VBD	O
dementia	NN	B-PROBLEM
.	.	O

there	EX	O
was	VBD	O
no	DT	O
history	NN	O
of	IN	O
strokes	NNS	B-PROBLEM
or	CC	O
bleeding	VBG	B-PROBLEM
disorders	NNS	I-PROBLEM
in	IN	O
the	DT	O
family	NN	O
.	.	O

vital	JJ	B-TEST
signs	NNS	I-TEST
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
were	VBD	O
210/100	CD	O
for	IN	O
blood	NN	B-TEST
pressure	NN	I-TEST
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
70	CD	O
and	CC	O
irregular	JJ	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
afebrile	RB	B-PROBLEM
.	.	O

in	IN	O
general	JJ	O
he	PRP	O
was	VBD	O
an	DT	O
intubated	JJ	O
elderly	JJ	O
frail	NN	O
appearing	VBG	O
white	JJ	O
male	NN	O
with	IN	O
blood	NN	B-PROBLEM
about	IN	I-PROBLEM
his	PRP$	I-PROBLEM
face	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
,	,	I-TEST
eyes	NNS	I-TEST
,	,	I-TEST
ears	NNS	I-TEST
,	,	I-TEST
nose	RB	I-TEST
and	CC	I-TEST
throat	JJ	I-TEST
examination	NN	I-TEST
;	:	O
abrasions	NNS	B-PROBLEM
about	IN	I-PROBLEM
his	PRP$	I-PROBLEM
forehead	NN	I-PROBLEM
,	,	O
there	EX	O
was	VBD	O
some	DT	B-PROBLEM
minimal	JJ	I-PROBLEM
swelling	NN	I-PROBLEM
associated	VBN	O
.	.	O

his	PRP$	O
neck	NN	O
was	VBD	O
rigid	JJ	B-PROBLEM
;	:	O
1+	CD	B-TEST
carotids	NNS	I-TEST
without	IN	O
bruits	NNS	B-PROBLEM
.	.	O

oropharynx	NN	O
was	VBD	O
intubated	VBN	B-TREATMENT
with	IN	O
blood	NN	B-PROBLEM
as	RB	O
well	RB	O
.	.	O

lungs	NNS	O
;	:	O
clear	JJ	O
to	TO	O
auscultation	VB	B-TEST
bilaterally	RB	I-TEST
.	.	O

cardiovascular	JJ	B-TEST
examination	NN	I-TEST
;	:	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
rubs	NNS	B-PROBLEM
,	,	O
or	CC	O
gallops	NNS	B-PROBLEM
.	.	O

abdominal	JJ	B-TEST
examination	NN	I-TEST
;	:	O
soft	JJ	O
,	,	O
non-tender	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
normal	JJ	O
active	JJ	O
bowel	NN	O
sounds	NNS	O
.	.	O

no	DT	O
clubbing	NN	B-PROBLEM
,	,	O
cyanosis	NN	B-PROBLEM
,	,	O
or	CC	O
edema	NN	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
no	DT	B-PROBLEM
blink	NN	I-PROBLEM
to	TO	O
threat	NN	B-TEST
.	.	O

according	VBG	O
to	TO	O
the	DT	O
family	NN	O
this	DT	B-PROBLEM
iansicoria	NN	I-PROBLEM
was	VBD	O
old	JJ	O
.	.	O

he	PRP	O
had	VBD	O
no	DT	O
gag	NN	B-PROBLEM
to	TO	O
tube	VB	B-TREATMENT
manipulation	NN	I-TREATMENT
.	.	O

motor	NN	B-TEST
examination	NN	I-TEST
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
weak	JJ	I-PROBLEM
withdrawal	NN	I-PROBLEM
to	TO	O
nail	VB	B-TEST
bed	NN	I-TEST
pressure	NN	I-TEST
in	IN	O
both	DT	O
hands	NNS	O
.	.	O

he	PRP	O
triple	VBD	O
flexed	JJ	O
his	PRP$	O
bilateral	JJ	O
lower	JJR	O
extremities	NNS	O
to	TO	O
pain	VB	B-PROBLEM
.	.	O

his	PRP$	B-TEST
deep	JJ	I-TEST
tendon	NN	I-TEST
reflexes	NNS	I-TEST
were	VBD	O
2+	CD	O
at	IN	O
the	DT	O
right	JJ	O
brachial	NN	O
radialis	NN	O
and	CC	O
right	JJ	O
patella	NN	O
;	:	O
everywhere	RB	O
else	RB	O
his	PRP$	B-TEST
reflexes	NNS	I-TEST
were	VBD	O
1	CD	O
.	.	O

sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
3.5	CD	O
,	,	O
chloride	RB	B-TEST
107	CD	O
,	,	O
bicarbonates	VBZ	B-TEST
23.8	CD	O
,	,	O
bun	NN	B-TEST
23	CD	O
,	,	O
creatinine	NN	B-TEST
1.1	CD	O
,	,	O
glucose	RB	B-TEST
165	CD	O
,	,	O
po2	NN	B-TEST
377	CD	O
,	,	O
pco2	NN	B-TEST
32	CD	O
,	,	O
ph	NN	B-TEST
7.50	CD	O
,	,	O
asomus	RB	B-TEST
298	CD	O
,	,	O
toxic	JJ	B-TEST
screen	NN	I-TEST
negative	JJ	O
,	,	O
white	JJ	B-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
11.1	CD	O
,	,	O
hematocrit	NN	B-TEST
39.6	CD	O
,	,	O
platelet	NN	B-TEST
count	NN	I-TEST
137	CD	O
,	,	O
prothrombin	JJ	B-TEST
time	NN	I-TEST
25.2	CD	O
,	,	O
inr	NN	B-TEST
4.3	CD	O
,	,	O
partial	JJ	B-TEST
thromboplastin	NN	I-TEST
time	NN	I-TEST
34.7	CD	O
,	,	O
urinalysis	NN	B-TEST
1+	CD	B-PROBLEM
albumin,	IN	I-PROBLEM
0-5	JJ	B-PROBLEM
high	JJ	I-PROBLEM
link	NN	I-PROBLEM
caths	NNS	I-PROBLEM
,	,	O
cervical	JJ	B-TEST
spine	NN	I-TEST
negative	JJ	O
,	,	O
pelvis	JJ	B-TEST
negative	JJ	O
,	,	O
lumbar	JJ	B-TEST
spine	NN	I-TEST
;	:	O
negative	JJ	O
,	,	O
thoracic	JJ	B-TEST
spine	NN	I-TEST
negative	NN	O
.	.	O

chest	JJS	B-TEST
x-ray	JJ	I-TEST
clear	JJ	O
.	.	O

electrocardiogram	NN	B-TEST
showed	VBD	O
2	CD	O
mm	NN	O
of	IN	O
st	JJ	B-PROBLEM
depressions	NNS	I-PROBLEM
in	IN	I-PROBLEM
v4-6	NN	I-PROBLEM
.	.	O

head	NN	B-TEST
ct	NN	I-TEST
scan	JJ	I-TEST
showed	VBD	O
a	DT	B-PROBLEM
2	CD	I-PROBLEM
x	NN	I-PROBLEM
2	CD	I-PROBLEM
x	JJ	I-PROBLEM
2	CD	I-PROBLEM
left	VBD	I-PROBLEM
anterior	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
hemorrhage	NN	I-PROBLEM
with	IN	O
minimal	JJ	B-PROBLEM
surrounding	VBG	I-PROBLEM
edema	NN	I-PROBLEM
.	.	O

there	EX	O
was	VBD	O
also	RB	O
evidence	NN	O
of	IN	O
an	DT	B-PROBLEM
old	JJ	I-PROBLEM
right	JJ	I-PROBLEM
frontal	NN	I-PROBLEM
infarction	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
admitted	VBN	O
to	TO	O
the	DT	O
neurology	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
for	IN	O
intensive	JJ	B-TEST
monitoring	NN	I-TEST
due	JJ	O
to	TO	O
his	PRP$	B-PROBLEM
frail	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
an	DT	B-TEST
electroencephalogram	NN	I-TEST
performed	VBN	O
on	IN	O
his	PRP$	O
initial	JJ	O
admittance	NN	O
to	TO	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
which	WDT	O
did	VBD	O
not	RB	O
show	VB	O
any	DT	O
evidence	NN	O
of	IN	O
seizure	NN	B-PROBLEM
activity	NN	I-PROBLEM
.	.	O

it	PRP	O
did	VBD	O
,	,	O
however	RB	O
,	,	O
show	VBP	O
diffuse	IN	B-PROBLEM
slowing	VBG	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
given	VBN	O
1.5	CD	O
grams	NNS	O
of	IN	O
dilantin	NN	B-TREATMENT
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
as	RB	O
well	RB	O
as	IN	O
2	CD	O
mgs	NN	O
of	IN	O
intravenous	JJ	B-TREATMENT
ativan	NNS	I-TREATMENT
which	WDT	O
did	VBD	O
little	JJ	O
to	TO	O
stop	VB	O
his	PRP$	B-PROBLEM
rhythmic	JJ	I-PROBLEM
blinking	NN	I-PROBLEM
that	IN	O
he	PRP	O
showed	VBD	O
from	IN	O
time	NN	O
to	TO	O
time	NN	O
on	IN	O
examination	NN	B-TEST
.	.	O

his	PRP$	B-PROBLEM
hypertension	NN	I-PROBLEM
;	:	O
his	PRP$	B-PROBLEM
high	JJ	I-PROBLEM
blood	NN	I-PROBLEM
pressure	NN	I-PROBLEM
was	VBD	O
controlled	VBN	O
with	IN	O
intravenous	JJ	B-TREATMENT
nitroglycerine	NN	I-TREATMENT
in	IN	O
the	DT	O
early	JJ	O
going	VBG	O
and	CC	O
then	RB	O
he	PRP	O
was	VBD	O
switched	VBN	O
to	TO	O
an	DT	B-TREATMENT
oral	JJ	I-TREATMENT
regimen	NNS	I-TREATMENT
for	IN	O
better	JJR	O
control	NN	O
after	IN	O
he	PRP	O
was	VBD	O
removed	VBN	O
from	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
.	.	O

he	PRP	O
did	VBD	O
consistently	RB	O
have	VB	O
more	RBR	O
movement	NN	O
on	IN	O
the	DT	O
left	JJ	O
side	NN	O
of	IN	O
his	PRP$	O
body	NN	O
than	IN	O
on	IN	O
the	DT	O
right	NN	O
,	,	O
but	CC	O
he	PRP	O
gradually	RB	O
became	VBD	O
more	RBR	O
awake	JJ	O
and	CC	O
alert	JJ	O
and	CC	O
communicative	JJ	O
and	CC	O
his	PRP$	B-TREATMENT
endotracheal	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
removed	VBN	O
on	IN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

his	PRP$	O
diagnosis	NN	O
of	IN	O
progressive	JJ	B-PROBLEM
supranuclear	JJ	I-PROBLEM
palsy	NN	I-PROBLEM
was	VBD	O
placed	VBN	O
under	IN	O
question	NN	O
on	IN	O
further	JJ	B-TEST
examination	NN	I-TEST
of	IN	I-TEST
his	PRP$	I-TEST
eye	NN	I-TEST
movement	NN	I-TEST
since	IN	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
have	VB	O
excellent	JJ	O
superior	JJ	O
gaze	NN	O
especially	RB	O
with	IN	O
the	DT	B-TEST
bells	NNS	I-TEST
phenomenon	NN	I-TEST
which	WDT	O
would	MD	O
not	RB	O
be	VB	O
seen	VBN	O
with	IN	O
progressive	JJ	B-PROBLEM
supranuclear	JJ	I-PROBLEM
palsy	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
felt	VBN	O
that	IN	O
his	PRP$	B-PROBLEM
dementing	VBG	I-PROBLEM
illness	NN	I-PROBLEM
and	CC	O
rigidity	NN	B-PROBLEM
was	VBD	O
most	RBS	O
likely	JJ	O
due	JJ	O
to	TO	O
some	DT	O
type	NN	O
of	IN	O
cortico-basal	JJ	B-PROBLEM
ganglia	JJ	I-PROBLEM
degeneration	NN	I-PROBLEM
process	NN	I-PROBLEM
,	,	O
but	CC	O
this	DT	O
was	VBD	O
not	RB	O
clarified	VBN	O
during	IN	O
this	DT	O
admission	NN	O
.	.	O

it	PRP	O
was	VBD	O
not	RB	O
felt	VBN	O
likely	JJ	O
to	TO	O
be	VB	O
due	JJ	O
to	TO	O
parkinson	VB	B-PROBLEM
&apos;s	JJ	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
as	IN	O
he	PRP	O
had	VBD	O
no	DT	O
significant	JJ	O
response	NN	O
to	TO	O
eldopa	VB	B-TREATMENT
in	IN	O
the	DT	O
past	NN	O
and	CC	O
the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
tremor	NN	B-PROBLEM
,	,	O
although	IN	O
he	PRP	O
was	VBD	O
quite	RB	B-PROBLEM
rigid	JJ	I-PROBLEM
and	CC	O
bradykinetic	JJ	B-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
an	DT	B-TEST
magnetic	JJ	I-TEST
resonance	NN	I-TEST
imaging	NN	I-TEST
performed	VBN	O
on	IN	O
october	PRP	O
18	CD	O
,	,	O
1996	CD	O
.	.	O

this	DT	O
showed	VBD	O
the	DT	B-PROBLEM
unchanged	JJ	I-PROBLEM
left	JJ	I-PROBLEM
temporal	JJ	I-PROBLEM
parenchymal	NN	I-PROBLEM
interparenchymal	JJ	I-PROBLEM
hematoma	NN	I-PROBLEM
and	CC	O
the	DT	B-PROBLEM
old	JJ	I-PROBLEM
embolic	JJ	I-PROBLEM
right	NN	I-PROBLEM
frontal	NN	I-PROBLEM
infarct	NN	I-PROBLEM
,	,	O
but	CC	O
there	EX	O
were	VBD	O
no	DT	O
new	JJ	B-PROBLEM
lesions	NNS	I-PROBLEM
and	CC	O
no	DT	O
evidence	NN	O
of	IN	O
his	PRP$	B-TEST
susceptibility	NN	I-TEST
studies	NNS	I-TEST
to	TO	O
suggest	VB	O
old	JJ	B-PROBLEM
bleeds	NNS	I-PROBLEM
which	WDT	O
might	MD	O
have	VB	O
been	VBN	O
consistent	JJ	O
with	IN	O
amylase	NN	B-PROBLEM
angiopathy	NN	I-PROBLEM
.	.	O

in	IN	O
addition	NN	O
,	,	O
he	PRP	O
gadolinium	VBD	B-TEST
scan	JJ	I-TEST
did	VBD	O
not	RB	O
show	VB	O
enhancement	NN	B-PROBLEM
at	IN	O
the	DT	O
area	NN	O
of	IN	O
his	PRP$	B-PROBLEM
hemorrhage	NN	I-PROBLEM
,	,	O
so	RB	O
tumor	NN	B-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
unlikely	JJ	O
.	.	O

however	RB	O
,	,	O
this	DT	O
issue	NN	O
will	MD	O
need	VB	O
to	TO	O
be	VB	O
re-evaluated	JJ	O
in	IN	O
six	CD	O
months	NNS	O
time	NN	O
once	IN	O
the	DT	B-PROBLEM
hematoma	NN	I-PROBLEM
is	VBZ	O
less	RBR	O
prominent	JJ	O
to	TO	O
see	VB	O
if	IN	O
there	EX	O
is	VBZ	O
possibly	RB	O
an	DT	B-PROBLEM
underlying	JJ	I-PROBLEM
tumor	NN	I-PROBLEM
or	CC	O
arterial	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
malformation	NN	I-PROBLEM
that	WDT	O
could	MD	O
be	VB	O
currently	RB	O
compressed	VBN	O
by	IN	O
the	DT	O
area	NN	O
of	IN	O
hemorrhage	NN	B-PROBLEM
.	.	O

the	DT	O
etiology	NN	O
of	IN	O
his	PRP$	B-PROBLEM
bleed	NN	I-PROBLEM
was	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
most	RBS	O
likely	JJ	O
secondary	JJ	O
to	TO	O
hypertension	NN	B-PROBLEM
,	,	O
but	CC	O
these	DT	O
other	JJ	O
causes	NNS	O
could	MD	O
also	RB	O
not	RB	O
be	VB	O
ruled	VBN	O
out	RP	O
.	.	O

his	PRP$	B-TEST
electrocardiogram	NN	I-TEST
was	VBD	O
concerning	VBG	O
for	IN	O
ischemia	NN	B-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
on	IN	O
intravenous	JJ	B-TREATMENT
tng	NN	I-TREATMENT
and	CC	O
was	VBD	O
supratherapeutic	VBN	B-PROBLEM
on	IN	O
his	PRP$	B-TREATMENT
anti-coagulation	NN	I-TREATMENT
.	.	O

he	PRP	O
did	VBD	O
have	VB	O
a	DT	B-PROBLEM
slight	JJ	I-PROBLEM
elevation	NN	I-PROBLEM
of	IN	O
his	PRP$	B-TEST
tpk	NN	I-TEST
with	IN	O
an	DT	O
additional	JJ	O
value	NN	O
of	IN	O
198	CD	O
with	IN	O
a	DT	B-TEST
mb	JJ	I-TEST
fraction	NN	I-TEST
of	IN	O
5.7	CD	O
,	,	O
which	WDT	O
makes	VBZ	O
for	IN	O
a	DT	O
percentage	NN	O
of	IN	O
2.9	CD	O
.	.	O

that	DT	O
was	VBD	O
at	IN	O
the	DT	O
highest	JJS	O
percentage	NN	O
that	IN	O
he	PRP	O
had	VBD	O
and	CC	O
after	IN	O
this	DT	O
his	PRP$	O
percentage	NN	O
came	VBD	O
down	RB	O
to	TO	O
1.6	CD	O
,	,	O
1.0	CD	O
on	IN	O
subsequent	JJ	B-TEST
ckmbs	NN	I-TEST
and	CC	O
was	VBD	O
felt	VBN	O
that	IN	O
he	PRP	O
had	VBD	O
a	DT	B-PROBLEM
very	RB	I-PROBLEM
small	JJ	I-PROBLEM
&quot;	NNP	I-PROBLEM
leaflet	NN	I-PROBLEM
&quot;	NNP	I-PROBLEM
.	.	O

he	PRP	O
remained	VBD	O
chest	JJS	B-PROBLEM
pain	NN	I-PROBLEM
free	JJ	O
throughout	IN	O
his	PRP$	O
admission	NN	O
.	.	O

after	IN	O
his	PRP$	B-TREATMENT
initial	JJ	I-TREATMENT
intubation	NN	I-TREATMENT
he	PRP	O
remained	VBD	O
quite	RB	O
stable	JJ	O
.	.	O

he	PRP	O
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
at	IN	O
a	DT	B-PROBLEM
large	JJ	I-PROBLEM
aspiration	NN	I-PROBLEM
risk	NN	I-PROBLEM
given	VBN	O
his	PRP$	B-PROBLEM
decreased	JJ	I-PROBLEM
mental	JJ	I-PROBLEM
status	NN	I-PROBLEM
and	CC	O
the	DT	O
lack	NN	O
of	IN	O
presence	NN	O
of	IN	O
a	DT	B-TEST
gag	NN	I-TEST
reflex	NN	I-TEST
.	.	O

however	RB	O
,	,	O
he	PRP	O
was	VBD	O
given	VBN	O
aggressive	JJ	B-TREATMENT
pulmonary	JJ	I-TREATMENT
toilets	NNS	I-TREATMENT
including	VBG	O
chest	JJS	B-TREATMENT
physical	JJ	I-TREATMENT
therapy	NN	I-TREATMENT
and	CC	O
aspiration	NN	B-TREATMENT
precautions	NNS	I-TREATMENT
and	CC	O
the	DT	O
patient	NN	O
did	VBD	O
not	RB	O
develop	VB	O
any	DT	B-PROBLEM
pulmonary	JJ	I-PROBLEM
symptoms	NNS	I-PROBLEM
during	IN	O
his	PRP$	O
admission	NN	O
.	.	O

he	PRP	O
had	VBD	O
his	PRP$	B-TEST
prothrombin	JJ	I-TEST
time	NN	I-TEST
reversed	VBN	O
with	IN	O
vitamin	NN	B-TREATMENT
k	NN	I-TREATMENT
2	CD	O
mgs	NN	O
on	IN	O
admission	NN	O
subcutaneously	RB	O
as	RB	O
well	RB	O
as	IN	O
two	CD	O
units	NNS	O
of	IN	O
fresh	JJ	B-TREATMENT
frozen	JJ	I-TREATMENT
plasma	NN	I-TREATMENT
given	VBN	O
in	IN	O
the	DT	O
emergency	NN	O
room	NN	O
.	.	O

his	PRP$	O
anticoagulation	NN	O
status	NN	O
had	VBD	O
to	TO	O
be	VB	O
monitored	VBN	O
very	RB	O
closely	RB	O
due	JJ	O
to	TO	O
his	PRP$	O
history	NN	O
of	IN	O
deep	JJ	B-PROBLEM
venous	JJ	I-PROBLEM
thrombosis	NN	I-PROBLEM
and	CC	O
pulmonary	JJ	B-PROBLEM
embolus	NN	I-PROBLEM
as	RB	O
well	RB	O
as	IN	O
atrial	JJ	B-PROBLEM
fibrillation	NN	I-PROBLEM
,	,	O
but	CC	O
he	PRP	O
could	MD	O
not	RB	O
be	VB	O
placed	VBN	O
on	IN	O
a	DT	O
high	JJ	O
amount	NN	O
of	IN	O
anticoagulation	NN	B-TREATMENT
because	IN	O
of	IN	O
the	DT	B-PROBLEM
new	JJ	I-PROBLEM
intraparenchymal	JJ	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
his	PRP$	O
goal	NN	O
inr	NN	B-TEST
was	VBD	O
to	TO	O
be	VB	O
2.0	CD	O
.	.	O

he	PRP	O
did	VBD	O
drop	VB	O
below	IN	O
1.5	CD	O
at	IN	O
one	CD	O
time	NN	O
,	,	O
at	IN	O
which	WDT	O
time	NN	O
he	PRP	O
was	VBD	O
placed	VBN	O
on	IN	O
heparin	NN	B-TREATMENT
intravenous	JJ	I-TREATMENT
to	TO	O
carry	VB	O
him	PRP	O
through	IN	O
that	DT	O
period	NN	O
,	,	O
but	CC	O
his	PRP$	B-TEST
discharge	NN	I-TEST
inr	NN	I-TEST
was	VBD	O
around	IN	O
2	CD	O
and	CC	O
he	PRP	O
was	VBD	O
off	IN	O
of	IN	O
heparin	NN	B-TREATMENT
at	IN	O
that	DT	O
time	NN	O
.	.	O

it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
he	PRP	O
would	MD	O
have	VB	O
very	RB	O
close	JJ	O
monitoring	NN	B-TEST
of	IN	O
his	PRP$	O
anticoagulation	NN	O
status	NN	O
in	IN	O
the	DT	O
future	NN	O
to	TO	O
prevent	VB	O
further	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
.	.	O

he	PRP	O
was	VBD	O
evaluated	VBN	O
by	IN	O
the	DT	O
speech	NN	O
and	CC	O
swallow	JJ	O
pathology	NN	O
group	NN	O
at	IN	O
the	DT	O
ph	NN	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
and	CC	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
he	PRP	O
was	VBD	O
able	JJ	O
to	TO	O
swallow	VB	O
on	IN	O
his	PRP$	O
own	JJ	O
with	IN	O
a	DT	B-TREATMENT
soft	JJ	I-TREATMENT
solid	JJ	I-TREATMENT
diet	NN	I-TREATMENT
with	IN	O
supervision	NN	O
.	.	O

thus	RB	O
,	,	O
his	PRP$	B-TREATMENT
nasogastric	JJ	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
discontinued	VBN	O
on	IN	O
october	PRP	O
19	CD	O
,	,	O
1996	CD	O
and	CC	O
he	PRP	O
tolerated	VBD	O
feeding	VBG	O
quite	RB	O
well	RB	O
.	.	O

in	IN	O
discussions	NNS	O
with	IN	O
the	DT	O
family	NN	O
,	,	O
given	VBN	O
his	PRP$	O
age	NN	O
and	CC	O
number	NN	O
of	IN	O
medical	JJ	B-PROBLEM
problems	NNS	I-PROBLEM
,	,	O
it	PRP	O
was	VBD	O
decided	VBN	O
that	IN	O
the	DT	O
patient	NN	O
should	MD	O
be	VB	O
do	VB	O
not	RB	O
resuscitate	VB	O
should	MD	O
he	PRP	O
have	VB	O
a	DT	B-PROBLEM
terminal	JJ	I-PROBLEM
cardiac	JJ	I-PROBLEM
event	NN	I-PROBLEM
during	IN	O
his	PRP$	O
admission	NN	O
or	CC	O
during	IN	O
future	JJ	O
admissions	NNS	O
.	.	O

however	RB	O
,	,	O
he	PRP	O
was	VBD	O
still	RB	O
an	DT	B-TREATMENT
intubation	NN	I-TREATMENT
candidate	NN	O
if	IN	O
it	PRP	O
were	VBD	O
felt	VBN	O
to	TO	O
be	VB	O
a	DT	B-TREATMENT
short	JJ	I-TREATMENT
term	NN	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

the	DT	O
family	NN	O
realizes	VBZ	O
that	IN	O
the	DT	O
long	JJ	O
term	NN	O
outlook	NN	O
for	IN	O
this	DT	O
patient	NN	O
is	VBZ	O
not	RB	O
very	RB	O
good	JJ	O
,	,	O
but	CC	O
they	PRP	O
would	MD	O
like	VB	O
to	TO	O
currently	RB	O
continue	VB	O
to	TO	O
provide	VB	O
him	PRP	O
with	IN	O
all	DT	B-TREATMENT
support	NN	I-TREATMENT
necessary	JJ	I-TREATMENT
,	,	O
short	JJ	O
of	IN	O
resuscitation	NN	B-TREATMENT
measures	NNS	I-TREATMENT
or	CC	O
heroic	NN	B-TREATMENT
measures	NNS	I-TREATMENT
should	MD	O
he	PRP	O
have	VB	O
a	DT	B-PROBLEM
cardiopulmonary	JJ	I-PROBLEM
arrest	NN	I-PROBLEM
.	.	O

dilantin	NN	B-TREATMENT
100	CD	O
mgs	NN	O
po	NN	O
tid	NN	O
,	,	O
carafate	VBP	B-TREATMENT
1	CD	O
gram	NN	O
po	NN	O
qid	NN	O
,	,	O
digoxin	NN	B-TREATMENT
0.25	CD	O
mgs	NN	O
po	NN	O
qd	NN	O
,	,	O
isordil	JJ	B-TREATMENT
20	CD	O
mgs	NN	O
po	NN	O
tid	NN	O
,	,	O
captopril	VBP	B-TREATMENT
25	CD	O
mgs	NN	O
po	NN	O
tid	NN	O
,	,	O
lopressor	VBZ	B-TREATMENT
50	CD	O
mgs	NN	O
po	NN	O
bid	NN	O
,	,	O
colace	NN	B-TREATMENT
100	CD	O
mgs	NN	O
po	NN	O
tid	NN	O
,	,	O
and	CC	O
coumadin	VBZ	B-TREATMENT
2	CD	O
mgs	NN	O
po	NN	O
qhs	NN	O
.	.	O

cryptogenic	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

cryptogenic	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

variceal	NN	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

variceal	NN	B-TREATMENT
banding	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
70-year-old	JJ	O
female	NN	O
with	IN	O
cryptogenic	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
esophageal	JJ	B-PROBLEM
varices	NNS	I-PROBLEM
and	CC	O
a	DT	O
history	NN	O
of	IN	O
an	DT	B-PROBLEM
upper	JJ	I-PROBLEM
gi	NN	I-PROBLEM
bleed	NN	I-PROBLEM
.	.	O

she	PRP	O
has	VBZ	O
had	VBD	O
one	CD	O
pervious	JJ	O
episode	NN	O
of	IN	O
variceal	NN	B-PROBLEM
bleeding	VBG	I-PROBLEM
with	IN	O
an	DT	O
unclear	JJ	O
date	NN	O
.	.	O

she	PRP	O
was	VBD	O
in	IN	O
her	PRP$	O
usual	JJ	O
state	NN	O
of	IN	O
health	NN	O
until	IN	O
one	CD	O
day	NN	O
prior	RB	O
to	TO	O
admission	NN	O
when	WRB	O
she	PRP	O
felt	VBD	O
increasing	VBG	B-PROBLEM
fatigue	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
and	CC	O
vomiting	VBG	B-PROBLEM
productive	NN	O
of	IN	O
bright	JJ	B-PROBLEM
red	JJ	I-PROBLEM
blood	NN	I-PROBLEM
and	CC	O
coffee	NN	B-PROBLEM
ground	NN	I-PROBLEM
emesis	NN	I-PROBLEM
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
some	DT	B-PROBLEM
black	JJ	I-PROBLEM
,	,	I-PROBLEM
tarry	JJ	I-PROBLEM
stool	NN	I-PROBLEM
in	IN	O
her	PRP$	B-TREATMENT
colostomy	NN	I-TREATMENT
bag	NN	I-TREATMENT
.	.	O

at	IN	O
vaila	NNP	O
medical	JJ	O
center	NN	O
,	,	O
she	PRP	O
had	VBD	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
25	CD	O
and	CC	O
was	VBD	O
transfused	VBN	O
2	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
an	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
at	IN	O
va	JJ	O
sit	NN	O
namar	NN	O
healthcare	NN	O
showing	VBG	O
an	DT	O
esophagus	NN	O
filled	VBN	O
with	IN	O
clots	NNS	B-PROBLEM
and	CC	O
small	JJ	O
amount	NN	O
of	IN	O
bleeding	VBG	B-PROBLEM
varices	NNS	I-PROBLEM
,	,	O
clot	NN	B-PROBLEM
in	IN	I-PROBLEM
the	DT	I-PROBLEM
stomach	NN	I-PROBLEM
with	IN	O
antral	JJ	B-PROBLEM
gastritis	NN	I-PROBLEM
,	,	O
and	CC	O
a	DT	O
normal	JJ	O
duodenum	NN	O
.	.	O

she	PRP	O
was	VBD	O
started	VBN	O
on	IN	O
pitressin	NN	B-TREATMENT
,	,	O
a	DT	B-TREATMENT
blakemore	NN	I-TREATMENT
tube	NN	I-TREATMENT
was	VBD	O
inserted	VBN	O
.	.	O

she	PRP	O
was	VBD	O
transferred	VBN	O
to	TO	O
the	DT	O
ph	NN	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
intensive	JJ	O
care	NN	O
unit	NN	O
where	WRB	O
on	IN	O
january	JJ	O
25	CD	O
in	IN	O
the	DT	O
morning	NN	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
found	VBN	O
to	TO	O
be	VB	O
27.4	CD	O
.	.	O

she	PRP	O
was	VBD	O
transfused	VBN	O
another	DT	O
2	CD	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
day	NN	O
and	CC	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
improved	VBD	O
to	TO	O
29.4	CD	O
and	CC	O
then	RB	O
31.2	CD	O
.	.	O

the	DT	O
gi	NN	O
service	NN	O
was	VBD	O
consulted	VBN	O
and	CC	O
an	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
study	NN	I-TEST
showed	VBD	O
grade	JJ	B-PROBLEM
iii	NN	I-PROBLEM
varices	NNS	I-PROBLEM
with	IN	O
no	DT	O
active	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
and	CC	O
a	DT	B-PROBLEM
clean	JJ	I-PROBLEM
base	NN	I-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
possibly	RB	O
secondary	JJ	O
to	TO	O
the	DT	B-TREATMENT
blakemore	NN	I-TREATMENT
tube	NN	I-TREATMENT
.	.	O

her	PRP$	B-PROBLEM
varices	NNS	I-PROBLEM
had	VBD	O
stigmata	NNS	B-PROBLEM
of	IN	O
recent	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
,	,	O
were	VBD	O
banded	VBN	B-TREATMENT
successfully	RB	O
.	.	O

after	IN	O
the	DT	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
2	CD	O
more	JJR	O
units	NNS	O
of	IN	O
packed	JJ	B-TREATMENT
red	JJ	I-TREATMENT
blood	NN	I-TREATMENT
cells	NNS	I-TREATMENT
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
hemodynamically	RB	O
stable	JJ	O
and	CC	O
hematocrit	NN	B-TEST
was	VBD	O
stable	JJ	O
at	IN	O
31.2	CD	O
.	.	O

cryptogenic	JJ	B-PROBLEM
cirrhosis	NN	I-PROBLEM
with	IN	O
an	DT	B-TEST
unclear	JJ	I-TEST
work	NN	I-TEST
up	RB	I-TEST
.	.	O

diverticular	JJ	B-PROBLEM
bleed	NN	I-PROBLEM
requiring	VBG	O
colostomy	NNS	B-TREATMENT
on	IN	O
may	MD	O
96	CD	O
.	.	O

spinal	JJ	B-PROBLEM
stenosis	NN	I-PROBLEM
.	.	O

hysterectomy	NN	B-TREATMENT
at	IN	O
the	DT	O
age	NN	O
of	IN	O
32	CD	O
.	.	O

no	DT	O
coronary	JJ	B-PROBLEM
disease	NN	I-PROBLEM
,	,	O
no	DT	O
diabetes	NNS	B-PROBLEM
and	CC	O
no	DT	O
hypertension	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
medications	NNS	B-TREATMENT
on	IN	O
transfer	NN	O
which	WDT	O
included	VBD	O
synthroid	NN	B-TREATMENT
0.15	CD	O
mg	NN	O
qd	NN	O
,	,	O
zoloft	JJ	B-TREATMENT
50	CD	O
mg	NN	O
qd	NN	O
,	,	O
inderal	JJ	B-TREATMENT
10	CD	O
mg	NN	O
bid	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
mg	NN	O
qd	NN	O
,	,	O
neomycin	RB	B-TREATMENT
500	CD	O
tid	NN	O
,	,	O
feosol	VBP	B-TREATMENT
3	CD	O
mg	NN	O
and	CC	O
darvocet	NN	B-TREATMENT
prn	NN	O
.	.	O

she	PRP	O
has	VBZ	O
allergies	NNS	B-PROBLEM
to	TO	O
morphine	VB	B-TREATMENT
,	,	O
percocet	NN	B-TREATMENT
,	,	O
codeine	NN	B-TREATMENT
,	,	O
penicillin	NN	B-TREATMENT
,	,	O
xanax	NNP	B-TREATMENT
and	CC	O
toradol	NN	B-TREATMENT
.	.	O

her	PRP$	O
husband	NN	O
died	VBD	O
of	IN	O
lung	NN	B-PROBLEM
cancer	NN	I-PROBLEM
.	.	O

she	PRP	O
is	VBZ	O
an	DT	O
obese	JJ	O
,	,	O
elderly	JJ	O
woman	NN	O
in	IN	O
no	DT	O
acute	JJ	B-PROBLEM
distress	NN	I-PROBLEM
.	.	O

158/60	CD	O
with	IN	O
a	DT	B-TEST
heart	NN	I-TEST
rate	NN	I-TEST
of	IN	O
85	CD	O
,	,	O
temperature	NN	B-TEST
99.7	CD	O
,	,	O
respirations	NNS	B-TEST
14	CD	O
.	.	O

her	PRP$	O
neck	NN	O
showed	VBD	O
no	DT	O
jvd	NN	B-PROBLEM
.	.	O

lungs	NNS	O
clear	JJ	O
to	TO	O
auscultation	NN	B-TEST
.	.	O

her	PRP$	O
abdomen	NNS	O
was	VBD	O
obese	JJ	B-PROBLEM
and	CC	O
distended	VBN	B-PROBLEM
with	IN	O
good	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
large	JJ	B-PROBLEM
ventral	JJ	I-PROBLEM
hernia	NN	I-PROBLEM
.	.	O

colostomy	NN	B-TREATMENT
with	IN	O
black	JJ	B-PROBLEM
stool	NN	I-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
some	DT	B-PROBLEM
mid	JJ	I-PROBLEM
epigastric	JJ	I-PROBLEM
tenderness	NN	I-PROBLEM
and	CC	O
no	DT	O
rebound	NN	B-PROBLEM
.	.	O

her	PRP$	O
heart	NN	O
showed	VBD	O
a	DT	O
regular	JJ	O
rate	NN	O
and	CC	O
rhythm	NN	O
with	IN	O
an	DT	O
s1-s2	JJ	O
,	,	O
no	DT	O
murmur	NN	B-PROBLEM
.	.	O

her	PRP$	B-TEST
neurological	JJ	I-TEST
exam	NN	I-TEST
was	VBD	O
alert	JJ	O
and	CC	O
oriented	VBN	O
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
asterixis	NN	B-PROBLEM
.	.	O

she	PRP	O
had	VBD	O
no	DT	O
spider	NN	B-PROBLEM
angiomata	NN	I-PROBLEM
,	,	O
no	DT	O
palmar	NN	B-PROBLEM
erythema	NN	I-PROBLEM
,	,	O
no	DT	O
xanthomas	NNP	B-PROBLEM
and	CC	O
no	DT	O
caput	NN	B-PROBLEM
medusae	NN	I-PROBLEM
.	.	O

she	PRP	O
did	VBD	O
not	RB	O
look	VB	O
teric	JJ	B-PROBLEM
(	(	O
???	JJ	O
)	)	O
.	.	O

notable	JJ	O
for	IN	O
sodium	NN	B-TEST
141	CD	O
,	,	O
potassium	NN	B-TEST
4.2	CD	O
,	,	O
chloride	RB	B-TEST
109	CD	O
,	,	O
bicarb	NN	B-TEST
19.8	CD	O
,	,	O
bun	NN	B-TEST
38	CD	O
,	,	O
creatinine	NN	B-TEST
1.2	CD	O
and	CC	O
glucose	JJ	B-TEST
388	CD	O
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
pneumonia	NN	I-PROBLEM
of	IN	O
31	CD	O
,	,	O
calcium	NN	B-TEST
was	VBD	O
7.5	CD	O
,	,	O
phosphorous	JJ	B-TEST
3.0	CD	O
,	,	O
magnesium	NN	B-TEST
1.3	CD	O
.	.	O

her	PRP$	B-TEST
bilirubin	NN	I-TEST
was	VBD	O
1.4	CD	O
total	NN	O
,	,	O
0.2	CD	O
direct	NN	B-TEST
.	.	O

alkaline	JJ	B-TEST
phosphatase	NN	I-TEST
101	CD	O
.	.	O

sgpt	NN	B-TEST
22	CD	O
,	,	O
sgot	VBD	B-TEST
41	CD	O
,	,	O
amylase	NN	B-TEST
31	CD	O
,	,	O
lipase	JJR	B-TEST
less	JJR	O
than	IN	O
1	CD	O
.	.	O

ldh	NN	B-TEST
was	VBD	O
38.9	CD	O
,	,	O
ck	NN	B-TEST
was	VBD	O
66	CD	O
,	,	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
27.4	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
was	VBD	O
8.0	CD	O
and	CC	O
her	PRP$	B-TEST
platelets	NNS	I-TEST
were	VBD	O
55	CD	O
.	.	O

pt	NN	B-TEST
was	VBD	O
14.5	CD	O
,	,	O
ptt	RB	B-TEST
25.5	CD	O
.	.	O

as	IN	O
described	VBN	O
above	IN	O
the	DT	O
patient	NN	O
was	VBD	O
transfused	VBN	O
an	DT	B-TREATMENT
additional	JJ	I-TREATMENT
2	CD	I-TREATMENT
units	NNS	I-TREATMENT
in	IN	O
the	DT	O
intensive	JJ	O
care	NN	O
unit	NN	O
and	CC	O
the	DT	O
patient	NN	O
also	RB	O
received	VBD	O
an	DT	B-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
study	NN	I-TEST
and	CC	O
her	PRP$	B-PROBLEM
varices	NNS	I-PROBLEM
were	VBD	O
banded	VBN	B-TREATMENT
.	.	O

on	IN	O
transfer	NN	O
to	TO	O
the	DT	O
lemgarson	JJ	O
hospital	NN	O
service	NN	O
,	,	O
her	PRP$	B-TEST
hematocrit	NN	I-TEST
was	VBD	O
31.2	CD	O
,	,	O
white	JJ	B-TEST
count	NN	I-TEST
11.1	CD	O
and	CC	O
a	DT	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
80	CD	O
.	.	O

her	PRP$	B-TEST
pt	NN	I-TEST
was	VBD	O
13.1	CD	O
,	,	O
ptt	RB	B-TEST
26.7	CD	O
.	.	O

the	DT	O
rest	NN	O
of	IN	O
her	PRP$	B-TEST
labs	NNS	I-TEST
were	VBD	O
unremarkable	JJ	O
.	.	O

she	PRP	O
was	VBD	O
on	IN	O
gi	NNS	B-TREATMENT
bleed	VBN	I-TREATMENT
precautions	NNS	I-TREATMENT
at	IN	O
all	DT	O
times	NNS	O
,	,	O
was	VBD	O
too	RB	O
large	JJ	O
for	IN	O
iv	NN	B-TREATMENT
.	.	O

she	PRP	O
had	VBD	O
a	DT	B-PROBLEM
clot	NN	I-PROBLEM
at	IN	O
the	DT	O
blood	NN	O
bank	NN	O
and	CC	O
she	PRP	O
had	VBD	O
bid	VBN	B-TEST
hematocrits	NNS	I-TEST
checked	VBN	O
.	.	O

she	PRP	O
was	VBD	O
kept	JJ	O
npo	RB	B-TREATMENT
until	IN	O
january	JJ	O
26	CD	O
when	WRB	O
she	PRP	O
began	VBD	O
to	TO	O
feel	VB	O
hungry	JJ	O
.	.	O

at	IN	O
that	DT	O
time	NN	O
clear	JJ	B-TREATMENT
liquids	NNS	I-TREATMENT
were	VBD	O
started	VBN	O
.	.	O

she	PRP	O
also	RB	O
began	VBD	O
nadolol	JJ	B-TREATMENT
40	CD	O
mg	NN	O
qd	NN	O
to	TO	O
reduce	VB	O
her	PRP$	B-PROBLEM
portal	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

therefore	IN	O
we	PRP	O
decided	VBD	O
to	TO	O
work	VB	B-TEST
up	RP	I-TEST
her	PRP$	O
cirrhosis	NN	B-PROBLEM
.	.	O

she	PRP	O
was	VBD	O
described	VBN	O
as	IN	O
having	VBG	O
_______	JJ	O
cirrhosis	NN	B-PROBLEM
and	CC	O
we	PRP	O
decided	VBD	O
that	IN	O
we	PRP	O
wanted	VBD	O
to	TO	O
try	VB	O
to	TO	O
figure	VB	O
out	RP	O
the	DT	O
etiology	NN	O
.	.	O

her	PRP$	B-TEST
ferritin	NN	I-TEST
and	CC	O
iron	NN	B-TEST
studies	NNS	I-TEST
did	VBD	O
not	RB	O
reveal	VB	O
any	DT	O
evidence	NN	O
of	IN	O
hemochromatosis	NN	B-PROBLEM
and	CC	O
her	PRP$	B-TEST
hep	NN	I-TEST
serologies	NNS	I-TEST
were	VBD	O
all	DT	O
negative	JJ	O
.	.	O

she	PRP	O
also	RB	O
had	VBD	O
negative	JJ	O
antimitochondrial	JJ	O
antibody	NN	O
and	CC	O
she	PRP	O
also	RB	O
had	VBD	O
no	DT	O
evidence	NN	O
of	IN	O
ceruloplasmin	NN	B-PROBLEM
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
admission	NN	O
were	VBD	O
also	RB	O
sent	VBN	O
an	DT	B-TEST
alpha-1-antitrypsin	NN	I-TEST
,	,	O
which	WDT	O
was	VBD	O
negative	JJ	O
.	.	O

she	PRP	O
did	VBD	O
very	RB	O
well	RB	O
over	IN	O
the	DT	O
course	NN	O
of	IN	O
her	PRP$	O
admission	NN	O
with	IN	O
no	DT	O
evidence	NN	O
of	IN	O
further	JJ	B-PROBLEM
bleeding	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
hematocrit	NN	I-TEST
stayed	VBD	O
stable	JJ	O
at	IN	O
approximately	RB	O
32	CD	O
.	.	O

we	PRP	O
also	RB	O
did	VBD	O
an	DT	B-TEST
ultrasound	NN	I-TEST
guided	VBD	I-TEST
paracentesis	NN	I-TEST
.	.	O

the	DT	B-TEST
peritoneal	NN	I-TEST
fluid	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
glucose	NN	I-TEST
of	IN	O
244	CD	O
,	,	O
total	JJ	B-TEST
protein	NN	I-TEST
0.8	CD	O
and	CC	O
a	DT	B-TEST
albumin	NN	I-TEST
of	IN	O
0.5	CD	O
,	,	O
globulin	NN	B-TEST
0.3	CD	O
,	,	O
amylase	NN	B-TEST
16	CD	O
,	,	O
ldh	NN	B-TEST
of	IN	O
51	CD	O
.	.	O

the	DT	B-TEST
serum	NN	I-TEST
albumin	NN	I-TEST
gradient	NN	I-TEST
was	VBD	O
1.8	CD	O
consistent	JJ	O
with	IN	O
portal	JJ	B-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
cell	NN	I-TEST
count	NN	I-TEST
showed	VBD	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
160	CD	O
with	IN	O
16%	CD	B-TEST
polys	NNS	I-TEST
.	.	O

she	PRP	O
therefore	RB	O
_________	VBD	O
criteria	NNS	O
for	IN	O
a	DT	B-PROBLEM
spontaneous	JJ	I-PROBLEM
bacterial	JJ	I-PROBLEM
peritonitis	NN	I-PROBLEM
.	.	O

her	PRP$	B-TEST
platelet	NN	I-TEST
count	NN	I-TEST
stayed	VBD	O
persistently	RB	B-PROBLEM
low	JJ	I-PROBLEM
and	CC	O
we	PRP	O
decided	VBD	O
that	IN	O
it	PRP	O
might	MD	O
be	VB	O
due	JJ	O
to	TO	O
cimetidine	VB	B-TREATMENT
.	.	O

therefore	RB	O
we	PRP	O
switched	VBD	O
her	PRP	O
cimetidine	NN	B-TREATMENT
to	TO	O
prilosec	VB	B-TREATMENT
.	.	O

after	IN	O
discussion	NN	O
with	IN	O
her	PRP$	O
private	JJ	O
physician	NN	O
,	,	O
dr.	JJ	O
joasscchird	NN	O
,	,	O
tel.	JJ	O
090-249-6079	NN	O
,	,	O
at	IN	O
va	JJ	O
sit	NN	O
namar	NN	O
healthcare	NN	O
and	CC	O
dr.	NN	O
acrookesjo	NN	O
at	IN	O
do	NN	O
of	IN	O
hospital	NN	O
,	,	O
the	DT	O
patient	NN	O
was	VBD	O
judged	VBN	O
to	TO	O
be	VB	O
fit	JJ	O
for	IN	O
discharge	NN	O
and	CC	O
she	PRP	O
was	VBD	O
sent	VBN	O
home	NN	O
with	IN	O
ah	NN	B-TREATMENT
and	CC	O
physical	JJ	B-TREATMENT
therapy	NN	I-TREATMENT
.	.	O

she	PRP	O
may	MD	O
require	VB	O
a	DT	B-TEST
repeat	NN	I-TEST
upper	JJ	I-TEST
endoscopy	NN	I-TEST
study	NN	I-TEST
to	TO	O
see	VB	O
if	IN	O
she	PRP	O
needs	VBZ	O
any	DT	B-TREATMENT
rebanding	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
however	RB	O
complained	VBD	O
of	IN	O
a	DT	B-PROBLEM
persistent	JJ	I-PROBLEM
wheeze	NN	I-PROBLEM
with	IN	O
beta	NN	B-TREATMENT
blocker	NN	I-TREATMENT
,	,	O
therefore	IN	O
it	PRP	O
was	VBD	O
agreed	VBN	O
that	IN	O
we	PRP	O
would	MD	O
stop	VB	O
the	DT	B-TREATMENT
beta	NN	I-TREATMENT
blocker	NN	I-TREATMENT
until	IN	O
the	DT	O
patient	NN	O
was	VBD	O
followed	VBN	O
up	RP	O
as	IN	O
an	DT	O
outpatient	NN	O
.	.	O

zoloft	RB	B-TREATMENT
50	CD	O
mg	NNS	O
po	JJ	O
qd	NN	O
,	,	O
lactulose	JJ	B-TREATMENT
15	CD	O
g	JJ	O
po	NN	O
bid	NN	O
,	,	O
synthroid	JJ	B-TREATMENT
0.15	CD	O
mg	NN	O
po	NN	O
qd	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
20	CD	O
mg	JJ	O
po	NN	O
bid	NN	O
.	.	O

fever	NN	B-PROBLEM

1.	CD	O
neutropenia	NN	B-PROBLEM

2.	CD	O
cellulitis	NN	B-PROBLEM
.	.	O

3.	CD	O
fever	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
60-year-old	JJ	O
male	NN	O
with	IN	O
a	DT	O
past	JJ	O
medical	JJ	O
history	NN	O
notable	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
cabg	NN	B-TREATMENT
x2	NN	O
in	IN	O
2001	CD	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
felt	VBN	O
unwell	JJ	B-PROBLEM
since	IN	O
7/21	CD	O
after	IN	O
his	PRP$	B-PROBLEM
non-q	JJ	I-PROBLEM
wave	NN	I-PROBLEM
mi	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
,	,	O
at	IN	O
this	DT	O
time	NN	O
,	,	O
was	VBD	O
started	VBN	O
on	IN	O
statin	NN	B-TREATMENT
and	CC	O
developed	VBN	O
in	IN	O
arthritis	NN	B-PROBLEM
approximately	RB	O
one	CD	O
month	NN	O
later	RB	O
with	IN	O
joint	JJ	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
myalgia	NN	B-PROBLEM
and	CC	O
fatigue	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
presumed	VBN	O
to	TO	O
have	VB	O
a	DT	B-PROBLEM
rheumatoid	JJ	I-PROBLEM
factor	NN	I-PROBLEM
negative	JJ	I-PROBLEM
,	,	I-PROBLEM
rheumatoid	JJ	I-PROBLEM
arthritis	NN	I-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
prescribed	VBN	O
naprosyn	RB	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
and	CC	O
sulfasalazine	NN	B-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
cabg	NN	I-TEST
review	NN	I-TEST
in	IN	O
2/21	CD	O
.	.	O

his	PRP$	B-TREATMENT
first	JJ	I-TREATMENT
cabg	NN	I-TREATMENT
was	VBD	O
in	IN	O
02/89	CD	O
.	.	O

since	IN	O
2/21	CD	O
,	,	O
he	PRP	O
has	VBZ	O
had	VBD	O
increasing	VBG	B-PROBLEM
weight	JJ	I-PROBLEM
loss	NN	I-PROBLEM
of	IN	O
30-49	JJ	O
pounds	NNS	O
,	,	O
night	NN	B-PROBLEM
sweats	NNS	I-PROBLEM
which	WDT	O
he	PRP	O
attributed	VBD	O
to	TO	O
the	DT	B-TREATMENT
prednisone	NN	I-TREATMENT
and	CC	O
increased	VBD	B-PROBLEM
fatigue	NN	I-PROBLEM
and	CC	O
myalgias	NN	B-PROBLEM
.	.	O

in	IN	O
late	JJ	O
7/22	CD	O
,	,	O
sulfasalazine	NN	B-TREATMENT
was	VBD	O
started	VBN	O
at	IN	O
one	CD	O
tab	NN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

the	DT	O
patient	NN	O
subsequently	RB	O
developed	VBN	O
diffuse	IN	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
,	,	O
nausea	NN	B-PROBLEM
,	,	O
vomiting	NN	B-PROBLEM
,	,	O
and	CC	O
decreased	VBD	B-PROBLEM
p.o.	NNS	I-PROBLEM
intake	NN	I-PROBLEM
.	.	O

a	DT	B-PROBLEM
guaiac	JJ	I-PROBLEM
positive	JJ	I-PROBLEM
stool	NN	I-PROBLEM
was	VBD	O
also	RB	O
noted	VBN	O
in	IN	O
the	DT	O
month	NN	O
of	IN	O
july	NN	O
.	.	O

10	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
&apos;s	NNP	O
primary	JJ	O
care	NN	O
physician	NN	O
increased	VBD	O
his	PRP$	B-TREATMENT
sulfasalazine	NN	I-TREATMENT
dose	NN	I-TREATMENT
to	TO	O
two	CD	O
tabs	NNS	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NNP	I-TREATMENT
prednisone	NN	I-TREATMENT
was	VBD	O
increased	VBN	O
to	TO	O
60	CD	O
mg	NNS	O
q.d.	RB	O
as	IN	O
the	DT	O
patient	NN	O
was	VBD	O
diagnosed	VBN	O
with	IN	O
an	DT	B-PROBLEM
arthritis	NN	I-PROBLEM
flare	NN	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
prednisone	NN	I-TREATMENT
dose	NN	I-TREATMENT
was	VBD	O
gradually	RB	O
tapered	VBN	O
to	TO	O
20	CD	O
mg	NNS	O
q.d.	NN	O

the	DT	O
day	NN	O
before	IN	O
admission	NN	O
,	,	O
the	DT	O
patient	NN	O
developed	VBD	O
a	DT	B-PROBLEM
fever	NN	I-PROBLEM
to	TO	O
102	CD	O
degrees	NNS	O
and	CC	O
increasing	VBG	B-PROBLEM
abdominal	JJ	I-PROBLEM
pain	NN	I-PROBLEM
.	.	O

he	PRP	O
presented	VBD	O
to	TO	O
an	DT	O
outside	JJ	O
hops	NN	O
where	WRB	O
he	PRP	O
was	VBD	O
noted	VBN	O
to	TO	O
be	VB	O
leukopenic	JJ	B-PROBLEM
with	IN	O
a	DT	B-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
0.6	CD	O
,	,	O
0	CD	O
neutrophils	NNS	B-TEST
,	,	O
a	DT	B-TEST
hematocrit	NN	I-TEST
of	IN	O
32	CD	O
,	,	O
platelets	NNS	B-TEST
of	IN	O
326	CD	O
,	,	O
a	DT	B-TEST
mcv	NN	I-TEST
of	IN	O
79	CD	O
,	,	O
and	CC	O
rdw	NN	B-TEST
of	IN	O
22	CD	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
given	VBN	O
iv	JJ	B-TREATMENT
fluids	NNS	I-TREATMENT
and	CC	O
treated	VBN	O
with	IN	O
imipenem	NN	B-TREATMENT
,	,	O
transferred	VBN	O
to	TO	O
ca	MD	O
valley	VB	O
hospital	NN	O
ed	NN	O
,	,	O
where	WRB	O
it	PRP	O
was	VBD	O
noted	VBN	O
that	IN	O
the	DT	O
patient	NN	O
had	VBD	O
face	NN	B-PROBLEM
and	CC	I-PROBLEM
neck	NN	I-PROBLEM
swelling	NN	I-PROBLEM
,	,	O
as	RB	O
well	RB	O
as	IN	O
erythema	NN	B-PROBLEM
and	CC	O
cervical	JJ	B-PROBLEM
lymphadenopathy	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
states	VBZ	O
that	IN	O
his	PRP$	B-PROBLEM
swelling	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
face	NN	I-PROBLEM
began	VBD	O
two	CD	O
days	NNS	O
prior	RB	O
to	TO	O
admission	NN	O
and	CC	O
has	VBZ	O
doubled	VBN	O
since	IN	O
then	RB	O
.	.	O

in	IN	O
the	DT	O
emergency	NN	O
department	NN	O
,	,	O
ct	NN	B-TEST
of	IN	I-TEST
head	NN	I-TEST
,	,	I-TEST
neck	NN	I-TEST
and	CC	I-TEST
abdomen	NNS	I-TEST
were	VBD	O
performed	VBN	O
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
the	DT	I-TEST
abdomen	NNS	I-TEST
was	VBD	O
without	IN	O
lymphadenopathy	JJ	B-PROBLEM
,	,	O
revealed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
renal	JJ	I-PROBLEM
cyst	NN	I-PROBLEM
,	,	O
otherwise	RB	O
unremarkable	JJ	O
.	.	O

the	DT	B-TEST
ct	NN	I-TEST
of	IN	I-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
was	VBD	O
likewise	RB	O
unremarkable	JJ	O
showing	VBG	O
no	DT	O
evidence	NN	O
of	IN	O
fasciitis	NN	B-PROBLEM
or	CC	O
deep	JJ	B-PROBLEM
tissue	NN	I-PROBLEM
thread	NN	I-PROBLEM
.	.	O

no	DT	O
abscesses	NNS	B-PROBLEM
were	VBD	O
noted	VBN	O
.	.	O

the	DT	O
patient	NN	O
denies	VBZ	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
,	,	O
chest	NN	B-PROBLEM
pain	NN	I-PROBLEM
,	,	O
orthopnea	NN	B-PROBLEM
,	,	O
no	DT	O
dysuria	NN	B-PROBLEM
,	,	O
hematuria	NN	B-PROBLEM
,	,	O
no	DT	O
visual	JJ	B-PROBLEM
changes	NNS	I-PROBLEM
,	,	O
no	DT	O
rashes	NNS	B-PROBLEM
,	,	O
no	DT	O
blurry	NN	B-PROBLEM
vision	NN	I-PROBLEM
.	.	O

coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
mi	NN	B-PROBLEM
x2	NNP	O
,	,	O
cabg	NN	B-TREATMENT
x2	NN	O
in	IN	O
02/89	CD	O
and	CC	O
2/21	CD	O
,	,	O
history	NN	O
of	IN	O
arthritis	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
bilateral	JJ	B-PROBLEM
rotator	NN	I-PROBLEM
cuff	NN	I-PROBLEM
degeneration	NN	I-PROBLEM
and	CC	O
tears	NNS	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
hypertension	NN	B-PROBLEM
,	,	O
history	NN	O
of	IN	O
hyperlipidemia	NN	B-PROBLEM
.	.	O

sulfasalazine	NN	B-TREATMENT
,	,	O
prednisone	NN	B-TREATMENT
20	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
naprosyn	RB	B-TREATMENT
500	CD	O
mg	NN	O
t.i.d.	NN	O
,	,	O
zestril	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
q.d.	NN	O
,	,	O
lopressor	VBZ	B-TREATMENT
50	CD	O
mg	NN	O
b.i.d.	NN	O
and	CC	O
iron	NN	B-TREATMENT
supplementation	NN	I-TREATMENT
.	.	O

positive	JJ	O
for	IN	O
coronary	JJ	B-PROBLEM
artery	NN	I-PROBLEM
disease	NN	I-PROBLEM
and	CC	O
mi	NN	B-PROBLEM
.	.	O

no	DT	O
history	NN	O
of	IN	O
cancer	NN	B-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	JJ	I-TEST
temperature	NN	I-TEST
was	VBD	O
102	CD	O
,	,	O
heart	NN	B-TEST
rate	NN	I-TEST
118	CD	O
,	,	O
blood	NN	B-TEST
pressure	NN	I-TEST
111/56	CD	O
,	,	O
respiratory	NN	B-TEST
rate	NN	I-TEST
28	CD	O
,	,	O
satting	VBG	B-TEST
92%	CD	O
on	IN	O
room	NN	O
air	NN	O
.	.	O

pupils	NNS	O
equal	JJ	O
,	,	O
round	NN	O
,	,	O
and	CC	O
reactive	JJ	O
to	TO	O
light	JJ	O
,	,	O
extraocular	JJ	O
movements	NNS	O
,	,	O
fundi	VBP	O
bilaterally	RB	O
without	IN	O
exudate	NN	B-PROBLEM
or	CC	O
hemorrhage	NN	B-PROBLEM
.	.	O

on	IN	O
the	DT	O
left	JJ	O
nasolabial	JJ	O
,	,	O
there	EX	O
was	VBD	O
a	DT	B-PROBLEM
boil	NN	I-PROBLEM
with	IN	O
pus	NN	B-PROBLEM
and	CC	O
surrounding	VBG	B-PROBLEM
erythema	NN	I-PROBLEM
and	CC	O
tenderness	NN	B-PROBLEM
.	.	O

left	VBN	O
eye	NN	O
with	IN	O
conjunctivae	NN	B-PROBLEM
injected	VBN	I-PROBLEM
,	,	O
no	DT	O
exudate	NN	B-PROBLEM
or	CC	O
pus	NN	B-PROBLEM
.	.	O

dentition	NN	B-PROBLEM
very	RB	I-PROBLEM
poor	JJ	I-PROBLEM
,	,	O
large	JJ	B-PROBLEM
bilateral	JJ	I-PROBLEM
neck	NN	I-PROBLEM
and	CC	I-PROBLEM
submandibular	JJ	I-PROBLEM
swelling	VBG	I-PROBLEM
very	RB	B-PROBLEM
tender	NN	I-PROBLEM
to	TO	O
palpation	NN	B-TEST
.	.	O

scattered	VBN	B-PROBLEM
bibasilar	JJ	I-PROBLEM
rales	NNS	I-PROBLEM
,	,	O
no	DT	O
wheezes	NN	B-PROBLEM
.	.	O

regular	JJ	O
rhythm	NN	O
,	,	O
tachycardia	NN	B-PROBLEM
,	,	O
no	DT	O
murmurs	NNS	B-PROBLEM
,	,	O
no	DT	O
jvd	NN	B-PROBLEM
.	.	O

obese	JJ	B-PROBLEM
,	,	O
non-distended	JJ	B-PROBLEM
,	,	O
positive	JJ	O
bowel	NN	O
sounds	NNS	O
,	,	O
mild	JJ	B-PROBLEM
diffuse	NN	I-PROBLEM
tenderness	NN	I-PROBLEM
.	.	O

no	DT	O
edema	NN	B-PROBLEM
,	,	O
positive	JJ	O
dorsalis	NN	O
pedis	NN	O
pulses	NNS	O
.	.	O

non-focal	JJ	O
,	,	O
alert	JJ	O
and	CC	O
oriented	JJ	O
x3	NN	O
,	,	O
5/5	CD	O
motor	NN	O
strength	NN	O
in	IN	O
the	DT	O
upper	JJ	O
extremities	NNS	O
and	CC	O
lower	JJR	O
extremities	NNS	O
,	,	O
babinski	NN	B-TEST
reflex	NN	I-TEST
,	,	O
toes	NNS	O
are	VBP	O
downgoing	VBG	O
.	.	O

remarkable	NN	O
for	IN	O
a	DT	B-TEST
white	JJ	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
of	IN	O
0.4	CD	O
,	,	O
with	IN	O
0	CD	O
neutrophils	NNS	B-TEST
,	,	O
0	CD	O
bands	NNS	B-TEST
,	,	O
19	CD	O
lymphs	NN	B-TEST
,	,	O
0	CD	O
monos	NNS	B-TEST
,	,	O
hematocrit	NN	B-TEST
28.8%	CD	O
,	,	O
platelets	NNS	B-TEST
300,000	CD	O
.	.	O

alt	RB	B-TEST
141	CD	O
,	,	O
ast	RB	B-TEST
40	CD	O
,	,	O
alk	VBP	B-TEST
phos	JJ	I-TEST
108	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
total	JJ	I-TEST
bili	NN	I-TEST
of	IN	O
1.0.	CD	O
total	JJ	B-TEST
protein	NN	I-TEST
was	VBD	O
5.7	CD	O
,	,	O
albumin	RB	B-TEST
2.5	CD	O
and	CC	O
globulin	$	B-TEST
3.2	CD	O
.	.	O

his	PRP$	B-TEST
electrolyte	JJ	I-TEST
panel	NN	I-TEST
of	IN	O
sodium	NN	B-TEST
135	CD	O
,	,	O
sodium	NN	B-TEST
4.1	CD	O
,	,	O
chloride	RB	B-TEST
99	CD	O
,	,	O
bicarb	NN	B-TEST
30	CD	O
,	,	O
bun	NN	B-TEST
15	CD	O
,	,	O
creatinine	NN	B-TEST
2.1	CD	O
,	,	O
blood	NN	B-TEST
glucose	NN	I-TEST
of	IN	O
196	CD	O
.	.	O

iron	NN	B-TEST
studies	NNS	I-TEST
included	VBD	O
a	DT	B-TEST
ferritin	NN	I-TEST
of	IN	O
607	CD	O
,	,	O
an	DT	B-TEST
iron	NN	I-TEST
of	IN	O
10	CD	O
,	,	O
and	CC	O
a	DT	B-TEST
tibc	NN	I-TEST
of	IN	O
239	CD	O
.	.	O

ekg	NN	B-TEST
showed	VBD	O
tachycardia	NN	B-PROBLEM
with	IN	O
a	DT	O
sinus	NN	O
rhythm	NN	O
of	IN	O
103	CD	O
,	,	O
normal	JJ	O
axis	NN	O
,	,	O
normal	JJ	O
intervals	NNS	O
,	,	O
no	DT	O
q-waves	NNS	B-PROBLEM
,	,	O
no	DT	O
st-t	JJ	B-PROBLEM
wave	NN	I-PROBLEM
changes	NNS	I-PROBLEM
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	JJ	I-TEST
chest	JJS	I-TEST
x-ray	NN	I-TEST
at	IN	O
the	DT	O
outside	JJ	O
hospital	NN	O
was	VBD	O
unremarkable	JJ	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
started	VBN	O
on	IN	O
ceftazidime	NN	B-TREATMENT
,	,	O
nafcillin	NN	B-TREATMENT
and	CC	O
flagyl	NN	B-TREATMENT
for	IN	O
concern	NN	O
of	IN	O
a	DT	B-PROBLEM
soft	JJ	I-PROBLEM
tissue	NN	I-PROBLEM
infection	NN	I-PROBLEM
.	.	O

neutropenic	JJ	B-TREATMENT
precautions	NNS	I-TREATMENT
were	VBD	O
taken	VBN	O
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
which	WDT	O
showed	VBD	O
myeloid	JJ	B-PROBLEM
arrest	NN	I-PROBLEM
and	CC	O
probable	JJ	O
neutropenia	NN	B-PROBLEM
from	IN	O
a	DT	O
drug-related	JJ	O
cause	NN	O
presumed	VBD	O
to	TO	O
be	VB	O
the	DT	B-TREATMENT
sulfasalazine	NN	I-TREATMENT
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
hospitalization	NN	O
,	,	O
the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
white	JJ	I-TEST
blood	NN	I-TEST
cell	NN	I-TEST
count	NN	I-TEST
rose	VBD	O
from	IN	O
0.4	CD	O
to	TO	O
6.3	CD	O
after	IN	O
he	PRP	O
was	VBD	O
given	VBN	O
g-csf	JJ	B-TREATMENT
,	,	O
a	DT	O
course	NN	O
lasting	VBG	O
from	IN	O
9/28/01	CD	O
until	IN	O
9/30/01	CD	O
.	.	O

after	IN	O
the	DT	B-TREATMENT
g-csf	NN	I-TREATMENT
,	,	O
the	DT	B-TEST
absolute	NN	I-TEST
neutrophil	NN	I-TEST
count	NN	I-TEST
was	VBD	O
greater	JJR	O
than	IN	O
8000	CD	O
.	.	O

on	IN	O
10/3/01	CD	O
,	,	O
the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TEST
repeat	NN	I-TEST
head	NN	I-TEST
and	CC	I-TEST
neck	NN	I-TEST
ct	NN	I-TEST
,	,	O
which	WDT	O
showed	VBD	O
a	DT	B-PROBLEM
right	JJ	I-PROBLEM
parotitis	NN	I-PROBLEM
and	CC	O
left	VBD	B-PROBLEM
submandibular	JJ	I-PROBLEM
lymphadenopathy	NN	I-PROBLEM
with	IN	O
some	DT	B-PROBLEM
necrosis	NN	I-PROBLEM
.	.	O

no	DT	O
frank	JJ	B-PROBLEM
abscesses	NNS	I-PROBLEM
.	.	O

the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NN	I-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
changed	VBN	O
to	TO	O
clindamycin	VB	B-TREATMENT
300	CD	O
mg	NN	O
q.i.d.	NN	O
and	CC	O
patient	NN	O
was	VBD	O
also	RB	O
put	VBN	O
on	IN	O
sialagogue	NN	B-TREATMENT
.	.	O

over	IN	O
the	DT	O
course	NN	O
of	IN	O
the	DT	O
hospitalization	NN	O
,	,	O
the	DT	B-PROBLEM
swelling	NN	I-PROBLEM
and	CC	O
tenderness	NN	B-PROBLEM
and	CC	O
erythema	NN	B-PROBLEM
have	VBP	O
steadily	RB	O
decreased	VBN	O
.	.	O

recommendations	NNS	O
on	IN	O
antibiotics	NNS	B-TREATMENT
were	VBD	O
made	VBN	O
by	IN	O
infectious	JJ	O
disease	NN	O
team	NN	O
,	,	O
who	WP	O
was	VBD	O
consulted	VBN	O
.	.	O

rheumatology	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
for	IN	O
patient	NN	O
and	CC	O
after	IN	O
workup	NN	B-TEST
,	,	O
it	PRP	O
was	VBD	O
believed	VBN	O
that	IN	O
arthritis	NN	B-PROBLEM
may	MD	O
be	VB	O
a	DT	O
rheumatoid	JJ	B-PROBLEM
factor	NN	I-PROBLEM
negative	JJ	I-PROBLEM
,	,	I-PROBLEM
rheumatoid	JJ	I-PROBLEM
polyarthritis	NN	I-PROBLEM
.	.	O

rheumatology	NN	O
recommended	VBD	O
a	DT	B-TREATMENT
taper	NN	I-TREATMENT
of	IN	I-TREATMENT
his	PRP$	I-TREATMENT
prednisone	NN	I-TREATMENT
to	TO	O
20	CD	O
mg	NNS	O
q.d.	RB	O
and	CC	O
the	DT	O
patient	NN	O
will	MD	O
be	VB	O
followed	VBN	O
by	IN	O
the	DT	O
rheumatology	NN	O
service	NN	O
.	.	O

the	DT	O
oncology	NN	O
service	NN	O
was	VBD	O
also	RB	O
consulted	VBN	O
for	IN	O
patient	NN	O
and	CC	O
performed	VBD	O
a	DT	B-TEST
bone	NN	I-TEST
marrow	NN	I-TEST
biopsy	NN	I-TEST
.	.	O

the	DT	O
ent	JJ	O
physicians	NNS	O
did	VBD	O
not	RB	O
recommend	VB	O
any	DT	B-TREATMENT
procedures	NNS	I-TREATMENT
,	,	O
incision	NN	B-TREATMENT
and	CC	O
drainage	NN	B-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
right	JJ	I-PROBLEM
parotitis	NN	I-PROBLEM
or	CC	O
left	VBD	B-PROBLEM
submandibular	JJ	I-PROBLEM
cervical	JJ	I-PROBLEM
lymph	NN	I-PROBLEM
node	JJ	I-PROBLEM
necrosis	NN	I-PROBLEM
.	.	O

the	DT	O
ent	NN	O
team	NN	O
recommended	VBD	O
watching	VBG	O
patient	JJ	O
in-house	NN	O
for	IN	O
two	CD	O
days	NNS	O
after	IN	O
his	PRP$	B-TEST
repeat	NN	I-TEST
imaging	VBG	I-TEST
on	IN	O
10/3/01	CD	O
,	,	O
and	CC	O
to	TO	O
continue	VB	O
antibiotic	JJ	B-TREATMENT
coverage	NN	I-TREATMENT
with	IN	O
clindamycin	NN	B-TREATMENT
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
no	DT	O
positive	JJ	B-PROBLEM
blood	NN	I-PROBLEM
cultures	NNS	I-PROBLEM
during	IN	O
his	PRP$	O
hospitalization	NN	O
and	CC	O
remained	VBD	O
afebrile	RB	B-PROBLEM
after	IN	O
the	DT	O
second	JJ	O
day	NN	O
of	IN	O
admission	NN	O
.	.	O

topical	JJ	B-TREATMENT
bactroban	NN	I-TREATMENT
to	TO	O
be	VB	O
applied	VBN	O
three	CD	O
times	NNS	O
a	DT	O
day	NN	O
to	TO	O
affected	VBN	O
naris	NN	O
,	,	O
prednisone	NN	B-TREATMENT
5	CD	O
mg	NN	O
p.o.	NN	O
q.a.m.	NN	O
,	,	O
k-dur	JJ	B-TREATMENT
10	CD	O
meq	NN	O
x2	NNP	O
p.o.	NN	O
q.d.	NN	O
,	,	O
oxycontin	RB	B-TREATMENT
10	CD	O
mg	NNS	O
p.o.	JJ	O
q.12h.	NN	O
,	,	O
clindamycin	VBP	B-TREATMENT
300	CD	O
mg	NN	O
p.o.	NN	O
q.i.d.	NN	O
,	,	O
lisinopril	VBZ	B-TREATMENT
10	CD	O
mg	NN	O
p.o.	NN	O
q.d.	NN	O
,	,	O
atenolol	RB	B-TREATMENT
25	CD	O
mg	NNS	O
p.o.	JJ	O
q.d.	NN	O
,	,	O
trazodone	NN	B-TREATMENT
100	CD	O
mg	NN	O
p.o.	NN	O
q.h.s.	NN	O
,	,	O
prilosec	VBP	B-TREATMENT
40	CD	O
mg	NN	O
p.o.	NN	O
q.d	NN	O
,	,	O
clotrimazole	JJ	B-TREATMENT
1%	CD	I-TREATMENT
cream	NN	I-TREATMENT
topical	NN	I-TREATMENT
to	TO	O
be	VB	O
applied	VBN	O
b.i.d.	NN	O

there	EX	O
were	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
during	IN	O
the	DT	O
patient	JJ	O
&apos;s	NNP	O
hospitalization	NN	O
and	CC	O
he	PRP	O
was	VBD	O
discharged	VBN	O
in	IN	O
stable	JJ	O
condition	NN	O
.	.	O

gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
gastric	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
,	,	O

gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
gastric	JJ	B-PROBLEM
pericardial	JJ	I-PROBLEM
fistula	NN	I-PROBLEM
,	,	O
constricting	VBG	B-PROBLEM
pericarditis	NN	I-PROBLEM
,	,	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
,	,	O
status	NN	O
post	NN	O
gunshot	NN	B-PROBLEM
wounds	NNS	I-PROBLEM
and	CC	O
paraplegia	NN	B-PROBLEM
since	IN	O
1991	CD	O
of	IN	O
t4	NN	O
on	IN	O
down	RP	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-TREATMENT
greenfield	NN	I-TREATMENT
filter	NN	I-TREATMENT
in	IN	O
.	.	O

he	PRP	O
has	VBZ	O
multiple	JJ	B-PROBLEM
decubiti	NN	I-PROBLEM
on	IN	I-PROBLEM
his	PRP$	I-PROBLEM
buttocks	NNS	I-PROBLEM
and	CC	I-PROBLEM
penis	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
gastric	JJ	I-TREATMENT
pull	NN	I-TREATMENT
up	RB	I-TREATMENT
in	IN	O
1992	CD	O
of	IN	O
the	DT	O
stomach	NN	O
into	IN	O
the	DT	O
left	JJ	O
thorax	NN	O
and	CC	O
he	PRP	O
has	VBZ	O
a	DT	B-TREATMENT
transverse	JJ	I-TREATMENT
colostomy	NN	I-TREATMENT
and	CC	O
a	DT	B-PROBLEM
sinus	NN	I-PROBLEM
tract	NN	I-PROBLEM
on	IN	I-PROBLEM
the	DT	I-PROBLEM
abdomen	NNS	I-PROBLEM
.	.	O

bactrim	NN	B-TREATMENT
and	CC	O
vancomycin	NN	B-TREATMENT
.	.	O

albuterol	NN	B-TREATMENT
inhaler	NN	I-TREATMENT
.	.	O

amphotericin	NN	B-TREATMENT
b	NN	I-TREATMENT
40	CD	O
mg.	NN	O
qday	NN	O
.	.	O

ceftazidime	NN	B-TREATMENT
1	CD	O
gram	NN	O
intravenous	JJ	O
q	RB	O
8	CD	O
.	.	O

ciprofloxacin	NN	B-TREATMENT
500	CD	O
mg.	NN	O
po.	NN	O
q12	NN	O
.	.	O

cisapride	RB	B-TREATMENT
10	CD	O
mg.	NNS	O
po.	JJ	O
qid	NN	O
.	.	O

dakin	JJ	B-TREATMENT
&apos;s	NNP	I-TREATMENT
solution	NN	I-TREATMENT
1/4	CD	O
strength	NN	O
to	TO	O
ulcer	NN	O
of	IN	O
penis	NN	O
.	.	O

benadryl	NN	B-TREATMENT
50	CD	O
mg.	NN	O
intravenous	JJ	O
tid	NN	O
prn	NN	O
.	.	O

______________	NN	O
capsule	NN	B-TREATMENT
1	CD	O
po.	NN	O
tid	NN	O
.	.	O

lasix	NN	B-TREATMENT
prn	NN	O
.	.	O

nystatin	JJ	B-TREATMENT
swish	JJ	I-TREATMENT
and	CC	I-TREATMENT
swallow	JJ	I-TREATMENT
tid	NN	O
.	.	O

percocet	NN	B-TREATMENT
po.	NN	O
q4	NN	O
to	TO	O
6	CD	O
prn	NN	O
.	.	O

trazodone	NN	B-TREATMENT
50	CD	O
mg.	NN	O
qhs.	NN	O
multivitamins	VBZ	B-TREATMENT
1	CD	O
po.	NN	O
qd	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
a	DT	O
25	CD	O
year	NN	O
old	JJ	O
who	WP	O
has	VBZ	O
a	DT	O
history	NN	O
of	IN	O
a	DT	B-PROBLEM
gunshot	JJ	I-PROBLEM
wound	NN	I-PROBLEM
many	JJ	O
years	NNS	O
ago	RB	O
and	CC	O
has	VBZ	O
had	VBN	O
multiple	JJ	B-TREATMENT
surgical	JJ	I-TREATMENT
procedures	NNS	I-TREATMENT
since	IN	O
then	RB	O
.	.	O

most	RBS	O
recently	RB	O
he	PRP	O
was	VBD	O
admitted	VBN	O
to	TO	O
an	DT	O
outside	JJ	O
hospital	NN	O
with	IN	O
a	DT	B-PROBLEM
drug	NN	I-PROBLEM
overdose	NN	I-PROBLEM
in	IN	O
adult	NN	B-PROBLEM
respiratory	NN	I-PROBLEM
distress	NN	I-PROBLEM
syndrome	NN	I-PROBLEM
and	CC	O
ultimately	RB	O
found	VBN	O
to	TO	O
have	VB	O
candidal	NNS	B-PROBLEM
pericarditis	NN	I-PROBLEM
which	WDT	O
eventually	RB	O
led	VBD	O
to	TO	O
constrictive	VB	B-PROBLEM
pericarditis	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TREATMENT
pericardial	JJ	I-TREATMENT
window	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
barium	NN	I-TEST
swallow	NN	I-TEST
and	CC	O
endoscopy	NN	B-TEST
and	CC	O
was	VBD	O
said	VBD	O
not	RB	O
to	TO	O
have	VB	O
gastric	JJ	B-PROBLEM
or	CC	I-PROBLEM
pericardial	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
previous	JJ	B-TREATMENT
substernal	JJ	I-TREATMENT
gastric	JJ	I-TREATMENT
bypass	NN	I-TREATMENT
because	IN	O
of	IN	O
an	DT	B-PROBLEM
interruption	NN	I-PROBLEM
of	IN	I-PROBLEM
his	PRP$	I-PROBLEM
esophagus	NN	I-PROBLEM
at	IN	O
the	DT	O
time	NN	O
of	IN	O
his	PRP$	B-PROBLEM
gunshot	NN	I-PROBLEM
wound	NN	I-PROBLEM
.	.	O

he	PRP	O
had	VBD	O
been	VBN	O
noted	VBN	O
to	TO	O
have	VB	O
an	DT	B-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
ultimately	RB	O
when	WRB	O
he	PRP	O
stabilized	VBD	O
it	PRP	O
was	VBD	O
our	PRP$	O
feeling	NN	O
that	IN	O
he	PRP	O
most	RBS	O
likely	JJ	O
had	VBD	O
a	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
pericardial	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
he	PRP	O
was	VBD	O
transferred	VBN	O
here	RB	O
for	IN	O
further	JJ	B-TREATMENT
management	NN	I-TREATMENT
.	.	O

it	PRP	O
was	VBD	O
a	DT	O
very	RB	O
high	JJ	O
risk	NN	O
in	IN	O
very	RB	B-PROBLEM
poor	JJ	I-PROBLEM
condition	NN	I-PROBLEM
and	CC	O
a	DT	O
cachectic	JJ	O
malnourished	VBN	O
edematous	JJ	O
individuals	NNS	O
who	WP	O
have	VBP	O
very	RB	B-PROBLEM
high	JJ	I-PROBLEM
venous	JJ	I-PROBLEM
pressures	NNS	I-PROBLEM
and	CC	O
shortness	NN	B-PROBLEM
of	IN	I-PROBLEM
breath	NN	I-PROBLEM
.	.	O

the	DT	O
family	NN	O
understood	VBD	O
that	IN	O
this	DT	O
was	VBD	O
a	DT	B-TREATMENT
life	NN	I-TREATMENT
saving	VBG	I-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
only	RB	O
carried	VBD	O
with	IN	O
it	PRP	O
approximately	RB	O
50%	CD	O
chance	NN	O
of	IN	O
success	NN	O
.	.	O

esophagoscopy	NN	B-TEST
,	,	O
bronchoscopy	NN	B-TEST
,	,	O
pericardectomy	NN	B-TREATMENT
,	,	O
excision	NN	B-TREATMENT
of	IN	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
,	,	O
repair	NN	B-TREATMENT
of	IN	O
gastric	JJ	B-PROBLEM
ulcer	NN	I-PROBLEM
and	CC	O
pectoralis	NN	B-TREATMENT
major	JJ	I-TREATMENT
myocutaneous	JJ	I-TREATMENT
flap	NN	I-TREATMENT
performed	VBN	O
on	IN	O
december	NN	O
4	CD	O
,	,	O
1995	CD	O
by	IN	O
dr.	NN	O
reg	NN	O
cranka	NN	O
and	CC	O
dr.	NN	O
win	VBP	O
shufffyfe	NN	O
.	.	O

in	IN	O
lieu	NN	O
of	IN	O
a	DT	O
standard	JJ	O
discharge	NN	O
summary	JJ	O
given	VBN	O
this	DT	O
patient	NN	O
&apos;s	NN	O
complicated	VBD	O
hospital	JJ	O
course	NN	O
and	CC	O
associated	JJ	B-PROBLEM
illnesses	NNS	I-PROBLEM
i	VBP	O
feel	VBP	O
it	PRP	O
best	JJS	O
to	TO	O
just	RB	O
provide	VB	O
a	DT	O
system	NN	O
summary	JJ	O
concerning	VBG	O
this	DT	O
patient	NN	O
&apos;s	NNP	O
current	JJ	O
status	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
nortriptyline	NN	B-TREATMENT
for	IN	O
depression	NN	B-PROBLEM
.	.	O

he	PRP	O
is	VBZ	O
a	DT	B-PROBLEM
paraplegic	NN	I-PROBLEM
from	IN	I-PROBLEM
t4	JJ	I-PROBLEM
down	RP	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
however	RB	O
spends	VBZ	O
most	JJS	O
of	IN	O
his	PRP$	O
time	NN	O
at	IN	O
bedrest	JJS	O
due	JJ	O
to	TO	O
decubiti	VB	B-PROBLEM
ulcer	JJ	I-PROBLEM
disease	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
constrictive	JJ	B-PROBLEM
pericarditis	NN	I-PROBLEM
that	WDT	O
was	VBD	O
relieved	VBN	O
by	IN	O
his	PRP$	B-TREATMENT
surgical	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
.	.	O

he	PRP	O
had	VBD	O
a	DT	B-TEST
cardiac	JJ	I-TEST
catheterization	NN	I-TEST
on	IN	O
december	NN	O
1	CD	O
,	,	O
1995	CD	O
that	WDT	O
showed	VBD	O
no	DT	O
complications	NNS	B-PROBLEM
,	,	O
elevated	VBD	B-PROBLEM
right	JJ	I-PROBLEM
atrial	JJ	I-PROBLEM
pressure	NN	I-PROBLEM
and	CC	O
moderate	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
hypertension	NN	I-PROBLEM
.	.	O

the	DT	B-TEST
cardiac	JJ	I-TEST
output	NN	I-TEST
was	VBD	O
five	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
with	IN	O
an	DT	B-TEST
index	NN	I-TEST
at	IN	O
2.9	CD	O
liters	NNS	O
per	IN	O
minute	NN	O
per	IN	O
meter	NN	O
2	CD	O
which	WDT	O
is	VBZ	O
normal	JJ	O
.	.	O

the	DT	O
patient	NN	O
also	RB	O
underwent	JJ	O
cardiac	JJ	B-TEST
ultrasound	NN	I-TEST
on	IN	O
december	NN	O
11	CD	O
,	,	O
1995	CD	O
that	WDT	O
showed	VBD	O
abnormal	JJ	B-PROBLEM
right	JJ	I-PROBLEM
ventricle	NN	I-PROBLEM
wall	NN	I-PROBLEM
motion	NN	I-PROBLEM
,	,	O
trace	NN	B-PROBLEM
mitral	JJ	I-PROBLEM
regurgitation	NN	I-PROBLEM
,	,	O
normal	JJ	O
left	VBD	O
ventricular	JJ	O
size	NN	O
and	CC	O
function	NN	O
with	IN	O
an	DT	B-TEST
estimated	VBN	I-TEST
ejection	NN	I-TEST
fraction	NN	I-TEST
of	IN	O
64%	CD	O
.	.	O

there	EX	O
is	VBZ	O
doppler	JJ	B-TEST
evidence	NN	O
of	IN	O
tricuspid	JJ	B-PROBLEM
insufficiency	NN	I-PROBLEM
and	CC	O
right	JJ	B-PROBLEM
atrial	JJ	I-PROBLEM
dilatation	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
trace	JJ	B-PROBLEM
pulmonary	JJ	I-PROBLEM
insufficiency	NN	I-PROBLEM
.	.	O

the	DT	O
right	JJ	O
ventricle	NN	O
is	VBZ	O
dilated	VBN	B-PROBLEM
and	CC	O
diffusely	RB	B-PROBLEM
hypokinetic	JJ	I-PROBLEM
and	CC	O
there	EX	O
is	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
constrictive	JJ	B-PROBLEM
physiology	NN	I-PROBLEM
which	WDT	O
was	VBD	O
seen	VBN	O
on	IN	O
december	NN	O
6	CD	O
,	,	O
1995	CD	O
.	.	O

a	DT	O
copy	NN	O
of	IN	O
this	DT	B-TEST
ultrasound	NN	I-TEST
is	VBZ	O
also	RB	O
found	VBN	O
in	IN	O
his	PRP$	O
records	NNS	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
no	DT	O
specific	JJ	B-TREATMENT
medications	NNS	I-TREATMENT
for	IN	O
his	PRP$	B-PROBLEM
cardiac	JJ	I-PROBLEM
condition	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
status	NN	O
post	NN	O
thoracotomy	NN	B-TREATMENT
and	CC	O
has	VBZ	O
staples	NNS	B-TREATMENT
and	CC	O
sutures	NNS	B-TREATMENT
on	IN	I-TREATMENT
his	PRP$	I-TREATMENT
chest	NN	I-TREATMENT
.	.	O

these	DT	O
may	MD	O
be	VB	O
removed	VBN	O
when	WRB	O
the	DT	B-PROBLEM
incisions	NNS	I-PROBLEM
are	VBP	O
noted	VBN	O
to	TO	O
be	VB	O
well	RB	O
healed	VBN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
approximately	RB	O
three	CD	O
weeks	NNS	O
following	VBG	O
his	PRP$	B-TREATMENT
procedure	NN	I-TREATMENT
and	CC	O
several	JJ	O
of	IN	O
these	DT	B-TREATMENT
stitches	NNS	I-TREATMENT
will	MD	O
be	VB	O
removed	VBN	O
prior	RB	O
to	TO	O
discharge	VB	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
on	IN	O
oxygen	NN	B-TREATMENT
by	IN	O
face	NN	B-TREATMENT
mask	NN	I-TREATMENT
and	CC	O
his	PRP$	B-TEST
saturations	NNS	I-TEST
have	VBP	O
been	VBN	O
remaining	VBG	O
normal	JJ	O
.	.	O

his	PRP$	B-TREATMENT
medications	NNS	I-TREATMENT
for	IN	O
his	PRP$	O
respiratory	NN	O
system	NN	O
are	VBP	O
albuterol	JJ	B-TREATMENT
nebulizer	JJ	I-TREATMENT
0.5	CD	O
mg.	NN	O
2.5	CD	O
cc.	NN	O
q4hours	NNS	O
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
had	VBN	O
gastric	JJ	B-TREATMENT
ulcer	JJ	I-TREATMENT
repair	NN	I-TREATMENT
and	CC	O
also	RB	O
has	VBZ	O
a	DT	B-TREATMENT
colostomy	NN	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-PROBLEM
sinus	NN	I-PROBLEM
tract	NN	I-PROBLEM
that	WDT	O
was	VBD	O
studied	VBN	O
with	IN	O
a	DT	B-TEST
fistulogram	NN	I-TEST
on	IN	O
december	NN	O
25	CD	O
,	,	O
1995	CD	O
.	.	O

this	DT	O
showed	VBD	O
no	DT	O
communication	NN	B-PROBLEM
with	IN	I-PROBLEM
the	DT	I-PROBLEM
intestines	NNS	I-PROBLEM
and	CC	O
was	VBD	O
simply	RB	O
a	DT	B-PROBLEM
sinus	NN	I-PROBLEM
tract	NN	I-PROBLEM
.	.	O

there	EX	O
is	VBZ	O
no	DT	O
fistula	NN	B-PROBLEM
seen	VBN	O
.	.	O

dr.	NN	O
asha	NN	O
vengloan	NN	O
of	IN	O
general	JJ	O
surgery	NN	O
consulted	VBN	O
on	IN	O
the	DT	O
patient	NN	O
and	CC	O
concluded	VBD	O
the	DT	O
patient	NN	O
does	VBZ	O
not	RB	O
require	VB	O
any	DT	B-TREATMENT
surgical	JJ	I-TREATMENT
treatment	NN	I-TREATMENT
of	IN	O
this	DT	B-PROBLEM
problem	NN	I-PROBLEM
at	IN	O
the	DT	O
current	JJ	O
time	NN	O
and	CC	O
the	DT	B-TREATMENT
best	JJS	I-TREATMENT
treatment	NN	I-TREATMENT
for	IN	O
this	DT	O
situation	NN	O
would	MD	O
be	VB	O
to	TO	O
increase	VB	O
the	DT	O
patient	JJ	O
&apos;s	JJ	O
nutrition	NN	O
.	.	O

he	PRP	O
just	RB	O
claims	NNS	O
to	TO	O
have	VB	O
no	DT	B-PROBLEM
appetite	NN	I-PROBLEM
and	CC	O
has	VBZ	O
very	RB	B-PROBLEM
poor	JJ	I-PROBLEM
effort	NN	I-PROBLEM
with	IN	O
feeding	NN	O
.	.	O

the	DT	O
patient	NN	O
is	VBZ	O
able	JJ	O
to	TO	O
tolerate	VB	O
po.	JJ	B-TREATMENT
medicines	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
an	DT	B-PROBLEM
ulcer	NN	I-PROBLEM
on	IN	I-PROBLEM
his	PRP$	I-PROBLEM
penis	NN	I-PROBLEM
that	WDT	O
has	VBZ	O
been	VBN	O
treated	VBN	O
with	IN	O
dressing	NN	B-TREATMENT
changes	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
a	DT	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
in	IN	O
and	CC	O
when	WRB	O
the	DT	O
penile	NN	O
skin	NN	O
is	VBZ	O
very	RB	O
well	RB	O
healed	VBN	O
his	PRP$	B-TREATMENT
foley	NN	I-TREATMENT
catheter	NN	I-TREATMENT
may	MD	O
be	VB	O
removed	VBN	O
.	.	O

until	IN	O
this	DT	O
time	NN	O
he	PRP	O
should	MD	O
be	VB	O
kept	VBN	O
on	IN	O
three	CD	O
times	NNS	O
daily	RB	O
wet	VBP	B-TREATMENT
to	TO	I-TREATMENT
dry	VB	I-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
.	.	O

the	DT	O
patient	NN	O
has	VBZ	O
multiple	JJ	B-PROBLEM
decubiti	NN	I-PROBLEM
over	IN	O
his	PRP$	O
body	NN	O
,	,	O
in	IN	O
particular	JJ	O
his	PRP$	O
perineum	NN	O
and	CC	O
buttocks	NNS	O
have	VBP	O
large	JJ	B-PROBLEM
decubiti	NN	I-PROBLEM
.	.	O

these	DT	B-PROBLEM
wounds	NNS	I-PROBLEM
should	MD	O
be	VB	O
treated	VBN	O
with	IN	O
three	CD	O
times	NNS	O
daily	RB	O
wet	VBP	B-TREATMENT
to	TO	I-TREATMENT
dry	VB	I-TREATMENT
dressings	NNS	I-TREATMENT
.	.	O

the	DT	B-TEST
patient	NN	I-TEST
&apos;s	NNP	I-TEST
white	JJ	I-TEST
count	NN	I-TEST
at	IN	O
the	DT	O
time	NN	O
of	IN	O
discharge	NN	O
is	VBZ	O
within	IN	O
normal	JJ	O
limits	NNS	O
.	.	O

the	DT	O
patient	NN	O
remains	VBZ	O
on	IN	O
fluconazole	NN	B-TREATMENT
.	.	O

his	PRP$	B-TREATMENT
other	JJ	I-TREATMENT
antibiotics	NNS	I-TREATMENT
were	VBD	O
discontinued	VBN	O
.	.	O

his	PRP$	B-TEST
most	RBS	I-TEST
recent	JJ	I-TEST
cultures	NNS	I-TEST
are	VBP	O
negative	JJ	O
.	.	O

the	DT	B-TEST
chest	JJS	I-TEST
x-ray	JJ	I-TEST
shows	VBZ	O
no	DT	O
evidence	NN	O
of	IN	O
pneumonia	NN	B-PROBLEM
.	.	O

7.	CD	O
pain	NN	B-PROBLEM
.	.	O

he	PRP	O
has	VBZ	O
been	VBN	O
placed	VBN	O
on	IN	O
oxycodone	NN	B-TREATMENT
10	CD	O
mg.	NN	O
po.	NN	O
q3hours	NNS	O
as	IN	O
needed	VBN	O
for	IN	O
pain	NN	B-PROBLEM
.	.	O

the	DT	O
patient	NN	O
had	VBD	O
a	DT	B-TREATMENT
pca	NN	I-TREATMENT
and	CC	O
several	JJ	B-TREATMENT
other	JJ	I-TREATMENT
medications	NNS	I-TREATMENT
have	VBP	O
been	VBN	O
discontinued	VBN	O
.	.	O

the	DT	O
patient	NN	O
for	IN	O
sleep	NN	O
was	VBD	O
given	VBN	O
benadryl	RB	B-TREATMENT
25	CD	O
to	TO	O
50	CD	O
mg.	NNS	O
qhs.	NN	O
and	CC	O
was	VBD	O
not	RB	O
allowed	VBN	O
any	DT	O
increases	NNS	O
in	IN	O
his	PRP$	B-TREATMENT
narcotics	NNS	I-TREATMENT
after	IN	O
weaning	VBG	O
him	PRP	O
down	RP	O
to	TO	O
just	RB	O
requiring	VBG	O
the	DT	B-TREATMENT
oxycodone	NN	I-TREATMENT
.	.	O

a	DT	O
complete	JJ	O
summary	NN	O
of	IN	O
the	DT	B-TREATMENT
patient	NN	I-TREATMENT
&apos;s	NN	I-TREATMENT
medications	NNS	I-TREATMENT
are	VBP	O
as	IN	O
follows	VBZ	O
:	:	O

cimetidine	NN	B-TREATMENT
300	CD	O
mg.	NN	O
intravenous	JJ	O
q6hours	NNS	O
.	.	O

albuterol	NN	B-TREATMENT
nebulizer	VBZ	I-TREATMENT
0.5	CD	O
mg.	NN	O
2.5	CD	O
cc.	NN	O
q4hours	NNS	O
.	.	O

senokot	NN	B-TREATMENT
two	CD	O
tablets	NNS	O
po.	VBP	O
bid	NN	O
or	CC	O
metamucil	VB	B-TREATMENT
one	CD	O
tablespoon	NN	O
po.	NN	O
bid	NN	O
.	.	O

nortriptyline	JJ	B-TREATMENT
25	CD	O
mg.	NN	O
po.	NN	O
qhs	NN	O
.	.	O

kcl	VB	B-TREATMENT
40	CD	O
meq.	JJ	O
po.	NN	O
bid	NN	O
.	.	O

saline	NN	B-TREATMENT
wet	NN	I-TREATMENT
to	TO	I-TREATMENT
dry	VB	I-TREATMENT
dressing	NN	I-TREATMENT
changes	NNS	I-TREATMENT
three	CD	O
times	NNS	O
daily	RB	O
to	TO	O
penis	VB	B-PROBLEM
and	CC	I-PROBLEM
pelvis	VB	I-PROBLEM
decubiti	NN	I-PROBLEM
,	,	O
40%	CD	B-TREATMENT
humidified	VBD	I-TREATMENT
oxygen	NN	I-TREATMENT
,	,	O
fluconazole	JJ	B-TREATMENT
200	CD	O
mg.	JJ	O
po.	NN	O
bid	NN	O
.	.	O

lasix	RB	B-TREATMENT
2.5	CD	O
mg.	NNS	O
intravenous	JJ	O
qid	NNS	O
.	.	O

prilosec	NN	B-TREATMENT
20	CD	O
mg.	NN	O
po.	NN	O
qd	NN	O
.	.	O

benadryl	RB	B-TREATMENT
25	CD	O
to	TO	O
50	CD	O
mg.	NNS	O
po.	JJ	O
qhs	JJ	O
prn	NN	O
.	.	O

oxycodone	RB	B-TREATMENT
10	CD	O
mg.	NNS	O
po.	JJ	O
q3	JJ	O
hours	NNS	O
prn	NN	O
.	.	O

the	DT	O
patient	NN	O
was	VBD	O
seen	VBN	O
at	IN	O
ph	JJ	O
university	NN	O
of	IN	O
medical	JJ	O
center	NN	O
for	IN	O
problem	NN	O
regarding	VBG	O
his	PRP$	B-PROBLEM
constrictive	JJ	I-PROBLEM
pericarditis	NN	I-PROBLEM
and	CC	O
underwent	NN	O
a	DT	B-TREATMENT
surgical	JJ	I-TREATMENT
procedure	NN	I-TREATMENT
to	TO	O
correct	VB	O
this	DT	O
.	.	O

followup	JJ	B-TEST
cardiac	JJ	I-TEST
studies	NNS	I-TEST
showed	VBD	O
there	EX	O
was	VBD	O
a	DT	O
resolution	NN	O
of	IN	O
his	PRP$	B-PROBLEM
constrictive	JJ	I-PROBLEM
pericarditis	NN	I-PROBLEM
.	.	O

the	DT	O
patient	NN	O
also	RB	O
had	VBD	O
a	DT	B-PROBLEM
gastric	JJ	I-PROBLEM
ulcer	NN	I-PROBLEM
repaired	VBN	O
at	IN	O
the	DT	O
same	JJ	O
time	NN	O
.	.	O

